PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wijnen, J; Khan, PM; Vasen, H; Menko, F; vanderKlift, H; vandenBroek, M; vanLeeuwenCornelisse, I; Nagengast, F; MeijersHeijboer, EJ; Lindhout, D; Griffioen, G; Cats, A; Kleibeuker, J; Varesco, L; Bertario, L; Bisgaard, ML; Mohr, J; Kolodner, R; Fodde, R				Wijnen, J; Khan, PM; Vasen, H; Menko, F; vanderKlift, H; vandenBroek, M; vanLeeuwenCornelisse, I; Nagengast, F; MeijersHeijboer, EJ; Lindhout, D; Griffioen, G; Cats, A; Kleibeuker, J; Varesco, L; Bertario, L; Bisgaard, ML; Mohr, J; Kolodner, R; Fodde, R			Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SINGLE-BASE CHANGES; GENETIC INSTABILITY; COLON-CANCER; POLYPOSIS; SPECTRUM; HOMOLOG	Hereditary nonpolyposis colorectal cancer (HNPCC) is a common autosomal dominant cancer susceptibility condition. Inherited mutations in at least four DNA mismatch repair genes, hMSH2, hMLH1, hPMS1, and hPMS2, are known to cause HNPCC. In this study we used denaturing gradient gel electrophoresis (DGGE) to screen for hMLH1 mutations in 34 unrelated HNPCC families (30 Dutch, 3 Italian, and 1 Danish). Ten novel pathogenic germ-line mutations (seven affecting splice sites, two frameshifts, and one in-frame deletion of a single amino acid) have been identified in 12 (35%) of these families. In a previous study, hMSH2 mutations were found in 21% of the same families. While the spectrum of mutations at the hMSH2 gene among HNPCC patients appears heterogeneous, a cluster of hMLH1 mutations has been found in the region encompassing exons 15 and 16, which accounts for 50% of all the independent hMLH1 mutations described to date and for >20% of the unrelated HNPCC kindreds here analyzed. This unexpected finding has a great practical value in the clinical scenario of genetic services.	LEIDEN UNIV,SYLVIUS LAB,CTR MED GENET,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; LEIDEN UNIV,MED CTR,FDN DETECT HEREDITARY TUMORS,LEIDEN,NETHERLANDS; LEIDEN UNIV,MED CTR,DEPT GASTROENTEROL,LEIDEN,NETHERLANDS; FREE UNIV AMSTERDAM HOSP,DEPT CLIN GENET,AMSTERDAM,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT GASTROENTEROL,6500 HB NIJMEGEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; UNIV GRONINGEN HOSP,DEPT GASTROENTEROL,GRONINGEN,NETHERLANDS; IST NAZL RIC CANC,I-16132 GENOA,ITALY; UNIV MILAN,REGISTRO ITALIANO POLIPOSI FAMILIARI,MILAN,ITALY; UNIV COPENHAGEN,PANUM INST,INST MED BIOCHEM & GENET,DK-2200 COPENHAGEN,DENMARK; HVIDOVRE UNIV HOSP,DANISH HNPCC REGISTRY,HVIDOVRE,DENMARK; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CELLULAR & MOLEC BIOL,BOSTON,MA 02115	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; Erasmus University Rotterdam; University of Groningen; University of Genoa; IRCCS AOU San Martino IST; University of Milan; University of Copenhagen; University of Copenhagen; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School			Varesco, Liliana/AAF-6521-2019; Fodde, Riccardo/AAW-9394-2021; Lindhout, Dick/AAH-5765-2019	Varesco, Liliana/0000-0003-4871-6668; Fodde, Riccardo/0000-0001-9839-4324; Bertario, Lucio/0000-0001-5653-1431; Vasen, Hans/0000-0003-2682-2603; Lindhout, Dick/0000-0001-9580-624X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50006] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BURKS RT, 1994, ONCOGENE, V9, P1163; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FODDE R, 1992, GENOMICS, V13, P1162, DOI 10.1016/0888-7543(92)90032-N; FODDE R, 1994, HUM MUTAT, V3, P83, DOI 10.1002/humu.1380030202; FROGGATT NJ, 1995, LANCET, V345, P727, DOI 10.1016/S0140-6736(95)90900-1; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; HAN HJ, 1993, CANCER RES, V53, P5087; HAN HJ, 1995, HUM MOL GENET, V4, P237; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; KOLODNER RD, 1995, CANCER RES, V55, P242; KRAWCZAK M, 1992, HUM GENET, V90, P41; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; LIU B, 1994, CANCER RES, V54, P4590; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; RISINGER JI, 1993, CANCER RES, V53, P5100; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WATSON P, 1993, CANCER, V71, P677, DOI 10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIJNEN J, 1995, AM J HUM GENET, V56, P1060; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152	34	112	119	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					300	307						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571956				2022-12-18	WOS:A1996TR79100006
J	FISHER, JM; HARVEY, JF; MORTON, NE; JACOBS, PA				FISHER, JM; HARVEY, JF; MORTON, NE; JACOBS, PA			TRISOMY-18 - STUDIES OF THE PARENT AND CELL-DIVISION OF ORIGIN AND THE EFFECT OF ABERRANT RECOMBINATION ON NONDISJUNCTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-LINKAGE MAP; EXTRA CHROMOSOME; REDUCED RECOMBINATION; DNA POLYMORPHISMS; HUMAN GENOME; POLYMERASE	We have studied the mechanism of origin of 63 cases of trisomy 18. In 2 the additional chromosome was paternal in origin, and in the remaining 61 it was maternal in origin. Both paternal cases were attributable to a postzygotic mitotic (PZM) error. Among the 54 maternal cases for which the cell division of error was established, only 16 were attributable to an error at the first meiotic division (mat MI), whereas no fewer than 35 were due to an error at the second meiotic division (mat MII), the remaining 3 being the result of a PZM error involving the maternal chromosome 18. A standard map of chromosome 18 was constructed and compared with the nondisjunctional map, Approximately one-third of the mat MI errors were associated with complete absence of recombination, whereas in the remaining two-thirds and in all the mat MII errors recombination in the nondisjoined chromosomes appeared to be normal. Ah the maternal errors were associated with an increased maternal age, although this reached significance only for the mat MII category of nondisjunction. Our observations on chromosome 18 are compared with those on other chromosomes for which there are comparable data.	SALISBURY DIST HOSP, WESSEX REG GENET LAB, SALISBURY SP2 8BJ, WILTS, ENGLAND; PRINCESS ANNE HOSP, CRC, EPIDEMIOL RES GRP, SOUTHAMPTON, HANTS, ENGLAND	Salisbury District Hospital								ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; BERRETTINI WH, IN PRESS ARCH GEN PS; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; BUGGE M, 1994, CYTOGENET CELL GENET, V65, P163; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; FISHER JM, 1993, AM J HUM GENET, V52, P1139; GREEN P, 1988, DOCUMENTATION CRI MA; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD T, 1987, J MED GENET, V24, P725, DOI 10.1136/jmg.24.12.725; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hook EB, 1977, POPULATION CYTOGENET, P63; HUGHES AE, 1994, HUM MOL GENET, V3, P359, DOI 10.1093/hmg/3.2.359; KUPKE KG, 1989, AM J HUM GENET, V45, P599; LEBEAU MM, 1993, CYTOGENET CELL GENET, V63, P77, DOI 10.1159/000133508; MACDONALD M, 1994, HUM MOL GENET, V3, P1365, DOI 10.1093/hmg/3.8.1365; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MORTON NE, 1990, ANN HUM GENET, V54, P235, DOI 10.1111/j.1469-1809.1990.tb00381.x; MORTON NE, 1990, ANN HUM GENET, V54, P39, DOI 10.1111/j.1469-1809.1990.tb00359.x; MORTON NE, 1989, ANN HUM GENET, V53, P263, DOI 10.1111/j.1469-1809.1989.tb01793.x; MORTON NE, 1988, ANN HUM GENET, V52, P85, DOI 10.1111/j.1469-1809.1988.tb01083.x; MORTON NE, 1991, ANN HUM GENET, V55, P235, DOI 10.1111/j.1469-1809.1991.tb00418.x; NOTHEN MM, 1993, HUM GENET, V92, P347, DOI 10.1007/BF01247332; OCONNELL P, 1987, CYTOGENET CELL GENET, V46, P671; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHAHAR S, 1986, HUM GENET, V74, P215; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; VANKESSEL AG, 1994, CYTOGENET CELL GENET, V65, P142; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; XIE YG, 1993, CLIN GENET, V44, P57	37	112	113	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					669	675						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887421				2022-12-18	WOS:A1995QK91800016
J	HAWKINS, JR; TAYLOR, A; GOODFELLOW, PN; MIGEON, CJ; SMITH, KD; BERKOVITZ, GD				HAWKINS, JR; TAYLOR, A; GOODFELLOW, PN; MIGEON, CJ; SMITH, KD; BERKOVITZ, GD			EVIDENCE FOR INCREASED PREVALENCE OF SRY MUTATIONS IN XY FEMALES WITH COMPLETE RATHER THAN PARTIAL GONADAL-DYSGENESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEX-DETERMINING GENE; HUMAN Y-CHROMOSOME; HUMAN DNA; REVERSAL; MICE; DIFFERENTIATION; POLYMORPHISM; FRAGMENT	The Y chromosome gene SRY (sex-determining region, Y gene) has been equated with the mammalian testis-determining factor. The SRY gene of five subjects with 46,XY complete gonadal dysgenesis (46,XY karyotype, completely female external genitalia, normal Mullerian ducts, and streak gonads) was evaluated for possible mutations in the coding region by using both single-strand conformation polymorphism (SSCP) assay and DNA sequencing. Mutations were identified in three subjects, of which two gave altered SSCP patterns. Two of them were point mutations causing amino acid substitutions, and the third was a single-base deletion causing a frameshift. All three mutations caused alterations in the putative DNA-binding region of the SRY protein. Genomic DNA was obtained from the fathers of two of the three mutant patients: one mutation was demonstrated to be de novo, and the other was inherited. The presence of SRY mutations in three of five patients suggests that the frequency of SRY mutations in XY females is higher than current estimates.	IMPERIAL CANC RES FUND,HUMAN MOLEC GENET LAB,LONDON WC2A 3PX,ENGLAND; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205	Cancer Research UK; Johns Hopkins University; Johns Hopkins University			Hawkins, Ross/M-7702-2014		NIDDK NIH HHS [R01-DK-00180] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK000180] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERKOVITZ GD, 1991, MEDICINE, V70, P375, DOI 10.1097/00005792-199111000-00003; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; EICHER EM, 1983, J EXP ZOOL, V228, P297, DOI 10.1002/jez.1402280213; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; ELLIS N, 1990, NATURE, V344, P663, DOI 10.1038/344663a0; FORD CE, 1959, LANCET, V1, P711; GOODFELLOW PJ, 1989, ANN HUM GENET, V53, P15, DOI 10.1111/j.1469-1809.1989.tb01118.x; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; JAKUBICZKA S, 1989, HUM GENET, V84, P86, DOI 10.1007/BF00210680; Jost A., 1973, Recent Progress Hormone Res, V29, P1; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; MALASPINA P, 1990, ANN HUM GENET, V54, P297, DOI 10.1111/j.1469-1809.1990.tb00385.x; OGATA T, 1992, J MED GENET, V29, P226, DOI 10.1136/jmg.29.4.226; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PALMER SJ, 1991, DEVELOPMENT, V113, P709; Sambrook J., 1989, MOL CLONING LAB MANU; SINCLAIR AH, 1990, NATURE, V346, P204; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x	25	112	116	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					979	984						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415266				2022-12-18	WOS:A1992JU84000007
J	POTTER, H				POTTER, H			REVIEW AND HYPOTHESIS - ALZHEIMER-DISEASE AND DOWN-SYNDROME CHROMOSOME-21 NONDISJUNCTION MAY UNDERLIE BOTH DISORDERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PREMATURE CENTROMERE DIVISION; BRAIN AMYLOID DEPOSITS; HEREDITARY CEREBRAL-HEMORRHAGE; PRECURSOR MESSENGER-RNAS; BETA-PROTEIN GENE; PRESENILE-DEMENTIA; DOWNS-SYNDROME; INSITU HYBRIDIZATION; MOSAIC TRISOMY-21; SYNDROME CHILD				POTTER, H (corresponding author), HARVARD UNIV, SCH MED, DEPT NEUROBIOL, 220 LONGWOOD AVE, BOSTON, MA 02115 USA.							ABRAHAM CR, 1989, NEUROSCIENCE, V32, P715, DOI 10.1016/0306-4522(89)90292-3; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; ABRAHAM CR, 1989, BIO-TECHNOL, V7, P147, DOI 10.1038/nbt0289-147; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; AULT B, 1990, Society for Neuroscience Abstracts, V16, P1347; BERG JM, 1959, LANCET, V2, P441; BUCKTON KE, 1983, J MED GENET, V20, P46, DOI 10.1136/jmg.20.1.46; CASTANO EM, 1988, LAB INVEST, V58, P122; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FELDMAN RG, 1963, NEUROLOGY, V13, P811, DOI 10.1212/WNL.13.10.811; FITZGERALD PH, 1975, ANN HUM GENET, V38, P417, DOI 10.1111/j.1469-1809.1975.tb00631.x; FITZGERALD PH, 1986, HUM GENET, V72, P58, DOI 10.1007/BF00278818; FORD CE, 1981, TRISOMY, V21, P103; FUSCOE JC, 1989, GENOMICS, V5, P100, DOI 10.1016/0888-7543(89)90092-X; GANROT PO, 1986, ENVIRON HEALTH PERSP, V65, P363, DOI 10.2307/3430204; GAUDET A, 1987, MOL CELL BIOL, V7, P68, DOI 10.1128/MCB.7.1.68; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE AM, 1989, LANCET, V1, P352; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HARDY J, 1989, LANCET, V2, P743; HARRIS WS, 1968, NEW ENGL J MED, V279, P407, DOI 10.1056/NEJM196808222790805; HESTON LL, 1981, ARCH GEN PSYCHIAT, V38, P1085; HESTON LL, 1977, ARCH GEN PSYCHIAT, V34, P976; HEYMAN A, 1983, ANN NEUROL, V14, P507, DOI 10.1002/ana.410140503; HIGGINS GA, 1988, P NATL ACAD SCI USA, V85, P1297, DOI 10.1073/pnas.85.4.1297; HOLTZMAN D M, 1990, Society for Neuroscience Abstracts, V16, P1138; Jabs E W, 1989, Prog Clin Biol Res, V318, P111; JARVIK LF, 1974, ARCH GEN PSYCHIAT, V30, P186; JARVIK LF, 1986, BIOL SUBSTRATES ALZH, P17; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664; MADAN K, 1987, HUM GENET, V77, P193, DOI 10.1007/BF00272391; MARTYN CN, 1989, LANCET, V1, P59; MATSUYAMA SS, 1989, P NATL ACAD SCI USA, V86, P8152, DOI 10.1073/pnas.86.20.8152; MOORHEAD PS, 1983, AM J MED GENET, V14, P545, DOI 10.1002/ajmg.1320140319; MULLERHILL B, 1989, ANNU REV BIOCHEM, V58, P287; MURRAY AW, 1985, ANNU REV CELL BIOL, V1, P289, DOI 10.1146/annurev.cellbio.1.1.289; NEE LE, 1987, NEUROLOGY, V37, P359, DOI 10.1212/WNL.37.3.359; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; NEVE RL, IN PRESS MOL GENETIC; NORDENSON I, 1980, LANCET, V1, P481; OLSON MI, 1969, BRAIN, V92, P147, DOI 10.1093/brain/92.1.147; PAGON RA, 1979, AM J HUM GENET, V31, P54; PALEKAR LD, 1987, CARCINOGENESIS, V8, P553, DOI 10.1093/carcin/8.4.553; PALMERT MR, 1988, SCIENCE, V241, P1080, DOI 10.1126/science.2457949; PASTERNACK JM, 1989, AM J PATHOL, V135, P827; PERCY ME, IN PRESS AM J MED GE; PRICE DL, 1986, ANNU REV NEUROSCI, V9, P489; RABIN M, 1986, SOMAT CELL MOLEC GEN, V12, P209, DOI 10.1007/BF01560668; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; RICHARDS SJ, 1991, EMBO J, V10, P297, DOI 10.1002/j.1460-2075.1991.tb07950.x; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROMKE C, 1987, CLIN GENET, V31, P170; Roses A D, 1990, Adv Neurol, V51, P185; ROWE IF, 1989, LANCET, V2, P229; SACKS B, 1989, J NEUROL NEUROSUR PS, V52, P1294, DOI 10.1136/jnnp.52.11.1294; SCHAPIRO M B, 1989, Neurology, V39, P169; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHWEBER M, 1985, ANN NY ACAD SCI, V450, P223, DOI 10.1111/j.1749-6632.1985.tb21495.x; SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P463, DOI 10.1146/annurev.ne.12.030189.002335; SELKOE DJ, 1989, NEUROBIOL AGING, V10, P387, DOI 10.1016/0197-4580(89)90072-9; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; TALAMO BR, 1989, NATURE, V337, P736, DOI 10.1038/337736a0; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TERRY RD, 1978, AGING-US, V7, P11; UCHIDA IA, 1975, AM J HUM GENET, V27, P419; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; WARD BE, 1979, AM J MED GENET, V3, P137, DOI 10.1002/ajmg.1320030204; WEITKAMP LR, 1983, AM J HUM GENET, V35, P443; WHALLEY LJ, 1982, BRIT J PSYCHIAT, V140, P249, DOI 10.1192/bjp.140.3.249; WHITE BJ, 1981, AM J MED GENET, V10, P77, DOI 10.1002/ajmg.1320100110; WISNIEWSKI HM, 1988, BANBURY REPORT, P399; WISNIEWSKI HM, 1973, PROGR BRAIN RES, V40, P1108	83	112	117	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1192	1200						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	1827946				2022-12-18	WOS:A1991FP09200024
J	KANG, SS; WONG, PWK; BOCK, HGO; HORWITZ, A; GRIX, A				KANG, SS; WONG, PWK; BOCK, HGO; HORWITZ, A; GRIX, A			INTERMEDIATE HYPERHOMOCYSTEINEMIA RESULTING FROM COMPOUND HETEROZYGOSITY OF METHYLENETETRAHYDROFOLATE REDUCTASE MUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; RISK FACTOR; HOMOCYSTINURIA; HOMOCYSTEINEMIA; DEFICIENCY; FOLATE; PLASMA	Four subjects with thermolabile methylenetetrahydrofolate reductase (MTHFR) were discovered among 16 "obligate" heterozygotes for severe MTHFR deficiency and their family members. All four subjects had less than 25% of normal mean MTHFR specific activity in lymphocyte extracts. Three of them with normal serum folate and cyanocobalamin had intermediate hyperhomocysteinemia, and one with high serum folate and cyanocobalamin had no excessive accumulation of serum homocysteine. The biochemical features in these four subjects are distinguishable from subjects homozygous for the thermolabile MTHFR, whose specific activity is approximately 50% of the normal mean, and from heterozygotes for severe MTHFR deficiency, in whom the enzyme is thermostable and has a specific activity of about 50% of the normal mean. We propose that these four subjects are genetic compounds of the allele for the severe mutation and the allele for thermolabile mutation of the MTHFR gene. It is postulated that subjects with this genetic compound are more susceptible to the development of intermediate hyperhomocysteinemia despite normal folate and B-12 levels. Nonetheless, hyperhomocysteinemia due to this compound heterozygosity is correctable by oral folic acid therapy.	RUSH MED COLL,DEPT PEDIAT,CHICAGO,IL 60612; UNIV CHICAGO,SCH MED,DEPT PEDIAT,CHICAGO,IL 60637; UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT PREVENT MED,JACKSON,MS 39216; UNIV CALIF DAVIS,SCH MED,DEPT PEDIAT,DAVIS,CA 95616	Rush University; University of Chicago; University of Mississippi; University of Mississippi Medical Center; University of California System; University of California Davis	KANG, SS (corresponding author), RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT PEDIAT,1753 W CONGRESS PKWY,CHICAGO,IL 60612, USA.				NCRR NIH HHS [M01-RR02303] Funding Source: Medline; NHLBI NIH HHS [HL 36135] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002303] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036135] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		DUNN RT, 1973, CLIN CHEM, V19, P1101; ERBE RW, 1986, FOLATE PTERINE, V3, P413; HERBERT V, 1966, BLOOD-J HEMATOL, V28, P130; JONDAL M, 1972, J EXP MED, V136, P207, DOI 10.1084/jem.136.2.207; KANG SS, 1979, PEDIATR RES, V13, P1141, DOI 10.1203/00006450-197910000-00012; KANG SS, 1988, METABOLISM, V37, P611, DOI 10.1016/0026-0495(88)90076-5; KANG SS, 1988, AM J HUM GENET, V43, P414; KANG SS, 1991, AM J HUM GENET, V48, P536; KANG SS, 1986, J CLIN INVEST, V77, P1482, DOI 10.1172/JCI112461; KANG SS, 1987, METABOLISM, V36, P458, DOI 10.1016/0026-0495(87)90043-6; MCGILL JJ, 1990, AM J MED GENET, V36, P45, DOI 10.1002/ajmg.1320360111; MUDD SH, 1972, BIOCHEM BIOPH RES CO, V46, P905; Mudd Sh, 1989, METABOLIC BASIS INHE, V1, P693; MURPHYCHUTORIAN DR, 1985, J AM COLL CARDIOL, V6, P725, DOI 10.1016/S0735-1097(85)80473-3; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; SARDHARWALLA IB, 1974, ARCH DIS CHILD, V49, P553, DOI 10.1136/adc.49.7.553; UELAND PM, 1989, J LAB CLIN MED, V114, P473; WILCKEN DEL, 1983, METABOLISM, V32, P363, DOI 10.1016/0026-0495(83)90045-8; WONG PWK, 1977, PEDIATRICS, V59, P749; WONG PWK, 1977, J LAB CLIN MED, V90, P283	20	112	120	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					546	551						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998340				2022-12-18	WOS:A1991FK47000015
J	MAJUMDER, PP; STJEAN, PL; FERRELL, RE; WEBSTER, MW; STEED, DL				MAJUMDER, PP; STJEAN, PL; FERRELL, RE; WEBSTER, MW; STEED, DL			ON THE INHERITANCE OF ABDOMINAL AORTIC-ANEURYSM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; MORTALITY; RELATIVES; HISTORY	To determine the mode of inheritance of abdominal aortic aneurysm, data on first-degree relatives of 91 probands were collected. Results of segregation analysis performed on these data are reported. Many models, including nongenetic and genetic models, were compared using likelihood methods. The non-genetic model was rejected; statistically significant evidence in favor of a genetic model was found. Among the many genetic models compared, the most parsimonious genetic model was that susceptibility to abdominal aortic aneurysm is determined by a recessive gene at an autosomal diallelic major locus. A multifactorial component in addition to the major locus does not increase the likelihood of the data significantly.	UNIV PITTSBURGH, PITTSBURGH, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	MAJUMDER, PP (corresponding author), INDIAN STAT INST, DIV APPL STAT, 203 BARRACKPORE TRUNK RD, Kolkata 700035, W BENGAL, INDIA.							ALLEN PIM, 1987, LANCET, V2, P736; AUERBACH O, 1980, CHEST, V78, P805, DOI 10.1378/chest.78.6.805; BICKERSTAFF LK, 1984, J VASC SURG, V1, P6, DOI 10.1067/mva.1984.avs0010006; BORKETTJONES HJ, 1988, J ROY SOC MED, V81, P471, DOI 10.1177/014107688808100819; BOWERS D, 1985, J ROY SOC MED, V78, P812, DOI 10.1177/014107688507801005; BUSUTTIL RW, 1980, ARCH SURG-CHICAGO, V115, P1373; BUSUTTIL RW, 1982, ANEURYSMS DIAGNOSIS, P83; CAMPBELL WB, 1986, ANN ROY COLL SURG, V68, P275; CANNON DJ, 1982, ANN THORAC SURG, V34, P10, DOI 10.1016/S0003-4975(10)60845-4; CLIFTON MA, 1977, BRIT J SURG, V64, P765, DOI 10.1002/bjs.1800641102; COHEN JR, 1988, J VASC SURG, V7, P210; COHEN JR, 1987, SURG GYNECOL OBSTET, V164, P355; COLE CW, 1989, CAN MED ASSOC J, V141, P393; COLE CW, 1989, CAN J SURG, V32, P117; COLLIN J, 1989, BRIT MED J, V299, P493, DOI 10.1136/bmj.299.6697.493; FOWKES FGR, 1989, BRIT MED J, V298, P33, DOI 10.1136/bmj.298.6665.33; GRAEVE AH, 1982, AM J SURG, V144, P627, DOI 10.1016/0002-9610(82)90539-6; INGOLDBY CJH, 1986, BRIT J SURG, V73, P551, DOI 10.1002/bjs.1800730711; JENKINS AM, 1986, BRIT J SURG, V73, P395, DOI 10.1002/bjs.1800730528; JOHANSEN K, 1986, JAMA-J AM MED ASSOC, V256, P1934, DOI 10.1001/jama.256.14.1934; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1980, POINTER COMPUTER PRO; LILIENFELD DE, 1987, ARTERIOSCLEROSIS, V7, P637, DOI 10.1161/01.ATV.7.6.637; LOOSEMORE TM, 1988, J ROY SOC MED, V81, P472, DOI 10.1177/014107688808100820; MELTON LJ, 1984, AM J EPIDEMIOL, V120, P379, DOI 10.1093/oxfordjournals.aje.a113902; MORTON NE, 1974, AM J HUM GENET, V26, P489; NORRGARD O, 1984, SURGERY, V95, P650; OKELLY TJ, 1989, BRIT J SURG, V76, P479, DOI 10.1002/bjs.1800760517; Powell J T, 1987, Eur J Vasc Surg, V1, P29, DOI 10.1016/S0950-821X(87)80020-8; REILLY JM, 1989, SURG CLIN N AM, V69, P705; ROBERTS WC, 1982, ANEURYSMS DIAGNOSIS, P17; SILVERBERG E, 1983, CANCER STATISTICS 19; SOREIDE O, 1982, SURGERY, V91, P188; SPITTELL JA, 1983, J AM COLL CARDIOL, V1, P533, DOI 10.1016/S0735-1097(83)80085-0; STERPETTI AV, 1988, J VASC SURG, V7, P763, DOI 10.1067/mva.1988.avs0070763; SUMNER DS, 1970, SURG GYNECOL OBSTETR, V131, P417; THAYER C, 1984, AM J SURG, V147, P553; TILSON MD, 1984, AM J SURG, V147, P551, DOI 10.1016/0002-9610(84)90020-5; TILSON MD, 1984, SURG GYNECOL OBSTET, V158, P129; TILSON ME, 1988, STATUS RES ABDOMINAL; VICTOR DW, 1985, J K MED ASS, V4, P601; WEBSTER MW, IN PRESS J VASC SURG; WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X; 1987, VITAL STATISTICS U A, V2	45	112	118	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					164	170						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985458				2022-12-18	WOS:A1991ET18800022
J	SCHINDLER, D; HOEHN, H				SCHINDLER, D; HOEHN, H			FANCONI ANEMIA MUTATION CAUSES CELLULAR-SUSCEPTIBILITY TO AMBIENT OXYGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SCHINDLER, D (corresponding author), UNIV WURZBURG,DEPT HUMAN GENET,KOELLIKERSTR 2,D-8700 WURZBURG,FED REP GER.							BACHUR NR, 1982, CANCER RES, V42, P1078; BALIN AK, 1978, J CELL BIOL, V78, P390, DOI 10.1083/jcb.78.2.390; BERGER NA, 1982, NATURE, V299, P271, DOI 10.1038/299271a0; CATHCART R, 1984, P NATL ACAD SCI-BIOL, V81, P5633, DOI 10.1073/pnas.81.18.5633; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; CHAUDHRY AN, 1982, BLOOD, V60, P979; DALLAPICCOLA B, 1985, HUM GENET, V69, P62, DOI 10.1007/BF00295530; DEAN SW, 1983, J CELL SCI, V64, P265; DUTRILLAUX B, 1982, HUM GENET, V62, P327, DOI 10.1007/BF00304549; ELMORE E, 1976, J CELL PHYSIOL, V87, P229, DOI 10.1002/jcp.1040870211; German J., 1983, CHROMOSOME MUTATION, P97; GILLE JJP, 1987, HUM GENET, V77, P28; HIRSCHKAUFFMANN M, 1978, HUM GENET, V45, P25, DOI 10.1007/BF00277570; HOEHN H, IN PRES FANCONI ANEM; JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0; KUBBIES M, 1985, AM J HUM GENET, V37, P1022; LATT SA, 1975, P NATL ACAD SCI USA, V72, P4066, DOI 10.1073/pnas.72.10.4066; NAGASAWA H, 1983, CARCINOGENESIS, V4, P795, DOI 10.1093/carcin/4.7.795; NORDENSON I, 1977, HEREDITAS, V86, P147; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; POOT M, 1986, BIOCHIM BIOPHYS ACTA, V883, P580, DOI 10.1016/0304-4165(86)90300-4; RABINOVITCH PS, 1983, P NATL ACAD SCI-BIOL, V80, P2951, DOI 10.1073/pnas.80.10.2951; REMSEN JF, 1976, P NATL ACAD SCI USA, V73, P2419, DOI 10.1073/pnas.73.7.2419; SASAKI MS, 1973, CANCER RES, V33, P1829; SASAKI MS, 1975, NATURE, V257, P501, DOI 10.1038/257501a0; SUDHARSAN RA, 1980, MUTAT RES, V78, P59; TAYLOR WG, 1974, EXP CELL RES, V86, P152, DOI 10.1016/0014-4827(74)90660-0; TAYLOR WG, 1978, J CELL PHYSIOL, V95, P33, DOI 10.1002/jcp.1040950105; WEKSBERG R, 1979, J CELL PHYSIOL, V101, P311, DOI 10.1002/jcp.1041010211	29	112	114	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1988	43	4					429	435						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q4736	3177386				2022-12-18	WOS:A1988Q473600009
J	BALE, SJ; CHAKRAVARTI, A; GREENE, MH				BALE, SJ; CHAKRAVARTI, A; GREENE, MH			CUTANEOUS MALIGNANT-MELANOMA AND FAMILIAL DYSPLASTIC NEVI - EVIDENCE FOR AUTOSOMAL DOMINANCE AND PLEIOTROPY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PITTSBURGH,DEPT BIOSTAT,HUMAN GENET PROGRAM,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	BALE, SJ (corresponding author), NCI,ENVIRONM EPIDEMIOL PROGRAM,BETHESDA,MD 20205, USA.				NIGMS NIH HHS [GM33771] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033771] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON DE, 1967, J AMER MED ASSOC, V200, P741, DOI 10.1001/jama.200.9.741; BOVET R, 1980, ANN DERMATOL VENER, V107, P1173; BRAUNFALCO O, 1979, FORTSCHR MED, V97, P1494; CHASE GA, 1983, AM J EPIDEMIOL, V117, P590, DOI 10.1093/oxfordjournals.aje.a113581; CLARK WH, 1978, ARCH DERMATOL, V114, P732, DOI 10.1001/archderm.114.5.732; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; CRUTCHER WA, 1984, LANCET, V1, P729; DUGGLEBY WF, 1981, AM J EPIDEMIOL, V114, P63, DOI 10.1093/oxfordjournals.aje.a113175; GOLDIN L R, 1984, Genetic Epidemiology, V1, P285, DOI 10.1002/gepi.1370010307; GREENE MH, 1985, ANN INTERN MED, V102, P458, DOI 10.7326/0003-4819-102-4-458; GREENE MH, 1985, NEW ENGL J MED, V312, P91, DOI 10.1056/NEJM198501103120205; GREENE MH, 1980, LANCET, V2, P1024; GREENE MH, 1983, P NATL ACAD SCI-BIOL, V80, P6071, DOI 10.1073/pnas.80.19.6071; Greene MH, 1979, HUMAN MALIGNANT MELA, P139; HAUESISEN S, 1979, AKTUEL DERMATOL, V5, P61; HODGE SE, 1983, AM J HUM GENET, V35, P1139; HOLMAN CD, 1984, JNCI-J NATL CANCER I, V73, P75; HOLMAN CDJ, 1984, JNCI-J NATL CANCER I, V72, P257; HOWELL JN, 1984, P NATL ACAD SCI-BIOL, V81, P1179, DOI 10.1073/pnas.81.4.1179; HUNDEIKER M, 1980, HAUTARZT, V31, P42; LYNCH HT, 1983, J MED GENET, V20, P342, DOI 10.1136/jmg.20.5.342; LYNCH HT, 1968, CAN MED ASSOC J, V99, P17; LYNCH HT, 1978, J MED GENET, V15, P352, DOI 10.1136/jmg.15.5.352; MORTON NE, 1955, AM J HUM GENET, V7, P277; Norris William, 1820, Edinb Med Surg J, V16, P562; OTT J, 1976, AM J HUM GENET, V28, P528; PERERA MIR, 1983, CLIN RES, V31, pA595; RAMSAY RG, 1982, CANCER RES, V42, P2909; REIMER RR, 1978, JAMA-J AM MED ASSOC, V239, P744, DOI 10.1001/jama.239.8.744; RHODES AR, 1980, CLIN RES, V28, P252; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SMITH PJ, 1982, INT J CANCER, V30, P39, DOI 10.1002/ijc.2910300108; STEVENS RG, 1984, AM J EPIDEMIOL, V119, P890, DOI 10.1093/oxfordjournals.aje.a113811; TUCKER MA, 1983, J PEDIATR-US, V103, P65, DOI 10.1016/S0022-3476(83)80777-X; WALLACE DC, 1971, CANCER, V27, P1262, DOI 10.1002/1097-0142(197105)27:5<1262::AID-CNCR2820270534>3.0.CO;2-6; 1974, DHEW NIH75637 PUBL; 1984, J AM MED ASS, V251, P1864	37	112	112	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1986	38	2					188	196						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A3111	3456198				2022-12-18	WOS:A1986A311100007
J	GARDNER, EJ; STEPHENS, FE				GARDNER, EJ; STEPHENS, FE			CANCER OF THE LOWER DIGESTIVE TRACT IN ONE FAMILY GROUP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HABS H, 1938, Z KLIN MED, V135, P676; Macklin MT, 1932, Q REV BIOL, V7, P255, DOI 10.1086/394407; WASSINK W. F., 1935, GENETICA, V17, P103, DOI 10.1007/BF01984184; 1946, MORBIDITY MORTALITY	4	112	115	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	1					41	48						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS388	15425504				2022-12-18	WOS:A1950XS38800003
J	Monies, D; Abouelhoda, M; Assoum, M; Moghrabi, N; Rafiullah, R; Almontashiri, N; Alowain, M; Alzaidan, H; Alsayed, M; Subhani, S; Cupler, E; Faden, M; Alhashem, A; Qari, A; Chedrawi, A; Aldhalaan, H; Kurdi, W; Khan, S; Rahbeeni, Z; Alotaibi, M; Goljan, E; Elbardisy, H; ElKalioby, M; Shah, Z; Alruwaili, H; Jaafar, A; Albar, R; Akilan, A; Tayeb, H; Tahir, A; Fawzy, M; Nasr, M; Makki, S; Alfaifi, A; Akleh, H; Yamani, S; Bubshait, D; Mahnashi, M; Basha, T; Alsagheir, A; Abu Khaled, M; Alsaleem, K; Almugbel, M; Badawi, M; Bashiri, F; Bohlega, S; Sulaiman, R; Tous, E; Ahmed, S; Algoufi, T; Al-Mousa, H; Alaki, E; Alhumaidi, S; Althagafi, M; Alghamdi, H; Alghamdi, M; Sahly, A; Nahrir, S; Al-Ahmari, A; Alkuraya, H; Almehaidib, A; Abanemai, M; Alsohaibaini, F; Alsaud, B; Arnaout, R; Abdel-Salam, GMH; Aldhekri, H; AlKhater, S; Alqadi, K; Alsabban, E; Alshareef, T; Awartani, K; Banjar, H; Alsahan, N; Abosoudah, I; Alashwal, A; Aldekhail, W; Alhajjar, S; Al-Mayouf, S; Alsemari, A; Alshuaibi, W; Altala, S; Altalhi, A; Baz, S; Hamad, M; Abalkhail, T; Alenazi, B; Alkaff, A; Almohareb, F; Al Mutairi, F; Alsaleh, M; Alsonbul, A; Alzelaye, S; Bahzad, S; Bin Manee, A; Jarrad, O; Meriki, N; Albeirouti, B; Alqasmi, A; AlBalwi, M; Makhseed, N; Hassan, S; Salih, I; Salih, MA; Shaheen, M; Sermin, S; Shahrukh, S; Hashmi, S; Shawli, A; Tajuddin, A; Tamim, A; Alnahari, A; Ghemlas, I; Hussein, M; Wali, S; Murad, H; Meyer, BF; Alkuraya, FS				Monies, Dorota; Abouelhoda, Mohammed; Assoum, Mirna; Moghrabi, Nabil; Rafiullah, Rafiullah; Almontashiri, Naif; Alowain, Mohammed; Alzaidan, Hamad; Alsayed, Moeen; Subhani, Shazia; Cupler, Edward; Faden, Maha; Alhashem, Amal; Qari, Alya; Chedrawi, Aziza; Aldhalaan, Hisham; Kurdi, Wesam; Khan, Sameena; Rahbeeni, Zuhair; Alotaibi, Maha; Goljan, Ewa; Elbardisy, Hadeel; ElKalioby, Mohamed; Shah, Zeeshan; Alruwaili, Hibah; Jaafar, Amal; Albar, Ranad; Akilan, Asma; Tayeb, Hamsa; Tahir, Asma; Fawzy, Mohammed; Nasr, Mohammed; Makki, Shaza; Alfaifi, Abdullah; Akleh, Hanna; Yamani, Suad; Bubshait, Dalal; Mahnashi, Mohammed; Basha, Talal; Alsagheir, Afaf; Abu Khaled, Musad; Alsaleem, Khalid; Almugbel, Maisoon; Badawi, Manal; Bashiri, Fahad; Bohlega, Saeed; Sulaiman, Raashida; Tous, Ehab; Ahmed, Syed; Algoufi, Talal; Al-Mousa, Hamoud; Alaki, Emadia; Alhumaidi, Susan; Althagafi, Malak; Alghamdi, Hadeel; Alghamdi, Malak; Sahly, Ahmed; Nahrir, Shapar; Al-Ahmari, Ali; Alkuraya, Hisham; Almehaidib, Ali; Abanemai, Mohammed; Alsohaibaini, Fahad; Alsaud, Bandar; Arnaout, Rand; Abdel-Salam, Ghada M. H.; Aldhekri, Hasan; AlKhater, Suzan; Alqadi, Khalid; Alsabban, Essam; Alshareef, Turki; Awartani, Khalid; Banjar, Hanaa; Alsahan, Nada; Abosoudah, Ibraheem; Alashwal, Abdullah; Aldekhail, Wajeeh; Alhajjar, Sami; Al-Mayouf, Sulaiman; Alsemari, Abdulaziz; Alshuaibi, Walaa; Altala, Saeed; Altalhi, Abdulhadi; Baz, Salah; Hamad, Muddathir; Abalkhail, Tariq; Alenazi, Badi; Alkaff, Alya; Almohareb, Fahad; Al Mutairi, Fuad; Alsaleh, Mona; Alsonbul, Abdullah; Alzelaye, Somaya; Bahzad, Shakir; Bin Manee, Abdulaziz; Jarrad, Ola; Meriki, Neama; Albeirouti, Bassem; Alqasmi, Amal; AlBalwi, Mohammed; Makhseed, Nawal; Hassan, Saeed; Salih, Isam; Salih, Mustafa A.; Shaheen, Marwan; Sermin, Saadeh; Shahrukh, Shamsad; Hashmi, Shahrukh; Shawli, Ayman; Tajuddin, Ameen; Tamim, Abdullah; Alnahari, Ahmed; Ghemlas, Ibrahim; Hussein, Maged; Wali, Sami; Murad, Hatem; Meyer, Brian F.; Alkuraya, Fowzan S.			Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-HETEROGENEITY; GONADAL MOSAICISM; MEDICAL GENETICS; AMERICAN-COLLEGE; ARABIA REVEALS; MUTATIONS; DISEASE; MECHANISMS; MATURATION; DISORDERS	We report the results of clinical exome sequencing (CES) on >2,200 previously unpublished Saudi families as a first-tier test. The predominance of autosomal-recessive causes allowed us to make several key observations. We highlight 155 genes that we propose to be recessive, disease-related candidates. We report additional mutational events in 64 previously reported candidates (40 recessive), and these events support their candidacy. We report recessive forms of genes that were previously associated only with dominant disorders and that have phenotypes ranging from consistent with to conspicuously distinct from the known dominant phenotypes. We also report homozygous loss-of-function events that can inform the genetics of complex diseases. We were also able to deduce the likely causal variant in most couples who presented after the loss of one or more children, but we lack samples from those children. Although a similar pattern of mostly recessive causes was observed in the prenatal setting, the higher proportion of loss-of-function events in these cases was notable. The allelic series presented by the wealth of recessive variants greatly expanded the phenotypic expression of the respective genes. We also make important observations about dominant disorders; these observations include the pattern of de novo variants, the identification of 74 candidate dominant, disease-related genes, and the potential confirmation of 21 previously reported candidates. Finally, we describe the influence of a predominantly autosomal-recessive landscape on the clinical utility of rapid sequencing (Flash Exome). Our cohort's genotypic and phenotypic data represent a unique resource that can contribute to improved variant interpretation through data sharing.	[Monies, Dorota; Abouelhoda, Mohammed; Moghrabi, Nabil; Subhani, Shazia; Shah, Zeeshan; Alruwaili, Hibah; Jaafar, Amal; Akilan, Asma; Tayeb, Hamsa; Tahir, Asma; Fawzy, Mohammed; Meyer, Brian F.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Assoum, Mirna; Alzaidan, Hamad; Alsayed, Moeen; Kurdi, Wesam; Goljan, Ewa; Albar, Ranad; Akilan, Asma; Tahir, Asma; Makki, Shaza; Basha, Talal; Badawi, Manal; Al-Mousa, Hamoud; Sahly, Ahmed; Arnaout, Rand; Baz, Salah; Salih, Mustafa A.; Tajuddin, Ameen; Ghemlas, Ibrahim; Alkuraya, Fowzan S.] King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 12354, Saudi Arabia; [Moghrabi, Nabil; Rafiullah, Rafiullah; Alzaidan, Hamad; Qari, Alya; Akilan, Asma; Fawzy, Mohammed; Alfaifi, Abdullah; Mahnashi, Mohammed; Bashiri, Fahad; Alaki, Emadia; Alghamdi, Hadeel; Alsaud, Bandar; Aldhekri, Hasan; Makhseed, Nawal; Salih, Mustafa A.; Tamim, Abdullah; Meyer, Brian F.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Saudi Diagnost Labs, Riyadh 11211, Saudi Arabia; [Almontashiri, Naif; Kurdi, Wesam; Goljan, Ewa; Elbardisy, Hadeel; Akilan, Asma; Tayeb, Hamsa; Alfaifi, Abdullah; Akleh, Hanna; Alsagheir, Afaf; Badawi, Manal; Alhumaidi, Susan; Nahrir, Shapar; Alsaud, Bandar; Alashwal, Abdullah; Al-Mayouf, Sulaiman; Abalkhail, Tariq; Almohareb, Fahad; Hassan, Saeed; Shaheen, Marwan; Tajuddin, Ameen; Ghemlas, Ibrahim] Taibah Univ, Clin Mol & Biochem Genet, Madinah 42353, Saudi Arabia; [Alowain, Mohammed; Cupler, Edward; Alhashem, Amal; Kurdi, Wesam; Rahbeeni, Zuhair; Goljan, Ewa; ElKalioby, Mohamed; Tahir, Asma; Alfaifi, Abdullah; Mahnashi, Mohammed; Abu Khaled, Musad; Alghamdi, Hadeel; Nahrir, Shapar; Abanemai, Mohammed; Alsaud, Bandar; Alshuaibi, Walaa; Baz, Salah; Alnahari, Ahmed] King Faisal Specialist Hosp & Res Ctr, Dept Med Genetics, Riyadh 11211, Saudi Arabia; [Alzaidan, Hamad; Alsayed, Moeen; Qari, Alya; Rahbeeni, Zuhair] King Faisal Specialist Hosp & Res Ctr, Neurosci Dept, Jeddah 23433, Saudi Arabia; [Cupler, Edward] King Saud Med Complex, Genet & Metab, King, WI, Saudi Arabia; [Akleh, Hanna; Basha, Talal; Alghamdi, Hadeel; Almehaidib, Ali; Alsohaibaini, Fahad; Altala, Saeed; Alenazi, Badi; Alsonbul, Abdullah; Salih, Mustafa A.; Shahrukh, Shamsad; Alnahari, Ahmed; Wali, Sami] Prince Sultan Mil Med Complex, Pediat Dept, Riyadh 12233, Saudi Arabia; [Alowain, Mohammed; Cupler, Edward; Qari, Alya; Aldhalaan, Hisham; Khan, Sameena; Akilan, Asma; Fawzy, Mohammed; Akleh, Hanna; Mahnashi, Mohammed; Almugbel, Maisoon; Bohlega, Saeed; Tous, Ehab; Alghamdi, Hadeel; Sahly, Ahmed; Almehaidib, Ali; Alsohaibaini, Fahad; Abdel-Salam, Ghada M. H.; Altalhi, Abdulhadi; Alkaff, Alya; Shaheen, Marwan; Tajuddin, Ameen] King Faisal Specialist Hosp & Res Ctr, Neurosci Dept, Riyadh 11211, Saudi Arabia; [Alsayed, Moeen; Chedrawi, Aziza; Kurdi, Wesam; Alotaibi, Maha; ElKalioby, Mohamed; Akilan, Asma; Nasr, Mohammed; Basha, Talal; Althagafi, Malak; Al-Ahmari, Ali; Alsohaibaini, Fahad; Awartani, Khalid; Alsahan, Nada; Alhajjar, Sami; Altalhi, Abdulhadi; Al Mutairi, Fuad; Makhseed, Nawal; Salih, Isam; Shahrukh, Shamsad; Alnahari, Ahmed] King Faisal Specialist Hosp & Res Ctr, Dept Obstet & Gynecol, Riyadh 11211, Saudi Arabia; [Alsayed, Moeen; Alhashem, Amal; Alotaibi, Maha; Goljan, Ewa; ElKalioby, Mohamed; Mahnashi, Mohammed; Alsaleem, Khalid] Secur Forces Hosp, Pediat Dept, Riyadh 11481, Saudi Arabia; [Nasr, Mohammed; Makki, Shaza; Alfaifi, Abdullah; Mahnashi, Mohammed; Almugbel, Maisoon; Alhumaidi, Susan; Althagafi, Malak; Al-Ahmari, Ali; Arnaout, Rand; Alsabban, Essam; Al-Mayouf, Sulaiman; Altala, Saeed; Alkaff, Alya; Bin Manee, Abdulaziz] King Faisal Specialist Hosp & Res Ctr, Acad & Training Affairs, Riyadh 11211, Saudi Arabia; [Alzaidan, Hamad; Faden, Maha; Aldhalaan, Hisham; Rahbeeni, Zuhair; Goljan, Ewa; Nasr, Mohammed; Akleh, Hanna; Mahnashi, Mohammed; Alsagheir, Afaf; Badawi, Manal; Sulaiman, Raashida; Alsemari, Abdulaziz; Baz, Salah; Alenazi, Badi; Almohareb, Fahad; Shaheen, Marwan; Hashmi, Shahrukh; Shawli, Ayman; Alnahari, Ahmed; Ghemlas, Ibrahim] King Fahad Hosp Univ, Pediat Dept, Al Khobar 31952, Saudi Arabia; [Tahir, Asma; Bubshait, Dalal; Basha, Talal; Abu Khaled, Musad] King Fahd Cent Hosp, Genet & Med, Gizan 82666, Saudi Arabia; [Nasr, Mohammed; Yamani, Suad; Basha, Talal; Almugbel, Maisoon] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Jeddah 23433, Saudi Arabia; [Akleh, Hanna; Mahnashi, Mohammed; Abu Khaled, Musad] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; [Akleh, Hanna; Mahnashi, Mohammed; Abu Khaled, Musad] King Saud Univ, Med & King Khalid Univ Hosp, Riyadh 11461, Saudi Arabia; [Makki, Shaza; Mahnashi, Mohammed; Basha, Talal; Almugbel, Maisoon; Meriki, Neama] King Khalid Univ Hosp, Maternal & Fetal Med, Riyadh 12372, Saudi Arabia; [Makki, Shaza; Akleh, Hanna; Bubshait, Dalal; Mahnashi, Mohammed; Basha, Talal; Abu Khaled, Musad] King Faisal Specialist Hosp & Res Ctr, Hematol & Bone Marrow Transplant, Riyadh 11211, Saudi Arabia; [Alfaifi, Abdullah; Mahnashi, Mohammed; Abu Khaled, Musad; Sulaiman, Raashida] King Fahad Cent Hosp, Pediat Dept, Gizan 82666, Saudi Arabia; [Tayeb, Hamsa; Nasr, Mohammed; Makki, Shaza; Alfaifi, Abdullah; Akleh, Hanna; Ahmed, Syed] King Faisal Specialist Hosp & Res Ctr, Pediat Hematol & Oncol, Riyadh 11211, Saudi Arabia; [Tayeb, Hamsa; Makki, Shaza; Bubshait, Dalal] King Faisal Specialist Hosp & Res Ctr, Allergy Immunol, Riyadh 11211, Saudi Arabia; [Nasr, Mohammed; Yamani, Suad; Basha, Talal; Abu Khaled, Musad; Nahrir, Shapar] King Saud Med City, Pediat Dept, Riyadh, Saudi Arabia; [Shah, Zeeshan; Fawzy, Mohammed; Akleh, Hanna; Mahnashi, Mohammed; Alsagheir, Afaf] Specialized Med Ctr, Vitreoretinal Surg, Riyadh 11564, Saudi Arabia; [Alhumaidi, Susan; Alghamdi, Hadeel; Nahrir, Shapar; Alkuraya, Hisham; Alsaud, Bandar; Abdel-Salam, Ghada M. H.] King Faisal Specialist Hosp & Res Ctr, Gastroenterol, Riyadh 11211, Saudi Arabia; [Alghamdi, Malak; Alkuraya, Hisham; Abanemai, Mohammed; Abdel-Salam, Ghada M. H.] Natl Res Ctr, Dept Clin Genet, Cairo 12622, Egypt; [Althagafi, Malak; Nahrir, Shapar; Almehaidib, Ali; Alsohaibaini, Fahad; Alshareef, Turki; Sermin, Saadeh] King Faisal Specialist Hosp & Res Ctr, Pediat Nephrol, Riyadh 11211, Saudi Arabia; [Althagafi, Malak; Nahrir, Shapar; Almehaidib, Ali; Arnaout, Rand; Banjar, Hanaa] King Faisal Specialist Hosp & Res Ctr, Pediat Pulmonol, Riyadh 11211, Saudi Arabia; [Alghamdi, Hadeel; Nahrir, Shapar; Alkuraya, Hisham; Alsohaibaini, Fahad; Alsaud, Bandar; Arnaout, Rand; Abosoudah, Ibraheem] King Faisal Specialist Hosp & Res Ctr, Pediat Hematol & Oncol, Jeddah 23433, Saudi Arabia; [Al-Mayouf, Sulaiman; Baz, Salah; Alkaff, Alya; Almohareb, Fahad; Alsaleh, Mona; Alzelaye, Somaya] King Faisal Specialist Hosp & Res Ctr, Pediat Endocrine & Metab, Riyadh 11211, Saudi Arabia; [Alsemari, Abdulaziz; Alshuaibi, Walaa; Altalhi, Abdulhadi; Hamad, Muddathir; Alkaff, Alya; Bahzad, Shakir] King Faisal Specialist Hosp & Res Ctr, Pediat Infect Dis, Riyadh 11211, Saudi Arabia; [Aldekhail, Wajeeh; Alsemari, Abdulaziz; Alshuaibi, Walaa; Hamad, Muddathir; Alsonbul, Abdullah] King Khalid Univ Hosp, Pediat Dept, Riyadh 12372, Saudi Arabia; [Al-Mayouf, Sulaiman; Altala, Saeed; Baz, Salah; Alenazi, Badi] Armed Forces Hosp, Pediat Dept, Khamis Mushait 62451, Saudi Arabia; [Alsemari, Abdulaziz; Altalhi, Abdulhadi; Abalkhail, Tariq; Almohareb, Fahad; Alsonbul, Abdullah; Bin Manee, Abdulaziz] King Saud Med City, Pediat Nephrol, King, WI, Saudi Arabia; [Aldekhail, Wajeeh; Alshuaibi, Walaa; Altala, Saeed; Hamad, Muddathir; Abalkhail, Tariq; Alkaff, Alya; Almohareb, Fahad] Alyamama Hosp, Pediat Dept, Riyadh 14222, Saudi Arabia; [Alsemari, Abdulaziz; Altalhi, Abdulhadi; Hamad, Muddathir; Alenazi, Badi; Al Mutairi, Fuad; Alsonbul, Abdullah] King Faisal Specialist Hosp & Res Ctr, Oncol Ctr, Riyadh 11211, Saudi Arabia; [Al-Mayouf, Sulaiman; Alshuaibi, Walaa; Abalkhail, Tariq; Alsaleh, Mona; Alzelaye, Somaya; Bin Manee, Abdulaziz] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Riyadh 11564, Saudi Arabia; [Alhajjar, Sami; Altala, Saeed; Altalhi, Abdulhadi; Alenazi, Badi; Almohareb, Fahad; Alsonbul, Abdullah] King Faisal Specialist Hosp & Res Ctr, Pediat Rheumatol, Riyadh 11211, Saudi Arabia; [Alsemari, Abdulaziz; Altalhi, Abdulhadi; Abalkhail, Tariq; Alsaleh, Mona] Qunfudah Gen Hosp, Pediat Endocrine & Diabet, Al Qunfudhah 28821, Saudi Arabia; [Al-Mayouf, Sulaiman; Altala, Saeed; Hamad, Muddathir; Almohareb, Fahad; Al Mutairi, Fuad; Alsonbul, Abdullah] Kuwait Med Genet Ctr, Kuwait 65000, Kuwait; [Alhajjar, Sami; Altala, Saeed; Alenazi, Badi; Alsonbul, Abdullah; Albeirouti, Bassem] King Faisal Specialist Hosp & Res Ctr, Hematol & Oncol, Jeddah 23433, Saudi Arabia; [Alhajjar, Sami; Alshuaibi, Walaa; Altalhi, Abdulhadi; Almohareb, Fahad; Alsaleh, Mona; Alzelaye, Somaya; AlBalwi, Mohammed] King Saud bin Abdulaziz Univ Hlth Sci ences, Dept Pathol & Lab Med, King Abdullah Int Med Res Ctr, King, WI, Saudi Arabia; [Al-Mayouf, Sulaiman; Alshuaibi, Walaa; Altala, Saeed; Altalhi, Abdulhadi; Abalkhail, Tariq; Alenazi, Badi] Dept Pediat, Alsoor Clin, Kuwait 65000, Kuwait; [Alhajjar, Sami; Altalhi, Abdulhadi; Alkaff, Alya; Alzelaye, Somaya; Bin Manee, Abdulaziz] King Faisal Specialist Hosp & Res Ctr, Hepat Pancreat Surg, Riyadh 11211, Saudi Arabia; [Al-Mayouf, Sulaiman; Alshuaibi, Walaa; Altalhi, Abdulhadi; Hamad, Muddathir; Alenazi, Badi; Almohareb, Fahad] King Abdul Aziz Med City, Dept Pediat, Jeddah 9515, Saudi Arabia; [Alsemari, Abdulaziz; Altalhi, Abdulhadi; Almohareb, Fahad; Alsaleh, Mona; Bahzad, Shakir] King Fahad Hosp, Neurol, Medina 59046, Saudi Arabia; [Alhajjar, Sami; Alsemari, Abdulaziz; Altala, Saeed; Baz, Salah; Alenazi, Badi; Alsonbul, Abdullah; Bahzad, Shakir] King Faisal Specialist Hosp & Res Ctr, Pediat Neurol, Jeddah 23433, Saudi Arabia; [Alsemari, Abdulaziz; Altala, Saeed; Abalkhail, Tariq; Almohareb, Fahad; Alsaleh, Mona; Alzelaye, Somaya; Jarrad, Ola] King Faisal Specialist Hosp & Res Ctr, Dept Nephrol, Riyadh 11211, Saudi Arabia; [Altala, Saeed; Alenazi, Badi; Almohareb, Fahad; Alzelaye, Somaya] Alfaisal Univ, Coll Med, Riyadh 11533, Saudi Arabia; [Alsemari, Abdulaziz; Altalhi, Abdulhadi; Hamad, Muddathir; Al Mutairi, Fuad] Imam Abdulrahman Bin Faisal Univ, Dept Pediat, Coll Med, Dammam 34221, Saudi Arabia; [Alhajjar, Sami; Alqasmi, Amal; Salih, Mustafa A.; Hashmi, Shahrukh; Tamim, Abdullah; Hussein, Maged; Murad, Hatem; Alkuraya, Fowzan S.] King Abdul Aziz Med City, Dept Pediat, Med Genet Div, Riyadh 14611, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Taibah University; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Prince Sultan Military Medical City; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Security Forces Hospital - Saudi Arabia; King Faisal Specialist Hospital & Research Center; Imam Abdulrahman Bin Faisal University; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud University; King Saud University; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud Medical City; King Faisal Specialist Hospital & Research Center; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud University; King Faisal Specialist Hospital & Research Center; King Saud Bin Abdulaziz University for Health Sciences; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud Bin Abdulaziz University for Health Sciences; King Faisal Specialist Hospital & Research Center; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Alfaisal University; Imam Abdulrahman Bin Faisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.; Alkuraya, FS (corresponding author), King Abdulaziz City Sci & Technol, Saudi Human Genome Program, Riyadh 12354, Saudi Arabia.; Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Saudi Diagnost Labs, Riyadh 11211, Saudi Arabia.; Alkuraya, FS (corresponding author), King Abdul Aziz Med City, Dept Pediat, Med Genet Div, Riyadh 14611, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Nasr, Mohammed/X-7106-2019; Al-Mousa, Hamoud/AAS-4477-2020; ALSaleem, Khalid/W-4705-2019; Almontashiri, Naif/AAR-3806-2020; Bashiri, Fahad A./AAY-1953-2020; Mahnashi, Mohammed/ABE-3645-2020; AlKhater, Suzan/ABA-8653-2020; Almontashiri, Naif/GQH-2893-2022; Ahmed, Syed/GSN-7305-2022	Almontashiri, Naif/0000-0003-3607-395X; Bashiri, Fahad A./0000-0003-1436-6727; Nahari, Ahmed Ali/0000-0002-7552-5237; Cupler, Edward/0000-0003-0958-8931; AlKhater, Suzan/0000-0001-7315-6581; Mahnashi, Mohammed/0000-0003-0263-5301; Al Balwi, Mohammed/0000-0003-2910-0390; Alhashem, Amal/0000-0002-9668-7809; Bubshait, Dalal/0000-0002-7498-698X; Fawzy, Mohamed/0000-0003-0322-2816	Saudi Human Genome Program; Molecular Diagnostic Laboratory	Saudi Human Genome Program; Molecular Diagnostic Laboratory	We thank all those who participated in the clinical care of the study individuals beyond those who requested CES and provided phenotypic data. We acknowledge the support of the Saudi Human Genome Program as well as the Molecular Diagnostic Laboratory administration and staff. The authors declare no conflict of interest.	Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Abouelhoda M, 2016, GENET MED, V18, P1244, DOI 10.1038/gim.2016.37; Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Abu-Safieh L, 2011, AM J HUM GENET, V89, P313, DOI 10.1016/j.ajhg.2011.07.010; Adly N, 2014, HUM MUTAT, V35, P36, DOI 10.1002/humu.22477; Alazami AM, 2016, HUM GENET, V135, P525, DOI 10.1007/s00439-016-1660-z; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Aldahmesh MA, 2011, GENET MED, V13, P978, DOI 10.1097/GIM.0b013e31822623d5; Alkuraya FS, 2013, CLIN GENET, V84, P203, DOI 10.1111/cge.12131; Alkuraya FS, 2015, TRENDS GENET, V31, P108, DOI 10.1016/j.tig.2014.11.003; Alkuraya FS, 2014, MOL GENET GENOM MED, V2, P369, DOI 10.1002/mgg3.97; Alkuraya FS, 2013, HUM GENET, V132, P1197, DOI 10.1007/s00439-013-1344-x; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Alkuraya FS, 2012, CURR PROTOC HUM GENE, V6, P12, DOI DOI 10.1002/0471142905.HG0612S75; Alsalem AB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004030; Anazi S, 2017, MOL PSYCHIATR, V22, P615, DOI 10.1038/mp.2016.113; Anazi S, 2014, CLIN GENET, V85, P278, DOI 10.1111/cge.12156; Anazi S, 2017, HUM GENET, V136, P1419, DOI 10.1007/s00439-017-1843-2; Banks G, 2018, MOL PSYCHIATR, V23, P713, DOI 10.1038/mp.2017.54; Boycott KM, 2017, AM J HUM GENET, V100, P695, DOI 10.1016/j.ajhg.2017.04.003; Cookson MR, 2011, CELL, V146, P9, DOI 10.1016/j.cell.2011.06.031; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Firat-Karalar EN, 2014, J CELL SCI, V127, P4128, DOI 10.1242/jcs.157008; Gingras S, 2015, J NEUROSCI, V35, P10510, DOI 10.1523/JNEUROSCI.2056-14.2015; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Koohian A, 2018, EURASIP J ADV SIG PR, DOI 10.1186/s13634-018-0529-9; Kulkarni N, 2016, J CHILD NEUROL, V31, P211, DOI 10.1177/0883073815587945; Maddirevula S, 2018, GENET MED, V20, P1609, DOI 10.1038/gim.2018.50; Maddirevula S, 2018, GENET MED, V20, P64, DOI 10.1038/gim.2017.78; Martin HC, 2018, SCIENCE, V362, P1161, DOI 10.1126/science.aar6731; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Monies D, 2019, AM J HUM GENET, V104, P1202, DOI 10.1016/j.ajhg.2019.03.026; Monies D, 2017, GENET MED, V19, P1144, DOI 10.1038/gim.2017.22; Monies D, 2017, HUM GENET, V136, P921, DOI 10.1007/s00439-017-1821-8; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Patel N, 2016, GENET MED, V18, P554, DOI 10.1038/gim.2015.127; Patel N, 2014, GUT, V63, P1831, DOI 10.1136/gutjnl-2014-307859; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Scott EM, 2016, NAT GENET, V48, P1071, DOI 10.1038/ng.3592; Seidahmed MZ, 2016, AM J MED GENET A, V170, P2219, DOI 10.1002/ajmg.a.37768; Shaheen R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1099-5; Shaheen R, 2016, GENET MED, V18, P686, DOI 10.1038/gim.2015.147; Shaheen R, 2016, AM J HUM GENET, V98, P643, DOI 10.1016/j.ajhg.2016.02.010; Shaheen R, 2015, J MED GENET, V52, P322, DOI 10.1136/jmedgenet-2015-102992; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Shamseldin HE, 2018, GENET MED, V20, P420, DOI 10.1038/gim.2017.111; Tsuchiya Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12567; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.e04-12-1116; Van De Weghe JC, 2017, AM J HUM GENET, V101, P23, DOI 10.1016/j.ajhg.2017.05.010; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	50	111	112	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2019	104	6					1182	1201		10.1016/j.ajhg.2019.04.011	http://dx.doi.org/10.1016/j.ajhg.2019.04.011			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IB4KJ	31130284	Green Published, Bronze			2022-12-18	WOS:000470240000013
J	Lim, JS; Gopalappa, R; Kim, SH; Ramakrishna, S; Lee, M; Kim, WI; Kim, J; Park, SM; Lee, J; Oh, JH; Kim, HD; Park, CH; Lee, JS; Kim, S; Kim, DS; Han, JM; Kang, HC; Kim, HH; Lee, JH				Lim, Jae Seok; Gopalappa, Ramu; Kim, Se Hoon; Ramakrishna, Suresh; Lee, Minji; Kim, Woo-il; Kim, Junho; Park, Sang Min; Lee, Junehawk; Oh, Jung-Hwa; Kim, Heung Dong; Park, Chang-Hwan; Lee, Joon Soo; Kim, Sangwoo; Kim, Dong Seok; Han, Jung Mm; Kang, Hoon-Chul; Kim, Hyongbum (Henry); Lee, Jeong Ho			Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUBEROUS SCLEROSIS COMPLEX; MAMMALIAN TARGET; CELL-GROWTH; IN-VIVO; MTOR; EPILEPSY; BRAIN; MALFORMATIONS; PATHWAY; CRISPR-CAS9	Focal cortical dysplasia (FCD) is a major cause of the sporadic form of intractable focal epilepsies that require surgical treatment. It has recently been reported that brain somatic mutations in MTOR account for 15%-25% of FCD type II (FCDII), characterized by cortical dyslamination and dysmorphic neurons. However, the genetic etiologies of FCDII-affected individuals who lack the MTOR mutation remain unclear. Here, we performed deep hybrid capture and amplicon sequencing (read depth of 100 x-20,012 x) of five important mTOR pathway genes-PIK3CA, PIK3R2, AKT3, TSC1, and TSC2-by using paired brain and saliva samples from 40 FCDII individuals negative for MTOR mutations. We found that 5 of 40 individuals (12.5%) had brain somatic mutations in TSC1 (c.64C>T [p.Arg22Trp] and c.610C>T [p.Arg204Cys]) and TSC2 (c.4639G>A [p.Va11547I1e]), and these results were reproducible on two different sequencing platforms. All identified mutations induced hyperactivation of the mTOR pathway by disrupting the formation or function of the TSC1TSC2 complex. Furthermore, in utero CRISPR-Cas9-mediated genome editing of Tsc1 or Tsc2 induced the development of spontaneous behavioral seizures, as well as cytomegalic neurons and cortical dyslamination. These results show that brain somatic mutations in TSC1 and TSC2 cause FCD and that in utero application of the CRISPR-Cas9 system is useful for generating neurodevelopmental disease models of somatic mutations in the brain.	[Lim, Jae Seok; Kim, Woo-il; Park, Sang Min; Lee, Jeong Ho] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Brain Korea Plus Project 21, Daejeon 34141, South Korea; [Gopalappa, Ramu; Ramakrishna, Suresh; Park, Chang-Hwan] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 04763, South Korea; [Gopalappa, Ramu; Kim, Hyongbum (Henry)] Yonsei Univ, Coll Med, Dept Pharmacol, Brain Korea Plus Project Med Sci 21,Grad Program, Seoul 03722, South Korea; [Kim, Se Hoon] Yonsei Univ, Dept Pathol, Coll Med, Seoul 03722, South Korea; [Lee, Minji; Han, Jung Mm] Yonsei Univ, Dept Integrated OMICS Biomed Sci, Seoul 03722, South Korea; [Han, Jung Mm] Yonsei Univ, Coll Pharm, Seoul 03722, South Korea; [Kim, Junho; Kim, Sangwoo; Kim, Hyongbum (Henry)] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 03722, South Korea; [Lee, Junehawk] Korea Inst Sci & Technol Informat, Biomed HPC Technol Res Ctr, Daejeon 34141, South Korea; [Oh, Jung-Hwa] Korea Inst Toxicol, Dept Predict Toxicol, Daejeon 34114, South Korea; [Kim, Heung Dong; Lee, Joon Soo; Kang, Hoon-Chul] Yonsei Univ, Coll Med, Div Pediat Neurol,Epilepsy Res Inst, Dept Pediat,Pediat Epilepsy Clin,Severance Childr, Seoul 03722, South Korea; [Kim, Dong Seok] Yonsei Univ, Coll Med, Pediat Neurosurg, Severance Childrens Hosp,Dept Neurosurg, Seoul 03722, South Korea; [Kim, Hyongbum (Henry)] Yonsei Univ, Inst Basic Sci, Ctr Nanomed, Seoul 03722, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Hanyang University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Korea Institute of Science & Technology Information (KISTI); Korea Institute of Toxicology; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Institute for Basic Science - Korea (IBS); Yonsei University	Lee, JH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Brain Korea Plus Project 21, Daejeon 34141, South Korea.; Kim, HH (corresponding author), Yonsei Univ, Coll Med, Dept Pharmacol, Brain Korea Plus Project Med Sci 21,Grad Program, Seoul 03722, South Korea.; Kim, HH (corresponding author), Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 03722, South Korea.; Kim, HH (corresponding author), Yonsei Univ, Inst Basic Sci, Ctr Nanomed, Seoul 03722, South Korea.	hkim1@yuhs.ac; jhlee4246@kaist.ac.kr	Kim, Hyongbum Henry/D-5804-2019; Lee, Jeong Ho/G-7361-2012; Ramakrishna, Suresh/AAX-4096-2021	Kim, Hyongbum Henry/0000-0002-4693-738X; Kim, Sangwoo/0000-0001-5356-0827; Park, Sang Min/0000-0002-9938-4045; Lee, Joon Soo/0000-0001-9036-9343; Lee, Junehawk/0000-0001-8908-0884; Kim, Heung Dong/0000-0002-8031-7336; Han, Jung Min/0000-0003-3372-7575; Kang, Hoon-Chul/0000-0002-3659-8847; Kim, Se Hoon/0000-0001-7516-7372	Korean Health Technology R&D Project of the Korean Ministry of Health Welfare [H15C3143, H16C0415, HI14C1588, HI15C1601, HI14C2019]; Citizens United for Research in Epilepsy; Brain Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2013M3C7A1056564, 2015R1A2A1A15052668]; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT, and Future Planning	Korean Health Technology R&D Project of the Korean Ministry of Health Welfare; Citizens United for Research in Epilepsy; Brain Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT, and Future Planning	We thank Dr. Sun Min Park at the Korea Advanced Institute of Science and Technology (KAIST) for coordinating clinical information. This work was supported by the Korean Health Technology R&D Project of the Korean Ministry of Health & Welfare (grants H15C3143 and H16C0415 to J.H.L., HI14C1588 and HI15C1601 to H.C.K., and HI14C2019 to H.K.); Citizens United for Research in Epilepsy (J.H.L.); the Brain Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, ICT, and Future Planning (grants 2013M3C7A1056564 to J.H.L. and 2015R1A2A1A15052668 to H.K.); and the KAIST Future Systems Healthcare Project from the Ministry of Science, ICT, and Future Planning (J.H.L.).	An KS, 2007, GENET MED, V9, P88, DOI 10.1097/GIM.0b013e31803068c7; Aronica E, 2007, ACTA NEUROPATHOL, V114, P287, DOI 10.1007/s00401-007-0225-6; Bast T, 2006, ACTA NEUROL SCAND, V113, P72, DOI 10.1111/j.1600-0404.2005.00555.x; Baulac S, 2015, ANN NEUROL, V77, P675, DOI 10.1002/ana.24368; Baybis M, 2004, ANN NEUROL, V56, P478, DOI 10.1002/ana.20211; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2009, EPILEPTIC DISORD, V11, P181, DOI 10.1684/epd.2009.0261; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costa-Mattioli M, 2013, NAT NEUROSCI, V16, P1537, DOI 10.1038/nn.3546; D'Gama AM, 2015, ANN NEUROL, V77, P720, DOI 10.1002/ana.24357; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fauser S, 2004, BRAIN, V127, P2406, DOI 10.1093/brain/awh277; Fauser S, 2006, BRAIN, V129, P1907, DOI 10.1093/brain/awl133; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hoogeveen-Westerveld M, 2012, HUM MUTAT, V33, P476, DOI 10.1002/humu.22007; Hoogeveen-Westerveld M, 2011, HUM MUTAT, V32, P424, DOI 10.1002/humu.21451; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Jansen LA, 2015, BRAIN, V138, P1613, DOI 10.1093/brain/awv045; Kalebic N, 2016, EMBO REP, V17, P338, DOI 10.15252/embr.201541715; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r90; Kim YH, 2011, EPILEPSIA, V52, P722, DOI 10.1111/j.1528-1167.2010.02950.x; Kim YH, 2014, METHODS, V69, P108, DOI 10.1016/j.ymeth.2014.04.012; Kuilman T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0617-1; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.53; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824; Lin DC, 2014, NAT GENET, V46, P866, DOI 10.1038/ng.3006; Ljungberg MC, 2006, ANN NEUROL, V60, P420, DOI 10.1002/ana.20949; Lozovaya N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5563; Magri L, 2013, DIS MODEL MECH, V6, P1185, DOI 10.1242/dmm.012096; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Miyata H, 2004, ANN NEUROL, V56, P510, DOI 10.1002/ana.20234; Mozaffari M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-88; Nakashima M, 2015, ANN NEUROL, V78, P375, DOI 10.1002/ana.24444; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Qin W, 2010, HUM GENET, V127, P573, DOI 10.1007/s00439-010-0801-z; Ramakrishna S, 2014, GENOME RES, V24, P1020, DOI 10.1101/gr.171264.113; Ramakrishna S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4378; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ratan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055089; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Sim JC, 2016, ANN NEUROL, V79, P132, DOI 10.1002/ana.24502; Sisodiya SM, 2000, BRAIN, V123, P1075, DOI 10.1093/brain/123.6.1075; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Tassi L, 2002, BRAIN, V125, P1719, DOI 10.1093/brain/awf175; Tyburczy ME, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005637; Walsh R, 2016, GENET MED; Wong M., 2012, SOURCEJASPERS BASIC; Wong M, 2015, EPILEPSY CURR, V15, P129, DOI 10.5698/1535-7597-15.3.129; Zech R, 2016, J BIOL CHEM, V291, P20008, DOI 10.1074/jbc.M116.732446; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zuckermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8391	70	111	118	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					454	472		10.1016/j.ajhg.2017.01.030	http://dx.doi.org/10.1016/j.ajhg.2017.01.030			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28215400	Bronze, Green Published			2022-12-18	WOS:000395851900012
J	Brown, BC; Ye, CJ; Price, AL; Zaitlen, N				Brown, Brielin C.; Ye, Chun Jimmie; Price, Alkes L.; Zaitlen, Noah		Asian Genetic Epidemiology Network	Transethnic Genetic-Correlation Estimates from Summary Statistics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSING HERITABILITY; COMPLEX TRAITS; HUMAN HEIGHT; VARIANTS; ASSOCIATION; POPULATIONS; ARCHITECTURE; IMPUTATION; SUSCEPTIBILITY; METAANALYSIS	The increasing number of genetic association studies conducted in multiple populations provides an unprecedented opportunity to study how the genetic architecture of complex phenotypes varies between populations, a problem important for both medical and population genetics. Here, we have developed a method for estimating the transethnic genetic correlation: the correlation of causal-variant effect sizes at SNPs common in populations. This methods takes advantage of the entire spectrum of SNP associations and uses only summary-level data from genome-wide association studies. This avoids the computational costs and privacy concerns associated with genotype-level information while remaining scalable to hundreds of thousands of individuals and millions of SNPs. We applied our method to data on gene expression, rheumatoid arthritis, and type 2 diabetes and overwhelmingly found that the genetic correlation was significantly less than 1. Our method is implemented in a Python package called Popcorn.	[Brown, Brielin C.] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; [Ye, Chun Jimmie] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94117 USA; [Price, Alkes L.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Zaitlen, Noah] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco	Brown, BC (corresponding author), Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA.	brielin@berkeley.edu	Ye, Chun/AAK-4868-2021	Ye, Chun/0000-0001-6560-3783	National Science Foundation Graduate Research Fellowship Program; NIH [R01 HG006399, K25HL121295]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL121295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to acknowledge Lior Pachter, Hilary Finucane, and Yukinori Okada for insightful discussion about the problem. B.C.B. is supported by the National Science Foundation Graduate Research Fellowship Program. A.L.P. is supported by NIH grant R01 HG006399. N.Z. is supported by NIH grant K25HL121295.	Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chang MH, 2011, CIRC-CARDIOVASC GENE, V4, P523, DOI 10.1161/CIRCGENETICS.111.959577; Chen X, 2015, AM J HUM GENET, V97, P708, DOI 10.1016/j.ajhg.2015.10.004; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Coram MA, 2015, AM J HUM GENET, V96, P740, DOI 10.1016/j.ajhg.2015.03.008; de Candia TR, 2013, AM J HUM GENET, V93, P463, DOI 10.1016/j.ajhg.2013.07.007; Falconer DS, 1996, INTRO QUANTITATIVE G; Fesinmeyer MD, 2013, OBESITY, V21, P835, DOI 10.1002/oby.20268; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gaffney DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003501; Hormozdiari F, 2015, BIOINFORMATICS, V31, P206, DOI 10.1093/bioinformatics/btv240; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee S, 2013, AM J HUM GENET, V93, P42, DOI 10.1016/j.ajhg.2013.05.010; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Palla L, 2015, AM J HUM GENET, V97, P250, DOI 10.1016/j.ajhg.2015.06.005; Park DS, 2015, BIOINFORMATICS, V31, P181, DOI 10.1093/bioinformatics/btv230; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Robinson MR, 2015, NAT GENET, V47, P1357, DOI 10.1038/ng.3401; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Xu Z, 2015, BIOINFORMATICS, V31, P2434, DOI 10.1093/bioinformatics/btv168; Yang J, 2015, HUM MOL GENET, V24, P7445, DOI 10.1093/hmg/ddv443; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhu ZH, 2015, AM J HUM GENET, V96, P377, DOI 10.1016/j.ajhg.2015.01.001; Zuo LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026726	52	111	111	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					76	88		10.1016/j.ajhg.2016.05.001	http://dx.doi.org/10.1016/j.ajhg.2016.05.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27321947	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000381616600006
J	Baurecht, H; Hotze, M; Brand, S; Buning, C; Cormican, P; Corvin, A; Ellinghaus, D; Ellinghaus, E; Esparza-Gordillo, J; Folster-Holst, R; Franke, A; Gieger, C; Hubner, N; Illig, T; Irvine, AD; Kabesch, M; Lee, YAE; Lieb, W; Marenholz, I; McLean, WHI; Morris, DW; Mrowietz, U; Nair, R; Nothen, MM; Novak, N; O'Regan, GM; Schreiber, S; Smith, C; Strauch, K; Stuart, PE; Trembath, R; Tsoi, LC; Weichenthal, M; Barker, J; Elder, JT; Weidinger, S; Cordell, HJ; Brown, SJ				Baurecht, Hansjoerg; Hotze, Melanie; Brand, Stephan; Buening, Carsten; Cormican, Paul; Corvin, Aiden; Ellinghaus, David; Ellinghaus, Eva; Esparza-Gordillo, Jorge; Foelster-Holst, Regina; Franke, Andre; Gieger, Christian; Hubner, Norbert; Illig, Thomas; Irvine, Alan D.; Kabesch, Michael; Lee, Young A. E.; Lieb, Wolfgang; Marenholz, Ingo; McLean, W. H. Irwin; Morris, Derek W.; Mrowietz, Ulrich; Nair, Rajan; Noethen, Markus M.; Novak, Natalija; O'Regan, Grainne M.; Schreiber, Stefan; Smith, Catherine; Strauch, Konstantin; Stuart, Philip E.; Trembath, Richard; Tsoi, Lam C.; Weichenthal, Michael; Barker, Jonathan; Elder, James T.; Weidinger, Stephan; Cordell, Heather J.; Brown, Sara J.		PAGE Consortium	Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASSICAL HLA ALLELES; ANALYSIS IDENTIFIES 3; OF-FUNCTION VARIANTS; CD8(+) T-CELLS; SUSCEPTIBILITY LOCI; CELLULAR ACTIVATOR; ASSOCIATION; FILAGGRIN; DISEASE; DIFFERENTIATION	Atopic dermatitis and psoriasis are the two most common immune-mediated inflammatory disorders affecting the skin. Genome-wide studies demonstrate a high degree of genetic overlap, but these diseases have mutually exclusive clinical phenotypes and opposing immune mechanisms. Despite their prevalence, atopic dermatitis and psoriasis very rarely co-occur within one individual. By utilizing genome-wide association study and ImmunoChip data from >19,000 individuals and methodologies developed from meta-analysis, we have identified opposing risk alleles at shared loci as well as independent disease-specific loci within the epidermal differentiation complex (chromosome 1q21.3), the Th2 locus control region (chromosome 5q31.1), and the major histocompatibility complex (chromosome 6p21-22). We further identified previously unreported pleiotropic alleles with opposing effects on atopic dermatitis and psoriasis risk in PRKRA and ANXA6/TNIP1. In contrast, there was no evidence for shared loci with effects operating in the same direction on both diseases. Our results show that atopic dermatitis and psoriasis have distinct genetic mechanisms with opposing effects in shared pathways influencing epidermal differentiation and immune response. The statistical analysis methods developed in the conduct of this study have produced additional insight from previously published data sets. The approach is likely to be applicable to the investigation of the genetic basis of other complex traits with overlapping and distinct clinical features.	[Baurecht, Hansjoerg; Hotze, Melanie; Foelster-Holst, Regina; Mrowietz, Ulrich; Weichenthal, Michael; Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venereol, D-24105 Kiel, Germany; [Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, D-81377 Munich, Germany; [Buening, Carsten] Charite, Dept Gastroenterol Hepatol & Endocrinol, D-10117 Berlin, Germany; [Cormican, Paul; Corvin, Aiden; Morris, Derek W.] Univ Dublin Trinity Coll, Dept Psychiat, Neuropsychiat Genet Res Grp, Dublin 2, Ireland; [Cormican, Paul; Corvin, Aiden; Morris, Derek W.] Univ Dublin Trinity Coll, Inst Mol Med, Dublin 2, Ireland; [Ellinghaus, David; Ellinghaus, Eva; Franke, Andre; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Esparza-Gordillo, Jorge; Hubner, Norbert; Lee, Young A. E.; Marenholz, Ingo] Max Delbruck Ctr MDC Mol Med, D-13092 Berlin, Germany; [Esparza-Gordillo, Jorge; Lee, Young A. E.; Marenholz, Ingo] Charite, Pediat Allergy Expt & Clin Res Ctr, D-10117 Berlin, Germany; [Gieger, Christian; Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Gieger, Christian; Illig, Thomas] German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Irvine, Alan D.; O'Regan, Grainne M.] Our Ladys Childrens Hosp, Dept Paediat Dermatol, Dublin 12, Ireland; [Irvine, Alan D.] Natl Childrens Res Ctr, Dublin 12, Ireland; [Irvine, Alan D.] Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland; [Kabesch, Michael] Univ Childrens Hosp Regensburg KUNO, Dept Pediat Pneumol & Allergy, D-93042 Regensburg, Germany; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, Inst Epidemiol, D-24105 Kiel, Germany; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, PopGen Biobank, D-24105 Kiel, Germany; [McLean, W. H. Irwin] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [McLean, W. H. Irwin] Univ Dundee, Coll Med, Dundee DD1 5EH, Scotland; [Morris, Derek W.] Natl Univ Ireland, Sch Psychol, Cognit Genet & Therapy Grp, Galway, Ireland; [Morris, Derek W.] Natl Univ Ireland, Discipline Biochem, Galway, Ireland; [Nair, Rajan; Stuart, Philip E.; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Novak, Natalija] Univ Bonn, Med Ctr, Dept Dermatol & Allergy, D-53105 Bonn, Germany; [Schreiber, Stefan] Univ Med Ctr Schleswig Holstein, Dept Internal Med, D-24105 Kiel, Germany; [Smith, Catherine; Barker, Jonathan] Kings Coll London, St Johns Inst Dermatol, Div Genet & Mol Med, London SE1 9RT, England; [Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, D-80539 Munich, Germany; [Trembath, Richard] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 4NS, England; [Tsoi, Lam C.] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI 48105 USA; [Cordell, Heather J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Brown, Sara J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland	University of Kiel; Schleswig Holstein University Hospital; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Trinity College Dublin; Trinity College Dublin; University of Kiel; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; National Children's Research Centre (NCRC); Trinity College Dublin; Trinity College Dublin; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Dundee; University of Dundee; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; University of Michigan System; University of Michigan; University of Bonn; University of Bonn; University of Bonn; University of Kiel; Schleswig Holstein University Hospital; University of London; King's College London; University of Munich; University of London; Queen Mary University London; University of Michigan System; University of Michigan; Newcastle University - UK; University of Dundee	Weidinger, S (corresponding author), Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venereol, Campus Kiel, D-24105 Kiel, Germany.	sweidinger@dermatology.uni-kiel.de; s.j.brown@dundee.ac.uk	Franke, Andre/B-2151-2010; Ellinghaus, Eva/E-6490-2012; Smith, Catherine H./G-5268-2012; Irvine, Alan D/A-3982-2008; Brown, Sara J/AAF-7095-2019; Kabesch, Michael/AAB-5701-2020; Morris, Derek/AAW-8343-2021; Ellinghaus, David/G-4467-2012; Ellinghaus, David/ABC-3610-2020; Weidinger, Stephan/C-8461-2011; Lieb, Wolfgang/AAC-7650-2022; Kabesch, Michael/GZM-1583-2022; Baurecht, Hansjorg/C-4035-2013	Franke, Andre/0000-0003-1530-5811; Ellinghaus, Eva/0000-0003-2914-3382; Smith, Catherine H./0000-0001-9918-1144; Irvine, Alan D/0000-0002-9048-2044; Brown, Sara J/0000-0002-3232-5251; Morris, Derek/0000-0002-3413-570X; Ellinghaus, David/0000-0002-4332-6110; Weidinger, Stephan/0000-0003-3944-252X; Trembath, Richard/0000-0003-0550-3400; Barker, Jonathan/0000-0002-9030-183X; Walters, James/0000-0002-6980-4053; Corvin, Aiden/0000-0001-6717-4089; Baurecht, Hansjorg/0000-0002-9265-5594; Cordell, Heather/0000-0002-1879-5572; Tsoi, Lam Cheung/0000-0003-1627-5722; Nothen, Markus/0000-0002-8770-2464; Gieger, Christian/0000-0001-6986-9554	Wellcome Trust [076113, 085475, WT086398MA, 087436/Z/08/Z, 102858/Z/13/Z, 092530/Z/10/Z, 098439/Z/12/Z]; Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ; DFG Clusters of Excellence "Inflammation at Interfaces" [EXC306, EXC306/2]; German Federal Ministry of Education and Research [01ZX1306A]; National Children's Research Centre, Dublin; NIH [R01AR042742, R01AR050511, R01AR054966, R01AR062886-01, R01AR062382]; Babcock Memorial Trust; Ann Arbor Veterans Affairs Hospital; MRC [G0700314, G0802780] Funding Source: UKRI; Medical Research Council [G0802780, G0700314] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062886, R01AR054966, R01AR042742, R01AR050511, R01AR063611, R01AR065183] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ; DFG Clusters of Excellence "Inflammation at Interfaces"; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Children's Research Centre, Dublin; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Babcock Memorial Trust; Ann Arbor Veterans Affairs Hospital; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to the individuals who provided clinical data and DNA for research. This study makes use of genome-wide analysis data generated by the Wellcome Trust Case-Control Consortium (WTCCC); a full list of investigators is available at http://www.wtccc.org.uk. Funding for the WTCCC was provided by Wellcome Trust awards 076113 and 085475. This work was additionally supported by the Wellcome Trust through an Intermediate Clinical Fellowship (WT086398MA) to S.J.B., Senior Research Fellowship in Basic Biomedical Science (087436/Z/08/Z and 102858/Z/13/Z) to H.J.C., Programme Grant (092530/Z/10/Z) to W.H.I.M. and A.D.I., and Strategic Award (098439/Z/12/Z) to W.H.I.M. The KORA research platform was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, funded by the German Federal Ministry of Education and Research and by the State of Bavaria. KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. The project received infrastructure support through DFG Clusters of Excellence "Inflammation at Interfaces" (grants EXC306 and EXC306/2) and the German Federal Ministry of Education and Research within the framework of e:Med research and funding concept (sysINFLAME, 01ZX1306A). M.M.N. is a member of the Cluster of Excellence "ImmunoSensation." The NCRC-ADC is supported by the National Children's Research Centre, Dublin. We also acknowledge use of Trinity Biobank samples from the Irish Blood Transfusion Service. This work was supported by the NIH (R01AR042742, R01AR050511, R01AR054966, R01AR062886-01, R01AR062382) and by the Babcock Memorial Trust. J.T.E. is supported by the Ann Arbor Veterans Affairs Hospital.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bergboer JGM, 2010, J INVEST DERMATOL, V130, P2057, DOI 10.1038/jid.2010.88; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Deckert S, 2014, ALLERGY, V69, P37, DOI 10.1111/all.12246; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Eyerich S, 2011, NEW ENGL J MED, V365, P231, DOI 10.1056/NEJMoa1104200; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Gunderson AJ, 2013, J INVEST DERMATOL, V133, P955, DOI 10.1038/jid.2012.390; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Hemminki K, 2009, ARTHRITIS RHEUM, V60, P2845, DOI 10.1002/art.24749; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Hijnen D, 2013, J INVEST DERMATOL, V133, P973, DOI 10.1038/jid.2012.456; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Huffmeier U, 2007, J INVEST DERMATOL, V127, P1367, DOI 10.1038/sj.jid.5700720; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Kapila S, 2012, AUSTRALAS J DERMATOL, V53, P98, DOI 10.1111/j.1440-0960.2012.00878.x; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Knight J, 2012, HUM MOL GENET, V21, P5185, DOI 10.1093/hmg/dds344; Kok KH, 2011, CELL HOST MICROBE, V9, P299, DOI 10.1016/j.chom.2011.03.007; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Maas T, 2014, PRIM CARE RESP J, V23, P14, DOI 10.4104/pcrj.2013.00108; Mangalam AK, 2013, J IMMUNOL, V190, P513, DOI 10.4049/jimmunol.1201891; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marenholz I, 2011, J INVEST DERMATOL, V131, P1644, DOI 10.1038/jid.2011.90; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Strong CD, 2010, HUM MOL GENET, V19, P1453, DOI 10.1093/hmg/ddq019; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Takaishi M, 2005, J BIOL CHEM, V280, P4696, DOI 10.1074/jbc.M409026200; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Weiland SK, 1999, EUR RESPIR J, V14, P862, DOI 10.1034/j.1399-3003.1999.14d23.x; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhao Y, 2007, J INVEST DERMATOL, V127, P1878, DOI 10.1038/sj.jid.5700817	66	111	115	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					104	120		10.1016/j.ajhg.2014.12.004	http://dx.doi.org/10.1016/j.ajhg.2014.12.004			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25574825	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000347707800008
J	Bhatia, S; Bengani, H; Fish, M; Brown, A; Divizia, MT; de Marco, R; Damante, G; Grainger, R; van Heyningen, V; Kleinjan, DA				Bhatia, Shipra; Bengani, Hemant; Fish, Margaret; Brown, Alison; Divizia, Maria Teresa; de Marco, Riccardo; Damante, Guiseppe; Grainger, Robert; van Heyningen, Veronica; Kleinjan, Dirk A.			Disruption of Autoregulatory Feedback by a Mutation in a Remote, Ultraconserved PAX6 Enhancer Causes Aniridia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; IDENTIFICATION; ELEMENTS; DOMAIN; TRANSGENESIS; EXPRESSION; DELETIONS; SEQUENCE	The strictly regulated expression of most pleiotropic developmental control genes is critically dependent on the activity of long-range cis-regulatory elements. This was revealed by the identification of individuals with a genetic condition lacking coding-region mutations in the gene commonly associated with the disease but having a variety of nearby chromosomal abnormalities, collectively described as cis-ruption disease cases. The congenital eye malformation aniridia is caused by haploinsufficiency of the developmental regulator PAX6. We discovered a de novo point mutation in an ultraconserved cis-element located 150 kb downstream from PAX6 in an affected individual with intact coding region and chromosomal locus. The element SIMO acts as a strong enhancer in developing ocular structures. The mutation disrupts an autoregulatory PAX6 binding site, causing loss of enhancer activity, resulting in defective maintenance of PAX6 expression. These findings reveal a distinct regulatory mechanism for genetic disease by disruption of an autoregulatory feedback loop critical for maintenance of gene expression through development.	[Bhatia, Shipra; Bengani, Hemant; Brown, Alison; van Heyningen, Veronica; Kleinjan, Dirk A.] Univ Edinburgh, MRC Human Genet Unit, MRC IGMM, Edinburgh EH4 2XU, Midlothian, Scotland; [Fish, Margaret; Grainger, Robert] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Divizia, Maria Teresa] Gaslini Childrens Hosp, Med Genet Unit, I-16147 Genoa, Italy; [de Marco, Riccardo] Inst G Gaslini, Ophtalmol Unit, I-16147 Genoa, Italy; [Damante, Guiseppe] Azienda Osped Univ S Maria della Misericordia, Dipartimento Med Lab, I-33100 Udine, Italy	University of Edinburgh; University of Virginia; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Hospital Santa Maria della Misericordia	van Heyningen, V (corresponding author), Univ Edinburgh, MRC Human Genet Unit, MRC IGMM, Edinburgh EH4 2XU, Midlothian, Scotland.	veronica.vanheyningen@igmm.ed.ac.uk; dirk-jan.kleinjan@igmm.ed.ac.uk	Divizia, Maria Teresa/AAC-1622-2021; van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022; Divizia, Maria Teresa/AAB-1120-2020	Divizia, Maria Teresa/0000-0002-8776-0015; van Heyningen, Veronica/0000-0003-0359-0141; Damante, Giuseppe/0000-0003-2312-4009	National Institutes of Health [1RO1 EY01 8000-02]; EU [Health-F4-2009-223262]; Medical Research Council UK; MRC [MC_U127527199, MC_PC_U127527199] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY022954, R01EY018000] Funding Source: NIH RePORTER; Medical Research Council [MC_PC_U127527199, MC_U127527199] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the affected individual and parents for their cooperation with the study. We thank Nick Hastie, David Fitzpatrick, Bob Hill, Jacky Guy, and Nick Gilbert for comments on the manuscript; Kathy Williamson for the original aniridia mutation screening of the PAX6 exonic regions; Philippe Gautier and Hajime Ogino for bio-informatics support; and Emma Murdoch, Jacek Mendrychowski, and Harris Morrison for technical assistance. The iTol2AMP plasmid used in BAG recombineering was kindly provided by K. Kawakami. S.B. was supported by National Institutes of Health grant 1RO1 EY01 8000-02. H.B. was supported by EU collaborative project NeuroXsys Health-F4-2009-223262. Work at the IGMM Human Genetics Unit was supported by the Medical Research Council UK.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Coutinho P, 2011, GENOME RES, V21, P1349, DOI 10.1101/gr.124115.111; Davis-Silberman N, 2005, HUM MOL GENET, V14, P2265, DOI 10.1093/hmg/ddi231; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; Fish MB, 2012, GENESIS, V50, P307, DOI 10.1002/dvg.20819; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hingorani M, 2012, EUR J HUM GENET, V20, P1011, DOI 10.1038/ejhg.2012.100; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Kleinjan Dirk-Jan, 2009, Briefings in Functional Genomics & Proteomics, V8, P317, DOI 10.1093/bfgp/elp022; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Lettice LA, 2008, HUM MOL GENET, V17, P978, DOI 10.1093/hmg/ddm370; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; PLAZA S, 1995, MOL CELL BIOL, V15, P892; Ravi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003177; Robinson DO, 2008, AM J MED GENET A, V146A, P558, DOI 10.1002/ajmg.a.32209; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Suster Maximiliano L, 2009, Methods Mol Biol, V561, P41, DOI 10.1007/978-1-60327-019-9_3; Wang SW, 2009, MOL BIOTECHNOL, V42, P110, DOI 10.1007/s12033-009-9142-3; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Wolf LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004159; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Xu PX, 1999, DEVELOPMENT, V126, P383	38	111	119	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1126	1134		10.1016/j.ajhg.2013.10.028	http://dx.doi.org/10.1016/j.ajhg.2013.10.028			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24290376	Green Published, Bronze			2022-12-18	WOS:000328521300012
J	Sacconi, S; Lemmers, RJLF; Balog, J; van der Vliet, PJ; Lahaut, P; van Nieuwenhuizen, MP; Straasheijm, KR; Debipersad, RD; Vos-Versteeg, M; Salviati, L; Casarin, A; Pegoraro, E; Tawil, R; Bakker, E; Tapscott, SJ; Desnuelle, C; van der Maarel, SM				Sacconi, Sabrina; Lemmers, Richard J. L. F.; Balog, Judit; van der Vliet, Patrick J.; Lahaut, Pauline; van Nieuwenhuizen, Merlijn P.; Straasheijm, Kirsten R.; Debipersad, Rashmie D.; Vos-Versteeg, Marianne; Salviati, Leonardo; Casarin, Alberto; Pegoraro, Elena; Tawil, Rabi; Bakker, Egbert; Tapscott, Stephen J.; Desnuelle, Claude; van der Maarel, Silvere M.			The FSHD2 Gene SMCHD1 Is a Modifier of Disease Severity in Families Affected by FSHD1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; MOLECULAR DIAGNOSIS; DNA REARRANGEMENTS; POPULATION ANALYSIS; DUX4 EXPRESSION; D4Z4; PHENOTYPE; 4Q35; HYPOMETHYLATION; SUBTELOMERES	Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is caused by contraction of the D4Z4 repeat array on chromosome 4 to a size of 1-10 units. The residual number of D4Z4 units inversely correlates with clinical severity, but significant clinical variability exists. Each unit contains a copy of the DUX4 retrogene. Repeat contractions are associated with changes in D4Z4 chromatin structure that increase the likelihood of DUX4 expression in skeletal muscle, but only when the repeat resides in a genetic background that contains a DUX4 polyadenylation signal. Mutations in the structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1) gene, encoding a chromatin modifier of D4Z4, also result in the increased likelihood of DUX4 expression in individuals with a rare form of FSHD (FSHD2). Because SMCHD1 directly binds to D4Z4 and suppresses somatic expression of DUX4, we hypothesized that SMCHD1 may act as a genetic modifier in FSHD1. We describe three unrelated individuals with FSHD1 presenting an unusual high clinical severity based on their upper-sized FSHD1 repeat array of nine units. Each of these individuals also carries a mutation in the SMCHD1 gene. Familial carriers of the FSHD1 allele without the SMCHD1 mutation were only mildly affected, suggesting a modifier effect of the SMCHD1 mutation. Knocking down SMCHD1 in FSHD1 myotubes increased DUX4 expression, lending molecular support to a modifier role for SMCBD1 in FSHD1. We conclude that FSHD1 and FSHD2 share a common pathophysiological pathway in which the PSHD2 gene can act as modifier for disease severity in families affected by FSHD1.	[Sacconi, Sabrina; Lahaut, Pauline; Desnuelle, Claude] Univ Hosp Nice, Neuromuscular Dis Ctr, F-06000 Nice, France; [Sacconi, Sabrina; Desnuelle, Claude] Univ Nice, Fac Med, IBV, CNRS,UMR7277, F-06108 Nice, France; [Lemmers, Richard J. L. F.; Balog, Judit; van der Vliet, Patrick J.; Straasheijm, Kirsten R.; Debipersad, Rashmie D.; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [van Nieuwenhuizen, Merlijn P.; Vos-Versteeg, Marianne; Bakker, Egbert] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Salviati, Leonardo; Casarin, Alberto] Univ Padua, Dept Woman & Child Hlth, Clin Genet Unit, I-35128 Padua, Italy; [Salviati, Leonardo; Casarin, Alberto] Citta Speranza, Inst Ric Pediat, I-35128 Padua, Italy; [Pegoraro, Elena] Univ Padua, NPSRR, Dept Neurosci, I-35128 Padua, Italy; [Tawil, Rabi] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	CHU Nice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Padua; Fondazione Citta della Speranza; University of Padua; University of Rochester; Fred Hutchinson Cancer Center	Sacconi, S (corresponding author), Univ Hosp Nice, Neuromuscular Dis Ctr, F-06000 Nice, France.	sacconi@unice.fr	Bakker, Egbert/D-3525-2009; Salviati, Leonardo/L-1007-2016; van der Maarel, Silvere/X-3631-2018; SACCONI, Sabrina/AFT-1096-2022	Bakker, Egbert/0000-0002-2843-7357; Salviati, Leonardo/0000-0001-5642-9963; van der Maarel, Silvere/0000-0001-8103-711X; SACCONI, Sabrina/0000-0002-0246-1455; Tapscott, Stephen/0000-0002-0319-0968	US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke [NINDS]) [P01NS069539]; US National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS]) [R01AR045203]; Muscular Dystrophy Association (MDA) [217596]; Fields Center for FSHD Research; Geraldi Norton and Eklund family foundation; FSH Society; Friends of FSH Research; French Association Against Myopathies (AFM); European Union [7 2012-305121]; Prinses Beatrix Spierfonds [W.OR-12-20]; Stichting FSHD; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke [NINDS])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health (NIH) (National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Fields Center for FSHD Research; Geraldi Norton and Eklund family foundation; FSH Society; Friends of FSH Research; French Association Against Myopathies (AFM)(Association Francaise contre les Myopathies); European Union(European Commission); Prinses Beatrix Spierfonds; Stichting FSHD; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all families for participating in this study. This work was supported by grants from the US National Institutes of Health (NIH) (National Institute of Neurological Disorders and Stroke [NINDS] P01NS069539 and National Institute of Arthritis and Musculoskeletal and Skin Diseases [NIAMS] R01AR045203), the Muscular Dystrophy Association (MDA; 217596), the Fields Center for FSHD Research, the Geraldi Norton and Eklund family foundation, the FSH Society, The Friends of FSH Research, the French Association Against Myopathies (AFM), European Union Framework Programme 7 2012-305121 (NEUROMICS), the Prinses Beatrix Spierfonds (W.OR-12-20), and the Stichting FSHD.	Balog J, 2012, EPIGENETICS-US, V7, P579, DOI 10.4161/epi.20001; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Butz M, 2003, J NEUROL, V250, P932, DOI 10.1007/s00415-003-1116-y; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Emond MJ, 2012, NAT GENET, V44, P886, DOI 10.1038/ng.2344; Felice Kevin J, 2005, J Clin Neuromuscul Dis, V6, P119, DOI 10.1097/01.cnd.0000158302.79014.c4; Gendrel A.V., DEV CELL, V23, P265; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; GOTO K, 1995, NEUROMUSCULAR DISORD, V5, P201, DOI 10.1016/0960-8966(94)00055-E; Hamilton BA, 2012, PLOS GENET, V8, P326, DOI 10.1371/journal.pgen.1002644; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Jones TI, 2012, HUM MOL GENET, V21, P4419, DOI 10.1093/hmg/dds284; Landouzy L, 1885, REV MED, V5, P81; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2010, AM J HUM GENET, V86, P364, DOI 10.1016/j.ajhg.2010.01.035; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; LUNT PW, 1995, MUSCLE NERVE       S, V2, P103; Mitsuhashi H, 2013, HUM MOL GENET, V22, P568, DOI 10.1093/hmg/dds467; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; Padberg GW, 1982, THESIS LEIDEN U LEID; Pandya S, 2008, PHYS THER, V88, P105, DOI 10.2522/ptj.20070104; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Ricci G, 2012, NEUROMUSCULAR DISORD, V22, P534, DOI 10.1016/j.nmd.2011.12.001; Rudnik-Schoneborn S, 2008, NEUROMUSCULAR DISORD, V18, P881, DOI 10.1016/j.nmd.2008.06.387; Sacconi S, 2006, NEUROLOGY, V67, P1464, DOI 10.1212/01.wnl.0000240071.62540.6f; Sacconi S, 2012, J MED GENET, V49, P41, DOI 10.1136/jmedgenet-2011-100101; Scionti I, 2012, AM J HUM GENET, V90, P628, DOI 10.1016/j.ajhg.2012.02.019; Scionti I, 2012, J MED GENET, V49, P171, DOI 10.1136/jmedgenet-2011-100454; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; Tonini MMO, 2004, NEUROMUSCULAR DISORD, V14, P33, DOI 10.1016/j.nmd.2003.07.001; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; Upadhyaya M, 1997, J MED GENET, V34, P476, DOI 10.1136/jmg.34.6.476; van der Maarel SM, 2012, CURR OPIN NEUROL, V25, P614, DOI 10.1097/WCO.0b013e328357f22d; van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; Wallace LM, 2012, MOL THER, V20, P1417, DOI 10.1038/mt.2012.68; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Zatz M, 1998, AM J MED GENET, V77, P155, DOI 10.1002/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.3.CO;2-G; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559; Zhang YZ, 2001, ANN GENET-PARIS, V44, P105, DOI 10.1016/S0003-3995(01)01075-9	52	111	115	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					744	751		10.1016/j.ajhg.2013.08.004	http://dx.doi.org/10.1016/j.ajhg.2013.08.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24075187	Green Published, Bronze			2022-12-18	WOS:000326305600016
J	Moore, DJ; Onoufriadis, A; Shoemark, A; Simpson, MA; zur Lage, PI; de Castro, SC; Bartoloni, L; Gallone, G; Petridi, S; Woollard, WJ; Antony, D; Schmidts, M; Didonna, T; Makrythanasis, P; Bevillard, J; Mongan, NP; Djakow, J; Pals, G; Lucas, JS; Marthin, JK; Nielsen, KG; Santoni, F; Guipponi, M; Hogg, C; Antonarakis, SE; Emes, RD; Chung, EMK; Greene, NDE; Blouin, JL; Jarman, AP; Mitchison, HM				Moore, Daniel J.; Onoufriadis, Alexandros; Shoemark, Amelia; Simpson, Michael A.; zur Lage, Petra I.; de Castro, Sandra C.; Bartoloni, Lucia; Gallone, Giuseppe; Petridi, Stavroula; Woollard, Wesley J.; Antony, Dinu; Schmidts, Miriam; Didonna, Teresa; Makrythanasis, Periklis; Bevillard, Jeremy; Mongan, Nigel P.; Djakow, Jana; Pals, Gerard; Lucas, Jane S.; Marthin, June K.; Nielsen, Kim G.; Santoni, Federico; Guipponi, Michel; Hogg, Claire; Antonarakis, Stylianos E.; Emes, Richard D.; Chung, Eddie M. K.; Greene, Nicholas D. E.; Blouin, Jean-Louis; Jarman, Andrew P.; Mitchison, Hannah M.			Mutations in ZMYND10, a Gene Essential for Proper Axonemal Assembly of Inner and Outer Dynein Arms in Humans and Flies, Cause Primary Ciliary Dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; ELECTRON-MICROSCOPY; REGULATORY COMPLEX; DEFECTS; FAMILY; EXPRESSION; HEARING; MEMBER; DIFFERENTIATION; RANDOMIZATION	Primary ciliary dyskinesia (PCD) is a ciliopathy characterized by airway disease, infertility, and laterality defects, often caused by dual loss of the inner dynein arms (IDAs) and outer dynein arms (ODAs), which power cilia and flagella beating. Using whole-exome and candidate-gene Sanger resequencing in PCD-affected families afflicted with combined IDA and ODA defects, we found that 6/38 (16%) carried biallelic mutations in the conserved zinc-finger gene BLU (ZMYND10). ZMYND10 mutations conferred dynein-arm loss seen at the ultrastructural and immunofluorescence level and complete cilia immotility, except in hypomorphic p.Val16Gly (c.47T>G) homozygote individuals, whose cilia retained a stiff and slowed beat. In mice, Zmynd10 mRNA is restricted to regions containing motile cilia. In a Drosophila model of PCD, Zmynd10 is exclusively expressed in cells with motile cilia: chordotonal sensory neurons and sperm. In these cells, P-element-mediated gene silencing caused IDA and ODA defects, proprioception deficits, and sterility due to immotile sperm. Drosophila Zmynd10 with an equivalent c.47T>G (p.Val16Gly) missense change rescued mutant male sterility less than the wild-type did. Tagged Drosophila ZMYND10 is localized primarily to the cytoplasm, and human ZMYND10 interacts with LRRC6, another cytoplasmically localized protein altered in PCD. Using a fly model of PCD, we conclude that ZMYND10 is a cytoplasmic protein required for IDA and ODA assembly and that its variants cause ciliary dysmotility and PCD with laterality defects.	[Moore, Daniel J.; zur Lage, Petra I.; Gallone, Giuseppe; Jarman, Andrew P.] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Onoufriadis, Alexandros; Petridi, Stavroula; Antony, Dinu; Schmidts, Miriam] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Onoufriadis, Alexandros; de Castro, Sandra C.; Petridi, Stavroula; Antony, Dinu; Schmidts, Miriam; Greene, Nicholas D. E.; Mitchison, Hannah M.] UCL, Inst Child Hlth, Birth Defects Res Ctr, London WC1N 1EH, England; [Shoemark, Amelia; Hogg, Claire] Royal Brompton & Harefield NHS Fdn Trust, Dept Paediat Resp Med, London SW3 6NP, England; [Simpson, Michael A.; Woollard, Wesley J.] Kings Coll London, Sch Med, Div Genet & Mol Med, Guys Hosp, London SE1 9RT, England; [de Castro, Sandra C.; Greene, Nicholas D. E.] UCL, Inst Child Hlth, Neural Dev Unit, London WC1N 1EH, England; [Bartoloni, Lucia; Didonna, Teresa; Makrythanasis, Periklis; Bevillard, Jeremy; Santoni, Federico; Guipponi, Michel; Antonarakis, Stylianos E.; Blouin, Jean-Louis] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; [Mongan, Nigel P.; Emes, Richard D.] Univ Nottingham, Sch Vet Med & Sci, Loughborough LE12 5RD, Leics, England; [Djakow, Jana] Charles Univ Prague, Fac Med 2, Dept Paediat, Prague 15006 5, Czech Republic; [Djakow, Jana] Motol Univ Hosp, Prague 15006 5, Czech Republic; [Pals, Gerard] Med Ctr, Med Ctr, Dept Clin Genet, NL-1077 MC Amsterdam, Netherlands; [Lucas, Jane S.] Univ Southampton, NIHR Resp Biomed Res Unit, Primary Ciliary Dyskinesia Ctr, Southampton SO16 6YD, Hants, England; [Lucas, Jane S.] Univ Hosp Southampton NHS Fdn Trust, Southampton SO16 6YD, Hants, England; [Marthin, June K.; Nielsen, Kim G.] Univ Copenhagen Hosp, Dept Paediat & Adolescent Med, Paediat Pulm Serv, DK-2100 Copenhagen, Denmark; [Guipponi, Michel; Antonarakis, Stylianos E.; Blouin, Jean-Louis] Univ Hosp Geneva, Div Med Genet, CH-1211 Geneva 4, Switzerland; [Antonarakis, Stylianos E.] Univ Geneva, Ctr Med Univ Geneva, Inst Genet & Genom, CH-1211 Geneva 4, Switzerland; [Emes, Richard D.] Univ Nottingham, Adv Data Anal Ctr, Loughborough LE12 5RD, Leics, England; [Chung, Eddie M. K.] UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, London WC1E 6DE, England	University of Edinburgh; University of London; University College London; University of London; University College London; Royal Brompton & Harefield NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; University of Geneva; University of Nottingham; Charles University Prague; Motol University Hospital; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Copenhagen; University of Geneva; University of Geneva; University of Nottingham; University of London; University College London	Jarman, AP (corresponding author), Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	andrew.jarman@ed.ac.uk	Schmidts, Miriam/A-3777-2012; Shoemark, Amelia/I-4068-2019; Bartoloni, Lucia/I-2504-2013; Nielsen, KG/AAE-6575-2020; Lucas, Jane S/C-3620-2013; Simpson, Michael/F-4737-2011; Emes, Richard D/C-5341-2008; Makrythanasis, Periklis/AAD-7180-2019; Mongan, Nigel/B-7410-2011; Antonarakis, Stylianos E/N-8866-2014	Schmidts, Miriam/0000-0002-1714-6749; Shoemark, Amelia/0000-0001-7360-6060; Nielsen, KG/0000-0001-5906-9449; Simpson, Michael/0000-0002-8539-8753; Emes, Richard D/0000-0001-6855-5481; Antonarakis, Stylianos E/0000-0001-8907-5823; Greene, Nicholas D.E./0000-0002-4170-5248; Lucas, Jane/0000-0001-8701-9975; Pals, Gerard/0000-0003-4091-7115; Toddie-Moore, Daniel/0000-0002-8043-9763; Jarman, Andrew/0000-0003-4036-5701; Mongan, Nigel/0000-0001-5438-1126; Santoni, Federico/0000-0002-3258-4747	Gebert Foundation; Swiss National Science Foundation [32003B_135709]; Milena Carvajal Pro-Kartagener Foundation of Geneva; Bodossakis Foundation; Action Medical Research UK Clinical Training Fellowship [RTF-1411]; Action Medical Research [GN1773, GN2101]; Newlife Foundation for Disabled Children UK [10-11/15]; Medical Research Council of Great Britain [MR/K018558/10]; Biotechnology and Biological Sciences Research Council; Medical Research Council;  [ERC 249968];  [SNF 144082]; MRC [MR/K018558/1] Funding Source: UKRI; Medical Research Council [MR/K018558/1] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1299] Funding Source: researchfish; Action Medical Research [1773, 2101] Funding Source: researchfish	Gebert Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Milena Carvajal Pro-Kartagener Foundation of Geneva; Bodossakis Foundation; Action Medical Research UK Clinical Training Fellowship; Action Medical Research; Newlife Foundation for Disabled Children UK; Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; Action Medical Research	We would like to thank all the primary ciliary dyskinesia (PCD)-affected families for their participation in the study, Fiona Copeland, and the UK PCD Family Support Group. We wish to acknowledge the contribution of Bjorn Afzelius, who originally ascertained the GVA-09 family. We thank Jeanette Dankert-Roelse, Maggie Meeks, Celia D. Delozier, and R. Mark Gardiner for family recruitment and their past involvement in the project. We thank Paul Griffin, Sarah Ollosson, Mellisa Dixon, Patricia Goggin, Claire Jackson, and Maria Philipsen for light and electron microscopy. We acknowledge technical assistance from Panagiotis Maghsoudlou, Corinne Gehrig, and Anne Vannier. The pBID-UASC-GV plasmid was a gift from B. McCabe. S.E.A. is supported by a Gebert Foundation grant and grants ERC 249968 and SNF 144082. J.-L.B. is supported by grants from the Swiss National Science Foundation (#32003B_135709). J.-L.B., L.B., and H.M.M. are supported by grants from the Milena Carvajal Pro-Kartagener Foundation of Geneva. P.M. is supported by a grant from the Bodossakis Foundation. M.S. is supported by an Action Medical Research UK Clinical Training Fellowship (RTF-1411). A.O., S.P., E.M.K.C., and H.M.M. are supported by Action Medical Research awards GN1773 and GN2101 and Newlife Foundation for Disabled Children UK award 10-11/15. P.I.z.L. and A.P.J. are supported by the Medical Research Council of Great Britain (MR/K018558/10). D.J.M. and G.G. are supported by studentships from the Biotechnology and Biological Sciences Research Council and the Medical Research Council, respectively.	Afzelius BA, 1998, THORAX, V53, P894, DOI 10.1136/thx.53.10.894; Agathanggelou A, 2003, ONCOGENE, V22, P1580, DOI 10.1038/sj.onc.1206243; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnaiz O, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap022; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Blouin JL, 2000, EUR J HUM GENET, V8, P109, DOI 10.1038/sj.ejhg.5200429; Bower R, 2013, MOL BIOL CELL, V24, P1134, DOI 10.1091/mbc.E12-11-0801; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Bukowy-Bieryllo Z, 2013, PEDIATR PULM, V48, P352, DOI 10.1002/ppul.22632; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Cachero S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000568; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chang JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012847; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Fatima R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027822; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Geremek M, 2011, HUM GENET, V129, P283, DOI 10.1007/s00439-010-0922-4; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gopfert MC, 2003, P NATL ACAD SCI USA, V100, P5514, DOI 10.1073/pnas.0737564100; Gopfert MC, 2005, P NATL ACAD SCI USA, V102, P325, DOI 10.1073/pnas.0405741102; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Hyde SJ, 2010, P NATL ACAD SCI USA, V107, P20305, DOI 10.1073/pnas.1010436107; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Jarman AP, 2002, HUM MOL GENET, V11, P1215, DOI 10.1093/hmg/11.10.1215; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kavlie RG, 2010, GENETICS, V185, P177, DOI 10.1534/genetics.110.114009; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kester HA, 1999, J BIOL CHEM, V274, P27439, DOI 10.1074/jbc.274.39.27439; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Lee J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011012; Liang X, 2011, CYTOSKELETON, V68, P1, DOI 10.1002/cm.20493; Lindemann CB, 2010, J CELL SCI, V123, P519, DOI 10.1242/jcs.051326; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Newton FG, 2012, DEV CELL, V22, P1221, DOI 10.1016/j.devcel.2012.05.010; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raff EC, 2008, CURR BIOL, V18, P911, DOI 10.1016/j.cub.2008.05.031; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Shoemark A, 2012, J CLIN PATHOL, V65, P267, DOI 10.1136/jclinpath-2011-200415; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263	66	111	118	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					346	356		10.1016/j.ajhg.2013.07.009	http://dx.doi.org/10.1016/j.ajhg.2013.07.009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23891471	Green Published, hybrid			2022-12-18	WOS:000323186200015
J	Boukhris, A; Schule, R; Loureiro, JL; Lourenco, CM; Mundwiller, E; Gonzalez, MA; Charles, P; Gauthier, J; Rekik, I; Lebrigio, RFA; Gaussen, M; Speziani, F; Ferbert, A; Feki, I; Caballero-Oteyza, A; Dionne-Laporte, A; Amri, M; Noreau, A; Forlani, S; Cruz, VT; Mochel, F; Coutinho, P; Dion, P; Mhiri, C; Schols, L; Pouget, J; Darios, F; Rouleau, GA; Marques, W; Brice, A; Durr, A; Zuchner, S; Stevanin, G				Boukhris, Amir; Schule, Rebecca; Loureiro, Jose L.; Lourenco, Charles Marques; Mundwiller, Emeline; Gonzalez, Michael A.; Charles, Perrine; Gauthier, Julie; Rekik, Imen; Acosta Lebrigio, Rafael F.; Gaussen, Marion; Speziani, Fiorella; Ferbert, Andreas; Feki, Imed; Caballero-Oteyza, Andres; Dionne-Laporte, Alexandre; Amri, Mohamed; Noreau, Anne; Forlani, Sylvie; Cruz, Vitor T.; Mochel, Fanny; Coutinho, Paula; Dion, Patrick; Mhiri, Chokri; Schols, Ludger; Pouget, Jean; Darios, Frederic; Rouleau, Guy A.; Marques, Wilson; Brice, Alexis; Durr, Alexandra; Zuchner, Stephan; Stevanin, Giovanni			Alteration of Ganglioside Biosynthesis Responsible for Complex Hereditary Spastic Paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICE; GENETICS; DEGENERATION; MYELINATION; MAINTENANCE; MUTATION; DEFECTS; ROLES; FORM	Hereditary spastic paraplegias (HSPs) form a heterogeneous group of neurological disorders. A whole-genome linkage mapping effort was made with three HSP-affected families from Spain, Portugal, and Tunisia and it allowed us to reduce the SPG26 locus interval from 34 to 9 Mb. Subsequently, a targeted capture was made to sequence the entire exome of affected individuals from these three families, as well as from two additional autosomal-recessive HSP-affected families of German and Brazilian origins. Five homozygous truncating (n = 3) and missense (n = 2) mutations were identified in B4GALNT1. After this finding, we analyzed the entire coding region of this gene in 65 additional cases, and three mutations were identified in two subjects. All mutated cases presented an early-onset spastic paraplegia, with frequent intellectual disability, cerebellar ataxia, and peripheral neuropathy as well as cortical atrophy and white matter hyperintensities on brain imaging. B4GALNT1 encodes beta-1,4-N-acetyl-galactosaminyl transferase 1 (B4GALNT1), involved in ganglioside biosynthesis. These findings confirm the increasing interest of lipid metabolism in HSPs. Interestingly, although the catabolism of gangliosides is implicated in a variety of neurological diseases, SPG26 is only the second human disease involving defects of their biosynthesis.	[Boukhris, Amir; Rekik, Imen; Feki, Imed; Amri, Mohamed; Mhiri, Chokri] Hop Univ Habib Bourguiba, Serv Neurol, Sfax 3029, Tunisia; [Boukhris, Amir; Feki, Imed; Mhiri, Chokri] Univ Sfax, Fac Med, Sfax 3029, Tunisia; [Boukhris, Amir; Rekik, Imen; Gaussen, Marion; Forlani, Sylvie; Mochel, Fanny; Darios, Frederic; Stevanin, Giovanni] Inst Natl Sante & Rech Medicate, Unite 975, F-75013 Paris, France; [Schule, Rebecca; Caballero-Oteyza, Andres; Schols, Ludger] Univ Tubingen, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Schule, Rebecca; Caballero-Oteyza, Andres; Schols, Ludger] Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Loureiro, Jose L.; Cruz, Vitor T.; Coutinho, Paula] Inst Mol & Cellular Biol, UnIGENe & Ctr Genet Predit Prevent, P-4050 Oporto, Portugal; [Lourenco, Charles Marques; Marques, Wilson] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurol, BR-14049900 Ribeirao Preto, SP, Brazil; [Mundwiller, Emeline; Brice, Alexis; Stevanin, Giovanni] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Gonzalez, Michael A.; Acosta Lebrigio, Rafael F.; Speziani, Fiorella; Zuchner, Stephan] Univ Miami, Miller Sch Med, Dept Human Genet, Miami, FL 33136 USA; [Gonzalez, Michael A.; Acosta Lebrigio, Rafael F.; Zuchner, Stephan] Univ Miami, Miller Sch Med, Hussman Inst Human Gen, Miami, FL 33136 USA; [Charles, Perrine; Mochel, Fanny; Brice, Alexis; Durr, Alexandra; Stevanin, Giovanni] Hop La Pitie Salpetriere, APHP, F-75013 Paris, France; [Gauthier, Julie; Dionne-Laporte, Alexandre; Noreau, Anne; Dion, Patrick] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Gaussen, Marion; Forlani, Sylvie; Mochel, Fanny; Darios, Frederic; Brice, Alexis; Durr, Alexandra; Stevanin, Giovanni] Univ Paris 06, Pitie Salpetriere Hosp, Ctr Rech Inst Cerveau & Moelle Epiniere, Unite Mixte Rech S975, F-75013 Paris, France; [Gaussen, Marion; Mochel, Fanny; Darios, Frederic; Brice, Alexis; Durr, Alexandra; Stevanin, Giovanni] Ctr Natl Rech Sci, Unite Mixte Rech 7225, F-75013 Paris, France; [Gaussen, Marion] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Ecole Prat Hautes Etud, Neurogenet Team, F-75013 Paris, France; [Ferbert, Andreas] Klinikum Kassel, Dept Neurol, D-34125 Kassel, Germany; [Dion, Patrick] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal H2L 2W5, PQ, Canada; [Schols, Ludger] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; CHU Timone, Ctr Reference Malad Neuromusculaires & SLA, F-13005 Marseille, France	Universite de Monastir; Hopital Fattouma Bourguiba; Universite de Sfax; Institut National de la Sante et de la Recherche Medicale (Inserm); Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Universidade do Porto; Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Miami; University of Miami; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; McGill University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Klinikum Kassel; Universite de Montreal; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Brice, A (corresponding author), Inst Natl Sante & Rech Medicate, Unite 975, F-75013 Paris, France.	alexis.brice@upmc.fr; giovanni.stevanin@upmc.fr	Lourenço, Charles M/O-2731-2013; Marques Junior, Wilson/G-4240-2012; Brice, Alexis/A-2170-2009; Coutinho, Paula/K-6053-2013; Schöls, Ludger/ABB-2482-2021; Stevanin, Giovanni/E-5038-2016; brice, alexis/AAE-8275-2019; Cruz, Vítor Tedim/AAM-3014-2020; Loureiro, José Leal/K-6379-2013; Schüle, Rebecca/B-5763-2019; MHIRI, Chokri/O-8801-2014	Marques Junior, Wilson/0000-0002-4589-2749; Schöls, Ludger/0000-0001-7774-5025; Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Cruz, Vítor Tedim/0000-0002-5333-4771; Loureiro, José Leal/0000-0002-6195-5412; Schüle, Rebecca/0000-0002-7781-2766; MHIRI, Chokri/0000-0001-7591-6994; Caballero Garcia de Oteyza, Andres/0000-0002-8892-1255; Coutinho, Paula/0000-0002-3461-230X; Darios, Frederic/0000-0001-9800-5990	French-Tunisian Cooperation Project; INSERM (France); DGRSRT (Tunisia); VERUM Foundation; French Agency for Research (ANR); Association Francaise contre les Myopathies ("LIGENAX"); Strumpell-Lorrain association; Deutsches Zentrum fur Neurodegenerative Erkrankungen; Interdisziplinaren Zentrums fur Klinische Forschung University of Tubingen [1970-0-0]; European Community with the ANR; program "Investissements d'avenir" [ANR-10-IAIHU-06]; Canadian Institutes of Health Research [119191]; National Institutes of Health [R01NS072248]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072248] Funding Source: NIH RePORTER	French-Tunisian Cooperation Project; INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); DGRSRT (Tunisia); VERUM Foundation; French Agency for Research (ANR)(French National Research Agency (ANR)); Association Francaise contre les Myopathies ("LIGENAX")(Association Francaise contre les Myopathies); Strumpell-Lorrain association; Deutsches Zentrum fur Neurodegenerative Erkrankungen; Interdisziplinaren Zentrums fur Klinische Forschung University of Tubingen; European Community with the ANR(French National Research Agency (ANR)); program "Investissements d'avenir"(French National Research Agency (ANR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to the family members who participated in this study, to M.A.M. Salih and M. Koenig for family referral, and to S. Trefouret and P. Ribai as well as the DNA and cell Bank of CRICM and the Centre National de Genotypage (Evry, France) for their help. This work was financially supported by the French-Tunisian Cooperation Project (to A. Brice and C.M.) led by INSERM (France) and DGRSRT (Tunisia), the VERUM Foundation (to A. Brice), the French Agency for Research (ANR) (to G.S. and A.D.), the Association Francaise contre les Myopathies ("LIGENAX" to G.S.), the Strumpell-Lorrain association (to the SPATAX network), the Deutsches Zentrum fur Neurodegenerative Erkrankungen (to L.S.), the Interdisziplinaren Zentrums fur Klinische Forschung University of Tubingen (grant 1970-0-0 to R.S.), and the European Community with the ANR ("Eurospa" project to A. Brice and L.S.; 7th Framework Programme Neuromics to A. Brice). This study also benefited from funding from the program "Investissements d'avenir" ANR-10-IAIHU-06 (to the Brain and Spine Institute, Paris), a Canadian Institutes of Health Research grant (#119191) entitled "Emerging Team to identify and characterize novel and existing Hereditary Spastic Paraplegia (HSP) disease genes," and a National Institutes of Health grant (R01NS072248 to S.Z.).	BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; Boukhris A, 2010, NEUROGENETICS, V11, P441, DOI 10.1007/s10048-010-0249-2; Cox TM, 2001, J INHERIT METAB DIS, V24, P106; Fink JK, 2006, CURR NEUROL NEUROSCI, V6, P65, DOI 10.1007/s11910-996-0011-1; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; FISHMAN PH, 1975, SCIENCE, V187, P68, DOI 10.1126/science.803227; Gonzalez MA, 2013, HUM MUTAT, V34, P842, DOI 10.1002/humu.22305; HARDING AE, 1983, LANCET, V1, P1151; Ma Q, 2003, ARCH HISTOL CYTOL, V66, P37, DOI 10.1679/aohc.66.37; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; MAX SR, 1974, NEW ENGL J MED, V291, P929, DOI 10.1056/NEJM197410312911802; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ohmi Y, 2012, NEUROCHEM RES, V37, P1185, DOI 10.1007/s11064-012-0764-7; Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x; Schule R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Stevanin G, 2004, ANN NEUROL, V55, P97, DOI 10.1002/ana.10798; Stevanin G, 2008, CURR NEUROL NEUROSCI, V8, P198, DOI 10.1007/s11910-008-0032-z; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; Wilkinson PA, 2005, J MED GENET, V42, P80, DOI 10.1136/jmg.2004.020172; Wu GS, 2001, P NATL ACAD SCI USA, V98, P307, DOI 10.1073/pnas.011523698; Xu YH, 2010, J LIPID RES, V51, P1643, DOI 10.1194/jlr.R003996	28	111	115	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					118	123		10.1016/j.ajhg.2013.05.006	http://dx.doi.org/10.1016/j.ajhg.2013.05.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23746551	Green Published, Bronze			2022-12-18	WOS:000321804500011
J	Baranzini, SE; Khankhanian, P; Patsopoulos, NA; Li, M; Stankovich, J; Cotsapas, C; Sondergaard, HB; Ban, M; Barizzone, N; Bergamaschi, L; Booth, D; Buck, D; Cavalla, P; Celius, EG; Comabella, M; Comi, G; Compston, A; Cournu-Rebeix, I; D'alfonso, S; Damotte, V; Din, L; Dubois, B; Elovaara, I; Esposito, F; Fontaine, B; Franke, A; Goris, A; Gourraud, PA; Graetz, C; Guerini, FR; Guillot-Noel, L; Hafler, D; Hakonarson, H; Hall, P; Hamsten, A; Harbo, HF; Hemmer, B; Hillert, J; Kemppinen, A; Kockum, I; Koivisto, K; Larsson, M; Lathrop, M; Leone, M; Lill, CM; Macciardi, F; Martin, R; Martinelli, V; Martinelli-Boneschi, F; McCauley, JL; Myhr, KM; Naldi, P; Olsson, T; Oturai, A; Pericak-Vance, MA; Perla, F; Reunanen, M; Saarela, J; Saker-Delye, S; Salvetti, M; Sellebjerg, F; Sorensen, PS; Spurkland, A; Stewart, G; Taylor, B; Tienari, P; Winkelmann, J; Zipp, F; Ivinson, AJ; Haines, JL; Sawcer, S; DeJager, P; Hauser, SL; Oksenberg, JR				Baranzini, Sergio E.; Khankhanian, Pouya; Patsopoulos, Nikolaos A.; Li, Michael; Stankovich, Jim; Cotsapas, Chris; Sondergaard, Helle Bach; Ban, Maria; Barizzone, Nadia; Bergamaschi, Laura; Booth, David; Buck, Dorothea; Cavalla, Paola; Celius, Elisabeth G.; Comabella, Manuel; Comi, Giancarlo; Compston, Alastair; Cournu-Rebeix, Isabelle; D'alfonso, Sandra; Damotte, Vincent; Din, Lennox; Dubois, Benedicte; Elovaara, Irina; Esposito, Federica; Fontaine, Bertrand; Franke, Andre; Goris, An; Gourraud, Pierre-Antoine; Graetz, Christiane; Guerini, Franca R.; Guillot-Noel, Lena; Hafler, David; Hakonarson, Hakon; Hall, Per; Hamsten, Anders; Harbo, Hanne F.; Hemmer, Bernhard; Hillert, Jan; Kemppinen, Anu; Kockum, Ingrid; Koivisto, Keijo; Larsson, Maim; Lathrop, Mark; Leone, Maurizio; Lill, Christina M.; Macciardi, Fabio; Martin, Roland; Martinelli, Vittorio; Martinelli-Boneschi, Filippo; McCauley, Jacob L.; Myhr, Kjell-Morten; Naldi, Paola; Olsson, Tomas; Oturai, Annette; Pericak-Vance, Margaret A.; Perla, Franco; Reunanen, Mauri; Saarela, Janna; Saker-Delye, Safa; Salvetti, Marco; Sellebjerg, Finn; Sorensen, Per Soelberg; Spurkland, Anne; Stewart, Graeme; Taylor, Bruce; Tienari, Pentti; Winkelmann, Juliane; Zipp, Frauke; Ivinson, Adrian J.; Haines, Jonathan L.; Sawcer, Stephen; DeJager, Philip; Hauser, Stephen L.; Oksenberg, Jorge R.		Int Multiple Sclerosis Genetics Co; Wellcome Trust Case Control Consor	Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DISEASE GENES; RISK ALLELES; SUSCEPTIBILITY; VARIANTS; COMMON; LOCI; SNP	Multiple sclerosis (MS) is an inflammatory CNS disease with a substantial genetic component, originally mapped to only the human leukocyte antigen (HLA) region. In the last 5 years, a total of seven genome-wide association studies and one meta-analysis successfully identified 57 non-HLA susceptibility loci. Here, we merged nominal statistical evidence of association and physical evidence of interaction to conduct a protein-interaction-network-based pathway analysis (PINBPA) on two large genetic MS studies comprising a total of 15,317 cases and 29,529 controls. The distribution of nominally significant loci at the gene level matched the patterns of extended linkage disequilibrium in regions of interest. We found that products of genome-wide significantly associated genes are more likely to interact physically and belong to the same or related pathways. We next searched for subnetworks (modules) of genes (and their encoded proteins) enriched with nominally associated loci within each study and identified those modules in common between the two studies. We demonstrate that these modules are more likely to contain genes with bona fide susceptibility variants and, in addition, identify several high-confidence candidates (including BCL10, CD48, REL, TRAF3, and TEC). PINBPA is a powerful approach to gaining further insights into the biology of associated genes and to prioritizing candidates for subsequent genetic studies of complex traits.				sergio.baranzini@ucsf.edu	Lill, Christina/J-9449-2015; Hauser, Stephen L/J-2978-2016; Leone, Maurizio A./J-4130-2016; D'Alfonso, Sandra/K-7295-2014; Goris, An/F-2943-2010; Salvetti, Marco/K-3836-2016; Haines, Jonathan/C-3374-2012; Hemmer, Bernhard/GPX-8451-2022; Franke, Andre/B-2151-2010; Hemmer, Bernhard/AAT-8388-2021; Macciardi, Fabio/N-3768-2014; Gourraud, Pierre-Antoine FD/O-3024-2015; Tienari, Pentti J/A-4893-2012; Bergamaschi, Laura/ABE-1175-2020; Martinelli, Vittorio/AAN-7240-2020; Saarela, Janna S/E-5369-2014; Celius, Elisabeth Gulowsen/S-1387-2019; Goris, An/L-5852-2019; Myhr, Kjell-Morten/H-1528-2018; Kockum, Ingrid/O-8781-2018; Lill, Christina M/GSI-4054-2022; Zipp, Frauke/C-9968-2015; Damotte, Vincent/ABH-4760-2020; Dubois, Benedicte/A-4338-2019	Lill, Christina/0000-0002-2805-1307; Leone, Maurizio A./0000-0002-6339-5738; D'Alfonso, Sandra/0000-0002-3983-9925; Goris, An/0000-0002-1276-6682; Haines, Jonathan/0000-0002-4351-4728; Hemmer, Bernhard/0000-0001-5985-6784; Franke, Andre/0000-0003-1530-5811; Macciardi, Fabio/0000-0003-0537-4266; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Goris, An/0000-0002-1276-6682; Myhr, Kjell-Morten/0000-0002-0980-510X; Kockum, Ingrid/0000-0002-0867-4726; Zipp, Frauke/0000-0002-1231-1928; Damotte, Vincent/0000-0002-7321-8575; Stankovich, Jim/0000-0001-9344-7749; Gourraud, Pierre-Antoine/0000-0003-1131-9554; Dubois, Benedicte/0000-0003-0604-8702; Sellebjerg, Finn/0000-0002-1333-9623; Saarela, Janna/0000-0002-0853-6219; Olsson, Tomas/0000-0002-2938-1877; Cotsapas, Chris/0000-0002-7772-5910; Martin, Roland/0000-0002-0982-1329; Baranzini, Sergio/0000-0003-0067-194X; Comabella Lopez, Manuel/0000-0002-2373-6657; Sondergaard, Helle Bach/0000-0001-9435-0658	Research Fund KU Leuven [OT/11/087]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS049477] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish	Research Fund KU Leuven(KU Leuven); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the research subjects, their families, and the healthy control individuals who participated in this study. S.E.B. and P.D.J. are Harry Weaver Neuroscience Scholars from the US National Multiple Sclerosis Society. B.D. is a clinical investigator of the Research Foundation Flanders (FWO-Vlaanderen), and A.G. and B.D. are supported by the Research Fund KU Leuven (OT/11/087).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Ban M, 2010, GENES IMMUN, V11, P660, DOI 10.1038/gene.2010.36; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Comabella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003490; Compston Alastair., 2005, MCALPINES MULTIPLE S, V4th; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberle MA, 2007, PLOS GENET, V3, P1827, DOI 10.1371/journal.pgen.0030170; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hauser MA, 2003, HUM MOL GENET, V12, P671, DOI 10.1093/hmg/ddg070; Hauser SL, 2012, HARRISONS PRINCIPLES, P3395; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Jakkula E, 2010, AM J HUM GENET, V86, P285, DOI 10.1016/j.ajhg.2010.01.017; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Jia PL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S15; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee YH, 2012, MOL BIOL REP, V39, P10627, DOI 10.1007/s11033-012-1952-x; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Fernandez RM, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-103; Nischwitz S, 2010, J NEUROIMMUNOL, V227, P162, DOI 10.1016/j.jneuroim.2010.06.003; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2008, BRAIN, V131, P3118, DOI 10.1093/brain/awn081; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006	41	111	115	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					854	865		10.1016/j.ajhg.2013.04.019	http://dx.doi.org/10.1016/j.ajhg.2013.04.019			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23731539	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000320415300003
J	Wei, Z; Wang, W; Bradfield, J; Li, J; Cardinale, C; Frackelton, E; Kim, C; Mentch, F; Van Steen, K; Visscher, PM; Baldassano, RN; Hakonarson, H				Wei, Zhi; Wang, Wei; Bradfield, Jonathan; Li, Jin; Cardinale, Christopher; Frackelton, Edward; Kim, Cecilia; Mentch, Frank; Van Steen, Kristel; Visscher, Peter M.; Baldassano, Robert N.; Hakonarson, Hakon		Int IBD Genetics Consortium	Large Sample Size, Wide Variant Spectrum, and Advanced Machine-Learning Technique Boost Risk Prediction for Inflammatory Bowel Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CROHNS-DISEASE; SELECTION; METAANALYSIS; ASSOCIATION; NUMBER; LOCI	We performed risk assessment for Crohn's disease (CD) and ulcerative colitis (UC), the two common forms of inflammatory bowel disease (IBD), by using data from the International IBD Genetics Consortium's Immunochip project. This data set contains similar to 17,000 CD cases, similar to 13,000 UC cases, and similar to 22,000 controls from 15 European countries typed on the Immunochip. This custom chip provides a more comprehensive catalog of the most promising candidate variants by picking up the remaining common variants and certain rare variants that were missed in the first generation of GWAS. Given this unprecedented large sample size and wide variant spectrum, we employed the most recent machine-learning techniques to build optimal predictive models. Our final predictive models achieved areas under the curve (AUCs) of 0.86 and 0.83 for CD and UC, respectively, in an independent evaluation. To our knowledge, this is the best prediction performance ever reported for CD and UC to date.	[Wei, Zhi; Wang, Wei] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Bradfield, Jonathan; Li, Jin; Cardinale, Christopher; Frackelton, Edward; Kim, Cecilia; Mentch, Frank; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; [Van Steen, Kristel] Univ Liege, Syst & Modeling Unit, Inst Montefiore, B-4000 Cointe Ougree, Belgium; [Van Steen, Kristel] Univ Liege, GIGA R, B-4000 Cointe Ougree, Belgium; [Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Visscher, Peter M.] Univ Queensland, Diamantina Inst, Brisbane, Qld 4072, Australia; [Baldassano, Robert N.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19102 USA	New Jersey Institute of Technology; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Liege; University of Liege; University of Queensland; University of Queensland; University of Pennsylvania	Wei, Z (corresponding author), New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA.	zhiwei04@gmail.com; hakonarson@email.chop.edu	Visscher, Peter/ABB-6151-2020; D'Amato, Mauro/B-5050-2019; D'Amato, Mauro/F-2450-2010; , AndyWei/H-4415-2012; Franke, Andre/B-2151-2010; Cardinale, Christopher J./G-3351-2013	Visscher, Peter/0000-0002-2143-8760; D'Amato, Mauro/0000-0003-2743-5197; D'Amato, Mauro/0000-0003-2743-5197; Franke, Andre/0000-0003-1530-5811; Cardinale, Christopher J./0000-0001-7513-8977; Van Steen, Kristel/0000-0001-9868-5033; Wei, Zhi/0000-0001-6059-4267	NIGMS NIH HHS [P01 GM099568] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham G, 2013, GENET EPIDEMIOL, V37, P184, DOI 10.1002/gepi.21698; Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Austin E, 2013, STAT ANAL DATA MIN, V6, P315, DOI 10.1002/sam.11183; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Fan JQ, 2010, STAT SINICA, V20, P101; Fan JQ, 2008, ANN STAT, V36, P2605, DOI 10.1214/07-AOS504; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Hall P, 2005, J R STAT SOC B, V67, P427, DOI 10.1111/j.1467-9868.2005.00510.x; Hastie T., 2009, SPRINGER, V2nd, DOI DOI 10.1007/978-0-387-21606-5; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kang J, 2011, HUM MOL GENET, V20, P2435, DOI 10.1093/hmg/ddr116; Kooperberg C, 2010, GENET EPIDEMIOL, V34, P643, DOI 10.1002/gepi.20509; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Peeters M, 1996, GASTROENTEROLOGY, V111, P597, DOI 10.1053/gast.1996.v111.pm8780562; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Zhang H.H., 2008, J R STAT SOC B, V70, P849; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	21	111	116	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					1008	1012		10.1016/j.ajhg.2013.05.002	http://dx.doi.org/10.1016/j.ajhg.2013.05.002			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23731541	Green Published, Bronze			2022-12-18	WOS:000320415300019
J	Nieminen, P; Morgan, NV; Fenwick, AL; Parmanen, S; Veistinen, L; Mikkola, ML; van der Spek, PJ; Giraud, A; Judd, L; Arte, S; Brueton, LA; Wall, SA; Mathijssen, IMJ; Maher, ER; Wilkie, AOM; Kreiborg, S; Thesleff, I				Nieminen, Pekka; Morgan, Neil V.; Fenwick, Aimee L.; Parmanen, Satu; Veistinen, Lotta; Mikkola, Marja L.; van der Spek, Peter J.; Giraud, Andrew; Judd, Louise; Arte, Sirpa; Brueton, Louise A.; Wall, Steven A.; Mathijssen, Irene M. J.; Maher, Eamonn R.; Wilkie, Andrew O. M.; Kreiborg, Sven; Thesleff, Irma			Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BONE MORPHOGENETIC PROTEIN-2; RECEPTOR ALPHA-CHAIN; INTERLEUKIN-11 RECEPTOR; EXPRESSION; GP130; MOUSE; MECHANISMS; IL-11; DIFFERENTIATION; IDENTIFICATION	Craniosynostosis and supernumerary teeth most often occur as isolated developmental anomalies, but they are also separately manifested in several malformation syndromes. Here, we describe a human syndrome featuring craniosynostosis, maxillary hypoplasia, delayed tooth eruption, and supernumerary teeth. We performed homozygosity mapping in three unrelated consanguineous Pakistani families and localized the syndrome to a region in chromosome 9. Mutational analysis of candidate genes in the region revealed that all affected children harbored homozygous missense mutations (c.662C>G [p.Pro221Arg], c.734C>G [p.Ser245Cys] or c.886C>T [p.Arg296Trp]) in IL11RA (encoding interleukin 11 receptor, alpha) on chromosome 9p13.3. In addition, a homozygous nonsense mutation, c.475C>T (p.Gln159X), and a homozygous duplication, c.916_924dup (p.Thr306_Ser308dup), were observed in two north European families. In cell-transfection experiments, the p.Arg296Trp mutation rendered the receptor unable to mediate the IL11 signal, indicating that the mutation causes loss of IL11RA function. We also observed disturbed cranial growth and suture activity in the IL11ra null mutant mice, in which reduced size and remodeling of limb bones has been previously described. We conclude that IL11 signaling is essential for the normal development of craniofacial bones and teeth and that its function is to restrict suture fusion and tooth number. The results open up the possibility of modulation of IL11 signaling for the treatment of craniosynostosis.	[Nieminen, Pekka; Parmanen, Satu; Veistinen, Lotta; Arte, Sirpa] Univ Helsinki, Biomedicum, Inst Dent, FIN-00014 Helsinki, Finland; [Morgan, Neil V.; Brueton, Louise A.; Maher, Eamonn R.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin Expt Med, Ctr Rare Dis & Personalised Med, Birmingham B15 2TT, W Midlands, England; [Fenwick, Aimee L.; Wilkie, Andrew O. M.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Mikkola, Marja L.; Thesleff, Irma] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [van der Spek, Peter J.] Erasmus MC Dept Bioinformat Ee1540, NL-3000 CA Rotterdam, Netherlands; [Giraud, Andrew; Judd, Louise] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Arte, Sirpa] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, FIN-00029 Helsinki, Finland; [Brueton, Louise A.; Maher, Eamonn R.] Birmingham Womens Hosp, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England; [Wall, Steven A.; Wilkie, Andrew O. M.] Oxford Radcliffe Hosp NHS Trust, John Radcliffe Hosp, Oxford Craniofacial Unit, Oxford OX3 9DU, England; [Mathijssen, Irene M. J.] Erasmus MC Dept Plast Surg HS509, NL-3000 CA Rotterdam, Netherlands; [Kreiborg, Sven] Univ Copenhagen, Sch Dent, Dept Pediat Dent & Clin Sci, DK-2200 Copenhagen N, Denmark; [Kreiborg, Sven] Copenhagen Univ Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark	University of Helsinki; University of Birmingham; University of Oxford; University of Helsinki; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Helsinki; Helsinki University Central Hospital; Birmingham Women's Hospital; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Copenhagen; University of Copenhagen	Nieminen, P (corresponding author), Univ Helsinki, Biomedicum, Inst Dent, POB 63, FIN-00014 Helsinki, Finland.	pekka.nieminen@helsinki.fi	Mathijssen, Irene M.J./B-1955-2013; Morgan, Neil V/A-5475-2009; MAHER, EAMONN R/A-9507-2008; Wilkie, Andrew/AAC-3820-2020	Morgan, Neil V/0000-0001-6433-5692; MAHER, EAMONN R/0000-0002-6226-6918; Wilkie, Andrew/0000-0002-2972-5481; Judd, Louise/0000-0003-3613-4839; Jones, Aimee/0000-0003-0279-1814	Academy of Finland; Finnish Dental Society Apollonia; Sigrid Juselius Foundation; HUCH EVO; WellChild; Wellcome Trust [078666]	Academy of Finland(Academy of Finland); Finnish Dental Society Apollonia; Sigrid Juselius Foundation(Sigrid Juselius Foundation); HUCH EVO; WellChild; Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful for Brendan Jenkins and Meegan Howlett in Melbourne, Australia, for collecting the mouse heads. We thank Lorraine Robb and Tracy Willson, Melbourne, for the plasmid containing human IL11RA cDNA and Syed Qasim Mehdi and Sayed Hajan Shah for providing Pakistani control DNA samples. The skilful technical help of Riikka Santalahti, Merja Makinen, Marjatta Kivekas, Hanne Ahola, Maarit Hakkarainen, and Raija Savolainen is gratefully acknowledged. We thank Steve Twigg for help in curating the Oxford craniosynostosis samples and Clare Taylor for help with clinical review. We also thank Shanaz Pasha for help with collecting DNA and Louise Tee and Tim Forshew for genotyping the families. The project has been funded by the Academy of Finland (I.T.), Finnish Dental Society Apollonia (L.V., S.A.), the Sigrid Juselius Foundation (I.T.), HUCH EVO (RN., S.A.), WellChild (N.V.M., E.R.M.), and Wellcome Trust (A.O.M.W; Programme Grant 078666).	Aberg T, 2004, DEV BIOL, V270, P76, DOI 10.1016/j.ydbio.2004.02.012; Ahlen J, 2002, BONE, V31, P242, DOI 10.1016/S8756-3282(02)00784-6; [Anonymous], NETCGLYC; [Anonymous], DBSNP; [Anonymous], POLYPHEN; Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Cohen MM, 2000, CRANIOSYNOSTOSIS DIA, V2nd; Coussens AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-458; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Dahmen H, 1998, BIOCHEM J, V331, P695, DOI 10.1042/bj3310695; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Du XX, 1996, J CELL PHYSIOL, V168, P362; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Graves DT, 2002, BONE, V31, P282, DOI 10.1016/S8756-3282(02)00829-3; Haavikko K, 1971, Suom Hammaslaak Toim, V67, P219; Hajihosseini MK, 2001, P NATL ACAD SCI USA, V98, P3855, DOI 10.1073/pnas.071586898; Hill PA, 1998, ENDOCRINOLOGY, V139, P1564, DOI 10.1210/en.139.4.1564; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Howlett M, 2009, BBA-MOL CELL RES, V1793, P1623, DOI 10.1016/j.bbamcr.2009.07.009; IDA M, 1981, ORAL SURG ORAL MED O, V52, P2, DOI 10.1016/0030-4220(81)90164-X; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jenkins BJ, 2007, BLOOD, V109, P2380, DOI 10.1182/blood-2006-08-040352; JENSEN BL, 1990, J ORAL PATHOL MED, V19, P89, DOI 10.1111/j.1600-0714.1990.tb00803.x; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Kiessling S, 2004, J BIOL CHEM, V279, P10304, DOI 10.1074/jbc.M312757200; Kreiborg S., 2000, CRANIOSYNOSTOSIS DIA, V2nd ed, P158; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Leon ER, 2007, J PERIODONTAL RES, V42, P527, DOI 10.1111/j.1600-0765.2007.00977.x; Marks SC, 1996, ANAT RECORD, V245, P374, DOI 10.1002/(SICI)1097-0185(199606)245:2<374::AID-AR18>3.0.CO;2-M; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nandurkar HH, 1997, BLOOD, V90, P2148; NEUHAUS H, 1994, DEV BIOL, V166, P531, DOI 10.1006/dbio.1994.1335; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Proff P, 2009, CLIN ORAL INVEST, V13, P355, DOI 10.1007/s00784-009-0268-2; Rice David P., 2008, V12, P22, DOI 10.1159/000115030; Rice DPC, 2005, CURR MOL MED, V5, P699, DOI 10.2174/156652405774641043; Rice DPC, 1997, BONE, V21, P479, DOI 10.1016/S8756-3282(97)00182-8; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Romas E, 1996, J EXP MED, V183, P2581, DOI 10.1084/jem.183.6.2581; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Sims NA, 2009, MOL CELL ENDOCRINOL, V310, P30, DOI 10.1016/j.mce.2008.08.025; Sobel E, 1996, AM J HUM GENET, V58, P1323; Suga K, 2004, J INTERF CYTOK RES, V24, P343, DOI 10.1089/107999004323142204; Suga K, 2003, J INTERF CYTOK RES, V23, P203, DOI 10.1089/107999003765027401; Suga K, 2001, J INTERF CYTOK RES, V21, P695, DOI 10.1089/107999001753124435; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Thesleff I, 2005, ENCY LIFE SCI; Twigg SRF, 2009, DEV DYNAM, V238, P331, DOI 10.1002/dvdy.21790; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509; YANG YC, 1992, BIOFACTORS, V4, P15; Yang YC, 1995, ANN NY ACAD SCI, V762, P31; Zhu J F, 1996, J Clin Pediatr Dent, V20, P87	61	111	117	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					67	81		10.1016/j.ajhg.2011.05.024	http://dx.doi.org/10.1016/j.ajhg.2011.05.024			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21741611	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000293041700006
J	Lasky-Su, J; Lyon, HN; Emilsson, V; Heid, IM; Molony, C; Raby, BA; Lazarus, R; Klanderman, B; Soto-Quiros, ME; Avila, L; Silverman, EK; Thorleifsson, G; Thorsteinsdottir, U; Kronenberg, F; Vollmert, C; Illig, T; Fox, CS; Levy, D; Laird, N; Ding, X; McQueen, MB; Butler, J; Ardlie, K; Papoutsakis, C; Dedoussis, G; O'Donnell, CJ; Wichmann, HE; Celedon, JC; Schadt, E; Hirschhorn, J; Weiss, ST; Stefansson, K; Lange, C				Lasky-Su, Jessica; Lyon, Helen N.; Emilsson, Valur; Heid, Iris M.; Molony, Cliona; Raby, Benjamin A.; Lazarus, Ross; Klanderman, Barbara; Soto-Quiros, Manuel E.; Avila, Lydiana; Silverman, Edwin K.; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Kronenberg, Florian; Vollmert, Caren; Illig, Thomas; Fox, Caroline S.; Levy, Daniel; Laird, Nan; Ding, Xiao; McQueen, Matt B.; Butler, Johannah; Ardlie, Kristin; Papoutsakis, Constantina; Dedoussis, George; O'Donnell, Christopher J.; Wichmann, H. -Erich; Celedon, Juan C.; Schadt, Eric; Hirschhorn, Joel; Weiss, Scott T.; Stefansson, Kari; Lange, Christoph			On the replication of genetic associations: Timing can be everything!	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; RECEPTOR LEPR POLYMORPHISMS; LINKAGE; VARIANT; PHENOTYPES; DISEASE	The failure of researchers to replicate genetic-association findings is most commonly attributed to insufficient statistical power, population stratification, or various forms of between-study heterogeneity or environmental influences.' Here, we illustrate another potential cause for nonreplications that has so far not received much attention in the literature. We illustrate that the strength of a genetic effect can vary by age, causing "age-varying associations." If not taken into account during the design and the analysis of a study, age-varying genetic associations can cause nonreplication. By using the 100K SNP scan of the Framingham Heart Study, we identified an age-varying association between a SNP in ROBO1 and obesity and hypothesized an age-gene interaction. This finding was followed up in eight independent samples comprising 13,584 individuals. The association was replicated in five of the eight studies, showing an age-dependent relationship (one-sided combined p = 3.92 x 10(-9), combined p value from pediatric cohorts = 2.21 X 10(-8), combined p value from adult cohorts = 0.00422). Furthermore, this study illustrates that it is difficult for cross-sectional study designs to detect age-varying associations. If the specifics of age- or time-varying genetic effects are not considered in the selection of both the follow-up samples and in the statistical analysis, important genetic associations may be missed.	[Lasky-Su, Jessica] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Lasky-Su, Jessica; Raby, Benjamin A.; Lazarus, Ross; Klanderman, Barbara; Silverman, Edwin K.; Celedon, Juan C.; Weiss, Scott T.; Lange, Christoph] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Heid, Iris M.; Vollmert, Caren; Illig, Thomas; Wichmann, H. -Erich] GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; [Heid, Iris M.; Wichmann, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-80539 Munich, Germany; [Emilsson, Valur; Thorleifsson, Gudmar] DeCode Genet, IS-101 Reykjavik, Iceland; [Lyon, Helen N.; Butler, Johannah; Hirschhorn, Joel] Childrens Hosp, Program Genom, Div Genet, Boston, MA 02115 USA; [Lyon, Helen N.; Butler, Johannah; Hirschhorn, Joel] Childrens Hosp, Program Genom, Div Endocrinol, Boston, MA 02115 USA; [Lyon, Helen N.; Butler, Johannah; Ardlie, Kristin; Hirschhorn, Joel] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lyon, Helen N.; Butler, Johannah; Ardlie, Kristin; Hirschhorn, Joel] MIT, Cambridge, MA 02142 USA; [Lyon, Helen N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Soto-Quiros, Manuel E.; Avila, Lydiana] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Div Pediat Pulmonol, San Jose, Costa Rica; [Fox, Caroline S.; Levy, Daniel; O'Donnell, Christopher J.] NHLBI, Framingham, MA 01702 USA; [Fox, Caroline S.; Levy, Daniel; O'Donnell, Christopher J.] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Laird, Nan; Ding, Xiao; Lange, Christoph] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [McQueen, Matt B.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Emilsson, Valur; Molony, Cliona; Schadt, Eric] Rosetta Inpharmat, Seattle, WA 98109 USA; [Hirschhorn, Joel] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Papoutsakis, Constantina; Dedoussis, George] Harokopio Univ, Dept Nutr & Dietet, Athens 17671, Greece	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Medical University of Innsbruck; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Boulder; Merck & Company; Harvard University; Harvard Medical School; Harokopio University Athens	Lasky-Su, J (corresponding author), SUNY Upstate Med Univ, Syracuse, NY 13210 USA.	jessica.a.su@gmail.com; clange@hsph.harvard.edu	Stefansson, Kari/AAE-7187-2019; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021; Wichmann, Heinz Erich/AAA-5695-2022; Avila, Lydiana/D-5638-2015; Genetic Epidemiology, Innsbruck Med.Univ./C-2095-2008; Raby, Benjamin/AAK-3866-2021; Kronenberg, Florian/B-1736-2008; Dedoussis, George/AAN-7252-2021	Levy, Daniel/0000-0003-1843-8724; Avila, Lydiana/0000-0002-9579-1591; Kronenberg, Florian/0000-0003-2229-1120; Dedoussis, George/0000-0002-7798-6221; lazarus, ross/0000-0003-3939-1961; Emilsson, Valur/0000-0001-9982-0524	NHLBI NIH HHS [N01-HR-16052, N01-HR-16044, P01 HL083069, U01 HL65899, N01-HR-16049, N01HC25195, R01 HL066289, R37 HL066289, K01 HL004370, N01-HC-25195, N01-HR-16046, N01HR16044, N01-HR-16047, N01-HR-16050, HL04370, HL066289, N01-HR-16045, U01 HL065899, N01-HR-16048, P01HL083069, N01-HR-16051] Funding Source: Medline; NICHD NIH HHS [R01 HD060726] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; DIVISION OF LUNG DISEASES [N01HR016045, N01HR016048, N01HR016047, N01HR016051, N01HR016044, N01HR016052, N01HR016046, N01HR016050, N01HR016049] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL083069, R37HL066289, R01HL066289, ZIAHL006001, U01HL065899, K01HL004370, Z01HL006002] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Gorlova OY, 2003, EUR J HUM GENET, V11, P425, DOI 10.1038/sj.ejhg.5200979; Gulcher JR, 2000, NEW ENGL J MED, V342, P1827, DOI 10.1056/NEJM200006153422411; Hall DH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-83; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Heid IM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027011; Heo M, 2002, INT J OBESITY, V26, P640, DOI 10.1038/sj.ijo.0801990; Heo M, 2001, GENETICS, V159, P1163; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jellema A, 2003, DIABETOLOGIA, V46, P990, DOI 10.1007/s00125-003-1126-4; Kannel W B, 2000, Curr Hypertens Rep, V2, P239, DOI 10.1007/s11906-000-0004-4; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; LANGE C, 2004, STAT APPL GENET MOL, V3; Lyon H, 2004, GENET EPIDEMIOL, V26, P155, DOI 10.1002/gepi.10298; Lyon HN, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030061; Lyon HN, 2006, DIABETES, V55, P3180, DOI 10.2337/db06-0407; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Papoutsakis C, 2007, CLIN CHEM LAB MED, V45, P309, DOI 10.1515/CCLM.2007.080; Rosskopf D, 2007, SCIENCE, V315, DOI [10.1126/science.1130571, 10.1126/science.1129402, 10.1126/science.1130012]; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Swarbrick MM, 2005, PLOS BIOL, V3, P1662, DOI 10.1371/journal.pbio.0030315; TANG K, 1995, NUCLEIC ACIDS RES, V23, P3126, DOI 10.1093/nar/23.16.3126; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582	31	111	113	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					849	858		10.1016/j.ajhg.2008.01.018	http://dx.doi.org/10.1016/j.ajhg.2008.01.018			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18387595	Green Published, Bronze			2022-12-18	WOS:000255103900004
J	Ramser, J; Ahearn, ME; Lenski, C; Yariz, KO; Hellebrand, H; von Rhein, M; Clark, RD; Schmutzler, RK; Lichtner, P; Hoffman, EP; Meindl, A; Baumbach-Reardon, L				Ramser, Juliane; Ahearn, Mary Ellen; Lenski, Claus; Yariz, Kemal O.; Hellebrand, Heide; von Rhein, Michael; Clark, Robin D.; Schmutzler, Rita K.; Lichtner, Peter; Hoffman, Eric P.; Meindl, Alfons; Baumbach-Reardon, Lisa			Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTRACELLULAR PROTEIN-DEGRADATION; GENE; METHYLATION; SURVIVAL; DISEASES; PATHWAY	X-linked infantile spinal muscular atrophy (XL-SMA) is an X-linked disorder presenting with the clinical features hypotonia, areflexia, and multiple congenital contractures (arthrogryposis) associated with loss of anterior horn cells and infantile death. To identify the XL-SMA disease gene, we performed large-scale mutation analysis in genes located between markers DXS8080 and DXS7132 (Xp11.3-Xq11.1). This resulted in detection of three rare novel variants in exon 15 of UBE1 that segregate with disease: two missense mutations (c.1617 G -> T, p.Met539Ile; c.1639 A -> G, p.Ser547Gly) present each in one XL-SMA family, and one synonymous C-T substitution (c.1731 C -> T, p.Asn577Asn) identified in another three unrelated families. Absence of the missense mutations was demonstrated for 3550 and absence of the synonymous mutation was shown in 7914 control X chromosomes; therefore, these results yielded statistical significant evidence for the association of the synonymous substitution and the two missense mutations with XL-SMA (p = 2.416 x 10(-10), p = 0.001815). We also demonstrated that the svnonymous C -> T substitution leads to significant reduction of UBE1 expression and alters the methylation pattern of exon 15, implying a plausible role of this DNA element in developmental UBE1 expression in humans. Our observations indicate first that XL-SMA is part of a growing list of neurodegenerative disorders associated with defects in the ubiquitin-proteasome pathway and second that synonymous C -> T transitions might have the potential to affect gene expression.	[Ramser, Juliane; Lenski, Claus; Hellebrand, Heide; Meindl, Alfons] Tech Univ Munich, Dept Obstet & Gynecol, D-81675 Munich, Germany; [Ahearn, Mary Ellen; Yariz, Kemal O.; Baumbach-Reardon, Lisa] Univ Miami, Miller Sch Med, Dr John T Macdonald Ctr Med Genet, Miami, FL 33136 USA; [von Rhein, Michael] Univ Childrens Hosp Mainz, Dept Neuropediat, D-55101 Mainz, Germany; [Clark, Robin D.] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA; [Schmutzler, Rita K.] Univ Cologne, Dept Gynecol & Obstet, D-50931 Cologne, Germany; [Lichtner, Peter] GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; [Hoffman, Eric P.] Childrens Natl Med Ctr, Res Ctr Genet Med, Washington, DC 20010 USA	Technical University of Munich; University of Miami; Loma Linda University; University of Cologne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Children's National Health System	Meindl, A (corresponding author), Tech Univ Munich, Dept Obstet & Gynecol, D-81675 Munich, Germany.	alfons.meindl@lrz.tu-muenchen.de		Hoffman, Eric/0000-0001-6470-5139				Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; BANKER BQ, 1994, MYOLOGY, P1905; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Brahe C, 1996, J MOL MED-JMM, V74, P555, DOI 10.1007/s001090050059; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Dressman D, 2007, GENET MED, V9, P52, DOI 10.1097/GIM.0b013e31802d8353; Dubowitz V, 1991, Neuromuscul Disord, V1, P77, DOI 10.1016/0960-8966(91)90051-S; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; KOBAYASHI H, 1995, HUM MOL GENET, V4, P1213, DOI 10.1093/hmg/4.7.1213; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Nino-Soto MI, 2005, CYTOGENET GENOME RES, V111, P57, DOI 10.1159/000085671; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Tanaka K., 2004, BIOCHIM BIOPHYS ACTA, V1695, P226; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Thiselton DL, 2002, GENOMICS, V79, P560, DOI 10.1006/geno.2002.6733; Zerres K, 1997, NEUROMUSCULAR DISORD, V7, P202, DOI 10.1016/S0960-8966(97)00459-8	21	111	115	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					188	193		10.1016/j.ajhg.2007.09.009	http://dx.doi.org/10.1016/j.ajhg.2007.09.009			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179898	Bronze, Green Published			2022-12-18	WOS:000253223800020
J	Lafreniere, RG; MacDonald, MLE; Dube, MP; MacFarlane, J; O'Driscoll, M; Brais, B; Meilleur, S; Brinkman, RR; Dadivas, O; Pape, T; Platon, C; Radomski, C; Risler, J; Thompson, J; Guerra-Escobio, AM; Davar, G; Breakefield, XO; Pimstone, SN; Green, R; Pryse-Phillips, W; Goldberg, YP; Younghusband, HB; Hayden, MR; Sherrington, R; Rouleau, GA; Samuels, ME				Lafreniere, RG; MacDonald, MLE; Dube, MP; MacFarlane, J; O'Driscoll, M; Brais, B; Meilleur, S; Brinkman, RR; Dadivas, O; Pape, T; Platon, C; Radomski, C; Risler, J; Thompson, J; Guerra-Escobio, AM; Davar, G; Breakefield, XO; Pimstone, SN; Green, R; Pryse-Phillips, W; Goldberg, YP; Younghusband, HB; Hayden, MR; Sherrington, R; Rouleau, GA; Samuels, ME			Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the study of Canadian genetic isolates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NERVE GROWTH-FACTOR; LINKAGE ANALYSIS; FAMILIAL DYSAUTONOMIA; MUTATIONS; HYPERTENSION; RECEPTOR; KINASE; SPTLC1; PAIN	Hereditary sensory and autonomic neuropathy ( HSAN) type II is an autosomal recessive disorder characterized by impairment of pain, temperature, and touch sensation owing to reduction or absence of peripheral sensory neurons. We identified two large pedigrees segregating the disorder in an isolated population living in Newfoundland and performed a 5-cM genome scan. Linkage analysis identified a locus mapping to 12p13.33 with a maximum LOD score of 8.4. Haplotype sharing defined a candidate interval of 1.06 Mb containing all or part of seven annotated genes, sequencing of which failed to detect causative mutations. Comparative genomics revealed a conserved ORF corresponding to a novel gene in which we found three different truncating mutations among five families including patients from rural Quebec and Nova Scotia. This gene, termed "HSN2," consists of a single exon located within intron 8 of the PRKWNK1 gene and is transcribed from the same strand. The HSN2 protein may play a role in the development and/or maintenance of peripheral sensory neurons or their supporting Schwann cells.	Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Xenon Genet Res, Montreal, PQ, Canada; Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; McGill Univ, Neurosci Res Ctr, Montreal, PQ, Canada; Mem Univ Newfoundland, Discipline Genet, St Johns, NF, Canada; Mem Univ Newfoundland, Fac Med, St Johns, NF, Canada; Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Womens & Childrens Hosp, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada	Universite de Montreal; Universite de Montreal; McGill University; Memorial University Newfoundland; Memorial University Newfoundland; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of British Columbia	Samuels, ME (corresponding author), Xenon Genet Inc, Burnaby, BC V5G 4W8, Canada.	msamuels@xenongenetics.com	Brinkman, Ryan/B-1108-2008; Hayden, Michael R/D-8581-2011; Brais, Bernard/Y-3910-2019; Dubé, Marie-Pierre/B-9364-2008	Brinkman, Ryan/0000-0002-9765-2990; Hayden, Michael R/0000-0001-5159-1419; Dubé, Marie-Pierre/0000-0001-8442-4393; MacDonald, Marcia/0000-0001-7946-0023	NINDS NIH HHS [NS24279, P01 NS024279] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod F.B., 2002, CLIN AUTON RES S1, V12, pI2, DOI DOI 10.1007/S102860200014; Basu Sriparna, 2002, Indian Pediatr, V39, P870; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Davar G, 1996, PAIN, V67, P135, DOI 10.1016/0304-3959(96)03113-2; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Dyck P. J., 1993, PERIPHERAL NEUROPATH, V3rd, P1065; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; FERRIERE G, 1992, J CHILD NEUROL, V7, P364, DOI 10.1177/088307389200700406; HERNANDEZ EZ, 1994, GAC MED MEX, V130, P18; Hilz M. J, 2002, CLIN AUTON RES S1, V12, pI33, DOI DOI 10.1007/S10286020; Houlden H, 2001, ANN NEUROL, V49, P521; Kok C, 2003, AM J HUM GENET, V73, P632, DOI 10.1086/377591; KONDO K, 1974, ARCH NEUROL-CHICAGO, V30, P336, DOI 10.1001/archneur.1974.00490340064017; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KUMAR RK, 2002, J INDIAN SOC PEDOD P, V20, P51; LLEWELYN JG, 1991, BRAIN, V114, P867, DOI 10.1093/brain/114.2.867; Luciano CA, 2003, CURR OPIN NEUROL, V16, P403, DOI 10.1097/00019052-200306000-00022; Mardy S, 1999, AM J HUM GENET, V64, P1570, DOI 10.1086/302422; MURRAY TJ, 1973, BRAIN, V96, P387, DOI 10.1093/brain/96.2.387; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OGRYZLO MA, 1946, CAN MED ASSOC J, V54, P547; OHTA M, 1973, ARCH NEUROL-CHICAGO, V29, P23, DOI 10.1001/archneur.1973.00490250041005; Polydefkis M, 2002, NEUROLOGY, V58, P115, DOI 10.1212/WNL.58.1.115; Rahman P, 2003, HUM MOL GENET, V12, pR167, DOI 10.1093/hmg/ddg257; RODDIER K, 2003, 53 ANN M AM SOC HUM; Sanvito WL, 2003, ARQ NEURO-PSIQUIAT, V61, P654, DOI 10.1590/S0004-282X2003000400024; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Toscano E, 2002, ANN NEUROL, V52, P224, DOI 10.1002/ana.10245; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0	36	111	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					1064	1073		10.1086/420795	http://dx.doi.org/10.1086/420795			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15060842	Green Published, Bronze			2022-12-18	WOS:000220926100025
J	Laivuori, H; Lahermo, P; Ollikainen, V; Widen, E; Haiva-Mallinen, L; Sundstrom, H; Laitinen, T; Kaaja, R; Ylikorkala, O; Kere, J				Laivuori, H; Lahermo, P; Ollikainen, V; Widen, E; Haiva-Mallinen, L; Sundstrom, H; Laitinen, T; Kaaja, R; Ylikorkala, O; Kere, J			Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SCAN; METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM; COMPLEX TRAITS; POPULATION; GENE; HYPERTENSION; PREGNANCY; ANGIOTENSINOGEN; ECLAMPSIA; LINKAGE	Preeclampsia is a common, pregnancy-specific disorder characterized by reduced placental perfusion, endothelial dysfunction, elevated blood pressure, and proteinuria. The pathogenesis of this heterogeneous disorder is incompletely understood, but it has a familial component, which suggests that one or more common alleles may act as susceptibility genes. We hypothesized that, in a founder population, the genetic background of preeclampsia might also show reduced heterogeneity, and we have performed a genomewide scan in 15 multiplex families recruited predominantly in the Kainuu province in central eastern Finland. We found two loci that exceeded the threshold for significant linkage: chromosome 2p25, near marker D2S168 (nonparametric linkage [NPL] score 3.77; P = .000761) at 21.70 cM, and 9p13, near marker D9S169 (NPL score 3.74;) at P = .000821) at 38.90 cM. In addition, there was a locus showing suggestive linkage at chromosome 4q32 between D4S413 and D4S3046 (NPL score 3.13; P = .003238) at 163.00 cM. In the present study the susceptibility locus on chromosome 2p25 is clearly different (21.70 cM) from the locus at 2p12 found in an Icelandic study (94.05 cM) and the locus at 2q23 (144.7 cM) found in an Australian/New Zealand study. The locus at 9p13 has been shown to be a candidate region for type 2 diabetes in two recently published genomewide scans from Finland and China. The regions on chromosomes 2p25 and 9p13 may harbor susceptibility genes for preeclampsia.	Karolinska Inst, Novum, Dept Biosci, SE-14157 Huddinge, Sweden; Karolinska Inst, Clin Res Ctr, Huddinge, Sweden; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, Haartman Inst, FIN-00290 Helsinki, Finland; Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA USA; Kainuu Cent Hosp, Dept Obstet & Gynecol, Kajaani, Finland; Cent Hosp Cent Finland, Dept Obstet & Gynecol, Jyvaskyla, Finland	Karolinska Institutet; Karolinska Institutet; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Central Finland Central Hospital	Laivuori, H (corresponding author), Karolinska Inst, Novum, Dept Biosci, Halsovagen 7-9, SE-14157 Huddinge, Sweden.		Kere, Juha/AAX-9117-2021; Laivuori, Hannele/F-2953-2011; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Laivuori, Hannele/0000-0003-3212-7826; Kere, Juha/0000-0003-1974-0271				Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; ARNGRIMSSON R, 1993, NAT GENET, V4, P114, DOI 10.1038/ng0693-114; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; Arngrimsson R, 1997, AM J HUM GENET, V61, P354, DOI 10.1086/514843; Arya R, 2002, NAT GENET, V30, P102, DOI 10.1038/ng810; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Esplin MS, 2001, NEW ENGL J MED, V344, P867, DOI 10.1056/NEJM200103223441201; Guo GL, 1997, ELECTROPHORESIS, V18, P1646, DOI 10.1002/elps.1150180929; Harrison GA, 1997, AM J HUM GENET, V60, P1158; HAYWARD C, 1992, AM J HUM GENET, V50, P749; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; Kaaja R, 1999, METABOLISM, V48, P892, DOI 10.1016/S0026-0495(99)90225-1; Kere J, 2002, TRENDS MOL MED, V8, P197, DOI 10.1016/S1471-4914(02)02342-0; Kere J, 2001, ANNU REV GENOM HUM G, V2, P103, DOI 10.1146/annurev.genom.2.1.103; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lachmeijer AMA, 2001, EUR J HUM GENET, V9, P758, DOI 10.1038/sj.ejhg.5200706; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/88319; Laivuori H, 2000, OBSTET GYNECOL, V96, P277, DOI 10.1016/S0029-7844(00)00896-6; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Lindgren CM, 2002, AM J HUM GENET, V70, P509, DOI 10.1086/338629; Luo TH, 2001, DIABETOLOGIA, V44, P501, DOI 10.1007/s001250051649; Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; O'Shaughnessy KM, 1999, HYPERTENSION, V33, P1338, DOI 10.1161/01.HYP.33.6.1338; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Pipkin FB, 1999, BIOL NEONATE, V76, P325, DOI 10.1159/000014175; Powers RW, 1999, J SOC GYNECOL INVEST, V6, P74, DOI 10.1016/S1071-5576(98)00052-5; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Sohda S, 1997, J MED GENET, V34, P525, DOI 10.1136/jmg.34.6.525; Thornton JG, 1999, BRIT J OBSTET GYNAEC, V106, P570, DOI 10.1111/j.1471-0528.1999.tb08326.x; Treloar SA, 2001, AM J OBSTET GYNECOL, V184, P374, DOI 10.1067/mob.2001.109400; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; Watanabe H, 2001, THROMB HAEMOSTASIS, V86, P1594	38	111	116	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					168	177		10.1086/345311	http://dx.doi.org/10.1086/345311			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12474145	Bronze, Green Published			2022-12-18	WOS:000180186800017
J	Ilkovski, B; Cooper, ST; Nowak, K; Ryan, MM; Yang, N; Schnell, C; Durling, HJ; Roddick, LG; Wilkinson, I; Kornberg, AJ; Collins, KJ; Wallace, G; Gunning, P; Hardeman, EC; Laing, NG; North, KN				Ilkovski, B; Cooper, ST; Nowak, K; Ryan, MM; Yang, N; Schnell, C; Durling, HJ; Roddick, LG; Wilkinson, I; Kornberg, AJ; Collins, KJ; Wallace, G; Gunning, P; Hardeman, EC; Laing, NG; North, KN			Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BINDING-SITES; ISOFORM; ALPHA-ACTININ-3; DEFICIENCY; MYOSIN; HEART	Nemaline myopathy (NM) is a clinically and genetically heterogeneous disorder characterized by muscle weakness and the presence of nemaline bodies (rods) in skeletal muscle. Disease-causing mutations have been reported in five genes, each encoding a protein component of the sarcomeric thin filament. Recently, we identified mutations in the muscle alpha -skeletal-actin gene (ACTA1) in a subset of patients with NM. In the present study, we evaluated a new series of 35 patients with NM. We identified five novel missense mutations in ACTA1, which suggested that mutations in muscle alpha -skeletal actin account for the disease in similar to 15% of patients with NM. The mutations appeared de novo and represent new dominant mutations. One proband subsequently had two affected children, a result consistent with autosomal dominant transmission. The seven patients exhibited marked clinical variability, ranging from severe congenital-onset weakness, with death from respiratory failure during the 1st year of life, to a mild childhood-onset myopathy, with survival into adulthood. There was marked variation in both age at onset and clinical severity in the three affected members of one family. Common pathological features included abnormal fiber type differentiation, glycogen accumulation, myofibrillar disruption, and "whorling" of actin thin filaments. The percentage of fibers with rods did not correlate with clinical severity; however, the severe, lethal phenotype was associated with both severe, generalized disorganization of sarcomeric structure and abnormal localization of sarcomeric actin. The marked variability, in clinical phenotype, among patients with different mutations in ACTA1 suggests that both the site of the mutation and the nature of the amino acid change have differential effects on thin-filament formation and protein-protein interactions. The intrafamilial variability suggests that alpha -actin genotype is not the sole determinant of phenotype.	Childrens Hosp, Inst Neuromuscular Res, Westmead, NSW 2145, Australia; Childrens Hosp, Oncol Res Unit, Westmead, NSW 2145, Australia; Univ Sydney, Dept Paediat & Child Hlth, Sydney, NSW 2006, Australia; Childrens Med Res Inst, Muscle Dev Unit, Sydney, NSW, Australia; Univ Western Australia, Australian Neuromuscular Res Inst, Queen Elizabeth II Med Ctr, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia; Murdoch Univ, Div Vet & Biomed Sci, Murdoch, WA 6150, Australia; John Hunter Childrens Hosp, Newcastle, NSW, Australia; Royal Childrens Hosp, Childrens Neurosci Ctr, Dept Neurol, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Child Dev & Rehabil, Melbourne, Vic, Australia; Mater Childrens Hosp, Raymond Terrace, S Brisbane, Australia	University of Sydney; University of Sydney; University of Sydney; Children's Medical Research Institute - Australia; University of Sydney; University of Western Australia; Murdoch University; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne	North, KN (corresponding author), Childrens Hosp, Inst Neuromuscular Res, Locked Bag 4001, Westmead, NSW 2145, Australia.		North, Kathryn N/K-6476-2012; Wallace, Geoff/H-1252-2013; Hardeman, Edna C/F-8872-2012; Ryan, Monique Marie/AAG-9870-2019; Gunning, Peter W/E-9058-2010	North, Kathryn N/0000-0003-0841-8009; Wallace, Geoff/0000-0001-9306-3542; Cooper, Sandra/0000-0002-7314-5097; Gunning, Peter/0000-0003-0833-3128; Laing, Nigel/0000-0001-5111-3732; Ryan, Monique/0000-0001-6397-1910; Hardeman, Edna/0000-0003-1649-7712				ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V49, P921, DOI 10.1146/annurev.bi.49.070180.004421; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; BOHELER KR, 1991, J CLIN INVEST, V88, P323, DOI 10.1172/JCI115295; Collins Teresa, 1997, American Journal of Physiology, V273, pC1801; DONNER K, 2000, NEUROMUSCULAR DISORD, V10, P342; ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919; Goebel HH, 1997, NEUROMUSCULAR DISORD, V7, P160, DOI 10.1016/S0960-8966(97)00441-0; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KINGSTON RE, 1997, CURRENT PROTOCOLS MO; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lammens M, 1997, NEUROPEDIATRICS, V28, P116, DOI 10.1055/s-2007-973683; LEBART MC, 1993, J BIOL CHEM, V268, P5642; MEJEAN C, 1992, EUR J BIOCHEM, V209, P555, DOI 10.1111/j.1432-1033.1992.tb17320.x; MIIKE T, 1986, BRAIN DEV-JPN, V8, P526, DOI 10.1016/S0387-7604(86)80098-5; MIMURA N, 1987, J BIOL CHEM, V262, P4717; MOIR AJG, 1986, J INORG BIOCHEM, V28, P271, DOI 10.1016/0162-0134(86)80091-5; North KN, 1996, NEUROMUSCULAR DISORD, V6, P229, DOI 10.1016/0960-8966(96)00361-6; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; POLGAR J, 1973, J NEUROL SCI, V19, P307, DOI 10.1016/0022-510X(73)90094-4; SCHEVZOV G, 1993, J CELL BIOL, V121, P811, DOI 10.1083/jcb.121.4.811; SHETERLINE P, 1999, ACTIN 1 272; VOLPE P, 1982, NEUROLOGY, V32, P37, DOI 10.1212/WNL.32.1.37; Wallgren-Pettersson C, 2000, Neuromuscul Disord, V10, P299, DOI 10.1016/S0960-8966(99)00129-7	30	111	114	0	14	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1333	1343		10.1086/320605	http://dx.doi.org/10.1086/320605			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11333380	Green Published, Bronze			2022-12-18	WOS:000169094600004
J	de Knijff, P				de Knijff, P			Messages through bottlenecks: On the combined use of slow and fast evolving polymorphic markers on the human Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							COMMON ANCESTOR; ZFY INTRON; NEW-WORLD; POPULATION-STRUCTURE; HUMAN-EVOLUTION; MEN; DNA; AGE; MICROSATELLITES; HAPLOTYPES		Leiden Univ, Med Ctr, Dept Human & Clin Genet, MRC, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Knijff, P (corresponding author), Leiden Univ, Med Ctr, Dept Human & Clin Genet, MRC, POB 9503, NL-2300 RA Leiden, Netherlands.		de Knijff, Peter/Y-2519-2018	de Knijff, Peter/0000-0002-0899-771X				Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bertranpetit J, 2000, P NATL ACAD SCI USA, V97, P6927, DOI 10.1073/pnas.97.13.6927; BERTRANPETIT J, 1996, VARIATION HUMAN GENO, P97; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cooper G, 1999, P NATL ACAD SCI USA, V96, P11916, DOI 10.1073/pnas.96.21.11916; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; Donnelly P, 1996, SCIENCE, V272, P1357, DOI 10.1126/science.272.5266.1357; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; Fu YX, 1996, SCIENCE, V272, P1356, DOI 10.1126/science.272.5266.1356; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Jobling MA, 2000, TRENDS GENET, V16, P356, DOI 10.1016/S0168-9525(00)02057-6; Jobling MA, 1999, HUM MOL GENET, V8, P2117, DOI 10.1093/hmg/8.11.2117; Jobling MA, 1998, HUM MOL GENET, V7, P643, DOI 10.1093/hmg/7.4.643; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Lahermo P, 1999, EUR J HUM GENET, V7, P447, DOI 10.1038/sj.ejhg.5200316; PAABO S, 1995, SCIENCE, V268, P1141, DOI 10.1126/science.7761828; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Rogers J, 1996, SCIENCE, V272, P1360, DOI 10.1126/science.272.5266.1360; Ruiz-Linares A, 1999, P NATL ACAD SCI USA, V96, P6312, DOI 10.1073/pnas.96.11.6312; Santos FR, 2000, HUM MOL GENET, V9, P421, DOI 10.1093/hmg/9.3.421; Skorecki K, 1997, NATURE, V385, P32, DOI 10.1038/385032a0; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Weiss G, 1996, SCIENCE, V272, P1359, DOI 10.1126/science.272.5266.1359; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; WILLIAMS JT, 1993, HUM BIOL, V65, P167; Wilson IJ, 1998, GENETICS, V150, P499; Zerjal T, 1997, AM J HUM GENET, V60, P1174	44	111	111	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1055	1061						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11023811				2022-12-18	WOS:000165091600002
J	Tepper, BJ				Tepper, BJ			6-n-propylthiouracil: A genetic marker for taste, with implications for food preference and dietary habits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEDONIC RESPONSE; SENSITIVITY; CAPSAICIN; PROP; SEX; ACCEPTANCE; PERCEPTION; ZINGERONE; RATINGS; SWEET		Rutgers State Univ, Cook Coll, Dept Food Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Tepper, BJ (corresponding author), Rutgers State Univ, Cook Coll, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	Tepper@taste-test.rutgers.edu						ANLIKER JA, 1991, AM J CLIN NUTR, V54, P316, DOI 10.1093/ajcn/54.2.316; [Anonymous], FLAVOUR ITS CHEM BEH; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Birch L. L., 1996, FOOD CHOICE ACCEPTAN, P161; Cardello A. V., 1996, FOOD CHOICE ACCEPTAN, P1; Drewnowski A, 1997, PHYSIOL BEHAV, V62, P649, DOI 10.1016/S0031-9384(97)00193-5; Drewnowski A, 1997, AM J CLIN NUTR, V66, P391, DOI 10.1093/ajcn/66.2.391; Drewnowski A, 1998, PHYSIOL BEHAV, V63, P771, DOI 10.1016/S0031-9384(97)00540-4; DREWNOWSKI A, 1990, APPETITE, V14, P203, DOI 10.1016/0195-6663(90)90088-P; DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P506, DOI 10.1093/ajcn/62.3.506; GREEN BG, 1990, CHEM SENSES, V2, P171; KARRER T, 1991, PHYSIOL BEHAV, V49, P757, DOI 10.1016/0031-9384(91)90315-F; Liu L, 1996, J NEUROPHYSIOL, V76, P1858, DOI 10.1152/jn.1996.76.3.1858; LOOY H, 1992, PHYSIOL BEHAV, V52, P75, DOI 10.1016/0031-9384(92)90435-5; MELA DJ, 1990, CHEM SENSES, V15, P485, DOI 10.1093/chemse/15.4.485; Mela DJ, 1991, DIETARY FATS DETERMI, P43; OLSON JM, 1989, GENET EPIDEMIOL, V6, P423, DOI 10.1002/gepi.1370060305; Prescott J, 1996, PHYSIOL BEHAV, V60, P617, DOI 10.1016/0031-9384(96)00064-9; REDDY BM, 1989, GENET EPIDEMIOL, V6, P413, DOI 10.1002/gepi.1370060304; REED DR, 1995, CHEM SENSES, V20, P529, DOI 10.1093/chemse/20.5.529; ROZIN P, 1980, Motivation and Emotion, V4, P77, DOI 10.1007/BF00995932; SILVER WL, 1991, SMELL TASTE HLTH DIS, P97; STEVENSON RJ, 1993, CHEM SENSES, V18, P471, DOI 10.1093/chemse/18.5.471; STEVENSON RJ, 1994, CHEM SENSES, V19, P651, DOI 10.1093/chemse/19.6.651; Tepper BJ, 1998, ANN NY ACAD SCI, V855, P802, DOI 10.1111/j.1749-6632.1998.tb10662.x; Tepper BJ, 1997, PHYSIOL BEHAV, V61, P949, DOI 10.1016/S0031-9384(96)00608-7; WHISSELLBUECHY D, 1989, ANN HUM BIOL, V16, P131, DOI 10.1080/03014468700006982; WHISSELLBUECHY D, 1990, CHEM SENSES, V15, P39, DOI 10.1093/chemse/15.1.39; [No title captured]	29	111	114	0	30	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1271	1276		10.1086/302124	http://dx.doi.org/10.1086/302124			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792854	Bronze, Green Published			2022-12-18	WOS:000076985200003
J	Middleton, A; Hewison, J; Mueller, RF				Middleton, A; Hewison, J; Mueller, RF			Attitudes of deaf adults toward genetic testing for hereditary deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CULTURAL CONSIDERATIONS	Recent advances within molecular genetics to identify the genes for deafness mean that it is now possible for genetic-counseling services to offer genetic testing for deafness to certain families. The purpose of this study is to document the attitudes of deaf adults toward genetic testing for deafness. A structured, self-completion questionnaire was given to delegates at an international conference on the "Deaf Nation," held at the University of Central Lancashire in 1997. The conference was aimed at well-educated people, with an emphasis on Deaf culture issues. Eighty-seven deaf delegates from the United Kingdom returned completed questionnaires. The questionnaire had been designed to quantitatively assess attitudes toward genetics, interest in prenatal diagnosis (PND) for deafness, and preference for having deaf or hearing children. The results from this study provide evidence of a predominantly negative attitude toward genetics and its impact on deaf people, in a population for whom genetic-counseling services are relevant. Fifty-five percent of the sample thought that genetic testing would do more harm than good, 46% thought that its potential use devalued deaf people, and 49% were concerned about new discoveries in genetics. When asked about testing in pregnancy, 16% of participants said that they would consider having PND, and, of these, 29% said that they would prefer to have deaf children. Geneticists need to appreciate that some deaf persons may prefer to have deaf children and may consider the use of genetic technology to achieve this. Any genetic-counseling service set up for families with deafness can only be effective and appropriate if clinicians and counselors take into consideration the beliefs and values of the deaf community at large.	St James Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Middleton, A (corresponding author), St James Hosp, Dept Clin Genet, Ashley Wing, Leeds LS9 7TF, W Yorkshire, England.	am@psychology.leeds.ac.uk		Middleton, Anna/0000-0003-3103-8098				ARNOS KS, 1991, ANN NY ACAD SCI, V630, P212, DOI 10.1111/j.1749-6632.1991.tb19590.x; BAHAN B, 1989, AM DEAF CULTURE, P83; Bowling A., 1997, RES METHODS HLTH; Chapple Alison, 1995, J Genet Couns, V4, P281, DOI 10.1007/BF01408074; DARR A, 1997, CULTURE KINSHIP GENE, P83; Gibson W P, 1991, Med J Aust, V155, P212; GRUNDFAST KM, 1992, OTOLARYNG CLIN N AM, V25, P973; HIETALA M, 1995, AM J HUM GENET, V56, P1493; HOLMES M, 1997, DEAF WORLDS, V13, P13; ISRAEL JN, 1995, INTRO DEAFNESS MANUA; KALLA K, 1996, AM SOC HUM GEN ANN M; MARTEAU T, 1996, TROUBLED HELIX SOCIA; Michie S, 1995, PUBLIC UNDERST SCI, V4, P243, DOI DOI 10.1088/0963-6625/4/3/003; Oppenheim A., 1992, QUESTIONNAIRE DESIGN; RICHARDS M, 1997, CULTURE KINSHIP GENE, P175; *ROY NAT I DEAF PE, 1996, STAT DEAFN FACHSH; SHAKESPEARE T, IN PRESS DISABIL SOC; SINGER E, 1993, SOC INDIC RES, V28, P117, DOI 10.1007/BF01079654	18	111	118	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1175	1180		10.1086/302060	http://dx.doi.org/10.1086/302060			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758618	Green Published, Bronze			2022-12-18	WOS:000076577800031
J	Malzac, P; Webber, H; Moncla, A; Graham, JM; Kukolich, M; Williams, C; Pagon, RA; Ramsdell, LA; Kishino, T; Wagstaff, J				Malzac, P; Webber, H; Moncla, A; Graham, JM; Kukolich, M; Williams, C; Pagon, RA; Ramsdell, LA; Kishino, T; Wagstaff, J			Mutation analysis of UBE3A in Angelman syndrome patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; E6-AP; P53	Angelman syndrome (AS) is caused by chromosome 15q11-q13 deletions of maternal origin, by paternal uniparental disomy (UPD) 15, by imprinting defects, and by mutations in the UBE3A gene. UBE3A encodes a ubiquitin-protein ligase and shows brain-specific imprinting. Here we describe UBE3A coding-region mutations detected by SSCP analysis in 13 AS individuals or families. Two identical de novo 5-bp duplications in exon 16 were found. Among the other 11 unique mutations, 8 were small deletions or insertions predicted to cause frameshifts, 1 was a mutation to a stop codon, 1 was a missense mutation, and 1 was predicted to cause insertion of an isoleucine in the hect domain of the UBE3A protein, which functions in E2 binding and ubiquitin transfer. Eight of the cases were familial, and five were sporadic. In two familial cases and one sporadic case, mosaicism for UBE3A mutations was detected: in the mother of three AS sons, in the maternal grandfather of two AS first cousins, and in the mother of an AS daughter. The frequencies with which we detected mutations were 5 (14%) of 35 in sporadic cases and 8 (80%) of 10 in familial cases.	Childrens Hosp, Div Genet, Boston, MA 02115 USA; Hop Enfants La Timone, Dept Med Genet, Marseille, France; Univ Calif Los Angeles, Sch Med,Steven Spielberg Pediat Res Ctr, Cedars Sinai Med Ctr, Med Genet Birth Defects Ctr,Ahmanson Dept Pediat, Los Angeles, CA USA; Cook Childrens Genet Serv, Ft Worth, TX USA; Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; Childrens Hosp & Med Ctr, Div Med Genet, Seattle, WA 98105 USA	Harvard University; Boston Children's Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cook Children's Medical Center; State University System of Florida; University of Florida; Seattle Children's Hospital	Wagstaff, J (corresponding author), Childrens Hosp, Div Genet, Enders 5,300 Longwood Ave, Boston, MA 02115 USA.		Graham, John M./J-1429-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035658] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD35658-01, P30-HD18655] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Greger V, 1997, AM J HUM GENET, V60, P574; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; KISHINO T, 1998, GENOMICS, V47; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; Rougeulle C, 1997, NAT GENET, V17, P14, DOI 10.1038/ng0997-14; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; WAGSTAFF J, 1993, AM J HUM GENET, V53, P105; Williams C A, 1995, Curr Probl Pediatr, V25, P216, DOI 10.1016/S0045-9380(06)80036-8; Yamamoto Y, 1997, GENOMICS, V41, P263, DOI 10.1006/geno.1997.4617	15	111	118	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1353	1360		10.1086/301877	http://dx.doi.org/10.1086/301877			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585605	Green Published, Bronze			2022-12-18	WOS:000074174700011
J	Van Hul, W; Balemans, W; Van Hul, E; Dikkers, FG; Obee, H; Stokroos, RJ; Hildering, P; Vanhoenacker, F; Van Camp, G; Willems, PJ				Van Hul, W; Balemans, W; Van Hul, E; Dikkers, FG; Obee, H; Stokroos, RJ; Hildering, P; Vanhoenacker, F; Van Camp, G; Willems, PJ			Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VANBUCHEM DISEASE; GENETIC-MAP; SCLEROSTEOSIS; DEFICIENCY	Van Buchem disease (hyperostosis corticalis generalisata; OMIM 239100 [http://www3.ncbi.nlm.nih.gov: 80/htbin-post/Omim/dispmim?239100]) is an autosomal recessive disorder characterized by hyperostosis of the skull, mandible, clavicles, ribs, and diaphyseal cortices of the long bones. The most striking clinical features are the enlargement of the jaw and the thickness of the skull, which may lead to facial nerve palsy, hearing loss, and optic atrophy. Increased formation, by osteoblasts, of qualitatively normal bone has been proposed as the underlying pathological mechanism, but the molecular defect is unknown. We studied 11 van Buchem patients and their highly inbred family, who live in The Netherlands in a small ethnic isolate, that had a common ancestor similar to 9 generations ago. A genomewide search with highly polymorphic microsatellite markers showed linkage to marker D17S1299 on chromosome 17q12-21 (maximum LOD score of 8.82 at a recombination fraction [theta] of .01). Analysis of additional markers from that region delineated a candidate region of <1 cM between markers D17S1787 and D17S934. Interestingly, the only marker not showing recombination with the disease locus was an intragenic marker of the thyroid-hormone receptor alpha 1 (THRA1) gene, which generated a LOD score of 12.84 at theta = .00. Since thyroid hormones are known to stimulate bone resorption, the THRA1 gene might be involved in the etiology and pathogenesis of van Buchem disease. Unraveling the underlying mechanism for this disorder could contribute to the understanding of the regulatory processes conditioning bone density and the underlying pathological processes.	Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; Univ Antwerp, Dept Radiol, B-2610 Antwerp, Belgium; Univ Groningen Hosp, Dept Otorhinolaryngol, Groningen, Netherlands	University of Antwerp; University of Antwerp; University of Groningen	Van Hul, W (corresponding author), Univ Antwerp, Dept Med Genet, Univ Plein 1, B-2610 Antwerp, Belgium.		stokroos, robert/M-6244-2015; Dikkers, Frederik G/ABA-5218-2020; Van Camp, Guy/F-3386-2013; stokroos, robert/AAC-9814-2021; Dikkers, Frederik/M-1212-2013	Dikkers, Frederik G/0000-0001-5265-3722; Van Camp, Guy/0000-0001-5105-9000; Van Hul, Wim/0000-0002-5065-7858				ALVES AFD, 1982, REV BRAS GENET, V4, P825; ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BANBUCHEM FSP, 1971, ACTA MED SCNAD, V189, P257; BEIGHTON P, 1977, CLIN GENET, V11, P1; BEIGHTON P, 1984, CLIN GENET, V25, P175; BEIGHTON P, 1988, INHERITED DISORDERS; BETTINI R, 1991, Recenti Progressi in Medicina, V82, P24; BLACK DM, 1993, AM J HUM GENET, V52, P702; CANALIS E, 1983, ENDOCR REV, V4, P62, DOI 10.1210/edrv-4-1-62; Canalis Ernesto, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P155; COOK JV, 1989, BRIT J RADIOL, V62, P74, DOI 10.1259/0007-1285-62-733-74; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIXON JM, 1982, J NEUROL NEUROSUR PS, V45, P913, DOI 10.1136/jnnp.45.10.913; Dyson D P, 1972, Br J Oral Surg, V9, P237; EASTMAN JR, 1977, RADIOLOGY, V125, P297, DOI 10.1148/125.2.297; FAIN PR, 1991, CYTOGENET CELL GENET, V57, P66; FOSMOE RJ, 1968, RADIOLOGY, V90, P771, DOI 10.1148/90.4.771; FRYNS JP, 1988, EUR J PEDIATR, V147, P99, DOI 10.1007/BF00442624; FUTREAL PA, 1992, HUM MOL GENET, V1, P66, DOI 10.1093/hmg/1.1.66-a; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; HOUSE JW, 1983, LARYNGOSCOPE, V93, P1056; HUGHES AE, 1993, GENOMICS, V15, P433, DOI 10.1006/geno.1993.1083; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; LOPEZ AG, 1985, REV CLIN ESP, V177, P2933; MIGUEZ AM, 1986, MED CLIN-BARCELONA, V87, P719; MUNDY GR, 1976, J CLIN INVEST, V58, P529, DOI 10.1172/JCI108497; OWEN RH, 1976, BRIT J RADIOL, V49, P126, DOI 10.1259/0007-1285-49-578-126; RODRIGUEZ NG, 1995, ANN MED INTERN MED, V12, P229; RUCKERT EW, 1985, J ORAL MAXIL SURG, V43, P801, DOI 10.1016/0278-2391(85)90339-8; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHENDEL SA, 1988, ANN PLAS SURG, V20, P462, DOI 10.1097/00000637-198805000-00011; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Van Buchem FSPP, 1976, HYPEROSTOSIS CORTICA; VANBUCHEM FSP, 1955, ACTA RADIOL, V44, P109, DOI 10.3109/00016925509170789; VANBUCHEM FSP, 1962, AM J MED, V33, P387, DOI 10.1016/0002-9343(62)90235-8; VANCAMP G, 1997, TRENDS GENET, V13, P82; VANDERWOUDEN A, 1971, BONE DIS TEMPORAL BO; VanHul W, 1997, AM J HUM GENET, V61, P363, DOI 10.1086/514844; Whyte Michael P., 1996, P363; Whyte MP, 1997, AM J HUM GENET, V60, P1309, DOI 10.1086/515486; Worth H M, 1966, J Can Assoc Radiol, V17, P67	42	111	135	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					391	399		10.1086/301721	http://dx.doi.org/10.1086/301721			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463328	Green Published, Bronze			2022-12-18	WOS:000072416000023
J	Schimmenti, LA; Cunliffe, HE; McNoe, LA; Ward, TA; French, MC; Shim, HH; Zhang, YH; Proesmans, W; Leys, A; Byerly, KA; Braddock, SR; Masuno, M; Imaizumi, K; Devriendt, K; Eccles, MR				Schimmenti, LA; Cunliffe, HE; McNoe, LA; Ward, TA; French, MC; Shim, HH; Zhang, YH; Proesmans, W; Leys, A; Byerly, KA; Braddock, SR; Masuno, M; Imaizumi, K; Devriendt, K; Eccles, MR			Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OPTIC-NERVE COLOBOMAS; MOUSE NEURAL-TUBE; PAIRED BOX GENE; WAARDENBURG SYNDROME; VESICOURETERAL REFLUX; JOUBERT SYNDROME; POINT MUTATIONS; EXPRESSION; ANIRIDIA; ANOMALIES	Renal-coloboma syndrome is a recently described autosomal dominant syndrome of abnormal optic nerve and renal development. Two families have been reported with renal-coloboma syndrome and mutations of the PAX2 gene, The PAX2 gene, which encodes a DNA-binding protein, is expressed in the developing ear, CNS, eye, and urogenital tract. Ocular and/or renal abnormalities have been consistently noted in the five reports of patients with renal-coloboma syndrome, to date, but PAX2 expression patterns suggest that auditory and CNS abnormalities may be additional features of renal-coloboma syndrome. To determine whether additional clinical features are associated with PAX2 mutations, we have used PCR-SSCP to identify PAX2 gene mutations in patients. We report here four patients with mutations in exon 2, one of whom has severe ocular and renal disease, microcephaly, and retardation, and another who has ocular and renal disease with high-frequency hearing loss; Unexpectedly, extreme variability in clinical presentation was observed between a mother, her son, and an unrelated patient, all of whom had the same PAX2 mutation as previously described in two siblings with renal-coloboma syndrome. These results suggest that a sequence of seven Gs in PAX2 exon 2 may be particularly prone to mutation.	UNIV OTAGO,DEPT BIOCHEM,CANC GENET LAB,DUNEDIN,NEW ZEALAND; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA; CATHOLIC UNIV LEUVEN,PAEDIAT NEPHROL UNIT,B-3000 LOUVAIN,BELGIUM; CATHOLIC UNIV LEUVEN,DEPT OPHTHALMOL,B-3000 LOUVAIN,BELGIUM; CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,B-3000 LOUVAIN,BELGIUM; UNIV MISSOURI,DEPT CHILD HLTH,COLUMBIA,MO 65201; KANAGAWA CHILDRENS MED CTR,DIV MED GENET,YOKOHAMA,KANAGAWA,JAPAN	University of Otago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; KU Leuven; KU Leuven; KU Leuven; University of Missouri System; University of Missouri Columbia			Braddock, Stephen/AAL-1667-2021	Schimmenti, Lisa/0000-0003-3154-4249				Azuma N, 1996, NAT GENET, V13, P141, DOI 10.1038/ng0696-141; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BRON AJ, 1988, OPHTHALMOL PAEDIAT G, V10, P185; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; ECCLES MR, 1992, CELL GROWTH DIFFER, V3, P279; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; FRY M, 1992, P NATL ACAD SCI USA, V89, P763, DOI 10.1073/pnas.89.2.763; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HANSON I, 1995, TRENDS GENET, V11, P268, DOI 10.1016/S0168-9525(00)89073-3; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; HOTH CF, 1993, AM J HUM GENET, V52, P455; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KARCHER H, 1979, KLIN MONATSBL AUGENH, V175, P835; LEGROS Y, 1992, AN ESP PEDIATR, V36, P317; MOASE CE, 1990, TERATOLOGY, V42, P171, DOI 10.1002/tera.1420420208; NELSON LB, 1984, SURV OPHTHALMOL, V28, P621, DOI 10.1016/0039-6257(84)90184-X; NODEN DM, 1992, TRENDS NEUROSCI, V15, P235, DOI 10.1016/0166-2236(92)90056-E; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; NORNES HO, 1990, DEVELOPMENT, V109, P797; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; PUSCHEL AW, 1992, MECH DEVELOP, V38, P197, DOI 10.1016/0925-4773(92)90053-M; RIEGER G, 1977, KLIN MONATSBL AUGENH, V170, P697; Sambrook J, 1989, MOL CLONING LAB MANU; Sanyanusin P, 1996, GENOMICS, V35, P258, DOI 10.1006/geno.1996.0350; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SANYANUSIN P, 1995, HUM MOL GENET, V4, P2183, DOI 10.1093/hmg/4.11.2183; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; SCHIMMENTI LA, 1995, AM J MED GENET, V59, P204, DOI 10.1002/ajmg.1320590217; STUART ET, 1995, HUM MOL GENET, V4, P1717, DOI 10.1093/hmg/4.suppl_1.1717; STUART ET, 1993, ANNU REV GENET, V27, P219; SYLVESTERJACKSON DA, 1993, ARCH PATHOL LAB MED, V117, P1110; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Torres M, 1995, DEVELOPMENT, V121, P4057; Torres MA, 1996, DEVELOPMENT, V122, P3381; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; VANDORP DB, 1991, AM J MED GENET, V40, P100, DOI 10.1002/ajmg.1320400121; VERLOES A, 1989, AM J MED GENET, V32, P227, DOI 10.1002/ajmg.1320320217; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WEAVER RG, 1988, AM J MED GENET, V29, P597, DOI 10.1002/ajmg.1320290318	45	111	113	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					869	878						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106533				2022-12-18	WOS:A1997WT61400016
J	Bickeboller, H; Campion, D; Brice, A; Amouyel, P; Hannequin, D; Didierjean, O; Penet, C; Martin, C; PerezTur, J; Michon, A; Dubois, B; Ledoze, F; ThomasAnterion, C; Pasquier, F; Puel, M; Demonet, JF; Moreaud, O; Babron, MC; Meulien, D; Guez, D; ChartierHarlin, MC; Frebourg, T; Agid, Y; Martinez, M; ClergetDarpoux, F				Bickeboller, H; Campion, D; Brice, A; Amouyel, P; Hannequin, D; Didierjean, O; Penet, C; Martin, C; PerezTur, J; Michon, A; Dubois, B; Ledoze, F; ThomasAnterion, C; Pasquier, F; Puel, M; Demonet, JF; Moreaud, O; Babron, MC; Meulien, D; Guez, D; ChartierHarlin, MC; Frebourg, T; Agid, Y; Martinez, M; ClergetDarpoux, F			Apolipoprotein E and Alzheimer disease: Genotype-specific risks by age and sex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; E ALLELE EPSILON-4; LATE-ONSET; E POLYMORPHISM; ASSOCIATION; POPULATION; DIAGNOSIS; PHENOTYPE; SURVIVAL	The distribution of apolipoprotein E (APOE) genotypes as a function of age and sex has been examined in a French population of 417 Alzheimer disease (AD) patients and 1,030 control subjects. When compared to the APOE epsilon 3 allele, an increased risk associated with the APOE epsilon 4 allele (odds ratio [OR] [epsilon 4] = 2.7 with 95% confidence interval [CI] = 2.0-3.6; P < .001) and a protective effect of the APOE epsilon 2 allele (OR[epsilon 2] = 0.5 with 95% CI = 0.3-0.98; P = .012) were retrieved. An effect of the epsilon 4 allele dosage on susceptibility was confirmed (OR[epsilon 4/epsilon 4] vs. the epsilon 3/epsilon 3 genotype = 11.2 [95% CI = 4.0-31.6]; OR[epsilon 3/epsilon 4] vs. the epsilon 3/epsilon 3 genotype = 2.2 [95% CI = 1.5-3.5]). The frequency of the epsilon 4 allele was lower in male cases than in female cases, but, since a similar difference was found in controls, this does not lead to a difference in OR between sex. ORs for the epsilon 4 allele versus the epsilon 3 allele, OR(epsilon 4), were not equal in all age classes: OR(epsilon 4) in the extreme groups with onset at <60 years or >79 years were significantly lower than those from the age groups 60-79 years. In epsilon 3/epsilon 4 individuals, sex-specific lifetime risk estimates by age 85 years (i.e., sex-specific penetrances by age 85 years) were 0.14 (95% CI 0.04-0.30) for men and 0.17 (95% CI 0.09-0.28) for women.	INSERM, U155, F-75016 PARIS, FRANCE; HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS, FRANCE; HOP ST LOUIS, INSERM, U358, PARIS, FRANCE; TECH UNIV MUNICH, IMSE, D-8000 MUNICH, GERMANY; CHU ROUEN, GENET MOL LAB, ROUEN, FRANCE; CHSR, ROUEN, FRANCE; CHR ROUEN, NEUROL CLIN, ROUEN, FRANCE; INST PASTEUR, CJF, INSERM 9505, LILLE, FRANCE; CHU LILLE, NEUROL CLIN, F-59037 LILLE, FRANCE; INSERM, U320, CAEN, FRANCE; CHU ST ETIENNE, NEUROL CLIN, ST ETIENNE, FRANCE; INSERM, U230, TOULOUSE, FRANCE; CHU GRENOBLE, NEUROL CLIN, F-38043 GRENOBLE, FRANCE; IRIS, COURBEVOIE, FRANCE; INSERM, U156, F-59045 LILLE, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Technical University of Munich; CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Servier; Institut de Recherches Internationales Servier; Institut National de la Sante et de la Recherche Medicale (Inserm)			Perez-Tur, Jordi/A-2143-2010; Pasquier, Florence/F-1527-2017; Demonet, Jean-Francois/E-6725-2010; Bickeböller, Heike/V-2318-2018; Martinez, Maria/B-3111-2013; Chartier-Harlin, Marie-Christine/L-4527-2018; Brice, Alexis/A-2170-2009; Frebourg, Thierry/AAK-8390-2020; brice, alexis/AAE-8275-2019; Clerget-Darpoux, Francoise/I-4825-2017	Perez-Tur, Jordi/0000-0002-9111-1712; Pasquier, Florence/0000-0001-9880-9788; Bickeböller, Heike/0000-0002-3361-5488; Martinez, Maria/0000-0003-2180-4537; Chartier-Harlin, Marie-Christine/0000-0001-6416-6526; brice, alexis/0000-0002-0941-3990; Amouyel, Philippe/0000-0001-9088-234X; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Demonet, Jean-Francois/0000-0003-0100-6175; Babron, Marie-Claude/0000-0002-4100-0299				AMOUYEL P, 1994, NEUROBIOL AGING, V15, pS43; APA, 1987, DIAGN STAT MAN MENT, V3rd; BIRD TD, 1995, ANN NEUROL, V38, P2, DOI 10.1002/ana.410380103; Breslow N, 1980, STATISTICAL METHODS, V32; Breslow NE, 1996, J AM STAT ASSOC, V91, P14, DOI 10.2307/2291379; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; CORDER EH, 1995, NEUROLOGY, V45, P1323, DOI 10.1212/WNL.45.7.1323; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORDER EH, 1995, JAMA-J AM MED ASSOC, V273, P373, DOI 10.1001/jama.273.5.373; CUMMING AM, 1984, CLIN GENET, V25, P310; DAI XY, 1994, NEUROSCI LETT, V175, P74, DOI 10.1016/0304-3940(94)91081-2; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; Fleiss JL, 1981, STAT METHODS RATES P; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISONI GB, 1995, ANN NEUROL, V37, P596, DOI 10.1002/ana.410370509; HIXSON JE, 1990, J LIPID RES, V31, P545; Jarvik GP, 1996, AM J HUM GENET, V58, P191; KUUSISTO J, 1994, BRIT MED J, V309, P636, DOI 10.1136/bmj.309.6955.636; KUUSISTO J, 1995, ARTERIOSCL THROM VAS, V15, P1280, DOI 10.1161/01.ATV.15.9.1280; LAAKSO M, 1991, BMJ-BRIT MED J, V303, P1159, DOI 10.1136/bmj.303.6811.1159; LEHTOVIRTA M, 1995, NEUROSCI LETT, V185, P13, DOI 10.1016/0304-3940(94)11213-3; LENZEN HJ, 1986, CLIN CHEM, V32, P778; LOCKE PA, 1995, GENET EPIDEMIOL, V12, P83, DOI 10.1002/gepi.1370120108; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martinez M, 1996, AM J MED GENET, V67, P9, DOI 10.1002/ajmg.1320670102; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; NORRMAN J, 1995, BRIT J PSYCHIAT, V167, P533, DOI 10.1192/bjp.167.4.533; PAYAMI H, 1994, JAMA-J AM MED ASSOC, V271, P1316, DOI 10.1001/jama.271.17.1316; Payami H, 1996, AM J HUM GENET, V58, P803; PerezTur J, 1995, AM J MED GENET, V60, P550, DOI 10.1002/ajmg.1320600613; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; SMITH AD, 1994, LANCET, V344, P473; SORBI S, 1994, NEUROSCI LETT, V177, P100, DOI 10.1016/0304-3940(94)90054-X; STCLAIR D, 1995, J MED GENET, V32, P57, DOI 10.1136/jmg.32.1.57; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; TALBOT C, 1994, LANCET, V343, P1432, DOI 10.1016/S0140-6736(94)92557-7; Tang MX, 1996, AM J HUM GENET, V58, P574; THOMPSON WD, 1981, J PSYCHIAT RES, V16, P113, DOI 10.1016/0022-3956(81)90026-1; TSAI MS, 1994, AM J HUM GENET, V54, P643; TSUDA T, 1994, ANN NEUROL, V36, P97, DOI 10.1002/ana.410360118; VANBOCKXMEER FM, 1992, LANCET, V340, P879, DOI 10.1016/0140-6736(92)93288-X; VANDUIJN CM, 1995, ANN NEUROL, V37, P605, DOI 10.1002/ana.410370510; VANDUIJN CM, 1994, NAT GENET, V7, P74, DOI 10.1038/ng0594-74; YOSHIZAWA T, 1994, ANN NEUROL, V36, P656, DOI 10.1002/ana.410360416	53	111	115	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					439	446						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012418				2022-12-18	WOS:A1997WE93100024
J	Hecht, JT; Hogue, D; Wang, Y; Blanton, SH; Wagner, M; Strong, LC; Raskind, W; Hansen, MF; Wells, D				Hecht, JT; Hogue, D; Wang, Y; Blanton, SH; Wagner, M; Strong, LC; Raskind, W; Hansen, MF; Wells, D			Hereditary multiple exostoses (EXT): Mutational studies of familial EXTI cases and EXT-associated malignancies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RET PROTOONCOGENE; HIRSCHSPRUNG DISEASE; CHROMOSOME-11; HETEROZYGOSITY; MARKERS; GENE	Hereditary multiple exostoses (EXT) is an autosomal dominant disorder characterized by the formation of cartilage-capped prominences that develop from the growth centers of the long bones, EXT is genetically heterogeneous, with three loci, currently identified on chromosomes 8q24.1, 11p13, and 19q, The EXT1 gene, located on chromosome 8q24.1, has been cloned and is encoded by a 3.4-kb cDNA, Five mutations in the EXT1 gene have been identified-four germ-line mutations, including two unrelated families with the same mutation, and one somatic mutation in a patient with chondrosarcoma, Four of the mutations identified resulted in frameshifts and premature termination codons, while the fifth mutation resulted in a substitution of leucine for arginine. Loss of heterozygosity (LOH) analysis of chondrosarcomas and chondroblastomas revealed multiple LOH events at loci on chromosomes 3q, 8q, 10q, and 19q, One sporadic chondrosarcoma demonstrated LOH for EXT1 and EXT3, while a second underwent LOH for EXT2 and chromosome 10. A third chondrosarcoma underwent LOH for EXT1 and chromosome 3q, These results agree with previous findings that mutations at EXT1 and multiple generic events that include LOH at other loci may be required for thr development of chondrosarcoma.	UNIV HOUSTON, HOUSTON, TX USA; UNIV TEXAS, MD ANDERSON CANC CTR, HOUSTON, TX USA; UNIV VIRGINIA, CHARLOTTESVILLE, VA USA; UNIV WASHINGTON, SEATTLE, WA 98195 USA; BOSTON UNIV, SCH MED, BOSTON, MA 02118 USA	University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; University of Virginia; University of Washington; University of Washington Seattle; Boston University	Hecht, JT (corresponding author), UNIV TEXAS, SCH MED, DEPT PEDIAT, POB 20708, HOUSTON, TX 77225 USA.		Blanton, Susan Halloran/ABF-1323-2021; /AAD-2181-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027981] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA060122] Funding Source: NIH RePORTER; NCI NIH HHS [CA60122] Funding Source: Medline; NICHD NIH HHS [HD27981] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; Blanton SH, 1996, AM J MED GENET, V62, P150; BOLINO A, 1995, ONCOGENE, V10, P2415; COOK A, 1993, AM J HUM GENET, V53, P71; ENG C, 1995, GENE CHROMOSOME CANC, V12, P209, DOI 10.1002/gcc.2870120308; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Jaffe HL, 1943, ARCH PATHOL, V36, P335; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; OGLE RF, 1991, J MED GENET, V28, P881, DOI 10.1136/jmg.28.12.881; Raskind WH, 1996, GENE CHROMOSOME CANC, V16, P138, DOI 10.1002/(SICI)1098-2264(199606)16:2<138::AID-GCC8>3.0.CO;2-0; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; WELLS DE, IN PRESS HUM GENET; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; YAMAGUCHI T, 1992, CANCER RES, V52, P2419	21	111	113	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					80	86						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981950				2022-12-18	WOS:A1997WA81800013
J	Willing, MC; Deschenes, SP; Slayton, R; Roberts, EJ				Willing, MC; Deschenes, SP; Slayton, R; Roberts, EJ			Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DEGRADATION; NONSENSE MUTATIONS; PRO-ALPHA-1(I) CHAIN; GENE; COLLAGEN; CODONS; DISEASE; DNA; POLYMORPHISMS; HETEROGENEITY	Nonsense and frameshift mutations, which predict premature termination of translation, often cause a dramatic reduction in the amount of transcript from the mutant allele (nonsense-mediated mRNA decay). In some genes, these mutations also influence RNA splicing and induce skipping of the exon that contains the nonsense codon. To begin to dissect how premature termination alters the metabolism of RNA from the COL1A1 gene, we studied nonsense and frameshift mutations distributed over exons 11-49 of the gene. These mutations were originally identified in 10 unrelated families with osteogenesis imperfecta (OI) type I. We observed marked reduction in steady-state amounts of mRNA from the mutant allele in both total cellular and nuclear RNA extracts of cells from affected individuals, suggesting that nonsense-mediated decay of COL1A1 RNA is a nuclear phenomenon. Position of the mutation within the gene did not influence this observation. None of the mutations induced skipping of either the exon containing the mutation or, for the frameshifts, the downstream exons with the new termination sites. Our data suggest that nonsense and frameshift mutations throughout most of the COL1A1 gene result in a null allele, which is associated with the predictable mild clinical phenotype, OI type I.	UNIV IOWA, COLL MED, IOWA CITY, IA USA; UNIV IOWA, COLL DENT, IOWA CITY, IA USA	University of Iowa; University of Iowa	Willing, MC (corresponding author), UNIV IOWA, DEPT PEDIAT, IOWA CITY, IA 52242 USA.				NIAMS NIH HHS [AR 40334] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040334] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARSH GS, 1982, P NATL ACAD SCI-BIOL, V79, P3838, DOI 10.1073/pnas.79.12.3838; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Byers Peter H., 1993, P317; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; DAS S, 1994, AM J HUM GENET, V55, P883; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; ELDADAH ZA, 1995, NAT MED, V1, P798, DOI 10.1038/nm0895-798; FISHER CW, 1993, AM J HUM GENET, V52, P414; GENOVESE C, 1987, METHOD ENZYMOL, V145, P223; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; GREENBERG ME, 1987, CURRENT PROTOCOLS MO; KIELTY CM, 1993, CONNECTIVE TISSUES I, P112; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; LIM SK, 1992, MOL CELL BIOL, V12, P1149, DOI 10.1128/MCB.12.3.1149; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MAGNUS T, 1990, ANN NY ACAD SCI, V612, P55; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PODUSLO SE, 1991, AM J HUM GENET, V49, P106; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; RedfordBadwal DA, 1996, J CLIN INVEST, V97, P1035, DOI 10.1172/JCI118495; ROWE DW, 1985, J CLIN INVEST, V76, P604, DOI 10.1172/JCI112012; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Slayton R. I., 1995, American Journal of Human Genetics, V57, pA9; STOVER ML, 1993, J CLIN INVEST, V92, P1994, DOI 10.1172/JCI116794; SYKES B, 1977, NEW ENGL J MED, V296, P1200, DOI 10.1056/NEJM197705262962104; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; WESTERHAUSEN A, 1991, MATRIX, V11, P375, DOI 10.1016/S0934-8832(11)80191-5; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424; WILLING MC, 1994, AM J HUM GENET, V55, P638; WILLING MC, 1992, AM J HUM GENET, V51, P508; ZHANG ZX, 1994, HUM MOL GENET, V3, P139, DOI 10.1093/hmg/3.1.139; ZHOU MY, 1994, BIOTECHNIQUES, V16, P58	42	111	117	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					799	809						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808594				2022-12-18	WOS:A1996VL28300008
J	Fouad, GT; Servidei, S; Durcan, S; Bertini, E; Ptacek, LJ				Fouad, GT; Servidei, S; Durcan, S; Bertini, E; Ptacek, LJ			A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; LONG QT SYNDROME; PARAMYOTONIA-CONGENITA; ANION-EXCHANGER; CARDIAC-ARRHYTHMIA; CLINICAL-FEATURES; MOLECULAR-CLONING; CHANNEL GENE; MUTATIONS; CHOREOATHETOSIS	Dyskinesias are hyperkinetic and involuntary movements that may result from any of a number of different genetic, infectious, and drug-induced causes. Some of the hereditary dyskinetic syndromes are characterized by paroxysmal onset of the abnormal movements. The classification of the familial paroxysmal dyskinesias (FPD) recognizes several distinct, although overlapping, phenotypes. Different forms of the disorder include attacks that are (1) induced by sudden movement (kinesiogenic); (2) spontaneous (non-kinesiogenic); and (3) induced by prolonged periods of exertion. Linkage analysis was pursued in a family segregating an autosomal dominant allele for non-kinesiogenic FPD. The disease allele was mapped to a locus on chromosome 2q31-36 (LOD score 4.64, theta = 0). Identification of distinct genetic loci for the paroxysmal dyskinesias will lead to a new genetic classification and to better understanding of these disorders.	UNIV UTAH,SCH MED,PROGRAM HUMAN MOL BIOL & GENET,ECCLES INST HUMAN GENET 2260,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT NEUROL,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,SCH MED,PROGRAM NEUROSCI,SALT LAKE CITY,UT 84112; UNIV CATTOLICA SACRO CUORE,DEPT NEUROL,I-20123 MILAN,ITALY; BAMBINO GESU,ROME,ITALY	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Catholic University of the Sacred Heart			Bertini, Enrico/A-2284-2014; Servidei, Serenella/ABC-4262-2021; Bertini, Enrico/ABG-1278-2020	Bertini, Enrico/0000-0001-9276-4590; SERVIDEI, Serenella/0000-0001-8478-2799	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000940] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [8 R01 HG00367] Funding Source: Medline; NICHD NIH HHS [HD00940] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Auburger G, 1996, GENOMICS, V31, P90, DOI 10.1006/geno.1996.0013; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; DEMIRKIRAN M, 1995, ANN NEUROL, V38, P571, DOI 10.1002/ana.410380405; FAHN S, 1994, MOVEMENT DISORD, V3, P310; GOODENOUGH DJ, 1978, ARCH NEUROL-CHICAGO, V35, P827, DOI 10.1001/archneur.1978.00500360051010; HIRATA K, 1991, EPILEPSIA, V32, P492, DOI 10.1111/j.1528-1157.1991.tb04682.x; JURKATROTT K, 1994, HUM MOL GENET, V3, P1415, DOI 10.1093/hmg/3.8.1415; KERTESZ AZ, 1967, NEUROLOGY, V17, P680, DOI 10.1212/WNL.17.7.680; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LINN SC, 1992, J BIOL CHEM, V267, P7927; LOMBROSO CT, 1995, ITAL J NEUROL SCI, V16, P271; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; Mount LA, 1940, ARCH NEURO PSYCHIATR, V44, P841, DOI 10.1001/archneurpsyc.1940.02280100143011; PTACEK LJ, 1993, ANN NEUROL, V33, P300, DOI 10.1002/ana.410330312; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; PTACEK LJ, 1994, CELL, V77, P863; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; SU YR, 1994, GENOMICS, V22, P605, DOI 10.1006/geno.1994.1433; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; YANNOUKAKOS D, 1994, CIRC RES, V75, P603, DOI 10.1161/01.RES.75.4.603	26	111	118	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					135	139						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659517				2022-12-18	WOS:A1996VL45500019
J	SUDBRAK, R; PROCACCIO, V; KLAUSNITZER, M; CURRAN, JL; MONSIEURS, K; Van Broeckhoven, C; ELLIS, R; HEYETENS, L; HARTUNG, EJ; KOZAKRIBBENS, G; HEILINGER, D; WEISSENBACH, J; LEHMANHORN, F; MUELLER, CR; DEUFEL, T; STEWART, AD; LUNARDI, J				SUDBRAK, R; PROCACCIO, V; KLAUSNITZER, M; CURRAN, JL; MONSIEURS, K; Van Broeckhoven, C; ELLIS, R; HEYETENS, L; HARTUNG, EJ; KOZAKRIBBENS, G; HEILINGER, D; WEISSENBACH, J; LEHMANHORN, F; MUELLER, CR; DEUFEL, T; STEWART, AD; LUNARDI, J			MAPPING OF A FURTHER MALIGNANT HYPERTHERMIA SUSCEPTIBILITY LOCUS TO CHROMOSOME 3Q13.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RYANODINE RECEPTOR GENE; HYPERKALEMIC PERIODIC PARALYSIS; DEPENDENT CALCIUM-CHANNEL; MUSCLE CONTRACTURE TEST; CENTRAL CORE DISEASE; LINKAGE ANALYSIS; ALPHA-SUBUNIT; GAMMA-SUBUNIT; HUMAN GENOME; MUTATION	Malignant hyperthermia (MH) is a potentially lethal pharmacogenetic disease for which MH susceptibility (MHS) is transmitted as an autosomal dominant trait. A potentially life-threatening MH crisis is triggered by exposure to commonly used inhalational anesthetics and depolarizing muscle relaxants. The first malignant hyperthermia susceptibility locus (MHS1) was identified on human chromosome 19q13.1, and evidence has been obtained that defects in the gene for the calcium-release channel of skeletal muscle sarcoplasmic reticulum (ryanodine receptor; RYR1) can cause some forms of MH. However, MH has been shown to be genetically heterogeneous, and additional loci on chromosomes 17q and 7q have been suggested. In a collaborative search of the human genome with polymorphic microsatellite markers, we now found linkage of the MHS phenotype, as assessed by the European in vitro contracture test protocol, to markers defining a 1-cM interval on chromosome 3q13.1. A maximum multipoint led score of 3.22 was obtained in a single German pedigree with classical MH, and none of the other pedigrees investigated in this study showed linkage to this region. Linkage to both MHS1/RYR1 and putative loci on chromosome 17q and 7q were excluded. This study supports the view that considerable genetic heterogeneity exists in MH.	UNIV MUNSTER, KINDERHEILKUNDE KLIN & POLIKLIN, STOFFWECHSELLAB, D-48129 MUNSTER, GERMANY; CHU GRENOBLE, ADN, BIOCHIM LAB, F-38043 GRENOBLE, FRANCE; UNIV WURZBURG, INST HUMANGENET, W-8700 WURZBURG, GERMANY; UNIV WURZBURG, INST ANASTHESIOL, W-8700 WURZBURG, GERMANY; UNIV LEEDS, DEPT GENET, LEEDS LS2 9JT, W YORKSHIRE, ENGLAND; UNIV LEEDS, DEPT CLIN MED, ACAD ANAESTHESIA UNIT, LEEDS LS2 9JT, W YORKSHIRE, ENGLAND; UNIV ANTWERP, BORN BUNGE FDN, MALIGNANT HYPERTHEMIA LAB, B-2020 ANTWERP, BELGIUM; CRMBM, MARSEILLE, FRANCE; UNIV VIENNA KLINIKUM, ANASTHESIS KLIN, ABT B, VIENNA, AUSTRIA; GENETHON, EVRY, FRANCE; UNIV ULM, ANGEW PHYSIOL ABT, ULM, GERMANY; UNIV ANTWERP, NEUROGENET LAB, B-2020 ANTWERP, BELGIUM	University of Munster; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Wurzburg; University of Wurzburg; University of Leeds; University of Leeds; University of Antwerp; UDICE-French Research Universities; Aix-Marseille Universite; Ulm University; University of Antwerp			Van Broeckhoven, Christine/G-8362-2017; Monsieurs, Koen/W-2145-2019; Van Broeckhoven, Christine/M-7853-2019	Van Broeckhoven, Christine/0000-0003-0183-7665; Monsieurs, Koen/0000-0002-5068-4848; Van Broeckhoven, Christine/0000-0003-0183-7665; procaccio, Vincent/0000-0002-1537-4684; Deufel, Thomas/0000-0003-4839-3117				BALL SP, 1993, J MED GENET, V30, P89, DOI 10.1136/jmg.30.2.89; BALL SP, 1993, BRIT J ANAESTH, V70, P70, DOI 10.1093/bja/70.1.70; DEUFEL T, 1992, AM J HUM GENET, V50, P1151; DEUFEL T, 1992, NEUROMUSCULAR DISORD, V2, P389, DOI 10.1016/S0960-8966(06)80010-6; Deufel T., 1992, American Journal of Human Genetics, V51, pA213; FAGERLUND T, 1992, CLIN GENET, V41, P270; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GREGG RG, 1993, GENOMICS, V15, P107, DOI 10.1006/geno.1993.1017; GREGG RG, 1993, GENOMICS, V15, P185, DOI 10.1006/geno.1993.1029; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEALY JMS, 1991, BRIT MED J, V303, P1225, DOI 10.1136/bmj.303.6812.1225; HEINE R, 1993, HUM MOL GENET, V2, P1349, DOI 10.1093/hmg/2.9.1349; ILES DE, 1993, HUM MOL GENET, V2, P863; ILES DE, 1992, GENOMICS, V14, P749, DOI 10.1016/S0888-7543(05)80179-X; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; JOHNSON K, 1993, HUM MOL GENET, V2, P849, DOI 10.1093/hmg/2.7.849; KALOW W, 1987, MALIGNANT HYPERTHERM, P155; KLEIN W, 1987, ANAESTHESIST, V36, P685; KOCH MC, 1991, HUM GENET, V88, P71, DOI 10.1007/BF00204932; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LARACH MG, 1989, ANESTH ANALG, V69, P511; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; LEVITT RC, 1992, GENOMICS, V14, P562, DOI 10.1016/S0888-7543(05)80152-1; MACKENZIE AE, 1991, ANESTHESIOLOGY, V75, P4, DOI 10.1097/00000542-199107000-00002; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OLCKERS A, 1992, GENOMICS, V14, P829, DOI 10.1016/S0888-7543(05)80206-X; ORDING H, 1988, BRIT J ANAESTH, V60, P287, DOI 10.1093/bja/60.3.287; ORDING H, 1987, MALIGNANT HYPERTHERM, P269; OTSU K, 1991, GENOMICS, V11, P744, DOI 10.1016/0888-7543(91)90083-Q; POWERS PA, 1993, J BIOL CHEM, V268, P9269; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; QUANE KA, 1994, HUM MOL GENET, V3, P471, DOI 10.1093/hmg/3.3.471; RICKER K, 1994, ARCH NEUROL-CHICAGO, V51, P1095, DOI 10.1001/archneur.1994.00540230033009; RUBSAM B, 1993, ANAESTHESIST, V42, P868; RUBSAM B, 1992, ANAESTHESIST, V41, P722; RYSAVY FR, 1992, COMPUT APPL BIOSCI, V8, P149; SUDBRAK R, 1993, HUM MOL GENET, V2, P857, DOI 10.1093/hmg/2.7.857; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; 1984, BRIT J ANAESTH, V56, P1267	47	111	111	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					684	691						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887423				2022-12-18	WOS:A1995QK91800018
J	GOLDSTEIN, AM; DRACOPOLI, NC; ENGELSTEIN, M; FRASER, MC; CLARK, WH; TUCKER, MA				GOLDSTEIN, AM; DRACOPOLI, NC; ENGELSTEIN, M; FRASER, MC; CLARK, WH; TUCKER, MA			LINKAGE OF CUTANEOUS MALIGNANT-MELANOMA DYSPLASTIC NEVI TO CHROMOSOME 9P, AND EVIDENCE FOR GENETIC-HETEROGENEITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR PROGRESSION; DYSPLASTIC NEVI; MELANOMA; CANCER; LOCUS	We examined the relationship between cutaneous malignant melanoma/dysplastic nevi (CMM/DN) and chromosome 9p in 13 pedigrees with two or more living cases of invasive melanoma. We used two highly informative (CA)(n) repeats, D9S126 and IFNA, previously implicated in familial malignant melanoma (MLM), to conduct linkage analysis. Three analyses were performed: (1) CMM alone-all individuals without either confirmed melanoma or borderline lesions were considered unaffected (model A); (2) CMM/DN with both variable age at onset and sporadics (model B); and (3) CMM affecteds only-all individuals either without confirmed melanoma or with borderline lesions were designated ''unknown'' (model C). There was significant evidence for linkage to IFNA in all three models. For CMM alone, the maximum lod score (Z(max)) was 4.36 at theta =.10 for model A and 3.39 at theta =.10 for model C. For CMM/DN (model B), Z(max) = 3.05 at theta =.20. There was no significant evidence for linkage between CMM alone or CMM/DN and chromosome 9p marker D9S126. In addition, there was significant evidence for heterogeneity when a homogeneity test allowing for linkage to chromosome 9p or chromosome 3p or neither region was used. These results suggest that there is an MLM susceptibility locus on chromosome 9p but that familial melanoma is heterogeneous and not all families with CMM/DN are linked to a locus in this region.	MIT,DEPT BIOL,CAMBRIDGE,MA; UNIV PENN,SCH MED,PIGMENTED LES STUDY GRP,PHILADELPHIA,PA; UNIV PENN,SCH MED,DEPT DERMATOL,PHILADELPHIA,PA 19104	Massachusetts Institute of Technology (MIT); University of Pennsylvania; University of Pennsylvania	GOLDSTEIN, AM (corresponding author), NCI,GENET EPIDEMIOL BRANCH,EXECUT PLAZA N,ROOM 439,6130 EXECUT BLVD,BETHESDA,MD 20892, USA.		Tucker, Margaret A/B-4297-2015	Dracopoli, Nicholas/0000-0003-3962-4059				BALE SJ, 1986, AM J HUM GENET, V38, P188; BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; BALE SJ, 1988, J NATL CANCER I, V81, P70; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CLARK WH, 1991, BRIT J CANCER, V64, P631, DOI 10.1038/bjc.1991.375; CLARK WH, 1990, PATHOLOGY SKIN, P684; COWAN JM, 1988, J NATL CANCER I, V80, P1159, DOI 10.1093/jnci/80.14.1159; DRACOPOLI NC, 1987, CANCER RES, V47, P3995; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; FOUNTAIN JW, 1993, HUM MOL GENET, V2, P823, DOI 10.1093/hmg/2.6.823-a; FOUNTAIN JW, 1992, GENOMICS, V14, P105, DOI 10.1016/S0888-7543(05)80290-3; GOLDSTEIN AM, 1993, AM J HUM GENET, V52, P537; Greene MH., 1979, HEREDITARY VARIANT M; KWIATKOWSKI DJ, 1992, HUM MOL GENET, V1, P658, DOI 10.1093/hmg/1.8.658-a; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACKIE R, 1992, LANCET, V339, P971, DOI 10.1016/0140-6736(92)91539-K; MACKIE RM, 1989, LANCET, V2, P487; MACLENNAN R, 1992, J NATL CANCER I, V84, P1427, DOI 10.1093/jnci/84.18.1427; MILLER BA, 1993, NIH932789 US DEP HLT; MORTON NE, 1956, AM J HUM GENET, V8, P80; NANCARROW DJ, 1993, AM J HUM GENET, V53, P936; OSTERLIND A, 1988, BRIT J CANCER, V58, P385, DOI 10.1038/bjc.1988.225; Ott J., 1991, ANAL HUMAN GENETIC L; OTT J, 1992, HOMOG PROGRAMS; PETTY EM, 1993, AM J HUM GENET, V53, P96; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; TUCKER MA, 1983, J PEDIATR-US, V103, P65, DOI 10.1016/S0022-3476(83)80777-X; TUCKER MA, 1993, J INVEST DERMATOL, V100, pS350, DOI 10.1111/1523-1747.ep12470264; TUCKER MA, 1988, PIGMENT CELL, V9, P95; 1992, 1992 NIH CONS DEV C, V10	30	111	117	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					489	496						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	8116618				2022-12-18	WOS:A1994MZ15800012
J	NESSLINGER, NJ; GORSKI, JL; KURCZYNSKI, TW; SHAPIRA, SK; SIEGELBARTELT, J; DUMANSKI, JP; CULLEN, RF; FRENCH, BN; MCDERMID, HE				NESSLINGER, NJ; GORSKI, JL; KURCZYNSKI, TW; SHAPIRA, SK; SIEGELBARTELT, J; DUMANSKI, JP; CULLEN, RF; FRENCH, BN; MCDERMID, HE			CLINICAL, CYTOGENETIC, AND MOLECULAR CHARACTERIZATION OF 7 PATIENTS WITH DELETIONS OF CHROMOSOME 22Q13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARYLSULFATASE-A; SUBMICROSCOPIC DELETIONS; REGIONAL LOCALIZATION; DIGEORGE SYNDROME; PARTIAL MONOSOMY; GROWTH-FACTOR; GENE; MICRODELETIONS; FRAGMENTS; SEQUENCE	We have studied seven patients who have chromosome 22q13.3 deletions as revealed by high-resolution cytogenetic analysis. Clinical evaluation of the patients revealed a common phenotype that includes generalized developmental delay, normal or accelerated growth, hypotonia, severe delays in expressive speech, and mild facial dysmorphic features. Dosage analysis using a series of genetically mapped probes showed that the proximal breakpoints of the deletions varied over similar to 13.8 cM, between loci D22S92 and D22S94. The most distally mapped locus, arylsulfatase A (ARSA), was deleted in all seven patients. Therefore, the smallest region of overlap (critical region) extends between locus D22S94 and a region distal to ARSA, a distance of > 25.5 cM.	UNIV ALBERTA,DEPT GENET,EDMONTON T6G 2E9,AB,CANADA; UNIV MICHIGAN,DEPT PEDIAT,DIV PEDIAT GENET,ANN ARBOR,MI 48109; MED COLL OHIO,DEPT PEDIAT,TOLEDO,OH 43699; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; HOSP SICK CHILDREN,DEPT CLIN GENET,TORONTO,ON,CANADA; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN; MIAMI CHILDRENS HOSP,MIAMI,FL	University of Alberta; University of Michigan System; University of Michigan; Baylor College of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Karolinska Institutet; Karolinska University Hospital				Dumanski, Jan Piotr/0000-0002-1489-1452				BUDARF ML, 1991, GENOMICS, V10, P996, DOI 10.1016/0888-7543(91)90190-P; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; DUMANSKI JP, 1991, GENOMICS, V11, P709, DOI 10.1016/0888-7543(91)90079-T; Epstein C.J, 1986, CONSEQUENCES CHROMOS; FANTES JA, 1992, AM J HUM GENET, V51, P1286; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRACCARO M, 1980, HUM GENET, V56, P21, DOI 10.1007/BF00281567; GANDELMAN KY, 1992, AM J HUM GENET, V51, P571; GELEHRTER TD, 1990, PRINCIPLES MED GENET; GIESELMANN V, 1991, HUM GENET, V86, P251; GOUGH AC, 1993, GENOMICS, V15, P430, DOI 10.1006/geno.1993.1082; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HERMAN GE, 1988, AM J MED GENET, V29, P909, DOI 10.1002/ajmg.1320290423; HERZOG R, 1990, NUCLEIC ACIDS RES, V18, P6746, DOI 10.1093/nar/18.22.6746-a; KELLY D, 1993, AM J MED GENET, V45, P308, DOI 10.1002/ajmg.1320450306; KIRSHENBAUM G, 1988, J MED GENET, V25, P780, DOI 10.1136/jmg.25.11.780; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; MEHRABIAN M, 1993, GENOMICS, V15, P418, DOI 10.1006/geno.1993.1078; NARAHARA K, 1992, J MED GENET, V29, P432, DOI 10.1136/jmg.29.6.432; PHELAN MC, 1992, AM J MED GENET, V43, P872, DOI 10.1002/ajmg.1320430524; RATNER L, 1985, NUCLEIC ACIDS RES, V13, P5007, DOI 10.1093/nar/13.14.5007; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROMAIN DR, 1990, J MED GENET, V27, P588, DOI 10.1136/jmg.27.9.588; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; Sambrook J., 1989, MOL CLONING LAB MANU; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STENMAN G, 1992, CYTOGENET CELL GENET, V59, P22, DOI 10.1159/000133191; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; WANG AM, 1991, GENOMICS, V10, P133, DOI 10.1016/0888-7543(91)90493-X; WATT JL, 1985, J MED GENET, V22, P283, DOI 10.1136/jmg.22.4.283; Wilcoxon F, 1964, SOME RAPID APPROXIMA; YAMADA Y, 1993, GENOMICS, V15, P449, DOI 10.1006/geno.1993.1088	38	111	112	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1994	54	3					464	472						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ158	7906921				2022-12-18	WOS:A1994MZ15800009
J	SEIBOLD, A; BRABET, P; ROSENTHAL, W; BIRNBAUMER, M				SEIBOLD, A; BRABET, P; ROSENTHAL, W; BIRNBAUMER, M			STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN ANTIDIURETIC-HORMONE RECEPTOR GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; YEAST ARTIFICIAL CHROMOSOMES; SOMATIC-CELL HYBRIDS; HUMAN XQ24-XQ28; DNA; VASOPRESSIN; XQ28; POLYMERASE; PROBES; DXS52	Applying a genomic DNA-expression approach, we cloned the gene and cDNA coding for the human antidiuretic hormone receptor, also called "vasopressin V2 receptor" (V2R). The nucleotide sequence of both cloned DNAs provided the information to elucidate the structure of the isolated transcriptional unit. The structure of this gene is unusual in that it is the first G protein-coupled receptor gene that contains two very small intervening sequences, the second of which separates the region encoding the seventh transmembrane region from the rest of the open reading frame. The sequence information was used to synthesize appropriate oligonucleotides to be used as primers in the PCR. The V2R gene was localized by PCR using DNA from hybrid cells as template. The gene was found to reside in the q28-qter portion of the human X chromosome, a region identified as the locus for congenital nephrogenic diabetes insipidus.	BAYLOR COLL MED,DEPT CELL BIOL,1 BAYLOR PL,HOUSTON,TX 77030	Baylor College of Medicine			Brabet, Philippe/AAO-8522-2020	Brabet, Philippe/0000-0003-2739-1622	NIDDK NIH HHS [DK-27685, DK-21244] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027685] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABIDI FE, 1990, GENOMICS, V7, P363, DOI 10.1016/0888-7543(90)90170-Y; BICHET DG, 1988, NEW ENGL J MED, V318, P881, DOI 10.1056/NEJM198804073181403; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BIRNBAUMER M, 1990, MOL ENDOCRINOL, V4, P245, DOI 10.1210/mend-4-2-245; BREATHNACH R, 1977, NATURE, V270, P314, DOI 10.1038/270314a0; CULPEPPER RM, 1983, METABOLIC BASIS INHE, P1867; DILELLA AG, 1987, METHOD ENZYMOL, V152, P199; FEIL R, 1990, AM J HUM GENET, V46, P720; HARRIS HW, 1990, AM J PHYSIOL, V258, pF237, DOI 10.1152/ajprenal.1990.258.2.F237; JANS DA, 1990, J BIOL CHEM, V265, P15379; KAMBOURIS M, 1988, AM J MED GENET, V29, P239, DOI 10.1002/ajmg.1320290138; KNOERS N, 1988, NEPHRON, V50, P187, DOI 10.1159/000185155; LICHTER P, 1990, P NATL ACAD SCI USA, V87, P6634, DOI 10.1073/pnas.87.17.6634; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; OBERLE I, 1985, NEW ENGL J MED, V312, P682, DOI 10.1056/NEJM198503143121103; ORLOFF J, 1967, AM J MED, V42, P757, DOI 10.1016/0002-9343(67)90093-9; ORLOFF J, 1962, J CLIN INVEST, V47, P1154; POUTSKA AM, 1991, P NATL ACAD SCI USA, V88, P8302; ROBERTSON GL, 1974, ANNU REV MED, V25, P315, DOI 10.1146/annurev.me.25.020174.001531; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SUTHERS GK, 1991, GENOMICS, V9, P37, DOI 10.1016/0888-7543(91)90218-4; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; TRAUPE H, 1992, GENOMICS, V13, P481, DOI 10.1016/0888-7543(92)90279-2; WADA M, 1990, AM J HUM GENET, V46, P95; WARREN ST, 1990, P NATL ACAD SCI USA, V87, P3856, DOI 10.1073/pnas.87.10.3856; WILSON PJ, 1991, HUM GENET, V86, P505	27	111	114	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1078	1083						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415251				2022-12-18	WOS:A1992JU84000018
J	BOLL, W; WAGNER, P; MANTEI, N				BOLL, W; WAGNER, P; MANTEI, N			STRUCTURE OF THE CHROMOSOMAL GENE AND CDNAS CODING FOR LACTASE-PHLORIZIN HYDROLASE IN HUMANS WITH ADULT-TYPE HYPOLACTASIA OR PERSISTENCE OF LACTASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA; RAT INTESTINE; DNA; BIOSYNTHESIS; ENZYME; SEQUENCE; PROTEINS; EXPRESSION; POLYMERASE	Lactase-phlorizin hydrolase (LPH) splits lactose in the small intestine. LPH activity is high in the suckling; in many human populations the activity declines in adults, leading to adult-type hypolactasia, whereas in other populations the high LPH activity persists in adults. In the present work, we compared LPH sequences at the gene and cDNA level among adult subjects with high and low LPH activity. The complete intron-exon organization, including the sequences of all 17 exons and of the borders of all introns (as well as about 1,000 bp of 5' flanking region), was established for the cloned chromosomal LPH gene of a subject with persistence of lactase. Using PCR, we directly sequenced the exons of a hypolactasic subject. Except for silent mutations and the unknown linkage phase at two heterozygous positions, both coding sequences were identical. We further examined the LPH mRNA of a hypolactasic subject by S1 mapping and by sequencing a set of overlapping PCR products produced from cDNA templates. Except for allelic differences, the LPH sequence of the hypolactasic subject was identical to that of the LPH cDNAs of three subjects with persistence of lactase (one cDNA isolated previously by cloning and two characterized in the present work by PCR). No allele was peculiar to the hypolactasic subject. We conclude that humans with high or low levels of lactase can code for identical LPH enzymes.	SWISS FED INST TECHNOL, DEPT BIOCHEM, BIOCHEM LAB 2, CH-8092 ZURICH, SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich								ARSENAULT P, 1985, J PEDIATR GASTR NUTR, V4, P893, DOI 10.1097/00005176-198512000-00008; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; AURICCHIO S, 1963, LANCET, V2, P324; BARALLE FE, 1978, NATURE, V274, P84, DOI 10.1038/274084a0; BOORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; BULLER HA, 1987, J BIOL CHEM, V262, P17206; BULLER HA, 1990, J BIOL CHEM, V265, P6978; CRANE RK, 1976, MEMBRANES DISEASE, P229; DAHLQVIST A, 1963, GASTROENTEROLOGY, V45, P488, DOI 10.1016/S0016-5085(19)34844-9; DANIELSEN EM, 1984, BIOCHEM BIOPH RES CO, V122, P82; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Favaloro J, 1980, Methods Enzymol, V65, P718; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLATZ G, 1989, METABOLIC BASIS INHE, V2, P2999; FREUND JN, 1990, BIOCHEM J, V268, P99, DOI 10.1042/bj2680099; FREUND JN, 1989, FEBS LETT, V248, P39, DOI 10.1016/0014-5793(89)80427-2; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KREITMAN M, 1989, GENE ANAL TECH, V6, P84, DOI 10.1016/0735-0651(89)90021-6; KRETCHMER N, 1971, GASTROENTEROLOGY, V61, P805; KRUSE TA, 1988, FEBS LETT, V240, P123, DOI 10.1016/0014-5793(88)80352-1; KRUSE TA, 1989, CYTOGENET CELL GENET, V51, P1026; LORENZMEYER H, 1972, EUR J CLIN INVEST, V2, P326, DOI 10.1111/j.1365-2362.1972.tb00658.x; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; POTTER J, 1985, BIOCHEM GENET, V23, P423, DOI 10.1007/BF00499084; RACKWITZ HR, 1984, GENE, V30, P195, DOI 10.1016/0378-1119(84)90120-3; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEBASTIO G, 1989, AM J HUM GENET, V45, P489; SEMENZA G, 1989, METABOLIC BASIS INHE, V2, P2976; SIMONASSMANN P, 1984, CELL BIOL INT REP, V8, P41, DOI 10.1016/0309-1651(84)90180-2; SKOVBJERG H, 1980, GUT, V21, P360, DOI 10.1136/gut.21.5.360; SKOVBJERG H, 1984, BIOCHIM BIOPHYS ACTA, V798, P247, DOI 10.1016/0304-4165(84)90312-X; SMITH HO, 1976, NUCLEIC ACIDS RES, V3, P2387, DOI 10.1093/nar/3.9.2387; STERCHI EE, 1990, J CLIN INVEST, V86, P1329, DOI 10.1172/JCI114842; TUNG JS, 1989, PCR TECHNOLOGY PRINC, P99; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; WELSH JD, 1978, GASTROENTEROLOGY, V75, P847; WITTE J, 1990, J CLIN INVEST, V86, P1338, DOI 10.1172/JCI114843	44	111	117	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					889	902						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	1902057				2022-12-18	WOS:A1991FK89700008
J	NOWINSKI, GP; VANDYKE, DL; TILLEY, BC; JACOBSEN, G; BABU, VR; WORSHAM, MJ; WILSON, GN; WEISS, L				NOWINSKI, GP; VANDYKE, DL; TILLEY, BC; JACOBSEN, G; BABU, VR; WORSHAM, MJ; WILSON, GN; WEISS, L			THE FREQUENCY OF ANEUPLOIDY IN CULTURED LYMPHOCYTES IS CORRELATED WITH AGE AND GENDER BUT NOT WITH REPRODUCTIVE HISTORY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HENRY FORD HOSP,CTR MED GENET & BIRTH DEFECTS,DETROIT,MI 48202; HENRY FORD HOSP,DIV BIOSTAT & RES EPIDEMIOL,DETROIT,MI 48202; UNIV TEXAS,TEXAS MED CTR,DEPT PEDIAT,HOUSTON,TX 77025	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston								ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; ALBERMAN E, 1987, SPONTANEOUS RECURREN, P77; Bond D, 1983, OXFORD MONOGRAPHS ME, P198; BROOK JD, 1984, HUM GENET, V66, P41, DOI 10.1007/BF00275184; BROWN T, 1983, MUTAT RES, V122, P403, DOI 10.1016/0165-7992(83)90027-1; BROWN WMC, 1966, EUGENICS LABORATORY, V42; CAMPANA M, 1986, AM J MED GENET, V24, P341, DOI 10.1002/ajmg.1320240214; CASTLE D, 1988, AM J MED GENET, V29, P549, DOI 10.1002/ajmg.1320290312; DELACHAPELLE A, 1982, CANCER GENET CYTOGEN, V5, P173, DOI 10.1016/0165-4608(82)90007-3; DIEDRICH U, 1983, HUM GENET, V65, P48, DOI 10.1007/BF00285027; FITZGERALD PH, 1975, ANN HUM GENET, V38, P417, DOI 10.1111/j.1469-1809.1975.tb00631.x; FITZGERALD PH, 1986, HUM GENET, V72, P58, DOI 10.1007/BF00278818; FITZGERALD PH, 1977, HUM GENET, V39, P329, DOI 10.1007/BF00295428; FORD JH, 1985, AM J HUM GENET, V37, P973; FORD JH, 1984, HUM GENET, V68, P295, DOI 10.1007/BF00292587; GALLOWAY SM, 1978, CYTOGENET CELL GENET, V20, P78, DOI 10.1159/000130842; HAMERTON JL, 1965, NATURE, V206, P1232, DOI 10.1038/2061232a0; HARRIS DJ, 1982, AM J HUM GENET, V34, P125; HASSOLD T, 1988, GENET EPIDEMIOL, V5, P65, DOI 10.1002/gepi.1370050202; HECHT F, 1984, CLIN GENET, V26, P43; HOLZGREVE W, 1984, OBSTET GYNECOL, V63, P237; HOOK EB, 1983, HUM GENET, V64, P267, DOI 10.1007/BF00279407; HORSMAN DE, 1987, AM J MED GENET, V28, P981, DOI 10.1002/ajmg.1320280425; JACOBS PA, 1964, ANN HUM GENET, V27, P353; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; JACOBS PA, 1961, NATURE, V191, P1178, DOI 10.1038/1911178a0; JARVIK LF, 1970, AM J HUM GENET, V22, P562; JARVIK LF, 1976, HUM GENET, V33, P17, DOI 10.1007/BF00447282; JARVIK LF, 1974, ARCH GEN PSYCHIAT, V30, P186; JUBERG RC, 1985, J MED GENET, V22, P32, DOI 10.1136/jmg.22.1.32; MATTEVI MS, 1975, HUMANGENETIK, V27, P1; MEYERS CM, 1986, FERTIL STERIL, V46, P615; MICHELS VV, 1982, AM J HUM GENET, V34, P507; NETER J, 1974, APPLIED LINEAR STATI; NEURATH P, 1970, NATURE, V225, P281, DOI 10.1038/225281a0; NICHOLLS P, 1978, J THEOR BIOL, V73, P237, DOI 10.1016/0022-5193(78)90188-1; NIELSEN J, 1968, BRIT J PSYCHIAT, V114, P303, DOI 10.1192/bjp.114.508.303; NIELSEN J, 1970, J GERONTOL, V25, P312, DOI 10.1093/geronj/25.4.312; OSZTOVICS MK, 1982, ANN GENET-PARIS, V25, P232; PANTZAR JT, 1984, AM J MED GENET, V17, P615, DOI 10.1002/ajmg.1320170310; PIERRE RV, 1971, MAYO CLIN PROC, V46, P52; PIERRE RV, 1972, CANCER, V30, P889, DOI 10.1002/1097-0142(197210)30:4<889::AID-CNCR2820300405>3.0.CO;2-1; SACHS ES, 1985, OBSTET GYNECOL, V65, P375; SANDBERG AA, 1967, AM J HUM GENET, V19, P633; SMITH A, 1980, J MENT DEFIC RES, V24, P159; STAESSEN C, 1983, CLIN GENET, V24, P184; STALLARD R, 1981, CYTOGENET CELL GENET, V30, P50, DOI 10.1159/000131588; VANDYKE DL, 1986, HUM GENET, V73, P130, DOI 10.1007/BF00291602; WENGER SL, 1984, AM J MED GENET, V19, P715, DOI 10.1002/ajmg.1320190411	49	111	117	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1101	1111						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339703				2022-12-18	WOS:A1990DF20200011
J	VANTUINEN, P; DOBYNS, WB; RICH, DC; SUMMERS, KM; ROBINSON, TJ; NAKAMURA, Y; LEDBETTER, DH				VANTUINEN, P; DOBYNS, WB; RICH, DC; SUMMERS, KM; ROBINSON, TJ; NAKAMURA, Y; LEDBETTER, DH			MOLECULAR-DETECTION OF MICROSCOPIC AND SUBMICROSCOPIC DELETIONS ASSOCIATED WITH MILLER-DIEKER SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; MED COLL WISCONSIN,DEPT NEUROL,MILWAUKEE,WI 53226; UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112	Baylor College of Medicine; Medical College of Wisconsin; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah			Summers, Kim M/M-4086-2015; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021; Robinson, Terence J./K-7342-2017	Summers, Kim M/0000-0002-7084-4386; Dobyns, William/0000-0002-7681-2844; Robinson, Terence J./0000-0002-4298-4891	NICHD NIH HHS [HD06814, HD20619] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD006814, R01HD020619] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; ANAND R, 1986, TRENDS GENET, V2, P278, DOI 10.1016/0168-9525(86)90269-6; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; CANNIZZARO LA, 1986, AM J HUM GENET, V38, P812; DIEKER H, 1969, BIRTH DEFECTS, V2, P53; Dobyns W B, 1987, Birth Defects Orig Artic Ser, V23, P225; DOBYNS WB, 1983, J PEDIATR-US, V102, P552, DOI 10.1016/S0022-3476(83)80183-8; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; DOBYNS WB, 1985, AM J MED GENET, V22, P197, DOI 10.1002/ajmg.1320220119; DOBYNS WB, IN PRESS NEUROLOGIC; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANKE U, 1986, HUM GENET, P201; GREENBERG F, 1986, AM J MED GENET, V23, P853, DOI 10.1002/ajmg.1320230402; GREENBERG F, IN PRESS AM J MED GE; GRUNEBAUM L, 1984, J CLIN INVEST, V73, P1491, DOI 10.1172/JCI111354; JONES KL, 1980, PEDIATRICS, V66, P277; KONDOLEON S, 1987, NUCLEIC ACIDS RES, V15, P10605, DOI 10.1093/nar/15.24.10605; LASKEY RA, 1977, FEBS LETT, V82, P314, DOI 10.1016/0014-5793(77)80609-1; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; MANIATIS T, 1982, MOL CLONING LABORATO; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; MILLER JQ, 1963, NEUROLOGY, V13, P841, DOI 10.1212/WNL.13.10.841; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NAKAMURA Y, IN PRESS GENOMICS; RAPPOLD GA, 1983, HUM GENET, V65, P195, DOI 10.1007/BF00286663; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STRATTON RF, 1984, HUM GENET, V67, P193, DOI 10.1007/BF00273000; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; SU TS, 1984, AM J HUM GENET, V36, P954; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANTUINEN P, 1987, 38TH ANN M AM SOC HU; VANTUINEN P, 1987, 9TH INT WORKSH HUM G; WILLARD H F, 1987, Genomics, V1, P368, DOI 10.1016/0888-7543(87)90041-3; WILLARD HF, 1986, P NATL ACAD SCI USA, V83, P5611, DOI 10.1073/pnas.83.15.5611	35	111	114	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					587	596						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189330				2022-12-18	WOS:A1988Q933600004
J	HAGEMAN, MJ; DELLEMAN, JW				HAGEMAN, MJ; DELLEMAN, JW			HETEROGENEITY IN WAARDENBURG SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review									UNIV HOSP AMSTERDAM, NETHERLANDS OPHTHALM RES INST, DEPT OPHTHALMOGENET, AMSTERDAM 1013, NETHERLANDS	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam								AASVED H, 1962, ACTA OPHTHALMOL, V40, P622; Ahrendts H, 1965, Z Kinderheilkd, V93, P295, DOI 10.1007/BF00443569; AKYILDIZ N, 1966, ANKARA HAST DERGISI, V1, P179; ALEMAN E, 1964, REV CUBANA PEDIATR, V36, P266; ALEZZANDRINI A. A., 1964, OPHTHALMOLOGICA, V147, P409; AMALRIC MP, 1960, B MEM SOC FR OPHTALM, V71, P196; AMALRIC MP, 1959, B MEM SOC FR OPHTALM, V72, P97; AMER M, 1974, BRIT J DERMATOL, V90, P255, DOI 10.1111/j.1365-2133.1974.tb06399.x; AMIN-ZAKI L, 1971, Journal of Laryngology and Otology, V85, P471, DOI 10.1017/S0022215100073692; AMINIELIHOU S, 1970, J GENET HUM, V18, P307; ARIAS S, 1971, Birth Defects Original Article Series, V7, P87; ARNVIG J, 1960, Nord Med, V64, P953; ARNVIG J, 1959, Acta Genet Stat Med, V9, P41; AVANZA C, 1962, ATTI SOC OFTALMOL LO, V2, P155; BASILE R, 1965, J GENET HUM, V14, P87; BENGISU N, 1969, TURK OFTALMOL B, P117; Bernabei L, 1968, Otorinolaringol Ital, V36, P333; Bieder J, 1970, Ann Med Psychol (Paris), V1, P117; BISARIA KK, 1966, ORIENT ARCH OPHTHALM, V4, P27; BISCHLER V, 1956, Confin Neurol, V16, P230; BISCHLER V, 1955, REV SUISSE ZOOL, V62, P83; Boniface L, 1966, Ann Pediatr (Paris), V13, P788; BORBOLLA VACHER L, 1961, Rev Cubana Pediatr, V33, P161; BRAENDSTRUP P, 1941, ACTA OPHTHALMOL, V19, P281; BROWN KS, 1964, P INT C EDUCATION DE; BWIBO NO, 1970, HUM HERED, V20, P19, DOI 10.1159/000152290; CALINIKOS J, 1963, J Laryngol Otol, V77, P59, DOI 10.1017/S0022215100060369; Calmettes L, 1968, Bull Mem Soc Fr Ophtalmol, V81, P144; CAMPBELL B, 1962, ARCH DERMATOL, V86, P718, DOI 10.1001/archderm.1962.01590120016003; CANT JS, 1967, BRIT J OPHTHALMOL, V51, P755, DOI 10.1136/bjo.51.11.755; CHARAMIS J, 1968, Journal of Pediatric Ophthalmology, V5, P230; CHARAMIS J, 1959, ARCH OPHTALMOL-PARIS, V16, P700; CHUNG TW, 1972, ASIAN MED J, V8, P439; COLLIER MM, 1960, B SOC OPHTALMOL FR, V60, P206; Conde I, 1971, Acta Otorinolaryngol Iber Am, V22, P60; Cordier J, 1971, Rev Otoneuroophtalmol, V43, P192; COTTERMAN CW, 1951, AM J HUM GENET, V3, P254; COUTEAULAGARDE JM, 1963, J GENET HUM, V12, P146; Czerwinska W, 1968, Klin Oczna, V38, P395; DADA VK, 1969, ORIENT ARCH OPHTHALM, V7, P49; DAVID TJ, 1972, P ROY SOC MED, V65, P601, DOI 10.1177/003591577206500713; DAVID TJ, 1971, HUMANGENETIK, V14, P81, DOI 10.1007/BF00273041; DAVIS DG, 1969, PLAST RECONSTR SURG, V44, P81, DOI 10.1097/00006534-196907000-00021; DELLEMAN JW, IN PRESS; DELMARCELLE Y, 1958, B SOC BELGE OPHTAL, V118, P380; DIALLINAS NP, 1959, J GENET HUM, V8, P255; DIGEORGE AM, 1960, J PEDIATR-US, V57, P649, DOI 10.1016/S0022-3476(60)80159-X; DIVEKAR MV, 1957, J ALL INDIA OPHTHALM, V5, P1; DUNN M, 1964, MED OFFICER, V112, P144; ELLIS R. W. B., 1931, PROC ROY SOC MED, V24, P1057; FAUCI A, 1963, ARCH OTTALMOL, V67, P345; FEINBERG DL, 1965, J NEWARD CITY HOSPIT, V11, P44; FEINGOLD M, 1967, J PEDIATR-US, V71, P874, DOI 10.1016/S0022-3476(67)80015-5; FERE C, 1896, J ANAT  PARIS, V32, P365; FERRER J, 1965, ARCH PEDIATR URUG, V36, P419; FISCH L, 1959, J Laryngol Otol, V73, P355, DOI 10.1017/S0022215100055420; FISCH L, 1956, TEACH DEAF, V54, P150; FRANCOIS J, 1965, ACTA GENET MED GEMEL, V14, P353, DOI 10.1017/S1120962300015079; Fregonese B, 1969, Minerva Pediatr, V21, P1513; FUGULYAN G, 1962, OFTALMOLOGICA, V6, P349; GALVEZMONTES J, 1958, ARCH SOC OFTAL HISP, V18, P1053; GEDDA L, 1961, ACTA GENET MED GEMEL, V10, P21, DOI 10.1017/S1120962300017182; GELLIS SS, 1967, AM J DIS CHILD, V113, P371, DOI 10.1001/archpedi.1967.02090180131014; GHOSH S, 1962, Indian J Child Health, V11, P448; GIACOIA JP, 1969, AM J DIS CHILD, V117, P344, DOI 10.1001/archpedi.1969.02100030346020; GLADSTONE RM, 1969, ARCH NEUROL-CHICAGO, V21, P184, DOI 10.1001/archneur.1969.00480140084008; GOEDBLOED J, 1951, AM J HUM GENET, V3, P195; GOLDBERG MF, 1966, ARCH OPHTHALMOL-CHIC, V76, P797; GORLIN RJ, 1969, AM J DIS CHILD, V117, P371, DOI 10.1001/archpedi.1969.02100030373027; Greenwood R D, 1973, J Kans Med Soc, V74, P301; GREINER G F, 1964, Rev Otoneuroophtalmol, V36, P199; Grimaud R, 1966, Rev Otoneuroophtalmol, V38, P89; GRIMAUD R, 1961, B SOC OPHTALMOL FR, V61, P693; GRIMAUD R, 1966, REV LARYNGOL OTOL RH, V87, P323; GRIMAUD R, 1961, J FR OTORHINOLARYNG, V10, P351; HAAS EBH, 1966, DOC OPHTHALMOL, V21, P239; Hageman M E, 1974, Ned Tijdschr Geneeskd, V118, P1393; HAGEMAN MJ, 1977, J LARYNGOL OTOL, V91, P575, DOI 10.1017/S0022215100084073; HAGEMAN MJ, IN PRESS; HAMMERSCHLAG V, 1905, MONATSSCHR OHRENHEIL, V39, P554; HAMMERSCHLAG V, 1908, Z OHRENHEILKD, V56, P126; HANSEN A C, 1965, J Natl Med Assoc, V57, P8; HARPE PL, 1962, SA MED J, V36, P920; HAUGEN LK, 1968, TIDSSKR NOR LAEGEFOR, V88, P165; HENNING EMB, 1928, OHRENARTZLICHE UNTER; HOUGHTON N. ISABEL, 1964, NEW ZEAL MED J, V63, P83; JAIN IS, 1963, ORIENT ARCH OPHTHALM, V1, P318; JEMMA S, 1964, ARCH ITAL LARINGOL, V72, P115; JENSEN J, 1967, AMER J ROENTGENOL RA, V101, P828, DOI 10.2214/ajr.101.4.828; JENSEN J, 1969, ACTA RADIOL S, V286, P1; JOHN I, 1935, AV GRAEFES ARCH KLIN, V133, P60; JOHR P, 1953, J Genet Hum, V2, P247; KADOWAKI J, 1969, JAP PEDIAT JAP, V22, P663; KANZAKI J, 1971, PRACT OTOL, V64, P1439; KATTULA S, 1964, J Otolaryngol Soc Aust, V1, P307; KEIZER D P R, 1952, Ned Tijdschr Geneeskd, V96, P2541; KLEIN D, 1947, Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg, V22, P336; Klein D, 1950, HELV PAEDIATR ACTA, V5, P38; KLENKA L, 1956, Cesk Oftalmol, V12, P270; LARBRE F, 1961, Pediatrie, V16, P199; LAVERGNE G, 1959, Bull Soc Belge Ophtalmol, V122, P403; LAVERGNE MG, 1959, J GENET HUM, V10, P80; LEONARDI E, 1931, B OCUL, V10, P165; LEWIS PM, 1963, AM J OPHTHALMOL, V56, P149; LIAN CK, 1968, AM J OPHTHALMOL, V65, P174, DOI 10.1016/0002-9394(68)93582-4; LLARDENT RV, 1962, ACTA OTORINOLARYNGOL, V13, P174; MADIGNIERBOURRO.M, 1966, THESIS U LYON; MAHAJAN C M, 1969, Indian Journal of Pediatrics, V36, P11, DOI 10.1007/BF02749360; MAJUMDAR D K, 1969, Indian Journal of Pediatrics, V36, P483, DOI 10.1007/BF02821375; Mallardi A, 1971, Minerva Pediatr, V23, P1560; Marcus R E, 1969, Trans Am Acad Ophthalmol Otolaryngol, V73, P409; Marcus RE, 1968, ACTA OTO-LARYNGOL, V229, P1; MARCUS RE, 1970, INT AUDIOL, V9, P95; MARQUET J, 1966, CAH OTORHINOLARYNGOL, V1, P47; Marx P, 1968, Bull Soc Ophtalmol Fr, V68, P444; MATSUYAMA S, 1967, RINSHO GANKA, V21, P643; MAZZINI G, 1924, RIV BIOL, V6, P413; MCDONALD R, 1965, CLIN PEDIATR, V4, P739, DOI 10.1177/000992286500401210; MCKENZIE J, 1958, ARCH DIS CHILD, V33, P477, DOI 10.1136/adc.33.171.477; MELLOEOLIVERO HD, 1968, REV BRAS OFTALMOL, V27, P15; MENDE J, 1926, ARCH KINDERHEILKD, V79, P214; MEYER R, 1964, PLAST RECONSTR SURG, V34, P363; MILA JJ, 1965, ARCH PEDIATR URUG, V36, P82; MIZUKOSHI O, 1958, OTOLARYNGOL TOKYO, V7, P261; Mohamed M A, 1971, Bull Ophthalmol Soc Egypt, V64, P333; MOUNIERKUHN P, 1958, J FR OTORHINOLARYNG, V8, P915; MOURAUX JM, 1962, THESIS U NANCY; NAGATANI K, 1958, ZIBI KOKA RINSYO, V51, P717; NAJMAN E, 1968, AN BOLNICE DR M STOJ, V7, P290; NEMANSKY J, 1975, AM J ROENTGENOL, V124, P250, DOI 10.2214/ajr.124.2.250; NICOLAISSEN B, 1962, ACTA OPHTHALMOL, V40, P622; NOMURA Y, 1963, OTOLARYNGOLOGY, V35, P117; OGUCHI Y, 1969, JPN J CLIN OPHTHAL, V23, P1391; OGURA, COMMUNICATION; OHKURA K, 1963, JPN J HUM GENET, V8, P70; OWSLEY PJ, 1962, VOLTA REV, V64, P429; Pandit M M, 1967, Indian Pediatr, V4, P267; PANTKE O A, 1971, Birth Defects Original Article Series, V7, P147; PAPAZOV G, 1967, VATRECHIN B, V6, P107; PARTINGTON MW, 1959, ARCH DIS CHILD, V34, P154, DOI 10.1136/adc.34.174.154; PARTINGTON MW, 1964, CAN MED ASSOC J, V90, P1008; PARTSCH CJ, 1962, LARYNGOLOGIE RHINOLO, V41, P752; PAUFIQUE L, 1964, Bull Soc Ophtalmol Fr, V64, P694; PELICANO C, 1967, INF ANORM, V77, P427; PESTEL M, 1963, PRESSE MED, V71, P572; PINCA A, 1965, ARCISPED S A FERRARA, V18, P1095; PIRODDA A, 1961, Ann Ottalmol Clin Ocul, V87, P401; PIRODDA A, 1965, B OCUL, V44, P240; POROT M, 1967, REV NEUROPSYCH INFAN, V15, P359; POROT M, 1959, Rev Otoneuroophtalmol, V31, P481; POROT M, 1959, PRESSE MED, V67, P1709; POROT M, 1959, REV OTONEUROOPHTALMO, V31, P380; PRYOR HB, 1971, AM J DIS CHILD, V122, P177, DOI 10.1001/archpedi.1971.02110020111020; PUXEDDU P, 1965, RIV OTONEUROOFTALMOL, V40, P1; RAPPOPORT A S, 1970, South African Medical Journal, V44, P412; Ray D K, 1961, Br J Ophthalmol, V45, P568, DOI 10.1136/bjo.45.8.568; REED WB, 1967, ARCH DERMATOL, V95, P176, DOI 10.1001/archderm.95.2.176; ROBINSON GC, 1968, AM J DIS CHILD, V116, P106, DOI 10.1001/archpedi.1968.02100020108017; ROUX C, 1970, ANN GENET-PARIS, V13, P125; Ruben R J, 1971, Trans Pa Acad Ophthalmol Otolaryngol, V24, P121; RUGEL SJ, 1965, AM J DIS CHILD, V109, P579, DOI 10.1001/archpedi.1965.02090020581016; RYSENAER L, 1967, ACTA OTORHINOLARYNGO, V21, P167; SACHS R, 1964, ANN OCUL PARIS, V197, P627; SCHONE D, 1968, VISUM MUNCHEN, V3, P74; SCHULZE W, 1972, HNO-WEGW FACHARZT PR, V20, P203; SCOTT F P, 1962, S Afr Med J, V36, P299; SETTELMAYER J, 1961, NEW ENGL J MED, V264, P500, DOI 10.1056/NEJM196103092641008; SHIONO H, 1969, TOHOKU J EXP MED, V99, P45, DOI 10.1620/tjem.99.45; SIEDLANOWSKA-BRZOSKO H, 1965, Otolaryngol Pol, V19, P143; Silenzi M, 1968, Riv Clin Pediatr, V81, P321; Sinabulya P M, 1972, East Afr Med J, V49, P693; SINGH RW, 1972, PEDIATR CLIN INDIA, V7, P169; SOUSSI J., 1965, S AFRICAN J SCI, V61, P243; SOUSSI J, 1974, LIGHT EYED NEGROES K; SOUSSI J, 1968, THESIS U JOHANNESBUR; STANNUS H, 1931, P ROY SOC MED, V24, P1057; STEPHENS RA, 1964, ARCH DERMATOL, V89, P881; STEVENS PR, 1970, BRIT J OPHTHALMOL, V54, P621, DOI 10.1136/bjo.54.9.621; STOLLER FM, 1962, ARCHIV OTOLARYNGOL, V76, P42; SUDA E, 1969, JPN J CLIN OPHTHAL, V23, P637; SUGA F, 1972, OTOLARYNGOL FUKUOKA, V18, P83; TAY CH, 1971, POSTGRAD MED J, V47, P354, DOI 10.1136/pgmj.47.548.354; THORKILGARD O, 1962, ACTA OPHTHALMOL, V40, P590; TOJO H, 1958, FOL OPHTHAL JAP, V9, P734; TORRESCOURTNEY G, 1964, ANN SOC MEXICO, V7, P1; TOURAINE A, 1936, B SOC FRANC DERM SYP, V43, P1813; UCHERMANN V, 1901, SOURDS MUETS NORVEGE, P16; ULIVELLI A, 1969, HELV PAEDIATR ACTA, V24, P123; URBANTSCHITSCH E, 1910, VERH DTSCH OTOL GES, V19, P153; UYAMA S, 1966, FOLIA OPHTHALMOL JPN, V17, P150; Vacalebre L, 1968, Arch Ital Laringol, V76, P199; VALLEDOR I, 1960, REV CUBANA PEDIATR, V32, P567; VANDERHOEVE J, 1916, KLIN MBL AUGENHEILK, V56, P232; VANGILSE PHG, 1926, NED TIJDSCHR GENEES, V70, P479; VERWOERDVERHOEF HL, 1974, THESIS U AMSTERDAM; VISWANATHAN B, 1973, PRACTITIONER, V211, P785; WAARDENBURG P J, 1948, Ned Tijdschr Geneeskd, V92, P3463; WAARDENBURG P J, 1952, Ned Tijdschr Geneeskd, V96, P914; WAARDENBURG P J, 1952, Ned Tijdschr Geneeskd, V96, P58; WAARDENBURG P J, 1965, Ned Tijdschr Geneeskd, V109, P1057; WAARDENBURG P J, 1957, Acta Ophthalmol (Copenh), V35, P311; Waardenburg P.J., 1961, GENETICS OPHTHALMOLO, V1; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WAARDENBURG PJ, 1965, GENET OPHTHALMOL, V9, P261; WAARDENBURG PJ, 1950, 16 ACTA CONC OPHTH, V1, P479; WAARDENBURG PJ, 1970, REMARKABLE FACTS HUM; WAARDENBURG PJ, 1955, MOD TRENDS OPHTHALMO, V3, P191; WALSH FB, 1969, CLIN NEURO OPHTH, V1, P685; WALSH FB, 1947, CLINICAL NEURO OPHTH; Wilbrandt H R, 1964, Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg, V39, P80; WILDERVANCK L S, 1957, Ned Tijdschr Geneeskd, V101, P1120; WILHELMI BF, 1873, MBL MED STAT OFF  S9, V25, P65; WILLEMOT J, 1964, Ann Otolaryngol Chir Cervicofac, V81, P587; WILLEMOT J, 1963, CR C SOC FR, P210; ZELIG SILVIU, 1961, LARYNGOSCOPE, V71, P19	215	111	115	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1977	29	5					468	485						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV673	331943				2022-12-18	WOS:A1977DV67300006
J	VANDENBERG, SG				VANDENBERG, SG			HEREDITARY ABILITIES STUDY - HEREDITARY COMPONENTS IN A PSYCHOLOGICAL TEST BATTERY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALEXANDER WP, 1935, BRIT J PSYCHOL MON S, V6; AMMONS RB, 1950, J CONSULTING PSYCHOL, V14, P150; Ammons RB, 1950, EDUC PSYCHOL MEAS, V10, P307, DOI 10.1177/001316445001000212; Ammons RB, 1950, J CLIN PSYCHOL, V6, P164, DOI 10.1002/1097-4679(195004)6:2<164::AID-JCLP2270060214>3.0.CO;2-L; Ammons RB, 1949, CHILD DEV, V20, P5; Ammons RB, 1949, J PSYCHOL, V28, P51, DOI 10.1080/00223980.1949.9915994; ANASTASIA A, 1958, DIFFERENTIAL PSYCHOL; Arthur G, 1944, J CONSULT PSYCHOL, V8, P33, DOI 10.1037/h0061111; Bennett GK., 1947, DIFFERENTIAL APTITUD; Cattell RB, 1953, J APPL PSYCHOL, V37, P446, DOI 10.1037/h0056224; CATTELL RB, 1950, JUNIOR PERSONALITY Q; CLARK PJ, 1956, AM J HUM GENET, V8, P49; Cornell E. L., 1934, PERFORMANCE ABILITY; Crown S, 1952, B J PSYCHOL-GEN SECT, V43, P103, DOI 10.1111/j.2044-8295.1952.tb00333.x; DUBOIS PH, 1948, AM PSYCHOL, V3, P363; EYSENCK HJ, 1952, SCIENTIFIC STUDY PER; FARNSWORTH PR, 1958, SOCIAL PSYCHOLOGY MU; FRENCH JW, 1951, 5 PSYCHOM MON CHIC; GRAY WS, 1915, STANDARDIZED ORAL RE; GRAY WS, 1920, 1 SUPPL ED MON CHIC; GUILFORD JP, 1960, SCIENCE, V131, P1318; GUILFORD JP, 1956, PSYCHOL B, V53, P287; HEIM A, 1955, AH4 GROUP TEST INT; Heim AW, 1947, B J PSYCHOL-GEN SECT, V37, P70, DOI 10.1111/j.2044-8295.1947.tb01122.x; Hunt T, 1928, J APPL PSYCHOL, V12, P317, DOI 10.1037/h0075832; KELLEY TL, 1940, STANFORD ACHIEVEMENT; Kohs SC., 1923, INTELLIGENCE MEASURE; Loevinger J., 1951, THEORETICAL FDN PSYC, P557; MACKINNON DW, 1948, EXPERIMENTAL STUDIES; MILES WR, 1950, METHODS MEDICAL RESE, P157; MILLER DR, 1945, SURVEY MECHANICAL IN; Mooney CM, 1954, CAN J PSYCHOLOGY, V8, P51, DOI 10.1037/h0083599; MOSS FA, 1930, SOCIAL INTELLIGENCE; OCONNOR J, 1938, 16 TECHN REP HUM ENG; OCONNOR J, 1928, BORN THAT WAY; Raven JC, 1938, INTELLIGENCE; Raven JC, 1941, BRIT J MED PSYCHOL, V19, P137, DOI 10.1111/j.2044-8341.1941.tb00316.x; SCHEINFELD A, 1956, HUMAN HEREDITY HANDB; SUTTON H. ELDON, 1962, AMER JOUR HUMAN GENET, V14, P52; THURSTONE LL, 1949, 4 PSYCHOM MON CHIC; THURSTONE LL, 1941, CHICAGO TESTS PRIMAR; THURSTONE LL, 1949, 2 PSYCHOM MON CHIC; THURSTONE LL, 1938, 1 PSYCHOM MON CHIC; THURSTONE LL, 1952, PROGRESS REPORT COLO; Wechsler D., 1949, WECHSLER INTELLIGENC; WECHSLER D, 1944, MEASUREMENT ADULT IN; Witkin H. A., 1954, PERSONALITY PERCEPTI; [No title captured]	48	111	113	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	2					220	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2963A	17948470				2022-12-18	WOS:A19622963A00010
J	Xu, Y; Shi, YL; Fu, J; Yu, M; Feng, RZ; Sang, Q; Liang, B; Chen, BB; Qu, RG; Li, B; Yan, Z; Mao, XY; Kuang, YP; Jin, L; He, L; Sun, XX; Wang, L				Xu, Yao; Shi, Yingli; Fu, Jing; Yu, Min; Feng, Ruizhi; Sang, Qing; Liang, Bo; Chen, Biaobang; Qu, Ronggui; Li, Bin; Yan, Zheng; Mao, Xiaoyan; Kuang, Yanping; Jin, Li; He, Lin; Sun, Xiaoxi; Wang, Lei			Mutations in PADI6 Cause Female Infertility Characterized by Early Embryonic Arrest	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL EFFECT GENE; ZYGOTIC TRANSITION; GENOME ACTIVATION; OOCYTE	Early embryonic arrest is one of the major causes of female infertility. However, because of difficulties in phenotypic evaluation, genetic determinants of human early embryonic arrest are largely unknown. With the development of assisted reproductive technology, the phenotype of early human embryonic arrest can now be carefully evaluated. Here, we describe a consanguineous family with a recessive inheritance pattern of female infertility characterized by recurrent early embryonic arrest in cycles of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). We have identified a homozygous PADI6 nonsense mutation (c.1141C>T [p.G1n381*]) that is responsible for the phenotype. Mutational analysis of PADI6 in a cohort of 36 individuals whose embryos displayed developmental arrest identified two affected individuals with compound-heterozygous mutations (c.2009_2010del [p.G1u670Glyfs*48] and c.633T>A [p.His211G1n]; c.1618G>A [p.Gly540Arg] and c.970C>T [p.G1n3241). Immunostaining indicated a lack of PADI6 in affected individuals' oocytes. In addition, the amount of phosphorylated RNA polymerase II and expression levels of seven genes involved in zygotic genome activation were reduced in the affected individuals' embryos. This phenotype is consistent with Padi6 knockout mice. These findings deepen our understanding of the genetic basis of human early embryonic arrest, which has been a largely ignored Mendelian phenotype. Our findings lay the foundation for uncovering other genetic causes of infertility resulting from early embryonic arrest.	[Xu, Yao; Feng, Ruizhi; Sang, Qing; Chen, Biaobang; Qu, Ronggui; Wang, Lei] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China; [Xu, Yao; Feng, Ruizhi; Sang, Qing; Chen, Biaobang; Qu, Ronggui; Jin, Li; Wang, Lei] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200438, Peoples R China; [Xu, Yao; Feng, Ruizhi; Sang, Qing; Chen, Biaobang; Qu, Ronggui; Jin, Li; Wang, Lei] Fudan Univ, Key Lab Contemporary Anthropol, Sch Life Sci, Minist Educ, Shanghai 200438, Peoples R China; [Xu, Yao; Feng, Ruizhi; Sang, Qing; Chen, Biaobang; Qu, Ronggui; He, Lin; Wang, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Shi, Yingli; Fu, Jing; Yu, Min; Sun, Xiaoxi] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai 200011, Peoples R China; [Liang, Bo] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Joint Int Res Lab Metab & Dev Sci, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Li, Bin; Yan, Zheng; Mao, Xiaoyan; Kuang, Yanping] Shanghai Jiao Tong Univ, Reprod Med Ctr, Shanghai Hosp 9, Shanghai 200011, Peoples R China; [He, Lin] Shanghai Jiao Tong Univ, Minist Educ, BioX Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, L (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200011, Peoples R China.; Wang, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200438, Peoples R China.; Wang, L (corresponding author), Fudan Univ, Key Lab Contemporary Anthropol, Sch Life Sci, Minist Educ, Shanghai 200438, Peoples R China.; Wang, L (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Sun, XX (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Shanghai Ji Ai Genet & IVF Inst, Shanghai 200011, Peoples R China.	xiaoxi_sun@aliyun.com; wangleiwanglei@fudan.edu.cn	Xu, Yao/AFL-6014-2022; Kuang, Yanping/T-4070-2019; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Xu, Yao/0000-0002-0792-1158; Jin, Li/0000-0002-4546-2415	National Key R&D Program of China [2016YFC1000600]; National Basic Research Program of China [2015CB943300]; National Natural Science Foundation of China [81270747, 81571501, 81571506]	National Key R&D Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key R&D Program of China (2016YFC1000600), the National Basic Research Program of China (2015CB943300), and the National Natural Science Foundation of China (81270747, 81571501, and 81571506). We want to thank Dr. Scott Coonrod from Cornell University and Dr. Xueseng Zhang from Nan Jing Medical University for their help.	Adamson GD, 2013, FERTIL STERIL, V100, pS42, DOI 10.1016/j.fertnstert.2013.07.1807; Alazami AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0792-0; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Esposito G, 2007, MOL CELL ENDOCRINOL, V273, P25, DOI 10.1016/j.mce.2007.05.005; Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367; Hardarson T, 2001, HUM REPROD, V16, P313, DOI 10.1093/humrep/16.2.313; Harper J, 2008, HUM REPROD, V23, P478, DOI 10.1093/humrep/dem424; Horibata S, 2012, J REPROD DEVELOP, V58, P274, DOI 10.1262/jrd.2011-040; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Mascarenhas MN, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001356; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Veeck LL, 1999, ATLAS HUMAN GAMETES, P46; WARNER CM, 1974, NATURE, V248, P678, DOI 10.1038/248678a0; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4; Yanez LZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10809; Yurttas P, 2008, DEVELOPMENT, V135, P2627, DOI 10.1242/dev.016329; Zheng P, 2009, P NATL ACAD SCI USA, V106, P7473, DOI 10.1073/pnas.0900519106	27	110	116	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					744	752		10.1016/j.ajhg.2016.06.024	http://dx.doi.org/10.1016/j.ajhg.2016.06.024			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27545678	Green Published, Bronze			2022-12-18	WOS:000383114800020
J	Arndt, AK; Schafer, S; Drenckhahn, JD; Sabeh, MK; Plovie, ER; Caliebe, A; Klopocki, E; Musso, G; Werdich, AA; Kalwa, H; Heinig, M; Padera, RF; Wassilew, K; Bluhm, J; Harnack, C; Martitz, J; Barton, PJ; Greutmann, M; Berger, F; Hubner, N; Siebert, R; Kramer, HH; Cook, SA; MacRae, CA; Klaassen, S				Arndt, Anne-Karin; Schafer, Sebastian; Drenckhahn, Jorg-Detlef; Sabeh, M. Khaled; Plovie, Eva R.; Caliebe, Almuth; Klopocki, Eva; Musso, Gabriel; Werdich, Andreas A.; Kalwa, Hermann; Heinig, Matthias; Padera, Robert F.; Wassilew, Katharina; Bluhm, Julia; Harnack, Christine; Martitz, Janine; Barton, Paul J.; Greutmann, Matthias; Berger, Felix; Hubner, Norbert; Siebert, Reiner; Kramer, Hans-Heiner; Cook, Stuart A.; MacRae, Calum A.; Klaassen, Sabine			Fine Mapping of the 1p36 Deletion Syndrome Identifies Mutation of PRDM16 as a Cause of Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; SHPRINTZEN-GOLDBERG SYNDROME; MONOSOMY 1P36; MOLECULAR-MECHANISMS; CLINICAL PHENOTYPE; ARRAY-CGH; GENE; COMPLEX; REARRANGEMENTS; DELINEATION	Deletion 1p36 syndrome is recognized as the most common terminal deletion syndrome. Here, we describe the loss of a gene within the deletion that is responsible for the cardiomyopathy associated with monosomy 1p36, and we confirm its role in nonsyndromic left ventricular noncompaction cardiomyopathy (LVNC) and dilated cardiomyopathy (DCM). With our own data and publically available data from array comparative genomic hybridization (aCGH), we identified a minimal deletion for the cardiomyopathy associated with 1p36del syndrome that included only the terminal 14 exons of the transcription factor PRDM16 (PR domain containing 16), a gene that had previously been shown to direct brown fat determination and differentiation. Resequencing of PRDM16 in a cohort of 75 nonsyndromic individuals with LVNC detected three mutations, including one truncation mutant, one frameshift null mutation, and a single missense mutant. In addition, in a series of cardiac biopsies from 131 individuals with DCM, we found 5 individuals with 4 previously unreported nonsynonymous variants in the coding region of PRDM16. None of the PRDM16 mutations identified were observed in more than 6,400 controls. PRDM16 has not previously been associated with cardiac disease but is localized in the nuclei of cardiomyocytes throughout murine and human development and in the adult heart. Modeling of PRDM16 haploinsufficiency and a human truncation mutant in zebrafish resulted in both contractile dysfunction and partial uncoupling of cardiomyocytes and also revealed evidence of impaired cardiomyocyte proliferative capacity. In conclusion, mutation of PRDM16 causes the cardiomyopathy in 1p36 deletion syndrome as well as a proportion of nonsyndromic LVNC and DCM.	[Arndt, Anne-Karin; Kramer, Hans-Heiner] Univ Hosp Schleswig Holstein, Dept Congenital Heart Dis & Pediat Cardiol, D-24105 Kiel, Germany; [Arndt, Anne-Karin; Sabeh, M. Khaled; Plovie, Eva R.; Musso, Gabriel; Werdich, Andreas A.; Kalwa, Hermann; MacRae, Calum A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Arndt, Anne-Karin; Sabeh, M. Khaled; Plovie, Eva R.; Musso, Gabriel; Werdich, Andreas A.; Kalwa, Hermann; MacRae, Calum A.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Schafer, Sebastian; Drenckhahn, Jorg-Detlef; Heinig, Matthias; Hubner, Norbert] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Caliebe, Almuth; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Caliebe, Almuth; Siebert, Reiner] Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; [Klopocki, Eva] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Klopocki, Eva] Univ Wurzburg, Inst Human Genet, D-97074 Wurzburg, Germany; [Heinig, Matthias] Max Planck Inst Mol Genet, Dept Computat Biol, D-14195 Berlin, Germany; [Padera, Robert F.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wassilew, Katharina] German Heart Inst, Dept Pathol, D-13353 Berlin, Germany; [Bluhm, Julia; Harnack, Christine; Martitz, Janine; Klaassen, Sabine] Charite Med Fac, ECRC, D-13125 Berlin, Germany; [Bluhm, Julia; Harnack, Christine; Martitz, Janine; Klaassen, Sabine] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Barton, Paul J.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Barton, Paul J.] NIHR Royal Brompton Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Greutmann, Matthias] Univ Zurich Hosp, Ctr Cardiovasc, CH-8001 Zurich, Switzerland; [Berger, Felix] German Heart Inst, Dept Congenital Heart Defects & Pediat Cardiol, D-13353 Berlin, Germany; [Berger, Felix] Charite, Dept Pediat Cardiol, D-13353 Berlin, Germany; [Hubner, Norbert] DZHK German Ctr Cardiovasc Res, Berlin, Germany; [Cook, Stuart A.] Natl Heart Ctr, Singapore 168752, Singapore; [Cook, Stuart A.] Duke NUS Grad Med Sch, Singapore 169857, Singapore	University of Kiel; Schleswig Holstein University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Max Planck Society; Harvard University; Brigham & Women's Hospital; Harvard Medical School; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Imperial College London; University of Zurich; University Zurich Hospital; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; National Heart Centre Singapore; National University of Singapore	Klaassen, S (corresponding author), Charite Med Fac, ECRC, D-13125 Berlin, Germany.	klaassen@mdc-berlin.de	Kalwa, Hermann/ABG-2323-2021; Siebert, Reiner/A-8049-2010; Greutmann, Matthias/AFU-2025-2022; Caliebe, Almuth/G-1248-2018; Cook, Stuart/G-9567-2011; Klopocki, Eva/B-6823-2017; Wassilew, Katharina/D-7813-2017	Caliebe, Almuth/0000-0003-2157-425X; Klopocki, Eva/0000-0003-1438-2081; Wassilew, Katharina/0000-0002-8683-465X; Werdich, Andreas/0000-0002-1222-1180; Drenckhahn, Jorg-Detlef/0000-0001-8347-7696; Schafer, Sebastian/0000-0002-6909-8275; Heinig, Matthias/0000-0002-5612-1720; Cook, Stuart/0000-0001-6628-194X; Barton, Paul/0000-0002-1165-7767; Berger, Felix/0000-0001-7881-1557; Klaassen, Sabine/0000-0001-5925-9912; Musso, Gabriel/0000-0001-8778-8248	Wellcome Trust; Competence Network for Congenital Heart Defects, Germany; Federal Ministry of Education and Research (BMBF) [FKZ01GI0601]; DZHK (German Centre for Cardiovascular Research); Harvard Stem Cell Institute; Leducq Foundation; Fondation Leducq; National Institute for Health Research Cardiovascular BRU at the Brompton; Harefield & Harefield NHS Foundation Trust; Imperial College London; Heart Research U.K.; Deutsche Herzstiftung; MRC [MC_U120085815] Funding Source: UKRI; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120085815] Funding Source: researchfish; Heart Research UK [RG2596] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL112724, R01HL109264] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Competence Network for Congenital Heart Defects, Germany; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DZHK (German Centre for Cardiovascular Research); Harvard Stem Cell Institute; Leducq Foundation(Leducq Foundation); Fondation Leducq(Leducq Foundation); National Institute for Health Research Cardiovascular BRU at the Brompton; Harefield & Harefield NHS Foundation Trust; Imperial College London(General Electric); Heart Research U.K.; Deutsche Herzstiftung; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Heart Research UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study makes use of data generated by the DECIPHER Consortium. A full list of centers that contributed to the generation of the data is available from http://decipher.sanger.ac.uk and via email from decipher@sanger.ac.uk and funding of the project was provided by the Wellcome Trust. We are pleased to cite the database Ecaruca for cytogenetic information. We are grateful to L. Thierfelder, S. Bahring, and F.C. Luft for infrastructural support. This study was supported by the Competence Network for Congenital Heart Defects, Germany, funded by the Federal Ministry of Education and Research (BMBF), FKZ01GI0601, the DZHK (German Centre for Cardiovascular Research) as well as support to C.A.M. from the Harvard Stem Cell Institute and the Leducq Foundation. S.A.C. is supported by the Fondation Leducq. S.A.C. and P.J.B. are supported by the National Institute for Health Research Cardiovascular BRU at the Brompton and Harefield & Harefield NHS Foundation Trust and Imperial College London and P.J.B. by Heart Research U.K. A.-K.A. was supported by a personal grant from the Deutsche Herzstiftung.	Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Caliebe A, 2010, EUR J MED GENET, V53, P179, DOI 10.1016/j.ejmg.2010.04.001; Carmignac V, 2012, AM J HUM GENET, V91, P950, DOI 10.1016/j.ajhg.2012.10.002; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Feenstra I, 2006, EUR J MED GENET, V49, P279, DOI 10.1016/j.ejmg.2005.10.131; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gajecka M, 2005, EUR J HUM GENET, V13, P139, DOI 10.1038/sj.ejhg.5201302; Gajecka M, 2007, AM J MED GENET C, V145C, P346, DOI 10.1002/ajmg.c.30154; Gajecka M, 2010, AM J MED GENET A, V152A, P3074, DOI 10.1002/ajmg.a.33733; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Giannikou K, 2012, GENE, V506, P360, DOI 10.1016/j.gene.2012.06.060; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Heilstedt HA, 2001, EPILEPSIA, V42, P1103, DOI 10.1046/j.1528-1157.2001.08801.x; Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Klaassen S, 2008, CIRCULATION, V117, P2893, DOI 10.1161/CIRCULATIONAHA.107.746164; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lombardi R, 2011, CIRC RES, V109, P1342, DOI 10.1161/CIRCRESAHA.111.255075; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Probst S, 2011, CIRC-CARDIOVASC GENE, V4, P367, DOI 10.1161/CIRCGENETICS.110.959270; Redon R, 2005, J MED GENET, V42, P166, DOI 10.1136/jmg.2004.023861; Rosenfeld JA, 2010, AM J MED GENET A, V152A, P1951, DOI 10.1002/ajmg.a.33516; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shapria SK, 1997, AM J HUM GENET, V61, P642, DOI 10.1086/515520; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Ham TJ, 2010, FASEB J, V24, P4336, DOI 10.1096/fj.10-161018; Werdich AA, 2012, PROG BIOPHYS MOL BIO, V110, P154, DOI 10.1016/j.pbiomolbio.2012.07.006	41	110	116	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					67	77		10.1016/j.ajhg.2013.05.015	http://dx.doi.org/10.1016/j.ajhg.2013.05.015			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23768516	Green Published, Bronze			2022-12-18	WOS:000321804500006
J	Oz-Levi, D; Ben-Zeev, B; Ruzzo, EK; Hitomi, Y; Gelman, A; Pelak, K; Anikster, Y; Reznik-Wolf, H; Bar-Joseph, I; Olender, T; Alkelai, A; Weiss, M; Ben-Asher, E; Ge, DL; Shianna, KV; Elazar, Z; Goldstein, DB; Pras, E; Lancet, D				Oz-Levi, Danit; Ben-Zeev, Bruria; Ruzzo, Elizabeth K.; Hitomi, Yuki; Gelman, Amir; Pelak, Kimberly; Anikster, Yair; Reznik-Wolf, Haike; Bar-Joseph, Ifat; Olender, Tsviya; Alkelai, Anna; Weiss, Meira; Ben-Asher, Edna; Ge, Dongliang; Shianna, Kevin V.; Elazar, Zvulun; Goldstein, David B.; Pras, Elon; Lancet, Doron			Mutation in TECPR2 Reveals a Role for Autophagy in Hereditary Spastic Paraparesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TROYER-SYNDROME; COPY NUMBER; INVOLVEMENT; PARAPLEGIA; CEREBELLAR; ATG8; LC3	We studied five individuals from three Jewish Bukharian families affected by an apparently autosomal-recessive form of hereditary spastic paraparesis accompanied by severe intellectual disability, fluctuating central hypoventilation, gastresophageal reflux disease, wake apnea, areflexia, and unique dysmorphic features. Exome sequencing identified one homozygous variant shared among all affected individuals and absent in controls: a 1 bp frameshift TECPR2 deletion leading to a premature stop codon and predicting significant degradation of the protein. TECPR2 has been reported as a positive regulator of autophagy. We thus examined the autophagy-related fate of two key autophagic proteins, SQSTM1 (p62) and MAP1LC3B (LC3), in skin fibroblasts of an affected individual, as compared to a healthy control, and found that both protein levels were decreased and that there was a more pronounced decrease in the lipidated form of LC3 (LC3II). siRNA knockdown of TECPR2 showed similar changes, consistent with aberrant autophagy. Our results are strengthened by the fact that autophagy dysfunction has been implicated in a number of other neurodegenerative diseases. The discovered TECPR2 mutation implicates autophagy, a central intracellular mechanism, in spastic paraparesis.	[Oz-Levi, Danit; Olender, Tsviya; Alkelai, Anna; Weiss, Meira; Ben-Asher, Edna; Lancet, Doron] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Gelman, Amir; Elazar, Zvulun] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Ruzzo, Elizabeth K.; Hitomi, Yuki; Pelak, Kimberly; Ge, Dongliang; Shianna, Kevin V.; Goldstein, David B.] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA; [Ben-Zeev, Bruria; Anikster, Yair; Bar-Joseph, Ifat] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, IL-52621 Ramat Gan, Israel; [Reznik-Wolf, Haike; Bar-Joseph, Ifat; Pras, Elon] Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Ramat Gan, Israel; [Ben-Zeev, Bruria; Anikster, Yair; Reznik-Wolf, Haike; Bar-Joseph, Ifat; Pras, Elon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Duke University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Oz-Levi, D (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	ozdanit@gmail.com	Hitomi, Yuki/V-8236-2019; Goldstein, David/AAY-8125-2020		American Recovery and Reinvestment Act; National Institute on Aging; National Institute of Mental Health; Ellison Medical Foundation; Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID) (National Institutes of Health); Center for HIV/AIDS Vaccine Immunology under NIAID; Crown Human Genome Center; Benoziyo Center of the Weizmann Institute of Science; Legacy Heritage Fund; Israeli Science Foundation; German Israeli Foundation	American Recovery and Reinvestment Act; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ellison Medical Foundation(Lawrence Ellison Foundation); Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID) (National Institutes of Health); Center for HIV/AIDS Vaccine Immunology under NIAID; Crown Human Genome Center; Benoziyo Center of the Weizmann Institute of Science; Legacy Heritage Fund; Israeli Science Foundation(Israel Science Foundation); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	We thank the individuals and their families, as well as the following individuals for contributing control samples: J. Burke, C. Hulette, K. Welsh-Bohmer, F.J. McMahon, N. Akula, J. Hoover-Fong, N.L. Sobreira, D. Valle, M.C. Manzini, A. Poduri, N. Calakos, David H. Murdock, The MURDOCK Study Community Registry and Biorepository, J.P. McEvoy, A. Need, J. Silver, M. Silver, E.J. Holtzman, G. Cavalleri, N. Delanty, C. Depondt, S. Sisodiya, W.B. Gallentine, E.L. Heinzen, A.M. Husain, K.N. Linney, M.A. Mikati, K. Pelak, R.A. Radtke, S.A. Sinha, N.M. Walley, D. Koltai Attix, O. Chiba-Falek, E.T. Cirulli, V. Dixon, J. McEvoy, K. Schmader, S. McDonald, H.K. White, M. Yanamadala, the Carol Woods and Crosdaile Retirement Communities, V. Shashi, P. Lugar, W.L. Lowe, S.M. Palmer, D. Marchuk, D. Levy, Z. Farfel, D. Lancet, E. Pras, Y. Jiang, Q. Zhao, J. Milner, D. Daskalakis, R. Gbadegesin, M. Winn, A. Holden, E. Behr, R.H. Brown, Jr., S. Kerns, and H. Oster. We thank the Weizmann Institute Electron Microscopy unit. This study was funded by the American Recovery and Reinvestment Act; Bryan Alzheimer's Disease Research Center funded by the National Institute on Aging; National Institute of Mental Health; Ellison Medical Foundation New Scholar award; Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID) (National Institutes of Health) and Center for HIV/AIDS Vaccine Immunology under NIAID (to D.B.G.); Crown Human Genome Center and Benoziyo Center of the Weizmann Institute of Science (to D.L.); and Legacy Heritage Fund, Israeli Science Foundation, and German Israeli Foundation (to Z.E).	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Bakowska JC, 2007, MOL BIOL CELL, V18, P1683, DOI 10.1091/mbc.E06-09-0833; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Blumen SC, 2000, NEUROLOGY, V55, P1267, DOI 10.1212/WNL.55.9.1267; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Ge DL, 2011, BIOINFORMATICS, V27, P1998, DOI 10.1093/bioinformatics/btr317; Heger A, 2008, NUCLEIC ACIDS RES, V36, pD276, DOI 10.1093/nar/gkm879; Henson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036505; Knaevelsrud H, 2010, FEBS LETT, V584, P2635, DOI 10.1016/j.febslet.2010.04.041; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Menzies FM, 2010, AUTOPHAGY, V6, P286, DOI 10.4161/auto.6.2.11078; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Need AC, 2012, AM J HUM GENET, V91, P303, DOI 10.1016/j.ajhg.2012.06.018; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pasquali L, 2009, MUSCLE NERVE, V40, P173, DOI 10.1002/mus.21423; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosulescu E, 2009, ROM J MORPHOL EMBRYO, V50, P299; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Schule R, 2011, SEMIN NEUROL, V31, P484, DOI 10.1055/s-0031-1299787; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wharton SB, 2003, J NEUROPATH EXP NEUR, V62, P1166, DOI 10.1093/jnen/62.11.1166; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575	39	110	112	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1065	1072		10.1016/j.ajhg.2012.09.015	http://dx.doi.org/10.1016/j.ajhg.2012.09.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23176824	Green Published, Bronze			2022-12-18	WOS:000312417400009
J	Belaya, K; Finlayson, S; Slater, CR; Cossins, J; Liu, WW; Maxwell, S; McGowan, SJ; Maslau, S; Twigg, SRF; Walls, TJ; Pascual, SIP; Palace, J; Beeson, D				Belaya, Katsiaryna; Finlayson, Sarah; Slater, Clarke R.; Cossins, Judith; Liu, Wei Wei; Maxwell, Susan; McGowan, Simon J.; Maslau, Siarhei; Twigg, Stephen R. F.; Walls, Timothy J.; Pascual, Samuel I. Pascual; Palace, Jacqueline; Beeson, David			Mutations in DPAGT1 Cause a Limb-Girdle Congenital Myasthenic Syndrome with Tubular Aggregates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROMUSCULAR-JUNCTION SYNAPTOPATHY; ACETYLCHOLINE-RECEPTOR SUBUNITS; GLYCOSYLATION TYPE IJ; TRANSFERASE DPAGT1; N-GLYCOSYLATION; GENOME BROWSER; TRANSMISSION; DEFICIENCY; EXPRESSION; DISORDER	Congenital myasthenic syndromes are a heterogeneous group of inherited disorders that arise from impaired signal transmission at the neuromuscular synapse. They are characterized by fatigable muscle weakness. We performed whole-exome sequencing to determine the underlying defect in a group of individuals with an inherited limb-girdle pattern of myasthenic weakness. We identify DPAGT1 as a gene in which mutations cause a congenital myasthenic syndrome. We describe seven different mutations found in five individuals with DPAGT1 mutations. The affected individuals share a number of common clinical features, including involvement of proximal limb muscles, response to treatment with cholinesterase inhibitors and 3,4-diaminopyridine, and the presence of tubular aggregates in muscle biopsies. Analyses of motor endplates from two of the individuals demonstrate a severe reduction of endplate acetylcholine receptors. DPAGT1 is an essential enzyme catalyzing the first committed step of N-linked protein glycosylation. Our findings underscore the importance of N-linked protein glycosylation for proper functioning of the neuromuscular junction. Using the DPAGT1-specific inhibitor tunicamycin, we show that DPAGT1 is required for efficient glycosylation of acetylcholine-receptor subunits and for efficient export of acetylcholine receptors to the cell surface. We suggest that the primary pathogenic mechanism of DPAGT1 mutations is reduced levels of acetylcholine receptors at the endplate region. These individuals share clinical features similar to those of congenital myasthenic syndrome due to GFPT1 mutations, and their disorder might be part of a larger subgroup comprising the congenital myasthenic syndromes that result from defects in the N-linked glycosylation pathway and that manifest through impaired neuromuscular transmission.	[Belaya, Katsiaryna; Finlayson, Sarah; Cossins, Judith; Liu, Wei Wei; Maxwell, Susan; Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Neurosci Grp, Oxford OX3 9DS, England; [Finlayson, Sarah; Palace, Jacqueline] John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Slater, Clarke R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [McGowan, Simon J.] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford OX3 9DS, England; [Belaya, Katsiaryna; Maslau, Siarhei] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Walls, Timothy J.] Newcastle Gen Hosp, Reg Neurosci Ctr, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Pascual, Samuel I. Pascual] Univ Autonoma Madrid, Dept Pediat, Hosp Univ La Paz, Serv Neurol Pediat, Madrid 28046, Spain	University of Oxford; University of Oxford; Newcastle University - UK; University of Oxford; University of Oxford; Newcastle General Hospital; Autonomous University of Madrid; Hospital Universitario La Paz	Beeson, D (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Neurosci Grp, Oxford OX3 9DS, England.	dbeeson@hammer.imm.ox.ac.uk	Twigg, Stephen/AAU-1135-2021	Twigg, Stephen/0000-0001-5024-049X; Pascual Pascual, Samuel Ignacio/0000-0002-5428-8121; McGowan, Simon/0000-0001-9720-1914	Wellcome Trust [090532/Z/09/Z]; Medical Research Council [G0900747 91070]; Medical Research Council, UK; Muscular Dystrophy Campaign; Myasthenia Gravis Association; Medical Research Council [G0701521] Funding Source: researchfish; MRC [G0701521] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Myasthenia Gravis Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z and Medical Research Council Hub grant G0900747 91070) for the generation of the sequencing data. We are grateful to Gerton Lunter and Andy Rimmer for providing their program Platypus ahead of its publication. We thank Carol Young for electron-microscopy work. K.B. is a fellow of the Wellcome Trust-funded OXION: Ion Channels and Disease Initiative. S.R.F.T. is supported by a grant from the Wellcome Trust. We are grateful for funding from the Medical Research Council, UK, the Muscular Dystrophy Campaign, and the Myasthenia Gravis Association. We thank the cases with congenital myasthenic syndromes and their families for participating in this study and for their consent, which was obtained with ethical approval from Oxfordshire Research Ethics Committees B (04.OXB.017) and C (09/H0606/74).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], EX VAR SERV; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Bretthauer RK, 2009, CURR DRUG TARGETS, V10, P477, DOI 10.2174/138945009788488369; Chaouch A, 2012, NEUROMUSCULAR DISORD, V22, pS16, DOI 10.1016/j.nmd.2011.12.004; Croxen R, 2001, BRAIN, V124, P1362, DOI 10.1093/brain/124.7.1362; Dal Nogare AR, 1998, GLYCOBIOLOGY, V8, P625, DOI 10.1093/glycob/8.6.625; Dan N, 1996, J BIOL CHEM, V271, P30717, DOI 10.1074/jbc.271.48.30717; Engel AG, 2012, NEUROMUSCULAR DISORD, V22, P99, DOI 10.1016/j.nmd.2011.10.009; GEHLE VM, 1991, MOL BRAIN RES, V11, P17, DOI 10.1016/0169-328X(91)90016-Q; Gehle VM, 1997, MOL BRAIN RES, V45, P219, DOI 10.1016/S0169-328X(96)00256-2; Guergueltcheva V, 2011, J NEUROL; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; LEHLE L, 1976, FEBS LETT, V71, P167, DOI 10.1016/0014-5793(76)80922-2; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Marklova E, 2007, CLIN CHIM ACTA, V385, P6, DOI 10.1016/j.cca.2007.07.002; Meola G, 2003, EUR J HISTOCHEM, V47, P17; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; NOMOTO H, 1986, EUR J BIOCHEM, V157, P233, DOI 10.1111/j.1432-1033.1986.tb09661.x; Oh SJ, 2006, MUSCLE NERVE, V34, P572, DOI 10.1002/mus.20622; Ohno K, 1997, HUM MOL GENET, V6, P753, DOI 10.1093/hmg/6.5.753; Palace J, 2007, BRAIN, V130, P1507, DOI 10.1093/brain/awm072; Pascual-Castroviejo I, 2006, REV NEUROLOGIA, V42, P723, DOI 10.33588/rn.4212.2005675; Rimmer A., 2012, PLATYPUS PROGRAM INT; Ruff RL, 2011, MUSCLE NERVE, V44, P854, DOI 10.1002/mus.22177; Senderek J, 2011, AM J HUM GENET, V88, P162, DOI 10.1016/j.ajhg.2011.01.008; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Slater CR, 2006, BRAIN, V129, P2061, DOI 10.1093/brain/awl200; Slater Clarke R, 2008, Handb Clin Neurol, V91, P27, DOI 10.1016/S0072-9752(07)01502-3; Slater CR, 1997, BRAIN, V120, P1513, DOI 10.1093/brain/120.9.1513; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Wanamaker CP, 2003, ANN NY ACAD SCI, V998, P66, DOI 10.1196/annals.1254.009; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wu XH, 2003, HUM MUTAT, V22, P144, DOI 10.1002/humu.10239; Wurde AE, 2012, MOL GENET METAB, V105, P634, DOI 10.1016/j.ymgme.2012.01.001; ZHU XY, 1990, J BIOL CHEM, V265, P14250	39	110	112	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					193	201		10.1016/j.ajhg.2012.05.022	http://dx.doi.org/10.1016/j.ajhg.2012.05.022			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22742743	Green Published, hybrid			2022-12-18	WOS:000306445000018
J	Hu, XL; Kim, H; Stahl, E; Plenge, R; Daly, M; Raychaudhuri, S				Hu, Xinli; Kim, Hyun; Stahl, Eli; Plenge, Robert; Daly, Mark; Raychaudhuri, Soumya			Integrating Autoimmune Risk Loci with Gene-Expression Data Identifies Specific Pathogenic Immune Cell Subsets	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; CROHNS-DISEASE; RECEPTOR GENE; B-CELLS; VARIANTS; ITGAM	Although genome-wide association studies have implicated many individual loci in complex diseases, identifying the exact causal alleles and the cell types within which they act remains greatly challenging. To ultimately understand disease mechanism, researchers must carefully conceive functional studies in relevant pathogenic cell types to demonstrate the cellular impact of disease-associated genetic variants. This challenge is highlighted in autoimmune diseases, such as rheumatoid arthritis, where any of a broad range of immunological cell types might potentially be impacted by genetic variation to cause disease. To this end, we developed a statistical approach to identify potentially pathogenic cell types in autoimmune diseases by using a gene-expression data set of 223 murine-sorted immune cells from the Immunological Genome Consortium. We found enrichment of transitional B cell genes in systemic lupus erythematosus (p = 5.9 x 10(-6)) and epithelial-associated stimulated dendritic cell genes in Crohn disease (p = 1.6 x 10(-5)). Finally, we demonstrated enrichment of CD4+ effector memory T cell genes within rheumatoid arthritis loci (p < 10(-6)). To further validate the role of CD4+ effector memory T cells within rheumatoid arthritis, we identified 436 loci that were not yet known to be associated with the disease but that had a statistically suggestive association in a recent genome-wide association study (GWAS) meta-analysis (PG WAS < 0.001). Even among these putative loci, we noted a significant enrichment for genes specifically expressed in CD4+ effector memory T cells (p = 1.25 x 10(-4)). These cell types are primary candidates for future functional studies to reveal the role of risk alleles in autoimmunity. Our approach has application in other phenotypes, outside of autoimmunity, where many loci have been discovered and high-quality cell-type-specific gene expression is available.	[Hu, Xinli; Kim, Hyun; Stahl, Eli; Plenge, Robert; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hu, Xinli; Kim, Hyun; Stahl, Eli; Plenge, Robert; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Rheumatol Immunol & Allergy, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hu, Xinli; Stahl, Eli; Plenge, Robert; Daly, Mark; Raychaudhuri, Soumya] Broad Inst, Med & Populat Genet Grp, Cambridge, MA 02142 USA; [Hu, Xinli] Harvard Univ, Hlth Sci & Technol MD Program, Boston, MA 02115 USA; [Hu, Xinli] MIT, Boston, MA 02115 USA; [Daly, Mark] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02214 USA; [Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Partners Healthcare System	Raychaudhuri, S (corresponding author), Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA.	soumya@broadinstitute.org	Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Kim, Hyun/0000-0002-6970-8387; Raychaudhuri, Soumya/0000-0002-1901-8265	National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS) [1K08AR055688]; Harvard Health Sciences and Technology Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Harvard Health Sciences and Technology Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work benefitted from data assembled by the ImmGen Consortium. This work was supported in part by the National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH-NIAMS) Development Award (1K08AR055688) and by the Harvard Health Sciences and Technology Program. We thank Joel Hirschorn, Michael B. Brenner, David Altshuler, and Lude Franke for helpful discussions.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Chan OTM, 1999, IMMUNOL REV, V169, P107, DOI 10.1111/j.1600-065X.1999.tb01310.x; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hyatt G, 2006, NAT IMMUNOL, V7, P686, DOI 10.1038/ni0706-686; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Pinkney J, 2002, Obes Rev, V3, P27, DOI 10.1046/j.1467-789X.2002.00052.x; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Raychaudhuri S, 2010, CURR OPIN RHEUMATOL, V22, P109, DOI 10.1097/BOR.0b013e328336474d; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; STRYER L, 2000, BIOCHEMISTRY; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zhong H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000932	54	110	110	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 7	2011	89	4					496	506		10.1016/j.ajhg.2011.09.002	http://dx.doi.org/10.1016/j.ajhg.2011.09.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	834HV	21963258	Green Published, Bronze			2022-12-18	WOS:000295951300004
J	Senderek, J; Muller, JS; Dusl, M; Strom, TM; Guergueltcheva, V; Diepolder, I; Laval, SH; Maxwell, S; Cossins, J; Krause, S; Muelas, N; Vilchez, JJ; Colomer, J; Mallebrera, CJ; Nascimento, A; Nafissi, S; Kariminejad, A; Nilipour, Y; Bozorgmehr, B; Najmabadi, H; Rodolico, C; Sieb, JP; Steinlein, OK; Schlotter, B; Schoser, B; Kirschner, J; Herrmann, R; Voit, T; Oldfors, A; Lindbergh, C; Urtizberea, A; von der Hagen, M; Hubner, A; Palace, J; Bushby, K; Straub, V; Beeson, D; Abicht, A; Lochmuller, H				Senderek, Jan; Mueller, Juliane S.; Dusl, Marina; Strom, Tim M.; Guergueltcheva, Velina; Diepolder, Irmgard; Laval, Steven H.; Maxwell, Susan; Cossins, Judy; Krause, Sabine; Muelas, Nuria; Vilchez, Juan J.; Colomer, Jaume; Jimenez Mallebrera, Cecilia; Nascimento, Andres; Nafissi, Shahriar; Kariminejad, Ariana; Nilipour, Yalda; Bozorgmehr, Bita; Najmabadi, Hossein; Rodolico, Carmelo; Sieb, Joern P.; Steinlein, Ortrud K.; Schlotter, Beate; Schoser, Benedikt; Kirschner, Janbernd; Herrmann, Ralf; Voit, Thomas; Oldfors, Anders; Lindbergh, Christopher; Urtizberea, Andoni; von der Hagen, Maja; Huebner, Angela; Palace, Jacqueline; Bushby, Kate; Straub, Volker; Beeson, David; Abicht, Angela; Lochmueller, Hanns			Hexosamine Biosynthetic Pathway Mutations Cause Neuromuscular Transmission Defect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MYASTHENIC SYNDROME; ACETYLCHOLINE-RECEPTOR; LINKAGE ANALYSIS; MESSENGER-RNA; GLYCOSYLATION; GLUTAMINE; GENES; ROLES; SLOW	Neuromuscular junctions (NMJs) are synapses that transmit impulses from motor neurons to skeletal muscle fibers leading to muscle contraction. Study of hereditary disorders of neuromuscular transmission, termed congenital myasthenic syndromes (CMS), has helped elucidate fundamental processes influencing development and function of the nerve-muscle synapse. Using genetic linkage, we find 18 different biallelic mutations in the gene encoding glutamine-fructose-6-phosphate transaminase 1 (GFPT1) in 13 unrelated families with an autosomal recessive CMS. Consistent with these data, downregulation of the GFPT1 ortholog gfpt1 in zebrafish embryos altered muscle fiber morphology and impaired neuromuscular junction development. GFPT1 is the key enzyme of the hexosamine pathway yielding the amino sugar UDP-N-acetylglucosamine, an essential substrate for protein glycosylation. Our findings provide further impetus to study the glycobiology of NMJ and synapses in general.	[Senderek, Jan] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Senderek, Jan; Diepolder, Irmgard] Rhein Westfal TH Aachen, Inst Human Genet, D-52074 Aachen, Germany; [Mueller, Juliane S.; Laval, Steven H.; Bushby, Kate; Straub, Volker; Lochmueller, Hanns] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Dusl, Marina; Krause, Sabine; Schlotter, Beate; Schoser, Benedikt; Abicht, Angela] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany; [Strom, Tim M.] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Guergueltcheva, Velina] Univ Hosp Alexandrovska, Neurol Clin, Sofia 1431, Bulgaria; [Maxwell, Susan; Cossins, Judy; Beeson, David] Univ Oxford, Neurosci Grp, Weatherall Inst Mol Med, Dept Clin Neurol, Oxford OX3 9DU, England; [Muelas, Nuria; Vilchez, Juan J.] Hosp La Fe, Serv Neurol, Valencia 46009, Spain; [Muelas, Nuria; Vilchez, Juan J.] Ctr Invest Biomed Red CIBER Enfermedade Neurodege, Valencia 46009, Spain; [Colomer, Jaume; Jimenez Mallebrera, Cecilia; Nascimento, Andres] Hosp St Joan de Deu, Unitat Patol Neuromuscular, Serv Neurol, Esplugues 08950, Barcelona, Spain; [Nafissi, Shahriar] Univ Tehran Med Sci, Dept Neurol, Tehran 14155, Iran; [Kariminejad, Ariana; Bozorgmehr, Bita; Najmabadi, Hossein] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14667, Iran; [Nilipour, Yalda] Toos Hosp, Neuropathol Lab, Tehran 15969, Iran; [Rodolico, Carmelo] Azienda Osped Univ G Martino, Dept Neurosci, I-98125 Messina, Italy; [Rodolico, Carmelo] Azienda Osped Univ AOU G Martino, Dept Psychiat, I-98125 Messina, Italy; [Rodolico, Carmelo] Azienda Osped Univ AOU G Martino, Dept Anaesthesiol, I-98125 Messina, Italy; [Sieb, Joern P.] Hanse Klinikum, Dept Neurol Geriatr Med & Palliat Care, D-18435 Stralsund, Germany; [Steinlein, Ortrud K.] Univ Munich, Inst Human Genet, D-80336 Munich, Germany; [Kirschner, Janbernd] Univ Med Ctr, Div Neuropaediat & Muscle Disorders, D-79106 Freiburg, Germany; [Herrmann, Ralf] Univ Hosp Essen, Dept Pediat 1, D-45122 Essen, Germany; [Voit, Thomas] Univ Paris 06, INSERM, AIM, CNRS,Inst Myol,UMR S974,UMR 7215, F-75013 Paris, France; [Oldfors, Anders] Univ Gothenburg, Dept Pathol, Inst Biomed, S-40530 Gothenburg, Sweden; [Lindbergh, Christopher] Sahlgrens Univ Hosp, Neuromuscular Ctr, S-41345 Gothenburg, Sweden; [Urtizberea, Andoni] Hop Marin, F-64701 Hendaye, France; [von der Hagen, Maja; Huebner, Angela] Tech Univ Dresden, Univ Childrens Hosp, D-01307 Dresden, Germany; [Palace, Jacqueline] John Radcliffe Hosp, CMS NCG, Dept Clin Neurol, Oxford OX3 9DU, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; RWTH Aachen University; Newcastle University - UK; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Medical University Sofia; University of Oxford; Hospital Universitari i Politecnic La Fe; CIBERNED; Tehran University of Medical Sciences; AOU Policlinico Gaetano Martino; University of Munich; University of Freiburg; University of Duisburg Essen; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Gothenburg; Sahlgrenska University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Marin de Hendaye - APHP; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oxford	Senderek, J (corresponding author), ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.	jan.senderek@cell.biol.ethz.ch; hanns.lochmuller@ncl.ac.uk	Schoser, Benedikt/AAH-6286-2020; Kirschner, Janbernd/Q-1493-2019; Najmabadi, Hossein/P-8182-2017; Nafissi, Shahriar/AAX-9954-2020; Krause, Sabine/AAJ-1163-2020; Nilipour, Yalda/AAY-2110-2021; nafissi, shahriar/A-1839-2013; Kirschner, Janbernd/H-7418-2016; Jiménez-Mallebrera, Cecilia/F-5030-2016; Nafissi, Shahriar/AAS-1597-2020; Senderek, Jan/F-8405-2015	Kirschner, Janbernd/0000-0003-1618-7386; Nafissi, Shahriar/0000-0003-4763-4310; Krause, Sabine/0000-0002-3141-886X; Kirschner, Janbernd/0000-0003-1618-7386; Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; Senderek, Jan/0000-0002-8263-1783; Kariminejad, Ariana/0000-0002-8467-4728; Vilchez, Juan J/0000-0002-0532-2872; Straub, Volker/0000-0001-9046-3540; Oldfors, Anders/0000-0002-5758-7397; RODOLICO, Carmelo/0000-0003-2543-6356; Najmabadi, Hossein/0000-0002-6084-7778; Lochmuller, Hanns/0000-0003-2324-8001; Schoser, Benedikt/0000-0002-2757-8131	Association Francaise contre les Myopathies (AFM); Science City Newcastle; Gebert Ruf Foundation; Deutsche Forschungsgemeinschaft (DFG) [Ab 130/2-1]; MRC, MRC Centre for Neuromuscular Diseases; Myasthenia Gravis Association; Muscular Dystrophy Campaign; Instituto de Salud Carlos III and Fundacion para la Investigacion del Hospital Universitario La Fe [CM06/00154]; Faculty of Medical Sciences, Newcastle University; MRC; MRC [G0601943, G0701521] Funding Source: UKRI; Medical Research Council [G0601943, G0701521] Funding Source: researchfish	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Science City Newcastle; Gebert Ruf Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); MRC, MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Myasthenia Gravis Association; Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Instituto de Salud Carlos III and Fundacion para la Investigacion del Hospital Universitario La Fe; Faculty of Medical Sciences, Newcastle University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank the patients and their families for participating in this study, C. Jepson, M. Reza, and M. Ritso for technical assistance; A. Vincent for reporting results from end-plate studies; and D. Burns and the staff of the Institute of Human Genetics Zebrafish Facility for expert fish care. We are grateful to the Research Institute for Rare Diseases within the Instituto de Salud Carlos III, Madrid, for providing control DNA samples; the Medical Research Council (MRC) Centre for Neuromuscular Diseases Biobank, Newcastle; and the Muscle Tissue Culture Collection, Friedrich-Baur-Institut, Munich, for providing primary human myoblasts. All three institutions are partners of the EuroBioBank Network. The present study was supported by a grant from the Association Francaise contre les Myopathies (AFM) to H.L. and J.S.M., by Science City Newcastle, and by the MRC as part of the MRC Centre for Neuromuscular Diseases. J.S. is supported by a grant from the Gebert Ruf Foundation, A.A. by a grant from the Deutsche Forschungsgemeinschaft (DFG, Ab 130/2-1) and D.B., J.C., and S.M. by grants from the MRC, the Myasthenia Gravis Association, and the Muscular Dystrophy Campaign. J.S. is a Heisenberg fellow of the DFG. J.S.M. receives a research fellowship from the Faculty of Medical Sciences, Newcastle University. V.G. is a research fellow of the Alexander von Humboldt Foundation. N.M. received a fellowship from the Instituto de Salud Carlos III and Fundacion para la Investigacion del Hospital Universitario La Fe (CM06/00154). J.J.V. and N.M. are members of CIBER de Enfermedades Neurodegenerativas (CIBERNED), Valencia, Spain. Newcastle University is the coordinating partner of TREAT-NMD (EC, 6th FP, proposal #036825; www.treat-nmd.eu).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Chen JM, 2006, HUM GENET, V120, P301, DOI 10.1007/s00439-006-0218-x; DeHaven JE, 2001, DIABETES, V50, P2419, DOI 10.2337/diabetes.50.11.2419; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Eguchi S, 2009, GENES CELLS, V14, P179, DOI 10.1111/j.1365-2443.2008.01260.x; Engel AG, 2010, J MOL NEUROSCI, V40, P143, DOI 10.1007/s12031-009-9229-0; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLT GD, 1987, J CELL BIOL, V104, P1157, DOI 10.1083/jcb.104.5.1157; Jing LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008843; JOHNS TR, 1966, NEUROLOGY, V16, P307; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LI WH, 1984, J MOL EVOL, V21, P58, DOI 10.1007/BF02100628; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Martin PT, 2002, GLYCOBIOLOGY, V12, p1R, DOI 10.1093/glycob/12.1.1R; MCQUILLEN MP, 1966, BRAIN, V89, P121, DOI 10.1093/brain/89.1.121; Mouilleron S, 2006, J BIOL CHEM, V281, P4404, DOI 10.1074/jbc.M511689200; Muller JS, 2010, HUM MOL GENET, V19, P1726, DOI 10.1093/hmg/ddq049; Nakaishi Y, 2009, FEBS LETT, V583, P163, DOI 10.1016/j.febslet.2008.11.041; Newsom-Davis J, 2007, Acta Myol, V26, P5; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; Oki T, 1999, GENOMICS, V57, P227, DOI 10.1006/geno.1999.5785; Ono F, 2002, J NEUROSCI, V22, P6491; Ono F, 2001, J NEUROSCI, V21, P5439, DOI 10.1523/JNEUROSCI.21-15-05439.2001; PRIVES J, 1983, J BIOL CHEM, V258, P1775; Rodolico C, 2002, NEUROMUSCULAR DISORD, V12, P964, DOI 10.1016/S0960-8966(02)00137-2; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sieb JP, 1996, NEUROMUSCULAR DISORD, V6, P115, DOI 10.1016/0960-8966(95)00034-8; VINCENT A, 1981, MUSCLE NERVE, V4, P306, DOI 10.1002/mus.880040407; von der Hagen M, 2006, NEUROMUSCULAR DISORD, V16, P4, DOI 10.1016/j.nmd.2005.10.001; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Ye F, 2004, J BIOCHEM BIOPH METH, V59, P201, DOI 10.1016/j.jbbm.2003.02.001	42	110	115	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					162	172		10.1016/j.ajhg.2011.01.008	http://dx.doi.org/10.1016/j.ajhg.2011.01.008			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21310273	Green Published, Bronze			2022-12-18	WOS:000287684100004
J	Wang, K; Dickson, SP; Stolle, CA; Krantz, ID; Goldstein, DB; Hakonarson, H				Wang, Kai; Dickson, Samuel P.; Stolle, Catherine A.; Krantz, Ian D.; Goldstein, David B.; Hakonarson, Hakon			Interpretation of Association Signals and Identification of Causal Variants from Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM PATTERNS; COMMON DISEASE; RARE VARIANTS; CROHNS-DISEASE; MISSING HERITABILITY; COMPLEX DISEASES; MUTATIONS; GENETICS; SUSCEPTIBILITY; CONTRIBUTE	GWAS have been successful in identifying disease susceptibility loci, but it remains a challenge to pinpoint the causal variants in subsequent fine-mapping studies. A conventional fine-mapping effort starts by sequencing dozens of randomly selected samples at susceptibility loci to discover candidate variants, which are then placed on custom arrays or used in imputation algorithms to find the causal variants. We propose that one or several rare or low-frequency causal variants can hitchhike the same common tag SNP, so causal variants may not be easily unveiled by conventional efforts. Here, we first demonstrate that the true effect size and proportion of variance explained by a collection of rare causal variants can be underestimated by a common tag SNP, thereby accounting for some of the "missing heritability" in GWAS. We then describe a case-selection approach based on phasing long-range haplotypes and sequencing cases predicted to harbor causal variants. We compare this approach with conventional strategies on a simulated data set, and we demonstrate its advantages when multiple causal variants are present. We also evaluate this approach in a GWAS on hearing loss, where the most common causal variant has a minor allele frequency (MAF) of 1.3% in the general population and 8.2% in 329 cases. With our case-selection approach, it is present in 88% of the 32 selected cases (MAF = 66%), so sequencing a subset of these cases can readily reveal the causal allele. Our results suggest that thinking beyond common variants is essential in interpreting GWAS signals and identifying causal variants.	[Wang, Kai; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Dickson, Samuel P.; Goldstein, David B.] Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Stolle, Catherine A.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Krantz, Ian D.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Krantz, Ian D.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Duke University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Wang, K (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	kaichop@gmail.com; hakonarson@email.chop.edu	Goldstein, David/AAY-8125-2020		Wellcome Trust [076113]; Methodological Study Award; National Institutes of Health; National Center for Research Resources [UL1 RR025774]; CHOP; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Methodological Study Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CHOP; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We gratefully thank all of the patients and their families who were enrolled in this study, as well as all of the control subjects who donated blood samples to Children's Hospital of Philadelphia (CHOP) for genetic research purposes. We thank the technical staff at the Center for Applied Genomics at CHOP for producing the genotypes used for analyses and the nursing, medical assistant, and medical staff for their invaluable help with recruitment of patient and control subjects for the study. We thank the Wellcome Trust Case Control Consortium (WTCCC) for making the Affymetrix data available for our analysis. The WTCCC is funded by Wellcome Trust award 076113, and a full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. The study was supported by a Methodological Study Award (KW. and H.H.) from the National Institutes of Health and National Center for Research Resources (UL1 RR025774). All genome-wide genotyping was funded by an Institute Development Award from CHOP.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; FRANCKS C, 2008, MOL PSYCHIATR, V15, P19; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Hartl DL, 2000, PRINCIPLES POPULATIO; Hemminki K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002504; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lewis CM, 2007, J MED GENET, V44, P689, DOI 10.1136/jmg.2007.051672; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Liang LM, 2007, BIOINFORMATICS, V23, P1565, DOI 10.1093/bioinformatics/btm138; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marlin S, 2005, ARCH OTOLARYNGOL, V131, P481, DOI 10.1001/archotol.131.6.481; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pascoe L, 2007, EUR J HUM GENET, V15, P864, DOI 10.1038/sj.ejhg.5201839; Peng B, 2007, GENETICS, V175, P763, DOI 10.1534/genetics.106.058164; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; RISCH N, 1990, AM J HUM GENET, V46, P222; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Schroeder KB, 2009, MOL BIOL EVOL, V26, P995, DOI 10.1093/molbev/msp024; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; Smith DJ, 2002, HUM MOL GENET, V11, P2455, DOI 10.1093/hmg/11.20.2455; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang T, 2007, AM J HUM GENET, V80, P911, DOI 10.1086/516794; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wright AF, 2001, GENOME BIOL, V2; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710; Zhu XF, 2005, HUM MOL GENET, V14, P639, DOI 10.1093/hmg/ddi060; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	59	110	113	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					730	742		10.1016/j.ajhg.2010.04.003	http://dx.doi.org/10.1016/j.ajhg.2010.04.003			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20434130	Green Published, Bronze			2022-12-18	WOS:000278045300009
J	Dathe, K; Kjaer, KW; Brehm, A; Meinecke, P; Nurnberg, P; Neto, JC; Brunoni, D; Tommerup, N; Ott, CE; Klopocki, E; Seemann, P; Mundlos, S				Dathe, Katarina; Kjaer, Klaus W.; Brehm, Anja; Meinecke, Peter; Nuernberg, Peter; Neto, Jordao C.; Brunoni, Decio; Tommerup, Nils; Ott, Claus E.; Klopocki, Eva; Seemann, Petra; Mundlos, Stefan			Duplications Involving a Conserved Regulatory Element Downstream of BMP2 Are Associated with Brachydactyly Type A2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; MUTATIONS; GENE; DIFFERENTIATION; MOUSE; EXPRESSION; CARTILAGE; RECOMBINATION; DISRUPTION; INVERSION	Autosomal-dominant brachydactyly type A2 (BDA2), a limb malformation characterized by hypoplastic middle phalanges of the second and fifth fingers, has been shown to be due to mutations in the Bone morphogenetic protein receptor 1B (BMPR1B) or in its ligand Growth and differentiation factor 5 (GDF5). A linkage analysis performed in a mutation-negative family identified a novel locus for BDA2 on chromosome 20p12.3 that incorporates the gene for Bone morphogenetic protein 2 (BMP2). No point mutation was identified in BMP2, so a high-density array CGH analysis covering the critical interval of similar to 1.3 Mb was performed. A microduplication of: similar to 5.5 kb in a noncoding sequence similar to 110 kb downstream of BMP2 was detected. Screening of other patients by qPCR revealed a similar duplication in a second family. The duplicated region contains evolutionary highly conserved sequences suggestive of a long-range regulator. By using a transgenic mouse model we can show that this sequence is able to drive expression of a X-Gal reporter construct in the limbs. The almost complete overlap with endogenous Bmp2 expression indicates that a limb-specific enhancer of Bmp2 is located within the identified duplication. Our results reveal an additional functional mechanism for the pathogenesis of BDA2, which is duplication of a regulatory element that affects the expression of BMP2 in the developing limb.	[Dathe, Katarina; Brehm, Anja; Ott, Claus E.; Klopocki, Eva; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany; [Kjaer, Klaus W.] Univ Copenhagen, Inst Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen, Denmark; [Brehm, Anja; Seemann, Petra] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Brehm, Anja] Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany; [Meinecke, Peter] Altonaer Kinderkrankenhaus, Abt Med Genet, D-22763 Hamburg, Germany; [Nuernberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Neto, Jordao C.; Brunoni, Decio] Univ Fed Sao Paulo, Ctr Genet Med, BR-04023062 Sao Paulo, Brazil; [Seemann, Petra; Mundlos, Stefan] Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Copenhagen; Max Planck Society; Free University of Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Cologne; University of Cologne; Universidade Federal de Sao Paulo (UNIFESP)	Mundlos, S (corresponding author), Charite Univ Med Berlin, Inst Med Genet, D-13353 Berlin, Germany.	stefan.mundlos@charite.de	Brunoni, Decio/K-3155-2012; Klopocki, Eva/B-6823-2017; Ott, Claus/U-8226-2019; Seemann, Petra/G-3606-2011; Tommerup, Niels/T-8776-2017; Mundlos, Stefan/ABH-9585-2020; Ott, Claus E/G-1936-2011	Klopocki, Eva/0000-0003-1438-2081; Ott, Claus/0000-0003-3627-3791; Seemann, Petra/0000-0002-6056-6669; Tommerup, Niels/0000-0003-2304-0112; Ott, Claus E/0000-0003-3627-3791; Mundlos, Stefan/0000-0002-9788-3166; Dathe, Katarina/0000-0002-8674-5817	DFG [LE1851/1-2]; SFB [760]; Danish National Research Foundation.	DFG(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF)); Danish National Research Foundation.(Danmarks Grundforskningsfond)	We thank Eleidi A. Chautard-Freire-Maia for helping to retrace the family originally published by her husband, Newton Freire-Maia. We thank the patients and their family members for participating in this study. We thank Douglas P. Mortlock for generously providing us with the vector pSfi-Hsp68lacZ. We acknowledge the technical help of Randi Koll, Fabienne Trotier, and Ingo Voigt. This work was funded by the DFG to K.D. (LE1851/1-2) and SFB 760 to F.S. and S.M. WJC is established by the Danish National Research Foundation. The authors declare no conflict of interest.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Albrecht AN, 2002, MECH DEVELOP, V112, P53, DOI 10.1016/S0925-4773(01)00639-6; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; DiLeone RJ, 1998, GENETICS, V148, P401; FREIREMAIA N, 1980, HUM HERED, V30, P225, DOI 10.1159/000153133; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Hill RE, 2007, DEV GROWTH DIFFER, V49, P439, DOI 10.1111/j.1440-169x.2007.00943.x; Howard ML, 2004, DEV BIOL, V271, P109, DOI 10.1016/j.ydbio.2004.03.031; Johnson D, 2003, AM J HUM GENET, V72, P984, DOI 10.1086/374721; Kishigami S, 2005, CYTOKINE GROWTH F R, V16, P265, DOI 10.1016/j.cytogfr.2005.04.002; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Klopocki E, 2008, J MED GENET, V45, P370, DOI 10.1136/jmg.2007.055699; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Kotzsch A, 2008, J BIOL CHEM, V283, P5876, DOI 10.1074/jbc.M706029200; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Lehmann K, 2006, EUR J HUM GENET, V14, P1248, DOI 10.1038/sj.ejhg.5201708; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Lettice LA, 2008, HUM MOL GENET, V17, P978, DOI 10.1093/hmg/ddm370; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; LUCAS J, 1985, ANN GENET-PARIS, V28, P167; LYONS KM, 1990, DEVELOPMENT, V109, P833; Mortlock DP, 2003, GENOME RES, V13, P2069, DOI 10.1101/gr.1306003; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pathi S, 1999, DEV BIOL, V209, P239, DOI 10.1006/dbio.1998.9181; Pfeiffer RA, 1997, CLIN GENET, V51, P357; Ploger F, 2008, HUM MOL GENET, V17, P1222, DOI 10.1093/hmg/ddn012; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Schwabe GC, 2004, AM J MED GENET A, V124A, P356, DOI 10.1002/ajmg.a.20349; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Seemann Petra, 2008, P141, DOI 10.1007/978-3-7643-8552-1_8; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Zhu J, 1996, MOL CELL BIOL, V16, P1805; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	45	110	115	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					483	492		10.1016/j.ajhg.2009.03.001	http://dx.doi.org/10.1016/j.ajhg.2009.03.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19327734	Green Published, Bronze			2022-12-18	WOS:000265232800007
J	Windpassinger, C; Schoser, B; Straub, V; Hochmeister, S; Noor, A; Lohberger, B; Farra, N; Petek, E; Schwarzbraun, T; Ofner, L; Loscher, WN; Wagner, K; Lochmuller, H; Vincent, JB; Quasthoff, S				Windpassinger, Christian; Schoser, Benedikt; Straub, Volker; Hochmeister, Sonja; Noor, Abdul; Lohberger, Birgit; Farra, Natalie; Petek, Erwin; Schwarzbraun, Thomas; Ofner, Lisa; Loescher, Wolfgang N.; Wagner, Klaus; Lochmueller, Hanns; Vincent, John. B.; Quasthoff, Stefan			An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BINDING-PROTEIN-C; MUSCULAR-DYSTROPHIES; LIM DOMAIN; GENE; CARDIOMYOPATHY; HOMEODOMAIN; DEFICIENT; MOTIF	We have identified a large multigenerational Austrian family displaying a novel form of X-linked recessive myopathy. Affected individuals develop an adult-onset scapulo-axio-peroneal myopathy with bent-spine syndrome characterized by specific atrophy of postural muscles along with pseudoathleticism or hypertrophy and cardiac involvement. Known X-linked myopathies were excluded by simple-tandem-repeat polymorphism (STRP) and single-nucleotide polymorphism (SNP) analysis, direct gene sequencing, and immunohistochernical analysis. STRP analysis revealed significant linkage at Xq25-q27.1. Haplotype analysis based on SNP microarray data from selected family members confirmed this linkage region on the distal arm of the X chromosome, thereby narrowing down the critical interval to 12 Mb. Sequencing of functional candidate genes led to the identification of a missense mutation within the four and a half LIM domain 1 gene (FHL1), which putatively disrupts the fourth LIM domain of the protein. Mutation screening of FHL1 in a myopathy family from the UK exhibiting an almost identical phenotype revealed a 3 bp insertion mutation within the second LIM domain. FHL1 on Xq26.3 is highly expressed in skeletal and cardiac muscles. Western-blot analysis of muscle biopsies showed a marked decrease in protein expression of FHL1 in patients, in concordance with the genetic data. In summary, we have to our knowledge characterized a new disorder, X-linked myopathy with postural muscle atrophy (XMPMA), and identified FHL1 as the causative gene. This is the first FHL protein to be identified in conjunction with a human genetic disorder and further supports the role of FHL proteins in the development and maintenance of muscle tissue. Mutation screening of FHL1 should be considered for patients with uncharacterized myopathies and cardiomyopathies.	[Windpassinger, Christian; Noor, Abdul; Farra, Natalie; Vincent, John. B.] Univ Toronto, Ctr Addict & Mental Hlth, Neurogenet Sect, Toronto, ON M5T 1R8, Canada; [Windpassinger, Christian; Petek, Erwin; Schwarzbraun, Thomas; Ofner, Lisa; Wagner, Klaus] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria; [Schoser, Benedikt; Lochmueller, Hanns] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany; [Straub, Volker] Univ Newcastle Upon Tyne, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Hochmeister, Sonja; Lohberger, Birgit; Quasthoff, Stefan] Med Univ Graz, Dept Neurol, A-8036 Graz, Austria; [Loescher, Wolfgang N.] Innsbruck Med Univ, Clin Dept Neurol, A-6020 Innsbruck, Austria	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Medical University of Graz; University of Munich; Newcastle University - UK; Medical University of Graz; Medical University of Innsbruck	Windpassinger, C (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, Neurogenet Sect, 100 Coll St, Toronto, ON M5T 1R8, Canada.	christian.windpassinger@meduni-graz.at	Noor, Abdul/J-2345-2016; Schoser, Benedikt/AAH-6286-2020	Straub, Volker/0000-0001-9046-3540; Schwarzbraun, Thomas/0000-0002-9111-4219; Farra, Natalie/0000-0002-5117-2641; Lochmuller, Hanns/0000-0003-2324-8001; Loscher, Wolfgang/0000-0002-7593-3222; Schoser, Benedikt/0000-0002-2757-8131	Medical Research Council [G0601943B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Blanco G, 2001, HUM MOL GENET, V10, P9, DOI 10.1093/hmg/10.1.9; Brown R., 1999, HOMOL HOMOTOPY APPL, V1, P1, DOI DOI 10.4310/HHA.1999.V1.N1.A1; Carrier L, 1997, CIRC RES, V80, P427, DOI 10.1161/01.res.0000435859.24609.b3; Chauvigne F, 2005, DEV DYNAM, V233, P659, DOI 10.1002/dvdy.20371; Danek A, 2001, ANN NEUROL, V50, P755, DOI 10.1002/ana.10035; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Ellis JA, 2006, CELL MOL LIFE SCI, V63, P2702, DOI 10.1007/s00018-006-6247-8; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; Geier C, 2003, CIRCULATION, V107, P1390, DOI 10.1161/01.CIR.0000056522.82563.5F; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hofmann S, 2002, J BIOL CHEM, V277, P23287, DOI 10.1074/jbc.M201154200; JOHNSON MA, 1973, J NEUROL SCI, V20, P345, DOI 10.1016/0022-510X(73)90169-X; KALIMO H, 1988, ANN NEUROL, V23, P258, DOI 10.1002/ana.410230308; Kong YF, 2001, CIRCULATION, V103, P2731; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Loughna P. T., 2000, Molecular Cell Biology Research Communications, V3, P136, DOI 10.1006/mcbr.2000.0206; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; Mendell JR, 2006, PEDIATR DEVEL PATHOL, V9, P427, DOI 10.2350/06-07-0127.1; MICHELSEN JW, 1993, P NATL ACAD SCI USA, V90, P4404, DOI 10.1073/pnas.90.10.4404; MICHELSEN JW, 1994, J BIOL CHEM, V269, P11108; Ng EKO, 2001, J CELL BIOCHEM, V82, P1, DOI 10.1002/jcb.1110; OTT J, 1991, ANAL HUMAN GENETIC L, P65; SCHWARZMEIER J, 1971, KLIN WOCHENSCHR, V49, P156, DOI 10.1007/BF01496810; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Walter MC, 2007, BRAIN, V130, P1485, DOI 10.1093/brain/awm039; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434	29	110	118	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					88	99		10.1016/j.ajhg.2007.09.004	http://dx.doi.org/10.1016/j.ajhg.2007.09.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179888	Bronze, Green Published			2022-12-18	WOS:000253223800010
J	Suarez, BK; Duan, JB; Sanders, AR; Hinrichs, AL; Jin, CH; Hou, CP; Buccola, NG; Hale, N; Weilbaecher, AN; Nertney, DA; Olincy, A; Green, S; Schaffer, AW; Smith, CJ; Hannah, DE; Rice, JP; Cox, NJ; Martinez, M; Mowry, BJ; Amin, F; Silverman, JM; Black, DW; Byerley, WF; Crowe, RR; Freedman, R; Cloninger, CR; Levinson, DF; Gejman, PV				Suarez, BK; Duan, JB; Sanders, AR; Hinrichs, AL; Jin, CH; Hou, CP; Buccola, NG; Hale, N; Weilbaecher, AN; Nertney, DA; Olincy, A; Green, S; Schaffer, AW; Smith, CJ; Hannah, DE; Rice, JP; Cox, NJ; Martinez, M; Mowry, BJ; Amin, F; Silverman, JM; Black, DW; Byerley, WF; Crowe, RR; Freedman, R; Cloninger, CR; Levinson, DF; Gejman, PV			Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: Suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCI; BIPOLAR DISORDER; ROSCOMMON FAMILY; GENETIC MAPS; WIDE SEARCH; PSYCHOSIS; INVERSION; DISEQUILIBRIUM; POLYMORPHISMS; NEUREGULIN-1	We report the clinical characteristics of a schizophrenia sample of 409 pedigrees-263 of European ancestry ( EA) and 146 of African American ancestry ( AA)-together with the results of a genome scan ( with a simple tandem repeat polymorphism interval of 9 cM) and follow-up fine mapping. A family was required to have a proband with schizophrenia ( SZ) and one or more siblings of the proband with SZ or schizoaffective disorder. Linkage analyses included 403 independent full-sibling affected sibling pairs ( ASPs) ( 279 EA and 124 AA) and 100 all-possible half-sibling ASPs ( 15 EA and 85 AA). Nonparametric multipoint linkage analysis of all families detected two regions with suggestive evidence of linkage at 8p23.3-q12 and 11p11.2-q22.3 ( empirical Z likelihood-ratio score [ Z(lr)] threshold >= 2.65) and, in exploratory analyses, two other regions at 4p16.1-p15.32 in AA families and at 5p14.3-q11.2 in EA families. The most significant linkage peak was in chromosome 8p; its signal was mainly driven by the EA families. Z(lr) scores >= 2.0 in 8p were observed from 30.7 cM to 61.7 cM ( Center for Inherited Disease Research map locations). The maximum evidence in the full sample was a multipoint Z(lr) of 3.25 ( equivalent Kong-Cox LOD of 2.30) near D8S1771 ( at 52 cM); there appeared to be two peaks, both telomeric to neuregulin 1 ( NRG1). There is a paracentric inversion common in EA individuals within this region, the effect of which on the linkage evidence remains unknown in this and in other previously analyzed samples. Fine mapping of 8p did not significantly alter the significance or length of the peak. We also performed fine mapping of 4p16.3-p15.2, 5p15.2-q13.3, 10p15.3-p14, 10q25.3-q26.3, and 11p13-q23.3. The highest increase in Z(lr) scores was observed for 5p14.1-q12.1, where the maximum Z(lr) increased from 2.77 initially to 3.80 after fine mapping in the EA families.	Washington Univ, Dept Psychiat, St Louis, MO USA; Washington Univ, Dept Genet, St Louis, MO USA; Evanston NW Healthcare, Dept Psychiat & Behav Sci, Ctr Psychiat Genet, Evanston, IL USA; Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; Louisiana State Univ, Hlth Sci Ctr, Sch Nursing, New Orleans, LA USA; Univ Iowa, Coll Med, Mental Hlth Clin Res Ctr, Iowa City, IA USA; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA USA; Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Ctr Mental Hlth, Queensland Ctr Schizophrenia Mental Hlth Res, Wacol, Australia; Univ Queensland, Dept Psychiat, Brisbane, Qld, Australia; Univ Colorado, Sch Med, Dept Psychiat & Colorado Psychiatr Hlth, Denver, CO 80262 USA; Emory Univ, Atlanta VA Med Ctr, Atlanta, GA 30322 USA; Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; INSERM, Evry, France; Baylor Coll Med, Houston, TX 77030 USA; Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); NorthShore University Health System; Northwestern University; Feinberg School of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Iowa; University of Iowa; Northwestern University; Feinberg School of Medicine; University of Chicago; University of Queensland; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Baylor College of Medicine; University of California System; University of California Irvine; University of California System; University of California San Francisco; University of Pennsylvania	Gejman, PV (corresponding author), Evanston NW Healthcare Res Inst, 1001 Univ Pl, Evanston, IL 60201 USA.	pgejman@northwestern.edu	Silverman, Jeremy M./AAO-4268-2020; Cloninger, Claude/F-5357-2012; Martinez, Maria/B-3111-2013; Mowry, Bryan/G-5046-2010	Cloninger, Claude/0000-0003-3096-4807; Martinez, Maria/0000-0003-2180-4537; Buccola, Nancy/0000-0003-1378-4636; Mowry, Bryan/0000-0002-4115-5645; Black, Donald/0000-0001-8038-1971	NIMH NIH HHS [R01 MH061675, R01 MH60879, R01 MH59566, R01 MH59588, R01 MH59586, R01 MH59587, R01 MH59565, R01 MH060870, R01 MH61675, R01 MH059571, R01 MH059565, R01 MH59571, R01 MH059587, R01 MH059586, R01 MH059566, R01 MH059588, R01 MH60870, R01 MH060879] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059586, R01MH060870, R01MH060879, R01MH059565, R01MH059588, R01MH059571, R01MH061675, R01MH059587, R01MH059566] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; APA, 1994, DIAGN STAT MAN MENT; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bespalova IN, 2005, PSYCHIAT GENET, V15, P205, DOI 10.1097/00041444-200509000-00012; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Broman KW, 2003, INST MATH S, V40, P237; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cloninger CR, 1998, AM J MED GENET, V81, P275, DOI 10.1002/(SICI)1096-8628(19980710)81:4<275::AID-AJMG1>3.3.CO;2-U; Cloninger CR, 2002, P NATL ACAD SCI USA, V99, P13365, DOI 10.1073/pnas.222532599; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooper-Casey K, 2005, MOL PSYCHIATR, V10, P651, DOI 10.1038/sj.mp.4001640; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Curtis D, 1996, ANN HUM GENET, V60, P261, DOI 10.1111/j.1469-1809.1996.tb00430.x; DeLisi LE, 2002, AM J MED GENET, V114, P497, DOI 10.1002/ajmg.10538; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Duan J, 2005, PSYCHOL MED, V35, P1599, DOI 10.1017/S0033291705005428; DUNN G, IN PRESS BMC GENET; Garver DL, 2001, SCHIZOPHR RES, V52, P145, DOI 10.1016/S0920-9964(01)00157-8; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; GERSHON ES, 1988, ARCH GEN PSYCHIAT, V45, P328; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; Grigull J, 2001, GENET EPIDEMIOL, V21, pS61, DOI 10.1002/gepi.2001.21.s1.s61; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; HESTON LL, 1966, BRIT J PSYCHIAT, V112, P819, DOI 10.1192/bjp.112.489.819; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Holmans P, 2004, AM J HUM GENET, V74, P1154, DOI 10.1086/421333; Huang QQ, 2004, AM J HUM GENET, V75, P1106, DOI 10.1086/426000; Johns LC, 2004, BRIT J PSYCHIAT, V185, P298, DOI 10.1192/bjp.185.4.298; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P952; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P645; KETY SS, 1971, AM J PSYCHIAT, V128, P302, DOI 10.1176/ajp.128.3.302; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2002, SCHIZOPHRENIA BULL, V28, P683, DOI 10.1093/oxfordjournals.schbul.a006972; LEVINSON DF, IN PRESS BMC GENET; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; LINDSAY EA, 1995, AM J HUM GENET, V56, P1502; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Maxwell M.E., 1992, FAMILY INTERVIEW GEN; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OROURKE DH, 1982, AM J HUM GENET, V34, P630; OTT J, 1985, Genetic Epidemiology, V2, P79, DOI 10.1002/gepi.1370020108; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; Park N, 2004, MOL PSYCHIATR, V9, P1091, DOI 10.1038/sj.mp.4001541; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Pritchard JK, 2000, GENETICS, V155, P945; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; ROSENTHAL D, 1971, AM J PSYCHIAT, V128, P307, DOI 10.1176/ajp.128.3.307; Shields J, 1982, SCHIZOPHRENIA EPIGEN; Silverman JM, 1996, AM J MED GENET, V67, P162, DOI 10.1002/(SICI)1096-8628(19960409)67:2<162::AID-AJMG6>3.0.CO;2-U; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stompe T, 1998, PSYCHOPATHOLOGY, V31, P45, DOI 10.1159/000029022; Straub RE, 2002, MOL PSYCHIATR, V7, P542, DOI 10.1038/sj.mp.4001051; STRAUSS JS, 1969, ARCH GEN PSYCHIAT, V21, P581; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; TAYLOR MA, 1993, AM J PSYCHIAT, V150, P278; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; van Os J, 2000, SCHIZOPHR RES, V45, P11, DOI 10.1016/S0920-9964(99)00224-8; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	79	110	113	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2006	78	2					315	333		10.1086/500272	http://dx.doi.org/10.1086/500272			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	031ZY	16400611	Green Published, Bronze			2022-12-18	WOS:000236744900012
J	Xu, JF; Dimitrov, L; Chang, BL; Adams, TS; Turner, AR; Meyers, DA; Eeles, RA; Easton, DF; Foulkes, WD; Simard, J; Giles, GG; Hopper, JL; Mahle, L; Moller, P; Bishop, T; Evans, C; Edwards, S; Meitz, J; Bullock, S; Hope, Q; Hsieh, CL; Halpern, J; Balise, RN; Oakley-Girvan, I; Whittemore, AS; Ewing, CM; Gielzak, M; Isaacs, SD; Walsh, PC; Wiley, KE; Isaacs, WB; Thibodeau, SN; McDonnell, SK; Cunningham, JM; Zarfas, KE; Hebbring, S; Schaid, DJ; Friedrichsen, DM; Deutsch, K; Kolb, S; Badzioch, M; Jarvik, GP; Janer, M; Hood, L; Ostrander, EA; Stanford, JL; Lange, EM; Beebe-Dimmer, JL; Mohai, CE; Cooney, KA; Ikonen, T; Baffoe-Bonnie, A; Fredriksson, H; Matikainen, MP; Tammela, TLJ; Bailey-Wilson, J; Schleutker, J; Maier, C; Herkommer, K; Hoegel, JJ; Vogel, W; Paiss, T; Wiklund, F; Emanuelsson, M; Stenman, E; Jonsson, BA; Gronberg, H; Camp, NJ; Farnham, J; Cannon-Albright, LA; Seminara, D				Xu, JF; Dimitrov, L; Chang, BL; Adams, TS; Turner, AR; Meyers, DA; Eeles, RA; Easton, DF; Foulkes, WD; Simard, J; Giles, GG; Hopper, JL; Mahle, L; Moller, P; Bishop, T; Evans, C; Edwards, S; Meitz, J; Bullock, S; Hope, Q; Hsieh, CL; Halpern, J; Balise, RN; Oakley-Girvan, I; Whittemore, AS; Ewing, CM; Gielzak, M; Isaacs, SD; Walsh, PC; Wiley, KE; Isaacs, WB; Thibodeau, SN; McDonnell, SK; Cunningham, JM; Zarfas, KE; Hebbring, S; Schaid, DJ; Friedrichsen, DM; Deutsch, K; Kolb, S; Badzioch, M; Jarvik, GP; Janer, M; Hood, L; Ostrander, EA; Stanford, JL; Lange, EM; Beebe-Dimmer, JL; Mohai, CE; Cooney, KA; Ikonen, T; Baffoe-Bonnie, A; Fredriksson, H; Matikainen, MP; Tammela, TLJ; Bailey-Wilson, J; Schleutker, J; Maier, C; Herkommer, K; Hoegel, JJ; Vogel, W; Paiss, T; Wiklund, F; Emanuelsson, M; Stenman, E; Jonsson, BA; Gronberg, H; Camp, NJ; Farnham, J; Cannon-Albright, LA; Seminara, D		ACTANE Consortium	A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WIDE SCAN; GERMLINE MUTATIONS; MODELS; SCREEN; BREAST; TESTS; LOCI; MAP	Evidence of the existence of major prostate cancer (PC)-susceptibility genes has been provided by multiple segregation analyses. Although genomewide screens have been performed in over a dozen independent studies, few chromosomal regions have been consistently identified as regions of interest. One of the major difficulties is genetic heterogeneity, possibly due to multiple, incompletely penetrant PC-susceptibility genes. In this study, we explored two approaches to overcome this difficulty, in an analysis of a large number of families with PC in the International Consortium for Prostate Cancer Genetics (ICPCG). One approach was to combine linkage data from a total of 1,233 families to increase the statistical power for detecting linkage. Using parametric ( dominant and recessive) and nonparametric analyses, we identified five regions with "suggestive" linkage (LOD score > 1.86): 5q12, 8p21, 15q11, 17q21, and 22q12. The second approach was to focus on subsets of families that are more likely to segregate highly penetrant mutations, including families with large numbers of affected individuals or early age at diagnosis. Stronger evidence of linkage in several regions was identified, including a "significant" linkage at 22q12, with a LOD score of 3.57, and five suggestive linkages (1q25, 8q13, 13q14, 16p13, and 17q21) in 269 families with at least five affected members. In addition, four additional suggestive linkages (3p24, 5q35, 11q22, and Xq12) were found in 606 families with mean age at diagnosis of <= 65 years. Although it is difficult to determine the true statistical significance of these findings, a conservative interpretation of these results would be that if major PC-susceptibility genes do exist, they are most likely located in the regions generating suggestive or significant linkage signals in this large study.	Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; Mayo Clin, Rochester, MN 55905 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Univ Tampere, FIN-33101 Tampere, Finland; Tampere Univ Hosp, FIN-33101 Tampere, Finland; Univ Ulm, D-89069 Ulm, Germany; Umea Univ, S-90187 Umea, Sweden; Univ Utah, Salt Lake City, UT 84112 USA; NCI, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic; University of Michigan System; University of Michigan; Tampere University; Tampere University Hospital; Ulm University; Umea University; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Isaacs, WB (corresponding author), Johns Hopkins Univ Hosp, Marburg 115,600 N Wolfe St, Baltimore, MD 21287 USA.	wisaacs@jhmi.edu	Foulkes, William D./AAR-9586-2021; Meitz-Hopkins, Julia/M-3938-2016; Jarvik, Gail P/N-6476-2014	Foulkes, William D./0000-0001-7427-4651; Meitz-Hopkins, Julia/0000-0002-8127-6978; Jarvik, Gail P/0000-0002-6710-8708; albright, lisa/0000-0003-2602-3668; Bailey-Wilson, Joan/0000-0002-9153-2920; Farnham, James/0000-0002-8213-949X; Ostrander, Elaine/0000-0001-6075-9738; Bishop, Tim/0000-0002-8752-8785; Eeles, Rosalind/0000-0002-3698-6241; Simard, Jacques/0000-0001-6906-3390; Cooney, Kathleen/0000-0003-3831-6943; Giles, Graham/0000-0003-4946-9099; Durocher, Francine/0000-0001-8012-4641; Karyadi, Danielle/0000-0003-4164-5625; McDonnell, Shannon/0000-0001-6201-369X; Balise, Raymond/0000-0002-9856-5901; Schleutker, Johanna/0000-0002-1863-0305	NCI NIH HHS [T32 CA080416, R01 CA067044, R01 CA106523, K07 CA98364, R01 CA080122, CA079596, CA89600, R01 CA090752, R01 CA90752, CA080122, R01 CA079596, K07 CA098364, CA67044, CA72818, CA95052-01, R01 CA072818, CA106523-01A1, CA58236, U01 CA067044, CA78835, U01 CA089600, R01 CA095052, N01PC35141, N01-PC-35141, P50 CA058236, R01 CA89600] Funding Source: Medline; NCRR NIH HHS [M01 RR000064, M01-RR00064] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058236, R01CA067044, K07CA098364, T32CA080416, R01CA079596, R01CA080122, R01CA072818, R01CA106523, R01CA090752, R01CA095052, U01CA089600, U01CA067044] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403, Z01HG200325, Z01HG200331] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Camp NJ, 2001, ANN HUM GENET, V65, P577, DOI [10.1046/j.1469-1809.2001.6560577.x, 10.1017/S0003480001008922]; CAMP NJ, IN PRESS PROSTATE; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; CLERGETDARPOUX F, 1986, GENET EPIDEMIOL, P313; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Cunningham JM, 2003, PROSTATE, V57, P335, DOI 10.1002/pros.10308; Easton DF, 2003, PROSTATE, V57, P261, DOI 10.1002/pros.10300; EASTON DF, 1993, AM J HUM GENET, V52, P678; Edwards S, 2003, PROSTATE, V57, P270, DOI 10.1002/pros.10301; Edwards SM, 2004, AM J MED GENET C, V129C, P65, DOI 10.1002/ajmg.c.30027; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hsieh CL, 2001, AM J HUM GENET, V69, P148, DOI 10.1086/321281; ISAACS WB, 2002, GENETIC BASIS COMMON; Janer M, 2003, PROSTATE, V57, P309, DOI 10.1002/pros.10305; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lange EM, 2003, PROSTATE, V57, P326, DOI 10.1002/pros.10307; Lio P, 1997, P NATL ACAD SCI USA, V94, P5344, DOI 10.1073/pnas.94.10.5344; Maier C, 2005, EUR J HUM GENET, V13, P352, DOI 10.1038/sj.ejhg.5201333; Ostrander EA, 2004, ANNU REV GENOM HUM G, V5, P151, DOI 10.1146/annurev.genom.5.061903.180044; Ott J, 1999, ANAL HUMAN GENETIC L; Schaid DJ, 2005, PROSTATE, V63, P276, DOI 10.1002/pros.20198; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Schleutker J, 2003, PROSTATE, V57, P280, DOI 10.1002/pros.10302; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wiklund F, 2003, PROSTATE, V57, P290, DOI 10.1002/pros.10303; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2003, PROSTATE, V57, P320, DOI 10.1002/pros.10306	32	110	116	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					219	229		10.1086/432377	http://dx.doi.org/10.1086/432377			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	15988677	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000230387200004
J	Brooks, AS; Bertoli-Avella, AM; Burzynski, GM; Breedveld, GJ; Osinga, J; Boven, LG; Hurst, JA; Mancini, GMS; Lequin, MH; de Coo, RF; Matera, I; de Graaff, E; Meijers, C; Willems, PJ; Tibboel, D; Oostra, BA; Hofstra, RMW				Brooks, AS; Bertoli-Avella, AM; Burzynski, GM; Breedveld, GJ; Osinga, J; Boven, LG; Hurst, JA; Mancini, GMS; Lequin, MH; de Coo, RF; Matera, I; de Graaff, E; Meijers, C; Willems, PJ; Tibboel, D; Oostra, BA; Hofstra, RMW			Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIRSCHSPRUNG-DISEASE; MENTAL-RETARDATION; GENE; POLYMICROGYRIA; 2Q22-Q23; DISTINCT; DNA	We identified, by homozygosity mapping, a novel locus on 10q21.3- q22.1 for Goldberg- Shprintzen syndrome ( GOSHS) in a consanguineous Moroccan family. Phenotypic features of GOSHS in this inbred family included microcephaly and mental retardation, which are both central nervous system defects, as well as Hirschsprung disease, an enteric nervous system defect. Furthermore, since bilateral generalized polymicogyria was diagnosed in all patients in this family, this feature might also be considered a key feature of the syndrome. We demonstrate that homozygous nonsense mutations in KIAA1279 at 10q22.1, encoding a protein with two tetratrico peptide repeats, underlie this syndromic form of Hirschsprung disease and generalized polymicrogyria, establishing the importance of KIAA1279 in both enteric and central nervous system development.	Univ Groningen, Dept Med Genet, NL-9713 AW Groningen, Netherlands; Sophia Childrens Univ Hosp, Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; Sophia Childrens Univ Hosp, Erasmus MC, Dept Radiol, Rotterdam, Netherlands; Sophia Childrens Univ Hosp, Erasmus MC, Dept Pathol, Rotterdam, Netherlands; Sophia Childrens Univ Hosp, Erasmus MC, Dept Child Neurol, Rotterdam, Netherlands; Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Surg, Rotterdam, Netherlands; Oxford Radcliffe Hosp, Dept Clin Genet, Oxford, England; Inst G Gaslini, Genet Mol Lab, Genoa, Italy; Gendia, Antwerp, Belgium	University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Oxford; University of Genoa; IRCCS Istituto Giannina Gaslini	Hofstra, RMW (corresponding author), Univ Groningen, Dept Med Genet, Antonius Deusinglaan 4, NL-9713 AW Groningen, Netherlands.	r.m.w.hofstra@medgen.umcg.nl	Bertoli-Avella, Aida/AAW-2751-2020; de Graaff, Esther/D-3287-2011; Burzynski, Grzegorz M/D-2800-2009	Bertoli-Avella, Aida/0000-0001-9544-1877; Hofstra, Robert/0000-0001-7498-3829; de Coo, Irenaeus/0000-0003-0533-7422				Amiel J, 2001, AM J HUM GENET, V69, P1370, DOI 10.1086/324342; BARTH PG, 1985, ACTA NEUROPATHOL, V67, P345, DOI 10.1007/BF00687825; BARTH PG, 2003, DISORDERS NEURONAL M, P182; Brooks AS, 1999, J MED GENET, V36, P485; Chang BS, 2004, NEUROLOGY, V62, P1722, DOI 10.1212/01.WNL.0000125187.52952.E9; Ciardo F, 2001, NEUROPEDIATRICS, V32, P325; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Friede R.L., 1989, DEV NEUROPATHOLOGY; GOLDBERG RB, 1981, J CRAN GENET DEV BIO, V1, P185; HURST JA, 1988, J MED GENET, V25, P494, DOI 10.1136/jmg.25.7.494; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Okamoto E, 1967, J PEDIATR SURG, V2, P437; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Senderek J, 2003, AM J HUM GENET, V73, P1106, DOI 10.1086/379525; Silengo M, 2004, AM J MED GENET A, V127A, P109, DOI 10.1002/ajmg.a.20607; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Zweier C, 2002, AM J MED GENET, V108, P177, DOI 10.1002/ajmg.10226	23	110	114	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					120	126		10.1086/431244	http://dx.doi.org/10.1086/431244			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15883926	Bronze, Green Published			2022-12-18	WOS:000229794500011
J	Bongers, EMHF; Duijf, PHG; van Beersum, SEM; Schoots, J; van Kampen, A; Burckhardt, A; Hamel, BCJ; Losan, F; Hoefsloot, LH; Yntema, HG; Knoers, NVAM; van Bokhoven, H				Bongers, EMHF; Duijf, PHG; van Beersum, SEM; Schoots, J; van Kampen, A; Burckhardt, A; Hamel, BCJ; Losan, F; Hoefsloot, LH; Yntema, HG; Knoers, NVAM; van Bokhoven, H			Mutations in the human TBX4 gene cause small patella syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							T-BOX GENES; ULNAR-MAMMARY SYNDROME; APLASIA-HYPOPLASIA; LIMB; DYSPLASIA; SPECIFICATION; LOCALIZATION; INITIATION; IDENTITY; LMX1B	Small patella syndrome (SPS) is an autosomal-dominant skeletal dysplasia characterized by patellar aplasia or hypoplasia and by anomalies of the pelvis and feet, including disrupted ossification of the ischia and inferior pubic rami. We identified an SPS critical region of 5.6 cM on chromosome 17q22 by haplotype analysis. Putative loss-of-function mutations were found in a positional gene encoding T-box protein 4 (TBX4) in six families with SPS. TBX4 encodes a transcription factor with a strongly conserved DNA-binding T-box domain that is known to play a crucial role in lower limb development in chickens and mice. The present identification of heterozygous TBX4 mutations in SPS patients, together with the similar skeletal phenotype of animals lacking Tbx4, establish the importance of TBX4 in the developmental pathways of the lower limbs and the pelvis in humans.	Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Dept Orthoped Surg, NL-6500 HB Nijmegen, Netherlands; Kantonsspital Olten, Dept Orthoped Surg, Olten, Switzerland; Dept Med Genet, Plzen, Czech Republic	Radboud University Nijmegen; Radboud University Nijmegen; Kantonsspital Olten	Knoers, NVAM (corresponding author), Univ Nijmegen, Med Ctr, Dept Human Genet, Geert Grooteplein 10,POB 9101, NL-6500 HB Nijmegen, Netherlands.	n.knoers@antrg.umcn.nl	Yntema, H.G./L-4771-2015; van Beersum, Sylvia E.C./P-8653-2015; Bongers, M.H.F./L-4214-2015; van Bokhoven, Hans/D-8764-2012; Bokhoven, J.H.L.M. van van/H-8015-2014; Duijf, Pascal H.G./E-7110-2012; Kampen, A./H-8056-2014	van Beersum, Sylvia E.C./0000-0002-4552-2908; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Duijf, Pascal H.G./0000-0001-8646-9843; 				Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Azouz EM, 1997, PEDIATR RADIOL, V27, P432, DOI 10.1007/s002470050163; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; BERNHANG AM, 1973, J BONE JOINT SURG AM, VA 55, P1088, DOI 10.2106/00004623-197355050-00021; Bongers EMHF, 2002, AM J MED GENET, V108, P78, DOI 10.1002/ajmg.10198; Bongers EMHF, 2001, J MED GENET, V38, P209, DOI 10.1136/jmg.38.3.209; BURCKHARDT A, 1988, Z ORTHOP GRENZGEB, V126, P22, DOI 10.1055/s-2008-1044862; CHINEA G, 1995, PROTEINS, V23, P415, DOI 10.1002/prot.340230315; Coll M, 2002, STRUCTURE, V10, P343, DOI 10.1016/S0969-2126(02)00722-0; Dellestable F, 1996, J BONE JOINT SURG BR, V78B, P63, DOI 10.1302/0301-620X.78B1.0780063; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; Habboub HK, 1997, PEDIATR RADIOL, V27, P430, DOI 10.1007/s002470050162; Khan P, 2002, DEV BIOL, V250, P383, DOI 10.1006/dbio.2002.0801; KOZLOWSKI K, 1995, AM J MED GENET, V57, P558, DOI 10.1002/ajmg.1320570408; KREMER H, 1994, HUM MOL GENET, V3, P299, DOI 10.1093/hmg/3.2.299; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Mangino M, 1999, AM J HUM GENET, V65, P441, DOI 10.1086/302505; Mansour S, 2002, J MED GENET, V39, P597, DOI 10.1136/jmg.39.8.597; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORIN P, 1985, Journal de Radiologie (Paris), V66, P441; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Poznanski AK, 1997, PEDIATR RADIOL, V27, P428, DOI 10.1007/s002470050161; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; SANDHAUS YS, 1987, CLIN GENET, V31, P143; SCOTT JE, 1979, J BONE JOINT SURG BR, V61, P172, DOI 10.1302/0301-620X.61B2.438269; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Takeuchi JK, 2003, DEVELOPMENT, V130, P2729, DOI 10.1242/dev.00474; Vanek J, 1981, Rofo, V135, P354, DOI 10.1055/s-2008-1056892; Yi CH, 2000, GENOMICS, V67, P92, DOI 10.1006/geno.2000.6222	33	110	113	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1239	1248		10.1086/421331	http://dx.doi.org/10.1086/421331			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15106123	Green Published, Bronze			2022-12-18	WOS:000221651900016
J	Dgany, O; Avidan, N; Delaunay, J; Krasnov, T; Shalmon, L; Shalev, H; Eidelitz-Markus, T; Kapelushnik, J; Cattan, D; Pariente, A; Tulliez, M; Cretien, A; Schischmanoff, PO; Iolascon, A; Fibach, E; Koren, A; Rossler, J; Le Merrer, M; Yaniv, I; Zaizov, R; Ben-Asher, E; Olender, T; Lancet, D; Beckmann, JS; Tamary, H				Dgany, O; Avidan, N; Delaunay, J; Krasnov, T; Shalmon, L; Shalev, H; Eidelitz-Markus, T; Kapelushnik, J; Cattan, D; Pariente, A; Tulliez, M; Cretien, A; Schischmanoff, PO; Iolascon, A; Fibach, E; Koren, A; Rossler, J; Le Merrer, M; Yaniv, I; Zaizov, R; Ben-Asher, E; Olender, T; Lancet, D; Beckmann, JS; Tamary, H			Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTIGUOUS GENE DELETION; ALPHA-INTERFERON THERAPY; MULTIPLE-ALIGNMENTS; LOCALIZATION; ERYTHROPOIESIS; DISEASE; SEARCH	Congenital dyserythropoietic anemias (CDAs) constitute a rare group of inherited red-blood-cell disorders associated with dysplastic changes in late erythroid precursors. CDA type I (CDAI [MIM 224120], gene symbol CDAN1) is characterized by erythroid pathological features such as internuclear chromatin bridges, spongy heterochromatin, and invagination of the nuclear membrane, carrying cytoplasmic organelles into the nucleus. A cluster of 45 highly inbred Israeli Bedouin with CDAI enabled the mapping of the CDAN1 disease gene to a 2-Mb interval, now refined to 1.2 Mb, containing 15 candidate genes on human chromosome 15q15 (Tamary et al. 1998). After the characterization and exclusion of 13 of these genes, we identified the CDAN1 gene through 12 different mutations in 9 families with CDAI. This 28-exon gene, which is transcribed ubiquitously into 4738 nt mRNA, was reconstructed on the basis of gene prediction and homology searches. It encodes codanin-1, a putative o-glycosylated protein of 1,226 amino acids, with no obvious transmembrane domains. Codanin-1 has a 150-residue amino-terminal domain with sequence similarity to collagens and two shorter segments that show weak similarities to the microtubule-associated proteins, MAP1B (neuraxin) and synapsin. These findings, and the cellular phenotype, suggest that codanin-1 may be involved in nuclear envelope integrity, conceivably related to microtubule attachments. The specific mechanisms by which codanin-1 underlies normal erythropoiesis remain to be elucidated.	Schneider Childrens Med Ctr Israel, Rabin Med Ctr, Felsenstein Res Ctr, Pediat Hematol Lab, IL-49202 Petah Tiqwa, Israel; Schneider Childrens Med Ctr Israel, Dept Pediat E, IL-49202 Petah Tiqwa, Israel; Schneider Childrens Med Ctr Israel, Dept Pediat Hematol Oncol, IL-49202 Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Crown Human Genome Ctr, IL-76100 Rehovot, Israel; Hop Bicetre, Fac Med Paris Sud, Hematol Serv, Le Kremlin Bicetre, France; INSERM, U473, Le Kremlin Bicetre, France; Soroka Med Ctr, Dept Pediat, IL-84101 Beer Sheva, Israel; Ctr Hosp, Serv Hepatogastroenterol, Villeneuve St Georges, France; Ctr Hosp, Unite Hepatogastroenterol, Pau, France; Hop Henri Mondor, Serv Hematol Biol, F-94010 Creteil, France; Univ Foggia, Dept Pediat, Naples, Italy; Univ Naples Federico II, CEINGE, Naples, Italy; Hadassah Univ Hosp, Dept Hematol, IL-91120 Jerusalem, Israel; HaEmek Med Ctr, Pediat Dept B, Afula, Israel; Childrens Univ Hosp, Essen, Germany; Hop Enfants Malad, Paris, France	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science; Weizmann Institute of Science; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Ben Gurion University; Soroka Medical Center; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Foggia; CEINGE Biotecnologie Avanzate; University of Naples Federico II; Hebrew University of Jerusalem; Emek Medical Center; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP	Tamary, H (corresponding author), Schneider Childrens Med Ctr Israel, Rabin Med Ctr, Felsenstein Res Ctr, Pediat Hematol Lab, IL-49202 Petah Tiqwa, Israel.		Beckmann, Jacques S/A-9772-2008; Iolascon, Achille/A-4461-2014	Beckmann, Jacques S/0000-0002-9741-1900; Rossler, Jochen/0000-0003-4022-4917				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angers A, 2002, J NEUROSCI, V22, P5412; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Delaunay J, 1999, BEST PRACT RES CL HA, V12, P691, DOI 10.1053/beha.1999.0048; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Gasparini P, 1997, AM J HUM GENET, V61, P1112, DOI 10.1086/301609; Henikoff JG, 2000, NUCLEIC ACIDS RES, V28, P228, DOI 10.1093/nar/28.1.228; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Iolascon A, 2001, BLOOD, V98, P1258, DOI 10.1182/blood.V98.4.1258; Kunin V, 2001, J MOL BIOL, V307, P939, DOI 10.1006/jmbi.2001.4466; LAVABREBERTRAND T, 1995, BRIT J HAEMATOL, V89, P929; LIND L, 1995, HUM MOL GENET, V4, P109, DOI 10.1093/hmg/4.1.109; Lippincott-Schwartz J, 2002, NATURE, V416, P31, DOI 10.1038/416031a; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; Parez N, 2000, BRIT J HAEMATOL, V110, P420, DOI 10.1046/j.1365-2141.2000.02168.x; Parvari R, 2001, AM J HUM GENET, V69, P869, DOI 10.1086/323624; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P3836, DOI 10.1093/nar/24.19.3836; Pope SH, 2000, EUR J HAEMATOL, V64, P292, DOI 10.1034/j.1600-0609.2000.90032.x; Sauer S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.5.e22; Shanske A, 2001, AM J MED GENET, V102, P231, DOI 10.1002/ajmg.1451; Silver FH, 2002, J THEOR BIOL, V216, P243, DOI 10.1006/jtbi.2002.2542; Tamary H, 1998, AM J HUM GENET, V62, P1062, DOI 10.1086/301834; Tamary H, 1996, BLOOD, V87, P1763; Wickramasinghe SN, 1997, BRIT J HAEMATOL, V98, P295, DOI 10.1046/j.1365-2141.1997.1993016.x; Wickramasinghe SN, 1997, BRIT J HAEMATOL, V98, P785, DOI 10.1046/j.1365-2141.1997.2513065.x	27	110	119	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1467	1474		10.1086/344781	http://dx.doi.org/10.1086/344781			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12434312	Bronze, Green Published			2022-12-18	WOS:000179586800022
J	Xu, J; Burgoyne, P; Arnold, AP				Xu, J; Burgoyne, P; Arnold, AP			Expression of sex chromosome genes in mouse brain.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90024 USA; MRC, Natl Inst Med Res, Div Dev Genet, London, England	University of California System; University of California Los Angeles; MRC National Institute for Medical Research			Xu, Jun/B-7351-2012		NCI NIH HHS [CA58236, P50 CA058236] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	110	114	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4		1		925	341	341		10.1086/321967	http://dx.doi.org/10.1086/321967			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	483RD	11443539	Green Published, Bronze			2022-12-18	WOS:000171648900926
J	Xu, JF; Zheng, SQL; Hawkins, GA; Faith, DA; Kelly, B; Isaacs, SD; Wiley, KE; Chang, BL; Ewing, CM; Bujnovszky, P; Carpten, JD; Bleecker, ER; Walsh, PC; Trent, JM; Meyers, DA; Isaacs, WB				Xu, JF; Zheng, SQL; Hawkins, GA; Faith, DA; Kelly, B; Isaacs, SD; Wiley, KE; Chang, BL; Ewing, CM; Bujnovszky, P; Carpten, JD; Bleecker, ER; Walsh, PC; Trent, JM; Meyers, DA; Isaacs, WB			Linkage and association studies of prostate cancer susceptibility: Evidence for linkage at 8p22-23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; COLORECTAL-CANCER; ALLELIC LOSS; DELETION; HETEROZYGOSITY; CHROMOSOME-8; CARCINOMAS; EXPRESSION; REGIONS; TESTS	Multiple lines of evidence have implicated the short arm of chromosome 8 as harboring genes important in prostate carcinogenesis. Although most of this evidence comes from the identification of frequent somatic alterations of 8p loci in prostate cancer cells (e.g., loss of heterozygosity), studies have also suggested a role for 8p genes in mediation of inherited susceptibility to prostate cancer. To further examine this latter possibility, we performed linkage analyses, in 159 pedigrees affected by hereditary prostate cancer (HPC), using 24 markers on the short arm of chromosome 8. In the complete set of families, evidence for prostate cancer linkage was found at 8p22-23, with a peak HLOD of 1.84 (P = .004), and an estimate of the proportion of families linked (alpha) of 0.14, at D8S1130. In the 79 families with average age at diagnosis >65 years, an allele-sharing LOD score of 2.64 (P = .005) was observed, and six markers spanning a distance of 10 cM had LOD scores >2.0. Interestingly, the small number of Ashkenazi Jewish pedigrees (n = 11) analyzed in this study contributed disproportionately to this linkage. Mutation screening in HPC probands and association analyses in case subjects (a group that includes HPC probands and unrelated case subjects) and unaffected control subjects were carried out for the putative prostate cancer-susceptibility gene, PG1, previously localized to the 8p22-23 region. No statistical differences in the allele, genotype, or haplotype frequencies of the SNPs or other sequence variants in the PG1 gene were observed between case and control subjects. However, case subjects demonstrated a trend toward higher homozygous rates of less-frequent alleles in all three PG1 SNPs, and overtransmission of a PG1 variant to case subjects was observed. In summary, these results provide evidence for the existence of a prostate cancer-susceptibility gene at 8p22-23. Evaluation of the PG1 gene and other candidate genes in this area appears warranted.	Johns Hopkins Univ Hosp, Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA; Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; NHGRI, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest Baptist Medical Center; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Isaacs, WB (corresponding author), Johns Hopkins Univ Hosp, Johns Hopkins Med Inst, Dept Urol, Marburg 115,600 N Wolfe St, Baltimore, MD 21287 USA.	wisaacs@jhmi.edu	Xu, Jun/B-7351-2012		NCI NIH HHS [CA58236, P50 CA058236] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOOKSTEIN R, 2001, PROSTATE CANC BIOL G; Bova GS, 1996, GENOMICS, V35, P46, DOI 10.1006/geno.1996.0321; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CHUAQUI RF, 1995, CANCER RES, V55, P4995; CLIBY W, 1993, CANCER RES, V53, P2393; COHEN D, 1999, Patent No. 005945522; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CUNNINGHAM C, 1993, ONCOGENE, V8, P1391; Cunningham JM, 1996, CANCER RES, V56, P4475; Deubler DA, 1997, AM J PATHOL, V150, P841; EMI M, 1992, CANCER RES, V52, P5368; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; Gibbs M, 2000, AM J HUM GENET, V67, P100, DOI 10.1086/302969; Ishii H, 1999, P NATL ACAD SCI USA, V96, P3928, DOI 10.1073/pnas.96.7.3928; KAGAN J, 1995, ONCOGENE, V11, P2121; KNOWLES MA, 1993, ONCOGENE, V8, P1357; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MacGrogan D, 1996, GENOMICS, V35, P55, DOI 10.1006/geno.1996.0322; MACOSKA JA, 1995, CANCER RES, V55, P5390; OTT J, 1998, ANAL HUMAN GENETIC L; Prasad MA, 1998, GENE CHROMOSOME CANC, V23, P255, DOI 10.1002/(SICI)1098-2264(199811)23:3<255::AID-GCC8>3.3.CO;2-Q; Ransom DT, 1996, HEAD NECK-J SCI SPEC, V18, P248; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Vocke CD, 1996, CANCER RES, V56, P2411; Wang CY, 1999, CARCINOGENESIS, V20, P1591, DOI 10.1093/carcin/20.8.1591; Weir B., 1996, GENETIC DATA ANAL; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wilson PJ, 2000, HUM MUTAT, V15, P156, DOI 10.1002/(SICI)1098-1004(200002)15:2<156::AID-HUMU4>3.0.CO;2-4; Wistuba II, 1999, CANCER RES, V59, P1973; Yuan BZ, 1999, CYTOGENET CELL GENET, V87, P189, DOI 10.1159/000015462; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	36	110	114	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					341	350		10.1086/321967	http://dx.doi.org/10.1086/321967			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443539	Green Published, Bronze			2022-12-18	WOS:000170108200009
J	Svenson, IK; Ashley-Koch, AE; Gaskell, PC; Riney, TJ; Cumming, WJK; Kingston, HM; Hogan, EL; Boustany, RMN; Vance, JM; Nance, MA; Pericak-Vance, MA; Marchuk, DA				Svenson, IK; Ashley-Koch, AE; Gaskell, PC; Riney, TJ; Cumming, WJK; Kingston, HM; Hogan, EL; Boustany, RMN; Vance, JM; Nance, MA; Pericak-Vance, MA; Marchuk, DA			Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROPOSED LINKAGE; SPG4; LOCUS; ATPASES; PROTEIN; POWER	Pure hereditary spastic paraplegia (SPG) type 4 is the most common form of autosomal dominant hereditary SPG, a neurodegenerative disease characterized primarily by hyperreflexia and progressive spasticity of the lower limbs. It is caused by mutations in the gene encoding spastin, a member of the AAA family of ATPases. We have screened the spastin gene for mutations in 15 families consistent with linkage to the spastin gene locus, SPG4, and have identified 11 mutations, 10 of which are novel. Five of the mutations identified are in noninvariant splice-junction sequences. Reverse transcription-PCR analysis of mRNA from patients shows that each of these five mutations results in aberrant splicing. One mutation was found to be "leaky," or partially penetrant; that is, the mutant allele produced both mutant (skipped exon) and wild-type (full-length) transcripts. This phenomenon was reproduced in in vitro splicing experiments, with a minigene splicing-vector construct only in the context of the endogenous splice junctions flanking the splice junctions of the skipped exon. In the absence of endogenous splice junctions, only mutant transcript was detected. The existence of at least one leaky mutation suggests that relatively small differences in the level of wild-type spastin expression can have significant functional consequences. This may account, at least in part, for the wide ranges in age at onset, symptom severity, and rate of symptom progression that have been reported to occur both among and within families with SPG linked to SPG4. In addition, these results suggest caution in the interpretation of data solely obtained with minigene constructs to study the effects of sequence variation on splicing. The lack of full genomic sequence context in these constructs can mask important functional consequences of the mutation.	Duke Univ, Med Ctr, Durham, NC 27710 USA; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Med Univ S Carolina, Charleston, SC 29425 USA; Pk Nicollet Clin, Minneapolis, MN USA	Duke University; University of Manchester; Medical University of South Carolina	Marchuk, DA (corresponding author), Duke Univ, Med Ctr, Box 3175, Durham, NC 27710 USA.	march004@mc.duke.edu		Vance, Jeffery/0000-0003-3815-8199; Marchuk, Douglas/0000-0002-3110-6671; Ashley-Koch, Allison/0000-0001-5409-9155	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS026630, 2P01-NS26630-11A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOEHNKE M, 1986, AM J HUM GENET, V39, P513; Burger J, 2000, EUR J HUM GENET, V8, P771, DOI 10.1038/sj.ejhg.5200528; Fink JK, 1997, CURR OPIN NEUROL, V10, P313, DOI 10.1097/00019052-199708000-00006; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; Fontaine B, 2000, AM J HUM GENET, V66, P702, DOI 10.1086/302776; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hentati A, 2000, NEUROLOGY, V55, P1388, DOI 10.1212/WNL.55.9.1388; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Lindsey JC, 2000, J MED GENET, V37, P759, DOI 10.1136/jmg.37.10.759; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; Neuwald AF, 1999, GENOME RES, V9, P27; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; Reid E, 2000, AM J HUM GENET, V66, P728, DOI 10.1086/302783; Santorelli FM, 2000, NEUROLOGY, V55, P702, DOI 10.1212/WNL.55.5.702; Scott WK, 1997, NEUROGENETICS, V1, P95, DOI 10.1007/s100480050014	16	110	114	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1077	1085		10.1086/320111	http://dx.doi.org/10.1086/320111			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11309678	Green Published, Bronze			2022-12-18	WOS:000168171200001
J	Baharloo, S; Service, SK; Risch, N; Gitschier, J; Freimer, NB				Baharloo, S; Service, SK; Risch, N; Gitschier, J; Freimer, NB			Familial aggregation absolute pitch	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTIFICATION	Absolute pitch (AP) is a behavioral trait that is defined as the ability to identify the pitch of tones in the absence of a reference pitch. AP is an ideal phenotype for investigation of gene and environment interactions in the development of complex human behaviors. Individuals who score exceptionally well on formalized auditory tests of pitch perception are designated as "AP-1." As described in this report, auditory testing of siblings of AP-1 probands and of a control sample indicates that AP-1 aggregates in families. The implications of this finding for the mapping of loci for AP-1 predisposition are discussed.	Univ Calif San Francisco, Dept Psychiat, Neurogenet Lab, San Francisco, CA 94143 USA; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Stanford University	Freimer, NB (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Dept Psychiat, Los Angeles, CA 90024 USA.							Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Gregersen PK, 1999, AM J HUM GENET, V65, P911, DOI 10.1086/302541; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; RISCH N, 1990, AM J HUM GENET, V46, P222; SERGEANT D, 1969, J RES MUSIC EDUC, V17, P135, DOI 10.2307/3344200; Vogel F., 1997, HUMAN GENETICS	7	110	112	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					755	758		10.1086/303057	http://dx.doi.org/10.1086/303057			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10924408	Bronze, Green Published			2022-12-18	WOS:000089002300022
J	Sgambati, MT; Stolle, C; Choyke, PL; Walther, MM; Zbar, B; Linehan, WM; Glenn, GM				Sgambati, MT; Stolle, C; Choyke, PL; Walther, MM; Zbar, B; Linehan, WM; Glenn, GM			Mosaicism in von Hippel-Lindau disease: Lessons from kindreds with germline mutations identified in offspring with mosaic parents	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; LINE MOSAICISM; PHENOTYPE; FEATURES; LOCUS	von Hippel-Lindau disease (VHL [MIM 193300]) is a heritable autosomal dominant multiple-neoplastic disorder with high penetrance. It is characterized by brain and spinal-cord hemangioblastomas, retinal angiomas, clear-cell renal carcinoma, neuroendocrine tumors and cysts of the pancreas, pheochromocytomas, endolymphatic-sac tumors, and papillary cystadenomas of the epididymis and broad ligament. Although most index cases have a positive family history of VHL, some do not and may represent de novo cases. Cases without a family history of VHL may or may not have a germline mutation in their VHL tumor-suppressor gene. We present two cases of VHL mosaicism. In each of two families, standard testing methods (Southern blot analysis and direct sequencing) identified the germline mutation in the VHL gene of the offspring, but not in their clinically affected parent. Additional methods of analysis of the affected parents' blood detected the VHL-gene mutation in a portion of their peripheral blood lymphocytes. In one case, detection of the deleted allele was by FISH, and, in the second case, the 3-bp deletion was detected by conformational sensitive gel electrophoresis and DNA sequencing of cloned genomic DNA. Mosaicism in VHL is important to search for and recognize when an individual without a family history of VHL has VHL. Patients diagnosed without family histories of the disease have been reported in as many as 23% of kindreds with VHL. Identification of individuals potentially mosaic for VHL will affect counseling of families, and these individuals should themselves be included in clinical screening programs for occult disease.	NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; NCI, Urol Oncol Branch, Div Clin Sci, NIH, Bethesda, MD 20892 USA; NIH, Warren G Magnuson Clin Ctr, Dept Radiol, Bethesda, MD 20892 USA; Univ Penn, Sch Med, Genet Diagnost Lab, Philadelphia, PA 19104 USA; NCI, Immunobiol Lab, Div Basic Sci, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Glenn, GM (corresponding author), 6120 Execut Blvd,EPS 7108,MSC 7236, Bethesda, MD 20892 USA.				DIVISION OF BASIC SCIENCES - NCI [Z01BC008577] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01CP004410, ZIACP004410] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUSTIN KD, 1992, PEDIATR CLIN N AM, V39, P335; CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; Choyke PL, 1997, UROLOGY, V49, P926, DOI 10.1016/S0090-4295(97)00074-5; CHOYKE PL, 1995, RADIOLOGY, V194, P629, DOI 10.1148/radiology.194.3.7862955; Evans DA, 1998, KLUW S INF, V2, P63; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Glenn G., 1999, Proceedings of the American Association for Cancer Research Annual Meeting, V40, P464; GLENN GM, 1991, HUM GENET, V87, P207, DOI 10.1007/BF00204184; GLENN GM, 1990, PROBL UROL, V4, P312; KENTFIRST M, 1999, J NAT I HLTH RES, V9, P29; Kluwe L, 1998, HUM MOL GENET, V7, P2051, DOI 10.1093/hmg/7.13.2051; Kwiatkowska J, 1999, NEW ENGL J MED, V340, P703, DOI 10.1056/NEJM199903043400905; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; Maddock IR, 1996, J MED GENET, V33, P120, DOI 10.1136/jmg.33.2.120; MAHER ER, 1991, J MED GENET, V28, P443, DOI 10.1136/jmg.28.7.443; Manski TJ, 1997, JAMA-J AM MED ASSOC, V277, P1461, DOI 10.1001/jama.277.18.1461; NEUMANN HPH, 1991, LANCET, V337, P1052, DOI 10.1016/0140-6736(91)91705-Y; Neumann HPH, 1998, J INTERN MED, V243, P541; Pack SD, 1999, CANCER RES, V59, P5560; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Stolle C, 1998, HUM MUTAT, V12, P417, DOI 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K; STOLLE CA, 1987, BLOOD, V70, P293; Yates JRW, 1997, HUM MOL GENET, V6, P2265, DOI 10.1093/hmg/6.13.2265; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.3.CO;2-9; Zlotogora J, 1998, HUM GENET, V102, P381, DOI 10.1007/s004390050708	28	110	113	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					84	91		10.1086/302726	http://dx.doi.org/10.1086/302726			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631138	Green Published, Bronze			2022-12-18	WOS:000085033600009
J	Mimault, C; Giraud, G; Courtois, V; Cailloux, F; Boire, JY; Dastugue, B; Boespflug-Tanguy, O				Mimault, C; Giraud, G; Courtois, V; Cailloux, F; Boire, JY; Dastugue, B; Boespflug-Tanguy, O		Clinical European Network Brain Dysmyelinating	Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher disease: Duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEOLIPID PROTEIN GENE; DUCHENNE MUSCULAR-DYSTROPHY; SEVERE HEMOPHILIA-A; FACTOR-VIII GENE; SEX-RATIO; WILLIAMS-SYNDROME; PARENTAL ORIGIN; X-CHROMOSOME; PLP GENE; DELETIONS	Pelizaeus-Merzbacher Disease (PMD) is an X-linked developmental defect of myelination affecting the central nervous system and segregating with the proteolipoprotein (PLP) locus. Investigating 82 strictly selected sporadic cases of PMD, we found PLP mutations in 77%; complete PLP-gene duplications were the most frequent abnormality (62%), whereas point mutations in coding or splice-site regions of the gene were involved less frequently (38%). We analyzed the maternal both types of status of 56 cases to determine the origin ofPLP mutation, since this is relevant to genetic counseling. In the 22 point mutations, 68% of mothers were heterozygous for the mutation, a value identical to the two-thirds of carrier mothers that would be expected if there were an equal mutation rate in male and female germ cells. In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi(2) = 9.20, P < .01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 3.3. Moreover, we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three-generation families, which allowed a direct estimation of the k value (k = 11). Again, a significant male mutation imbalance was observed only for the duplications. The mechanism responsible for this strong male bias in the duplications may involve an unequal sister chromatid exchange, since two deletion events, responsible for mild clinical manifestations, have been reported in PLP-related diseases.	Fac Med, INSERM, U384, F-63001 Clermont Ferrand, France; Fac Med, ERIM, F-63001 Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Boespflug-Tanguy, O (corresponding author), Fac Med, INSERM, U384, 28 Pl Henri Dunant,BP 38, F-63001 Clermont Ferrand, France.		Courtois, Virginie/GRF-1895-2022	Courtois, Virginie/0000-0001-6446-4582				Becker J, 1996, AM J HUM GENET, V58, P657; BoespflugTanguy O, 1996, TRENDS IN CHILD NEUROLOGY - A FESTSCHRIFT FOR JEAN AICARDI, P189; BOESPFLUGTANGUY O, 1994, AM J HUM GENET, V55, P461; BOESPFLUGTANGUY O, 1997, MED GENET S, V9, P144; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; GENCIC S, 1989, AM J HUM GENET, V45, P435; GEOFFREY MM, 1992, DISCRIMINANT ANAL ST; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HU XY, 1990, AM J HUM GENET, V46, P682; Inoue K, 1996, AM J HUM GENET, V59, P32; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; Jurado LAP, 1996, AM J HUM GENET, V59, P781; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; KORNREICH R, 1992, GENOMICS, V13, P70, DOI 10.1016/0888-7543(92)90203-5; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; MATTEI MG, 1986, HUM GENET, V72, P352, DOI 10.1007/BF00290964; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; MIMAULT C, 1995, HUM GENET, V96, P236, DOI 10.1007/BF00207388; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MULLER B, 1992, HUM GENET, V89, P204; Nave KA, 1996, NEUROSCIENTIST, V2, P33, DOI 10.1177/107385849600200111; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; Pelizaeus F., 1885, ARCH PSYCHIAT NERVEN, V16, P698; PENROSE LS, 1955, LANCET, V2, P312; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; ROSENDAAL FR, 1990, HUM GENET, V86, P139, DOI 10.1007/BF00197695; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; Sommer SS, 1996, HUM MOL GENET, V5, P1505, DOI 10.1093/hmg/5.Supplement_1.1505; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; Urban Z, 1996, AM J HUM GENET, V59, P958; VANESSEN AJ, 1992, HUM GENET, V88, P249, DOI 10.1007/BF00197255; Woodward K, 1998, AM J HUM GENET, V63, P207, DOI 10.1086/301933; WU JS, 1987, NUCLEIC ACIDS RES, V15, P1882, DOI 10.1093/nar/15.4.1882	45	110	116	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					360	369		10.1086/302483	http://dx.doi.org/10.1086/302483			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417279	Bronze, Green Published			2022-12-18	WOS:000081836900012
J	Bogenhagen, DF				Bogenhagen, DF			Repair of mtDNA in vertebrates	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAMSTER OVARY CELLS; DNA-LIGASE-IV; MITOCHONDRIAL-DNA; OXIDATIVE DAMAGE; MAMMALIAN MITOCHONDRIA; RINR-38 CELLS; GENE; NUCLEAR; ENZYME; RAT		SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.				NIEHS NIH HHS [ES04068] Funding Source: Medline; NIGMS NIH HHS [GM29681] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES004068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029681] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACKER JM, 1980, SCIENCE, V209, P297, DOI 10.1126/science.6770466; Berdal KG, 1998, EMBO J, V17, P363, DOI 10.1093/emboj/17.2.363; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; CARRODEGUAS JA, 1999, IN PRESS MOL CELL BI; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338; Cullinane C, 1998, CANCER RES, V58, P1400; DRIGGERS WJ, 1993, J BIOL CHEM, V268, P22042; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; MARTIN NC, 1994, BIOCHIMIE, V76, P1161, DOI 10.1016/0300-9084(94)90045-0; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MITA S, 1988, CANCER RES, V48, P4578; MYERS KA, 1988, CARCINOGENESIS, V9, P285, DOI 10.1093/carcin/9.2.285; PETTEPHER CC, 1991, J BIOL CHEM, V266, P3113; PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0; REENAN RAG, 1992, GENETICS, V132, P975; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; SATOH MS, 1988, J BIOL CHEM, V263, P6854; SHEN CC, 1995, MUTAT RES, V337, P12; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SINGH G, 1990, CANCER CHEMOTH PHARM, V26, P97, DOI 10.1007/BF02897252; SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579; SNYDERWINE EG, 1992, CANCER RES, V52, P4183; Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917; TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532; Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690; WEI YF, 1995, MOL CELL BIOL, V15, P3206	33	110	113	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1276	1281		10.1086/302392	http://dx.doi.org/10.1086/302392			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205257	Green Published, Bronze			2022-12-18	WOS:000080093000004
J	Koga, H; Sakou, T; Taketomi, E; Hayashi, K; Numasawa, T; Harata, S; Yone, K; Matsunaga, S; Otterud, B; Inoue, I; Leppert, M				Koga, H; Sakou, T; Taketomi, E; Hayashi, K; Numasawa, T; Harata, S; Yone, K; Matsunaga, S; Otterud, B; Inoue, I; Leppert, M			Genetic mapping of ossification of the posterior longitudinal ligament of the spine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-2(XI) COLLAGEN; IDENTIFICATION; ASSOCIATION; EXPRESSION; MUTATION; LINKAGE; COL11A2; COMPLEX; LOCUS; DISH	Ossification of the posterior longitudinal ligament of the spine (OPLL) is recognized as a common disorder among Japanese and throughout Asia. Estimates of its prevalence are in the range of 1.9%-4.3%. Although its etiology is thought to involve a multiplicity of factors, epidemiological and family studies strongly implicate genetic susceptibility in the pathogenesis of OPLL. In this study we report an identification of a predisposing locus for OPLL, on chromosome 6p, close to the HLA complex. The evidence for this localization is provide by a genetic-linkage study of 91 affected sib pairs from 53 Japanese families. In this sib-pair study, D6S276, a marker lying close to the HLA complex, gives evidence for strongly significant linkage (P =.000006) to the OPLL locus. A candidate gene in the region, that for collagen 11A2, was analyzed for the presence of molecular variants in affected probands. Of 19 distinct variants identified, 4 showed strong statistical associations with OPLL (highest P =.0004). These observations of linkage and association, taken together, show that a genetic locus for OPLL lies close to the HLA region, on chromosome 6p.	Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84112 USA; Hirosaki Univ, Fac Med, Dept Orthoped Surg, Hirosaki, Aomori, Japan; Kagoshima Univ, Fac Med, Dept Orthoped Surg, Kagoshima 890, Japan	Utah System of Higher Education; University of Utah; Hirosaki University; Kagoshima University	Leppert, M (corresponding author), Univ Utah, Eccles Inst Human Genet, Dept Human Genet, 15 N 2030 East St,Room 7160, Salt Lake City, UT 84112 USA.	mleppert@genetics.utah.edu			NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NCI NIH HHS [5P30 CA42014] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FRANCOMANO CA, 1995, NAT GENET, V9, P6, DOI 10.1038/ng0195-6; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; Hayashi K, 1997, BONE, V21, P23, DOI 10.1016/S8756-3282(97)00080-X; Jeunemaitre X, 1997, AM J HUM GENET, V60, P1448, DOI 10.1086/515452; KAWAGUCHI H, 1992, SPINE, V17, pS33; Koga H, 1996, SPINE, V21, P469, DOI 10.1097/00007632-199602150-00011; Line Sergio, 1993, P539; Liu L, 1996, AM J MED GENET, V67, P306; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Lui VCH, 1996, GENOMICS, V32, P401, DOI 10.1006/geno.1996.0135; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; Matsunaga S., 1997, OSSIFICATION POSTERI, P11; MCCONLOGUE L, 1988, NUCLEIC ACIDS RES, V16, P9869, DOI 10.1093/nar/16.20.9869; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; RESNICK D, 1976, RADIOLOGY, V119, P559, DOI 10.1148/119.3.559; RESNICK D, 1978, AM J ROENTGENOL, V131, P1049, DOI 10.2214/ajr.131.6.1049; SAKOU T, 1991, SPINE, V16, P1249, DOI 10.1097/00007632-199111000-00001; TERAYAMA K, 1989, SPINE, V14, P1184, DOI 10.1097/00007632-198911000-00009; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TROJAN DA, 1992, AM J MED, V92, P296, DOI 10.1016/0002-9343(92)90080-U; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; UEHARA H, 1994, SEIKEIGEKA, V45, P1341; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; VUORISTO MM, 1995, J BIOL CHEM, V270, P22873, DOI 10.1074/jbc.270.39.22873; WAKAMATSU N, 1992, J BIOL CHEM, V267, P2406; Weinfeld RM, 1997, SKELETAL RADIOL, V26, P222, DOI 10.1007/s002560050225; YAMAZAKI M, 1991, CALCIFIED TISSUE INT, V48, P182, DOI 10.1007/BF02570553; YAMAZAKI M, 1992, EXPRESSION TYPE 11 C; Yonemori K, 1997, AM J PATHOL, V150, P1335	31	110	120	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1460	1467		10.1086/301868	http://dx.doi.org/10.1086/301868			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585596	Green Published, Bronze			2022-12-18	WOS:000074174700023
J	Manning, BM; Quane, KA; Ording, H; Urwyler, A; Tegazzin, V; Lehane, M; O'Halloran, J; Hartung, E; Giblin, LM; Lynch, PJ; Vaughan, P; Censier, K; Bendixen, D; Comi, G; Heytens, L; Monsieurs, K; Fagerlund, T; Wolz, W; Heffron, JJA; Muller, CR; McCarthy, TV				Manning, BM; Quane, KA; Ording, H; Urwyler, A; Tegazzin, V; Lehane, M; O'Halloran, J; Hartung, E; Giblin, LM; Lynch, PJ; Vaughan, P; Censier, K; Bendixen, D; Comi, G; Heytens, L; Monsieurs, K; Fagerlund, T; Wolz, W; Heffron, JJA; Muller, CR; McCarthy, TV			Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: Genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTRAL CORE DISEASE; MUSCLE SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; SUSCEPTIBILITY LOCUS; RELEASE CHANNEL; CHROMOSOME 19Q12-13.2; LOCALIZATION; POLYMORPHISMS; SUBSTITUTION; PEDIGREE	Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that is triggered in genetically predisposed individuals by common anesthetics and muscle relaxants. The ryanodine receptor (RYR1) is mutated in a number of MH pedigrees, some members of which also have central core disease (CCD), an inherited myopathy closely associated with MH. Mutation screening of 6 kb of the RYR1 gene has identified four adjacent novel mutations, C6487T, G6488A, G6502A, and C6617T, which result in the amino acid alterations Arg2163Cys, Arg2163His, Val2168Met, and Thr2206Met, respectively. Collectively, these mutations account for 11% of MH cases and identify the gene segment 6400-6700 as a mutation hot spot. Correlation analysis of the in vitro contracture-test data available for pedigrees bearing these and other RYR1 mutations showed an exceptionally good correlation between caffeine threshold and tension values, whereas no correlation was observed between halothane threshold and tension values, This finding has important ramifications for assignment of the MI-I-susceptible phenotype, in genotyping studies, and indicates that assessment of recombinant individuals on the basis of caffeine response is justified, whereas assessment on the basis of halothane response may be problematic. Interestingly, the data suggest a link between the caffeine threshold and tension values and the MH/CCD phenotype.	Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Dept Zool & Anim Ecol, Cork, Ireland; Cork Univ Hosp, Dept Anaesthesia, Cork, Ireland; Univ Copenhagen, Herlev Hosp, Dept Anaesthesiol, Copenhagen, Denmark; Univ Basel Hosp, Dept Anaesthesia, Kantonsspital, CH-4031 Basel, Switzerland; Traumatol Orthopaed Hosp, Dept Anaesthesiol & Crit Care Med, Padua, Italy; Univ Wurzburg, Inst Anaesthesiol, Wurzburg, Germany; Biozentrum, Inst Human Genet, Wurzburg, Germany; Univ Milan, Inst Clin Neurol, Inst Ricovero & Cura, Carattere Sci Osped Maggiore Policlin, Milan, Italy; Univ Antwerp, Born Bunge Fdn, Malignant Hyperthermia Lab, Dept Intens Care, B-2020 Antwerp, Belgium; Univ Antwerp, Born Bunge Fdn, Neurogenet Lab, B-2020 Antwerp, Belgium; Ulleval Univ Hosp, Inst Med Genet, Blindern, Norway	University College Cork; University College Cork; University College Cork; University of Copenhagen; Herlev & Gentofte Hospital; Kantonsspital Aarau AG (KSA); University of Basel; University of Wurzburg; University of Wurzburg; University of Milan; University of Antwerp; University of Antwerp; University of Oslo	McCarthy, TV (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland.	t.mccarthy@ucc.ie	Giblin, Linda/P-2436-2016; Monsieurs, Koen/W-2145-2019; Comi, Giacomo P/K-5702-2016	Giblin, Linda/0000-0002-9354-3121; Monsieurs, Koen/0000-0002-5068-4848; Comi, Giacomo P/0000-0002-1383-5248; McCarthy, Tommie/0000-0003-4884-6972	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHEN SRW, 1993, BIOCHEMISTRY-US, V32, P3743, DOI 10.1021/bi00065a029; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; DEUFEL T, 1995, AM J HUM GENET, V56, P1334; ELLIS FR, 1984, BRIT J ANAESTH, V56, P1267; ELLIS FR, 1973, BRIT J ANAESTH, V45, P638; ELLIS FR, 1985, RECENT ADV ANAESTHES, V15, P173; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; GRONERT GA, 1986, MYOLOGY, V2, P1763; HAYASHI K, 1989, MUSCLE NERVE, V12, P95, DOI 10.1002/mus.880120203; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; KALOW W, 1970, LANCET, V2, P895, DOI 10.1016/S0140-6736(70)92069-6; KALOW W, 1987, MALIGNANT HYPERTHERM, P155; KEATING KE, 1994, HUM MOL GENET, V3, P1855, DOI 10.1093/hmg/3.10.1855; Keating KE, 1997, J MED GENET, V34, P291, DOI 10.1136/jmg.34.4.291; LEVITT RC, 1992, GENOMICS, V14, P562, DOI 10.1016/S0888-7543(05)80152-1; Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; Manning BM, 1998, HUM MUTAT, V11, P45, DOI 10.1002/(SICI)1098-1004(1998)11:1<45::AID-HUMU7>3.0.CO;2-K; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; ODriscoll S, 1996, BIOCHEM J, V319, P421, DOI 10.1042/bj3190421; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Phillips MS, 1996, GENOMICS, V34, P24, DOI 10.1006/geno.1996.0238; PHILLIPS MS, 1994, HUM MOL GENET, V3, P2181, DOI 10.1093/hmg/3.12.2181; QUANE KA, 1994, GENOMICS, V23, P236, DOI 10.1006/geno.1994.1483; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; QUANE KA, 1994, HUM MOL GENET, V3, P471, DOI 10.1093/hmg/3.3.471; Quane KA, 1997, BRIT J ANAESTH, V79, P332, DOI 10.1093/bja/79.3.332; Robinson RL, 1997, HUM MOL GENET, V6, P953, DOI 10.1093/hmg/6.6.953; RYAN BF, 1985, MINITAB; SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004; SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610; SUDBRAK R, 1995, AM J HUM GENET, V56, P684; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; TEGAZZIN V, 1994, MINERVA ANESTHESIOL, V60, P217; URWYLER A, 1994, ANESTHESIOLOGY, V80, P1287, DOI 10.1097/00000542-199406000-00016; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	41	110	113	0	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					599	609		10.1086/301748	http://dx.doi.org/10.1086/301748			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497245	Green Published, Bronze			2022-12-18	WOS:000072894400013
J	Huizing, M; Iacobazzi, V; Ijlst, L; Savelkoul, P; Ruitenbeek, W; van den Heuvel, L; Indiveri, C; Smeitink, J; Trijbels, F; Wanders, R; Palmieri, F				Huizing, M; Iacobazzi, V; Ijlst, L; Savelkoul, P; Ruitenbeek, W; van den Heuvel, L; Indiveri, C; Smeitink, J; Trijbels, F; Wanders, R; Palmieri, F			Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAT-LIVER MITOCHONDRIA; FATTY-ACID OXIDATION; TRANSLOCASE DEFICIENCY; UNIDIRECTIONAL TRANSPORT; HEART-MITOCHONDRIA; DIAGNOSIS; MECHANISM; PROTEIN; FIBROBLASTS	The carnitine-acylcarnitine carrier (CAC) catalyzes the translocation of long-chain fatty acids across the inner mitochondrial membrane. We cloned and sequenced the human CAC cDNA, which has an open reading frame of 903 nucleotides. Northern blot studies revealed different expression levels of CAC in various human tissues. Furthermore, mutation analysis was performed for a CAC-deficient infant. Direct sequencing of the patient's cDNA revealed a homozygous cytosine nucleotide insertion. This insertion provokes a frameshift and an extension of the open reading frame with 23 novel codons. This is the first report documenting a mutation, in the CAC cDNA, responsible for mitochondrial beta-oxidation impairment.	Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Amsterdam, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	Universita degli Studi di Bari Aldo Moro; Radboud University Nijmegen; University of Amsterdam; University of Amsterdam	Palmieri, F (corresponding author), Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, Via E Orabona 4, I-70125 Bari, Italy.		Smeitink, Jan/C-1351-2013; van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014; Iacobazzi, Vito/A-6106-2016; Huizing, Marjan/AAR-8860-2020	van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Iacobazzi, Vito/0000-0002-0470-2056; Indiveri, Cesare/0000-0001-9818-6621	Telethon [985] Funding Source: Medline	Telethon(Fondazione Telethon)		BRIVET M, 1994, J INHERIT METAB DIS, V17, P271, DOI 10.1007/BF00711805; Brivet M, 1996, J INHERIT METAB DIS, V19, P181, DOI 10.1007/BF01799424; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COATES PM, 1992, J LIPID RES, V33, P1099; CRABEEL M, 1996, J BIOL CHEM, V271, P5141; DEBAULNY HO, 1995, J PEDIATR-US, V127, P723, DOI 10.1016/S0022-3476(95)70160-5; DOLCE V, 1994, DNA SEQUENCE, V5, P103, DOI 10.3109/10425179409039711; DOLCE V, 1994, J BIOL CHEM, V269, P10451; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FERREIRA GC, 1989, J BIOL CHEM, V264, P15628; Iacobazzi V, 1992, DNA Seq, V3, P79, DOI 10.3109/10425179209034000; Iacobazzi V, 1997, DNA SEQUENCE, V7, P127, DOI 10.3109/10425179709034029; IDELLWENGER JA, 1981, J BIOL CHEM, V256, P5597; INDIVERI C, 1991, BIOCHIM BIOPHYS ACTA, V1069, P110, DOI 10.1016/0005-2736(91)90110-T; INDIVERI C, 1990, BIOCHIM BIOPHYS ACTA, V1020, P81, DOI 10.1016/0005-2728(90)90096-M; INDIVERI C, 1991, BIOCHIM BIOPHYS ACTA, V1065, P231, DOI 10.1016/0005-2736(91)90235-Z; Indiveri C, 1997, BIOCHEM J, V321, P713, DOI 10.1042/bj3210713; INDIVERI C, 1992, BIOCHIM BIOPHYS ACTA, V1140, P53, DOI 10.1016/0005-2728(92)90019-X; INDIVERI C, 1995, EUR J BIOCHEM, V228, P271; INDIVERI C, 1994, BBA-BIOMEMBRANES, V1189, P65, DOI 10.1016/0005-2736(94)90281-X; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; KELLY DP, 1994, NEW ENGL J MED, V330, P913; MURTHY MSR, 1984, J BIOL CHEM, V259, P9082; NIEZENKONING KE, 1995, J INHERIT METAB DIS, V18, P230, DOI 10.1007/BF00711775; OLPIN SE, 1992, J INHERIT METAB DIS, V15, P883, DOI 10.1007/BF01800227; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; PANDE SV, 1975, P NATL ACAD SCI USA, V72, P883, DOI 10.1073/pnas.72.3.883; PANDE SV, 1980, J BIOL CHEM, V255, P2994; PANDE SV, 1994, BBA-MOL BASIS DIS, V1226, P269, DOI 10.1016/0925-4439(94)90037-X; PANDE SV, 1993, J CLIN INVEST, V91, P1247, DOI 10.1172/JCI116288; POLLITT RJ, 1995, J INHERIT METAB DIS, V18, P473, DOI 10.1007/BF00710058; RAMSAY RR, 1975, FEBS LETT, V54, P21, DOI 10.1016/0014-5793(75)81059-3; Stanley C A, 1987, Adv Pediatr, V34, P59; STANLEY CA, 1992, NEW ENGL J MED, V327, P19, DOI 10.1056/NEJM199207023270104; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401	36	110	112	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1239	1245		10.1086/301628	http://dx.doi.org/10.1086/301628			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399886	Bronze, Green Published			2022-12-18	WOS:000071555900005
J	Cody, JD; Singer, FR; Roodman, GD; Otterund, B; Lewis, TB; Leppert, M; Leach, RJ				Cody, JD; Singer, FR; Roodman, GD; Otterund, B; Lewis, TB; Leppert, M; Leach, RJ			Genetic linkage of Paget disease of the bone to chromosome 18q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL EXPANSILE OSTEOLYSIS; GIANT-CELL TUMOR; NUCLEAR INCLUSIONS; OSTEOCLASTS; FEATURES; REGION	Paget disease is a common bone disease characterized by abnormal osteoclasts that are large, multinucleated, and overactive and that contain paramyxovirus-like nuclear inclusions. There is evidence for a major genetic component to Paget disease, with up to 40% of patients having affected first-degree relatives; however, the locus (loci) and-gene(s) involved are unknown. Another bone disorder, familial expansile osteolysis (FEO), although extremely rare, also is characterized by similar osteoclast abnormalities but has an earlier age at onset and a more aggressive clinical progression. The causative gene for FEO has been localized to a region of human chromosome 18q. On the basis of the presence of similar clinical findings and of viral-like nuclear inclusions in osteoclasts, we hypothesized that FEO and Paget disease are allelic versions of the same locus. Therefore, a large kindred with a high incidence of Paget disease was examined to determine if Paget disease was linked to genetic markers in the same region of chromosome 18 as that for FEO. Our analysis yielded a two-point LOD score of 3.40, with the genetic marker D18S42, a marker tightly linked to the FEO locus. This demonstrates that the gene(s) responsible for FEO and that for Paget disease are either closely linked or the same locus.	UNIV TEXAS, HLTH SCI CTR, DEPT CELLULAR & STRUCT BIOL, SAN ANTONIO, TX 78284 USA; UNIV TEXAS, HLTH SCI CTR, DEPT MED, SAN ANTONIO, TX 78284 USA; VET ADM MED CTR, DEPT MED, SAN ANTONIO, TX USA; ST JOHNS HOSP, JOHN WAYNE CANC INST, SANTA MONICA, CA USA; UNIV UTAH, SCH MED, ECCLES INST HUMAN GENET, DEPT HUMAN GENET, SALT LAKE CITY, UT USA; INDIANA UNIV, SCH MED, DEPT MED GENET, INDIANAPOLIS, IN 46204 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; John Wayne Cancer Institute; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University-Purdue University Indianapolis				Leach, Robin/0000-0002-3201-5579	NIAMS NIH HHS [P01AR39529] Funding Source: Medline; NIA NIH HHS [1P30AG1319] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039529] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARKER DJP, 1974, BRIT J PREV SOC MED, V28, P226; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENETON MNC, 1987, BONE, V8, P211, DOI 10.1016/8756-3282(87)90167-0; BIANCO P, 1992, VIRCHOWS ARCH A, V421, P427, DOI 10.1007/BF01606916; Cody JD, 1997, AM J MED GENET, V69, P280, DOI 10.1002/(SICI)1096-8628(19970331)69:3<280::AID-AJMG12>3.0.CO;2-N; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DICKSON GR, 1991, BONE, V12, P331, DOI 10.1016/8756-3282(91)90019-F; GHERARDI G, 1980, HISTOPATHOLOGY, V4, P63, DOI 10.1111/j.1365-2559.1980.tb02898.x; GORDON M, 1990, J BONE MINER RES, V5, pS272; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HAMDY RC, 1995, ENDOCRIN METAB CLIN, V24, P421, DOI 10.1016/S0889-8529(18)30047-1; HARVEY L, 1982, J CLIN PATHOL, V35, P771, DOI 10.1136/jcp.35.7.771; HASLAM SI, 1997, BONE, V20, P95; HUGHES AE, 1994, HUM MOL GENET, V3, P359, DOI 10.1093/hmg/3.2.359; HUGHES AE, 1996, MOL BIOL PAGETS DIS, P179; JACOBS TP, 1979, CANCER-AM CANCER SOC, V44, P742, DOI 10.1002/1097-0142(197908)44:2<742::AID-CNCR2820440247>3.0.CO;2-U; KLEIN RM, 1995, ENDOCRIN METAB CLIN, V24, P437, DOI 10.1016/S0889-8529(18)30048-3; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEBEAU MM, 1993, CYTOGENET CELL GENET, V63, P77, DOI 10.1159/000133508; MILLS BG, 1976, SCIENCE, V194, P201, DOI 10.1126/science.959849; MILLS BG, 1988, J BONE MINER RES, V3, P101; MIRRA JM, 1986, NEW ENGL J MED, V314, P105; MORALESPIGA AA, 1995, J BONE MINER RES, V10, P663; REBEL A, 1976, CALC TISS RES, V20, P187, DOI 10.1007/BF02546407; REBEL A, 1974, NOUV PRESSE MED, V3, P1299; REDDY SV, 1995, J CLIN ENDOCR METAB, V80, P2108, DOI 10.1210/jc.80.7.2108; Schmorl G, 1932, VIRCHOWS ARCH A, V283, P694, DOI 10.1007/BF01887990; Singer FR, 1996, TRENDS ENDOCRIN MET, V7, P258, DOI 10.1016/S1043-2760(96)00117-8; SIRIS ES, 1994, SEMIN ARTHRITIS RHEU, V23, P222, DOI 10.1016/0049-0172(94)90037-X; SOFAER JA, 1983, J EPIDEMIOL COMMUN H, V37, P226, DOI 10.1136/jech.37.3.226; VACHERLAVENU MC, 1981, CR ACAD SCI III-VIE, V293, P639; WALLACE RGH, 1989, CLIN ORTHOP RELAT R, P265; WELSH RA, 1970, LAB INVEST, V22, P63	33	110	110	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1117	1122		10.1086/301601	http://dx.doi.org/10.1086/301601			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345096	Bronze, Green Published			2022-12-18	WOS:A1997YH01700017
J	Pegoraro, E; Whitaker, J; MoweryRushton, P; Surti, U; Lanasa, M; Hoffman, EP				Pegoraro, E; Whitaker, J; MoweryRushton, P; Surti, U; Lanasa, M; Hoffman, EP			Familial skewed X inactivation: A molecular trait associated with high spontaneous-abortion rate maps to Xq28	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; CHROMOSOME INACTIVATION; CONTROLLING ELEMENTS; LINKED AGAMMAGLOBULINEMIA; INCONTINENTIA PIGMENTI; LETHAL ALLELES; GENE; CARRIERS; MOUSE; METHYLATION	We report a family ascertained for molecular diagnosis of muscular dystrophy in a young girl, in which preferential activation (greater than or equal to 95% of cells) of the paternal X chromosome was seen in both the proband and her mother. To determine the molecular basis for skewed X inactivation, we studied X-inactivation patterns in peripheral blood and/or oral mucosal cells from 50 members of this family and from a cohort of normal females. We found excellent concordance between X-inactivation patterns in blood and oral mucosal cell nuclei in all females. Of the 50 female pedigree members studied, 16 showed preferential use (greater than or equal to 95% cells) of the paternal X chromosome; none of 62 randomly selected females showed similarly skewed X inactivation (P <.0003). The trait for skewed X inactivation was maternally inherited in this family. A linkage study using the molecular trait of skewed X inactivation as the scored phenotype localized this trait to Xq28 (DXS1108; maximum LOD score [Z(max)] = 4.34, recombination fraction [theta] = 0). Both genotyping of additional markers and FISH of a YAC probe in Xq28 showed a deletion spanning from intron 22 of the factor VIII gene to DXS115-3. This deletion completely cosegregated with the trait (Z(max) = 6.92, theta = 0). Comparison of clinical findings between affected and unaffected females in the 50-member pedigree showed a statistically significant increase in spontaneous-abortion rate in the females carrying the trait (P <.02). To our knowledge, this is the first gene-mapping study of abnormalities of X-inactivation patterns and is the first association of a specific locus for recurrent spontaneous abortion in a cytogenetically normal family. The involvement of this locus in cell lethality, cell-growth disadvantage, developmental abnormalities, or the X-inactivation process is discussed.	UNIV PITTSBURGH, SCH MED, DEPT MOL GENET & BIOCHEM, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT HUMAN GENET, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT NEUROL, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, SCH MED, DEPT PEDIAT, PITTSBURGH, PA 15261 USA; UNIV PITTSBURGH, MAGEE WOMENS HOSP, DEPT PATHOL & GENET, PITTSBURGH, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh				Hoffman, Eric/0000-0001-6470-5139				ALLEN RC, 1994, AM J HUM GENET, V54, P25; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ALTERMAN LA, 1993, J IMMUNOL METHODS, V166, P111, DOI 10.1016/0022-1759(93)90334-4; ANTONARAKIS SE, 1995, HUM MUTAT, V5, P1, DOI 10.1002/humu.1380050102; AZOFEIFA J, 1995, HUM GENET, V96, P167, DOI 10.1007/BF00207374; CATTANACH BM, 1970, GENET RES, V15, P183, DOI 10.1017/S0016672300001518; CATTANACH BM, 1969, GENET RES, V14, P223, DOI 10.1017/S0016672300002068; CATTANACH BM, 1991, CYTOGENET CELL GENET, V56, P137, DOI 10.1159/000133070; CONLEY ME, 1990, J CLIN INVEST, V85, P1548, DOI 10.1172/JCI114603; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; DESAINTBASILE G, 1991, ANN HEMATOL, V63, P107, DOI 10.1007/BF01707282; DeSario A, 1996, P NATL ACAD SCI USA, V93, P1298, DOI 10.1073/pnas.93.3.1298; FAIN PR, 1995, NAT GENET, V9, P261, DOI 10.1038/ng0395-261; FREIJE D, 1992, AM J HUM GENET, V51, P66; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GOODSHIP J, 1988, LANCET, V1, P729; GOSDEN CM, 1992, HUMAN CYTOGENETICS P; HARRIS A, 1992, J MED GENET, V29, P608, DOI 10.1136/jmg.29.9.608; Hoffman E. P., 1995, American Journal of Human Genetics, V57, pA49; Hoffman EP, 1996, AM J MED GENET, V63, P573, DOI 10.1002/(SICI)1096-8628(19960628)63:4<573::AID-AJMG11>3.0.CO;2-F; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; KENWRICK S, 1992, HUM MOL GENET, V1, P179, DOI 10.1093/hmg/1.3.179; KOBAYASHI H, 1995, HUM GENET, V95, P483; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAWTON G, 1992, J ORAL PATHOL MED, V21, P265, DOI 10.1111/j.1600-0714.1992.tb01008.x; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; LYON MF, 1989, PROG NUCLEIC ACID RE, V36, P119; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MATTEI MG, 1982, HUM GENET, V61, P295; MIGEON BR, 1989, AM J HUM GENET, V44, P100; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NANCE WE, 1990, AM J HUM GENET, V46, P646; Naumova AK, 1996, AM J HUM GENET, V58, P1111; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P308; Ohno S., 1967, SEX CHROMOSOMES SEX; Orstavik KH, 1996, AM J MED GENET, V64, P31, DOI 10.1002/(SICI)1096-8628(19960712)64:1<31::AID-AJMG4>3.0.CO;2-U; PALMIERI G, 1994, GENOMICS, V24, P149, DOI 10.1006/geno.1994.1592; PEGORARO E, 1995, NEUROLOGY, V45, P677, DOI 10.1212/WNL.45.4.677; PEGORARO E, 1994, AM J HUM GENET, V54, P989; PUCK JM, 1992, AM J HUM GENET, V50, P742; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; ROTH DB, 1963, INT J FERTIL, V8, P431; SEABRIGH.M, 1971, LANCET, V2, P971; SIMMLER MC, 1993, MAMM GENOME, V4, P523, DOI 10.1007/BF00364788; STEPHAN DA, 1994, NEUROLOGY, V44, P1915, DOI 10.1212/WNL.44.10.1915; STIRRAT GM, 1990, LANCET, V336, P728, DOI 10.1016/0140-6736(90)92215-4; THODE A, 1988, AM J MED GENET, V30, P239, DOI 10.1002/ajmg.1320300125; Thomas GH, 1996, AM J HUM GENET, V58, P1364; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WARBURTON D, 1964, AM J HUM GENET, V16, P1; WELLS S, 1991, J MED GENET, V28, P163, DOI 10.1136/jmg.28.3.163	51	110	111	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1997	61	1					160	170		10.1086/513901	http://dx.doi.org/10.1086/513901			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XM728	9245997	Green Published, Bronze			2022-12-18	WOS:A1997XM72800024
J	Wong, ACC; Ning, Y; Flint, J; Clark, K; Dumanski, JP; Ledbetter, DH; McDermid, HE				Wong, ACC; Ning, Y; Flint, J; Clark, K; Dumanski, JP; Ledbetter, DH; McDermid, HE			Molecular characterization of a 130-kb terminal microdeletion at 22q in a child with mild mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSITU HYBRIDIZATION; ALPHA-THALASSEMIA; HUMAN PROACROSIN; ACROSIN ACTIVITY; HUMAN GENOME; CLONING; CHROMOSOMES; INFERTILITY; BREAKPOINT; LIBRARIES	We have analyzed a recently described 22q13.3 microdeletion in a child with some overlapping features of the cytologically visible 22q13.3 deletion syndrome. Patient NT, who shows mild mental retardation and delay of expressive speech, was previously found to have a paternal microdeletion in the subtelomeric region of 22q. In order to characterize this abnormality further, we have constructed a cosmid/P1 contig covering the terminal 150 kb of 22q, which encompasses the 130-kb microdeletion. The microdeletion breakpoint is within the VNTR locus D22S163. The cloning of the breakpoint sequence revealed that the broken chromosome end was healed by the addition of telomeric repeats, indicating that the microdeletion is terminal. This is the first cloned terminal deletion breakpoint on a human chromosome other than 16p. The cosmid/P1 contig was mapped by pulsed-field gel electrophoresis analysis to within 120 kb of the arylsulfatase A gene, which places the contig in relation to genetic and physical maps of the chromosome. The acrosin gene maps within the microdeletion, similar to 70 kb from the telomere. With the distal end of chromosome 22q cloned, it is now possible to isolate genes that may be involved in the overlapping phenotype of this microdeletion and 22q13.3 deletion syndrome.	UNIV ALBERTA,DEPT BIOL SCI,BIOL SCI CTR CW405,EDMONTON,AB T6G 2E9,CANADA; NIH,NATL CTR HUMAN GENOME RES,DIAGNOST DEV BRANCH,BETHESDA,MD 20892; JOHN RADCLIFFE HOSP,INST MOL MED,OXFORD OX3 9DU,ENGLAND; KAROLINSKA INST,DEPT MOL MED,CLIN GENET UNIT,STOCKHOLM,SWEDEN	University of Alberta; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Oxford; Karolinska Institutet				Dumanski, Jan Piotr/0000-0002-1489-1452				ARMOUR JAL, 1991, NUCLEIC ACIDS RES, V19, P3158, DOI 10.1093/nar/19.11.3158; ARMOUR JAL, 1990, GENOMICS, V8, P501, DOI 10.1016/0888-7543(90)90037-U; BABA T, 1989, FEBS LETT, V244, P296, DOI 10.1016/0014-5793(89)80549-6; COLLINS JE, 1995, NATURE S, V377, P267; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; DUMANSKI JP, 1991, GENOMICS, V11, P709, DOI 10.1016/0888-7543(91)90079-T; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; FLINT J, 1994, AM J HUM GENET, V55, P505; GREGER V, 1993, HUM MOL GENET, V2, P921, DOI 10.1093/hmg/2.7.921; HERZOG R, 1990, NUCLEIC ACIDS RES, V18, P6746, DOI 10.1093/nar/18.22.6746-a; HUBER I, 1994, HUM MOL GENET, V3, P1151, DOI 10.1093/hmg/3.7.1151; IJDO JW, 1991, P NATL ACAD SCI USA, V88, P9051, DOI 10.1073/pnas.88.20.9051; KLEMM U, 1991, HUM GENET, V87, P635; KOUKOULIS GN, 1989, FERTIL STERIL, V52, P120; KUWANO A, 1991, AM J HUM GENET, V49, P707; LAMB J, 1993, AM J HUM GENET, V52, P668; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; LIU DY, 1993, BIOL REPROD, V48, P340, DOI 10.1095/biolreprod48.2.340; MCDERMID HE, 1993, GENOMICS, V18, P308, DOI 10.1006/geno.1993.1470; MOHSENIAN M, 1982, FERTIL STERIL, V37, P223; NESSLINGER NJ, 1994, AM J HUM GENET, V54, P464; Ning Y, 1996, HUM GENET, V97, P765; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SPINNER NB, 1989, AM J HUM GENET, V44, P631; STEWART GD, 1985, NUCLEIC ACIDS RES, V13, P4125, DOI 10.1093/nar/13.11.4125; Takano H, 1993, ZYGOTE, V1, P79, DOI 10.1017/S0967199400001325; VAZQUEZLEVIN MH, 1992, EUR J BIOCHEM, V207, P23, DOI 10.1111/j.1432-1033.1992.tb17014.x; WEIER HUG, 1991, HUM GENET, V87, P489; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0	30	110	112	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					113	120						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981954				2022-12-18	WOS:A1997WA81800017
J	Labuda, M; Labuda, D; KorabLaskowska, M; Cole, DEC; Zietkiewicz, E; Weissenbach, J; Popowska, E; Pronicka, E; Root, AW; Glorieux, FH				Labuda, M; Labuda, D; KorabLaskowska, M; Cole, DEC; Zietkiewicz, E; Weissenbach, J; Popowska, E; Pronicka, E; Root, AW; Glorieux, FH			Linkage disequilibrium analysis in young populations: Pseudo vitamin D deficiency rickets and the founder effect in French Canadians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOMAL LOCATION; GENETIC CONTRIBUTION; ASHKENAZI JEWS; DISEASE GENE; D DEPENDENCY; MAP; QUEBEC; FINLAND; REGION; LOCI	Pseudo-vitamin D-deficiency rickets (PDDR) was mapped close to D12S90 and between proximal D12S312 and distal (D12S305,D12S104) microsatellites that were subsequently found on a single YAC clone. Analysis of a complex haplotype in linkage disequilibrium (LD) with the disease discriminated among distinct founder effects in French Canadian populations in Acadia and in Charlevoix-Saguenay-Lac-Saint-Jean (Ch-SLSJ), as well as an earlier one in precolonial Europe. A simple demographic model suggested the historical age of the founder effect in Ch-SLSJ to be similar to 12 generations. The corresponding LD data are consistent with this figure when they are analyzed within the framework of Luria-Delbruck model, which takes into account the population growth. Population sampling due to a limited number of first settlers and the rapid demographic expansion appear to have played a major role in the founding of PDDR in Ch-SLSJ and, presumably, other genetic disorders endemic to French Canada. Similarly, the founder effect in Ashkenazim, coinciding with their early settlement in medieval Poland and subsequent expansion eastward, could explain the origin of frequent genetic diseases in this population.	MCGILL UNIV,DEPT SURG,MONTREAL,PQ H3A 2T5,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL,PQ H3A 2T5,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ H3A 2T5,CANADA; UNIV MONTREAL,DEPT PEDIAT,MONTREAL,PQ H3C 3J7,CANADA; HOP ST JUSTINE,CTR RECH,CTR CANCEROL CHARLES BRUNEAU,MONTREAL,PQ H3T 1C5,CANADA; BANTING & BEST INST,DEPT CLIN BIOCHEM,TORONTO,ON,CANADA; GENETHON,CNRS URA 1922,EVRY,FRANCE; CENTRUM ZDROWIA DZIECKA,WARSAW,POLAND; UNIV S FLORIDA,TAMPA,FL	McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; University of Toronto; Centre National de la Recherche Scientifique (CNRS); Children's Memorial Health Institute; State University System of Florida; University of South Florida	Labuda, M (corresponding author), SHRINERS HOSP CRIPPLED CHILDREN,GENET UNIT,1529 CEDAR AVE,MONTREAL,PQ H3G 1A6,CANADA.		Zietkiewicz, Ewa/ABP-3539-2022	Zietkiewicz, Ewa/0000-0003-2437-5088; Pronicka, Ewa/0000-0002-5705-4814				ARSENAULT B, 1978, HIST ACADIENS; Beinart Haim, 1992, ATLAS MEDIEVAL JEWIS; BODMER WF, 1972, HISTOCOMPATIBILITY T, P611; BOUCHARD G, 1990, HIST UN GENOME, P21; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DAVIES N, 1984, GODS PLAYGROUND HIST; DEBRAEKELEER M, 1991, HUM HERED, V41, P141, DOI 10.1159/000153992; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DELVIN EE, 1981, J PEDIATR-US, V99, P26, DOI 10.1016/S0022-3476(81)80952-3; ELLIS NA, 1994, AM J HUM GENET, V55, P453; FRASER D, 1973, NEW ENGL J MED, V289, P717; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; Gauvreau D, 1991, HIST DUN GENOME, P145; GRAVEL RA, 1995, METABOLIC MOL BASIS, P2859; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING A, 1984, HEREDITARY ATAXIAS R; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEYER E, 1995, AM J HUM GENET, V56, P970; HEYER E, 1995, AM J HUM GENET, V56, P1450; Jennings HS, 1917, GENETICS, V2, P97; Jette R., 1991, HIST GENOME POPULATI, P75; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KORNFELD S, 1995, METABOLIC MOL BASES, P2495; KWIATKOWSKI DJ, 1993, AM J HUM GENET, V53, P1279; LABUDA M, 1990, AM J HUM GENET, V47, P28; LABUDA M, 1992, J BONE MINER RES, V7, P1447; LABUDA M, 1993, J BONE MINER RES, V8, P1397; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; Levy EN, 1996, AM J HUM GENET, V58, P523; LEVY HL, 1995, METABOLIC MOL BASES, P1107; Luria SE, 1943, GENETICS, V28, P491; Mitchell G, 1995, METABOLIC MOL BASES, P1077; MITCHISON HM, 1995, AM J HUM GENET, V56, P654; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; PRADER A, 1961, HELV PAEDIATR ACTA, V16, P452; RISCH N, 1995, NAT GENET, V11, P14, DOI 10.1038/ng0995-14; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROBBINS RB, 1917, GENETICS, V3, P375; SCOTT CR, 1995, METABOLIC MOL BASES, P1329; SERRE JL, 1990, HUM GENET, V84, P449; SULISALO T, 1994, AM J HUM GENET, V55, P937; TANAKA KR, 1995, METABOLIC MOL BASES, P3485; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Varilo T, 1996, AM J HUM GENET, V58, P506; WATKINS WS, 1994, AM J HUM GENET, V55, P348; 1984, CANADIAN ENCY, V1, P5	48	110	112	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					633	643						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751865				2022-12-18	WOS:A1996VN62500018
J	Juyal, RC; Figuera, LE; Hauge, X; Elsea, SH; Lupski, JR; Greenberg, F; Baldini, A; Patel, PI				Juyal, RC; Figuera, LE; Hauge, X; Elsea, SH; Lupski, JR; Greenberg, F; Baldini, A; Patel, PI			Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH DISEASE; CONTIGUOUS-GENE SYNDROME; HUMAN X-CHROMOSOME; DISTAL SHORT ARM; INTERSTITIAL DELETION; FREQUENT DELETIONS; (17)(P11.2P11.2); POLYMORPHISMS; CANDIDATE; MUTATION	Smith-Magenis syndrome (SMS) is a clinically recognizable, multiple congenital anomalies/mental retardation syndrome caused by an interstitial deletion involving band p11.2 of chromosome 17. Toward the molecular definition of the interval. defining this microdeletion syndrome, 62 unrelated SMS patients in conjunction with 70 available unaffected parents were molecularly analyzed with respect to the presence or absence of 14 loci in the proximal region of the short arm of chromosome 17. A multifaceted approach was used to determine deletion status at the various loci that combined (i) FISH analysis, (ii) PCR and Southern analysis of somatic cell hybrids retaining the deleted chromosome 17 from selected patients, and (iii) genotype determination of patients for whom a parent(s) was available at four microsatellite marker loci and at four loci with associated RFLPs. The relative order of two novel anonymous markers and a new microsatellite marker was determined in 17p11.2. The results confirmed that the proximal deletion breakpoint in the majority of SMS patients is located between markers D17S58 (EW301) and D17S446 (FG1) within the 17p11.1-17p11.2 region. The common distal. breakpoint was mapped between markers cCI17-638, which lies distal to D17S71, and cCI17-498, which lies proximal to the Charcot Marie-Tooth disease type 1A locus. The locus D17S258 was found to be deleted in all 62 patients, and probes from this region can be used for diagnosis of the SMS deletion by FISH. Ten patients demonstrated molecularly distinct deletions; of these, two patients had smaller deletions and will enable the definition of the critical interval for SMS.	BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DIV NEUROSCI,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Figuera, Luis E/V-8429-2017; genes, anthony/F-2541-2012; Baldini, Antonio/M-2355-2015; Patel, Pragna/H-9129-2017	Figuera, Luis E/0000-0002-6096-4579; Baldini, Antonio/0000-0002-5330-0256; Patel, Pragna/0000-0003-3584-1072; Elsea, Sarah/0000-0002-1400-8519	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028458] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00188] Funding Source: Medline; NICHD NIH HHS [HD28458] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN WP, 1991, P GREENWOOD GENET CT, V10, P18; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; CHEN KS, 1995, AM J HUM GENET, V56, P175; CHEVILLARD C, 1993, HUM MOL GENET, V2, P1235, DOI 10.1093/hmg/2.8.1235; COLLEY AF, 1990, J PAEDIATR CHILD H, V26, P17, DOI 10.1111/j.1440-1754.1990.tb02372.x; DERIJKVANANDEL JF, 1991, DEV MED CHILD NEUROL, V33, P343; ELSEA SH, 1995, AM J HUM GENET, V57, P1342; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FAN YS, 1994, AM J MED GENET, V49, P253, DOI 10.1002/ajmg.1320490220; FINUCANE BM, 1993, AM J MED GENET, V45, P447, DOI 10.1002/ajmg.1320450410; FINUCANE BM, 1993, AM J MED GENET, V45, P443, DOI 10.1002/ajmg.1320450409; FINUCANE BM, 1994, DEV MED CHILD NEUROL, V36, P78; FRANCO B, 1990, NUCLEIC ACIDS RES, V18, P7196, DOI 10.1093/nar/18.23.7196-a; GERKEN SC, 1995, AM J HUM GENET, V56, P484; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GREENBERG F, IN PRESS AM J MED GE; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAMILL MA, 1988, ANN GENET-PARIS, V31, P36; IJDO JW, 1992, GENOMICS, V14, P1019, DOI 10.1016/S0888-7543(05)80125-9; INAZAWA J, 1993, GENOMICS, V17, P153, DOI 10.1006/geno.1993.1297; JUYAL RC, 1995, AM J MED GENET, V58, P286, DOI 10.1002/ajmg.1320580317; JUYAL RC, 1995, AM J MED GENET, V59, P406, DOI 10.1002/ajmg.1320590332; KALLIONIEMI OP, 1994, GENOMICS, V20, P125, DOI 10.1006/geno.1994.1138; KONDO I, 1991, AM J MED GENET, V41, P225, DOI 10.1002/ajmg.1320410219; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LOCKWOOD D, 1988, J MED GENET, V25, P732, DOI 10.1136/jmg.25.11.732; MONCLA A, 1993, HUM GENET, V90, P657; MONCLA A, 1991, J MED GENET, V28, P627, DOI 10.1136/jmg.28.9.627; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PATIL SR, 1984, HUM GENET, V67, P237, DOI 10.1007/BF00273011; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; RAY R, 1990, NUCLEIC ACIDS RES, V18, P4958, DOI 10.1093/nar/18.16.4958; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; Sambrook J, 1989, MOL CLONING LAB MANU; Smith A.C.M.M.L., 1982, AM J HUM GENET, V34; SMITH ACM, 1986, AM J MED GENET, V24, P393, DOI 10.1002/ajmg.1320240303; STRATTON RF, 1986, AM J MED GENET, V24, P421, DOI 10.1002/ajmg.1320240305; SUTER U, 1994, J BIOL CHEM, V269, P25795; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; YUAN Y, 1989, BIOCHIM BIOPHYS ACTA, V1008, P14, DOI 10.1016/0167-4781(89)90164-4; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589; ZORI RT, 1993, AM J MED GENET, V47, P504, DOI 10.1002/ajmg.1320470414	49	110	112	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					998	1007						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651284				2022-12-18	WOS:A1996UH19200012
J	KLITZ, W; STEPHENS, JC; GROTE, M; CARRINGTON, M				KLITZ, W; STEPHENS, JC; GROTE, M; CARRINGTON, M			DISCORDANT PATTERNS OF LINKAGE DISEQUILIBRIUM OF THE PEPTIDE-TRANSPORTER LOCI WITHIN THE HLA CLASS-II REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GENE CONVERSION; MHC; POLYMORPHISM; EVOLUTION; RECOMBINATION; POPULATION; VARIANTS; ALLELES	Disequilibrium between genetic markers is expected to decline monotonically with recombinational map distance. We present evidence from the HLA class II region that seems to violate this principle. Pairwise disequilibrium values were calculated for six loci ranging in physical separation from 15 kb to 550 kb. The histocompatibility Loci DRB1, DQA1, and DQB1, located on the distal end of the class II region, behave as a single evolutionary unit within which extremely high linkage disequilibrium exists. Lower but still significant levels of disequilibrium are present between these loci and DPB1, located at the proximal edge of the HLA complex. The peptide-transporter loci TAP1 and TAP2, located in the intervening region, reveal no disequilibrium with each other and low or negligible disequilibrium with the flanking loci. The action of two genetic processes is required to account for this phenomenon: a recombinational hotspot operating between TAP1 and TAP2, to eliminate disequilibrium between these loci, and at the same time selection operating on particular combinations of alleles across the DR-DP region, to create disequilibrium in the favored haplotypes. The forces producing the patterns of disequilibrium observed here have implications for the mapping of trait loci and disease genes: markers of TAP1, for example, would give a false impression as to the influence of DPB1 on a trait known to be associated with DQB1.	NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC DYNCORP,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	KLITZ, W (corresponding author), UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,3060 VALLEY LIFE SCI,BERKELEY,CA 94720, USA.				NIGMS NIH HHS [GM07127, GM35326] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007127, R01GM035326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BUGAWAN TL, 1994, AM J HUM GENET, V54, P331; CARRINGTON M, 1993, IMMUNOGENETICS, V37, P266; CARRINGTON M, 1994, HUM IMMUNOL, V41, P234, DOI 10.1016/0198-8859(94)90041-8; COHEN J, 1988, STATISTICAL POWER AN; COLONNA M, 1992, P NATL ACAD SCI USA, V89, P3932, DOI 10.1073/pnas.89.9.3932; CULLEN M, 1995, AM J HUM GENET, V56, P1350; DECAMPOSLIMA PO, 1993, SCIENCE, V260, P98, DOI 10.1126/science.7682013; DEVRIES RRP, 1989, IMMUNOBIOLOGY HLA, V2, P461; ERLICH HA, 1991, HUM IMMUNOL, V30, P110, DOI 10.1016/0198-8859(91)90079-O; GYLLENSTEN UB, 1989, P NATL ACAD SCI USA, V86, P9986, DOI 10.1073/pnas.86.24.9986; HEDRICK PW, 1991, EVOLUTION AT THE MOLECULAR LEVEL, P248; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HOWARD JC, 1993, P NATL ACAD SCI USA, V90, P3777, DOI 10.1073/pnas.90.9.3777; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HYNAM GE, 1970, SELECTED TABLES MATH; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JORDE LB, 1993, AM J HUM GENET, V53, P1038; JORDE LB, 1994, AM J HUM GENET, V54, P884; KENDALL MG, 1979, ADV THEORY STATISTIC, V2; KLEIN J, 1990, IMMUNOL REV, V113, P27; KLITZ W, 1986, AM J HUM GENET, V39, P340; KLITZ W, 1992, EVOL BIOL, V26, P35; KLITZ W, 1987, GENETICS, V116, P633; KUHNER M, 1990, GENETICS, V126, P1115; KUHNER MK, 1991, TISSUE ANTIGENS, V38, P152, DOI 10.1111/j.1399-0039.1991.tb01889.x; KWOK WW, 1993, J IMMUNOL, V150, P2263; MANTEL N, 1967, CANCER RES, V27, P209; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; POWIS SH, 1992, P NATL ACAD SCI USA, V99, P1463; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; RONNINGEN KS, 1990, HUM IMMUNOL, V29, P275, DOI 10.1016/0198-8859(90)90041-M; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; THOMSON G, 1992, HLA 1991, P485; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; UEMATSU Y, 1988, IMMUNOGENETICS, V27, P96, DOI 10.1007/BF00351082; VANENDERT PM, 1992, P NATL ACAD SCI USA, V89, P11594, DOI 10.1073/pnas.89.23.11594; WATTERSON GA, 1978, GENETICS, V88, P405; WEIR BS, 1978, GENETICS, V88, P633	44	110	110	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1436	1444						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533774				2022-12-18	WOS:A1995TE65500022
J	VANDYKE, DL; WEISS, L; ROBERSON, JR; BABU, VR				VANDYKE, DL; WEISS, L; ROBERSON, JR; BABU, VR			THE FREQUENCY AND MUTATION-RATE OF BALANCED AUTOSOMAL REARRANGEMENTS IN MAN ESTIMATED FROM PRENATAL GENETIC-STUDIES FOR ADVANCED MATERNAL AGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											VANDYKE, DL (corresponding author), HENRY FORD HOSP,CTR MED GENET & BIRTH DEFECTS,DETROIT,MI 48202, USA.							ADAMS MM, 1981, AM J OBSTET GYNECOL, V139, P673, DOI 10.1016/0002-9378(81)90483-X; Boue A, 1981, CHROMOSOMES TODAY, V7, P281; BUCKTON KE, 1980, ANN HUM GENET, V43, P227, DOI 10.1111/j.1469-1809.1980.tb01556.x; CHANDLEY AC, 1979, BRIT MED BULL, V35, P181, DOI 10.1093/oxfordjournals.bmb.a071567; CRANDALL BF, 1980, AM J MED GENET, V5, P345, DOI 10.1002/ajmg.1320050405; FRACCARO M, 1973, LANCET, V1, P488; FRIEDRICH U, 1973, CLIN GENET, V4, P333; GOLBUS MS, 1979, NEW ENGL J MED, V300, P157, DOI 10.1056/NEJM197901253000402; HAMERTON JL, 1975, CLIN GENET, V8, P223; HOOK EB, 1981, NEW ENGL J MED, V305, P1410, DOI 10.1056/NEJM198112033052312; Hook EB, 1977, POPULATION CYTOGENET, P63; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; JACOBS PA, 1972, ANN HUM GENET, V35, P301, DOI 10.1111/j.1469-1809.1957.tb01403.x; JACOBS PA, 1981, AM J HUM GENET, V33, P44; LIN CC, 1976, HUM GENET, V31, P315, DOI 10.1007/BF00270861; LUBS HA, 1970, SCIENCE, V169, P495, DOI 10.1126/science.169.3944.495; MARION JP, 1980, AM J OBSTET GYNECOL, V138, P11, DOI 10.1016/0002-9378(80)90004-6; NIELSEN J, 1975, HUMANGENETIK, V30, P1, DOI 10.1007/BF00273626; NIELSEN J, 1982, HEREDITAS, V96, P109, DOI 10.1111/j.1601-5223.1982.tb00042.x; Palmer C G, 1969, J Med Genet, V6, P166, DOI 10.1136/jmg.6.2.166; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; SOKAL DC, 1980, JAMA-J AM MED ASSOC, V244, P1355, DOI 10.1001/jama.244.12.1355; Sokal R.R., 1969, BIOMETRY PRINCIPLES, Vsecond; VANDYKE DL, 1980, J HISTOTECHNOL, V3, P148; Walzer S, 1977, POPULATION CYTOGENET, P45; YUNIS JJ, 1981, NEW ENGL J MED, V305, P135, DOI 10.1056/NEJM198107163050304; ZUFFARDI O, 1975, J GENET HUM, V23, P347	27	110	113	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	2					301	308						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QJ265	6837576				2022-12-18	WOS:A1983QJ26500012
J	LATT, SA; SCHRECK, RR				LATT, SA; SCHRECK, RR			SISTER CHROMATID EXCHANGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review									BOSTON HOSP WOMEN,DIV GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,CAMBRIDGE,MA 02138	Harvard University	LATT, SA (corresponding author), CHILDRENS HOSP MED CTR,CTR MENTAL RETARDAT,DIV GENET,BOSTON,MA 02115, USA.							ABE S, 1977, J NATL CANCER I, V58, P1635, DOI 10.1093/jnci/58.6.1635; ABRAMOVSKY I, 1978, MUTAT RES, V50, P93, DOI 10.1016/0027-5107(78)90064-7; ALLEN JW, 1976, NATURE, V260, P449, DOI 10.1038/260449a0; ALLEN JW, 1978, SOMAT CELL GENET, V4, P393, DOI 10.1007/BF01538862; ALLEN JW, 1976, CHROMOSOMA, V58, P325, DOI 10.1007/BF00292841; ALLEN JW, 1979, CHROMOSOMA, V74, P189, DOI 10.1007/BF00292272; AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; ANGELL RR, 1975, CHROMOSOMA, V51, P301, DOI 10.1007/BF00326317; AUERBACH AD, 1978, NATURE, V271, P69, DOI 10.1038/271069a0; AUERBACH AD, 1979, AM J HUM GENET, V31, P77; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; BALABANMALENBAU.G, 1978, AM J HUM GENET, V29, pA21; BARTRAM CR, 1979, HUM GENET, V46, P331, DOI 10.1007/BF00273317; BARTRAM CR, 1976, ANN HUM GENET, V40, P79, DOI 10.1111/j.1469-1809.1976.tb00166.x; BASLER A, 1979, MUTAT RES, V59, P209, DOI 10.1016/0027-5107(79)90159-3; BLOOM S, 1978, MUTAGENS 5, V5, P203; BLOOM SE, 1975, CHROMOSOMA, V51, P261; BOSTOCK CJ, 1976, CHROMOSOMA, V56, P275, DOI 10.1007/BF00293191; BREWEN JG, 1969, MUTAT RES, V7, P433, DOI 10.1016/0027-5107(69)90114-6; BRYANT EM, 1979, NATURE, V279, P795, DOI 10.1038/279795a0; BURKHOLDER GD, 1978, EXP CELL RES, V111, P489, DOI 10.1016/0014-4827(78)90199-4; CARRANO AV, 1978, NATURE, V271, P551, DOI 10.1038/271551a0; CARRANO AV, 1975, CHROMOSOMA, V53, P361, DOI 10.1007/BF00294083; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; CHEN PC, 1978, NATURE, V274, P484, DOI 10.1038/274484a0; CHENG WS, 1978, CANCER RES, V38, P1601; CROSSEN PE, 1977, HUM GENET, V35, P345, DOI 10.1007/BF00446625; DEWEERDKASTELEIN EA, 1977, MUTAT RES, V45, P253, DOI 10.1016/0027-5107(77)90025-2; EVANS HJ, 1978, CYTOGENET CELL GENET, V20, P124, DOI 10.1159/000130844; FINKELBERG R, 1977, AM J HUM GENET, V29, pA42; FUJIWARA Y, 1975, BIOCHEM BIOPH RES CO, V66, P592, DOI 10.1016/0006-291X(75)90551-3; FUJIWARA Y, 1977, J MOL BIOL, V113, P634; FUNESCRAVIOTO F, 1977, LANCET, V2, P322; GALLOWAY SM, 1975, EXP CELL RES, V94, P454, DOI 10.1016/0014-4827(75)90517-0; GALLOWAY SM, 1975, CYTOGENET CELL GENET, V15, P17, DOI 10.1159/000130495; GALLOWAY SM, 1977, MUTAT RES, V45, P343, DOI 10.1016/0027-5107(77)90144-0; GALLOWAY SM, 1979, MUTAT RES, V60, P321, DOI 10.1016/0027-5107(79)90022-8; GATTI M, 1979, GENETICS, V91, P255; GERMAN J, 1972, PROG MED GENET, V8, P61; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GIANNELLI F, 1977, NATURE, V265, P466, DOI 10.1038/265466a0; GIBAS Z, 1978, CHROMOSOMA, V69, P113, DOI 10.1007/BF00327385; GIBSON DA, 1972, EXP CELL RES, V74, P397, DOI 10.1016/0014-4827(72)90393-X; GOTHGOLDSTEIN R, 1977, NATURE, V267, P81, DOI 10.1038/267081a0; GOTO K, 1978, CHROMOSOMA, V66, P351, DOI 10.1007/BF00328535; GOTO K, 1975, CHROMOSOMA, V53, P223, DOI 10.1007/BF00329173; GRATZNER HG, 1976, J HISTOCHEM CYTOCHEM, V24, P34, DOI 10.1177/24.1.815428; HAND R, 1977, HUM GENET, V38, P297, DOI 10.1007/BF00402156; HATCHER NH, 1976, MUTAT RES, V35, P333, DOI 10.1016/0027-5107(76)90197-4; HOEHN H, 1974, PEDIATR RES, V8, P746; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HSU TC, 1976, CHROMOSOMA, V58, P269, DOI 10.1007/BF00292093; HUANG CC, 1967, CHROMOSOMA, V23, P162; HUANG CC, 1978, EXP CELL RES, V111, P458, DOI 10.1016/0014-4827(78)90191-X; HUTTEROTH TH, 1975, J CLIN INVEST, V56, P1, DOI 10.1172/JCI108058; ISHIDATE M, 1977, MUTAT RES, V48, P337, DOI 10.1016/0027-5107(77)90177-4; ISHII Y, 1978, MUTAT RES, V51, P419, DOI 10.1016/0027-5107(78)90130-6; ISHII Y, 1978, MUTAT RES, V51, P411, DOI 10.1016/0027-5107(78)90129-X; JACOBS MM, 1977, CANCER, V40, P2557, DOI 10.1002/1097-0142(197711)40:5+<2557::AID-CNCR2820400925>3.0.CO;2-T; KATO H, 1974, NATURE, V251, P70, DOI 10.1038/251070a0; KATO H, 1977, CHROMOSOMA, V59, P179, DOI 10.1007/BF00292776; KATO H, 1974, NATURE, V252, P739, DOI 10.1038/252739a0; KATO H, 1974, EXP CELL RES, V85, P239, DOI 10.1016/0014-4827(74)90123-2; KATO H, 1973, EXP CELL RES, V82, P382; KAUFMAN E R, 1979, Journal of Cell Biology, V83, p443A; KIM MA, 1974, HUMANGENETIK, V25, P179, DOI 10.1007/BF00281425; KINSELLA AR, 1978, P NATL ACAD SCI USA, V75, P6149, DOI 10.1073/pnas.75.12.6149; KLIGERMAN AD, 1976, CHROMOSOMA, V56, P101, DOI 10.1007/BF00293110; KNUUTILA S, 1978, HEREDITAS, V89, P175; KORENBERG JR, 1974, CHROMOSOMA, V48, P355, DOI 10.1007/BF00290992; KRAM D, 1978, EXP CELL RES, V114, P471, DOI 10.1016/0014-4827(78)90512-8; KRAM D, 1979, NATURE, V279, P531, DOI 10.1038/279531a0; KREPINSKY AB, 1979, 10TH ANN M ENV MUT S; KUHN EM, 1978, CHROMOSOMA, V66, P287, DOI 10.1007/BF00330557; KURNIT DM, 1979, HUM GENET, V47, P169, DOI 10.1007/BF00273199; KURVINK K, 1978, HUM GENET, V44, P137, DOI 10.1007/BF00295406; LAMBERT B, 1978, HEREDITAS, V88, P147; LATT SA, 1974, EXP CELL RES, V87, P425, DOI 10.1016/0014-4827(74)90510-2; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LATT SA, 1978, CYTOGENET CELL GENET, V21, P184, DOI 10.1159/000130896; LATT SA, 1975, J HISTOCHEM CYTOCHEM, V23, P493, DOI 10.1177/23.7.1095650; LATT SA, 1975, P NATL ACAD SCI USA, V72, P4066, DOI 10.1073/pnas.72.10.4066; LATT SA, 1974, SCIENCE, V185, P74, DOI 10.1126/science.185.4145.74; LATT SA, 1974, P NATL ACAD SCI USA, V71, P3162, DOI 10.1073/pnas.71.8.3162; LATT SA, ADV HUM GENET; LATT SA, 1980, CYTOGENETIC TESTING; LIN MS, 1974, EXP CELL RES, V86, P392, DOI 10.1016/0014-4827(74)90727-7; LIN MS, 1977, CHROMOSOMA, V60, P15, DOI 10.1007/BF00330407; LOVEDAY KS, 1978, NUCLEIC ACIDS RES, V5, P4087, DOI 10.1093/nar/5.11.4087; LOVEDAY KS, 1979, MUTAT RES, V67, P343, DOI 10.1016/0165-1218(79)90030-2; MACRAE WD, 1979, CHROMOSOMA, V72, P15, DOI 10.1007/BF00286427; MAHER VM, 1976, NATURE, V261, P593, DOI 10.1038/261593a0; MARTIN CN, 1978, CANCER RES, V38, P2621; MAZRIMAS JA, 1978, EXP CELL RES, V117, P23, DOI 10.1016/0014-4827(78)90423-8; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; MEYN MS, 1977, P NATL ACAD SCI USA, V74, P1152, DOI 10.1073/pnas.74.3.1152; MOORE PD, 1976, CELL, V8, P573, DOI 10.1016/0092-8674(76)90225-7; NAGASAWA H, 1979, P NATL ACAD SCI USA, V76, P1943, DOI 10.1073/pnas.76.4.1943; NICHOLS WW, 1978, CANCER RES, V38, P960; NORDENSON I, 1977, HEREDITAS, V87, P151; NOVOTNA B, 1979, HUM GENET, V49, P41; OTTER M, 1978, CANCER RES, V19; PATTERSON MC, 1976, NATURE, V260, P444; PEACOCK WJ, 1970, GENETICS, V65, P593; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; PERRY P, 1975, NATURE, V258, P121, DOI 10.1038/258121a0; PERRY P, 1980, CHEM MUTAGENS, V6; POLANI PE, 1979, NATURE, V278, P348, DOI 10.1038/278348a0; POPESCU NC, 1977, J NATL CANCER I, V59, P289, DOI 10.1093/jnci/59.1.289; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; RAPOSA T, 1978, MUTAT RES, V57, P241, DOI 10.1016/0027-5107(78)90274-9; REGAN JD, 1971, SCIENCE, V174, P147, DOI 10.1126/science.174.4005.147; ROMMELAERE J, 1975, J MOL BIOL, V98, P195, DOI 10.1016/S0022-2836(75)80109-4; ROSIN MP, 1978, MUTAT RES, V54, P73, DOI 10.1016/0165-1161(78)90137-1; SAKANISHI SI, 1978, EXP CELL RES, V115, P448, DOI 10.1016/0014-4827(78)90306-3; SASAKI MS, 1973, CANCER RES, V33, P1829; SCHERES JMJC, 1977, EXP CELL RES, V109, P466, DOI 10.1016/0014-4827(77)90031-3; SCHNEIDER EL, 1979, HUM GENET, V46, P57, DOI 10.1007/BF00278902; SCHONWALD AD, 1977, HUM GENET, V36, P213, DOI 10.1007/BF00273260; SHAFER DA, 1977, HUM GENET, V39, P177, DOI 10.1007/BF00287010; SHIRISASHI Y, 1978, MUTAT RES, V49, P239; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; STETKA DG, 1976, MUTAT RES, V41, P343, DOI 10.1016/0027-5107(76)90107-X; STETKA DG, 1979, HUM GENET, V49, P63; STETKA DG, 1978, MUTAT RES, V51, P383, DOI 10.1016/0027-5107(78)90126-4; SWIFT M, 1976, CANCER RES, V36, P209; SWIFT M, 1971, NATURE, V230, P370, DOI 10.1038/230370a0; SWIFT M, 1977, GENETICS HUMAN CANCE, P209; TAKAYAMA S, 1977, CHROMOSOMA, V64, P109, DOI 10.1007/BF00327050; TAYLOR JH, 1965, J CELL BIOL, V25, P57, DOI 10.1083/jcb.25.2.57; TAYLOR JH, 1957, P NATL ACAD SCI USA, V43, P122, DOI 10.1073/pnas.43.1.122; TEASE C, 1978, NATURE, V272, P823, DOI 10.1038/272823a0; TEASE C, 1978, CHROMOSOMA, V69, P163, DOI 10.1007/BF00329915; TICE R, 1978, NATURE, V273, P538, DOI 10.1038/273538a0; TICE R, 1975, NATURE, V256, P642, DOI 10.1038/256642a0; UMEZAWA K, 1979, CHEM-BIOL INTERACT, V24, P107, DOI 10.1016/0009-2797(79)90106-6; van Buul P P, 1978, Hum Genet, V44, P187; VOGEL W, 1976, NATURE, V260, P448, DOI 10.1038/260448a0; WAKSVIK H, 1977, HUM GENET, V38, P195, DOI 10.1007/BF00527403; WATERS R, 1978, BIOCHEM BIOPH RES CO, V83, P536, DOI 10.1016/0006-291X(78)91023-9; WOLFF S, 1974, MUTAT RES, V25, P73, DOI 10.1016/0165-1218(74)90082-2; WOLFF S, 1977, ANNU REV GENET, V11, P183, DOI 10.1146/annurev.ge.11.120177.001151; WOLFF S, 1975, EXP CELL RES, V93, P23, DOI 10.1016/0014-4827(75)90418-8; WOLFF S, 1977, NATURE, V265, P345; YU CW, 1977, CLIN GENET, V11, P397; ZAKHAROV AF, 1972, CHROMOSOMA, V38, P341, DOI 10.1007/BF00320156	146	110	112	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	3					297	313						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JX059	6992563				2022-12-18	WOS:A1980JX05900001
J	KRAVITZ, K; SKOLNICK, M; CANNINGS, C; CARMELLI, D; BATY, B; AMOS, B; JOHNSON, A; MENDELL, N; EDWARDS, C; CARTWRIGHT, G				KRAVITZ, K; SKOLNICK, M; CANNINGS, C; CARMELLI, D; BATY, B; AMOS, B; JOHNSON, A; MENDELL, N; EDWARDS, C; CARTWRIGHT, G			GENETIC-LINKAGE BETWEEN HEREDITARY HEMOCHROMATOSIS AND HLA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710; UNIV UTAH,MED CTR,DEPT INTERNAL MED,SALT LAKE CITY,UT 84132; UNIV SHEFFIELD,DEPT PROBABIL & STAT,SHEFFIELD S3 7RH,S YORKSHIRE,ENGLAND	Duke University; Utah System of Higher Education; University of Utah; University of Sheffield	KRAVITZ, K (corresponding author), UNIV UTAH,MED CTR,DEPT MED BIOPHYS & COMPUTING,SALT LAKE CITY,UT 84132, USA.			Baty, Bonnie/0000-0001-5478-6078				ALBERT E, 1978, HISTOCOMPATIBILITY T, P14; AMOS DB, 1969, TRANSPLANTATION, V7, P220, DOI 10.1097/00007890-196903000-00023; AMOS DB, 1975, HISTOCOMPATIBILITY T, P5; AMOS DB, 1976, MANUAL CLIN IMMUNOLO, P797; BALCERZAK SP, 1966, AM J MED, V40, P857, DOI 10.1016/0002-9343(66)90201-4; BEAMISH MR, 1974, BRIT J HAEMATOL, V27, P219, DOI 10.1111/j.1365-2141.1974.tb06788.x; BODMER WF, 1973, HISTOCOMPATIBILITY T, P611; BOMFORD A, 1977, LANCET, V1, P327; BOTHWELL TH, 1959, AM J MED, V27, P730, DOI 10.1016/0002-9343(59)90189-5; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1976, ADV APPL PROBAB, V8, P622, DOI 10.2307/1425918; CANNINGS C, 1977, CLIN GENET, V12, P208; CARTER CO, 1961, BRIT MED B, V17, P51; Cartwright G E, 1978, Trans Assoc Am Physicians, V91, P273; CARTWRIGHT GE, 1968, DIAGNOSTIC LABORATOR; CONTE M, 1958, Bull Mem Soc Med Hop Paris, V74, P267; CROSBY WH, 1977, SEMIN HEMATOL, V14, P135; DAVISON RH, 1961, BMJ-BRIT MED J, V2, P1262, DOI 10.1136/bmj.2.5262.1262; DEBRE R, 1958, ANN HUM GENET, V23, P16, DOI 10.1111/j.1469-1809.1958.tb01438.x; DREYFUS JC, 1964, IRON METABOLISM, P296; DYRSZKA H, 1978, GASTROENTEROLOGY, V75, P555; EDWARDS CQ, 1977, NEW ENGL J MED, V297, P7, DOI 10.1056/NEJM197707072970102; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FELLER ER, 1977, NEW ENGL J MED, V296, P1422, DOI 10.1056/NEJM197706232962501; FELTS JH, 1967, ANN INTERN MED, V67, P117, DOI 10.7326/0003-4819-67-1-117; FINCH SC, 1955, MEDICINE, V34, P381, DOI 10.1097/00005792-195512000-00001; GRACE ND, 1974, GASTROENTEROLOGY, V67, P1257; HEUCH I, 1975, CLIN GENET, V3, P501; KRAVITZ K, 1979, 9 U UT DEP MED BIOPH; KRAVITZ K, 1978, GENETIC EPIDEMIOLOGY, P241; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LESIEUR M, 1950, ARCH MAL APPAR DIG, V39, P960; MALECOT G, 1966, PROBABILITES HEREDIT; MCDEVITT HO, 1972, AM J MED, V52, P1, DOI 10.1016/0002-9343(72)90002-2; MCDEVITT HO, 1974, LANCET, V1, P1269; MORGAN EH, 1961, AUSTRALAS ANN MED, V10, P114, DOI 10.1111/imj.1961.10.2.114; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1962, METHODOLOGY HUMAN GE; MORTON NE, 1969, COMPUTER APPLICATION; MUIR WA, 1978, AM J HUM GENET, V30, pA61; NUSSBAUMER TT, 1955, J GENET HUM, V1, P139; OTT J, 1974, AM J HUM GENET, V26, P588; POWELL LW, 1975, ARCH INTERN MED, V135, P1269, DOI 10.1001/archinte.1975.00330090141019; RAY JG, 1974, NIH75545 HEW PUBL; ROWE JW, 1977, MEDICINE, V56, P197, DOI 10.1097/00005792-197705000-00002; SADDI R, 1974, CLIN GENET, V5, P234; SCHEINBERG IH, 1973, ARCH INTERN MED, V132, P126, DOI 10.1001/archinte.132.1.126; SHEWAN WG, 1976, BMJ-BRIT MED J, V1, P281, DOI 10.1136/bmj.1.6004.281-b; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332; SIMON M, 1977, CLIN GENET, V11, P327; SIMON M, 1975, NOUV PRESSE MED, V4, P1432; SUTTER J, 1962, POPULATION, V17, P683, DOI 10.2307/1526249; THOMPSON EA, 1979, GENETIC ANAL COMMON; THOMPSON EA, 1977, 5 U UT DEP MED BIOPH; THOMSON G, 1976, POPULATION GENETICS, P465; WALTERS JM, 1975, BMJ-BRIT MED J, V4, P520, DOI 10.1136/bmj.4.5995.520-b; WANDS JR, 1976, NEW ENGL J MED, V294, P302, DOI 10.1056/NEJM197602052940603; WARD FE, 1978, HISTOCOMPATIBILITY T; WILLIAMS R, 1962, Q J MED, V31, P249	61	110	110	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	5					601	619						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HS030	507053				2022-12-18	WOS:A1979HS03000010
J	Li, D; Yuan, HJ; Ortiz-Gonzalez, XR; Marsh, ED; Tian, LF; McCormick, EM; Kosobucki, GJ; Chen, WJ; Schulien, AJ; Chiavacci, R; Tankovic, A; Naase, C; Brueckner, F; von Stulpnagel-Steinbeis, C; Hu, C; Kusumoto, H; Hedrich, UBS; Elsen, G; Hortnagel, K; Aizenman, E; Lemke, JR; Hakonarson, H; Traynelis, SF; Falk, MJ				Li, Dong; Yuan, Hongjie; Ortiz-Gonzalez, Xilma R.; Marsh, Eric D.; Tian, Lifeng; McCormick, Elizabeth M.; Kosobucki, Gabrielle J.; Chen, Wenjuan; Schulien, Anthony J.; Chiavacci, Rosetta; Tankovic, Anel; Naase, Claudia; Brueckner, Frieder; von Stuelpnagel-Steinbeis, Celina; Hu, Chun; Kusumoto, Hirofumi; Hedrich, Ulrike B. S.; Elsen, Gina; Hoertnagel, Konstanze; Aizenman, Elias; Lemke, Johannes R.; Hakonarson, Hakon; Traynelis, Stephen F.; Falk, Marni J.			GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENDELIAN DISORDERS; SPECTRUM DISORDERS; SEQUENCING DATA; FOCAL EPILEPSY; QUINIDINE; MEMANTINE; CHILDREN; SUBUNITS; THERAPY; APHASIA	N-methyl-D-aspartate receptors (NMDARs) are ligand-gated cation channels that mediate excitatory synaptic transmission. Genetic mutations in multiple NMDAR subunits cause various childhood epilepsy syndromes. Here, we report a de novo recurrent heterozygous missense mutation-c.1999G>A (p.Val667Ile) in a NMDAR gene previously unrecognized to harbor disease causing mutations, GRIN2D, identified by exome and candidate panel sequencing in two unrelated children with epileptic encephalopathy. The resulting GluN2D p.Val667Ile exchange occurs in the M3 transmembrane domain involved in channel gating. This gain-of-function mutation increases glutamate and glycine potency by 2-fold, increases channel open probability by 6-fold, and reduces receptor sensitivity to endogenous negative modulators such as extracellular protons. Moreover, this mutation prolongs the deactivation time course after glutamate removal, which controls the synaptic time course. Transfection of cultured neurons with human GRIN2D cDNA harboring c.1999G>A leads to dendritic swelling and neuronal cell death, suggestive of excitotoxicity mediated by NMDAR over-activation. Because both individuals' seizures had proven refractory to conventional anti epileptic medications, the sensitivity of mutant NMDARs to FDA-approved NMDAR antagonists was evaluated. Based on these results, oral memantine was administered to both children, with resulting mild to moderate improvement in seizure burden and development. The older proband subsequently developed refractory status epilepticus, with dramatic electroclinical improvement upon treatment with ketamine and magnesium. Overall, these results suggest that NMDAR antagonists can be useful as adjuvant epilepsy therapy in individuals with GRIN2D gain-of-function mutations. This work further demonstrates the value of functionally evaluating a mutation, enabling mechanistic understanding and therapeutic modeling to realize precision medicine for epilepsy.	[Li, Dong; Tian, Lifeng; McCormick, Elizabeth M.; Chiavacci, Rosetta; Hakonarson, Hakon] Childrens Hosp Philadelphia, Dept Pediat, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Yuan, Hongjie; Chen, Wenjuan; Tankovic, Anel; Hu, Chun; Kusumoto, Hirofumi; Traynelis, Stephen F.] Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Atlanta, GA 30322 USA; [Yuan, Hongjie; Chen, Wenjuan; Tankovic, Anel; Hu, Chun; Kusumoto, Hirofumi; Traynelis, Stephen F.] Emory Univ, Sch Med, Rollins Res Ctr, CFERV, Atlanta, GA 30322 USA; [Ortiz-Gonzalez, Xilma R.; Marsh, Eric D.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Ortiz-Gonzalez, Xilma R.; Marsh, Eric D.; Hakonarson, Hakon; Falk, Marni J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [McCormick, Elizabeth M.; Hakonarson, Hakon; Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA; [Kosobucki, Gabrielle J.; Schulien, Anthony J.; Aizenman, Elias] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15261 USA; [Naase, Claudia] Childrens Hosp Bayreuth, D-95445 Bayreuth, Germany; [Brueckner, Frieder] Inst Neuropediat & Social Pediat Hamburg East, D-22111 Hamburg, Germany; [von Stuelpnagel-Steinbeis, Celina] Hosp Neuropediat & Neurol Rehabil, Epilepsy Ctr Children & Adolescents, D-83569 Vogtareuth, Germany; [von Stuelpnagel-Steinbeis, Celina] Paracelsus Med Univ Salzburg, Inst Transit Rehabil & Palliat Children & Adolesc, A-5020 Salzburg, Austria; [Hedrich, Ulrike B. S.; Elsen, Gina] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, D-72076 Tubingen, Germany; [Hoertnagel, Konstanze] CeGaT GmbH, D-72076 Tubingen, Germany; [Lemke, Johannes R.] Univ Leipzig Hosp & Clin, Inst Human Genet, D-04103 Leipzig, Germany	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Emory University; Emory University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Paracelsus Private Medical University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; CeGaT; Leipzig University	Falk, MJ (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Falk, MJ (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA.	falkm@email.chop.edu	Hu, Chun/AAZ-7920-2021; Ortiz-Gonzalez, Xilma/AAD-2211-2021	Hu, Chun/0000-0002-0949-9878; Ortiz-Gonzalez, Xilma/0000-0002-1710-4696; Yuan, Hongjie/0000-0002-8127-7145; Aizenman, Elias/0000-0001-9610-4194; Hedrich, Ulrike/0000-0003-3801-1306	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [R01HD082373]; National Center for Advancing Translational Sciences of the NIH [UL1TR000454]; National Institute of Neurological Disorders and Stroke [NS043277, NS036654, NS007413, NS049453]; Xiangya-Emory Medical Schools Visiting Student Program; Institutional Development Funds to the Center for Applied Genomics (CAG grant] [7225940617]; Institutional Development Funds (eMERGE grant at the Children's Hospital of Philadelphia (CHOP) [U01-HG006830]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD082373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006830, U01HG008684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS092989, R56NS043277, R01NS036654, R37NS036654, R01NS043277, T32NS007413, K12NS049453] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Xiangya-Emory Medical Schools Visiting Student Program; Institutional Development Funds to the Center for Applied Genomics (CAG grant]; Institutional Development Funds (eMERGE grant at the Children's Hospital of Philadelphia (CHOP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank both families involved in this study for their participation. We acknowledge Frank D. Mentch, Fengxiang Wang, and James Snyder, who helped in the DNA sample extraction and handling; and Cuiping Hou, Tiancheng Wang, Jing Zhang, John DiRaddo, and Phuong Le, who provided technical assistance. Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (R01HD082373 to H.Y.), the National Center for Advancing Translational Sciences of the NIH (UL1TR000454 to H.Y.), the National Institute of Neurological Disorders and Stroke (NS043277 to E.A., NS036654 to S.F.T., NS007413 and NS049453 to X.R.O.-G.), the Xiangya-Emory Medical Schools Visiting Student Program (to W.C.), and Institutional Development Funds to the Center for Applied Genomics (CAG grant #7225940617 and eMERGE grant [U01-HG006830 to H.H.]) at the Children's Hospital of Philadelphia (CHOP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; ARAS MA, 2008, CURR PROTOC NEUROSCI, P18; Aras MA, 2009, EUR J NEUROSCI, V30, P2250, DOI 10.1111/j.1460-9568.2009.07026.x; Aras MA, 2009, J NEUROCHEM, V110, P106, DOI 10.1111/j.1471-4159.2009.06106.x; Bearden D, 2014, ANN NEUROL, V76, P457, DOI 10.1002/ana.24229; Bhoj EJ, 2015, AM J MED GENET A, V167, P2497, DOI 10.1002/ajmg.a.37217; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Chez MG, 2007, J CHILD NEUROL, V22, P574, DOI 10.1177/0883073807302611; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Chong PF, 2016, ANN NEUROL, V79, P502, DOI 10.1002/ana.24598; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Erickson CA, 2007, PSYCHOPHARMACOLOGY, V191, P141, DOI 10.1007/s00213-006-0518-9; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; Hansen KB, 2013, MOL PHARMACOL, V84, P114, DOI 10.1124/mol.113.085803; Hedegaard M, 2012, NEUROCHEM INT, V61, P601, DOI 10.1016/j.neuint.2011.11.016; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lemke JR, 2012, EPILEPSIA, V53, P1387, DOI 10.1111/j.1528-1167.2012.03516.x; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Li D, 2014, J CLIN ENDOCR METAB, V99, pE1774, DOI 10.1210/jc.2014-1029; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mikati MA, 2015, ANN NEUROL, V78, P995, DOI 10.1002/ana.24520; Numis AL, 2014, NEUROLOGY, V82, P368, DOI 10.1212/WNL.0000000000000060; Ohba C, 2015, EPILEPSIA, V56, P841, DOI 10.1111/epi.12987; Pierson TM, 2014, ANN CLIN TRANSL NEUR, V1, P190, DOI 10.1002/acn3.39; Srivastava S, 2014, ANN NEUROL, V76, P473, DOI 10.1002/ana.24251; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Yuan HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4251; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009	44	109	116	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					802	816		10.1016/j.ajhg.2016.07.013	http://dx.doi.org/10.1016/j.ajhg.2016.07.013			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27616483	Green Published, Bronze			2022-12-18	WOS:000385333700002
J	Laue, K; Pogoda, HM; Daniel, PB; van Haeringen, A; Alanay, Y; von Ameln, S; Rachwalski, M; Morgan, T; Gray, MJ; Breuning, MH; Sawyer, GM; Sutherland-Smith, AJ; Nikkels, PG; Kubisch, C; Bloch, W; Wollnik, B; Hammerschmidt, M; Robertson, SP				Laue, Kathrin; Pogoda, Hans-Martin; Daniel, Philip B.; van Haeringen, Arie; Alanay, Yasemin; von Ameln, Simon; Rachwalski, Martin; Morgan, Tim; Gray, Mary J.; Breuning, Martijn H.; Sawyer, Gregory M.; Sutherland-Smith, Andrew J.; Nikkels, Peter G.; Kubisch, Christian; Bloch, Wilhelm; Wollnik, Bernd; Hammerschmidt, Matthias; Robertson, Stephen P.			Craniosynostosis and Multiple Skeletal Anomalies in Humans and Zebrafish Result from a Defect in the Localized Degradation of Retinoic Acid	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SITE-DIRECTED MUTAGENESIS; CYTOCHROME-P450 OXIDOREDUCTASE; METABOLIZING ENZYME; CRYSTAL-STRUCTURES; MOUSE; GROWTH; CYP26B1; LIMB; OSTEOGENESIS; ORGANOGENESIS	Excess exogenous retinoic acid (RA) has been well documented to have teratogenic effects in the limb and craniofacial skeleton. Malformations that have been observed in this context include craniosynostosis, a common developmental defect of the skull that occurs in 1 in 2500 individuals and results from premature fusion of the cranial sutures. Despite these observations, a physiological role for RA during suture formation has not been demonstrated. Here, we present evidence that genetically based alterations in RA signaling interfere with human development. We have identified human null and hypomorphic mutations in the gene encoding the RA-degrading enzyme CYP26B1 that lead to skeletal and craniofacial anomalies, including fusions of long bones, calvarial bone hypoplasia, and craniosynostosis. Analyses of murine embryos exposed to a chemical inhibitor of Cyp26 enzymes and zebrafish lines with mutations in cyp26b1 suggest that the endochondral bone fusions are due to unrestricted chondrogenesis at the presumptive sites of joint formation within cartilaginous templates, whereas craniosynostosis is induced by a defect in osteoblastic differentiation. Ultrastructural analysis, in situ expression studies, and in vitro quantitative RT-PCR experiments of cellular markers of osseous differentiation indicate that the most likely cause for these phenomena is aberrant osteoblast-osteocyte transitioning. This work reveals a physiological role for RA in partitioning skeletal elements and in the maintenance of cranial suture patency.	[Laue, Kathrin; Pogoda, Hans-Martin; Hammerschmidt, Matthias] Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany; [Daniel, Philip B.; Morgan, Tim; Gray, Mary J.; Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin 9054, New Zealand; [van Haeringen, Arie; Breuning, Martijn H.] Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 ZA Leiden, Netherlands; [Alanay, Yasemin] Hacettepe Univ, Fac Med, Dept Pediat, TR-06532 Ankara, Turkey; [von Ameln, Simon; Rachwalski, Martin; Kubisch, Christian; Wollnik, Bernd] Univ Cologne, Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Rachwalski, Martin; Wollnik, Bernd; Hammerschmidt, Matthias] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Sawyer, Gregory M.; Sutherland-Smith, Andrew J.] Massey Univ, Inst Mol BioSci, Palmerston North 4472, New Zealand; [Nikkels, Peter G.] Univ Med Ctr, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Kubisch, Christian; Bloch, Wilhelm; Wollnik, Bernd; Hammerschmidt, Matthias] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Kubisch, Christian] Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; [Bloch, Wilhelm] German Sport Univ Cologne, Inst Cardiol & Sports Med, D-50933 Cologne, Germany	University of Cologne; University of Otago; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hacettepe University; University of Cologne; University of Cologne; Massey University; Utrecht University; Utrecht University Medical Center; University of Cologne; Ulm University; German Sport University Cologne	Hammerschmidt, M (corresponding author), Univ Cologne, Inst Dev Biol, D-50674 Cologne, Germany.	matthias.hammerschmidt@uni-koeln.de; stephen.robertson@otago.ac.nz	Sutherland-Smith, Andrew/F-1813-2011; Alanay, Yasemin/A-1516-2016; Sawyer, Gregory M/G-1979-2012; Wollnik, Bernd/GRY-6062-2022; Rachwalski, Martin/AAY-6488-2020; Gray, Mary/J-9669-2014; Kubisch, Christian/F-1893-2011	Sutherland-Smith, Andrew/0000-0001-9485-1428; Alanay, Yasemin/0000-0003-0683-9731; Sawyer, Gregory M/0000-0002-8784-9327; Wollnik, Bernd/0000-0003-2589-0364; Gray, Mary/0000-0003-1610-0674; Kubisch, Christian/0000-0003-4220-0978; Robertson, Stephen/0000-0002-5181-7809; von Ameln, Simon/0000-0002-2242-3165	German Research Foundation (DFG) [SFB 572]; European Union; EC [HEALTH-F4-2010-242048]; German Federal Ministry of Education and Research (BMBF) [01GM0801]; Curekids; Marsden Fund	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Curekids; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	The families are thanked for their participation. Stefan Schulte-Merker is thanked for the zebrafish sst mutant and Christine Hartmann and Yingzi Yang are thanked for sending plasmids for the mouse probe synthesis. This work was supported by the German Research Foundation (DFG; SFB 572) (M.H.), the European Union (Seventh Framework Programme, Integrated Project ZE-HEALTH, EC Grant Agreement HEALTH-F4-2010-242048) (M.H.), the German Federal Ministry of Education and Research (BMBF; grant 01GM0801; E-RARE network CRANIRARE) (B.W.) and Curekids and the Marsden Fund (S.P.R.). Evelin Fahle, Christel Schenkel, Iris Riedl-Quinkertz, Mogdan Ghilav, Boidinh Chung, and Dan Mornin are thanked for their assistance. K.L. thanks Gerard Karsenty for support.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Abu-Abed S, 2002, MECH DEVELOP, V110, P173, DOI 10.1016/S0925-4773(01)00572-X; [Anonymous], DBSNP; [Anonymous], GEN BANK; Bonewald LF, 2009, COLD SPRING HARB MON, V53, P277; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Clay H, 2005, ZEBRAFISH, V2, P105, DOI 10.1089/zeb.2005.2.105; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Gupta RR, 2010, BIOCHEM BIOPH RES CO, V402, P258, DOI 10.1016/j.bbrc.2010.10.011; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Hatae T, 1996, FEBS LETT, V389, P268, DOI 10.1016/0014-5793(96)00600-X; James AW, 2010, PLAST RECONSTR SURG, V125, P1352, DOI 10.1097/PRS.0b013e3181d62980; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kuhnel K, 2008, BIOCHEMISTRY-US, V47, P6552, DOI 10.1021/bi800328s; KWASIGROCH TE, 1991, TERATOLOGY, V44, P605, DOI 10.1002/tera.1420440603; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6; Li N, 2010, DEVELOPMENT, V137, P389, DOI 10.1242/dev.044164; Maclean G, 2009, DEV DYNAM, V238, P732, DOI 10.1002/dvdy.21878; Mic FA, 2004, J BIOL CHEM, V279, P26698, DOI 10.1074/jbc.M401920200; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Nica G, 2006, DEV BIOL, V292, P189, DOI 10.1016/j.ydbio.2005.12.036; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2002, DEVELOPMENT, V129, P3563; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Quarto N, 2005, CELLS TISSUES ORGANS, V181, P109, DOI 10.1159/000091100; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; Rotllant J, 2008, MATRIX BIOL, V27, P561, DOI 10.1016/j.matbio.2008.03.001; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmidt K, 2009, MOL CELL BIOL, V29, P2716, DOI 10.1128/MCB.01638-08; Scott RR, 2008, HORM RES, V69, P266, DOI 10.1159/000114857; SHIMIZU T, 1991, J BIOL CHEM, V266, P3372; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; ucsc, UCSC GEN BROWS; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; YIP JE, 1980, TERATOLOGY, V21, P29, DOI 10.1002/tera.1420210105	53	109	114	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					595	606		10.1016/j.ajhg.2011.09.015	http://dx.doi.org/10.1016/j.ajhg.2011.09.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22019272	Bronze, Green Published			2022-12-18	WOS:000297090100001
J	Bakircioglu, M; Carvalho, OP; Khurshid, M; Cox, JJ; Tuysuz, B; Barak, T; Yilmaz, S; Caglayan, O; Dincer, A; Nicholas, AK; Quarrell, O; Springell, K; Karbani, G; Malik, S; Gannon, C; Sheridan, E; Crosier, M; Lisgo, SN; Lindsay, S; Bilguvar, K; Gergely, F; Gunel, M; Woods, CG				Bakircioglu, Mehmet; Carvalho, Ofelia P.; Khurshid, Maryam; Cox, James J.; Tuysuz, Beyhan; Barak, Tanyeri; Yilmaz, Saliha; Caglayan, Okay; Dincer, Alp; Nicholas, Adeline K.; Quarrell, Oliver; Springell, Kelly; Karbani, Gulshan; Malik, Saghira; Gannon, Caroline; Sheridan, Eamonn; Crosier, Moira; Lisgo, Steve N.; Lindsay, Susan; Bilguvar, Kaya; Gergely, Fanni; Gunel, Murat; Woods, C. Geoffrey			The Essential Role of Centrosomal NDE1 in Human Cerebral Cortex Neurogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROCEPHALY GENES; CYTOPLASMIC DYNEIN; MITOTIC SPINDLE; CELL BIOLOGY; NEURAL STEM; BRAIN SIZE; EVOLUTION; NUDE; LIS1; PROTEIN	We investigated three families whose offspring had extreme microcephaly at birth and profound mental retardation. Brain scans and postmortem data showed that affected individuals had brains less than 10% of expected size (<= 10 standard deviation) and that in addition to a massive reduction in neuron production they displayed partially deficient cortical lamination tinicrolissencephaly). Other body systems were apparently unaffected and overall growth was normal. We found two distinct homozygous mutations of NDE1, c.83+1G>T (p.Ala29GlnfsX114) in a Turkish family and c.684_685del (p.Pro229TrpfsX85) in two families of Pakistani origin. Using patient cells, we found that c.83+1G>T led to the use of a novel splice site and to a frameshift after NDE1 exon 2. Transfection of tagged NDE1 constructs showed that the c.684_685del mutation resulted in a NDE1 that was unable to localize to the centrosome. By staining a patient-derived cell line that carried the c.83+1G>T mutation, we found that this endogeneously expressed mutated protein equally failed to localize to the centrosome. By examining human and mouse embryonic brains, we determined that NDE1 is highly expressed in neuroepithelial cells of the developing cerebral cortex, particularly at the centrosome. We show that NDE1 accumulates on the mitotic spindle of apical neural precursors in early neurogenesis. Thus, NDE1 deficiency causes both a severe failure of neurogenesis and a deficiency in cortical lamination. Our data further highlight the importance of the centrosome in multiple aspects of neurodevelopment.	[Bakircioglu, Mehmet; Barak, Tanyeri; Yilmaz, Saliha; Caglayan, Okay; Bilguvar, Kaya; Gunel, Murat] Yale Sch Med, Ctr Human Genet & Genom, Dept Neurosurg, New Haven, CT 06510 USA; [Bakircioglu, Mehmet; Barak, Tanyeri; Yilmaz, Saliha; Caglayan, Okay; Bilguvar, Kaya; Gunel, Murat] Yale Sch Med, Ctr Human Genet & Genom, Dept Neurobiol, New Haven, CT 06510 USA; [Carvalho, Ofelia P.; Khurshid, Maryam; Cox, James J.; Nicholas, Adeline K.; Woods, C. Geoffrey] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Fac Med, Dept Pediat, Div Genet, TR-34098 Istanbul, Turkey; [Dincer, Alp] Acibadem Univ, Sch Med, Dept Radiol, TR-34742 Istanbul, Turkey; [Quarrell, Oliver] Sheffield Childrens Hosp, Western Bank, Dept Clin Genet, Sheffield S10 2TH, S Yorkshire, England; [Springell, Kelly; Karbani, Gulshan; Malik, Saghira; Sheridan, Eamonn] St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Gannon, Caroline] Queens Univ Hosp, Dept Pathol, Belfast BT9 7BL, Antrim, North Ireland; [Crosier, Moira; Lisgo, Steve N.; Lindsay, Susan] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Gergely, Fanni] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Bakircioglu, Mehmet; Barak, Tanyeri; Yilmaz, Saliha; Caglayan, Okay; Bilguvar, Kaya; Gunel, Murat] Yale Sch Med, Ctr Human Genet & Genom, Dept Genet, New Haven, CT 06510 USA; [Bakircioglu, Mehmet; Barak, Tanyeri; Yilmaz, Saliha; Caglayan, Okay; Bilguvar, Kaya; Gunel, Murat] Yale Sch Med, Program Neurogenet, New Haven, CT 06510 USA	Yale University; Yale University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Istanbul University; Istanbul University - Cerrahpasa; Acibadem University; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Saint James's University Hospital; University of Leeds; Newcastle University - UK; Cancer Research UK; CRUK Cambridge Institute; Yale University; Yale University	Gunel, M (corresponding author), Yale Sch Med, Ctr Human Genet & Genom, Dept Neurosurg, New Haven, CT 06510 USA.	murat.gunel@yale.edu; cw347@cam.ac.uk	Carvalho, Ofelia/L-2780-2014; Dincer, Alp/D-3658-2015; Tüysüz, Beyhan/AAN-4858-2020; Caglayan, Ahmet O/D-1066-2012; Cox, James/R-1910-2016	Carvalho, Ofelia/0000-0002-7450-9980; Dincer, Alp/0000-0001-9158-8353; Caglayan, Ahmet O/0000-0002-2332-322X; Gergely, Fanni/0000-0002-2441-8095; Lindsay, Susan/0000-0003-2980-4582; Barak, Tanyeri/0000-0002-8522-1552; Lisgo, Steven/0000-0001-5186-3971; Tuysuz, Beyhan/0000-0002-9620-5021; Nicholas, Adeline/0000-0002-7124-629X	Higher Education Commission of Pakistan; Action Research; Wellcome Trust; MRC [G0700089]; Wellcome Trust [GR082557]; Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; National Institutes of Health [RC2NS070477]; MRC [G9900837] Funding Source: UKRI; Medical Research Council [G9900837, G0700089] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070477] Funding Source: NIH RePORTER	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Action Research; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank the research families for their participation in this project, Ilias Kazanis and Veronique Marthiens for assistance with the project, and the Higher Education Commission of Pakistan, Action Research, and Wellcome Trust for funding (O.P.C., M.K., J.J.C., A.K.N., C.G.W.). The human embryonic and fetal material was provided by the MRC/Wellcome Trust-funded Human Developmental Biology Resource at the Institute of Human Genetics, Newcastle Upon Tyne, with funding from grant numbers G0700089 (MRC) and GR082557 (Wellcome Trust). We thank Cathy Camputaro for her help with the imaging studies. We acknowledge the use of Yale University Biomedical High Performance Computing Center for data analysis and storage. This study was supported by the Yale Program on Neurogenetics, the Yale Center for Human Genetics and Genomics, and National Institutes of Health grants RC2NS070477 (to M.G.).	Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bradshaw NJ, 2008, BIOCHEM BIOPH RES CO, V377, P1091, DOI 10.1016/j.bbrc.2008.10.120; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Efimov VP, 2003, MOL BIOL CELL, V14, P871, DOI 10.1091/mbc.E02-06-0359; FALK D, 1986, SCIENCE, V234, P11, DOI 10.1126/science.234.4772.11-a; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hirohashi Y, 2006, ONCOGENE, V25, P6048, DOI 10.1038/sj.onc.1209637; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Montgomery SH, 2011, MOL BIOL EVOL, V28, P625, DOI 10.1093/molbev/msq237; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rao M, 2004, J NEUROTRAUM, V21, P415, DOI 10.1089/089771504323004566; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Uylings HBM, 2000, EUR J MORPHOL, V38, P309, DOI 10.1076/0924-3860(200012)38:5;1-H;FT309; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wainman A, 2009, J CELL SCI, V122, P1747, DOI 10.1242/jcs.041798; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003	39	109	115	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					523	535		10.1016/j.ajhg.2011.03.019	http://dx.doi.org/10.1016/j.ajhg.2011.03.019			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21529752	Green Published, hybrid			2022-12-18	WOS:000290832100001
J	Falace, A; Filipello, F; La Padula, V; Vanni, N; Madia, F; Tonelli, DD; de Falco, FA; Striano, P; Bricarelli, FD; Minetti, C; Benfenati, F; Fassio, A; Zara, F				Falace, Antonio; Filipello, Fabia; La Padula, Veronica; Vanni, Nicola; Madia, Francesca; Tonelli, Davide De Pietri; de Falco, Fabrizio A.; Striano, Pasquale; Bricarelli, Franca Dagna; Minetti, Carlo; Benfenati, Fabio; Fassio, Anna; Zara, Federico			TBC1D24, an ARF6-Interacting Protein, Is Mutated in Familial Infantile Myoclonic Epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORTICAL DEVELOPMENT; ARF6; ACTIVATION; ISOFORM; PATHWAY; SYSTEM; ARNO	Idiopathic epilepsies (IEs) are a group of disorders characterized by recurrent seizures in the absence of detectable brain lesions or metabolic abnormalities. IEs include common disorders with a complex mode of inheritance and rare Mendelian traits suggesting the occurrence of several alleles with variable penetrance. We previously described a large family with a recessive form of idiopathic epilepsy, named familial infantile myoclonic epilepsy (FIME), and mapped the disease locus on chromosome 16p13.3 by linkage analysis. In the present study, we found that two compound heterozygous missense mutations (D147H and A509V) in TBC1D24, a gene of unknown function, are responsible for RIME. In situ hybridization analysis revealed that Tbc1d24 is mainly expressed at the level of the cerebral cortex and the hippocampus. By coimmunoprecipitation assay we found that TBC1D24 binds ARF6, a Ras-related family of small GTPases regulating exo-endocytosis dynamics. The main recognized function of ARF6 in the nervous system is the regulation of dendritic branching, spine formation, and axonal extension. TBC1D24 overexpression resulted in a significant increase in neurite length and arborization and the FIME mutations significantly reverted this phenotype. In this study we identified a gene mutation involved in autosomal-recessive idiopathic epilepsy, unveiled the involvement of ARM-dependent molecular pathway in brain hyperexcitability and seizures, and confirmed the emerging role of subtle cytoarchitectural alterations in the etiology of this group of common epileptic disorders.	[Filipello, Fabia; Benfenati, Fabio; Fassio, Anna] Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy; [Filipello, Fabia; Benfenati, Fabio; Fassio, Anna] Natl Inst Neurosci, I-16132 Genoa, Italy; [Falace, Antonio; Vanni, Nicola; Striano, Pasquale; Minetti, Carlo; Zara, Federico] Inst G Gaslini, Dept Neurosci, Neurogenet Lab, I-16147 Genoa, Italy; [Falace, Antonio; Vanni, Nicola; Striano, Pasquale; Minetti, Carlo; Zara, Federico] Univ Genoa, I-16147 Genoa, Italy; [La Padula, Veronica; Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Madia, Francesca; Bricarelli, Franca Dagna] EO Osped Galliera, Genet Lab, I-16128 Genoa, Italy; [de Falco, Fabrizio A.] UO Neurol, I-90100 Naples, Italy	University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; Istituto Italiano di Tecnologia - IIT; Ente Ospedaliero Ospedali Galliera	Fassio, A (corresponding author), Univ Genoa, Dept Expt Med, I-16132 Genoa, Italy.	afassio@unige.it; federicozara@ospedale-gaslini.ge.it	Filipello, Fabia/AAO-9663-2021; Striano, Pasquale/F-9117-2014; Minetti, Carlo/K-4666-2018; Madia, Francesca/AAA-7356-2020; de Falco, Fabrizio Antonio/A-7343-2011; Zara, Federico/U-3477-2017; De Pietri Tonelli, Davide/E-2102-2011; De Pietri Tonelli, Davide/AAD-8055-2021; Falace, Antonio/AAV-1878-2020; fassio, anna/K-4482-2014	Striano, Pasquale/0000-0002-6065-1476; Minetti, Carlo/0000-0002-0640-1804; Madia, Francesca/0000-0002-7807-1322; Zara, Federico/0000-0001-9744-5222; De Pietri Tonelli, Davide/0000-0001-9537-8900; De Pietri Tonelli, Davide/0000-0001-9537-8900; Falace, Antonio/0000-0001-5336-0251; fassio, anna/0000-0002-8801-038X; De Falco, Fabrizio/0000-0001-5065-1678	Italian Telethon Foundation [GGP02179, GGP06180, GGP09134]; Italian Ministry of Health [GR-2007-657156]; Italian Ministry of Research; Compagnia di San Paolo-Torino; Italian League against Epilepsy	Italian Telethon Foundation(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo-Torino(Compagnia di San Paolo); Italian League against Epilepsy	The authors wish to thank the family members for their participation in this study. We also thank Philippe Chavrier and Guillaume Montagnac (Institut Curie, Paris, France) for the kind gift of ARM-HA constructs; Michele Zoli (University of Modena and Reggio Emilia, Modena, Italy) for statistical analysis and invaluable discussions, and Sonia Congia, Yoanne Clovis, and Franco Onofri for precious technical help. This work was supported by grants from the Italian Telethon Foundation (GGP02179 and GGP06180 to F.Z., GGP09134 to F.B.), the Italian Ministry of Health (GR-2007-657156 to A.F. and F.Z.), and the Italian Ministry of Research (to F.B.). The support of Compagnia di San Paolo-Torino (to F.B. and A.F.) and of the Italian League against Epilepsy is also acknowledged. The authors declare no conflict of interest.	Andrade DM, 2009, HUM GENET, V126, P173, DOI 10.1007/s00439-009-0702-1; Avanzini G, 2003, LANCET NEUROL, V2, P33, DOI 10.1016/S1474-4422(03)00265-5; CASERTA F, 1995, J NEUROSCI METH, V56, P133, DOI 10.1016/0165-0270(94)00115-W; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de Falco FA, 2001, EPILEPSIA, V42, P1541, DOI 10.1046/j.1528-1157.2001.26701.x; de Nijs L, 2009, NAT NEUROSCI, V12, P1266, DOI 10.1038/nn.2390; Fischer H, 2001, BIOCHEM BIOPH RES CO, V281, P795, DOI 10.1006/bbrc.2001.4345; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hernandez-Deviez DJ, 2002, NAT NEUROSCI, V5, P623, DOI 10.1038/nn865; Jaworski J, 2007, EUR J CELL BIOL, V86, P513, DOI 10.1016/j.ejcb.2007.04.007; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Shkolnik K, 2008, REPRODUCTION, V135, P321, DOI 10.1530/REP-07-0402; Tonelli DDP, 2006, BIOTECHNIQUES, V41, P727, DOI 10.2144/000112296; Traverso M, 2006, BIOCHEM BIOPH RES CO, V339, P145, DOI 10.1016/j.bbrc.2005.11.006; Turnbull J, 2005, HUM MOL GENET, V14, P2491, DOI 10.1093/hmg/ddi250; Zara F, 2000, AM J HUM GENET, V66, P1552, DOI 10.1086/302876; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019	25	109	122	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					365	370		10.1016/j.ajhg.2010.07.020	http://dx.doi.org/10.1016/j.ajhg.2010.07.020			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20727515	Bronze, Green Published			2022-12-18	WOS:000281923500005
J	Duquesnoy, P; Escudier, E; Vincensini, L; Freshour, J; Bridoux, AM; Coste, A; Deschildre, A; de Blic, J; Legendre, M; Montantin, G; Tenreiro, H; Vojtek, AM; Loussert, C; Clement, A; Escalier, D; Bastin, P; Mitchell, DR; Amselem, S				Duquesnoy, Philippe; Escudier, Estelle; Vincensini, Laetitia; Freshour, Judy; Bridoux, Anne-Marie; Coste, Andre; Deschildre, Antoine; de Blic, Jacques; Legendre, Marie; Montantin, Guy; Tenreiro, Henrique; Vojtek, Anne-Marie; Loussert, Celine; Clement, Annick; Escalier, Denise; Bastin, Philippe; Mitchell, David R.; Amselem, Serge			Loss-of-Function Mutations in the Human Ortholog of Chlamydomonas reinhordtii ODA7 Disrupt Dynein Arm Assembly and Cause Primary Ciliary Dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEUCINE-RICH-REPEAT; TRYPANOSOMA-BRUCEI; ZEBRAFISH PRONEPHROS; GENE-EXPRESSION; PROTEIN; ABNORMALITIES; DEFECTS; MOTILITY; DISEASES; PATTERN	Cilia and flagella are evolutionarily conserved structures that play various physiological roles in diverse cell types. Defects in motile cilia result in primary ciliary dyskinesia (PCD), the most prominent ciliopathy, characterized by the association of respiratory symptoms, male infertility, and, in nearly 50% of cases, situs inversus. So far, most identified disease-causing mutations involve genes encoding various ciliary components, such those belonging to the dynein arms that are essential for ciliary motion. Following a candidate-gene approach based on data from a mutant strain of the biflagellated alga Chlamydomonas reinhardtii carrying an ODA7 defect, we identified four families with a PCD phenotype characterized by the absence of both dynein arms and loss-of-function mutations in the human orthologous gene called LRRC50. Functional analyses performed in Chlamydomonas reinhardtii and in another flagellated protist, Trypanosoma brucei, support a key role for LRRC50, a member of the leucine-rich-repeat superfamily, in cytoplasmic preassembly of dynein arms.	[Duquesnoy, Philippe; Escudier, Estelle; Vincensini, Laetitia; Bridoux, Anne-Marie; Legendre, Marie; Montantin, Guy; Tenreiro, Henrique; Escalier, Denise; Amselem, Serge] Univ Paris 06, INSERM, U933, F-75571 Paris 12, France; [Clement, Annick] Hop Armand Trousseau, AP HP, Unite Pneumol Pediat, Ctr Reference Malad Resp Rares, F-75571 Paris 12, France; [Vincensini, Laetitia; Bastin, Philippe] Inst Pasteur, Trypanosome Cell Biol Unit, F-75015 Paris, France; [Vincensini, Laetitia; Bastin, Philippe] CNRS, URA2581, F-75015 Paris, France; [Freshour, Judy; Mitchell, David R.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Coste, Andre] Hop Intercommunal Creteil, AP HP, F-94010 Creteil, France; [Coste, Andre] Grp Hosp Henri Mondor Albert Chenevier, Serv ORL & Chirurg Cerv Faciale, F-94010 Creteil, France; [Deschildre, Antoine] CHRU, Hop Jeanne Flandre, Unite Pneumol & Allergol Pediat, F-59037 Lille, France; [de Blic, Jacques] Hop Intercommunal, AP HP, F-75743 Paris 5, France; [de Blic, Jacques] Grp Hosp Necker Enfants Malad, Serv Pneumol & Allergol Pediat, F-75743 Paris 5, France; [Vojtek, Anne-Marie] Hop Intercommunal Creteil, Serv Anatomopathol, Lab Microscopie Elect, F-94010 Creteil, France; [Loussert, Celine] Inst Pasteur, Plateforme Microscopie Ultrastruct, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Amselem, S (corresponding author), Univ Paris 06, INSERM, U933, F-75571 Paris 12, France.	serge.amselem@inserm.fr	Vincensini, Laetitia/P-6925-2017; Bastin, Philippe/O-4230-2019; Bastin, Philippe/B-1402-2014; Bastin, Philippe/E-6688-2017; Legendre, Marie/AAD-7018-2021	Bastin, Philippe/0000-0002-3042-8679; Legendre, Marie/0000-0003-2178-0846; Mitchell, David/0000-0003-2821-7511; Loussert, celine/0000-0002-6725-043X; COSTE, Andre/0000-0002-8386-3455	Legs Poix from the Chancellerie des Universites; Assistance Publique-Hopitaux de Paris [AOM06053, P060245]; Agence Nationale pour la Recherche [ANR-05-MRAR-022-01]; NIH [GM44228]; Institut Pasteur and CNRS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044228] Funding Source: NIH RePORTER	Legs Poix from the Chancellerie des Universites; Assistance Publique-Hopitaux de Paris; Agence Nationale pour la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur and CNRS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the patients and their family members, whose cooperation made this study possible, and we thank all referring physicians. This work was supported by grants from the Legs Poix from the Chancellerie des Universites, the Assistance Publique-Hopitaux de Paris (PHRC AOM06053, P060245), and the Agence Nationale pour la Recherche (ANR-05-MRAR-022-01). D.R.M. was supported by NIH-GM44228. Work on T. brucei was funded by Institut Pasteur and CNRS.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; BANGS JD, 1993, J CELL SCI, V105, P1101; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Branche C, 2006, J CELL SCI, V119, P3443, DOI 10.1242/jcs.03078; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Escudier E, 2002, AM J RESP CRIT CARE, V166, P1257, DOI 10.1164/rccm.2111070; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Freshour J, 2007, J BIOL CHEM, V282, P5404, DOI 10.1074/jbc.M607509200; HAIMO LT, 1981, J CELL BIOL, V91, pS125, DOI 10.1083/jcb.91.3.125s; Jorissen M, 2000, Acta Otorhinolaryngol Belg, V54, P343; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lin TK, 1998, J ASSIST REPROD GEN, V15, P625, DOI 10.1023/A:1020341629516; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Matsushima N, 2005, CELL MOL LIFE SCI, V62, P2771, DOI 10.1007/s00018-005-5187-z; MITCHELL DR, 1991, J CELL BIOL, V113, P835, DOI 10.1083/jcb.113.4.835; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Ong ACM, 2005, AM J KIDNEY DIS, V45, P1096, DOI 10.1053/j.ajkd.2005.02.019; PAPON JF, 2009, EUR RESP J; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Silflow CD, 2001, J CELL BIOL, V153, P63, DOI 10.1083/jcb.153.1.63; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	35	109	112	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					890	896		10.1016/j.ajhg.2009.11.008	http://dx.doi.org/10.1016/j.ajhg.2009.11.008			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	19944405	Green Published, Bronze			2022-12-18	WOS:000272797100012
J	Yang, T; Gurrola, JG; Wu, H; Chiu, SM; Wangemann, P; Snyder, PM; Smith, RJH				Yang, Tao; Gurrola, Jose G., II; Wu, Hao; Chiu, Sui M.; Wangemann, Philine; Snyder, Peter M.; Smith, Richard J. H.			Mutations of KCNJ10 Together with Mutations of SLC26A4 Cause Digenic Nonsyndromic Hearing Loss Associated with Enlarged Vestibular Aqueduct Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOTYPE-PHENOTYPE CORRELATION; SYNDROME MOUSE MODEL; PENDRED-SYNDROME; INNER-EAR; GENE PDS; DEAFNESS; POTASSIUM; VARIANTS; INHIBITION; EXPRESSION	Mutations in SLC26A4 cause nonsyndromic hearing loss associated with an enlarged vestibular aqueduct (EVA, also known as DFNB4) and Pendred syndrome (PS), the most common type of autosomal-recessive syndromic deafness. In many patients with an EVA/PS phenotype, mutation screening of SLC26A4 fails to identify two disease-causing allele variants. That a sizable fraction of patients carry only one SLC26A4 mutation suggests that EVA/PS is a complex disease involving other genetic factors. Here, we show that mutations in the inwardly rectifying K+ channel gene KCNJ10 are associated with nonsyndromic hearing loss in carriers of SLC26A4 mutations with an EVA/PS phenotype. In probands from two families, we identified double heterozygosity in affected individuals. These persons carried single mutations in both SLC26A4 and KCNJ10. The identified SLC26A4 mutations have been previously implicated in EVA/PS, and the KCNJ10 mutations reduce K+ conductance activity, which is critical for generating and maintaining the endocochlear potential. In addition, we show that haploinsufficiency of Slc26a4 in the Slc26a4(+/-) mouse mutant results in reduced protein expression of Kcnj10 in the stria vascularis of the inner ear. Our results link KCNJ10 mutations with EVA/PS and provide further support for the model of EVA/PS as a multigenic complex disease.	[Yang, Tao; Gurrola, Jose G., II; Smith, Richard J. H.] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Xinhua Hosp, Shanghai 200092, Peoples R China; [Snyder, Peter M.; Smith, Richard J. H.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Chiu, Sui M.] McGill Univ, Ctr Hlth, Dept Med Genet, Montreal, PQ H3H 1P3, Canada; [Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	University of Iowa; Shanghai Jiao Tong University; University of Iowa; McGill University; Kansas State University	Smith, RJH (corresponding author), Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA.	richard-smith@uiowa.edu	Wangemann, Philine/N-2826-2013	Smith, Richard/0000-0003-1201-6731; Yang, Tao/0000-0001-6011-987X; Gurrola II, Jose/0000-0001-6801-5768	National Institute on Deafness and Other Communication Disorders (NIDCD) [R01-DC02842, R01-DC1098]; National Heart, Lung, and Blood Institute (NHLBI) [HL072256]; Science and Technology Commission of Shanghai Municipality, China (STCSM) [08411954500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001098, R01DC002842] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Science and Technology Commission of Shanghai Municipality, China (STCSM)(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This Study was supported in part by grants from the National Institute on Deafness and Other Communication Disorders (NIDCD) to RJ.H.S. (R01-DC02842) and P.W. (R01-DC1098), from the National Heart, Lung, and Blood Institute (NHLBI) to P.M.S. (HL072256), and from the Science and Technology Commission of Shanghai Municipality, China (STCSM) to H.W. (08411954500). The authors would like to thank the families who made this research possible.	Abe S, 1999, AM J MED GENET, V82, P322, DOI 10.1002/(SICI)1096-8628(19990212)82:4<322::AID-AJMG9>3.3.CO;2-S; Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Azaiez H, 2007, HUM GENET, V122, P451, DOI 10.1007/s00439-007-0415-2; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; MARCUS DC, 1984, AM J PHYSIOL, V247, pC240, DOI 10.1152/ajpcell.1984.247.3.C240; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Pera A, 2008, EUR J HUM GENET, V16, P888, DOI 10.1038/ejhg.2008.30; Pera A, 2008, P NATL ACAD SCI USA, V105, P18608, DOI 10.1073/pnas.0805831105; Pessia M, 1996, EMBO J, V15, P2980, DOI 10.1002/j.1460-2075.1996.tb00661.x; Prasad S, 2004, AM J MED GENET A, V124A, P1, DOI 10.1002/ajmg.a.20272; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Rotman-Pikielny P, 2002, HUM MOL GENET, V11, P2625, DOI 10.1093/hmg/11.21.2625; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Stinckens C, 2002, ADV OTO-RHINO-LARYNG, V61, P131; Takeuchi S, 1996, HEARING RES, V101, P181, DOI 10.1016/S0378-5955(96)00151-7; Takeuchi S, 1998, CELL TISSUE RES, V293, P271, DOI 10.1007/s004410051118; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314; Yoshino T, 2004, HEARING RES, V195, P9, DOI 10.1016/j.heares.2004.05.005	35	109	123	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					651	657		10.1016/j.ajhg.2009.04.014	http://dx.doi.org/10.1016/j.ajhg.2009.04.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19426954	Green Published, Bronze			2022-12-18	WOS:000266338800009
J	Xue, YL; Sun, DL; Daly, A; Yang, FT; Zhou, X; Zhao, MY; Huang, N; Zerjal, T; Lee, C; Carter, NP; Hurles, ME; Tyler-Smith, C				Xue, Yali; Sun, Donglin; Daly, Allan; Yang, Fengtang; Zhou, Xue; Zhao, Mengyao; Huang, Ni; Zerjal, Tatiana; Lee, Charles; Carter, Nigel P.; Hurles, Matthew E.; Tyler-Smith, Chris			Adaptive evolution of UGT2B17 copy-number variation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; DELETION POLYMORPHISM; PROSTATE-CANCER; GENE-EXPRESSION; HAPLOTYPE RECONSTRUCTION; BALANCING SELECTION; POSITIVE SELECTION; STATISTICAL-METHOD; SEQUENCE VARIATION; HUMANS	The human UGT2B17 gene varies in copy number from zero to two per individual and also differs in mean number between populations from Africa, Europe, and East Asia. We show that such a high degree of geographical variation is unusual and investigate its evolutionary history. This required first reinterpreting the reference sequence in this region of the genome, which is misassembled from the two different alleles separated by an artifactual gap. A corrected assembly identifies the polymorphism as a 117 kb deletion arising by nonallelic homologous recombination between similar to 4.9 kb segmental duplications and allows the deletion breakpoint to be identified. We resequenced similar to 12 kb of DNA spanning the breakpoint in 91 humans from three HapMap and one extended HapMap populations and one chimpanzee. Diversity was unusually high and the time to the most recent common ancestor was estimated at similar to 2.4 or similar to 3.0 million years by two different methods, with evidence of balancing selection in Europe. In contrast, diversity was low in East Asia where a single haplotype predominated, suggesting positive selection for the deletion in this part of the world.	[Xue, Yali; Sun, Donglin; Daly, Allan; Yang, Fengtang; Zhou, Xue; Zhao, Mengyao; Huang, Ni; Zerjal, Tatiana; Carter, Nigel P.; Hurles, Matthew E.; Tyler-Smith, Chris] Sanger Inst, Wellcome Trust, Hinxton CB10 1SA, England; [Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Tyler-Smith, C (corresponding author), Sanger Inst, Wellcome Trust, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	cts@sanger.ac.uk	zerjal, tatiana/AAO-9473-2020; Yang, Fan/GYU-4249-2022	Yang, Fengtang/0000-0002-3573-2354	The Wellcome Trust	The Wellcome Trust(Wellcome TrustEuropean Commission)	We thank all the sample donors for making this work possible, Nancy Holroyd and the Sanger Faculty Small Sequencing Projects Group for generating the sequence data, all CNV Consortium members for contributions, Howard M. Cann for providing the HGDP-CEPH DNA panel, Jianxiang Chi for help with FISH, and Richard Redon for advice on F<INF>ST</INF> calculation using R. This work was supported by The Wellcome Trust.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bahlo M, 2000, THEOR POPUL BIOL, V57, P79, DOI 10.1006/tpbi.1999.1447; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baysal BE, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-12; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Calafell F, 2008, HUM GENET, V124, P123, DOI 10.1007/s00439-008-0530-8; Cann HM, 2002, SCIENCE, V296, P261; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fay JC, 2000, GENETICS, V155, P1405; Ferrer-Admetlla A, 2008, J IMMUNOL, V181, P1315, DOI 10.4049/jimmunol.181.2.1315; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gallagher CJ, 2007, CANCER DETECT PREV, V31, P310, DOI 10.1016/j.cdp.2007.07.005; Gardner M, 2007, HUM GENET, V121, P759, DOI 10.1007/s00439-007-0364-9; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Karypidis AH, 2008, PHARMACOGENOMICS J, V8, P147, DOI 10.1038/sj.tpj.6500449; Kehrer-Sawatzki H, 2007, HUM GENET, V120, P759, DOI 10.1007/s00439-006-0270-6; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Olsson M, 2008, PROSTATE, V68, P571, DOI 10.1002/pros.20700; Park J, 2006, CANCER EPIDEM BIOMAR, V15, P1473, DOI 10.1158/1055-9965.EPI-06-0141; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schulze JJ, 2008, J CLIN ENDOCR METAB, V93, P2500, DOI 10.1210/jc.2008-0218; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Swanson C, 2007, J CLIN ENDOCR METAB, V92, P4878, DOI 10.1210/jc.2007-0359; TAJIMA F, 1989, GENETICS, V123, P585; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116	56	109	113	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					337	346		10.1016/j.ajhg.2008.08.004	http://dx.doi.org/10.1016/j.ajhg.2008.08.004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18760392	Bronze, Green Published			2022-12-18	WOS:000259307200005
J	Mio, F; Chiba, K; Hirose, Y; Kawaguchi, Y; Mikami, Y; Oya, T; Mori, M; Kamata, M; Matsumoto, M; Ozaki, K; Tanaka, T; Takahashi, A; Kubo, T; Kimura, T; Toyama, Y; Ikegawa, S				Mio, Futoshi; Chiba, Kazuhiro; Hirose, Yuichiro; Kawaguchi, Yoshiharu; Mikami, Yasuo; Oya, Takeshi; Mori, Masaki; Kamata, Michihiro; Matsumoto, Morio; Ozaki, Kouichi; Tanaka, Toshihiro; Takahashi, Atsushi; Kubo, Toshikazu; Kimura, Tomoatsu; Toyama, Yoshiaki; Ikegawa, Shiro			A functional polymorphism in COL11A1, which encodes the alpha 1 chain of type XI collagen, is associated with susceptibility to lumbar disc herniation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA STABILITY; LOW-BACK-PAIN; INTERVERTEBRAL DISC; ARTICULAR-CARTILAGE; DEGENERATION; DISEASE; GENE; MICE; AGGRECAN; FIBRILS	Lumbar disc herniation (LDH), degeneration and herniation of the nucleus pulposus of the intervertebral disc (IVD) of the lumbar spine, is one of the most common musculoskeletal diseases. Its etiology and pathogenesis, however, remain unclear. Type XI collagen is important for cartilage collagen formation and for organization of the extracellular matrix. We identified an association between one of the type XI collagen genes, COL11A1, and LDH in Japanese populations. COL11A1, which encodes the alpha 1 chain of type XI collagen, was highly expressed in IVD, but its expression was decreased in the IVD of patients with LDH. The expression level was inversely correlated with the severity of disc degeneration. A single-nucleotide polymorphism (c.4603C -> T [rs1676486]) had the most significant association with LDH (P = 3.3 x 10(-6)), and the transcript containing the disease-associated allele was decreased because of its decreased stability. These observations indicate that type XI collagen is critical for IVD metabolism and that its decrease is related to LDH.	RIKEN, SNP Res Ctr, Lab Bone & Joinr Dis, Minato Ku, Tokyo 1088639, Japan; Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo, Japan; Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Tokyo, Japan; Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama 930, Japan; Toyama Univ, Fac Med, Dept Pathol, Toyama 930, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto, Japan; Keiyu Hosp, Dept Orthopaed, Yokohama, Kanagawa, Japan	RIKEN; Keio University; Keio University; University of Toyama; University of Toyama; Kyoto Prefectural University of Medicine	Ikegawa, S (corresponding author), RIKEN, SNP Res Ctr, Lab Bone & Joinr Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Toyama, Yoshiaki/K-5743-2013; Ikegawa, Shiro/N-6895-2015; Matsumoto, Morio M/L-6227-2013	Ikegawa, Shiro/0000-0003-0316-2147; 				Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Gregory KE, 2000, J BIOL CHEM, V275, P11498, DOI 10.1074/jbc.275.15.11498; Kawaguchi Y, 1999, SPINE, V24, P2456, DOI 10.1097/00007632-199912010-00006; KEENE DR, 1995, J HISTOCHEM CYTOCHEM, V43, P967, DOI 10.1177/43.10.7560887; KEMPSON GE, 1973, BIOCHIM BIOPHYS ACTA, V297, P456, DOI 10.1016/0304-4165(73)90093-7; Kimura T, 1996, INT ORTHOP, V20, P177, DOI 10.1007/s002640050058; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Matsui H, 1998, SPINE, V23, P1029, DOI 10.1097/00007632-199805010-00013; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Paassilta P, 2001, JAMA-J AM MED ASSOC, V285, P1843, DOI 10.1001/jama.285.14.1843; Rose PS, 2001, SPINE, V26, P403, DOI 10.1097/00007632-200102150-00017; Sambrook PN, 1999, ARTHRITIS RHEUM-US, V42, P366, DOI 10.1002/1529-0131(199902)42:2<366::AID-ANR20>3.0.CO;2-6; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; SCHNEIDERMAN G, 1987, SPINE, V12, P276, DOI 10.1097/00007632-198704000-00016; SEEGMILLER RE, 1981, CONNECT TISSUE RES, V9, P69, DOI 10.3109/03008208109160242; Seki S, 2005, NAT GENET, V37, P607, DOI 10.1038/ng1557; SKOVRON ML, 1992, BAILLIERE CLIN RHEUM, V6, P559, DOI 10.1016/S0950-3579(05)80127-X; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SMITH GN, 1985, J BIOL CHEM, V260, P761; Spranger J, 1998, PEDIATR RADIOL, V28, P745, DOI 10.1007/s002470050459; Tanaka T, 2003, AM J HUM GENET, V73, P812, DOI 10.1086/378593; Videman T, 1996, LOW BACK PAIN: A SCIENTIFIC AND CLINICAL OVERVIEW, P317; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943	28	109	112	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2007	81	6					1271	1277		10.1086/522377	http://dx.doi.org/10.1086/522377			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233NY	17999364	Green Published, Bronze			2022-12-18	WOS:000251098800012
J	Karadimas, CL; Vu, TH; Holve, SA; Chronopoulou, P; Quinzii, C; Johnsen, SD; Kurth, J; Eggers, E; Palenzuela, L; Tanji, K; Bonilla, E; De Vivo, DC; DiMauro, S; Hirano, M				Karadimas, Charalampos L.; Vu, Tuan H.; Holve, Stephen A.; Chronopoulou, Penelope; Quinzii, Catarina; Johnsen, Stanley D.; Kurth, Janice; Eggers, Elizabeth; Palenzuela, Lluis; Tanji, Kurenai; Bonilla, Eduardo; De Vivo, Darryl C.; DiMauro, Salvatore; Hirano, Michio			Navajo neurohepatopathy is caused by a mutation in the MPV17 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DEPLETION; ALPERS-SYNDROME; POLG MUTATIONS; NEUROPATHY; DISEASE; DEFICIENCY; CHILDREN; PROTEIN; ENCODES; KINASE	Navajo neurohepatopathy (NNH) is an autosomal recessive disease that is prevalent among Navajo children in the southwestern United States. The major clinical features are hepatopathy, peripheral neuropathy, corneal anesthesia and scarring, acral mutilation, cerebral leukoencephalopathy, failure to thrive, and recurrent metabolic acidosis with intercurrent infections. Infantile, childhood, and classic forms of NNH have been described. Mitochondrial DNA ( mtDNA) depletion was detected in the livers of two patients, suggesting a primary defect in mtDNA maintenance. Homozygosity mapping of two families with NNH suggested linkage to chromosome 2p24. This locus includes the MPV17 gene, which, when mutated, causes a hepatocerebral form of mtDNA depletion. Sequencing of the MPV17 gene in six patients with NNH from five families revealed the homozygous R50Q mutation described elsewhere. Identification of a single missense mutation in patients with NNH confirms that the disease is probably due to a founder effect and extends the phenotypic spectrum associated with MPV17 mutations.	Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; Wellspan Neurol, York, PA USA; Tuba City Reg Healthcare Corp, Tuba City, AZ USA; St Josephs Childrens Hlth Ctr, Div Pediat Neurol, Phoenix, AZ USA; Barrow Neurol Inst, Phoenix, AZ 85013 USA; Visual Technol LLC, Phoenix, AZ USA	Columbia University; Columbia University; Columbia University; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute	Hirano, M (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, 630 W 168th St,P&S 4-443, New York, NY 10032 USA.	mh29@columbia.edu	Vu, Tuan H/I-6812-2012		NICHD NIH HHS [R01 HD037529, HD32062, P01 HD032062] Funding Source: Medline; NINDS NIH HHS [NS11766, P01 NS011766] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032062] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APPENZELLER O, 1976, ARCH NEUROL-CHICAGO, V33, P733, DOI 10.1001/archneur.1976.00500110001001; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284; SINGLETON R, 1990, NEUROLOGY, V40, P363, DOI 10.1212/WNL.40.2.363; SNYDER RD, 1988, ANN NEUROL, V24, P327; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; WILLIAMS KD, 1990, AM J NEURORADIOL, V11, P400; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	18	109	111	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					544	548		10.1086/506913	http://dx.doi.org/10.1086/506913			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909392	Bronze, Green Published			2022-12-18	WOS:000239830700016
J	Schaid, DJ; McDonnell, SK; Hebbring, SJ; Cunningham, JM; Thibodeau, SN				Schaid, DJ; McDonnell, SK; Hebbring, SJ; Cunningham, JM; Thibodeau, SN			Nonparametric tests of association of multiple genes with human disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SAMPLE-SIZE; POWER; HETEROGENEITY; PHENOTYPE	The genetic basis of many common human diseases is expected to be highly heterogeneous, with multiple causative loci and multiple alleles at some of the causative loci. Analyzing the association of disease with one genetic marker at a time can have weak power, because of relatively small genetic effects and the need to correct for multiple testing. Testing the simultaneous effects of multiple markers by multivariate statistics might improve power, but they too will not be very powerful when there are many markers, because of the many degrees of freedom. To overcome some of the limitations of current statistical methods for case-control studies of candidate genes, we develop a new class of nonparametric statistics that can simultaneously test the association of multiple markers with disease, with only a single degree of freedom. Our approach, which is based on U-statistics, first measures a score over all markers for pairs of subjects and then compares the averages of these scores between cases and controls. Genetic scoring for a pair of subjects is measured by a "kernel" function, which we allow to be fairly general. However, we provide guidelines on how to choose a kernel for different types of genetic effects. Our global statistic has the advantage of having only one degree of freedom and achieves its greatest power advantage when the contrasts of average genotype scores between cases and controls are in the same direction across multiple markers. Simulations illustrate that our proposed methods have the anticipated type I-error rate and that they can be more powerful than standard methods. Application of our methods to a study of candidate genes for prostate cancer illustrates their potential merits, and offers guidelines for interpretation.	Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin, Coll Med, Dept Hlth Sci Res, Harwick 7,200 1st St SW, Rochester, MN 55905 USA.	schaid@mayo.edu		McDonnell, Shannon/0000-0001-6201-369X	NATIONAL CANCER INSTITUTE [U01CA089600, P50CA091956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065450] Funding Source: NIH RePORTER; NCI NIH HHS [CA89600, U01 CA089600, P50 CA091956, CA91956] Funding Source: Medline; NIGMS NIH HHS [R01 GM065450, GM65450] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Conti DV, 2003, HUM HERED, V56, P83, DOI 10.1159/000073736; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fan RZ, 2003, AM J HUM GENET, V72, P850, DOI 10.1086/373966; HOEFFDING W, 1948, ANN MATH STAT, V22, P165; Kowalski J, 2002, J AM STAT ASSOC, V97, P398, DOI 10.1198/016214502760046952; Kowalski J, 2001, BIOINFORMATICS, V17, P775, DOI 10.1093/bioinformatics/17.9.775; Longmate JA, 2001, AM J HUM GENET, V68, P1229, DOI 10.1086/320106; McPeek MS, 2004, BIOMETRICS, V60, P359; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Serfling RJ, 1980, APPROXIMATION THEORE; Slager SL, 2000, GENET EPIDEMIOL, V18, P143, DOI 10.1002/(SICI)1098-2272(200002)18:2<143::AID-GEPI4>3.0.CO;2-5; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; Tzeng JY, 2003, J AM STAT ASSOC, V98, P236, DOI 10.1198/016214503388619256; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; TZENG JY, 2003, THESIS CARNEGIE MELL; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEI LJ, 1985, BIOMETRIKA, V72, P359; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	23	109	115	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					780	793		10.1086/429838	http://dx.doi.org/10.1086/429838			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15786018	Green Published, Bronze			2022-12-18	WOS:000228198300006
J	Weiss, LA; Abney, M; Cook, EH; Ober, C				Weiss, LA; Abney, M; Cook, EH; Ober, C			Sex-specific genetic architecture of whole blood serotonin levels	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCI; TRANSPORTER GENE; LINKAGE ANALYSIS; HEALTH-CARE; ASSOCIATION; EXPRESSION; WOMEN; FAMILIES; REGION; PREVALENCE	Recently, a quantitative-trait locus (QTL) for whole blood serotonin level was identified in a genomewide linkage and association study in a founder population. Because serotonin level is a sexually dimorphic trait, in the present study, we evaluated the sex-specific genetic architecture of whole blood serotonin level in the same population. Here, we use an extended homozygosity-by-descent linkage method that is suitable for large complex pedigrees. Although both males and females have high broad heritability (H-2 = 0.99), females have a higher additive component (h(2) = 0.63 in females; h(2) = 0.27 in males). Furthermore, the serotonin QTL on 17q that was identified previously in this population, integrin beta3 (ITGB3), and a novel locus on 2q influence serotonin levels only in males, whereas linkage to a region on chromosome 6q is specific to females. Both sexes contribute to linkage signals on 12q and 16p. There were, overall, more associations meeting criteria for suggestive significance in males than in females, including those of ITGB3 and the serotonin transporter gene (5HTT). This analysis is consistent with heritable sexual dimorphism in whole blood serotonin levels resulting from the effects of a combination of sex-specific and sex-independent loci.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,Room 507C, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu		Cook, Edwin/0000-0002-5848-5114; Ober, Carole/0000-0003-4626-9809	NHGRI NIH HHS [R01 HG002899, HG 02899] Funding Source: Medline; NHLBI NIH HHS [R01 HL066533, HL 56399, P50 HL056399, HL 66533] Funding Source: Medline; NICHD NIH HHS [U19 HD035482, P01 HD035482, HD 35482] Funding Source: Medline; NIDDK NIH HHS [R01 DK055889, DK 55889] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066533, P50HL056399] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; ASHCROFT GW, 1964, CLIN CHIM ACTA, V9, P364, DOI 10.1016/0009-8981(64)90027-0; Clark AS, 2003, NEUROSCI BIOBEHAV R, V27, P413, DOI 10.1016/S0149-7634(03)00064-2; Conroy J, 2004, MOL PSYCHIATR, V9, P587, DOI 10.1038/sj.mp.4001459; Cook EH, 1997, MOL PSYCHIATR, V2, P247; Davis S, 1996, AM J HUM GENET, V58, P867; Fisher SA, 2002, EUR J HUM GENET, V10, P259, DOI 10.1038/sj.ejhg.5200792; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; GONZALES GF, 1980, LIFE SCI, V27, P647, DOI 10.1016/0024-3205(80)90004-1; Hanna GL, 1998, NEUROPSYCHOPHARMACOL, V18, P102, DOI 10.1016/S0893-133X(97)00097-3; Heninger GR, 1997, P NATL ACAD SCI USA, V94, P4823, DOI 10.1073/pnas.94.10.4823; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; Kim SJ, 2002, MOL PSYCHIATR, V7, P278, DOI 10.1038/sj.mp.4001033; Kimmins S, 2003, DOMEST ANIM ENDOCRIN, V25, P141, DOI 10.1016/S0739-7240(03)00015-8; Klauck SM, 1997, HUM MOL GENET, V6, P2233, DOI 10.1093/hmg/6.13.2233; Kornstein SG, 2000, AM J PSYCHIAT, V157, P1445, DOI 10.1176/appi.ajp.157.9.1445; Leips J, 2000, GENETICS, V155, P1773; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; LOOP FD, 1983, J AM COLL CARDIOL, V1, P383, DOI 10.1016/S0735-1097(83)80064-3; Loughlin J, 2000, RHEUMATOLOGY, V39, P377, DOI 10.1093/rheumatology/39.4.377; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; McCauley JL, 2004, AM J MED GENET B, V127B, P104, DOI 10.1002/ajmg.b.20151; Newman DL, 2004, EUR J HUM GENET, V12, P584, DOI 10.1038/sj.ejhg.5201191; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; ORTIZ J, 1988, LIFE SCI, V43, P983, DOI 10.1016/0024-3205(88)90543-7; Palferman S, 2001, AM J HUM GENET, V69, P570; Pecins-Thompson M, 1998, MOL BRAIN RES, V53, P120, DOI 10.1016/S0169-328X(97)00286-6; Saintier D, 2004, J CELL PHYSIOL, V198, P269, DOI 10.1002/jcp.10406; Schousboe K, 2003, DIABETOLOGIA, V46, P1276, DOI 10.1007/s00125-003-1165-x; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Steiner M, 1999, PSYCHIAT RES, V87, P107, DOI 10.1016/S0165-1781(99)00062-1; Tordjman S, 2001, MOL PSYCHIATR, V6, P434, DOI 10.1038/sj.mp.4000873; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; van Beijsterveldt CEM, 2003, BEHAV GENET, V33, P591, DOI 10.1023/A:1025735002864; Weaver WD, 1996, JAMA-J AM MED ASSOC, V275, P777, DOI 10.1001/jama.275.10.777; Weiss LA, 2004, EUR J HUM GENET, V12, P949, DOI 10.1038/sj.ejhg.5201239; WEISSMAN MM, 1995, SCIENCE, V269, P799, DOI 10.1126/science.7638596; WIRZJUSTICE A, 1977, J NEURAL TRANSM, V41, P7, DOI 10.1007/BF01252961; Yirmiya N, 2001, AM J MED GENET, V105, P381, DOI 10.1002/ajmg.1365; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	45	109	112	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					33	41		10.1086/426697	http://dx.doi.org/10.1086/426697			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15526234	Bronze, Green Published			2022-12-18	WOS:000225643600003
J	Montana, G; Pritchard, JK				Montana, G; Pritchard, JK			Statistical tests for admixture mapping with case-control and cases-only data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; LINKAGE DISEQUILIBRIUM; AFRICAN-AMERICAN; POPULATION-STRUCTURE; ADMIXED POPULATIONS; ADMIRED POPULATIONS; ETHNIC-DIFFERENCES; DISEASE GENES; ASSOCIATION; MARKERS	Admixture mapping is a promising new tool for discovering genes that contribute to complex traits. This mapping approach uses samples from recently admixed populations to detect susceptibility loci at which the risk alleles have different frequencies in the original contributing populations. Although the idea for admixture mapping has been around for more than a decade, the genomic tools are only now becoming available to make this a feasible and attractive option for complex-trait mapping. In this article, we describe new statistical methods for analyzing multipoint data from admixture-mapping studies to detect "ancestry association." The new test statistics do not assume a particular disease model; instead, they are based simply on the extent to which the sample's ancestry proportions at a locus deviate from the genome average. Our power calculations show that, for loci at which the underlying risk-allele frequencies are substantially different in the ancestral populations, the power of admixture mapping can be comparable to that of association mapping but with a far smaller number of markers. We also show that, although "ancestry informative markers" (AIMs) are superior to random single-nucleotide polymorphisms ( SNPs), random SNPs can perform quite well when AIMs are not available. Hence, researchers who study admixed populations in which AIMs are not available can perform admixture mapping with the use of modestly higher densities of random markers. Software to perform the gene-mapping calculations, "MALDsoft," is freely available on the Pritchard Lab Web site.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Pritchard, JK (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St CLSC 507, Chicago, IL 60637 USA.	pritch@uchicago.edu	Peng, Bo/A-6920-2009; Montana, Giovanni/H-2598-2013	Peng, Bo/0000-0001-8225-2284; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002772-01, R01 HG002772] Funding Source: Medline; PHS HHS [GR 2772] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Halder Indrani, 2003, Human Genomics, V1, P52; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee WC, 2003, ANN HUM GENET, V67, P580, DOI 10.1046/j.1529-8817.2003.00052.x; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1999, GENETICS, V152, P713; Risch N, 1997, SCIENCE, V275, P1329; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch N, 2002, GENOME BIOL, V3, DOI [10.1186/GB-2002-3-7-COMMENT2007, DOI 10.1186/GB-2002-3-7-C0MMENT2007, 10.1186/gb-2002-3-7-comment2007]; Rosenberg NA, 2003, SCIENCE, V300; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabatti C, 2003, GENETICS, V164, P829; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N	40	109	115	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					771	789		10.1086/425281	http://dx.doi.org/10.1086/425281			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15386213	Green Published, Bronze			2022-12-18	WOS:000224303500003
J	Collins, JS; Schwartz, CE				Collins, JS; Schwartz, CE			Detecting polymorphisms and mutations in candidate genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA	Greenwood Genetic Center	Collins, JS (corresponding author), Greenwood Genet Ctr, JC Self Res Inst, 1 Gregor Mendel Circle, Greenwood, SC 29646 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH057840] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26202, R01 HD026202] Funding Source: Medline; NIMH NIH HHS [MH57840, R24 MH057840] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))			0	109	111	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1251	1252		10.1086/344344	http://dx.doi.org/10.1086/344344			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12452182	Bronze, Green Published			2022-12-18	WOS:000178884300033
J	Verrelli, BC; McDonald, JH; Argyropoulos, G; Destrol-Bisol, G; Froment, A; Drousiotou, A; Lefranc, G; Helal, AN; Loiselet, J; Tishkoff, SA				Verrelli, BC; McDonald, JH; Argyropoulos, G; Destrol-Bisol, G; Froment, A; Drousiotou, A; Lefranc, G; Helal, AN; Loiselet, J; Tishkoff, SA			Evidence for balancing selection from nucleotide sequence analyses of human G6PD	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MODERN HUMAN ORIGINS; DROSOPHILA-MELANOGASTER; LINKAGE DISEQUILIBRIUM; MOLECULAR EVOLUTION; HAPLOTYPE STRUCTURE; HUMAN POLYMORPHISM; AFRICAN-AMERICANS; HUMAN-POPULATIONS; DNA POLYMORPHISM; COLOR-VISION	Glucose-6-phosphate dehydrogenase (G6PD) mutations that result in reduced enzyme activity have been implicated in malarial resistance and constitute one of the best examples of selection in the human genome. In the present study, we characterize the nucleotide diversity across a 5.2-kb region of G6PD in a sample of 160 Africans and 56 non-Africans, to determine how selection has shaped patterns of DNA variation at this gene. Our global sample of enzymatically normal B alleles and A,A-, and Med alleles with reduced enzyme activities reveals many previously uncharacterized silent-site polymorphisms. In comparison with the absence of amino acid divergence between human and chimpanzee G6PD sequences, we find that the number of G6PD amino acid polymorphisms in human populations is significantly high. Unlike many other G6PD-activity alleles with reduced activity, we find that the age of the A variant, which is common in Africa, may not be consistent with the recent emergence of severe malaria and therefore may have originally had a historically different adaptive function. Overall, our observations strongly support previous genotype-phenotype association studies that proposed that balancing selection maintains G6PD deficiencies within human populations. The present study demonstrates that nucleotide sequence analyses can reveal signatures of both historical and recent selection in the genome and may elucidate the impact that infectious disease has had during human evolution.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Delaware, Newark, DE USA; Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Univ Roma La Sapienza, Dept Anim & Human Biol, Rome, Italy; IRD, UR 092, Orleans, France; Inst Neurol & Genet, Dept Biochem Genet, Nicosia, Cyprus; Univ Sci, Montpellier, France; CNRS, Montpellier, France; Fac Pharm, Immunogenet Lab, Monastir, Tunisia; Univ St Joseph, Unit Med Genet, Beirut, Lebanon	University System of Maryland; University of Maryland College Park; University of Delaware; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Sapienza University Rome; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Universite de Monastir; Saint Joseph University Beirut	Verrelli, BC (corresponding author), Univ Maryland, Dept Biol, Biol Psychol Bldg 144, College Pk, MD 20742 USA.	verrelli@wam.umd.edu	Verrelli, Brian/AAW-9523-2021	Verrelli, Brian/0000-0002-9670-4920; Destro Bisol, Giovanni/0000-0002-4232-9715; Helal, Ahmed Noureddine/0000-0001-8178-2566				Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Aquadro CF, 2001, CURR OPIN GENET DEV, V11, P627, DOI 10.1016/S0959-437X(00)00245-8; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; BERRY A, 1993, GENETICS, V134, P869; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1992, HUM HERED, V42, P327, DOI 10.1159/000154092; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; CHANG JG, 1992, BLOOD, V80, P1079; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; DEEB SS, 1992, AM J HUM GENET, V51, P687; Deinard AS, 2000, AM J PHYS ANTHROPOL, V111, P25, DOI 10.1002/(SICI)1096-8644(200001)111:1<25::AID-AJPA3>3.0.CO;2-R; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Fay JC, 2001, GENETICS, V158, P1227; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; GANCZAKOWSKI M, 1995, AM J HUM GENET, V56, P294; Greenwood B, 2002, NATURE, V415, P670, DOI 10.1038/415670a; GRIFFITHS RC, 1997, PROGR POPULATION GEN, P165; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Harris EE, 2001, CURR BIOL, V11, P774, DOI 10.1016/S0960-9822(01)00223-8; Hey J, 1999, MOL BIOL EVOL, V16, P1423, DOI 10.1093/oxfordjournals.molbev.a026054; Hey J, 1997, MOL BIOL EVOL, V14, P166, DOI 10.1093/oxfordjournals.molbev.a025749; Hoffman SL, 2002, NATURE, V415, P702, DOI 10.1038/415702a; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1992, GENETICS, V132, P583; HUDSON RR, 1985, GENETICS, V111, P147; Jaruzelska J, 1999, GENETICS, V152, P1091; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; KAEDA JS, 1995, AM J HUM GENET, V57, P1335; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; KAY AC, 1992, AM J HUM GENET, V50, P394; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Koda Y, 2001, GENETICS, V158, P747; Kumar S., 2001, MEGA2 MOL EVOLUTIONA; LIVINGSTONE FB, 1971, ANNU REV GENET, V5, P33, DOI 10.1146/annurev.ge.05.120171.000341; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1994, P NATL ACAD SCI USA, V91, P2415, DOI 10.1073/pnas.91.7.2415; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; Nachman MW, 2000, GENETICS, V155, P1855; Nachman MW, 1996, GENETICS, V142, P953; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Nielsen R, 1999, GENETICS, V153, P497; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Ollomo B, 1997, AM J TROP MED HYG, V56, P440, DOI 10.4269/ajtmh.1997.56.440; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Salamon H, 1999, GENETICS, V152, P393; SAUNDERS MA, IN PRESS GENETICS; SIMONSEN KL, 1995, GENETICS, V141, P413; Slatkin M, 1997, AM J HUM GENET, V60, P447; Smirnova I, 2001, GENETICS, V158, P1657; Sokal R. R., 1995, BIOMETRY; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939; TOWN M, 1992, HUM MOL GENET, V1, P171, DOI 10.1093/hmg/1.3.171; Verrelli BC, 2001, GENETICS, V157, P1649; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; Wall JD, 2000, GENETICS, V155, P1865; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WUIF C, 1999, THEOR POPUL BIOL, V56, P183; [No title captured]	79	109	112	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1112	1128		10.1086/344345	http://dx.doi.org/10.1086/344345			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12378426	Green Published, Bronze			2022-12-18	WOS:000178884300009
J	Nakajima, T; Jorde, LB; Ishigami, T; Umemura, S; Emi, M; Lalouel, JM; Inoue, I				Nakajima, T; Jorde, LB; Ishigami, T; Umemura, S; Emi, M; Lalouel, JM; Inoue, I			Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN LIPOPROTEIN-LIPASE; HUMAN ESSENTIAL-HYPERTENSION; DNA-SEQUENCE VARIATION; COMMON DISEASE GENES; MODERN HUMAN ORIGINS; LINKAGE-DISEQUILIBRIUM; BLOOD-PRESSURE; HUMAN-EVOLUTION; UTAH MORMONS; HUMAN GENOME	Variation in the angiotensinogen gene, AGT, has been associated with variation in plasma angiotensinogen levels. In addition, the T235M polymorphism in the AGT product is associated with an increased risk of essential hypertension in multiple populations, making AGT a good example of a quantitative-trait locus underlying susceptibility to a common disease. To better understand genetic variation in AGT, we sequenced a 14.4-kb genomic region spanning the entire AGT and identified 44 single-nucleotide polymorphisms (SNPs). Forty-two SNPs were observed both in 88 white and in 77 Japanese unselected subjects. Six major haplotypes accounted for most of the variation in this region, indicating less allelic complexity than in many other genomic regions. Although the two populations were found to share all of the major AGT haplotypes, there were substantial differences in haplotype frequencies. Pairwise linkage disequilibrium (LD), measured by the D, r(2), and d(2) statistics, demonstrated a general pattern of decline with increasing distance, but, as expected in a small genomic region, individual LD values were highly variable. LD between T235M and each of the other 39 SNPs was assessed in order to model the usefulness of LD to detect a disease-associated mutation. Among the Japanese subjects, 13 (33%) of the SNPs had r(2) values >0.1, whereas this statistic was substantially higher for the white subjects (occurring in 35/39 [90%]). LD between a hypertension-associated promoter mutation, A-6G, and 39 SNPs was also measured. Similar results were obtained, with 33% of the SNPs showing in the Japanese subjects and 92% of the SNPs showing r(2) > 0.1 in the white subjects. This difference, which occurs despite an overall similarity in LD patterns in the two populations, reflects a much higher frequency of the M235-associated haplotype in the white sample. These results have important implications for the usefulness of LD approaches in the mapping of genes underlying susceptibility to complex diseases.	Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, Tokyo 1088639, Japan; Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT USA; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Nippon Med Coll, Inst Gerontol, Dept Mol Biol, Kawasaki, Kanagawa, Japan	University of Tokyo; Utah System of Higher Education; University of Utah; Yokohama City University; Nippon Medical School	Inoue, I (corresponding author), Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	ituro@ims.u-tokyo.ac.jp			NHLBI NIH HHS [HL-54471, U01 HL054471, U10 HL054471] Funding Source: Medline; NIGMS NIH HHS [R01 GM059290, GM-59290] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL054471, U01HL054471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Ajioka RS, 1997, AM J HUM GENET, V60, P1439, DOI 10.1086/515466; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bengtsson K, 1999, J HYPERTENS, V17, P1569, DOI 10.1097/00004872-199917110-00010; Bonnen PE, 2000, AM J HUM GENET, V67, P1437, DOI 10.1086/316908; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Brand E, 1998, HYPERTENSION, V31, P725, DOI 10.1161/01.HYP.31.3.725; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Corvol P, 1997, ENDOCR REV, V18, P662, DOI 10.1210/er.18.5.662; Corvol P, 1999, HYPERTENSION, V33, P1324, DOI 10.1161/01.HYP.33.6.1324; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Dufour C, 2000, GENOMICS, V69, P14, DOI 10.1006/geno.2000.6313; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Eaves IA, 2000, NAT GENET, V25, P320; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hedges SB, 2000, NATURE, V408, P652, DOI 10.1038/35047193; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huttley GA, 1999, GENETICS, V152, P1711; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Iso H, 2000, J HYPERTENS, V18, P1197, DOI 10.1097/00004872-200018090-00005; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jeunemaitre X, 1997, AM J HUM GENET, V60, P1448, DOI 10.1086/515452; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; JORDE LB, 1993, AM J HUM GENET, V53, P1038; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; JORDE LB, 1994, AM J HUM GENET, V54, P884; JORDE LB, 1995, AM J HUM GENET, V56, P11; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Kato N, 1999, J HYPERTENS, V17, P757, DOI 10.1097/00004872-199917060-00006; Kato N, 2000, J HYPERTENS, V18, P1025, DOI 10.1097/00004872-200018080-00006; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kreitman M, 2000, ANNU REV GENOM HUM G, V1, P539, DOI 10.1146/annurev.genom.1.1.539; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lalouel JM, 2001, ADV GENET, V42, P517, DOI 10.1016/S0065-2660(01)42040-2; Larson N, 2000, HYPERTENSION, V35, P1297, DOI 10.1161/01.HYP.35.6.1297; LEWONTIN RC, 1964, GENETICS, V49, P49; LEWONTIN RC, 1973, GENETICS, V74, P175; Lonjou C, 1999, P NATL ACAD SCI USA, V96, P1621, DOI 10.1073/pnas.96.4.1621; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; McGuire G, 2000, BIOINFORMATICS, V16, P130, DOI 10.1093/bioinformatics/16.2.130; McGuire G, 1997, MOL BIOL EVOL, V14, P1125, DOI 10.1093/oxfordjournals.molbev.a025722; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; Nakajima T, 2000, J HUM GENET, V45, P212, DOI 10.1007/s100380070029; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; Niu TH, 1999, ANN EPIDEMIOL, V9, P245, DOI 10.1016/S1047-2797(98)00060-X; OBRIEN E, 1994, HUM BIOL, V66, P743; OBrien E, 1996, AM J HUM BIOL, V8, P609, DOI 10.1002/(SICI)1520-6300(1996)8:5<609::AID-AJHB6>3.0.CO;2-Q; Pan WH, 2000, HUM GENET, V107, P210, DOI 10.1007/s004390000365; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Province MA, 2000, J HYPERTENS, V18, P867, DOI 10.1097/00004872-200018070-00008; Rankinen T, 2000, AM J PHYSIOL-HEART C, V279, pH368, DOI 10.1152/ajpheart.2000.279.1.H368; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sato N, 2000, LIFE SCI, V68, P259, DOI 10.1016/S0024-3205(00)00795-5; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Taittonen L, 1999, AM J HYPERTENS, V12, P858, DOI 10.1016/S0895-7061(99)00060-6; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wall JD, 2000, GENETICS, V155, P1865; Xiong MM, 1998, HUM HERED, V48, P295, DOI 10.1159/000022821; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947	84	109	113	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					108	123		10.1086/338454	http://dx.doi.org/10.1086/338454			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11731937	Green Published, Bronze			2022-12-18	WOS:000172571900011
J	Sun, XF; Marks, DL; Park, WD; Wheatley, CL; Puri, V; O'Brien, JF; Kraft, DL; Lundquist, PA; Patterson, MC; Pagano, RE; Snow, K				Sun, XF; Marks, DL; Park, WD; Wheatley, CL; Puri, V; O'Brien, JF; Kraft, DL; Lundquist, PA; Patterson, MC; Pagano, RE; Snow, K			Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE TYPE-C; SENSITIVE GEL-ELECTROPHORESIS; PROTEIN; STORAGE; GENE; TRANSPORT; REDUCTASE; ANALOG	Niemann-Pick disease type C (NPC) is a fatal, autosomal recessive lipidosis characterized by lysosomal accumulation of unesterified cholesterol and multiple neurological symptoms, such as vertical supranuclear ophthalmoplegia, progressive ataxia, and dementia. More than 90% of cases of NPC are due to a defect in Niemann-Pick C1 (NPC1), a late endosomal, integral membrane protein that plays a role in cholesterol transport or homeostasis. Biochemical diagnosis of NPC has relied on the use of patient skin fibroblasts in an assay to demonstrate delayed low-density lipoprotein (LDL)-derived cholesterol esterification and a cytological technique-filipin staining-to demonstrate the intracellular accumulation of cholesterol. A small percentage of patients, referred to as "NPC variants," present with clinical symptoms of NPC but show near-normal results of these biochemical tests, making laboratory confirmation of NPC disease problematic. Here, we demonstrate that NPC-variant fibroblast samples can be detected as sphingolipid storage disease cells, using a fluorescent sphingolipid analog, BODIPY-lactosylceramide. This lipid accumulated in endosomes/lysosomes in variant cells preincubated with LDL cholesterol but targeted to the Golgi complex in normal cells under these conditions. The reproducibility of this technique was validated in a blinded study. In addition, we performed mutation analysis of the NPC1 gene in NPC variant and "classical" NPC cell samples and found a high incidence of specific mutations within the cysteine-rich region of NPC1 in variants. We also found that 5 of the 12 variant cell samples had no apparent defect in NPC1 but were otherwise indistinguishable from other variant cells. This is a surprising result, since, in general, similar to 90% of patients with NPC possess defects in NPC1. Our findings should be useful for the detection of NPC variants and also may provide significant new insight regarding NPC1 genotype/phenotype correlations.	Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Div Lab Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Neurol, Div Child & Adolescent Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Pagano, RE (corresponding author), Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Guggenheim 621-C,200 1st St SW, Rochester, MN 55905 USA.	Pagano.Richard@mayo.edu	Patterson, Marc/AAI-5056-2020; Patterson, Marc C./H-5331-2019	Park, Walter/0000-0002-0536-9515; Patterson, Marc/0000-0002-1116-126X	NIGMS NIH HHS [GM60934, R01 GM022942, GM22942, R01 GM060934] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022942, R01GM022942, R01GM060934] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chen CS, 1999, LANCET, V354, P901, DOI 10.1016/S0140-6736(98)10034-X; Chen CS, 1997, BIOPHYS J, V72, P37, DOI 10.1016/S0006-3495(97)78645-4; Cruz JC, 2000, J BIOL CHEM, V275, P4013, DOI 10.1074/jbc.275.6.4013; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Greer WL, 1998, AM J HUM GENET, V63, P52, DOI 10.1086/301931; Greer WL, 1999, AM J HUM GENET, V65, P1252, DOI 10.1086/302620; Ioannou YA, 2000, MOL GENET METAB, V71, P175, DOI 10.1006/mgme.2000.3061; Jan MMS, 1998, J CHILD NEUROL, V13, P75, DOI 10.1177/088307389801300206; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; KOVAL M, 1990, J CELL BIOL, V111, P429, DOI 10.1083/jcb.111.2.429; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Mao R, 2000, GENET MED, V2, P131, DOI 10.1097/00125817-200003000-00003; Markoff A, 1998, EUR J HUM GENET, V6, P145, DOI 10.1038/sj.ejhg.5200171; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Morris JA, 1998, MOL MED TODAY, V4, P525, DOI 10.1016/S1357-4310(98)01374-4; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Pagano RE, 2000, METHOD ENZYMOL, V312, P523; Patterson M. C., 2001, METABOLIC MOL BASES, VIII, P3611; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; SIDHU HS, 1993, BIOCHEM CELL BIOL, V71, P467, DOI 10.1139/o93-069; Uc EY, 2000, MOVEMENT DISORD, V15, P1199, DOI 10.1002/1531-8257(200011)15:6<1199::AID-MDS1020>3.0.CO;2-1; Vanier Marie T., 2000, Journal of Inherited Metabolic Disease, V23, P232; VANIER MT, 1988, CLIN GENET, V33, P331; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Vanier MT, 1996, AM J HUM GENET, V58, P118; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; WALKLEY SU, 1995, NEUROSCIENCE, V68, P1027, DOI 10.1016/0306-4522(95)00208-Z; Watari H, 2000, EXP CELL RES, V259, P247, DOI 10.1006/excr.2000.4976; WINSOR EJT, 1978, AM J HUM GENET, V30, P530; Yamamoto T, 2000, J MED GENET, V37, P707, DOI 10.1136/jmg.37.9.707; Yamamoto T, 1999, HUM GENET, V105, P10, DOI 10.1007/s004390051057; Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200	37	109	119	3	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1361	1372		10.1086/320599	http://dx.doi.org/10.1086/320599			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11349231	Bronze, Green Published			2022-12-18	WOS:000169094600007
J	Caraballo, R; Pavek, S; Lemainque, A; Gastaldi, M; Echenne, B; Motte, J; Genton, P; Cersosimo, R; Humbertclaude, V; Fejerman, N; Monaco, AP; Lathrop, MG; Rochette, J; Szepetowski, P				Caraballo, R; Pavek, S; Lemainque, A; Gastaldi, M; Echenne, B; Motte, J; Genton, P; Cersosimo, R; Humbertclaude, V; Fejerman, N; Monaco, AP; Lathrop, MG; Rochette, J; Szepetowski, P			Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POTASSIUM CHANNEL GENE; FRONTAL-LOBE EPILEPSY; MUTATION; SUBUNIT	The syndrome of benign familial infantile convulsions (BFIC) is an autosomal dominant epileptic disorder that is characterized by convulsions, with onset at age 3-12 mo and a favorable outcome. BFIC had been linked to chromosome 19q, whereas the infantile convulsions and choreoathetosis (ICCA) syndrome, in which BFIC is associated with paroxysmal dyskinesias, had been linked to chromosome 16p12-q12. BFIC appears to be frequently associated with paroxysmal dyskinesias, because many additional families from diverse ethnic backgrounds have similar syndromes that have been linked to the chromosome 16 ICCA region. Moreover, one large pedigree with paroxysmal kinesigenic dyskinesias only, has also been linked to the same genomic area. This raised the possibility that families with pure BFIC may be linked to chromosome 16 as well. We identified and studied seven families with BFIC inherited as an autosomal dominant trait. Genotyping was performed with markers at chromosome 19q and 16p12-q12. Although chromosome 19q could be excluded, evidence for linkage in the ICCA region was found, with a maximum two-point LOD score of 3.32 for markers D16S3131 and SPN. This result proves that human chromosome 16p12-q12 is a major genetic locus underlying both BFIC and paroxysmal dyskinesias. The unusual phenotype displayed by one homozygous patient suggests that variability of the ICCA syndrome could be sustained by genetic modifiers.	Hosp Nacl Pediat Professor Juan P Garrahan, Buenos Aires, DF, Argentina; Ctr Natl Genotypage, Evry, France; INSERM, U491, F-13258 Marseille, France; Hop Henri Gastaut, F-13258 Marseille, France; Hop St Eloi, Serv Neuropediat, Montpellier, France; Amer Mem Hosp, Reims, France; Wellcome Trust Ctr Human Genet, Oxford, England; Dept Med Genet, Amiens, France	Hospital de Pediatria Doctor Juan Garrahan; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; CHU de Reims; University of Oxford; Wellcome Centre for Human Genetics	Szepetowski, P (corresponding author), Fac Med Timone, INSERM, U491, 27 Blvd J Moulin, F-13385 Marseille 5, France.		Monaco, Anthony P/A-4495-2010; Humbertclaude, Veronique/A-8383-2008	Monaco, Anthony P/0000-0001-7480-3197; 				Baralle D, 2000, J Med Genet, V37, pE31, DOI 10.1136/jmg.37.10.e31; Bennett LB, 2000, NEUROLOGY, V54, P125, DOI 10.1212/WNL.54.1.125; Berkovic SF, 2000, NEUROLOGY, V55, P169, DOI 10.1212/WNL.55.2.169; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Caraballo R, 1997, REV NEUROLOGIA, V25, P682; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; De Fusco M, 2000, NAT GENET, V26, P275; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ECHENNE B, 1994, BRAIN DEV-JPN, V16, P108, DOI 10.1016/0387-7604(94)90044-2; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gennaro E, 1999, EPILEPSIA, V40, P1799, DOI 10.1111/j.1528-1157.1999.tb01601.x; Giordano L, 1999, NEUROPEDIATRICS, V30, P99, DOI 10.1055/s-2007-973469; Guerrini R, 2000, NEUROLOGY, V55, P738; Guerrini R, 1999, ANN NEUROL, V45, P344, DOI 10.1002/1531-8249(199903)45:3<344::AID-ANA10>3.0.CO;2-9; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEE WL, 1993, J PEDIATR-US, V123, P588, DOI 10.1016/S0022-3476(05)80958-8; Lee WL, 1998, HUM GENET, V103, P608, DOI 10.1007/s004390050876; Leppert MF, 1999, SEMIN NEUROL, V19, P397, DOI 10.1055/s-2008-1040854; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Steinlein OK, 1997, HUM MOL GENET, V6, P943, DOI 10.1093/hmg/6.6.943; Steinwald PM, 1999, CRIT CARE, V3, P11, DOI 10.1186/cc300; Swoboda KJ, 2000, NEUROLOGY, V55, P224, DOI 10.1212/WNL.55.2.224; Szepetowski P., 2000, Annals Academy of Medicine Singapore, V29, P284; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; Szepetowski P, 1998, NEUROGENETICS, V1, P153, DOI 10.1007/s100480050024; Tomita H, 1999, AM J HUM GENET, V65, P1688, DOI 10.1086/302682; Valente EM, 2000, BRAIN, V123, P2040, DOI 10.1093/brain/123.10.2040; VIGEVANO F, 1992, EUR J PEDIATR, V151, P608, DOI 10.1007/BF01957732; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	33	109	122	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					788	794		10.1086/318805	http://dx.doi.org/10.1086/318805			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179027	Green Published, Bronze			2022-12-18	WOS:000166994200024
J	Nyholt, DR				Nyholt, DR			All LODs are not created equal	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							GENETICALLY COMPLEX TRAITS; SIB-PAIR LINKAGE; AFFECTED RELATIVE PAIRS; SINGLE-LOCUS; QUANTITATIVE TRAITS; MODELS; STRATEGIES; SCORES; TESTS; MAPS		Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	Rockefeller University	Nyholt, DR (corresponding author), Rockefeller Univ, Lab Stat Genet, 1230 York Ave, New York, NY 10021 USA.		Nyholt, Dale Robert/J-3174-2017	Nyholt, Dale Robert/0000-0001-7159-3040	NIMH NIH HHS [MH44292] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292, R37MH044292] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barrett S, 1999, AM J MED GENET, V88, P609; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CORDELL HJ, 1995, ANN HUM GENET, V59, P435, DOI 10.1111/j.1469-1809.1995.tb00761.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P225, DOI 10.1002/gepi.1370100403; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hodge SE, 1997, AM J HUM GENET, V60, P217; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; KNAPP M, 1997, GENETIC MAPPING DIS, P150; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1989, GENETICS, V121, P185; MORTON NE, 1955, AM J HUM GENET, V7, P277; Ott J, 2000, AM J HUM GENET, V67, P289, DOI 10.1086/303031; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; Sham P., 1998, STAT HUMAN GENETICS; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Whittemore AS, 1996, AM J HUM GENET, V59, P704	33	109	113	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					282	288		10.1086/303029	http://dx.doi.org/10.1086/303029			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10884360	Bronze, Green Published			2022-12-18	WOS:000089357800004
J	Olson, JM				Olson, JM			A general conditional-logistic model for affected-relative-pair linkage studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; ASYMPTOTIC PROPERTIES; SUSCEPTIBILITY GENES; SIB PAIRS; TESTS; STRATEGIES	Model-free LOD-score methods are often employed to detect linkage between marker loci and common diseases, with samples of affected sib pairs, Although extensions of the basic one-disease-locus model have been proposed that allow separate inclusion of other types of affected relative pairs, discordant relative pairs, covariates, or additional disease loci, a unified framework that can handle all of these features has been lacking. In this report, I propose a conditional-logistic parameterization that generalizes easily to include all of these features. Two data examples, one using simulated data and one using type 1 diabetes, illustrate applications of the models.	Case Western Reserve Univ, Metrohlth Med Ctr R258, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System	Olson, JM (corresponding author), Case Western Reserve Univ, Metrohlth Med Ctr R258, Dept Epidemiol & Biostat, Rammelkamp Ctr Educ & Res, Metrohlth Campus,2500 Metrohlth Dr, Cleveland, OH 44109 USA.				NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NHGRI NIH HHS [HG01577, R01 HG001577, R29 HG001577] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001577, R01HG001577] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CORDELL HJ, 1995, AM J HUM GENET, V57, P920; CORDELL HJ, 1999, GENET EPIDEMIOL, V17, P194; Farrall M, 1997, GENET EPIDEMIOL, V14, P103, DOI 10.1002/(SICI)1098-2272(1997)14:2<103::AID-GEPI1>3.0.CO;2-8; Greenwood CMT, 1999, AM J HUM GENET, V64, P1248, DOI 10.1086/302315; Greenwood CMT, 1997, GENET EPIDEMIOL, V14, P635; Greenwood CMT, 1999, AM J HUM GENET, V64, P871, DOI 10.1086/302288; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Idury RM, 1997, HUM HERED, V47, P197, DOI 10.1159/000154413; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lunetta KL, 1998, GENET EPIDEMIOL, V15, P595, DOI 10.1002/(SICI)1098-2272(1998)15:6<595::AID-GEPI4>3.0.CO;2-4; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Olson JM, 1997, HUM HERED, V47, P110, DOI 10.1159/000154398; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Rogus JJ, 1996, AM J HUM GENET, V59, P1376; *SAGE, 1999, STAT AN GEN EP VERS; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Sham PC, 1997, ANN HUM GENET, V61, P61; Whittemore AS, 1998, AM J HUM GENET, V62, P1228, DOI 10.1086/301820	20	109	111	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1760	1769		10.1086/302662	http://dx.doi.org/10.1086/302662			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577930	Bronze, Green Published			2022-12-18	WOS:000084282500031
J	Rahman, S; Taanman, JW; Cooper, JM; Nelson, I; Hargreaves, I; Meunier, B; Hanna, MG; Garcia, JJ; Capaldi, RA; Lake, BD; Leonard, JV; Schapira, AHV				Rahman, S; Taanman, JW; Cooper, JM; Nelson, I; Hargreaves, I; Meunier, B; Hanna, MG; Garcia, JJ; Capaldi, RA; Lake, BD; Leonard, JV; Schapira, AHV			A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN SKELETAL-MUSCLE; C-OXIDASE; MITOCHONDRIAL-DNA; POINT MUTATION; DEPLETION SYNDROME; CLINICAL-FEATURES; DEFICIENCY; PATIENT; MTDNA; ENCEPHALOMYOPATHY	We report the first missense mutation in the mtDNA gene for subunit II of cytochrome c oxidase (COX). The mutation was identified in a 14-year-old boy with a proximal myopathy and lactic acidosis. Muscle histochemistry and mitochondrial respiratory-chain enzymology demonstrated a marked reduction in COX activity. Immunohistochemistry and immunoblot analyses with COX subunit-specific monoclonal antibodies showed a pattern suggestive of a primary mtDNA defect, most likely involving CO II; for COX subunit II (COX II). mtDNA-sequence analysis demonstrated a novel heteroplasmic T-->A transversion at nucleotide position 7,671 in CO II. This mutation changes a methionine to a lysine residue in the middle of the first N-terminal membrane-spanning region of COX II. The immunoblot studies demonstrated a severe reduction in cross-reactivity, not only for COX II but also for the mtDNA-encoded subunit COX III and for nuclear-encoded subunits Vb, Via, VIb, and VIc. Steady-state levels of the mtDNA-encoded subunit COX I showed a mild reduction, but spectrophotometric analysis revealed a dramatic decrease in COX I-associated heme a(3) levels. These observations suggest that, in the COX protein, a structural association of COX II with COX I is necessary to stabilize the binding of heme a(3) to COX I.	Royal Free & Univ Coll, Sch Med, Univ Dept Clin Neurosci, London NW3 2PF, England; Inst Neurol, Dept Clin Neurol, London, England; Natl Hosp Neurol & Neurosurg, Dept Biochem, London, England; UCL, Dept Biol, London WC1E 6BT, England; Great Ormond St Hosp Sick Children, Dept Histochem, London WC1N 3JH, England; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of London; University College London; UCL Medical School; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Oregon	Schapira, AHV (corresponding author), Royal Free & Univ Coll, Sch Med, Univ Dept Clin Neurosci, Rowland Hill St, London NW3 2PF, England.	schapira@rfhsm.ac.uk	Hargreaves, Iain/AAJ-6757-2020; Cooper, Jonathan/GLS-9195-2022; Cooper, J Mark/D-5826-2013; Taanman, Jan W/A-5379-2011; Rahman, Shamima/C-5232-2008; Rahman, Shamima/M-7904-2019; Schapira, Anthony H V/A-1245-2010; Hanna, Michael G/B-1995-2009	Cooper, Jonathan/0000-0002-2358-1050; Cooper, J Mark/0000-0002-3007-3054; Taanman, Jan W/0000-0002-5476-9785; Rahman, Shamima/0000-0003-2088-730X; Schapira, Anthony H V/0000-0002-3018-3966; Hanna, Michael/0000-0003-0825-4075; Meunier, Brigitte/0000-0002-6988-4663; nelson, isabelle/0000-0001-6390-622X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams PL, 1997, ANN NEUROL, V41, P268, DOI 10.1002/ana.410410219; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U; DARLEYUSMAR VM, 1983, P NATL ACAD SCI-BIOL, V80, P5103, DOI 10.1073/pnas.80.16.5103; DIMAURO S, 1983, ANN NEUROL, V14, P226, DOI 10.1002/ana.410140209; DIMAURO S, 1994, MITOCHONDRIAL DISORD, P91; FILIP MI, 1990, HISTOCHEMISTRY PATHO; Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835; Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910; HARTLEY A, 1993, BRAIN RES, V627, P349, DOI 10.1016/0006-8993(93)90341-J; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410; Lee N, 1998, BBA-MOL BASIS DIS, V1406, P1, DOI 10.1016/S0925-4439(98)00003-9; MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; Meunier B, 1998, J MOL BIOL, V283, P727, DOI 10.1006/jmbi.1998.2132; Meunier B, 1998, ANAL BIOCHEM, V260, P237, DOI 10.1006/abio.1998.2704; Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; RAHMAN S, 1997, METAB DIS S1, V20, P56; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239; STOWARD PJ, 1991, HISTOCHEMISTRY; Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935; TAANMAN JW, 1994, BIOCHEMISTRY-US, V33, P11833, DOI 10.1021/bi00205a020; Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Weber K, 1997, AM J HUM GENET, V60, P373; YASIN R, 1977, J NEUROL SCI, V32, P347, DOI 10.1016/0022-510X(77)90018-1; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	36	109	110	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1030	1039		10.1086/302590	http://dx.doi.org/10.1086/302590			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486321	Green Published, Bronze			2022-12-18	WOS:000082910000011
J	Azuma, N; Yamaguchi, Y; Handa, H; Hayakawa, M; Kanai, A; Yamada, M				Azuma, N; Yamaguchi, Y; Handa, H; Hayakawa, M; Kanai, A; Yamada, M			Missense mutation in the alternative splice region of the PAX6 gene in eye anomalies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-BINDING SUBDOMAINS; PAIRED BOX GENE; WAARDENBURG SYNDROME; POINT MUTATION; DOMAIN; ANIRIDIA; RECOGNITION; SEQUENCE; PROTEINS	The PAX6 gene is involved in ocular morphogenesis, and PAX6 mutations have been detected in various types of ocular anomalies, including aniridia, Peters anomaly, corneal dystrophy, congenital cataract, and foveal hypoplasia. The gene encodes a transcriptional regulator that recognizes target genes through its paired-type DNA-binding domain. The paired domain is composed of two distinct DNA-binding subdomains, the N-terminal subdomain (NTS) and the C-terminal subdomain. (CTS), which bind respective consensus DNA sequences. The human PAX6 gene produces two alternative splice isoforms that have the distinct structure of the paired domain. The insertion, into the NTS, of 14 additional amino acids encoded by exon 5a abolishes the DNA-binding activity of the NTS and unmasks the DNA-binding ability of the CTS. Thus, exon 5a appears to function as a molecular switch that specifies target genes. We ascertained a novel missense mutation in four pedigrees with Peters anomaly, congenital cataract, Axen-feldt anomaly, and/or foveal hypoplasia, which, to our knowledge, is the first mutation identified in the splice-variant region. A T-->A transition at the 20th nucleotide position of exon 5a results in a Val-->Asp (GTC-->GAC) substitution at the 7th codon of the alternative splice region. Functional analyses demonstrated that the V54D mutation slightly increased NTS binding and decreased CTS transactivation activity to almost half.	Natl Childrens Hosp, Dept Ophthalmol, Setagaya Ku, Tokyo 1548509, Japan; Juntendo Univ, Sch Med, Dept Ophthalmol, Tokyo 113, Japan; Natl Childrens Med Res Ctr, Tokyo 154, Japan; Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Biomol Engn, Yokohama, Kanagawa 227, Japan	Juntendo University; National Center for Child Health & Development - Japan; Tokyo Institute of Technology	Azuma, N (corresponding author), Natl Childrens Hosp, Dept Ophthalmol, Setagaya Ku, 3-35-31 Taishido, Tokyo 1548509, Japan.		Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X				Azuma N, 1996, NAT GENET, V13, P141, DOI 10.1038/ng0696-141; Azuma N, 1998, INVEST OPHTH VIS SCI, V39, P2524; Azuma N, 1998, INVEST OPHTH VIS SCI, V39, P828; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; CHISHOLM AD, 1995, NATURE, V377, P52, DOI 10.1038/377052a0; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; Gehring WJ, 1996, GENES CELLS, V1, P11, DOI 10.1046/j.1365-2443.1996.11011.x; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; MARTHA A, 1994, AM J HUM GENET, V54, P801; MIRZAYANS F, 1995, AM J HUM GENET, V57, P539; Moore DD, 1995, GLOB MOB SURV; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; TADOKORO K, 1993, HUM MOL GENET, V2, P2205, DOI 10.1093/hmg/2.12.2205; Tang HK, 1997, HUM MOL GENET, V6, P381, DOI 10.1093/hmg/6.3.381; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; VOGAN KJ, 1993, GENOMICS, V17, P364, DOI 10.1006/geno.1993.1333; WALTHER C, 1991, DEVELOPMENT, V113, P1435; XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9; Yamaguchi Y, 1997, GENES CELLS, V2, P255, DOI 10.1046/j.1365-2443.1997.1170315.x	28	109	110	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					656	663		10.1086/302529	http://dx.doi.org/10.1086/302529			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441571	Green Published, Bronze			2022-12-18	WOS:000082426400009
J	McIntosh, I; Dreyer, SD; Clough, MV; Dunston, JA; Eyaid, W; Roig, CM; Montgomery, T; Ala-Mello, S; Kaitila, I; Winterpacht, A; Zabel, B; Frydman, M; Cole, WG; Francomano, CA; Lee, B				McIntosh, I; Dreyer, SD; Clough, MV; Dunston, JA; Eyaid, W; Roig, CM; Montgomery, T; Ala-Mello, S; Kaitila, I; Winterpacht, A; Zabel, B; Frydman, M; Cole, WG; Francomano, CA; Lee, B			Mutation analysis of LMX1B gene in nail-patella syndrome patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANTENNAPEDIA HOMEODOMAIN; VERTEBRATE LIMB; SPECTROSCOPY; DOMAIN	Nail-patella syndrome (NPS), a pleiotropic disorder exhibiting autosomal dominant inheritance, has been studied for >100 years. Recent evidence shows that NPS is the result of mutations in the LIM-homeodomain gene LMX1B. To determine whether specific LMX1B mutations are associated with different aspects of the NPS phenotype, we screened a cohort of 41 NPS families for LMX1B mutations. A total of 25 mutations were identified in 37 families. The nature of the mutations supports the hypothesis that NPS is the result of haploin-sufficiency for LMX1B. There was no evidence of correlation between aspects of the NPS phenotype and specific mutations.	Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21287 USA; Johns Hopkins Univ, Predoctoral Training Program Human Genet, Baltimore, MD 21287 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA; Univ Newcastle, Dept Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; Univ Mainz, Dept Pediat, Mainz, Germany; Chaim Sheba Med Ctr, Inst Human Genet, IL-52621 Tel Hashomer, Israel; Hosp Sick Children, Div Orthoped, Toronto, ON M5G 1X8, Canada	Johns Hopkins University; Johns Hopkins University; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Newcastle University - UK; University of Helsinki; Helsinki University Central Hospital; Johannes Gutenberg University of Mainz; Chaim Sheba Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McIntosh, I (corresponding author), Johns Hopkins Univ, Inst Med Genet, 600 N Wolfe St,Blalock 1012G, Baltimore, MD 21287 USA.				NIAMS NIH HHS [AR44702, AR44738] Funding Source: Medline; NIGMS NIH HHS [GM07814] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044738, R55AR044738, R29AR044738, R01AR044702] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ausubel FM, 1994, CURRENT PROTOCOLS MO; BEALS RK, 1969, J BONE JOINT SURG AM, VA 51, P505, DOI 10.2106/00004623-196951030-00008; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BELLUS GA, 1995, AM J HUM GENET, V56, P368; BYERS PH, 1997, METABOLIC MOL BASIS, P4029; CARBONARA P, 1964, AM J MED SCI, V248, P139, DOI 10.1097/00000441-196408000-00002; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; COOPER DN, 1997, METABOLIC MOL BASIS, P259; Curtiss J, 1998, BIOESSAYS, V20, P58, DOI 10.1002/(SICI)1521-1878(199801)20:1&lt;58::AID-BIES9&gt;3.0.CO;2-O; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Duba HC, 1998, EUR J HUM GENET, V6, P75, DOI 10.1038/sj.ejhg.5200155; Engelkamp D, 1996, CURR OPIN GENET DEV, V6, P334, DOI 10.1016/S0959-437X(96)80011-6; Eyaid WM, 1998, HUM GENET, V103, P525, DOI 10.1007/s004390050862; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Iannotti CA, 1997, GENOMICS, V46, P520, DOI 10.1006/geno.1997.5075; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lichter PR, 1997, AM J OPHTHALMOL, V124, P506, DOI 10.1016/S0002-9394(14)70866-9; LITTLE EM, 1897, LANCET, V2, P781; MAQUAT LE, 1995, RNA, V1, P453; MCINTOSH L, 1997, AM J HUM GENET, V60, P133; QIAN YQ, 1994, P NATL ACAD SCI USA, V91, P4091, DOI 10.1073/pnas.91.9.4091; QIAN YQ, 1993, J MOL BIOL, V234, P1070, DOI 10.1006/jmbi.1993.1660; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; QIAN YQ, 1990, CELL, V61, P548; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0; Vollrath D, 1998, HUM MOL GENET, V7, P1091, DOI 10.1093/hmg/7.7.1091; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; ZENG WL, 1993, DEVELOPMENT, V118, P339	33	109	112	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1651	1658		10.1086/302165	http://dx.doi.org/10.1086/302165			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837817	hybrid, Green Published			2022-12-18	WOS:000077707700010
J	Boye, E; Mollet, G; Forestier, L; Cohen-Solal, L; Heidet, H; Cochat, P; Grunfeld, JP; Palcoux, JB; Gubler, MC; Antignac, C				Boye, E; Mollet, G; Forestier, L; Cohen-Solal, L; Heidet, H; Cochat, P; Grunfeld, JP; Palcoux, JB; Gubler, MC; Antignac, C			Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASEMENT-MEMBRANE COLLAGEN; IV COLLAGEN; CHAIN; IDENTIFICATION; ALPHA-6(IV); EXPRESSION; SEQUENCE; PROTEIN; ORGANIZATION; CHROMOSOME-2	Autosomal recessive Alport syndrome is a progressive hematuric glomerulonephritis characterized by glomerular basement membrane abnormalities and associated with mutations in either the COL4A3 or the COL4A4 gene, which encode the alpha 3 and alpha 4 type IV collagen chains, respectively. To date, mutation screening in the two genes has been hampered by the lack of genomic structure information. We report here the complete characterization of the 48 exons of the COL4A4 gene, a comprehensive gene screen, and the subsequent detection of 10 novel mutations in eight patients diagnosed with autosomal recessive Abort syndrome. Furthermore, we identified a glycine to alanine substitution in the collagenous domain that is apparently silent in the heterozygous carriers, in 11.5% of all control individuals, and in one control individual homozygous for this glycine substitution. There has been no previous finding of a glycine substitution that is not associated with any obvious phenotype in homozygous individuals.	Univ Paris 05, INSERM U423, Hop Necker Enfants Malad, F-75015 Paris, France; Univ Paris 05, Serv Nephrol, Hop Necker Enfants Malad, F-75015 Paris, France; Hop Edouard Herriot, Dept Pediat, Lyon, France; Hop Hotel Dieu, Serv Pediat B, Clermont Ferrand, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; CHU Clermont Ferrand	Antignac, C (corresponding author), Univ Paris 05, INSERM U423, Hop Necker Enfants Malad, Tour Lavoisier 6 Etage,149 Rue Sevres, F-75015 Paris, France.	antignac@necker.fr	Mollet, Geraldine/E-8049-2017; ANTIGNAC, Corinne/H-8945-2017	Mollet, Geraldine/0000-0003-4685-5736; ANTIGNAC, Corinne/0000-0002-9934-4940; Heidet, Laurence/0000-0002-1362-5515; Gubler, Marie-Claire/0000-0002-3526-5661				ANTIGNAC C, 1994, J CLIN INVEST, V93, P1195, DOI 10.1172/JCI117073; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BUTTICE G, 1990, J MOL EVOL, V30, P479, DOI 10.1007/BF02101102; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; CAMERON JS, 1998, OXFORD TXB CLIN NEPH, P441; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DING J, 1995, J AM SOC NEPHROL, V5, P1714; GUBLER MC, 1995, KIDNEY INT, V47, P1142, DOI 10.1038/ki.1995.163; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Jefferson JA, 1997, NEPHROL DIAL TRANSPL, V12, P1595, DOI 10.1093/ndt/12.8.1595; KAMAGATA Y, 1992, J BIOL CHEM, V267, P23753; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; KLEPPEL MM, 1989, AM J PATHOL, V134, P813; KNEBELMANN B, 1995, HUM MOL GENET, V4, P675, DOI 10.1093/hmg/4.4.675; Knebelmann B, 1996, AM J HUM GENET, V59, P1221; Krawczak M, 1997, TRENDS GENET, V13, P121, DOI 10.1016/S0168-9525(97)01068-8; LEINONEN A, 1994, J BIOL CHEM, V269, P26172; Lemmink HH, 1997, HUM MUTAT, V9, P477; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; MARIYAMA M, 1992, GENOMICS, V13, P809, DOI 10.1016/0888-7543(92)90157-N; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Momota R, 1998, FEBS LETT, V424, P11, DOI 10.1016/S0014-5793(98)00128-8; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; OOHASHI T, 1995, J BIOL CHEM, V270, P26863, DOI 10.1074/jbc.270.45.26863; PEISSEL B, 1995, J CLIN INVEST, V96, P1948, DOI 10.1172/JCI118241; Rozet JM, 1996, GENOMICS, V36, P554, DOI 10.1006/geno.1996.0508; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SOININEN R, 1989, J BIOL CHEM, V264, P13565; SUGIMOTO M, 1993, FEBS LETT, V330, P122, DOI 10.1016/0014-5793(93)80256-T; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; WESTERHAUSEN A, 1990, J BIOL CHEM, V265, P13995; ZHOU J, 1994, J BIOL CHEM, V269, P13193; [No title captured]	35	109	117	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1329	1340		10.1086/302106	http://dx.doi.org/10.1086/302106			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792860	Bronze, Green Published			2022-12-18	WOS:000076985200009
J	Grice, DE; Leckman, JF; Pauls, DL; Kurlan, R; Kidd, KK; Pakstis, AJ; Chang, FM; Buxbaum, JD; Cohen, DJ; Gelernter, J				Grice, DE; Leckman, JF; Pauls, DL; Kurlan, R; Kidd, KK; Pakstis, AJ; Chang, FM; Buxbaum, JD; Cohen, DJ; Gelernter, J			Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D2-DOPAMINE RECEPTOR; DRD4 GENE; DISORDER; DISEASE; INHERITANCE; ASSOCIATION; EXPRESSION; EXCLUSION; CLOZAPINE; VARIANTS	Dopaminergic abnormalities are implicated in the pathogenesis of Tourette syndrome (TS) and chronic multiple ties, We used the transmission-disequilibrium test (TDT) method to test for linkage disequilibrium between a specific allele (the seven-repeat allele (DRD4*7R) of the exon 3 VNTR polymorphic site) at the D4 dopamine receptor locus (DRD4) and expression of chronic multiple ties and TS, This particular allele had been shown in functional studies to have different binding properties compared with the other common alleles in this DRD4 polymorphic system, We studied 64 family trios (consisting of an affected person and two parents, at least one heterozygous for DRD4*7R), including 12 nuclear family trios and 52 trios from four large TS kindreds, The DRD4*7R allele was transmitted significantly more frequently than expected (chi(TDT)(2) ranging from 8.47 [P < .004] to 10.80 [P = .001], depending on breadth of disease definition and inclusion or exclusion of inferred genotypes), Confirmation of this finding will depend on either replication in other samples or the identification of a transmitted functional mutation within this sample.	VET ADM CONNECTICUT HEALTHCARE SYST,DEPT PSYCHIAT,W HAVEN,CT 06516; YALE UNIV,SCH MED,CTR CHILD STUDY,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,CHILDRENS RES CTR,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PSYCHIAT,DIV MOL PSYCHIAT,NEW HAVEN,CT 06510; UNIV ROCHESTER,SCH MED & DENT,ROCHESTER,NY; ROCKEFELLER UNIV,NEW YORK,NY 10021	Yale University; Yale University; Yale University; Yale University; University of Rochester; Rockefeller University			Leckman, James/O-2426-2015; Buxbaum, Joseph D/G-6001-2010; Grice, Dorothy E/X-3372-2019	Grice, Dorothy E/0000-0002-8833-2549; Buxbaum, Joseph/0000-0001-8898-8313; Gelernter, Joel/0000-0002-4067-1859	NATIONAL INSTITUTE OF MENTAL HEALTH [K20MH000931, P01MH049351] Funding Source: NIH RePORTER; NIMH NIH HHS [MH18268, MH49351, MH00931] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASGHARI V, 1994, MOL PHARMACOL, V46, P364; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; CATALANO M, 1993, BIOL PSYCHIAT, V34, P459, DOI 10.1016/0006-3223(93)90236-7; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; COHEN DJ, 1994, J AM ACAD CHILD PSY, V33, P2, DOI 10.1097/00004583-199401000-00002; COMINGS DE, 1987, AM J HUM GENET, V41, P701; CURTIS D, 1995, AM J HUM GENET, V56, P811; DENKLA MB, 1976, JAMA-J AM MED ASSOC, V235, P1379; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; ERENBERG G, 1985, NEUROLOGY, V35, P1346, DOI 10.1212/WNL.35.9.1346; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FEINBERG M, 1979, ARCH GEN PSYCHIAT, V36, P979; GELERNTER J, 1990, ARCH GEN PSYCHIAT, V47, P1073; GELERNTER J, 1992, GENOMICS, V13, P208, DOI 10.1016/0888-7543(92)90222-E; GELERNTER J, 1993, AM J PSYCHIAT, V150, P449; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; Gelernter J, 1995, GENOMICS, V30, P459, DOI 10.1006/geno.1995.1265; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HASSTEDT SJ, 1995, AM J HUM GENET, V57, P682; HIGGINS MJ, 1994, GENOMICS, V23, P211, DOI 10.1006/geno.1994.1479; JANKOVIC J, 1984, NEUROLOGY, V34, P688, DOI 10.1212/WNL.34.5.688; KIDD KK, 1980, ARCH GEN PSYCHIAT, V37, P1336; KIDD KK, 1993, AM J MED GENET, V48, P71, DOI 10.1002/ajmg.1320480202; Klawans H L, 1982, Adv Neurol, V35, P415; KURLAN R, 1986, NEUROLOGY, V36, P772, DOI 10.1212/WNL.36.6.772; KURLAN R, 1992, ARCH NEUROL-CHICAGO, V49, P874, DOI 10.1001/archneur.1992.00530320106020; KURLAN R, 1989, NEUROLOGY, V39, P1625, DOI 10.1212/WNL.39.12.1625; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LECKMAN JF, 1995, NEUROPSYCHOPHARMACOL, V12, P73, DOI 10.1016/0893-133X(94)00070-G; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; LOMBROSO PJ, 1991, NEUROLOGY, V41, P1984, DOI 10.1212/WNL.41.12.1984; MALISON RT, 1995, AM J PSYCHIAT, V152, P1359; MEADORWOODRUFF JH, 1994, NEUROPSYCHOPHARMACOL, V10, P239, DOI 10.1038/npp.1994.27; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; NOTHEN MM, 1994, HUM MOL GENET, V3, P2207, DOI 10.1093/hmg/3.12.2207; Ott J, 1996, NATURE, V379, P772, DOI 10.1038/379772a0; PAKSTIS AJ, 1991, AM J HUM GENET, V48, P281; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; PAULS DL, 1993, J AM ACAD CHILD PSY, V32, P1044, DOI 10.1097/00004583-199309000-00025; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PETERSON BS, 1992, PSYCHONEUROENDOCRINO, V17, P553, DOI 10.1016/0306-4530(92)90015-Y; RAO PA, 1994, ARCH GEN PSYCHIAT, V51, P912; SEEMAN P, 1994, AM J MED GENET, V54, P384, DOI 10.1002/ajmg.1320540419; SHAPIRO E, 1989, ARCH GEN PSYCHIAT, V46, P722; SINGER HS, 1991, ANN NEUROL, V30, P558, DOI 10.1002/ana.410300408; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SVERD J, 1989, J AM ACAD CHILD PSY, V28, P574, DOI 10.1097/00004583-198907000-00016; SWEET RD, 1976, ARCH GEN PSYCHIAT, V31, P857; THOMSON G, 1995, AM J HUM GENET, V57, P487; VANTOL HHM, 1992, NATURE, V358, P149; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; WALKUP JT, 1996, AM J HUM GENET, V59; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WONG DF, 1994, J NUCL MED, V35, pP130; 1993, ARCH NEUROL-CHICAGO, V50, P1013	56	109	118	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1996	59	3					644	652						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN625	8751866				2022-12-18	WOS:A1996VN62500019
J	Strass, E; McCabe, ERB; Biesecker, L; Cassidy, S; Chakravarti, A; Grody, W; Juengst, E; Khory, M; Knoppers, BM; Motulsky, A; Phillips, JA; Spence, MA				Strass, E; McCabe, ERB; Biesecker, L; Cassidy, S; Chakravarti, A; Grody, W; Juengst, E; Khory, M; Knoppers, BM; Motulsky, A; Phillips, JA; Spence, MA			ASHG REPORT - Statement on informed consent for genetic research	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; CASE WESTERN RESERVE UNIV,SCH MED,CTR HUMAN GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CLEVELAND,OH 44106; UNIV CALIF LOS ANGELES,SCH MED,DEPT PATHOL & LAB MED,LOS ANGELES,CA 90024; CASE WESTERN RESERVE UNIV,SCH MED,CTR BIOMED ETH,CLEVELAND,OH 44106; CTR DIS CONTROL,DIV BIRTH DEFECTS & DEV DISABIL,ATLANTA,GA 30333; UNIV MONTREAL,SCH LAW,CTR RES PUBL LAW,MONTREAL,PQ H3C 3J7,CANADA; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; VANDERBILT UNIV,MED CTR,DIV GENET,NASHVILLE,TN; UNIV CALIF IRVINE,MED CTR,DEPT PEDIAT,IRVINE,CA 92717	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Case Western Reserve University; Case Western Reserve University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Case Western Reserve University; Centers for Disease Control & Prevention - USA; Universite de Montreal; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; University of California System; University of California Irvine	Strass, E (corresponding author), AMER SOC HUMAN GENET,9650 ROCKVILLE PIKE,BETHESDA,MD 20814, USA.		Biesecker, Leslie/AAG-2526-2021					CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; EARLEY CL, 1995, AM J HUM GENET, V57, P727; GRODY WW, 1995, DIAGN MOL PATHOL, V4, P155, DOI 10.1097/00019606-199509000-00001; *NAT ACAD SCI I ME, 1994, ASS GEN RISKS IMPL H; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, SCREEN COUNS GEN CON; 1995, AM J HUM GENET, V57, P1499	6	109	109	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					471	474						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288					2022-12-18	WOS:A1996VM28800025
J	WATKINS, PA; GOULD, SJ; SMITH, MA; BRAITERMAN, LT; WEI, HM; KOK, F; MOSER, AB; MOSER, HW; SMITH, KD				WATKINS, PA; GOULD, SJ; SMITH, MA; BRAITERMAN, LT; WEI, HM; KOK, F; MOSER, AB; MOSER, HW; SMITH, KD			ALTERED EXPRESSION OF ALDP IN X-LINKED ADRENOLEUKODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEROXISOMAL TARGETING SIGNAL; CHAIN FATTY-ACIDS; LONG-CHAIN; FIREFLY LUCIFERASE; OXIDATION; PROTEINS	X-linked adrenoleukodystrophy (ALD) is a neurodegenerative disorder with variable phenotypic expression that is characterized by elevated plasma and tissue levels of very long-chain fatty acids. However, the product of the gene defective in ALD (ALDP) is a membrane transporter of the ATP-binding cassette family of proteins and is not related to enzymes known to activate or oxidize fatty acids. We generated an antibody that specifically recognizes the C-terminal 18 amino acids of ALDP and can detect ALDP by indirect immunofluorescence. To better understand the mechanism by which mutations in ALDP lead to disease, we used this antibody to examine the subcellular distribution and relative abundance of ALDP in skin fibroblasts from normal individuals and ALD patients. Punctate immunoreactive material typical of fibroblast peroxisomes was observed in cells from seven normal controls and eight non-ALD patients. Of 35 ALD patients tested, 17 had the childhood-onset cerebral form of the disease, 13 had the milder adult phenotype adrenomyeloneuropathy, 3 had adrenal insufficiency only, and 2 were affected fetuses. More than two-thirds (69%) of all patients studied showed no punctate immunoreactive material. There was no correlation between the immunofluorescence pattern and clinical phenotype. We determined the mutation in the ALD gene in 15 of these patients. Patients with either a deletion or frameshift mutation lacked ALDP immunoreactivity, as expected. Four of 11 patients with missense mutations were also immunonegative, indicating that these mutations affected the stability or localization of ALDP. In the seven immunopositive patients with missense mutations, correlation of the location and nature of the amino acid substitution may provide new insights into the function of this peroxisomal membrane protein. Furthermore, the study of female relatives of immunonegative ALD probands may aid in the assessment of heterozygote status.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	WATKINS, PA (corresponding author), JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER RES INST,707 N BROADWAY,BALTIMORE,MD 21205, USA.			Watkins, Paul A./0000-0002-3246-1405	NCRR NIH HHS [RR 00035] Funding Source: Medline; NICHD NIH HHS [HD 10981, HD 24061] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERGER J, 1994, BIOCHEM BIOPH RES CO, V205, P1638, DOI 10.1006/bbrc.1994.2855; CARTIER N, 1993, HUM MOL GENET, V2, P1949, DOI 10.1093/hmg/2.11.1949; FANEN P, 1994, HUM MOL GENET, V3, P1903; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; IGARASHI M, 1976, J NEUROCHEM, V26, P851, DOI 10.1111/j.1471-4159.1976.tb04462.x; JANSKI AM, 1980, BIOCHEM J, V186, P423, DOI 10.1042/bj1860423; KELLER GA, 1987, P NATL ACAD SCI USA, V84, P3264, DOI 10.1073/pnas.84.10.3264; KEMP S, 1994, BIOCHEM BIOPH RES CO, V202, P647, DOI 10.1006/bbrc.1994.1979; KOK F, IN PRESS HUM MUTAT; KOSTER W, 1992, MOL GEN GENET, V232, P399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZO O, 1988, P NATL ACAD SCI USA, V85, P7647, DOI 10.1073/pnas.85.20.7647; LIGTENBERG MJL, 1995, AM J HUM GENET, V56, P44; MASUMOTO T, 1994, JPN J HUM GENET, V39, P345, DOI 10.1007/BF01874053; McCombie W R, 1992, DNA Seq, V2, P289, DOI 10.3109/10425179209030961; MCGUINNESS MC, 1993, BIOCHEM MED METAB B, V49, P228, DOI 10.1006/bmmb.1993.1025; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; MOSER HW, 1980, ANN NEUROL, V7, P542, DOI 10.1002/ana.410070607; Moser HW, 1995, METABOLIC MOL BASES, V7h, P2325; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Sambrook J., 1989, MOL CLONING LAB MANU; SAURIN W, 1994, MOL MICROBIOL, V12, P993, DOI 10.1111/j.1365-2958.1994.tb01087.x; SHANI N, IN PRESS P NATL ACAD; SINGH H, 1988, ARCH BIOCHEM BIOPHYS, V266, P486, DOI 10.1016/0003-9861(88)90281-0; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V359, P382; SINGH I, 1984, P NATL ACAD SCI-BIOL, V81, P4203, DOI 10.1073/pnas.81.13.4203; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; UCHIYAMA A, 1994, BIOCHEM BIOPH RES CO, V198, P632, DOI 10.1006/bbrc.1994.1092; WALKER JE, 1992, EMBO J, V1, P945; WANDERS RJA, 1988, BIOCHEM BIOPH RES CO, V153, P618, DOI 10.1016/S0006-291X(88)81140-9	32	109	111	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					292	301						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668254				2022-12-18	WOS:A1995RL77100011
J	ROBINSON, WP; BINKERT, F; BERNASCONI, F; LORDASANCHEZ, I; WERDER, EA; SCHINZEL, AA				ROBINSON, WP; BINKERT, F; BERNASCONI, F; LORDASANCHEZ, I; WERDER, EA; SCHINZEL, AA			MOLECULAR STUDIES OF CHROMOSOMAL MOSAICISM - RELATIVE FREQUENCY OF CHROMOSOME GAIN OR LOSS AND POSSIBLE ROLE OF CELL SELECTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARENTAL ORIGIN; EXTRA CHROMOSOME; REDUCED RECOMBINATION; UNIPARENTAL DISOMY; LINKAGE MAP; NONDISJUNCTION; TRISOMY-21; ASSOCIATION; AGE	Studies of uniparental disomy and origin of nonmosaic trisomies indicate that both gain and loss of a chromosome can occur after fertilization. It is therefore of interest to determine both the relative frequency with which gain or loss can contribute to chromosomal mosaicism and whether these frequencies are influenced by selective factors. Thirty-two mosaic cases were examined with molecular markers, to try to determine which was the primary and which was the secondary cell line: 16 cases of disomy/trisomy mosaicism (5 trisomy 8, 2 trisomy 13, 1 trisomy 18, 4 trisomy 21, and 4 involving the X chromosome), 14 cases of 45,X/46,XX, and 2 cases of 45,X/47,XXX. Of the 14 cases of mosaic 45,X/46,XX, chromosome loss from a normal disomic fertilization predominated, supporting the hypothesis that 45,X might be compatible with survival only when the 45,X cell line arises relatively late in development. Most cases of disomy/trisomy mosaicism involving chromosomes 13, 18, 21, and X were also frequently associated with somatic loss of one (or more) chromosome, in these cases from a trisomic fertilization. By contrast, four of the five trisomy 8 cases were consistent with a somatic gain of a chromosome 8 during development from a normal zygote. It is possible that survival of trisomy 8 is also much more likely when the aneuploid cell line arises relatively late in development.	UNIV ZURICH, INST MED GENET, ZURICH, SWITZERLAND; UNIV ZURICH, KINDERKLIN, ZURICH, SWITZERLAND	University of Zurich; University of Zurich			Robinson, Wendy/AAB-6420-2020; Robinson, Wendy P/I-9590-2014	Robinson, Wendy/0000-0002-2010-6174; Robinson, Wendy P/0000-0002-2010-6174				ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; CASSIDY SB, 1992, AM J HUM GENET, V51, P701; DEBRASI D, IN PRESS HUM GENET; FISHER JM, 1993, AM J HUM GENET, V52, P1139; GUYER M, 1992, SCIENCE, V258, P67; HALL JG, 1988, AM J HUM GENET, V43, P355; HALL JG, 1990, AM J HUM GENET, V46, P857; HASSOLD T, 1992, HUM GENET, V89, P647; HASSOLD T, 1987, J MED GENET, V24, P725, DOI 10.1136/jmg.24.12.725; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HSU LYF, 1984, PRENATAL DIAG, V4, P97, DOI 10.1002/pd.1970040708; JACOBS P, 1989, MOL CYTOGENETIC STUD, P135; JACOBS PA, 1988, ANN HUM GENET, V52, P93, DOI 10.1111/j.1469-1809.1988.tb01084.x; JACOBS PA, 1990, ANN HUM GENET, V54, P209, DOI 10.1111/j.1469-1809.1990.tb00379.x; KALOUSEK DK, 1993, AM J HUM GENET, V52, P8; KALOUSEK DK, 1991, PRENATAL DIAG, V11, P743, DOI 10.1002/pd.1970111002; KUPKE KG, 1989, AM J HUM GENET, V45, P599; Lorda-Sanchez I, 1993, Ergeb Inn Med Kinderheilkd, V61, P57; LORDASANCHEZ I, 1992, HUM GENET, V89, P524; MARTIN RH, 1991, AM J MED GENET, V39, P321, DOI 10.1002/ajmg.1320390315; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; MORTON NE, 1988, ANN HUM GENET, V52, P85, DOI 10.1111/j.1469-1809.1988.tb01083.x; NOTHEN MM, 1993, HUM GENET, V92, P347, DOI 10.1007/BF01247332; PAGON RA, 1979, AM J HUM GENET, V31, P54; PANGALOS C, 1994, AM J HUM GENET, V54, P473; PETERSEN MB, 1993, HUM MOL GENET, V2, P1691; PURVISSMITH SG, 1992, AM J HUM GENET, V50, P1348; ROBINSON W, 1994, J MED GENET, V31, P424, DOI 10.1136/jmg.31.5.424; ROBINSON WP, 1994, AM J HUM GENET, V54, P290; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; RUTZLER L, 1974, HELV PAEDIATR ACTA, V29, P541; SCHINZEL A, 1974, HELV PAEDIATR ACTA, V29, P531; SCHINZEL AA, 1993, HUM GENET, V92, P175; SCHMID W, 1974, HUMANGENETIK, V24, P93; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; THOMAS IT, 1989, AM J HUM GENET, V45, P193; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; XIE YG, 1993, CLIN GENET, V44, P57	41	109	110	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					444	451						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847381				2022-12-18	WOS:A1995QF42300014
J	RISCH, N; GHOSH, S; TODD, JA				RISCH, N; GHOSH, S; TODD, JA			STATISTICAL EVALUATION OF MULTIPLE-LOCUS LINKAGE DATA IN EXPERIMENTAL SPECIES AND ITS RELEVANCE TO HUMAN STUDIES - APPLICATION TO NONOBESE DIABETIC (NOD) MOUSE AND HUMAN INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; GENES; MICE; STRATEGIES; DISEASE	Common, familial human disorders generally do not follow Mendelian inheritance patterns, presumably because multiple loci are involved in disease susceptibility. One approach to mapping genes for such traits in humans is to first study an analogous form in an animal model, such as mouse, by using inbred strains and backcross experiments. Here we describe methodology for analyzing multiple-locus linkage data from such experimental backcrosses, particularly in light of multilocus genetic models, including the effects of epistasis. We illustrate these methods by using data from backcrosses involving nonobese diabetic mouse, which serves as an animal model for human insulin-dependent diabetes mellitus. We show that it is likely that a minimum of nine loci contribute to susceptibility, with strong epistasis effects among these loci. Three of the loci actually confer a protective effect in the homozygote, compared with the heterozygote. Further, we discuss the relevance of these studies for analogous studies of the human form of the trait. Specifically, we show that the magnitude of the gene effect in the experimental backcross is likely to correlate only weakly, at best, with the expected magnitude of effect for a human form, because in humans the gene effect will depend more heavily on disease allele frequencies than on the observed penetrance ratios; such allele frequencies are unpredictable. Hence, the major benefit from animal studies may be a better understanding of the disease process itself, rather than identification of cells through comparison mapping in humans by using regions of homology.	YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT SURG,OXFORD OX3 9DU,ENGLAND	Yale University; University of Oxford	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.		Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148	NHGRI NIH HHS [HG00348] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; DIXON WJ, 1990, BMDP STATISTICAL SOF, V1; GHOSH S, IN PRESS NATURE GENE; HYER RN, 1991, AM J HUM GENET, V48, P243; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KAPLAN EB, 1972, I STATISTICS MIMEOGR, V823; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1987, AM J HUM GENET, V40, P1; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0	12	109	111	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					702	714						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352278				2022-12-18	WOS:A1993LU55900014
J	MYERS, RH; LEAVITT, J; FARRER, LA; JAGADEESH, J; MCFARLANE, H; MASTROMAURO, CA; MARK, RJ; GUSELLA, JF				MYERS, RH; LEAVITT, J; FARRER, LA; JAGADEESH, J; MCFARLANE, H; MASTROMAURO, CA; MARK, RJ; GUSELLA, JF			HOMOZYGOTE FOR HUNTINGTON DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BOSTON UNIV,SCH PUBL HLTH,BOSTON,MA 02215; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,NEUROL SERV,NEUROGENET LAB,BOSTON,MA 02114	Boston University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	MYERS, RH (corresponding author), BOSTON UNIV,DEPT NEUROL,720 HARRISON AVE,SUITE 1105,BOSTON,MA 02118, USA.		Farrer, Lindsay/AAS-1035-2020	Myers, Richard/0000-0002-8365-2674; Farrer, Lindsay/0000-0001-5533-4225	PHS HHS [16367] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BRACKENRIDGE CJ, 1973, J MED GENET, V10, P333, DOI 10.1136/jmg.10.4.333; BYERS RK, 1973, NEUROLOGY, V23, P561, DOI 10.1212/WNL.23.6.561; CONNEALLY PM, 1984, AM J HUM GENET, V36, P506; FARRER LA, 1985, AM J HUM GENET, V37, P350; FARRER LA, 1988, J MED GENET, V25, P577, DOI 10.1136/jmg.25.9.577; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GRANDCHAMP B, 1977, LANCET, V2, P1348; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HALL J G, 1969, Birth Defects Original Article Series, V5, P24; HARPER PS, 1972, LANCET, V2, P53; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; KILLIAN JM, 1979, ANN NEUROL, V5, P515, DOI 10.1002/ana.410050604; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACDONALD M E, 1987, Genomics, V1, P29, DOI 10.1016/0888-7543(87)90101-7; MERETOJA J, 1973, CLIN GENET, V4, P173; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MILLER M, 1978, LANCET, V2, P1071; Myers R H, 1985, Prog Med Genet, V6, P91; MYERS RH, 1982, AM J HUM GENET, V34, P481; MYERS RH, 1985, AM J HUM GENET, V37, P511; MYERS RH, 1985, J NEUROL NEUROSUR PS, V48, P530, DOI 10.1136/jnnp.48.6.530; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; Snyder LH, 1944, J LAB CLIN MED, V29, P1211; STEVENS DL, 1976, THESIS U LONDON LOND; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WELANDER L, 1957, Acta Genet Stat Med, V7, P321; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	27	109	112	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					615	618						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2535231				2022-12-18	WOS:A1989AW39500016
J	MUNKE, M; KRAUS, JP; OHURA, T; FRANCKE, U				MUNKE, M; KRAUS, JP; OHURA, T; FRANCKE, U			THE GENE FOR CYSTATHIONINE BETA-SYNTHASE (CBS) MAPS TO THE SUBTELOMERIC REGION ON HUMAN CHROMOSOME-21Q AND TO PROXIMAL MOUSE CHROMOSOME-17	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,POB 3333,NEW HAVEN,CT 06510	Yale University					NIGMS NIH HHS [GM26105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBOTT MH, 1987, AM J MED GENET, V26, P959, DOI 10.1002/ajmg.1320260427; AULA P, 1973, CLIN GENET, V4, P241; BERG JM, 1980, J MED GENET, V17, P144, DOI 10.1136/jmg.17.2.144; BOERS GHJ, 1985, N ENGL J MED, V313, P707; CACHEIRO NLA, 1975, GENET RES, V25, P193, DOI 10.1017/S0016672300015597; CASALONE R, 1979, ANN GENET-PARIS, V22, P17; CERVENKA J, 1977, CLIN GENET, V11, P119; CHADEFAUX B, 1984, HUM GENET, V68, P136, DOI 10.1007/BF00279302; CHADEFAUX B, 1985, BIOCHEM BIOPH RES CO, V128, P40, DOI 10.1016/0006-291X(85)91641-9; CHENG S V, 1987, American Journal of Human Genetics, V41, pA161; COX DR, 1985, ANN NY ACAD SCI, V450, P169, DOI 10.1111/j.1749-6632.1985.tb21491.x; COX DR, 1980, P NATL ACAD SCI-BIOL, V77, P2168, DOI 10.1073/pnas.77.4.2168; COX DR, 1982, P NATL ACAD SCI-BIOL, V79, P1930, DOI 10.1073/pnas.79.6.1930; DANIEL A, 1979, J MED GENET, V16, P227, DOI 10.1136/jmg.16.3.227; EMBERGER JM, 1980, ANN GENET-PARIS, V23, P179; EPSTEIN CJ, 1985, TRENDS GENET, V1, P129, DOI 10.1016/0168-9525(85)90054-X; EPSTEIN CJ, 1985, ANN NY ACAD SCI, V450, P157, DOI 10.1111/j.1749-6632.1985.tb21490.x; FOWLER B, 1978, J CLIN INVEST, V61, P645, DOI 10.1172/JCI108976; FRANCKE U, 1981, SOMAT CELL GENET, V7, P171; FRANCKE U, 1982, CYTOGENET CELL GENET, V33, P267, DOI 10.1159/000131769; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P1147, DOI 10.1073/pnas.74.3.1147; FRANCKE U, 1977, CYTOGENET CELL GENET, V19, P57, DOI 10.1159/000130799; FRANCKE U, 1976, SOMAT CELL GENET, V2, P27, DOI 10.1007/BF01539240; FRANCKE U, 1979, P NATL ACAD SCI USA, V76, P5230, DOI 10.1073/pnas.76.10.5230; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; FRANCKE U, 1981, TRISOMY, V21, P237; FREEMAN JM, 1975, NEW ENGL J MED, V292, P491, DOI 10.1056/NEJM197503062921001; HABEDANK M, 1982, HUM GENET, V60, P74, DOI 10.1007/BF00281269; HAGEMEIJER A, 1977, HUM GENET, V38, P15, DOI 10.1007/BF00295803; HARDS RG, 1986, AM J HUM GENET, V39, P179; HARKER LA, 1976, J CLIN INVEST, V58, P731, DOI 10.1172/JCI108520; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HAWKINS JW, 1987, HUM GENET, V76, P375, DOI 10.1007/BF00272448; HURET JL, 1987, HUM GENET, V75, P251, DOI 10.1007/BF00281069; KANG SS, 1986, J CLIN INVEST, V77, P1482, DOI 10.1172/JCI112461; KIRKILIONIS AJ, 1986, J PEDIATR-US, V108, P793, DOI 10.1016/S0022-3476(86)81077-0; KITSIOUTZELI S, 1984, AM J MED GENET, V18, P725, DOI 10.1002/ajmg.1320180419; KRAUS JP, 1986, P NATL ACAD SCI USA, V83, P2047, DOI 10.1073/pnas.83.7.2047; Lejeune J, 1975, PONT ACAD SCI, V3, P1; LESCHOT NJ, 1981, HUM GENET, V57, P220, DOI 10.1007/BF00282029; MATTEI JF, 1981, HUM GENET, V56, P409, DOI 10.1007/BF00274703; MCBREEN P, 1977, CYTOGENET CELL GENET, V19, P208, DOI 10.1159/000130810; MIKKELSEN M, 1974, HUM HERED, V24, P160, DOI 10.1159/000152648; MUDD SH, 1985, AM J HUM GENET, V37, P1; MUNKE M, 1988, AM J HUM GENET, V42, P542; MUNKE M, 1984, SOMAT CELL MOLEC GEN, V10, P589, DOI 10.1007/BF01535224; NESBITT MN, 1973, CHROMOSOMA, V41, P145, DOI 10.1007/BF00319691; NIEBUHR E, 1974, HUMANGENETIK, V21, P99, DOI 10.1007/BF00278575; PFEIFFER RA, 1977, CLIN GENET, V11, P207; PHILIP M, 1987, American Journal of Human Genetics, V41, pA233; POISSONNIER M, 1976, ANN GENET-PARIS, V19, P69; QUAXJEUKEN Y, 1985, P NATL ACAD SCI USA, V82, P5819, DOI 10.1073/pnas.82.17.5819; RAOUL O, 1976, ANN GENET-PARIS, V19, P187; RAZIUDDIN A, 1984, P NATL ACAD SCI-BIOL, V81, P5504, DOI 10.1073/pnas.81.17.5504; REEVES RH, 1986, BRAIN RES BULL, V16, P803, DOI 10.1016/0361-9230(86)90076-6; REEVES RH, 1987, CYTOGENET CELL GENET, V44, P76, DOI 10.1159/000132347; REEVES RH, IN PRESS CYTOGENET C; SINET PM, 1976, EXP CELL RES, V97, P47, DOI 10.1016/0014-4827(76)90653-4; SKOVBY F, 1984, HUM GENET, V65, P291, DOI 10.1007/BF00286520; SKOW LC, 1985, IMMUNOGENETICS, V22, P291, DOI 10.1007/BF00404489; SKOW LC, 1985, GENETICS, V110, P723; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; SUMMITT RL, 1981, TRISOMY, V21, P225; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TAYSI K, 1982, J MED GENET, V19, P144, DOI 10.1136/jmg.19.2.144; VANKEUREN M, 1986, HUM GENET, V74, P34, DOI 10.1007/BF00278782; WAHRMAN J, 1976, CHROMOSOMES TODAY, V5, P241; WATSON DK, 1986, P NATL ACAD SCI USA, V83, P1792, DOI 10.1073/pnas.83.6.1792; WILLIAMS JD, 1975, AM J HUM GENET, V27, P478	70	109	120	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1988	42	4					550	559						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6316	2894761				2022-12-18	WOS:A1988M631600004
J	FEDER, J; YEN, L; WIJSMAN, E; WANG, L; WILKINS, L; SCHRODER, J; SPURR, N; CANN, H; BLUMENBERG, M; CAVALLISFORZA, LL				FEDER, J; YEN, L; WIJSMAN, E; WANG, L; WILKINS, L; SCHRODER, J; SPURR, N; CANN, H; BLUMENBERG, M; CAVALLISFORZA, LL			A SYSTEMATIC-APPROACH FOR DETECTING HIGH-FREQUENCY RESTRICTION FRAGMENT LENGTH POLYMORPHISMS USING LARGE GENOMIC PROBES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									STANFORD UNIV,DEPT MED,STANFORD,CA 94305; STANFORD UNIV,DEPT PATHOL,STANFORD,CA 94305; STANFORD UNIV,DEPT PEDIAT,STANFORD,CA 94305; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND	Stanford University; Stanford University; Stanford University; Cancer Research UK	FEDER, J (corresponding author), STANFORD UNIV,DEPT GENET,STANFORD,CA 94305, USA.			Blumenberg, Miroslav/0000-0002-8672-7774	PHS HHS [28428] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANTONARAKIS SE, 1983, P NATL ACAD SCI-BIOL, V80, P6615, DOI 10.1073/pnas.80.21.6615; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; DRYJA TP, 1984, HUM GENET, V65, P320, DOI 10.1007/BF00291555; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; GERHARD DS, 1984, CYTOGENET CELL GENET, V37, P478; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HELENTJARIS T, 1983, Journal of Molecular and Applied Genetics, V2, P237; KAO FT, 1982, P NATL ACAD SCI-BIOL, V79, P865, DOI 10.1073/pnas.79.3.865; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; MANIATIS T, 1982, MOL CLONING LABORATO, P104; MANIATIS T, 1982, MOL CLONING LABORATO, P371; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PEARSON PL, 1982, CYTOGENET CELL GENET, V32, P308; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCHAFER M, 1982, CYTOGENET CELL GENET, V32, P314; SKOLNICK MH, 1982, CYTOGENET CELL GENET, V32, P58, DOI 10.1159/000131687; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; Snedecor G. W., 1980, STATISTICAL METHODS, P166; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WIJSMAN EM, 1984, NUCLEIC ACIDS RES, V12, P9209, DOI 10.1093/nar/12.23.9209; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; YUNIS JJ, 1977, PROGR CLIN PATHOL, V7, P267	34	109	109	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					635	649						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556655				2022-12-18	WOS:A1985APR1800002
J	GRAVEL, RA; LAM, KF; SCULLY, KJ; HSIA, YE				GRAVEL, RA; LAM, KF; SCULLY, KJ; HSIA, YE			GENETIC COMPLEMENTATION OF PROPIONYL-COA CARBOXYLASE DEFICIENCY IN CULTURED HUMAN FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOSP SICK CHILDREN,DEPT HUMAN GENET,TORONTO M5G 1X8,ONTARIO,CANADA; YALE UNIV,DEPT HUMAN GENET,NEW HAVEN,CT 06510	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Yale University								ANDO T, 1971, J PEDIATR-US, V78, P827, DOI 10.1016/S0022-3476(71)80354-2; BARNES ND, 1970, LANCET, V2, P244; BARTLETT K, 1976, LANCET, V2, P804; BRANDT IK, 1974, PEDIATRICS, V53, P391; CALLAHAN JW, 1975, PEDIATR RES, V9, P914; CALLAHAN JW, 1975, PEDIATR RES, V9, P908, DOI 10.1203/00006450-197512000-00009; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; GIORGIO AJ, 1973, BIOCHEM MED METAB B, V7, P473, DOI 10.1016/0006-2944(73)90069-0; GOMPERTZ D, 1970, LANCET, V1, P1140; GOMPERTZ D, 1975, CLIN GENET, V8, P244; GRAVEL RA, 1975, P NATL ACAD SCI USA, V72, P3181, DOI 10.1073/pnas.72.8.3181; GUIBAUD P, 1975, ARCH FR PEDIATR, V32, P259; HILL HZ, 1974, CLIN GENET, V6, P79; HSIA YE, 1969, LANCET, V1, P757; HSIA YE, 1971, J CLIN INVEST, V50, P127, DOI 10.1172/JCI106466; HSIA YE, IN PRESS; KRAEMER KH, 1975, MUTAT RES, V33, P327, DOI 10.1016/0027-5107(75)90208-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYONS LB, 1973, NATURE, V243, P533, DOI 10.1038/243533a0; MAHONEY MJ, 1971, PEDIATRIC RESEARCH, V5, P395; OCHOA SEVERO, 1965, COMPR BIOCHEM, V16, P210; PAULSEN EP, 1974, AM J HUM GENET, V26, pA66; RATTAZZI MC, 1976, AM J HUM GENET, V28, P143; Seegmiller J E, 1976, Adv Hum Genet, V6, P75; STANNERS CP, 1971, NATURE-NEW BIOL, V230, P52, DOI 10.1038/newbio230052a0; SWEETMAN L, 1975, CLIN RES, V23, pA156; SWEETMAN L, 1974, CLIN RES, V22, pA237; WADLINGTON WB, 1975, J PEDIATR-US, V86, P707, DOI 10.1016/S0022-3476(75)80354-4	28	109	110	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	4					378	388						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN459	195466				2022-12-18	WOS:A1977DN45900007
J	CRAIGHOLMES, AP; MOORE, FB; SHAW, MW				CRAIGHOLMES, AP; MOORE, FB; SHAW, MW			POLYMORPHISM OF HUMAN C-BAND HETEROCHROMATIN .2. FAMILY STUDIES WITH SUGGESTIVE EVIDENCE FOR SOMATIC CROSSING OVER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,HLTH SCI CTR,GRAD SCH BIOMED SCI,MED GENET CTR,HOUSTON,TX 77025; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,SYST CANC CTR,DEPT BIOL,HOUSTON,TX 77025	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center								ALLDERDICE PW, 1973, J CELL SCI, V12, P809; ARRIGHI FE, 1973, MODERN ASPECTS CYTOG, P113; BECKER HJ, 1969, MOL GEN GENET, V105, P203, DOI 10.1007/BF00337472; BOBROW M, 1972, NATURE-NEW BIOL, V238, P122, DOI 10.1038/newbio238122a0; CHEN TR, 1974, CHROMOSOMA, V47, P147, DOI 10.1007/BF00331802; COOK PJL, 1974, ANN HUM GENET, V37, P261, DOI 10.1111/j.1469-1809.1974.tb01834.x; CRAIGHOLMES AP, 1973, AM J HUM GENET, V25, P181; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; EIBERG H, 1974, NATURE, V248, P55, DOI 10.1038/248055a0; FITZGERALD PH, 1973, CYTOGENET CELL GENET, V12, P404, DOI 10.1159/000130483; GAGNE R, 1973, CHROMOSOMA, V41, P159, DOI 10.1007/BF00319692; GAGNE R, 1972, EXP CELL RES, V73, P239, DOI 10.1016/0014-4827(72)90127-9; GERMAN J, 1973, J INVEST DERMATOL, V60, P427; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GRUNEBERG H, 1966, GENET RES, V7, P58, DOI 10.1017/S0016672300009472; HAMERTON JL, 1974, CYTOGENET CELL GENET, V13, P13, DOI 10.1159/000130226; HOLLIDAY R, 1964, GENETICS, V50, P323; HOLZER S, 1972, HUMANGENETIK, V16, P341; HSU TC, 1972, P NATL ACAD SCI USA, V69, P1464, DOI 10.1073/pnas.69.6.1464; JONES KW, 1971, NATURE-NEW BIOL, V233, P268, DOI 10.1038/newbio233268a0; KAPLAN WD, 1953, GENETICS, V38, P630; KIM MA, 1973, HUMANGENETIK, V18, P213; MCKENZIE WH, 1973, CHROMOSOMA, V41, P175, DOI 10.1007/BF00319694; MCKENZIE WH, 1973, THESIS ANN ARBOR U M; PEARSON PL, 1973, MODERN ASPECTS CYTOG, P201; PONTECORVO G, 1958, ADV GENET, V9, P71, DOI 10.1016/S0065-2660(08)60160-1; POPESCU NC, 1974, LANCET, V1, P209; SAUNDERS GF, 1972, J MOL BIOL, V63, P323, DOI 10.1016/0022-2836(72)90430-5; SHAW MW, 1965, GENETICS, V51, P181; SMITHIES O, 1967, SCIENCE, V157, P267, DOI 10.1126/science.157.3786.267; Stern C, 1936, GENETICS, V21, P625; TOKUNAGA C, 1966, GENETICS, V54, P267; WALEN KH, 1964, GENETICS, V49, P905; WEAVER EC, 1960, GENETICS, V45, P345	34	109	109	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	2					178	189						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V9467	47710				2022-12-18	WOS:A1975V946700004
J	RICHTERICH, R; ROSIN, S; ROSSI, E; AEBI, U				RICHTERICH, R; ROSIN, S; ROSSI, E; AEBI, U			PROGRESSIVE MUSCULAR DYSTROPHY .5. IDENTIFICATION OF CARRIER STATE IN DUCHENNE TYPE BY SERUM CREATINE KINASE DETERMINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AEBI U, 1961, HELV PAEDIATR ACTA, V16, P543; AEBI U, 1961, Epilepsia, V1, P61; AEBI U, TO BE PUBLISHED; BAUMANN P, 1962, Schweiz Z Sportmed, V10, P33; BECKER P E, 1957, Acta Genet Stat Med, V7, P303; BLYTH H, 1958, ANN HUM GENET, V23, P127, DOI 10.1111/j.1469-1809.1958.tb01457.x; BRUGSCH J, 1960, Z GES INN MED IHRE, V15, P891; CHEESEMAN EA, 1958, ANN HUM GENET, V22, P235, DOI 10.1111/j.1469-1809.1958.tb01418.x; CHUNG CS, 1959, AM J HUM GENET, V11, P339; CHUNG CS, 1960, AM J HUM GENET, V12, P52; COLOMBO JP, 1962, KLIN WOCHENSCHR, V40, P37, DOI 10.1007/BF01483449; DREYFUS JC, 1962, KLIN WOCHENSCHR, V40, P373, DOI 10.1007/BF01732835; DREYFUS JC, 1960, REV FR ETUD CLIN BIO, V5, P384; DREYFUS JC, 1961, 6 INT K INN MED; DUBOWITZ V, 1960, BRAIN, V83, P432, DOI 10.1093/brain/83.3.432; EBASHI S, 1959, J BIOCHEM-TOKYO, V46, P103; EVANS JH, 1957, BRAIN, V80, P557, DOI 10.1093/brain/80.4.557; HALDANE JBS, 1956, ANN HUM GENET, V20, P344; KLOEPFER HW, 1957, ANN HUM GENET, V22, P138, DOI 10.1111/j.1469-1809.1957.tb01928.x; Kryschowa N, 1934, Z GESAMTE NEUROL PSY, V150, P421, DOI 10.1007/BF02890922; LAMY MAURICE, 1954, JOUR GENET HUMAINE, V3, P219; LEYBURN P, 1961, ANN HUM GENET, V25, P41, DOI 10.1111/j.1469-1809.1961.tb01495.x; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; MEISTER A, 1947, SCIENCE, V106, P167, DOI 10.1126/science.106.2747.167; MORTON NE, 1959, AM J HUM GENET, V11, P360; OKINAKA S, 1961, ARCH NEUROL-CHICAGO, V4, P520, DOI 10.1001/archneur.1961.00450110050006; OLIVER IT, 1955, BIOCHEM J, V61, P116, DOI 10.1042/bj0610116; PHILIP U, 1956, ANN HUM GENET, V21, P155, DOI 10.1111/j.1469-1809.1971.tb00276.x; RICHTERICH R, 1961, SCHWEIZ MED WSCHR, V91, P601; RICHTERICH R, 1962, ERBLICHE STOFFWECHSE; ROTTHAUWE H, 1961, KLIN WOCHENSCHR, V39, P1269, DOI 10.1007/BF01481966; SCHAPIRA F, 1960, REV FR ETUD CLIN BIO, V5, P990; SIDLER A, 1944, ARCH JULIUS KLAUS ST, V19, P213; SOLTAN HC, 1959, J PEDIATR-US, V54, P27, DOI 10.1016/S0022-3476(59)80033-0; STEVENSON A. C., 1955, ANN HUMAN GENETICS, V19, P159, DOI 10.1111/j.1469-1809.1955.tb01340.x; STEVENSON AC, 1953, ANN EUGENIC, V18, P50; TANZER ML, 1959, J BIOL CHEM, V234, P3201; THOMPSON RA, 1959, ARCH INTERN MED, V103, P551, DOI 10.1001/archinte.1959.00270040037004; TYLER FH, 1951, ANN INTERN MED, V35, P169, DOI 10.7326/0003-4819-35-1-169; VANDERWAERDEN BL, 1956, TAFELN VERGLEICH ZWE; WACHSTEIN M, 1958, AM J CLIN PATHOL, V30, P523; WALTON JN, 1955, ANN HUM GENET, V20, P1, DOI 10.1111/j.1469-1809.1955.tb01274.x; WALTON JN, 1954, BRAIN, V77, P169, DOI 10.1093/brain/77.2.169; WALTON JN, 1956, ANN HUM GENET, V21, P40, DOI 10.1111/j.1469-1809.1971.tb00264.x	44	109	109	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1963	15	2					133	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2970A	17948483				2022-12-18	WOS:A19632970A00008
J	Gonorazky, HD; Naumenko, S; Ramani, AK; Nelakuditi, V; Mashouri, P; Wang, PQ; Kao, D; Ohri, K; Viththiyapaskaran, S; Tarnopolsky, MA; Mathews, KD; Moore, SA; Osorio, AN; Villanova, D; Kemaladewi, DU; Cohn, RD; Brudno, M; Dowling, JJ				Gonorazky, Hernan D.; Naumenko, Sergey; Ramani, Arun K.; Nelakuditi, Viswateja; Mashouri, Pouria; Wang, Peiqui; Kao, Dennis; Ohri, Krish; Viththiyapaskaran, Senthuri; Tarnopolsky, Mark A.; Mathews, Katherine D.; Moore, Steven A.; Osorio, Andres N.; Villanova, David; Kemaladewi, Dwi U.; Cohn, Ronald D.; Brudno, Michael; Dowling, James J.			Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROMUSCULAR DISORDERS; SPLICING CONSEQUENCES; GENETIC DIAGNOSIS; VARIANTS; FIBROBLASTS; DATABASE; EXPRESSION; OPPORTUNITIES; DYSTROGLYCAN; INHERITANCE	Gene-panel and whole-exome analyses are now standard methodologies for mutation detection in Mendelian disease. However, the diagnostic yield achieved is at best 50%, leaving the genetic basis for disease unsolved in many individuals. New approaches are thus needed to narrow the diagnostic gap. Whole-genome sequencing is one potential strategy, but it currently has variant-interpretation challenges, particularly for non-coding changes. In this study we focus on transcriptome analysis, specifically total RNA sequencing (RNA-seq), by using monogenetic neuromuscular disorders as proof of principle. We examined a cohort of 25 exome and/or panel "negative" cases and provided genetic resolution in 36% (9/25). Causative mutations were identified in coding and non-coding exons, as well as in intronic regions, and the mutational pathomechanisms included transcriptional repression, exon skipping, and intron inclusion. We address a key barrier of transcriptome-based diagnostics: the need for source material with disease-representative expression patterns. We establish that blood-based RNA-seq is not adequate for neuromuscular diagnostics, whereas myotubes generated by transdifferentiation from an individual's fibroblasts accurately reflect the muscle transcriptome and faithfully reveal disease-causing mutations. Our work confirms that RNA-seq can greatly improve diagnostic yield in genetically unresolved cases of Mendelian disease, defines strengths and challenges of the technology, and demonstrates the suitability of cell models for RNA-based diagnostics. Our data set the stage for development of RNA-seq as a powerful clinical diagnostic tool that can be applied to the large population of individuals with undiagnosed, rare diseases and provide a framework for establishing minimally invasive strategies for doing so.	[Gonorazky, Hernan D.; Dowling, James J.] Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada; [Naumenko, Sergey; Ramani, Arun K.; Nelakuditi, Viswateja; Mashouri, Pouria; Wang, Peiqui; Kao, Dennis; Brudno, Michael] Hosp Sick Children, Ctr Computat Med, Toronto, ON M5G 1X8, Canada; [Ohri, Krish; Viththiyapaskaran, Senthuri; Cohn, Ronald D.; Dowling, James J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON L8S 4L8, Canada; [Mathews, Katherine D.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Mathews, Katherine D.] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Moore, Steven A.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Osorio, Andres N.] Inst Recerca Hosp Univ St Joan de Deu, Neuromuscular Unit, Neuropaediat Dept, Barcelona 08950, Spain; [Osorio, Andres N.] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Barcelona 08950, Spain; [Villanova, David] GenomicTales Parc Mola, AD-700 Escaldes Engordany, Andorra; [Gonorazky, Hernan D.; Kemaladewi, Dwi U.; Cohn, Ronald D.; Brudno, Michael; Dowling, James J.] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Brudno, Michael] Univ Toronto, Dept Comp Sci, Toronto, ON M5G 0A4, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McMaster University; University of Iowa; University of Iowa; University of Iowa; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Dowling, JJ (corresponding author), Hosp Sick Children, Div Neurol, Toronto, ON M5G 1X8, Canada.; Brudno, M (corresponding author), Hosp Sick Children, Ctr Computat Med, Toronto, ON M5G 1X8, Canada.; Dowling, JJ (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada.; Brudno, M; Dowling, JJ (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada.; Brudno, M (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON M5G 0A4, Canada.	brudno@cs.toronto.edu; james.dowling@sickkids.ca	Cohn, Ronald/AAC-5835-2021	Moore, Steven/0000-0002-6353-7900; Kemaladewi, Dwi/0000-0002-0747-4589; Mashouri, Pouria/0000-0003-4332-530X	Genome Canada Disruptive Innovations in Genomics grant; Chase-an-Idea grant mechanism (Centre for Brain and Mental Health, the Hospital for Sick Children); Muscular Dystrophy Association [MDA 380397]; Genome Canada; Genome Quebec; Restracomp grant (the Hospital for Sick Children); National Institutes of Health (NIH) grant [U54, NS053672]; NIH [U01, HG007672]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER	Genome Canada Disruptive Innovations in Genomics grant; Chase-an-Idea grant mechanism (Centre for Brain and Mental Health, the Hospital for Sick Children); Muscular Dystrophy Association(Muscular Dystrophy Association); Genome Canada(Genome Canada); Genome Quebec; Restracomp grant (the Hospital for Sick Children); National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from a Genome Canada Disruptive Innovations in Genomics grant (J.J.D. and M.B.), as well as by seed funding to J.J.D. from the Chase-an-Idea grant mechanism (Centre for Brain and Mental Health, the Hospital for Sick Children) and by funding from the Muscular Dystrophy Association (J.J.D., MDA 380397). Computational analysis was conducted by the Canadian Centre for Computational Genomics (C3G), funded by Genome Canada and Genome Quebec. H.D.G. was supported by a Restracomp grant (the Hospital for Sick Children). K.D.M. and S.A.M. are partially supported by a National Institutes of Health (NIH) grant, U54, NS053672, that funds the IowaWellstone Muscular Dystrophy Cooperative Research Center (MDCRC). Carrie Stephan and Mary Cox provided extensive clinical or laboratory support for the Iowa MDCRC. A.N.O. would like to acknowledge l'Hospital Infantil Sant Joan de Deu per a la Investigacio, integrated as part of the biobank (BioNER) of the Carlos III Health Institute (ISCIII), for samples and data procurement. We thank Vandana Shashi and Kelly Schoch for contributing samples. They are partially supported by NIH grant U01, HG007672.	Abramowicz A, 2018, J APPL GENET, V59, P253, DOI 10.1007/s13353-018-0444-7; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Al-Hashim A, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000182; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barateau A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169189; Bonnemann CG, 2014, NEUROMUSCULAR DISORD, V24, P289, DOI 10.1016/j.nmd.2013.12.011; Bonne G, 2017, NEUROMUSCULAR DISORD, V27, P1152, DOI 10.1016/j.nmd.2017.10.005; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Brun BN, 2018, NEUROMUSCULAR DISORD, V28, P592, DOI 10.1016/j.nmd.2018.04.003; Butterfield RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189664; Byron SA, 2016, NAT REV GENET, V17, P257, DOI 10.1038/nrg.2016.10; Cacchiarelli D, 2018, CELL SYST, V7, P258, DOI 10.1016/j.cels.2018.07.006; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chae JH, 2015, J MED GENET, V52, P208, DOI 10.1136/jmedgenet-2014-102819; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Clark MM, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0053-8; Cooper GM, 2015, GENOME RES, V25, P1423, DOI 10.1101/gr.190116.115; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Darras BT, 2000, PEDIATR NEUROL, V23, P289, DOI 10.1016/S0887-8994(00)00202-2; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dowling JJ, 2018, AM J MED GENET A, V176, P804, DOI 10.1002/ajmg.a.38418; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eberle MA, 2017, GENOME RES, V27, P157, DOI 10.1101/gr.210500.116; Engel JL, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/1435746; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Fernandez-Fuente M, 2014, NEUROMUSCULAR DISORD, V24, P250, DOI 10.1016/j.nmd.2013.11.009; Gallego-Paez LM, 2017, HUM GENET, V136, P1015, DOI 10.1007/s00439-017-1790-y; Ghaoui R, 2015, JAMA NEUROL, V72, P1424, DOI 10.1001/jamaneurol.2015.2274; Gonorazky H, 2016, ANN CLIN TRANSL NEUR, V3, P55, DOI 10.1002/acn3.267; Gopalakrishnan S, 2017, BRAIN RES, V1656, P2, DOI 10.1016/j.brainres.2015.10.012; Hartley SW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw501; Herzog C, 2004, J INVEST DERMATOL, V122, P1372, DOI 10.1111/j.0022-202X.2004.22605.x; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Jensen BS, 2015, HUM MUTAT, V36, P1159, DOI 10.1002/humu.22898; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Kress W, 2017, NEUROPEDIATRICS, V48, P242, DOI 10.1055/s-0037-1602660; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leman R, 2018, NUCLEIC ACIDS RES, V46, P11656, DOI 10.1093/nar/gky979; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Lohmann K, 2014, NEUROTHERAPEUTICS, V11, P699, DOI 10.1007/s13311-014-0288-8; Ma M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S3; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; McDonald CM, 2012, PHYS MED REH CLIN N, V23, P495, DOI 10.1016/j.pmr.2012.06.011; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; North KN, 2014, NEUROMUSCULAR DISORD, V24, P97, DOI 10.1016/j.nmd.2013.11.003; Ohno K, 2018, WILEY INTERDISCIP RE, V9, P1451; Pagliarini V, 2017, HUM GENET, V136, P1215, DOI 10.1007/s00439-017-1802-y; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pedersen BS, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0973-5; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schofield D, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0006-7; Schuelke M, 2017, NEUROPATH APPL NEURO, V43, P44, DOI 10.1111/nan.12374; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Shibata A, 2016, J HUM GENET, V61, P633, DOI 10.1038/jhg.2016.23; Sibley CR, 2016, NAT REV GENET, V17, P407, DOI 10.1038/nrg.2016.46; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571; Stark Z, 2016, GENET MED, V18, P1090, DOI 10.1038/gim.2016.1; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Stevens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068958; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tan TY, 2017, JAMA PEDIATR, V171, P855, DOI 10.1001/jamapediatrics.2017.1755; Todd EJ, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0364-0; Vasli N, 2012, ACTA NEUROPATHOL, V124, P273, DOI 10.1007/s00401-012-0982-8; Vaz-Drago R, 2017, HUM GENET, V136, P1093, DOI 10.1007/s00439-017-1809-4; Volk AE, 2017, CURR OPIN NEUROL, V30, P523, DOI 10.1097/WCO.0000000000000478; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25	79	108	110	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2019	104	3					466	483		10.1016/j.ajhg.2019.01.012	http://dx.doi.org/10.1016/j.ajhg.2019.01.012			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN9SY	30827497	hybrid, Green Published			2022-12-18	WOS:000460541200012
J	Stray-Pedersen, A; Backe, PH; Sorte, HS; Morkrid, L; Chokshi, NY; Erichsen, HC; Gambin, T; Elgstoen, KBP; Bjoras, M; Wlodarski, MW; Kruger, M; Jhangiani, SN; Muzny, DM; Patel, A; Raymond, KM; Sasa, GS; Krance, RA; Martinez, CA; Abraham, SM; Speckmann, C; Ehl, S; Hall, P; Forbes, LR; Merckoll, E; Westvik, J; Nishimura, G; Rustad, CF; Abrahamsen, TG; Ronnestad, A; Osnes, LT; Egeland, T; Rodningen, OK; Beck, CR; Boerwinkle, EA; Gibbs, RA; Lupski, JR; Orange, JS; Lausch, E; Hanson, IC				Stray-Pedersen, Asbjorg; Backe, Paul H.; Sorte, Hanne S.; Morkrid, Lars; Chokshi, Niti Y.; Erichsen, Hans Christian; Gambin, Tomasz; Elgstoen, Katja B. P.; Bjoras, Magnar; Wlodarski, Marcin W.; Krueger, Marcus; Jhangiani, Shalini N.; Muzny, Donna M.; Patel, Ankita; Raymond, Kimiyo M.; Sasa, Ghadir S.; Krance, Robert A.; Martinez, Caridad A.; Abraham, Shirley M.; Speckmann, Carsten; Ehl, Stephan; Hall, Patricia; Forbes, Lisa R.; Merckoll, Else; Westvik, Jostein; Nishimura, Gen; Rustad, Cecilie F.; Abrahamsen, Tore G.; Ronnestad, Arild; Osnes, Liv T.; Egeland, Torstein; Rodningen, Olaug K.; Beck, Christine R.; Boerwinkle, Eric A.; Gibbs, Richard A.; Lupski, James R.; Orange, Jordan S.; Lausch, Ekkehart; Hanson, I. Celine		Baylor-Johns Hopkins Ctr Mendelian	PGM3 Mutations Cause a Congenital Disorder of Glycosylation with Severe Immunodeficiency and Skeletal Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANDIDA-ALBICANS; DEFICIENCY; MUTASE; GENE; IDENTIFICATION; NOMENCLATURE; VALIDATION; SPECTRUM; REVEALS; PATIENT	Human phosphoglucomutase 3 (PGM3) catalyzes the conversion of N-acetyl-glucosamine (G1cNAc)-6-phosphate into GlcNAc-l-phosphate during the synthesis of uridine diphosphate (UDP)-G1cNAc, a sugar nucleotide critical to multiple glycosylation pathways. We identified three unrelated children with recurrent infections, congenital leukopenia including neutropenia, B and T cell lymphopenia, and progression to bone marrow failure. Whole-exome sequencing demonstrated deleterious mutations in PGM3 in all three subjects, delineating their disease to be due to an unsuspected congenital disorder of glycosylation (CDG). Functional studies of the disease-associated PGM3 variants in E. coli cells demonstrated reduced PGM3 activity for all mutants tested. Two of the three children had skeletal anomalies resembling Desbuquois dysplasia: short stature, brachydactyly, dysmorphic facial features, and intellectual disability. However, these additional features were absent in the third child, showing the clinical variability of the disease. Two children received hematopoietic stem cell transplantation of cord blood and bone marrow from matched related donors; both had successful engraftment and correction of neutropenia and lymphopenia. We define PGM3-CDG as a treatable immunodeficiency, document the power of whole-exome sequencing in gene discoveries for rare disorders, and illustrate the utility of genomic analyses in studying combined and variable phenotypes.	[Stray-Pedersen, Asbjorg; Gambin, Tomasz; Jhangiani, Shalini N.; Muzny, Donna M.; Beck, Christine R.; Boerwinkle, Eric A.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stray-Pedersen, Asbjorg; Forbes, Lisa R.; Orange, Jordan S.] Texas Childrens Hosp, Ctr Human Immunobiol, Houston, TX 77030 USA; [Stray-Pedersen, Asbjorg; Chokshi, Niti Y.; Forbes, Lisa R.; Orange, Jordan S.; Hanson, I. Celine] Baylor Coll Med, Dept Pediat, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Stray-Pedersen, Asbjorg; Chokshi, Niti Y.; Sasa, Ghadir S.; Krance, Robert A.; Martinez, Caridad A.; Forbes, Lisa R.; Orange, Jordan S.; Hanson, I. Celine] Texas Childrens Hosp, Houston, TX 77030 USA; [Stray-Pedersen, Asbjorg; Sorte, Hanne S.; Rustad, Cecilie F.; Rodningen, Olaug K.] Oslo Univ Hosp, Dept Med Genet, N-0424 Oslo, Norway; [Backe, Paul H.; Bjoras, Magnar] Oslo Univ Hosp, Dept Microbiol, N-0424 Oslo, Norway; [Backe, Paul H.; Morkrid, Lars; Elgstoen, Katja B. P.] Oslo Univ Hosp, Dept Med Biochem, N-0424 Oslo, Norway; [Backe, Paul H.; Morkrid, Lars; Bjoras, Magnar; Abrahamsen, Tore G.; Egeland, Torstein] Univ Oslo, Inst Clin Med, N-0318 Oslo, Norway; [Chokshi, Niti Y.; Sasa, Ghadir S.; Krance, Robert A.; Martinez, Caridad A.; Forbes, Lisa R.; Lupski, James R.; Orange, Jordan S.; Hanson, I. Celine] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Erichsen, Hans Christian; Abrahamsen, Tore G.; Ronnestad, Arild] Oslo Univ Hosp, Dept Pediat, N-0424 Oslo, Norway; [Wlodarski, Marcin W.; Krueger, Marcus; Speckmann, Carsten; Ehl, Stephan; Lausch, Ekkehart] Freiburg Univ Hosp, Dept Pediat, D-79106 Freiburg, Germany; [Jhangiani, Shalini N.; Muzny, Donna M.; Boerwinkle, Eric A.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Patel, Ankita; Lupski, James R.] Baylor Coll Med, Med Genet Labs, Houston, TX 77030 USA; [Raymond, Kimiyo M.] Mayo Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Sasa, Ghadir S.; Krance, Robert A.; Martinez, Caridad A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Sasa, Ghadir S.; Krance, Robert A.; Martinez, Caridad A.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Sasa, Ghadir S.; Krance, Robert A.; Martinez, Caridad A.] Baylor Coll Med, Texas Childrens Hematol Ctr, Houston, TX 77030 USA; [Abraham, Shirley M.] Univ New Mexico, Albuquerque, NM 87106 USA; [Hall, Patricia] Emory Univ, Dept Human Genet, Emory Genet Lab, Decatur, GA 30033 USA; [Merckoll, Else; Westvik, Jostein] Oslo Univ Hosp, Dept Radiol, N-0424 Oslo, Norway; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Fuchu, Tokyo 1838561, Japan; [Osnes, Liv T.; Egeland, Torstein] Oslo Univ Hosp, Dept Immunol & Transfus Med, N-0424 Oslo, Norway; [Boerwinkle, Eric A.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Baylor College of Medicine; University of Oslo; University of Freiburg; Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; University of New Mexico; Emory University; University of Oslo; Tokyo Metropolitan Children's Medical Center; University of Oslo; University of Texas System; University of Texas Health Science Center Houston	Stray-Pedersen, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	strayped@bcm.edu; jlupski@bcm.tmc.edu	Hall, Patricia/I-1229-2019; Gambin, Tomasz/HDN-5840-2022; Ehl, Stephan/AAM-6006-2020; Hall, Patricia L/C-2125-2015; Bjørås, Magnar/N-9286-2017; Wlodarski, Marcin W/M-9345-2018	Hall, Patricia/0000-0001-9218-6233; Gambin, Tomasz/0000-0002-0941-4571; Hall, Patricia L/0000-0001-9218-6233; Wlodarski, Marcin W/0000-0001-6638-9643; Ehl, Stephan/0000-0002-9265-2721; Stray-Pedersen, Asbjorg/0000-0002-9168-0878; Hanson, Imelda/0000-0001-9457-0757; Speckmann, Carsten/0000-0002-6217-1556; Rustad, Cecilie Fremstad/0000-0001-7903-9087; Elgstoen, Katja Benedikte Presto/0000-0002-0087-0714; orange, jordan/0000-0001-7117-7725	NIH National Human Genome Research Institute [U54HG006542, U54HG003273]; German Federal Ministry of Education and Research [01GM1109A]; European Commission [602300]; South-Eastern Norway Regional Health Authority [2012085]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542, U54HG003273] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); South-Eastern Norway Regional Health Authority; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors are grateful to the families for their participation in this study. Special thanks go to Eric A. Smith for his technical contributions. The study was performed at the Baylor-Johns Hopkins Center for Mendelian Genomics, funded by the NIH National Human Genome Research Institute (U54HG006542 and U54HG003273). The Centers for Mendelian Genomics represents a cooperative, international research effort to determine the genetic cause(s) of Mendelian disorders. The German branch of this study was supported by a grant from the German Federal Ministry of Education and Research to E.L. (FACE consortium TP1, 01GM1109A). E.L. was also supported by the European Commission Seventh Framework Programme (the SYBIL consortium, grant agreement 602300). P.H.B. was supported by the South-Eastern Norway Regional Health Authority's Technology Platform for Structural Biology and Bioinformatics (grant 2012085). J.R.L. holds stock ownership in 23andMe Inc. and is a coinventor on multiple United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered in the Medical Genetics Laboratories.	Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Baratela WAR, 2012, AM J MED GENET A, V158A, P1815, DOI 10.1002/ajmg.a.35445; Boone PM, 2013, GENOME RES, V23, P1383, DOI 10.1101/gr.156075.113; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Bui C, 2014, AM J HUM GENET, V94, P405, DOI 10.1016/j.ajhg.2014.01.020; Cali T, 2012, J BIOL CHEM, V287, P17914, DOI [10.1074/jbc.M111.302794, 10.1074/jbc.M111.304733]; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Coman D, 2008, AM J MED GENET A, V146A, P389, DOI 10.1002/ajmg.a.32119; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; de Ligt J, 2013, HUM MUTAT, V34, P1439, DOI 10.1002/humu.22387; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drijvers JM, 2010, CLIN GENET, V77, P507, DOI 10.1111/j.1399-0004.2009.01349.x; ELORZA V, 1989, BIOCHEM BIOPH RES CO, V162, P1118, DOI 10.1016/0006-291X(89)90789-4; Faivre L, 2004, AM J MED GENET A, V128A, P29, DOI 10.1002/ajmg.a.30042; Fang WX, 2013, BIOSCIENCE REP, V33, P689, DOI 10.1042/BSR20130053; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Freeze HH, 2009, ESSENTIALS GLYCOBIOL, P47; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Greig KT, 2007, MOL CELL BIOL, V27, P5849, DOI 10.1128/MCB.00802-07; Harms HK, 2002, ACTA PAEDIATR, V91, P1065, DOI 10.1080/080352502760311566; Huber C, 2009, AM J HUM GENET, V85, P706, DOI 10.1016/j.ajhg.2009.10.001; Jaeken J, 2008, J INHERIT METAB DIS, V31, P669, DOI 10.1007/s10545-008-0983-x; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; Kang P, 2008, RAPID COMMUN MASS SP, V22, P721, DOI 10.1002/rcm.3395; Keerthikumar S, 2009, NUCLEIC ACIDS RES, V37, pD863, DOI 10.1093/nar/gkn682; Kranz C, 2007, AM J MED GENET A, V143A, P1371, DOI 10.1002/ajmg.a.31791; Lacey JM, 2001, CLIN CHEM, V47, P513; Lausch E, 2009, AM J HUM GENET, V85, P168, DOI 10.1016/j.ajhg.2009.06.014; Li CY, 2000, GENE, V242, P97, DOI 10.1016/S0378-1119(99)00543-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lupski JR, 2013, GENOME MED, V5, DOI 10.1186/gm461; Mariappa D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002335; Maruyama D, 2007, J BIOL CHEM, V282, P17221, DOI 10.1074/jbc.M611873200; MILEWSKI S, 1986, ARCH MICROBIOL, V145, P234, DOI 10.1007/BF00443651; Morava E, 2007, EUR J HUM GENET, V15, P638, DOI 10.1038/sj.ejhg.5201813; Ng BG, 2007, MOL GENET METAB, V91, P201, DOI 10.1016/j.ymgme.2007.02.011; Nizon M, 2012, HUM MUTAT, V33, P1261, DOI 10.1002/humu.22104; Pang H, 2002, ANN HUM GENET, V66, P139, DOI 10.1017/S0003480002001033; Perez B, 2013, J INHERIT METAB DIS, V36, P535, DOI 10.1007/s10545-012-9525-7; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Timal S, 2012, HUM MOL GENET, V21, P4151, DOI 10.1093/hmg/dds123; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vissers LELM, 2011, AM J HUM GENET, V88, P608, DOI 10.1016/j.ajhg.2011.04.002; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013	54	108	113	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2014	95	1					96	107		10.1016/j.ajhg.2014.05.007	http://dx.doi.org/10.1016/j.ajhg.2014.05.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL1RP	24931394	Green Published, Bronze			2022-12-18	WOS:000338904100008
J	Wissemann, WT; Hill-Burns, EM; Zabetian, CP; Factor, SA; Patsopouos, N; Hoglund, B; Holcomb, C; Donahue, RJ; Thomson, G; Erlich, H; Payami, H				Wissemann, William T.; Hill-Burns, Erin M.; Zabetian, Cyrus P.; Factor, Stewart A.; Patsopouos, Nikolaos; Hoglund, Bryan; Holcomb, Cherie; Donahue, Ryan J.; Thomson, Glenys; Erlich, Henry; Payami, Haydeh			Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; C EXPRESSION; SUSCEPTIBILITY; ALLELES; SNP	Historically, association of disease with the major histocompatibility complex (HLA) genes has been tested with HLA alleles that encode antigen-binding affinity. The association with Parkinson disease (PD), however, was discovered with noncoding SNPs in a genome-wide association study (GWAS). We show here that several HLA-region SNPs that have since been associated with PD form two blocks tagged by rs3129882 (p = 9 x 10(-11)) and by rs9268515 and/or rs2395163 (p = 3 x 10-11). We investigated whether these SNP-associations were driven by HLA-alleles at adjacent loci. We imputed class I and class II HLA-alleles for 2000 PD cases and 1986 controls from the NeuroGenetics Research Consortium GWAS and sequenced a subset of 194 cases and 204 controls. We were therefore able to assess accuracy of two imputation algorithms against next-generation-sequencing while taking advantage of the larger imputed data sets for disease study. Additionally, we imputed HLA alleles for 843 cases and 856 controls from another GWAS for replication. PD risk was positively associated with the B*07:02_C*07:02 DRB5*01_DRB1*15:01_DQA1*01:02_DQB1*06:02 haplotype and negatively associated with the C*03:04, DRB1*04:04 and DQA1*03:01 alleles. The risk haplotype and DQA1*03:01 lost significance when conditioned on the SNPs, but C*03:04 (OR = 0.72, p = 8 x 10(-6)) and DRB1*04:04 (OR = 0.65, p = 4 x 10(-5)) remained significant. Similarly, rs3129882 and the closely linked rs9268515 and rs2395163 remained significant irrespective of HLA alleles. rs3129882 and rs2395163 are expression quantitative trait loci (eQTLs) for HLA-DR and HLA-DQ (9 x 10(-5) >= P-eQTL, 2 x 10(-79)), suggesting that HLA gene expression might influence PD. Our data suggest that PD is associated with both structural and regulatory elements in HLA. Furthermore, our study demonstrates that noncoding SNPs in the HLA region can be associated with disease irrespective of HLA alleles, and that observed associations with HLA alleles can sometimes be secondary to a noncoding variant.	[Wissemann, William T.; Hill-Burns, Erin M.; Donahue, Ryan J.; Payami, Haydeh] New York State Dept Hlth, Wadsworth Ctr, Div Genet, Albany, NY 12208 USA; [Zabetian, Cyrus P.] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Zabetian, Cyrus P.] Univ Washington, Dept Neurol, Seattle, WA 98108 USA; [Factor, Stewart A.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Patsopouos, Nikolaos] Brigham & Womens Hosp, Inst Neurosci, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Patsopouos, Nikolaos] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Patsopouos, Nikolaos] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hoglund, Bryan; Holcomb, Cherie] Roche Mol Syst, Dept Human Genet, Pleasanton, CA 94588 USA; [Thomson, Glenys] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Erlich, Henry] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Payami, Haydeh] SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA	State University of New York (SUNY) System; Wadsworth Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Emory University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Roche Holding; University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Payami, H (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Genet, Albany, NY 12208 USA.	hpayami@wadsworth.org	Payami, Haydeh/ABE-1944-2020	Zabetian, Cyrus/0000-0002-7739-4306; Patsopoulos, Nikolaos/0000-0003-3757-8941; Payami, Haydeh/0000-0001-9084-5338	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS36960]; Global Genetic Consortium Grant from the Michael J. Fox Foundation for Parkinson's Disease Research; Department of Veterans Affairs [1I01BX000531]; National Institutes of Aging [P30AG08017]; Office of Research Development; Clinical Sciences Research & Development Service; Department of Veteran Affairs; Close to the Cure Foundation; National Institutes of Health [HHSN272201200028C]; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000531] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Global Genetic Consortium Grant from the Michael J. Fox Foundation for Parkinson's Disease Research; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Research Development; Clinical Sciences Research & Development Service; Department of Veteran Affairs(US Department of Veterans Affairs); Close to the Cure Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank the research participants. We thank Tatiana Foroud and Richard Myers for making their datasets available for replication. The project was supported by award number R01NS36960 from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by a Global Genetic Consortium Grant from the Michael J. Fox Foundation for Parkinson's Disease Research, a Merit Review Award from the Department of Veterans Affairs (1I01BX000531), the National Institutes of Aging (P30AG08017), the Office of Research & Development, the Clinical Sciences Research & Development Service, the Department of Veteran Affairs, Close to the Cure Foundation, and National Institutes of Health contract HHSN272201200028C. Funding for PROGENI and GenePD studies, which generated the data used for replication, was provided by NINDS, and the GWAS data were obtained from the NINDS database at dbGaP accession number phs000126.v1.p1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Ahmed I, 2012, MOVEMENT DISORD, V27, P1104, DOI 10.1002/mds.25035; Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Hill-Burns EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027109; Holcomb CL, 2011, TISSUE ANTIGENS, V77, P206, DOI 10.1111/j.1399-0039.2010.01606.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Knight JC, 2013, TRENDS GENET, V29, P74, DOI 10.1016/j.tig.2012.10.006; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mosley RL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009381; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saiki M, 2010, J NEUROL NEUROSUR PS, V81, P890, DOI 10.1136/jnnp.2008.162883; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	31	108	109	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					984	993		10.1016/j.ajhg.2013.10.009	http://dx.doi.org/10.1016/j.ajhg.2013.10.009			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24183452	Green Published, Bronze			2022-12-18	WOS:000326996600019
J	Cheng, CY; Schache, M; Ikram, MK; Young, TL; Guggenheim, JA; Vitart, V; MacGregor, S; Verhoeven, VJM; Barathi, VA; Liao, JM; Hysi, PG; Bailey-Wilson, JE; St Pourcain, B; Kemp, JP; McMahon, G; Timpson, NJ; Evans, DM; Montgomery, GW; Mishra, A; Wang, YX; Wang, JJ; Rochtchina, E; Polasek, O; Wright, AF; Amin, N; van Leeuwen, EM; Wilson, JF; Pennell, CE; van Duijn, CM; de Jong, PTVM; Vingerling, JR; Zhou, X; Chen, P; Li, RY; Tay, WT; Zheng, YF; Chew, M; Burdon, KP; Craig, JE; Iyengar, SK; Igo, RP; Lass, JH; Chew, EY; Haller, T; Mihailov, E; Metspalu, A; Wedenoja, J; Simpson, CL; Wojciechowski, R; Hohn, R; Mirshahi, A; Zeller, T; Pfeiffer, N; Lackner, KJ; Bettecken, T; Meitinger, T; Oexle, K; Pirastu, M; Portas, L; Nag, A; Williams, KM; Yonova-Doing, E; Klein, R; Klein, BE; Hosseini, SM; Paterson, AD; Makela, KM; Lehtimaki, T; Kahonen, M; Raitakari, O; Yoshimura, N; Matsuda, F; Chen, LJ; Pang, CP; Yip, SP; Yap, MKH; Meguro, A; Mizuki, N; Inoko, H; Foster, PJ; Zhao, JH; Vithana, E; Tai, ES; Fan, Q; Xu, L; Campbell, H; Fleck, B; Rudan, I; Aung, T; Hofman, A; Uitterlinden, AG; Bencic, G; Khor, CC; Forward, H; Parssinen, O; Mitche, P; Rivadeneira, F; Hewitt, AW; Williams, C; Oostra, BA; Teo, YY; Hammond, CJ; Stambolian, D; Mackey, DA; Klaver, CCW; Wong, TY; Saw, SM; Baird, PN				Cheng, Ching-Yu; Schache, Maria; Ikram, M. Kamran; Young, Terri L.; Guggenheim, Jeremy A.; Vitart, Veronique; MacGregor, Stuart; Verhoeven, Virginie J. M.; Barathi, Veluchamy A.; Liao, Jiemin; Hysi, Pirro G.; Bailey-Wilson, Joan E.; St Pourcain, Beate; Kemp, John P.; McMahon, George; Timpson, Nicholas J.; Evans, David M.; Montgomery, Grant W.; Mishra, Aniket; Wang, Ya Xing; Wang, Jie Jin; Rochtchina, Elena; Polasek, Ozren; Wright, Alan F.; Amin, Najaf; van Leeuwen, Elisabeth M.; Wilson, James F.; Pennell, Craig E.; van Duijn, Cornelia M.; de Jong, Paulus T. V. M.; Vingerling, Johannes R.; Zhou, Xin; Chen, Peng; Li, Ruoying; Tay, Wan-Ting; Zheng, Yingfeng; Chew, Merwyn; Burdon, Kathryn P.; Craig, Jamie E.; Iyengar, Sudha K.; Igo, Robert P., Jr.; Lass, Jonathan H., Jr.; Chew, Emily Y.; Haller, Toomas; Mihailov, Evelin; Metspalu, Andres; Wedenoja, Juho; Simpson, Claire L.; Wojciechowski, Robert; Hoehn, Rene; Mirshahi, Alireza; Zeller, Tanja; Pfeiffer, Norbert; Lackner, Karl J.; Bettecken, Thomas; Meitinger, Thomas; Oexle, Konrad; Pirastu, Mario; Portas, Laura; Nag, Abhishek; Williams, Katie M.; Yonova-Doing, Ekaterina; Klein, Ronald; Klein, Barbara E.; Hosseini, S. Mohsen; Paterson, Andrew D.; Makela, Kari-Matti; Lehtimaki, Terho; Kahonen, Mika; Raitakari, Olli; Yoshimura, Nagahisa; Matsuda, Fumihiko; Chen, Li Jia; Pang, Chi Pui; Yip, Shea Ping; Yap, Maurice K. H.; Meguro, Akira; Mizuki, Nobuhisa; Inoko, Hidetoshi; Foster, Paul J.; Zhao, Jing Hua; Vithana, Eranga; Tai, E-Shyong; Fan, Qiao; Xu, Liang; Campbell, Harry; Fleck, Brian; Rudan, Igor; Aung, Tin; Hofman, Albert; Uitterlinden, Andre G.; Bencic, Goran; Khor, Chiea-Chuen; Forward, Hannah; Parssinen, Olavi; Mitchell, Paul; Rivadeneira, Fernando; Hewitt, Alex W.; Williams, Cathy; Oostra, Ben A.; Teo, Yik-Ying; Hammond, Christopher J.; Stambolian, Dwight; Mackey, David A.; Klaver, Caroline C. W.; Wong, Tien-Yin; Saw, Seang-Mei; Baird, Paul N.		Consortium Refractive Error Myopia; Fuchs Genetics Multictr Study Grp; Wellcome Trust Case Control Consor; Diabet Control Complications Trial	Nine Loci for Ocular Axial Length Identified through Genome-wide Association Studies, Including Shared Loci with Refractive Error	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							URBAN INDIAN POPULATION; VISUAL IMPAIRMENT; SUSCEPTIBILITY LOCI; SPHERICAL EQUIVALENT; CORNEAL CURVATURE; EYE DISEASES; MYOPIA; PREVALENCE; HERITABILITY; CHINESE	Refractive errors are common eye disorders of public health importance worldwide. Ocular axial length (AL) is the major determinant of refraction and thus of myopia and hyperopia. We conducted a meta-analysis of genome-wide association studies for AL, combining 12,531 Europeans and 8,216 Asians. We identified eight genome-wide significant loci for AL (RSPO1, C3orf26, LAMA2, GJD2, ZNRF3, CD55, MIP, and ALPPL2) and confirmed one previously reported AL locus (ZC3H11B). Of the nine loci, five (LAMA2, GJD2, CD55, ALPPL2, and ZC3H11B) were associated with refraction in 18 independent cohorts (n = 23,591). Differential gene expression was observed for these loci in minus-lens-induced myopia mouse experiments and human ocular tissues. Two of the AL genes, RSPO1 and ZNRF3, are involved in Wnt signaling, a pathway playing a major role in the regulation of eyeball size. This study provides evidence of shared genes between AL and refraction, but importantly also suggests that these traits may have unique pathways.	[Cheng, Ching-Yu; Schache, Maria; Barathi, Veluchamy A.; Liao, Jiemin; Aung, Tin; Khor, Chiea-Chuen; Wong, Tien-Yin; Saw, Seang-Mei] Natl Univ Singapore, Dept Ophthalmol, Singapore 119228, Singapore; [Cheng, Ching-Yu; Schache, Maria; Barathi, Veluchamy A.; Liao, Jiemin; Tai, E-Shyong; Aung, Tin; Khor, Chiea-Chuen; Wong, Tien-Yin; Saw, Seang-Mei] Natl Univ Hlth Syst, Singapore 119228, Singapore; [Cheng, Ching-Yu; Zhou, Xin; Chen, Peng; Li, Ruoying; Tai, E-Shyong; Fan, Qiao; Teo, Yik-Ying; Wong, Tien-Yin; Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Cheng, Ching-Yu; Zhou, Xin; Chen, Peng; Li, Ruoying; Tai, E-Shyong; Fan, Qiao; Teo, Yik-Ying; Wong, Tien-Yin; Saw, Seang-Mei] Natl Univ Hlth Syst, Singapore 117597, Singapore; [Cheng, Ching-Yu; Ikram, M. Kamran; Barathi, Veluchamy A.; Liao, Jiemin; Tay, Wan-Ting; Zheng, Yingfeng; Chew, Merwyn; Vithana, Eranga; Aung, Tin; Wong, Tien-Yin; Saw, Seang-Mei] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore; [Cheng, Ching-Yu; Ikram, M. Kamran; Saw, Seang-Mei] Duke Natl Univ Singapore, Grad Sch Med, Off Clin Sci, Ctr Quantitat Med, Singapore 169857, Singapore; [Schache, Maria; Wang, Jie Jin; Hewitt, Alex W.; Mackey, David A.; Baird, Paul N.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Ikram, M. Kamran; Verhoeven, Virginie J. M.; Vingerling, Johannes R.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, NL-3000 CA Rotterdam, Netherlands; [Young, Terri L.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Young, Terri L.] Duke Natl Univ Singapore, Grad Sch Med, Div Neurosci & Behav Disorders, Singapore 169857, Singapore; [Guggenheim, Jeremy A.; Yap, Maurice K. H.] Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Kowloon, Hong Kong, Peoples R China; [Vitart, Veronique; Wright, Alan F.] Univ Edinburgh, Inst Genet & Mol Med, Human Genet Unit, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [MacGregor, Stuart; Montgomery, Grant W.; Mishra, Aniket] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Verhoeven, Virginie J. M.; Amin, Najaf; van Leeuwen, Elisabeth M.; van Duijn, Cornelia M.; Vingerling, Johannes R.; Hofman, Albert; Uitterlinden, Andre G.; Rivadeneira, Fernando; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Barathi, Veluchamy A.; Tai, E-Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore; [Hysi, Pirro G.; Nag, Abhishek; Williams, Katie M.; Yonova-Doing, Ekaterina; Hammond, Christopher J.] Kings Coll London, Sch Med, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Bailey-Wilson, Joan E.; Simpson, Claire L.; Wojciechowski, Robert] NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD 21224 USA; [St Pourcain, Beate; Kemp, John P.; McMahon, George; Timpson, Nicholas J.; Evans, David M.] Univ Bristol, Sch Social & Community Med, Ctr Causal Anal Translat Epidemiol, MRC, Bristol BS8 2BN, Avon, England; [St Pourcain, Beate; Kemp, John P.; McMahon, George; Timpson, Nicholas J.; Evans, David M.; Williams, Cathy] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Wang, Ya Xing; Xu, Liang] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing 100730, Peoples R China; [Wang, Jie Jin; Rochtchina, Elena; Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2145, Australia; [Polasek, Ozren] Univ Split, Fac Med, Split 21000, Croatia; [Wilson, James F.; Campbell, Harry; Rudan, Igor] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Pennell, Craig E.; Forward, Hannah] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [de Jong, Paulus T. V. M.] Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [de Jong, Paulus T. V. M.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [de Jong, Paulus T. V. M.] Leids Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA 5001, Australia; [Iyengar, Sudha K.; Igo, Robert P., Jr.; Lass, Jonathan H., Jr.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Iyengar, Sudha K.; Lass, Jonathan H., Jr.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Iyengar, Sudha K.; Lass, Jonathan H., Jr.] Univ Hosp Cleveland, Inst Eye, Cleveland, OH 44106 USA; [Iyengar, Sudha K.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Iyengar, Sudha K.] Case Western Reserve Univ, Ctr Clin Invest, Cleveland, OH 44106 USA; [Chew, Emily Y.] NEI, NIH, Bethesda, MD 20892 USA; [Haller, Toomas; Mihailov, Evelin; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Mihailov, Evelin] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Wedenoja, Juho] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki 00014, Finland; [Wojciechowski, Robert] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Hoehn, Rene; Mirshahi, Alireza; Pfeiffer, Norbert] Univ Med Ctr Mainz, Dept Ophthalmol, D-55131 Mainz, Germany; [Zeller, Tanja] Univ Heart Ctr Hamburg, Clin Gen & Intervent Cardiol, D-20246 Hamburg, Germany; [Lackner, Karl J.] Univ Med Ctr Mainz, Dept Clin Chem & Lab Med, D-55131 Mainz, Germany; [Bettecken, Thomas; Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas; Oexle, Konrad] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Pirastu, Mario; Portas, Laura] Natl Res Council Italy, Inst Populat Genet, I-07100 Sassari, Italy; [Klein, Ronald; Klein, Barbara E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53705 USA; [Hosseini, S. Mohsen; Paterson, Andrew D.] Univ Toronto, Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Hosseini, S. Mohsen; Paterson, Andrew D.] Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; [Makela, Kari-Matti; Lehtimaki, Terho] Univ Tampere, Tampere Univ Hosp, Filmlab Labs, Dept Clin Chem, Tampere 33520, Finland; [Makela, Kari-Matti; Lehtimaki, Terho] Univ Tampere, Sch Med, Tampere 33520, Finland; [Kahonen, Mika] Univ Tampere, Tampere Univ Hosp, Dept Clin Physiol, Tampere 33521, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Tampere 33521, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20041, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku 20041, Finland; [Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Dept Human Dis Genom, Kyoto 6068501, Japan; [Chen, Li Jia] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Ophthalmol & Visual Sci, Shatin, Hong Kong, Peoples R China; [Pang, Chi Pui] Chinese Univ Hong Kong, Hong Kong Eye Hosp, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China; [Yip, Shea Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Meguro, Akira; Mizuki, Nobuhisa] Yokohama City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Yokohama, Kanagawa 2360004, Japan; [Inoko, Hidetoshi] Tokai Univ, Sch Med, Dept Genet Informat, Div Mol Life Sci, Tokyo, Kanagawa 2591193, Japan; [Foster, Paul J.] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London EC1V 2PD, England; [Foster, Paul J.] UCL Inst Ophthalmol, London EC1V 2PD, England; [Zhao, Jing Hua] Univ Cambridge, Inst Metab Sci, Epidemiol Unit, MRC, Cambridge CB2 0QQ, England; [Tai, E-Shyong] Natl Univ Singapore, Dept Med, Singapore 119228, Singapore; [Fleck, Brian] Princess Alexandra Eye Pavil, Edinburgh EH3 9HA, Midlothian, Scotland; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Bencic, Goran] Sisters Mercy Univ Hosp, Dept Ophthalmol, Zagreb 10000, Croatia; [Khor, Chiea-Chuen] Genome Inst Singapore, Div Human Genet, Singapore 138672, Singapore; [Parssinen, Olavi] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla 40014, Finland; [Parssinen, Olavi] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla 40014, Finland; [Parssinen, Olavi] Cent Hosp Cent Finland, Dept Ophthalmol, Jyvaskyla 40620, Finland; [Hewitt, Alex W.; Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117546, Singapore; [Stambolian, Dwight] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Erasmus University Rotterdam; Erasmus MC; Duke University; National University of Singapore; Hong Kong Polytechnic University; University of Edinburgh; QIMR Berghofer Medical Research Institute; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); University of Bristol; University of Bristol; Capital Medical University; University of Sydney; Westmead Institute for Medical Research; University of Split; University of Edinburgh; University of Western Australia; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Flinders University South Australia; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Tartu; University of Tartu; University of Helsinki; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Consiglio Nazionale delle Ricerche (CNR); University of Wisconsin System; University of Wisconsin Madison; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku; Kyoto University; Kyoto University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Hong Kong Polytechnic University; Yokohama City University; Tokai University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Cambridge; National University of Singapore; Erasmus University Rotterdam; Erasmus MC; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Jyvaskyla; University of Jyvaskyla; Central Finland Central Hospital; Lions Eye Institute; University of Western Australia; Erasmus University Rotterdam; Erasmus MC; National University of Singapore; University of Pennsylvania	Saw, SM (corresponding author), Natl Univ Singapore, Dept Ophthalmol, Singapore 119228, Singapore.	seang_mei_saw@nuhs.edu.sg; pnb@unimelb.edu.au	Biino, Ginevra/B-5334-2013; Zheng, Yingfeng/AAE-2983-2022; Mackey, David A/H-5340-2014; Wong, Tien Yin/AAC-9724-2020; Kemp, John P./R-3091-2018; Montgomery, Grant W/B-7148-2008; Raitakari, Olli/AAQ-7389-2021; Deloukas, Panos/B-2922-2013; Yip, Shea Ping/A-1185-2016; Rivadeneira, Fernando/O-5385-2015; Campbell, Harry/E-2959-2010; Hosseini, S. Mohsen/K-7133-2013; Blackwell, Jenefer M/H-3015-2015; Macgregor, Stuart/C-6442-2009; Burdon, Kathryn/AAD-2334-2022; Cheng, Ching-Yu/K-7017-2013; Paterson, Andrew/AAQ-7511-2020; Mishra, Aniket/T-6886-2019; Mishra, Aniket/T-7966-2019; Timpson, Nicholas John/O-7548-2015; Wilson, James F/A-5704-2009; Hewitt, Alex W/D-1936-2013; Chen, Peng/E-5546-2015; Polasek, Ozren/B-6002-2011; Attrill, Lauren/V-1688-2018; Cheng, Ching-Yu/Y-2229-2019; Pfeiffer, Norbert/AAO-7586-2020; Meitinger, Thomas/O-1318-2015; Fox, Laura J/C-6249-2016; DeAngelis, e/J-7863-2015; /S-1190-2019; W, Robert/AAE-4192-2019; Pang, Chi P/I-5388-2014; Wedenoja, Juho/AAX-7008-2020; Jankowski, Janusz/H-2706-2012; Wang, Jie Jin/P-1499-2014; Bellenguez, Céline/X-4004-2019; Haller, Toomas/N-3797-2019; Foster, Paul/V-7288-2019; Igo, Rob/P-3438-2019; van Leeuwen, Elisabeth/G-3382-2017; wang, jie/GRS-0942-2022; Mitchell, Paul/P-1498-2014; Rudan, Igor/I-1467-2012; Lehtimäki, Terho/AAD-1094-2022; Chen, Li Jia/I-5078-2014; Paterson, Andrew D/A-4088-2011; Zheng, Yingfeng/CAE-9225-2022; Yap, Maurice KH/K-4927-2016; Belllenguez, Céline/Y-3183-2018; Evans, David M/H-6325-2013; Pennell, Craig/ABD-6902-2020; Klaver, Caroline C.W./A-2013-2016; Study, Raine/K-4517-2013; van der Geest, Rob J/J-8193-2015; Wojciechowski, Robert/L-4970-2017; St Pourcain, Beate/K-8004-2017; Wegner, Aharon/H-8448-2019; Burdon, Kathryn/A-5026-2009; wang, YA XING/K-9671-2016; Delcourt, Cecile/I-2627-2013; Williams, Cathy/K-4919-2015	Biino, Ginevra/0000-0002-9936-946X; Mackey, David A/0000-0001-7914-4709; Wong, Tien Yin/0000-0002-8448-1264; Kemp, John P./0000-0002-9105-2249; Montgomery, Grant W/0000-0002-4140-8139; Deloukas, Panos/0000-0001-9251-070X; Yip, Shea Ping/0000-0002-2170-8185; Rivadeneira, Fernando/0000-0001-9435-9441; Campbell, Harry/0000-0002-6169-6262; Hosseini, S. Mohsen/0000-0003-3626-9928; Macgregor, Stuart/0000-0001-6731-8142; Burdon, Kathryn/0000-0001-8217-1249; Cheng, Ching-Yu/0000-0003-0655-885X; Paterson, Andrew/0000-0002-9169-118X; Mishra, Aniket/0000-0002-8141-1543; Mishra, Aniket/0000-0002-8141-1543; Timpson, Nicholas John/0000-0002-7141-9189; Wilson, James F/0000-0001-5751-9178; Hewitt, Alex W/0000-0002-5123-5999; Chen, Peng/0000-0002-1422-4641; Polasek, Ozren/0000-0002-5765-1862; Cheng, Ching-Yu/0000-0003-0655-885X; /0000-0001-7488-250X; W, Robert/0000-0002-9593-4652; Wedenoja, Juho/0000-0002-6155-0378; Jankowski, Janusz/0000-0003-2130-9181; Wang, Jie Jin/0000-0001-9491-4898; Bellenguez, Céline/0000-0002-1240-7874; Haller, Toomas/0000-0002-5069-6523; Foster, Paul/0000-0002-4755-177X; Igo, Rob/0000-0002-0024-1993; Rudan, Igor/0000-0001-6993-6884; Lehtimäki, Terho/0000-0002-2555-4427; Chen, Li Jia/0000-0003-3500-5840; Paterson, Andrew D/0000-0002-9169-118X; Zheng, Yingfeng/0000-0002-0914-7864; Yap, Maurice KH/0000-0003-4687-4101; Belllenguez, Céline/0000-0002-1240-7874; Evans, David M/0000-0003-0663-4621; Pennell, Craig/0000-0002-0937-6165; van der Geest, Rob J/0000-0002-9084-5597; Wojciechowski, Robert/0000-0002-9593-4652; St Pourcain, Beate/0000-0002-4680-3517; Wegner, Aharon/0000-0002-1969-3076; Burdon, Kathryn/0000-0001-8217-1249; wang, YA XING/0000-0003-2749-7793; Delcourt, Cecile/0000-0002-2099-0481; Khor, Chiea Chuen/0000-0002-1128-4729; Meitinger, Thomas/0000-0002-8838-8403; Amin, Najaf/0000-0002-8944-1771; Tai, E Shyong/0000-0003-2929-8966; Oexle, Konrad/0000-0001-7447-2252; Williams, Katie M/0000-0003-4596-3938; Makela, Kari-Matti/0000-0002-8318-8584; Craig, Jamie/0000-0001-9955-9696; Hysi, Pirro/0000-0001-5752-2510; Gillman, Matthew S./0000-0002-2340-6930; Van Duijn, Cornelia/0000-0002-2374-9204; Rahi, Jugnoo/0000-0002-5718-9209; Vitart, Veronique/0000-0002-4991-3797; Bailey-Wilson, Joan/0000-0002-9153-2920; Zeller, Tanja/0000-0003-3379-2641; Baird, Paul/0000-0002-1305-3502; Jurkunas, Ula/0000-0002-5059-608X; Klein, Ronald/0000-0002-4428-6237; Hohn, Rene/0000-0003-2870-1469; Williams, Cathy/0000-0002-9133-2021; Hammond, Christopher/0000-0002-3227-2620; Ikram, Mohammad Kamran/0000-0003-0173-9571; Kiss, Szilard/0000-0003-3433-8432; Klaver, Caroline/0000-0002-2355-5258; Chew, Merwyn/0000-0002-3136-4769; Simpson, Claire/0000-0003-2244-7690; Kahonen, Mika/0000-0002-4510-7341; Yamashiro, Kenji/0000-0001-9354-8558; Portas, Laura/0000-0003-1789-1893; Guggenheim, Jeremy/0000-0001-5164-340X; Plomin, Robert/0000-0002-0756-3629; Murgia, Federico/0000-0002-3608-845X; Verhoeven, Virginie/0000-0001-7359-7862	23andMe; MRC [MC_PC_U127561128, MR/K023721/1, MC_UU_12013/4, MC_UU_12013/3, MC_U127584475] Funding Source: UKRI; Medical Research Council [G9815508, MC_UU_12013/3, MR/K023721/1, MC_UU_12013/4, MC_PC_15018, MC_PC_U127561128, MC_U127584475] Funding Source: researchfish; National Institute for Health Research [SRF/01/010] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY016482, R01EY023196, R01EY014685, R01EY016379, R01EY020483, K08EY022943] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200327] Funding Source: NIH RePORTER	23andMe; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank the staff and participants of all studies for their important contributions. Complete funding information and acknowledgements are provided in the Supplemental Data. ALSPAC thanks 23andMe for funding the generation of the ALSPAC GWA data.	Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Barathi VA, 2008, VISION RES, V48, P904, DOI 10.1016/j.visres.2008.01.004; Barathi VA, 2009, VISION RES, V49, P383, DOI 10.1016/j.visres.2008.11.005; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Biino G, 2005, HUM GENET, V116, P152, DOI 10.1007/s00439-004-1231-6; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brink N, 2000, INFLAMM RES, V49, P290, DOI 10.1007/PL00000209; Brockschmidt A, 2007, HUM MOL GENET, V16, P1488, DOI 10.1093/hmg/ddm099; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Chen CYC, 2007, HUM GENET, V121, P511, DOI 10.1007/s00439-006-0312-0; Dirani M, 2008, INVEST OPHTH VIS SCI, V49, P4336, DOI 10.1167/iovs.07-1516; Dirani M, 2010, INVEST OPHTH VIS SCI, V51, P1348, DOI 10.1167/iovs.09-3587; Evans S, 1996, EARLY HUM DEV, V45, P203, DOI 10.1016/0378-3782(96)01728-8; Fan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002753; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Foran S, 2003, OPHTHALMIC EPIDEMIOL, V10, P215, DOI 10.1076/opep.10.4.215.15906; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Guggenheim JA, 2013, INVEST OPHTH VIS SCI, V54, P1715, DOI 10.1167/iovs.12-10560; Guggenheim JA, 2013, MOL VIS, V19, P243; Guo YH, 2012, EYE, V26, P684, DOI 10.1038/eye.2012.9; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hsiang HW, 2008, AM J OPHTHALMOL, V146, P102, DOI 10.1016/j.ajo.2008.03.010; Hsu WM, 2004, OPHTHALMOLOGY, V111, P62, DOI 10.1016/j.ophtha.2003.05.011; Ip JM, 2007, INVEST OPHTH VIS SCI, V48, P4846, DOI 10.1167/iovs.07-0101; JAVITT JC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1526, DOI 10.1001/archopht.1994.01090240032022; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Klein AP, 2009, ARCH OPHTHALMOL-CHIC, V127, P649, DOI 10.1001/archophthalmol.2009.61; Klein R, 2010, OPHTHALMOLOGY, V117, P63, DOI 10.1016/j.ophtha.2009.06.051; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lim LS, 2011, INVEST OPHTH VIS SCI, V52, P8878, DOI 10.1167/iovs.11-7269; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Louttit MD, 2012, CORNEA, V31, P26, DOI 10.1097/ICO.0b013e31821c9b8f; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Lyhne N, 2001, BRIT J OPHTHALMOL, V85, P1470, DOI 10.1136/bjo.85.12.1470; Mackey DA, 2009, TWIN RES HUM GENET, V12, P441, DOI 10.1375/twin.12.5.441; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Oexle K, 2011, HUM MOL GENET, V20, P1042, DOI 10.1093/hmg/ddq538; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P6636, DOI 10.1167/iovs.10-7148; Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x; Parssinen O, 2010, OPHTHALMOLOGY, V117, P1908, DOI 10.1016/j.ophtha.2010.02.008; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Saw SM, 2005, INVEST OPHTH VIS SCI, V46, P51, DOI 10.1167/iovs.04-0565; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P1408; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Sim X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001363; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Verhoeven VJM, 2012, HUM GENET, V131, P1467, DOI 10.1007/s00439-012-1176-0; Vitale S, 2006, OPHTHALMOLOGY, V113, P2163, DOI 10.1016/j.ophtha.2006.06.033; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Vitart V, 2010, INVEST OPHTH VIS SCI, V51, P737, DOI 10.1167/iovs.09-3720; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Wong TY, 2008, ARCH OPHTHALMOL-CHIC, V126, P1091, DOI 10.1001/archopht.126.8.1091; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1237; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	81	108	114	0	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					264	277		10.1016/j.ajhg.2013.06.016	http://dx.doi.org/10.1016/j.ajhg.2013.06.016			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	24144296	Green Published, Bronze			2022-12-18	WOS:000323186200006
J	Krawitz, PM; Murakami, Y; Hecht, J; Kruger, U; Holder, SE; Mortier, GR; Delle Chiaie, B; De Baere, E; Thompson, MD; Roscioli, T; Kielbasa, S; Kinoshita, T; Mundlos, S; Robinson, PN; Horn, D				Krawitz, Peter M.; Murakami, Yoshiko; Hecht, Jochen; Krueger, Ulrike; Holder, Susan E.; Mortier, Geert R.; Delle Chiaie, Barbara; De Baere, Elfride; Thompson, Miles D.; Roscioli, Tony; Kielbasa, Szymon; Kinoshita, Taroh; Mundlos, Stefan; Robinson, Peter N.; Horn, Denise			Mutations in PIGO, a Member of the GPI-Anchor-Synthesis Pathway, Cause Hyperphosphatasia with Mental Retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY; SEQUENCING DATA; PROTEINS; SEIZURES; GENE; REQUIREMENT; EFFICIENT; PROMOTER	Hyperphosphatasia with mental retardation syndrome (HPMRS), an autosomal-recessive form of intellectual disability characterized by facial dysmorphism, seizures, brachytelephalangy, and persistent elevated serum alkaline phosphatase (hyperphosphatasia), was recently shown to be caused by mutations in PIGV, a member of the glycosylphosphatidylinositol (GPI)-anchor-synthesis pathway. However, not all individuals with HPMRS harbor mutations in this gene. By exome sequencing, we detected compound-heterozygous mutations in PIGO, a gene coding for a membrane protein of the same molecular pathway, in two siblings with HPMRS, and we then found by Sanger sequencing further mutations in another affected individual; these mutations cosegregated in the investigated families. The mutant transcripts are aberrantly spliced, decrease the membrane stability of the protein, or impair enzyme function such that GPI-anchor synthesis is affected and the level of GPI-anchored substrates localized at the cell surface is reduced. Our data identify PIGO as the second gene associated with HPMRS and suggest that a deficiency in GPI-anchor synthesis is the underlying molecular pathomechanism of HPMRS.	[Krawitz, Peter M.; Krueger, Ulrike; Mundlos, Stefan; Robinson, Peter N.; Horn, Denise] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Krawitz, Peter M.; Hecht, Jochen; Mundlos, Stefan; Robinson, Peter N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Krawitz, Peter M.; Hecht, Jochen; Mundlos, Stefan; Robinson, Peter N.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Suita, Osaka 565, Japan; [Murakami, Yoshiko; Kinoshita, Taroh] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 565, Japan; [Holder, Susan E.] NW London Hosp Natl Hlth Serv Trust, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Mortier, Geert R.] Univ Antwerp Hosp, Dept Med Genet, B-2650 Antwerp, Belgium; [Mortier, Geert R.] Univ Antwerp, B-2650 Antwerp, Belgium; [Delle Chiaie, Barbara; De Baere, Elfride] Ghent Univ Hosp, Ctr Med Genet Ghent, B-9000 Ghent, Belgium; [Thompson, Miles D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; [Roscioli, Tony] Univ New S Wales, Sydney Childrens Hosp, Sch Womens & Childrens Hlth, Randwick, NSW 2031, Australia; [Roscioli, Tony] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6525 Nijmegen, Netherlands; [Kielbasa, Szymon] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2300 RC Leiden, Netherlands	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Osaka University; Osaka University; University of Antwerp; University of Antwerp; Ghent University; Ghent University Hospital; University of Toronto; University of New South Wales Sydney; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Robinson, PN (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	peter.robinson@charite.de; denise.horn@charite.de	Kiełbasa, Szymon M./K-2792-2019; Mundlos, Stefan/ABH-9585-2020; Mortier, Geert/D-2542-2012; De Baere, Elfride/E-7405-2017; Kiełbasa, Szymon/G-1636-2018; Krawitz, Peter M/F-3142-2012; Kinoshita, Taroh/C-7353-2009	Mortier, Geert/0000-0001-9871-4578; De Baere, Elfride/0000-0002-5609-6895; Kiełbasa, Szymon/0000-0003-2805-6535; Krawitz, Peter M/0000-0002-3194-8625; Robinson, Peter/0000-0002-0736-9199; Mundlos, Stefan/0000-0002-9788-3166	Bundesministerium fur Forschung und Technologie [0313911]; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan	Bundesministerium fur Forschung und Technologie; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grant 0313911 from the Bundesministerium fur Forschung und Technologie and by grants from the Ministry of Education, Culture, Sports, Science, and Technology and the Ministry of Health, Labour, and Welfare of Japan. We wish to thank all patients and their families involved in this study for their generous help.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Flury I, 2000, J BIOL CHEM, V275, P24458, DOI 10.1074/jbc.M003844200; Hong Y, 2000, J BIOL CHEM, V275, P20911, DOI 10.1074/jbc.M001913200; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3; Johnston JJ, 2012, AM J HUM GENET, V90, P295, DOI 10.1016/j.ajhg.2011.11.031; Kang JY, 2005, J BIOL CHEM, V280, P9489, DOI 10.1074/jbc.M413867200; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; KRUSE K, 1988, J PEDIATR-US, V112, P436, DOI 10.1016/S0022-3476(88)80331-7; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; MABRY CC, 1970, J PEDIATR-US, V77, P74, DOI 10.1016/S0022-3476(70)80047-6; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Thompson MD, 2012, AM J MED GENET A, V158A, P553, DOI 10.1002/ajmg.a.35202; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	26	108	112	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					146	151		10.1016/j.ajhg.2012.05.004	http://dx.doi.org/10.1016/j.ajhg.2012.05.004			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22683086	Green Published, Bronze			2022-12-18	WOS:000306445000012
J	Mochida, GH; Mahajnah, M; Hill, AD; Basel-Vanagaite, L; Gleason, D; Hill, RS; Bodell, A; Crosier, M; Straussberg, R; Walsh, CA				Mochida, Ganeshwaran H.; Mahajnah, Muhammad; Hill, Anthony D.; Basel-Vanagaite, Lina; Gleason, Danielle; Hill, R. Sean; Bodell, Adria; Crosier, Moira; Straussberg, Rachel; Walsh, Christopher A.			A Truncating Mutation of TRAPPC9 Is Associated with Autosomal-Recessive Intellectual Disability and Postnatal Microcephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONSYNDROMIC MENTAL-RETARDATION; NF-KAPPA-B; X-CHROMOSOME; GENE; NEUROGENESIS; DEFECT	Although autosomal genes are increasingly recognized as important causes of intellectual disability, very few of them are known. We identified a genetic locus for autosomal-recessive nonsyndromic intellectual disability associated with variable postnatal microcephaly through homozygosity mapping of a consanguineous Israeli Arab family. Sequence analysis of genes in the candidate interval identified a nonsense nucleotide change in the gene that encodes TRAPPC9 (trafficking protein particle complex 9, also known as NIBP), which has been implicated in NF-kappa B activation and possibly in intracellular protein trafficking. TRAPPC9 is highly expressed in the postmitotic neurons of the cerebral cortex, and MRI analysis of affected patients shows defects in axonal connectivity. This suggests essential roles of TRAPPC9 in human brain development, possibly through its effect on NF-kappa B activation and protein trafficking in the postmitotic neurons of the cerebral cortex.	[Mochida, Ganeshwaran H.; Hill, Anthony D.; Hill, R. Sean; Bodell, Adria; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.; Hill, Anthony D.; Hill, R. Sean; Bodell, Adria; Walsh, Christopher A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.; Gleason, Danielle; Walsh, Christopher A.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.; Gleason, Danielle; Walsh, Christopher A.] Childrens Hosp, Manton Ctr Orphan Dis Res, Dept Med, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA; [Mahajnah, Muhammad] Hillel Yaffe Med Ctr, Pediat Neurol & Child Dev Ctr, IL-38100 Hadera, Israel; [Mahajnah, Muhammad] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Basel-Vanagaite, Lina] Schneider Childrens Med Ctr Israel, Dept Med Genet, IL-49202 Petah Tiqwa, Israel; [Straussberg, Rachel] Schneider Childrens Med Ctr Israel, Neurogenet Clin, IL-49202 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Rabin Med Ctr, Raphael Recanati Genet Inst, IL-49202 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina; Straussberg, Rachel] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Crosier, Moira] Newcastle Univ, MRC Wellcome Trust Human Dev Biol Resource Newcas, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Newcastle University - UK	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu		Mochida, Ganeshwaran/0000-0001-7912-4097; Walsh, Christopher/0000-0002-0156-2238; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; HILL, ANTHONY/0000-0003-2179-6493	National Institutes of Health to The Johns Hopkins University [FIHSN268200782096C]; NINDS [2R01NS035129-12]; Nancy Lurie Marks Family Foundation; Dubai Harvard Foundation for Medical Research; Simons Foundation; Manton Center for Orphan Disease Research; Young Investigator Award of NARSAD as a NARSAD Lieber Investigator; Investigator of the Howard Hughes Medical Institute; MRC [G9900837, G0700089] Funding Source: UKRI; Medical Research Council [G9900837, G0700089] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129] Funding Source: NIH RePORTER	National Institutes of Health to The Johns Hopkins University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Nancy Lurie Marks Family Foundation; Dubai Harvard Foundation for Medical Research; Simons Foundation; Manton Center for Orphan Disease Research; Young Investigator Award of NARSAD as a NARSAD Lieber Investigator(NARSAD); Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank the patients and family for their participation in this research. Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number FIHSN268200782096C. We thank Jennifer Partlow and Brenda Barry for coordinating patient studies, James Barkovich for help in interpretation of brain MRI of Patient 2, Jillian Felie and Dan Rakiec for technical assistance in DNA sequencing, the Partners HealthCare Center for Personalized Genetic Medicine for establishing the lymphoblast cell lines, and Urs Berger for help with in situ hybridization using the mouse brain. The authors would like to thank Jacques Michaud for sharing DNA samples. The human embryonic and fetal material was provided by, the joint MRC-Wellcome Trust Human Developmental Biology Resource at the Institute of Human Genetics, Newcastle-upon-Tyne, UK. We thank the consenting women who made this study possible and A. Farnworth, who gained consent on our behalf. This research was supported by grants from the NINDS (2R01NS035129-12) to C.A.W. and by the Nancy Lurie Marks Family Foundation, the Dubai Harvard Foundation for Medical Research, the Simons Foundation, and the Manton Center for Orphan Disease Research. G.H.M. was supported by the Young Investigator Award of NARSAD as a NARSAD Lieber Investigator. C.A.W. is an Investigator of the Howard Hughes Medical Institute.	Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Denis-Donini S, 2008, J NEUROSCI, V28, P3911, DOI 10.1523/JNEUROSCI.0148-08.2008; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Molinari F, 2008, AM J HUM GENET, V82, P1150, DOI 10.1016/j.ajhg.2008.03.021; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; *WHO, 2001, MENT HLTH NEW UND NE, P35; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64	22	108	112	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					897	902		10.1016/j.ajhg.2009.10.027	http://dx.doi.org/10.1016/j.ajhg.2009.10.027			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004763	Green Published, Bronze			2022-12-18	WOS:000272797100013
J	Verkerk, AJMH; Schot, R; Dumee, B; Schellekens, K; Swagemakers, S; Bertoli-Avella, AM; Lequin, MH; Dudink, J; Govaert, P; van Zwol, AL; Hirst, J; Wessels, MW; Catsman-Berrevoets, C; Verheijen, FW; de Graaff, E; de Coo, IFM; Kros, JM; Willemsen, R; Willems, PJ; van der Spek, PJ; Mancini, GMS				Verkerk, Annemieke J. M. H.; Schot, Rachel; Dumee, Belinda; Schellekens, Karlijn; Swagemakers, Sigrid; Bertoli-Avella, Aida M.; Lequin, Maarten H.; Dudink, Jeroen; Govaert, Paul; van Zwol, A. L.; Hirst, Jennifer; Wessels, Marja W.; Catsman-Berrevoets, Coriene; Verheijen, Frans W.; de Graaff, Esther; de Coo, Irenaeus F. M.; Kros, Johan M.; Willemsen, Rob; Willems, Patrick J.; van der Spek, Peter J.; Mancini, Grazia M. S.			Mutation in the AP4M1 Gene Provides a Model for Neuroaxonal Injury in Cerebral Palsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTERIAL-TORTUOSITY-SYNDROME; DELTA-2 GLUTAMATE RECEPTORS; LINKED MENTAL-RETARDATION; ADAPTER PROTEIN-1 COMPLEX; AMPA RECEPTORS; PERIVENTRICULAR LEUKOMALACIA; FRACTIONAL ANISOTROPY; SYNAPTIC PLASTICITY; LINKAGE ANALYSIS; NERVOUS-SYSTEM	Cerebral palsy due to perinatal injury to cerebral white matter is usually not caused by genetic mutations, but by ischemia and/or inflammation. Here, we describe an autosomal-recessive type of tetraplegic cerebral palsy with mental retardation, reduction of cerebral white matter, and atrophy of the cerebellum in an inbred sibship. The phenotype was recorded and evolution followed for over 20 years. Brain lesions were studied by diffusion tensor MR tractography. Homozygosity mapping with SNPs was performed for identification of the chromosomal locus for the disease. In the 14 Mb candidate region on chromosome 7q22, RNA expression profiling was used for selecting among the 203 genes in the area. In postmortem brain tissue available from one patient, histology and immunohistochemistry were performed. Disease course and imaging were mostly reminiscent of hypoxic-ischemic tetraplegic cerebral palsy, with neuroaxonal degeneration and white matter loss. In all five patients, a donor splice site pathogenic mutation in intron 14 of the AP4M1 gene (c.1137+1G -> T), was identified. AP4M1, encoding for the mu subunit of the adaptor protein complex-4, is involved in intracellular trafficking of glutamate receptors. Aberrant GluR delta 2 glutamate receptor localization and dendritic spine morphology were observed in the postmortem brain specimen. This disease entity, which we refer to as congenital spastic tetraplegia (CST), is therefore a genetic model for congenital cerebral palsy with evidence for neuroaxonal damage and glutamate receptor abnormality mimicking perinatally acquired hypoxic-ischemic white matter injury.	[Schot, Rachel; Bertoli-Avella, Aida M.; Wessels, Marja W.; Verheijen, Frans W.; de Graaff, Esther; Willemsen, Rob; Mancini, Grazia M. S.] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Verkerk, Annemieke J. M. H.; Dumee, Belinda; Schellekens, Karlijn; Swagemakers, Sigrid; van der Spek, Peter J.] Erasmus MC, Dept Bioinformat, NL-3015 GE Rotterdam, Netherlands; [Lequin, Maarten H.] Erasmus MC, Dept Radiol, NL-3015 GE Rotterdam, Netherlands; [Dudink, Jeroen; Govaert, Paul; van Zwol, A. L.] Erasmus MC, Dept Radiol & Neonatol, NL-3015 GE Rotterdam, Netherlands; [Hirst, Jennifer] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 OXY, England; [Catsman-Berrevoets, Coriene; de Coo, Irenaeus F. M.] Erasmus MC, Dept Neurol & Child Neurol, NL-3015 GE Rotterdam, Netherlands; [Kros, Johan M.] Erasmus MC, Dept Pathol, NL-3015 GE Rotterdam, Netherlands; [Willems, Patrick J.] GENDIA Genet Diagnost Network, B-2000 Antwerp, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Mancini, GMS (corresponding author), Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands.	g.mancini@erasmusmc.nl	Bertoli-Avella, Aida/AAW-2751-2020; de Graaff, Esther/D-3287-2011	Bertoli-Avella, Aida/0000-0001-9544-1877; de Coo, Irenaeus/0000-0003-0533-7422; Dudink, Jeroen/0000-0003-0446-3646; Verkerk, Annemieke JMH/0000-0002-7523-3656				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armstrong DD, 1998, J NEUROPATH EXP NEUR, V57, P1013, DOI 10.1097/00005072-199811000-00003; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Callewaert BL, 2008, HUM MUTAT, V29, P150, DOI 10.1002/humu.20623; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Coucke PJ, 2006, NAT GENET, V38, P452, DOI 10.1038/ng1764; Crosby AH, 2003, LANCET NEUROL, V2, P311, DOI 10.1016/S1474-4422(03)00383-1; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Deng WB, 2008, ARCH NEUROL-CHICAGO, V65, P1291, DOI 10.1001/archneur.65.10.1291; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Folkerth RD, 2005, J CHILD NEUROL, V20, P940, DOI 10.1177/08830738050200120301; Follett PL, 2004, J NEUROSCI, V24, P4412, DOI 10.1523/JNEUROSCI.0477-04.2004; Gissen P, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050294; Glenn OA, 2007, AM J NEURORADIOL, V28, P1796, DOI 10.3174/ajnr.A0676; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Huizing M, 2002, PEDIATR RES, V51, P150, DOI 10.1203/00006450-200202000-00006; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Jensen FE, 2005, J CHILD NEUROL, V20, P950, DOI 10.1177/08830738050200120401; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Matsuda S, 2002, EUR J NEUROSCI, V16, P1507, DOI 10.1046/j.1460-9568.2002.02219.x; Matsuda S, 2008, NEURON, V57, P730, DOI 10.1016/j.neuron.2008.02.012; Matsuda S, 2006, J BIOL CHEM, V281, P17501, DOI 10.1074/jbc.M600240200; McQuillen PS, 2005, BRAIN PATHOL, V15, P250; Metin C, 2000, J NEUROSCI, V20, P696, DOI 10.1523/JNEUROSCI.20-02-00696.2000; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nelson KB, 2008, CLIN OBSTET GYNECOL, V51, P749, DOI 10.1097/GRF.0b013e318187087c; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Rennie JM, 2007, SEMIN FETAL NEONAT M, V12, P398, DOI 10.1016/j.siny.2007.07.006; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saillour Y, 2007, J MED GENET, V44, P739, DOI 10.1136/jmg.2007.051334; Schaefer GB, 2008, SEMIN PEDIATR NEUROL, V15, P21, DOI 10.1016/j.spen.2008.01.004; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wessels MW, 2004, AM J MED GENET A, V131A, P134, DOI 10.1002/ajmg.a.30272; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; Yap CC, 2003, MOL CELL NEUROSCI, V24, P283, DOI 10.1016/S1044-7431(03)00164-7; Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919; Zhang YT, 2005, CHINESE MED J-PEKING, V118, P1059; Zhao HM, 1997, J NEUROCHEM, V68, P1041	56	108	112	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 10	2009	85	1					40	52		10.1016/j.ajhg.2009.06.004	http://dx.doi.org/10.1016/j.ajhg.2009.06.004			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	470RO	19559397	Bronze, Green Published			2022-12-18	WOS:000267997600006
J	van den Berg, IM; Laven, JSE; Stevens, M; Jonkers, I; Galjaard, RJ; Gribnau, J; van Doorninck, JH				van den Berg, Ilse M.; Laven, Joop S. E.; Stevens, Mary; Jonkers, Iris; Galjaard, Robert-Jan; Gribnau, Joost; van Doorninck, J. Hikke			X Chromosome Inactivation Is Initiated in Human Preimplantation Embryos	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							XIST EXPRESSION; DOSAGE COMPENSATION; CHORIONIC VILLI; GENE-EXPRESSION; MOUSE EMBRYOS; CELL-CYCLE; REACTIVATION; ANEUPLOIDY; MEMBRANES; REVEALS	X chromosome inactivation (XCI) is the mammalian mechanism that compensates for the difference in gene dosage between XX females and XY males. Genetic and epigenetic regulatory mechanisms induce transcriptional silencing of one X chromosome in female cells. In mouse embryos, XCI is initiated at the preimplantation stage following early whole-genome activation. It is widely thought that human embryos do not employ XCI prior to implantation. Here, we show that female preimplantation embryos have a progressive accumulation of XIST RNA on one of the two X chromosomes, starting around the 8-cell stage. XIST RNA accumulates at the morula and blastocyst stages and is associated with transcriptional silencing of the XIST-coated chromosomal region. These findings indicate that XCI is initiated in female human preimplantation-stage embryos and suggest that preimplantation dosage compensation is evolutionarily conserved in placental mammals.	[van den Berg, Ilse M.; Laven, Joop S. E.; Stevens, Mary; van Doorninck, J. Hikke] Erasmus Sch Ctr, Dept Obstet & Gynecol, Subdiv Reprod Med, NL-3015 GE Rotterdam, Netherlands; [van den Berg, Ilse M.; Stevens, Mary; Galjaard, Robert-Jan; van Doorninck, J. Hikke] Erasmus Sch Ctr, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Jonkers, Iris; Gribnau, Joost] Erasmus Sch Ctr, Dept Reprod & Dev, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam	van Doorninck, JH (corresponding author), Erasmus Sch Ctr, Dept Obstet & Gynecol, Subdiv Reprod Med, NL-3015 GE Rotterdam, Netherlands.	j.vandoorninck@erasmusmc.nl						Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Baart EB, 2006, HUM REPROD, V21, P223, DOI 10.1093/humrep/dei291; Bamforth F, 1996, AM J MED GENET, V61, P209; Bretherick K, 2005, CYTOGENET GENOME RES, V111, P260, DOI 10.1159/000086898; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Brown WM, 1997, PROTEIN SCI, V6, P5; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Daniels R, 1997, AM J HUM GENET, V61, P33, DOI 10.1086/513892; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Goto T, 1997, MOL HUM REPROD, V3, P77, DOI 10.1093/molehr/3.1.77; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; HARRISON KB, 1986, CYTOGENET CELL GENET, V41, P163, DOI 10.1159/000132221; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; Hartshorn C, 2003, MOL REPROD DEV, V64, P41, DOI 10.1002/mrd.10223; Hartshorn C, 2002, MOL REPROD DEV, V61, P425, DOI 10.1002/mrd.10037; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Hohmann FP, 2003, J CLIN ENDOCR METAB, V88, P166, DOI 10.1210/jc.2002-020788; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Huynh KD, 2001, CURR OPIN CELL BIOL, V13, P690, DOI 10.1016/S0955-0674(00)00272-6; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Latham KE, 2005, TRENDS GENET, V21, P120, DOI 10.1016/j.tig.2004.12.003; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Looijenga LHJ, 1999, AM J HUM GENET, V64, P1445, DOI 10.1086/302382; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1984, DIFFERENTIATION, V26, P63, DOI 10.1111/j.1432-0436.1984.tb01375.x; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Matsui J, 2001, HUM MOL GENET, V10, P1393, DOI 10.1093/hmg/10.13.1393; Migeon BR, 2005, AM J HUM GENET, V77, P355, DOI 10.1086/432815; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; MIGEON BR, 1986, P NATL ACAD SCI USA, V83, P2182, DOI 10.1073/pnas.83.7.2182; Migeon BR, 2002, AM J HUM GENET, V71, P286, DOI 10.1086/341605; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Okamoto I, 2006, CYTOGENET GENOME RES, V113, P318, DOI 10.1159/000090848; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ray PF, 1997, HUM MOL GENET, V6, P1323, DOI 10.1093/hmg/6.8.1323; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; ROPERS HH, 1978, HUM GENET, V43, P265, DOI 10.1007/BF00278833; SCHULTZ GA, 1992, MUTAT RES, V296, P17, DOI 10.1016/0165-1110(92)90029-9; SHAO CS, 1990, DEVELOPMENT, V110, P969; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; SUGAWARA O, 1985, CYTOGENET CELL GENET, V39, P210, DOI 10.1159/000132137; Tada T, 2000, DEVELOPMENT, V127, P3101; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Takagi N, 2003, SEMIN CELL DEV BIOL, V14, P319, DOI 10.1016/j.semcdb.2003.09.027; Uehara S, 2000, J HUM GENET, V45, P119, DOI 10.1007/s100380050197; Wells D, 2005, HUM REPROD, V20, P1339, DOI 10.1093/humrep/deh778; WEST JD, 1977, J EMBRYOL EXP MORPH, V41, P233; Zeng SM, 2003, PLACENTA, V24, P270, DOI 10.1053/plac.2002.0889; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	65	108	108	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					771	779		10.1016/j.ajhg.2009.05.003	http://dx.doi.org/10.1016/j.ajhg.2009.05.003			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	19481196	Green Published, Bronze			2022-12-18	WOS:000267042800007
J	Scott, SA; Edelmann, L; Kornreich, R; Desnick, RJ				Scott, Stuart A.; Edelmann, Lisa; Kornreich, Ruth; Desnick, Robert J.			Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							K EPOXIDE REDUCTASE; CYTOCHROME P4502C9 POLYMORPHISMS; COMPLEX SUBUNIT-1; COAGULATION-FACTOR; DOSE REQUIREMENTS; DOSING REGIMEN; GENE; ANTICOAGULATION; HAPLOTYPES; PATIENT	Warfarin is a widely used anticoagulant that has a narrow therapeutic range because of both genetic and environmental factors. CYP2C9*2 (p.R144C), CYP2C9*3 (p.I359L), and the VKORC.1 promoter (g.-1639G -> A) polymorphisms occur frequently in patients who are warfarin "sensitive" and require lower doses, whereas patients with VKORC1 missense mutations are warfarin "resistant" and require higher doses. To compare the CYP2C9 and VKORC1 allele and genotype frequencies among 260 Ashkenazi (AJ) and 80 Sephardi Jewish (SJ) individuals, we genotyped six CYP2C9 and eight VKORC1 alleles by using the Tag-It Mutation Detection Kit and PCR-RFLP assays. The "sensitive" CYP2C9*2 and *3 alleles had significantly higher frequencies in SJ than in AJ individuals, 0.194 and 0.144 versus 0.127 and 0.081, respectively (p <= 0.001). In contrast, the VKORC1 p.D36Y mutation, which predicts warfarin "resistance," had a significantly higher frequency in AJ than in SJ individuals, 0.043 versus 0.006, respectively (p <= 0.025). Of note, 11.3% of AJ individuals predicted to be CYP2C9 extensive metabolizers and 8.7% of those predicted to be intermediate and poor metabolizers were VKORC1 p.D36Y carriers who require markedly higher warfarin doses. Thus, similar to 10% of all AJ individuals would be misclassified when only genotyping CYP2C9*2, *3, and VKORC1 g.-1639G -> A, underscoring the importance of screening for p.D36Y prior to initiating warfarin anticoagulation in AJ individuals. Taken together, our findings show that similar to 85% of AJ and similar to 90% of SJ individuals have at least one "sensitive" (CYP2C9*2, *3, VKORC1 g.-1639G -> A) or "resistant" (VKORC1 p.D36Y) allele, indicating that each group has different warfarin pharmacogenetics and would benefit from genotype-based dose predictions.	[Scott, Stuart A.; Edelmann, Lisa; Kornreich, Ruth; Desnick, Robert J.] NYU, Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University	Desnick, RJ (corresponding author), NYU, Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	ridesnick@mssm.edu		Scott, Stuart/0000-0001-5720-1864	NCRR NIH HHS [M01 RR000071, 5 M01 RR00071] Funding Source: Medline; NIDDK NIH HHS [5 R01 DK26824, R01 DK026824] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026824] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Bodin L, 2005, J THROMB HAEMOST, V3, P1533, DOI 10.1111/j.1538-7836.2005.01449.x; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; D'Ambrosio RL, 2007, J THROMB HAEMOST, V5, P191, DOI 10.1111/j.1538-7836.2006.02261.x; D'Andrea G, 2005, BLOOD, V105, P645, DOI 10.1182/blood-2004-06-2111; El Rouby S, 2004, J HEART VALVE DIS, V13, P15; GAGE BF, 2006, PHARMACOGENETICS BAS, P467; Gan GG, 2003, INT J HEMATOL, V78, P84, DOI 10.1007/BF02983247; Geisen C, 2005, THROMB HAEMOSTASIS, V94, P773, DOI 10.1160/TH05-04-0290; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Harrington DJ, 2005, THROMB HAEMOSTASIS, V93, P23, DOI 10.1160/TH04-08-0540; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Kamali F, 2006, CURR OPIN HEMATOL, V13, P357, DOI 10.1097/01.moh.0000239708.70792.4f; Kirchheiner J, 2005, CLIN PHARMACOL THER, V77, P1, DOI 10.1016/j.clpt.2004.08.009; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; Montes R, 2006, BRIT J HAEMATOL, V133, P183, DOI 10.1111/j.1365-2141.2006.06007.x; Osman A, 2006, J THROMB HAEMOST, V4, P1723, DOI 10.1111/j.1538-7836.2006.02039.x; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Schwarz UI, 2003, EUR J CLIN INVEST, V33, P23, DOI 10.1046/j.1365-2362.33.s2.6.x; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Sconce EA, 2006, EUR J HAEMATOL, V77, P457, DOI 10.1111/j.0902-4441.2006.t01-1-EJH2957.x; Scott S, 2007, PHARMACOGENOMICS, V8, P721, DOI 10.2217/14622416.8.7.721; Sim SC, 2006, METHOD MOL BIOL, V320, P183, DOI DOI 10.1002/PBC.20074; Tham LS, 2006, CLIN PHARMACOL THER, V80, P346, DOI 10.1016/j.clpt.2006.06.009; Visser LE, 2004, THROMB HAEMOSTASIS, V92, P61, DOI 10.1160/th03-12-0741; Wadelius M, 2007, PHARMACOGENOMICS J, V7, P99, DOI 10.1038/sj.tpj.6500417; Xie HG, 2002, ADV DRUG DELIVER REV, V54, P1257, DOI 10.1016/S0169-409X(02)00076-5; Yin T, 2007, THROMB RES, V120, P1, DOI 10.1016/j.thromres.2006.10.021; Yuan HY, 2005, HUM MOL GENET, V14, P1745, DOI 10.1093/hmg/ddi180; Zhu Y, 2007, CLIN CHEM, V53, P1199, DOI 10.1373/clinchem.2006.078139	33	108	121	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					495	500		10.1016/j.ajhg.2007.10.002	http://dx.doi.org/10.1016/j.ajhg.2007.10.002			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252229	Green Published, Bronze			2022-12-18	WOS:000253223900021
J	Tian, C; Hinds, DA; Shigeta, R; Adler, SG; Lee, A; Pahl, MV; Silva, G; Belmont, JW; Hanson, RL; Knowler, WC; Gregersen, PK; Ballinger, DG; Seldin, MF				Tian, Chao; Hinds, David A.; Shigeta, Russell; Adler, Sharon G.; Lee, Annette; Pahl, Madeleine V.; Silva, Gabriel; Belmont, John W.; Hanson, Robert L.; Knowler, William C.; Gregersen, Peter K.; Ballinger, Dennis G.; Seldin, Michael F.			A genomewide single-nucleotide-polymorphism panel for Mexican American admixture mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; ADMIXED POPULATIONS; AFRICAN-AMERICAN; RHEUMATOID-ARTHRITIS; DISEASE; ANCESTRY; MARKERS; MAP	For admixture mapping studies in Mexican Americans (MAM), we define a genomewide single-nucleotide-polymorphism (SNP) panel that can distinguish between chromosomal segments of Amerindian (AMI) or European (EUR) ancestry. These studies used genotypes for > 400,000 SNPs, defined in EUR and both Pima and Mayan AMI, to define a set of ancestry-informative markers (AIMs). The use of two AMI populations was necessary to remove a subset of SNPs that distinguished genotypes of only one AMI subgroup from EUR genotypes. The AIMs set contained 8,144 SNPs separated by a minimum of 50 kb with only three intermarker intervals > 1 Mb and had EUR/AMI values F-ST > 0.30 (mean F-ST = 0.48) and Mayan/Pima values F-ST < 0.05 (mean Fst < 0.01). Analysis of a subset of these SNP AIMs suggested that this panel may also distinguish ancestry between EUR and other disparate AMI groups, including Quechuan from South America. We show, using realistic simulation parameters that are based on our analyses of MAM genotyping results, that this panel of SNP AIMs provides good power for detecting disease-associated chromosomal segments for genes with modest ethnicity risk ratios. A reduced set of 5,287 SNP AIMs captured almost the same admixture mapping information, but smaller SNP sets showed substantial drop-off in admixture mapping information and power. The results will enable studies of type 2 diabetes, rheumatoid arthritis, and other diseases among which epidemiological studies suggest differences in the distribution of ancestry-associated susceptibility.	Univ Calif Davis, Dept Biochem, Rowe Program Human Genet, Davis, CA 95616 USA; Univ Calif Davis, Dept Med, Rowe Program Human Genet, Davis, CA 95616 USA; Perlegen Sci, Mountain View, CA USA; Calif State Univ Los Angeles, David Geffen Sch Med, Los Angeles Biomed Res Inst Harbor, Div Nephrol & Hypertens, Torrance, CA 90032 USA; Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, N Shore Long Isl Jewish Hlth Syst, Manhasset, NY USA; Univ Calif Irvine, Ctr Med, Div Nephrol & Hypertens, Orange, CA 92668 USA; Obras Sociales Hermano Pedro, Antigua, Guatemala; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; NIDDKD, NIH, Phoenix, AZ 85016 USA	University of California System; University of California Davis; University of California System; University of California Davis; California State University System; California State University Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwell Health; University of California System; University of California Irvine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Seldin, MF (corresponding author), Univ Calif Davis, Dept Biochem, Rowe Program Human Genet, Room 4453,Tupper Hall,1 Shields Ave, Davis, CA 95616 USA.	mfseldin@ucdavis.edu	Hanson, Robert L/O-3238-2015; Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021	Hanson, Robert L/0000-0002-4252-7068; Belmont, John W/0000-0001-7409-3578; Hinds, David/0000-0002-4911-803X	Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [U01 DK57249, R01 DK071185, U01 DK057249] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069092, R01DK071185, U01DK057249] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adler SG, 2000, CURR OPIN NEPHROL HY, V9, P99, DOI 10.1097/00041552-200003000-00002; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Collins-Schramm HE, 2004, HUM GENET, V114, P263, DOI 10.1007/s00439-003-1058-6; Collins-Schramm HE, 2002, HUM GENET, V111, P566, DOI 10.1007/s00439-002-0818-z; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; DELPUENTE A, 1989, AM J EPIDEMIOL, V129, P1170; Falush D, 2003, GENETICS, V164, P1567; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; HARVEY J, 1981, ARTHRITIS RHEUM, V24, P717, DOI 10.1002/art.1780240515; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hinds David A., 2004, Human Genomics, V1, P421; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Knowler WC, 2005, J DIABETES COMPLICAT, V19, P1, DOI 10.1016/j.jdiacomp.2003.12.007; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Salzano FM, 2006, GENETICA, V126, P237, DOI 10.1007/s10709-005-1452-1; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WEISS KM, 1984, YEARB PHYS ANTHROPOL, V27, P153; WENDORF M, 1989, AM J PHYS ANTHROPOL, V79, P503, DOI 10.1002/ajpa.1330790407; WEST KM, 1974, DIABETES, V23, P841, DOI 10.2337/diab.23.10.841; Yang N, 2005, HUM GENET, V118, P382, DOI 10.1007/s00439-005-0012-1; Zhang C, 2004, GENET EPIDEMIOL, V27, P225, DOI 10.1002/gepi.20021; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329	38	108	110	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1014	1023		10.1086/513522	http://dx.doi.org/10.1086/513522			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17557415	Bronze, Green Published			2022-12-18	WOS:000246553800002
J	Lesage, S; Leutenegger, AL; Ibanez, P; Janin, S; Lohmann, E; Durr, A; Brice, A				Lesage, S; Leutenegger, AL; Ibanez, P; Janin, S; Lohmann, E; Durr, A; Brice, A		French Parkinsons Dis Genetics Stu	LRRK2 haplotype analyses in European and North African families with Parkinson disease: A common founder for the G2019S mutation dating from the 13th century	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							AUTOSOMAL-DOMINANT PARKINSONISM; GENE; FREQUENT; AGE		Hop La Pitie Salpetriere, INSERM, U679, F-75651 Paris, France; Hop La Pitie Salpetriere, Dept Genet, F-75651 Paris, France; CHU Pitie Salpetriere, Federat Neurol, Paris, France; Unite Format & Rech Pierre & Marie Curie, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Brice, A (corresponding author), Hop La Pitie Salpetriere, INSERM, U679, 47 Blvd Hop, F-75651 Paris, France.	brice@ccr.jussieu.fr	Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019; Leutenegger, Anne-Louise/B-5597-2009	brice, alexis/0000-0002-0941-3990; Leutenegger, Anne-Louise/0000-0002-1302-4357				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Di Fonzo A, 2005, LANCET, V365, P412; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Lesage S, 2005, NEUROLOGY, V64, P1826, DOI 10.1212/WNL.64.10.1826-b; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	10	108	111	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					330	332		10.1086/432422	http://dx.doi.org/10.1086/432422			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	16145815	Green Published, Bronze			2022-12-18	WOS:000230387200016
J	Bender, HU; Almashanu, S; Steel, G; Hu, CA; Lin, WW; Willis, A; Pulver, A; Valle, D				Bender, HU; Almashanu, S; Steel, G; Hu, CA; Lin, WW; Willis, A; Pulver, A; Valle, D			Functional consequences of PRODH missense mutations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; L-PROLINE TRANSPORTER; SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN ARGININOSUCCINATE LYASE; HYPERPROLINEMIA TYPE-I; AMINO-ACID-TRANSPORT; INTRAGENIC COMPLEMENTATION; FAMILIAL HYPERPROLINEMIA; DEHYDROGENASE DOMAIN; MOLECULAR-CLONING	PRODH maps to 22q11 in the region deleted in the velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS) and encodes proline oxidase (POX), a mitochondrial inner-membrane enzyme that catalyzes the first step in the proline degradation pathway. At least 16 PRODH missense mutations have been identified in studies of type I hyperprolinemia (HPI) and schizophrenia, 10 of which are present at polymorphic frequencies. The functional consequences of these missense mutations have been inferred by evolutionary conservation, but none have been tested directly. Here, we report the effects of these mutations on POX activity. We find that four alleles (R185Q, L289M, A455S, and A472T) result in mild (<30%), six (Q19P, A167V, R185W, D426N, V427M, and R431H) in moderate (30% - 70%), and five (P406L, L441P, R453C, T466M, and Q521E) in severe (>70%) reduction in POX activity, whereas one (Q521R) increases POX activity. The POX encoded by one severe allele ( T466M) shows in vitro responsiveness to high cofactor ( flavin adenine dinucleotide) concentrations. Although there is limited information on plasma proline levels in individuals of known PRODH genotype, extant data suggest that severe hyperprolinemia (>800 muM) occurs in individuals with large deletions and/or PRODH missense mutations with the most-severe effect on function (L441P and R453C), whereas modest hyperprolinemia (300 - 500 muM) is associated with PRODH alleles with a moderate reduction in activity. Interestingly, three of the four alleles associated with or found in schizophrenia ( V427M, L441P, and R453C) resulted in severe reduction of POX activity and hyperprolinemia. These observations plus the high degree of polymorphism at the PRODH locus are consistent with the hypothesis that reduction in POX function is a risk factor for schizophrenia.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Univ New Mexico, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; Tri Serv Gen Hosp, Dept Psychiat, Taipei, Taiwan	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of New Mexico; Tri-Service General Hospital	Valle, D (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, 733 N Broadway,BRB 519, Baltimore, MD 21205 USA.	dvalle@jhmi.edu	Bender, Hans-Ulrich/AAM-4857-2020	Bender, Hans-Ulrich/0000-0002-4518-4371				Bassett AS, 2003, AM J PSYCHIAT, V160, P1580, DOI 10.1176/appi.ajp.160.9.1580; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Bussolati O, 2001, MOL MEMBR BIOL, V18, P27, DOI 10.1080/09687680110033756; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chakravarti A, 2002, P NATL ACAD SCI USA, V99, P4755, DOI 10.1073/pnas.092158299; DalL'Asta V, 1999, AM J PHYSIOL-CELL PH, V276, pC865, DOI 10.1152/ajpcell.1999.276.4.C865; Delwing D, 2003, INT J DEV NEUROSCI, V21, P105, DOI 10.1016/S0736-5748(02)00109-0; Delwing D, 2003, METAB BRAIN DIS, V18, P79, DOI 10.1023/A:1021934803724; Donald SP, 2001, CANCER RES, V61, P1810; DONOHOUE PA, 2001, METABOLIC MOL BASES, P4077; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EFRON ML, 1965, NEW ENGL J MED, V272, P1243, DOI 10.1056/NEJM196506172722401; FLYNN MP, 1989, ARCH DIS CHILD, V64, P1699, DOI 10.1136/adc.64.12.1699; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; Geraghty MT, 1998, HUM MOL GENET, V7, P1411, DOI 10.1093/hmg/7.9.1411; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Goodman BK, 2000, J INHERIT METAB DIS, V23, P847, DOI 10.1023/A:1026773005303; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hoogendoorn B, 2004, HUM MUTAT, V24, P35, DOI 10.1002/humu.20061; Humbertclaude V, 2001, J CHILD NEUROL, V16, P622, DOI 10.1177/088307380101600820; Ivanov D, 2003, BRIT J PSYCHIAT, V183, P409, DOI 10.1192/bjp.183.5.409; Jacquet H, 2003, J Med Genet, V40, pe7, DOI 10.1136/jmg.40.1.e7; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; JACQUET H, 2004, MOL PSYCHIATR, P1; Jaeken J, 1996, J INHERIT METAB DIS, V19, P275, DOI 10.1007/BF01799254; KACSER H, 1981, GENETICS, V97, P639; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kiyosue T, 1996, PLANT CELL, V8, P1323, DOI 10.1105/tpc.8.8.1323; Lee YH, 2003, NAT STRUCT BIOL, V10, P109, DOI 10.1038/nsb885; Li T, 2004, AM J MED GENET B, V129B, P13, DOI 10.1002/ajmg.b.30049; LINDSAY EA, 1995, AM J MED GENET, V56, P296, DOI 10.1002/ajmg.1320560316; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Ohtsuki T, 2004, SCHIZOPHR RES, V67, P111, DOI 10.1016/S0920-9964(03)00160-9; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Phang J. M., 2001, METABOLIC MOL BASES, P1821; PHANG JM, 1975, J LAB CLIN MED, V85, P312; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; SCHAFER IA, 1962, NEW ENGL J MED, V267, P51, DOI 10.1056/NEJM196207122670201; SCRIVER CR, 1961, NATURE, V192, P672, DOI 10.1038/192672a0; SCRIVER CR, 1978, METABOLIC BASIS INHE, P336; SHAFQAT S, 1995, MOL PHARMACOL, V48, P219; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131; Sibani S, 2003, HUM MUTAT, V21, P509, DOI 10.1002/humu.10193; Takagi H, 2000, FEMS MICROBIOL LETT, V184, P103, DOI 10.1016/S0378-1097(00)00023-9; Turner MA, 1997, P NATL ACAD SCI USA, V94, P9063, DOI 10.1073/pnas.94.17.9063; VALLE D, 1973, BIOCHEM BIOPH RES CO, V53, P1130, DOI 10.1016/0006-291X(73)90582-2; VALLE D, 1976, J CLIN INVEST, V58, P598, DOI 10.1172/JCI108506; Velaz-Faircloth M, 1995, J Biol Chem, V270, P15755; Walker DC, 1997, J BIOL CHEM, V272, P6777, DOI 10.1074/jbc.272.10.6777; Williams HJ, 2003, MOL PSYCHIATR, V8, P644, DOI 10.1038/sj.mp.4001276; Williams HJ, 2003, AM J MED GENET B, V120B, P42, DOI 10.1002/ajmg.b.20049; Williams NM, 2003, AM J HUM GENET, V73, P1355, DOI 10.1086/380206; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e	67	108	115	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					409	420		10.1086/428142	http://dx.doi.org/10.1086/428142			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15662599	Bronze, Green Published			2022-12-18	WOS:000226851900004
J	Zhang, XX; Snijders, A; Segraves, R; Zhang, XQ; Niebuhr, A; Albertson, D; Yang, HM; Gray, J; Niebuhr, E; Bolund, L; Pinkel, D				Zhang, XX; Snijders, A; Segraves, R; Zhang, XQ; Niebuhr, A; Albertson, D; Yang, HM; Gray, J; Niebuhr, E; Bolund, L; Pinkel, D			High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAT-LIKE CRY; SHORT ARM; 5P; DELETIONS; REGION; MAP; CHROMOSOME-5; MICROARRAYS; PATIENT; NO	We have used array comparative genomic hybridization to map DNA copy-number changes in 94 patients with cri du chat syndrome who had been carefully evaluated for the presence of the characteristic cry, speech delay, facial dysmorphology, and level of mental retardation (MR). Most subjects had simple deletions involving 5p (67 terminal and 12 interstitial). Genotype-phenotype correlations localized the region associated with the cry to 1.5 Mb in distal 5p15.31, between bacterial artificial chromosomes (BACs) containing markers D5S2054 and D5S676; speech delay to 3.2 Mb in 5p15.32-15.33, between BACs containing D5S417 and D5S635; and the region associated with facial dysmorphology to 2.4 Mb in 5p15.2-15.31, between BACs containing D5S208 and D5S2887. These results overlap and refine those reported in previous publications. MR depended approximately on the 5p deletion size and location, but there were many cases in which the retardation was disproportionately severe, given the 5p deletion. All 15 of these cases, approximately two-thirds of the severely retarded patients, were found to have copy-number aberrations in addition to the 5p deletion. Restriction of consideration to patients with only 5p deletions clarified the effect of such deletions and suggested the presence of three regions, MRI-III, with differing effect on retardation. Deletions including MRI, a 1.2-Mb region overlapping the previously defined cri du chat critical region but not including MRII and MRIII, produced a moderate level of retardation. Deletions restricted to MRII, located just proximal to MRI, produced a milder level of retardation, whereas deletions restricted to the still-more proximal MRIII produced no discernible phenotype. However, MR increased as deletions that included MRI extended progressively into MRII and MRIII, and MR became profound when all three regions were deleted.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Aarhus, Inst Human Genet, Aarhus, Denmark; Univ Copenhagen, Inst Med Biochem & Genet, Copenhagen, Denmark; Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Aarhus University; University of Copenhagen; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Pinkel, D (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, Box 0808, San Francisco, CA 94143 USA.	pinkel@cc.ucsf.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017665] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 17665] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Church DM, 1997, GENOME RES, V7, P787, DOI 10.1101/gr.7.8.787; CHURCH DM, 1995, AM J HUM GENET, V56, P1162; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Gersh M, 1997, CYTOGENET CELL GENET, V77, P246, DOI 10.1159/000134586; GERSH M, 1995, AM J HUM GENET, V56, P1404; Hand JL, 2000, PRENATAL DIAG, V20, P144, DOI 10.1002/(SICI)1097-0223(200002)20:2<144::AID-PD770>3.0.CO;2-9; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Johnson EI, 2000, J MED GENET, V37, P125, DOI 10.1136/jmg.37.2.125; Kjaer I, 1999, AM J MED GENET, V82, P6, DOI 10.1002/(SICI)1096-8628(19990101)82:1<6::AID-AJMG2>3.0.CO;2-#; Levy B, 2002, AM J MED GENET, V108, P192, DOI 10.1002/ajmg.10261; Lupski JR, 1996, AM J HUM GENET, V58, P21; Mainardi PC, 2001, J MED GENET, V38, P151, DOI 10.1136/jmg.38.3.151; Marinescu RC, 1999, AM J MED GENET, V86, P66, DOI 10.1002/(SICI)1096-8628(19990903)86:1<66::AID-AJMG13>3.0.CO;2-N; Marinescu RC, 1999, CLIN GENET, V56, P282; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; NIEBUHR E, 1978, HUM GENET, V42, P143, DOI 10.1007/BF00283634; OVERHAUSER J, 1990, AM J MED GENET, V37, P83, DOI 10.1002/ajmg.1320370119; OVERHAUSER J, 1994, HUM MOL GENET, V3, P247, DOI 10.1093/hmg/3.2.247; Peterson ET, 1999, GENOME RES, V9, P1250, DOI 10.1101/gr.9.12.1250; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sreekantaiah C, 1999, AM J MED GENET, V86, P264, DOI 10.1002/(SICI)1096-8628(19990917)86:3<264::AID-AJMG13>3.0.CO;2-Y; WILKINS LE, 1983, J PEDIATR-US, V102, P528, DOI 10.1016/S0022-3476(83)80179-6	31	108	124	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					312	326		10.1086/427762	http://dx.doi.org/10.1086/427762			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15635506	Green Published, Bronze			2022-12-18	WOS:000226215100016
J	Schwarze, U; Hata, RI; McKusick, VA; Shinkai, H; Hoyme, HE; Pyeritz, RE; Byers, PH				Schwarze, U; Hata, RI; McKusick, VA; Shinkai, H; Hoyme, HE; Pyeritz, RE; Byers, PH			Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; PRE-MESSENGER-RNAS; OSTEOGENESIS IMPERFECTA; INTRON REMOVAL; V COLLAGEN; INTERVENING SEQUENCES; PREMESSENGER RNA; SITE MUTATION; COL5A1 GENE; GRAVIS FORM	Splice site mutations in the COL1A2 gene of type I collagen can give rise to forms of Ehlers-Danlos syndrome (EDS) because of partial or complete skipping of exon 6, as well as to mild, moderate, or lethal forms of osteogenesis imperfecta as a consequence of skipping of other exons. We identified three unrelated individuals with a rare recessively inherited form of EDS ( characterized by joint hypermobility, skin hyperextensibility, and cardiac valvular defects); in two of them, COL1A2 messenger RNA (mRNA) instability results from compound heterozygosity for splice site mutations in the COL1A2 gene, and, in the third, it results from homozygosity for a nonsense codon. The splice site mutations led to use of cryptic splice donor sites, creation of a downstream premature termination codon, and extremely unstable mRNA. In the wild-type allele, the two introns (IVS11 and IVS24) in which these mutations occurred were usually spliced slowly in relation to their respective immediate upstream introns. In the mutant alleles, the upstream intron was removed, so that exon skipping could not occur. In the context of the mutation in IVS24, computer-generated folding of a short stretch of mRNA surrounding the mutation site demonstrated realignment of the relationships between the donor and acceptor sites that could facilitate use of a cryptic donor site. These findings suggest that the order of intron removal is an important variable in prediction of mutation outcome at splice sites and that folding of the nascent mRNA could be one element that contributes to determination of order of splicing. The complete absence of proalpha2(I) chains has the surprising effect of producing cardiac valvular disease without bone involvement.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA USA; Kanagawa Dent Coll, Dept Biochem & Mol Biol, Yokosuka, Kanagawa 238, Japan; Kanagawa Dent Coll, Res Ctr Adv Technol Craniomandibular Funct, Yokosuka, Kanagawa 238, Japan; McKusick Nathans Inst Genet Med, Baltimore, MD USA; Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kanagawa Dental College; Kanagawa Dental College; Chiba University; Stanford University; University of Pennsylvania	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.	pbyers@u.washington.edu		Byers, Peter H./0000-0001-7786-7030; Hoyme, Harold/0000-0002-1979-693X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, R01AR041223] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41223, P01 AR021557, R01 AR041223, AR21557] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Attanasio C, 2003, BLOOD, V101, P1851, DOI 10.1182/blood-2002-03-0853; BALVAY L, 1993, BIOESSAYS, V15, P165, DOI 10.1002/bies.950150304; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Bouma P, 2001, J BIOL CHEM, V276, P13356, DOI 10.1074/jbc.M011742200; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; CHIPMAN SD, 1993, P NATL ACAD SCI USA, V90, P1701, DOI 10.1073/pnas.90.5.1701; DePaepe A, 1997, AM J HUM GENET, V60, P547; Giunta C, 2000, AM J MED GENET, V90, P72, DOI 10.1002/(SICI)1096-8628(20000103)90:1<72::AID-AJMG13>3.0.CO;2-C; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; GUDAS JM, 1990, MOL CELL BIOL, V10, P5591, DOI 10.1128/MCB.10.10.5591; HATA R, 1988, EUR J BIOCHEM, V174, P231, DOI 10.1111/j.1432-1033.1988.tb14087.x; Howe KJ, 1997, P NATL ACAD SCI USA, V94, P12467, DOI 10.1073/pnas.94.23.12467; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; KOJIMA T, 1988, Journal of Dermatology (Tokyo), V15, P155; LANG KM, 1987, MOL CELL BIOL, V7, P3428, DOI 10.1128/MCB.7.10.3428; LANG KM, 1985, EMBO J, V4, P1991, DOI 10.1002/j.1460-2075.1985.tb03882.x; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; Neugebauer KM, 1997, GENE DEV, V11, P3279, DOI 10.1101/gad.11.24.3279; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; NICHOLLS AC, 1979, LANCET, V1, P1193; Nicholls AC, 2001, J MED GENET, V38, P132, DOI 10.1136/jmg.38.2.132; Nuytinck L, 2000, AM J HUM GENET, V66, P1398, DOI 10.1086/302859; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; Richards AJ, 1998, J MED GENET, V35, P846, DOI 10.1136/jmg.35.10.846; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SASAKI T, 1987, ARCH DERMATOL, V123, P76, DOI 10.1001/archderm.123.1.76; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; Schwartz BB, 1999, MEMORY, V7, P1, DOI 10.1080/741943714; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Takahara K, 2002, AM J HUM GENET, V71, P451, DOI 10.1086/342099; VOGEL A, 1979, LAB INVEST, V40, P201; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	108	114	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					917	930		10.1086/420794	http://dx.doi.org/10.1086/420794			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15077201	Bronze, Green Published			2022-12-18	WOS:000220926100012
J	Tzeng, JY; Devlin, B; Wasserman, L; Roeder, K				Tzeng, JY; Devlin, B; Wasserman, L; Roeder, K			On the identification of disease mutations by the analysis of haplotype similarity and goodness of fit	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDENTITY-BY-DESCENT; LINKAGE-DISEQUILIBRIUM; FOUNDER POPULATIONS; AFFECTED INDIVIDUALS; GENOMIC CONTROL; ASSOCIATION; GENES; SEGMENTS; SEARCH	The observation that haplotypes from a particular region of the genome differ between affected and unaffected individuals or between chromosomes transmitted to affected individuals versus those not transmitted is sound evidence for a disease-liability mutation in the region. Tests for differentiation of haplotype distributions often take the form of either Pearson's chi(2) statistic or tests based on the similarity among haplotypes in the different populations. In this article, we show that many measures of haplotype similarity can be expressed in the same quadratic form, and we give the general form of the variance. As we describe, these methods can be applied to either phase-known or phase-unknown data. We investigate the performance of Pearson's chi(2) statistic and haplotype similarity tests through use of evolutionary simulations. We show that both approaches can be powerful, but under quite different conditions. Moreover, we show that the power of both approaches can be enhanced by clustering rare haplotypes from the distributions before performing a test.	Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roeder, K (corresponding author), Carnegie Mellon Univ, Dept Stat, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.			Tzeng, Jung-Ying/0000-0002-5505-1775; Roeder, Kathryn/0000-0002-8869-6254	NATIONAL CANCER INSTITUTE [R01CA054852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057881, R01MH057881] Funding Source: NIH RePORTER; NCI NIH HHS [CA54852-07] Funding Source: Medline; NIMH NIH HHS [R01 MH057881, R37 MH057881, MH57881] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bourgain C, 2001, AM J HUM GENET, V68, P154, DOI 10.1086/316933; Bourgain C, 2000, ANN HUM GENET, V64, P255, DOI 10.1046/j.1469-1809.2000.6430255.x; Cheung VG, 1998, GENOMICS, V47, P1, DOI 10.1006/geno.1997.5082; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Culverhouse R, 2001, GENET EPIDEMIOL, V21, pS429, DOI 10.1002/gepi.2001.21.s1.s429; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; Devlin B, 2001, GENET EPIDEMIOL, V21, P273, DOI 10.1002/gepi.1034; Durham LK, 1997, AM J HUM GENET, V61, P830, DOI 10.1086/514891; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fan RZ, 1998, THEOR POPUL BIOL, V53, P184, DOI 10.1006/tpbi.1997.1354; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grant GR, 1999, ANN HUM GENET, V63, P441, DOI 10.1046/j.1469-1809.1999.6350441.x; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Lam JC, 2000, AM J HUM GENET, V66, P659, DOI 10.1086/302756; Lee A.J., 2019, U STAT THEORY PRACTI; MacLean CJ, 2000, AM J HUM GENET, V66, P1062, DOI 10.1086/302796; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Ophoff RA, 2002, AM J HUM GENET, V71, P565, DOI 10.1086/342291; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; Qian DJ, 2001, GENET EPIDEMIOL, V21, pS582, DOI 10.1002/gepi.2001.21.s1.s582; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; Thomas AB, 2001, SERV IND J, V21, P1, DOI 10.1080/714005033; TZENG JY, IN PRESS J AM STAT A; Van der Meulen MA, 1997, GENET EPIDEMIOL, V14, P915, DOI 10.1002/(SICI)1098-2272(1997)14:6<915::AID-GEPI59>3.0.CO;2-P	30	108	111	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					891	902		10.1086/373881	http://dx.doi.org/10.1086/373881			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12610778	Green Published, Bronze			2022-12-18	WOS:000181972600010
J	Marlow, AJ; Fisher, SE; Francks, C; MacPhie, IL; Cherny, SS; Richardson, AJ; Talcott, JB; Stein, JF; Monaco, AP; Cardon, LR				Marlow, AJ; Fisher, SE; Francks, C; MacPhie, IL; Cherny, SS; Richardson, AJ; Talcott, JB; Stein, JF; Monaco, AP; Cardon, LR			Use of multivariate linkage analysis for dissection of a complex cognitive trait	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEVELOPMENTAL DYSLEXIA; QUANTITATIVE TRAITS; READING-DISABILITY; GENETIC-LINKAGE; VARIANCE-COMPONENTS; MEXICAN-AMERICANS; CHROMOSOME 6P; LOCUS; PHENOTYPE; POWER	Replication of linkage results for complex traits has been exceedingly difficult, owing in part to the inability to measure the precise underlying phenotype, small sample sizes, genetic heterogeneity, and statistical methods employed in analysis. Often, in any particular study, multiple correlated traits have been collected, yet these have been analyzed independently or, at most, in bivariate analyses. Theoretical arguments suggest that full multivariate analysis of all available traits should offer more power to detect linkage; however, this has not yet been evaluated on a genomewide scale. Here, we conduct multivariate genomewide analyses of quantitative-trait loci that influence reading- and language-related measures in families affected with developmental dyslexia. The results of these analyses are substantially clearer than those of previous univariate analyses of the same data set, helping to resolve a number of key issues. These outcomes highlight the relevance of multivariate analysis for complex disorders for dissection of linkage results in correlated traits. The approach employed here may aid positional cloning of susceptibility genes in a wide spectrum of complex traits.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Physiol, Oxford OX3 7BN, England; Aston Univ, Psychol Grp, Neurosci Res Inst, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Aston University	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.		Cherny, Stacey S/B-3315-2008; Fisher, Simon E./E-9130-2012; Francks, Clyde/AGU-8875-2022; Monaco, Anthony P/A-4495-2010; Francks, Clyde/E-1384-2012	Cherny, Stacey S/0000-0002-0269-3352; Fisher, Simon E./0000-0002-3132-1996; Monaco, Anthony P/0000-0001-7480-3197; Francks, Clyde/0000-0002-9098-890X; Richardson, Alex/0000-0001-5650-4409	NEI NIH HHS [R01 EY012562, EY-12562] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Allison DB, 1998, AM J HUM GENET, V63, P1190, DOI 10.1086/302038; Amos CI, 2001, HUM HERED, V51, P133, DOI 10.1159/000053334; AMOS CI, 1990, AM J HUM GENET, V47, P247; AMOS CI, 1994, AM J HUM GENET, V54, P535; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Boomsma DI, 1998, BEHAV GENET, V28, P329, DOI 10.1023/A:1021665501312; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CASTLES A, 1993, COGNITION, V47, P149, DOI 10.1016/0010-0277(93)90003-E; Cookson WOC, 2002, CHEST, V121, p7S, DOI 10.1378/chest.121.3_suppl.7S-a; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; Elliot C. D., 1983, BRIT ABILITY SCALES; Evans DM, 2002, AM J HUM GENET, V70, P1599, DOI 10.1086/340850; Fagerheim T, 1999, J MED GENET, V36, P664; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Gallagher A., 1995, ED CHILD PSYCHOL, V12, P53; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Habib M, 2000, BRAIN, V123, P2373, DOI 10.1093/brain/123.12.2373; Marlow AJ, 2001, BEHAV GENET, V31, P219, DOI 10.1023/A:1010209629021; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEALE MC, 1995, MX STAT MODELING; Newbury DF, 2002, AM J HUM GENET, V70, P384; Nopola-Hemmi J, 2001, J MED GENET, V38, P658, DOI 10.1136/jmg.38.10.658; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; SCHORK NJ, 1992, GENET EPIDEMIOL, V9, P73, DOI 10.1002/gepi.1370090202; Schultz JE, 1998, IEEE SOFTWARE, V15, P63, DOI 10.1109/52.676742; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571; Wiltshire S, 2002, AM J HUM GENET, V70, P543, DOI 10.1086/338760	41	108	109	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					561	570		10.1086/368201	http://dx.doi.org/10.1086/368201			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12587094	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000181152600006
J	Lange, C; DeMeo, DL; Laird, NM				Lange, C; DeMeo, DL; Laird, NM			Power and design considerations for a general class of family-based association tests: Quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION-DISEQUILIBRIUM; LINKAGE DISEQUILIBRIUM; UNIFIED APPROACH	In the present article, we address family-based association tests (FBATs) for quantitative traits. We propose an approach to analytical power and sample-size calculations for general FBATs; this approach can be applied to virtually any scenario (missing parental information, multiple offspring per family, etc.). The power calculations are used to discuss optimal choices of the phenotypes for the FBAT statistic and its power's dependence on ascertainment conditions, on study design, and on the correct specification of the distributional assumptions for the phenotypes. We also compare the general FBAT approach with PDT and QTDT. The practical relevance of our theoretical considerations is illustrated by their application to an asthma study.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Lange, C (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA.	clange@hsph.harvard.edu			DIVISION OF LUNG DISEASES [N01HR016049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067664, T32HL007427] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01 HR16049, P01 HL067664, N01HR16044, T32 HL007427, N01HR16049, N01 HLC6795, T32 HL07427, P01 HL67664] Funding Source: Medline; PHS HHS [R01 NL66386] Funding Source: Medline	DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2001, AM J HUM GENET, V68, P1463, DOI 10.1086/320590; Allison DB, 1999, AM J HUM GENET, V64, P1754, DOI 10.1086/302404; Allison DB, 1997, AM J HUM GENET, V60, P676; Billingsley P., 1995, MEASURE PROBABILITY; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Cox DR., 1974, THEORETICAL STAT; Falconer D.S., 1997, INTRO QUANTITATIVE G, VFourth; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; George V, 1999, AM J HUM GENET, V65, P236, DOI 10.1086/302444; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; LANGE C, IN PRESS BIOSTATISTI; Lunetta KL, 2000, AM J HUM GENET, V66, P605, DOI 10.1086/302782; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Risch NJ, 1996, AM J HUM GENET, V58, P836; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Whittaker JC, 1999, AM J HUM GENET, V65, P578, DOI 10.1086/302485; Zhu XF, 2001, HUM HERED, V51, P183, DOI 10.1159/000053341	23	108	111	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1330	1341		10.1086/344696	http://dx.doi.org/10.1086/344696			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12454799	Bronze, Green Published			2022-12-18	WOS:000179586800008
J	Guida, S; Trettel, F; Pagnutti, S; Mantuano, E; Tottene, A; Veneziano, L; Fellin, T; Spadaro, M; Stauderman, KA; Williams, ME; Volsen, S; Ophoff, RA; Frants, RR; Jodice, C; Frontali, M; Pietrobon, D				Guida, S; Trettel, F; Pagnutti, S; Mantuano, E; Tottene, A; Veneziano, L; Fellin, T; Spadaro, M; Stauderman, KA; Williams, ME; Volsen, S; Ophoff, RA; Frants, RR; Jodice, C; Frontali, M; Pietrobon, D			Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HEMIPLEGIC MIGRAINE; CEREBELLAR-ATAXIA; MOLECULAR DETERMINANTS; CHROMOSOME 19P; GENE MUTATION; BLOCK; INACTIVATION; POLYMORPHISM; SUBUNIT; SCA6	Familial hemiplegic migraine, episodic ataxia type 2 (EA2), and spinocerebellar ataxia type 6 are allelic disorders of the CACNA1A gene (coding for the alpha (1A) subunit of P/Q calcium channels), usually associated with different types of mutations (missense, protein truncating, and expansion, respectively). However, the finding of expansion and missense mutations in patients with EA2 has blurred this genotype-phenotype correlation. We report the first functional analysis of a new missense mutation, associated with an EA2 phenotype-that is, T-->C transition of nt 4747 in exon 28, predicted to change a highly conserved phenylalanine residue to a serine at codon 1491, located in the putative transmembrane segment S6 of domain III. Patch-clamp recording in HEK 293 cells, coexpressing the mutagenized human alpha (1A-2) subunit, together with human beta (4) and alpha (2)delta subunits, showed that channel activity was completely abolished, although the mutated protein is expressed in the cell. These results indicate that a complete loss of P/Q channel function is the mechanism underlying EA2, whether due to truncating or to missense mutations.	Univ Roma Tor Vergata, Dept Biol, Rome, Italy; CNR, Inst Expt Med, Rome, Italy; Univ La Sapienza, Ist Clin Malattie Nervose & Mentali, Rome, Italy; Univ Padua, Ctr Biomembranes, Natl Res Council, Padua, Italy; Univ Padua, Dept Biomed Sci, Padua, Italy; SIBIA Neurosci, La Jolla, CA USA; Eli Lilly Co Ltd, Lilly Res Ctr, Windlesham, Surrey, England; Univ Calif Los Angeles, Ctr Neurobehav Genet, Dept Psychiat & Human Genet, Los Angeles, CA USA; Leiden Univ, Med Ctr, Dept Human & Clin Genet, Ctr Med Genet, Leiden, Netherlands	University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; University of Padua; University of Padua; Eli Lilly; University of California System; University of California Los Angeles; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Frontali, M (corresponding author), CNR, Ist Med Sperimentale, Via Fosso Cavaliere, I-00044 Frascati, Roma, Italy.		Veneziano, Liana/F-7858-2018; mantuano, elide/AAB-3526-2019	Veneziano, Liana/0000-0002-9921-8450; mantuano, elide/0000-0003-1656-5543; iodice, carla/0000-0002-1549-5005; trettel, flavia/0000-0002-7983-2955	Telethon [E.0847, E.1297] Funding Source: Medline	Telethon(Fondazione Telethon)		Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Battistini S, 1999, NEUROLOGY, V53, P38, DOI 10.1212/WNL.53.1.38; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; FLETCHER C, IN PRESS FASEB J; Friend KL, 1999, HUM GENET, V105, P261, DOI 10.1007/s004390051099; Frontali M, 1999, PHILOS T ROY SOC B, V354, P1089, DOI 10.1098/rstb.1999.0464; FRONTALI M, IN PRESS CEREBELLUM; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hans M, 1999, J NEUROSCI, V19, P1610; HARRIS CM, 1993, NEUROPEDIATRICS, V24, P117, DOI 10.1055/s-2008-1071526; Hering S, 1997, P NATL ACAD SCI USA, V94, P13323, DOI 10.1073/pnas.94.24.13323; Hering S, 1998, TRENDS PHARMACOL SCI, V19, P439, DOI 10.1016/S0165-6147(98)01258-9; Hockerman GH, 1997, J BIOL CHEM, V272, P18759, DOI 10.1074/jbc.272.30.18759; Jen J, 1999, NEUROLOGY, V53, P34, DOI 10.1212/WNL.53.1.34; Jodice C, 1997, HUM MOL GENET, V6, P1973, DOI 10.1093/hmg/6.11.1973; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; KERN I, 1994, HUM MOL GENET, V3, P216, DOI 10.1093/hmg/3.1.216-a; Kraus RL, 1998, J BIOL CHEM, V273, P5586, DOI 10.1074/jbc.273.10.5586; Matsuyama Z, 1999, J Neurosci, V19, pRC14; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RAVNIKGLAVAC M, 1994, HUM MOL GENET, V3, P801, DOI 10.1093/hmg/3.5.801; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; Trettel F, 2000, GENE, V241, P45, DOI 10.1016/S0378-1119(99)00470-9; Volsen SG, 1995, MOL BRAIN RES, V34, P271, DOI 10.1016/0169-328X(95)00234-J; VONBREDERLOW B, 1995, HUM MOL GENET, V4, P279, DOI 10.1093/hmg/4.2.279; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; Yue Q, 1997, AM J HUM GENET, V61, P1078, DOI 10.1086/301613; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	31	108	113	1	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					759	764		10.1086/318804	http://dx.doi.org/10.1086/318804			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179022	Green Published, Bronze			2022-12-18	WOS:000166994200019
J	Greenberg, DA; Durner, M; Keddache, M; Shinnar, S; Resor, SR; Moshe, SL; Rosenbaum, D; Cohen, J; Harden, C; Kang, H; Wallace, S; Luciano, D; Ballaban-Gil, K; Tomasini, L; Zhou, GL; Klotz, I; Dicker, E				Greenberg, DA; Durner, M; Keddache, M; Shinnar, S; Resor, SR; Moshe, SL; Rosenbaum, D; Cohen, J; Harden, C; Kang, H; Wallace, S; Luciano, D; Ballaban-Gil, K; Tomasini, L; Zhou, GL; Klotz, I; Dicker, E			Reproducibility and complications in gene searches: Linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IDIOPATHIC GENERALIZED EPILEPSIES; SUSCEPTIBILITY LOCUS; ADOLESCENT-ONSET; NO EVIDENCE; LOD SCORES; HLA REGION; FAMILIES; SEIZURES; POWER; BF	Evidence for genetic influences in epilepsy is strong, but reports identifying specific chromosomal origins of those influences conflict. One early study reported that human leukocyte antigen (HLA) markers were genetically linked to juvenile myoclonic epilepsy (JME); this was confirmed in a later study. Other reports did trot find linkage to HLA markers. One found evidence of linkage to markers on chromosome 15, another to markers on chromosome 6, centromeric to HLA. We identified families through a patient with JME and genotyped markers throughout chromosome 6. Linkage analysis assuming equal male-female recombination probabilities showed evidence for linkage (LOD score 2.5), but at a high recombination fraction (theta), suggesting heterogeneity. When linkage analysis was redone to allow independent male-female theta s, the LOD score was significantly higher (4.2) at a male-female theta of .5, .01. Although the overall pattern of LOD scores with respect to male-female theta could not he explained solely by heterogeneity, the presence of heterogeneity and predominantly maternal inheritance of JME might explain it. By analyzing loci between HLA-DP and KLA-DR and stratifying the families on the basis of evidence for or against linkage, we were able to show evidence of heterogeneity within JME and to propose a marker associated with the linked form. These data also suggest that JME may be predominantly maternally inherited and that the HLA-linked form is more likely to occur in families of European origin.	Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; Montefiore Med Ctr, Dept Neurol, New York, NY USA; Montefiore Med Ctr, Dept Pediat, New York, NY USA; Albert Einstein Coll Med, New York, NY USA; Columbia Presbyterian Med Ctr, New York, NY 10032 USA; Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA; Mt Sinai Med Ctr, Div Neuropediat, New York, NY 10029 USA; Cornell Univ, Beth Israel Med Ctr, New York, NY USA; Cornell Univ, New York Hosp, New York, NY 10021 USA; NYU, Comprehens Epilepsy Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; Montefiore Medical Center; Montefiore Medical Center; Yeshiva University; Columbia University; NewYork-Presbyterian Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Cornell University; NewYork-Presbyterian Hospital; New York University	Greenberg, DA (corresponding author), Mt Sinai Sch Med, Dept Psychiat, Box 1229, New York, NY 10029 USA.	dag@shallot.salad.mssm.edu			NIDDK NIH HHS [R01 DK031775, DK31775] Funding Source: Medline; NIMH NIH HHS [R01 MH048858] Funding Source: Medline; NINDS NIH HHS [R01 NS037466, NS27941, R01 NS027941, NS37466] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027941, R01NS037466] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Durner M, 1999, AM J HUM GENET, V64, P1411, DOI 10.1086/302371; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; DURNER M, 1992, EPILEPSIA, V33, P814, DOI 10.1111/j.1528-1157.1992.tb02186.x; DURNER M, IN PRESS AM J MED GE; Elmslie FV, 1996, AM J HUM GENET, V59, P653; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Greenberg DA, 1996, NEUROLOGY, V47, P750, DOI 10.1212/WNL.47.3.750; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1992, NEUROLOGY, V42, P56; GREENBERG DA, 1995, NEUROLOGY, V45, P942, DOI 10.1212/WNL.45.5.942; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GREENBERG DA, 1989, CYTOGENET CELL GENET, V51, P1008; Greenberg DA, 1996, GENET EPIDEMIOL, V13, P243; Greenhalgh L, 1998, SLOAN MANAGE REV, V39, P6; Hodge SE, 1997, AM J HUM GENET, V60, P217; HODGE SE, 1993, AM J HUM GENET, V53, P775; JANZ D, 1992, NEUROLOGY, V42, P48; KLOTZ R, 1999, EPILIPSIA, V40, P23; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1988, AM J HUM GENET, V43, P396; LIU AW, 1995, AM J HUM GENET, V57, P368; Liu AW, 1996, AM J MED GENET, V63, P438; MOEN T, 1995, SEIZURE-EUR J EPILEP, V4, P119, DOI 10.1016/S1059-1311(95)80090-5; MORTON NE, 1955, AM J HUM GENET, V7, P277; Neubauer BA, 1998, NEUROLOGY, V51, P1608, DOI 10.1212/WNL.51.6.1608; OBEID T, 1994, EPILEPSIA, V35, P319, DOI 10.1111/j.1528-1157.1994.tb02437.x; OTT J, 1976, AM J HUM GENET, V28, P528; OTT J, 1991, ANAL HUMAN GENETIC L, P212; OTTMAN R, 1985, AM J EPIDEMIOL, V122, P923, DOI 10.1093/oxfordjournals.aje.a114197; OTTMAN R, 1988, AM J HUM GENET, V43, P257; Sander T, 1997, ACTA NEUROL SCAND, V96, P1; Sander T, 1997, NEUROLOGY, V49, P842, DOI 10.1212/WNL.49.3.842; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652	38	108	108	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					508	516		10.1086/302763	http://dx.doi.org/10.1086/302763			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677311	Bronze, Green Published			2022-12-18	WOS:000088373100018
J	Abreu, PC; Greenberg, DA; Hodge, SE				Abreu, PC; Greenberg, DA; Hodge, SE			Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-LOCUS APPROXIMATIONS; 2-LOCUS MODELS; REDUCED PENETRANCE; OLIGOGENIC TRAITS; DETECT LINKAGE; INFERRING MODE; INHERITANCE; TESTS; HETEROGENEITY; ADEQUACY	Several methods have been proposed for linkage analysis of complex traits with unknown mode of inheritance. These methods include the LOD score maximized over disease models (MMLS) and the "nonparametric" linkage (NPL) statistic. In previous work, we evaluated the increase of type I error when maximizing over two or more genetic models, and we compared the power of MMLS to detect linkage, in a number of complex modes of inheritance, with analysis assuming the true model. In the present study, we compare MMLS and NPL directly. We simulated 100 data sets with 20 families each, using 26 generating models: (1) 4 intermediate models (penetrance of heterozygote between that of the two homozygotes); (2) 6 two-locus additive models; and (3) 16 two-locus heterogeneity models (admixture alpha = 1.0, .7, .5, and .3; alpha = 1.0 replicates simple Mendelian models). For LOD scores, we assumed dominant and recessive inheritance with 50% penetrance. We took the higher of the two maximum LOD scores and subtracted 0.3 to correct for multiple tests (MMLS-C). We compared expected maximum LOD scores and power, using MMLS-C and NPL as well as the true model. Since NPL uses only the affected family members, we also performed an affecteds-only analysis using MMLS-C. The MMLS-C was both uniformly more powerful than NPL for most cases we examined, except when linkage information was low, and close to the results for the true model under locus heterogeneity. We still found better power for the MMLS-C compared with NPL in affecteds-only analysis. The results show that use of two simple modes of inheritance at a fixed penetrance can have more power than NPL when the trait mode of inheritance is complex and when there is heterogeneity in the data set.	CUNY, Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; CUNY, Mt Sinai Med Ctr, Dept Biomath, New York, NY 10029 USA; New York State Psychiat Inst, Div Clin Genet Epidemiol, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA; Columbia Univ, Sch Publ Hlth, Div Biostat, New York, NY 10027 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; New York State Psychiatry Institute; Columbia University; Columbia University	Greenberg, DA (corresponding author), CUNY, Mt Sinai Med Ctr, Dept Psychiat, Box 1229, New York, NY 10029 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031813, R55DK031813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH028274, R01MH028274, R01MH048858] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-31813] Funding Source: Medline; NIMH NIH HHS [MH-48858, MH-28274] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Badner JA, 1998, AM J HUM GENET, V63, P880, DOI 10.1086/302007; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Davis S, 1997, AM J HUM GENET, V61, P1431, DOI 10.1086/301635; Dizier MH, 1996, AM J HUM GENET, V58, P1338; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; GREENBERG DA, 1981, AM J HUM GENET, V33, P519; GREENBERG DA, 1994, AM J HUM GENET, V55, P834; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; GREENBERG DA, 1990, GENET EPIDEMIOL, V7, P467, DOI 10.1002/gepi.1370070608; Greenberg DA, 1996, GENET EPIDEMIOL, V13, P243; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; Lin MW, 1997, AM J MED GENET, V74, P601; Ott J., 1991, ANAL HUMAN GENETIC L; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201	26	108	109	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					847	857		10.1086/302536	http://dx.doi.org/10.1086/302536			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441591	Green Published, Bronze			2022-12-18	WOS:000082426400029
J	Matera, AG; Frey, MR				Matera, AG; Frey, MR			Coiled bodies and gems: Janus or Gemini?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; NUCLEAR-RNA; HUMAN-CELLS; PROTEIN; BODY; SNRNPS; IDENTIFICATION; ORGANIZATION; COMPONENTS		Case Western Reserve Univ, Sch Med, Dept Genet, Ctr Human Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cell Biol Program, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Matera, AG (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Ctr Human Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.	gxm26@po.cwru.edu		Matera, A. Gregory/0000-0002-6406-0630	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053034] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53034, R01 GM053034] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; ANDRADE LEC, 1993, P NATL ACAD SCI USA, V90, P1947, DOI 10.1073/pnas.90.5.1947; Bauer DW, 1997, MOL BIOL CELL, V8, P73, DOI 10.1091/mbc.8.1.73; BEVEN AF, 1995, J CELL SCI, V108, P509; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; CALLAN HG, 1991, CHROMOSOMA, V101, P69, DOI 10.1007/BF00357056; Campbell L, 1997, AM J HUM GENET, V61, P40, DOI 10.1086/513886; CARMOFONSECA M, 1992, J CELL BIOL, V117, P1, DOI 10.1083/jcb.117.1.1; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DiDonato CJ, 1997, GENOME RES, V7, P339, DOI 10.1101/gr.7.4.339; FAKAN S, 1971, EXP CELL RES, V67, P129, DOI 10.1016/0014-4827(71)90628-8; FERREIRA JA, 1994, J CELL BIOL, V126, P11, DOI 10.1083/jcb.126.1.11; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Francis JW, 1998, P NATL ACAD SCI USA, V95, P6492, DOI 10.1073/pnas.95.11.6492; FREY MR, 1995, P NATL ACAD SCI USA, V92, P5915, DOI 10.1073/pnas.92.13.5915; GALL JG, 1995, DEV GENET, V16, P25, DOI 10.1002/dvg.1020160107; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Gao LI, 1997, NUCLEIC ACIDS RES, V25, P4740, DOI 10.1093/nar/25.23.4740; Grande MA, 1997, J CELL SCI, V110, P1781; HOZAK P, 1995, EXP CELL RES, V216, P285, DOI 10.1006/excr.1995.1036; Jordan P, 1997, MOL BIOL CELL, V8, P1207, DOI 10.1091/mbc.8.7.1207; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lyon CE, 1997, EXP CELL RES, V230, P84, DOI 10.1006/excr.1996.3380; Matera AG, 1998, J CELL BIOCHEM, V70, P181; MATERA AG, 1993, J CELL BIOL, V121, P715, DOI 10.1083/jcb.121.4.715; MATTAJ IW, 1993, MOL BIOL REP, V18, P79, DOI 10.1007/BF00986760; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; MONNERON A, 1969, J ULTRA MOL STRUCT R, V27, P266, DOI 10.1016/S0022-5320(69)80017-1; Noble SM, 1996, EMBO J, V15, P4368, DOI 10.1002/j.1460-2075.1996.tb00810.x; Ramon y Cajal S., 1903, TRAD LAB INVEST BIOL, V2, P129; RASKA I, 1991, EXP CELL RES, V195, P27, DOI 10.1016/0014-4827(91)90496-H; Santama N, 1996, EUR J NEUROSCI, V8, P892, DOI 10.1111/j.1460-9568.1996.tb01576.x; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Schul W, 1998, MOL BIOL CELL, V9, P1025, DOI 10.1091/mbc.9.5.1025; SLEEMAN J, IN PRESS EXP CELL RE; SMITH TJ, 1995, AMBION TECHNOTES, V2, P1; TUMA RS, 1993, J CELL BIOL, V122, P767, DOI 10.1083/jcb.122.4.767	44	108	110	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					317	321		10.1086/301992	http://dx.doi.org/10.1086/301992			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683623	Green Published, Bronze			2022-12-18	WOS:000075360800005
J	IshidaYamamoto, A; McGrath, JA; Lam, HM; Iizuka, H; Friedman, RA; Christiano, AM				IshidaYamamoto, A; McGrath, JA; Lam, HM; Iizuka, H; Friedman, RA; Christiano, AM			The molecular pathology of progressive symmetric erythrokeratoderma: A frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PSORIATIC EPIDERMIS; VOHWINKELS-SYNDROME; KERATODERMA; PROTEIN; INVOLUCRIN; VARIABILIS; ACCURACY; LINKAGE	The erythrokeratodermas (EKs) are a group of disorders characterized by erythematous plaques associated with variable features that include palmoplantar keratoderma. One type of EK is known as ''progressive symmetric erythrokeratoderma'' (PSEK). We studied members of a family of Japanese origin in which the index case with PSEK had had well-demarcated nonmigratory erythematous plaques on her extremities since birth. Sequence determination of the loricrin gene revealed an insertion of a C following nucleotide 709. The mutation results in a frameshift that changes the terminal 91 amino acids in the wild-type polypeptide into missense amino acids and adds 65 additional residues. This further implicates loricrin defects in the pathogenesis of disorders with palmoplantar keratoderma and pseudoainhum.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT DERMATOL,NEW YORK,NY 10032; ASAHIKAWA MED COLL,DEPT DERMATOL,ASAHIKAWA,HOKKAIDO 078,JAPAN; UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,ST JOHNS INST DERMATOL,LONDON SE1 7EH,ENGLAND; COLUMBIA PRESBYTERIAN MED CTR,HERBERT IRVING COMPREHENS CANC CTR,COMP FACIL,NEW YORK,NY 10032	Columbia University; Asahikawa Medical College; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Columbia University; NewYork-Presbyterian Hospital			McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964	NCI NIH HHS [P30CA13696-23] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BROWN J, 1966, ARCH DERMATOL, V93, P194, DOI 10.1001/archderm.93.2.194; CAMISA C, 1984, ARCH DERMATOL, V120, P1323, DOI 10.1001/archderm.120.10.1323; CAMISA C, 1988, DERMATOLOGICA, V177, P341, DOI 10.1159/000248604; CANDI E, 1995, J BIOL CHEM, V270, P26382, DOI 10.1074/jbc.270.44.26382; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Christiano AM, 1997, TRENDS GENET, V13, P227, DOI 10.1016/S0168-9525(97)01104-9; DACOSTA SM, 1925, ACTA DERM-VENEREOL, V6, P300; DARIER J, 1911, B SOC FR DERMATOL SY, V22, P252; De Viragh Pierre A., 1997, Journal of Investigative Dermatology, V108, P555; Genetic Computer Group, 1994, PROGR MAN WISC PACK; Gray LC, 1996, J AM ACAD DERMATOL, V34, P858, DOI 10.1016/S0190-9622(96)90047-X; HOHL D, 1991, J BIOL CHEM, V266, P6626; HOPSUHAVU VK, 1971, DERMATOLOGICA, V142, P137, DOI 10.1159/000252381; HOPSUHAVU VK, 1970, DERMATOLOGICA, V141, P321, DOI 10.1159/000252496; HUDSON DL, 1992, HYBRIDOMA, V11, P367, DOI 10.1089/hyb.1992.11.367; ISHIDA A, 1986, JPN J CLIN DERMATOL, V40, P695; ISHIDA A, 1987, JPN J DERMATOL, V97, P785; ISHIDAYAMAMOTO A, 1995, J INVEST DERMATOL, V104, P391, DOI 10.1111/1523-1747.ep12665870; IshidaYamamoto A, 1996, J HISTOCHEM CYTOCHEM, V44, P167, DOI 10.1177/44.2.8609373; KIESEWETTER F, 1993, DERMATOLOGY, V186, P222, DOI 10.1159/000247351; Kudsi S, 1990, Dermatologica, V180, P196; LAMPRECHT A, 1988, INT J PEDIATR OTORHI, V15, P279, DOI 10.1016/0165-5876(88)90083-3; MACFARLANE AW, 1991, BRIT J DERMATOL, V124, P487, DOI 10.1111/j.1365-2133.1991.tb00632.x; Maestrini E, 1996, NAT GENET, V13, P70, DOI 10.1038/ng0596-70; MALDONADORUIZ R, 1982, DERMATOLOGICA, V164, P133; MIURA Y, 1991, JPN J DERMATOL, V101, P635; NAZZARO V, 1986, ARCH DERMATOL, V122, P434, DOI 10.1001/archderm.122.4.434; NIEMI KM, 1993, J CUTAN PATHOL, V20, P242, DOI 10.1111/j.1600-0560.1993.tb00650.x; NIR M, 1978, DERMATOLOGICA, V156, P268, DOI 10.1159/000250927; RICHARD G, 1996, J INVEST DERMATOL, V107, P481; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROST B, 1995, PROTEIN SCI, V4, P521; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; ROST B, 1995, 3 INT C INT SYST MOL, P314; SAMBROOK J, 1979, MOL CLONING LAB MANU; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; Stevens HP, 1996, ARCH DERMATOL, V132, P640, DOI 10.1001/archderm.132.6.640; VANDERSCHROEFF JG, 1988, HUM GENET, V80, P97, DOI 10.1007/BF00451466; VANDERSCHROEFF JG, 1984, HUM GENET, V68, P165, DOI 10.1007/BF00279308; Vohwinkel KH, 1929, ARCH DERMATOL SYPH-G, V158, P354, DOI 10.1007/BF01826619; YONEDA K, 1992, J BIOL CHEM, V267, P18060	42	108	114	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					581	589		10.1086/515518	http://dx.doi.org/10.1086/515518			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326323	Green Published, Green Submitted, hybrid			2022-12-18	WOS:A1997XY52300015
J	Arngrimsson, R; Hayward, C; Nadaud, S; Baldursdottir, A; Walker, JJ; Liston, WA; Bjarnadottir, RI; Brock, DJH; Geirsson, RT; Connor, JM; Soubrier, F				Arngrimsson, R; Hayward, C; Nadaud, S; Baldursdottir, A; Walker, JJ; Liston, WA; Bjarnadottir, RI; Brock, DJH; Geirsson, RT; Connor, JM; Soubrier, F			Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; LINKAGE DISEQUILIBRIUM; CANDIDATE GENE; PRE-ECLAMPSIA; PREECLAMPSIA; ANGIOTENSINOGEN; SUSCEPTIBILITY; INHERITANCE; WOMEN; PLASMA	Pregnancy-induced hypertension may be regarded as a manifestation of endothelial-cell dysfunction. The role of the eNOS gene in the development of a familial pregnancy-induced hypertension was evaluated by analysis of linkage among affected sisters and in multiplex families (n = 50). Markers from a 4-cM region encoding the eNOS gene showed distortion from the expected allele sharing among affected sisters (P = .001-.05), and the statistic obtained from the multilocus application of the affected-pedigree-member method also showed distortion (T-[f(P=sqrt(P)]) = 3.53; P < .001). A LOD score of 3.36 was obtained for D7S505 when a best-fitting model derived from genetic epidemiological data was used, and LOD scores of 2.54-4.03 were obtained when various other genetic models were used. Estimates of recombination rate, rather than maximum LOD-score values, were affected by changes in the genetic parameters. The transmission-disequilibrium test, a model-free estimate of linkage, showed strongest association and linkage with a microsatellite within intron 13 of the eNOS gene (P = .005). These results support the localization of a familial pregnancy-induced hypertension-susceptibility locus in the region of chromosome 7q36 encoding the eNOS gene.	UNIV GLASGOW, INST MED GENET, GLASGOW, LANARK, SCOTLAND; UNIV EDINBURGH, WESTERN GEN HOSP, HUMAN GENET UNIT, EDINBURGH, MIDLOTHIAN, SCOTLAND; SIMPSON MEM HOSP, EDINBURGH, MIDLOTHIAN, SCOTLAND; HOP ST LOUIS, INSERM U358, PARIS, FRANCE; ST JAMES UNIV HOSP, DEPT OBSTET & GYNECOL, LEEDS LS9 7TF, W YORKSHIRE, ENGLAND	University of Glasgow; University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint James's University Hospital	Arngrimsson, R (corresponding author), NATL UNIV HOSP REYKJAVIK, DEPT OBSTET & GYNECOL, DIV CLIN GENET & PRENATAL DIAGNOST, IS-101 REYKJAVIK, ICELAND.		Nadaud, Sophie/GXV-0505-2022; Nadaud, Sophie/A-7063-2013; Hayward, Caroline/M-8818-2016	Nadaud, Sophie/0000-0002-1452-6009; Hayward, Caroline/0000-0002-9405-9550; Arngrimsson, Reynir/0000-0003-1142-2914; Walker, James/0000-0002-8922-083X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARNGRIMSSON R, 1993, NAT GENET, V4, P114, DOI 10.1038/ng0693-114; ARNGRIMSSON R, 1994, ACTA OBSTET GYN SCAN, V73, P10, DOI 10.3109/00016349409013385; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; ARNGRIMSSON R, 1995, HYPERTENS PREGNANCY, V14, P27, DOI 10.3109/10641959509058048; BAKER PN, 1995, HYPERTENSION, V26, P244, DOI 10.1161/01.HYP.26.2.244; BLACKWELDER WC, 1985, GENET EPIDEMIOL, V2, P83; BROWNE FJ, 1956, J OBSTET GYNAECOL, V63, P677; CHESLEY LC, 1947, AM J OBSTET GYNECOL, V53, P851, DOI 10.1016/S0002-9378(15)31611-2; COOPER DW, 1979, J MED GENET, V16, P409, DOI 10.1136/jmg.16.6.409; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DELACRETAZ E, 1995, CLIN SCI, V88, P607, DOI 10.1042/cs0880607; DURNER M, 1992, AM J MED GENET, V42, P271, DOI 10.1002/ajmg.1320420302; GANT NF, 1973, J CLIN INVEST, V52, P2682, DOI 10.1172/JCI107462; GOETZ RM, 1994, BIOCHEM BIOPH RES CO, V205, P905, DOI 10.1006/bbrc.1994.2750; GRIFFITH TM, 1987, NATURE, V329, P442, DOI 10.1038/329442a0; GROENENDIJK R, 1984, AM J OBSTET GYNECOL, V150, P232, DOI 10.1016/S0002-9378(84)90357-0; HAYWARD C, 1992, AM J HUM GENET, V50, P749; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; HUMPHRIES JO, 1960, B JOHNS HOPKINS HOSP, V107, P271; KAKU M, 1959, AM J OBSTET GYNECOL, V78, P399, DOI 10.1016/0002-9378(59)90191-7; KOVACS GA, 1994, HYPERTENS PREGNANCY, V13, P163, DOI 10.3109/10641959409009569; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LISTON WA, 1991, BRIT J OBSTET GYNAEC, V98, P1079, DOI 10.1111/j.1471-0528.1991.tb15358.x; MCCARTHY AL, 1993, AM J OBSTET GYNECOL, V168, P1323, DOI 10.1016/0002-9378(93)90389-Z; MOLNAR M, 1994, AM J OBSTET GYNECOL, V170, P1458; NADAUD S, 1994, BIOCHEM BIOPH RES CO, V198, P1027, DOI 10.1006/bbrc.1994.1146; NATHAN L, 1995, BRIT J PHARMACOL, V114, P955, DOI 10.1111/j.1476-5381.1995.tb13297.x; Ott J., 1991, ANAL HUMAN GENETIC L; RAMSAY B, 1994, EUR J CLIN INVEST, V24, P76, DOI 10.1111/j.1365-2362.1994.tb02064.x; REDMAN CWG, 1977, LANCET, V2, P248; REDMAN CWG, 1989, OBSTETRICS, P515; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SIBAI BM, 1981, OBSTET GYNECOL, V58, P609; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILTON AN, 1995, HYPERTENS PREGNANCY, V14, P251, DOI 10.3109/10641959509009586; WILTON AN, 1990, LANCET, V336, P653, DOI 10.1016/0140-6736(90)92149-C; YALLAMPALLI C, 1993, AM J OBSTET GYNECOL, V169, P1316, DOI 10.1016/0002-9378(93)90299-X	44	108	115	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					354	362		10.1086/514843	http://dx.doi.org/10.1086/514843			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311740	Bronze, Green Published			2022-12-18	WOS:A1997XX70100013
J	MIRZAYANS, F; PEARCE, WG; MACDONALD, IM; WALTER, MA				MIRZAYANS, F; PEARCE, WG; MACDONALD, IM; WALTER, MA			MUTATION OF THE PAX6 GENE IN PATIENTS WITH AUTOSOMAL-DOMINANT KERATITIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMEOBOX-CONTAINING GENE; SMALL-EYE; ANIRIDIA; MOUSE; FAMILY; CELLS; TRANSCRIPTION; MIGRATION; DELETION; PROTEIN	Autosomal dominant keratitis (ADK) is an eye disorder chiefly characterized by corneal opacification and vascularization and by foveal hypoplasia. Aniridia (shown recently to result from mutations in the PAX6 gene) has overlapping clinical findings and a similar pattern of inheritance with ADK. On the basis of these similarities, we used a candidate-gene approach to investigate whether mutations in the PAX6 gene also result in ADK. Significant linkage was found between two polymorphic loci in the PAX6 region and ADK in a family with 15 affected members in four generations (peak LOD score = 4.45; theta = .00 with D11S914), consistent with PAX6 mutations being responsible for ADK. SSCP analysis and direct sequencing revealed a mutation in the PAX6 exon 11 splice-acceptor site. The predicted consequent incorrect splicing results in truncation of the PAX6 proline-serine-threonine activation domain. The Sey(Nett) mouse results from a mutation in the Pax-6 exon 10 splice-donor site that produces a PAX6 protein truncated from the same point as occurs in our family with ADK. Therefore, the Sey(Nett) mouse is an excellent animal model of ADK. The finding that mutations in PAX6 underlie ADK, along with a recent report that mutations in PAX6 also underlie Peters anomaly, implicates PAX6 broadly in human anterior segment malformations.	UNIV ALBERTA, DEPT OPHTHALMOL, EDMONTON, AB, CANADA	University of Alberta				MacDonald, Ian/0000-0001-7472-8385				CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; DAVIS A, 1993, HUM MOL GENET, V2, P2093, DOI 10.1093/hmg/2.12.2093; FAVOR J, 1988, MUTAT RES, V198, P269, DOI 10.1016/0027-5107(88)90003-6; FICKENSCHER HR, 1993, DNA CELL BIOL, V12, P381, DOI 10.1089/dna.1993.12.381; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; GLASER T, 1994, GENOMICS, V19, P145, DOI 10.1006/geno.1994.1024; Glaser T., 1995, MOL GENETICS OCULAR, P51; GRANEK H, 1980, ARCH OPHTHALMOL-CHIC, V98, P469; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSON IM, 1993, HUM MOL GENET, V2, P915; HANSON IM, 1994, NAT GENET, V6, P168, DOI 10.1038/ng0294-168; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HILL RE, 1992, CURR OPIN CELL BIOL, V4, P497; HITTNER HM, 1980, AM J OPHTHALMOL, V89, P531, DOI 10.1016/0002-9394(80)90062-8; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KIVLIN JD, 1986, ARCH OPHTHALMOL-CHIC, V104, P1621; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; MANNENS M, 1989, CYTOGENET CELL GENET, V52, P32, DOI 10.1159/000132834; MARTHA A, 1994, AM J HUM GENET, V54, P801; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; MAWHORTER LG, 1985, OPHTHALMOLOGY, V92, P1427; NICHOLS BE, 1993, COMPUT APPL BIOSCI, V9, P757; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Ott J., 1991, ANAL HUMAN GENETIC L; PEARCE WG, 1994, CAN J OPHTHALMOL, V29, P25; PEARCE WG, 1995, CAN J OPHTHALMOL, V30, P131; PLAZA S, 1993, CELL GROWTH DIFFER, V4, P1041; Read Andrew P., 1994, Seminars in Developmental Biology, V5, P323, DOI 10.1006/sedb.1994.1041; RICCARDI VM, 1978, PEDIATRICS, V61, P604; RUUSUVAARA P, 1987, ACTA OPHTHALMOL, V65, P159; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHAW MW, 1960, AM J HUM GENET, V12, P389; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; VANDERMEERDEJONG R, 1990, GENOMICS, V7, P270, DOI 10.1016/0888-7543(90)90550-E; WILSON GN, 1991, AM J MED GENET, V40, P255, DOI 10.1002/ajmg.1320400302; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	42	108	113	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					539	548						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668281				2022-12-18	WOS:A1995RR60500002
J	BOERKOEL, CF; EXELBERT, R; NICASTRI, C; NICHOLS, RC; MILLER, FW; PLOTZ, PH; RABEN, N				BOERKOEL, CF; EXELBERT, R; NICASTRI, C; NICHOLS, RC; MILLER, FW; PLOTZ, PH; RABEN, N			LEAKY SPLICING MUTATION IN THE ACID MALTASE GENE IS ASSOCIATED WITH DELAYED-ONSET OF GLYCOGENOSIS TYPE-II	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYSOSOMAL ALPHA-GLUCOSIDASE; PROTEIN MESSENGER-RNAS; DISEASE TYPE-II; MISSENSE MUTATION; DNA FRAGMENTS; POMPE DISEASE; ONE ALLELE; GC-CLAMP; DEFICIENCY; EXPRESSION	An autosomal recessive deficiency of acid alpha-gIucosidase (GAA), type II glycogenosis, is genetically and clinically heterogeneous. The discovery of an enzyme-inactivating genomic deletion of exon 18 in three unrelated genetic compound patients-two infants and an adult-provided a rare opportunity to analyze the effect of the second mutation in patients who displayed dramatically different phenotypes. A deletion of Lys-903 in one patient and a substitution of Arg for Leu-299 in another resulted in the fatal infantile form. In the adult, a T-to-G base change at position -13 of intron 1 resulted in alternatively spliced transcripts with deletion of exon 2, the location of the start codon. The low level of active enzyme (12% of normal) generated from the leakage of normally spliced mRNA sustained the patient to adult life.	NIAMSD,ARTHRIT & RHEUMATISM BRANCH,BETHESDA,MD 20892; US FDA,ROCKVILLE,MD 20857	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); US Food & Drug Administration (FDA)			Boerkoel, Cornelius Franciscus/AFW-4948-2022; Miller, Frederick/D-2431-2019	Boerkoel, Cornelius Franciscus/0000-0003-3097-241X; Miller, Frederick/0000-0003-2831-9593				AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARSY TD, 1972, EUR J BIOCHEM, V31, P156, DOI 10.1111/j.1432-1033.1972.tb02514.x; BERATIS NG, 1983, ISOZYMES-CURR T BIOL, V11, P25; BERATIS NG, 1983, AM J HUM GENET, V35, P21; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BROWN BI, 1970, BIOCHEMISTRY-US, V9, P1423, DOI 10.1021/bi00808a017; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COURTECU.V, 1965, ARCH FR PEDIATR, V22, P1153; DIMAURO S, 1978, MUSCLE NERVE, V1, P27, DOI 10.1002/mus.880010105; ENGEL AG, 1973, NEUROLOGY, V23, P95, DOI 10.1212/WNL.23.1.95; ENGEL AG, 1970, BRAIN, V93, P599, DOI 10.1093/brain/93.3.599; ENGEL AG, 1970, NEUROLOGY, V20, P382; ENGEL AG, 1968, MAYO CLIN PROC, V43, P233; ENGEL AG, 1986, ACID MALTASE DEFICIE, P1629; GALJAARD H, 1973, CLIN CHIM ACTA, V49, P361, DOI 10.1016/0009-8981(73)90234-9; HAVERSTICK DM, 1990, J NEUROCHEM, V55, P764, DOI 10.1111/j.1471-4159.1990.tb04557.x; HERMANS MMP, 1993, BIOCHEM J, V289, P687, DOI 10.1042/bj2890687; HERMANS MMP, 1993, BIOCHEM J, V289, P681, DOI 10.1042/bj2890681; HERMANS MMP, 1991, J BIOL CHEM, V266, P13507; HERMANS MMP, 1991, BIOCHEM BIOPH RES CO, V179, P919, DOI 10.1016/0006-291X(91)91906-S; HERMANS MMP, 1993, HUM MUTAT, V2, P268, DOI 10.1002/humu.1380020406; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Higuchi R., 1989, PCR TECHNOLOGY, P61; HOEFSLOOT LH, 1990, BIOCHEM J, V272, P493, DOI 10.1042/bj2720493; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; HOEFSLOOT LH, 1990, BIOCHEM J, V272, P485, DOI 10.1042/bj2720485; HUDGSON P, 1968, BRAIN, V91, P435, DOI 10.1093/brain/91.3.435; HUIE ML, 1994, HUM MOL GENET, V3, P2231; HUIE ML, 1994, HUM MOL GENET, V3, P1081, DOI 10.1093/hmg/3.7.1081; JEFFREY PL, 1970, BIOCHEMISTRY-US, V9, P1416, DOI 10.1021/bi00808a016; JEZEQUEL AM, 1965, LAB INVEST, V14, P1894; Kawasaki E.S., 1990, PCR PROTOCOLS GUIDE, P146; MARTINIUK F, 1991, DNA CELL BIOL, V10, P681, DOI 10.1089/dna.1991.10.681; MARTINIUK F, 1991, DNA CELL BIOL, V10, P283, DOI 10.1089/dna.1991.10.283; MARTINIUK F, 1990, DNA CELL BIOL, V9, P85, DOI 10.1089/dna.1990.9.85; MARTINIUK F, 1986, P NATL ACAD SCI USA, V83, P9641, DOI 10.1073/pnas.83.24.9641; MARTINIUK F, 1990, AM J HUM GENET, V47, P440; MARTINIUK F, 1990, AM J HUM GENET, V47, P73; MEHLER M, 1977, NEUROLOGY, V27, P178, DOI 10.1212/WNL.27.2.178; MIRANDA AF, 1985, ARCH NEUROL-CHICAGO, V42, P371, DOI 10.1001/archneur.1985.04060040081017; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; NICHOLS RC, 1994, BIOTECHNIQUES, V17, P412; NINOMIYA N, 1984, J NEUROL SCI, V66, P129, DOI 10.1016/0022-510X(84)90001-7; Pompe JC, 1932, NED TIJDSCHR GENEESK, V76, P304; Putschar W, 1932, BEITR PATHOL ANAT AL, V90, P222; REUSER AJJ, 1978, AM J HUM GENET, V30, P132; REUSER AJJ, 1985, J BIOL CHEM, V260, P8336; REUSER AJJ, 1987, J CLIN INVEST, V79, P1689, DOI 10.1172/JCI113008; REUSER AJJ, 1988, LIPID STORAGE DISORD, P547; ROSENOW EC, 1978, AM J MED, V64, P485, DOI 10.1016/0002-9343(78)90235-8; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SHANSKE S, 1984, EXP NEUROL, V84, P565, DOI 10.1016/0014-4886(84)90204-8; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHINBUEHRING YS, 1978, CLIN CHIM ACTA, V89, P393, DOI 10.1016/0009-8981(78)90401-1; SOYAMA K, 1977, CLIN CHIM ACTA, V78, P473; STECKEL F, 1982, FEBS LETT, V150, P69, DOI 10.1016/0014-5793(82)81306-9; TANAKA S, 1992, MOL BRAIN RES, V15, P303, DOI 10.1016/0169-328X(92)90122-R; TANAKA S, 1993, NEUROSCI LETT, V163, P19, DOI 10.1016/0304-3940(93)90219-B; VANDERKRAAN M, 1994, BIOCHEM BIOPH RES CO, V203, P1535, DOI 10.1006/bbrc.1994.2360; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; ZHONG N, 1991, AM J HUM GENET, V49, P635	61	108	116	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1995	56	4					887	897						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QP663	7717400				2022-12-18	WOS:A1995QP66300010
J	LIGTENBERG, MJL; KEMP, S; SARDE, CO; VANGEEL, BM; KLEIJER, WJ; BARTH, PG; MANDEL, JL; VANOOST, BA; BOLHUIS, PA				LIGTENBERG, MJL; KEMP, S; SARDE, CO; VANGEEL, BM; KLEIJER, WJ; BARTH, PG; MANDEL, JL; VANOOST, BA; BOLHUIS, PA			SPECTRUM OF MUTATIONS IN THE GENE ENCODING THE ADRENOLEUKODYSTROPHY PROTEIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-LINKED ADRENOLEUKODYSTROPHY	X-linked adrenoleukodystrophy (ALD) has been associated with mutations in a gene encoding an ATP-binding transporter, which is located in the peroxisomal membrane. Deficiency of the gene leads to impaired peroxisomal beta-oxidation. Systematic analysis of the open reading frame of the ALD gene, using reverse transcriptase-PCR, followed by direct sequencing, revealed mutations in all 28 unrelated kindreds analyzed. No entire gene deletions or drastic promoter mutations were detected. In only one kindred did the mutation involve multiple exons. The other mutations were small alterations leading to missense (13 of 28) or nonsense mutations, a single amino acid deletion, frameshifts, or splice acceptor-site defects. Mutations affecting a single amino acid were concentrated in the region between the third and fourth putative transmembrane domains and in the ATP-binding domain. Mutations were detected in all investigated ALD kindreds, suggesting that this gene is the only gene responsible for X-linked ALD. This overview of mutations is useful in the determination of structurally and functionally important regions and provides an efficient screening strategy for identification of mutations in the ALD gene.	UNIV NIJMEGEN HOSP,HB,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,1105 AZ AMSTERDAM,NETHERLANDS; INSERM,U184,CNRS,MOLEC GENET LAB,STRASBOURG,FRANCE; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,ROTTERDAM,NETHERLANDS	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Erasmus University Rotterdam			Ligtenberg, Marjolijn/N-9666-2013; Kemp, Stephan/A-3935-2008	Ligtenberg, Marjolijn/0000-0003-1290-1474; Kemp, Stephan/0000-0003-2023-064X				CARTIER N, 1993, HUM MOL GENET, V2, P1949, DOI 10.1093/hmg/2.11.1949; CONTRERAS M, 1994, FEBS LETT, V344, P211, DOI 10.1016/0014-5793(94)00400-5; FANEN P, 1994, J CLIN INVEST, V94, P516, DOI 10.1172/JCI117363; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KEMP S, 1994, BIOCHEM BIOPH RES CO, V202, P647, DOI 10.1006/bbrc.1994.1979; KEMP S, 1994, IN PRESS HUM MUTAT; MAESTRI NE, 1992, AM J MED GENET, V44, P576, DOI 10.1002/ajmg.1320440509; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOSER HW, 1989, METABOLIC BASIS INHE, P1511; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; SARDE CO, 1994, GENOMICS, V22, P13, DOI 10.1006/geno.1994.1339; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; UCHIYAMA A, 1994, BIOCHEM BIOPH RES CO, V198, P632, DOI 10.1006/bbrc.1994.1092; VALLE D, 1993, NATURE, V361, P682, DOI 10.1038/361682a0	16	108	112	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					44	50						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825602				2022-12-18	WOS:A1995QC10100006
J	MACCOLLIN, M; RAMESH, V; JACOBY, LB; LOUIS, DN; RUBIO, MP; PULASKI, K; TROFATTER, JA; SHORT, MP; BOVE, C; ELDRIDGE, R; PARRY, DM; GUSELLA, JF				MACCOLLIN, M; RAMESH, V; JACOBY, LB; LOUIS, DN; RUBIO, MP; PULASKI, K; TROFATTER, JA; SHORT, MP; BOVE, C; ELDRIDGE, R; PARRY, DM; GUSELLA, JF			MUTATIONAL ANALYSIS OF PATIENTS WITH NEUROFIBROMATOSIS-2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BILATERAL ACOUSTIC NEUROFIBROMATOSIS; TUMOR-SUPPRESSOR; DISEASE	Neurofibromatosis 2 (NF2) is a genetic disorder characterized by the development of multiple nervous-system tumors in young adulthood. The NF2 gene has recently been isolated and found to encode a new member of the protein 4.1 family of cytoskeletal associated proteins, which we have named merlin. To define the molecular basis of NF2 in affected individuals, we have used SSCP analysis to scan the exons of the NF2 gene from 33 unrelated patients with NF2. Twenty unique SSCP variants were seen in 21 patients; 10 of these individuals were known to be the only affected person in their kindred, while 7 had at least one other known affected relative. In all cases in which family members were available, the SSCP variant segregated with the disease; comparison of sporadic cases with their parents confirmed the de novo variants. DNA sequence analysis revealed that 19 of the 20 variants observed are predicted to lead to a truncated protein due to frameshift, creation of a stop codon, or interference with normal RNA splicing. A single patient carried a 3-bp deletion removing a phenylalanine residue. We conclude that the majority of NF2 patients carry an inactivating mutation of the NF2 gene and that neutral polymorphism in the gene is rare.	MASSACHUSETTS GEN HOSP E,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; MASSACHUSETTS GEN HOSP E,NEUROSURG SERV,BOSTON,MA; MASSACHUSETTS GEN HOSP E,MOLEC NEUROONCOL LAB,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT SURG,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA; US PHS,BETHESDA,MD; NCI,CLIN EPIDEMIOL BRANCH,BETHESDA,MD 20892	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; United States Public Health Service; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Rubio, Mari-Paz/K-4364-2014	Rubio, Mari-Paz/0000-0003-3963-5903	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001291] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00317] Funding Source: Medline; NIDCD NIH HHS [NIDCD DC01291] Funding Source: Medline; NINDS NIH HHS [NS24279] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; EVANS DGR, 1992, Q J MED, V84, P603; HAASE VH, 1994, HUM MOL GENET, V3, P407, DOI 10.1093/hmg/3.3.407; IRVING RM, 1994, HUM MOL GENET, V3, P347, DOI 10.1093/hmg/3.2.347; JACOBY LB, 1994, HUM MOL GENET, V3, P413, DOI 10.1093/hmg/3.3.413; MACCOLLIN M, 1993, JAMA-J AM MED ASSOC, V270, P2316, DOI 10.1001/jama.270.19.2316; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; MULVIHILL JJ, 1990, ANN INTERN MED, V113, P39, DOI 10.7326/0003-4819-113-1-39; NAROD SA, 1992, AM J HUM GENET, V51, P486; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; RUBIO M, 1993, CANCER RES, V54, P45; RUTTLEDGE MH, 1994, NAT GENET, V6, P180, DOI 10.1038/ng0294-180; SAINZ J, 1993, AM J HUM GENET, V53, P354; SHORT MP, 1994, NEUROLOGY, V44, pA159; TROFATTER J, 1993, AM J HUM GENET, V75, P826; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TWIST EC, 1994, HUM MOL GENET, V3, P147, DOI 10.1093/hmg/3.1.147	19	108	111	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					314	320						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	7913580				2022-12-18	WOS:A1994NZ33600012
J	NANCARROW, DJ; MANN, GJ; HOLLAND, EA; WALKER, GJ; BEATON, SC; WALTERS, MK; LUXFORD, C; PALMER, JM; DONALD, JA; WEBER, JL; FOUNTAIN, JW; KEFFORD, RF; HAYWARD, NK				NANCARROW, DJ; MANN, GJ; HOLLAND, EA; WALKER, GJ; BEATON, SC; WALTERS, MK; LUXFORD, C; PALMER, JM; DONALD, JA; WEBER, JL; FOUNTAIN, JW; KEFFORD, RF; HAYWARD, NK			CONFIRMATION OF CHROMOSOME-9P LINKAGE IN FAMILIAL MELANOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CUTANEOUS MALIGNANT-MELANOMA; DYSPLASTIC NEVUS; LOCUS; AUSTRALIA; EXCLUSION; MLM; DNA; ARM	Malignant melanoma occurs as a familial cancer in 5%-10% of cases where it segregates in a manner consistent with autosomal dominant inheritance. Evidence from cytogenetics, fine-mapping studies of deletions in melanomas, and recent linkage studies supports the location of a human melanoma predisposition gene on the short arm of chromosome 9. We have carried out linkage analysis using the 9p markers IFNA and D9S126 in 26 Australian melanoma kindreds. Multipoint analysis gave a peak lod score of 4.43, 15 cM centromeric to D9S126, although a lod score of 4.13 was also found 15 cM telomeric of IFNA. These data confirm the existence of a melanoma susceptibility gene on 9p and indicate that this locus most probably lies outside of the IFNA-D9S126 interval. No significant heterogeneity was found between families, when either pairwise or multipoint data were analyzed using HOMOG.	QUEENSLAND INST MED RES,JOINT EXPTL ONCOL PROGRAM,QUEENSLAND CANC FUND RES UNIT,HERSTON 4029,AUSTRALIA; UNIV SYDNEY,WESTMEAD CTR,DEPT MED ONCOL,SYDNEY,NSW 2006,AUSTRALIA; MACQUARIE UNIV,SCH BIOL SCI,N RYDE,NSW 2113,AUSTRALIA; MARSHFIELD MED RES FDN,MARSHFIELD,WI; MIT,DEPT BIOL,CTR CANC RES,CAMBRIDGE,MA 02139	QIMR Berghofer Medical Research Institute; University of Sydney; Macquarie University; Massachusetts Institute of Technology (MIT)			Mann, Graham J/G-4758-2014; hayward, nick/AAV-8802-2020	Mann, Graham J/0000-0003-1301-405X; Kefford, Richard/0000-0001-9251-9229; Donald, Jennifer/0000-0002-2732-1379	NHGRI NIH HHS [HG00248] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000248] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; BALE SJ, 1989, J NATL CANCER I, V81, P70, DOI 10.1093/jnci/81.1.70; CANNONALBRIGHT LA, 1990, AM J HUM GENET, V46, P912; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; COWAN JM, 1988, J NATL CANCER I, V80, P1159, DOI 10.1093/jnci/80.14.1159; DRACOPOLI NC, 1987, CANCER RES, V47, P3995; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; FOUNTAIN JW, 1992, GENOMICS, V14, P105, DOI 10.1016/S0888-7543(05)80290-3; FREY C, 1991, J NATL CANCER I, V83, P170; GOLDSTEIN AM, 1993, AM J HUM GENET, V52, P537; GRUIS NA, 1990, NEW ENGL J MED, V322, P853; KEFFORD RF, 1991, CANCER GENET CYTOGEN, V51, P45, DOI 10.1016/0165-4608(91)90007-H; KWIATKOWSKI DJ, 1992, HUM MOL GENET, V1, P658, DOI 10.1093/hmg/1.8.658-a; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEVI S, 1991, CANCER RES, V51, P3497; LIMON J, 1988, CANCER GENET CYTOGEN, V30, P201, DOI 10.1016/0165-4608(88)90186-0; MACLENNAN R, 1992, J NATL CANCER I, V84, P1427, DOI 10.1093/jnci/84.18.1427; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NANCARROW DJ, 1992, GENOMICS, V12, P18, DOI 10.1016/0888-7543(92)90401-D; NANCARROW DJ, 1992, GENOMICS, V14, P939, DOI 10.1016/S0888-7543(05)80115-6; Ott J., 1991, ANAL HUMAN GENETIC L; PEDERSEN MI, 1986, CANCER GENET CYTOGEN, V20, P11, DOI 10.1016/0165-4608(86)90103-2; PETTY EM, 1991, AM J HUM GENET S, V49, pA1353; VANHAERINGEN A, 1989, GENOMICS, V5, P61, DOI 10.1016/0888-7543(89)90086-4; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R	25	108	114	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					936	942						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213823				2022-12-18	WOS:A1993LY62700019
J	NAVON, R; PADEH, B; ADAM, A				NAVON, R; PADEH, B; ADAM, A			APPARENT DEFICIENCY OF HEXOSAMINIDASE A IN HEALTHY MEMBERS OF A FAMILY WITH TAY-SACHS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEL AVIV UNIV,SHEBA MED CTR,SCH MED,DEPT HUMAN GENET,TEL HASHOMER,ISRAEL	Chaim Sheba Medical Center; Tel Aviv University								FRIEDLAN.J, 1970, CLIN CHIM ACTA, V28, P397, DOI 10.1016/0009-8981(70)90064-1; NAVON R, 1971, BRIT MED J, V4, P17, DOI 10.1136/bmj.4.5778.17; NAVON R, 1972, J PEDIATR-US, V80, P1026, DOI 10.1016/S0022-3476(72)80020-9; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OBRIEN JS, 1971, SCIENCE, V172, P61, DOI 10.1126/science.172.3978.61; OKADA S, 1970, J PEDIATR-US, V77, P1063, DOI 10.1016/S0022-3476(70)80096-8; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; OKADA S, 1971, AM J HUM GENET, V23, P55; PADEH B, 1971, ISRAEL J MED SCI, V7, P259; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; Sandhoff K, 1970, FEBS Lett, V11, P342, DOI 10.1016/0014-5793(70)80564-6; SCHNECK L, 1970, LANCET, V1, P582; SEGAL S, 1972, METABOLIC BASIS INHE; SUZUKI Y, 1971, J PEDIATR-US, V78, P643, DOI 10.1016/S0022-3476(71)80467-5	14	108	108	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	3					287	293						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P9182	4704860				2022-12-18	WOS:A1973P918200008
J	HO, MW; VEATH, ML; SCHMIDT, D; SECK, J; OBRIEN, JS; BRADY, RO; JOHNSON, W				HO, MW; VEATH, ML; SCHMIDT, D; SECK, J; OBRIEN, JS; BRADY, RO; JOHNSON, W			ADULT GAUCHERS-DISEASE - KINDRED STUDIES AND DEMONSTRATION OF A DEFICIENCY OF ACID BETA-GLUCOSIDASE IN CULTURED FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1970, LANCET, V1, P612; BEUTLER E, 1971, AM J HUM GENET, V23, P62; BRADY RO, 1970, BIOCHIM BIOPHYS ACTA, V210, P193, DOI 10.1016/0005-2760(70)90079-2; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRADY RO, 1966, NEW ENGL J MED, V275, P312, DOI 10.1056/NEJM196608112750606; GROEN JJ, 1964, ARCH INTERN MED, V113, P543, DOI 10.1001/archinte.1964.00280100051009; HO M, IN PRESS; HSIA DYY, 1962, GENETIC MECHANISM GA, P327; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OCKERMAN PA, 1968, BIOCHIM BIOPHYS ACTA, V165, P59, DOI 10.1016/0304-4165(68)90187-6; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; ROBINSON D, 1967, BIOCHEM J, V102, P525, DOI 10.1042/bj1020525	12	108	109	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	1					37	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L6958	5012691				2022-12-18	WOS:A1972L695800005
J	CHUNG, CS; MORTON, NE; PETERS, HA				CHUNG, CS; MORTON, NE; PETERS, HA			SERUM ENZYMES AND GENETIC CARRIERS IN MUSCULAR DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ASMUNDSON V. S., 1956, JOUR HEREDITY, V47, P248; BRUNS F, 1954, BIOCHEM Z, V325, P156; CHUNG CS, 1959, AM J HUM GENET, V11, P339; CLARK LC, 1949, ANAL CHEM, V21, P1218, DOI 10.1021/ac60034a023; DEGROUCHY J, 1953, THESIS PARIS; DREYFUS JC, 1955, CR SOC BIOL, V149, P1934; DREYFUS JC, 1956, CLIN CHIM ACTA, V1, P434, DOI 10.1016/0009-8981(56)90016-X; Dystrophia musculorum progressiva, 1954, J AMER MED ASSOC, V154, DOI [10.1001/jama.1954.02940490080030, DOI 10.1001/JAMA.1954.02940490080030]; EVANS JH, 1957, BRAIN, V80, P557, DOI 10.1093/brain/80.4.557; KARMEN A, 1955, J CLIN INVEST, V34, P126, DOI 10.1172/JCI103055; Kryschowa N, 1934, Z GESAMTE NEUROL PSY, V150, P421, DOI 10.1007/BF02890922; LOWRY OH, 1954, J BIOL CHEM, V207, P19; MICHELSON AM, 1955, P NATL ACAD SCI USA, V41, P1079, DOI 10.1073/pnas.41.12.1079; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1959, GENET, V11, P360; MURPHY EG, 1958, PEDIATRICS, V22, P1110; PEARSON CM, 1957, NEW ENGL J MED, V256, P1069, DOI 10.1056/NEJM195706062562301; SCHAPIRA F, 1957, REV FR ETUD CLIN BIO, V2, P728; SCHAPIRA F, 1957, C REND ACAD SC, V245, P1; SCHAPIRA G, 1953, Sem Hop, V29, P1917; SCHAPIRA G, 1955, Am J Phys Med, V34, P313; SIBLEY JA, 1949, J BIOL CHEM, V177, P859; SIBLEY JA, 1954, P STAFF M MAYO CLIN, V29, P591; STEINBERG D, 1956, J LAB CLIN MED, V48, P144; STEVENSON AC, 1953, ANN EUGENIC, V18, P50; SWINYARD C A, 1957, Arch Phys Med Rehabil, V38, P574; VAN METER J R, 1953, Calif Med, V79, P297; WALTON JN, 1955, ANN HUM GENET, V20, P1, DOI 10.1111/j.1469-1809.1955.tb01274.x; WHITE LAURENS P., 1959, CALIFORNIA MED, V90, P1; ZIERLER KL, 1958, B JOHNS HOPKINS HOSP, V102, P17	30	108	108	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1960	12	1					52	66						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF077	13810211				2022-12-18	WOS:A1960WF07700003
J	FORD, CE				FORD, CE			HUMAN CYTOGENETICS - ITS PRESENT PLACE AND FUTURE POSSIBILITIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARMSTRONG CN, 1955, BRIT MED J, V1, P1173, DOI 10.1136/bmj.1.4923.1173; ARMSTRONG CN, 1957, BRIT MED J, V2, P605, DOI 10.1136/bmj.2.5045.605; BAIKIE AG, 1959, LANCET, V2, P425; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; BENDER MA, 1957, SCIENCE, V126, P974, DOI 10.1126/science.126.3280.974; BOOK J A, 1959, Acta Paediatr, V48, P453; BRADBURY JT, 1956, J CLIN ENDOCR METAB, V16, P689, DOI 10.1210/jcem-16-5-689; BRADEN AWH, 1958, NATURE, V181, P786, DOI 10.1038/181786a0; CARTER T. C, 1955, JOUR GENETICS, V53, P154, DOI 10.1007/BF02981519; CHU EHY, 1959, AM J HUM GENET, V11, P63; DANON M, 1957, LANCET, V2, P20; Darlington C. D., 1937, RECENT ADV CYTOLOGY; DECOURT LUCIANO, 1954, REV ASSOC MED BRAZIL, V1, P203; EK JI, 1959, LANCET, V1, P1206; FANKHAUSER G, 1954, J EXP ZOOL, V126, P33, DOI 10.1002/jez.1401260104; FANKHAUSER G, 1950, J EXP ZOOL, V115, P207, DOI 10.1002/jez.1401150202; FORD C E, 1958, J Cell Physiol Suppl, V52, P235, DOI 10.1002/jcp.1030520412; FORD CE, 1959, NATURE, V183, P1030, DOI 10.1038/1831030a0; FORD CE, 1959, LANCET, V1, P711; FORD CE, 1958, NATURE, V181, P1565, DOI 10.1038/1811565a0; FORD CE, 1956, NATURE, V178, P1020, DOI 10.1038/1781020a0; FORD CE, 1959, BRIT J RADIOL, V32, P280; FORD CE, 1959, PROGR NUCLEAR ENERGY, V2; FRACCARO M, 1959, LANCET, V1, P886; GRUMBACH MM, 1958, RECENT PROG HORM RES, V14, P255; HARNDEN DG, 1959, BRIT MED J, V2, P1287, DOI 10.1136/bmj.2.5162.1287; HARNDEN DG, 1959, LANCET, V2, P126; HARNDEN DG, 1959, BRIT MED J, V2, P1285, DOI 10.1136/bmj.2.5162.1285; HARNDEN DG, BRIT J EXP PATH; HSU T. C., 1957, JOUR NATL CANCER INST, V19, P867; HUNEGRFORD DA, 1959, LANCET, V2, P98; HUNGERFORD DA, 1959, AM J HUM GENET, V11, P215; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; JACOBS PA, 1959, LANCET, V2, P423; JACOBS PA, 1959, LANCET, V2, P591; JACOBS PA, 1959, LANCET, V1, P710; KODANI M, 1958, AM J HUM GENET, V10, P125; KODANI M, 1957, P NATL ACAD SCI USA, V43, P285, DOI 10.1073/pnas.43.3.285; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P602; MAKINO S., 1959, PROC JAPANESE ACAD, V35, P99; Matthey R, 1949, CHROMOSOMES VERTEBRE; MOORE KL, 1959, LANCET, V1, P217; Morgan T. H., 1925, Bibliographia Genetica The Hague, V2, P1; NILSSON IM, 1959, LANCET, V2, P264; NOWAKOWSKI H, 1959, ACTA ENDOCRINOL-COP, V30, P296; PENROSE LS, 1954, ANN NY ACAD SCI, V57, P494, DOI 10.1111/j.1749-6632.1954.tb36424.x; Pettersson G, 1937, HEREDITAS, V23, P49; PLUNKETT ER, 1956, LANCET, V2, P853; POLANI PE, 1954, LANCET, V2, P120; POLANI PE, 1956, LANCET, V2, P118; PRADER A, 1958, LANCET, V1, P968; ROTHFELS KH, 1958, CHROMOSOMA, V9, P163; SCHULTZ JACK, 1949, JOUR HEREDITY, V40, P31; SHARMAN GB, 1959, INT J RADIAT BIOL RE, V1, P115, DOI 10.1080/09553005914550201; SNELL GD, 1946, GENETICS, V31, P157; STERN C, 1959, AM J HUM GENET, V11, P301; STERN C, 1959, NATURE, V183, P1452, DOI 10.1038/1831452a0; STEWART JSS, 1959, LANCET, V1, P833; TAILLARD W., 1957, JOUR GENET HUMAINE, V6, P13; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; TJIO JH, 1959, P NATL ACAD SCI USA, V45, P1008, DOI 10.1073/pnas.45.7.1008; TJIO JH, 1958, P NATL ACAD SCI USA, V44, P1229, DOI 10.1073/pnas.44.12.1229; TURPIN R, 1959, CR HEBD ACAD SCI, V248, P3636; WELSHONS W. J., 1959, PROC NATL ACAD SCI, V45, P560, DOI 10.1073/pnas.45.4.560; WESTERGAARD M., 1940, DANSK BOT ARK, V10, P1; WILKINS L, 1954, J CLIN ENDOCR METAB, V14, P1270, DOI 10.1210/jcem-14-10-1270; YERGANIAN G, 1957, AM J HUM GENET, V9, P42	68	108	108	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	1					104	117						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF077	13823894				2022-12-18	WOS:A1960WF07700008
J	STEINBERG, AG; GILES, BD; STAUFFER, R				STEINBERG, AG; GILES, BD; STAUFFER, R			A GM-LIKE FACTOR PRESENT IN NEGROES AND RARE OR ABSENT IN WHITES - ITS RELATION TO GMA AND GMX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BRONNESTAM R, 1957, Vox Sang, V2, P316; DELAY J, 1956, CR SOC BIOL, V150, P512; FINNEY DJ, 1949, ANN EUGENIC, V14, P319; GRUBB R., 1956, ACTA PATHOL ET MICROBIOL SCAND, V39, P195; GRUBB R., 1958, ACTA HAEMATOL, V20, P246; GRUBB R., 1956, ACTA PATHOL ET MICROBIOL SCAND, V39, P390; HARBOE M, 1959, NATURE, V183, P1468, DOI 10.1038/1831468a0; HARBOE MORTEN, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P191; HARBOE MORTEN, 1959, ACTA PATH ET MICROBIOL SCAND, V45, P357; LAURELL A B, 1957, Vox Sang, V2, P312; LINNET-JEPSEN P, 1958, Acta Genet Stat Med, V8, P164; PODLIACHOUK L, 1958, ANN I PASTEUR PARIS, V94, P590; SMITH CAB, 1956, ANN HUM GENET, V20, P257	13	108	109	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	1					44	51						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF077	13834156				2022-12-18	WOS:A1960WF07700002
J	Trost, B; Walker, S; Wang, ZZ; Thiruvahindrapuram, B; MacDonald, JR; Sung, WWL; Pereira, SL; Whitney, J; Chan, AJS; Pellecchia, G; Reuter, MS; Lok, S; Yuen, RKC; Marshall, CR; Merico, D; Scherer, SW				Trost, Brett; Walker, Susan; Wang, Zhuozhi; Thiruvahindrapuram, Bhooma; MacDonald, Jeffrey R.; Sung, Wilson W. L.; Pereira, Sergio L.; Whitney, Joe; Chan, Ada J. S.; Pellecchia, Giovanna; Reuter, Miriam S.; Lok, Si; Yuen, Ryan K. C.; Marshall, Christian R.; Merico, Daniele; Scherer, Stephen W.			A Comprehensive Workflow for Read Depth-Based Identification of Copy-Number Variation from Whole-Genome Sequence Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM SPECTRUM DISORDER; STRUCTURAL VARIATION; GENETIC-VARIATION; VARIANTS; DISCOVERY; RESOURCE; COMPLEXITY; PLATFORMS; FREQUENCY; FRAMEWORK	A remaining hurdle to whole-genome sequencing (WGS) becoming a first-tier genetic test has been accurate detection of copy-number variations (CNVs). Here, we used several datasets to empirically develop a detailed workflow for identifying germline CNVs >1 kb from short-read WGS data using read depth-based algorithms. Our workflow is comprehensive in that it addresses all stages of the CNV-detection process, including DNA library preparation, sequencing, quality control, reference mapping, and computational CNV identification. We used our workflow to detect rare, genic CNVs in individuals with autism spectrum disorder (ASD), and 120/120 such CNVs tested using orthogonal methods were successfully confirmed. We also identified 71 putative genic de novo CNVs in this cohort, which had a confirmation rate of 70%; the remainder were incorrectly identified as de novo due to false positives in the proband (7%) or parental false negatives (23%). In individuals with an ASD diagnosis in which both microarray and WGS experiments were performed, our workflow detected all clinically relevant CNVs identified by microarrays, as well as additional potentially pathogenic CNVs < 20 kb. Thus, CNVs of clinical relevance can be discovered from WGS with a detection rate exceeding microarrays, positioning WGS as a single assay for genetic variation detection.	[Trost, Brett; Walker, Susan; Wang, Zhuozhi; Thiruvahindrapuram, Bhooma; MacDonald, Jeffrey R.; Sung, Wilson W. L.; Pereira, Sergio L.; Whitney, Joe; Chan, Ada J. S.; Pellecchia, Giovanna; Reuter, Miriam S.; Lok, Si; Yuen, Ryan K. C.; Marshall, Christian R.; Merico, Daniele; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Chan, Ada J. S.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Marshall, Christian R.] Hosp Sick Children, Dept Paediat Lab Med, Genome Diagnost, Toronto, ON M5G 1X8, Canada; [Merico, Daniele] Deep Genom Inc, Toronto, ON M5G 1L7, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 0A4, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom Genet & Genome Biol, Toronto, ON M5G 0A4, Canada.; Scherer, SW (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.; Scherer, SW (corresponding author), Univ Toronto, McLaughlin Ctr, Toronto, ON M5G 0A4, Canada.	stephen.scherer@sickkids.ca	Scherer, Stephen W./B-3785-2013; Pereira, Sergio L/B-1984-2010; Yuen, Ryan K. C./J-4876-2012; MacDonald, Jeffrey Robert/GLU-2255-2022; Trost, Brett/K-4127-2016	Scherer, Stephen W./0000-0002-8326-1999; Pereira, Sergio L/0000-0002-2796-5625; Yuen, Ryan K. C./0000-0001-7273-4968; Trost, Brett/0000-0003-4863-7273; MacDonald, Jeffrey/0000-0001-5058-2393; Sung, Wilson/0000-0002-4703-5118; Merico, Daniele/0000-0002-3728-4401	Autism Speaks; Canada Foundation for Innovation; Canadian Institute for Advanced Research; University of Toronto McLaughlin Centre; Genome Canada/Ontario Genomics Institute; Government of Ontario; Canadian Institutes of Health Research (CIHR) [FDN-143295]; Ontario Brain Institute; Hospital for Sick Children Foundation; CIHR Banting Postdoctoral Fellowship; GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto; Hospital for Sick Children	Autism Speaks; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); University of Toronto McLaughlin Centre; Genome Canada/Ontario Genomics Institute(Genome Canada); Government of Ontario; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute; Hospital for Sick Children Foundation; CIHR Banting Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto; Hospital for Sick Children	We thank Richard Wintle for critical feedback on the manuscript, Sylvia Lamoureux, Kiera Drew, and Akshaya Raajkumar for validation work, Lok Kan Lee for assistance with writing scripts, David Glazer, Matt Bookman, and others at Verily (Google) for their work with the Autism Speaks MSSNG Whole Genome Sequencing Project, and The Centre for Applied Genomics for technical support. This work was funded by Autism Speaks, the Canada Foundation for Innovation, the Canadian Institute for Advanced Research, the University of Toronto McLaughlin Centre, Genome Canada/Ontario Genomics Institute, the Government of Ontario, the Canadian Institutes of Health Research (CIHR) (grant number FDN-143295), Ontario Brain Institute, and The Hospital for Sick Children Foundation. B.T. is funded by the CIHR Banting Postdoctoral Fellowship. S.W.S. is funded by the GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Brandler WM, 2016, AM J HUM GENET, V98, P667, DOI 10.1016/j.ajhg.2016.02.018; Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Eberle MA, 2017, GENOME RES, V27, P157, DOI 10.1101/gr.210500.116; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Guan P, 2016, METHODS, V102, P36, DOI 10.1016/j.ymeth.2016.01.020; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Huddleston J, 2017, GENOME RES, V27, P677, DOI 10.1101/gr.214007.116; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Kloosterman WP, 2015, GENOME RES, V25, P792, DOI 10.1101/gr.185041.114; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laehnemann D, 2016, BRIEF BIOINFORM, V17, P154, DOI 10.1093/bib/bbv029; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lionel AC, 2017, GENET MED; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Maretty L, 2017, NATURE, V548, P87, DOI 10.1038/nature23264; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Noll AC, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.26; Norris AL, 2016, CANCER BIOL THER, V17, P246, DOI 10.1080/15384047.2016.1139236; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Pang AWC, 2014, G3-GENES GENOM GENET, V4, P63, DOI 10.1534/g3.113.008797; Pang AWC, 2013, HUM MUTAT, V34, P345, DOI 10.1002/humu.22240; Parikh H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2366-2; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roller E, 2016, BIOINFORMATICS, V32, P2375, DOI 10.1093/bioinformatics/btw163; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Stavropoulos DJ, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.12; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Telenti A, 2016, P NATL ACAD SCI USA, V113, P11901, DOI 10.1073/pnas.1613365113; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; Uddin M, 2015, GENET MED, V17, P747, DOI 10.1038/gim.2014.178; Vassy JL, 2017, ANN INTERN MED, V167, P159, DOI 10.7326/M17-0188; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Yuen RKC, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.27; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhu MF, 2012, AM J HUM GENET, V91, P408, DOI 10.1016/j.ajhg.2012.07.004; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	64	107	108	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					142	155		10.1016/j.ajhg.2017.12.007	http://dx.doi.org/10.1016/j.ajhg.2017.12.007			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29304372	Bronze, Green Published			2022-12-18	WOS:000419305500011
J	Ormond, KE; Mortlock, DP; Scholes, DT; Bombard, Y; Brody, LC; Faucett, WA; Garrison, NA; Hercher, L; Isasi, R; Middleton, A; Musunuru, K; Shriner, D; Virani, A; Young, CE				Ormond, Kelly E.; Mortlock, Douglas P.; Scholes, Derek T.; Bombard, Yvonne; Brody, Lawrence C.; Faucett, W. Andrew; Garrison, Nanibaa' A.; Hercher, Laura; Isasi, Rosario; Middleton, Anna; Musunuru, Kiran; Shriner, Daniel; Virani, Alice; Young, Caroline E.			Human Germline Genome Editing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; CAS9 NUCLEASES; HUMAN-CELLS; CRISPR-CAS9; SPECIFICITY; CHILDREN; ENDONUCLEASE; CRISPR/CAS9; INTEGRATION; GENERATION	With CRISPR/Cas9 and other genome-editing technologies, successful somatic and germline genome editing are becoming feasible. To respond, an American Society of Human Genetics (ASHG) workgroup developed this position statement, which was approved by the ASHG Board in March 2017. The workgroup included representatives from the UK Association of Genetic Nurses and Counsellors, Canadian Association of Genetic Counsellors, International Genetic Epidemiology Society, and US National Society of Genetic Counselors. These groups, as well as the American Society for Reproductive Medicine, Asia Pacific Society of Human Genetics, British Society for Genetic Medicine, Human Genetics Society of Australasia, Professional Society of Genetic Counselors in Asia, and Southern African Society for Human Genetics, endorsed the final statement. The statement includes the following positions. (1) At this time, given the nature and number of unanswered scientific, ethical, and policy questions, it is inappropriate to perform germline gene editing that culminates in human pregnancy. (2) Currently, there is no reason to prohibit in vitro germline genome editing on human embryos and gametes, with appropriate oversight and consent from donors, to facilitate research on the possible future clinical applications of gene editing. There should be no prohibition on making public funds available to support this research. (3) Future clinical application of human germline genome editing should not proceed unless, at a minimum, there is (a) a compelling medical rationale, (b) an evidence base that supports its clinical use, (c) an ethical justification, and (d) a transparent public process to solicit and incorporate stakeholder input.	[Ormond, Kelly E.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Ormond, Kelly E.] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Stanford, CA 94305 USA; [Mortlock, Douglas P.] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37232 USA; [Mortlock, Douglas P.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Scholes, Derek T.; Young, Caroline E.] Amer Soc Human Genet, Bethesda, MD 20814 USA; [Bombard, Yvonne] Univ Toronto, St Michaels Hosp, Inst Hlth Policy Management & Evaluat, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Brody, Lawrence C.] NHGRI, Div Genom & Soc, Bethesda, MD 20892 USA; [Faucett, W. Andrew] Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA; [Faucett, W. Andrew; Hercher, Laura] Natl Soc Genet Counselors, Chicago, IL USA; [Garrison, Nanibaa' A.] Seattle Childrens Hosp & Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA; [Garrison, Nanibaa' A.] Univ Washington, Dept Pediat, Div Bioeth, Seattle, WA 98101 USA; [Hercher, Laura] Sarah Lawrence Coll, Joan H Marks Grad Program Human Genet, Bronxville, NY 10708 USA; [Isasi, Rosario] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn Dept Human Genet, Miami, FL 33136 USA; [Isasi, Rosario] Univ Miami, Miller Sch Med, Inst Bioeth & Hlth Policy, Miami, FL 33136 USA; [Middleton, Anna] Connecting Sci, Soc & Eth Res Grp, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Middleton, Anna] Assoc Genet Nurses & Counsellors, London, England; [Musunuru, Kiran] Univ Penn, Dept Med, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Musunuru, Kiran] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Shriner, Daniel] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Shriner, Daniel] Int Genet Epidemiol Soc, Bethesda, MD USA; [Virani, Alice] Univ British Columbia, Prov Hlth Serv Author British Columbia, Vancouver, BC V6H 3N1, Canada; [Virani, Alice] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Virani, Alice] Canadian Assoc Genet Counsellors, Oakville, ON, Canada	Stanford University; Stanford University; Vanderbilt University; Vanderbilt University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Geisinger Health System; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Sarah Lawrence College; University of Miami; University of Miami; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of British Columbia; University of British Columbia	Ormond, KE (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Ormond, KE (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Stanford, CA 94305 USA.	kormond@stanford.edu	Ormond, Kelly E/I-5676-2019	Ormond, Kelly E/0000-0002-1033-0818; Middleton, Anna/0000-0003-3103-8098; Virani, Alice/0000-0003-1374-3172; Shriner, Daniel/0000-0003-1928-5520	Intramural NIH HHS [ZIA HG200362] Funding Source: Medline; NHGRI NIH HHS [K01 HG008818] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000167, K01HG008818, ZIAHG200362] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ACMG Board of Directors, 2017, GEN ED CLIN GEN POIN; [Anonymous], 2004, Paediatr Child Health, V9, P99; Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Bombard Y, 2013, J NATL COMPR CANC NE, V11, P1343, DOI 10.6004/jnccn.2013.0158; Bombard Y, 2011, SOC SCI MED, V73, P135, DOI 10.1016/j.socscimed.2011.04.017; Botkin JR, 2015, AM J HUM GENET, V97, P6, DOI 10.1016/j.ajhg.2015.05.022; BOTKIN JR, 1988, JAMA-J AM MED ASSOC, V259, P1541, DOI 10.1001/jama.259.10.1541; Cho MK, 1999, SCIENCE, V286, P2087, DOI 10.1126/science.286.5447.2087; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Collins Francis, 2015, STATEMENT NIH FUNDIN; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies C., 2005, OPENING THE BOX; Diekema D., 2011, CLIN ETHICS PEDIAT C; Ding QR, 2014, CIRC RES, V115, P488, DOI 10.1161/CIRCRESAHA.115.304351; Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006; Drazen JM, 2004, NEW ENGL J MED, V351, P1789, DOI 10.1056/NEJMe048265; Egan JFX, 2011, PRENATAL DIAG, V31, P389, DOI 10.1002/pd.2702; European Group on Ethics in Science and New Technology, 2016, STAT GEN ED; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Friedmann T, 2015, MOL THER, V23, P1282, DOI 10.1038/mt.2015.118; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Funk C, 2016, US PUBLIC OPINION FU; Gupta RM, 2014, J CLIN INVEST, V124, P4154, DOI 10.1172/JCI72992; Hawkins AK, 2011, GENET MED, V13, P197, DOI 10.1097/GIM.0b013e31820c056e; Hayden EC, 2016, NATURE, V530, P402; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Human Fertilisation and Embryology Authority, 2016, HFEA APPR NEW GEN ED; Isasi R, 2016, SCIENCE, V351, P337, DOI 10.1126/science.aad6778; ISSCR, 2015, ISSCR STAT HUM GERML; Jacobs BM, 2015, J MED ETHICS, V41, P696, DOI 10.1136/medethics-2014-102400; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Lanphier E, 2015, NATURE, V519, P410, DOI 10.1038/519410a; Ledford H, 2015, NATURE, V526, P310, DOI 10.1038/526310a; Lehoux P, 2007, INT J TECHNOL ASSESS, V23, P9, DOI 10.1017/S0266462307051513; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; National Academies of Sciences Engineering and Medicine, 2015, HUM GEN ED INT SUMM; National Academy of Sciences and National Academy of Medicine, 2017, HUM GEN ED SCI ETH G; National Institutes of Health Office of Extramural Research, 2016, 4 PUBL POL REQ OBJ O; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Office of the Press Secretary, 2001, THE WHIT HOUS; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Rolland JS, 2006, CURR OPIN PEDIATR, V18, P527, DOI 10.1097/01.mop.0000245354.83454.68; Savulescu J, 2001, BIOETHICS, V15, P413, DOI 10.1111/1467-8519.00251; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smith CE, 2016, HEALTH AFFAIR, V35, P1367, DOI 10.1377/hlthaff.2015.1476; Smith C, 2014, CELL STEM CELL, V15, P13, DOI 10.1016/j.stem.2014.06.011; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; The Hinxton Group, 2015, STAT GEN ED TECHN HU; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017	61	107	115	5	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 3	2017	101	2					167	176		10.1016/j.ajhg.2017.06.012	http://dx.doi.org/10.1016/j.ajhg.2017.06.012			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FC5BD	28777929	Bronze, Green Published			2022-12-18	WOS:000406854800002
J	Butcher, DT; Cytrynbaum, C; Turinsky, AL; Siu, MT; Inbar-Feigenberg, M; Mendoza-Londono, R; Chitayat, D; Walker, S; Machado, J; Caluseriu, O; Dupuis, L; Grafodatskaya, D; Reardon, W; Gilbert-Dussardier, B; Verloes, A; Bilan, F; Milunsky, JM; Basran, R; Papsin, B; Stockley, TL; Scherer, SW; Choufani, S; Brudno, M; Weksberg, R				Butcher, Darci T.; Cytrynbaum, Cheryl; Turinsky, Andrei L.; Siu, Michelle T.; Inbar-Feigenberg, Michal; Mendoza-Londono, Roberto; Chitayat, David; Walker, Susan; Machado, Jerry; Caluseriu, Oana; Dupuis, Lucie; Grafodatskaya, Daria; Reardon, William; Gilbert-Dussardier, Brigitte; Verloes, Alain; Bilan, Frederic; Milunsky, Jeff M.; Basran, Raveen; Papsin, Blake; Stockley, Tracy L.; Scherer, Stephen W.; Choufani, Sanaa; Brudno, Michael; Weksberg, Rosanna			CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							H3K4 METHYLATION; HOX GENES; MUTATIONS; CHD7; IDENTIFICATION; EXPRESSION; MOUSE; VARIANTS; REGIONS; PROTEIN	Epigenetic dysregulation has emerged as a recurring mechanism in the etiology of neurodevelopmental disorders. Two such disorders, CHARGE and Kabuki syndromes, result from loss of function mutations in chromodomain helicase DNA-binding protein 7 (CHD7 LOF) and lysine (K) methyltransferase 2D (KMT2D LOF), respectively. Although these two syndromes are clinically distinct, there is significant phenotypic overlap. We therefore expected that epigenetically driven developmental pathways regulated by CHD7 and KMT2D would overlap and that DNA methylation (DNAm) alterations downstream of the mutations in these genes would identify common target genes, elucidating a mechanistic link between these two conditions, as well as specific target genes for each disorder. Genome-wide DNAm profiles in individuals with CHARGE and Kabuki syndromes with CHD7 LOF or KMT2D LOF identified distinct sets of DNAm differences in each of the disorders, which were used to generate two unique, highly specific and sensitive DNAm signatures. These DNAm signatures were able to differentiate pathogenic mutations in these two genes from controls and from each other. Analysis of the DNAm targets in each gene-specific signature identified both common gene targets, including homeobox A5 (HOXA5), which could account for some of the clinical overlap in CHARGE and Kabuki syndromes, as well as distinct gene targets. Our findings demonstrate how characterization of the epigenome can contribute to our understanding of disease pathophysiology for epigenetic disorders, paving the way for explorations of novel therapeutics.	[Butcher, Darci T.; Cytrynbaum, Cheryl; Turinsky, Andrei L.; Siu, Michelle T.; Mendoza-Londono, Roberto; Walker, Susan; Scherer, Stephen W.; Choufani, Sanaa; Brudno, Michael; Weksberg, Rosanna] Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Cytrynbaum, Cheryl; Inbar-Feigenberg, Michal; Mendoza-Londono, Roberto; Chitayat, David; Dupuis, Lucie; Weksberg, Rosanna] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Cytrynbaum, Cheryl; Chitayat, David; Scherer, Stephen W.; Weksberg, Rosanna] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Turinsky, Andrei L.; Brudno, Michael] Hosp Sick Children, Ctr Computat Med, Toronto, ON M5G 1X8, Canada; [Inbar-Feigenberg, Michal; Mendoza-Londono, Roberto; Chitayat, David; Weksberg, Rosanna] Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada; [Chitayat, David] Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada; [Walker, Susan] Hosp Sick Children, Ctr Appl Gen, Toronto, ON M5G 1X8, Canada; [Machado, Jerry] PreventionGenetics, Marshfield, WI 54449 USA; [Caluseriu, Oana] Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2R3, Canada; [Grafodatskaya, Daria] McMaster Univ, Pathol andMolecular Med, Hamilton, ON L8S 4L8, Canada; [Reardon, William] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin 12, Ireland; [Gilbert-Dussardier, Brigitte] CHU Poitiers, Ctr Reference Anomalies Developpement Ouest, Serv Genet, F-86021 Poitiers, France; [Gilbert-Dussardier, Brigitte; Bilan, Frederic] Univ Poitiers, EA3808, Poitiers, France; [Verloes, Alain] Hop Robert DEBRE, AP HP, Dept Genet, F-75019 Paris, France; [Milunsky, Jeff M.] Ctr Human Genetics Inc, Cambridge, MA 02139 USA; [Basran, Raveen] Hosp Sick Children, Paediat Lab Med, Toronto, ON M5G IX8, Canada; [Basran, Raveen] Univ Toronto, Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Papsin, Blake] Hosp Sick Children, Otolaryngol, Toronto, ON M5G 1X8, Canada; [Papsin, Blake] Univ Toronto, Dept Otolaryngol, Toronto, ON M5S 1A1, Canada; [Papsin, Blake; Weksberg, Rosanna] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Stockley, Tracy L.] Univ Hlth Network, Dept Clin Lab Genet, Genome Diagnost, Toronto, ON, Canada; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S 1A1, Canada; [Brudno, Michael] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; McMaster University; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Weksberg, R (corresponding author), Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 1X8, Canada.; Weksberg, R (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.; Weksberg, R (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada.; Weksberg, R (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON M5S 1A1, Canada.; Weksberg, R (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada.	rweksb@sickkids.ca	Scherer, Stephen W./B-3785-2013; Caluseriu, Oana/AAK-9563-2020; Inbar-Feigenberg, Michal/AAS-3187-2021; /AAK-8500-2021; BILAN, Frederic/AFR-2810-2022; Stockley, Tracy/AAW-6561-2021; Choufani, Sanaa/GWC-1820-2022; Machado, Jerry/I-2003-2019	Scherer, Stephen W./0000-0002-8326-1999; Choufani, Sanaa/0000-0002-5241-2213; Stockley, Tracy/0000-0002-4476-9722; Inbar-Feigenberg, Michal/0000-0001-8128-5789; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Bilan, Frederic/0000-0001-8589-6018; Reardon, Willie/0000-0001-7329-9179	Canadian Institutes of Health Research; Ontario Brain Institute; Rare Diseases Foundation; Canadian Centre for Computational Genomics (C3G) part of the Genome Innovation Network (GIN); Genome Canada through Genome Quebec; Ontario Genomics; Genome Canada through Ontario Genomics	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute; Rare Diseases Foundation; Canadian Centre for Computational Genomics (C3G) part of the Genome Innovation Network (GIN); Genome Canada through Genome Quebec(Genome Canada); Ontario Genomics; Genome Canada through Ontario Genomics(Genome Canada)	We would like to thank all of the patients and families for their participation in our research study, and the physicians, genetic counselors, and clinical staff for their assistance with recruitment. We would also like to thank Youliang Lou, Chunhua Zhao, and Khadine Wiltshire for their invaluable contributions to this work. Thank you as well to Dr. Greg Hanna (University of Michigan) for contributing blood DNA samples from neurotypical control individuals who had undergone cognitive/behavioral assessments. This research was funded by the Canadian Institutes of Health Research (R.W., D.T.B., M.T.S., and S.C.), the Ontario Brain Institute (R.W., D.T.B., and M.T.S.) and the Rare Diseases Foundation (R.W. and D.T.B.). This work was also supported by the Canadian Centre for Computational Genomics (C3G), part of the Genome Innovation Network (GIN), funded by Genome Canada through Genome Quebec and Ontario Genomics (M.B. and A.L.T.), and Genome Canada through Ontario Genomics (A.L.T., S.C., M.B., and R.W.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Ang SY, 2016, DEVELOPMENT, V143, P810, DOI 10.1242/dev.132688; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Banka S, 2015, CLIN GENET, V87, P252, DOI 10.1111/cge.12363; Barber BA, 2010, ANN ANAT, V192, P261, DOI 10.1016/j.aanat.2010.07.009; Basson M Albert, 2014, Rare Dis, V2, pe28688, DOI 10.4161/rdis.28688; Bergman JEH, 2011, J MED GENET, V48, P334, DOI 10.1136/jmg.2010.087106; Bergman JEH, 2012, HUM MUTAT, V33, P1251, DOI 10.1002/humu.22106; Bjornsson HT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009278; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; Bogershausen N, 2013, CLIN GENET, V83, P201, DOI 10.1111/cge.12051; Bouazoune K, 2012, P NATL ACAD SCI USA, V109, P19238, DOI 10.1073/pnas.1213825109; Buhule OD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00354; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cesario JM, 2016, GENE EXPR PATTERNS, V20, P111, DOI 10.1016/j.gep.2016.03.001; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chen YA, 2012, AM J HUM GENET, V91, P762, DOI 10.1016/j.ajhg.2012.06.020; Choufani S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10207; Delahaye A, 2007, CLIN GENET, V72, P112, DOI 10.1111/j.1399-0004.2007.00821.x; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Genevieve D, 2004, AM J MED GENET A, V129A, P64, DOI 10.1002/ajmg.a.30144; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Grafodatskaya D, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-1; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hale CL, 2016, AM J MED GENET A, V170, P344, DOI 10.1002/ajmg.a.37435; Hanna GL, 2016, J AM ACAD CHILD PSY, V55, P906, DOI 10.1016/j.jaac.2016.06.012; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Hutlet B, 2016, BRAIN STRUCT FUNCT, V221, P1223, DOI 10.1007/s00429-014-0965-8; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Joksimovic M, 2005, GENE EXPR PATTERNS, V5, P792, DOI 10.1016/j.modgep.2005.03.008; Jongmans MCJ, 2008, AM J MED GENET A, V146A, P43, DOI 10.1002/ajmg.a.31921; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Kernohan KD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0254-x; Kim JH, 2014, CANCER RES, V74, P1705, DOI 10.1158/0008-5472.CAN-13-1896; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lalani S.R., 1993, GENEREVIEWS R; Larochelle C, 1999, DEV DYNAM, V214, P127, DOI 10.1002/(SICI)1097-0177(199902)214:2<127::AID-AJA3>3.0.CO;2-F; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li DD, 2016, BIOORGAN MED CHEM, V24, P6109, DOI 10.1016/j.bmc.2016.09.073; Li DM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0641-x; Lin JL, 2015, CLIN GENET, V88, P255, DOI 10.1111/cge.12484; Lizen B, 2017, J COMP NEUROL, V525, P1155, DOI 10.1002/cne.24123; Long K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10354; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Martin Donna M, 2015, Curr Genet Med Rep, V3, P1; Martin DM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001010; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Micale L, 2014, HUM MUTAT, V35, P841, DOI 10.1002/humu.22547; Ming JE, 2003, AM J MED GENET A, V123A, P249, DOI 10.1002/ajmg.a.20277; Montavon T, 2014, SEMIN CELL DEV BIOL, V34, P76, DOI 10.1016/j.semcdb.2014.06.005; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Parrillo L, 2016, INT J OBESITY, V40, P929, DOI 10.1038/ijo.2016.36; Patel N, 2015, AM J MED GENET A, V167, P259, DOI 10.1002/ajmg.a.36804; Peters TJ, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-6; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Schulz Y, 2014, HUM MOL GENET, V23, P4396, DOI 10.1093/hmg/ddu156; Schulz Y, 2014, HUM GENET, V133, P997, DOI 10.1007/s00439-014-1444-2; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Song M, 2015, DEV CELL, V33, P690, DOI 10.1016/j.devcel.2015.04.009; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Tatton-Brown K, 2011, ONCOTARGET, V2, P1127, DOI 10.18632/oncotarget.385; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vallianatos CN, 2015, EPIGENOMICS-UK, V7, P503, DOI 10.2217/epi.15.1; Van Laarhoven PM, 2015, HUM MOL GENET, V24, P4443, DOI 10.1093/hmg/ddv180; van Rhijn JR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01816; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Verhagen JMA, 2014, EUR J MED GENET, V57, P510, DOI 10.1016/j.ejmg.2014.05.005; Verloes A, 2005, AM J MED GENET A, V133A, P306, DOI 10.1002/ajmg.a.30559; Vihinen M, 2014, HUM MUTAT, V35, P912, DOI 10.1002/humu.22600; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wang XQD, 2017, NUCLEIC ACIDS RES, V45, P1091, DOI 10.1093/nar/gkw966; Wong MTY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142350; Zadro C, 2009, BBA-MOL BASIS DIS, V1792, P27, DOI 10.1016/j.bbadis.2008.10.017; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang P, 2012, NUCLEIC ACIDS RES, V40, P4237, DOI 10.1093/nar/gkr1235	92	107	108	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2017	100	5					773	788		10.1016/j.ajhg.2017.04.004	http://dx.doi.org/10.1016/j.ajhg.2017.04.004			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET8OV	28475860	hybrid, Green Published			2022-12-18	WOS:000400560000007
J	Hosseinibarkooie, S; Peters, M; Torres-Benito, L; Rastetter, RH; Hupperich, K; Hoffmann, A; Mendoza-Ferreira, N; Kaczmarek, A; Janzen, E; Milbradt, J; Lamkemeyer, T; Rigo, F; Bennett, CF; Guschlbauer, C; Buschges, A; Hammerschmidt, M; Riessland, M; Kye, MJ; Clemen, CS; Wirth, B				Hosseinibarkooie, Seyyedmohsen; Peters, Miriam; Torres-Benito, Laura; Rastetter, Raphael H.; Hupperich, Kristina; Hoffmann, Andrea; Mendoza-Ferreira, Natalia; Kaczmarek, Anna; Janzen, Eva; Milbradt, Janine; Lamkemeyer, Tobias; Rigo, Frank; Bennett, C. Frank; Guschlbauer, Christoph; Bueschges, Ansgar; Hammerschmidt, Matthias; Riessland, Markus; Kye, Min Jeong; Clemen, Christoph S.; Wirth, Brunhilde			The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SURVIVAL-MOTOR-NEURON; MORPHOLINO ANTISENSE OLIGOMER; DISEASE GENE-PRODUCT; MOUSE MODEL; NEUROMUSCULAR-JUNCTION; MESSENGER-RNA; STEP PURIFICATION; NERVE-TERMINALS; ACTIN DYNAMICS; CELL-DEATH	Homozygous loss of SMN1 causes spinal muscular atrophy (SMA), the most common and devastating childhood genetic motor-neuron disease. The copy gene SMN2 produces only similar to 10% functional SMN protein, insufficient to counteract development of SMA. In contrast, the human genetic modifier plastin 3 (PLS3), an actin-binding and-bundling protein, fully protects against SMA in SMN/-deleted individuals carrying 3-4 SMN2 copies. Here, we demonstrate that the combinatorial effect of suboptimal SMN antisense oligonucleotide treatment and PLS3 overexpression a situation resembling the human condition in asymptomatic SMN1-deleted individuals rescues survival (from 14 to >250 days) and motoric abilities in a severe SMA mouse model. Because PLS3 knockout in yeast impairs endocytosis, we hypothesized that disturbed endocytosis might be a key cellular mechanism underlying impaired neurotransmission and neuromuscular junction maintenance in SMA. Indeed, SMN deficit dramatically reduced endocytosis, which was restored to normal levels by PLS3 overexpression. Upon low-frequency electro-stimulation, endocytotic FM1-43 (SynaptoGreen) uptake in the presynaptic terminal of neuromuscular junctions was restored to control levels in SMA-PLS3 mice. Moreover, proteomics and biochemical analysis revealed CORO1C, another F-actin binding protein, whose direct binding to PLS3 is dependent on calcium. Similar to PLS3 overexpression, CORO1C overexpression restored fluid-phase endocytosis in SMN-knockdown cells by elevating F-actin amounts and rescued the axonal truncation and branching phenotype in Smn-depleted zebrafish. Our findings emphasize the power of genetic modifiers to unravel the cellular pathomechanisms underlying SMA and the power of combinatorial therapy based on splice correction of SMN2 and endocytosis improvement to efficiently treat SMA.	[Hosseinibarkooie, Seyyedmohsen; Peters, Miriam; Torres-Benito, Laura; Hupperich, Kristina; Hoffmann, Andrea; Mendoza-Ferreira, Natalia; Kaczmarek, Anna; Janzen, Eva; Milbradt, Janine; Riessland, Markus; Kye, Min Jeong; Wirth, Brunhilde] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Hosseinibarkooie, Seyyedmohsen; Peters, Miriam; Torres-Benito, Laura; Hupperich, Kristina; Hoffmann, Andrea; Mendoza-Ferreira, Natalia; Kaczmarek, Anna; Janzen, Eva; Milbradt, Janine; Riessland, Markus; Wirth, Brunhilde] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Hosseinibarkooie, Seyyedmohsen; Peters, Miriam; Torres-Benito, Laura; Hupperich, Kristina; Hoffmann, Andrea; Mendoza-Ferreira, Natalia; Kaczmarek, Anna; Janzen, Eva; Milbradt, Janine; Hammerschmidt, Matthias; Riessland, Markus; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Lamkemeyer, Tobias] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Clemen, Christoph S.] Univ Cologne, Ctr Biochem, Inst Biochem 1, Fac Med, D-50931 Cologne, Germany; [Rigo, Frank; Bennett, C. Frank] IONIS Pharmaceut, Carlsbad, CA 92008 USA; [Guschlbauer, Christoph; Bueschges, Ansgar] Univ Cologne, Inst Zool, Bioctr, Neurophysiol, D-50674 Cologne, Germany; [Hammerschmidt, Matthias] Univ Cologne, Inst Zool, Bioctr, Dev Biol, D-50674 Cologne, Germany; [Riessland, Markus] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10065 USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Ionis Pharmaceuticals, Inc.; University of Cologne; University of Cologne; Rockefeller University	Wirth, B (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.; Wirth, B (corresponding author), Univ Cologne, Inst Genet, D-50674 Cologne, Germany.; Wirth, B (corresponding author), Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany.	brunhilde.wirth@uk-koeln.de	Kye, Min Jeong/ABC-3439-2020; Riessland, Markus/AAM-6708-2021; Wirth, Brunhilde/H-3192-2019; Torres-Benito, Laura/X-5491-2019; Clemen, Christoph/B-2761-2011	Kye, Min Jeong/0000-0002-1323-7256; Clemen, Christoph/0000-0002-1291-4219; Hosseini-Barkooie, Seyyedmohsen/0000-0001-6121-8562; Buschges, Ansgar/0000-0003-2123-1900; Wirth, Brunhilde/0000-0003-4051-5191; Riessland, Markus/0000-0003-2592-5045	Deutsche Forschungsgemeinschaft [Wi-945/13-1, Wi-945/14-1, RTG 1970, KY96/1-1]; SMA Europe; EU FP7 NEUROMICS; CMMC; IGSDHD; AFM-Telethon	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SMA Europe; EU FP7 NEUROMICS; CMMC; IGSDHD; AFM-Telethon(Association Francaise contre les Myopathies)	We thank CECAD for help with mass-spectrometry-based proteomics and imaging. This work was supported by grants from the Deutsche Forschungsgemeinschaft Wi-945/13-1, Wi-945/14-1, RTG 1970 (B.W.) and KY96/1-1 (M.J.K.), SMA Europe (M.R.), EU FP7 NEUROMICS (B.W.), CMMC (B.W.), IGSDHD (A.K.), and AFM-Telethon (L.T.B.). C.F.B. and F.R. are employees of IONIS Pharmaceuticals.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Babin PJ, 2014, PROG NEUROBIOL, V118, P36, DOI 10.1016/j.pneurobio.2014.03.001; Bernal S, 2011, NEUROMUSCULAR DISORD, V21, P413, DOI 10.1016/j.nmd.2011.03.009; Bogdanik LP, 2015, P NATL ACAD SCI USA, V112, pE5863, DOI 10.1073/pnas.1509758112; Bowerman M, 2007, J MOL NEUROSCI, V32, P120, DOI 10.1007/s12031-007-0024-5; Bricceno KV, 2014, HUM MOL GENET, V23, P4745, DOI 10.1093/hmg/ddu189; Chan KT, 2012, BIOCHEM J, V444, P89, DOI 10.1042/BJ20120209; Colaert N, 2011, J PROTEOME RES, V10, P3840, DOI 10.1021/pr2005154; Coque E, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00271; Crowe J, 1995, MOL BIOTECHNOL, V4, P247, DOI 10.1007/BF02779018; Delanote V, 2005, TRAFFIC, V6, P335, DOI 10.1111/j.1600-0854.2005.00276.x; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Feng ZH, 2016, HUM MOL GENET, V25, P964, DOI 10.1093/hmg/ddv629; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gabanella F, 2016, J CELL SCI, V129, P804, DOI 10.1242/jcs.176750; Gachet Y, 2005, J CELL SCI, V118, P4231, DOI 10.1242/jcs.02530; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gandhi Meghal, 2008, V48, P72, DOI 10.1007/978-0-387-09595-0_7; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hao LT, 2012, J NEUROSCI, V32, P5074, DOI 10.1523/JNEUROSCI.5808-11.2012; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Heesen L, 2016, CELL MOL LIFE SCI, V73, P2089, DOI 10.1007/s00018-015-2084-y; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kariya S, 2014, J CLIN INVEST, V124, P785, DOI 10.1172/JCI72017; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kononenko NL, 2014, NEURON, V82, P981, DOI 10.1016/j.neuron.2014.05.007; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; Kye MJ, 2014, HUM MOL GENET, V23, P6318, DOI 10.1093/hmg/ddu350; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Lyon AN, 2014, HUM MOL GENET, V23, P1990, DOI 10.1093/hmg/ddt595; Martinez-Carrera LA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00401; McArdle Bernadette, 2008, V48, P56, DOI 10.1007/978-0-387-09595-0_6; McGovern VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132364; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Praveen K, 2012, CELL REPORTS, V1, P624, DOI 10.1016/j.celrep.2012.05.014; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Ruiz R, 2014, J ANAT, V224, P74, DOI 10.1111/joa.12038; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; See K, 2014, HUM MOL GENET, V23, P1754, DOI 10.1093/hmg/ddt567; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Shurety W, 1998, MOL BIOL CELL, V9, P957, DOI 10.1091/mbc.9.4.957; Sleigh JN, 2011, DIS MODEL MECH, V4, P457, DOI 10.1242/dmm.007245; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Tilley Frances C, 2015, Small GTPases, V6, P36, DOI 10.4161/21541248.2014.992259; Torres-Benito L, 2012, DEV NEUROBIOL, V72, P126, DOI 10.1002/dneu.20912; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; van Dijk FS, 2013, NEW ENGL J MED, V369, P1529, DOI 10.1056/NEJMoa1308223; Vyas S, 2002, HUM MOL GENET, V11, P2751, DOI 10.1093/hmg/11.22.2751; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.3.CO;2-0; Wirth B, 2015, EXPERT OPIN EMERG DR, V20, P353, DOI 10.1517/14728214.2015.1041375; Wirth B, 2013, CURR OPIN GENET DEV, V23, P330, DOI 10.1016/j.gde.2013.03.003; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Xavier CP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00241; Zhou HY, 2015, HUM MOL GENET, V24, P6265, DOI 10.1093/hmg/ddv329; Zou JH, 2004, J BIOL CHEM, V279, P14922, DOI 10.1074/jbc.M309218200	90	107	112	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					647	665		10.1016/j.ajhg.2016.07.014	http://dx.doi.org/10.1016/j.ajhg.2016.07.014			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27499521	Green Published, Bronze			2022-12-18	WOS:000383114800010
J	Terao, C; Yoshifuji, H; Kimura, A; Matsumura, T; Ohmura, K; Takahashi, M; Shimizu, M; Kawaguchi, T; Chen, ZY; Naruse, TK; Sato-Otsubo, A; Ebana, Y; Maejima, Y; Kinoshita, H; Murakami, K; Kawabata, D; Wada, Y; Narita, I; Tazaki, J; Kawaguchi, Y; Yamanaka, H; Yurugi, K; Miura, Y; Maekawa, T; Ogawa, S; Komuro, I; Nagai, R; Yamada, R; Tabara, Y; Isobe, M; Mimori, T; Matsuda, F				Terao, Chikashi; Yoshifuji, Hajime; Kimura, Akinori; Matsumura, Takayoshi; Ohmura, Koichiro; Takahashi, Meiko; Shimizu, Masakazu; Kawaguchi, Takahisa; Chen, Zhiyong; Naruse, Taeko K.; Sato-Otsubo, Aiko; Ebana, Yusuke; Maejima, Yasuhiro; Kinoshita, Hideyuki; Murakami, Kosaku; Kawabata, Daisuke; Wada, Yoko; Narita, Ichiei; Tazaki, Junichi; Kawaguchi, Yasushi; Yamanaka, Hisashi; Yurugi, Kimiko; Miura, Yasuo; Maekawa, Taira; Ogawa, Seishi; Komuro, Issei; Nagai, Ryozo; Yamada, Ryo; Tabara, Yasuharu; Isobe, Mitsuaki; Mimori, Tsuneyo; Matsuda, Fumihiko			Two Susceptibility Loci to Takayasu Arteritis Reveal a Synergistic Role of the IL12B and HLA-B Regions in a Japanese Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BEHCETS-DISEASE SUSCEPTIBILITY; GENOME-WIDE ASSOCIATION; CLINICAL-MANIFESTATIONS; PROMOTER POLYMORPHISM; GENE; IDENTIFICATION; NUMBER; INTERLEUKIN-12; USTEKINUMAB; SEQUENCE	Takayasu arteritis (TAK) is an autoimmune systemic vasculitis of unknown etiology. Although previous studies have revealed that HLA-B*52:01 has an effect on TAK susceptibility, no other genetic determinants have been established so far. Here, we performed genome scanning of 167 TAK cases and 663 healthy controls via Illumina Infinium Human Exome Bead Chip arrays, followed by a replication study consisting of 212 TAK cases and 1,322 controls. As a result, we found that the IL12B region on chromosome 5 (rs6871626, overall p = 1.7 x 10(-13), OR = 1.75, 95% CI 1.42-2.16) and the MLX region on chromosome 17 (rs665268, overall p = 5.2 x 10(-7), OR = 1.50, 95% CI 1.28-1.76) as well as the HLA-B region (rs9263739, a proxy of HLA-B*52:01, overall p = 2.8 x 10(-21), OR = 2.44, 95% CI 2.03-2.93) exhibited significant associations. A significant synergistic effect of rs6871626 and rs9263739 was found with a relative excess risk of 3.45, attributable proportion of 0.58, and synergy index of 3.24 (p <= 0.00028) in addition to a suggestive synergistic effect between rs665268 and rs926379 (p <= 0.027). We also found that rs6871626 showed a significant association with clinical manifestations of TAK, including increased risk and severity of aortic regurgitation, a representative severe complication of TAK. Detection of these susceptibility loci will provide new insights to the basic mechanisms of TAK pathogenesis. Our findings indicate that IL12B plays a fundamental role on the pathophysiology of TAK in combination with HLA-B*52:01 and that common autoimmune mechanisms underlie the pathology of TAK and other autoimmune disorders such as psoriasis and inflammatory bowel diseases in which IL12B is involved as a genetic predisposing factor.	[Terao, Chikashi; Takahashi, Meiko; Shimizu, Masakazu; Kawaguchi, Takahisa; Yamada, Ryo; Tabara, Yasuharu; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan; [Terao, Chikashi; Yoshifuji, Hajime; Ohmura, Koichiro; Kawabata, Daisuke; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto 6068507, Japan; [Kimura, Akinori; Chen, Zhiyong; Naruse, Taeko K.] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo 1138510, Japan; [Matsumura, Takayoshi; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Sato-Otsubo, Aiko; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Tokyo 1138655, Japan; [Ebana, Yusuke] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat Pharmacol, Tokyo 1138510, Japan; [Maejima, Yasuhiro; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo 1138510, Japan; [Kinoshita, Hideyuki] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan; [Murakami, Kosaku] Osaka Red Cross Hosp, Osaka 5438555, Japan; [Wada, Yoko; Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata 9518510, Japan; [Tazaki, Junichi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Kawaguchi, Yasushi; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1620054, Japan; [Yurugi, Kimiko; Miura, Yasuo; Maekawa, Taira] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 6068507, Japan	Kyoto University; Kyoto University; Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kyoto University; Osaka Red Cross Hospital; Niigata University; Kyoto University; Tokyo Women's Medical University; Kyoto University	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto 6068507, Japan.	a0001101@kuhp.kyoto-u.ac.jp	Kosaku, Murakami/T-8806-2019; Narita, Ichiei/G-5204-2017; Ogawa, Seishi/AAE-7088-2019; Naruse, Taeko/ABA-3089-2021; Kimura, Akinori/I-5989-2018; Maejima, Yasuhiro/AAG-5580-2020; Yoshifuji, Hajime/AAZ-1657-2020	Narita, Ichiei/0000-0001-7692-3096; Kimura, Akinori/0000-0002-4933-2132; Takahashi, Meiko/0000-0002-8344-5472; Ebana, Yusuke/0000-0002-5162-0838; Yamada, Ryo/0000-0002-1587-630X	Kyoto University; Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; SENSHIN Medical Research Foundation; Japan Society for the Promotion of Science	Kyoto University; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We'd like to thank all the individuals with TAK who gave their blood samples and medical staffs to help us for this study; Mild. Kokubo for her excellent technique to extract DNA; Kayo Umemoto for coordination of meetings to obtain blood samples; and Masashi Akizuki for his help to collect DNA samples. This study is supported by Kyoto University Step-up grant, Grants-in-aid from Research on rare and intractable diseases, the Ministry of Health, Labor, and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, grants from SENSHIN Medical Research Foundation (to T. Matsumura), and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (to R.N.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Andrews J, 2007, RHEUMATOLOGY, V46, P6, DOI 10.1093/rheumatology/kel323; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Basu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046441; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Dreyer L, 2011, CLIN EXP RHEUMATOL, V29, pS40; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Isobe M, 2013, INT J CARDIOL, V168, P3, DOI 10.1016/j.ijcard.2013.01.022; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Johnston A, 2013, HUM MOL GENET, V22, P1807, DOI 10.1093/hmg/ddt034; Kitamura H, 1998, INT J CARDIOL, V66, pS121, DOI 10.1016/S0167-5273(98)00159-4; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu H, 2012, AM J HUM GENET, V91, P935, DOI 10.1016/j.ajhg.2012.09.010; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Ozaki S, 2011, CIRC J, V75, P474, DOI 10.1253/circj.CJ-88-0007; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sahin Z, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3730; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Saruhan-Direskeneli G, 2006, HUM IMMUNOL, V67, P735, DOI 10.1016/j.humimm.2006.06.003; Stanilova S, 2005, GENES IMMUN, V6, P364, DOI 10.1038/sj.gene.6364213; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Vargas-Alarcon G, 2001, CLIN EXP RHEUMATOL, V19, P439; Verma DK, 2005, J RHEUMATOL, V32, P2361; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; YAJIMA M, 1994, JPN CIRC J, V58, P9; Yanagihori H, 2006, J INVEST DERMATOL, V126, P1534, DOI 10.1038/sj.jid.5700203; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yeilding N, 2012, ANN NY ACAD SCI, V1263, P1, DOI 10.1111/j.1749-6632.2012.06670.x; Yilmaz V, 2005, CYTOKINE, V30, P188, DOI 10.1016/j.cyto.2005.01.006; YOSHIDA M, 1993, TISSUE ANTIGENS, V42, P87, DOI 10.1111/j.1399-0039.1993.tb02172.x; Yoshimura K, 2013, INT J UROL, V20, P911, DOI 10.1111/iju.12074	42	107	110	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					289	297		10.1016/j.ajhg.2013.05.024	http://dx.doi.org/10.1016/j.ajhg.2013.05.024			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23830516	Green Published, Bronze			2022-12-18	WOS:000323186200008
J	Beunders, G; Voorhoeve, E; Golzio, C; Pardo, LM; Rosenfeld, JA; Talkowski, ME; Simonic, I; Lionel, AC; Vergult, S; Pyatt, RE; van de Kamp, J; Nieuwint, A; Weiss, MM; Rizzu, P; Verwer, LENI; van Spaendonk, RML; Shen, YP; Wu, BL; Yu, TT; Yu, YG; Chiang, C; Gusella, JF; Lindgren, AM; Morton, CC; van Binsbergen, E; Bulk, S; van Rossem, E; Vanakker, O; Armstrong, R; Park, SM; Greenhalgh, L; Maye, U; Neill, NJ; Abbott, KM; Sell, S; Ladda, R; Farber, DM; Bader, PI; Cushing, T; Drautz, JM; Konczal, L; Nash, P; de Los Reyes, E; Carter, MT; Hopkins, E; Marshall, CR; Osborne, LR; Gripp, KW; Thrush, DL; Hashimoto, S; Gastier-Foster, JM; Astbury, C; Ylstra, B; Meijers-Heijboer, H; Posthuma, D; Menten, B; Mortier, G; Scherer, SW; Eichler, EE; Girirajan, S; Katsanis, N; Groffen, AJ; Sistermans, EA				Beunders, Gea; Voorhoeve, Els; Golzio, Christelle; Pardo, Luba M.; Rosenfeld, Jill A.; Talkowski, Michael E.; Simonic, Ingrid; Lionel, Anath C.; Vergult, Sarah; Pyatt, Robert E.; van de Kamp, Jiddeke; Nieuwint, Aggie; Weiss, Marjan M.; Rizzu, Patrizia; Verwer, Lucilla E. N. I.; van Spaendonk, Rosalina M. L.; Shen, Yiping; Wu, Bai-lin; Yu, Tingting; Yu, Yongguo; Chiang, Colby; Gusella, James F.; Lindgren, Amelia M.; Morton, Cynthia C.; van Binsbergen, Ellen; Bulk, Saskia; van Rossem, Els; Vanakker, Olivier; Armstrong, Ruth; Park, Soo-Mi; Greenhalgh, Lynn; Maye, Una; Neill, Nicholas J.; Abbott, Kristin M.; Sell, Susan; Ladda, Roger; Farber, Darren M.; Bader, Patricia I.; Cushing, Tom; Drautz, Joanne M.; Konczal, Laura; Nash, Patricia; de Los Reyes, Emily; Carter, Melissa T.; Hopkins, Elizabeth; Marshall, Christian R.; Osborne, Lucy R.; Gripp, Karen W.; Thrush, Devon Lamb; Hashimoto, Sayaka; Gastier-Foster, Julie M.; Astbury, Caroline; Ylstra, Bauke; Meijers-Heijboer, Hanne; Posthuma, Danielle; Menten, Bjoern; Mortier, Geert; Scherer, Stephen W.; Eichler, Evan E.; Girirajan, Santhosh; Katsanis, Nicholas; Groffen, Alexander J.; Sistermans, Erik A.			Exonic Deletions in AUTS2 Cause a Syndromic Form of Intellectual Disability and Suggest a Critical Role for the C Terminus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSLOCATION BREAKPOINT; MUTATIONS; AUTISM; ABNORMALITIES; GENERATION; PHENOTYPE; DATABASE; GENES	Genomic rearrangements involving AUTS2 (7q11.22) are associated with autism and intellectual disability (ID), although evidence for causality is limited. By combining the results of diagnostic testing of 49,684 individuals, we identified 24 microdeletions that affect at least one exon of AUTS2, as well as one translocation and one inversion each with a breakpoint within the AUTS2 locus. Comparison of 17 well-characterized individuals enabled identification of a variable syndromic phenotype including ID, autism, short stature, microcephaly, cerebral palsy, and facial dysmorphisms. The dysmorphic features were more pronounced in persons with 3' AUTS2 deletions. This part of the gene is shown to encode a C-terminal isoform (with an alternative transcription start site) expressed in the human brain. Consistent with our genetic data, suppression of auts2 in zebrafish embryos caused microcephaly that could be rescued by either the full-length or the C-terminal isoform of AUTS2. Our observations demonstrate a causal role of AUTS2 in neurocognitive disorders, establish a hitherto unappreciated syndromic phenotype at this locus, and show how transcriptional complexity can underpin human pathology. The zebrafish model provides a valuable tool for investigating the etiology of AUTS2 syndrome and facilitating gene-function analysis in the future.	[Beunders, Gea; Voorhoeve, Els; Pardo, Luba M.; van de Kamp, Jiddeke; Nieuwint, Aggie; Weiss, Marjan M.; Rizzu, Patrizia; Verwer, Lucilla E. N. I.; van Spaendonk, Rosalina M. L.; Meijers-Heijboer, Hanne; Posthuma, Danielle; Groffen, Alexander J.; Sistermans, Erik A.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1007 MB Amsterdam, Netherlands; [Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Rosenfeld, Jill A.; Neill, Nicholas J.] Perkin Elmer, Signature Genom Labs, Spokane, WA 99207 USA; [Talkowski, Michael E.; Shen, Yiping; Chiang, Colby; Gusella, James F.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res,Dept Genet, Boston, MA 02114 USA; [Talkowski, Michael E.; Shen, Yiping; Chiang, Colby; Gusella, James F.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res,Dept Neurol, Boston, MA 02114 USA; [Talkowski, Michael E.; Gusella, James F.; Morton, Cynthia C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Simonic, Ingrid; Armstrong, Ruth; Park, Soo-Mi; Abbott, Kristin M.] Natl Hlth Serv Fdn Trust, Cambridge Univ Hosp, Addenbrookes Hosp, E Anglian Med Genet Serv, Cambridge CB2 0QQ, England; [Lionel, Anath C.; Marshall, Christian R.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Lionel, Anath C.; Marshall, Christian R.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Lionel, Anath C.; Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Lionel, Anath C.; Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON M5S 1A1, Canada; [Vergult, Sarah; Vanakker, Olivier; Menten, Bjoern] Univ Hosp Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Pyatt, Robert E.; Thrush, Devon Lamb; Hashimoto, Sayaka; Gastier-Foster, Julie M.; Astbury, Caroline] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Pyatt, Robert E.; Gastier-Foster, Julie M.; Astbury, Caroline] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Shen, Yiping; Wu, Bai-lin; Yu, Tingting] Boston Childrens Hosp, Dept Lab Med, Boston, MA 02114 USA; [Shen, Yiping; Yu, Tingting; Yu, Yongguo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200025, Peoples R China; [Wu, Bai-lin] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Wu, Bai-lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Lindgren, Amelia M.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lindgren, Amelia M.; Morton, Cynthia C.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [van Binsbergen, Ellen; Bulk, Saskia] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 AB Utrecht, Netherlands; [van Rossem, Els] Onze Lieve Vrouwe Ziekenhuis, B-9300 Aalst, Belgium; [Greenhalgh, Lynn; Maye, Una] Royal Liverpool Childrens Hosp, Liverpool L12 2AP, Merseyside, England; [Sell, Susan; Ladda, Roger] Penn State Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Farber, Darren M.] Univ Louisville, Dept Neurol, Louisville, KY 40222 USA; [Bader, Patricia I.] NE Indiana Genet Counseling Ctr, Ft Wayne, IN 46804 USA; [Cushing, Tom; Drautz, Joanne M.] Univ New Mexico, Dept Pediat, Pediat Genet Div, Albuquerque, NM 87131 USA; [Konczal, Laura] Case Western Reserve Univ, Univ Hosp, Cleveland, OH 44106 USA; [Nash, Patricia] Nationwide Childrens Hosp, Dept Behav Pediat, Columbus, OH 43205 USA; [de Los Reyes, Emily] Ohio State Univ, Dept Pediat & Neurol, Columbus, OH 43210 USA; [Carter, Melissa T.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Hopkins, Elizabeth; Gripp, Karen W.] Alfred I duPont Hosp Children, Div Med Genet, Wilmington, DE 19803 USA; [Osborne, Lucy R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Osborne, Lucy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Thrush, Devon Lamb] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Ylstra, Bauke] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Posthuma, Danielle; Groffen, Alexander J.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Posthuma, Danielle] Erasmus Univ, Dept Child & Adolescent Psychiat, NL-3000 CB Rotterdam, Netherlands; [Mortier, Geert] Univ Antwerp, Dept Med Genet, B-2650 Edegem, Belgium; [Eichler, Evan E.; Girirajan, Santhosh] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.; Girirajan, Santhosh] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Girirajan, Santhosh] Penn State Univ, Dept Biochem & Mol Biol, Dept Anthropol, University Pk, PA 16803 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Ghent University; Ghent University Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Harvard University; Boston Children's Hospital; Shanghai Jiao Tong University; Fudan University; Fudan University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Louisville; University of New Mexico; Case Western Reserve University; University Hospitals of Cleveland; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Nemours Alfred I. duPont Hospital for Children; University of Toronto; University of Toronto; University System of Ohio; Ohio State University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; University of Antwerp; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Sistermans, EA (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1007 MB Amsterdam, Netherlands.	e.sistermans@vumc.nl	Weiss, Marjan M/AAN-4979-2020; Scherer, Stephen W./B-3785-2013; de los Reyes, Emily C/AAP-3836-2020; Menten, Björn/B-3072-2013; Ylstra, Bauke/D-2906-2012; Sistermans, Erik/B-1109-2009; Mortier, Geert/D-2542-2012; Groffen, A.J.A./C-1118-2009; Astbury, Caroline/E-2665-2011; Vanakker, Olivier M./AAN-2900-2021; Katsanis, Nicholas/E-1837-2012	Weiss, Marjan M/0000-0002-0936-1406; Scherer, Stephen W./0000-0002-8326-1999; Ylstra, Bauke/0000-0001-9479-3010; Sistermans, Erik/0000-0001-7187-4563; Mortier, Geert/0000-0001-9871-4578; Groffen, A.J.A./0000-0003-0046-4027; Vanakker, Olivier M./0000-0003-4491-0332; Katsanis, Nicholas/0000-0002-2480-0171; yu, yongguo/0000-0002-4472-0910; Chiang, Colby/0000-0002-4113-6065; Golzio, Christelle/0000-0002-4420-3921; Vervenne, Resie/0000-0002-6077-8725; Abbott, Kristin/0000-0002-4885-8124; Vergult, Sarah/0000-0002-0816-6262; Hashimoto, Sayaka/0000-0002-2661-4532; Menten, Bjorn/0000-0001-8182-659X; Posthuma, Danielle/0000-0001-7582-2365; Neill, Nicholas/0000-0003-4205-3488; Talkowski, Michael/0000-0003-2889-0992	Wellcome Trust [076113, 085475]; National Institutes of Health [GM061354, HD065286, MH095867]; American Heart Association [11POST7160006]; Distinguished Brumley Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH095867, R00MH095867] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Distinguished Brumley Professorship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank all patients and their families for their major contribution; without them, we would not have been able to describe this syndrome. We thank Marjolein van de Mespel, Desiree Linders, Stefan Strijbis, Amanda Clarkson, and Carrie Hanscom for their contribution to the laboratory work in this project and Shahrin Pereira for clinical coordination. This study made use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data is available at www.wtccc.org.uk. Funding for this project was provided by the Wellcome Trust under awards 076113 and 085475, as well as by the National Institutes of Health (GM061354, HD065286, and MH095867), the American Heart Association (11POST7160006), and a Distinguished Brumley Professorship to N.K. Evan Eichler is a Howards Hughes Medical Institute investigator. The authors thank Klaas Kok for making available the control data of The Low-Lands Consortium for this study and for developing the custom design of the 180K Agilent oligo array used in The Netherlands. We acknowledge Soheil Shams from Bio-Discovery for his help with processing the different array data files. J.A.R. and N.J.N. are employees of Signature Genomic Laboratories, a subsidiary of PerkinElmer, and E.E.E. is on the scientific advisory boards for Pacific Biosciences, SynapDx, and DNAnexus.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Deak KL, 2011, CLIN LAB MED, V31, P543, DOI 10.1016/j.cll.2011.08.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Huang XL, 2010, AM J MED GENET A, V152A, P2112, DOI 10.1002/ajmg.a.33497; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Nagamani SCS, 2012, EUR J HUM GENET, V20, P176, DOI 10.1038/ejhg.2011.171; Oeseburg B, 2011, INTELLECT DEV DISAB, V49, P59, DOI 10.1352/1934-9556-49.2.59; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; van Bon BWM, 2010, EUR J HUM GENET, V18, P163, DOI 10.1038/ejhg.2009.152	24	107	108	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					210	220		10.1016/j.ajhg.2012.12.011	http://dx.doi.org/10.1016/j.ajhg.2012.12.011			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23332918	Green Published, Bronze			2022-12-18	WOS:000315179600005
J	Saitsu, H; Osaka, H; Sasaki, M; Takanashi, J; Hamada, K; Yamashita, A; Shibayama, H; Shiina, M; Kondo, Y; Nishiyama, K; Tsurusaki, Y; Miyake, N; Doi, H; Ogata, K; Inoue, K; Matsumoto, N				Saitsu, Hirotomo; Osaka, Hitoshi; Sasaki, Masayuki; Takanashi, Jun-ichi; Hamada, Keisuke; Yamashita, Akio; Shibayama, Hidehiro; Shiina, Masaaki; Kondo, Yukiko; Nishiyama, Kiyomi; Tsurusaki, Yoshinori; Miyake, Noriko; Doi, Hiroshi; Ogata, Kazuhiro; Inoue, Ken; Matsumoto, Naomichi			Mutations in POLR3A and POLR3B Encoding RNA Polymerase III Subunits Cause an Autosomal-Recessive Hypomyelinating Leukoencephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; STRUCTURAL BASIS; SYNTHETASE MUTATIONS; ANGSTROM RESOLUTION; TRANSCRIPTION; ATAXIA; ATROPHY; HYPODONTIA; NEUROPATHY; BINDING	Congenital hypomyelinating disorders are a heterogeneous group of inherited leukoencephalopathies characterized by abnormal myelin formation. We have recently reported a hypomyelinating syndrome characterized by diffuse cerebral hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). We performed whole-exome sequencing of three unrelated individuals with HCAHC and identified compound heterozygous mutations in POLR3B in two individuals. The mutations include a nonsense mutation, a splice-site mutation, and two missense mutations at evolutionally conserved amino acids. Using reverse transcription-PCR and sequencing, we demonstrated that the splice-site mutation caused deletion of exon 18 from POLR3B mRNA and that the transcript harboring the nonsense mutation underwent nonsense-mediated mRNA decay. We also identified compound heterozygous missense mutations in POLR3A in the remaining individual. POLR3A and POLR3B encode the largest and second largest subunits of RNA Polymerase III (Pol III), RPC1 and RPC2, respectively. RPC1 and RPC2 together form the active center of the polymerase and contribute to the catalytic activity of the polymerase. Pol III is involved in the transcription of small noncoding RNAs, such as SS ribosomal RNA and all transfer RNAs (tRNA). We hypothesize that perturbation of Pal 111 target transcription, especially of tRNAs, could be a common pathological mechanism underlying POLR3A and POLR3B mutations.	[Saitsu, Hirotomo; Kondo, Yukiko; Nishiyama, Kiyomi; Tsurusaki, Yoshinori; Miyake, Noriko; Doi, Hiroshi; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Neurol, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Tokyo 1878551, Japan; [Takanashi, Jun-ichi] Kameda Med Ctr, Dept Pediat, Kamogawa, Chiba 2968602, Japan; [Hamada, Keisuke; Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Yamashita, Akio] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Shibayama, Hidehiro] Kameda Med Ctr, Dept Neurol, Kamogawa, Chiba 2968602, Japan; [Inoue, Ken] Natl Ctr Neurol & Psychiat, Dept Mental Retardat & Birth Defect Res, Natl Inst Neurosci, Tokyo 1878551, Japan	Yokohama City University; National Center for Neurology & Psychiatry - Japan; Yokohama City University; Yokohama City University; National Center for Neurology & Psychiatry - Japan	Saitsu, H (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hsaitsu@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp	Saitsu, Hirotomo/AAM-7131-2021	Tsurusaki, Yoshinori/0000-0002-7240-6355; Takanashi, Jun-ichi/0000-0002-1147-1938; Saitsu, Hirotomo/0000-0003-0723-0960	Ministry of Health, Labour, and Welfare; Japan Science and Technology Agency; Foundation of Synapse and Neurocircuit Pathology Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23659531, 22790823] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Foundation of Synapse and Neurocircuit Pathology Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We would like to thank all the individuals and their families for their participation in this study. This work was supported by research grants from the Ministry of Health, Labour, and Welfare (H.S., HO., M.S., J.T., N. Miyake, K.I. and N. Matsumoto), the Japan Science and Technology Agency (N. Matsumoto), a Grant-in-Aid for Scientific Research on Innovative Areas (Foundation of Synapse and Neurocircuit Pathology) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (N. Matsumoto), a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (H.O., N. Matsumoto), a Grant-in-Aid for Young Scientist from Japan Society for the Promotion of Science (H.S.). This work has been done at Advanced Medical Research Center, Yokohama City University.	[Anonymous], DBSNP; [Anonymous], POLYPHEN 2; [Anonymous], GEN BANK; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Bernard G, 2011, AM J HUM GENET, V89, P415, DOI 10.1016/j.ajhg.2011.07.014; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Doi H, 2011, AM J HUM GENET, V89, P320, DOI 10.1016/j.ajhg.2011.07.012; Dumay-Odelot H, 2010, CELL CYCLE, V9, P3687, DOI 10.4161/cc.9.18.13203; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Sasaki M, 2009, BRAIN DEV-JPN, V31, P582, DOI 10.1016/j.braindev.2008.09.003; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Timmons M, 2006, NEUROLOGY, V67, P2066, DOI 10.1212/01.wnl.0000247666.28904.35; van der Knaap MS, 2002, AM J NEURORADIOL, V23, P1466; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Werner M, 2009, CURR OPIN STRUC BIOL, V19, P740, DOI 10.1016/j.sbi.2009.10.005; Wolf NI, 2007, NEUROPEDIATRICS, V38, P64, DOI 10.1055/s-2007-985137; Wolf NI, 2005, NEUROLOGY, V64, P1461, DOI 10.1212/01.WNL.0000158615.56071.E3; Yee NS, 2007, PLOS BIOL, V5, P2484, DOI 10.1371/journal.pbio.0050312; SEATTLESEQ ANNOTATIO; CLUSTALW	33	107	113	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					644	651		10.1016/j.ajhg.2011.10.003	http://dx.doi.org/10.1016/j.ajhg.2011.10.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22036171	Green Published, Bronze			2022-12-18	WOS:000297090100006
J	Chen, LS; Hutter, CM; Potter, JD; Liu, Y; Prentice, RL; Peters, U; Hsu, L				Chen, Lin S.; Hutter, Carolyn M.; Potter, John D.; Liu, Yan; Prentice, Ross L.; Peters, Ulrike; Hsu, Li			Insights into Colon Cancer Etiology via a Regularized Approach to Gene Set Analysis of GWAS Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; TESTING ASSOCIATION; REGRESSION; SUSCEPTIBILITY; SELECTION; PATHWAY; DISEASE; LASSO; SCAN	Genome-wide association studies (GWAS) have successfully identified susceptibility loci from marginal association analysis of SNPs. Valuable insight into genetic variation underlying complex diseases will likely be gained by considering functionally related sets of genes simultaneously. One approach is to further develop gene set enrichment analysis methods, which are initiated in gene expression studies, to account for the distinctive features of GWAS data. These features include the large number of SNPs per gene, the modest and sparse SNP associations, and the additional information provided by linkage disequilibrium (LD) patterns within genes. We propose a "gene set ridge regression in association studies (GRASS)" algorithm. GRASS summarizes the genetic structure for each gene as eigenSNPs and uses a novel form of regularized regression technique, termed group ridge regression, to select representative eigenSNPs for each gene and assess their joint association with disease risk. Compared with existing methods, the proposed algorithm greatly reduces the high dimensionality of GWAS data while still accounting for multiple hits and/or LD in the same gene. We show by simulation that this algorithm performs well in situations in which there are a large number of predictors compared to sample size. We applied the GRASS algorithm to a genome-wide association study of colon cancer and identified nicotinate and nicotinamide metabolism and transforming growth factor beta signaling as the top two significantly enriched pathways. Elucidating the role of variation in these pathways may enhance our understanding of colon cancer etiology.	[Chen, Lin S.; Liu, Yan; Hsu, Li] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Biostat & Biomath Program, Seattle, WA 98109 USA; [Hutter, Carolyn M.; Potter, John D.; Prentice, Ross L.; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Canc Prevent Program, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Hsu, L (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Biostat & Biomath Program, Seattle, WA 98109 USA.	lih@fhcrc.org		Potter, John/0000-0001-5439-1500	National Institutes of Health [AG014358, CA053996, CA011821, CA059045, R25CA94880, U01ES015089]; National Heart, Lung and Blood Institute [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-19, 32122, 42107-26, 42129-32, 44221]; NATIONAL CANCER INSTITUTE [R25CA094880, U01CA137088, R01CA059045, P01CA053996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014358, R29AG014358, R56AG014358] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042113, N01WH042125, N01WH032115, N01WH042118, N01WH032113, N01WH032101, N01WH032119, N01WH032122, N01WH042107, N01WH032111, N01WH042130, N01WH042131, N01WH032112, N01WH042122, N01WH042126, N01WH032108, N01WH042132, N01WH042116, N01WH042115, N01WH042121, N01WH042108, N01WH042111, N01WH032106, N01WH042112, N01WH042119, N01WH042120, N01WH042129, N01WH022110, N01WH042109, N01WH042110, N01WH032102, N01WH042117, N01WH032105, N01WH032118, N01WH032100, N01WH032109, N01WH042123, N01WH042124, N01WH042114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to Chris Carlson for helping us with the gene definition and with the possible biological mechanism of germline variation for gene functions, David Duggan and his colleagues at TGen for generating the genotype data, Pei Wang for helpful discussions on sparse regression for high-dimensional data, and Ellen Wijsman for the critical reading and many helpful suggestions on the paper. The authors are also grateful to the editor and the anonymous reviewers for their suggestions and comments, which have greatly improved the paper. The work is partially supported by grants from the National Institutes of Health (AG014358, CA053996, CA011821, CA059045, R25CA94880, and U01ES015089). The Women's Health Initiative is supported by the National Heart, Lung and Blood Institute Contracts (N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-19, 32122, 42107-26, 42129-32, and 44221). The authors thank the WHI investigators and staff for their dedication and the study participants for making the WHI program possible. A listing of WHI investigators can be found at the WHI website. The authors declare no conflict of interest.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akhurst RJ, 2004, NAT GENET, V36, P790, DOI 10.1038/ng0804-790; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Genkin A, 2007, TECHNOMETRICS, V49, P291, DOI 10.1198/004017007000000245; Gmeiner WH, 2008, ONCOL REP, V19, P245; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Huang J, 2009, BIOMETRIKA, V96, P339, DOI 10.1093/biomet/asp020; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Katoh M, 2007, INT J ONCOL, V30, P247; Knight K, 2000, ANN STAT, V28, P1356; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Meier L, 2008, J R STAT SOC B, V70, P53, DOI 10.1111/j.1467-9868.2007.00627.x; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiao L, 2009, CARCINOGENESIS, V30, P1979, DOI 10.1093/carcin/bgp236; Rhodes JM, 2008, BIOCHEM SOC T, V36, P1482, DOI 10.1042/BST0361482; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Xu YF, 2007, HUM MOL GENET, V16, pR14, DOI 10.1093/hmg/ddl486; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang T, 2001, INFORM RETRIEVAL, V4, P5, DOI 10.1023/A:1011441423217; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	48	107	111	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					860	871		10.1016/j.ajhg.2010.04.014	http://dx.doi.org/10.1016/j.ajhg.2010.04.014			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20560206	Green Published, Bronze			2022-12-18	WOS:000278948900004
J	Johnston, JJ; Teer, JK; Cherukuri, PE; Hansen, NF; Loftus, SK; Chong, K; Mullikin, JC; Biesecker, LG				Johnston, Jennifer J.; Teer, Jamie K.; Cherukuri, Praveen E.; Hansen, Nancy F.; Loftus, Stacie K.; Chong, Karen; Mullikin, James C.; Biesecker, Leslie G.		NIH Intramural Sequencing Ctr	Massively Parallel Sequencing of Exons on the X Chromosome Identifies RBM10 as the Gene that Causes a Syndromic Form of Cleft Palate	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INACTIVATION; EXPRESSION; MUTATIONS	Micrognathia, glossoptosis, and cleft palate comprise one of the most common malformation sequences, Robin sequence. It is a component of the TARP syndrome, talipes equinovarus, atrial septal defect, Robin sequence, and persistent left superior vena cava. This disorder is X-linked and severe, with apparently 100% pre- or postnatal lethality in affected males. Here we characterize a second family with TARP syndrome, confirm linkage to Xp11.23-q13.3, perform massively parallel sequencing of X chromosome exons, filter the results via a number of criteria including the linkage region, use a unique algorithm to characterize sequence changes, and show that TARP syndrome is caused by mutations in the RBM10 gene, which encodes RNA binding motif 10. We further show that this previously uncharacterized gene is expressed in midgestation mouse embryos in the branchial arches and limbs, consistent with the human phenotype. We conclude that massively parallel sequencing is useful to characterize large candidate linkage intervals and that it can be used successfully to allow identification of disease-causing gene mutations.	[Johnston, Jennifer J.; Teer, Jamie K.; Cherukuri, Praveen E.; Loftus, Stacie K.; Biesecker, Leslie G.] NHGRI, NIH, Bethesda, MD 20892 USA; [Teer, Jamie K.; Cherukuri, Praveen E.; Hansen, Nancy F.; Mullikin, James C.; Biesecker, Leslie G.; NIH Intramural Sequencing Ctr] NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Chong, Karen] Mt Sinai Hosp, Prenatal Diag & Med Genet Program, Toronto, ON M5G 1X5, Canada	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Biesecker, LG (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov	Biesecker, Leslie/AAG-2526-2021; Cherukuri, Praveen/AFU-2005-2022	Cherukuri, Praveen/0000-0002-9509-1245; Loftus, Stacie/0000-0002-1958-4689	National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196, ZIAHG200328] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by Intramural Funds of the National Human Genome Research Institute, National Institutes of Health. The authors thank Joyce T. Turner for the initial consenting and records gathering for the family and Emma J. Spaulding for technical support. This paper is in memory of Robert J. Gorlin, the lead author of the paper describing family 1 and a generous, good-humored supporter of the work of L.G.B.	Brauch KM, 2009, J AM COLL CARDIOL, V54, P930, DOI 10.1016/j.jacc.2009.05.038; Coleman MP, 1996, GENOMICS, V31, P135, DOI 10.1006/geno.1996.0022; Glaser B, 2004, AM J MED GENET A, V126A, P229, DOI 10.1002/ajmg.a.20584; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GORLIN RJ, 1970, AM J DIS CHILD, V119, P176, DOI 10.1001/archpedi.1970.02100050178020; Goto Y, 2009, NUCLEIC ACIDS RES, V37, P7416, DOI 10.1093/nar/gkp860; Johnston JJ, 2005, AM J HUM GENET, V76, P609, DOI 10.1086/429346; Kurpinski KT, 2003, AM J MED GENET A, V120A, P1, DOI 10.1002/ajmg.a.10201; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P611, DOI 10.1111/j.1755-148X.2009.00584.x; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nousbeck J, 2008, AM J HUM GENET, V82, P1114, DOI 10.1016/j.ajhg.2008.03.014; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Thiselton DL, 2002, GENOMICS, V79, P560, DOI 10.1006/geno.2002.6733; Wilkinson David G., 1993, V225, P361	15	107	110	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					743	748		10.1016/j.ajhg.2010.04.007	http://dx.doi.org/10.1016/j.ajhg.2010.04.007			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20451169	Green Published, Bronze			2022-12-18	WOS:000278045300010
J	Stattin, EL; Wiklund, F; Lindblom, K; Onnerfjord, P; Jonsson, BA; Tegner, Y; Sasaki, T; Struglics, A; Lohmander, S; Dahl, N; Heinegard, D; Aspberg, A				Stattin, Eva-Lena; Wiklund, Fredrik; Lindblom, Karin; Onnerfjord, Patrik; Jonsson, Bjorn-Anders; Tegner, Yelverton; Sasaki, Takako; Struglics, Andre; Lohmander, Stefan; Dahl, Niklas; Heinegard, Dick; Aspberg, Anders			A Missense Mutation in the Aggrecan C-type Lectin Domain Disrupts Extracellular Matrix Interactions and Causes Dominant Familial Osteochondritis Dissecans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORE PROTEIN; TENASCIN-R; SPONDYLOEPIPHYSEAL DYSPLASIA; IDENTIFICATION; CARTILAGE; GENE; PROTEOGLYCANS; VERSICAN; BINDING; DWARFISM	Osteochondritis dissecans is a disorder in which fragments of articular cartilage and subchondral bone dislodge from the joint surface. We analyzed a five-generation family in which affected members had autosomal-dominant familial osteochondritis dissecans. A genome-wide linkage analysis identified aggrecan (ACAN) as a prime candidate gene for the disorder. Sequence analysis of ACAN revealed heterozygosity for a missense mutation (c.6907G > A) in affected individuals, resulting in a p.V2303M amino acid substitution in the aggrecan G3 domain C-type lectin, which mediates interactions with other proteins in the cartilage extracellular matrix. Binding studies with recombinant mutated and wild-type G3 proteins showed loss of fibulin-1, fibulin-2, and tenascin-R interactions for the V2303M protein. Mass spectrometric analyses of aggrecan purified from patient cartilage verified that V2303M aggrecan is produced and present in the tissue. Our results provide a molecular mechanism for the etiology of familial osteochondritis dissecans and show the importance of the aggrecan C-type lectin interactions for cartilage function in vivo.	[Aspberg, Anders] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Stattin, Eva-Lena; Jonsson, Bjorn-Anders] Umea Univ Hosp, Dept Med Biosci Med & Clin Genet, S-90185 Umea, Sweden; [Wiklund, Fredrik] Karolinska Inst, S-17177 Stockholm, Sweden; [Lindblom, Karin; Onnerfjord, Patrik; Struglics, Andre; Lohmander, Stefan; Heinegard, Dick] Lund Univ, Dept Clin Sci Lund, S-22184 Lund, Sweden; [Tegner, Yelverton] Lulea Tech Univ, Dept Hlth Sci, S-97187 Lulea, Sweden; [Sasaki, Takako] Univ Erlangen Nurnberg, Dept Expt Med 1, D-91054 Erlangen, Germany; [Dahl, Niklas] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden	University of Copenhagen; Umea University; Karolinska Institutet; Lund University; Lulea University of Technology; University of Erlangen Nuremberg; Uppsala University	Aspberg, A (corresponding author), Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark.	aaspberg@bio.ku.dk	Lohmander, Stefan/AAL-8314-2021; Lohmander, Stefan/I-8326-2012; Onnerfjord, Patrik/R-3131-2019	Lohmander, Stefan/0000-0002-5424-9448; Onnerfjord, Patrik/0000-0002-2345-2937; Aspberg, Anders/0000-0002-6588-6944; Tegner, Yelverton/0000-0003-3628-0705	Northern County Councils Cooperation Committee; Capio Research Foundation; Uppsala and Lund Universities; Kock's, Crafoord, and Lundbeck foundations; Swedish Research Council; Lundberg foundation, Gothenburg	Northern County Councils Cooperation Committee; Capio Research Foundation; Uppsala and Lund Universities; Kock's, Crafoord, and Lundbeck foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lundberg foundation, Gothenburg	We sincerely thank the family members who participated in this study. We also thank Susann Haraldsson, Department of Medical and Clinical Genetics, Umea University Hospital, Umea, for expert technical assistance, Gillian Wallis, The Wellcome Trust Centre for Cell-Matrix Research, Manchester, United Kingdom, for sharing primer sequences with Lis, and Lisa Cannon-Albright, University of Utah, Salt Lake City, USA, for providing access to the MCLINK software used for linkage analysis. This work was supported by grants from the Northern County Councils Cooperation Committee "Visare Norr"; the Capio Research Foundation; Uppsala and Lund Universities; the Kock's, Crafoord, and Lundbeck foundations; and the Swedish Research Council. The mass spectrometers were funded by the Lundberg foundation, Gothenburg.	Abkevich V, 2001, GENET EPIDEMIOL, V21, pS492, DOI 10.1002/gepi.2001.21.s1.s492; Adam S, 1997, J MOL BIOL, V272, P226, DOI 10.1006/jmbi.1997.1244; ANDREW TA, 1981, ACTA ORTHOP SCAND, V52, P519, DOI 10.3109/17453678108992141; Aspberg A, 1999, J BIOL CHEM, V274, P20444, DOI 10.1074/jbc.274.29.20444; ASPBERG A, 1995, P NATL ACAD SCI USA, V92, P10590, DOI 10.1073/pnas.92.23.10590; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; BJORNSSON S, 1993, ANAL BIOCHEM, V210, P282, DOI 10.1006/abio.1993.1197; Cavanagh JAL, 2007, MAMM GENOME, V18, P808, DOI 10.1007/s00335-007-9066-9; Day JM, 2004, J BIOL CHEM, V279, P12511, DOI 10.1074/jbc.M400242200; DOEGE K, 1987, J BIOL CHEM, V262, P17757; Eyre S, 2002, J MED GENET, V39, P634, DOI 10.1136/jmg.39.9.634; Gleghorn L, 2005, AM J HUM GENET, V77, P484, DOI 10.1086/444401; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; HEINEGARD D, 1989, FASEB J, V3, P2042, DOI 10.1096/fasebj.3.9.2663581; HEINEGARD D, 1987, METHOD ENZYMOL, V144, P319; HEINEGARD D, 1974, J BIOL CHEM, V249, P4250; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Krueger RC, 1999, MAMM GENOME, V10, P1119, DOI 10.1007/s003359901176; LI H, 1993, J BIOL CHEM, V268, P23504; Li Y, 2007, OSTEOARTHR CARTILAGE, V15, P1101, DOI 10.1016/j.joca.2007.04.013; LINDEN B, 1976, ACTA ORTHOP SCAND, V47, P664, DOI 10.3109/17453677608988756; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Lundell A, 2004, STRUCTURE, V12, P1495, DOI 10.1016/j.str.2004.05.021; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; PHILLIPS HO, 1985, J BONE JOINT SURG AM, V67A, P155, DOI 10.2106/00004623-198567010-00020; PICK MP, 1955, J BONE JOINT SURG BR, V37, P142, DOI 10.1302/0301-620X.37B1.142; Rauch U, 1997, J BIOL CHEM, V272, P26905, DOI 10.1074/jbc.272.43.26905; Sasaki T, 1997, EMBO J, V16, P3035, DOI 10.1093/emboj/16.11.3035; Sattin EL, 2008, OSTEOARTHR CARTILAGE, V16, P890, DOI 10.1016/j.joca.2007.11.009; Schenck RC, 1996, J BONE JOINT SURG AM, V78A, P439, DOI 10.2106/00004623-199603000-00018; Schwartz NB, 2002, GLYCOBIOLOGY, V12, p57R, DOI 10.1093/glycob/12.4.57R; SMILLIE IS, 1960, OSTEOCHONDRITIS DISS; STIRPE NS, 1987, DEV BIOL, V124, P77, DOI 10.1016/0012-1606(87)90461-1; STOUGAARD J, 1964, J BONE JOINT SURG BR, V46, P542, DOI 10.1302/0301-620X.46B3.542; Tompson SW, 2009, AM J HUM GENET, V84, P72, DOI 10.1016/j.ajhg.2008.12.001; VALHMU WB, 1995, BIOCHEM J, V309, P535, DOI 10.1042/bj3090535; VERTEL BM, 1993, J CELL SCI, V104, P939; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Xiao ZC, 1996, EUR J NEUROSCI, V8, P766, DOI 10.1111/j.1460-9568.1996.tb01262.x; Ytrehus B, 2007, VET PATHOL, V44, P429, DOI 10.1354/vp.44-4-429	43	107	115	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					126	137		10.1016/j.ajhg.2009.12.018	http://dx.doi.org/10.1016/j.ajhg.2009.12.018			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20137779	Green Published, Bronze			2022-12-18	WOS:000274637200003
J	Alders, M; Koopmann, TT; Christiaans, I; Postema, PG; Beekman, L; Tanck, MWT; Zeppenfeld, K; Loh, P; Koch, KT; Demolombe, S; Mannens, MMAM; Bezzina, CR; Wilde, AAM				Alders, Marielle; Koopmann, Tamara T.; Christiaans, Imke; Postema, Pieter G.; Beekman, Leander; Tanck, Michael W. T.; Zeppenfeld, Katja; Loh, Peter; Koch, Karel T.; Demolombe, Sophie; Mannens, Marcel M. A. M.; Bezzina, Connie R.; Wilde, Arthur A. M.			Haplotype-Sharing Analysis Implicates Chromosome 7q36 Harboring DPP6 in Familial Idiopathic Ventricular Fibrillation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; GENE; EXPRESSION	Idiopathic Ventricular Fibrillation (IVF) is defined as spontaneous VF without any known structural or electrical heart disease. A family history is present in up to 20% of probands with the disorder, suggesting that at least a subset of IVF is hereditary. A genome-wide haplotype-sharing analysis was performed for identification of the responsible gene in three distantly related families in which multiple individuals died suddenly or were successfully resuscitated at young age. We identified a haplotype, on chromosome 7q36, that was conserved in these three families and was also shared by 7 of 42 independent IVF patients. The shared chromosomal segment harbors part of the DPP6 gene, which encodes a putative component of the transient outward current in the heart. We demonstrated a 20-fold increase in DPP6 mRNA levels in the myocardium of carriers as compared to controls. Clinical evaluation of 84 risk-haplotype carriers and 71 noncarriers revealed no ECG or structural parameters indicative of cardiac disease. Penetrance of IVF was high; 50% of risk-haplotype carriers experienced (aborted) sudden cardiac death before the age of 58 years. We propose DPP6 as a gene for IVF and increased DPP6 expression as the likely pathogenetic mechanism.	[Koopmann, Tamara T.; Beekman, Leander; Bezzina, Connie R.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Alders, Marielle; Christiaans, Imke; Mannens, Marcel M. A. M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Christiaans, Imke; Postema, Pieter G.; Koch, Karel T.; Wilde, Arthur A. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Tanck, Michael W. T.] Univ Amsterdam, Acad Med Ctr, Dept Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Zeppenfeld, Katja] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Loh, Peter] Univ Med Ctr, Dept Cardiol, Utrecht, Netherlands; [Demolombe, Sophie] Inst Thorax, INSERM, UMR915, Nantes, France; [Demolombe, Sophie] CNRS, ERL3147, Nantes, France; [Demolombe, Sophie] Univ Nantes, Nantes, France	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Nantes Universite	Wilde, AAM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.a.wilde@aamc.uva.nl	Postema, Pieter/ABC-1469-2020	Postema, Pieter/0000-0003-2863-9159; Christiaans, Imke/0000-0001-5799-2344; Tanck, Michael/0000-0001-9828-4459; Bezzina, Connie/0000-0002-0633-3514	Netherlands Heart Foundation [2005T024, 2003T302]; Interuniversity Cardiology Institute of The Netherlands [27]; ZonMw [62000010]; Fondation Leducq Transatlantic Network of Excellence [05CVD01]	Netherlands Heart Foundation(Netherlands Heart Foundation); Interuniversity Cardiology Institute of The Netherlands; ZonMw(Netherlands Organization for Health Research and Development); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation)	This study was supported by The Netherlands Heart Foundation, grants 2005T024 (C.R.B.) and 2003T302 (A.A.M.W.); the Interuniversity Cardiology Institute of The Netherlands, project 27; ZonMw, project 62000010; and Fondation Leducq Transatlantic Network of Excellence, grant 05CVD01 (Preventing Sudden Cardiac Death). None of the authors have a financial interest related to this work. We thank J.M. Ruijter for assistance with statistical analysis of the quantitative PCR experiments, G.J. te Meerman for advice on the haplotype-sharing analysis, D.M. Roden for helpful discussions, and A.V. Postma for help with the LOD-score calculations. We thank J.P. van Tintelen, I.M. van Langen, N. Hofman, B.W. van Paassen, and M. Bronk for patient counseling; T.A. Simmers, B.A.J.M. de Mol, and A.J. Six for patient referral, examination, and tissue sampling; and L.M.E. Stoets and F.A.M. Hennekam for genealogical research. We are very grateful to the patients and their families who cooperated in this study.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Champagne J, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-1; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Goldenberg I, 2008, J AM COLL CARDIOL, V51, P2291, DOI 10.1016/j.jacc.2008.02.068; Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Hasegawa M, 2003, J IMMUNOL, V171, P1927, DOI 10.4049/jimmunol.171.4.1927; He B, 2002, EUR J HUM GENET, V10, P271, DOI 10.1038/sj.ejhg.5200802; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Noda T, 2005, J AM COLL CARDIOL, V46, P1288, DOI 10.1016/j.jacc.2005.05.077; Priori SG, 1997, CIRCULATION, V95, P265; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Soh H, 2008, J BIOL CHEM, V283, P15072, DOI 10.1074/jbc.M706964200; VISKIN S, 1990, AM HEART J, V120, P661, DOI 10.1016/0002-8703(90)90025-S; Yan GX, 1996, CIRCULATION, V93, P372, DOI 10.1161/01.CIR.93.2.372; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	23	107	110	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					468	476		10.1016/j.ajhg.2009.02.009	http://dx.doi.org/10.1016/j.ajhg.2009.02.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19285295	Green Published, Bronze			2022-12-18	WOS:000265232800005
J	Parry, DA; Mighell, AJ; El-Sayed, W; Shore, RC; Jalili, IK; Dollfus, H; Bloch-Zupan, A; Carlos, R; Carr, IM; Downey, LM; Blain, KM; Mansfield, DC; Shahrabi, M; Heidari, M; Aref, P; Abbasi, M; Michaelides, M; Moore, AT; Kirkham, J; Inglehearn, CF				Parry, David A.; Mighell, Alan J.; El-Sayed, Walid; Shore, Roger C.; Jalili, Ismail K.; Dollfus, Helene; Bloch-Zupan, Agnes; Carlos, Roman; Carr, Ian M.; Downey, Louise M.; Blain, Katharine M.; Mansfield, David C.; Shahrabi, Mehdi; Heidari, Mansour; Aref, Parissa; Abbasi, Mohsen; Michaelides, Michel; Moore, Anthony T.; Kirkham, Jennifer; Inglehearn, Chris F.			Mutations in CNNM4 Cause Jalili Syndrome, Consisting of Autosomal-Recessive Cone-Rod Dystrophy and Amelogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CGMP-GATED CHANNEL; GENETIC-BASIS; RETINITIS-PIGMENTOSA; TOTAL COLOURBLINDNESS; INHERITED ANOMALIES; MOLECULAR-CLONING; PROGRESSIVE CONE; ALPHA-SUBUNIT; ENAMEL; NEURONS	The combination of recessively inherited cone-rod dystrophy (CRD) and amelogenesis imperfecta (AI) was first reported by Jalili and Smith in 1988 in a family subsequently linked to a locus on chromosome 2q11, and it has since been reported in a second small family. We have identified five further ethnically diverse families cosegregating CRD and Al. Phenotypic characterization of teeth and visual function in the published and new families reveals a consistent syndrome in all seven families, and all link or are consistent with linkage to 2q11, confirming the existence of a genetically homogenous condition that we now propose to call Jalili syndrome. Using a positional-candidate approach, we have identified Mutations in the CNNM4 gene, encoding a putative metal transporter, accounting for the condition in all seven families. Nine mutations are described in all, three missense, three terminations, two large deletions, and a single base insertion. We confirmed expression of Cnnm4 in the neural retina and in ameloblasts in the developing tooth, suggesting a hitherto unknown connection between tooth biomineralization and retinal function. The identification of CNNM4 as the causative gene for Jalili syndrome, characterized by syndromic CRD with Al, has the potential to provide new insights into the roles of metal transport in visual function and biomineralization.	[Parry, David A.; Mighell, Alan J.; El-Sayed, Walid; Jalili, Ismail K.; Carr, Ian M.; Inglehearn, Chris F.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Mighell, Alan J.; El-Sayed, Walid; Shore, Roger C.; Kirkham, Jennifer] Univ Leeds, Leeds Dent Inst, Leeds LS2 9LU, W Yorkshire, England; [Dollfus, Helene] Univ Strasbourg, AVENIR, INSERM, F-67085 Strasbourg, France; [Dollfus, Helene] Hop Univ Strasbourg, Ctr Reference Affect Ophtalmol Hereditaires CARGO, F-67000 Strasbourg, France; [Bloch-Zupan, Agnes] Univ Strasbourg, Dept Paediat Dent, Fac Dent, F-67000 Strasbourg, France; [Bloch-Zupan, Agnes] Hop Univ Strasbourg, Reference Ctr Oral Manifestat Rare Dis, Serv Soins Buccodent, F-67000 Strasbourg, France; [Bloch-Zupan, Agnes] CNRS, INSERM, UMR7104, Inst Genet & Mol & Cellular Biol,U596, F-67404 Illkirch Graffenstaden, France; [Carlos, Roman] Ctr Clin Cabeza & Cuello, Guatemala City 01010, Guatemala; [Downey, Louise M.] Hull & E Yorkshire Eye Hosp, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Blain, Katharine M.] Dundee Dent Hosp, Child Dent Hlth, Dundee DD1 4HR, Scotland; [Mansfield, David C.] Inverclyde Royal Hosp, Dept Ophthalmol, Greenock PA16 0XN, Scotland; [Shahrabi, Mehdi; Aref, Parissa; Abbasi, Mohsen] Univ Tehran Med Sci, Fac Dent, Tehran 1417613151, Iran; [Heidari, Mansour] Univ Tehran Med Sci, Dept Med Genet, Tehran 1417613151, Iran; [Michaelides, Michel; Moore, Anthony T.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Michaelides, Michel; Moore, Anthony T.] Moorfields Eye Hosp, London EC1V 2PD, England	Saint James's University Hospital; University of Leeds; University of Leeds; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Dundee; Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Inglehearn, CF (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	c.inglehearn@leeds.ac.uk	Bloch-Zupan, Agnes/N-7822-2016; Inglehearn, Chris/GYD-9783-2022; aref, parissa/AAO-3798-2021	Bloch-Zupan, Agnes/0000-0002-6511-2615; aref, parissa/0000-0003-4781-3220; El-Sayed, walid/0000-0002-6647-516X; Dollfus, Helene/0000-0002-2249-895X; Parry, David/0000-0003-0376-7736; Shahrabi, Mahdi/0000-0002-1220-1518	Wellcome Trust [073477, 082448, 075945]; Yorkshire Eye Research [009]; Egyptian government; National Institute for Health Research	Wellcome Trust(Wellcome TrustEuropean Commission); Yorkshire Eye Research; Egyptian government; National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the Jalili syndrome families for their participation, Michael Aldred and James Simmer for information on additional families, Sue Keat for assistance with immunohistochemistry,Sarah Myers for assistance with ultrastructural analyses of teeth, and Jim Curry for advice on retinal histology. This work was funded by the Wellcome Trust (grant numbers 073477, 082448, and 075945), Yorkshire Eye Research (grant number 009), and an Egyptian government scholarship to W.E.S. A.T.M. and M.M. are supported by the National Institute for Health Research (Moorfields Biomedical Research Centre).	Alderton A, 2007, J NEUROCHEM, V103, P312, DOI 10.1111/j.1471-1471-4159.2007.04751.x; BACHRA B. N., 1965, ARCH ORAL BIOL, V10, P731, DOI 10.1016/0003-9969(65)90126-3; Bailleul-Forestier I, 2008, EUR J MED GENET, V51, P383, DOI 10.1016/j.ejmg.2008.05.003; Bailleul-Forestier I, 2008, EUR J MED GENET, V51, P273, DOI 10.1016/j.ejmg.2008.02.009; Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; Barron MJ, 2008, HUM MOL GENET, V17, P3509, DOI 10.1093/hmg/ddn243; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; Dong J, 2005, AM J MED GENET A, V133A, P138, DOI 10.1002/ajmg.a.30521; Downey LM, 2002, EUR J HUM GENET, V10, P865, DOI 10.1038/sj.ejhg.5200884; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; Gong HQ, 2001, EXP EYE RES, V72, P23, DOI 10.1006/exer.2000.0928; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Guo DH, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-15; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Jalevik B, 2001, ARCH ORAL BIOL, V46, P239, DOI 10.1016/S0003-9969(00)00113-8; JALILI IK, 1988, J MED GENET, V25, P738, DOI 10.1136/jmg.25.11.738; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Michaelides M, 2004, J MED GENET, V41, P468, DOI 10.1136/jmg.2003.015792; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; Rajpar MH, 2001, HUM MOL GENET, V10, P1673, DOI 10.1093/hmg/10.16.1673; ROBINSON C, 1984, ARCH ORAL BIOL, V29, P479, DOI 10.1016/0003-9969(84)90066-9; Shen Y, 2006, MOL NEUROBIOL, V34, P163, DOI 10.1385/MN:34:3:163; Shore RC, 2002, CONNECT TISSUE RES, V43, P466, DOI 10.1080/03008200290000871; Suda N, 2006, Orthod Craniofac Res, V9, P52, DOI 10.1111/j.1601-6343.2006.00337.x; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; Wang CY, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-7; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Zhang JA, 1997, VISUAL NEUROSCI, V14, P553, DOI 10.1017/S0952523800012219; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	37	107	110	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					266	273		10.1016/j.ajhg.2009.01.009	http://dx.doi.org/10.1016/j.ajhg.2009.01.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19200525	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000263799700016
J	Jakkula, E; Rehnstrom, K; Varilo, T; Pietilainen, OPH; Paunio, T; Pedersen, NL; Defaire, U; Jarvelin, MR; Saharinen, J; Freimer, N; Ripatti, S; Purcell, S; Collins, A; Daly, MJ; Palotie, A; Peltonen, L				Jakkula, Eveliina; Rehnstroem, Karola; Varilo, Teppo; Pietilaeinen, Olli P. H.; Paunio, Tiina; Pedersen, Nancy L.; deFaire, Ulf; Jaervelin, Marjo-Riitta; Saharinen, Juha; Freimer, Nelson; Ripatti, Samuli; Purcell, Shaun; Collins, Andrew; Daly, Mark J.; Palotie, Aarno; Peltonen, Leena			The Genome-wide Patterns of Variation Expose Significant Substructure in a Founder Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FINNISH-DISEASE HERITAGE; LINKAGE DISEQUILIBRIUM; ASSOCIATION; HOMOZYGOSITY; FINLAND; SCHIZOPHRENIA; INDIVIDUALS; HAPLOTYPE; REVEAL; LOCI	Although high-density SNP genotyping platforms generate a momentum for detailed genome-wide association (GWA) studies, an offshoot is a new insight into population genetics. Here, we present an example in one of the best-known founder populations by scrutinizing ten distinct Finnish early- and late-settlement subpopulations. By determining genetic distances, homozygosity, and patterns of linkage disequilibrium, we demonstrate that population substructure, and even individual ancestry, is detectable at a very high resolution and Supports the concept of multiple historical bottlenecks resulting from consecutive founder effects. Given that genetic studies are currently aiming at identifying smaller and smaller genetic effects, recognizing and controlling for population substructure even at this fine level becomes imperative to avoid confounding and spurious associations. This study provides an example of the power of GWA data sets to demonstrate stratification caused by population history even within a seemingly homogeneous population, like the Finns. Further, the results provide interesting lessons concerning the impact of population history on the genome landscape of humans, as well as approaches to identify rare variants enriched in these subpopulations.	[Jakkula, Eveliina; Rehnstroem, Karola; Varilo, Teppo; Pietilaeinen, Olli P. H.; Paunio, Tiina; Saharinen, Juha; Ripatti, Samuli; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Jakkula, Eveliina; Purcell, Shaun; Daly, Mark J.; Palotie, Aarno; Peltonen, Leena] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Jakkula, Eveliina; Purcell, Shaun; Daly, Mark J.; Palotie, Aarno; Peltonen, Leena] MIT, Cambridge, MA 02142 USA; [Rehnstroem, Karola; Varilo, Teppo; Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; [Paunio, Tiina] Univ Helsinki, Cent Hosp, Dept Psychiat, FIN-00290 Helsinki, Finland; [Pedersen, Nancy L.; Ripatti, Samuli] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [deFaire, Ulf] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden; [Jaervelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London SW7 2AZ, England; [Jaervelin, Marjo-Riitta] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, SF-90220 Oulu, Finland; [Freimer, Nelson] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Saharinen, Juha] Biomedicum, Genome Informat Unit, Helsinki 00290, Finland; [Freimer, Nelson] Univ Calif Los Angeles, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Freimer, Nelson] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; [Purcell, Shaun; Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Collins, Andrew] Univ Southampton, Human Genet Res Div, Southampton SO16 6YD, Hants, England; [Palotie, Aarno; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Jakkula, Eveliina; Palotie, Aarno] Univ Helsinki, Finnish Genome Ctr, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Dept Clin Chem, FIN-00290 Helsinki, Finland	Finland National Institute for Health & Welfare; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; Karolinska Institutet; Imperial College London; University of Oulu; University of California System; University of California Los Angeles; University of Helsinki; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; University of Southampton; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland.	leena.peltonen@ktl.fi	Daly, Mark J/B-2453-2017; Collins, Andrew/S-2196-2019; Ripatti, Samuli/H-9446-2014; Collins, Andrew/A-6595-2010	Daly, Mark J/0000-0002-0949-8752; Collins, Andrew/0000-0001-7108-0771; Ripatti, Samuli/0000-0002-0504-1202; Collins, Andrew/0000-0001-7108-0771; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Varilo, Teppo/0000-0002-5839-8854; Palotie, Aarno/0000-0002-2527-5874	National Institutes of Health [1R01HL087679-01]; STAMPEED, GenomEUtwin [QLG2-CT-2002-01254]; EU [LSHM-CT-2006-03 7761]; Nordic Centre of Excellence in Disease Genetics (NCoEDG); Center of Excellence in Complex Disease Genetics of the Academy of Finland; Helsinki University Finnish Genome Center; National Center for Research Resources [U54 RR020278]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STAMPEED, GenomEUtwin; EU(European Commission); Nordic Centre of Excellence in Disease Genetics (NCoEDG); Center of Excellence in Complex Disease Genetics of the Academy of Finland(Academy of Finland); Helsinki University Finnish Genome Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Murat Gunel and Richard Lifton for provision of control Helsinki genotypes prior to publication, and Arpo, Aromaa for access to the Health2000 samples. Jun Z. Li is gratefully acknowledged for providing tools for Fst analysis. The genotyping for this study has been financially supported by National Institutes of Health grant 1R01HL087679-01, STAMPEED, GenomEUtwin (QLG2-CT-2002-01254), EU grant LSHM-CT-2006-03 7761 (Project SGENE), the Nordic Centre of Excellence in Disease Genetics (NCoEDG), the Center of Excellence in Complex Disease Genetics of the Academy of Finland, and the Helsinki University Finnish Genome Center. The Swedish samples were collected with support from the Swedish Foundation for Strategic Research and the Swedish Research Council (M-2005-1112). The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources.	AROMAA A, 2004, BASELINE RESULTS HLT, pB12; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; JORDE LB, 1991, AM J PHYS ANTHROPOL, V84, P127, DOI 10.1002/ajpa.1330840203; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; Norio R, 2003, HUM GENET, V112, P470, DOI 10.1007/s00439-002-0877-1; Norio R, 2003, HUM GENET, V112, P457, DOI 10.1007/s00439-002-0876-2; Pastinen T, 2001, HUM MOL GENET, V10, P2961, DOI 10.1093/hmg/10.26.2961; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pedersen NL, 2002, TWIN RES, V5, P427, DOI 10.1375/twin.5.5.427; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Sumelahti ML, 2001, ACTA NEUROL SCAND, V103, P153, DOI 10.1034/j.1600-0404.2001.103003153.x; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Varilo T, 2003, HUM MOL GENET, V12, P51, DOI 10.1093/hmg/ddg005; VARILO T, 1999, AGE MUTATIONS FINNIS; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	34	107	107	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					787	794		10.1016/j.ajhg.2008.11.005	http://dx.doi.org/10.1016/j.ajhg.2008.11.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19061986	Green Published, Bronze			2022-12-18	WOS:000261822100014
J	Venugopal, B; Browning, MF; Curcio-Morelli, C; Varro, A; Michaud, N; Nanthakumar, N; Walkley, SU; Pickel, J; Slaugenhaupt, SA				Venugopal, Bhuvarahamurthy; Browning, Marsha F.; Curcio-Morelli, Cyntia; Varro, Andrea; Michaud, Norman; Nanthakumar, Nanda; Walkley, Steven U.; Pickel, James; Slaugenhaupt, Susan A.			Neurologic, gastric, and opthalmologic Pathologies in a murine model of Mucolipidosis type IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TARGETED DISRUPTION; LYSOSOMAL STORAGE; CATION CHANNEL; CULTURED FIBROBLASTS; ABNORMAL TRANSPORT; MEMBRANE-PROTEIN; ACID-SECRETION; MOUSE MODEL; GENE; DISEASE	Mucolipidosis type IV (MLIV) is an autosomal recessive lysosomal storage disorder caused by mutations in the MCOLN1 gene, which encodes the 65-kDa protein mucolipin-1. The most common clinical features of patients with MLIV include severe mental retardation, delayed motor milestones, ophthalmologic abnormalities, constitutive achlorhydria, and elevated plasma gastrin levels. Here, we describe the first murine model for MLIV, which accurately replicates the phenotype of patients with MLIV. The Mcoln1(-/-) mice present with numerous dense inclusion bodies in all cell types in brain and particularly in neurons, elevated plasma gastrin, vacuolization in parietal cells, and retinal degeneration. Neurobehavioral assessments, including analysis of gait and clasping, confirm the presence of a neurological defect. Gait deficits progress to complete hind-limb paralysis and death at age similar to 8 mo. The Mcoln1(-/-) mice are born in Mendelian ratios, and both male and female Mcoln1(-/-) mice are fertile and can breed to produce progeny. The creation of the first murine model for human MLIV provides an excellent system for elucidating disease pathogenesis. In addition, this model provides an invaluable resource for testing treatment strategies and potential therapies aimed at preventing or ameliorating the abnormal lysosomal storage in this devastating neurological disorder.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dev Gastroenterol Lab, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Univ Liverpool, Sch Biomed Sci, Physiol Labs, Liverpool L69 3BX, Merseyside, England; Albert Einstein Coll Med, Rose F Kennedy Ctr, Dominck P Purpura Dept Neurosci, Bronx, NY 10467 USA; Natl Inst Mental Hlth Transgen Core, NIH, Bethesda, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Liverpool; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Slaugenhaupt, SA (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	susan_slaugenhaupt@chgr.mgh.harvard.edu	Varro, Andras/M-2647-2016		NICHD NIH HHS [R01 HD045561, HD045561] Funding Source: Medline; NIDDK NIH HHS [DK70260, R01 DK070260, DK57521, DK40561, P30 DK040561, P30 DK043351, P30 DK057521, DK12437, DK43351] Funding Source: Medline; NIGMS NIH HHS [T32-GM077481-25] Funding Source: Medline; NINDS NIH HHS [1F32NS052072-01A1, NS39995, R01 NS039995, F32 NS052072] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, P30DK057521, R01DK070260, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002901, Z01MH002901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS052072, R01NS039995] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; BACH G, 1975, BIOCHEM BIOPH RES CO, V66, P1483, DOI 10.1016/0006-291X(75)90526-4; Bach Gideon, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9385; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; BARGAL R, 1988, J INHERIT METAB DIS, V11, P144, DOI 10.1007/BF01799863; Bargal R, 1997, J INHERIT METAB DIS, V20, P625, DOI 10.1023/A:1005362123443; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Berges BK, 2006, MOL THER, V13, P859, DOI 10.1016/j.ymthe.2005.12.017; BERMAN ER, 1974, J PEDIATR-US, V84, P519, DOI 10.1016/S0022-3476(74)80671-2; CAIMI L, 1982, J INHERIT METAB DIS, V5, P218; Cantiello HF, 2005, PFLUG ARCH EUR J PHY, V451, P304, DOI 10.1007/s00424-005-1448-9; Cardone M, 2006, HUM MOL GENET, V15, P1225, DOI 10.1093/hmg/ddl038; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; CRANDALL BF, 1982, AM J MED GENET, V12, P301, DOI 10.1002/ajmg.1320120308; Dobrovolny R, 2007, AM J OPHTHALMOL, V143, P663, DOI 10.1016/j.ajo.2006.11.049; DOCKRAY GJ, 1991, GASTROENTEROLOGY, V100, P1187; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Edelmann L, 2002, AM J HUM GENET, V70, P1023, DOI 10.1086/339519; Evers M, 1996, P NATL ACAD SCI USA, V93, P8214, DOI 10.1073/pnas.93.16.8214; Falardeau JL, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-3; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; FOLKERTH RD, 1995, J NEUROPATH EXP NEUR, V54, P154, DOI 10.1097/00005072-199503000-00002; GOLDIN E, 1995, PEDIATR RES, V37, P687, DOI 10.1203/00006450-199506000-00003; Goldin E, 2004, HUM MUTAT, V24, P460, DOI 10.1002/humu.20094; Grabowski Gregory A, 2006, Expert Opin Drug Deliv, V3, P771, DOI 10.1517/17425247.3.6.771; HANN CN, 1997, HUM MOL GENET, V6, P205; Hemsley KM, 2007, MOL GENET METAB, V90, P313, DOI 10.1016/j.ymgme.2006.10.005; Itoh M, 2001, BRAIN DEV-JPN, V23, P379, DOI 10.1016/S0387-7604(01)00244-3; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Kaye Edward M., 1995, Current Opinion in Pediatrics, V7, P650; Kenyon K R, 1976, Birth Defects Orig Artic Ser, V12, P133; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kiselyov K, 2007, J PHYSIOL-LONDON, V578, P641, DOI 10.1113/jphysiol.2006.119024; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; LIVNI N, 1978, ARCH PATHOL LAB MED, V102, P600; Malatack JJ, 2003, PEDIATR NEUROL, V29, P391, DOI 10.1016/j.pediatrneurol.2003.09.003; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Miedel MT, 2006, J BIOL CHEM, V281, P12751, DOI 10.1074/jbc.M511104200; Mollard RJ, 1996, CORNEA, V15, P25; Nagy A., 2003, MANIPULATING MOUSE E; NEWELL FW, 1975, AM J OPHTHALMOL, V80, P440, DOI 10.1016/0002-9394(75)90532-2; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pastores Gregory M, 2005, Expert Opin Emerg Drugs, V10, P891, DOI 10.1517/14728214.10.4.891; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; RIEDEL KG, 1985, AM J OPHTHALMOL, V99, P125, DOI 10.1016/0002-9394(85)90220-X; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Samuelson LC, 2003, ANNU REV PHYSIOL, V65, P383, DOI 10.1146/annurev.physiol.65.092101.142213; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Schaheen L, 2006, DEV BIOL, V293, P382, DOI 10.1016/j.ydbio.2006.02.008; Schiffmann R, 1998, P NATL ACAD SCI USA, V95, P1207, DOI 10.1073/pnas.95.3.1207; Schwartz M F, 1985, Cornea, V4, P58; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; Slaugenhaupt Susan A., 2002, Current Molecular Medicine (Hilversum), V2, P445, DOI 10.2174/1566524023362276; Smith JA, 2002, OPHTHALMOLOGY, V109, P588, DOI 10.1016/S0161-6420(01)00968-X; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Strauch OF, 2003, PEDIATR RES, V54, P701, DOI 10.1203/01.PDR.0000084085.65972.3F; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; TELLEZNAGEL I, 1976, ARCH NEUROL-CHICAGO, V33, P828, DOI 10.1001/archneur.1976.00500120032005; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Walkley SU, 2007, ACTA PAEDIATR, V96, P26, DOI 10.1111/j.1651-2227.2007.00202.x; WALKLEY SU, 1995, AM J MED GENET, V57, P196, DOI 10.1002/ajmg.1320570218; Wang ZH, 2001, GENET TEST, V5, P87, DOI 10.1089/109065701753145529; Wisniewski K E, 1988, Am J Med Genet Suppl, V5, P27; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Young RD, 2005, INVEST OPHTH VIS SCI, V46, P1973, DOI 10.1167/iovs.04-1309; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7	73	107	109	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1070	1083		10.1086/521954	http://dx.doi.org/10.1086/521954			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924347	Green Published, Bronze			2022-12-18	WOS:000250480900017
J	Mueller, JC; Lohmussaar, E; Magi, R; Remm, M; Bettecken, T; Lichtner, P; Biskup, S; Illig, T; Pfeufer, A; Luedemann, J; Schreiber, S; Pramstaller, P; Pichler, I; Romeo, G; Gaddi, A; Testa, A; Wichmann, HE; Metspalu, A; Meitinger, T				Mueller, JC; Lohmussaar, E; Magi, R; Remm, M; Bettecken, T; Lichtner, P; Biskup, S; Illig, T; Pfeufer, A; Luedemann, J; Schreiber, S; Pramstaller, P; Pichler, I; Romeo, G; Gaddi, A; Testa, A; Wichmann, HE; Metspalu, A; Meitinger, T			Linkage disequilibrium patterns and tagSNP transferability among European populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; HAPLOTYPE BLOCKS; HUMAN GENOME; ASSOCIATION; BOUNDARIES; DENSITY; GENE	The pattern of linkage disequilibrium (LD) is critical for association studies, in which disease-causing variants are identified by allelic association with adjacent markers. The aim of this study is to compare the LD patterns in several distinct European populations. We analyzed four genomic regions (in total, 749 kb) containing candidate genes for complex traits. Individuals were genotyped for markers that are evenly distributed at an average spacing of similar to 2 - 4 kb in eight population-based samples from ongoing epidemiological studies across Europe. The Centre d'Etude du Polymorphisme Humain (CEPH) trios of the HapMap project were included and were used as a reference population. In general, we observed a conservation of the LD patterns across European samples. Nevertheless, shifts in the positions of the boundaries of high-LD regions can be demonstrated between populations, when assessed by a novel procedure based on bootstrapping. Transferability of LD information among populations was also tested. In two of the analyzed gene regions, sets of tagging single-nucleotide polymorphisms (tagSNPs) selected from the HapMap CEPH trios performed surprisingly well in all local European samples. However, significant variation in the other two gene regions predicts a restricted applicability of CEPH-derived tagging markers. Simulations based on our data set show the extent to which further gain in tagSNP efficiency and transferability can be achieved by increased SNP density.	GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; CNR, CNR IBIM, Inst Biomed Clin Epidemiol & Physiopathol Renal D, Reggio Di Calabria, Italy; Univ Bologna, Dept Clin Med, Ctr Artherosclerosi Giancarlo Descovich, Bologna, Italy; Univ Bologna, Dept Med Genet, Bologna, Italy; European Acad, Dept Med Genet, Bolzano, Italy; Univ Kiel, Univ Clin Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; Tech Univ Munich, Inst Human Genet, D-8000 Munich, Germany; Univ Tartu, Estonian Bioctr, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Bologna; University of Bologna; European Academy of Bozen-Bolzano; University of Kiel; Schleswig Holstein University Hospital; Ernst Moritz Arndt Universitat Greifswald; Technical University of Munich; Estonian Biocentre; University of Tartu	Meitinger, T (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	meitinger@gsf.de	Testa, Alessandra/AAW-8619-2020; Org, Elin/AAJ-9631-2021; Pfeufer, Arne/B-6634-2013; Wichmann, Heinz Erich/AAA-5695-2022; Remm, Maido/L-9072-2019; Mägi, Reedik/AAJ-9679-2021; Meitinger, Thomas/O-1318-2015; Pramstaller, Peter P/C-2357-2008	Testa, Alessandra/0000-0002-0529-6571; Remm, Maido/0000-0003-3966-8422; Meitinger, Thomas/0000-0002-8838-8403; Magi, Reedik/0000-0002-2964-6011; Pichler, Irene/0000-0001-8251-0757; Org, Elin/0000-0001-8688-9717				BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Lao O, 2003, EUR J HUM GENET, V11, P385, DOI 10.1038/sj.ejhg.5200970; Mannila H, 2003, AM J HUM GENET, V73, P86, DOI 10.1086/376438; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Ng MCY, 2004, GENOMICS, V83, P559, DOI 10.1016/j.ygeno.2003.09.008; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schwartz R, 2003, J COMPUT BIOL, V10, P13, DOI 10.1089/106652703763255642; Stenzel A, 2004, HUM GENET, V114, P377, DOI 10.1007/s00439-003-1075-5; Thompson D, 2003, HUM HERED, V56, P48, DOI 10.1159/000073732; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wang WYS, 2003, HUM MOL GENET, V12, P3145, DOI 10.1093/hmg/ddg337; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	25	107	110	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					387	398		10.1086/427925	http://dx.doi.org/10.1086/427925			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15637659	Green Published, Bronze			2022-12-18	WOS:000226851900002
J	Morar, B; Gresham, D; Angelicheva, D; Tournev, I; Gooding, R; Guergueltcheva, V; Schmidt, C; Abicht, A; Lochmuller, H; Tordai, A; Kalmar, L; Nagy, M; Karcagi, V; Jeanpierre, M; Herczegfalvi, A; Beeson, D; Venkataraman, V; Carter, KW; Reeve, J; de Pablo, R; Kucinskas, V; Kalaydjieva, L				Morar, B; Gresham, D; Angelicheva, D; Tournev, I; Gooding, R; Guergueltcheva, V; Schmidt, C; Abicht, A; Lochmuller, H; Tordai, A; Kalmar, L; Nagy, M; Karcagi, V; Jeanpierre, M; Herczegfalvi, A; Beeson, D; Venkataraman, V; Carter, KW; Reeve, J; de Pablo, R; Kucinskas, V; Kalaydjieva, L			Mutation history of the Roma/Gypsies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSMORPHISM NEUROPATHY SYNDROME; MAXIMUM-LIKELIHOOD-ESTIMATION; FINNISH-DISEASE HERITAGE; LINKAGE DISEQUILIBRIUM; ISOLATED POPULATIONS; SENSORY NEUROPATHY; HEREDITARY MOTOR; DEMYELINATING NEUROPATHY; GALACTOKINASE DEFICIENCY; DIASTROPHIC DYSPLASIA	The 8-10 million European Roma/Gypsies are a founder population of common origins that has subsequently split into multiple socially divergent and geographically dispersed Gypsy groups. Unlike other founder populations, whose genealogy has been extensively documented, the demographic history of the Gypsies is not fully understood and, given the lack of written records, has to be inferred from current genetic data. In this study, we have used five disease loci harboring private Gypsy mutations to examine some missing historical parameters and current structure. We analyzed the frequency distribution of the five mutations in 832-1,363 unrelated controls, representing 14 Gypsy populations, and the diversification of chromosomal haplotypes in 501 members of affected families. Sharing of mutations and high carrier rates supported a strong founder effect, and the identity of the congenital myasthenia 1267delG mutation in Gypsy and Indian/Pakistani chromosomes provided the best evidence yet of the Indian origins of the Gypsies. However, dramatic differences in mutation frequencies and haplotype divergence and very limited haplotype sharing pointed to strong internal differentiation and characterized the Gypsies as a founder population comprising multiple subisolates. Using disease haplotype coalescence times at the different loci, we estimated that the entire Gypsy population was founded similar to32-40 generations ago, with secondary and tertiary founder events occurring similar to16-25 generations ago. The existence of multiple subisolates, with endogamy maintained to the present day, suggests a general approach to complex disorders in which initial gene mapping could be performed in large families from a single Gypsy group, whereas fine mapping would rely on the informed sampling of the divergent subisolates and searching for the shared genomic region that displays the strongest linkage disequilibrium with the disease.	Univ Western Australia, Western Australian Inst Med Res, QEII Med Ctr, Genet Mol Lab, Perth, WA 6008, Australia; Univ Western Australia, Western Australian Inst Med Res, Lab Genet Epidemiol, Perth, WA 6008, Australia; Univ Western Australia, UWA Ctr Med Res, Perth, WA 6009, Australia; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Med Univ, Dept Neurol, Sofia, Bulgaria; Univ Munich, Friedrich Baur Inst, Dept Neurol, Munich, Germany; Univ Munich, Gene Ctr, Munich, Germany; Bethesda Childrens Hosp, Natl Med Ctr, Genet Mol Lab, Inst Hematol & Immunol, Budapest, Hungary; Bethesda Childrens Hosp, Natl Ctr Publ Hlth, Natl Inst Environm Hlth, Dept Mol Genet & Diagnost, Budapest, Hungary; Bethesda Childrens Hosp, Dept Pediat Neurol, Budapest, Hungary; Univ Presov, Fac Humanities & Nat Sci, Dept Biol 2, Presov, Slovakia; Grp Hosp Cochin, Lab Biochim & Genet Mol, Paris, France; John Radcliffe Hosp, Weatherall Inst Mol Med, Neurosci Grp, Oxford OX3 9DU, England; Kanchi Kamakoti Childs Trust Hosp, Madras, Tamil Nadu, India; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2M7, Canada; Clin Puerta de Hierro, Unidad Immunol, Madrid, Spain; Vilnius State Univ, Fac Med, Dept Human & Med Genet, Vilnius, Lithuania	University of Western Australia; University of Western Australia; University of Western Australia; Princeton University; Medical University Sofia; University of Munich; University of Munich; University of Presov; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; University of Alberta; Clinica Veterinaria Puerta de Hierro; Hospital Puerta de Hierro-Majadahonda; Vilnius University	Kalaydjieva, L (corresponding author), Univ Western Australia, Western Australian Inst Med Res, QEII Med Ctr, Genet Mol Lab, Perth, WA 6008, Australia.	luba@cyllene.uwa.edu.au	de Pablo, Rosario/L-1853-2014; Kalmar, Lajos/C-3040-2014; Morar, Bharti/O-8697-2014; Kalmar, Lajos/A-3219-2009; KUČINSKAS, Vaidutis/A-4798-2013; Nagy, Melinda/A-5702-2010	Kalmar, Lajos/0000-0003-3691-8350; Morar, Bharti/0000-0003-3897-1403; Nagy, Melinda/0000-0001-7127-3055; Lochmuller, Hanns/0000-0003-2324-8001	Medical Research Council [G117/490] Funding Source: Medline; NIGMS NIH HHS [R01 GM107466] Funding Source: Medline; MRC [G117/490] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Abicht A, 1999, NEUROLOGY, V53, P1564, DOI 10.1212/WNL.53.7.1564; Agarwala R, 1999, AM J MED GENET, V86, P156, DOI 10.1002/(SICI)1096-8628(19990910)86:2<156::AID-AJMG13>3.0.CO;2-5; Angelicheva D, 1999, EUR J HUM GENET, V7, P560, DOI 10.1038/sj.ejhg.5200319; Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; [Anonymous], 1993, DISPAN GENETIC DISTA; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Chaix R, 2004, EUR J HUM GENET, V12, P285, DOI 10.1038/sj.ejhg.5201126; Chandler D, 2000, NEUROMUSCULAR DISORD, V10, P584, DOI 10.1016/S0960-8966(00)00148-6; Croxen R, 1999, ANN NEUROL, V46, P639, DOI 10.1002/1531-8249(199910)46:4<639::AID-ANA13>3.0.CO;2-1; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Fraser A., 1992, GYPSIES; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HANCOCK I, 1999, 5 INT ROM ARCH, P675; HANCOCK I, 1987, PARIAH SYNDROME; Hancock Ian, 2000, SCHOLARSHIP GYPSY ST, P1; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Heutink P, 2002, HUM MOL GENET, V11, P2507, DOI 10.1093/hmg/11.20.2507; Hunter M, 2002, PEDIATR RES, V51, P602, DOI 10.1203/00006450-200205000-00010; Kalaydjieva L, 2000, AM J HUM GENET, V67, P47, DOI 10.1086/302978; Kalaydjieva L, 1999, AM J HUM GENET, V65, P1299, DOI 10.1086/302611; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Kalaydjieva L, 1998, BRAIN, V121, P399, DOI 10.1093/brain/121.3.399; Kalaydjieva L, 2001, EUR J HUM GENET, V9, P97, DOI 10.1038/sj.ejhg.5200597; Kalaydjieva L, 2003, NATURE ENCY HUMAN GE, P160; KALAYDJIEVA L, 2001, ACTA MYOLOGICA, V20, P192; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kuhner MK, 1998, GENETICS, V149, P429; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; Liegeois Jean Pierre, 1994, ROMA GYPSIES TRAVELL; Marushiakova E, 1997, STUDIEN TSIGANOLOGIE, P15; Merlini L, 2000, NEUROLOGY, V54, P1075, DOI 10.1212/WNL.54.5.1075; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; Nei M., 1987, MOL EVOLUTIONARY GEN; Norio R, 2003, HUM GENET, V112, P457, DOI 10.1007/s00439-002-0876-2; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Pastinen T, 2001, HUM MOL GENET, V10, P2961, DOI 10.1093/hmg/10.26.2961; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Petulengro G, 1915, J GYPSY LORE SOC, V9, P1; Piccolo F, 1996, HUM MOL GENET, V5, P2019, DOI 10.1093/hmg/5.12.2019; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Risch N, 2003, AM J HUM GENET, V72, P812, DOI 10.1086/373882; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Roessli D, 2000, ARLEQUIN VERSION 2 0; Rogers T, 2000, AM J HUM GENET, V67, P664, DOI 10.1086/303053; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMPSON J, 1927, J GYPSY LORE SOC, V6, P57; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Sheffield VC, 1998, TRENDS GENET, V14, P391, DOI 10.1016/S0168-9525(98)01556-X; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Tournev I, 1999, ANN NEUROL, V45, P742; TURNER RL, 1926, J GYPSY LORE SOC, V5, P145; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243; Wilson IJ, 1998, GENETICS, V150, P499; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	64	107	111	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					596	609		10.1086/424759	http://dx.doi.org/10.1086/424759			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15322984	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000223634100006
J	Marie, S; Heron, B; Bitoun, P; Timmerman, T; Van den Berghe, G; Vincent, MF				Marie, S; Heron, B; Bitoun, P; Timmerman, T; Van den Berghe, G; Vincent, MF			AICA-ribosiduria: A novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ISOLATED RAT HEPATOCYTES; ACTIVATED PROTEIN-KINASE; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; INHIBITION; AMINOIMIDAZOLECARBOXAMIDE; CYCLOHYDROLASE; STIMULATION; MUSCLE	In a female infant with dysmorphic features, severe neurological defects, and congenital blindness, a positive urinary Bratton-Marshall test led to identification of a massive excretion of 5-amino-4- imidazolecarboxamide (AICA) riboside, the dephosphorylated counterpart of AICAR (also termed "ZMP"), an intermediate of de novo purine biosynthesis. ZMP and its di- and triphosphate accumulated in the patient's erythrocytes. Incubation of her fibroblasts with AICA-riboside led to accumulation of AICAR, not observed in control cells, suggesting impairment of the final steps of purine biosynthesis, catalyzed by the bifunctional enzyme AICAR transformylase/IMP cyclohydrolase (ATIC). AICAR transformylase was profoundly deficient, whereas the IMP cyclohydrolase level was 40% of normal. Sequencing of ATIC showed a K426R change in the transformylase region in one allele and a frameshift in the other. Recombinant protein carrying mutation K426R completely lacks AICAR transformylase activity.	Catholic Univ Louvain, Physiol Chem Lab, Christian De Duve Inst Cellular Pathol, B-3000 Louvain, Belgium; Catholic Univ Louvain, Clin Univ St Luc, B-3000 Louvain, Belgium; Hop St Vincent de Paul, Dept Pediat Neurol, F-75674 Paris, France; Hop Jean Verdier, Dept Pediat, Bondy, France; Hop Jean Verdier, Dept Med Genet, Bondy, France	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP	Vincent, MF (corresponding author), ICP UCL 7539, Grp Rech Metab, Ave Hippocrate 75, B-1200 Brussels, Belgium.	vincent@bchm.ucl.ac.be		Bitoun, Pierre/0000-0001-6557-6826				Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; Greasley SE, 2001, NAT STRUCT BIOL, V8, P402, DOI 10.1038/87555; GRUBER HE, 1989, CIRCULATION, V80, P1400, DOI 10.1161/01.CIR.80.5.1400; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Henin N, 1996, BBA-GEN SUBJECTS, V1290, P197, DOI 10.1016/0304-4165(96)00021-9; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; JAEKEN J, 1984, LANCET, V2, P1058; LAIKIND PK, 1986, ANAL BIOCHEM, V156, P81, DOI 10.1016/0003-2697(86)90158-2; LULENSKI G, 1970, PEDIATRICS, V45, P983; Marie S, 2000, PRENATAL DIAG, V20, P33, DOI 10.1002/(SICI)1097-0223(200001)20:1<33::AID-PD751>3.0.CO;2-3; MIDDLETON JE, 1964, LANCET, V284, P258; NEWCOMBE DS, 1970, PEDIATRICS, V46, P508; Rayl EA, 1996, J BIOL CHEM, V271, P2225, DOI 10.1074/jbc.271.4.2225; SABINA RL, 1982, J BIOL CHEM, V257, P178; SABINA RL, 1984, SCIENCE, V223, P1193, DOI 10.1126/science.6199843; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; SWEETMAN L, 1971, BIOCHEM MEDICA, V4, P121; VANDENBERGHE G, 2001, METABOLIC MOL BASES, P2653; Vincent MF, 1996, DIABETOLOGIA, V39, P1148, DOI 10.1007/BF02658500; VINCENT MF, 1991, DIABETES, V40, P1259, DOI 10.2337/diabetes.40.10.1259; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; Vincent MF, 1996, BIOCHEM PHARMACOL, V52, P999, DOI 10.1016/0006-2952(96)00413-3; VINCENT MF, 1997, THESIS U CATHOLIQUE	23	107	110	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1276	1281		10.1086/421475	http://dx.doi.org/10.1086/421475			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15114530	Green Published, Bronze			2022-12-18	WOS:000221651900021
J	Joutel, A; Monet, M; Domenga, V; Riant, F; Tournier-Lasserve, E				Joutel, A; Monet, M; Domenga, V; Riant, F; Tournier-Lasserve, E			Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling pathway	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CADASIL PATIENTS; RECEPTOR; LIGAND; STROKE; DROSOPHILA; SPECTRUM; SERRATE; DELTA; ONSET	Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited vascular dementia characterized by the degeneration of smooth-muscle cells in small cerebral arteries. CADASIL is caused by mutations in NOTCH3, one of the four mammalian homologs to the Drosophila melanogaster NOTCH gene. Disease-associated mutations are distributed throughout the 34 epidermal growth factor like repeats (EGFRs) that compose the extracellular domain of the Notch3 receptor and result in a loss or a gain of a cysteine residue in one of these EGFRs. In human adults, Notch3 expression is highly restricted to vascular smooth-muscle cells. In patients with CADASIL, there is an abnormal accumulation of Notch3 in the vessel. Molecular pathways linking NOTCH3 mutations to degeneration of vascular smooth-muscle cells are as yet poorly understood. In this study, we investigated the effect of CADASIL mutations on Notch3 activity. We studied five naturally occurring mutations: R90C and C212S, located in the previously identified mutational hotspot EGFR2-5; C428S, shown in this study to be located in the ligand-binding domain EGFR10-11; and C542Y and R1006C, located in EGFR13 and EGFR26, respectively. All five mutant proteins were correctly processed. The C428S and C542Y mutant receptors exhibited a significant reduction in Jagged1-induced transcriptional activity of a RBP/JK responsive luciferase reporter, relative to wild-type Notch3. Impaired signaling activity of these two mutants arose through different mechanisms; the C428S mutant lost its Jagged1-binding ability, whereas C542Y retained it but exhibited an impaired presentation to the cell surface. In contrast, the R90C, C212S, and R1006C mutants retained the ability to bind Jagged1 and were associated with apparently normal levels of signaling activity. We conclude that mutations in Notch3 differently affect Jagged1 binding and Notch3 signaling via the RBP/JK pathway.	Fac Med Lariboisiere, INSERM, E365, F-75010 Paris, France; Hop Lariboisiere, Lab Cytogenet, F-75475 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Joutel, A (corresponding author), Fac Med Lariboisiere, INSERM, E365, 10 Ave Verdun, F-75010 Paris, France.	joutel@paris7.jussieu.fr	Tournier-Lasserve, Elisabeth/N-7134-2017; Joutel, Anne/K-5601-2017	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; Joutel, Anne/0000-0003-3963-3860				Arboleda-Velasquez JF, 2002, NEUROLOGY, V59, P277, DOI 10.1212/WNL.59.2.277; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122; Brennan K, 1999, DEV BIOL, V216, P230, DOI 10.1006/dbio.1999.9501; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dichgans M, 2000, EUR J HUM GENET, V8, P280, DOI 10.1038/sj.ejhg.5200460; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Fortini ME, 2001, CURR OPIN CELL BIOL, V13, P627, DOI 10.1016/S0955-0674(00)00261-1; Haritunians T, 2002, CIRC RES, V90, P506, DOI 10.1161/01.RES.0000013796.73742.C8; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Joutel A, 2000, NEUROLOGY, V54, P1874, DOI 10.1212/WNL.54.9.1874; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 2001, LANCET, V358, P2049, DOI 10.1016/S0140-6736(01)07142-2; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Lawrence N, 2000, DEVELOPMENT, V127, P3185; Li YX, 2003, DEVELOPMENT, V130, P2829, DOI 10.1242/dev.00498; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Oberstein SAJL, 1999, NEUROLOGY, V52, P1913, DOI 10.1212/WNL.52.9.1913; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500; Ruchoux MM, 2003, AM J PATHOL, V162, P329, DOI 10.1016/S0002-9440(10)63824-2; Shawber C, 1996, DEVELOPMENT, V122, P3765; Spinner NB, 2000, J CLIN INVEST, V105, P561, DOI 10.1172/JCI9511; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Tuominen S, 2001, STROKE, V32, P1767, DOI 10.1161/01.STR.32.8.1767; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5	33	107	115	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					338	347		10.1086/381506	http://dx.doi.org/10.1086/381506			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14714274	Bronze, Green Published			2022-12-18	WOS:000188860000014
J	Li, JL; Hayden, MR; Almqvist, EW; Brinkman, RR; Durr, A; Dode, C; Morrison, PJ; Suchowersky, O; Ross, CA; Margolis, RL; Rosenblatt, A; Gomez-Tortosa, E; Cabrero, DM; Novelletto, A; Frontali, M; Nance, M; Trent, RJA; McCusker, E; Jones, R; Paulsen, JS; Harrison, M; Zanko, A; Abramson, RK; Russ, AL; Knowlton, B; Djousse, L; Mysore, JS; Tariot, S; Gusella, MF; Wheeler, VC; Atwood, LD; Cupples, LA; Saint-Hilaire, M; Cha, JHJ; Hersch, SM; Koroshetz, WJ; Gusella, JF; MacDonald, ME; Myers, RH				Li, JL; Hayden, MR; Almqvist, EW; Brinkman, RR; Durr, A; Dode, C; Morrison, PJ; Suchowersky, O; Ross, CA; Margolis, RL; Rosenblatt, A; Gomez-Tortosa, E; Cabrero, DM; Novelletto, A; Frontali, M; Nance, M; Trent, RJA; McCusker, E; Jones, R; Paulsen, JS; Harrison, M; Zanko, A; Abramson, RK; Russ, AL; Knowlton, B; Djousse, L; Mysore, JS; Tariot, S; Gusella, MF; Wheeler, VC; Atwood, LD; Cupples, LA; Saint-Hilaire, M; Cha, JHJ; Hersch, SM; Koroshetz, WJ; Gusella, JF; MacDonald, ME; Myers, RH			A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRINUCLEOTIDE REPEAT; LINKAGE ANALYSIS; OF-ONSET; GENE; INSTABILITY; NUCLEUS; LENGTH	Huntington disease (HD) is caused by the expansion of a CAG repeat within the coding region of a novel gene on 4p16.3. Although the variation in age at onset is partly explained by the size of the expanded repeat, the unexplained variation in age at onset is strongly heritable (h(2) = 0.56), which suggests that other genes modify the age at onset of HD. To identify these modifier loci, we performed a 10-cM density genomewide scan in 629 affected sibling pairs ( 295 pedigrees and 695 individuals), using ages at onset adjusted for the expanded and normal CAG repeat sizes. Because all those studied were HD affected, estimates of allele sharing identical by descent at and around the HD locus were adjusted by a positionally weighted method to correct for the increased allele sharing at 4p. Suggestive evidence for linkage was found at 4p16 (LOD = 1.93), 6p21 - 23 (LOD = 2.29), and 6q24 - 26(LOD = 2.28),which may be useful for investigation of genes that modify age at onset of HD.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Evans Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; Boston Univ, Sch Publ Hlth, Bioinformat Program, Boston, MA USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Mol Neurogenet Unit, Boston, MA USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Wyeth Res, Dept Genom, Cambridge, MA USA; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; Hop La Pitie Salpetriere, INSERM, U289, Paris, France; Hop Cochin, Serv Biochim & Genet Mol, F-75674 Paris, France; Belfast City Hosp, Dept Med Genet, Belfast BT9 7AD, Antrim, North Ireland; Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; Univ Calgary, Dept Med Genet, Calgary, AB, Canada; Johns Hopkins Univ, Dept Psychiat, Baltimore, MD USA; Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA; Johns Hopkins Univ, Program Cellular & Mol Med, Baltimore, MD USA; Fdn Jimenez Diaz, Serv Neurol & Genet, E-28040 Madrid, Spain; Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; CNR, Inst Neurobiol & Mol Med, Rome, Italy; Hennepin Cty Med Ctr, Dept Neurol, Minneapolis, MN 55415 USA; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Westmead Hosp, Dept Neurol, Sydney, NSW, Australia; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Virginia, Hlth Sci Ctr, Charlottesville, VA USA; Univ Calif San Francisco, Div Med Genet, San Francisco, CA 94143 USA; William S Hall Psychiat Inst, Columbia, SC USA	Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pfizer; University of British Columbia; University of British Columbia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Belfast City Hospital; Ulster University; University of Calgary; University of Calgary; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Calabria; Consiglio Nazionale delle Ricerche (CNR); Hennepin County Medical Center; University of Sydney; University of Sydney; Emory University; University of Iowa; University of Virginia; University of California System; University of California San Francisco	Myers, RH (corresponding author), Boston Univ, Sch Med, Dept Neurol, 715 Albany St,E-304, Boston, MA 02118 USA.		Paulsen, Jane/AAQ-2932-2020; Li, Jian-Liang/AAE-9315-2019; Ross, Christopher A/H-8395-2013; Li, J L/E-6100-2018; Djousse, Luc/F-5033-2017; Brinkman, Ryan/B-1108-2008; Hayden, Michael R/D-8581-2011	Li, Jian-Liang/0000-0002-6487-081X; Li, J L/0000-0002-6487-081X; Djousse, Luc/0000-0002-9902-3047; Brinkman, Ryan/0000-0002-9765-2990; Hayden, Michael R/0000-0001-5159-1419; Saint-Hilaire, Marie-Helene/0000-0002-2355-5979; Paulsen, Jane/0000-0002-0983-228X; Myers, Richard/0000-0002-8365-2674; Cupples, L. Adrienne/0000-0003-0273-7965; Novelletto, Andrea/0000-0002-1146-7680	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367] Funding Source: NIH RePORTER; NINDS NIH HHS [P50NS016367, P50 NS016367] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FARRER LA, 1993, AM J HUM GENET, V53, P125; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; Huntington G., 1872, MED SURG REP, V26, P320; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MacDonald ME, 1999, NEUROLOGY, V53, P1330, DOI 10.1212/WNL.53.6.1330; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Naze P, 2002, NEUROSCI LETT, V328, P1, DOI 10.1016/S0304-3940(02)00231-8; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; RANEN NG, 1995, AM J HUM GENET, V57, P593; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; White RF, 1992, CLIN SYNDROMES ADULT, P213	21	107	111	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					682	687		10.1086/378133	http://dx.doi.org/10.1086/378133			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12900792	Green Published, Bronze			2022-12-18	WOS:000185134000023
J	Pankratz, N; Nichols, WC; Uniacke, SK; Halter, C; Rudolph, A; Shults, C; Conneally, PM; Foroud, T				Pankratz, N; Nichols, WC; Uniacke, SK; Halter, C; Rudolph, A; Shults, C; Conneally, PM; Foroud, T		Parkinson Study Grp	Significant linkage of Parkinson disease to chromosome 2q36-37	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLINICAL-DIAGNOSIS; PAIR ANALYSIS; LOD SCORES; ONSET; GENOME; MUTATIONS; ACCURACY; PROGRAM; LOCUS; GENE	Parkinson disease (PD) is the second most common neurodegenerative disorder, surpassed in frequency only by Alzheimer disease. Elsewhere we have reported linkage to chromosome 2q in a sample of sibling pairs with PD. We have now expanded our sample to include 150 families meeting our strictest diagnostic definition of verified PD. To further delineate the chromosome 2q linkage, we have performed analyses using only those pedigrees with the strongest family history of PD. Linkage analyses in this subset of 65 pedigrees generated a LOD score of 5.1, which was obtained using an autosomal dominant model of disease transmission. This result strongly suggests that variation in a gene on chromosome 2q36-37 contributes to PD susceptibility.	Indiana Univ, Med Ctr, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; Univ Rochester, Dept Neurol, Rochester, NY USA; Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; VA San Diego Healthcare Syst, San Diego, CA USA	Indiana University System; Indiana University-Purdue University Indianapolis; Cincinnati Children's Hospital Medical Center; University of Rochester; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Foroud, T (corresponding author), Indiana Univ, Med Ctr, Dept Med & Mol Genet, IB 130,975 W Walnut St, Indianapolis, IN 46202 USA.		; Sanchez-Ramos, Juan/A-1188-2009; Tuite, Paul/P-3164-2014	Pankratz, Nathan/0000-0001-5958-693X; Sanchez-Ramos, Juan/0000-0002-3391-7857; Tuite, Paul/0000-0003-1413-7924; Afifa, Sayyidah/0000-0002-1151-9583; Marek, Kenneth/0000-0002-4197-5627; Kang, Un/0000-0002-5970-6839; Walker, Francis/0000-0002-7817-9421; Gordon, Paul/0000-0001-5714-9875; Martin, WR Wayne/0000-0002-3416-691X; Camicioli, Richard/0000-0003-2977-8660	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037167] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS37167, R01 NS037167] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; DeStefano AL, 2002, AM J HUM GENET, V70, P1089, DOI 10.1086/339814; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gwinn-Hardy K, 2002, MOVEMENT DISORD, V17, P645, DOI 10.1002/mds.10173; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Nichols WC, 2002, J MED GENET, V39, P489, DOI 10.1136/jmg.39.7.489; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oliveri RL, 2001, NEUROLOGY, V57, P359, DOI 10.1212/WNL.57.2.359; Pankratz N, 2002, AM J HUM GENET, V71, P124, DOI 10.1086/341282	21	107	111	1	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1053	1057		10.1086/374383	http://dx.doi.org/10.1086/374383			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12638082	Bronze, Green Published			2022-12-18	WOS:000181972600028
J	Okamoto, K; Makino, S; Yoshikawa, Y; Takaki, A; Nagatsuka, Y; Ota, M; Tamiya, G; Kimura, A; Bahram, S; Inoko, H				Okamoto, K; Makino, S; Yoshikawa, Y; Takaki, A; Nagatsuka, Y; Ota, M; Tamiya, G; Kimura, A; Bahram, S; Inoko, H			Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA CLASS-I; SHARED EPITOPE HYPOTHESIS; MHC GENE IKBL; 5'-FLANKING REGION; TNF LOCUS; AMERICAN PATIENTS; POLYMORPHISM; PREDISPOSITION; ASSOCIATION; DELTA-EF1	Rheumatoid arthritis (RA) is a chronic inflammatory joint disease with a complex etiology in which environmental factors within a genetically susceptible host maneuver the innate and adaptive arms of the immune system toward recognition of autoantigens. This ultimately leads to joint destruction and clinical symptomatology. Despite the identification of a number of disease-susceptibility regions across the genome, RA's major genetic linkage remains with the major histocompatibility complex (MHC), which contains not only the key immune-response class I and class II genes but also a host of other loci, some with potential immunological relevance. Inside the MHC itself, the sole consistent RA association is that with HLA-DRB1, although this does not encode all MHC-related susceptibility. Indeed, in a set of Japanese patients with RA and a control group, we previously reported the presence of a second RA-susceptibility gene within the telomeric human leukocyte antigen (HLA) class III region. Using microsatellites, we narrowed the susceptibility region to 70 kb telomeric of the TNF cluster, known to harbor four expressed genes (IkappaBL, ATP6G, BAT1, and MICB). Here, using numerous single-nucleotide polymorphisms (SNPs) and insertion/deletion polymorphisms, we identify the second RA-susceptibility locus within the HLA region, as the T allele of SNP 96452 (T/A), in the promoter region (position 5 62) of the IkappaBL gene (P = .0062). This -62T/A SNP disrupts the putative binding motif for the transcriptional repressor, deltaEF1, and hence may influence the transcription of IkappaBL, homologous to IkappaBalpha, the latter being a known inhibitor of NFkappaB, which is central to innate immunity. Therefore, the MHC may harbor RA genetic determinants affecting the innate and adaptive arms of the immune system.	Tokai Univ, Sch Med, Dept Mol Life Sci, Kanagawa 2591193, Japan; Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka, Japan; Nisshinbo Ind, Ctr Res & Dev, Chiba, Japan; Shinshu Univ, Sch Med, Dept Legal Med, Nagano, Japan; Shinshu Univ, Sch Med, Inst Organ Transplants,Reconstruct Med & Tissue, Nagano, Japan; Tokyo Med & Dent Univ, Med Res Inst, Div Adult Dis, Dept Mol Pathogenesis, Tokyo, Japan; Ctr Rech Immunol & Hematol, INSERM, CReS, Strasbourg, France	Tokai University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Nisshinbo Holdings Inc.; Shinshu University; Shinshu University; Tokyo Medical & Dental University (TMDU); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Inoko, H (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Kanagawa 2591193, Japan.	hinoko@is.icc.u-tokai.ac.jp	Kimura, Akinori/I-5989-2018; Bahram, Seiamak/GZA-7150-2022	Kimura, Akinori/0000-0002-4933-2132; Tamiya, Gen/0000-0002-0597-415X; Bahram, Seiamak/0000-0002-6928-9952				ALBERTELLA MR, 1994, HUM MOL GENET, V3, P793, DOI 10.1093/hmg/3.5.793; Allcock RJN, 1999, IMMUNOGENETICS, V49, P660, DOI 10.1007/s002510050662; Allcock RJN, 1999, HUM IMMUNOL, V60, P1266, DOI 10.1016/S0198-8859(99)00127-5; Allcock RJN, 2001, IMMUNOGENETICS, V52, P289; Ando H, 1997, IMMUNOGENETICS, V46, P499, DOI 10.1007/s002510050311; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bahram S, 2000, Adv Immunol, V76, P1; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Browning M., 1996, HLA MHC GENES MOL FU; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; De La Concha EG, 2000, GASTROENTEROLOGY, V119, P1491, DOI 10.1053/gast.2000.20258; DIZIER MH, 1993, AM J HUM GENET, V53, P715; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; FELSON DT, 1996, ARTHRITIS ALLIED CON, P3; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x; Jawaheer D, 2002, AM J HUM GENET, V71, P585, DOI 10.1086/342407; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jirholt J, 2001, ARTHRITIS RES, V3, P87, DOI 10.1186/ar145; JONGENEEL CV, 1991, P NATL ACAD SCI USA, V88, P9717, DOI 10.1073/pnas.88.21.9717; Lie BA, 1999, TISSUE ANTIGENS, V54, P162, DOI 10.1034/j.1399-0039.1999.540207.x; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Matsushita M, 1999, TISSUE ANTIGENS, V54, P478, DOI 10.1034/j.1399-0039.1999.540505.x; MCDANIEL DO, 1995, ANN INTERN MED, V123, P181, DOI 10.7326/0003-4819-123-3-199508010-00004; NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053; Neville MJ, 1999, J IMMUNOL, V162, P4745; Ota M, 2001, GENOMICS, V71, P263, DOI 10.1006/geno.2000.6371; OTA M, 2001, P 13 INT HIST WORKSH; Seki N, 1999, TISSUE ANTIGENS, V54, P194, DOI 10.1034/j.1399-0039.1999.540212.x; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Semple JI, 2002, BIOCHEM J, V361, P489, DOI 10.1042/0264-6021:3610489; Shiina T, 1999, P NATL ACAD SCI USA, V96, P13282, DOI 10.1073/pnas.96.23.13282; Takagi T, 1998, DEVELOPMENT, V125, P21; Tamiya G, 1998, TISSUE ANTIGENS, V51, P337; Teller K, 1996, J RHEUMATOL, V23, P1363; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P188; UDALOVA IA, 1993, GENOMICS, V16, P180, DOI 10.1006/geno.1993.1156; Zanelli E, 2001, HUM IMMUNOL, V62, P75, DOI 10.1016/S0198-8859(00)00227-5	43	107	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					303	312		10.1086/346067	http://dx.doi.org/10.1086/346067			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12509789	Bronze, Green Published			2022-12-18	WOS:000180680000011
J	Muller, B; Hedrich, K; Kock, N; Dragasevic, N; Svetel, M; Garrels, J; Landt, O; Nitschke, M; Pramstaller, PP; Reik, W; Schwinger, E; Sperner, J; Ozelius, L; Kostic, V; Klein, C				Muller, B; Hedrich, K; Kock, N; Dragasevic, N; Svetel, M; Garrels, J; Landt, O; Nitschke, M; Pramstaller, PP; Reik, W; Schwinger, E; Sperner, J; Ozelius, L; Kostic, V; Klein, C			Evidence that paternal expression of the epsilon-Sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR LOCUS; MECHANISMS	Myoclonus-dystonia (M-D) is a movement disorder characterized by rapid muscle contractions and sustained twisting and repetitive movements and has recently been associated with mutations in the epsilon-sarcoglycan gene (SGCE). The mode of inheritance is autosomal dominant with reduced penetrance upon maternal transmission, suggesting a putative maternal imprinting mechanism. We present an apparently sporadic M-D case and two patients from an M-D family with seemingly autosomal recessive inheritance. In both families, we detected an SGCE mutation that was inherited from the patients' clinically unaffected fathers in an autosomal dominant fashion. Whereas, in the first family, RNA expression studies revealed expression of only the mutated allele in affected individuals and expression of the normal allele exclusively in unaffected mutation carriers, the affected individual of the second family expressed both alleles. In addition, we identified differentially methylated regions in the promoter region of the SGCE gene as a characteristic feature of imprinted genes. Using a rare polymorphism in the promoter region in a family unaffected with M-D as a marker, we demonstrated methylation of the maternal allele, in keeping with maternal imprinting of the SGCE gene. Loss of imprinting in the patient with M-D who had biallelic expression of the SGCE gene was associated with partial loss of methylation at several CpG dinucleotides.	Univ Lubeck, Dept Neurol, Lubeck, Germany; Univ Lubeck, Dept Human Genet, Lubeck, Germany; Univ Lubeck, Dept Pediat, Lubeck, Germany; Univ Belgrade, Dept Neurol, Belgrade, Yugoslavia; TIB MOLBIOL, Berlin, Germany; Reg Gen Hosp Bolzano, Dept Neurol, Bolzano, Italy; Babraham Inst, Lab Dev Genet & Imprinting, Cambridge, England; Albert Einstein Coll Med, New York, NY USA	University of Lubeck; University of Lubeck; University of Lubeck; University of Belgrade; Krankenhaus Bozen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Yeshiva University	Klein, C (corresponding author), Med Univ Lubeck, Dept Neurol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	klein_ch@neuro.mu-luebeck.de	Kostić, Vladimir S/Q-6998-2018; Reik, Wolf/I-6794-2012; Klein, Christine/AGK-8003-2022; Pramstaller, Peter P/C-2357-2008	Reik, Wolf/0000-0003-0216-9881; Schuele, Birgitt/0000-0002-9952-5776; Klein, Christine/0000-0003-2102-3431				Asmus F, 2001, ANN NEUROL, V49, P121, DOI 10.1002/1531-8249(200101)49:1<121::AID-ANA20>3.0.CO;2-8; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gasser T, 1998, Adv Neurol, V78, P325; GRABOWSKI M, 2002, 34 EUR SOC HUM GEN C; Klein C, 2000, AM J HUM GENET, V67, P1314; KLEIN C, 2002, GENETICS MOVEMENT DI, P449; Nygaard TG, 1999, ANN NEUROL, V46, P794, DOI 10.1002/1531-8249(199911)46:5<794::AID-ANA19>3.0.CO;2-2; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Vidailhet M, 2001, NEUROLOGY, V56, P1213, DOI 10.1212/WNL.56.9.1213; VILJOEN D, 1992, J MED GENET, V29, P221, DOI 10.1136/jmg.29.4.221; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709	15	107	110	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1303	1311		10.1086/344531	http://dx.doi.org/10.1086/344531			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12444570	Green Published, Bronze			2022-12-18	WOS:000179586800005
J	Veal, CD; Capon, F; Allen, MH; Heath, EK; Evans, JC; Jones, A; Patel, S; Burden, D; Tillman, D; Barker, JNWN; Trembath, RC				Veal, CD; Capon, F; Allen, MH; Heath, EK; Evans, JC; Jones, A; Patel, S; Burden, D; Tillman, D; Barker, JNWN; Trembath, RC			Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA-C MOLECULES; CONFERS SUSCEPTIBILITY; COMPLEX DISEASES; HCR PG8; ASSOCIATION; VULGARIS; GENOME; HLA-CW-ASTERISK-0602; IDENTIFICATION; RECOMBINATION	Psoriasis is a common skin disorder of multifactorial origin. Genomewide scans for disease susceptibility have repeatedly demonstrated the existence of a major locus, PSORS1 (psoriasis susceptibility 1), contained within the major histocompatibility complex (MHC), on chromosome 6p21. Subsequent refinement studies have highlighted linkage disequilibrium (LD) with psoriasis, along a 150-kb segment that includes at least three candidate genes (encoding human leukocyte antigen-C [HLA-C], alpha-helix-coiled-coil-rod homologue, and corneodesmosin), each of which has been shown to harbor disease-associated alleles. However, the boundaries of the minimal PSORS1 region remain poorly defined. Moreover, interpretations of allelic association with psoriasis are compounded by limited insight of LD conservation within MHC class I interval. To address these issues, we have pursued a high-resolution genetic characterization of the PSORS1 locus. We resequenced genomic segments along a 220-kb region at chromosome 6p21 and identified a total of 119 high-frequency SNPs. Using 59 SNPs (18 coding and 41 noncoding SNPs) whose position was representative of the overall marker distribution, we genotyped a data set of 171 independently ascertained parent-affected offspring trios. Family-based association analysis of this cohort highlighted two SNPs (n.7 and n.9) respectively lying 7 and 4 kb proximal to HLA-C. These markers generated highly significant evidence of disease association (P<10(-9)), several orders of magnitude greater than the observed significance displayed by any other SNP that has previously been associated with disease susceptibility. This observation was replicated in a Gujarati Indian case/control data set. Haplotype-based analysis detected overtransmission of a cluster of chromosomes, which probably originated by ancestral mutation of a common disease-bearing haplotype. The only markers exclusive to the overtransmitted chromosomes are SNPs n.7 and n.9, which define a 10-kb PSORS1 core risk haplotype. These data demonstrate the power of SNP haplotype-based association analyses and provide high-resolution dissection of genetic variation across the PSORS1 interval, the major susceptibility locus for psoriasis.	Univ Leicester, Div Med Genet, Dept Genet & Med, Leicester LE1 7RH, Leics, England; Univ Roma Tor Vergata, Div Human Genet, Rome, Italy; Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; Univ Glasgow, Dept Dermatol, Glasgow G12 8QQ, Lanark, Scotland	University of Leicester; University of Rome Tor Vergata; University of London; King's College London; University of Glasgow	Trembath, RC (corresponding author), Univ Leicester, Div Med Genet, Dept Genet & Med, Adrian Bldg,Univ Rd, Leicester LE1 7RH, Leics, England.	rtrembat@hgmp.mrc.ac.uk	Capon, Francesca/F-4763-2011	Capon, Francesca/0000-0003-2432-5793; Trembath, Richard/0000-0003-0550-3400; Barker, Jonathan/0000-0002-9030-183X; Veal, Colin/0000-0002-9840-2512				Ahnini RT, 1999, HUM MOL GENET, V8, P1135, DOI 10.1093/hmg/8.6.1135; Allen MH, 1999, LANCET, V353, P1589, DOI 10.1016/S0140-6736(99)01618-9; Asahina A, 1996, J DERMATOL SCI, V13, P125, DOI 10.1016/S0923-1811(96)00518-X; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Asumalahti K, 2000, HUM MOL GENET, V9, P1533, DOI 10.1093/hmg/9.10.1533; Balendran N, 1999, J INVEST DERMATOL, V113, P322, DOI 10.1046/j.1523-1747.1999.00710.x; BARKER JNWN, 1991, LANCET, V338, P227, DOI 10.1016/0140-6736(91)90357-U; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Bos JD, 1999, IMMUNOL TODAY, V20, P40, DOI 10.1016/S0167-5699(98)01381-4; CAMP RDR, 1998, TXB DERMATOLOGY, P1589; Capon F, 2002, J INVEST DERMATOL, V118, P745, DOI 10.1046/j.1523-1747.2002.01749.x; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CERUNDOLO V, 1996, HLA MHC GENES MOL FU, P193; Chia NVC, 2001, J INVEST DERMATOL, V116, P823, DOI 10.1046/j.1523-1747.2001.01245-2.x; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; ELDER JT, 1994, J INVEST DERMATOL, V103, pS150, DOI 10.1111/1523-1747.ep12399486; Elder JT, 2001, ARCH DERMATOL, V137, P1447; Gonzalez S, 2000, J INVEST DERMATOL, V115, P824, DOI 10.1046/j.1523-1747.2000.00133.x; HELLGREN I, 1967, PSORIASIS PREVALENCE; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jenisch S, 1999, TISSUE ANTIGENS, V54, P439, DOI 10.1034/j.1399-0039.1999.540501.x; Lee YA, 2000, AM J HUM GENET, V67, P1020, DOI 10.1086/303075; LOHMOLT G, 1963, PSORIASIS PREVALENCE; Mallon E, 1997, J INVEST DERMATOL, V109, P183, DOI 10.1111/1523-1747.ep12319304; Mallon E, 1999, J INVEST DERMATOL, V113, P693, DOI 10.1046/j.1523-1747.1999.00724.x; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; Nickoloff BJ, 1999, ARCH DERMATOL, V135, P546, DOI 10.1001/archderm.135.5.546; O'Brien KP, 2001, J INVEST DERMATOL, V116, P750, DOI 10.1046/j.0022-202x.2001.01323.x; Oka A, 1999, HUM MOL GENET, V8, P2165, DOI 10.1093/hmg/8.12.2165; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; ROITBERGTAMBUR A, 1994, J AM ACAD DERMATOL, V31, P964, DOI 10.1016/S0190-9622(94)70265-9; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SANDER HM, 1993, J AM ACAD DERMATOL, V28, P422, DOI 10.1016/0190-9622(93)70062-X; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Veal CD, 2001, J MED GENET, V38, P7, DOI 10.1136/jmg.38.1.7; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866	44	107	116	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					554	564		10.1086/342289	http://dx.doi.org/10.1086/342289			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12148091	Green Published, Bronze			2022-12-18	WOS:000177489600009
J	Collins-Schramm, HE; Phillips, CM; Operario, DJ; Lee, JS; Weber, JL; Hanson, RL; Knowler, WC; Cooper, R; Li, HZ; Seldin, MF				Collins-Schramm, HE; Phillips, CM; Operario, DJ; Lee, JS; Weber, JL; Hanson, RL; Knowler, WC; Cooper, R; Li, HZ; Seldin, MF			Ethnic-difference markers for use in mapping by admixture linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADMIXED POPULATIONS; MEXICAN-AMERICANS; DISEASE; TEXAS; RISK	Mapping by admixture linkage disequilibrium (MALD) is a potentially powerful technique for the mapping of complex genetic diseases. The practical requirements of this method include (a) a set of markers spanning the genome that have large allele-frequency differences between the parental ethnicities contributing to the admixed population and (b) an understanding of the extent of admixture in the study population. To this end, a DNA-pooling technique was used to screen microsatellite and diallelic insertion/deletion markers for allele-frequency differences between putative representatives of the parental populations of the admixed Mexican American (MA) and African American (AA) populations. Markers with promising pooled differences were then confirmed by individual genotyping in both the parental and admixed populations. For the MA population, screening of >600 markers identified 151 ethnic-difference markers (EDMs) with delta > 0.30 (where delta is the absolute value of each allele-frequency differences between two populations, summed over all marker alleles and divided by two) that are likely to be useful for MALD analysis. For the AA population, analysis of >400 markers identified 97 EDMs. In addition, individual genotyping of these markers in Pima Amerindians, Yavapai Amerindians, European American (EA) individuals, Africans from Zimbabwe, MA individuals, and AA individuals, as well as comparison to the CEPH genotyping set, suggests that the differences between subpopulations of an ethnicity are small for many markers with large interethnic differences. Estimates of admixture that are based on individual genotyping of these markers are consistent with a 60% EA: 40% Amerindian contribution to MA populations and with a 20% EA: 80% African contribution to AA populations. Taken together, these data suggest that EDMs with large interpopulation and small intrapopulation differences can be readily identified for MALD studies in both AA and MA populations.	Univ Calif Davis, Dept Biol Chem & Med, Rowe Program Human Genet, Davis, CA 95616 USA; Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA; NIDDKD, NIH, Phoenix, AZ USA; Loyola Univ, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA	University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Loyola University Chicago	Seldin, MF (corresponding author), Univ Calif Davis, Dept Biol Chem & Med, Rowe Program Human Genet, 1 Shields Ave, Davis, CA 95616 USA.		Hanson, Robert L/O-3238-2015; Phillips, Carolyn/E-8305-2011	Hanson, Robert L/0000-0002-4252-7068; Phillips, Carolyn/0000-0002-6228-6468	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069036] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45508, N01-HV-48141, N01HV48141, R01-HV-62681, R37 HL045508] Funding Source: Medline; NIDDK NIH HHS [U01 DK057249, U01-DK57249] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bali D, 1999, GENES IMMUN, V1, P28, DOI 10.1038/sj.gene.6363635; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BRISCOE D, 1994, J HERED, V85, P59; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; CHAKRABORTY R, 1986, GENET EPIDEMIOL, V3, P435, DOI 10.1002/gepi.1370030608; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; Collins HE, 2000, HUM GENET, V106, P218, DOI 10.1007/s004390051031; DEAN M, 1994, AM J HUM GENET, V55, P788; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; Iliffe J., 1995, AFRICANS HIST CONTIN; Kaplan NL, 1998, AM J HUM GENET, V62, P703, DOI 10.1086/301760; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; Lewontin R.C., 1972, J EVOLUTION BIOL, V14, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LONG JC, 1991, GENETICS, V127, P417; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; NEI M, 1974, AM J HUM GENET, V26, P421; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; RIFE DC, 1954, AM J HUM GENET, V6, P26; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Zheng CX, 1999, GENET EPIDEMIOL, V17, P79, DOI 10.1002/(SICI)1098-2272(1999)17:2<79::AID-GEPI1>3.0.CO;2-N	28	107	111	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					737	750		10.1086/339368	http://dx.doi.org/10.1086/339368			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11845411	Green Published, Bronze			2022-12-18	WOS:000173880000016
J	Quintana-Murci, L; Krausz, C; Zerjal, T; Sayar, SH; Hammer, MF; Mehdi, SQ; Ayub, Q; Qamar, R; Mohyuddin, A; Radhakrishna, U; Jobling, MA; Tyler-Smith, C; McElreavey, K				Quintana-Murci, L; Krausz, C; Zerjal, T; Sayar, SH; Hammer, MF; Mehdi, SQ; Ayub, Q; Qamar, R; Mohyuddin, A; Radhakrishna, U; Jobling, MA; Tyler-Smith, C; McElreavey, K			Y-chromosome lineages trace diffusion of people and languages in southwestern Asia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EUROPE; ORIGINS; AFRICA	The origins and dispersal of farming and pastoral nomadism in southwestern Asia are complex, and there is controversy about whether they were associated with cultural transmission or demic diffusion. In addition, the spread of these technological innovations has been associated with the dispersal of Dravidian and Indo-Iranian languages in southwestern Asia. Here we present genetic evidence for the occurrence of two major population movements, supporting a model of demic diffusion of early farmers from southwestern Iran-and of pastoral nomads from western and central Asia-into India, associated with Dravidian and Indo-European-language dispersals, respectively.	Inst Pasteur, INSERM, E0021, Unite Immunogenet Humaine, F-75724 Paris 15, France; Univ Oxford, Dept Biochem, Oxford OX1 2JD, England; Iranian Blood TRansfus Org, Ctr Med Genet, Tehran, Iran; Univ Arizona, Lab Mol Systemat & Evolut, Tucson, AZ USA; Biomed & Genet Engn Labs, Islamabad, Pakistan; Green Cross Voluntary Blood Bank & RIA Lab, Ahmadabad, Gujarat, India; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford; University of Arizona; University of Leicester	Quintana-Murci, L (corresponding author), Inst Pasteur, INSERM, E0021, Unite Immunogenet Humaine, 25 rue Dr Roux, F-75724 Paris 15, France.	quintana@pasteur.fr	qamar, raheel/D-4543-2012; Qamar, Raheel/G-3355-2015; Mehdi, Syed Qasim/L-2385-2015; zerjal, tatiana/AAO-9473-2020; Quintana-Murci, Lluis/AAB-7468-2022	Krausz, Csilla Gabriella/0000-0001-6748-8918; Ayub, Qasim/0000-0003-3291-0917; Jobling, Mark/0000-0002-8061-1308; Quintana-Murci, Lluis/0000-0003-2429-6320	Telethon [281/B] Funding Source: Medline; Wellcome Trust [057559] Funding Source: Medline	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		Ammerman A.J., 1984, NEOLITHIC TRANSITION; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Casalotti R, 1999, P ROY SOC B-BIOL SCI, V266, P1959, DOI 10.1098/rspb.1999.0873; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 1988, MUNIBE S, V6, P129; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Malaspina P, 1998, AM J HUM GENET, V63, P847, DOI 10.1086/301999; Quintana-Murci L, 1999, EUR J HUM GENET, V7, P603, DOI 10.1038/sj.ejhg.5200347; Renfrew C., 1996, ORIGINS SPREAD AGR P, P70; Renfrew C., 1987, ARCHAEOLOGY LANGUAGE; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Ruhlen M, 1991, GUIDE WORLDS LANGUAG; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 1996, AM J HUM GENET, V59, P964; SLATKIN M, 1995, GENETICS, V139, P457; Zerjal T, 1999, GENOMIC DIVERSITY, P91; Zerjal T, 1997, AM J HUM GENET, V60, P1174; Zvelebil M., 1980, CAMBRIDGE ENCY ARCHA, P252	27	107	110	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					537	542		10.1086/318200	http://dx.doi.org/10.1086/318200			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11133362	Green Published, Bronze			2022-12-18	WOS:000166524800027
J	Belloni, E; Martucciello, G; Verderio, D; Ponti, E; Seri, M; Jasonni, V; Torre, M; Ferrari, M; Tsui, LC; Scherer, SW				Belloni, E; Martucciello, G; Verderio, D; Ponti, E; Seri, M; Jasonni, V; Torre, M; Ferrari, M; Tsui, LC; Scherer, SW			Involvement of the HLXB9 homeobox gene in Currarino syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							POINT MUTATIONS; SACRAL AGENESIS; EXPANSIONS; DNA		Hosp Sick Children, Dept Genet, Toronto, ON M5G 1X8, Canada; Hosp San Raffaele, Ist Ricovero & Cura Carattere Sci, Genet & Mol Diagnost Unit, I-20132 Milan, Italy; Univ Genoa, Giannina Gaslini Inst, Genoa, Italy	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Genoa; IRCCS Istituto Giannina Gaslini	Scherer, SW (corresponding author), Hosp Sick Children, Dept Genet, Room 9107,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	steve@genet.sickkids.on.ca	belloni, elena/H-9909-2013; Scherer, Stephen W./B-3785-2013; Ferrari, Maurizio/D-9107-2013; Martucciello, Giuseppe/J-6543-2018; Tsui, Lap-chee/A-1081-2010; Seri, Marco/A-4339-2014	Scherer, Stephen W./0000-0002-8326-1999; Martucciello, Giuseppe/0000-0002-7709-8937; Belloni, Elena/0000-0003-3214-0780; torre, michele/0000-0001-5197-4380; Seri, Marco/0000-0003-2425-2176				Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Cama A, 1996, EUR J PEDIATR SURG, V6, P44; Cremonesi L, 1997, BIOTECHNIQUES, V22, P326, DOI 10.2144/97222rr01; Cremonesi L, 1999, CLIN CHEM, V45, P35; CURRARINO G, 1981, AM J ROENTGENOL, V137, P395, DOI 10.2214/ajr.137.2.395; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; HALIASSOS A, 1989, NUCLEIC ACIDS RES, V17, P3606, DOI 10.1093/nar/17.9.3606; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; Heus HC, 1999, GENOMICS, V57, P342, DOI 10.1006/geno.1999.5796; KALITZKI M, 1965, LANCET, V2, P641; KALLEN B, 1974, TERATOLOGY, V9, P99, DOI 10.1002/tera.1420090113; Lerone M, 1997, Semin Pediatr Surg, V6, P170; Li H, 1999, NAT GENET, V23, P67; LYNCH SA, 1995, NAT GENET, V11, P93, DOI 10.1038/ng0995-93; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Pena A, 1995, Semin Pediatr Surg, V4, P35; RICH MA, 1988, PEDIATR SURG INT, V3, P110; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; Seri M, 1999, HUM GENET, V104, P108, DOI 10.1007/s004390050919	20	107	116	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					312	319		10.1086/302723	http://dx.doi.org/10.1086/302723			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631160	Green Published, Bronze			2022-12-18	WOS:000085033600031
J	Monk, D; Wakeling, EL; Proud, V; Hitchins, M; Abu-Amero, SN; Stanier, P; Preece, MA; Moore, GE				Monk, D; Wakeling, EL; Proud, V; Hitchins, M; Abu-Amero, SN; Stanier, P; Preece, MA; Moore, GE			Duplication of 7p11.2-p13, including GRB10, in Silver-Russell syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELE-SPECIFIC REPLICATION; UNIPARENTAL DISOMY-7; IMPRINTED GENE; 7P; TRANSLOCATION; RECEPTOR; REGIONS; INSULIN; IR	Silver-Russell syndrome (SRS) is characterized by pre-and postnatal growth failure and other dysmorphic features. The syndrome is genetically heterogenous, but maternal uniparental disomy of chromosome 7 has been demonstrated in similar to 7% of cases. This suggests that at least one gene on chromosome 7 is imprinted and involved in the pathogenesis of SRS. We have identified a de novo duplication of 7p11.2-p13 in a proband with features characteristic of SRS. FISH confirmed the presence of a tandem duplication encompassing the genes for growth factor receptor-binding protein 10 (GRB10) and insulinlike growth factor-binding proteins 1 and 3 (IGFBP1 and -3) but not that for epidermal growth factor-receptor (EGFR). Microsatellite markers showed that the duplication was of maternal origin. These findings provide the first evidence that SRS may result from overexpression of a maternally expressed imprinted gene, rather than from absent expression of a paternally expressed gene. GRB10 lies within the duplicated region and is a strong candidate, since it is a known growth supressor. Futhermore, the mouse homologue (Gub10/Meg1) is reported to be maternally expressed and maps to the imprinted region of proximal mouse chromosome 11 that demonstrates prenatal growth failure when it is maternally disomic. We have demonstrated that the GRB10 genomic interval replicates asynchronously in human lymphocytes, suggestive of imprinting. An additional 36 SRS probands were investigated for duplication of GRB10, but none were found. However, it remains possible that GRB10 and/or other genes within 7p11.2-p13 are responsible for some cases of SRS.	Queen Charlottes & Chelsea Hosp, Imperial Coll Sch Med, Div Paediat Obstet & Gynaecol, Act Res Lab Mol Biol Fetal Dev, London W6 0XG, England; UCL, Inst Child Hlth, London, England; Childrens Hosp Kings Daughters, Dept Pediat, Div Med Genet, Norfolk, VA USA	Imperial College London; University of London; University College London	Monk, D (corresponding author), Queen Charlottes & Chelsea Hosp, Imperial Coll Sch Med, Div Paediat Obstet & Gynaecol, Act Res Lab Mol Biol Fetal Dev, Goldhawk Rd, London W6 0XG, England.	d.monk@ic.ac.uk	Stanier, Philip/C-1593-2008; Moore, Gudrun/A-2092-2009	Stanier, Philip/0000-0001-9340-8117; Wakeling, Emma/0000-0001-5712-0044				[Anonymous], 1982, MOL CLONING LAB MANU; CARNEVALE A, 1978, CLIN GENET, V14, P202; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CHAUVEL PJ, 1975, DEV MED CHILD NEUROL, V17, P220; DUNCAN PA, 1990, AM J MED GENET, V35, P245, DOI 10.1002/ajmg.1320350220; GUNARATNE PH, 1995, GENE DEV, V9, P808, DOI 10.1101/gad.9.7.808; Harper Joyce C., 1996, P259; Jerome CA, 1997, GENOMICS, V40, P215, DOI 10.1006/geno.1996.4535; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; Li Madeline, 1997, Current Opinion in Pediatrics, V9, P623, DOI 10.1097/00008480-199712000-00012; LIU F, 1995, P NATL ACAD SCI USA, V92, P10287, DOI 10.1073/pnas.92.22.10287; MIDRO AT, 1993, CLIN GENET, V44, P53; Miyoshi N, 1998, P NATL ACAD SCI USA, V95, P1102, DOI 10.1073/pnas.95.3.1102; Miyoshi O, 1999, J MED GENET, V36, P326; ODELL JM, 1987, AM J MED GENET, V27, P687, DOI 10.1002/ajmg.1320270323; ONeill TJ, 1996, J BIOL CHEM, V271, P22506, DOI 10.1074/jbc.271.37.22506; Preece MA, 1997, J MED GENET, V34, P6, DOI 10.1136/jmg.34.1.6; Preece MA, 1999, J MED GENET, V36, P457; Rogan PK, 1996, AM J MED GENET, V62, P10, DOI 10.1002/(SICI)1096-8628(19960301)62:1<10::AID-AJMG3>3.3.CO;2-5; RUSSELL A, 1954, P ROY SOC MED, V47, P1040; SCHAEFER GB, 1995, AM J MED GENET, V56, P184, DOI 10.1002/ajmg.1320560214; Schinzel A A, 1994, Clin Dysmorphol, V3, P63; SILVER HK, 1953, PEDIATRICS, V12, P368; WAHLSTROM J, 1976, CLIN GENET, V9, P187; WAKELING EL, IN PRESS J MED GENET; White LM, 1996, AM J HUM GENET, V59, P423; ZERRES K, 1989, ANN GENET-PARIS, V32, P225	29	107	111	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					36	46		10.1086/302717	http://dx.doi.org/10.1086/302717			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631135	Green Published, Bronze			2022-12-18	WOS:000085033600006
J	Moulard, B; Guipponi, M; Chaigne, D; Mouthon, D; Buresi, C; Malafosse, A				Moulard, B; Guipponi, M; Chaigne, D; Mouthon, D; Buresi, C; Malafosse, A			Identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+) on chromosome 2q24-q33	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL NEONATAL CONVULSIONS; JUVENILE MYOCLONIC EPILEPSY; GENE; LINKAGE; 19P	We report the identification of a new locus for generalized epilepsy with febrile seizures plus (GEFS+). Six family members manifested isolated typical febrile seizures (FS), and five had typical FS associated with generalized epilepsy (FS+, generalized tonic/clonic seizures). Afebrile seizures occurred from childhood until the teenage years. The maximum two-point LOD score was 3.99 for markers D2S294 and D2S2314. Flanking markers place the GEFS+ locus between D2S141 and D2S116, with multipoint analysis favoring the 13-cM interval spanned by D2S294 and D2S364. This locus is the second GEFS+ locus to be reported, which suggests that this syndrome is genetically heterogeneous.	Hop Univ Geneve, Div Neuropsychiat, Chene Bourg, Switzerland; Expt Med Lab, Montpellier, France; Clin St Odile, Strasbourg, France	University of Geneva	Malafosse, A (corresponding author), Hop Belle Idee, Div Neuropsychiat, 2 Chemin Petit Bel Air, CH-1225 Chene Bourg, Switzerland.	malafoss@cmu.unige.ch						ANDERSON VE, 1995, EPILEPSIA, V36, pS215; [Anonymous], 1981, Epilepsia, V22, P489; BECKMANNAGETTA G, 1991, EPILEPSY RES, P105; Berg AT, 1997, ARCH PEDIAT ADOL MED, V151, P371, DOI 10.1001/archpedi.1997.02170410045006; Berkovic SF, 1998, ANN NEUROL, V43, P435, DOI 10.1002/ana.410430405; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Doose H, 1997, EUR J PEDIATR, V156, P476, DOI 10.1007/s004310050643; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; FRANTZEN E, 1970, NEUROLOGY, V20, P909, DOI 10.1212/WNL.20.9.909; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; Guipponi M, 1997, HUM MOL GENET, V6, P473, DOI 10.1093/hmg/6.3.473; Johnson EW, 1998, HUM MOL GENET, V7, P63, DOI 10.1093/hmg/7.1.63; Kugler SL, 1998, AM J MED GENET, V79, P354, DOI 10.1002/(SICI)1096-8628(19981012)79:5<354::AID-AJMG5>3.0.CO;2-J; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LENNOX MA, 1949, AM J DIS CHILD, V78, P868, DOI 10.1001/archpedi.1949.02030050887003; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEWIS TB, 1993, AM J HUM GENET, V53, P670; Lopes-Cendes Iscia, 1996, Epilepsia, V37, P127; Maher J, 1995, BRAIN, V118, P1521, DOI 10.1093/brain/118.6.1521; RICH SS, 1987, AM J HUM GENET, V41, P249; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Singh R, 1999, ANN NEUROL, V45, P75, DOI 10.1002/1531-8249(199901)45:1<75::AID-ART13>3.0.CO;2-W; Steinlein OK, 1998, CLIN GENET, V54, P169; TSUBOI T, 1977, HUM GENET, V36, P173, DOI 10.1007/BF00273256; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wallace RH, 1996, J MED GENET, V33, P308, DOI 10.1136/jmg.33.4.308	26	107	117	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1396	1400		10.1086/302621	http://dx.doi.org/10.1086/302621			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521305	Bronze, Green Published			2022-12-18	WOS:000083531000021
J	Puget, N; Sinilnikova, OM; Stoppa-Lyonnet, D; Audoynaud, C; Pages, S; Lynch, HT; Goldgar, D; Lenoir, GM; Mazoyer, S				Puget, N; Sinilnikova, OM; Stoppa-Lyonnet, D; Audoynaud, C; Pages, S; Lynch, HT; Goldgar, D; Lenoir, GM; Mazoyer, S			An Alu-mediated 6-kb duplication in the BRCA1 gene: A new founder mutation?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CANCER; FAMILIES; SEQUENCE; KB		CNRS, UMR 5641, Int Agcy Res Canc, Lyon, France; CNRS, Genet Lab, Lyon, France; Inst Curie, Unite Genet Oncol, Paris, France; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA	Centre National de la Recherche Scientifique (CNRS); World Health Organization; International Agency for Research on Cancer (IARC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Creighton University	Lenoir, GM (corresponding author), CNRS, UMR 5641, Int Agcy Res Canc, Lyon, France.		PUGET, Nadine/AAB-9689-2020; Mazoyer, Sylvie/N-7559-2017; , Otto/P-4127-2018	PUGET, Nadine/0000-0003-4046-737X; , Otto/0000-0003-2101-4105; Mazoyer, Sylvie/0000-0002-2135-0160				Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Puget N, 1997, CANCER RES, V57, P828; PUGET N, IN PRESS CANC RES; Serova O, 1996, AM J HUM GENET, V58, P42; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; StoppaLyonnet D, 1997, AM J HUM GENET, V60, P1021; Swensen J, 1997, HUM MOL GENET, V6, P1513, DOI 10.1093/hmg/6.9.1513	9	107	110	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					300	302		10.1086/302211	http://dx.doi.org/10.1086/302211			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915971	Green Published, Bronze			2022-12-18	WOS:000078477400037
J	Hurles, ME; Irven, C; Nicholson, J; Taylor, PG; Santos, FR; Loughlin, J; Jobling, MA; Sykes, BC				Hurles, ME; Irven, C; Nicholson, J; Taylor, PG; Santos, FR; Loughlin, J; Jobling, MA; Sykes, BC			European y-chromosomal lineages in Polynesians: A contrast to the population structure revealed by mtDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EVOLUTIONARY HISTORY; MITOCHONDRIAL DNAS; SEQUENCE VARIATION; POLYMORPHISMS; HAPLOTYPES; MUTATION; MINISATELLITES; AFFINITIES; ANCESTRY; VARIANTS	We have used Y-chromosomal polymorphisms to trace paternal lineages in Polynesians by use of samples previously typed for mtDNA variants. A genealogical approach utilizing hierarchical analysis of eight rare-event biallelic polymorphisms, seven microsatellite loci, and internal structural analysis of the hypervariable minisatellite, MSY1, has been used to define three major paternal-lineage clusters in Polynesians. Two of these clusters, both defined by novel MSY1 modular structures and representing 55% of the Polynesians studied, are also found in coastal Papua New Guinea. Reduced Polynesian diversity, relative to that in Melanesians, is illustrated by the presence of several examples of identical MSY1 codes and microsatellite haplotypes within these lineage clusters in Polynesians. The complete lack of Y chromosomes having the M4 base substitution in Polynesians, despite their prevalence (64%) in Melanesians, may also be a result of the multiple bottleneck events during the colonization of this region of the world. The origin of the M4 mutation has been dated by use of two independent methods based on microsatellite-haplotype and minisatellite-code diversity. Because of the wide confidence limits on the mutation rates of these loci, the M4 mutation cannot be conclusively dated relative to the colonization of Polynesia, 3,000 years ago. The other major lineage cluster found in Polynesians, defined by a base substitution at the 92R7 locus, represents 27% of the Polynesians studied and, most probably, originates in Europe. This is the first Y-chromosomal evidence of major European admixture with indigenous Polynesian populations and contrasts sharply with the picture given by mtDNA evidence.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Oxford, Inst Mol Med, Cellular Genet Grp, Oxford, England; Univ Oxford, Dept Biochem, CRC, Chromosome Mol Biol Grp, Oxford OX1 3QU, England; Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	University of Leicester; University of Oxford; University of Oxford; Universidade Federal de Minas Gerais	Jobling, MA (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Santos, Fabrício Rodrigues/H-2370-2011	Santos, Fabrício Rodrigues/0000-0001-9088-1750; Jobling, Mark/0000-0002-8061-1308; Loughlin, John/0000-0003-2018-3361	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bellwood P, 1987, POLYNESIANS, V2nd; BELLWOOD P, 1991, SCI AM           JUL, P70; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; Bellwood PS, 1979, MANS CONQUEST PACIFI; BERTRANPETIT J, 1996, VARIATION HUMAN GENO, P97; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Bouzekri N, 1998, HUM MOL GENET, V7, P655, DOI 10.1093/hmg/7.4.655; Bravi CM, 1997, HUM BIOL, V69, P641; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; FLINT J, 1989, HUM GENET, V83, P257, DOI 10.1007/BF00285167; Forster P, 1998, MOL BIOL EVOL, V15, P1108, DOI 10.1093/oxfordjournals.molbev.a026018; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; HEYERDAHL T, 1950, KONTIKI PACIFIC RAFT; HILL AVS, 1987, AM J HUM GENET, V40, P453; HILL AVS, 1989, COLONIZATION PACIFIC; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; Jennings J., PREHISTORY POLYNESIA, P308; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Jobling MA, 1998, HUM MOL GENET, V7, P643, DOI 10.1093/hmg/7.4.643; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Kwok C, 1996, J MED GENET, V33, P465, DOI 10.1136/jmg.33.6.465; LUM JK, 1994, HUM BIOL, V66, P567; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MELTON T, 1995, AM J HUM GENET, V57, P403; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; Santos FR, 1996, BRAZ J GENET, V19, P665, DOI 10.1590/S0100-84551996000400025; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P120; SPURDLE A, 1992, HUM MOL GENET, V1, P169, DOI 10.1093/hmg/1.3.169; SPURDLE AB, 1994, ANN HUM GENET, V58, P251, DOI 10.1111/j.1469-1809.1994.tb01889.x; SYKES B, 1995, AM J HUM GENET, V57, P1463; Terrell J., 1986, PREHISTORY PACIFIC I; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Veitia R, 1997, HUM GENET, V99, P648, DOI 10.1007/s004390050422; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1997, AM J HUM GENET, V60, P1174	44	107	112	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1793	1806		10.1086/302147	http://dx.doi.org/10.1086/302147			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837833	Green Published, Bronze			2022-12-18	WOS:000077707700026
J	Bonatto, SL; Salzano, FM				Bonatto, SL; Salzano, FM			Diversity and age of the four major mtDNA haplogroups, and their implications for the peopling of the new world	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; POPULATION EXPANSION; GENETIC-EVIDENCE; HAPLOTYPES; SEQUENCES; POLYMORPHISM; EVOLUTION; AMERINDS; LINEAGES; ORIGIN	Despite considerable investigation, two main questions on the origin of Native Americans remain the topic of intense debate-namely, the number and time of the migration(s) into the Americas. Using the 720 available Amerindian mtDNA control-region sequences, we reanalyzed the nucleotide diversity found within each of the four major mtDNA haplogroups (A-D) thought to have been present in the colonization of the New World. We first verified whether the within-haplogroup sequence diversity could be used as a measure of the haplogroup's age. The pattern of shared polymorphism, the mismatch distribution, the phylogenetic trees, the value of Tajima's D, and the computer simulations all suggested that the four haplogroups underwent a bottleneck followed by a large population expansion. The four haplogroup diversities were very similar to each other, offering a strong support for their single origin. They suggested that the beginning of the Native Americans' ancestral-population differentiation occurred similar to 30,000-40,000 years before the present (ybp), with a 95%-cofidence-interval lower bound of similar to 25,000 ybp. These values are in good agreement with the New World-settlement model that we have presented elsewhere, extending the results initially found for haplogroup A to the three other major groups of mtDNA sequences found in the Americas. These results put the peopling of the Americas clearly in an early, pre-Clovis time frame.	Univ Fed Rio Grande do Sul, Dept Genet, BR-91501970 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Bonatto, SL (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Caixa Postal 15053, BR-91501970 Porto Alegre, RS, Brazil.	sandro@if1.if.ufrgs.br	Salzano, Francisco M/L-7916-2015; Bonatto, Sandro L/A-1240-2010	Bonatto, Sandro L/0000-0002-0064-467X				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; BAILLIET G, 1994, AM J HUM GENET, V55, P27; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Bonatto SL, 1996, AM J HUM GENET, V59, P253; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Easton RD, 1996, AM J HUM GENET, V59, P213; Eller E, 1996, MOL BIOL EVOL, V13, P1155, DOI 10.1093/oxfordjournals.molbev.a025679; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 1996, AM J HUM GENET, V59, P935; GINTHER C, 1993, EXS, V67, P211; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOCHER TD, 1991, EVOLUTION OF LIFE, P391; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1996, GENETICS, V142, P1321; LEMMEN DS, 1994, QUATERNARY SCI REV, V13, P805, DOI 10.1016/0277-3791(94)90003-5; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Monsalve MV, 1996, ANN HUM GENET, V60, P293, DOI 10.1111/j.1469-1809.1996.tb01193.x; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1995, HUM BIOL, V67, P1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers AR, 1996, MOL BIOL EVOL, V13, P895, DOI 10.1093/molbev/13.7.895; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Salzano FM, 1988, S AM INDIANS CASE ST; SANTOS M, 1994, HUM BIOL, V66, P963; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SLATKIN M, 1991, GENETICS, V129, P555; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Szathmary Emoke J. E., 1993, EVOL ANTHROPOL, V1, P202; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALLACE DC, 1995, AM J HUM GENET, V57, P201; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Yang ZH, 1996, MOL BIOL EVOL, V13, P650, DOI 10.1093/oxfordjournals.molbev.a025625	52	107	114	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1413	1423		10.1086/301629	http://dx.doi.org/10.1086/301629			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399887	Bronze, Green Published			2022-12-18	WOS:000071555900026
J	Messina, DN; Speer, MC; PericakVance, MA; McNally, EM				Messina, DN; Speer, MC; PericakVance, MA; McNally, EM			Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LAMININ ALPHA-2-CHAIN; HUMAN GENOME; GENE; LOCUS; DEFICIENCY; DISEASE; MAPS	Inherited cardiomyopathies may arise from mutations in genes that are normally expressed in both heart and skeletal muscle and therefore may be accompanied by skeletal muscle weakness. Phenotypically, patients with familial dilated cardiomyopathy (FDC) show enlargement of all four chambers of the heart and develop symptoms of congestive heart failure. Inherited cardiomyopathies may also be accompanied by cardiac conduction-system defects that affect the atrioventricular node, resulting in bradycardia. Several different chromosomal regions have been linked with the development of autosomal dominant FDC, but the gene defects in these disorders remain unknown. We now characterize an autosomal dominant disorder involving dilated cardiomyopathy, cardiac conduction-system disease, and adult-onset limb-girdle muscular dystrophy (FDC, conduction disease, and myopathy [FDC-CDM]). Genetic linkage was used to exclude regions of the genome known to be linked to dilated cardiomyopathy and muscular dystrophy phenotypes and to confirm genetic heterogeneity of these disorders. A genomewide scan identified a region on the long arm of chromosome 6 that is significantly associated with the presence of myopathy (D6S262; maximum LOD score [Z(max)] 4.99 at maximum recombination fraction [theta(max)].00), identifying FDC-CDM as a genetically distinct disease. Haplotype analysis refined the interval containing the genetic defect, to a 3-cM interval between D6S1705 and D6S1656. This haplotype analysis excludes a number of striated muscle-expressed genes present in this region, including laminin alpha 2, laminin alpha 4, triadin, and phospholamban.	UNIV CHICAGO,DEPT MED,CARDIOL SECT,CHICAGO,IL 60637; UNIV CHICAGO,COMM GENET,CHICAGO,IL 60637; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710	University of Chicago; University of Chicago; Duke University			Messina, Dave/B-2405-2009; McNally, Elizabeth/W-4909-2019	Messina, David/0000-0002-2287-2761; McNally, Elizabeth/0000-0002-1221-719X	NHLBI NIH HHS [K08 HL03448-01] Funding Source: Medline; NINDS NIH HHS [NS23660] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS023660] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Bonnemann Carsten G., 1996, Current Opinion in Pediatrics, V8, P569; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; GRABER HL, 1986, CIRCULATION, V74, P21, DOI 10.1161/01.CIR.74.1.21; GREENLEE PR, 1986, WESTERN J MED, V144, P33; HelblingLeclerc A, 1995, CR ACAD SCI III-VIE, V318, P1245; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KELLY DP, 1994, NEW ENGL J MED, V330, P913; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MEIER H, 1970, LIFE SCI 2-BIOCH GEN, V9, P137, DOI 10.1016/0024-3205(70)90306-1; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MICHELSON AM, 1955, P NATL ACAD SCI USA, V41, P1079, DOI 10.1073/pnas.41.12.1079; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Naom IS, 1997, J MED GENET, V34, P99, DOI 10.1136/jmg.34.2.99; Nissinen M, 1996, AM J HUM GENET, V58, P1177; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; OZAWA E, 1995, HUM MOL GENET, V4, P1711, DOI 10.1093/hmg/4.suppl_1.1711; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SPEER MC, 1992, AM J HUM GENET, V50, P1211; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Vainzof M, 1995, NEUROPEDIATRICS, V26, P293, DOI 10.1055/s-2007-979777; Van Der Kooi A. J., 1996, Annals of Neurology, V39, P636, DOI 10.1002/ana.410390513; vanderKooi AJ, 1997, AM J HUM GENET, V60, P891; WARKINS H, 1995, HUM MOL GENET, V4, P1721; Wewer UM, 1996, NEUROMUSCULAR DISORD, V6, P409, DOI 10.1016/S0960-8966(96)00384-7	33	107	113	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					909	917		10.1086/514896	http://dx.doi.org/10.1086/514896			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382102	Green Published, Bronze			2022-12-18	WOS:A1997YA59100018
J	Nanji, MS; Nguyen, VTT; Kawasoe, JH; Inui, K; Endo, F; Nakajima, T; Anezaki, T; Cox, DW				Nanji, MS; Nguyen, VTT; Kawasoe, JH; Inui, K; Endo, F; Nakajima, T; Anezaki, T; Cox, DW			Haplotype and mutation analysis in Japanese patients with Wilson disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPPER-TRANSPORTING ATPASE; MENKES DISEASE; CANDIDATE GENE; ENCODES; CLONING	Wilson disease (WD), an autosomal recessive disorder of copper transport, is characterized by impaired biliary excretion and by impaired incorporation of copper into ceruloplasmin. Toxic accumulation of copper causes tissue damage, primarily in the liver, brain, and kidneys. The gene for WD (ATP7B) has been cloned, and the protein product is predicted to be a copper-transporting beta-type ATPase with high amino acid identity with that for Menkes disease, an X-linked disorder of copper transport. Mutation screening in WD patients has led to the identification of at least 40 mutations. In addition, haplotype analysis using three dinucleotide-regeat markers, D13S314, D13S301, and D13S316, has been a useful indicator of specific mutations. We have determined haplotypes for the patients and their parents and sibs, in 21 unrelated WD families from Japan. Twenty-eight different haplotypes were observed on 42 WD chromosomes. In all the patients, the ATP7B coding sequence, including the intron-exon boundaries, was screened for mutations, by SSCP, followed by direct-sequence analysis of the shifted fragments. We identified 13 mutations, of which 11 mutations are novel, including 7 mutations-1 insertion, 4 deletions, and 2 missense mutations-in the coding region. The mutations reported in previous studies are 2299insC and Arg778Leu. Two patients were shown to have the 2239insC mutation, which has occurred in many different haplotypes in several populations, indicating a mutation hot spot. Primer-extension analysis of ATP7B mRNA has revealed multiple transcription start sites. Four of the novel mutations (three 1-bp changes and one 5-bp deletion) occur in the 5' UTR and may result in altered expression of the WD gene.	UNIV ALBERTA,HERITAGE MED RES CTR 670,DEPT MED GENET,EDMONTON,AB T6G 2M7,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MICROBIOL & MOL GENET,TORONTO,ON,CANADA; OSAKA UNIV,FAC MED,DEPT PEDIAT,OSAKA,JAPAN; KUMAMOTO UNIV,SCH MED,DEPT PEDIAT,KUMAMOTO 860,JAPAN; NATL SAIGATA HOSP,DEPT NEUROL,NIIGATA,JAPAN; BRAIN RES INST,DEPT NEUROL,NIIGATA,JAPAN	University of Alberta; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Osaka University; Kumamoto University								BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chuang LM, 1996, J MED GENET, V33, P521, DOI 10.1136/jmg.33.6.521; Danks D. M, 1995, METABOLIC BASIS INHE, VI, P2211; FIGUS A, 1995, AM J HUM GENET, V57, P1318; Loudianos G, 1996, HUM GENET, V98, P640, DOI 10.1007/s004390050275; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; SCHEINBERG IH, 1984, MAJOR PROBLEMS INTER, V23, P10; SHIMIZU N, 1995, BIOCHEM BIOPH RES CO, V217, P16, DOI 10.1006/bbrc.1995.2739; SOLIOZ M, 1994, FEBS LETT, V346, P44, DOI 10.1016/0014-5793(94)00316-5; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; THOMAS GR, 1993, HUM MOL GENET, V2, P1401, DOI 10.1093/hmg/2.9.1401; THOMAS GR, 1995, AM J HUM GENET, V56, P1315; THOMAS GR, 1994, AM J HUM GENET, V54, P71; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7	20	107	120	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1423	1429		10.1086/515459	http://dx.doi.org/10.1086/515459			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199563	Green Published, Bronze			2022-12-18	WOS:A1997XE29400020
J	Cassidy, SB; Beaudet, AL; Knoll, JHM; Ledbetter, DH; Nicholls, RD; Schwartz, S; Butler, MG; Watson, M				Cassidy, SB; Beaudet, AL; Knoll, JHM; Ledbetter, DH; Nicholls, RD; Schwartz, S; Butler, MG; Watson, M			Diagnostic testing for Prader-Willi and Angelman syndromes: Report of the ASHC/ACMC Test and Technology Transfer Committee	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material											Cassidy, SB (corresponding author), CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,10900 EUCLID AVE,CLEVELAND,OH 44106, USA.							BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; DELACH JA, 1994, AM J MED GENET, V52, P85, DOI 10.1002/ajmg.1320520117; GILLESSENKAESBACH G, 1995, J MED GENET, V32, P88, DOI 10.1136/jmg.32.2.88; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; NICHOLLS RD, 1993, CURR OPIN GENET DEV, V3, P445, DOI 10.1016/0959-437X(93)90119-A; REIS A, 1994, AM J HUM GENET, V54, P741; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; WHITE LM, 1995, AM J MED GENET, V55, P221	11	107	110	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					1085	1088						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651269				2022-12-18	WOS:A1996UH19200021
J	CASTIGLIONE, CM; DEINARD, AS; SPEED, WC; SIRUGO, G; ROSENBAUM, HC; ZHANG, Y; GRANDY, DK; GRIGORENKO, EL; BONNETAMIR, B; PAKSTIS, AJ; KIDD, JR; KIDD, KK				CASTIGLIONE, CM; DEINARD, AS; SPEED, WC; SIRUGO, G; ROSENBAUM, HC; ZHANG, Y; GRANDY, DK; GRIGORENKO, EL; BONNETAMIR, B; PAKSTIS, AJ; KIDD, JR; KIDD, KK			EVOLUTION OF HAPLOTYPES AT THE DRD2 LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOPAMINE-D2 RECEPTOR GENE; NUCLEAR-DNA POLYMORPHISMS; D2-DOPAMINE RECEPTOR; MITOCHONDRIAL-DNA; D2 RECEPTOR; POPULATION; ASSOCIATION; EXPRESSION; ALCOHOLISM; SEQUENCE	We present here the first evolutionary perspective on haplotypes at DRD2, the locus for the dopamine D-2 receptor. The dopamine D-2 receptor plays a critical role in the functioning of many neural circuits in the human brain. If functionally relevant variation at the DRD2 locus exists, understanding the evolution of haplotypes on the basis of polymorphic sites encompassing the gene should provide a powerful framework for identifying that variation. Three DRD2 polymorphisms (TaqI ''A'' and ''B'' RFLPs and the (CA)(n) short tandem repeat polymorphism) encompassing the coding sequences have been studied in 15 populations; these markers are polymorphic in all the populations studied, and they display strong and significant linkage disequilibria with each other. The common haplotypes for the two TaqI RFLPs are separately derived from the ancestral haplotype but predate the spread of modern humans around the world. The knowledge of how the various haplotypes have evolved, the allele frequencies of the haplotypes in human populations, and the physical relationships of the polymorphisms to each other and to the functional parts of the gene should now allow proper design and interpretation of association studies.	YALE UNIV, SCH MED, DEPT GENET, NEW HAVEN, CT 06520 USA; YALE UNIV, SCH MED, DEPT BIOL, NEW HAVEN, CT 06520 USA; OREGON HLTH SCI UNIV, VOLLUM INST ADV BIOMED RES, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT CELL BIOL & ANAT, PORTLAND, OR 97201 USA; UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA; TEL AVIV UNIV, SACKLER FAC MED, IL-69978 TEL AVIV, ISRAEL	Yale University; Yale University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; Tel Aviv University; Sackler Faculty of Medicine			Grigorenko, Elena/V-2418-2019; Sirugo, Giorgio/L-1628-2016; Sirugo, Giorgio/N-9056-2019		NIAAA NIH HHS [AA09379] Funding Source: Medline; NIMH NIH HHS [MH30929, MH39029] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH030929, P50MH030929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ARAKI K, 1992, NEUROCHEM INT, V21, P91, DOI 10.1016/0197-0186(92)90071-X; BALAZS I, 1992, GENETICS, V131, P191; BARR CL, 1993, BIOL PSYCHIAT, V34, P204, DOI 10.1016/0006-3223(93)90073-M; BOLOS AM, 1990, JAMA-J AM MED ASSOC, V264, P3156; Bowcock A M, 1987, Gene Geogr, V1, P47; Bowcock A M, 1991, Gene Geogr, V5, P151; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; CAVALLISFORZA LL, 1986, COLD SPRING HARB SYM, V51, P411, DOI 10.1101/SQB.1986.051.01.049; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DEVLIN B, IN PRESS GENOMICS; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GANDELMAN KY, 1991, J NEUROCHEM, V56, P1024, DOI 10.1111/j.1471-4159.1991.tb02024.x; GEJMAN PV, 1994, JAMA-J AM MED ASSOC, V271, P204, DOI 10.1001/jama.271.3.204; GELERNTER J, 1989, CYTOGENET CELL GENET, V51, P1002; GELERNTER J, 1994, ARCH NEUROL-CHICAGO, V51, P397, DOI 10.1001/archneur.1994.00540160099012; GELERNTER J, 1990, ARCH GEN PSYCHIAT, V47, P1073; GIUFFRA LA, 1990, GENOMICS, V8, P340, DOI 10.1016/0888-7543(90)90291-2; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; GRANDY DK, 1989, AM J HUM GENET, V45, P778; GRANDY DK, 1993, HUM MOL GENET, V2, P2197, DOI 10.1093/hmg/2.12.2197-a; HAUGE XY, 1991, GENOMICS, V10, P527, DOI 10.1016/0888-7543(91)90431-D; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HIRSCHBERG HZ, 1969, RELIG MIDDLE E 3 REL, V2, P330; HORAI S, 1993, MOL BIOL EVOL, V10, P23; ITOKAWA M, 1993, BIOCHEM BIOPH RES CO, V196, P1369, DOI 10.1006/bbrc.1993.2404; JORDE LB, 1994, AM J HUM GENET, V54, P884; KIDD JR, 1991, HUM BIOL, V63, P775; KIDD JR, 1993, 4 INT S HUM ID MAD W, P21; LEWONTIN RC, 1964, GENETICS, V49, P49; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; LITT M, 1995, GENOMICS, V27, P101, DOI 10.1006/geno.1995.1011; LU RB, 1995, BIOL PSYCHIATRY, V38; MOUNTAIN JL, 1992, PHILOS T ROY SOC B, V337, P159, DOI 10.1098/rstb.1992.0093; NEVO S, 1992, HUM BIOL, V64, P587; OHARA BF, 1993, HUM HERED, V43, P209, DOI 10.1159/000154133; PARSIAN A, 1991, NUCLEIC ACIDS RES, V19, P6977, DOI 10.1093/nar/19.24.6977-a; Sambrook J., 1989, MOL CLONING LAB MANU; SARKAR G, 1991, GENOMICS, V11, P8, DOI 10.1016/0888-7543(91)90096-W; SEEMAN P, 1993, NEUROPSYCHOPHARMACOL, V8, P137, DOI 10.1038/npp.1993.15; SUAREZ BK, 1994, GENOMICS, V19, P12, DOI 10.1006/geno.1994.1005; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; TEMPLETON AR, 1993, GENETICS, V134, P659; TORRONI A, 1992, GENETICS, V130, P153; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WATKINS WS, 1994, AM J HUM GENET, V55, P348	48	107	109	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1445	1456						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533775				2022-12-18	WOS:A1995TE65500023
J	SCHERER, SW; POORKAJ, P; ALLEN, T; KIM, J; GESHURI, D; NUNES, M; SODER, S; STEPHENS, K; PAGON, RA; PATTON, MA; BERG, MA; DONLON, T; RIVERA, H; PFEIFFER, RA; NARITOMI, K; HUGHES, H; GENUARDI, M; GURRIERI, F; NERI, G; LOVREIN, E; MAGENIS, E; TSUI, LC; EVANS, JP				SCHERER, SW; POORKAJ, P; ALLEN, T; KIM, J; GESHURI, D; NUNES, M; SODER, S; STEPHENS, K; PAGON, RA; PATTON, MA; BERG, MA; DONLON, T; RIVERA, H; PFEIFFER, RA; NARITOMI, K; HUGHES, H; GENUARDI, M; GURRIERI, F; NERI, G; LOVREIN, E; MAGENIS, E; TSUI, LC; EVANS, JP			FINE MAPPING OF THE AUTOSOMAL-DOMINANT SPLIT HAND SPLIT FOOT LOCUS ON CHROMOSOME-7, BAND Q21.3-Q22.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LONG-ARM DELETION; REGIONAL LOCALIZATION; INTERSTITIAL DELETION; CYSTIC-FIBROSIS; GENE; DNA; PROTEIN; HAND; CLONING; BETA	Split hand/split foot (SHFD) is a human developmental defect characterized by missing digits, fusion of remaining digits, and a deep median cleft in the hands and feet. Cytogenetic studies of deletions and translocations associated with this disorder have indicated that an autosomal dominant split hand/split foot locus (gene SHFD1) maps to 7q21-q22. To characterize the SHFD1 locus, somatic cell hybrid lines were constructed from cytogenetically abnormal individuals with SHFD. Molecular analysis resulted in the localization of 93 DNA markers to one of 10 intervals surrounding the SHFD1 locus. The translocation breakpoints in four SHFD patients were encompassed by the smallest region of overlap among the SHFD-associated deletions. The order of DNA markers in the SHFD1 critical region has been defined as PON-D7S812-SHFD1-D7S811-ASNS. One DNA marker, D7S811, detected altered restriction enzyme fragments in three patients with translocations when examined by pulsed-field gel electrophoresis (PFGE). These data map SHFD1, a gene that is crucial for human limb differentiation, to a small interval in the q21.3-q22.1 region of human chromosome 7.	UNIV WASHINGTON, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON, CANADA; HOSP SICK CHILDREN, RES INST, DEPT GENET, TORONTO M5G 1X8, ON, CANADA; ST GEORGE HOSP, SCH MED, SW THAMES REG GEN SERV, LONDON, ENGLAND; STANFORD UNIV, DEPT GENET, PALO ALTO, CA 94304 USA; STANFORD UNIV, DEPT PEDIAT, PALO ALTO, CA 94304 USA; STANFORD UNIV, DEPT PATHOL, PALO ALTO, CA 94304 USA; STANFORD UNIV, HOWARD HUGHES MED INST, PALO ALTO, CA 94304 USA; UNIV ERLANGEN NURNBERG, INST HUMANGENET, W-8520 ERLANGEN, GERMANY; CTR MED OCCIDENTE, DIV GENET, GUADALAJARA, MEXICO; UNIV RYUKYUS, SCH MED, DEPT PEDIAT, NISHIHARA, OKINAWA 90301, JAPAN; UNIV WALES HOSP, INST MED GENET, CARDIFF CF4 4XN, S GLAM, WALES; UNIV CATTOLICA SACRO CUORE, IST GENET MED, ROME, ITALY; OREGON HLTH SCI UNIV, CTR CHILD DEV REHABIL, PORTLAND, OR 97201 USA	University of Washington; University of Washington Seattle; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); St Georges University London; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Erlangen Nuremberg; University of the Ryukyus; Cardiff University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Oregon Health & Science University			RIVERA, HORACIO/N-9557-2013; Allen, Todd/F-5473-2011; Scherer, Stephen W./B-3785-2013; Genuardi, Maurizio/K-3049-2018; Gurrieri, Fiorella/K-3214-2016; Tsui, Lap-chee/A-1081-2010	Allen, Todd/0000-0002-6609-1318; Scherer, Stephen W./0000-0002-8326-1999; Genuardi, Maurizio/0000-0002-7410-8351; Gurrieri, Fiorella/0000-0002-6775-5972; 				AHMAD M, 1987, HUM GENET, V75, P169, DOI 10.1007/BF00591081; Akita S, 1993, Clin Dysmorphol, V2, P62; ANDRULIS IL, 1987, MOL CELL BIOL, V7, P2435, DOI 10.1128/MCB.7.7.2435; BOSMA PJ, 1988, J BIOL CHEM, V263, P9129; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Del Porto G, 1983, Pathologica, V75 Suppl, P268; EHRLICH G, 1992, GENOMICS, V13, P1192, DOI 10.1016/0888-7543(92)90037-S; FONG HKW, 1987, P NATL ACAD SCI USA, V84, P3792, DOI 10.1073/pnas.84.11.3792; FOX MF, 1992, ANN HUM GENET, V56, P281, DOI 10.1111/j.1469-1809.1992.tb01154.x; FREIREMAIA A, 1971, J HERED, V62, P53, DOI 10.1093/oxfordjournals.jhered.a108124; FUKUSHIMA Y, 1993, CLIN GENET, V44, P50; FUKUYAMA R, 1991, GENOMICS, V11, P410, DOI 10.1016/0888-7543(91)90149-9; GENUARDI M, 1993, AM J MED GENET, V47, P823, DOI 10.1002/ajmg.1320470606; GUISE KS, 1985, GENE, V34, P105, DOI 10.1016/0378-1119(85)90300-2; HAQUE MFU, 1993, HUM GENET, V91, P17; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; HELMS C, 1992, GENOMICS, V14, P1041, DOI 10.1016/S0888-7543(05)80128-4; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KERE J, 1989, BLOOD, V73, P230; KERE J, 1989, NUCLEIC ACIDS RES, V17, P1511, DOI 10.1093/nar/17.4.1511; LAW ML, 1986, P NATL ACAD SCI USA, V83, P6920, DOI 10.1073/pnas.83.18.6920; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P874; McMullen G, 1913, BIOMETRIKA, V9, P381; MOREY MA, 1990, AM J MED GENET, V35, P95, DOI 10.1002/ajmg.1320350118; NARITOMI K, 1993, AM J MED GENET, V46, P492, DOI 10.1002/ajmg.1320460505; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NELSON K, 1989, NEW ENGL J MED, V320, P19, DOI 10.1056/NEJM198901053200104; NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50; OBRIEN WE, 1986, P NATL ACAD SCI USA, V83, P7211, DOI 10.1073/pnas.83.19.7211; Pearson K, 1908, BIOMETRIKA, V6, P69, DOI 10.2307/2331557; PFEIFFER RA, 1984, ANN GENET-PARIS, V27, P45; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454; PUCK JM, 1989, AM J HUM GENET, V44, P724; RIVERA H, 1991, Genetic Counseling, V2, P27; ROBERTS SH, 1991, J MED GENET, V28, P479, DOI 10.1136/jmg.28.7.479; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHERER S, 1991, P33; SCHERER SW, 1993, HUM MOL GENET, V2, P751, DOI 10.1093/hmg/2.6.751; SHARLAND M, 1991, AM J MED GENET, V39, P413, DOI 10.1002/ajmg.1320390410; SOLBERG R, 1992, GENOMICS, V14, P63, DOI 10.1016/S0888-7543(05)80284-8; STEVENSON AC, 1960, ANN HUM GENET, V24, P89; TAJARA EH, 1989, AM J MED GENET, V32, P192, DOI 10.1002/ajmg.1320320212; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; Temtamy SA, 1978, GENETICS HAND MALFOR; TSIPOURAS P, 1984, AM J HUM GENET, V36, P1172; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; TSUI LC, 1991, CYTOGENET CELL GENET, V58, P337, DOI 10.1159/000133167; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; VERMA IC, 1976, CLIN GENET, V9, P8; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAINWRIGHT BJ, 1987, AM J HUM GENET, V41, P944; WINQVIST R, 1993, CYTOGENET CELL GENET, V64, P64, DOI 10.1159/000133563	54	107	111	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					12	20						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023840				2022-12-18	WOS:A1994NW46100003
J	ROBINSON, WP; BERNASCONI, F; BASARAN, S; YUKSELAPAK, M; NERI, G; SERVILLE, F; BALICEK, P; HALUZA, R; FARAH, LMS; LULECI, G; SCHINZEL, AA				ROBINSON, WP; BERNASCONI, F; BASARAN, S; YUKSELAPAK, M; NERI, G; SERVILLE, F; BALICEK, P; HALUZA, R; FARAH, LMS; LULECI, G; SCHINZEL, AA			A SOMATIC ORIGIN OF HOMOLOGOUS ROBERTSONIAN TRANSLOCATIONS AND ISOCHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; UNIPARENTAL ISODISOMY; MOLECULAR DIAGNOSIS; DNA METHYLATION; NORMAL DAUGHTER; BLOOMS SYNDROME; DOWNS-SYNDROME; MOSAICISM; MOTHER; CHROMOSOME-14	One t(14q14q), three t(15q15q), two t(21q21q), and two t(22q22q) nonmosaic, apparently balanced, de novo Robertsonian translocation cases were investigated with polymorphic markers to establish the origin of the translocated chromosomes. Four cases had results indicative of an isochromosome: one t(14q14q) case with mild mental retardation and maternal uniparental disomy (UPD) for chromosome 14, one t(15q15q) case with the Prader-Willi syndrome and UPD(15), a phenotypically normal carrier of t(22q22q) with maternal UPD(22), and a phenotypically normal t(21q21q) case of paternal UPD(21). All UPD cases showed complete homozygosity throughout the involved chromosome, which is supportive of a postmeiotic origin. In the remaining four cases, maternal and paternal inheritance of the involved chromosome was found, which unambiguously implies a somatic origin. One t(15q15q) female had a child with a ring chromosome 15, which was also of probable postmeiotic origin as recombination between grandparental haplotypes had occurred prior to ring formation. UPD might be expected to result from de novo Robertsonian translocations of meiotic origin; however, all de novo homologous translocation cases, so far reported, with UPD of chromosomes 14, 15, 21, or 22 have been isochromosomes. These data provide the first direct evidence that nonmosaic Robertsonian translocations, as well as isochromosomes, are commonly the result of a mitotic exchange.	UNIV ISTANBUL,PRENATAL DIAG & RES CTR,ISTANBUL,TURKEY; UNIV ISTANBUL,INST CHILD HLTH,ISTANBUL,TURKEY; UNIV CATTOLICA,IST GENET MED,ROME,ITALY; CHU BORDEAUX,HOP ENFANTS PELLEGRIN,UNITE GENET,BORDEAUX,FRANCE; UNIV HOSP HRADEC KRALOVE,MOLEC GENET LAB,HRADEC KRALOVE,CZECH REPUBLIC; ESCUOLA PAULISTA MED,DEPT MORFOL,DISCIPLINA GENET,SAO PAULO,SP,BRAZIL; AKDENIZ UNIV,DIV MED BIOL & GENET,ANTALYA,TURKEY	Istanbul University; Istanbul University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; CHU Bordeaux; University Hospital Hradec Kralove; Akdeniz University	ROBINSON, WP (corresponding author), UNIV ZURICH,INST MED GENET,RAMISTR 74,CH-8001 ZURICH,SWITZERLAND.		Robinson, Wendy/AAB-6420-2020; Basaran, Seher/AAC-5463-2020; Robinson, Wendy P/I-9590-2014	Robinson, Wendy/0000-0002-2010-6174; Robinson, Wendy P/0000-0002-2010-6174				ANDERSON CE, 1979, AM J HUM GENET, V31, pA87; ANTONARAKIS SE, 1990, AM J HUM GENET, V47, P968; ANTONARAKIS SE, 1993, AM J HUM GENET, V52, P1145; ATKINS L, 1974, J MED GENET, V11, P306, DOI 10.1136/jmg.11.3.306; BLOUIN JL, 1993, AM J HUM GENET, V53, P1074; BOWCOCK AM, 1992, GENOMICS, V14, P833, DOI 10.1016/S0888-7543(05)80101-6; BREED ASPM, 1990, PRENATAL DIAG, V10, P101, DOI 10.1002/pd.1970100206; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CANTU ES, 1989, CLIN GENET, V36, P189; CREAUGOLDBERG N, 1987, HUM GENET, V76, P396, DOI 10.1007/BF00272452; DALLAPICCOLA B, 1982, ANN GENET-PARIS, V25, P56; DEALMEIDA JCC, 1983, ANN GENET-PARIS, V26, P112; DELPOL A, 1979, PATHOLOGY, V71, P410; DERKALOUSTIAN YM, 1987, HUM GENET, V75, P97; DITTRICH B, 1992, HUM GENET, V90, P313; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; DUCKETT DP, 1992, ANN GENET-PARIS, V35, P113; EMBERGER JM, 1972, ANN GENET-PARIS, V15, P111; FARAH LMS, 1975, HUMANGENETIK, V28, P357; FREEMAN SB, 1993, AM J MED GENET, V45, P625, DOI 10.1002/ajmg.1320450522; FRYNS JP, 1979, HUM GENET, V46, P237, DOI 10.1007/BF00291927; FRYNS JP, 1979, HUM GENET, V47, P213, DOI 10.1007/BF00273205; FRYNS JP, 1989, ANN GENET, V332, P177; GARDNER RJM, 1989, CHROMOSOME ABNORMALI, P54; GRASSO M, 1989, HUM GENET, V84, P63, DOI 10.1007/BF00210673; GRAVHOLT CH, 1992, GENOMICS, V14, P924, DOI 10.1016/S0888-7543(05)80113-2; GUANTI G, 1978, HUM GENET, V45, P355, DOI 10.1007/BF00278735; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HALL JG, 1988, AM J HUM GENET, V43, P355; HAMABE J, 1991, AM J MED GENET, V41, P54, DOI 10.1002/ajmg.1320410116; HORNSTEIN I, 1976, CLIN GENET, V9, P417; HSU LYF, 1984, PRENATAL DIAG, V4, P97, DOI 10.1002/pd.1970040708; HSU TC, 1978, CYTOGENET CELL GENET, V21, P86, DOI 10.1159/000130881; JACOBS PA, 1976, AM J HUM GENET, V28, P567; JALAL SM, 1990, ANN GENET-PARIS, V33, P173; KIRKELS VGHJ, 1980, CLIN GENET, V18, P456; KUHN EM, 1976, CHROMOSOMA, V57, P1, DOI 10.1007/BF00292945; LEDBETTER DH, 1987, AM J MED GENET, V28, P779, DOI 10.1002/ajmg.1320280402; LEDBETTER DH, 1992, PRENATAL DIAG, V12, P317, DOI 10.1002/pd.1970120503; LIPPMAN A, 1992, PRENATAL DIAG, V12, P385, DOI 10.1002/pd.1970120508; LORDASANCHEZ I, 1991, AM J HUM GENET, V49, P1034; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MARK HFL, 1977, J MED GENET, V14, P221, DOI 10.1136/jmg.14.3.221; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; MINY P, 1991, PRENATAL DIAG, V11, P581, DOI 10.1002/pd.1970110815; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; MUTIRANGURA A, IN PRESS GENOMICS; NERI G, 1983, AM J MED GENET, V14, P307, DOI 10.1002/ajmg.1320140211; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; ORYE E, 1974, HUM HERED, V24, P253, DOI 10.1159/000152658; PAGON RA, 1979, AM J HUM GENET, V31, P54; PALMER CG, 1980, CLIN GENET, V17, P418; PANGALOS C, 1984, ANN GENET-PARIS, V27, P38; PENTAO L, 1992, AM J HUM GENET, V50, P690; PETERSEN MB, 1992, GENOMICS, V13, P269, DOI 10.1016/0888-7543(92)90242-K; PRIEST JH, 1977, J PEDIATR-US, V90, P786, DOI 10.1016/S0022-3476(77)81252-3; PUNNETT H, 1981, AM J HUM GENET, V33, pA115; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; SCHINZEL A, 1990, ANN GENET-PARIS, V33, P60; Schinzel A, 1984, CATALOGUE UNBALANCED; SCHINZEL AA, 1994, AM J HUM GENET, V54, P21; SHAFFER LG, 1991, HUM GENET, V86, P375; SPINNER NB, 1992, PRENATAL DIAG, V12, P47, DOI 10.1002/pd.1970120107; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; THERMAN E, 1989, ANN HUM GENET, V53, P49, DOI 10.1111/j.1469-1809.1989.tb01121.x; THERMAN E, 1981, CHROMOSOMA, V82, P627, DOI 10.1007/BF00285772; Therman E., 1993, HUMAN CHROMOSOMES, P288; THOMAS IT, 1989, AM J HUM GENET, V45, P193; VANDYKE DL, 1987, CLIN GENET, V32, P75; VIANNAMORGANTE AM, 1978, J MED GENET, V15, P305, DOI 10.1136/jmg.15.4.305; WANG JCC, 1991, AM J HUM GENET, V48, P1069; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOLFF DJ, 1992, AM J HUM GENET, V50, P174; ZIZKA J, 1977, HUM GENET, V36, P123, DOI 10.1007/BF00390444	75	107	110	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1994	54	2					290	302						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU315	8304346				2022-12-18	WOS:A1994MU31500014
J	COON, H; BYERLEY, W; HOLIK, J; HOFF, M; MYLESWORSLEY, M; LANNFELT, L; SOKOLOFF, P; SCHWARTZ, JC; WALDO, M; FREEDMAN, R; PLAETKE, R				COON, H; BYERLEY, W; HOLIK, J; HOFF, M; MYLESWORSLEY, M; LANNFELT, L; SOKOLOFF, P; SCHWARTZ, JC; WALDO, M; FREEDMAN, R; PLAETKE, R			LINKAGE ANALYSIS OF SCHIZOPHRENIA WITH 5 DOPAMINE RECEPTOR GENES IN 9 PEDIGREES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUDITORY EVOKED-RESPONSES; MOLECULAR-CLONING; CHROMOSOME-5; EXPRESSION; CDNA; RFLP; D1; AFFINITY; BINDING; REGION	Alterations in dopamine neurotransmission have been strongly implicated in the pathogenesis of schizophrenia for nearly 2 decades. Recently, the genes for five dopamine receptors have been cloned and characterized, and genetic and physical map information has become available. Using these five loci as candidate genes, we have tested for genetic linkage to schizophrenia in nine multigenerational families which include multiple affected individuals. In addition to testing conservative disease models, we have used a neurophysiological indicator variable, the P50 auditory evoked response.. Deficits in gating of the P50 response have been shown to segregate with schizophrenia in this sample and may,identify carriers of gene(s) predisposing for schizophrenia. Linkage results were consistently negative, indicating that a defect at any of the actual receptor sites is unlikely to be a major contributor to schizophrenia in the nine families studied.	UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132; KAROLINSKA INST,DEPT GERIATR MED,S-10401 STOCKHOLM 60,SWEDEN; INSERM,UNITE NEUROBIOL & PHARMACOL,F-75005 PARIS,FRANCE; UNIV COLORADO,HLTH SCI CTR,DEPT PSYCHIAT,DENVER,CO 80262	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	COON, H (corresponding author), UNIV UTAH,SCH MED,DEPT PSYCHIAT,50 N MED DR,SALT LAKE CITY,UT 84132, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042643, F32MH010168, P50MH044212] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-44212, MH-42643, MH10168-F32] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADLER LE, 1988, BIOL PSYCHIAT, V24, P179, DOI 10.1016/0006-3223(88)90273-9; ADLER LE, 1990, PSYCHIAT RES, V31, P297, DOI 10.1016/0165-1781(90)90099-Q; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BUETOW KH, 1991, AM J HUM GENET, V48, P911; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; BYERLEY WF, 1989, MAY ANN M AM PSYCH A; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CROSS AJ, 1981, PSYCHOPHARMACOLOGY, V74, P122, DOI 10.1007/BF00432676; DAVIDSON M, 1987, AM J PSYCHIAT, V144, P934; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; EUBANKS JH, 1992, GENOMICS, V12, P510, DOI 10.1016/0888-7543(92)90442-U; FREEDMAN R, 1983, BIOL PSYCHIAT, V18, P537; FREEDMAN R, 1987, SCHIZOPHRENIA BULL, V13, P669, DOI 10.1093/schbul/13.4.669; GIROS B, 1990, CR ACAD SCI III-VIE, V311, P501; GLOOR P, 1986, LIMBIC SYSTEM FUNCTI, P159; GOTTESMAN II, 1991, SCHIZOPHRENIA GENETI; GRANDY DK, 1990, AM J HUM GENET, V47, P828; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; HAUGE XY, 1991, GENOMICS, V10, P527, DOI 10.1016/0888-7543(91)90431-D; JENSEN S, IN PRESS HUM HERED; JUDD LL, 1992, AM J PSYCHIAT, V149, P488; JUNIEN C, 1992, GENOMICS, V12, P620, DOI 10.1016/0888-7543(92)90461-Z; KIRCH D G, 1986, P325; LANNFELT L, IN PRESS PSYCHIATR G; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEWIN DI, 1991, J NIH RES, V3, P58; LITT M, 1991, NUCLEIC ACIDS RES, V19, P3161, DOI 10.1093/nar/19.11.3161-a; MOISES HW, 1991, ARCH GEN PSYCHIAT, V48, P643; NAGAMOTO HT, 1989, BIOL PSYCHIAT, V25, P549, DOI 10.1016/0006-3223(89)90215-1; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PATTERSON T, 1986, SCHIZOPHRENIA BULL, V12, P460, DOI 10.1093/schbul/12.3.460; PLAETKE R, 1992, GENET EPIDEMIOL, V8, P425; SEEMAN P, 1984, SCIENCE, V225, P728, DOI 10.1126/science.6147018; SIEGEL C, 1984, ARCH GEN PSYCHIAT, V41, P607; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SUNAHARA RK, 1990, NATURE, V347, P80, DOI 10.1038/347080a0; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; WALDO MC, 1986, PSYCHIAT RES, V19, P233, DOI 10.1016/0165-1781(86)90102-2; WALDO MC, 1991, PSYCHIAT RES, V39, P257, DOI 10.1016/0165-1781(91)90092-4; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEIFFENBACH B, 1991, GENOMICS, V10, P173, DOI 10.1016/0888-7543(91)90498-4; WYATT RJ, 1988, SCHIZOPHR RES, V1, P3, DOI 10.1016/0920-9964(88)90034-5; ZHOU QY, 1990, NATURE, V347, P76, DOI 10.1038/347076a0	47	107	107	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					327	334						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8094267				2022-12-18	WOS:A1993KN27500011
J	GIBBONS, RJ; SUTHERS, GK; WILKIE, AOM; BUCKLE, VJ; HIGGS, DR				GIBBONS, RJ; SUTHERS, GK; WILKIE, AOM; BUCKLE, VJ; HIGGS, DR			X-LINKED ALPHA-THALASSEMIA MENTAL-RETARDATION (ATR-X) SYNDROME - LOCALIZATION TO XQ12-Q21.31 BY X INACTIVATION AND LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME NONDELETIONAL TYPE; GLOBIN GENE-CLUSTER; CLINICAL-FEATURES; MOLECULAR ANALYSIS; CHROMOSOME; CHOROIDEREMIA; LOCUS; XQ21; INHERITANCE; DIAGNOSIS	We have examined seven pedigrees that include individuals with a recently described X-linked form of severe mental retardation associated with alpha-thalassemia (ATR-X syndrome). Using hematologic and molecular approaches, we have shown that intellectually normal female carriers of this syndrome may be identified by the presence of rare cells containing HbH inclusions in their peripheral blood and by an extremely skewed pattern of X inactivation seen in cells from a variety of tissues. Linkage analysis has localized the ATR-X locus to an interval of approximately 11 cM between the loci DXS106 and DXYS1X (Xq12-q21.31), with a peak LOD score of 5.4 (recombination fraction of 0) at DXS72. These findings provide the basis for genetic counseling, assessment of carrier risk, and prenatal diagnosis of the ATR-X syndrome. Furthermore, they represent an important step in developing strategies to understand how the mutant ATR-X allele causes mental handicap, dysmorphism, and down-regulation of the alpha-globin genes.	JOHN RADCLIFFE HOSP,MRC,MOLEC HAEMATOL UNIT,HEADINGTON,OXFORD OX3 9DU,ENGLAND; UNIV HOSP WALES,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC GENET GRP,OXFORD OX3 9DU,ENGLAND	Cardiff University; University of Oxford			Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481				ARVEILER B, 1988, AM J MED GENET, V30, P473, DOI 10.1002/ajmg.1320300150; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWNE DL, 1991, NUCLEIC ACIDS RES, V19, P1721, DOI 10.1093/nar/19.7.1721-a; CHOWCHECK FS, 1985, AM J MED GENET, V20, P307; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLE TRP, 1991, J MED GENET, V28, P734, DOI 10.1136/jmg.28.11.734; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; DONNAI D, 1991, J MED GENET, V28, P742, DOI 10.1136/jmg.28.11.742; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; FRASER NJ, 1989, GENOMICS, V5, P144, DOI 10.1016/0888-7543(89)90099-2; GIBBONS RJ, 1991, J MED GENET, V28, P729, DOI 10.1136/jmg.28.11.729; GLASS IA, 1991, J MED GENET, V28, P361, DOI 10.1136/jmg.28.6.361; GOLDBLATT J, 1989, CLIN GENET, V35, P116; HARVEY MP, 1990, J MED GENET, V27, P577, DOI 10.1136/jmg.27.9.577; HENDRIKS RW, 1991, CLIN EXP IMMUNOL, V84, P219; HIGGS DR, 1989, BLOOD, V73, P1081; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; HODGSON SV, 1987, HUM GENET, V75, P286, DOI 10.1007/BF00281076; Hopkins B., 1989, TECHNIQUE, V1, P96; JARMAN AP, 1991, MOL CELL BIOL, V11, P4679, DOI 10.1128/MCB.11.9.4679; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; LANGE K, 1986, AM J HUM GENET, V38, P681; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MAHTANI MM, 1991, GENOMICS, V10, P849, DOI 10.1016/0888-7543(91)90172-B; MATTEI MG, 1982, HUM GENET, V61, P295; MERRY DE, 1989, AM J HUM GENET, V45, P530; MIGEON BR, 1971, AM J HUM GENET, V23, P199; MILES JH, 1991, AM J MED GENET, V38, P215, DOI 10.1002/ajmg.1320380209; NANCE WE, 1964, SPR COLD HARB SYMP Q, V29, P415; NYHAN WL, 1970, P NATL ACAD SCI USA, V65, P214, DOI 10.1073/pnas.65.1.214; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; OTT J, 1985, ANAL HUMAN GENETIC L; PORTEOUS MEM, 1990, J MED GENET, V27, P339, DOI 10.1136/jmg.27.5.339; SAMANNS C, 1988, American Journal of Human Genetics, V43, pA157; SCHWABER J, 1990, Immunodeficiency Reviews, V2, P233; SCHWARTZ CE, 1990, AM J HUM GENET, V47, P454; SUTHERLAND GR, 1988, AM J MED GENET, V30, P493, DOI 10.1002/ajmg.1320300152; SUTHERS GK, 1990, AM J HUM GENET, V47, P53; SUTHERS GK, 1988, AM J MED GENET, V30, P485, DOI 10.1002/ajmg.1320300151; THODE A, 1988, AM J MED GENET, V30, P239, DOI 10.1002/ajmg.1320300125; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; WELLS S, 1991, J MED GENET, V28, P163, DOI 10.1136/jmg.28.3.163; WIEACKER P, 1987, AM J MED GENET, V28, P245, DOI 10.1002/ajmg.1320280137; WILKIE AOM, 1991, J MED GENET, V28, P738, DOI 10.1136/jmg.28.11.738; WILKIE AOM, 1991, J MED GENET, V28, P724, DOI 10.1136/jmg.28.10.724; WILKIE AOM, 1990, AM J HUM GENET, V46, P1127; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; WILSON M, 1991, AM J MED GENET, V40, P406, DOI 10.1002/ajmg.1320400405; WINKELSTEIN JA, 1990, J ALLERGY CLIN IMMUN, V85, P1090, DOI 10.1016/0091-6749(90)90055-9; YOUNG ID, 1991, INTRO RISK CALCULATI	53	107	110	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1136	1149						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1415255				2022-12-18	WOS:A1992JU84000024
J	DEEB, SS; LINDSEY, DT; HIBIYA, Y; SANOCKI, E; WINDERICKX, J; TELLER, DY; MOTULSKY, AG				DEEB, SS; LINDSEY, DT; HIBIYA, Y; SANOCKI, E; WINDERICKX, J; TELLER, DY; MOTULSKY, AG			GENOTYPE-PHENOTYPE RELATIONSHIPS IN HUMAN RED GREEN COLOR-VISION DEFECTS - MOLECULAR AND PSYCHOPHYSICAL STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VISUAL PIGMENTS; CONE PIGMENTS; GENES; GENETICS; DNA; POLYMERASE; RHODOPSIN; ANCESTRY; BIOLOGY; XQ28	The relationship between the molecular structure of the X-linked red and green visual pigment genes and color-vision phenotype as ascertained by anomaloscopy was studied in 64 color-defective males. The great majority of red-green defects were associated with either the deletion of the green-pigment gene or the formation of 5' red-green hybrid genes or 5' green-red hybrid genes. A rapid PCR-based method allowed detection of hybrid genes, including those undetectable by Southern blot analysis, as well as more precise localization of the fusion points in hybrid genes. Protan color-vision defects appeared always associated with 5' red-green hybrid genes. Carriers, of single red-green hybrid genes with fusion in introns 1-4 were protanopes. However, carriers of hybrid genes with red-green fusions in introns 2, 3, or 4 in the presence of additional normal green genes manifested as either protanopes or protanomalous trichromats, with the majority being protanomalous. Deutan defects were associated with green-pigment gene deletions, with 5' green-red hybrid genes, or, rarely, with 5' green-red-green hybrid genes. Complete green-pigment gene deletions or green-red fusions in intron 1 were usually associated with deuteranopia, although we unexpectedly found three carriers of a single red-pigment gene without any green-pigment genes to be deuteranomalous trichromats. All but one of the other deuteranomalous subjects had green-red hybrid genes with intron 1, 2, 3, or 4 fusions, as well as several normal green-pigment genes. The one exception had a grossly normal gene array, presumably with a more subtle mutation. Amino acid differences in exon 5 largely determine whether a hybrid gene will be more redlike or more greenlike in phenotype. Various discrepancies as to severity (dichromacy or trichromacy) remain unexplained but may arise because of variability of expression, postreceptoral variation, or both. When phenotypic color-vision defects exist, the kind of defect (protan or deutan) can be predicted by molecular analysis. Red-green hybrid genes are probably always associated with protan color-vision defects, while the presence of green-red hybrid genes may not always manifest phenotypically with color-vision defects. Four subjects who were found to have 5' green-red hybrid genes in addition to normal red- and green-pigment genes had normal color vision as determined by anomaloscopy. These were discovered among a group of 129 Caucasian males who had been recruited as volunteers for a vision study. We hypothesize that green-red hybrid genes in a more distal (3') position of a gene array that includes one or more normal green genes may not be expressed sufficiently to measurably affect color vision.	UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PSYCHOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	DEEB, SS (corresponding author), UNIV WASHINGTON,DEPT GENET,SK-50,SEATTLE,WA 98195, USA.				NEI NIH HHS [EY07031, EY07078, EY08395] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008395] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALPERN M, 1977, J PHYSIOL-LONDON, V266, P595, DOI 10.1113/jphysiol.1977.sp011784; APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; Birch J., 1979, CONGENITAL ACQUIRED, P83; BRETON ME, 1981, J OPT SOC AM, V71, P1220, DOI 10.1364/JOSA.71.001220; CHABRE M, 1982, METHOD ENZYMOL, V81, P605; Cornsweet T., 1970, VISUAL PERCEPTION; DRUMMONDBORG M, 1989, P NATL ACAD SCI USA, V86, P983, DOI 10.1073/pnas.86.3.983; DRUMMONDBORG M, 1988, AM J HUM GENET, V43, P675; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; HURVICH LM, 1972, HDB SENSORY PHYSIOLO, V7, P582; JORGENSEN AL, 1990, P NATL ACAD SCI USA, V87, P6512, DOI 10.1073/pnas.87.17.6512; KOSOWER EM, 1988, P NATL ACAD SCI USA, V85, P1076, DOI 10.1073/pnas.85.4.1076; LINKSZ A, 1964, ESSAY COLOR VISION C; NAGY AL, 1980, J OPT SOC AM, V70, P778, DOI 10.1364/JOSA.70.000778; NAGY AL, 1987, VISION RES, V27, P483, DOI 10.1016/0042-6989(87)90096-4; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NATHANS J, 1987, ANNU REV NEUROSCI, V10, P163; NEITZ J, 1989, NATURE, V342, P679, DOI 10.1038/342679a0; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; NEITZ M, 1987, Investigative Ophthalmology and Visual Science, V28, P91; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PINCKERS AJL, 1979, CONGENITAL ACQUIRED, P71; POKORNY J, 1987, FRONTIERS VISUAL SCI, P150; POKORNY J, 1982, COLOR RES, V7, P483; RAYLEIGH, 1881, NATURE, V25, P64; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT J, 1779, PHILOS T R SOC LOND, V8, P612; THOMAS DD, 1982, J MOL BIOL, V154, P145, DOI 10.1016/0022-2836(82)90422-3; THULINE TC, 1969, AM J HUM GENET, V21, P581; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; Wilson EB, 1911, ARCH MIKROSK ANAT, V77, P249; WINDERICKX J, 1992, NATURE, V356, P431, DOI 10.1038/356431a0; WINDERICKX J, IN PRESS NATURE GENE; Wyszecki Gunter, 1982, COLOR SCI, V8	36	107	109	0	13	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					687	700						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415215				2022-12-18	WOS:A1992JQ66700001
J	LEDBETTER, SA; KUWANO, A; DOBYNS, WB; LEDBETTER, DH				LEDBETTER, SA; KUWANO, A; DOBYNS, WB; LEDBETTER, DH			MICRODELETIONS OF CHROMOSOME-17P13 AS A CAUSE OF ISOLATED LISSENCEPHALY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; MILLER-DIEKER; YEAST; GENE; SEQUENCES; DNA	Lissencephaly (agyria-pachygyria) is a brain malformation manifested by a smooth cerebral surface, resulting from arrest of neuronal migration at 10-14 wk gestation. Type I, or classical, lissencephaly can occur either in association with the Miller-Dieker syndrome (MDS) or as an isolated finding, termed "isolated lissencephaly sequence" (ILS). About 90% of MDS patients have visible or submicroscopic deletions of 17p13.3. We therefore investigated the possibility that some ILS patients have smaller deletions in this chromosomal region. Forty-five ILS patients with gyral abnormalities ranging from complete agyria to mixed agyria/pachygyria and complete pachygyria were studied. RFLP analysis with five polymorphic loci in 17p13.3 was performed on all patients and their parents. Somatic cell hybrids were constructed on three patients, to confirm a deletion or to determine the boundaries of a deletion. In-situ hybridization using cosmid probes from within a newly defined lissencephaly critical region was performed on 31 patients as a further method of deletion detection. Six submicroscopic deletions were detected (13.3%). Three of the deletions among 45 ILS patients were detected by RFLP analysis, 4 deletions in 31 patients were detected by in situ hybridization, and one deletion was detected only by somatic cell hybrid studies (in situ hybridization was not performed). Overall, in situ hybridization proved to be the most rapid and sensitive method of deletion detection. The centromeric boundary of these deletions overlapped that of MDS patients, while the telomeric boundary for four ILS deletions was proximal to that of MDS and narrows the critical region for a lissencephaly locus. These data demonstrate that a locus in 17p13 represents a major genetic etiology for patients with lissencephaly, ranging from complete agyria to pachygyria. In situ hybridization allows rapid and sensitive deletion detection and is the preferred method for diagnostic evaluation of MDS and ILS patients.	INDIANA UNIV,SCH MED,DEPT NEUROL,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	LEDBETTER, SA (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030, USA.		Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; 	NHGRI NIH HHS [HG00024] Funding Source: Medline; NICHD NIH HHS [HD20619, P30 HD24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; DOBYNS WB, 1984, AM J MED GENET, V18, P509, DOI 10.1002/ajmg.1320180320; DOBYNS WB, 1989, NEUROL CLIN, V7, P89, DOI 10.1016/S0733-8619(18)30830-2; DOBYNS WB, IN PRESS NEUROLOGY; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; KUWANO A, 1991, AM J HUM GENET, V49, P707; LEDBETTER DH, 1989, P NATL ACAD SCI USA, V86, P5136, DOI 10.1073/pnas.86.13.5136; LEDBETTER SA, 1990, GENOMICS, V7, P265; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NELSON DL, 1991, P NATL ACAD SCI USA, V88, P6157, DOI 10.1073/pnas.88.14.6157; PAVONE L, 1990, J CHILD NEUROL, V5, P52, DOI 10.1177/088307389000500113; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; TKACHUK DC, 1990, SCIENCE, V250, P559, DOI 10.1126/science.2237408; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANOMMEN GJB, 1986, HUMAN GENETIC DISEAS, P113; WESTERVELD A, 1971, NATURE-NEW BIOL, V234, P20, DOI 10.1038/newbio234020a0	19	107	108	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					182	189						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1346078				2022-12-18	WOS:A1992HA04000019
J	HUEBNER, K; DRUCK, T; CROCE, CM; THIESEN, HJ				HUEBNER, K; DRUCK, T; CROCE, CM; THIESEN, HJ			27 NONOVERLAPPING ZINC FINGER CDNAS FROM HUMAN T-CELLS MAP TO 9 DIFFERENT CHROMOSOMES WITH APPARENT CLUSTERING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR; HUMAN GENES; INSITU HYBRIDIZATION; KRUPPEL FAMILY; HUMAN GENOME; GLI GENE; C-FOS; PROTEIN; DROSOPHILA; LOCALIZATION	cDNA clones encoding zinc finger structures were isolated by screening Molt4 and Jurkat cDNA libraries with zinc finger consensus sequences. Candidate clones were partially sequenced to verify the presence of zinc finger-encoding regions; nonoverlapping cDNA clones were chosen on the basis of sequences and genomic hybridization pattern. Zinc finger structure-encoding clones, which were designated by the term "Kox" and a number from 1 to 32 and which were apparently unique (i.e., distinct from each other and distinct from those isolated by other laboratories), were chosen for mapping in the human genome. DNAs from rodent-human somatic cell hybrids retaining defined complements of human chromosomes were analyzed for the presence of each of the Kox genes. Correlation between the presence of specific human chromosome regions and specific Kox genes established the chromosomal locations. Multiple Kox loci were mapped to 7q (Kox 18 and 25 and a locus detected by both Kox 8 cDNA and Kox 27 cDNA), 8q24 5' to the myc locus (Kox 9 and 32), 10cen-->q24 (Kox 2, 15, 19, 21, 30, and 31) 12q13-qter (Kox 1 and 20), 17p13 (Kox 11 and 26), and 19q (Kox 5, 6, 10, 22, 24, and 28). Single Kox loci were mapped to 7p22 (Kox 3), 18q12 (Kox 17), 19p (Kox 13), 22q11 between IG-lambda and BCR-1 (locus detected by both Kox 8 cDNA and Kox 27 cDNA), and Xp (Kox 14). Several of the Kox loci map to regions in which other zinc finger structure-encoding loci have already been localized, indicating possible zinc finger gene clusters. In addition, Kox genes at 8q24, 17p13, and 22q11-and perhaps other Kox genes-are located near recurrent chromosomal translocation breakpoints. Others, such as those on 7p and 7q, may be near regions specifically active in T cells.	BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND		HUEBNER, K (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,FELS INST CANC RES & MOLEC BIOL,3420 N BROAD ST,PHILADELPHIA,PA 19140, USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NCI NIH HHS [CA39860, CA21124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA039860, P01CA021124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARHEDEN K, 1989, HUM GENET, V82, P1, DOI 10.1007/BF00288260; ASHWORTH A, 1989, GENOMICS, V4, P323, DOI 10.1016/0888-7543(89)90337-6; BAUER SR, 1988, IMMUNOGENETICS, V28, P328, DOI 10.1007/BF00364231; BELLEFROID EJ, 1989, DNA-J MOLEC CELL BIO, V8, P377, DOI 10.1089/dna.1.1989.8.377; BERG JM, 1989, CELL, V57, P1065, DOI 10.1016/0092-8674(89)90042-1; BRAY P, 1990, New Biologist, V2, P325; BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CANNIZZARO LA, 1987, AM J HUM GENET, V41, P1; CHAVRIER P, 1989, MOL CELL BIOL, V9, P787, DOI 10.1128/MCB.9.2.787; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHOWDHURY K, 1987, CELL, V48, P771, DOI 10.1016/0092-8674(87)90074-2; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; DIAKUN GP, 1986, NATURE, V324, P689; DONTI E, 1990, HUM GENET, V84, P391; DRESSLER GR, 1989, DIFFERENTIATION, V41, P193, DOI 10.1111/j.1432-0436.1989.tb00747.x; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; FERRARI S, 1987, AM J HUM GENET, V41, P616; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; GRECO A, 1989, GENOMICS, V4, P240, DOI 10.1016/0888-7543(89)90326-1; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; HARPER PS, 1989, CYTOGENET CELL GENET, V51, P563, DOI 10.1159/000132808; HUEBNER K, 1990, AM J HUM GENET, V46, P26; HUEBNER K, 1988, ONCOGENE RES, V2, P299; HUEBNER K, 1986, AM J HUM GENET, V38, P819; HUEBNER K, 1989, ONCOGENE, V3, P449; HUEBNER K, 1988, ONCOGENE RES, V3, P1; JOHO KE, 1990, CELL, V61, P2983; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KAGAN J, 1989, P NATL ACAD SCI USA, V86, P4162; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; LANIA L, 1990, GENOMICS, V6, P333, DOI 10.1016/0888-7543(90)90574-E; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LESSIN SR, 1988, J INVEST DERMATOL, V91, P572, DOI 10.1111/1523-1747.ep12477087; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; MARTINERIE C, 1990, HUM GENET, V80, P65; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MULLER G, 1989, HUM GENET, V82, P82, DOI 10.1007/BF00288279; NADEAU JH, 1990, GENOMICS, V8, P469, DOI 10.1016/0888-7543(90)90033-Q; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAGE DC, 1990, GENOMICS, V7, P37, DOI 10.1016/0888-7543(90)90516-W; PANNUTI A, 1988, NUCLEIC ACIDS RES, V16, P4227, DOI 10.1093/nar/16.10.4227; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; ROUSSEAUMERCK MF, 1991, GENOMICS, V9, P154, DOI 10.1016/0888-7543(91)90233-5; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; RUSSO G, 1988, CELL, V53, P137, DOI 10.1016/0092-8674(88)90495-3; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; SEITE P, IN PRESS GENOMICS; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; THIESEN H-J, 1990, New Biologist, V2, P363; TRENT JM, 1989, CYTOGENET CELL GENET, V51, P533, DOI 10.1159/000132807; TSICHLIS PN, 1990, J VIROL, V64, P2236, DOI 10.1128/JVI.64.5.2236-2244.1990; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VINCENT A, 1985, J MOL BIOL, V186, P149, DOI 10.1016/0022-2836(85)90265-7	64	107	113	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					726	740						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014798				2022-12-18	WOS:A1991FK47800012
J	ZULIANI, G; HOBBS, HH				ZULIANI, G; HOBBS, HH			A HIGH-FREQUENCY OF LENGTH POLYMORPHISMS IN REPEATED SEQUENCES ADJACENT TO ALU SEQUENCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,5323 HARRY HINES BLVD,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NHLBI NIH HHS [HL 20984] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020984] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAINS W, 1986, J MOL EVOL, V23, P189, DOI 10.1007/BF02115575; BARSH GS, 1983, NUCLEIC ACIDS RES, V11, P3939, DOI 10.1093/nar/11.12.3939; COMB M, 1983, DNA-J MOLEC CELL BIO, V2, P213, DOI 10.1089/dna.1983.2.213; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DUNCAN CH, 1981, GENE, V13, P185, DOI 10.1016/0378-1119(81)90007-X; ECONOMOU E P, 1989, American Journal of Human Genetics, V45, pA138; ELDER JT, 1981, NUCLEIC ACIDS RES, V9, P1171, DOI 10.1093/nar/9.5.1171; FRESCO JR, 1960, P NATL ACAD SCI USA, V46, P311, DOI 10.1073/pnas.46.3.311; FUHRMAN SA, 1981, NUCLEIC ACIDS RES, V9, P6439, DOI 10.1093/nar/9.23.6439; FURUTANI Y, 1986, NUCLEIC ACIDS RES, V14, P3167, DOI 10.1093/nar/14.8.3167; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; HESS JF, 1983, P NATL ACAD SCI-BIOL, V80, P5970, DOI 10.1073/pnas.80.19.5970; HUANG LS, 1989, J BIOL CHEM, V264, P11394; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JOHNSON EM, 1986, P NATL ACAD SCI USA, V83, P4660, DOI 10.1073/pnas.83.13.4660; KANT JA, 1983, P NATL ACAD SCI-BIOL, V80, P3953, DOI 10.1073/pnas.80.13.3953; KORNBERG JR, 1988, CELL, V53, P391; KUDO S, 1989, P NATL ACAD SCI USA, V86, P4619, DOI 10.1073/pnas.86.12.4619; LEE MGS, 1984, NUCLEIC ACIDS RES, V12, P5823, DOI 10.1093/nar/12.14.5823; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LITT M, 1989, AM J HUM GENET, V44, P397; LUSKEY KL, 1985, J BIOL CHEM, V260, P271; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; Maxam A M, 1980, Methods Enzymol, V65, P499; MIESFELD R, 1981, NUCLEIC ACIDS RES, V9, P5931, DOI 10.1093/nar/9.22.5931; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; NAKAMURA Y, 1987, NATURE, V235, P2616; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; PAULSON KE, 1986, NUCLEIC ACIDS RES, V14, P6145, DOI 10.1093/nar/14.15.6145; PROTTER AA, 1984, DNA-J MOLEC CELL BIO, V3, P449, DOI 10.1089/dna.1.1984.3.449; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; ROYLE NJ, 1987, CYTOGENET CELL GENET, V46, P685; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; VNENCAKJONES CL, 1988, P NATL ACAD SCI USA, V85, P5615, DOI 10.1073/pnas.85.15.5615; WEBER J L, 1988, American Journal of Human Genetics, V43, pA161; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; ZULIANI G, IN PRESS NUCLEIC A A; ZULIANI G, IN PRESS NUCLEIC A B	43	107	110	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					963	969						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2339694				2022-12-18	WOS:A1990DD89600015
J	HOOK, EB				HOOK, EB			CHROMOSOME-ABNORMALITIES AND SPONTANEOUS FETAL DEATH FOLLOWING AMNIOCENTESIS - FURTHER DATA AND ASSOCIATIONS WITH MATERNAL AGE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNION UNIV ALBANY MED COLL,DEPT PEDIAT,ALBANY,NY 12208	Albany Medical College	HOOK, EB (corresponding author), NEW YORK STATE DEPT HLTH,BUR MATERNAL & CHILD HLTH,ALBANY,NY 12237, USA.							AYME S, 1981, AM J EPIDEMIOL, V114, P437; CARR DH, 1963, LANCET, V2, P603; Hook E B, 1978, Birth Defects Orig Artic Ser, V14, P249; Hook E B, 1979, Birth Defects Orig Artic Ser, V15, P81; HOOK EB, 1978, NEW ENGL J MED, V299, P1036, DOI 10.1056/NEJM197811092991903; HOOK EB, 1978, LANCET, V1, P1053; HOOK EB, 1982, CLIN GENETICS PROBLE, P119; LYNCH HT, 1980, INT DIRECTORY GENETI, P1; OAKLEY GP, 1978, NEW ENGL J MED, V299, P1068, DOI 10.1056/NEJM197811092991911; POLANI PE, 1976, LANCET, V2, P516; SPIELMAN RS, 1978, LANCET, V1, P1306; 1980, DHHS HSA805135 PUBL, P1	12	107	107	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	1					110	116						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB703	6218752				2022-12-18	WOS:A1983QB70300012
J	Ulirsch, JC; Verboon, JM; Kazerounian, S; Guo, MH; Yuan, D; Ludwig, LS; Handsaker, RE; Abdulhay, NJ; Fiorini, C; Genovese, G; Lim, ET; Cheng, A; Cummings, BB; Chao, KR; Beggs, AH; Genetti, CA; Sieff, CA; Newburger, PE; Niewiadomska, E; Matysiak, M; Vlachos, A; Lipton, JM; Atsidaftos, E; Glader, B; Narla, A; Gleizes, PE; O'Donohue, MF; Montel-Lehry, N; Amor, DJ; McCarroll, SA; O'Donnell-Luria, AH; Gupta, N; Gabriel, SB; MacArthur, DG; Lander, ES; Lek, M; Da Costa, L; Nathan, DG; Korostelev, AK; Do, R; Sankaran, VG; Gazda, HT				Ulirsch, Jacob C.; Verboon, Jeffrey M.; Kazerounian, Shideh; Guo, Michael H.; Yuan, Daniel; Ludwig, Leif S.; Handsaker, Robert E.; Abdulhay, Nour J.; Fiorini, Claudia; Genovese, Giulio; Lim, Elaine T.; Cheng, Aaron; Cummings, Beryl B.; Chao, Katherine R.; Beggs, Alan H.; Genetti, Casie A.; Sieff, Colin A.; Newburger, Peter E.; Niewiadomska, Edyta; Matysiak, Michal; Vlachos, Adrianna; Lipton, Jeffrey M.; Atsidaftos, Eva; Glader, Bertil; Narla, Anupama; Gleizes, Pierre-Emmanuel; O'Donohue, Marie-Francoise; Montel-Lehry, Nathalie; Amor, David J.; McCarroll, Steven A.; O'Donnell-Luria, Anne H.; Gupta, Namrata; Gabriel, Stacey B.; MacArthur, Daniel G.; Lander, Eric S.; Lek, Monkol; Da Costa, Lydie; Nathan, David G.; Korostelev, Andrei K.; Do, Ron; Sankaran, Vijay G.; Gazda, Hanna T.			The Genetic Landscape of Diamond-Blackfan Anemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; EX-VIVO MODELS; RNA-SEQ; GATA1 MUTATIONS; IDENTIFICATION; DATABASE; MICRODELETIONS; VISUALIZATION; TRANSLATION; DEFICIENCY	Diamond-Blackfan anemia (DBA) is a rare bone marrow failure disorder that affects 7 out of 1,000,000 live births and has been associated with mutations in components of the ribosome. In order to characterize the genetic landscape of this heterogeneous disorder, we recruited a cohort of 472 individuals with a clinical diagnosis of DBA and performed whole-exome sequencing (WES). We identified relevant rare and predicted damaging mutations for 78% of individuals. The majority of mutations were singletons, absent from population databases, predicted to cause loss of function, and located in 1 of 19 previously reported ribosomal protein (RP)-encoding genes. Using exon coverage estimates, we identified and validated 31 deletions in RP genes. We also observed an enrichment for extended splice site mutations and validated their diverse effects using RNA sequencing in cell lines obtained from individuals with DBA. Leveraging the size of our cohort, we observed robust genotype-phenotype associations with congenital abnormalities and treatment outcomes. We further identified rare mutations in seven previously unreported RP genes that may cause DBA, as well as several distinct disorders that appear to phenocopy DBA, including nine individuals with biallelic CECR1 mutations that result in deficiency of ADA2. However, no new genes were identified at exome-wide significance, suggesting that there are no unidentified genes containing mutations readily identified by WES that explain >5% of DBA-affected case subjects. Overall, this report should inform not only clinical practice for DBA-affected individuals, but also the design and analysis of rare variant studies for heterogeneous Mendelian disorders.	[Ulirsch, Jacob C.; Verboon, Jeffrey M.; Ludwig, Leif S.; Abdulhay, Nour J.; Fiorini, Claudia; Cheng, Aaron; Sieff, Colin A.; Nathan, David G.; Sankaran, Vijay G.] Boston Childrens Hosp, Div Hematol Oncol, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Ulirsch, Jacob C.; Verboon, Jeffrey M.; Ludwig, Leif S.; Abdulhay, Nour J.; Fiorini, Claudia; Cheng, Aaron; Sieff, Colin A.; Nathan, David G.; Sankaran, Vijay G.] Harvard Med Sch, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Ulirsch, Jacob C.; Verboon, Jeffrey M.; Guo, Michael H.; Ludwig, Leif S.; Handsaker, Robert E.; Abdulhay, Nour J.; Fiorini, Claudia; Genovese, Giulio; Lim, Elaine T.; Cheng, Aaron; Cummings, Beryl B.; Chao, Katherine R.; McCarroll, Steven A.; O'Donnell-Luria, Anne H.; Gupta, Namrata; Gabriel, Stacey B.; MacArthur, Daniel G.; Lander, Eric S.; Lek, Monkol; Sankaran, Vijay G.; Gazda, Hanna T.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Ulirsch, Jacob C.; Cummings, Beryl B.] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Kazerounian, Shideh; Yuan, Daniel; Beggs, Alan H.; Genetti, Casie A.; O'Donnell-Luria, Anne H.; Gazda, Hanna T.] Harvard Med Sch, Div Genet & Genom, Manton Ctr Orphan Dis Res, Boston Childrens Hosp, Boston, MA 02115 USA; [Handsaker, Robert E.; McCarroll, Steven A.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Newburger, Peter E.] Univ Massachusetts, Dept Pediat, Sch Med, Worcester, MA 01605 USA; [Niewiadomska, Edyta; Matysiak, Michal] Med Univ Warsaw, Dept Pediat Hematol Oncol, Warsaw, Poland; [Vlachos, Adrianna; Lipton, Jeffrey M.; Atsidaftos, Eva] Feinstein Inst Med Res, Manhasset, NY USA; [Vlachos, Adrianna; Lipton, Jeffrey M.; Atsidaftos, Eva] Cohen Childrens Med Ctr, Div Hematol Oncol & Stem Cell Transplantat, New Hyde Pk, NY USA; [Vlachos, Adrianna; Lipton, Jeffrey M.; Atsidaftos, Eva] Hofstra Northwell Sch Med, Hempstead, NY 11030 USA; [Glader, Bertil; Narla, Anupama] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 02114 USA; [Gleizes, Pierre-Emmanuel; O'Donohue, Marie-Francoise; Montel-Lehry, Nathalie] Univ Toulouse, Ctr Integrat Biol CBI, Lab Eukaryot Mol Biol, CNRS, Toulouse, France; [Amor, David J.] Univ Melbourne, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Amor, David J.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [O'Donnell-Luria, Anne H.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Da Costa, Lydie] Univ Paris VII Denis DIDEROT, Fac Med Xavier Bichat, F-75019 Paris, France; [Da Costa, Lydie] LABEX GR Ex, Lab Excellence Red Cell, F-75015 Paris, France; [Korostelev, Andrei K.] Univ Massachusetts, RNA Therapeut Inst, Dept Biochem & Mol Pharmacol, Sch Med, 368 Plantat St, Worcester, MA 01605 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Sankaran, Vijay G.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Medical University of Warsaw; Northwell Health; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Northwell Health; Stanford University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Harvard University; Massachusetts General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Massachusetts System; University of Massachusetts Worcester; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University	Sankaran, VG (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Harvard Med Sch, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.; Sankaran, VG (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Sankaran, VG (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	sankaran@broadinstitute.org; hanna.gazda@childrens.harvard.edu	Handsaker, Bob/AAX-9095-2021; Amor, David J/A-6478-2018; Gleizes, Pierre-Emmanuel/ABB-9653-2021; Ludwig, Leif S./A-1913-2015	Handsaker, Bob/0000-0002-3128-3547; Amor, David J/0000-0001-7191-8511; Gleizes, Pierre-Emmanuel/0000-0003-0830-7341; Ludwig, Leif S./0000-0002-2916-2164; O'Donohue, Marie-Francoise/0000-0002-1204-8285; Ulirsch, Jacob/0000-0002-7947-0827; Cummings, Beryl/0000-0001-6346-1646; Korostelev, Andrei/0000-0003-1588-717X; O'Donnell-Luria, Anne/0000-0001-6418-9592; MacArthur, Daniel/0000-0002-5771-2290; Lim, Teng Ting/0000-0003-3651-0654	National Institutes of Health [R01 DK103794, R33 HL120791, R01 HL107558, K02 HL111156, UM1 HG008900, R01 HG009141]; DBA Foundation grant; New York Stem Cell Foundation award; ANR [CE12- 0001 -DBA]; NIH [5T32 GM007226-43]; ERA-NET programme E-RARE3 [ANR-15-RAR3-0007-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL111156, R33HL120791] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009141, UM1HG008900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DBA Foundation grant; New York Stem Cell Foundation award; ANR(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERA-NET programme E-RARE3; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We owe a great deal of gratitude to the individuals and families that were part of the cohort described here, without whom this study would not have been possible. We thank members of the Sankaran laboratory for valuable discussions and comments on this work. This work was supported by the National Institutes of Health grants R01 DK103794 and R33 HL120791 (to V.G.S.), R01 HL107558 and K02 HL111156 (to H.T.G.), UM1 HG008900 and R01 HG009141 (to D.G.M.), as well as a DBA Foundation grant and New York Stem Cell Foundation award (to V.G.S.). L.D.C., P.-E.G., and M.-F.O. are supported by ANR (ANR 2015 AAP generique CE12- 0001 -DBA Multigenes), and the EuroDBA project is funded by the ERA-NET programme E-RARE3 (ANR-15-RAR3-0007-04). J.C.U. is supported by NIH grant 5T32 GM007226-43. V.G.S. is New York Stem Cell Foundation-Robertson Investigator.	Abeyrathne PD, 2016, ELIFE, V5, DOI 10.7554/eLife.14874; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alter BP, 2014, BLOOD, V124, P312, DOI 10.1182/blood-2014-04-571687; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Arbiv OA, 2018, CLIN GENET, V93, P320, DOI 10.1111/cge.13158; Bahrami E, 2017, J ALLERGY CLIN IMMUN, V140, P1112, DOI 10.1016/j.jaci.2016.10.053; Bell AD, 2018, METHODS MOL BIOL, V1768, P143, DOI 10.1007/978-1-4939-7778-9_9; Ben-Ami T, 2016, J PEDIATR-US, V177, P316, DOI 10.1016/j.jpeds.2016.06.058; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Bergmann AK, 2010, PEDIATR BLOOD CANCER, V54, P273, DOI 10.1002/pbc.22244; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; Boria I, 2008, HUM MUTAT, V29, pE263, DOI 10.1002/humu.20864; Boultwood J, 2014, NAT MED, V20, P703, DOI 10.1038/nm.3630; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Carlston CM, 2017, AM J MED GENET A, V173, P2622, DOI 10.1002/ajmg.a.38360; Cheung R., 2017, BIORXIV, DOI [10.1101/199927, DOI 10.1101/199927]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Da Costa L, 2017, EUR J MED GENET, P1769; DeLano W. L, 2002, PYMOL MOL GENETICS G; DePristo MA., 2018, SCALING ACCURATE GEN, DOI [DOI 10.1101/201178, 10.1101/201178]; Diamond L K, 1976, Adv Pediatr, V22, P349; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Fargo JH, 2013, BRIT J HAEMATOL, V160, P547, DOI 10.1111/bjh.12167; Farrar JE, 2014, AM J HEMATOL, V89, P985, DOI 10.1002/ajh.23807; Farrar JE, 2011, BLOOD, V118, P6943, DOI 10.1182/blood-2011-08-375170; Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Gray VE, 2018, CELL SYST, V6, P116, DOI 10.1016/j.cels.2017.11.003; Gregory LA, 2007, NUCLEIC ACIDS RES, V35, P5913, DOI 10.1093/nar/gkm626; Gripp KW, 2014, AM J MED GENET A, V164, P2240, DOI 10.1002/ajmg.a.36633; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Guo MH, 2018, AM J HUM GENET, V103, P522, DOI 10.1016/j.ajhg.2018.08.016; Guo MH, 2016, AM J HUM GENET, V99, P527, DOI 10.1016/j.ajhg.2016.06.031; Gustavsson P, 1998, AM J HUM GENET, V63, P1388, DOI 10.1086/302100; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Hashem H, 2017, BONE MARROW TRANSPL, V52, P1575, DOI 10.1038/bmt.2017.173; Hashem H, 2017, J PEDIAT HEMATOL ONC, V39, pE293, DOI 10.1097/MPH.0000000000000805; Horos R, 2012, BRIT J HAEMATOL, V159, P514, DOI 10.1111/bjh.12058; Jagadeesh KA, 2016, NAT GENET, V48, P1581, DOI 10.1038/ng.3703; Khajuria RK, 2018, CELL, V173, P90, DOI 10.1016/j.cell.2018.02.036; Kim AR, 2017, CELL, V168, P1053, DOI 10.1016/j.cell.2017.02.026; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klar J, 2014, BRIT J HAEMATOL, V166, P949, DOI 10.1111/bjh.12919; Le Guen T, 2015, J ALLERGY CLIN IMMUN, V136, P1619, DOI 10.1016/j.jaci.2015.06.008; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lewis R, 2015, JAMA-J AM MED ASSOC, V313, P1301, DOI 10.1001/jama.2015.1389; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Lord J, 2018, BIORXIV, DOI [10.1101/256636, DOI 10.1101/256636]; Ludwig LS, 2014, NAT MED, V20, P748, DOI 10.1038/nm.3557; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Mirabello L, 2017, J MED GENET, V54, P417, DOI 10.1136/jmedgenet-2016-104346; Mirabello L, 2014, BLOOD, V124, P24, DOI 10.1182/blood-2013-11-540278; Narla A, 2016, AM J HEMATOL, V91, pE501, DOI 10.1002/ajh.24541; Narla A, 2016, BLOOD CELL MOL DIS, V61, P46, DOI 10.1016/j.bcmd.2016.08.001; Natchiar SK, 2017, NATURE, V551, P472, DOI 10.1038/nature24482; O'Brien KA, 2017, BLOOD, V129, P3111, DOI 10.1182/blood-2017-01-760462; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pedersen BS, 2017, AM J HUM GENET, V100, P406, DOI 10.1016/j.ajhg.2017.01.017; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Quarello P, 2012, HAEMATOL-HEMATOL J, V97, P1813, DOI 10.3324/haematol.2012.062281; Roy V, 2005, BIOL BLOOD MARROW TR, V11, P600, DOI 10.1016/j.bbmt.2005.05.005; Samocha K. E., 2017, REGIONAL MISSENSE CO, DOI [10.1101/148353, DOI 10.1101/148353]; Sankaran VG, 2012, J CLIN INVEST, V122, P2439, DOI 10.1172/JCI63597; Shamseldin HE, 2013, BLOOD, V122, P3844, DOI 10.1182/blood-2013-09-527127; Smith HS, 2019, GENET MED, V21, P3, DOI 10.1038/s41436-018-0024-6; Steinberg-Shemer O, 2017, COLD SPRING HARB MOL, V3, P3; Szvetnik EA, 2017, BLOOD, V130; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ulirsch JC, 2017, BLOOD, V130, P1165, DOI 10.1182/blood-2017-05-783191; van Montfrans J, 2014, NEW ENGL J MED, V371, P478, DOI 10.1056/NEJMc1405506; Veeneman BA, 2016, BIOINFORMATICS, V32, P43, DOI 10.1093/bioinformatics/btv642; Vlachos A, 2008, BRIT J HAEMATOL, V142, P859, DOI 10.1111/j.1365-2141.2008.07269.x; Vlachos A, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGENETICS.117.002044; Wang R, 2015, BRIT J HAEMATOL, V168, P854, DOI 10.1111/bjh.13229; Wat MJ, 2010, J MED GENET, V47, P777, DOI 10.1136/jmg.2009.075903; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	86	106	108	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 6	2018	103	6					930	947		10.1016/j.ajhg.2018.10.027	http://dx.doi.org/10.1016/j.ajhg.2018.10.027			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD4YX	30503522	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000452535600008
J	Riessland, M; Kaczmarek, A; Schneider, S; Swoboda, KJ; Lohr, H; Bradler, C; Grysko, V; Dimitriadi, M; Hosseinibarkooie, S; Torres-Benito, L; Peters, M; Upadhyay, A; Biglari, N; Krober, S; Holker, I; Garbes, L; Gilissen, C; Hoischen, A; Nurnberg, G; Nurnberg, P; Walter, M; Rigo, F; Bennett, CF; Kye, MJ; Hart, AC; Hammerschmidt, M; Kloppenburg, P; Wirth, B				Riessland, Markus; Kaczmarek, Anna; Schneider, Svenja; Swoboda, Kathryn J.; Loehr, Heiko; Bradler, Cathleen; Grysko, Vanessa; Dimitriadi, Maria; Hosseinibarkooie, Seyyedmohsen; Torres-Benito, Laura; Peters, Miriam; Upadhyay, Aaradhita; Biglari, Nasim; Kroeber, Sandra; Hoelker, Irmgard; Garbes, Lutz; Gilissen, Christian; Hoischen, Alexander; Nuernberg, Gudrun; Nuernberg, Peter; Walter, Michael; Rigo, Frank; Bennett, C. Frank; Kye, Min Jeong; Hart, Anne C.; Hammerschmidt, Matthias; Kloppenburg, Peter; Wirth, Brunhilde			Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOTOR-NEURON GENE; MOUSE MODEL; NERVE-TERMINALS; MESSENGER-RNA; NEUROMUSCULAR-JUNCTIONS; LINKAGE ANALYSIS; SMA PHENOTYPE; PLASTIN 3; SURVIVAL; PROTEINS	Homozygous SMN1 loss causes spinal muscular atrophy (SMA), the most common lethal genetic childhood motor neuron disease. SMN1 encodes SMN, a ubiquitous housekeeping protein, which makes the primarily motor neuron-specific phenotype rather unexpected. SMA-affected individuals harbor low SMN expression from one to six SMN2 copies, which is insufficient to functionally compensate for SMN1 loss. However, rarely individuals with homozygous absence of SMN1 and only three to four SMN2 copies are fully asymptomatic, suggesting protection through genetic modifier(s). Previously, we identified plastin 3 (PLS3) overexpression as an SMA protective modifier in humans and showed that SMN deficit impairs endocytosis, which is rescued by elevated PLS3 levels. Here, we identify reduction of the neuronal calcium sensor Neurocalcin delta (NCALD) as a protective SMA modifier in five asymptomatic SMN1-deleted individuals carrying only four SMN2 copies. We demonstrate that NCALD is a Ca2+-dependent negative regulator of endocytosis, as NCALD knockdown improves endocytosis in SMA models and ameliorates pharmacologically induced endocytosis defects in zebrafish. Importantly, NCALD knockdown effectively ameliorates SMA-associated pathological defects across species, including worm, zebrafish, and mouse. In conclusion, our study identifies a previously unknown protective SMA modifier in humans, demonstrates modifier impact in three different SMA animal models, and suggests a potential combinatorial therapeutic strategy to efficiently treat SMA. Since both protective modifiers restore endocytosis, our results confirm that endocytosis is a major cellular mechanism perturbed in SMA and emphasize the power of protective modifiers for understanding disease mechanism and developing therapies.	[Riessland, Markus; Kaczmarek, Anna; Schneider, Svenja; Grysko, Vanessa; Hosseinibarkooie, Seyyedmohsen; Torres-Benito, Laura; Peters, Miriam; Upadhyay, Aaradhita; Biglari, Nasim; Kroeber, Sandra; Hoelker, Irmgard; Garbes, Lutz; Kye, Min Jeong; Wirth, Brunhilde] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Riessland, Markus; Kaczmarek, Anna; Schneider, Svenja; Grysko, Vanessa; Hosseinibarkooie, Seyyedmohsen; Torres-Benito, Laura; Peters, Miriam; Upadhyay, Aaradhita; Biglari, Nasim; Kroeber, Sandra; Hoelker, Irmgard; Garbes, Lutz; Kye, Min Jeong; Hammerschmidt, Matthias; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Riessland, Markus; Kaczmarek, Anna; Schneider, Svenja; Grysko, Vanessa; Hosseinibarkooie, Seyyedmohsen; Torres-Benito, Laura; Peters, Miriam; Upadhyay, Aaradhita; Biglari, Nasim; Kroeber, Sandra; Hoelker, Irmgard; Garbes, Lutz; Wirth, Brunhilde] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Swoboda, Kathryn J.] MassGen Hosp Children, Boston, MA 02115 USA; [Loehr, Heiko; Hammerschmidt, Matthias] Univ Cologne, Inst Zool Dev Biol, D-50674 Cologne, Germany; [Bradler, Cathleen; Kloppenburg, Peter] Univ Cologne, Inst Zool Neurophysiol, D-50674 Cologne, Germany; [Loehr, Heiko; Bradler, Cathleen; Nuernberg, Gudrun; Nuernberg, Peter; Hammerschmidt, Matthias; Kloppenburg, Peter] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, D-50931 Cologne, Germany; [Dimitriadi, Maria; Hart, Anne C.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Gilissen, Christian; Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Ctr Neurosci, NL-6525 Nijmegen, Netherlands; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Ctr Genom Cologne, D-50931 Cologne, Germany; [Walter, Michael] Univ Tubingen, Inst Med Genet, D-72076 Tubingen, Germany; [Rigo, Frank; Bennett, C. Frank] IONIS Pharmaceut, Carlsbad, CA 92008 USA; [Riessland, Markus] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10065 USA; [Dimitriadi, Maria] Univ Hertfordshire, Dept Biol & Environm Sci, Hatfield AL10 9AB, Herts, England	University of Cologne; University of Cologne; University of Cologne; Harvard University; Massachusetts General Hospital; University of Cologne; University of Cologne; University of Cologne; Brown University; Radboud University Nijmegen; University of Cologne; Eberhard Karls University of Tubingen; Ionis Pharmaceuticals, Inc.; Rockefeller University; University of Hertfordshire	Wirth, B (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.; Wirth, B (corresponding author), Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany.; Wirth, B (corresponding author), Univ Cologne, Inst Genet, D-50674 Cologne, Germany.	brunhilde.wirth@uk-koeln.de	Gilissen, Christian/E-5246-2012; Riessland, Markus/AAM-6708-2021; Hoischen, Alexander/D-1282-2013; Torres-Benito, Laura/X-5491-2019; Wirth, Brunhilde/H-3192-2019; Hoischen, Alexander/AGF-7293-2022; Kye, Min Jeong/ABC-3439-2020	Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Kye, Min Jeong/0000-0002-1323-7256; Hosseini-Barkooie, Seyyedmohsen/0000-0001-6121-8562; Riessland, Markus/0000-0003-2592-5045; Swoboda, Kathryn/0000-0002-4593-6342; Wirth, Brunhilde/0000-0003-4051-5191	Deutsche Forschungsgemeinschaft [Wi-945/13-1, Wi-945/14-1, RTG 1970]; SMA Europe; European Community's Seventh Framework Programme (FP7) [2012-305121]; CMMC - C11; IGSDHD; AFM-Telethon; NIH [P01NS066888];  [US PCT/EP2014/066276]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS066888] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SMA Europe; European Community's Seventh Framework Programme (FP7); CMMC - C11; IGSDHD; AFM-Telethon(Association Francaise contre les Myopathies); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank SMA-affected families, Jay Gopalakrishnan and Natalia Kononenko for critical reading of the manuscript, and CECAD for help with imaging. This work was supported by grants from the Deutsche Forschungsgemeinschaft Wi-945/13-1, Wi-945/14-1, RTG 1970 (B.W.), SMA Europe (M.R.), European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 2012-305121 "Integrated European-omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NEUROMICS)" (B.W.), CMMC - C11 (B.W.), IGSDHD (A.K., S.S.), AFM-Telethon (L.T.-B.), and NIH P01NS066888 (A.C.H.). C.F.B. and F.R. are employees of IONIS Pharmaceuticals. B.W. and M.R. hold an US PCT/EP2014/066276 entitled "Neurocalcin delta inhibitors and therapeutic and non therapeutic uses thereof" with the international publication number WO/2015/014838 A1.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Arkblad E, 2009, ACTA PAEDIATR, V98, P865, DOI 10.1111/j.1651-2227.2008.01201.x; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benkhelifa-Ziyyat S, 2013, MOL THER, V21, P282, DOI 10.1038/mt.2012.261; Bogdanik LP, 2015, P NATL ACAD SCI USA, V112, pE5863, DOI 10.1073/pnas.1509758112; Briese M, 2009, HUM MOL GENET, V18, P97, DOI 10.1093/hmg/ddn320; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Burgoyne RD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-2; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; COBBEN JM, 1995, AM J HUM GENET, V57, P805; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; Dimitriadi M, 2016, P NATL ACAD SCI USA, V113, pE4377, DOI 10.1073/pnas.1600015113; Dimitriadi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001172; Drapeau P, 2001, J NEUROPHYSIOL, V86, P2951, DOI 10.1152/jn.2001.86.6.2951; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; Heesen L, 2016, CELL MOL LIFE SCI, V73, P2089, DOI 10.1007/s00018-015-2084-y; HIDAKA H, 1993, NEUROSCI RES, V16, P73, DOI 10.1016/0168-0102(93)90074-Z; Hosseinibarkooie S, 2016, AM J HUM GENET, V99, P647, DOI 10.1016/j.ajhg.2016.07.014; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Iino S, 1998, BRAIN RES, V808, P294, DOI 10.1016/S0006-8993(98)00750-1; Ivings L, 2002, BIOCHEM J, V363, P599, DOI 10.1042/0264-6021:3630599; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Kaczmarek A, 2015, EXPERT OPIN INV DRUG, V24, P867, DOI 10.1517/13543784.2015.1038341; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li X, 2010, EMBO J, V29, P992, DOI 10.1038/emboj.2009.410; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Martinez-Carrera LA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00401; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Neveling K, 2013, AM J HUM GENET, V92, P946, DOI 10.1016/j.ajhg.2013.04.011; Oates EC, 2013, AM J HUM GENET, V92, P965, DOI 10.1016/j.ajhg.2013.04.018; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Parsons RL, 1999, J NEUROPHYSIOL, V81, P2696, DOI 10.1152/jn.1999.81.6.2696; Peeters K, 2013, AM J HUM GENET, V92, P955, DOI 10.1016/j.ajhg.2013.04.013; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Schreij AMA, 2016, CELL MOL LIFE SCI, V73, P1529, DOI 10.1007/s00018-015-2105-x; See K, 2014, HUM MOL GENET, V23, P1754, DOI 10.1093/hmg/ddt567; Shababi M, 2016, MOL THER, V24, P855, DOI 10.1038/mt.2016.33; Shababi M, 2014, J ANAT, V224, P15, DOI 10.1111/joa.12083; Somers E, 2013, NEUROSCI LETT, V544, P100, DOI 10.1016/j.neulet.2013.03.052; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Suszynska-Zajczyk J, 2014, J ALZHEIMERS DIS, V40, P713, DOI 10.3233/JAD-132033; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Venkataraman V, 2008, BIOCHEMISTRY-US, V47, P6590, DOI 10.1021/bi800394s; Viviano J, 2016, DATA BRIEF, V7, P630, DOI 10.1016/j.dib.2016.03.021; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.3.CO;2-0; Wirth B, 2015, EXPERT OPIN EMERG DR, V20, P353, DOI 10.1517/14728214.2015.1041375; Wirth B, 2013, CURR OPIN GENET DEV, V23, P330, DOI 10.1016/j.gde.2013.03.003; Wishart TM, 2014, J CLIN INVEST, V124, P1821, DOI 10.1172/JCI71318; Yamatani H, 2010, DEV NEUROBIOL, V70, P523, DOI 10.1002/dneu.20794; Zerres K, 1997, NEUROMUSCULAR DISORD, V7, P202, DOI 10.1016/S0960-8966(97)00459-8	95	106	113	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					297	315		10.1016/j.ajhg.2017.01.005	http://dx.doi.org/10.1016/j.ajhg.2017.01.005			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28132687	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000393352000010
J	Kohl, S; Coppieters, F; Meire, F; Schaich, S; Roosing, S; Brennenstuhl, C; Bolz, S; van Genderen, MM; Riemslag, FCC; Lukowski, R; den Hollander, AI; Cremers, FPM; De Baere, E; Hoyng, CB; Wissinger, B				Kohl, Susanne; Coppieters, Frauke; Meire, Francoise; Schaich, Simone; Roosing, Susanne; Brennenstuhl, Christina; Bolz, Sylvia; van Genderen, Maria M.; Riemslag, Frans C. C.; Lukowski, Robert; den Hollander, Anneke I.; Cremers, Frans P. M.; De Baere, Elfride; Hoyng, Carel B.; Wissinger, Bernd		European Retinal Dis Consortium	A Nonsense Mutation in PDE6H Causes Autosomal-Recessive Incomplete Achromatopsia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAMMA-SUBUNIT; ALPHA-SUBUNIT; CGMP-PHOSPHODIESTERASE; TOTAL COLOURBLINDNESS; CONE DYSTROPHY; GENETIC-BASIS; CHANNEL	Achromatopsia (ACHM) is an autosomal-recessive retinal dystrophy characterized by color blindness, photophobia, nystagmus, and severely reduced visual acuity. Its prevalence has been estimated to about 1 in 30,000 individuals. Four genes, GNAT2, PDE6C, CNGA3, and CNGB3, have been implicated in ACHM, and all encode functional components of the phototransduction cascade in cone photoreceptors. Applying a functional-candidate-gene approach that focused on screening additional genes involved in this process in a cohort of 611 index cases with ACHM or other cone photoreceptor disorders, we detected a homozygous single base change (c.35C>G) resulting in a nonsense mutation (p.Ser12*) in PDE6H, encoding the inhibitory gamma subunit of the cone photoreceptor cyclic guanosine monophosphate phosphodiesterase. The c.35C>G mutation was present in three individuals from two independent families with a clinical diagnosis of incomplete ACHM and preserved short-wavelength-sensitive cone function. Moreover, we show through immunohistochemical colocalization studies in mouse retina that Pde6h is evenly present in all retinal cone photoreceptors, a fact that had been under debate in the past. These findings add PDE6H to the set of genes involved in autosomal-recessive cone disorders and demonstrate the importance of the inhibitory gamma subunit in cone phototransduction.	[Kohl, Susanne; Schaich, Simone; Wissinger, Bernd] Univ Tubingen, Mol Genet Lab, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany; [Coppieters, Frauke; De Baere, Elfride] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Coppieters, Frauke; De Baere, Elfride] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Meire, Francoise] Queen Fabiola Childrens Univ Hosp HUDERF, Dept Ophthalmol, B-1020 Brussels, Belgium; [Roosing, Susanne; den Hollander, Anneke I.; Cremers, Frans P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Brennenstuhl, Christina] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany; [van Genderen, Maria M.; Riemslag, Frans C. C.] Bartimeus Inst Visually Impaired, NL-3700 BA Zeist, Netherlands; [den Hollander, Anneke I.; Hoyng, Carel B.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 GA Nijmegen, Netherlands	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ghent University; Ghent University; Ghent University Hospital; Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Radboud University Nijmegen	Kohl, S (corresponding author), Univ Tubingen, Mol Genet Lab, Inst Ophthalm Res, Ctr Ophthalmol, D-72076 Tubingen, Germany.	susanne.kohl@uni-tuebingen.de; wissinger@uni-tuebingen.de	Roosing, Susanne/AAK-3454-2020; De Baere, Elfride/E-7405-2017; Roosing, Susanne/ABF-9604-2021; Hollander, Anneke den/N-4911-2014; Roosing, Susanne/F-1616-2018; Cremers, Frans/A-5625-2014; Hoyng, C.B./H-8050-2014; Sharon, Dror/P-4539-2015	Roosing, Susanne/0000-0001-9038-0067; De Baere, Elfride/0000-0002-5609-6895; Roosing, Susanne/0000-0001-9038-0067; Roosing, Susanne/0000-0001-9038-0067; Cremers, Frans/0000-0002-4954-5592; Sharon, Dror/0000-0002-1789-5811; Kohl, Susanne/0000-0002-6438-6331; Coppieters, Frauke/0000-0001-7224-0992; Toomes, Carmel/0000-0001-8373-9545	Deutsche Forschungsgemeinschaft [KFO134-Ko2176/1-2, KFO134-Ru571/5-2]; Bundesministerium fur Bildung und Forschung [HOPE: 01GM0850, 01GM1108A]; Foundation Fighting Blindness, USA [BR-GE-0510-0489-RAD, C-GE-0811-0545-RAD01]; Netherlands Organization for Health Research and Development (ZonMW) [40-00812-98-09047]; Research Foundation Flanders (FWO) [FWO11/KAN/013-31524611]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Foundation Fighting Blindness, USA; Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Research Foundation Flanders (FWO)(FWO)	We would like to thank all persons who participated in this study, the members of the European Retinal Disease Consortium for sharing DNA of the probands (ERDC: C. Ayuso, Madrid, Spain; S. Banfi, Naples, Italy; E. Banin and D. Sharon, Jerusalem, Israel; T. Ben-Yosef, Haifa, Israel; R.W.J. Collin, Nijmegen, The Netherlands; C. Hamel, Montpellier, France; C. Inglehearn and C. Toomes, Leeds, UK; R.K. Koenekoop and I. Lopez, Montreal, Canada; and BR Leroy, Ghent, Belgium), and our other clinical collaboration partners. Special thanks to Fanny Depasse, University Hospital Erasmus, Brussels, Belgium for clinical examination; to C. Van Nechel, Department of Electrophysiology, HUDERF, Belgium for ERG recordings; and to Sarah De Jaegere, Ghent University Hospital, for technical assistance. This work was supported by grants from the Deutsche Forschungsgemeinschaft (KFO134-Ko2176/1-2 and KFO134-Ru571/5-2 to S.K. and Peter Ruth, respectively), the Bundesministerium fur Bildung und Forschung (HOPE: 01GM0850 and 01GM1108A to B.W. and S.K.), the Foundation Fighting Blindness, USA (BR-GE-0510-0489-RAD to A.I.d.H. and C-GE-0811-0545-RAD01 to F.P.M.C., A.I.d.H., and R.W.J. Collin), the Netherlands Organization for Health Research and Development (ZonMW TOP-grant 40-00812-98-09047 to F.P.M.C., A.I.d.H., and H. Kremer), and the Research Foundation Flanders (FWO) (FWO11/KAN/013-31524611 to E.D.B.). F.C.P. is a postdoctoral fellow and E.D.B. a senior clinical investigator of the FWO.	Aligianis IA, 2002, J MED GENET, V39, P656, DOI 10.1136/jmg.39.9.656; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Grau T, 2011, HUM MOL GENET, V20, P719, DOI 10.1093/hmg/ddq517; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; LISMAN J, 1995, NAT MED, V1, P1254, DOI 10.1038/nm1295-1254; Piri N, 2005, OPHTHALMOLOGY, V112, P159, DOI 10.1016/j.ophtha.2004.07.011; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Thiadens AAHJ, 2010, INVEST OPHTH VIS SCI, V51, P5952, DOI 10.1167/iovs.10-5680; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; TUTEJA N, 1990, GENE, V88, P227, DOI 10.1016/0378-1119(90)90035-P; Wissinger B, 2008, INVEST OPHTH VIS SCI, V49, P751, DOI 10.1167/iovs.07-0471; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568	19	106	108	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					527	532		10.1016/j.ajhg.2012.07.006	http://dx.doi.org/10.1016/j.ajhg.2012.07.006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22901948	Bronze, Green Published			2022-12-18	WOS:000308683100013
J	Mir, A; Kaufman, L; Noor, A; Motazacker, MM; Jamil, T; Azam, M; Kahrizi, K; Rafiq, MA; Weksberg, R; Nasr, T; Naeem, F; Tzschach, A; Kuss, AW; Ishak, GE; Doherty, D; Ropers, HH; Barkovich, AJ; Najmabadi, H; Ayub, M; Vincent, JB				Mir, Asif; Kaufman, Liana; Noor, Abdul; Motazacker, Mahdi M.; Jamil, Talal; Azam, Matloob; Kahrizi, Kimia; Rafiq, Muhammad Arshad; Weksberg, Rosanna; Nasr, Tanveer; Naeem, Farooq; Tzschach, Andreas; Kuss, Andreas W.; Ishak, Gisele E.; Doherty, Dan; Ropers, H. Hilger; Barkovich, A. James; Najmabadi, Hossein; Ayub, Muhammad; Vincent, John B.			Identification of Mutations in TRAPPC9, which Encodes the NIK- and IKK-beta-Binding Protein, in Nonsyndromic Autosornal-Recessive Mental Retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; HEAD CIRCUMFERENCE; GENE; SUBUNITS; BIRTH	Mental retardation/intellectual disability is a devastating neurodevelopmental disorder with serious impact oil affected individuals and their families, as well as on health and social services. It occurs with a prevalence of similar to 2%, is an etiologically heterogeneous condition, and is frequently the result of genetic aberrations. Autosomal-recessive forms of nonsyndromic MR (NS-ARMR) are believed to be common, yet only five genes have been identified. We have used homozygosity mapping to search for the gene responsible for NS-ARMR in a large Pakistani pedigree. Using Affymetrix 5.0 single nucleotide polymorphism (SNP) microarrays, we identified a 3.2 Mb region on 8q24 with a continuous run of 606 homozygous SNPs shared among all affected members of the family. Additional genotype data from microsatellite markers verified this, allowing Lis to calculate a two-point LOD score of 5.18. Within this region, we identified a truncating homozygous mutation, R47SX, in exon 7 of the gene TRAPPC9. In a second large NS-ARMR/ID family, previously linked to 8q24 in a study of Iranian families, we identified a 4 bp deletion within exon 14 of TRAPPC9, also segregating with the phenotype and truncating the protein. This gene encodes NIK- and IKK-beta-binding protein (NIBP), which is involved in the NF-kappa B signaling pathway and directly interacts with IKK-beta and MAP3K14. Brain magnetic resonance imaging of affected individuals indicates the presence of mild cerebral white matter hypoplasia. Microcephaly is present in some but not all affected individuals. Thus, to Our knowledge, this is the sixth gene for NS-ARMR to be discovered.	[Kaufman, Liana; Noor, Abdul; Rafiq, Muhammad Arshad; Vincent, John B.] Ctr Addict & Mental Hlth, Neuropsychiat & Dev Lab, Neurogenet Sect, Toronto, ON M5T 1R8, Canada; [Mir, Asif; Jamil, Talal] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Motazacker, Mahdi M.; Tzschach, Andreas; Kuss, Andreas W.; Ropers, H. Hilger] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Azam, Matloob] Pakistan Inst Med Sci, Islamabad, Pakistan; [Kahrizi, Kimia; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran; [Weksberg, Rosanna] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Nasr, Tanveer; Ayub, Muhammad] Mayo Hosp, Lahore 54000, Pakistan; [Nasr, Tanveer] Chaudhry Hosp, Gujranwala 52250, Pakistan; [Naeem, Farooq] Univ Southampton, Sch Med, Southampton SO16 5ST, Hants, England; [Naeem, Farooq] Lahore Inst Res & Dev, Lahore 54000, Pakistan; [Ishak, Gisele E.] Univ Washington, Dept Radiol, Seattle Childrens Hosp, Seattle, WA 98105 USA; [Doherty, Dan] Univ Washington, Div Genet & Dev Med, Seattle Childrens Hosp, Seattle, WA 98105 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Ayub, Muhammad] St Lukes Hosp, Middlesbrough TS4 3AF, Cleveland, England; [Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; COMSATS University Islamabad (CUI); Max Planck Society; Pakistan Institute of Medical Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Southampton; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of Toronto	Vincent, JB (corresponding author), Ctr Addict & Mental Hlth, Neuropsychiat & Dev Lab, Neurogenet Sect, Toronto, ON M5T 1R8, Canada.	john_vincent@camh.net	Naeem, Farooq/M-2310-2019; Tzschach, Andreas/I-2648-2019; Najmabadi, Hossein/P-8182-2017; Mir, Asif/AAD-1788-2021; Noor, Abdul/J-2345-2016; Kahrizi, Kimia/D-7989-2017; Qazi, Talal/AAH-1986-2020	Naeem, Farooq/0000-0003-4760-4840; Tzschach, Andreas/0000-0002-6840-965X; Najmabadi, Hossein/0000-0002-6084-7778; Kuss, Andreas/0000-0002-9401-4627	Early Researcher Award from the Ontario provincial government; NARSAD Independent Investigator Award	Early Researcher Award from the Ontario provincial government; NARSAD Independent Investigator Award(NARSAD)	We would like to express our deepest gratitude to the families involved for their participation in this study. Funding Support for this work was through an Early Researcher Award from the Ontario provincial government to J.B.V. and also through a NARSAD Independent Investigator Award to J.B.V.	Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Cox R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-12; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; *DIAGN STAT MAN ME, 2005, TEXT REV DSM 4 TR; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; IshikawaBrush Y, 1997, HUM MOL GENET, V6, P1241, DOI 10.1093/hmg/6.8.1241; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Modell B, 2002, NAT REV GENET, V3, P225, DOI 10.1038/nrg754; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; NELLHAUS G, 1968, PEDIATRICS, V41, P106; ROCHE AF, 1987, PEDIATRICS, V79, P706; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; SHEARER MS, 1972, EXCEPT CHILDREN, V39, P210, DOI 10.1177/001440297203900304; Sparrow S.S., 2005, VINELAND ADAPTIVE BE, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; YAMAKAWA K, 1995, HUM MOL GENET, V4, P709, DOI 10.1093/hmg/4.4.709	20	106	112	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					909	915		10.1016/j.ajhg.2009.11.009	http://dx.doi.org/10.1016/j.ajhg.2009.11.009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004765	Green Published, Bronze			2022-12-18	WOS:000272797100015
J	Klar, J; Schweiger, M; Zimmerman, R; Zechner, R; Li, H; Torma, H; Vahlquist, A; Bouadjar, B; Dahl, N; Fischer, J				Klar, Joakim; Schweiger, Martina; Zimmerman, Robert; Zechner, Rudolf; Li, Hao; Torma, Hans; Vahlquist, Anders; Bouadjar, Bakar; Dahl, Niklas; Fischer, Judith			Mutations in the Fatty Acid Transport Protein 4 Gene Cause the Ichthyosis Prematurity Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE CONGENITAL ICHTHYOSIS; ACYL-COA SYNTHETASE; LAMELLAR ICHTHYOSIS; HARLEQUIN ICHTHYOSIS; WRINKLE-FREE; SKIN; LOCUS; MICE; ABNORMALITIES; EXPRESSION	Ichthyosis prematurity syndrome (IPS) is an autosomal-recessive disorder characterized by premature birth and neonatal asphyxia, followed by a lifelong nonscaly ichthyosis with atopic manifestations. Here we show that the gene encoding the fatty acid transport protein 4 (FATP4) is mutated in individuals with IPS. Fibroblasts derived from a patient with IPS show reduced activity of very long-chain fatty acids (VLCFA)-CoA synthetase and a specific reduction in the incorporation of VLCFA into cellular lipids. The human phenotype is consistent with Fatp4 deficiency in mice that is characterized by a severe skin phenotype, a defective permeability barrier function, and perturbed VLCFA metabolism. Our results further emphasize the importance of fatty acid metabolism for normal epidermal barrier function illustrated by deficiency of a member in the FATP family of proteins.	[Klar, Joakim; Dahl, Niklas] Uppsala Univ, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Schweiger, Martina; Zimmerman, Robert; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Li, Hao; Torma, Hans; Vahlquist, Anders] Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden; [Bouadjar, Bakar] CHU Bab El Oued, Dept Dermatol, Algiers 16000, Algeria; [Fischer, Judith] CNG, Inst Genom, CEA, F-91057 Evry, France	Uppsala University; University of Graz; Uppsala University; Uppsala University Hospital; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dahl, N (corresponding author), Uppsala Univ, Dept Genet & Pathol, S-75185 Uppsala, Sweden.	niklas.dahl@genpat.uu.se	Törmä, Hans/F-8152-2011; Fischer, Judith/E-6327-2016; Klar, Joakim/H-2900-2019	Törmä, Hans/0000-0002-3617-8551; Fischer, Judith/0000-0002-8580-8118; Klar, Joakim/0000-0003-4185-7409; Zimmermann, Robert/0000-0002-7354-870X; Zechner, Rudolf/0000-0001-5483-1182; Schweiger, Martina/0000-0002-3419-1007	Swedish Research Council; The Swedish Society for Medical Research; The Torsten and Ragnar Soderbergs Fund; Uppsala University, and University Hospital; CEA InStitut de Genonuque; Austrian Science Fund (FWF) [F 3002, Z 136] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); The Swedish Society for Medical Research; The Torsten and Ragnar Soderbergs Fund; Uppsala University, and University Hospital; CEA InStitut de Genonuque; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank the individuals with IPS and their families for participating in this research. We would like to thank Florence jobard for assistance in sequencing. The Norwegian patients were diagnosed and sampled in collaboration with Tobias Gedde-Dahl, who passed away in 2006. This work has been financially supported by the Swedish Research Council, The Swedish Society for Medical Research, The Torsten and Ragnar Soderbergs Fund, Uppsala University, and University Hospital. The work has also been financially supported by CEA InStitut de Genonuque. The authors declare no conflict of interest.	Akiyama M, 2008, EXP DERMATOL, V17, P373, DOI 10.1111/j.1600-0625.2007.00691.x; Akiyama M, 2006, J DERMATOL SCI, V42, P83, DOI 10.1016/j.jdermsci.2006.01.003; ANTONLAMPRECHT I, 1992, SKIN, P459; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Dahlqvist J, 2007, J MED GENET, V44, P615, DOI 10.1136/jmg.2007.050542; Dirusso CC, 2008, BBA-MOL CELL BIOL L, V1781, P135, DOI 10.1016/j.bbalip.2008.01.002; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Fischer J, 2000, AM J HUM GENET, V66, P904, DOI 10.1086/302814; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Herrmann T, 2005, J INVEST DERMATOL, V125, P1228, DOI 10.1111/j.0022-202X.2005.23972.x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Klar J, 2004, J MED GENET, V41, P208, DOI 10.1136/jmg.2003.012567; Lefevre C, 2006, HUM MOL GENET, V15, P767, DOI 10.1093/hmg/ddi491; Lefevre C, 2004, HUM MOL GENET, V13, P2473, DOI 10.1093/hmg/ddh263; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Melin M, 2006, J HUM GENET, V51, P864, DOI 10.1007/s10038-006-0035-z; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Mizrachi-Koren M, 2005, J INVEST DERMATOL, V125, P456, DOI 10.1111/j.0022-202X.2005.23777.x; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Schmuth M, 2005, J INVEST DERMATOL, V125, P1174, DOI 10.1111/j.0022-202X.2005.23934.x; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Virolainen E, 2000, AM J HUM GENET, V66, P1132, DOI 10.1086/302813; Zou ZY, 2002, J BIOL CHEM, V277, P31062, DOI 10.1074/jbc.M205034200	31	106	110	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					248	253		10.1016/j.ajhg.2009.06.021	http://dx.doi.org/10.1016/j.ajhg.2009.06.021			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19631310	Green Published, Bronze			2022-12-18	WOS:000269332900013
J	Zivna, M; Hulkova, H; Matignon, M; Hodanova, K; Vylet'al, P; Kalbacova, M; Baresova, V; Sikora, J; Blazkova, H; Zivny, J; Ivanek, R; Stranecky, V; Sovova, J; Claes, K; Lerut, E; Fryns, JP; Hart, PS; Hart, TC; Adams, JN; Pawtowski, A; Clemessy, M; Gasc, JM; Gubler, MC; Antignac, C; Elleder, M; Kapp, K; Grimbert, P; Bleyer, AJ; Kmoch, S				Zivna, Martina; Hulkova, Helena; Matignon, Marie; Hodanova, Katerina; Vylet'al, Petr; Kalbacova, Marie; Baresova, Veronika; Sikora, Jakub; Blazkova, Hana; Zivny, Jan; Ivanek, Robert; Stranecky, Viktor; Sovova, Jana; Claes, Kathleen; Lerut, Evelyne; Fryns, Jean-Pierre; Hart, P. Suzanne; Hart, Thomas C.; Adams, Jeremy N.; Pawtowski, Audrey; Clemessy, Maud; Gasc, Jean-Marie; Guebler, Marie-Claire; Antignac, Corinne; Elleder, Milan; Kapp, Katja; Grimbert, Philippe; Bleyer, Anthony J.; Kmoch, Stanislav			Dominant Renin Gene Mutations Associated with Early-Onset Hyperuricemia, Anemia, and Chronic Kidney Failure	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARBONIC-ANHYDRASE-IV; GLOMERULAR-FILTRATION-RATE; SIGNAL SEQUENCE MUTATION; ENDOPLASMIC-RETICULUM; RETINITIS-PIGMENTOSA; ANGIOTENSIN SYSTEM; MOLECULAR-BASIS; APOPTOSIS; DISEASE; PROTEIN	Through linkage analysis and candidate gene sequencing, we identified three unrelated families with the autosomal-dominant inheritance of early onset anemia, hypouricosuric hyperuricemia, progressive kidney failure, and mutations resulting either in the deletion (p.Leu16del) or the amino acid exchange (p.Leu16Arg) of a single leucine residue in the signal sequence of renin. Both mutations decrease signal sequence hydrophobicity and are predicted by bioinformatic analyses to damage targeting and cotranslational translocation of preprorenin into the endoplasmic reticulum (ER). Transfection and in vitro studies confirmed that both mutations affect ER translocation and processing of nascent preprorenin, resulting either in reduced (p.Leu16del) or abolished (p.Leu16Arg) prorenin and renin biosynthesis and secretion. Expression of renin and other components of the renin-angiotensin system was decreased accordingly in kidney biopsy specimens from affected individuals. Cells stably expressing the p.Leu16del protein showed activated ER stress, unfolded protein response, and reduced growth rate. It is likely that expression of the mutant proteins has a dominant toxic effect gradually reducing the viability of renin-expressing cells. This alters the intrarenal renin-angiotensin system and the juxtaglomerular apparatus functionality and leads to nephron dropout and progressive kidney failure. Our findings provide insight into the functionality of renin-angiotensin system and stress the importance of renin analysis in families and individuals with early onset hyperuricemia, anemia, and progressive kidney failure.	[Zivna, Martina; Hodanova, Katerina; Vylet'al, Petr; Kalbacova, Marie; Baresova, Veronika; Ivanek, Robert; Stranecky, Viktor; Elleder, Milan; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Ctr Appl Genom, Prague 12000, Czech Republic; [Zivna, Martina; Hulkova, Helena; Hodanova, Katerina; Vylet'al, Petr; Kalbacova, Marie; Baresova, Veronika; Sikora, Jakub; Blazkova, Hana; Ivanek, Robert; Stranecky, Viktor; Sovova, Jana; Elleder, Milan; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12000, Czech Republic; [Zivny, Jan] Charles Univ Prague, Fac Med 1, Inst Pathophysiol, Prague 12000, Czech Republic; [Matignon, Marie; Grimbert, Philippe] Hop Henri Mondor, AP HP, Nephrol & Transplantat Unit, F-94010 Creteil, France; [Matignon, Marie; Grimbert, Philippe] Univ Paris 12, F-94010 Creteil, France; [Claes, Kathleen; Lerut, Evelyne] Univ Hosp Gasthuisberg, Dept Nephrol, B-3000 Louvain, Belgium; [Fryns, Jean-Pierre] Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium; [Hart, P. Suzanne; Adams, Jeremy N.] NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA; [Hart, Thomas C.] Natl Inst Dent & Craniofacial Res, Human Craniofacial Genet Sect, NIH, Bethesda, MD 20892 USA; [Pawtowski, Audrey; Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France; [Guebler, Marie-Claire; Antignac, Corinne] Hop Necker Enfants Malad, INSERM, U574, F-75015 Paris, France; [Clemessy, Maud; Gasc, Jean-Marie] Coll France, INSERM, U833, F-75005 Paris, France; [Guebler, Marie-Claire; Antignac, Corinne] Univ Paris 05, Fac Med, F-75006 Paris, France; [Kapp, Katja] Univ Heidelberg, ZMBH Ctr Mol Biol Heidelberg, D-69120 Heidelberg, Germany; [Bleyer, Anthony J.] Wake Forest Univ, Bowman Gray Sch Med, Nephrol Sect, Winston Salem, NC 27157 USA	Charles University Prague; Charles University Prague; Charles University Prague; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); KU Leuven; University Hospital Leuven; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Universite Paris Cite; Ruprecht Karls University Heidelberg; Wake Forest University; Wake Forest Baptist Medical Center	Kmoch, S (corresponding author), Charles Univ Prague, Fac Med 1, Ctr Appl Genom, Prague 12000, Czech Republic.	skmoch@lf1.cuni.cz	grimbert, philippe/Q-5337-2018; Sikora, Jakub/F-4842-2017; Vyleťal, Petr/F-4771-2017; Stranecky, Viktor/I-8524-2017; Ivanek, Robert/A-8852-2008; Hůlková, Helena/O-2268-2017; Zivny, Jan/C-2545-2008; Hodaňová, Kateřina/I-4727-2017; Matignon, Marie B/Q-8091-2018; Kalbáčová, Marie Hubálek/G-2307-2017; Hanzlikova, Hana/O-2615-2019; Vyleťal, Petr/AAC-3468-2021; Hanzlikova, Hana/G-6183-2014; Vyleťal, Petr/AHE-7903-2022; ANTIGNAC, Corinne/H-8945-2017; Kmoch, Stanislav/C-1575-2010; Baresova, Veronika/H-4931-2017	Sikora, Jakub/0000-0003-4104-2023; Vyleťal, Petr/0000-0002-9357-1237; Stranecky, Viktor/0000-0002-2599-6479; Hůlková, Helena/0000-0002-7441-6610; Zivny, Jan/0000-0002-1811-8977; Hodaňová, Kateřina/0000-0001-9172-9945; Kalbáčová, Marie Hubálek/0000-0002-3886-2218; Hanzlikova, Hana/0000-0001-7235-7269; ANTIGNAC, Corinne/0000-0002-9934-4940; Kmoch, Stanislav/0000-0002-6239-707X; Baresova, Veronika/0000-0001-8989-6090; Ivanek, Robert/0000-0002-8403-056X; Gubler, Marie-Claire/0000-0002-3526-5661	Novartis Pharma [R3-36-16]; Grant Agency of Charles University of Prague [257672, 257750]; Ministry of Education of the Czech Republic [MSM0021620806, IM6837805002]	Novartis Pharma; Grant Agency of Charles University of Prague; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	We thank Gert Matthijs, Elly Pijkels, Vicki Robins, Sharon Moe, Concei ao Mota, and Fatima Torres for collection of biological materials and patient data, Olivier Gribouval for contribution to the genetic analysis, Maria Leidenberger and Klaus Meese for in vitro translation experiments, Zdena VernerovA for nephropathologic expertise, Novartis Pharma for R3-36-16 renin antibody, and Pierre Corvol and Genevieve Nguyen for pro/renin antibody. The authors report no conflict of interest. This work was supported by the Grant Agency of Charles University of Prague (projects 257672 and 257750). Institutional support was provided by the Ministry of Education of the Czech Republic (projects MSM0021620806 and IM6837805002).	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bonapace G, 2004, P NATL ACAD SCI USA, V101, P12300, DOI 10.1073/pnas.0404764101; DANOVITCH GM, 1972, NEPHRON, V9, P291, DOI 10.1159/000180160; Datta R, 2007, P NATL ACAD SCI USA, V104, P19989, DOI 10.1073/pnas.0708725104; Datta R, 2009, P NATL ACAD SCI USA, V106, P3437, DOI 10.1073/pnas.0813178106; Donnelly S, 1999, AM J KIDNEY DIS, V33, P947, DOI 10.1016/S0272-6386(99)70431-2; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; Gribouval O, 2005, NAT GENET, V37, P964, DOI 10.1038/ng1623; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hodanova K, 2005, KIDNEY INT, V68, P1472, DOI 10.1111/j.1523-1755.2005.00560.x; Hubert C, 2006, NAT CLIN PRACT CARD, V3, P80, DOI 10.1038/ncpcardio0449; IMAI T, 1983, P NATL ACAD SCI-BIOL, V80, P7405, DOI 10.1073/pnas.80.24.7405; Ito M, 1997, J CLIN INVEST, V99, P1897, DOI 10.1172/JCI119357; Jarjanazi H, 2008, PROTEINS, V70, P394, DOI 10.1002/prot.21548; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kmoch S, 2000, HUM MOL GENET, V9, P1501, DOI 10.1093/hmg/9.10.1501; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LYKO F, 1995, J BIOL CHEM, V270, P19873, DOI 10.1074/jbc.270.34.19873; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; PAUL M, 1988, J HYPERTENS, V6, pS487, DOI 10.1097/00004872-198812040-00154; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pentz ES, 2004, AM J PHYSIOL-REG I, V286, pR474, DOI 10.1152/ajpregu.00426.2003; Rebello G, 2004, P NATL ACAD SCI USA, V101, P6617, DOI 10.1073/pnas.0401529101; ROTHWELL V, 1993, DNA CELL BIOL, V12, P291, DOI 10.1089/dna.1993.12.291; SAGNELLA GA, 1979, BIOCHEM J, V182, P301, DOI 10.1042/bj1820301; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; VILLARD E, 1994, J BIOL CHEM, V269, P30307; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Wilcox WD, 1996, J PEDIATR-US, V128, P731, DOI 10.1016/S0022-3476(96)70322-0; WILTFANG J, 1991, ELECTROPHORESIS, V12, P352, DOI 10.1002/elps.1150120507; Wong C, 2008, PEDIATR NEPHROL, V23, P1037, DOI 10.1007/s00467-008-0816-z; Yeap BB, 2009, INTERN MED J, V39, P532, DOI 10.1111/j.1445-5994.2008.01789.x; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	36	106	116	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					204	213		10.1016/j.ajhg.2009.07.010	http://dx.doi.org/10.1016/j.ajhg.2009.07.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19664745	Green Published, Bronze			2022-12-18	WOS:000269332900009
J	Di Fonzo, A; Ronchi, D; Lodi, T; Fassone, E; Tigano, M; Lamperti, C; Corti, S; Bordoni, A; Fortunato, F; Nizzardo, M; Napoli, L; Donadoni, C; Salani, S; Saladino, F; Moggio, M; Bresolin, N; Ferrero, I; Comi, GP				Di Fonzo, Alessio; Ronchi, Dario; Lodi, Tiziana; Fassone, Elisa; Tigano, Marco; Lamperti, Costanza; Corti, Stefania; Bordoni, Andreina; Fortunato, Francesco; Nizzardo, Monica; Napoli, Laura; Donadoni, Chiara; Salani, Sabrina; Saladino, Francesca; Moggio, Maurizio; Bresolin, Nereo; Ferrero, Iliana; Comi, Giacomo P.			The Mitochondrial Disulfide Relay System Protein GFER Is Mutated in Autosomal-Recessive Myopathy with Cataract and Combined Respiratory-Chain Deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C-OXIDASE; INTERMEMBRANE SPACE; LIVER-REGENERATION; SACCHAROMYCES-CEREVISIAE; SULFHYDRYL OXIDASE; SKELETAL-MUSCLE; AUGMENTOR; IDENTIFICATION; DISORDERS; MUTATIONS	A disulfide relay system (DRS) was recently identified in the yeast mitochondrial intermembrane space (IMS) that consists of two essential components: the sulfhydryl oxidase Erv1 and the redox-regulated import receptor Mia40. The DRS drives the import of cysteine-rich proteins into the IMS via an oxidative folding mechanism. Erv1p is reoxidized within this system, transferring its electrons to molecular oxygen through interactions with cytochrome c and cytochrome c oxidase (COX), thereby linking the DRS to the respiratory chain. The role of the human Erv1 ortholog, GFER, in the DRS has been poorly explored. Using homozygosity mapping, we discovered that a mutation in the GFER gene causes an infantile mitochondrial disorder. Three children born to healthy consanguineous parents presented with progressive myopathy and partial combined respiratory-chain deficiency, congenital cataract, sensorineural hearing loss, and developmental delay. The consequences of the mutation at the level of the patient's muscle tissue and fibroblasts were 1) a reduction in complex I, II, and IV activity; 2) a lower cysteine-rich protein content; 3) abnormal ultrastructural morphology of the mitochondria, with enlargement of the IMS space; and 4) accelerated time-dependent accumulation of multiple mtDNA deletions. Moreover, the Saccharomyces cerevisiae erv1(R182H) mutant strain reproduced the complex IV activity defect and exhibited genetic instability of the mtDNA and mitochondrial morphological defects. These findings shed light on the mechanisms of mitochondrial biogenesis, establish the role of GFER in the human DRS, and promote an understanding of the pathogenesis of a new mitochondrial disease.	[Di Fonzo, Alessio; Ronchi, Dario; Fassone, Elisa; Lamperti, Costanza; Corti, Stefania; Bordoni, Andreina; Fortunato, Francesco; Nizzardo, Monica; Napoli, Laura; Donadoni, Chiara; Salani, Sabrina; Saladino, Francesca; Moggio, Maurizio; Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Dino Ferrari Ctr, Dept Neurol Sci, I-20122 Milan, Italy; [Di Fonzo, Alessio; Ronchi, Dario; Fassone, Elisa; Lamperti, Costanza; Corti, Stefania; Bordoni, Andreina; Fortunato, Francesco; Nizzardo, Monica; Napoli, Laura; Donadoni, Chiara; Salani, Sabrina; Saladino, Francesca; Moggio, Maurizio; Bresolin, Nereo; Comi, Giacomo P.] Osped Maggiore Policlin, Fdn IRCCS, I-20122 Milan, Italy; [Lodi, Tiziana; Tigano, Marco; Ferrero, Iliana] Univ Parma, Dept Genet Anthropol & Evolut, I-43100 Parma, Italy; [Bresolin, Nereo; Comi, Giacomo P.] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy; [Bresolin, Nereo] IRCCS Eugenio Medea, I-23842 Bosisio Parini, Lecco, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Parma; University of Milan; IRCCS Eugenio Medea	Comi, GP (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Neurol Sci, I-20122 Milan, Italy.	giacomo.comi@unimi.it	lodi, tiziana/A-5993-2012; Ronchi, Dario/K-8011-2016; lamperti, costanza/J-8801-2016; Ronchi, Dario/O-4138-2019; Nizzardo, Monica/J-1817-2015; Di Fonzo, Alessio/A-5702-2013; Comi, Giacomo P/K-5702-2016; Corti, Stefania/K-6034-2016	lodi, tiziana/0000-0002-7294-8971; Ronchi, Dario/0000-0002-6093-9816; lamperti, costanza/0000-0002-2280-2253; Ronchi, Dario/0000-0002-6093-9816; Nizzardo, Monica/0000-0001-5447-0882; Di Fonzo, Alessio/0000-0001-6478-026X; Comi, Giacomo P/0000-0002-1383-5248; Corti, Stefania/0000-0001-5425-969X; Bresolin, Nereo/0000-0001-6694-3595; Napoli, Laura/0000-0003-4607-8084; Tigano, Marco/0000-0002-4353-9220; Ripolone, Michela/0000-0001-9293-6823	Italian Ministry of University [PRIN 2006 2006069034]; Italian Ministry of Health; Telethon Network of Genetics Biobanks [GTB 07001E]; Eurobiobank [QLTR-2001-02769]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Telethon Network of Genetics Biobanks(Fondazione Telethon); Eurobiobank	We wish to thank the patients and their families for their support and collaboration. This research received support from Associazione Amici del Centro Dino Ferrari. G.RC. and I F. received funding from Research Grant PRIN 2006 2006069034 from the Italian Ministry of University and Research for the project entitled "An integrated approach to the Study of the etiopathogenesis of mitochondrial disorders." G.RC. was also funded by the Italian Ministry of Health for the 2009 project entitled "Mitochondrial disorders: From medical genetics to molecular mechanisms, toward the development of therapeutic strategies." The Telethon Network of Genetics Biobanks (no. GTB 07001E) was the source of muscle, DNA, and cells used in this study. Eurobiobank project QLTR-2001-02769 is also gratefully acknowledged. We thank M. Aguennouz and V. Bonifati for providing DNA from healthy Moroccan Subjects. We also thank T. G. Weiss for providing a control GFER antibody.	Baruffini E, 2007, BBA-MOL BASIS DIS, V1772, P1225, DOI 10.1016/j.bbadis.2007.10.002; Becher D, 1999, YEAST, V15, P1171, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1171::AID-YEA443>3.0.CO;2-T; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; BRESOLIN N, 1985, NEUROLOGY, V35, P802, DOI 10.1212/WNL.35.6.802; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; FRANCAVILLA A, 1994, HEPATOLOGY, V20, P747, DOI 10.1002/hep.1840200328; Gatzidou E, 2006, WORLD J GASTROENTERO, V12, P4951, DOI 10.3748/wjg.v12.i31.4951; HECKMATT JZ, 1984, MUSCLE NERVE, V7, P594; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Li Y, 2002, EUR J BIOCHEM, V269, P3888, DOI 10.1046/j.1432-1033.2002.03054.x; Lisowsky T, 2001, DIGEST LIVER DIS, V33, P173, DOI 10.1016/S1590-8658(01)80074-8; Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Perie S, 2006, NEUROMUSCULAR DISORD, V16, P770, DOI 10.1016/j.nmd.2006.07.022; Salani S, 2004, MUSCLE NERVE, V30, P366, DOI 10.1002/mus.20106; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157; Wharton DC., 1967, METHOD ENZYMOL, P245; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.0.CO;2-9; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	31	106	109	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					594	604		10.1016/j.ajhg.2009.04.004	http://dx.doi.org/10.1016/j.ajhg.2009.04.004			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19409522	Bronze, Green Published			2022-12-18	WOS:000266338800004
J	Brancati, F; Barrano, G; Silhavy, JL; Marsh, SE; Travaglini, L; Bielas, SL; Amorini, M; Zablocka, D; Kayserili, H; Al-Gazali, L; Bertini, E; Boltshauser, E; D'Hooghe, M; Fazzi, E; Fenerci, EY; Hennekam, RCM; Kiss, A; Lees, MM; Marco, E; Phadke, SR; Rigoli, L; Romano, S; Salpietro, CD; Sherr, EH; Signorini, S; Stromme, P; Stuart, B; Sztriha, L; Viskochil, DH; Yuksel, A; Dallapiccola, B; Valente, EM; Gleeson, JG				Brancati, Francesco; Barrano, Giuseppe; Silhavy, Jennifer L.; Marsh, Sarah E.; Travaglini, Lorena; Bielas, Stephanie L.; Amorini, Maria; Zablocka, Dominika; Kayserili, Hulya; Al-Gazali, Lihadh; Bertini, Enrico; Boltshauser, Eugen; D'Hooghe, Marc; Fazzi, Elisa; Fenerci, Elif Y.; Hennekam, Raoul C. M.; Kiss, Andrea; Lees, Melissa M.; Marco, Elysa; Phadke, Shubha R.; Rigoli, Luciana; Romano, Stephane; Salpietro, Carmelo D.; Sherr, Elliott H.; Signorini, Sabrina; Stromme, Petter; Stuart, Bernard; Sztriha, Laszlo; Viskochil, David H.; Yuksel, Adnan; Dallapiccola, Bruno; Valente, Enza Maria; Gleeson, Joseph G.		Int JSRD Study Grp	CEP290 mutations are frequently identified in the oculo-renal form of Joubert syndrome-related disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABNORMAL EYE-MOVEMENTS; LEFT-RIGHT ASYMMETRY; NPHP1 GENE DELETION; CENTROSOMAL PROTEIN; EPISODIC HYPERPNEA; CEREBELLAR VERMIS; CYSTIC-DISEASE; AHI1 GENE; MOUSE; CILIA	Joubert syndrome-related disorders (JSRDs) are a group of clinically and genetically heterogeneous conditions that share a midbrain-hindbrain malformation, the molar tooth sign (MTS) visible on brain imaging, with variable neurological, ocular, and renal manifestations. Mutations in the CEP290 gene were recently identified in families with the MTS-related neurological features, many of which showed oculo-renal involvement typical of Senior-Loken syndrome (JSRD- SLS phenotype). Here, we performed comprehensive CEP290-mutation analysis on two nonoverlapping cohorts of JSRD-affected patients with a proven MTS. We identified mutations in 19 of 44 patients with JSRD- SLS. The second cohort consisted of 84 patients representing the spectrum of other JSRD subtypes, with mutations identified in only two patients. The data suggest that CEP290 mutations are frequently encountered and are largely specific to the JSRD- SLS subtype. One patient with mutation displayed complete situs inversus, confirming the clinical and genetic overlap between JSRDs and other ciliopathies.	IRCCS, CSS, Mendel Inst, I-00198 Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy; IRCCS Bambino Gesu Hosp, Dept Lab Med, Mol Med Unit, I-00198 Rome, Italy; G dAnnunzio Univ Fdn, CeSI, Aging Res Ctr, Chieti, Italy; G dAnnunzio Univ Fdn, Dept Biomed Sci, Chieti, Italy; Univ Calif San Diego, Dept Neurosci, Neurogenet Lab, San Diego, CA 92103 USA; Univ Messina, Operat Unit Paediat Genet & Immunol, Dept Med & Surg Paediat Sci, I-98100 Messina, Italy; Univ Istanbul, Istanbul Med Fac, Med Genet Dept, TR-34452 Istanbul, Turkey; Univ Istanbul, Cerrahpasa Med Sch, Dept Genet, TR-34452 Istanbul, Turkey; Univ Istanbul, Cerrahpasa Med Sch, Dept Med Biol, TR-34452 Istanbul, Turkey; Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; Childrens Univ Hosp, Dept Neurol, Zurich, Switzerland; Univ Pavia, IRCCS C Mondino Fdn, Dept Child Neurol & Psychiat, I-27100 Pavia, Italy; Sint Jan Hosp, Dept Neurol, Brugge, Belgium; Inst Child Hlth, London WC1, England; Fed Fac Fdn Med Sci, Dept Morphol Sci, Porto Alegre, RS, Brazil; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Sanjay Gandhi Postgrad Inst Med Sci, Dept Med Genet, Lucknow 226014, Uttar Pradesh, India; Hop Necker Enfants Malad, AP HP, Dept Pediat, F-75730 Paris, France; Ullevaal Univ Hosp, Fac Div, Dept Paediat, Oslo, Norway; Univ Coll Dublin, Dept Obstet & Gynaecol, Coombe Womens Hosp, Dublin 2, Ireland; Univ Szeged, Dept Paediat, Div B, H-6720 Szeged, Hungary; Univ Utah, Sch Med, Dept Pediat Adm, Salt Lake City, UT 84112 USA	IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; IRCCS Bambino Gesu; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of California System; University of California San Diego; University of Messina; Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; Istanbul University; Istanbul University - Cerrahpasa; United Arab Emirates University; University Children's Hospital Zurich; IRCCS Fondazione Casimiro Mondino; University of Pavia; University of California System; University of California San Francisco; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Oslo; Trinity College Dublin; University College Dublin; Szeged University; Utah System of Higher Education; University of Utah	Valente, EM (corresponding author), IRCCS, CSS, Mendel Inst, Viale Regina Margherita 261, I-00198 Rome, Italy.	e.valente@css-mendel.it	Damiano, Carmelo Salpietro/AAL-2945-2020; Valente, Enza Maria/G-2942-2017; pantaleoni, chiara/K-4492-2016; Bertini, Enrico/A-2284-2014; d'arrigo, stefano/K-3640-2016; Travaglini, Lorena/AAA-6245-2020; Fazzi, Elisa/J-6076-2016; Martí-Carrera, Itxaso/AGP-5583-2022; Marsh, Sarah/E-9164-2010; Bertini, Enrico/ABG-1278-2020; Barbot, Clara/K-6378-2013; Abdel-Salam, Ghada/W-1718-2017; Signorini, Sabrina Giovanna/AAA-8467-2019; Brancati, Francesco/AAC-3778-2022; Aleem, Alice Abdel/AAY-2598-2020; Gentile, Mattia/AEQ-3183-2022; Kayserili, Hülya/AAA-5593-2021; Dallapiccola, Bruno/K-8692-2016; battini, roberta/P-9095-2017; VERLOES, Alain/E-7287-2014	Damiano, Carmelo Salpietro/0000-0001-8794-2292; Valente, Enza Maria/0000-0002-0600-6820; pantaleoni, chiara/0000-0003-4417-1672; Bertini, Enrico/0000-0001-9276-4590; d'arrigo, stefano/0000-0001-5188-9418; Fazzi, Elisa/0000-0003-4805-7906; Martí-Carrera, Itxaso/0000-0003-0578-9568; Barbot, Clara/0000-0002-5597-107X; Abdel-Salam, Ghada/0000-0003-2893-8802; Brancati, Francesco/0000-0003-3624-2354; Gentile, Mattia/0000-0002-5299-6036; Kayserili, Hülya/0000-0003-0376-499X; Maegawa, Gustavo/0000-0001-6933-4138; Marsh, Sarah/0000-0003-4194-043X; Dallapiccola, Bruno/0000-0002-5031-1013; Zaki, Maha/0000-0001-7840-0002; Swoboda, Kathryn/0000-0002-4593-6342; Phadke, Shubha/0000-0002-6624-082X; Ghiggeri, Gian Marco/0000-0003-3659-9062; battini, roberta/0000-0002-7889-1355; VERLOES, Alain/0000-0003-4819-0264; Abdel Aleem, Alice/0000-0001-5137-3382; Bielas, Stephanie/0000-0003-0567-5632; FERLINI, ALESSANDRA/0000-0001-8385-9870; Travaglini, Lorena/0000-0003-0142-6516; AMORINI, MARIA/0000-0002-5194-631X; Yuksel, Adnan/0000-0002-7275-8254; MARIA ALICE, DONATI/0000-0003-4769-5025; Dobyns, William/0000-0002-7681-2844; BRIUGLIA, Silvana/0000-0002-5213-441X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS048453] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; BOLTSHAUSER E, 1977, NEUROPADIATRIE, V8, P57, DOI 10.1055/s-0028-1091505; Castori M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027375; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; O'Toole JF, 2006, NEPHROL DIAL TRANSPL, V21, P1989, DOI 10.1093/ndt/gfl088; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; SALONEN R, 1984, AM J MED GENET, V18, P671, DOI 10.1002/ajmg.1320180414; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805	29	106	109	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					104	113		10.1086/519026	http://dx.doi.org/10.1086/519026			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564967	Bronze, Green Published			2022-12-18	WOS:000247039700009
J	De Luca, A; Bottillo, I; Sarkozy, A; Carta, C; Neri, C; Bellacchio, E; Schirinzi, A; Conti, E; Zampino, G; Battaglia, A; Majore, S; Rinaldi, MM; Carella, M; Marino, B; Pizzuti, A; Digilio, MC; Tartaglia, M; Dallapiccola, B				De Luca, A; Bottillo, I; Sarkozy, A; Carta, C; Neri, C; Bellacchio, E; Schirinzi, A; Conti, E; Zampino, G; Battaglia, A; Majore, S; Rinaldi, MM; Carella, M; Marino, B; Pizzuti, A; Digilio, MC; Tartaglia, M; Dallapiccola, B			NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; SOMATIC PTPN11 MUTATIONS; ACUTE MYELOID-LEUKEMIA; GAP-RELATED DOMAIN; TYPE-1 NEUROFIBROMATOSIS; LEOPARD-SYNDROME; FAMILY; DISORDERS; IDENTIFICATION; PHENOTYPE	Neurofibromatosis type 1 (NF1) demonstrates phenotypic overlap with Noonan syndrome (NS) in some patients, which results in the so-called neurofibromatosis-Noonan syndrome (NFNS). From a genetic point of view, NFNS is a poorly understood condition, and controversy remains as to whether it represents a variable manifestation of either NF1 or NS or is a distinct clinical entity. To answer this question, we screened a cohort with clinically wellcharacterized NFNS for mutations in the entire coding sequence of the NF1 and PTPN11 genes. Heterozygous NF1 defects were identified in 16 of the 17 unrelated subjects included in the study, which provides evidence that mutations in NF1 represent the major molecular event underlying this condition. Lesions included nonsense mutations, out-of-frame deletions, missense changes, small inframe deletions, and one large multiexon deletion. Remarkably, a high prevalence of inframe defects affecting exons 24 and 25, which encode a portion of the GAP-related domain of the protein, was observed. On the other hand, no defect in PTPN11 was observed, and no lesion affecting exons 11-27 of the NF1 gene was identified in 100 PTPN11 mutation-negative subjects with NS, which provides further evidence that NFNS and NS are genetically distinct disorders. These results support the view that NFNS represents a variant of NF1 and is caused by mutations of the NF1 gene, some of which have been demonstrated to cause classic NF1 in other individuals.	Ist CSS Mendel, I-00198 Rome, Italy; IRCCS San Giovanni Rotondo, CSS Hosp, Rome, Italy; Univ Roma La Sapienza, Dept Pediat, Pediat Cardiol Sect, Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy; Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; Univ Cattolica Sacro Cuore, Ist Clin Pediat, Rome, Italy; Bambino Gesu Pediat Hosp, IRCCS, AO San Camillo Forlanini, Rome, Italy; Stella Maris Sci Res Inst, Pisa, Italy; Osped Antonio Cardarelli, Naples, Italy; Mt Sinai Sch Med, Dept Pediat, New York, NY USA	IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Sapienza University Rome; Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Azienda Ospedaliera San Camillo-Forlanini; IRCCS Bambino Gesu; IRCCS Fondazione Stella Maris; Antonio Cardarelli Hospital; Icahn School of Medicine at Mount Sinai	Dallapiccola, B (corresponding author), Ist CSS Mendel, Viale Regina Margherita 261, I-00198 Rome, Italy.	dallapiccola@css-mendel.it	Carella, Massimo/A-2804-2014; Bottillo, Irene/AFM-2547-2022; Bottillo, Irene/K-5361-2012; Tartaglia, Marco/K-2955-2018; Carta, Claudio/A-7305-2013; Digilio, Maria Cristina/AAI-2434-2019; Bellacchio, Emanuele/AAH-9255-2019; De Luca, Alessandro/B-2179-2017; Zampino, Giuseppe/AAC-2152-2019; Battaglia, Agatino/AAG-1406-2020; Dallapiccola, Bruno/K-8692-2016	Carella, Massimo/0000-0002-6830-6829; Bottillo, Irene/0000-0003-0396-7981; Bottillo, Irene/0000-0003-0396-7981; Tartaglia, Marco/0000-0001-7736-9672; Carta, Claudio/0000-0003-3545-198X; De Luca, Alessandro/0000-0002-4408-8062; Battaglia, Agatino/0000-0002-7128-7606; PIZZUTI, Antonio/0000-0003-3245-1925; Dallapiccola, Bruno/0000-0002-5031-1013; Majore, Silvia/0000-0001-7153-9351; Bellacchio, Emanuele/0000-0002-2757-849X	Telethon [GGP04172] Funding Source: Medline	Telethon(Fondazione Telethon)		ABUELO DN, 1988, AM J MED GENET, V29, P937, DOI 10.1002/ajmg.1320290426; ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Arun D, 2004, CURR OPIN NEUROL, V17, P101, DOI 10.1097/00019052-200404000-00004; Bahuau M, 1998, AM J MED GENET, V75, P265, DOI 10.1002/(SICI)1096-8628(19980123)75:3<265::AID-AJMG8>3.0.CO;2-P; Bahuau M, 1996, AM J MED GENET, V66, P347, DOI 10.1002/(SICI)1096-8628(19961218)66:3<347::AID-AJMG20>3.0.CO;2-L; Baralle D, 2003, AM J MED GENET A, V119A, P1, DOI 10.1002/ajmg.a.20023; Bertola DR, 2005, AM J MED GENET A, V136A, P242, DOI 10.1002/ajmg.a.30813; Carey JC, 1998, AM J MED GENET, V75, P263, DOI 10.1002/(SICI)1096-8628(19980123)75:3<263::AID-AJMG7>3.0.CO;2-R; CAREY JC, 1997, P GREENWOOD GENET CT, V17, P52; Castle B, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e109; Colley A, 1996, CLIN GENET, V49, P59; Correa CL, 1999, HUM MUTAT, V14, P387, DOI 10.1002/(SICI)1098-1004(199911)14:5<387::AID-HUMU4>3.0.CO;2-4; Dasgupta B, 2003, CURR OPIN GENET DEV, V13, P20, DOI 10.1016/S0959-437X(02)00015-1; De Luca A, 2004, HUM MUTAT, V23, DOI 10.1002/humu.9245; De Luca A, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9111; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Horan MP, 2000, HUM GENET, V107, P33, DOI 10.1007/s004390050007; Jongmans M, 2005, AM J MED GENET A, V134A, P165, DOI 10.1002/ajmg.a.30598; KAPLAN P, 1985, AM J MED GENET, V21, P463, DOI 10.1002/ajmg.1320210308; Kluwe L, 2004, HUM MUTAT, V23, P111, DOI 10.1002/humu.10299; KORF BR, 1998, NEUROFIBROMATOSIS TY, V1, P57; Lee JS, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.024091; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MEINECKE P, 1987, AM J MED GENET, V26, P741, DOI 10.1002/ajmg.1320260331; MENDEZ HMM, 1985, AM J MED GENET, V21, P471, DOI 10.1002/ajmg.1320210309; Morcos P, 1996, MOL CELL BIOL, V16, P2496; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; OPITZ JM, 1985, AM J MED GENET, V21, P477, DOI 10.1002/ajmg.1320210310; Park VM, 1998, J MED GENET, V35, P813, DOI 10.1136/jmg.35.10.813; POULLET P, 1994, MOL CELL BIOL, V14, P815, DOI 10.1128/MCB.14.1.815; PURANDARE SM, 1994, HUM MOL GENET, V3, P1109, DOI 10.1093/hmg/3.7.1109; QUATTRIN T, 1987, AM J MED GENET, V26, P645, DOI 10.1002/ajmg.1320260320; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Sarkozy A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013466; Sarkozy A, 2003, J MED GENET, V40, P704, DOI 10.1136/jmg.40.9.704; SAUL RA, 1985, AM J MED GENET, V21, P491, DOI 10.1002/ajmg.1320210311; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; SHARLAND M, 1992, ARCH DIS CHILD, V67, P178, DOI 10.1136/adc.67.2.178; SHUPER A, 1987, ARCH DIS CHILD, V62, P196, DOI 10.1136/adc.62.2.196; Side LE, 1998, BLOOD, V92, P267, DOI 10.1182/blood.V92.1.267.413a31_267_272; STERN HJ, 1992, J MED GENET, V29, P184, DOI 10.1136/jmg.29.3.184; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2005, BRIT J HAEMATOL, V129, P333, DOI 10.1111/j.1365-2141.2005.05457.x; Tartaglia M, 2004, CURR OPIN HEMATOL, V11, P44, DOI 10.1097/00062752-200401000-00007; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; Upadhyaya M, 1998, NEUROFIBROMATOSIS TY, P65; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	60	106	112	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1092	1101		10.1086/498454	http://dx.doi.org/10.1086/498454			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380919	Green Published, Bronze			2022-12-18	WOS:000233241200017
J	Gleghorn, L; Ramesar, R; Beighton, P; Wallis, G				Gleghorn, L; Ramesar, R; Beighton, P; Wallis, G			A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORE PROTEIN; CANDIDATE GENE; IDENTIFICATION; NANOMELIA; PROTEOGLYCAN; CHONDROCYTES; SYNTHESIZE; EXCLUSION; DELETION; MUTANT	Spondyloepiphyseal dysplasia (SED) encompasses a heterogeneous group of disorders characterized by shortening of the trunk and limbs. The autosomal dominant SED type Kimberley (SEDK) is associated with premature degenerative arthropathy and has been previously mapped in a multigenerational family to a novel locus on 15q26.1. This locus contains the gene AGC1, which encodes aggrecan, the core protein of the most abundant proteoglycan of cartilage. We screened AGC1 for mutations and identified a single-base-pair insertion, within the variable repeat region of exon 12 in affected individuals from the family with SEDK, that introduces a frameshift of 212 amino acids, including 22 cysteine residues, followed by a premature stop codon. This is the first identification of an AGC1 mutation causing a human disorder. This finding extends the spectrum of mutated genes that may cause SED and thus will aid in the molecular delineation of this complex group of conditions.	Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Med, Manchester M13 9PT, Lancs, England; Univ Cape Town, Div Human Genet, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Manchester; University of Manchester; University of Cape Town	Wallis, G (corresponding author), Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, C3252 Smith Bldg, Manchester M13 9PT, Lancs, England.	g.wallis@manchester.ac.uk	Ramesar, Raj S/I-6941-2015	Ramesar, Raj S/0000-0001-5688-1634				ANDERSON IJ, 1990, AM J MED GENET, V37, P272, DOI 10.1002/ajmg.1320370223; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; Doege KJ, 1997, J BIOL CHEM, V272, P13974, DOI 10.1074/jbc.272.21.13974; Domowicz MS, 2000, J BIOL CHEM, V275, P35098, DOI 10.1074/jbc.275.45.35098; Eyre S, 2005, J MED GENET, V42; Eyre S, 2002, J MED GENET, V39, P634, DOI 10.1136/jmg.39.9.634; Horton WA, 2002, CONNECTIVE TISSUE IT, P909; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Krueger RC, 1999, MAMM GENOME, V10, P1119, DOI 10.1007/s003359901176; LANDAUER W, 1965, J HERED, V56, P131, DOI 10.1093/oxfordjournals.jhered.a107392; LI H, 1993, J BIOL CHEM, V268, P23504; STIRPE NS, 1987, DEV BIOL, V124, P77, DOI 10.1016/0012-1606(87)90461-1; VALHMU WB, 1995, BIOCHEM J, V309, P535, DOI 10.1042/bj3090535; VERTEL BM, 1993, J CELL SCI, V104, P939; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154	16	106	114	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2005	77	3					484	490		10.1086/444401	http://dx.doi.org/10.1086/444401			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	956QE	16080123	Bronze, Green Published			2022-12-18	WOS:000231314100014
J	Kehrer-Sawatzki, H; Kluwe, L; Sandig, C; Kohn, M; Wimmer, K; Krammer, U; Peyrl, A; Jenne, DE; Hansmann, I; Mautner, VF				Kehrer-Sawatzki, H; Kluwe, L; Sandig, C; Kohn, M; Wimmer, K; Krammer, U; Peyrl, A; Jenne, DE; Hansmann, I; Mautner, VF			High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-COPY REPEATS; LONG-TERM POTENTIATION; GENOME ARCHITECTURE; STRAND EXCHANGE; PHYSICAL MAP; DELETION; REGION; PHENOTYPE; DUPLICATION; MECHANISMS	Detailed analyses of 20 patients with sporadic neurofibromatosis type 1 (NF1) microdeletions revealed an unexpected high frequency of somatic mosaicism (8/20 [40%]). This proportion of mosaic deletions is much higher than previously anticipated. Of these deletions, 16 were identified by a screen of unselected patients with NF1. None of the eight patients with mosaic deletions exhibited the mental retardation and facial dysmorphism usually associated with NF1 microdeletions. Our study demonstrates the importance of a general screening for NF1 deletions, regardless of a special phenotype, because of a high estimated number of otherwise undetected mosaic NF1 microdeletions. In patients with mosaicism, the proportion of cells with the deletion was 91%-100% in peripheral leukocytes but was much lower (51%-80%) in buccal smears or peripheral skin fibroblasts. Therefore, the analysis of other tissues than blood is recommended, to exclude mosaicism with normal cells in patients with NF1 microdeletions. Furthermore, our study reveals breakpoint heterogeneity. The classic 1.4-Mb deletion was found in 13 patients. These type I deletions encompass 14 genes and have breakpoints in the NF1 low-copy repeats. However, we identified a second major type of NF1 microdeletion, which spans 1.2 Mb and affects 13 genes. This type II deletion was found in 8 (38%) of 21 patients and is mediated by recombination between the JJAZ1 gene and its pseudogene. The JJAZ1 gene, which is completely deleted in patients with type I NF1 microdeletions and is disrupted in deletions of type II, is highly expressed in brain structures associated with learning and memory. Thus, its haploinsufficiency might contribute to mental impairment in patients with constitutional NF1 microdeletions. Conspicuously, seven of the eight mosaic deletions are of type II, whereas only one was a classic type I deletion. Therefore, the JJAZ1 gene is a preferred target of strand exchange during mitotic nonallelic homologous recombination. Although type I NF1 microdeletions occur by interchromosomal recombination during meiosis, our findings imply that type II deletions are mediated by intrachromosomal recombination during mitosis. Thus, NF1 microdeletions acquired during mitotic cell divisions differ from those occurring in meiosis and are caused by different mechanisms.	Univ Ulm, Dept Human Genet, D-89081 Ulm, Germany; Univ Hosp Hamburg Eppendorf, Dept Maxillofacial Surg, Lab Tumor Biol & Dev Disorders, Hamburg, Germany; Med Univ Vienna, Dept Med Biol, Vienna, Austria; Med Univ Vienna, Dept Pediat, Vienna, Austria; St Anna Childrens Hosp, A-1090 Vienna, Austria; Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany; Univ Halle Saale, Dept Human Genet & Med Biol, Halle An Der Saale, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna; Medical University of Vienna; Saint Anna Children's Hospital; Max Planck Society	Kehrer-Sawatzki, H (corresponding author), Univ Ulm, Dept Human Genet, Albert Einstein Allee 11, D-89081 Ulm, Germany.	hildegard.kehrer-sawatzki@medizin.uni-ulm.de	Jenne, Dieter Erich/AAP-1414-2020					Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bliss T, 2000, CURR BIOL, V10, P1607, DOI 10.1016/S0960-9822(00)00865-4; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cnossen MH, 1997, HUM MUTAT, V9, P458, DOI 10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Correa CL, 1999, HUM MUTAT, V14, P387, DOI 10.1002/(SICI)1098-1004(199911)14:5<387::AID-HUMU4>3.0.CO;2-4; CORREA CL, 2001, HUM MOL GENET, V10, P1387; De Raedt T, 2003, AM J HUM GENET, V72, P1288, DOI 10.1086/374821; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eisenbarth I, 2000, AM J HUM GENET, V67, P873, DOI 10.1086/303085; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; HUSON SM, 1989, ARCH DIS CHILD, V64, P745, DOI 10.1136/adc.64.5.745; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jenne DE, 2000, GENOMICS, V66, P93, DOI 10.1006/geno.2000.6179; Jenne DE, 2003, GENE CHROMOSOME CANC, V37, P111, DOI 10.1002/gcc.10206; Jenne DE, 2001, AM J HUM GENET, V69, P516, DOI 10.1086/323043; KAYES LM, 1994, AM J HUM GENET, V54, P424; Kluwe L, 2004, HUM MUTAT, V23, P111, DOI 10.1002/humu.10299; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marchuk D. A., 1994, P23; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Petek E, 2003, J MED GENET, V40, P520, DOI 10.1136/jmg.40.7.520; Rasmussen SA, 1998, J MED GENET, V35, P468, DOI 10.1136/jmg.35.6.468; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; SCHMID P, 1989, SCIENCE, V243, P226, DOI 10.1126/science.2911736; Sengupta K, 2002, BIOCHEMISTRY-US, V41, P15315, DOI 10.1021/bi026378m; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; WU BL, 1995, AM J MED GENET, V59, P528, DOI 10.1002/ajmg.1320590427; Wu BL, 1997, AM J MED GENET, V69, P98, DOI 10.1002/(SICI)1096-8628(19970303)69:1<98::AID-AJMG19>3.0.CO;2-J	44	106	114	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					410	423		10.1086/423624	http://dx.doi.org/10.1086/423624			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15257518	Green Published, Bronze			2022-12-18	WOS:000223272200006
J	Donaudy, F; Snoeckx, R; Pfister, M; Zenner, HP; Blin, N; Di Stazio, M; Ferrara, A; Lanzara, C; Ficarella, R; Declau, F; Pusch, CM; Nurnberg, P; Melchionda, S; Zelante, L; Ballana, E; Estivill, X; Van Camp, G; Gasparini, P; Savoia, A				Donaudy, F; Snoeckx, R; Pfister, M; Zenner, HP; Blin, N; Di Stazio, M; Ferrara, A; Lanzara, C; Ficarella, R; Declau, F; Pusch, CM; Nurnberg, P; Melchionda, S; Zelante, L; Ballana, E; Estivill, X; Van Camp, G; Gasparini, P; Savoia, A			Nonmuscle myosin heavy-chain gene MYH14 is expressed in cochlea and mutated in patients affected by autosomal dominant hearing impairment (DFNA4)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NON-SYNDROMIC DEAFNESS; UNCONVENTIONAL MYOSIN; VIIA GENE; II-C; MUTATIONS; FAMILY; MICE	Myosins have been implicated in various motile processes, including organelle translocation, ion-channel gating, and cytoskeleton reorganization. Different members of the myosin superfamily are responsible for syndromic and nonsyndromic hearing impairment in both humans and mice. MYH14 encodes one of the heavy chains of the class II nonmuscle myosins, and it is localized within the autosomal dominant hearing impairment (DFNA4) critical region. After demonstrating that MYH14 is highly expressed in mouse cochlea, we performed a mutational screening in a large series of 300 hearing-impaired patients from Italy, Spain, and Belgium and in a German kindred linked to DFNA4. This study allowed us to identify a nonsense and two missense mutations in large pedigrees, linked to DFNA4, as well as a de novo allele in a sporadic case. Absence of these mutations in healthy individuals was tested in 200 control individuals. These findings clearly demonstrate the role of MYH14 in causing autosomal dominant hearing loss and further confirm the crucial role of the myosin superfamily in auditive functions.	Univ Naples 2, Dipartimento Patol Gen, Telethon Inst Genet & Med, Naples, Italy; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Hosp, Dept Otolaryngol, Antwerp, Belgium; Univ Hosp, Dept Otolaryngol, Tubingen, Germany; Univ Tubingen, Inst Anthropol & Human Genet, Div Mol Genet, Tubingen, Germany; Max Delbruck Ctr Mol Med, Gene Mapping Ctr, Berlin, Germany; Humboldt Univ, Charite, Inst Med Genet, Berlin, Germany; IRCCS, CSS, Serv Genet Med, Foggia, Italy; Pompeu Fabra Univ, Ctr Gen Regulat, Barcelona, Spain	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; University of Antwerp; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Casa Sollievo Della Sofferenza; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Gasparini, P (corresponding author), Univ Naples 2, Dipartimento Patol Gen, Telethon Inst Genet & Med & Genet Med, Naples, Italy.	gasparini@tigem.it	Van Camp, Guy/F-3386-2013; Estivill, Xavier/E-2957-2012; Guix, Ester Ballana/R-4117-2018; Savoia, Anna/AIC-4560-2022; Declau, Frank/AAH-6784-2021; Savoia, Anna/B-6463-2014; Estivill, Xavier/A-3125-2013	Van Camp, Guy/0000-0001-5105-9000; Savoia, Anna/0000-0002-2407-2696; Declau, Frank/0000-0001-6969-1565; Savoia, Anna/0000-0002-2407-2696; Estivill, Xavier/0000-0002-0723-2256; Gasparini, Paolo/0000-0002-0859-0856; Ballana, Ester/0000-0002-5215-7363	NIDCD NIH HHS [R01 DC001402, 5R01 DC001402-09] Funding Source: Medline; Telethon [TGM03P12, TGM06S01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001402] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Buxton DB, 2003, J BIOL CHEM, V278, P15449, DOI 10.1074/jbc.M210145200; CHEN AH, 1995, HUM MOL GENET, V4, P1073, DOI 10.1093/hmg/4.6.1073; CHIRIVI RGS, 1994, INT J CANCER, V58, P460, DOI 10.1002/ijc.2910580326; Donaudy F, 2003, AM J HUM GENET, V72, P1571, DOI 10.1086/375654; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Leal A, 2003, GENE, V312, P165, DOI 10.1016/S0378-1119(03)00613-9; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Mirghomizadeh F, 2002, EUR J HUM GENET, V10, P95, DOI 10.1038/sj.ejhg.5200769; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191	19	106	121	0	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					770	776		10.1086/383285	http://dx.doi.org/10.1086/383285			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	15015131	Green Published, Bronze			2022-12-18	WOS:000220280800018
J	Meng, ZL; Zaykin, DV; Xu, CF; Wagner, M; Ehm, MG				Meng, ZL; Zaykin, DV; Xu, CF; Wagner, M; Ehm, MG			Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIATION; HUMAN GENOME; BLOCKS; MAP	The genotyping of closely spaced single-nucleotide polymorphism ( SNP) markers frequently yields highly correlated data, owing to extensive linkage disequilibrium (LD) between markers. The extent of LD varies widely across the genome and drives the number of frequent haplotypes observed in small regions. Several studies have illustrated the possibility that LD or haplotype data could be used to select a subset of SNPs that optimize the information retained in a genomic region while reducing the genotyping effort and simplifying the analysis. We propose a method based on the spectral decomposition of the matrices of pairwise LD between markers, and we select markers on the basis of their contributions to the total genetic variation. We also modify Clayton's "haplotype tagging SNP" selection method, which utilizes haplotype information. For both methods, we propose sliding window - based algorithms that allow the methods to be applied to large chromosomal regions. Our procedures require genotype information about a small number of individuals for an initial set of SNPs and selection of an optimum subset of SNPs that could be efficiently genotyped on larger numbers of samples while retaining most of the genetic variation in samples. We identify suitable parameter combinations for the procedures, and we show that a sample size of 50 - 100 individuals achieves consistent results in studies of simulated data sets in linkage equilibrium and LD. When applied to experimental data sets, both procedures were similarly effective at reducing the genotyping requirement while maintaining the genetic information content throughout the regions. We also show that haplotype-association results that Hosking et al. obtained near CYP2D6 were almost identical before and after marker selection.	N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; GlaxoSmithKline, Dept Populat Genet, Res Triangle Pk, NC USA	University of North Carolina; North Carolina State University; GlaxoSmithKline	Meng, ZL (corresponding author), N Carolina State Univ, Bioinformat Res Ctr, Campus Box 7566, Raleigh, NC 27695 USA.	zmeng@unity.ncsu.edu	Zaykin, Dmitri/C-3752-2019	Zaykin, Dmitri/0000-0002-9444-2859; Xu, Chun-Fang/0000-0002-8747-0683				[Anonymous], 2005, USERS GUIDE PRINCIPA; BENNETT JH, 1954, ANN EUGENIC, V18, P311; CLAYTON D, 2001, CHOOSING SET HAPLOTY; Couzin J, 2002, SCIENCE, V296, P1391, DOI 10.1126/science.296.5572.1391; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hosking L. K., 2002, Pharmacogenomics Journal, V2, P165, DOI 10.1038/sj.tpj.6500096; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Subrahmanyan L, 2001, AM J HUM GENET, V69, P381, DOI 10.1086/321297; Weir B., 1996, GENETIC DATA ANAL; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	16	106	109	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					115	130		10.1086/376561	http://dx.doi.org/10.1086/376561			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12796855	Bronze, Green Published			2022-12-18	WOS:000183904900011
J	Suchy, SF; Nussbaum, RL				Suchy, SF; Nussbaum, RL			The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GREEN FLUORESCENT PROTEIN; CELL-CELL ADHESION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; OCULOCEREBRORENAL SYNDROME; EPITHELIAL-CELLS; OCRL1 GENE; GELSOLIN; DIFFERENTIATION; FIBROBLASTS; MUTATIONS	Lowe syndrome is a rare X-linked disorder characterized by bilateral congenital cataracts, renal Fanconi syndrome, and mental retardation. Lowe syndrome results from mutations in the OCRL1 gene, which encodes a phosphatidylinositol 4,5 bisphosphate 5-phosphatase located in the trans-Golgi network. As a first step in identifying the link between ocrl1 deficiency and the clinical disorder, we have identified a reproducible cellular abnormality of the actin cytoskeleton in fibroblasts from patients with Lowe syndrome. The cellular abnormality is characterized by a decrease in long actin stress fibers, enhanced sensitivity to actin depolymerizing agents, and an increase in punctate F-actin staining in a distinctly anomalous distribution in the center of the cell. We also demonstrate an abnormal distribution of two actin-binding proteins, gelsolin and alpha-actinin, proteins regulated by both PIP2 and Ca+2 that would be expected to be altered in Lowe cells. Actin polymerization plays a key role in the formation, maintenance, and proper function of tight junctions and adherens junctions, which have been demonstrated to be critical in renal proximal tubule function, and in the differentiation of the lens. These findings point to a general mechanism to explain how this PIP2 5-phosphatase deficiency might produce the Lowe syndrome phenotype.	NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Suchy, SF (corresponding author), NHGRI, NIH, Bldg 49,Room 4A 66, Bethesda, MD 20892 USA.	suchy@nhgri.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000040] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; CEREIJIDO M, 1993, J CELL SCI, P127; DISSMANN E, 1994, EUR J CELL BIOL, V63, P336; Dressman MA, 2000, J HISTOCHEM CYTOCHEM, V48, P179, DOI 10.1177/002215540004800203; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Ferreira-Cornwell MC, 2000, EXP CELL RES, V256, P237, DOI 10.1006/excr.2000.4819; Gropman A, 2000, AM J MED GENET, V95, P461, DOI 10.1002/1096-8628(20001218)95:5<461::AID-AJMG10>3.0.CO;2-D; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Lee A, 2000, DEV DYNAM, V217, P257, DOI 10.1002/(SICI)1097-0177(200003)217:3<257::AID-DVDY4>3.0.CO;2-5; Lin KM, 1997, J BIOL CHEM, V272, P20443, DOI 10.1074/jbc.272.33.20443; Lin T, 1998, MOL GENET METAB, V64, P58, DOI 10.1006/mgme.1998.2687; Lin T, 1997, AM J HUM GENET, V60, P1384, DOI 10.1086/515471; MIRALLES F, 1993, EUR J CELL BIOL, V60, P115; Nussbaum R., 2001, METABOLIC MOL BASIS, V4, P6257; Ofner LD, 2002, BIOCHEM J, V362, P191, DOI 10.1042/0264-6021:3620191; OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; STEVENSON BR, 1994, J CELL SCI, V107, P367; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; VERDERAME M, 1980, P NATL ACAD SCI-BIOL, V77, P6624, DOI 10.1073/pnas.77.11.6624; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Zhang XL, 1998, J BIOL CHEM, V273, P1574, DOI 10.1074/jbc.273.3.1574; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	27	106	111	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1420	1427		10.1086/344517	http://dx.doi.org/10.1086/344517			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12428211	Bronze, Green Published			2022-12-18	WOS:000179586800015
J	Stone, S; Abkevich, V; Hunt, SC; Gutin, A; Russell, DL; Neff, CD; Riley, R; Frech, GC; Hensel, CH; Jammulapati, S; Potter, J; Sexton, D; Tran, T; Gibbs, D; Iliev, D; Gress, R; Bloomquist, B; Amatruda, J; Rae, PMM; Adams, TD; Skolnick, MH; Shattuck, D				Stone, S; Abkevich, V; Hunt, SC; Gutin, A; Russell, DL; Neff, CD; Riley, R; Frech, GC; Hensel, CH; Jammulapati, S; Potter, J; Sexton, D; Tran, T; Gibbs, D; Iliev, D; Gress, R; Bloomquist, B; Amatruda, J; Rae, PMM; Adams, TD; Skolnick, MH; Shattuck, D			A major predisposition locus for severe obesity, at 4p15-p14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BODY-MASS INDEX; DEPENDENT DIABETES-MELLITUS; QUANTITATIVE TRAIT LOCUS; AUTOSOMAL GENOMIC SCAN; A RECEPTOR GENE; LINKAGE ANALYSIS; MEXICAN-AMERICANS; COMPLEX TRAITS; UNITED-STATES; PIMA-INDIANS	Although the predisposition to morbid obesity is heritable, the identities of the disease-causing genes are largely unknown. Therefore, we have conducted a genomewide search with 628 markers, using multigenerational Utah pedigrees to identify genes involved in predisposition to obesity. In the genomewide search, we identified a highly significant linkage to high body-mass index in female patients, at D4S2632, with a multipoint heterogeneity LOD (HLOD) score of 6.1 and a nonparametric linkage (NPL) score of 5.3. To further delineate the linkage, we increased both the marker density around D4S2632 and the size of our pedigree data set. As a result, the linkage evidence increased to a multipoint HLOD score of 9.2 (at D4S3350) and an NPL score of 11.3. Evidence from almost half of the families in this analysis support this linkage, and therefore the gene in this region might account for a significant percentage of the genetic predisposition to severe obesity in females. However, further studies are necessary to clarify the effect that this gene has in males and in the general population.	Myriad Genet Inc, Salt Lake City, UT 84108 USA; Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; Bayer Corp, Res Ctr, West Haven, CT USA	Myriad Genetics, Inc; Utah System of Higher Education; University of Utah; Bayer AG	Stone, S (corresponding author), Myriad Genet Inc, 320 Wakara Way, Salt Lake City, UT 84108 USA.	sstone@myriad.com	Russell, Darryl L/I-6654-2012	Russell, Darryl L/0000-0002-4930-7658; Russell, Deanna/0000-0002-9650-2309	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044655, R55DK044655] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 44655] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arya R, 2001, OBES RES, V9, p70S; Borecki I B, 1994, Obes Res, V2, P213; BORECKI IB, 1993, AM J HUM GENET, V53, P676; Bottini E, 1999, METABOLISM, V48, P949, DOI 10.1016/S0026-0495(99)90187-7; BOUCHARD C, 1987, ANN BEHAV, V9, P9; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Camp NJ, 2001, GENET EPIDEMIOL, V21, pS461, DOI 10.1002/gepi.2001.21.s1.s461; COMUZZIE AG, 1995, GENET EPIDEMIOL, V12, P475, DOI 10.1002/gepi.1370120505; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; DRENICK EJ, 1980, JAMA-J AM MED ASSOC, V243, P443, DOI 10.1001/jama.243.5.443; Elbers JMH, 1999, AM J PHYSIOL-ENDOC M, V276, pE317, DOI 10.1152/ajpendo.1999.276.2.E317; Feitosa MF, 2002, AM J HUM GENET, V70, P72, DOI 10.1086/338144; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Funakoshi A, 2000, FEBS LETT, V466, P264, DOI 10.1016/S0014-5793(00)01080-2; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Garenc C, 2002, INT J OBESITY, V26, P220, DOI 10.1038/sj.ijo.0801872; Goring HHH, 2000, AM J HUM GENET, V66, P1095, DOI 10.1086/302797; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Gu DF, 2002, HUM GENET, V110, P173, DOI 10.1007/s00439-001-0663-5; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Hunt SC, 2001, HUM GENET, V109, P279, DOI 10.1007/s004390100581; Inoue H, 1997, GENOMICS, V42, P331, DOI 10.1006/geno.1997.4749; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Martin LJ, 2002, OBES RES, V10, P14, DOI 10.1038/oby.2002.3; MILLER LJ, 1995, GASTROENTEROLOGY, V109, P1375, DOI 10.1016/0016-5085(95)90601-0; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ott J., 1991, ANAL HUMAN GENETIC L; Perusse L, 2001, OBES RES, V9, P135, DOI 10.1038/oby.2001.17; PRICE RA, 1990, HUM BIOL, V62, P747; RISCH N, 1990, AM J HUM GENET, V46, P222; Sina M, 1999, AM J HUM GENET, V65, P1501, DOI 10.1086/302660; SMITH RC, 1995, TOP MAGN RESON IMAG, V7, P3; Thomas A, 2000, STAT COMPUT, V10, P259, DOI 10.1023/A:1008947712763; Troiano RP, 1996, INT J OBESITY, V20, P63; ULRICH CD, 1993, BIOCHEM BIOPH RES CO, V193, P204, DOI 10.1006/bbrc.1993.1610; Van der Ploeg LHT, 2000, CURR OPIN CHEM BIOL, V4, P452, DOI 10.1016/S1367-5931(00)00114-9; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WILLIAMS RR, 1988, AM J PUBLIC HEALTH, V78, P1283, DOI 10.2105/AJPH.78.10.1283	50	106	106	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1459	1468		10.1086/340670	http://dx.doi.org/10.1086/340670			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11957135	Green Published, Bronze			2022-12-18	WOS:000175445700007
J	Rodriguez, D; Gauthier, F; Bertini, E; Bugiani, M; Brenner, M; N'guyen, S; Goizet, C; Gelot, A; Surtees, R; Pedespan, JM; Hernandorena, X; Troncoso, M; Uziel, G; Messing, A; Ponsot, G; Pham-Dinh, D; Dautigny, A; Boespflug-Tanguy, O				Rodriguez, D; Gauthier, F; Bertini, E; Bugiani, M; Brenner, M; N'guyen, S; Goizet, C; Gelot, A; Surtees, R; Pedespan, JM; Hernandorena, X; Troncoso, M; Uziel, G; Messing, A; Ponsot, G; Pham-Dinh, D; Dautigny, A; Boespflug-Tanguy, O			Infantile Alexander disease: Spectrum of GFAP mutations and genotype-phenotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBRILLARY ACIDIC PROTEIN; EPIDERMOLYTIC PALMOPLANTAR KERATODERMA; PALATAL MYOCLONUS; ROSENTHAL FIBERS; TRANSGENIC MICE; ASTROCYTES; DIAGNOSIS; KERATIN-9; ATAXIA; ADULT	Heterozygous, de novo mutations in the glial fibrillary acidic protein (GFAP) gene have recently been reported in 12 patients affected by neuropathologically proved Alexander disease. We searched for GFAP mutations in a series of patients who had heterogeneous clinical symptoms but were candidates for Alexander disease on the basis of suggestive neuroimaging abnormalities. Missense, heterozygous, de novo GFAP mutations were found in exons 1 or 4 for 14 of the 15 patients analyzed, including patients without macrocephaly. Nine patients carried arginine mutations (four had R79H; four had R239C; and one had R239H) that have been described elsewhere, whereas the other five had one of four novel mutations, of which two affect arginine (2R88C and 1R88S) and two affect nonarginine residues (1L76F and 1N77Y). All mutations were located in the rod domain of GFAP, and there is a correlation between clinical severity and the affected amino acid. These results confirm that GFAP mutations are a reliable molecular marker for the diagnosis of infantile Alexander disease, and they also form a basis for the recommendation of GFAP analysis for prenatal diagnosis to detect potential cases of germinal mosaicism.	Univ Paris 06, INSERM, U546, Mol Neurogenet Lab, F-75252 Paris 05, France; Hop St Vincent de Paul, Unite Neuropathol, F-75674 Paris, France; Hop Armand Trousseau, Serv Neuropediat, Paris, France; Bambino Gesu Res Hosp IRCCS, Dept Neurosci, Rome, Italy; Carlo Besta Inst, Milan, Italy; Univ Alabama, Dept Neurobiol, Birmingham, AL USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA; Fac Med, INSERM, U384, Clermont Ferrand, France; CHU Nantes, Clin Med Pediat, F-44035 Nantes 01, France; CHU Pellegrin, Serv Genet Med, Pellegrin, France; CHU Pellegrin, Serv Pediat, Pellegrin, France; UCL, Inst Child Hlth, London WC1E 6BT, England; CH Cote Basque, Dept Pediat, Bayonne, France; Hosp San Borja Arriaran, Santiago, Chile; Univ Wisconsin, Waisman Ctr, Dept Pathol Sci, Madison, WI 53705 USA; Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; Hop St Vincent de Paul, Unite Neuropathol, F-75674 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; IRCCS Bambino Gesu; IRCCS Istituto Neurologico Besta; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Bordeaux; CHU Bordeaux; University of London; University College London; Universidad de Chile; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Rodriguez, D (corresponding author), Univ Paris 06, INSERM, U546, Mol Neurogenet Lab, Boite Courrier 16,9 Quai St Bernard, F-75252 Paris 05, France.	Diana.Rodriguez@snv.jussieu.fr	Bertini, Enrico/A-2284-2014; Rodriguez, Diana/GVR-7668-2022; GOIZET, Cyril/M-4576-2014; Bertini, Enrico/ABG-1278-2020	Bertini, Enrico/0000-0001-9276-4590; GOIZET, Cyril/0000-0002-1913-889X; Gelot, Antoinette/0000-0002-3032-014X				ALEXANDER WS, 1949, BRAIN, V72, P373, DOI 10.1093/brain/72.3.373; BONIFAS JM, 1994, J INVEST DERMATOL, V103, P474, DOI 10.1111/1523-1747.ep12395570; BORRETT D, 1985, BRAIN, V108, P367, DOI 10.1093/brain/108.2.367; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; BRENNER M, 1990, MOL BRAIN RES, V7, P277, DOI 10.1016/0169-328X(90)90078-R; Endo H, 1997, J INVEST DERMATOL, V109, P113, DOI 10.1111/1523-1747.ep12276751; Eng LF, 1998, J NEUROSCI RES, V53, P353, DOI 10.1002/(SICI)1097-4547(19980801)53:3<353::AID-JNR9>3.0.CO;2-9; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; HENNIES HC, 1994, HUM GENET, V93, P649; HERNDON RM, 1970, J NEUROPATH EXP NEUR, V29, P524, DOI 10.1097/00005072-197010000-00002; HOWARD RS, 1993, J NEUROL NEUROSUR PS, V56, P977, DOI 10.1136/jnnp.56.9.977; JOHNSON AB, 1996, HDB CLIN NEUROLOGY, V66, P701; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2001, J NEUROPATH EXP NEUR, V60, P563, DOI 10.1093/jnen/60.6.563; PRIDMORE CL, 1993, J CHILD NEUROL, V8, P134, DOI 10.1177/088307389300800205; Quinlan R, 2001, NAT GENET, V27, P10, DOI 10.1038/83657; Reichard EAP, 1996, PEDIATR PATHOL LAB M, V16, P327, DOI 10.1080/107710496175804; RUSSO LS, 1976, NEUROLOGY, V26, P607, DOI 10.1212/WNL.26.7.607; Schwankhaus JD, 1995, NEUROLOGY, V45, P2266, DOI 10.1212/WNL.45.12.2266; SEIL FJ, 1968, ARCH NEUROL-CHICAGO, V19, P494, DOI 10.1001/archneur.1968.00480050064006; Springer S, 2000, NEUROPEDIATRICS, V31, P86, DOI 10.1055/s-2000-7479; van der Knaap MS, 2001, AM J NEURORADIOL, V22, P541; WOHLWILL FJ, 1959, J NEUROPATH EXP NEUR, V18, P359, DOI 10.1097/00005072-195907000-00001	23	106	115	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1134	1140		10.1086/323799	http://dx.doi.org/10.1086/323799			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11567214	Green Published, Bronze			2022-12-18	WOS:000171413400020
J	Laurin, N; Brown, JP; Lemainque, A; Duchesne, A; Huot, D; Lacourciere, Y; Drapeau, G; Verreault, J; Raymond, V; Morissette, J				Laurin, N; Brown, JP; Lemainque, A; Duchesne, A; Huot, D; Lacourciere, Y; Drapeau, G; Verreault, J; Raymond, V; Morissette, J			Paget disease of bone: Mapping of two loci at 5q35-qter and 5q31	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANINE-DISTEMPER VIRUS; FAMILIAL EXPANSILE OSTEOLYSIS; POLYMERASE CHAIN-REACTION; LINKAGE ANALYSIS; MEASLES-VIRUS; CHROMOSOME 18Q; GENETIC-LINKAGE; HETEROGENEITY; OSTEOCLASTS; CELLS	Paget disease of bone is characterized by focal increases of the bone-remodeling process. It is the second most common metabolic bone disease after osteoporosis. Genetic factors play a major role in the etiology of Paget disease of bone, and two loci have been mapped for the disorder: PDB1 and PDB2. The gene(s) causing the typical form of the disorder remains to be characterized. To decipher the molecular basis of Paget disease of bone, we performed genetic linkage analysis in 24 large French Canadian families (479 individuals) in which the disorder was segregating as an autosomal dominant trait. After exclusion of PDB2, a genomewide scan was performed on the three most informative family nuclei. LOD scores >1.0 were observed at seven locations. The 24 families were then used to detect strong evidence for linkage to chromosome 5q35-qter. Under heterogeneity, a maximum LOD score of 8.58 was obtained at D5S2073, at theta = .01. The same characteristic haplotype was carried by all patients in eight families, suggesting a founder effect. A recombination event in a key family confined the disease region within a 6-cM interval between D5S469 and the telomere. The 16 other families, with very low conditional probability of linkage to 5q35-qter, were further used, to map a second locus at 5q31. Under heterogeneity, a maximum LOD score of 3.70 was detected at D5S500 with theta = .00. Recombination events refined the 5q31 region within 12.2 cM, between D5S642 and D5S1972. These observations demonstrate the mapping of two novel loci for Paget disease of bone and provide further evidence for genetic heterogeneity of this highly prevalent disorder. It is proposed that the 5q35-qter and 5q31 loci be named "PDB3" and "PDB4," respectively.	CHU Laval, Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; CHU Laval, Res Ctr, Grp Rech Malad Osseuses Rhumatol Immunol, Quebec City, PQ G1V 4G2, Canada; CHU Laval, Res Ctr, Dept Nucl Med, Quebec City, PQ G1V 4G2, Canada; Ctr Natl Genotypage, Evry, France; Ctr Hosp Reg Amiante, Dept Nucl Med, Thetford Mines, PQ, Canada; Hotel Dieu Arthabaska, Dept Nucl Med, Victoriaville, PQ, Canada; Ctr Univ Sante Estrie, Dept Nucl Med, Sherbrooke, PQ, Canada	Laval University; Laval University; Laval University; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Sherbrooke	Raymond, V (corresponding author), CHU Laval, Res Ctr, Mol Endocrinol & Oncol Res Ctr, 2705 Laurier Blvd,Room T3-67, Quebec City, PQ G1V 4G2, Canada.	vincent.raymond@crchul.ulaval.ca		Brown, Jacques/0000-0003-1910-788X				ABE S, 1995, ULTRASTRUCT PATHOL, V19, P455, DOI 10.3109/01913129509014619; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BARKER DJP, 1980, BRIT MED J, V280, P1105, DOI 10.1136/bmj.280.6222.1105; BARKER DJP, 1984, BRIT MED BULL, V40, P396, DOI 10.1093/oxfordjournals.bmb.a072011; BIRCH MA, 1994, J BONE MINER RES, V9, P11; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BOUCHARD G, 1991, HIST UNE GENOME POPU; CARTWRIGHT EJ, 1993, J MED VIROL, V40, P133, DOI 10.1002/jmv.1890400210; Cody JD, 1997, AM J HUM GENET, V61, P1117, DOI 10.1086/301601; DETHERIDGE FM, 1983, BRIT MED J, V287, P1345, DOI 10.1136/bmj.287.6402.1345; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FOTINO M, 1977, TRANSPLANT P, V9, P1867; FREIMER NB, 1993, AM J HUM GENET, V52, P1102; GHERARDI G, 1980, HISTOPATHOLOGY, V4, P63, DOI 10.1111/j.1365-2559.1980.tb02898.x; Good D, 2001, J BONE MINER RES, V16, P33, DOI 10.1359/jbmr.2001.16.1.33; GORDON MT, 1991, BONE, V12, P195, DOI 10.1016/8756-3282(91)90042-H; GUYER PB, 1980, BRIT MED J, V280, P985, DOI 10.1136/bmj.280.6219.985; HAMDY RC, 1995, ENDOCRIN METAB CLIN, V24, P421, DOI 10.1016/S0889-8529(18)30047-1; HARVEY L, 1982, J CLIN PATHOL, V35, P771, DOI 10.1136/jcp.35.7.771; Haslam SI, 1998, J BONE MINER RES, V13, P911, DOI 10.1359/jbmr.1998.13.6.911; Helfrich MH, 2000, J BONE MINER RES, V15, P2315, DOI 10.1359/jbmr.2000.15.12.2315; Hocking L, 2000, BONE, V26, P577, DOI 10.1016/S8756-3282(00)00278-7; HOWATSON AF, 1982, INTERVIROLOGY, V18, P150, DOI 10.1159/000149318; HUGHES AE, 1994, HUM MOL GENET, V3, P359, DOI 10.1093/hmg/3.2.359; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Janssen B, 1997, HUM HERED, V47, P223, DOI 10.1159/000154416; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; Kanis J., 1998, PATHOPHYSIOLOGY TREA, VSecond; KLEIN RM, 1995, ENDOCRIN METAB CLIN, V24, P437, DOI 10.1016/S0889-8529(18)30048-3; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Leach RJ, 2001, J CLIN ENDOCR METAB, V86, P24, DOI 10.1210/jc.86.1.24; Mc Kusick V.A., 1972, HERITABLE DISORDERS, P718; Mee AP, 1998, BONE, V23, P171, DOI 10.1016/S8756-3282(98)00079-9; MEUNIER PJ, 1987, CLIN ORTHOP RELAT R, P37; MILLS BG, 1976, SCIENCE, V194, P201, DOI 10.1126/science.959849; MILLS BG, 1984, CLIN ORTHOP RELAT R, P303; MOORE SB, 1988, TISSUE ANTIGENS, V31, P69, DOI 10.1111/j.1399-0039.1988.tb02065.x; MORALESPIGA AA, 1995, J BONE MINER RES, V10, P663; Morissette J, 1998, NAT GENET, V19, P319, DOI 10.1038/1203; MORISSETTE J, 1995, AM J HUM GENET, V56, P1431; MORISSETTE J, 1992, GENETIQUE HUMAINE IN, P89; Nance MA, 2000, AM J MED GENET, V92, P303, DOI 10.1002/1096-8628(20000619)92:5<303::AID-AJMG2>3.0.CO;2-E; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ooi CG, 2000, BONE, V27, P417, DOI 10.1016/S8756-3282(00)00343-4; OTT J, 1986, AM J HUM GENET, V39, P159; Ott J., 1991, ANAL HUMAN GENETIC L; RALSTON SH, 1991, J BONE MINER RES, V6, P1243; REASBECK JC, 1983, BRIT MED J, V286, P1937, DOI 10.1136/bmj.286.6382.1937; REBEL A, 1980, LANCET, V2, P344; REBEL A, 1980, ARTHRITIS RHEUM-US, V23, P1104, DOI 10.1002/art.1780231006; Reddy SV, 1996, J BONE MINER RES, V11, P1602; Reddy SV, 1999, EXP HEMATOL, V27, P1528, DOI 10.1016/S0301-472X(99)00097-1; REDDY SV, 1995, J CLIN ENDOCR METAB, V80, P2108, DOI 10.1210/jc.80.7.2108; RENIER JC, 1995, REV RHUM, V62, P571; ROSENBAUM HD, 1969, RADIOLOGY, V92, P959, DOI 10.1148/92.5.959; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SIRIS ES, 1991, J BONE MINER RES, V6, P495; SIRIS ES, 1990, PRINCIPLES PRACTICE, P504; Sobel E, 1996, AM J HUM GENET, V58, P1323; SOFAER JA, 1983, J EPIDEMIOL COMMUN H, V37, P226, DOI 10.1136/jech.37.3.226; Sparks AB, 2001, CALCIFIED TISSUE INT, V68, P151, DOI 10.1007/s002230001211; TILYARD MW, 1982, AUST NZ J MED, V12, P498, DOI 10.1111/j.1445-5994.1982.tb03830.x; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211	64	106	112	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					528	543		10.1086/322975	http://dx.doi.org/10.1086/322975			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11473345	Green Published, Bronze			2022-12-18	WOS:000170271400006
J	de los Santos, T; Schweizer, J; Rees, CA; Francke, U				de los Santos, T; Schweizer, J; Rees, CA; Francke, U			Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which is highly expressed in brain	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOUSE NECDIN GENE; ANGELMAN-SYNDROME; SNRPN GENE; DIAGNOSTIC-CRITERIA; UNIPARENTAL DISOMY; CPG ISLAND; UBE3A; METHYLATION; LETHALITY; MUTATIONS	Prader-Willi syndrome is a complex neurodevelopmental disorder caused by the inactivation or deletion of imprinted, paternally expressed genes in chromosome band 15q11.2. We report the identification and characterization of PWCR1, a novel imprinted gene within that region, and its mouse orthologue, Pwcr1, which was mapped to the conserved syntenic region on mouse chromosome 7. Expressed only from the paternal allele, both genes require the imprinting-center regulatory element for expression and are transcribed from the same strand. They are intronless and do not appear to encode a protein product. High human/mouse sequence similarity (87% identity) is limited to a 99-bp region called "HMCR" (for "human-mouse conserved region"). The HMCR sequence has features of a C/D box small nucleolar RNA (snoRNA) and is represented in an abundant small transcript in both species. Located in nucleoli, snoRNAs serve as methylation guidance RNAs in the modification of ribosomal RNA and other small nuclear RNAs. In addition to the nonpolyadenylated small RNAs, larger polyadenylated PWCR1 transcripts are found in most human tissues, whereas expression of any Pwcr1 RNAs is limited to mouse brain. Genomic sequence analysis reveals the presence of multiple copies of PWCR1 and Pwcr1 that are organized within local tandem-repeat clusters. On a multispecies Southern blot, hybridization to an HMCR probe encoding the putative snoRNA is limited to mammals.	Stanford Univ, Med Ctr, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Francke, U (corresponding author), Stanford Univ, Med Ctr, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.		De+Los+Santos, Teresa/AAU-2840-2021					Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; BUITING K, 1995, NAT GENET, V10, P249, DOI 10.1038/ng0695-249c; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Dunbar DA, 2000, NUCLEIC ACIDS RES, V28, P2855, DOI 10.1093/nar/28.15.2855; Farber C, 2000, GENOMICS, V65, P174, DOI 10.1006/geno.2000.6158; Farber C, 1999, HUM MOL GENET, V8, P337, DOI 10.1093/hmg/8.2.337; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HOLM VA, 1993, PEDIATRICS, V91, P398; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Ji YG, 1999, HUM MOL GENET, V8, P533, DOI 10.1093/hmg/8.3.533; JOHNSON DK, 1995, GENETICS, V141, P1563; Jong MTC, 1999, HUM MOL GENET, V8, P795, DOI 10.1093/hmg/8.5.795; Jong MTC, 1999, HUM MOL GENET, V8, P783, DOI 10.1093/hmg/8.5.783; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Kishino T, 1997, NAT GENET, V15, P411, DOI 10.1038/ng0497-411d; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; Konat Gregory W., 1994, P37; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Liao DQ, 1997, EMBO J, V16, P588, DOI 10.1093/emboj/16.3.588; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Schweizer J, 1999, HUM MOL GENET, V8, P555, DOI 10.1093/hmg/8.4.555; Smith R, 1998, J MED SCREEN, V5, P5, DOI 10.1136/jms.5.1.5; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tsai TF, 1999, NAT GENET, V22, P15, DOI 10.1038/8722; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; VARMUZA S, 1994, TRENDS GENET, V10, P118, DOI 10.1016/0168-9525(94)90212-7; Watrin F, 1997, EUR J HUM GENET, V5, P324, DOI 10.1159/000484784; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Wevrick R, 1997, HUM MOL GENET, V6, P325, DOI 10.1093/hmg/6.2.325; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yee F, 1997, BIOL PSYCHIAT, V41, P759, DOI 10.1016/S0006-3223(96)00553-7	56	106	107	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1067	1082		10.1086/303106	http://dx.doi.org/10.1086/303106			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11007541	Bronze, Green Published			2022-12-18	WOS:000165091600004
J	Perez-Lezaun, A; Calafell, F; Comas, D; Mateu, E; Bosch, E; Martinez-Arias, R; Clarimon, J; Fiori, G; Luiselli, D; Facchini, F; Pettener, D; Bertranpetit, J				Perez-Lezaun, A; Calafell, F; Comas, D; Mateu, E; Bosch, E; Martinez-Arias, R; Clarimon, J; Fiori, G; Luiselli, D; Facchini, F; Pettener, D; Bertranpetit, J			Sex-specific migration patterns in central Asian populations, revealed by analysis of Y-chromosome short tandem repeats and mtDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; GEOGRAPHIC-DISTRIBUTION; SUBSTITUTION RATE; HAPLOTYPES; POLYMORPHISMS; MUTATION; GENETICS; EUROPE	Eight Y-linked short-tandem-repeat polymorphisms (DYS19, DYS388, DYS389I, DYS389II, DYS390, DYS391, DYS392, and DYS393) were analyzed in four populations of Central Asia, comprising two lowland samples-Uighurs and lowland Kirghiz-and two highland samples-namely, the Kazakhs (altitude 2,500 m above sea level) and highland Kirghiz (altitude 3,200 m above sea level). The results were compared with mtDNA sequence data on the same individuals, to study possible differences in male versus female genetic-variation patterns in these Central Asian populations. Analysis of molecular variance (AMOVA) showed a very high degree of genetic differentiation among the populations tested, in discordance with the results obtained with mtDNA sequences, which showed high homogeneity. Moreover, a dramatic reduction of the haplotype genetic diversity was observed in the villages at high altitude, especially in the highland Kirghiz, when compared with the villages at low altitude, which suggests a male founder effect in the settlement of high-altitude lands. Nonetheless, mtDNA genetic diversity in these highland populations is equivalent to that in the lowland populations. The present results suggest a very different migration pattern in males versus females, in an extended historical frame, with a higher migration rate for females.	Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolutiva, Barcelona 08003, Catalonia, Spain; Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, Unita Antropol, Bologna, Italy	Pompeu Fabra University; University of Bologna	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolutiva, Doctor Aiguader 80, Barcelona 08003, Catalonia, Spain.		Bertranpetit, Jaume/F-8550-2012; Mateu, Enric/AAZ-8429-2021; Bosch, Elena/N-7603-2019; Calafell, Francesc/C-8595-2014; Bosch, Elena/D-8681-2014; Comas, David/D-5382-2014; Pettener, Davide/E-1576-2017	Bertranpetit, Jaume/0000-0003-0100-0590; Bosch, Elena/0000-0003-2848-103X; Calafell, Francesc/0000-0002-1083-9438; Bosch, Elena/0000-0003-2848-103X; Comas, David/0000-0002-5075-0956; Clarimon, Jordi/0000-0002-6824-6942				Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; BARBUJANI G, 1990, P NATL ACAD SCI USA, V87, P1816, DOI 10.1073/pnas.87.5.1816; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 1996, AM J HUM GENET, V59, P935; Hammer MF, 1997, GENETICS, V145, P787; Hammer Michael F., 1996, Evolutionary Anthropology, V5, P116, DOI 10.1002/(SICI)1520-6505(1996)5:4<116::AID-EVAN2>3.0.CO;2-E; Hassan FA, 1981, DEMOGRAPHIC ARCHAEOL; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Huoponen K, 1997, EUR J HUM GENET, V5, P25, DOI 10.1159/000484728; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; KELLY RL, 1995, FORAGING SPECTRUM DI; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malaspina P, 1998, AM J HUM GENET, V63, P847, DOI 10.1086/301999; Menges Karl H., 1994, CENTRAL ASIA 130 YEA, P60; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; PerezLezaun A, 1997, J MOL EVOL, V45, P265, DOI 10.1007/PL00006229; PESTONI C, 1999, J LEGAL MED, V112, P15; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Rolf B, 1998, EUR J HUM GENET, V6, P583, DOI 10.1038/sj.ejhg.5200223; Salem AH, 1996, AM J HUM GENET, V59, P741; SANTOS FR, 1993, HUM GENET, V90, P655; SCHNEIDER S, 1996, ARLEKIN VERSION 1 0; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Stoneking M, 1998, NAT GENET, V20, P219, DOI 10.1038/3012; TORRONI A, 1992, GENETICS, V130, P153; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; WAKELEY J, 1993, J MOL EVOL, V37, P613; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHITE DR, 1988, CURR ANTHROPOL, V29, P529, DOI 10.1086/203674; WRIGHT S, 1951, ANN EUGENIC, V15, P323	41	106	109	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					208	219		10.1086/302451	http://dx.doi.org/10.1086/302451			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364534	Green Published, Bronze			2022-12-18	WOS:000081224300026
J	Reed, DR; Nanthakumar, E; North, M; Bell, C; Bartoshuk, LM; Price, RA				Reed, DR; Nanthakumar, E; North, M; Bell, C; Bartoshuk, LM; Price, RA			Localization of a gene for bitter-taste perception to human chromosome 5p15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LIKELIHOOD; MAGNITUDE; SCALE		Univ Penn, Ctr Neurobiol & Behav, Dept Psychiat, Philadelphia, PA 19104 USA; Axys Pharmaceut, La Jolla, CA USA; Yale Univ, Sch Med, New Haven, CT USA	University of Pennsylvania; Pennsylvania Medicine; Yale University	Price, RA (corresponding author), Univ Penn, Ctr Neurobiol & Behav, Dept Psychiat, 415 Curie Blvd,CRB135B, Philadelphia, PA 19104 USA.	arlen@bgl.psycha.upenn.edu		Reed, Danielle/0000-0002-4374-6107	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044073, R01DK048095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC003509] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03DC03509] Funding Source: Medline; NIDDK NIH HHS [R01DK48095, R01DK44073] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; Boyd William C., 1950, GENETICS RACES MAN I; CHAUTARD.EA, 1974, ANN HUM GENET, V38, P191, DOI 10.1111/j.1469-1809.1974.tb01950.x; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; INTRANUOVA L, 1998, ANN NY ACAD SCI, V855, P816; JOHNSTON FE, 1966, AM J PHYS ANTHROPOL, V24, P253, DOI 10.1002/ajpa.1330240214; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Li WD, 1999, AM J HUM GENET, V65, pA106; Lucchina LA, 1998, ANN NY ACAD SCI, V855, P816, DOI 10.1111/j.1749-6632.1998.tb10666.x; OLSON JM, 1989, GENET EPIDEMIOL, V6, P423, DOI 10.1002/gepi.1370060305; Price RA, 1998, INT J OBESITY, V22, P406, DOI 10.1038/sj.ijo.0800601; PRUTKIN J, IN PRESS CHEM SENSES; REED DR, 1995, CHEM SENSES, V20, P529, DOI 10.1093/chemse/20.5.529; RYCHKOV YG, 1973, GENETIKA+, V9, P141; SCHWARTZ S, 1998, CHEM SENSES, V23, P560; Snyder D. J., 1996, CHEM SENSES, V21, P673; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; SPENCE MA, 1984, HUM GENET, V67, P183; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; [No title captured]	22	106	112	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1478	1480		10.1086/302367	http://dx.doi.org/10.1086/302367			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205283	Green Published, Bronze			2022-12-18	WOS:000080093000031
J	Semb, H; Christofori, G				Semb, H; Christofori, G			The tumor-suppressor function of E-cadherin	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR LEF-1; EPIDERMAL GROWTH-FACTOR; HUMAN CARCINOMA-CELLS; BETA-CATENIN; AXIS FORMATION; ALPHA-CATENIN; BREAST-CANCER; ADHESION; COMPLEX; PROTEIN		Univ Gothenburg, Inst Med Biochem, S-40530 Gothenburg, Sweden; Res Inst Mol Pathol, A-1030 Vienna, Austria	University of Gothenburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Semb, H (corresponding author), Univ Gothenburg, Inst Med Biochem, Box 440, S-40530 Gothenburg, Sweden.	Henrik.Semb@medkem.gu.se		Semb, Henrik/0000-0002-6747-787X				Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; Bullions Linda C., 1998, Current Opinion in Oncology, V10, P81, DOI 10.1097/00001622-199801000-00013; DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9; EYRE RW, 1987, J EXP MED, V165, P1719, DOI 10.1084/jem.165.6.1719; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Graff JR, 1998, CANCER RES, V58, P2063; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Gumbiner BM, 1997, CURR BIOL, V7, pR443, DOI 10.1016/S0960-9822(06)00214-4; Gumbiner BM, 1998, CURR OPIN GENET DEV, V8, P430, DOI 10.1016/S0959-437X(98)80114-7; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hennig G, 1996, J BIOL CHEM, V271, P595, DOI 10.1074/jbc.271.1.595; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lee SW, 1996, NAT MED, V2, P776, DOI 10.1038/nm0796-776; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; OYAMA T, 1994, CANCER RES, V54, P6282; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; SHIBAMOTO S, 1994, CELL ADHES COMMUN, V1, P295, DOI 10.3109/15419069409097261; Sparks AB, 1998, CANCER RES, V58, P1130; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Thiery JP, 1996, J CELL BIOCHEM, V61, P489; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	45	106	110	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1588	1593		10.1086/302173	http://dx.doi.org/10.1086/302173			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837810	Bronze, Green Published			2022-12-18	WOS:000077707700003
J	Hanna, MG; Nelson, IP; Rahman, S; Lane, RJM; Land, J; Heales, S; Cooper, MJ; Schapira, AHV; Morgan-Hughes, JA; Wood, NW				Hanna, MG; Nelson, IP; Rahman, S; Lane, RJM; Land, J; Heales, S; Cooper, MJ; Schapira, AHV; Morgan-Hughes, JA; Wood, NW			Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; KEARNS-SAYRE SYNDROME; RAGGED-RED FIBERS; MITOCHONDRIAL-DNA; SKELETAL-MUSCLE; SUBUNIT-III; MYOCLONIC EPILEPSY; LACTIC-ACIDOSIS; MYOPATHY; DELETIONS	We have identified the first stop-codon point mutation in mtDNA to be reported in association with human disease. A SG-year-old woman experienced episodes of encephalopathy accompanied by lactic acidemia and had exercise intolerance and proximal myopathy Histochemical analysis showed that 90% of muscle fibers exhibited decreased or absent cytochrome c oxidase (COX) activity. Biochemical studies confirmed a severe isolated reduction in COX activity. Muscle immunocytochemistry revealed a pattern suggestive of a primary mtDNA defect in the COX-deficient fibers and was consistent with either reduced stability or impaired assembly of the holoenzyme. Sequence analysis of mtDNA identified a novel heteroplasmic G-->A point mutation at position 9952 in the patient's skeletal muscle, which was not detected in her leukocyte mtDNA or in that of 120 healthy controls or 60 additional patients with mitochondrial disease. This point mutation is located in the 3' end of the gene for subunit III of COX and is predicted to result in the loss of the last 13 amino acids of the highly conserved C-terminal region of this subunit. It was not detected in mtDNA extracted from leukocytes, skeletal muscle, or myoblasts of the patient's mother or her two sons, indicating that this mutation is not maternally transmitted. Single-fiber PCR studies provided direct evidence for an association between this point mutation and COX deficiency and indicated that the proportion of mutant mtDNA required to induce COX deficiency is lower than that reported for tRNA-gene point mutations. The findings reported here represent only the second case of isolated COX deficiency to be defined at the molecular genetic level and reveal a new mutational mechanism in mitochondrial disease.	Univ London, Inst Neurol, Dept Clin Neurol, Neurogenet Sect, London WC1N 3BG, England; Univ London, Inst Neurol, Dept Neurochem, London WC1N 3BG, England; Univ London, Royal Free Hosp, Dept Clin Neurosci, London WC1N 3BG, England; Charing Cross Hosp, Inst Child Hlth, London, England; Charing Cross Hosp, W London Neurosci Ctr, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Imperial College London; University of London; University College London; Imperial College London	Hanna, MG (corresponding author), Univ London, Inst Neurol, Dept Clin Neurol, Neurogenet Sect, Queen Sq, London WC1N 3BG, England.	mhanna@ion.ucl.ac.uk	Cooper, J Mark/D-5826-2013; Wood, Nicholas W/C-2505-2009; Rahman, Shamima/C-5232-2008; Rahman, Shamima/M-7904-2019; Hanna, Michael G/B-1995-2009; Cooper, Jonathan/GLS-9195-2022; Schapira, Anthony H V/A-1245-2010	Cooper, J Mark/0000-0002-3007-3054; Wood, Nicholas W/0000-0002-9500-3348; Rahman, Shamima/0000-0003-2088-730X; Cooper, Jonathan/0000-0002-2358-1050; Schapira, Anthony H V/0000-0002-3018-3966; Hanna, Michael/0000-0003-0825-4075; nelson, isabelle/0000-0001-6390-622X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams PL, 1997, ANN NEUROL, V41, P268, DOI 10.1002/ana.410410219; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X; BOULET L, 1992, AM J HUM GENET, V51, P1187; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CHOMYN A, 1994, AM J HUM GENET, V54, P966; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; DESJARDIN P, 1989, J MOL BIOL, V212, P599; DIMAURO S, 1994, MITOCHONDRIAL DISORD, P91; ENGEL W, 1963, NEUROLOGY, V19, P919; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135; HALTIA T, 1991, EMBO J, V10, P2015, DOI 10.1002/j.1460-2075.1991.tb07731.x; HANNA MG, 1995, J NEUROL SCI, V130, P154, DOI 10.1016/0022-510X(95)00022-T; HANNA MG, 1995, AM J HUM GENET, V56, P1026; HANNA MG, 1998, IN PRESS J NEUROL NE; HARDING AE, 1994, MITOCHONDRIAL DISORD, P181; Hauswirth W., 1985, ACHIEVEMENT PERSPECT, V2, P49; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; LARSSON NG, 1992, AM J HUM GENET, V50, P360; MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O; MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333; MARTIN GM, 1973, TISSUE CULTURE METHO, P39; Moraes C T, 1996, Methods Enzymol, V264, P522, DOI 10.1016/S0076-6879(96)64046-4; Moraes CT, 1996, CURR OPIN NEUROL, V9, P369, DOI 10.1097/00019052-199610000-00010; MORGANHUGHES JA, 1977, BRAIN, V100, P617, DOI 10.1093/brain/100.4.617; MORGANHUGHES JA, 1994, MYOLOGY, P1610; Munaro M, 1997, HUM MOL GENET, V6, P221, DOI 10.1093/hmg/6.2.221; NELSON I, 1989, NUCLEIC ACIDS RES, V17, P8117, DOI 10.1093/nar/17.20.8117; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; POULTON J, 1989, LANCET, V1, P236; Rahman S., 1997, Journal of Inherited Metabolic Disease, V20, P56; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SHOUBRIDGE EA, 1997, HUM MOL GENET, V6, P223; Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Weber K, 1997, AM J HUM GENET, V60, P373; Wu SL, 1995, BIOCHEMISTRY-US, V34, P16298, DOI 10.1021/bi00050a009	43	106	106	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					29	36		10.1086/301910	http://dx.doi.org/10.1086/301910			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634511	Bronze, Green Published			2022-12-18	WOS:000074761000006
J	Johnston, J; Kelley, RI; Feigenbaum, A; Cox, GF; Iyer, GS; Funanage, VL; Proujansky, R				Johnston, J; Kelley, RI; Feigenbaum, A; Cox, GF; Iyer, GS; Funanage, VL; Proujansky, R			Mutation characterization and genotype-phenotype correlation in Barth syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RESPIRATORY-CHAIN ABNORMALITIES; LINKED CARDIOSKELETAL MYOPATHY; 3-METHYLGLUTACONIC ACIDURIA; DILATED CARDIOMYOPATHY; NEUTROPENIA; MITOCHONDRIA; XQ28	Barth syndrome is an X-linked cardiomyopathy with neutropenia and 3-methylglutaconic aciduria. Recently, mutations in the G4.5 gene, located in Xq28, have been described in four probands with Barth syndrome. We have now evaluated 14 Barth syndrome pedigrees for mutations in G4.5 and have identified unique mutations in all, including four splice-site mutations, three deletions, one insertion, five missense mutations, and one nonsense mutation. Nine of the 14 mutations are predicted to significantly disrupt the protein products of G4.5. The occurrence of missense mutations in exons 3 and 8 suggests that these exons encode essential portions of the G4.5 proteins, whose functions remain unknown. We found no correlation between the location or type of mutation and any of the clinical or laboratory abnormalities of Barth syndrome, which suggests that additional factors modify the expression of the Barth phenotype. The characterization of mutations of the G4.5 gene will be useful for carrier detection, genetic counseling, and the identification of patients with Barth syndrome who do not manifest all of the cardinal features of this disorder.	DUPONT HOSP CHILDREN,DEPT PEDIAT,WILMINGTON,DE 19899; DUPONT HOSP CHILDREN,DEPT CLIN SCI,WILMINGTON,DE; JEFFERSON MED COLL,PHILADELPHIA,PA; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; CHILDRENS HOSP,HOWARD HUGHES MED INST,DIV GENET,BOSTON,MA 02115	Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children; Jefferson University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute				, Vicky L. Funanage/0000-0002-8006-8077	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044933] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline; NIDDK NIH HHS [DK44933] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; CHRISTODOULOU J, 1994, AM J MED GENET, V50, P255, DOI 10.1002/ajmg.1320500309; DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886; GEDEON AK, 1995, J MED GENET, V32, P383, DOI 10.1136/jmg.32.5.383; GIBSON KM, 1991, J PEDIATR-US, V118, P885, DOI 10.1016/S0022-3476(05)82199-7; GIBSON KM, 1992, J PEDIATR-US, V121, P940, DOI 10.1016/S0022-3476(05)80348-8; HODGSON S, 1987, J MED GENET, V24, P210, DOI 10.1136/jmg.24.4.210; HOLME E, 1992, PEDIATR RES, V32, P731, DOI 10.1203/00006450-199212000-00022; IBEL H, 1993, EUR J PEDIATR, V152, P665, DOI 10.1007/BF01955244; INO T, 1988, J PEDIATR-US, V113, P511, DOI 10.1016/S0022-3476(88)80642-5; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; NEUSTEIN HB, 1979, PEDIATRICS, V64, P24; OSTMANSMITH I, 1994, BRIT HEART J, V72, P349	17	106	108	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1053	1058		10.1086/301604	http://dx.doi.org/10.1086/301604			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345098	hybrid, Green Published			2022-12-18	WOS:A1997YH01700009
J	vanderKooi, AJ; vanMeegen, M; Ledderhof, TM; McNally, EM; deVisser, M; Bolhuis, PA				vanderKooi, AJ; vanMeegen, M; Ledderhof, TM; McNally, EM; deVisser, M; Bolhuis, PA			Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; BETA-SARCOGLYCAN; LINKAGE; LOCUS; MUTATIONS; MAPS; HETEROGENEITY; CONFIRMATION; CONDUCTION	Limb-girdle muscular dystrophy (LGMD) constitutes a clinically and genetically heterogeneous group of myogenic disorders with a limb-girdle distribution of weakness. One autosomal dominant family, LGMD1A, has been linked to chromosome 5q, whereas in other autosomal dominant families linkage to this chromosome has been excluded. We studied 58 members of three families with a newly recognized autosomal dominantly inherited LGMD with cardiac involvement. A search with highly polymorphic microsatellite markers was carried out. The gene for this newly recognized dominant form of LGMD was located on chromosome 1q11-21, with a combined maximum two-point LOD score >12 at theta = 0.	CHILDRENS HOSP,DIV GENET,BOSTON,MA 02115	Harvard University; Boston Children's Hospital	vanderKooi, AJ (corresponding author), UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,POB 22700,NL-1100 DE AMSTERDAM,NETHERLANDS.		McNally, Elizabeth/W-4909-2019	van der Kooi, Anneke/0000-0002-5261-5512; McNally, Elizabeth/0000-0002-1221-719X				ALLAMAND V, 1995, HUM MOL GENET, V4, P459, DOI 10.1093/hmg/4.3.459; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; Bushby K.M.D., 1994, DIAGNOSTIC CRITERIA, P25; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; CHUMAKOV IM, 1995, NATURE, V377, P175; GILCHRIST JM, 1988, NEUROLOGY, V37, P5; GRABER HL, 1986, CIRCULATION, V74, P21, DOI 10.1161/01.CIR.74.1.21; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; McNally E. M., 1995, American Journal of Human Genetics, V57, pA54; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; OHNO S, 1990, CYTOGENET CELL GENET, V53, P225, DOI 10.1159/000132937; PassosBueno MR, 1996, HUM MOL GENET, V5, P815, DOI 10.1093/hmg/5.6.815; PASSOSBUENO MR, 1995, GENOMICS, V27, P192, DOI 10.1006/geno.1995.1024; RAMPAZZO A, 1995, HUM MOL GENET, V4, P2151, DOI 10.1093/hmg/4.11.2151; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; SPEER MC, 1992, AM J HUM GENET, V50, P1211; SPEER MC, 1995, AM J HUM GENET, V57, P1371; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Van Der Kooi A. J., 1996, Annals of Neurology, V39, P636, DOI 10.1002/ana.410390513; YOUNG K, 1992, GENOMICS, V13, P1370, DOI 10.1016/0888-7543(92)90074-3	32	106	107	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1997	60	4					891	895						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WT614	9106535				2022-12-18	WOS:A1997WT61400018
J	Chen, CJ; Yu, MW; Liaw, YF; Wang, LW; Chiamprasert, S; Matin, F; Hirvonen, A; Bell, DA; Santella, RM				Chen, CJ; Yu, MW; Liaw, YF; Wang, LW; Chiamprasert, S; Matin, F; Hirvonen, A; Bell, DA; Santella, RM			Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C VIRUS-ANTIBODIES; HUMAN LIVER CANCER; DIETARY AFLATOXINS; ALBUMIN ADDUCTS; DNA ADDUCTS; ASSOCIATION; INFECTION; TAIWAN; RATS; SUSCEPTIBILITY	This study was carried out to elucidate the effect of glutathione S-transferase (GST) M1 and T1 polymorphisms on the aflatoxin-related hepatocarcinogenesis among chronic carriers of hepatitis B surface antigen (HBsAg). A total of 32 newly diagnosed hepatocellular carcinoma (HCC) cases and 73 age-matched controls selected from a cohort of 4,841 chronic HBsAg carriers who had been followed for 5 years were studied. The level of aflatoxin B-1 (AFB(1))-albumin adducts in their serum samples collected at the recruitment was examined by competitive enzyme-linked immunosorbance assay, and genotypes of GST hll and T1 were determined by PCR. There was a dose-response relationship between serum level of AFB(1)-albumin adducts and risk of HCC. The biological gradients between serum AFB(1)-albumin adducts level and HCC risk were observed among chronic HBsAg carriers who had null genotypes of GST M1 and/or T1 but not among those who had non-null genotypes. The multivariate-adjusted odds ratios of developing HCC for those who had low and high serum levels of AFB(1)-albumin adducts compared with those who had a undetectable adduct level as the referent (odds ratio = 1.0) were 4.1 and 12.4, respectively, for HBsAg carriers with null GST M1 genotype (P < .01, on the basis of the significance test for trend); 0.7 and 1.4 for those with nonnull CST M1 genotype (P = .98); 1.8 and 10.2 for those with null GST T1 genotype (P < .05); and 1.3 and 0.8 for those with non-null GST T1 genotype (P = .93). The interaction between serum AFB(1)-albumin adduct level and polymorphisms of GST M1 and T1 was at marginal statistical significance levels (.05 < P < .10).	CHANG GUNG MEM HOSP, LIVER UNIT, TAIPEI 10591, TAIWAN; COLUMBIA UNIV, SCH PUBL HLTH, DIV ENVIRONM HLTH SCI, NEW YORK, NY 10027 USA; NIEHS, BIOCHEM RISK ANAL LAB, RES TRIANGLE PK, NC 27709 USA	Chang Gung Memorial Hospital; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chen, CJ (corresponding author), NATL TAIWAN UNIV, COLL PUBL HLTH, INST EPIDEMIOL, 1 JEN AI RD SECT 1, TAIPEI 10018, TAIWAN.		Chen, Chien-Jen/N-4723-2019; Liaw, Yun-Fan/B-4305-2009; Bell, Douglas A/C-7687-2019; Chen, Chien-Jen/C-6976-2008	Bell, Douglas A/0000-0001-7700-0840; Yu, Ming-Whei/0000-0002-8371-6236	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005116] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES05116, R01 ES005116] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P426, DOI 10.1016/0035-9203(92)90253-9; BAERTSCHI SW, 1988, J AM CHEM SOC, V110, P7929, DOI 10.1021/ja00231a083; BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; BELL DA, 1992, ENVIRON HEALTH PERSP, V98, P113, DOI 10.2307/3431256; BOSCH FX, 1989, FALK SYMP, V51, P3; CHANG CC, 1994, J MED VIROL, V43, P276, DOI 10.1002/jmv.1890430315; CHEN CJ, 1991, HEPATOLOGY, V13, P398, DOI 10.1016/0270-9139(91)90289-8; CHEN CJ, 1992, HEPATOLOGY, V16, P1150, DOI 10.1002/hep.1840160508; CHEN CJ, 1993, J GASTROEN HEPATOL, V8, P83; Dragan YP, 1994, TOXICOLOGY AFLATOXIN, P179; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; GALLAGHER EP, 1994, CANCER RES, V54, P101; Hall A. J., 1994, TOXICOLOGY AFLATOXIN, P233; HATCH MC, 1993, INT J CANCER, V54, P931, DOI 10.1002/ijc.2910540611; KENSLER TW, 1986, CANCER RES, V46, P3924; LIN TM, 1991, ANTICANCER RES, V11, P2063; LIU YH, 1991, CARCINOGENESIS, V12, P2269, DOI 10.1093/carcin/12.12.2269; PEERS F, 1987, INT J CANCER, V39, P545, DOI 10.1002/ijc.2910390502; PEERS FG, 1973, BRIT J CANCER, V27, P473, DOI 10.1038/bjc.1973.60; PEERS FG, 1976, INT J CANCER, V17, P167, DOI 10.1002/ijc.2910170204; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; QIAN GS, 1994, CANCER EPIDEM BIOMAR, V3, P3; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; SABBIONI G, 1987, CARCINOGENESIS, V8, P819, DOI 10.1093/carcin/8.6.819; SHANK RC, 1972, FOOD COSMET TOXICOL, V10, P71, DOI 10.1016/S0015-6264(72)80048-8; SHEABAR FZ, 1993, CARCINOGENESIS, V14, P1203, DOI 10.1093/carcin/14.6.1203; STRANGE RC, 1993, STRUCTURE FUNCTION G, P160; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; VANRENSBURG SJ, 1985, BRIT J CANCER, V51, P713, DOI 10.1038/bjc.1985.107; WILD CP, 1990, CANCER RES, V50, P245; WILD CP, 1990, CARCINOGENESIS, V11, P2271, DOI 10.1093/carcin/11.12.2271; WILD CP, 1986, CARCINOGENESIS, V7, P853, DOI 10.1093/carcin/7.6.853; YEH FS, 1989, CANCER RES, V49, P2506; YU MW, 1994, CRIT REV ONCOL HEMAT, V17, P71, DOI 10.1016/1040-8428(94)90020-5; YU MW, 1995, CANCER RES, V55, P1301; YU MW, 1993, CANCER RES, V53, P790; YU MW, 1991, CANCER RES, V51, P5621; ZHANG YJ, 1991, CANCER RES, V51, P1720; ZHANG YJ, 1991, CARCINOGENESIS, V12, P2249; ZHONG S, 1991, CARCINOGENESIS, V12, P1533, DOI 10.1093/carcin/12.9.1533	41	106	107	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					128	134						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659516				2022-12-18	WOS:A1996VL45500018
J	BRYNDORF, T; KIRCHHOFF, M; ROSE, H; MAAHR, J; GERDES, T; KARHU, R; KALLIONIEMI, A; CHRISTENSEN, B; LUNDSTEEN, C; PHILIP, J				BRYNDORF, T; KIRCHHOFF, M; ROSE, H; MAAHR, J; GERDES, T; KARHU, R; KALLIONIEMI, A; CHRISTENSEN, B; LUNDSTEEN, C; PHILIP, J			COMPARATIVE GENOMIC HYBRIDIZATION IN CLINICAL CYTOGENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSITU HYBRIDIZATION; CHROMOSOME; LIBRARIES	We report the results of applying comparative genomic hybridization (CGH) in a cytogenetic service laboratory for (1) determination of the origin of extra and missing chromosomal material in intricate cases of unbalanced aberrations and (2) detection of common prenatal numerical chromosome aberrations. A total of 11 fetal samples were analyzed. Seven cases of complex unbalanced aberrations that could not be identified reliably by conventional cytogenetics were successfully resolved by CGH analysis. CGH results were validated by using FISH with chromosome-specific probes. Four cases representing common prenatal numerical aberrations (trisomy 21, 18, and 13 and monosomy X) were also successfully diagnosed by CGH. We conclude that CGH is a powerful adjunct to traditional cytogenetic techniques that makes it possible to solve clinical cases of intricate unbalanced aberrations in a single hybridization. CGH may also be a useful adjunct to screen for euchromatic involvement in marker chromosomes. Further technical development may render CGH applicable for routine aberration screening.	TAMPERE UNIV HOSP,CANC GENET LAB,TAMPERE,FINLAND; TAMPERE UNIV,INST MED TECHNOL,TAMPERE,FINLAND	Tampere University; Tampere University Hospital; Tampere University	BRYNDORF, T (corresponding author), UNIV COPENHAGEN,RIGSHOSP,JULIANE MARIE CTR,DEPT OBSTET & GYNAECOL,CLIN GENET SECT,CHROMOSOME LAB,DK-2100 COPENHAGEN 0,DENMARK.			Kallioniemi, Anne/0000-0003-3552-8158				BLENNOW E, 1992, HUM GENET, V90, P371, DOI 10.1007/BF00220461; BLENNOW E, 1994, PRENATAL DIAG, V14, P1019, DOI 10.1002/pd.1970141103; DUMANOIR S, 1995, CYTOMETRY, V19, P4, DOI 10.1002/cyto.990190103; DUMANOIR S, 1993, HUM GENET, V90, P590, DOI 10.1007/BF00202476; DUMANOIR S, 1995, CYTOMETRY, V19, P27, DOI 10.1002/cyto.990190105; FLORIJN RJ, 1995, CYTOMETRY, V19, P177, DOI 10.1002/cyto.990190213; ISOLA J, 1994, AM J PATHOL, V145, P1301; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LUNDSTEEN C, 1995, CYTOMETRY, V19, P42, DOI 10.1002/cyto.990190106; MELTZER PS, 1992, NAT GENET, V1, P24, DOI 10.1038/ng0492-24; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; PIPER J, 1995, CYTOMETRY, V19, P10, DOI 10.1002/cyto.990190104; Sambrook J., 1989, MOL CLONING LAB MANU; SMIDTJENSEN S, 1989, PRENATAL DIAG, V9, P309, DOI 10.1002/pd.1970090503	16	106	109	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1211	1220						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485173				2022-12-18	WOS:A1995TA44900029
J	KAUL, R; GAO, GP; ALOYA, M; BALAMURUGAN, K; PETROSKY, A; MICHALS, K; MATALON, R				KAUL, R; GAO, GP; ALOYA, M; BALAMURUGAN, K; PETROSKY, A; MICHALS, K; MATALON, R			CANAVAN DISEASE - MUTATIONS AMONG JEWISH AND NON-JEWISH PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPARTOACYLASE DEFICIENCY; SPONGY DEGENERATION; DNA; BRAIN	Canavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA). Sixty-four probands were analyzed for mutations in the ASPA gene. Three point mutations-693C-->A, 854A-->C, and 914C-->A-were identified in the coding sequence. The 633C-->A and 914C-->A base changes, resulting in nonsense tyr231-->ter and missense ala305-->glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies. The 854A-->C transversion converted glu to ala in codon 285. The glu285-->ala mutant ASPA has 2.5% of the activity expressed by the wild-type enzyme. A fourth mutation, 433-2(A-->G) transition, was identified at the splice-acceptor site in intron 2. The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA. Of the 128 unrelated Canavan chromosomes analyzed, 88 were from probands of Ashkenazi Jewish descent. The glu285-->ala mutation was predominant (82.9%) in this population, followed by the tyr231-->ter (14.8%) and 433-2(A-->G) (1.1%) mutations. The three mutations account for 38.8% of the Canavan chromosomes of Ashkenazi Jewish origin. The ala305-->glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60% of the 40 mutant chromosomes. Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes.			KAUL, R (corresponding author), MIAMI CHILDRENS HOSP, RES INST, 6125 SW 31ST ST, MIAMI, FL 33155 USA.			Kaul, Rajinder/0000-0002-7895-9284				ADACHI M, 1973, HUM PATHOL, V4, P331, DOI 10.1016/S0046-8177(73)80098-X; ADACHI M, 1972, ACTA NEUROPATHOL, V20, P22, DOI 10.1007/BF00687899; ADORNATO BT, 1972, NEUROLOGY, V22, P202, DOI 10.1212/WNL.22.2.202; BANKER BQ, 1979, GENETIC DIS ASHKENAZ, P201; BIRNBAUM SM, 1952, J BIOL CHEM, V194, P455; BIRNBAUM SM, 1955, METHOD ENZYMOL, V2, P115, DOI 10.1016/S0076-6879(55)02176-9; Canavan MM, 1931, ARCH NEURO PSYCHIATR, V25, P299, DOI 10.1001/archneurpsyc.1931.02230020085005; Globus JH, 1928, ARCH NEURO PSYCHIATR, V20, P1190, DOI 10.1001/archneurpsyc.1928.02210180041003; KABACK M, 1993, JAMA-J AM MED ASSOC, V270, P2307, DOI 10.1001/jama.270.19.2307; KAUL R, 1993, NAT GENET, V5, P118, DOI 10.1038/ng1093-118; KAUL R, 1994, GENOMICS, V21, P364, DOI 10.1006/geno.1994.1278; KAUL R, 1991, J NEUROCHEM, V56, P129, DOI 10.1111/j.1471-4159.1991.tb02571.x; LOEFFLER JP, 1993, METHOD ENZYMOL, V217, P599; MATALON R, 1993, J INHERIT METAB DIS, V16, P744, DOI 10.1007/BF00711906; MATALON R, 1992, J INHERIT METAB DIS, V15, P392, DOI 10.1007/BF02435985; MATALON R, 1989, J INHERIT METAB DIS, V12, P329, DOI 10.1007/BF03335413; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OZAND PT, 1990, AM J MED GENET, V35, P266, DOI 10.1002/ajmg.1320350224; PAW BH, 1990, AM J HUM GENET, V47, P698; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; UNGAR M, 1983, CLIN GENET, V23, P23; van Bogaert L., 1949, ACTA NEUROL BELG, V49, P572; VANBOGAERT L, 1967, SPONGY DEGENERATION	25	106	110	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					34	41						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023850				2022-12-18	WOS:A1994NW46100006
J	FANTES, JA; BICKMORE, WA; FLETCHER, JM; BALLESTA, F; HANSON, IM; VANHEYNINGEN, V				FANTES, JA; BICKMORE, WA; FLETCHER, JM; BALLESTA, F; HANSON, IM; VANHEYNINGEN, V			SUBMICROSCOPIC DELETIONS AT THE WAGR LOCUS, REVEALED BY NONRADIOACTIVE INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILMS-TUMOR GENE; HUMAN CHROMOSOME-11; TRANSLOCATION BREAKPOINTS; GENITOURINARY DYSPLASIA; COSMID CLONES; BAND 11P13; ANIRIDIA; REGION; MAP; SEQUENCES	Fluorescence in situ hybridization (FISH) with biotin-labeled probes mapping to 11p13 has been used for the molecular analysis of deletions of the WAGR (Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation) locus. We have detected a submicroscopic 11p13 deletion in a child with inherited aniridia who subsequently presented with Wilms tumor in a horseshoe kidney, only revealed at surgery. The mother, who has aniridia, was also found to carry a deletion including both the aniridia candidate gene (AN2) and the Wilms tumor predisposition gene (WT1). This is therefore a rare case of an inherited WAGR deletion. Wilms tumor has so far only been associated with sporadic de novo aniridia cases. We have shown that a cosmid probe for a candidate aniridia gene, homologous to the mouse Pax-6 gene, is deleted in cell lines from aniridia patients with previously characterized deletions at 11p13, while another cosmid marker mapping between two aniridia-associated translocation breakpoints (and hence a second candidate marker) is present on both chromosomes. These results support the Pax-6 homologue as a strong candidate for the AN2 gene. FISH with cosmid probes has proved to be a fast and reliable technique for the molecular analysis of deletions. It can be used with limited amounts of material and has strong potential for clinical applications.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; PROV HOSP CLIN,CLIN I,BARCELONA,SPAIN	University of Edinburgh	VANHEYNINGEN, V (corresponding author), WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.		Bickmore, Wendy A/C-7314-2013; VAN HEYNINGEN, Veronica/GYE-0531-2022; fletcher, jack/Q-5975-2019; van Heyningen, Veronica/B-8039-2008	Bickmore, Wendy A/0000-0001-6660-7735; van Heyningen, Veronica/0000-0003-0359-0141; Hanson, Isabel/0000-0002-1878-0530	Medical Research Council [MC_U127527199] Funding Source: Medline; MRC [MC_U127527199] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BICKMORE W, 1988, NUCLEIC ACIDS RES, V16, P51, DOI 10.1093/nar/16.1.51; BICKMORE WA, 1989, GENOMICS, V5, P685, DOI 10.1016/0888-7543(89)90109-2; BRESLOW N, 1988, CANCER RES, V48, P1653; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; COMPTON DA, 1988, CELL, V55, P827, DOI 10.1016/0092-8674(88)90138-9; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; DEPAGTERHOLTHUIZEN P, 1987, FEBS LETT, V214, P259, DOI 10.1016/0014-5793(87)80066-2; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GESSLER M, 1989, SCIENCE, V244, P1575, DOI 10.1126/science.2544995; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GESSLER M, 1989, AM J HUM GENET, V44, P486; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOOVERS JMN, 1992, GENOMICS, V12, P254, DOI 10.1016/0888-7543(92)90372-Y; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; HUFF V, 1990, AM J HUM GENET, V47, P155; KUWANO A, 1991, AM J HUM GENET, V49, P707; LANDEGENT JE, 1987, HUM GENET, V77, P366, DOI 10.1007/BF00291428; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LEWIS W H, 1988, Genomics, V3, P25, DOI 10.1016/0888-7543(88)90154-1; LI FP, 1988, PEDIATRICS, V81, P147; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; MANNENS M, 1991, GENOMICS, V11, P284, DOI 10.1016/0888-7543(91)90134-Z; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; PELLETIER J, 1991, NATURE, V353, P431, DOI 10.1038/353431a0; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PORTEOUS DJ, 1987, P NATL ACAD SCI USA, V84, P5355, DOI 10.1073/pnas.84.15.5355; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; RIED T, 1990, HUM GENET, V85, P581, DOI 10.1007/BF00193578; ROYERPOKORA B, 1991, GENE CHROMOSOME CANC, V3, P89, DOI 10.1002/gcc.2870030203; SEAWRIGHT A, 1988, SOMAT CELL MOLEC GEN, V14, P21, DOI 10.1007/BF01535046; SIMOLA KOJ, 1983, HUM GENET, V63, P158, DOI 10.1007/BF00291536; SPURR NK, 1986, ANN HUM GENET, V50, P145, DOI 10.1111/j.1469-1809.1986.tb01033.x; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592; VANHEYNINGEN V, 1992, TRENDS GENET, V8, P16, DOI 10.1016/0168-9525(92)90019-Z; VANHEYNINGEN V, 1990, P NATL ACAD SCI USA, V87, P5383, DOI 10.1073/pnas.87.14.5383	41	106	106	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1286	1294						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1334370				2022-12-18	WOS:A1992KC99500011
J	REILLY, SL; FERRELL, RE; KOTTKE, BA; KAMBOH, MI; SING, CF				REILLY, SL; FERRELL, RE; KOTTKE, BA; KAMBOH, MI; SING, CF			THE GENDER-SPECIFIC APOLIPOPROTEIN-E GENOTYPE INFLUENCE ON THE DISTRIBUTION OF LIPIDS AND APOLIPOPROTEINS IN THE POPULATION OF ROCHESTER, MN .1. PLEIOTROPIC EFFECTS ON MEANS AND VARIANCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY-ARTERY DISEASE; E POLYMORPHISM; LIPOPROTEIN CHOLESTEROL; PLASMA-LIPOPROTEINS; FRAMINGHAM; SAMPLE; RADIOIMMUNOASSAY; IDENTIFICATION; TRIGLYCERIDES; VARIABILITY	The influences of the apolipoprotein E (Apo E) polymorphism and of gender on the distributions of plasma levels of total cholesterol (Total-C), In triglycerides (lnTrig), HDL cholesterol (HDL-C), and apolipoproteins AI (Apo AI), AII (Apo AII), ln E (lnApo E), B (Apo B), CII (Apo CII), and In CIII (lnApo CIII) were studied in 507 unrelated individuals representative of the adult population of Rochester, MN. Apo E genotypes influenced both phenotypic level and intragenotype phenotypic variability. The mean levels of six of the nine traits were influenced significantly by Apo E genotype. Intragenotype variability in eight of the nine traits was significantly different among Apo E genotypes. These effects were estimated separately in males and females. The contribution of allelic variation in the Apo E gene to the definition of the multivariate mean and variance of the lipid and apolipoprotein hyperspace was evaluated. These findings were used to demonstrate how heterogeneity of risk-factor-trait variance among genotype/gender-specific subgroups of the population at large may influence the evaluation of risk of coronary artery disease.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15260; MAYO CLIN & MAYO FDN,DIV CARDIOL,ROCHESTER,MN 55905	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic	REILLY, SL (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,M4708 MED SCI 2,ANN ARBOR,MI 48109, USA.			Sing, Charles/0000-0001-5872-7956; Kamboh, M. Ilyas/0000-0002-3453-1438	NHLBI NIH HHS [HL24489, HL30428, HL39107] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030428, R01HL039107, R01HL024489] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT RD, 1983, ARTERIOSCLEROSIS, V3, P260, DOI 10.1161/01.ATV.3.3.260; ANDERSON KM, 1987, ATHEROSCLEROSIS, V68, P59, DOI 10.1016/0021-9150(87)90094-3; ANSARI AR, 1960, ANN MATH STAT, V31, P1174, DOI 10.1214/aoms/1177705688; AU YPT, 1986, CLIN CHEM, V32, P1394; AU YPT, 1986, BIOCHEM BIOPH RES CO, V138, P455, DOI 10.1016/0006-291X(86)90302-5; BARHAM D, 1972, ANALYST, V97, P142, DOI 10.1039/an9729700142; BARR SI, 1981, BIOCHIM BIOPHYS ACTA, V663, P491, DOI 10.1016/0005-2760(81)90177-6; BARR SI, 1981, AM J CLIN NUTR, V34, P191, DOI 10.1093/ajcn/34.2.191; BARR SI, 1981, CLIN CHEM, V27, P1142; BERG K, 1990, FROM PHENOTYPE TO GENE IN COMMON DISORDERS, P77; BERG K, 1988, CLIN GENET, V33, P102; BISHOP GR, 1988, HUM HERED, V38, P216, DOI 10.1159/000153788; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BROWN MS, 1983, METABOLIC BASIS INHE, P655; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; DAVIGNON J, 1983, HYPERTENSION PHYSIOP, P810; ENHOLM C, 1986, J LIPID RES, V27, P227; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; GORDON T, 1977, ANN INTERN MED, V87, P393, DOI 10.7326/0003-4819-87-4-393; GUEGUEN R, 1989, AM J HUM GENET, V45, P793; HANIS CL, 1991, ARTERIOSCLER THROMB, V11, P362, DOI 10.1161/01.ATV.11.2.362; Havekes L M, 1988, Adv Exp Med Biol, V243, P87; HIGGINS M, 1989, INT J EPIDEMIOL, V18, pS58; IZZO C, 1981, CLIN CHEM, V27, P371; KAMBOH MI, 1988, J LIPID RES, V29, P1535; KAPRIO J, 1989, CLIN GENET, V36, P266; KAPRIO J, IN PRESS ARTERIOSCLE; KEMPTHORNE O, 1978, BIOMETRICS, V34, P1, DOI 10.2307/2529584; KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8; LEIBEL RL, 1989, ANNU REV NUTR, V9, P417, DOI 10.1146/annurev.nu.09.070189.002221; Lerner IM, 1954, GENETIC HOMEOSTASIS; LUSIS AJ, 1988, J LIPID RES, V29, P397; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; MILLIGAN GW, 1987, PSYCHOL BULL, V101, P464, DOI 10.1037/0033-2909.101.3.464; MOLL PP, 1989, AM J HUM GENET, V44, P124; MORRISON DF, 1971, MULTIVARIATE STATIST; MURPHY EA, 1979, SOC BIOL, V26, P126, DOI 10.1080/19485565.1979.9988371; NESTRUCK AC, 1987, METABOLISM, V36, P743, DOI 10.1016/0026-0495(87)90110-7; ORDOVAS JM, 1987, J LIPID RES, V28, P371; PEDERSEN JC, 1989, CLIN GENET, V35, P331; REILLY SL, 1990, J CLIN EPIDEMIOL, V43, P921, DOI 10.1016/0895-4356(90)90076-2; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; ROSE G, 1987, MOL APPROACHES HUMAN, P247; SING C, 1989, American Journal of Human Genetics, V45, pA249; SING CF, 1976, AM J HUM GENET, V28, P453; SING CF, 1985, AM J HUM GENET, V37, P268; THOM TJ, 1989, INT J EPIDEMIOL, V18, pS20; TOMARKEN AJ, 1986, PSYCHOL BULL, V99, P90, DOI 10.1037/0033-2909.99.1.90; TRUETT J, 1967, J CHRON DIS, V20, P511, DOI 10.1016/0021-9681(67)90082-3; VANVALEN L, 1974, J THEOR BIOL, V45, P235, DOI 10.1016/0022-5193(74)90053-8; Waddington C.H., 1957, STRATEGY GENES; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243; WILSON PWF, 1983, ARTERIOSCLEROSIS, V3, P273, DOI 10.1161/01.ATV.3.3.273; 1983, FISCAL YEAR 1983 FAC; 1979, CIRCULATION, V60, P427	58	106	108	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1155	1166						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1842218				2022-12-18	WOS:A1991GU67200003
J	SHEFFIELD, VC; FISHMAN, GA; BECK, JS; KIMURA, AE; STONE, EM				SHEFFIELD, VC; FISHMAN, GA; BECK, JS; KIMURA, AE; STONE, EM			IDENTIFICATION OF NOVEL RHODOPSIN MUTATIONS ASSOCIATED WITH RETINITIS-PIGMENTOSA BY GC-CLAMPED DENATURING GRADIENT GEL-ELECTROPHORESIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-BASE CHANGES; GENOMIC DNA; GENE; SEQUENCE; ATTACHMENT	Retinitis pigmentosa (RP) is a group of disorders characterized by progressive degeneration of the outer retina, resulting in night blindness, visual field loss, an abnormal electroretinogram, and characteristic retinal pigmentary changes. An important step in the understanding of RP has been the recognition that some cases of autosomal dominant RP (ADRP) are caused by mutations in the rhodopsin gene. Multiple different point mutations within the coding sequence of the rhodopsin gene have been associated with ADRP. We have developed a GC-clamped denaturing-gradient-gel electrophoresis (DGGE) assay for the coding region of the rhodopsin gene and have used this assay to screen ADRP patients for mutations. The assay consists of amplifying with PCR the five exons of the rhodopsin gene and then analyzing each PCR product by DGGE. We have used this assay to detect three previously unreported rhodopsin base substitutions associated with ADRP. The use of this assay to identify ADRP patients who have various rhodopsin mutations has allowed us to begin studies seeking to correlate molecular genotype with clinical phenotype. Furthermore, GC-clamped DGGE has allowed us to identify families with ADRP not caused by a rhodopsin mutation. Such families will be important in the search for other genes involved in ADRP.	UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52240; UNIV ILLINOIS,DEPT OPHTHALMOL,CHICAGO,IL 60680	University of Iowa; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	SHEFFIELD, VC (corresponding author), UNIV IOWA,MED CTR,DEPT PEDIAT,DIV MED GENET,2615 JCP,IOWA CITY,IA 52240, USA.			Stone, Edwin M./0000-0003-3343-4414	NEI NIH HHS [EYO1792, EYO8426] Funding Source: Medline; PHS HHS [P30H027748] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001792, R29EY008426] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; DUBOSE RF, 1990, BIOTECHNIQUES, V8, P277; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; INGELHEARN CF, 1991, AM J HUM GENET, V48, P26; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; Myers R, 1989, PCR TECHNOLOGY PRINC, P71; Myers R. M., 1988, Genome analysis: a practical approach., P95; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3111, DOI 10.1093/nar/13.9.3111; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	19	106	125	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					699	706						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1897520				2022-12-18	WOS:A1991GG66500001
J	BEUTLER, E; KUHL, W				BEUTLER, E; KUHL, W			THE NT-1311 POLYMORPHISM OF G6PD - G6PD MEDITERRANEAN MUTATION MAY HAVE ORIGINATED INDEPENDENTLY IN EUROPE AND ASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BEUTLER, E (corresponding author), SCRIPPS CLIN & RES FDN,RES INST,DEPT MOLEC & EXPTL MED,10666 N TORREY PINES RD,LA JOLLA,CA 92037, USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025552, R37HL025552] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NHLBI NIH HHS [HL25552] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEUTLER E, 1990, HUM GENET, V85, P9; BEUTLER E, 1990, SEMIN HEMATOL, V27, P137; DEVITA G, 1989, AM J HUM GENET, V44, P233; DURSO M, 1988, AM J HUM GENET, V42, P735; FEY MF, 1990, HUM GENET, V84, P471; Maniatis T., 1982, MOL CLONING; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; PERSICO MG, 1986, GLUCOSE 6 PHOSPHATE, P503; PRCHAL JT, 1980, BLOOD, V56, P476; TAKIZAWA T, 1986, P NATL ACAD SCI USA, V83, P4157, DOI 10.1073/pnas.83.12.4157; VIGLIETTO G, 1990, ANN HUM GENET, V54, P1, DOI 10.1111/j.1469-1809.1990.tb00355.x; VIVESCORRONS JL, 1990, AM J HUM GENET, V47, P575; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; YOSHIDA A, 1988, AM J HUM GENET, V42, P872; YOSHIDA A, 1986, GLUCOSE 6 PHOSPHATE, P517	16	106	108	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1990	47	6					1008	1012						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EK400	1978554				2022-12-18	WOS:A1990EK40000019
J	AUBURGER, G; DIAZ, GO; CAPOTE, RF; SANCHEZ, SG; PEREZ, MP; DELCUETO, ME; MENESES, MG; FARRALL, M; WILLIAMSON, R; CHAMBERLAIN, S; BAUTE, LH				AUBURGER, G; DIAZ, GO; CAPOTE, RF; SANCHEZ, SG; PEREZ, MP; DELCUETO, ME; MENESES, MG; FARRALL, M; WILLIAMSON, R; CHAMBERLAIN, S; BAUTE, LH			AUTOSOMAL DOMINANT ATAXIA - GENETIC-EVIDENCE FOR LOCUS HETEROGENEITY FROM A CUBAN FOUNDER-EFFECT POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									VI LENIN HOSP,DEPT NEUROL,HOLGUIN,CUBA; NATL CTR HUMAN GENET,PLAYA,CUBA; INST HEMATOL,HAVANA,CUBA; CLIN RES CTR,HARROW HA1 3UJ,MIDDX,ENGLAND		AUBURGER, G (corresponding author), ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,NORFOLK PL,LONDON W2 1PG,ENGLAND.							BIDWELL J, 1988, IMMUNOL TODAY, V9, P18, DOI 10.1016/0167-5699(88)91351-5; Brown S., 1892, BRAIN, V15, P250; CHAMBERLAIN S, 1989, AM J HUM GENET, V44, P518; DIAZ GO, IN PRESS NEUROLOGY; DIAZ GO, IN PRESS CEREBELLAR; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GILLIAM TC, 1984, HUM GENET, V69, P154; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KOEPPEN AH, 1981, ARCH NEUROL-CHICAGO, V38, P158, DOI 10.1001/archneur.1981.00510030052007; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; KUMAR D, 1986, HUM GENET, V72, P327, DOI 10.1007/BF00290959; MITTAL KK, 1968, TRANSPLANTATION, V6, P913, DOI 10.1097/00007890-196811000-00006; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; OROZCO G, 1989, J NEUROL SCI, V93, P37, DOI 10.1016/0022-510X(89)90159-7; ORR H T, 1989, American Journal of Human Genetics, V45, pA155; OTT J, 1979, TRANSPLANT P, V11, P1689; PEDERSEN L, 1980, HUM GENET, V54, P371, DOI 10.1007/BF00291585; RICH SS, 1989, CYTOGENET CELL GENET, V51, P1066; ROSENBERG RN, 1989, MOL GENETICS DISEASE, P356; SACHDEV HS, 1982, NEUROLOGY, V32, P192, DOI 10.1212/WNL.32.2.192; SASAKI H, 1988, JPN J HUM GENET, V33, P423, DOI 10.1007/BF01897783; SPENCE MA, 1989, CYTOGENET CELL GENET, V51, P152; WADIA NH, 1971, BRAIN, V94, P359, DOI 10.1093/brain/94.2.359; WASTIAUX JP, 1978, CAN J NEUROL SCI, V5, P75, DOI 10.1017/S0317167100024811; WERDELIN L, 1984, HUM GENET, V66, P85, DOI 10.1007/BF00275192; WILKIE P, 1987, CYTOGENET CELL GENET, V46, P715; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, GENOMICS, V3, P396, DOI 10.1016/0888-7543(88)90135-8; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255	31	106	107	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1163	1177						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	1971152				2022-12-18	WOS:A1990DF20200018
J	WADA, M; LITTLE, RD; ABIDI, F; PORTA, G; LABELLA, T; COOPER, T; DELLAVALLE, G; DURSO, M; SCHLESSINGER, D				WADA, M; LITTLE, RD; ABIDI, F; PORTA, G; LABELLA, T; COOPER, T; DELLAVALLE, G; DURSO, M; SCHLESSINGER, D			HUMAN XQ24-XQ28 - APPROACHES TO MAPPING WITH YEAST ARTIFICIAL CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WASHINGTON UNIV, SCH MED, CTR GENET MED, BOX 8031, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA; UNIV CATANIA, DEPARTIMENTO BIOL ANIM, I-95124 CATANIA, ITALY; IST INT GENET & BIOFIS, NAPLES, ITALY	Washington University (WUSTL); Washington University (WUSTL); University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)			Little, Randall/O-7172-2014	porta, giovanni/0000-0001-5260-2415	NIGMS NIH HHS [GM40606, GM41675, GM21357] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021357, P01GM040606, R01GM041675] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANSON DS, 1988, EMBO J, V7, P2795, DOI 10.1002/j.1460-2075.1988.tb03134.x; ANTONARAKIS SE, 1988, ADV HUM GENET, V17, P27; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BRUNS G, 1984, CYTOGENET CELL GENET, V37, P428; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAMERINO G, 1985, HUM GENET, V71, P79, DOI 10.1007/BF00295673; CARLE GF, 1984, NUCLEIC ACIDS RES, V12, P5647, DOI 10.1093/nar/12.14.5647; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; DURSO M, UNPUB YEAST ARTIFICI; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GUSELLA JF, 1982, P NATL ACAD SCI-BIOL, V79, P7804, DOI 10.1073/pnas.79.24.7804; HAMERTON JL, 1984, CYTOGENET CELL GENET, V37, P486; HOFKER MH, 1987, AM J HUM GENET, V40, P312; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; LANDEGENT JE, 1987, HUM GENET, V77, P366, DOI 10.1007/BF00291428; LAWRENCE JB, 1988, CELL, V52, P51; LITTLE RD, 1989, P NATL ACAD SCI USA, V86, P1598, DOI 10.1073/pnas.86.5.1598; LUBS HA, 1984, AM J MED GENET, V17, P133, DOI 10.1002/ajmg.1320170108; LUZZATTO L, 1985, ADV HUM GENET, V14, P217; Maniatis T., 1982, MOL CLONING; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; MCKUSICK VA, 1987, MEDICINE, V66, P237, DOI 10.1097/00005792-198707000-00001; MOSER HW, 1987, J CHILD NEUROL, V2, P140, DOI 10.1177/088307388700200211; MULLIGAN LM, 1985, AM J HUM GENET, V37, P463; MURPHY PD, 1985, SOMAT CELL MOLEC GEN, V11, P433, DOI 10.1007/BF01534837; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NOGUCHI T, 1988, ONCOGENE, V3, P709; NUSSBAUM RL, 1986, AM J MED GENET, V23, P457, DOI 10.1002/ajmg.1320230137; NUSSBAUM RL, 1986, ANNU REV GENET, V20, P109; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; PATTERSON M, 1987, NUCLEIC ACIDS RES, V15, P2639, DOI 10.1093/nar/15.6.2639; PATTERSON M, 1987, Genomics, V1, P297, DOI 10.1016/0888-7543(87)90028-0; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; RUBIN CM, 1980, NATURE, V284, P372, DOI 10.1038/284372a0; SHOWS TB, 1982, ADV HUM GENET, V12, P341; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; STOUT JT, 1985, ANNU REV GENET, V19, P127, DOI 10.1146/annurev.genet.19.1.127; VOLLRATH D, 1987, NUCLEIC ACIDS RES, V15, P7865, DOI 10.1093/nar/15.19.7865; WILLARD HF, 1983, NUCLEIC ACIDS RES, V11, P2017, DOI 10.1093/nar/11.7.2017; YE RD, 1987, J BIOL CHEM, V262, P3718	48	106	107	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					95	106						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2294758				2022-12-18	WOS:A1990CJ04300012
J	KOEBERL, DD; BOTTEMA, CDK; BUERSTEDDE, JM; SOMMER, SS				KOEBERL, DD; BOTTEMA, CDK; BUERSTEDDE, JM; SOMMER, SS			FUNCTIONALLY IMPORTANT REGIONS OF THE FACTOR-IX GENE HAVE A LOW RATE OF POLYMORPHISM AND A HIGH-RATE OF MUTATION IN THE DINUCLEOTIDE CPG	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO CLIN & MAYO FDN, DEPT BIOCHEM & MOLEC BIOL, ROCHESTER, MN 55905 USA	Mayo Clinic				Bottema, Cynthia/0000-0001-6245-0099	NCI NIH HHS [CA09441-06Q] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOTTEMA CDK, UNPUB DIRECT CARRIER; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DAVIS LM, 1984, BLOOD S, V64, pA262; ENGELKE DR, 1988, P NATL ACAD SCI USA, V85, P544, DOI 10.1073/pnas.85.2.544; EWENS WJ, 1981, P NATL ACAD SCI-BIOL, V78, P3748, DOI 10.1073/pnas.78.6.3748; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HAY CW, 1986, BLOOD, V67, P1508; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; JAGADEESWARAN P, 1984, SOMAT CELL MOLEC GEN, V10, P465, DOI 10.1007/BF01534851; JAYE M, 1983, NUCLEIC ACIDS RES, V11, P2325, DOI 10.1093/nar/11.8.2325; KATAYAMA K, 1979, P NATL ACAD SCI USA, V76, P4990, DOI 10.1073/pnas.76.10.4990; KURACHI K, 1982, P NATL ACAD SCI-BIOL, V79, P6461, DOI 10.1073/pnas.79.21.6461; LUBAHN DB, 1987, AM J HUM GENET, V40, P527; MCGRAW RA, 1985, P NATL ACAD SCI USA, V82, P2847, DOI 10.1073/pnas.82.9.2847; Nei M, 1987, MOL EVOLUTIONARY GEN; NOYES CM, 1983, P NATL ACAD SCI-BIOL, V80, P4200, DOI 10.1073/pnas.80.14.4200; PHEAR G, 1987, P NATL ACAD SCI USA, V84, P4450, DOI 10.1073/pnas.84.13.4450; PRENDERGAST FG, 1977, J BIOL CHEM, V252, P840; REITSMA PH, 1989, BLOOD, V73, P743; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SARKAR G, UNPUB DIRECT SEQUENC; SMITH KJ, 1987, BLOOD, V70, P1006; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; VOGEL F, 1986, HUMAN GENETICS PROBL, P433; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; WARE J, 1988, BLOOD, V72, P820; WINSHIP PR, 1984, NUCLEIC ACIDS RES, V12, P8861, DOI 10.1093/nar/12.23.8861; WINSHIP PR, 1986, LANCET, V2, P218; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	41	106	111	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1989	45	3					448	457						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AN879	2773937				2022-12-18	WOS:A1989AN87900014
J	RICH, SS; ANNEGERS, JF; HAUSER, WA; ANDERSON, VE				RICH, SS; ANNEGERS, JF; HAUSER, WA; ANDERSON, VE			COMPLEX SEGREGATION ANALYSIS OF FEBRILE CONVULSIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT GENET & CELL BIOL,MINNEAPOLIS,MN 55455; UNIV TEXAS,SCH PUBL HLTH,HOUSTON,TX 77025; COLUMBIA UNIV,SERGIEVSKY CTR,NEW YORK,NY 10027	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Columbia University	RICH, SS (corresponding author), UNIV MINNESOTA,DEPT LAB MED & PATHOL,BOX 511 UMHC,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455, USA.		Hauser, W Allen/AAB-5277-2020	Rich, Stephen/0000-0003-3872-7793	NCRR NIH HHS [RR-01632] Funding Source: Medline; NIGMS NIH HHS [GM-17173] Funding Source: Medline; NINDS NIH HHS [NS-16308] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016308] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		COX NJ, 1983, AM J HUM GENET, V35, pA196; FRANTZEN E, 1970, NEUROLOGY, V20, P909, DOI 10.1212/WNL.20.9.909; FUKUYAMA Y, 1979, EUR NEUROL, V18, P166, DOI 10.1159/000115073; HAUSER WA, 1985, NEUROLOGY, V35, P1268, DOI 10.1212/WNL.35.9.1268; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; HAUSER WA, 1983, EPILEPSY, P267; Kurland LT, 1970, COMMUNITY EPIDEMIOLO, P47; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; Lennox-Buchtal M., 1973, ELECROENCEPH CLIN NE, V32, P1; SCHIOTTZ.E, 1972, ACTA NEUROL SCAND, V48, P538, DOI 10.1111/j.1600-0404.1972.tb07574.x; SCHUMAN SH, 1966, CLIN PEDIATR, V5, P604, DOI 10.1177/000992286600501007; SMITH C, 1970, ANN HUM GENET, V34, P85, DOI 10.1111/j.1469-1809.1970.tb00223.x; TSUBOI T, 1976, BRIT J PSYCHIAT, V129, P239, DOI 10.1192/bjp.129.3.239; TSUBOI T, 1982, GENETIC BASIS EPILEP, P123; VANDENBERG BJ, 1974, DEV MED CHILD NEUROL, V16, P457	16	106	107	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					249	257						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3618594				2022-12-18	WOS:A1987J757500013
J	LIAN, ZH; ZACK, MM; ERICKSON, JD				LIAN, ZH; ZACK, MM; ERICKSON, JD			PATERNAL AGE AND THE OCCURRENCE OF BIRTH-DEFECTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CTR DIS CONTROL,CANC BRANCH,ATLANTA,GA 30333; CTR DIS CONTROL,BIRTH DEFECTS & GENET DIS BRANCH,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	LIAN, ZH (corresponding author), BEIJING MED COLL,DEPT EPIDEMIOL,BEIJING,PEOPLES R CHINA.							Breslow NE, 1980, ANAL CASE CONTROL ST; CHAMBERLIN J, 1980, HUM GENET, V53, P343, DOI 10.1007/BF00287054; EDMONDS LD, 1981, INT J EPIDEMIOL, V10, P247, DOI 10.1093/ije/10.3.247; ERICKSON JD, 1979, AM J HUM GENET, V31, P489; ERICKSON JD, 1984, JAMA-J AM MED ASSOC, V252, P903, DOI 10.1001/jama.252.7.903; ERICKSON JD, 1981, J MED GENET, V18, P22, DOI 10.1136/jmg.18.1.22; FRIEDMAN JM, 1981, OBSTET GYNECOL, V57, P745; HOOK EB, 1981, AM J HUM GENET, V33, P123; LAMSON SH, 1980, HUM GENET, V55, P49, DOI 10.1007/BF00329126; MANNING CH, 1981, HUM GENET, V59, P101, DOI 10.1007/BF00293054; MATSUNAGA E, 1978, HUM GENET, V40, P259, DOI 10.1007/BF00272186; McKusick V.A., 1983, MENDELIAN INHERITANC; PENROSE LS, 1955, LANCET, V2, P312; POLEDNAK AP, 1976, HUM BIOL, V48, P727; ROSENBAUM MS, 1983, PEDIATRICS, V71, P359; Schlesselman James J., 1982, CASE CONTROL STUDIES; STENE J, 1977, ANN HUM GENET, V40, P343, DOI 10.1111/j.1469-1809.1977.tb00198.x; STENE J, 1977, ANN HUM GENET, V40, P299, DOI 10.1111/j.1469-1809.1977.tb00194.x; STENE J, 1978, ANN HUM GENET, V41, P465, DOI 10.1111/j.1469-1809.1978.tb00917.x; [No title captured]; [No title captured]; [No title captured]	22	106	108	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1986	39	5					648	660						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	F3032	3788977				2022-12-18	WOS:A1986F303200010
J	BARKER, D; HOLM, T; WHITE, R				BARKER, D; HOLM, T; WHITE, R			A LOCUS ON CHROMOSOME 11P WITH MULTIPLE RESTRICTION SITE POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,SCH MED,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah				Barker, David/0000-0002-1438-4100				ADAMS JW, 1980, NUCLEIC ACIDS RES, V8, P6113, DOI 10.1093/nar/8.24.6113; Alwine J C, 1979, Methods Enzymol, V68, P220; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P6608, DOI 10.1073/pnas.79.21.6608; BARKER D, 1984, NUCLEIC ACIDS RES, V12, P5567, DOI 10.1093/nar/12.14.5567; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BISHOP DT, 1983, STATISTICAL ANAL DNA; BOLIVAR F, 1978, GENE, V4, P121, DOI 10.1016/0378-1119(78)90025-2; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHAPMAN BS, UNPUB LENGTH POLYMOR; DEWET JR, 1980, J VIROL, V33, P401, DOI 10.1128/JVI.33.1.401-410.1980; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; HARPER ME, 1983, BANBURY REPORT, V14, P159; HARTL DL, 1980, PRINCIPLES POPULATIO, P110; LANGE K, 1983, AM J HUM GENET, V35, P177; MCCLELLAN T, UNPUB GENETIC DISTAN; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MIGONE N, 1983, P NATL ACAD SCI-BIOL, V80, P467, DOI 10.1073/pnas.80.2.467; NAYLOR SL, 1984, P NATL ACAD SCI-BIOL, V81, P2447, DOI 10.1073/pnas.81.8.2447; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; SHAFITZAGARDO B, 1982, GENE, V20, P397, DOI 10.1016/0378-1119(82)90208-6; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P1; SKOLNICK MH, 1984, BIRTH DEFECTS, V20, P210; SMITH HO, 1976, NUCLEIC ACIDS RES, V3, P2387, DOI 10.1093/nar/3.9.2387; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; TAUB RA, 1983, NATURE, V304, P172, DOI 10.1038/304172a0; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WHITE R, UNPUB HIGH RESOLUTIO; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	33	106	107	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1159	1171						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6097109				2022-12-18	WOS:A1984TZ59000001
J	SUTHERLAND, GR				SUTHERLAND, GR			HERITABLE FRAGILE SITES ON HUMAN-CHROMOSOMES .8. PRELIMINARY POPULATION CYTOGENETIC DATA ON THE FOLIC-ACID-SENSITIVE FRAGILE SITES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											SUTHERLAND, GR (corresponding author), ADELAIDE CHILDRENS HOSP,DEPT HISTOPATHOL,CYTOGENET UNIT,N ADELAIDE,SA 5006,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012					DAKER MG, 1981, LANCET, V1, P780; GERALD PS, 1970, HUMAN POPULATION CYT, P143; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; JACOBS PA, 1974, NATURE, V249, P164, DOI 10.1038/249164a0; MANUEL A, 1981, 5TH ANN SCI M HUM GE; SUTHERLAND GR, 1979, MED J AUSTRALIA, V2, P58, DOI 10.5694/j.1326-5377.1979.tb112703.x; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1981, HUM GENET, V57, P217; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P136; SUTHERLAND GR, 1979, AM J HUM GENET, V31, P125; SUTHERLAND GR, 1979, HUM GENET, V53, P23, DOI 10.1007/BF00289445; SUTHERLAND GR, 1976, HUM GENET, V34, P231, DOI 10.1007/BF00295286; TURNER G, 1980, NEW ENGL J MED, V303, P662, DOI 10.1056/NEJM198009183031202; WILLIAMS AJ, 1976, J MENT DEFIC RES, V21, P227	15	106	106	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					452	458						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	7081222				2022-12-18	WOS:A1982NR13300010
J	VOGEL, F				VOGEL, F			ABO BLOOD GROUPS AND DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		AIRD J, 1953, BMJ-BRIT MED J, V1, P794; BERNHARD W, 1966, HOMO, V17, P111; CLARKE C. A., 1961, PROGR MED GENET, V1, P81; DOWNIE AW, 1965, B WORLD HEALTH ORGAN, V33, P623; EICHNER ER, 1963, NATURE, V198, P164, DOI 10.1038/198164a0; HARRIS R, 1963, ACTA GENET STAT MED, V13, P44; HAVERKORN MJ, 1969, AM J HUM GENET, V21, P360; HELMBOLD W, 1959, Blut, V5, P7, DOI 10.1007/BF01630238; JORGENSEN G, 1968, HUMANGENETIK, V5, P254; KIRCHER W, 1964, Monatsschr Kinderheilkd, V112, P415; KIRCHER W, 1961, Monatsschr Kinderheilkd, V109, P369; KRIEGER H, 1969, HUM HERED, V19, P654, DOI 10.1159/000152279; MCDONALD JC, 1962, BRIT MED J, P89, DOI 10.1136/bmj.2.5297.89; OTTEN CM, 1967, CURR ANTHROPOL, V8, P209, DOI 10.1086/200794; PETTENKOFER HJ, 1960, ZBL BAKT, V1, P433; SOCHA W, 1969, Folia Biologica (Cracow), V17, P259; SPRINGER GF, 1967, CROSS REACTION ANTIG; Sukumaran P K, 1966, Indian J Med Sci, V20, P119; VOGEL F., 1960, ACTA GENET ET STATIST MED, V10, P267; VOGEL F, 1966, HUMANGENETIK, V3, P166, DOI 10.1007/BF00291297; VOGEL F, 1969, HUMANGENETIK, V7, P149, DOI 10.1007/BF00287079; VOGEL F, 1964, HUMANGENETIK, V1, P31, DOI 10.1007/BF00289363; VOGEL F, 1968, BLUT, V16, P351, DOI 10.1007/BF01632080; VOGEL F, 1970, HUMANGENETIK KURZES, V1; VOGEL F, 1968, 8 P INT C ANTHR ETHN, P365; VOGEL F, 1965, 10 P C INT SOC BLOOD, P268; VOGEL FRIEDRICH, 1968, J MED GENET, V5, P56, DOI 10.1136/jmg.5.1.56; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; ZIH S, 1967, HUMANGENETIK, V4, P42, DOI 10.1007/BF00279178; ZUCKERMAN AJ, 1963, BMJ-BRIT MED J, P537, DOI 10.1136/bmj.2.5356.537	30	106	106	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	4					464	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0227	5432291				2022-12-18	WOS:A1970H022700011
J	Wang, J; Al-Ouran, R; Hu, YH; Kim, SY; Wan, YW; Wangler, MF; Yamamoto, S; Chao, HT; Comjean, A; Mohr, SE; Perrimon, N; Liu, ZD; Bellen, HJ				Wang, Julia; Al-Ouran, Rami; Hu, Yanhui; Kim, Seon-Young; Wan, Ying-Wooi; Wangler, Michael F.; Yamamoto, Shinya; Chao, Hsiao-Tuan; Comjean, Aram; Mohr, Stephanie E.; Perrimon, Norbert; Liu, Zhandong; Bellen, Hugo J.			MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCE VARIANTS; DATABASE; PHENOTYPES	One major challenge encountered with interpreting human genetic variants is the limited understanding of the functional impact of genetic alterations on biological processes. Furthermore, there remains an unmet demand for an efficient survey of the wealth of information on human homologs in model organisms across numerous databases. To efficiently assess the large volume of publically available information, it is important to provide a concise summary of the most relevant information in a rapid user-friendly format. To this end, we created MARRVEL (model organism aggregated resources for rare variant exploration). MARRVEL is a publicly available website that integrates information from six human genetic databases and seven model organism databases. For any given variant or gene, MARRVEL displays information from OMIM, ExAC, ClinVar, Geno2MP, DGV, and DECIPHER. Importantly, it curates model organism-specific databases to concurrently display a concise summary regarding the human gene homologs in budding and fission yeast, worm, fly, fish, mouse, and rat on a single webpage. Experiment-based information on tissue expression, protein subcellular localization, biological process, and molecular function for the human gene and homologs in the seven model organisms are arranged into a concise output. Hence, rather than visiting multiple separate databases for variant and gene analysis, users can obtain important information by searching once through MARRVEL. Altogether, MARRVEL dramatically improves efficiency and accessibility to data collection and facilitates analysis of human genes and variants by cross-disciplinary integration of 18 million records available in public databases to facilitate clinical diagnosis and basic research.	[Wang, Julia; Wangler, Michael F.; Yamamoto, Shinya; Bellen, Hugo J.] BCM, Program Dev Biol, Houston, TX 77030 USA; [Wang, Julia] BCM, Med Scientist Training Program, Houston, TX 77030 USA; [Al-Ouran, Rami; Kim, Seon-Young; Wan, Ying-Wooi; Wangler, Michael F.; Yamamoto, Shinya; Chao, Hsiao-Tuan; Liu, Zhandong; Bellen, Hugo J.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Al-Ouran, Rami; Wan, Ying-Wooi; Wangler, Michael F.; Chao, Hsiao-Tuan; Liu, Zhandong] BCM, Dept Pediat, Houston, TX 77030 USA; [Hu, Yanhui; Comjean, Aram; Mohr, Stephanie E.; Perrimon, Norbert] Harvard Med Sch, Dept Genet, Drosophila RNAi Screening Ctr, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Kim, Seon-Young; Wangler, Michael F.; Yamamoto, Shinya; Bellen, Hugo J.] BCM, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wan, Ying-Wooi] BCM, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Chao, Hsiao-Tuan] BCM, Sect Child Neurol, Dept Pediat, Houston, TX 77030 USA; [Perrimon, Norbert] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bellen, Hugo J.] BCM, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Bellen, HJ (corresponding author), BCM, Program Dev Biol, Houston, TX 77030 USA.; Liu, ZD; Bellen, HJ (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Liu, ZD (corresponding author), BCM, Dept Pediat, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), BCM, Dept Mol & Human Genet, Houston, TX 77030 USA.; Bellen, HJ (corresponding author), BCM, Howard Hughes Med Inst, Houston, TX 77030 USA.	zhandonl@bcm.edu; hbellen@bcm.edu	Gourdine, Jean-Philippe/P-4323-2018; Wang, Julia/AAZ-7000-2020; Wangler, Michael/H-6368-2019; Yamamoto, Shinya/ABB-2837-2021	Gourdine, Jean-Philippe/0000-0001-9969-8610; Wang, Julia/0000-0002-6984-8283; Wangler, Michael/0000-0001-5245-5910; Yamamoto, Shinya/0000-0003-2172-8036; Fisher, Paul/0000-0002-1196-1590; Murphy, Jennifer Louise Patrick/0000-0003-1586-0890; Wheeler, Matthew/0000-0001-8721-3022; Stong, Nicholas/0000-0002-0678-637X; Hackbarth, Mary/0000-0003-1325-3165; Sweetser, David/0000-0002-1621-3284; Hu, Yanhui/0000-0003-1494-1402; Brown, Donna/0000-0002-8805-7225; Liu, Zhandong/0000-0002-7608-0831; Haendel, Melissa/0000-0001-9114-8737; Holm, Ingrid/0000-0003-4712-8821; Mohr, Stephanie/0000-0001-9639-7708; Bellen, Hugo/0000-0001-5992-5989; orange, jordan/0000-0001-7117-7725; Webb-Robertson, Bobbie-Jo/0000-0002-4744-2397; Waters, Katrina/0000-0003-4696-5396; Azamian, Mahshid/0000-0002-8543-8284	NINDS [1U54NS093793-01]; NIH/ORIP [1R24 OD022005-01]; Robert and Janice McNair Foundation McNair MD/PhD Student Scholar Program; Baylor College of Medicine Medical Scientist Training Program; NIH [3U54NS093793-02S1, R01 GM067858, R01 GM120033, R24 RR032668, R24 OD021997, U01HG007709]; NSF [DMS 1263932]; CPRIT [RP170387]; Houston Endowment; Huffington Foundation; Belfer Foundation; T T Chao Family Foundation; NIH NIGMS [R01 GM067761]; NIH NIGMS (NIGMS) [R01 GM084947]; Dana Farber/Harvard Cancer Center (NCI Cancer Center Support Grant) [NIH 5 P30 CA06516]; Pediatric Neurology Basic Neuroscience Research Track residency training program at Baylor College of Medicine; Texas Children's Hospital (NRI Fellowship); Alzheimer's Association (New Investigator Research Grant) [NIRG-15-364099]; Simons Foundation [368479]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR032668] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007943, U01HG007709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067858, R01GM067761, R01GM084947, R01GM120033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS093793, K12NS098482] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD022005, R24OD017870, R24OD021997] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/ORIP; Robert and Janice McNair Foundation McNair MD/PhD Student Scholar Program; Baylor College of Medicine Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CPRIT; Houston Endowment; Huffington Foundation; Belfer Foundation; T T Chao Family Foundation; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIGMS (NIGMS); Dana Farber/Harvard Cancer Center (NCI Cancer Center Support Grant); Pediatric Neurology Basic Neuroscience Research Track residency training program at Baylor College of Medicine; Texas Children's Hospital (NRI Fellowship); Alzheimer's Association (New Investigator Research Grant); Simons Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Undiagnosed Diseases Network Model Organism Working Group and Coordinating Center, Jim Lupski, Zeynep Akdemir, Ender Karaca, John Seavitt, George Eisenhoffer, Swathi Arur, Grzegorz Ira, and Karen Schulze for providing input in the design of MARRVEL. We thank Wan Hee Yoon for providing input in the manuscript. This work was supported by the NINDS (1U54NS093793-01) to the Model Organisms Screening Center of the UDN and NIH/ORIP (1R24 OD022005-01). J. W. is supported by The Robert and Janice McNair Foundation McNair MD/PhD Student Scholar Program and Baylor College of Medicine Medical Scientist Training Program. H.J.B. and N.P. are Investigators of the Howard Hughes Medical Institute. S.-Y.K., S.Y., M.F.W., and H.J.B. are supported by NIH (3U54NS093793-02S1). H.J.B. is supported by NIH (R01 GM067858). Z.L., R.A.-O., and W.-W.W. are supported by NSF (DMS 1263932), CPRIT (RP170387), NIH (R01 GM120033), Houston Endowment, Huffington Foundation, Belfer Foundation, and T T Chao Family Foundation. N.P., Y.H., A.C., and S.E.M. are supported by NIH NIGMS (R01 GM067761, NIGMS R01 GM084947), NIH (R24 RR032668, R24 OD021997 to N.P., P.I.), and Dana Farber/Harvard Cancer Center (NCI Cancer Center Support Grant # NIH 5 P30 CA06516 to S.E.M.). H.-T.C. is supported by the Pediatric Neurology Basic Neuroscience Research Track residency training program at Baylor College of Medicine. S.Y. is supported by the Texas Children's Hospital (NRI Fellowship) and Alzheimer's Association (New Investigator Research Grant NIRG-15-364099). M.F.W. is supported by NIH (U01HG007709). S.Y. and M.F.W. are supported by the Simons Foundation (# 368479 SFARI Functional Screen of Autism-Associated Variants Award).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkv1290, 10.1093/nar/gkx1095]; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Axmark D., 2002, MYSQL REFERENCE MANU; Bellen HJ, 2015, CELL, V163, P12, DOI 10.1016/j.cell.2015.09.009; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Chao HT, 2017, AM J HUM GENET, V100, P128, DOI 10.1016/j.ajhg.2016.11.018; Chen K., 2016, ELIFE, V5, P43; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; den Dunnen JT, 2017, METHODS MOL BIOL, V1492, P243, DOI 10.1007/978-1-4939-6442-0_17; Eppig JT, 2017, METHODS MOL BIOL, V1488, P47, DOI 10.1007/978-1-4939-6427-7_3; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Howe KL, 2016, NUCLEIC ACIDS RES, V44, pD774, DOI 10.1093/nar/gkv1217; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Kaiser J, 2016, SCIENCE, V351, P14, DOI 10.1126/science.351.6268.14; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; Katsonis P, 2014, GENOME RES, V24, P2050, DOI 10.1101/gr.176214.114; Katsonis P, 2014, PROTEIN SCI, V23, P1650, DOI 10.1002/pro.2552; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Marygold SJ, 2016, METHODS MOL BIOL, V1478, P1, DOI 10.1007/978-1-4939-6371-3_1; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Miosge LA, 2015, P NATL ACAD SCI USA, V112, pE5189, DOI 10.1073/pnas.1511585112; Mungall C., 2016, BIORXIV; Mungall CJ, 2017, NUCLEIC ACIDS RES, V45, pD712, DOI 10.1093/nar/gkw1128; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Ruzicka L, 2015, GENESIS, V53, P498, DOI 10.1002/dvg.22868; Shimoyama M, 2015, NUCLEIC ACIDS RES, V43, pD743, DOI 10.1093/nar/gku1026; Sun S, 2016, GENOME RES, V26, P670, DOI 10.1101/gr.192526.115; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033; Yoon WH, 2017, NEURON, V93, P115, DOI 10.1016/j.neuron.2016.11.038; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230	46	105	105	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 1	2017	100	6					843	853		10.1016/j.ajhg.2017.04.010	http://dx.doi.org/10.1016/j.ajhg.2017.04.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EW7NL	28502612	Green Published, Bronze			2022-12-18	WOS:000402700600002
J	Al Turki, S; Manickaraj, AK; Mercer, CL; Gerety, SS; Hitz, MP; Lindsay, S; D'Alessandro, LCA; Swaminathan, GJ; Bentham, J; Arndt, AK; Low, J; Breckpot, J; Gewillig, M; Thienpont, B; Abdul-Khaliq, H; Harnack, C; Hoff, K; Kramer, HH; Schubert, S; Siebert, R; Toka, O; Cosgrove, C; Watkins, H; Lucassen, AM; O'Kelly, IM; Salmon, AP; Bu'Lock, FA; Granados-Riveron, J; Setchfield, K; Thornborough, C; Brook, JD; Mulder, B; Klaassen, S; Bhattacharya, S; Devriendt, K; FitzPatrick, DF; Wilson, DI; Mital, S; Hurles, ME				Al Turki, Saeed; Manickaraj, Ashok K.; Mercer, Catherine L.; Gerety, Sebastian S.; Hitz, Marc-Phillip; Lindsay, Sarah; D'Alessandro, Lisa C. A.; Swaminathan, G. Jawahar; Bentham, Jamie; Arndt, Anne-Karin; Low, Jacoba; Breckpot, Jeroen; Gewillig, Marc; Thienpont, Bernard; Abdul-Khaliq, Hashim; Harnack, Christine; Hoff, Kirstin; Kramer, Hans-Heiner; Schubert, Stephan; Siebert, Reiner; Toka, Okan; Cosgrove, Catherine; Watkins, Hugh; Lucassen, Anneke M.; O'Kelly, Ita M.; Salmon, Anthony P.; Bu'Lock, Frances A.; Granados-Riveron, Javier; Setchfield, Kerry; Thornborough, Chris; Brook, J. David; Mulder, Barbara; Klaassen, Sabine; Bhattacharya, Shoumo; Devriendt, Koen; FitzPatrick, David F.; Wilson, David I.; Mital, Seema; Hurles, Matthew E.		UK10K Consortium	Rare Variants in NR2F2 Cause Congenital Heart Defects in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ATRIOVENTRICULAR SEPTAL-DEFECTS; DIAPHRAGMATIC-HERNIA; COUP-TFII; CURRENT KNOWLEDGE; GENE-EXPRESSION; DISEASE; MUTATIONS; ORPHAN; DIFFERENTIATION	Congenital heart defects (CHDs) are the most common birth defect worldwide and are a leading cause of neonatal mortality. Non-syndromic atrioventricular septal defects (AVSDs) are an important subtype of CHDs for which the genetic architecture is poorly understood. We performed exome sequencing in 13 parent-offspring trios and 112 unrelated individuals with nonsyndromic AVSDs and identified five rare missense variants (two of which arose de novo) in the highly conserved gene NR2F2, a very significant enrichment (p 7.7 x 10(-7)) compared to 5,194 control subjects. We identified three additional CHD-affected families with other variants in NR2F2 including a de novo balanced chromosomal translocation, a de novo substitution disrupting a splice donor site, and a 3 bp duplication that cosegregated in a multiplex family. NR2F2 encodes a pleiotropic developmental transcription factor, and decreased dosage of NR2F2 in mice has been shown to result in abnormal development of atrioventricular septa. Via luciferase assays, we showed that all six coding sequence variants observed in individuals significantly alter the activity of NR2F2 on target promoters.	[Al Turki, Saeed; Gerety, Sebastian S.; Hitz, Marc-Phillip; Lindsay, Sarah; Swaminathan, G. Jawahar; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Al Turki, Saeed] King Abdul Aziz Med City, Dept Pathol, Riyadh 11426, Saudi Arabia; [Manickaraj, Ashok K.; D'Alessandro, Lisa C. A.; Mital, Seema] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Cardiol, Toronto, ON M5G 1X8, Canada; [Mercer, Catherine L.; Lucassen, Anneke M.; O'Kelly, Ita M.; Salmon, Anthony P.; Wilson, David I.] Univ Southampton, Southampton Gen Hosp, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO16 6YD, Hants, England; [Bentham, Jamie] Harvard Univ, Boston Childrens Hosp, Sch Med, Dept Cardiol, Boston, MA 02459 USA; [Arndt, Anne-Karin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02115 USA; [Arndt, Anne-Karin] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Arndt, Anne-Karin; Hoff, Kirstin; Kramer, Hans-Heiner] Univ Hosp Schleswig Holstein, Dept Congenital Heart Dis & Pediat Cardiol, D-24105 Kiel, Germany; [Low, Jacoba; Breckpot, Jeroen; Thienpont, Bernard; Devriendt, Koen] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Low, Jacoba; Gewillig, Marc] Katholieke Univ Leuven Hosp, Pediat Cardiol Unit, B-3000 Louvain, Belgium; [Abdul-Khaliq, Hashim] Saarland Univ Hosp, Dept Pediat Cardiol, D-66421 Homburg, Germany; [Abdul-Khaliq, Hashim; Kramer, Hans-Heiner; Schubert, Stephan; Toka, Okan; Klaassen, Sabine] Fac Med Charite, Competence Network Congenital Heart Defects, D-13125 Berlin, Germany; [Harnack, Christine; Klaassen, Sabine] Fac Med Charite, ECRC, D-13125 Berlin, Germany; [Harnack, Christine; Klaassen, Sabine] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hoff, Kirstin; Siebert, Reiner] Univ Kiel, Inst Human Genet, D-24105 Kiel, Germany; [Hoff, Kirstin; Siebert, Reiner] Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; [Schubert, Stephan] Deutsch Herzzentrum Berlin, Dept Congenital Heart Dis & Pediat Cardiol, D-13353 Berlin, Germany; [Toka, Okan] Univ Erlangen Nurnberg, Childrens Hosp, Dept Pediat Cardiol, D-91054 Erlangen, Germany; [Cosgrove, Catherine; Watkins, Hugh; Bhattacharya, Shoumo] Univ Oxford, Radcliffe Dept Med, Oxford OX3 7BN, England; [Cosgrove, Catherine; Watkins, Hugh; Bhattacharya, Shoumo] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bu'Lock, Frances A.; Thornborough, Chris] Univ Hosp Leicester NHS Trust, East Midlands Congenital Heart Ctr, Leicester LE3 9QP, Leics, England; [Granados-Riveron, Javier; Setchfield, Kerry; Brook, J. David] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England; [Mulder, Barbara] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands; [Klaassen, Sabine] Charite, Dept Pediat Cardiol, D-13353 Berlin, Germany; [FitzPatrick, David F.] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Wellcome Trust Sanger Institute; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Southampton; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; University of Kiel; Schleswig Holstein University Hospital; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Universitatsklinikum des Saarlandes; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; German Heart Center Berlin; University of Erlangen Nuremberg; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University Hospitals of Leicester NHS Trust; University of Leicester; University of Nottingham; University of Amsterdam; Academic Medical Center Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Edinburgh	Mital, S (corresponding author), Univ Toronto, Hosp Sick Children, Dept Pediat, Div Cardiol, Toronto, ON M5G 1X8, Canada.	seema.mital@sickkids.ca; meh@sanger.ac.uk	Hitz, Marc-Phillip/Q-5571-2018; Bhattacharya, Shoumo/F-4127-2010; Siebert, Reiner/A-8049-2010; Wilson, David/A-6264-2010; Thienpont, Bernard/AAG-5423-2019; Lindsay, Sarah/CAF-4613-2022; Schubert, Stephan/K-1490-2019; Hitz, Marc/ABD-9495-2021; Lucassen, Anneke/D-7764-2017; Schmidts, Miriam/A-3777-2012	Hitz, Marc-Phillip/0000-0001-9894-6897; Bhattacharya, Shoumo/0000-0002-5571-0478; Wilson, David/0000-0001-8779-2060; Kelly, Kirsten/0000-0003-4234-543X; Granados-Riveron, Javier Tadeo/0000-0001-5485-654X; Lucassen, Anneke/0000-0003-3324-4338; Thienpont, Bernard/0000-0002-8772-6845; Brook, John David/0000-0002-5946-6740; Klaassen, Sabine/0000-0001-5925-9912; Schmidts, Miriam/0000-0002-1714-6749; Mitchison, Hannah/0000-0002-3163-6293; Manickaraj, Ashok Kumar/0000-0002-4631-6495; Semple, Robert Kenneth/0000-0001-6539-3069; Granados-Riveron, Javier T./0000-0002-0368-225X; Lindsay, Sarah/0000-0002-0965-3070; Watkins, Hugh/0000-0002-5287-9016	Wellcome Trust [WT098051, WT091310]; MRC; Little Hearts Matter and the Competence Network for Congenital Heart Defects/National Register for Congenital Heart Defects (Germany); Federal Ministry of Education and Research (BMBF) [FKZ 01GI0601]; DZHK (German Centre for Cardiovascular Research); Heart and Stroke Foundation of Canada research fellowship; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Lung GO Sequencing Project [HL-102923]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102925, RC2HL102925, RC2HL102923, RC2HL102924, UC2HL103010, RC2HL102926, UC2HL102926, RC2HL103010, UC2HL102924, UC2HL102923] Funding Source: NIH RePORTER; MRC [MC_PC_U127561093, MC_U127561093] Funding Source: UKRI; British Heart Foundation [PG/07/045/22690, RG/10/17/28553, RG/07/010/23676, RG/13/10/30376] Funding Source: researchfish; Medical Research Council [MC_U127561093, MC_PC_U127561093] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Little Hearts Matter and the Competence Network for Congenital Heart Defects/National Register for Congenital Heart Defects (Germany); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DZHK (German Centre for Cardiovascular Research); Heart and Stroke Foundation of Canada research fellowship(Heart & Stroke Foundation of Canada); WHI Sequencing Project; Broad GO Sequencing Project; Lung GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors would like to thank the individuals and their families for their support and participation and Don Conrad for the DeNovoGear software. This study was supported by funding from the Wellcome Trust (grant number WT098051), an MRC training fellowship (to C. L. M.), Little Hearts Matter and the Competence Network for Congenital Heart Defects/National Register for Congenital Heart Defects (Germany) funded by the Federal Ministry of Education and Research (BMBF), Support Code FKZ 01GI0601, the DZHK (German Centre for Cardiovascular Research), and a Heart and Stroke Foundation of Canada research fellowship (to A. K. M.). This study makes use of data generated by the UK10K Consortium, derived from samples from TwinsUK and ALSPAC. A full list of the investigators who contributed to the generation of the data is available from http://www.UK10K.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310. The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010).	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; Ackerman C, 2012, AM J HUM GENET, V91, P646, DOI 10.1016/j.ajhg.2012.08.017; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; ALLAN LD, 1994, J AM COLL CARDIOL, V23, P1452, DOI 10.1016/0735-1097(94)90391-3; Arrington CB, 2012, AM J MED GENET A, V158A, P3137, DOI 10.1002/ajmg.a.35664; Baptista J, 2008, AM J HUM GENET, V82, P927, DOI 10.1016/j.ajhg.2008.02.012; Barriot R, 2010, GENOME MED, V2, DOI 10.1186/gm137; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Bentham J, 2008, ANN NY ACAD SCI, V1123, P10, DOI 10.1196/annals.1420.003; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Botto LD, 2001, EPIDEMIOLOGY, V12, P491, DOI 10.1097/00001648-200109000-00005; Brady PD, 2013, PRENATAL DIAG, V33, P1283, DOI 10.1002/pd.4244; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; FERENCZ C, 1989, J AM COLL CARDIOL, V14, P756, DOI 10.1016/0735-1097(89)90122-8; Fossey SC, 2000, MAMM GENOME, V11, P919, DOI 10.1007/s003350010174; Freeman SB, 2008, GENET MED, V10, P173, DOI 10.1097/GIM.0b013e3181634867; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gill HK, 2009, EUR J HUM GENET, V17, P1423, DOI 10.1038/ejhg.2009.91; Harewood L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012375; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P103, DOI 10.1007/BF00801907; Karkera JD, 2007, AM J HUM GENET, V81, P987, DOI 10.1086/522890; Klaassens M, 2005, AM J HUM GENET, V76, P877, DOI 10.1086/429842; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin FJ, 2012, ARTERIOSCL THROM VAS, V32, pE135, DOI 10.1161/ATVBAHA.112.300255; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; McElhinney DB, 2002, CIRCULATION, V106, P2567, DOI 10.1161/01.CIR.0000037221.45902.69; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nakamura E, 2011, EUR J MED GENET, V54, P354, DOI 10.1016/j.ejmg.2010.12.004; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perilhou A, 2008, MOL CELL BIOL, V28, P6568, DOI 10.1128/MCB.02211-07; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Rainger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002114; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Robinson SW, 2003, AM J HUM GENET, V72, P1047, DOI 10.1086/374319; Scott DA, 2007, HUM MOL GENET, V16, P424, DOI 10.1093/hmg/ddl475; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Slavotinek AM, 2006, EUR J HUM GENET, V14, P999, DOI 10.1038/sj.ejhg.5201652; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Winston JB, 2010, CIRCULATION, V121, P1313, DOI 10.1161/CIRCULATIONAHA.109.887687; You LR, 2005, P NATL ACAD SCI USA, V102, P16351, DOI 10.1073/pnas.0507832102; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zatyka M, 2005, CLIN GENET, V67, P526, DOI 10.1111/j.1399-0004.2005.00435.x; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	56	105	107	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					574	585		10.1016/j.ajhg.2014.03.007	http://dx.doi.org/10.1016/j.ajhg.2014.03.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24702954	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000333765300008
J	Basmanav, FB; Oprisoreanu, AM; Pasternack, SM; Thiele, H; Fritz, G; Wenzel, J; Grosser, L; Wehner, M; Wolf, S; Fagerberg, C; Bygum, A; Altmuller, J; Rutten, A; Parmentier, L; El Shabrawi-Caelen, L; Hafner, C; Nurnberg, P; Kruse, R; Schoch, S; Hanneken, S; Betz, RC				Basmanav, F. Buket; Oprisoreanu, Ana-Maria; Pasternack, Sandra M.; Thiele, Holger; Fritz, Guenter; Wenzel, Joerg; Groesser, Leopold; Wehner, Maria; Wolf, Sabrina; Fagerberg, Christina; Bygum, Anette; Altmueller, Janine; Ruetten, Arno; Parmentier, Laurent; El Shabrawi-Caelen, Laila; Hafner, Christian; Nuernberg, Peter; Kruse, Roland; Schoch, Susanne; Hanneken, Sandra; Betz, Regina C.			Mutations in POGLUT1, Encoding Protein O-Glucosyltransferase 1, Cause Autosomal-Dominant Dowling-Degos Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GALLI-GALLI-DISEASE; PHAGE BETA-GLUCOSYLTRANSFERASE; ACANTHOLYTIC VARIANT; NOTCH; KERATIN-5; GENE; DIFFERENTIATION; PROLIFERATION; MELANOBLASTS; SUBSTRATE	Dowling-Degos disease (DDD) is an autosomal-dominant genodermatosis characterized by progressive and disfiguring reticulate hyper-pigmentation. We previously identified loss-of-function mutations in KRT5 but were only able to detect pathogenic mutations in fewer than half of our subjects. To identify additional causes of DDD, we performed exome sequencing in five unrelated affected individuals without mutations in KRT5. Data analysis identified three heterozygous mutations from these individuals, all within the same gene. These mutations, namely c.11G>A (p.Trp4*), c.652C>T (p.Arg218*), and c.798-2A>C, are within POGLUT1, which encodes protein O-glucosyltransferase 1. Further screening of unexplained cases for POGLUT1 identified six additional mutations, as well as two of the above described mutations. Immunohistochemistry of skin biopsies of affected individuals with POGLUT1 mutations showed significantly weaker POGLUT1 staining in comparison to healthy controls with strong localization of POGLUT1 in the upper parts of the epidermis. Immunoblot analysis revealed that translation of either wild-type (WT) POGLUT1 or of the protein carrying the p.Arg279Trp substitution led to the expected size of about 50 kDa, whereas the c.652C>T (p.Arg218*) mutation led to translation of a truncated protein of about 30 kDa. Immunofluorescence analysis identified a colocalization of the WT protein with the endoplasmic reticulum and a notable aggregating pattern for the truncated protein. Recently, mutations in POFUT1, which encodes protein O-fucosyltransferase 1, were also reported to be responsible for DDD. Interestingly, both POGLUT1 and POFUT1 are essential regulators of Notch activity. Our results furthermore emphasize the important role of the Notch pathway in pigmentation and keratinocyte morphology.	[Basmanav, F. Buket; Pasternack, Sandra M.; Wehner, Maria; Wolf, Sabrina; Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Oprisoreanu, Ana-Maria; Schoch, Susanne] Univ Bonn, Dept Neuropathol, D-53127 Bonn, Germany; [Oprisoreanu, Ana-Maria; Schoch, Susanne] Univ Bonn, Dept Epileptol, D-53127 Bonn, Germany; [Thiele, Holger; Altmueller, Janine; Nuernberg, Peter] Univ Cologne, CCG, D-50931 Cologne, Germany; [Fritz, Guenter] Univ Freiburg, Neurozentrum, Dept Neuropathol, D-79106 Freiburg, Germany; [Wenzel, Joerg] Univ Bonn, Dept Dermatol, D-53127 Bonn, Germany; [Groesser, Leopold; Hafner, Christian] Univ Regensburg, Dept Dermatol, D-93053 Regensburg, Germany; [Fagerberg, Christina] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Bygum, Anette] Odense Univ Hosp, Dept Dermatol, DK-5000 Odense, Denmark; [Bygum, Anette] Odense Univ Hosp, Allergy Ctr, DK-5000 Odense, Denmark; [Ruetten, Arno] Lab Dermatohistopathol, D-88048 Friedrichshafen, Germany; [Parmentier, Laurent] Univ Hosp Berne, Dept Dermatol, CH-3008 Bern, Switzerland; [El Shabrawi-Caelen, Laila] Med Univ Graz, Dept Dermatol, A-8036 Graz, Austria; [Nuernberg, Peter] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50674 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Hanneken, Sandra] Univ Hosp Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany	University of Bonn; University of Bonn; University of Bonn; University of Cologne; University of Freiburg; University of Bonn; University of Regensburg; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Bern; University Hospital of Bern; Medical University of Graz; University of Cologne; University of Cologne; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany.	regina.betz@uni-bonn.de	/AAG-8046-2020; Wenzel, Jörg/AAX-2644-2020; Thiele, Holger/ABE-6792-2020; Fritz, Guenter/E-2933-2013; Betz, Regina C/E-8591-2011	Wenzel, Jörg/0000-0002-4744-5993; Thiele, Holger/0000-0002-0169-998X; Fritz, Guenter/0000-0002-4571-8812; Betz, Regina C/0000-0001-5024-3623; Oprisoreanu, Ana-Maria/0000-0002-9409-0830; Bygum, Anette/0000-0002-3004-0180; Fagerberg, Christina Ringmann/0000-0002-5206-4327; Altmuller, Janine/0000-0003-4372-1521	Deutsche Forschungsgemeinschaft (German Research Foundation) [SFB-1089/A1]; Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research); Unabhangige Forschergruppen in den Neurowissenschaften; BONFOR; Heisenberg Fellowship [FR 1488/3-2]; German Research Foundation (DFG) [BE 2346/4-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Unabhangige Forschergruppen in den Neurowissenschaften; BONFOR; Heisenberg Fellowship(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	We would like to thank the individuals and families for participating in this study. We thank Lodovica Borghese for fruitful discussions. This work was further supported by grants from the Deutsche Forschungsgemeinschaft (German Research Foundation) to S.S. (SFB-1089/A1, P2) and the Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) to S.S. ("Unabhangige Forschergruppen in den Neurowissenschaften"), as well as by local funding (BONFOR to S.S. and R.C.B.). G.F. is a recipient of a Heisenberg Fellowship (FR 1488/3-2) and R.C.B. is a recipient of a Heisenberg Professorship of the German Research Foundation (DFG) (BE 2346/4-1). P.N. is a founder, CEO, and shareholder of ATLAS Biolabs GmbH. ATLAS Biolabs GmbH is a service provider for genomic analyses.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Arnold AW, 2012, J INVEST DERMATOL, V132, P2100, DOI 10.1038/jid.2012.72; Aubin-Houzelstein G, 2008, J INVEST DERMATOL, V128, P2686, DOI 10.1038/jid.2008.120; Betz RC, 2006, AM J HUM GENET, V78, P510, DOI 10.1086/500850; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; DEGOS R, 1954, Ann Dermatol Syphiligr (Paris), V81, P147; Dowling G B, 1938, Proc R Soc Med, V31, P1147; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/cpps.20]; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Gilchrist H, 2008, J AM ACAD DERMATOL, V58, P299, DOI 10.1016/j.jaad.2007.05.041; Guo L, 2012, J EUR ACAD DERMATOL, V26, P908, DOI 10.1111/j.1468-3083.2011.04115.x; Hanneken S, 2011, HAUTARZT, V62, P842, DOI 10.1007/s00105-011-2222-x; Hanneken S, 2010, BRIT J DERMATOL, V163, P197, DOI 10.1111/j.1365-2133.2010.09741.x; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kumano K, 2008, PIGM CELL MELANOMA R, V21, P70, DOI 10.1111/j.1755-148X.2007.00423.x; Li CR, 2006, J INVEST DERMATOL, V126, P1297, DOI 10.1038/sj.jid.5700271; Li M, 2013, AM J HUM GENET, V92, P895, DOI 10.1016/j.ajhg.2013.04.022; Liao HH, 2007, J INVEST DERMATOL, V127, P298, DOI 10.1038/sj.jid.5700523; Ma WZ, 2011, BIOCHEM BIOPH RES CO, V408, P84, DOI 10.1016/j.bbrc.2011.03.124; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mauerer A, 2010, DERMATOLOGY, V221, P206, DOI 10.1159/000316091; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Morera S, 2001, J MOL BIOL, V311, P569, DOI 10.1006/jmbi.2001.4905; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmieder A, 2012, J AM ACAD DERMATOL, V66, pE250, DOI 10.1016/j.jaad.2011.07.038; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Schrodinger L, 2010, PYMOL MOL GRAPHICS S; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sprecher E, 2007, BRIT J DERMATOL, V156, P572, DOI 10.1111/j.1365-2133.2006.07703.x; Stuart PE, 2012, J INVEST DERMATOL, V132, P2407, DOI 10.1038/jid.2012.191; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Takeuchi H, 2010, SEMIN CELL DEV BIOL, V21, P638, DOI 10.1016/j.semcdb.2010.03.003; Teng Y, 2006, GENE, V371, P7, DOI 10.1016/j.gene.2005.08.027; Wenzel J, 2005, J PATHOL, V205, P435, DOI 10.1002/path.1721	42	105	107	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 2	2014	94	1					135	143		10.1016/j.ajhg.2013.12.003	http://dx.doi.org/10.1016/j.ajhg.2013.12.003			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	292FU	24387993	Green Published, Bronze			2022-12-18	WOS:000329888400015
J	Morris, DL; Taylor, KE; Fernando, MMA; Nititham, J; Alarcon-Riquelme, ME; Barcellos, LF; Behrens, TW; Cotsapas, C; Gaffney, PM; Graham, RR; Pons-Estel, BA; Gregersen, PK; Harley, JB; Hauser, SL; Hom, G; Langefeld, CD; Noble, JA; Rioux, JD; Seldin, MF; Criswel, LA; Vyse, TJ				Morris, David L.; Taylor, Kimberly E.; Fernando, Michelle M. A.; Nititham, Joanne; Alarcon-Riquelme, Marta E.; Barcellos, Lisa F.; Behrens, Timothy W.; Cotsapas, Chris; Gaffney, Patrick M.; Graham, Robert R.; Pons-Estel, Bernardo A.; Gregersen, Peter K.; Harley, John B.; Hauser, Stephen L.; Hom, Geoffrey; Langefeld, Carl D.; Noble, Janelle A.; Rioux, John D.; Seldin, Michael F.; Criswel, Lindsey A.; Vyse, Timothy J.		Int MHC Autoimmunity Genetics Netw; Systemic Lupus Erythematosus Genet	Unraveling Multiple MHC Gene Associations with Systemic Lupus Erythematosus: Model Choice Indicates a Role for HLA Alleles and Non-HLA Genes in Europeans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY VARIANTS; HAPLOTYPES; ITGAM; RISK	We have performed a meta-analysis of the major-histocompatibility-complex (MHC) region in systemic lupus erythematosus (SLE) to determine the association with both SNPs and classical human-leukocyte-antigen (HLA) alleles. More specifically, we combined results from six studies and well-known out-of-study control data sets, providing us with 3,701 independent SLE cases and 12,110 independent controls of European ancestry. This study used genotypes for 7,199 SNPs within the MHC region and for classical HLA alleles (typed and imputed). Our results from conditional analysis and model choice with the use of the Bayesian information criterion show that the best model for SLE association includes both classical loci (HLA-DRB1*03:01, HLA-DRB1*08:01, and HLA-DQA1*01:02) and two SNPs, rs8192591 (in class III and upstream of NOTCH4) and rs2246618 (MICB in class I). Our approach was to perform a stepwise search from multiple baseline models deduced from a priori evidence on HLA-DRB1 lupus-associated alleles, a stepwise regression on SNPs alone, and a stepwise regression on HLA alleles. With this approach, we were able to identify a model that was an overwhelmingly better fit to the data than one identified by simple stepwise regression either on SNPs alone (Bayes factor [BF] > 50) or on classical HLA alleles alone (BF > 1,000).	[Taylor, Kimberly E.; Nititham, Joanne; Criswel, Lindsey A.] Univ San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, San Francisco, CA 94117 USA; [Morris, David L.; Fernando, Michelle M. A.; Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London SE1 9RT, England; [Morris, David L.; Fernando, Michelle M. A.; Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London SE1 9RT, England; [Alarcon-Riquelme, Marta E.] Univ Granada, Junta Andalucia, Ctr Genom & Invest Oncol, Dept Human DNA Variabil,Pfizer, Granada 18007, Spain; [Alarcon-Riquelme, Marta E.; Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Calif Inst Quantitat Biosci QB3, Genet Epidemiol & Genom Lab,Div Epidemiol, Berkeley, CA 94720 USA; [Behrens, Timothy W.; Graham, Robert R.; Hom, Geoffrey] Genentech Inc, San Francisco, CA 94080 USA; [Cotsapas, Chris] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Pons-Estel, Bernardo A.] Hosp Prov Rosario, Rheumatol Serv, RA-2000 Rosario, Santa Fe, Argentina; [Gregersen, Peter K.] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Harley, John B.] US Dept Vet Affairs Med Ctr, Cincinnati, OH 45229 USA; [Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Langefeld, Carl D.] Wake Forest Univ Hlth Sci, Dept Biostat Sci, Wake Forest, NC 27157 USA; [Noble, Janelle A.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Rioux, John D.] Univ Montreal, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Rioux, John D.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Seldin, Michael F.] Univ Calif Davis, Davis, CA 95616 USA	University of San Francisco; University of London; King's College London; University of London; King's College London; Pfizer; University of Granada; Oklahoma Medical Research Foundation; University of California System; University of California Berkeley; Roche Holding; Genentech; Yale University; Northwell Health; Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University of California System; University of California San Francisco; Wake Forest University; Wake Forest University School of Medicine; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Universite de Montreal; Universite de Montreal; University of California System; University of California Davis	Criswel, LA (corresponding author), Univ San Francisco, Rosalind Russell Med Res Ctr Arthrit, Dept Med, San Francisco, CA 94117 USA.	lindsey.criswell@ucsf.edu; tim.vyse@kcl.ac.uk	Alarcón-Riquelme, Marta E./ABF-8163-2020; Rioux, John D/A-9599-2015; Martin, Javier/B-8141-2008; de Bakker, Paul IW/B-8730-2009	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Rioux, John D/0000-0001-7560-8326; Martin, Javier/0000-0002-2202-0622; de Bakker, Paul IW/0000-0001-7735-7858; Gaffney, Patrick/0000-0002-1580-869X; Cotsapas, Chris/0000-0002-7772-5910; Klareskog, Lars/0000-0001-9601-6186; Morris, David/0000-0002-1754-8932; Pons-Estel, Bernardo/0000-0003-2518-0266; Kimberly, Robert/0000-0002-5330-3086; Alfredsson, Lars/0000-0003-1688-6697	Arthritis Research UK [18239] Funding Source: Medline; NCI NIH HHS [5P50CA097007, 3P50CA093459, 5R01CA133996] Funding Source: Medline; NIAID NIH HHS [R37 AI024717, R01 AI024717, P01 AI083194, U19 AI067152] Funding Source: Medline; NIAMS NIH HHS [P60 AR053308] Funding Source: Medline; NIEHS NIH HHS [5R01ES011740] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA093459, P50CA097007, R01CA133996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152, R01AI024717, R37AI024717, P01AI083194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR053308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	Arthritis Research UK(Versus Arthritis); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fernando MMA, 2007, PLOS GENET, V3, P2109, DOI 10.1371/journal.pgen.0030192; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Lin DY, 2010, GENET EPIDEMIOL, V34, P60, DOI 10.1002/gepi.20435; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678	26	105	108	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					778	793		10.1016/j.ajhg.2012.08.026	http://dx.doi.org/10.1016/j.ajhg.2012.08.026			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23084292	Bronze, Green Published			2022-12-18	WOS:000311011400002
J	Lee, H; Graham, JM; Rimoin, DL; Lachman, RS; Krejci, P; Tompson, SW; Nelson, SF; Krakow, D; Cohn, DH				Lee, Hane; Graham, John M., Jr.; Rimoin, David L.; Lachman, Ralph S.; Krejci, Pavel; Tompson, Stuart W.; Nelson, Stanley F.; Krakow, Deborah; Cohn, Daniel H.			Exome Sequencing Identifies PDE4D Mutations in Acrodysostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT TRANSMISSION; PERIPHERAL DYSOSTOSIS; MENTAL-RETARDATION; NASAL HYPOPLASIA; G-PROTEIN; PHOSPHODIESTERASE; MUTANTS; DUNCE; GENE; GROWTH	Acrodysostosis is a dominantly-inherited, multisystem disorder characterized by skeletal, endocrine, and neurological abnormalities. To identify the molecular basis of acrodysostosis, we performed exome sequencing on five genetically independent cases. Three different missense mutations in PDE4D, which encodes cyclic AMP (cAMP)-specific phosphodiesterase 4D, were found to be heterozygous in three of the cases. Two of the mutations were demonstrated to have occurred de novo, providing strong genetic evidence of causation. Two additional cases were heterozygous for de novo missense mutations in PRKAR1A, which encodes the cAMP-dependent regulatory subunit of protein kinase A and which has been recently reported to be the cause of a form of acrodysostosis resistant to multiple hormones. These findings demonstrate that acrodysostosis is genetically heterogeneous and underscore the exquisite sensitivity of many tissues to alterations in cAMP homeostasis.	[Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Lee, Hane; Rimoin, David L.; Nelson, Stanley F.; Krakow, Deborah] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Lee, Hane; Nelson, Stanley F.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; [Graham, John M., Jr.; Rimoin, David L.] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90095 USA; [Rimoin, David L.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Lachman, Ralph S.] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Tompson, Stuart W.; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Graham, John M., Jr.; Rimoin, David L.; Lachman, Ralph S.; Krejci, Pavel] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Krejci, Pavel] Masaryk Univ, Inst Expt Biol, Brno 61265, Czech Republic; [Krejci, Pavel] Inst Biophys AS CR, Dept Cytokinet, Brno 61265, Czech Republic	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Cohn, DH (corresponding author), Univ Calif Los Angeles, Dept Orthoped Surg, Los Angeles, CA 90095 USA.	dcohn@mcdb.ucla.edu	Krakow, Deborah/B-5778-2009; Nelson, Stanley F/D-4771-2009; Graham, John M./J-1429-2019; Krejčí, Pavel/I-4285-2014	Krakow, Deborah/0000-0001-9906-4968; Nelson, Stanley F/0000-0002-2082-3114; Tompson, Stuart/0000-0001-9788-6730; Krejci, Pavel/0000-0003-0618-9134	Steven Spielberg Pediatric Research Center at Cedars-Sinai Medical Center; National Institutes of Health [HD22657]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	Steven Spielberg Pediatric Research Center at Cedars-Sinai Medical Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to thank Traci Toy and Bret Harry at the University of California, Los Angeles (UCLA) DNA Microarray Core for their assistance with constructing the sequencing libraries and computational support, Suhua Feng at the UCLA Broad Stem Cell Research Center for his assistance in running the HiSeq2000 instrument, Lisette Nevarez for assistance with Sanger-sequence analysis, and both Nancy Kramer and Daniel Gruskin for assistance with the clinical information. This study was supported in part by the Steven Spielberg Pediatric Research Center at Cedars-Sinai Medical Center and by National Institutes of Health grant HD22657.	BECKER S, 1989, HNO, V37, P165; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Bolger GB, 1997, BIOCHEM J, V328, P539; BUTLER MG, 1988, AM J MED GENET, V30, P971, DOI 10.1002/ajmg.1320300416; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Gong ZF, 1998, J INSECT PHYSIOL, V44, P1149, DOI 10.1016/S0022-1910(98)00076-6; Graham JM, 2001, PEDIATR RADIOL, V31, P2, DOI 10.1007/s002470000355; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; JONES KL, 1975, J PEDIATR-US, V86, P84, DOI 10.1016/S0022-3476(75)80709-8; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; MAROTEAUX P, 1968, Presse Medicale, V76, P2189; PATTEN JL, 1990, NEW ENGL J MED, V322, P1412, DOI 10.1056/NEJM199005173222002; ROBINOW M, 1971, AM J DIS CHILD, V121, P195, DOI 10.1001/archpedi.1971.02100140061002; Sakamoto A, 2005, J BONE MINER RES, V20, P663, DOI 10.1359/JBMR.041210; Sheela SR, 2005, INDIAN PEDIATR, V42, P822; Steiner R D, 1992, Clin Dysmorphol, V1, P201; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; ZHONG Y, 1992, J NEUROSCI, V12, P644	22	105	112	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					746	751		10.1016/j.ajhg.2012.03.004	http://dx.doi.org/10.1016/j.ajhg.2012.03.004			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22464252	Bronze, Green Published			2022-12-18	WOS:000302833400020
J	Arsov, T; Smith, KR; Damiano, J; Franceschetti, S; Canafoglia, L; Bromhead, CJ; Andermann, E; Vears, DF; Cossette, P; Rajagopalan, S; McDougall, A; Sofia, V; Farrell, M; Aguglia, U; Zini, A; Meletti, S; Morbin, M; Mullen, S; Andermann, F; Mole, SE; Bahlo, M; Berkovic, SF				Arsov, Todor; Smith, Katherine R.; Damiano, John; Franceschetti, Silvana; Canafoglia, Laura; Bromhead, Catherine J.; Andermann, Eva; Vears, Danya F.; Cossette, Patrick; Rajagopalan, Sulekha; McDougall, Alan; Sofia, Vito; Farrell, Michael; Aguglia, Umberto; Zini, Andrea; Meletti, Stefano; Morbin, Michela; Mullen, Saul; Andermann, Frederick; Mole, Sara E.; Bahlo, Melanie; Berkovic, Samuel F.			Kufs Disease, the Major Adult Form of Neuronal Ceroid Lipofuscinosis, Caused by Mutations in CLN6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEMBRANE-PROTEIN CLN6; INBREEDING COEFFICIENT; TRANSMEMBRANE PROTEIN; GENE; DEFICIENCY; THIOESTERASE-1; DEGRADATION; CHILDHOOD; JUVENILE; TOOL	The molecular basis of Kufs disease is unknown, whereas a series of genes accounting for most of the childhood-onset forms of neuronal ceroid lipofuscinosis (NCL) have been identified. Diagnosis of Kufs disease is difficult because the characteristic lipopigment is largely confined to neurons and can require a brain biopsy or aufopsy for final diagnosis. We mapped four families with Kufs disease for whom there was good evidence of autosomal-recessive inheritance and found two peaks on chromosome 15. Three of the families were affected by Kufs type A disease and presented with progressive myoclonus epilepsy, and one was affected by type B (presenting with dementia and motor system dysfunction). Sequencing of a candidate gene in one peak shared by all four families identified no mutations, but sequencing of CLN6, found in the second peak and shared by only the three families affected by Kufs type A disease, revealed pathogenic mutations in all three families. We subsequently sequenced CLN6 in eight other families, three of which were affected by recessive Kufs type A disease. Mutations in both CLN6 alleles were found in the three type A cases and in one family affected by unclassified Kufs disease. Mutations in CLN6 are the major cause Of recessive Kufs type A disease. The phenotypic differences between variant late-infantile NCL, previously found to be caused by CLN6, and Kufs type A disease are striking; there is a much later age at onset and lack of visual involvement in the latter. Sequencing of CLN6 will provide a simple diagnostic strategy in this disorder, in which definitive identification usually requires invasive biopsy.	[Smith, Katherine R.; Bromhead, Catherine J.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Arsov, Todor; Damiano, John; Vears, Danya F.; Mullen, Saul; Berkovic, Samuel F.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Heidelberg, Vic 3084, Australia; [Franceschetti, Silvana; Canafoglia, Laura] IRCCS Fdn, C Besta Neurol Inst, Unit Neurophysiopathol, I-20133 Milan, Italy; [Andermann, Eva; Andermann, Frederick] McGill Univ, Montreal Neurol Inst & Hosp, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Andermann, Eva] McGill Univ, Montreal Neurol Inst & Hosp, Dept Human Genet, Montreal, PQ H3A 2B4, Canada; [Cossette, Patrick] Univ Montreal, CHUM Hop Notre Dame, Dept Med, Montreal, PQ H2L 4M1, Canada; [Rajagopalan, Sulekha] Liverpool Hosp, Dept Clin Genet, Liverpool, NSW 1871, Australia; [McDougall, Alan] Liverpool Hosp, Dept Neurol, Liverpool, NSW 1871, Australia; [Sofia, Vito] Univ Catania, Dept Neurosci, I-95123 Catania, Italy; [Farrell, Michael] Beaumont Hosp, Dept Neuropathol, Dublin 9, Ireland; [Aguglia, Umberto] Magna Graecia Univ Catanzaro, Inst Neurol, I-88100 Catanzaro, Italy; [Zini, Andrea; Meletti, Stefano] Univ Modena & Reggio Emilia, Nuovo Osped Civile, Dept Neurosci, I-41100 Modena, Italy; [Andermann, Frederick] McGill Univ, Montreal Neurol Inst & Hosp, Dept Pediat, Montreal, PQ H3A 2B4, Canada; [Mole, Sara E.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Mole, Sara E.] UCL, Inst Child Hlth, Mol Med Unit, Med Res Council Lab Mol Cell Biol, London WC1E 6BT, England; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; IRCCS Ca Granda Ospedale Maggiore Policlinico; McGill University; McGill University; Universite de Montreal; Liverpool Hospital; Liverpool Hospital; University of Catania; Magna Graecia University of Catanzaro; Universita di Modena e Reggio Emilia; McGill University; University of London; University College London; University of London; University College London; University of Melbourne	Bahlo, M (corresponding author), Walter & Eliza Hall Inst Med Res, Bioinformat Div, 1G Royal Parade, Parkville, Vic 3052, Australia.	bahlo@wehi.edu.au; samuelfb@unimelb.edu.au	Franceschetti, Silvana/K-3438-2016; Zini, Andrea/K-1136-2014; Canafoglia, Laura/K-4787-2016; Meletti, Stefano/O-3622-2015; Aguglia, Umberto/AAB-9898-2019; Mullen, Saul A/B-2095-2012; jiang, yu/HGU-0029-2022	Franceschetti, Silvana/0000-0002-1921-6755; Zini, Andrea/0000-0003-1486-4507; Canafoglia, Laura/0000-0002-5385-761X; Meletti, Stefano/0000-0003-0334-539X; Aguglia, Umberto/0000-0002-4574-2951; Mole, Sara/0000-0003-4385-4957; Morbin, Michela/0000-0001-8034-3123; Berkovic, Samuel/0000-0003-4580-841X; Bahlo, Melanie/0000-0001-5132-0774; McDougall, Alan/0000-0002-7358-3548; Mullen, Saul/0000-0003-1224-4101	NHMRC Australia; NHMRC; Batten Disease Support and Research Association	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Batten Disease Support and Research Association	S.F.B. was supported by an NHMRC Australia Fellowship and an NHMRC Program Grant. M.B. was funded by an NHMRC Career Development Award and an NHMRC Program Grant. We thank the Batten Disease Support and Research Association for additional financial support (to S.M.) and the families themselves.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Muhaizea MA, 2009, PEDIATR NEUROL, V41, P74, DOI 10.1016/j.pediatrneurol.2009.01.012; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Benedict JW, 2009, J NEUROSCI RES, V87, P2157, DOI 10.1002/jnr.22032; BERKOVIC SF, 1988, BRAIN, V111, P27, DOI 10.1093/brain/111.1.27; BOEHME DH, 1971, BRAIN, V94, P745, DOI 10.1093/brain/94.4.745; Callagy C, 2000, CLIN NEUROPATHOL, V19, P109; Cannelli N, 2009, BIOCHEM BIOPH RES CO, V379, P892, DOI 10.1016/j.bbrc.2008.12.159; CARPENTER S, 1977, BRAIN, V100, P137, DOI 10.1093/brain/100.1.137; Cismondi I Adriana, 2008, Hum Genet, V124, P323; CONSTANTINIDIS J, 1992, ACTA NEUROPATHOL, V83, P461, DOI 10.1007/BF00310021; Gambardella A, 1998, NEUROLOGY, V51, P1180, DOI 10.1212/WNL.51.4.1180; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; GOEBEL HH, 1989, CLIN NEUROPATHOL, V8, P109; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Heine C, 2007, MOL MEMBR BIOL, V24, P74, DOI 10.1080/09687860600967317; Holopainen JM, 2001, EUR J BIOCHEM, V268, P5851, DOI 10.1046/j.0014-2956.2001.02530.x; Kousi M, 2009, BRAIN, V132, P810, DOI 10.1093/brain/awn366; Kufs H, 1925, Z GESAMTE NEUROL PSY, V95, P169, DOI 10.1007/BF02900989; Kurze AK, 2010, HUM MUTAT, V31, pE1163, DOI 10.1002/humu.21184; Lauronen L, 1999, NEUROLOGY, V52, P360, DOI 10.1212/WNL.52.2.360; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Lyly A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-83; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; MOLE SE, 2010, NEURONAL CEROID LIPO; Moore SJ, 2008, CLIN GENET, V74, P213, DOI 10.1111/j.1399-0004.2008.01054.x; Nijssen PCG, 2003, BRAIN PATHOL, V13, P574; Pasquinelli G, 2004, ULTRASTRUCT PATHOL, V28, P43, DOI 10.1080/01913120490275231; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramadan H, 2007, NEUROLOGY, V68, P387, DOI 10.1212/01.wnl.0000252825.85947.2f; Sadzot B, 2000, J NEUROL, V247, P447, DOI 10.1007/s004150070174; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; Sharp JD, 2003, HUM MUTAT, V22, P35, DOI 10.1002/humu.10227; Siintola E, 2005, CLIN GENET, V68, P167, DOI 10.1111/j.1399-0004.2005.00471.x; Sleat DE, 2009, MOL CELL PROTEOMICS, V8, P1708, DOI 10.1074/mcp.M900122-MCP200; Teixeira CA, 2003, HUM MUTAT, V21, P502, DOI 10.1002/humu.10207; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; van Diggelen OP, 2001, ANN NEUROL, V50, P269, DOI 10.1002/ana.1103; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Wisniewski KE, 2001, NEUROLOGY, V57, P576, DOI 10.1212/WNL.57.4.576; Xin W, 2010, NEUROLOGY, V74, P565, DOI 10.1212/WNL.0b013e3181cff70d; Zini A, 2008, NEUROLOGY, V71, P1709, DOI 10.1212/01.wnl.0000335164.02634.f6	44	105	113	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY 13	2011	88	5					566	573		10.1016/j.ajhg.2011.04.004	http://dx.doi.org/10.1016/j.ajhg.2011.04.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	767CE	21549341	Bronze, Green Published			2022-12-18	WOS:000290832100004
J	Lanktree, MB; Guo, YR; Murtaza, M; Glessner, JT; Bailey, SD; Onland-Moret, NC; Lettre, G; Ongen, H; Rajagopalan, R; Johnson, T; Shen, HQ; Nelson, CP; Klopp, N; Baumert, J; Padmanabhan, S; Pankratz, N; Pankow, JS; Shah, S; Taylor, K; Barnard, J; Peters, BJ; Maloney, CM; Lobmeyer, MT; Stanton, A; Zafarmand, MH; Romaine, SPR; Mehta, A; van Iperen, EPA; Gong, Y; Price, TS; Smith, EN; Kim, CE; Li, YR; Asselbergs, FW; Atwood, LD; Bailey, KM; Bhatt, D; Bauer, F; Behr, ER; Bhangale, T; Boer, JMA; Boehm, BO; Bradfield, JP; Brown, M; Braund, PS; Burton, PR; Carty, C; Chandrupatla, HR; Chen, W; Connell, J; Dalgeorgou, C; de Boer, A; Drenos, F; Elbers, CC; Fang, JC; Fox, CS; Frackelton, EC; Fuchs, B; Furlong, CE; Gibson, Q; Gieger, C; Goe, A; Grobbee, DE; Hastie, C; Howard, PJ; Huang, GH; Johnson, WC; Li, Q; Kleber, ME; Klein, BEK; Klein, R; Kooperberg, C; Ky, B; LaCroix, A; Lanken, P; Lathrop, M; Li, MY; Marshal, V; Melander, O; Mentch, FD; Meyer, NJ; Monda, KL; Montpetit, A; Murugesan, G; Nakayama, K; Nondah, D; Onipinla, A; Rafelt, S; Newhouse, SJ; Otieno, FG; Patel, SR; Putt, ME; Rodriguez, S; Safa, RN; Sawyer, DB; Schreiner, PJ; Simpson, C; Sivapalaratnam, S; Srinivasan, SR; Suver, C; Swergold, G; Sweitzer, NK; Thomas, KA; Thorand, B; Timpson, NJ; Tischfield, S; Tobin, M; Tomaszweski, M; Verschuren, WMM; Wallace, C; Winkelmann, B; Zhang, HT; Zheng, DL; Zhang, L; Zmuda, JM; Clarke, R; Balmforth, AJ; Danesh, J; Day, IN; Schork, NJ; de Bakker, PIW; Delles, C; Duggan, D; Hingorani, AD; Hirschhorn, JN; Hofker, MH; Humphries, SE; Kivimaki, M; Lawlor, DA; Kottke-Marchant, K; Mega, JL; Mitchell, BD; Morrow, DA; Palmen, J; Redline, S; Shields, DC; Shuldiner, AR; Sleiman, PM; Smith, GD; Farrall, M; Jamshidi, Y; Christiani, DC; Casas, JP; Hall, AS; Doevendans, PA; Christie, JD; Berenson, GS; Murray, SS; Illig, T; Dorn, GW; Cappola, TP; Boerwinkle, E; Sever, P; Rader, DJ; Reilly, MP; Caulfield, M; Talmud, PJ; Topol, E; Engert, JC; Wang, K; Dominiczak, A; Hamsten, A; Curtis, SP; Silverstein, RL; Lange, LA; Sabatine, MS; Trip, M; Saleheen, D; Peden, JF; Cruickshanks, KJ; Marz, W; O'Connell, JR; Klungel, OH; Wijmenga, C; Maitland-van der Zee, AH; Schadt, EE; Johnson, JA; Jarvik, GP; Papanicolaou, GJ; Watkins, H; Grant, SFA; Munroe, PB; North, KE; Samani, NJ; Koenig, W; Gaunt, TR; Anand, SS; van der Schouw, YT; Kumari, M; Soranzo, N; FitzGerald, GA; Reiner, A; Hegele, RA; Hakonarson, H; Keating, BJ				Lanktree, Matthew B.; Guo, Yiran; Murtaza, Muhammed; Glessner, Joseph T.; Bailey, Swneke D.; Onland-Moret, N. Charlotte; Lettre, Guillaume; Ongen, Halit; Rajagopalan, Ramakrishnan; Johnson, Toby; Shen, Haiqing; Nelson, Christopher P.; Klopp, Norman; Baumert, Jens; Padmanabhan, Sandosh; Pankratz, Nathan; Pankow, James S.; Shah, Sonia; Taylor, Kira; Barnard, John; Peters, Bas J.; Maloney, Cliona M.; Lobmeyer, Maximilian T.; Stanton, Alice; Zafarmand, M. Hadi; Romaine, Simon P. R.; Mehta, Amar; van Iperen, Erik P. A.; Gong, Yan; Price, Tom S.; Smith, Erin N.; Kim, Cecilia E.; Li, Yun R.; Asselbergs, Folkert W.; Atwood, Larry D.; Bailey, Kristian M.; Bhatt, Deepak; Bauer, Florianne; Behr, Elijah R.; Bhangale, Tushar; Boer, Jolanda M. A.; Boehm, Bernhard O.; Bradfield, Jonathan P.; Brown, Morris; Braund, Peter S.; Burton, Paul R.; Carty, Cara; Chandrupatla, Hareesh R.; Chen, Wei; Connell, John; Dalgeorgou, Chrysoula; de Boer, Anthonius; Drenos, Fotios; Elbers, Clara C.; Fang, James C.; Fox, Caroline S.; Frackelton, Edward C.; Fuchs, Barry; Furlong, Clement E.; Gibson, Quince; Gieger, Christian; Goe, Anuj; Grobbee, Diederik E.; Hastie, Claire; Howard, Philip J.; Huang, Guan-Hua; Johnson, W. Craig; Li, Qing; Kleber, Marcus E.; Klein, Barbara E. K.; Klein, Ronald; Kooperberg, Charles; Ky, Bonnie; LaCroix, Andrea; Lanken, Paul; Lathrop, Mark; Li, Mingyao; Marshal, Vanessa; Melander, Olle; Mentch, Frank D.; Meyer, Nuala J.; Monda, Keri L.; Montpetit, Alexandre; Murugesan, Gurunathan; Nakayama, Karen; Nondah, Dave; Onipinla, Abiodun; Rafelt, Suzanne; Newhouse, Stephen J.; Otieno, F. George; Patel, Sanjey R.; Putt, Mary E.; Rodriguez, Santiago; Safa, Radwan N.; Sawyer, Douglas B.; Schreiner, Pamela J.; Simpson, Claire; Sivapalaratnam, Suthesh; Srinivasan, Sathanur R.; Suver, Christine; Swergold, Gary; Sweitzer, Nancy K.; Thomas, Kelly A.; Thorand, Barbara; Timpson, Nicholas J.; Tischfield, Sam; Tobin, Martin; Tomaszweski, Maciej; Verschuren, W. M. Monique; Wallace, Chris; Winkelmann, Bernhard; Zhang, Haitao; Zheng, Dongling; Zhang, Li; Zmuda, Joseph M.; Clarke, Robert; Balmforth, Anthony J.; Danesh, John; Day, Ian N.; Schork, Nicholas J.; de Bakker, Paul I. W.; Delles, Christian; Duggan, David; Hingorani, Aroon D.; Hirschhorn, Joel N.; Hofker, Marten H.; Humphries, Steve E.; Kivimaki, Mika; Lawlor, Debbie A.; Kottke-Marchant, Kandice; Mega, Jessica L.; Mitchell, Braxton D.; Morrow, David A.; Palmen, Jutta; Redline, Susan; Shields, Denis C.; Shuldiner, Alan R.; Sleiman, Patrick M.; Smith, George Davey; Farrall, Martin; Jamshidi, Yalda; Christiani, David C.; Casas, Juan P.; Hall, Alistair S.; Doevendans, Pieter A.; Christie, Jason D.; Berenson, Gerald S.; Murray, Sarah S.; Illig, Thomas; Dorn, Gerald W., II; Cappola, Thomas P.; Boerwinkle, Eric; Sever, Peter; Rader, Daniel J.; Reilly, Muredach P.; Caulfield, Mark; Talmud, Philippa J.; Topol, Eric; Engert, James C.; Wang, Kai; Dominiczak, Anna; Hamsten, Anders; Curtis, Sean P.; Silverstein, Roy L.; Lange, Leslie A.; Sabatine, Marc S.; Trip, Mieke; Saleheen, Danish; Peden, John F.; Cruickshanks, Karen J.; Maerz, Winfried; O'Connell, Jeffrey R.; Klungel, Olaf H.; Wijmenga, Cisca; Maitland-van der Zee, Anke Hilse; Schadt, Eric E.; Johnson, Julie A.; Jarvik, Gail P.; Papanicolaou, George J.; Watkins, Hugh; Grant, Struan F. A.; Munroe, Patricia B.; North, Kari E.; Samani, Nilesh J.; Koenig, Wolfgang; Gaunt, Tom R.; Anand, Sonia S.; van der Schouw, Yvonne T.; Kumari, Meena; Soranzo, Nicole; FitzGerald, Garret A.; Reiner, Alex; Hegele, Robert A.; Hakonarson, Hakon; Keating, Brendan J.		PROCARDIS; Whitehall II Study; WHII 50K Grp	Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BIOLOGICAL PATHWAYS; ADULT HEIGHT; LOCI; POPULATION; INTERLEUKIN-11; IDENTIFICATION; HERITABILITY; TRAITS; MICE	Height is a classic complex trait with common variants in a growing list of genes known to contribute to the phenotype. Using a genecentric genotyping array targeted toward cardiovascular-related loci, comprising 49,320 SNPs across approximately 2000 loci, we evaluated the association of common and uncommon SNPs with adult height in 114,223 individuals from 47 studies and six ethnicities. A total of 64 loci contained a SNP associated with height at array-wide significance (p < 2.4 x 10(-6)), with 42 loci surpassing the conventional genome-wide significance threshold (p < 5 x 10(-8)). Common variants with minor allele frequencies greater than 5% were observed to be associated with height in 37 previously reported loci. In individuals of European ancestry, uncommon SNPs in IL11 and SMAD3, which would not be genotyped with the use of standard genome-wide genotyping arrays, were strongly associated with height (p < 3 x 10(-11)). Conditional analysis within associated regions revealed five additional variants associated with height independent of lead SNPs within the locus, suggesting allelic heterogeneity. Although underpowered to replicate findings from individuals of European ancestry, the direction of effect of associated variants was largely consistent in African American, South Asian, and Hispanic populations. Overall, we show that dense coverage of genes for uncommon SNPs, coupled with large-scale meta-analysis, can successfully identify additional variants associated with a common complex trait.	[Guo, Yiran; Glessner, Joseph T.; Kim, Cecilia E.; Li, Yun R.; Bradfield, Jonathan P.; Frackelton, Edward C.; Mentch, Frank D.; Otieno, F. George; Thomas, Kelly A.; Zhang, Haitao; Sleiman, Patrick M.; Wang, Kai; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Lanktree, Matthew B.; Hegele, Robert A.] Univ Western Ontario, Dept Med & Biochem, London, ON N6A 5C1, Canada; [Guo, Yiran] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Murtaza, Muhammed; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Lettre, Guillaume] Univ Montreal, Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Bailey, Swneke D.; Engert, James C.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Hingorani, Aroon D.; Kivimaki, Mika; Kumari, Meena; Whitehall II Study; WHII 50K Grp] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 6BT, England; [Ongen, Halit; Goe, Anuj; Farrall, Martin; Peden, John F.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Johnson, Toby; Howard, Philip J.; Onipinla, Abiodun; Newhouse, Stephen J.; Caulfield, Mark; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London EC1M 6BQ, England; [Rajagopalan, Ramakrishnan; Furlong, Clement E.; Nakayama, Karen; Jarvik, Gail P.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Shen, Haiqing; Gibson, Quince; Mitchell, Braxton D.; Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Klopp, Norman; Baumert, Jens; Gieger, Christian; Thorand, Barbara; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Neuherberg, Germany; [Taylor, Kira; North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Barnard, John; Zhang, Li] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Nelson, Christopher P.; Braund, Peter S.; Rafelt, Suzanne; Tomaszweski, Maciej; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Lobmeyer, Maximilian T.; Gong, Yan; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL 32610 USA; [Klein, Barbara E. K.; Klein, Ronald; Nondah, Dave; Cruickshanks, Karen J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53705 USA; [Zafarmand, M. Hadi; Asselbergs, Folkert W.; Doevendans, Pieter A.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Carty, Cara; Kooperberg, Charles; LaCroix, Andrea; Reiner, Alex] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Price, Tom S.] Inst Psychiat, MRC SGDP Ctr, London SE5 8AF, England; [Onland-Moret, N. Charlotte; Asselbergs, Folkert W.; Bauer, Florianne; Elbers, Clara C.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, DBG, Complex Genet Sect, Utrecht, Netherlands; [van Iperen, Erik P. A.] Durrer Ctr Cardiogenet Res, Amsterdam, Netherlands; [Romaine, Simon P. R.; Bailey, Kristian M.; Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Pankratz, Nathan] Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN 46202 USA; [Mehta, Amar; Christiani, David C.] Harvard Univ, Environm & Occupat Med & Epidemiol Program, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Sivapalaratnam, Suthesh; Trip, Mieke] Univ Amsterdam, Acad Med Ctr, Dept Cardiol & Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Drenos, Fotios; Humphries, Steve E.; Palmen, Jutta; Talmud, Philippa J.] UCL, Dept Med, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Boer, Jolanda M. A.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm RIVM, NL-3720 BA Bilthoven, Netherlands; [Chandrupatla, Hareesh R.; Li, Mingyao; Rader, Daniel J.; Reilly, Muredach P.; Keating, Brendan J.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Maloney, Cliona M.; Suver, Christine] Rosetta Inpharmat, Dept Genet, Seattle, WA 98109 USA; [Smith, Erin N.; Schork, Nicholas J.; Murray, Sarah S.] Scripps Genom Med & Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Burton, Paul R.; Tobin, Martin] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Murugesan, Gurunathan] Cleveland Clin, Pathol & Lab Med Inst, Dept Clin Pathol, Cleveland, OH 44106 USA; [Johnson, W. Craig] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Atwood, Larry D.; Fox, Caroline S.] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Fuchs, Barry; Lanken, Paul; Meyer, Nuala J.; Christie, Jason D.] Univ Penn, Med Ctr, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Zmuda, Joseph M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Connell, John] Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Dundee DD1 9SY, Scotland; [Schreiner, Pamela J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Monda, Keri L.; Lange, Leslie A.] Univ N Carolina, Dept Genet, Sch Med Chapel Hill, Chapel Hill, NC 27514 USA; [Patel, Sanjey R.; Redline, Susan] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Montpetit, Alexandre] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Bhangale, Tushar] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Tischfield, Sam; de Bakker, Paul I. W.; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Cambridge, MA 02115 USA; [Behr, Elijah R.] St Georges Univ London, Div Cardiovasc Sci, London SW17 0RE, England; [Dalgeorgou, Chrysoula; Zheng, Dongling; Jamshidi, Yalda] St Georges Univ London, Div Clin Dev Sci, London SW17 0RE, England; [Sweitzer, Nancy K.] Univ Wisconsin, Madison, WI 53792 USA; [Sawyer, Douglas B.] Vanderbilt Univ, Med Ctr, Div Cardiovasc, Nashville, TN 37232 USA; [Safa, Radwan N.] Boston Univ, Dept Mol Med, Boston, MA 02118 USA; [Ky, Bonnie; Cappola, Thomas P.] Univ Penn, Penn Cardiovasc Inst, Sch Med, Philadelphia, PA 19104 USA; [Fang, James C.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Huang, Guan-Hua] Natl Chiao Tung Univ, Inst Stat, Hsinchu 30010, Taiwan; [Rodriguez, Santiago; Timpson, Nicholas J.; Day, Ian N.; Lawlor, Debbie A.; Smith, George Davey; Gaunt, Tom R.] Univ Bristol, Sch Social & Community Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Padmanabhan, Sandosh; Hastie, Claire; Delles, Christian] Univ Glasgow, Western Infirm, Div Cardiovasc & Med Sci, BHP Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Melander, Olle] Malmo Univ Hosp, CRC, SE-20502 Malmo, Sweden; [Dominiczak, Anna] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Shields, Denis C.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Stanton, Alice] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Mega, Jessica L.; Morrow, David A.; Sabatine, Marc S.] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; [Silverstein, Roy L.] Case Western Reserve Univ, Dept Cell Biol, Lerner Res Inst,Cleveland Clin Fdn, Dept Mol Med,Cleveland Clin,Lerner Coll Med, Cleveland, OH 44195 USA; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [Danesh, John; Saleheen, Danish] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Murtaza, Muhammed; Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Engert, James C.] McGill Univ, Dept Med, Montreal, PQ H3A 1B1, Canada; [Boerwinkle, Eric] Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Div Epidemiol, Houston, TX 77030 USA; [Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Papanicolaou, George J.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Hingorani, Aroon D.] UCL, Dept Med, Ctr Clin Pharmacol, London WC1E 6JF, England; [Goe, Anuj; Farrall, Martin; Peden, John F.; Watkins, Hugh; PROCARDIS] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Anand, Sonia S.] McMaster Univ, Dept Med & Clin Epidemiol & Biostat, Populat Genom Program, Hamilton Gen Hosp, Hamilton, ON L8L 2X2, Canada; [Rader, Daniel J.; Reilly, Muredach P.; FitzGerald, Garret A.; Keating, Brendan J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [North, Kari E.] Univ N Carolina, Sch Publ Hlth, Carolina Ctr Genome Sci, Chapel Hill, NC 27514 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Cruickshanks, Karen J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53705 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Christiani, David C.] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp,Pulm & Crit Care Unit, Boston, MA 02114 USA; [van Iperen, Erik P. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1007 MB Amsterdam, Netherlands; [Pankratz, Nathan; Pankow, James S.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA 98109 USA; [Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogenet, St Louis, MO 63110 USA; [Nelson, Christopher P.; Braund, Peter S.; Rafelt, Suzanne; Tomaszweski, Maciej; Samani, Nilesh J.] Glenfield Hosp, Leicester Natl Inst Hlth Res, Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Shah, Sonia] UCL, UCL Genet Inst, London WC1E 6BT, England; [Kleber, Marcus E.] LURIC Nonprofit LLC, Freiburg, Germany; [Maerz, Winfried] Synlab Ctr Lab Diagnost Heidelberg, D-58509 Heidelberg, Germany; [Maerz, Winfried] Univ Heidelberg, Inst Publ Hlth, Social Med & Epidemiol Med Fac, D-68167 Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagriost, A-8036 Graz, Austria; [Boehm, Bernhard O.] Univ Ulm, Ctr Excellence Baden Wuerttemberg, Div Endocrinol Diabet & Metab, D-89081 Ulm, Germany; [Winkelmann, Bernhard] Cardiol Grp Frankfurt Sachsenhausen, Frankfurt, Germany; [Marshal, Vanessa] Drug Safety Res Unit, Southampton SO31 1AA, Hants, England; [Brown, Morris] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol & Cambridge Inst Med Res, Cambridge CB2 0SP, England; [Lathrop, Mark] Ctr Natl Genotypage, F-91057 Evry, France; [Wallace, Chris] Addenbrookes Hosp, JDRF WT Diabet & Inflammat Lab, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Topol, Eric] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kottke-Marchant, Kandice] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44195 USA; [Sever, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London W2 1NY, England; [Putt, Mary E.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-5050 Ulm Konto Nr, Germany; [Zafarmand, M. Hadi; Asselbergs, Folkert W.; Grobbee, Diederik E.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Chen, Wei; Srinivasan, Sathanur R.; Berenson, Gerald S.] Tulane Univ, Dept Epidemiol, New Orleans, LA 70112 USA; [Hamsten, Anders] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, SE-17177 Stockholm, Sweden; [Clarke, Robert] Clin Trial Serv Unit, Oxford OX3 7LF, England; [Peters, Bas J.; de Boer, Anthonius; Klungel, Olaf H.; Maitland-van der Zee, Anke Hilse] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, NL-3508 TC Utrecht, Netherlands; [Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Li, Qing; Simpson, Claire] NHGRI, NIH, Baltimore, MD 21224 USA; [Swergold, Gary] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Curtis, Sean P.] Merck Res Labs, Rahway, NJ 07065 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Western University (University of Western Ontario); Beijing Genomics Institute (BGI); Wellcome Trust Sanger Institute; Universite de Montreal; McGill University; University of London; University College London; University of Oxford; Wellcome Centre for Human Genetics; University of London; Queen Mary University London; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of North Carolina; University of North Carolina Chapel Hill; Cleveland Clinic Foundation; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; Utrecht University; Utrecht University Medical Center; Fred Hutchinson Cancer Center; University of London; King's College London; Utrecht University; Utrecht University Medical Center; University of Leeds; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Harvard T.H. Chan School of Public Health; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Netherlands National Institute for Public Health & the Environment; University of Pennsylvania; Merck & Company; University of Leicester; Cleveland Clinic Foundation; University of Washington; University of Washington Seattle; Boston University; Framingham Heart Study; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Dundee; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Beth Israel Deaconess Medical Center; McGill University; Roche Holding; Genentech; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; St Georges University London; St Georges University London; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Boston University; University of Pennsylvania; Case Western Reserve University; National Yang Ming Chiao Tung University; University of Bristol; University of Glasgow; Lund University; Skane University Hospital; University of Glasgow; University College Dublin; Royal College of Surgeons - Ireland; Translational Genomics Research Institute; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University System of Florida; University of Florida; University of Cambridge; McGill University; University of Groningen; University of Groningen; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of London; University College London; University of Oxford; McMaster University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; University College London; SYNLAB Group; Ruprecht Karls University Heidelberg; Medical University of Graz; Ulm University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CEA; UDICE-French Research Universities; Universite Paris Saclay; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Scripps Research Institute; Cleveland Clinic Foundation; Imperial College London; University of Pennsylvania; Ulm University; Utrecht University; Utrecht University Medical Center; Tulane University; Karolinska Institutet; University of Oxford; Utrecht University; University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); Regeneron; Merck & Company	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu; bkeating@chop.edu	van der Schouw, Yvonne T./F-8327-2014; Hegele, Robert/G-3301-2011; Gaunt, Tom R/O-3918-2014; Grobbee, Diederick/C-7651-2014; Burton, Paul R/H-7527-2016; Guo, Yiran/H-4120-2011; Smith, Erin/E-5933-2011; Onland-Moret, N. Charlotte/G-9185-2011; Price, Thomas S./B-7372-2008; Carty, Cara/B-8683-2013; Mitchell, Braxton/CAF-0876-2022; Stanton, Alice V/F-4697-2012; Hall, Alistair/K-1953-2019; Boehm, Bernhard Otto/F-8750-2015; Dominiczak, Anna F/P-9390-2017; Rajagopalan, Ramakrishnan/I-4349-2019; Wijmenga, Cisca/D-2173-2009; Newhouse, Stephen J/C-9330-2011; Kivimaki, Mika/B-3607-2012; Timpson, Nicholas John/O-7548-2015; Murtaza, Muhammed/A-4188-2011; Asselbergs, Folkert W./ABD-6752-2021; Padmanabhan, Sandosh/S-3963-2016; Davey Smith, George/A-7407-2013; Thorand, Barbara/B-5349-2014; Hegele, Robert/AAF-6482-2020; Jamshidi, Yalda/AAL-1377-2020; Lanktree, Matthew Bruce/I-9790-2019; Wijmenga, Cisca/AAE-7719-2019; de Bakker, Paul IW/B-8730-2009; Jarvik, Gail P/N-6476-2014; Sabatine, Marc/AAJ-6751-2020; Maitland-van der Zee, Anke/I-9572-2016; Rajagopalan, Ramakrishnan/Q-9018-2016	van der Schouw, Yvonne T./0000-0002-4605-435X; Gaunt, Tom R/0000-0003-0924-3247; Grobbee, Diederick/0000-0003-4472-4468; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Price, Thomas S./0000-0001-7356-2109; Dominiczak, Anna F/0000-0003-4913-3608; Newhouse, Stephen J/0000-0002-1843-9842; Kivimaki, Mika/0000-0002-4699-5627; Timpson, Nicholas John/0000-0002-7141-9189; Asselbergs, Folkert W./0000-0002-1692-8669; Davey Smith, George/0000-0002-1407-8314; Thorand, Barbara/0000-0002-8416-6440; Hegele, Robert/0000-0003-2861-5325; Jamshidi, Yalda/0000-0003-0151-6482; Lanktree, Matthew Bruce/0000-0002-5750-6286; Wijmenga, Cisca/0000-0002-5635-1614; de Bakker, Paul IW/0000-0001-7735-7858; Jarvik, Gail P/0000-0002-6710-8708; Sabatine, Marc/0000-0002-0691-3359; Glessner, Joseph/0000-0001-5131-2811; Suver, Christine/0000-0002-2986-385X; Schreiner, Pamela/0000-0002-9920-6257; Johnson, Toby/0000-0002-5998-3270; Caulfield, Mark/0000-0001-9295-3594; Munroe, Patricia/0000-0002-4176-2947; Schork, Nicholas/0000-0003-0920-5013; Ongen, Halit/0000-0002-4197-5790; Topol, Eric/0000-0002-1478-4729; Engert, James/0000-0001-8411-4790; Hingorani, Aroon/0000-0001-8365-0081; Patel, Sanjay/0000-0002-9142-5172; Maitland-van der Zee, Anke/0000-0002-0414-3442; Humphries, Stephen E/0000-0002-8221-6547; Tobin, Martin/0000-0002-3596-7874; Rodriguez, Santiago/0000-0001-6551-932X; Kleber, Marcus/0000-0003-0663-7275; Lawlor, Debbie A/0000-0002-6793-2262; Pankratz, Nathan/0000-0001-5958-693X; Melander, Olle/0000-0002-2581-484X; Pankow, James/0000-0001-7076-483X; Goel, Anuj/0000-0003-2307-4021; Simpson, Claire/0000-0003-2244-7690; Li, Yun Rose/0000-0002-8077-4975; Wallace, Chris/0000-0001-9755-1703; Klein, Ronald/0000-0002-4428-6237; Shuldiner, Alan/0000-0001-9921-4305; Padmanabhan, Sandosh/0000-0003-3869-5808; Talmud, Philippa/0000-0002-5560-1933; s, hema/0000-0002-3440-9475; Hall, Alistair/0000-0003-0306-7887; Murtaza, Muhammed/0000-0001-7557-2861; Koenig, Wolfgang/0000-0002-2064-9603; Tomaszewski, Maciej/0000-0001-8215-6567; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Stanton, Alice/0000-0002-4961-165X; Behr, Elijah/0000-0002-8731-2853; van Iperen, Erik/0000-0001-7107-3168; Rajagopalan, Ramakrishnan/0000-0002-5751-9239; Gieger, Christian/0000-0001-6986-9554; Drenos, Fotios/0000-0003-2469-5516; Reilly, Muredach/0000-0002-3035-9386; Nelson, Christopher/0000-0001-8025-2897; Mitchell, Braxton/0000-0003-4920-4744; Shields, Denis/0000-0003-4015-2474	Canadian Institutes of Health Research (CIHR) [79533]; Genome Canada through the Ontario Genomics Institute; MRC [G0902037, G0600705, MC_U137686857, G9521010] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, SP/08/002/24118, RG/07/008/23674, RG/08/008/25291] Funding Source: researchfish; Medical Research Council [G0902037, G9521010, G19/35, G0600705, G8802774, G9817803B, MC_U137686857, G0100222] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006094, K23HL095661, R01HL088577, R01HL074730] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011099, R01AG021917, R37AG011099] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the researchers, staff, and participants of all of the studies that contributed data. Specific cohort acknowledgements are cited in the Supplemental Acknowledgments. Matthew B. Lanktree is supported by a Canadian Institutes of Health Research (CIHR) M.D.-Ph.D. Studentship Award. Robert A. Hegele is funded by CIHR grant 79533 and by Genome Canada through the Ontario Genomics Institute.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kim JJ, 2010, J HUM GENET, V55, P27, DOI 10.1038/jhg.2009.116; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li CG, 2009, SPINE, V34, P1363, DOI 10.1097/BRS.0b013e3181a3c7c7; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Lorda-Diez CI, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-69; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	36	105	106	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					6	18		10.1016/j.ajhg.2010.11.007	http://dx.doi.org/10.1016/j.ajhg.2010.11.007			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21194676	Green Published, Bronze			2022-12-18	WOS:000286501500001
J	Ferrell, RE; Baty, CJ; Kimak, MA; Karlsson, JM; Lawrence, EC; Franke-Snyder, M; Meriney, SD; Feingold, E; Finegold, DN				Ferrell, Robert E.; Baty, Catherine J.; Kimak, Mark A.; Karlsson, Jenny M.; Lawrence, Elizabeth C.; Franke-Snyder, Marlise; Meriney, Stephen D.; Feingold, Eleanor; Finegold, David N.			GJC2 Missense Mutations Cause Human Lymphedema	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY LYMPHEDEMA; TRANSCRIPTION FACTOR; CONNEXINS; COORDINATION; DYSPLASIA; MIGRATION; CX43	Lymphedema is the clinical manifestation of defects in lymphatic structure or function. Mutations identified in genes regulating lymphatic development result in inherited lymphedema. No mutations have yet been identified in genes mediating lymphatic function that result in inherited lymphedema. Survey microarray studies comparing lymphatic and blood endothelial cells identified expression of several connexins in lymphatic endothelial cells. Additionally, gap junctions are implicated in maintaining lymphatic flow. By sequencing GJA1, GJA4, and GJC2 in a group of families with dominantly inherited lymphedema, we identified six probands with unique missense mutations in GJC2 (encoding connexin [Cx] 47). Two larger families cosegregate lymphedema and GJC2 mutation (LOD score = 6.5). We hypothesize that missense mutations in GJC2 alter gap junction function and disrupt lymphatic How. Until now, GJC2 mutations were only thought to cause dysmyelination, with primary expression of Cx47 limited to the central nervous system. The identification of GJC2 mutations as a cause of primary lymphedema raises the possibility of novel gap-junction-modifying agents as potential therapy for some forms of lymphedema.	[Ferrell, Robert E.; Kimak, Mark A.; Lawrence, Elizabeth C.; Franke-Snyder, Marlise; Feingold, Eleanor; Finegold, David N.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Baty, Catherine J.; Karlsson, Jenny M.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Meriney, Stephen D.] Univ Pittsburgh, Fac Arts & Sci, Dept Neurosci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Finegold, DN (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	dnf@pitt.edu		Feingold, Eleanor/0000-0003-2898-6484; Finegold, David/0000-0001-9901-2578	Office of the Dean of the Graduate School of Public Health; Office of the Senior Vice Chancellor of the University of Pittsburgh; UPMC Health System; National Institutes of Health [R01 HL092866, HD37243]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092866] Funding Source: NIH RePORTER	Office of the Dean of the Graduate School of Public Health; Office of the Senior Vice Chancellor of the University of Pittsburgh; UPMC Health System; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the partial support of institutional funds from the Office of the Dean of the Graduate School of Public Health and the Office of the Senior Vice Chancellor of the University of Pittsburgh, the Competitive Medical Research Fund of the UPMC Health System, and National Institutes of Health grants R01 HL092866 and HD37243. We gratefully acknowledge the cooperation and generous assistance of the patients and families participating in the University of Pittsburgh Lymphedema Family Study.	Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; ASELLI G, 1627, THESIS MEDIOLANI MIL; Berthoud VM, 2000, AM J PHYSIOL-LUNG C, V279, pL619, DOI 10.1152/ajplung.2000.279.4.L619; Connell F, 2010, HUM GENET, V127, P231, DOI 10.1007/s00439-009-0766-y; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Ferrell RE, 1998, HUM MOL GENET, V7, P2073, DOI 10.1093/hmg/7.13.2073; Finegold David N., 2008, Lymphatic Research and Biology, V6, P65, DOI 10.1089/lrb.2008.1524; Finegold DN, 2001, HUM MOL GENET, V10, P1185, DOI 10.1093/hmg/10.11.1185; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Irrthum A, 2003, AM J HUM GENET, V72, P1470, DOI 10.1086/375614; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Kjolbye AL, 2008, AM J PHYSIOL-HEART C, V294, pH41, DOI 10.1152/ajpheart.01089.2006; KOBAYASHI MR, 1987, CLIN PLAST SURG, V14, P303; MCHALE NG, 1992, J PHYSIOL-LONDON, V450, P503, DOI 10.1113/jphysiol.1992.sp019139; McLachlan E, 2005, CELL COMMUN ADHES, V12, P279, DOI 10.1080/15419060500514143; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Nagy JI, 2003, GLIA, V44, P205, DOI 10.1002/glia.10278; Odermatt B, 2003, J NEUROSCI, V23, P4549; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; RHODIN JAG, 1978, MICROVASC RES, V15, P169, DOI 10.1016/0026-2862(78)90017-1; Rockson SG, 2008, ANN NY ACAD SCI, V1131, P147, DOI 10.1196/annals.1413.014; Shibayama J, 2005, CIRC RES, V96, pE83, DOI 10.1161/01.RES.0000168369.79972.d2; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; UHLENHERG B, 2004, AM J HUM GENET, V75, P737; Verma V, 2009, CIRC RES, V105, P176, DOI 10.1161/CIRCRESAHA.109.200576; WARNER A, 1995, J PHYSIOL-LONDON, V488, P721, DOI 10.1113/jphysiol.1995.sp021003; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006; ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283, DOI 10.1152/ajpheart.1993.264.4.H1283	31	105	105	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					943	948		10.1016/j.ajhg.2010.04.010	http://dx.doi.org/10.1016/j.ajhg.2010.04.010			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20537300	Green Published, Bronze			2022-12-18	WOS:000278948900011
J	Maertens, O; De Schepper, S; Vandesompele, J; Brerns, H; Heyns, I; Janssens, S; Speleman, F; Legius, E; Messiaen, L				Maertens, Ophelia; De Schepper, Sofie; Vandesompele, Jo; Brerns, Hilde; Heyns, Ine; Janssens, Sandra; Speleman, Frank; Legius, Eric; Messiaen, Ludwine			Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AU-LAIT MACULES; NF1 GENE; SCHWANN-CELLS; SEGMENTAL NEUROFIBROMATOSIS; MAST-CELLS; IN-VIVO; MELANOCYTES; ALLELE; MELANOMA; MUTATION	Elucidation of the biological framework underlying the development of neurofibromatosis type I (NFI)-related symptoms has proved to be difficult. Complicating factors include the large size of the NFI gene, the presence of several NFI pseudogenes, the complex interactions between cell types, and the NFI-haploinsufficient state of all cells in the body. Here, we investigate three patients with distinct NFI-associated clinical manifestations (neurofibromas only, pigmentary changes only, and association of both symptoms). For each patient, various tissues and cell types were tested with comprehensive and quantitative assays capable of detecting low-percentage NFI mutations. This approach confirmed the biallelic NF1 inactivation in Schwann cells in neurofibromas and, for the first time, demonstrated biallelic NF1 inactivation in melanocytes in NF1-related cafe-au-lait macules. Interestingly, both disease features arise even within a background of predominantly NF1 wild-type cells. Together, the data provide molecular evidence that (1) the distinct clinical picture of the patients is due to mosaicism for the NF1 mutation and (2) the mosaic phenotype reflects the embryonic timing and, accordingly, the neural crest-derived cell type involved in the somatic W I mutation. The study of the affected cell types provides important insight into developmental concepts underlying particular NF1-related disease features and opens avenues for improved diagnosis and genetic counseling of individuals with mosaic NFI.	Univ Alabama Birmingham, Dept Genet, Med genom Lab, Birmingham, AL 35294 USA; Ghent Univ Hosp, Ctr Genet Med, B-9000 Ghent, Belgium; Ghent Univ Hosp, Dept Dermatol, B-9000 Ghent, Belgium; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium	University of Alabama System; University of Alabama Birmingham; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Universite Catholique Louvain	Messiaen, L (corresponding author), Univ Alabama Birmingham, Dept Genet, Med genom Lab, Kaul Human Genet Bldg,Suite 330,720 20th St S, Birmingham, AL 35294 USA.	lmessiaen@genetics.uab.edu	speleman, frank/AAR-5184-2020; Legius, Eric/H-1735-2011; Vandesompele, Jo/W-3411-2018	speleman, frank/0000-0002-6628-8559; Vandesompele, Jo/0000-0001-6274-0184				ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Consoli C, 2005, J INVEST DERMATOL, V125, P463, DOI 10.1111/j.0022-202X.2005.23834.x; Correa CL, 1999, HUM MUTAT, V14, P387, DOI 10.1002/(SICI)1098-1004(199911)14:5<387::AID-HUMU4>3.0.CO;2-4; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; De Raedt T, 2006, GENE CHROMOSOME CANC, V45, P893, DOI 10.1002/gcc.20353; De Schepper S, 2006, ARCH DERMATOL RES, V297, P439, DOI 10.1007/s00403-006-0644-6; Dupin E, 2000, P NATL ACAD SCI USA, V97, P7882, DOI 10.1073/pnas.97.14.7882; Eisenbarth I, 1997, BIOCHEM BIOPH RES CO, V237, P138, DOI 10.1006/bbrc.1997.7097; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Ingram DA, 2000, J EXP MED, V191, P181, DOI 10.1084/jem.191.1.181; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; KAUFMANN D, 1991, HUM GENET, V87, P144, DOI 10.1007/BF00204170; Kehrer-Sawatzki H, 2004, AM J HUM GENET, V75, P410, DOI 10.1086/423624; Kluwe L, 1999, GENE CHROMOSOME CANC, V24, P283, DOI 10.1002/(SICI)1098-2264(199903)24:3<283::AID-GCC15>3.0.CO;2-K; LAZARO C, 1993, HUM GENET, V92, P429, DOI 10.1007/BF01247353; LAZARO C, 1994, HUM GENET, V93, P351, DOI 10.1007/BF00212039; LAZARO C, 1993, HUM MOL GENET, V2, P725, DOI 10.1093/hmg/2.6.725; Maertens O, 2006, HUM MUTAT, V27, P1030, DOI 10.1002/humu.20389; Maertens O, 2006, ANAL BIOCHEM, V359, P144, DOI 10.1016/j.ab.2006.07.039; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Munchhof AM, 2006, HUM MOL GENET, V15, P1858, DOI 10.1093/hmg/ddl108; NAEYAERT JM, 1991, BRIT J DERMATOL, V125, P297, DOI 10.1111/j.1365-2133.1991.tb14161.x; Okazaki M, 2003, BRIT J DERMATOL, V148, P689, DOI 10.1046/j.1365-2133.2003.05283.x; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Rosenbaum T, 2000, J NEUROSCI RES, V61, P524, DOI 10.1002/1097-4547(20000901)61:5<524::AID-JNR7>3.3.CO;2-Q; Rubben A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-36; Ruggieri M, 2001, NEUROLOGY, V56, P1433, DOI 10.1212/WNL.56.11.1433; Rutkowski JL, 2000, HUM MOL GENET, V9, P1059, DOI 10.1093/hmg/9.7.1059; Schultz ES, 2002, DERMATOLOGY, V204, P296, DOI 10.1159/000063363; Serra E, 2000, HUM MOL GENET, V9, P3055, DOI 10.1093/hmg/9.20.3055; Tinschert S, 2000, EUR J HUM GENET, V8, P455, DOI 10.1038/sj.ejhg.5200493; Vandenbroucke I, 2004, HUM GENET, V114, P284, DOI 10.1007/s00439-003-1047-9; VANROY N, 1994, GENE CHROMOSOME CANC, V10, P103, DOI 10.1002/gcc.2870100205; Wilkie AL, 2002, DEVELOPMENT, V129, P3349; XU GF, 1991, NUCLEIC ACIDS RES, V19, P3764, DOI 10.1093/nar/19.13.3764; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yoshida H, 1996, DEVELOPMENT, V122, P1207; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	43	105	112	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					243	251		10.1086/519562	http://dx.doi.org/10.1086/519562			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668375	Green Published, Bronze			2022-12-18	WOS:000248540400005
J	Mannan, AU; Krawen, P; Sauter, SM; Boehm, J; Chronowska, A; Paulus, W; Neesen, J; Engel, W				Mannan, Ashraf U.; Krawen, Philip; Sauter, Simone M.; Boehm, Johann; Chronowska, Agnieszka; Paulus, Walter; Neesen, Juergen; Engel, Wolfgang			ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EARLY ENDOSOMES; FYVE-FINGER; GENE SPG4; IDENTIFICATION; LOCALIZATION; TRAFFICKING; EXPRESSION; MUTATIONS; INTERACTS; FUSION	Spastin, the most commonly mutated protein in the autosomal dominant form of hereditary spastic paraplegia (ADHSP) has been suggested to be involved in vesicular cargo trafficking; however, a comprehensive function of spastin has not yet been elucidated. To characterize the molecular function of spastin, we used the yeast two-hybrid approach to identify new interacting partners of spastin. Here, we report ZFYVE27, a novel member of the FYVE-finger family of proteins, as a specific spastin-binding protein, and we validate the interaction by both in vivo coimmunoprecipitation and colocalization experiments in mammalian cells. More importantly, we report a German family with AD-HSP in which ZFYVE27 (SPG33) is mutated; furthermore, we demonstrate that the mutated ZFYVE27 protein shows an aberrant intracellular pattern in its tubular structure and that its interaction with spastin is severely affected. We postulate that this specific mutation in ZFYVE27 affects neuronal intracellular trafficking in the corticospinal tract, which is consistent with the pathology of HSP.	Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Mannan, AU (corresponding author), Univ Gottingen, Inst Human Genet, Heinrich Dueker Weg 12, D-37073 Gottingen, Germany.	amannan@gwdg.de	Paulus, Walter/A-3544-2009; Böhm, Johann/O-1652-2016	Paulus, Walter/0000-0001-5549-8377; Böhm, Johann/0000-0001-8019-9504; Neesen, Jurgen/0000-0002-3635-2097; Bohm, Johann/0000-0001-7370-3469				Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; FinkenEigen M, 1997, CURR GENET, V31, P469, DOI 10.1007/s002940050232; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; HARDING AE, 1983, LANCET, V1, P1151; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Lindsey JC, 2000, J MED GENET, V37, P759, DOI 10.1136/jmg.37.10.759; Lo Nigro C, 2000, EUR J HUM GENET, V8, P777, DOI 10.1038/sj.ejhg.5200546; Meijer IA, 2004, ANN NEUROL, V56, P579, DOI 10.1002/ana.20239; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Phillips SA, 2001, J BIOL CHEM, V276, P5074, DOI 10.1074/jbc.M004671200; Raiborg C, 2001, J CELL SCI, V114, P2255; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447; Sauter S, 2002, HUM MUTAT, V20, P127, DOI 10.1002/humu.10105; Senden NHM, 1996, EUR J CELL BIOL, V69, P197; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Stenmark H, 1999, J CELL SCI, V112, P4175; Svenson IK, 2001, AM J HUM GENET, V68, P1077, DOI 10.1086/320111; Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	29	105	113	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					351	357		10.1086/504927	http://dx.doi.org/10.1086/504927			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826525	Bronze, Green Published			2022-12-18	WOS:000239040400016
J	Timms, AE; Crane, AM; Sims, AM; Cordell, HJ; Bradbury, LA; Abbott, A; Coyne, MRE; Beynon, O; Herzberg, I; Duff, GW; Calin, A; Cardon, LR; Wordsworth, BP; Brown, MA				Timms, AE; Crane, AM; Sims, AM; Cordell, HJ; Bradbury, LA; Abbott, A; Coyne, MRE; Beynon, O; Herzberg, I; Duff, GW; Calin, A; Cardon, LR; Wordsworth, BP; Brown, MA			The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISMS; SPONDYLARTHROPATHIES; POPULATION; GENOTYPE; CYP2D6; FAMILY; RISK; HLA	Ankylosing spondylitis (AS) is a common and highly heritable inflammatory arthropathy. Although the gene HLA-B27 is almost essential for the inheritance of the condition, it alone is not sufficient to explain the pattern of familial recurrence of the disease. We have previously demonstrated suggestive linkage of AS to chromosome 2q13, a region containing the interleukin 1 (IL-1) family gene cluster, which includes several strong candidates for involvement in the disease. In the current study, we describe strong association and transmission of IL-1 family gene cluster single-nucleotide polymorphisms and haplotypes with AS.	Univ Oxford, Botnar Res Ctr, Nuffield Orthopaed Ctr, Inst Musculoskeletal Sci, Oxford OX3 7LD, England; Wellcome Trust Ctr Human Genet, Oxford, England; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; Univ Sheffield, Div Genom Med, Sheffield, S Yorkshire, England; Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England	Nuffield Orthopaedic Centre; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sheffield; Royal National Hospital for Rheumatic Diseases (RNHRD)	Brown, MA (corresponding author), Univ Oxford, Botnar Res Ctr, Nuffield Orthopaed Ctr, Inst Musculoskeletal Sci, Windmill Rd, Oxford OX3 7LD, England.	mbrown@well.ox.ac.uk	Brown, Matthew A/E-5749-2010	Brown, Matthew A/0000-0003-0538-8211; Cordell, Heather/0000-0002-1879-5572; Mark Robert Edward, Coyne/0000-0002-1094-051X				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Beyeler C, 1996, ANN RHEUM DIS, V55, P66, DOI 10.1136/ard.55.1.66; Brand JM, 1997, RHEUMATOL INT, V16, P207, DOI 10.1007/BF01330297; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499, DOI 10.1002/art.1780380407; BREWERTON DA, 1973, LANCET, V1, P904; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 2000, HUM MOL GENET, V9, P1563, DOI 10.1093/hmg/9.11.1563; Brown MA, 2002, CLIN EXP RHEUMATOL, V20, pS43; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Djouadi K, 2001, CYTOKINE, V13, P98, DOI 10.1006/cyto.2000.0795; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Koeleman BPC, 2000, ANN HUM GENET, V64, P207, DOI 10.1017/S0003480000008095; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Laurincova Beata, 2000, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V143, P19; Laval SH, 2001, AM J HUM GENET, V68, P918, DOI 10.1086/319509; Maksymowych WP, 2003, ARTHRITIS RHEUM-US, V48, P2011, DOI 10.1002/art.11037; McGarry F, 2001, RHEUMATOLOGY, V40, P1359, DOI 10.1093/rheumatology/40.12.1359; Mercado MVD, 2002, J RHEUMATOL, V29, P522; Nicklin MJH, 2002, GENOMICS, V79, P718, DOI 10.1006/geno.2002.6751; Sims JE, 2001, TRENDS IMMUNOL, V22, P536, DOI 10.1016/S1471-4906(01)02040-3; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; van der Paardt M, 2002, RHEUMATOLOGY, V41, P1419, DOI 10.1093/rheumatology/41.12.1419; VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361	29	105	120	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					587	595		10.1086/424695	http://dx.doi.org/10.1086/424695			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15309690	Green Published, Bronze			2022-12-18	WOS:000223634100005
J	Stein, CM; Schick, JH; Taylor, HG; Shriberg, LD; Millard, C; Kundtz-Kluge, A; Russo, K; Minich, N; Hansen, A; Freebairn, LA; Elston, RC; Lewis, BA; Iyengar, SK				Stein, CM; Schick, JH; Taylor, HG; Shriberg, LD; Millard, C; Kundtz-Kluge, A; Russo, K; Minich, N; Hansen, A; Freebairn, LA; Elston, RC; Lewis, BA; Iyengar, SK			Pleiotropic effects of a chromosome 3 locus on speech-sound disorder and reading	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; COMPLEX COGNITIVE TRAIT; SPOKEN-WORD RECOGNITION; DEVELOPMENTAL DYSLEXIA; PHONOLOGICAL DISORDERS; LANGUAGE IMPAIRMENT; FOLLOW-UP; LINKAGE ANALYSIS; SUSCEPTIBILITY LOCUS; SPELLING DISABILITY	Speech-sound disorder (SSD) is a complex behavioral disorder characterized by speech-sound production errors associated with deficits in articulation, phonological processes, and cognitive linguistic processes. SSD is prevalent in childhood and is comorbid with disorders of language, spelling, and reading disability, or dyslexia. Previous research suggests that developmental problems in domains associated with speech and language acquisition place a child at risk for dyslexia. Recent genetic studies have identified several candidate regions for dyslexia, including one on chromosome 3 segregating in a large Finnish pedigree. To explore common genetic influences on SSD and reading, we examined linkage for several quantitative traits to markers in the pericentrometric region of chromosome 3 in 77 families ascertained through a child with SSD. The quantitative scores measured several processes underlying speech-sound production, including phonological memory, phonological representation, articulation, receptive and expressive vocabulary, and reading decoding and comprehension skills. Model-free linkage analysis was followed by identification of sib pairs with linkage and construction of core shared haplotypes. In our multipoint analyses, measures of phonological memory demonstrated the strongest linkage (marker D3S2465, P=5.6x10(-5) and marker D3S3716, P=6.8x10(-4)). Tests for single-word decoding also demonstrated linkage (real word reading: marker D3S2465, P=.004; nonsense word reading: marker D3S1595, P=.005). The minimum shared haplotype in sib pairs with similar trait values spans 4.9 cM and is bounded by markers D3S3049 and D3S3045. Our results suggest that domains common to SSD and dyslexia are pleiotropically influenced by a putative quantitative trait locus on chromosome 3.	Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Res, Cleveland, OH 44109 USA; Univ Wisconsin, Waisman Ctr Mental Retardat & Human Dev, Madison, WI 53706 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; MetroHealth System; University of Wisconsin System; University of Wisconsin Madison	Iyengar, SK (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Rammelkamp Ctr Res, R215 Rammelkamp Bldg,2500 MetroHlth Dr, Cleveland, OH 44109 USA.	ski@po.cwru.edu	Stein, Catherine/A-2715-2008; Stein, Catherine/P-9498-2019; /S-1190-2019	Stein, Catherine/0000-0002-9763-5023; /0000-0001-7488-250X	NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NHLBI NIH HHS [T32 HL007567] Funding Source: Medline; NIDCD NIH HHS [DC-004005, DC00528, R01 DC000528] Funding Source: Medline; NIGMS NIH HHS [GM 28656] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004005, R29DC000528, R01DC000528] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; [Anonymous], 1998, WOODCOCK READING MAS; ARAM DM, 1989, SCHOOL PSYCHOL REV, V18, P487; BISHOP DVM, 1990, J CHILD PSYCHOL PSYC, V31, P1027, DOI 10.1111/j.1469-7610.1990.tb00844.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CATTS HW, 1986, J LEARN DISABIL, V19, P504, DOI 10.1177/002221948601900813; Cordell HJ, 2001, ANN HUM GENET, V65, P491, DOI 10.1017/S0003480001008831; Denckla MB, 1999, ANN DYSLEXIA, V49, P29, DOI 10.1007/s11881-999-0018-9; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; ELSTON RC, 1979, AM J HUM GENET, V31, P655; Fagerheim T, 1999, J MED GENET, V36, P664; FELSENFELD S, 1995, J SPEECH HEAR RES, V38, P1091, DOI 10.1044/jshr.3805.1091; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; Francks C, 2002, PSYCHIATR GENET, V12, P35, DOI 10.1097/00041444-200203000-00005; GARDNER MF, 1990, EXPRESSIVE 1 WORD PI; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; GOLDMAN R, 1986, GOLDMANFRISTOE TEST; Grigorenko EL, 2003, AM J MED GENET B, V118B, P89, DOI 10.1002/ajmg.b.10032; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Grigorenko EL, 2001, AM J MED GENET, V105, P120, DOI 10.1002/1096-8628(20010108)105:1<120::AID-AJMG1075>3.3.CO;2-K; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOLLINGSHEAD A, 1975, 06520 YAL U DEP SOC; KAMHI AG, 1986, J SPEECH HEAR DISORD, V51, P337, DOI 10.1044/jshd.5104.337; Kaminen N, 2003, J MED GENET, V40, P340, DOI 10.1136/jmg.40.5.340; Kaplan DE, 2002, AM J HUM GENET, V70, P1287, DOI 10.1086/340449; KHAN L, 1986, KHANLEWIS PHONOLOGIC; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lewis BA, 1998, LANG SPEECH, V41, P45, DOI 10.1177/002383099804100103; LEWIS BA, 1993, BEHAV GENET, V23, P291, DOI 10.1007/BF01082469; LEWIS BA, 1992, J LEARN DISABIL-US, V25, P586, DOI 10.1177/002221949202500908; LEWIS BA, 1989, J SPEECH HEAR RES, V32, P713, DOI 10.1044/jshr.3204.713; LEWIS BA, 1992, J SPEECH HEAR RES, V35, P1086, DOI 10.1044/jshr.3505.1086; Lewis BA, 2000, J LEARN DISABIL-US, V33, P433, DOI 10.1177/002221940003300504; Marlow AJ, 2003, AM J HUM GENET, V72, P561, DOI 10.1086/368201; MENYUK P, 1991, J SPEECH HEAR RES, V34, P893, DOI 10.1044/jshr.3404.893; Metsala JL, 1997, MEM COGNITION, V25, P47, DOI 10.3758/BF03197284; Newbury DF, 2002, AM J HUM GENET, V70, P384; Newcomer P. L., 1988, TEST LANGUAGE DEV PR; Nopola-Hemmi J, 2002, DEV MED CHILD NEUROL, V44, P580; Nopola-Hemmi J, 2001, J MED GENET, V38, P658, DOI 10.1136/jmg.38.10.658; Nothen MM, 1999, EUR CHILD ADOLES PSY, V8, P56; Pennington BF, 2001, CHILD DEV, V72, P816, DOI 10.1111/1467-8624.00317; Petryshen TL, 2002, J MED GENET, V39, P125, DOI 10.1136/jmg.39.2.125; Petryshen TL, 2001, AM J MED GENET, V105, P507, DOI 10.1002/ajmg.1475; RABIN M, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91384-X; RAITANO NA, IN PRESS J CHILD PSY; Rice JP, 2001, ADV GENET, V42, P69, DOI 10.1016/S0065-2660(01)42015-3; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROBBINS J, 1987, J SPEECH HEAR DISORD, V52, P271, DOI 10.1044/jshd.5203.271; Roodenrys S, 2002, J EXP PSYCHOL LEARN, V28, P1019, DOI 10.1037//0278-7393.28.6.1019; *SAGE, 2003, STAT AN GEN EP; SCHICK J, 2002, EUR HUM GEN C STRASB; Schulte-Korne G, 1998, AM J HUM GENET, V63, P279, DOI 10.1086/301919; Semel EM, 1987, CLIN EVALUATION LANG; Shete S, 2003, HUM HERED, V55, P79, DOI 10.1159/000072312; Shriberg L., 1998, SPEECH LANGUAGE CONN, P73; Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; SHRIBERG LD, 1993, J SPEECH HEAR RES, V36, P105, DOI 10.1044/jshr.3601.105; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P708, DOI 10.1044/jslhr.4004.708; SHRIBERG LD, 1988, J SPEECH HEAR DISORD, V53, P144, DOI 10.1044/jshd.5302.144; SHRIBERG LD, 2002, ANN CONV AM SPEECH L; SHRIBERG LD, 2003, CLIN PHONETICS; Stein CM, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S99; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Tunick RA, 2002, ANN DYSLEXIA, V52, P75, DOI 10.1007/s11881-002-0007-8; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; WALLEY AC, 1990, PERCEPT PSYCHOPHYS, V47, P267, DOI 10.3758/BF03205001; Wechsler D., 1992, WECHSLER INDIVIDUAL; Wechsler D, 1989, MANUAL WECHSLER PRES; Wechsler D., 1997, WECHSLER INTELLIGENC	79	105	108	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					283	297		10.1086/381562	http://dx.doi.org/10.1086/381562			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	772UM	14740317	Green Published, Bronze			2022-12-18	WOS:000188860000009
J	Wall, JD; Pritchard, JK				Wall, JD; Pritchard, JK			Assessing the performance of the haplotype block model of linkage disequilibrium	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; SEQUENCE VARIATION; GENE CONVERSION; GLOBAL PATTERNS; RECOMBINATION; HUMANS; POLYMORPHISM; MUTATION; REGION; MAP	Several recent studies have suggested that linkage disequilibrium (LD) in the human genome has a fundamentally "blocklike" structure. However, thus far there has been little formal assessment of how well the haplotype block model captures the underlying structure of LD. Here we propose quantitative criteria for assessing how blocklike LD is and apply these criteria to both real and simulated data. Analyses of several large data sets indicate that real data show a partial fit to the haplotype block model; some regions conform quite well, whereas others do not. Some improvement could be obtained by genotyping higher marker densities but not by increasing the number of samples. Nonetheless, although the real data are only moderately blocklike, our simulations indicate that, under a model of uniform recombination, the structure of LD would actually fit the block model much less well. Simulations of a model in which much of the recombination occurs in narrow hotspots provide a much better fit to the observed patterns of LD, suggesting that there is extensive fine-scale variation in recombination rates across the human genome.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Wall, JD (corresponding author), Univ So Calif, Program Mol & Computat Biol, 1042 W 36th Pl,DRB 289, Los Angeles, CA 90089 USA.				NHGRI NIH HHS [R01 HG002772, R01 HG002772-03, HG 2772] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Andolfatto P, 1998, GENETICS, V148, P1397; Ardlie K, 2001, AM J HUM GENET, V69, P582, DOI 10.1086/323251; Ayres KL, 2001, GENETICS, V157, P413; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Innan H, 2003, GENOME RES, V13, P1158, DOI 10.1101/gr.466303; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; LEWONTIN RC, 1964, GENETICS, V49, P49; LI N, 2003, IN PRESS GENETICS; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; Long AD, 1999, GENOME RES, V9, P720; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; OHTA T, 1969, GENETICS, V63, P229; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pluzhnikov A, 2002, GENETICS, V161, P1209; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Wall JD, 2000, GENETICS, V154, P1271; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Wall JD, 2002, GENETICS, V162, P203; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799	41	105	112	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					502	515		10.1086/378099	http://dx.doi.org/10.1086/378099			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12916017	Bronze, Green Published			2022-12-18	WOS:000185134000004
J	Markova, D; Zou, YQ; Ringpfeil, F; Sasaki, T; Kostka, G; Timpl, R; Uitto, J; Chu, ML				Markova, D; Zou, YQ; Ringpfeil, F; Sasaki, T; Kostka, G; Timpl, R; Uitto, J; Chu, ML			Genetic heterogeneity of cutis laxa: A heterozygous tandem duplication within the fibulin-5 (FBLN5) gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXTRACELLULAR-MATRIX; HUMAN FIBROBLASTS; CALCIUM-BINDING; ELASTIC FIBER; IN-VIVO; PROTEIN; EXPRESSION; MUTATION	Inherited cutis laxa is a connective tissue disorder characterized by loose skin and variable internal organ involvement, resulting from paucity of elastic fibers. Elsewhere, frameshift mutations in the elastin gene have been reported in three families with autosomal dominant inheritance, and a family with autosomal recessive cutis laxa was recently reported to have a homozygous missense mutation in the fibulin-5 gene. In the present study, we analyzed the gene expression of elastin and fibulins 1-5 in fibroblasts from five patients with cutis laxa. One patient was found to express both normal (2.2 kb) and mutant (2.7 kb) fibulin-5 mRNA transcripts. The larger transcript contains an internal duplication of 483 nucleotides, which resulted in the synthesis and secretion of a mutant fibulin-5 protein with four additional tandem calcium-binding epidermal growth factor-like motifs. The mutation arose from a 22-kb tandem gene duplication, encompassing the sequence from intron 4 to exon 9. No fibulin-5 or elastin mutations were detected in the other patients. The results demonstrate that a heterozygous mutation in fibulin-5 can cause cutis laxa and also suggest that fibulin-5 and elastin gene mutations are not the exclusive cause of the disease.	Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Jefferson University; Jefferson University; Max Planck Society	Chu, ML (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	Mon-Li.Chu@mail.tju.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR028450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055625] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR028450, AR28450] Funding Source: Medline; NIGMS NIH HHS [GM55625, R01 GM055625] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGHA A, 1978, ACTA PAEDIATR SCAND, V67, P775, DOI 10.1111/j.1651-2227.1978.tb16260.x; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; Debeer P, 2002, J MED GENET, V39, P98, DOI 10.1136/jmg.39.2.98; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Grassel S, 1996, EUR J BIOCHEM, V242, P576, DOI 10.1111/j.1432-1033.1996.0576r.x; HASHIMOTO K, 1975, ARCH DERMATOL, V111, P861, DOI 10.1001/archderm.111.7.861; KITANO Y, 1989, J AM ACAD DERMATOL, V21, P378, DOI 10.1016/S0190-9622(89)80039-8; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; LECKACZERNIK B, 1995, MOL CELL BIOL, V15, P120, DOI 10.1128/MCB.15.1.120; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; OLSEN DR, 1988, J BIOL CHEM, V263, P6465; PAN TC, 1993, J CELL BIOL, V123, P1269, DOI 10.1083/jcb.123.5.1269; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; TIMPL R, 1982, METHOD ENZYMOL, V82, P472; UITTO J, 2002, EMERY RIMOINS PRINCI, P4044; WU YS, 1995, CHEM BIOL, V2, P91, DOI 10.1016/1074-5521(95)90281-3; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhang HY, 1996, DEV DYNAM, V205, P348, DOI 10.1002/(SICI)1097-0177(199603)205:3<348::AID-AJA13>3.0.CO;2-0; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981; ZHANG SH, 1995, J PLAST ENG, V2, P26	23	105	113	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					998	1004		10.1086/373940	http://dx.doi.org/10.1086/373940			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12618961	Bronze, Green Published			2022-12-18	WOS:000181972600019
J	Schutte, M; Seal, S; Barfoot, R; Meijers-Heijboer, H; Wasielewski, M; Evans, DG; Eccles, D; Meijers, C; Lohman, F; Klijn, J; van den Ouweland, A; Futreal, PA; Nathanson, KL; Weber, BL; Easton, DF; Stratton, MR; Rahman, N				Schutte, M; Seal, S; Barfoot, R; Meijers-Heijboer, H; Wasielewski, M; Evans, DG; Eccles, D; Meijers, C; Lohman, F; Klijn, J; van den Ouweland, A; Futreal, PA; Nathanson, KL; Weber, BL; Easton, DF; Stratton, MR; Rahman, N		Breast Canc Linkage Consortium	Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-DAMAGE CHECKPOINT; LI-FRAUMENI-SYNDROME; MUTATION ANALYSIS; HCHK2 MUTATIONS; FHA DOMAIN; CHK2 GENE; PHOSPHORYLATION; FAMILIES; KINASE; P53	We recently reported that a sequence variant in the cell-cycle-checkpoint kinase CHEK2 (CHEK2 1100delC) is a low-penetrance breast cancer-susceptibility allele in noncarriers of BRCA1 or BRCA2 mutations. To investigate whether other CHEK2 variants confer susceptibility to breast cancer, we screened the full CHEK2 coding sequence in BRCA1/2-negative breast cancer cases from 89 pedigrees with three or more cases of breast cancer. We identified one novel germline variant, R117G, in two separate families. To evaluate the possible association of R117G and two germline variants reported elsewhere, R145W and I157T with breast cancer, we screened 737 BRCA1/2-negative familial breast cancer cases from 605 families, 459 BRCA1/2-positive cases from 335 families, and 723 controls from the United Kingdom, the Netherlands, and North America. All three variants were rare in all groups, and none occurred at significantly elevated frequency in familial breast cancer cases compared with controls. These results indicate that 1100delC may be the only CHEK2 allele that makes an appreciable contribution to breast cancer susceptibility.	Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England; Erasmus Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Pathol, Rotterdam, Netherlands; Erasmus Med Ctr, Dept Pediat Surg, Rotterdam, Netherlands; Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; Univ Penn, Med Ctr, Dept Hematol Oncol, Philadelphia, PA 19104 USA; Univ Cambridge, Strangeways Res Labs, Canc Res UK Genet Epidemiol Unit, Cambridge, England	Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; Institute of Cancer Research - UK; University of Manchester; University of Pennsylvania; Cancer Research UK; University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.		Eccles, Diana/K-6327-2019; Rahman, Nazneen/B-8890-2012; Evans, D Gareth/AAB-4308-2022; Gray, John/D-2269-2009; Lucassen, Anneke/D-7764-2017; Rahman, Nazneen/D-2802-2013	Eccles, Diana/0000-0002-9935-3169; Evans, D Gareth/0000-0002-8482-5784; Gray, John/0000-0003-3554-0499; Lucassen, Anneke/0000-0003-3324-4338; Nathanson, Katherine/0000-0002-6740-0901; Rahman, Nazneen/0000-0003-4376-0440				Allinen M, 2001, BRIT J CANCER, V85, P209, DOI 10.1054/bjoc.2001.1858; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Bougeard G, 2001, J MED GENET, V38, P253, DOI 10.1136/jmg.38.4.253; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Hofmann WK, 2001, LEUKEMIA RES, V25, P333, DOI 10.1016/S0145-2126(00)00130-2; Ingvarsson S, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr435; Lee HJ, 2001, KOREAN J RADIOL, V2, P61, DOI 10.3348/kjr.2001.2.1.61; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Reddy A, 2002, BRIT J CANCER, V86, P756, DOI 10.1038/sj.bjc.6600131; Sodha N, 2002, HUM MUTAT, V19, P173, DOI 10.1002/humu.10031; Sullivan A, 2002, ONCOGENE, V21, P1316, DOI 10.1038/sj.onc.1205207; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Vahteristo P, 2001, CANCER RES, V61, P5718; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	27	105	110	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1023	1028		10.1086/373965	http://dx.doi.org/10.1086/373965			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12610780	Green Published, Bronze			2022-12-18	WOS:000181972600023
J	Foulkes, WD; Thiffault, I; Gruber, SB; Horwitz, M; Hamel, N; Lee, C; Shia, J; Markowitz, A; Figer, A; Friedman, E; Farber, D; Greenwood, CMT; Bonner, JD; Nafa, K; Walsh, T; Marcus, V; Tomsho, L; Gebert, J; Macrae, FA; Gaff, CL; Bressac-de Paillerets, B; Gregersen, PK; Weitzel, JN; Gordon, PH; MacNamara, E; King, MC; Hampel, H; de la Chapelle, A; Boyd, J; Offit, K; Rennert, G; Chong, G; Ellis, NA				Foulkes, WD; Thiffault, I; Gruber, SB; Horwitz, M; Hamel, N; Lee, C; Shia, J; Markowitz, A; Figer, A; Friedman, E; Farber, D; Greenwood, CMT; Bonner, JD; Nafa, K; Walsh, T; Marcus, V; Tomsho, L; Gebert, J; Macrae, FA; Gaff, CL; Bressac-de Paillerets, B; Gregersen, PK; Weitzel, JN; Gordon, PH; MacNamara, E; King, MC; Hampel, H; de la Chapelle, A; Boyd, J; Offit, K; Rennert, G; Chong, G; Ellis, NA			The founder mutation MSH2*1906G -> C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA MISMATCH REPAIR; COLON-CANCER; OVARIAN-CANCER; PROTEIN MUTS; HMLH1; HNPCC; HMSH2; FAMILIES; COMPLEX; RISK	Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by mutations in the mismatch-repair genes. We report here the identification and characterization of a founder mutation in MSH2 in the Ashkenazi Jewish population. We identified a nucleotide substitution, MSH2*1906G-->C, which results in a substitution of proline for alanine at codon 636 in the MSH2 protein. This allele was identified in 15 unrelated Ashkenazi Jewish families with HNPCC, most of which meet the Amsterdam criteria. Genotype analysis of 18 polymorphic loci within and flanking MSH2 suggested a single origin for the mutation. All colorectal cancers tested showed microsatellite instability and absence of MSH2 protein, by immunohistochemical analysis. In an analysis of a population-based incident series of 686 Ashkenazi Jews from Israel who have colorectal cancer, we identified 3 (0.44%) mutation carriers. Persons with a family history of colorectal or endometrial cancer were more likely to carry the mutation than were those without such a family history (P = .042), and those with colorectal cancer who carried the mutation were, on average, younger than affected individuals who did not carry it (P = .033). The mutation was not detected in either 566 unaffected Ashkenazi Jews from Israel or 1,022 control individuals from New York. In hospital-based series, the 1906C allele was identified in 5/463 Ashkenazi Jews with colorectal cancer, in 2/197 with endometrial cancer, and in 0/83 with ovarian cancer. When families identified by family history and in case series are included, 25 apparently unrelated Ashkenazi Jewish families have been found to harbor this mutation. Although this pathogenic mutation is not frequent in the Ashkenazi Jewish population (accounting for 2%-3% of colorectal cancer in those whose age at diagnosis is <60 years), it is highly penetrant and accounts for approximately one-third of HNPCC in Ashkenazi Jewish families that fulfill the Amsterdam criteria.	McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada; McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Oncol, Montreal, PQ, Canada; McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Surg, Montreal, PQ, Canada; McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Dept Diagnost Med, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Dept Pathol, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Dept Epidemiol, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Dept Biostat, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Inst Res, Montreal, PQ, Canada; McGill Univ, Program Canc Genet, Dept Oncol, Montreal, PQ, Canada; McGill Univ, Program Canc Genet, Dept Human Genet, Montreal, PQ, Canada; Univ Michigan, Div Med & Mol Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Div Med & Mol Genet, Dept Epidemiol, Ann Arbor, MI 48109 USA; Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Elias Sourasky Med Ctr, Gastrointestinal Tumor Serv, Tel Aviv, Israel; Chaim Sheba Med Ctr, Susanne Levy Gertner Oncogenet Unit, IL-52621 Tel Hashomer, Israel; Univ Heidelberg, Inst Pathol, Div Mol Pathol, D-6900 Heidelberg, Germany; Royal Melbourne Hosp, Family Canc Clin, Melbourne, Vic, Australia; Genet Hlth Serv Victoria, Melbourne, Vic, Australia; Inst Gustave Roussy, Paris, France; N Shore Long Isl Jewish Res Inst, Ctr Genom & Human Genet, Manhasset, NY USA; City Hope Canc Ctr, Dept Canc Genet, Duarte, CA USA; Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; Chalit Hlth Serv Canc Control Ctr, Haifa, Israel	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Chaim Sheba Medical Center; Ruprecht Karls University Heidelberg; Royal Melbourne Hospital; UNICANCER; Gustave Roussy; Northwell Health; City of Hope; University System of Ohio; Ohio State University; Clalit Health Services	Foulkes, WD (corresponding author), Montreal Gen Hosp, Room L10-116,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.		Hamel, Nancy/L-5122-2016; Hampel, Heather/AAV-4041-2020; Foulkes, William D./AAR-9586-2021; Gaff, Clara/ABD-5691-2021; Paillerets, Brigitte Bressac-de/D-8954-2018	Hamel, Nancy/0000-0001-8971-0428; Hampel, Heather/0000-0001-7558-9794; Foulkes, William D./0000-0001-7427-4651; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Shia, Jinru/0000-0002-4351-2511; Horwitz, Marshall/0000-0002-1683-1680; Walsh, Tom/0000-0002-8875-0310; Rennert, Gad/0000-0002-8512-068X; Gaff, Clara/0000-0003-0160-4159; Greenwood, Celia/0000-0002-2427-5696; King, Mary-Claire/0000-0001-9426-1743	NATIONAL CANCER INSTITUTE [R01CA175716, U01CA067941, R01CA081488, P30CA016058, R01CA067941] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA175716, R01 CA081488, P30 CA016058, R01 CA81488, U01 CA067941, R01 CA067941] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; AndreuttiZaugg C, 1997, CANCER RES, V57, P3288; Boland CR, 1998, CANCER RES, V58, P5248; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Chan TL, 2001, ONCOGENE, V20, P2976, DOI 10.1038/sj.onc.1204376; Desai DC, 2000, J MED GENET, V37, P646, DOI 10.1136/jmg.37.9.646; Fleiss JL, 1981, STAT METHODS RATES P; Gilks WR, 1996, MARKOV CHAIN MONTE C; GREEN RC, 1994, AM J HUM GENET, V54, P1067; Hutter P, 1996, J MED GENET, V33, P636, DOI 10.1136/jmg.33.8.636; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Levine DA, 2001, GYNECOL ONCOL, V80, P395, DOI 10.1006/gyno.2000.6082; Marcus VA, 1999, AM J SURG PATHOL, V23, P1248, DOI 10.1097/00000478-199910000-00010; Marra G, 2001, CANCER RES, V61, P7719; Moisio AL, 1996, AM J HUM GENET, V59, P1243; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Shiri-Sverdlov R, 2000, HUM MUTAT, V16, P491, DOI 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.3.CO;2-A; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Yuan ZQ, 1999, J MED GENET, V36, P790	27	105	108	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1395	1412		10.1086/345075	http://dx.doi.org/10.1086/345075			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12454801	Green Published, Bronze			2022-12-18	WOS:000179586800013
J	Suzuki, OT; Sertie, AL; Der Kaloustian, VM; Kok, F; Carpenter, M; Murray, J; Czeizel, AE; Kliemann, SE; Rosemberg, S; Monteiro, M; Olsen, BR; Passos-Bueno, MR				Suzuki, OT; Sertie, AL; Der Kaloustian, VM; Kok, F; Carpenter, M; Murray, J; Czeizel, AE; Kliemann, SE; Rosemberg, S; Monteiro, M; Olsen, BR; Passos-Bueno, MR			Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TISSUE-SPECIFIC DIFFERENCES; BASEMENT-MEMBRANE ZONES; CORRESPONDING TRANSCRIPTS; ANGIOGENESIS INHIBITOR; ENDOGENOUS INHIBITOR; TUMOR-GROWTH; XV COLLAGEN; EXPRESSION; ENDOSTATIN; FORMS	Knobloch syndrome (KS) is a rare disease characterized by severe ocular alterations, including vitreoretinal degeneration associated with retinal detachment and occipital scalp defect. The responsible gene, COL18A1, has been mapped to 21q22.3, and, on the basis of the analysis of one family, we have demonstrated that a mutation affecting only one of the three COL18A1 isoforms causes this phenotype. We report here the results of the screening of both the entire coding region and the exon-intron boundaries of the COL18A1 gene (which includes 43 exons), in eight unrelated patients with KS. Besides 20 polymorphic changes, we identified 6 different pathogenic changes in both alleles of five unrelated patients with KS (three compound heterozygotes and two homozygotes). All are truncating mutations leading to deficiency of one or all collagen XVIII isoforms and endostatin. We have verified that, in exon 41, the deletion c3514-3515delCT, found in three unrelated alleles, is embedded in different haplotypes, suggesting that this mutation has occurred more than once. In addition, our results provide evidence of nonallelic genetic heterogeneity in KS. We also show that the longest human isoform (NC11-728) is expressed in several tissues (including the human eye) and that lack of either the short variant or all of the collagen XVIII isoforms causes similar phenotypes but that those patients who lack all forms present more-severe ocular alterations. Despite the small sample size, we found low endostatin plasma levels in those patients with mutations leading to deficiency of all isoforms; in addition, it seems that absence of all collagen XVIII isoforms causes predisposition to epilepsy.	Univ Sao Paulo, Ctr Estudos Genoma Humano, Inst Biociencias, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Dept Biol, Inst Biociencias, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Dept Neurol, Fac Med, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Dept Oftalmol, BR-05508900 Sao Paulo, Brazil; Santa Casa Sao Paulo, Sch Med, Dept Pediat, Sao Paulo, Brazil; Univ Toronto, Toronto, ON, Canada; McGill Univ, Montreal, PQ, Canada; Maine Med Ctr, Div Maternal Fetal Med, Portland, ME USA; Univ Iowa, Iowa City, IA USA; Fdm Community Control Hereditary Dis, Budapest, Hungary; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Toronto; McGill University; Maine Medical Center; University of Iowa; Harvard University; Harvard Medical School	Passos-Bueno, MR (corresponding author), Univ Sao Paulo, Dept Biol, Inst Biociencias, Rua Matao 277, BR-05508900 Sao Paulo, Brazil.	passos@ib.usp.br	Rosemberg, Sergio/F-4464-2012; Passos-Bueno, Maria Rita/I-6796-2016; Sertie, Andrea Laurato/H-8312-2014; Kok, Fernando/E-7865-2016; MONTEIRO, MARIO L R/C-8891-2012	Passos-Bueno, Maria Rita/0000-0002-9248-3008; Sertie, Andrea Laurato/0000-0002-7453-0560; MONTEIRO, MARIO L R/0000-0002-7281-2791				Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Antonarakis SE, 1998, HUM MUTAT, V11, P1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CZEIZEL AE, 1992, AM J MED GENET, V42, P777, DOI 10.1002/ajmg.1320420605; Eklund L, 2001, P NATL ACAD SCI USA, V98, P1194, DOI 10.1073/pnas.031444798; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Iughetti P, 2001, CANCER RES, V61, P7375; KLIEMANN SE, IN PRESS AM J MED GE; Knobloch WH, 1971, J PEDIATR OPHTHALMOL, V8, P181; Lin YF, 2001, DEVELOPMENT, V128, P1573; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; MENZEL O, 2000, 50 ANN M AM SOC HUM; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; OH SP, 1994, P NATL ACAD SCI USA, V91, P4229, DOI 10.1073/pnas.91.10.4229; OH SP, 1994, GENOMICS, V19, P494, DOI 10.1006/geno.1994.1098; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; PASSOSBUENO MR, 1994, AM J MED GENET, V52, P170, DOI 10.1002/ajmg.1320520209; REHN M, 1995, J BIOL CHEM, V270, P4705, DOI 10.1074/jbc.270.9.4705; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; Saarela J, 1998, MATRIX BIOL, V16, P319, DOI 10.1016/S0945-053X(98)90003-8; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; SEAVER LH, 1993, AM J MED GENET, V46, P203, DOI 10.1002/ajmg.1320460221; Sertie A L, 1999, Hum Mutat, V13, P170; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Sniderman LC, 2000, AM J MED GENET, V90, P146, DOI 10.1002/(SICI)1096-8628(20000117)90:2<146::AID-AJMG11>3.3.CO;2-Q; Tomono Y, 2002, CELL STRUCT FUNCT, V27, P9, DOI 10.1247/csf.27.9; Wilson C, 1998, AM J MED GENET, V78, P286, DOI 10.1002/(SICI)1096-8628(19980707)78:3<286::AID-AJMG16>3.0.CO;2-B; Zorick TS, 2001, EUR J HUM GENET, V9, P811, DOI 10.1038/sj.ejhg.5200721	30	105	107	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1320	1329		10.1086/344695	http://dx.doi.org/10.1086/344695			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12415512	Green Published, Bronze			2022-12-18	WOS:000179586800007
J	Mackay, DS; Boskovska, OB; Knopf, HLS; Lampi, KJ; Shiels, A				Mackay, DS; Boskovska, OB; Knopf, HLS; Lampi, KJ; Shiels, A			A nonsense mutation in CRYBB1 associated with autosomal dominant cataract linked to human chromosome 22q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LENS BETA-CRYSTALLIN; ALPHA-CRYSTALLIN; GENE; PROTEINS; SEQUENCE	Autosomal dominant cataract is a clinically and genetically heterogeneous lens disorder that usually presents as a sight-threatening trait in childhood. Here we have mapped dominant pulverulent cataract to the beta-crystallin gene cluster on chromosome 22q11.2. Suggestive evidence of linkage was detected at markers D22S1167 (LOD score [Z] 2.09 at recombination fraction [theta] 0) and D22S1154 (Z = 1.39 at theta = 0), which closely flank the genes for betaB1-crystallin (CRYBB1) and betaA4-crystallin (CRYBA4). Sequencing failed to detect any nucleotide changes in CRYBA4; however, a G-->T transversion in exon 6 of CRYBB1 was found to cosegregate with cataract in the family. This single-nucleotide change was predicted to introduce a translation stop codon at glycine 220 (G220X). Expression of recombinant human betaB1-crystallin in bacteria showed that the truncated G220X mutant was significantly less soluble than wild type. This study has identified the first CRYBB1 mutation associated with autosomal dominant cataract in humans.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Oregon Hlth & Sci Univ, Dept Oral Mol Biol, Portland, OR USA	Washington University (WUSTL); Washington University (WUSTL); Oregon Health & Science University	Shiels, A (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, Box 8096,660 S Euclid Ave, St Louis, MO 63110 USA.	shiels@vision.wustl.edu		Mackay, Donna/0000-0002-2499-1203	NATIONAL EYE INSTITUTE [R01EY012239, P30EY002687, P30EY010572, R01EY012284, R29EY012239] Funding Source: NIH RePORTER; NEI NIH HHS [EY12284, EY12239, EY02687, R29 EY012239-04, R01 EY012239, EY10572, P30 EY002687, P30 EY010572, R01 EY012284, R29 EY012239] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ajaz MS, 1997, J BIOL CHEM, V272, P11250; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman JB, 2000, INVEST OPHTH VIS SCI, V41, P3278; Bateman OA, 2001, EXP EYE RES, V73, P321, DOI 10.1006/exer.2001.1038; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; Coop A, 1998, GRAEF ARCH CLIN EXP, V236, P146, DOI 10.1007/s004170050055; D'Alessio G, 2002, EUR J BIOCHEM, V269, P3122, DOI 10.1046/j.1432-1033.2002.03004.x; David A S, 1996, Cogn Neuropsychiatry, V1, P1; DAVID LL, 1987, INVEST OPHTH VIS SCI, V28, P1148; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; FERNALD RD, 1984, NATURE, V312, P292, DOI 10.1038/312292a0; FERNALD RD, 1983, NATURE, V301, P618, DOI 10.1038/301618a0; Gill D, 2000, INVEST OPHTH VIS SCI, V41, P159; Graw J, 1997, BIOL CHEM, V378, P1331; Graw J, 2001, INVEST OPHTH VIS SCI, V42, P1574; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Kannabiran C, 1998, Mol Vis, V4, P21; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Lampi KJ, 2001, EXP EYE RES, V72, P279, DOI 10.1006/exer.2000.0950; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MARINEAU C, 1992, NUCLEIC ACIDS RES, V20, P2624, DOI 10.1093/nar/20.10.2624; Norledge BV, 1997, PROTEIN SCI, V6, P1612, DOI 10.1002/pro.5560060802; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Ren ZX, 2000, HUM GENET, V106, P531, DOI 10.1007/s004390050021; Santhiya ST, 2002, J MED GENET, V39, P352, DOI 10.1136/jmg.39.5.352; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; TRINKL S, 1994, PROTEIN SCI, V3, P1392, DOI 10.1002/pro.5560030905; Vanita, 2001, J MED GENET, V38, P392, DOI 10.1136/jmg.38.6.392	37	105	118	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1216	1221		10.1086/344212	http://dx.doi.org/10.1086/344212			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12360425	Bronze, Green Published			2022-12-18	WOS:000178884300021
J	Herman-Bert, A; Stevanin, G; Netter, JC; Rascol, O; Brassat, D; Calvas, P; Camuzat, A; Yuan, QP; Schalling, M; Durr, A; Brice, A				Herman-Bert, A; Stevanin, G; Netter, JC; Rascol, O; Brassat, D; Calvas, P; Camuzat, A; Yuan, QP; Schalling, M; Durr, A; Brice, A			Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYGLUTAMINE EXPANSIONS; CLINICAL CORRELATIONS; LINKAGE; REPEAT; RECOMBINATION; TYPE-1; LOCUS; MAPS	We examined a large French family with autosomal dominant cerebellar ataxia (ADCA) that was excluded from all previously identified spinocerebellar ataxia genes and loci. The patients-seven women and a 4-year-old boy-exhibited slowly progressive childhood-onset cerebellar gait ataxia associated with cerebellar dysarthria, moderate mental retardation (IQ 62-76), and mild developmental delays in motor acquisition. Nystagmus and pyramidal signs were also observed in some cases. This unique association of clinical features clearly distinguishes this new entity from other previously described ADCA. Cerebral magnetic-resonance imaging showed moderate cerebellar and pontine atrophy in two patients. We performed a genomewide search and found significant evidence for linkage to chromosome 19q13.3-q13.4, in an similar to 8-cM interval between markers D19S219 and D19S553.	Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France; Hop La Pitie Salpetriere, Consultat Genet Med, F-75651 Paris, France; Ctr Hosp Intercommunal Tarbes, Serv Neonatol, Tarbes, France; Hop Purpan, Federat Neurol, Fac Med, Serv Pharmacol Clin, Toulouse, France; Hop Purpan, Consultat Genet Med, Toulouse, France; Karolinska Hosp, Dept Mol Med, Neurogenet Unit, S-10401 Stockholm, Sweden	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; CHU de Toulouse; Karolinska Institutet; Karolinska University Hospital	Brice, A (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, 47 Blvd Hop, F-75651 Paris 13, France.		Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019; Stevanin, Giovanni/E-5038-2016; Brassat, David/L-2173-2014; Schalling, Martin/F-1518-2015	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; Schalling, Martin/0000-0001-5011-2922				Barone R, 1999, BRAIN DEV-JPN, V21, P260, DOI 10.1016/S0387-7604(99)00020-0; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Burk K, 1999, BRAIN, V122, P769, DOI 10.1093/brain/122.4.769; Cancel G, 1997, HUM MOL GENET, V6, P709, DOI 10.1093/hmg/6.5.709; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBOURG O, 1995, ANN NEUROL, V37, P176, DOI 10.1002/ana.410370207; Giunti P, 1999, AM J HUM GENET, V64, P1594, DOI 10.1086/302406; HARDING AE, 1993, ADV NEUROL, V61, P1; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; Klockgether T, 1998, BRAIN, V121, P1687, DOI 10.1093/brain/121.9.1687; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Matsuura T, 1999, ANN NEUROL, V45, P407, DOI 10.1002/1531-8249(199903)45:3<407::AID-ANA21>3.0.CO;2-D; Nystuen A, 1996, HUM MOL GENET, V5, P525, DOI 10.1093/hmg/5.4.525; Stevanin G, 2000, EUR J HUM GENET, V8, P4, DOI 10.1038/sj.ejhg.5200403; STEVANIN G, 1994, AM J HUM GENET, V54, P11; Stevanin G, 1996, HUM MOL GENET, V5, P1887, DOI 10.1093/hmg/5.12.1887; Stevanin G, 1999, NEUROLOGY, V53, P1355, DOI 10.1212/WNL.53.6.1355; Trojano L, 1998, J NEUROL SCI, V157, P162, DOI 10.1016/S0022-510X(98)00070-7; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Zander C, 1998, GENOME RES, V8, P1085, DOI 10.1101/gr.8.10.1085; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247	25	105	106	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2000	67	1					229	235		10.1086/302958	http://dx.doi.org/10.1086/302958			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	347JY	10820125	Green Published, Bronze			2022-12-18	WOS:000088926900026
J	Dufourcq-Lagelouse, R; Jabado, N; Le Deist, F; Stephan, JL; Souillet, G; Bruin, M; Vilmer, E; Schneider, M; Janka, G; Fischer, A; Basile, GD				Dufourcq-Lagelouse, R; Jabado, N; Le Deist, F; Stephan, JL; Souillet, G; Bruin, M; Vilmer, E; Schneider, M; Janka, G; Fischer, A; Basile, GD			Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHEDIAK-HIGASHI-SYNDROME; BONE-MARROW TRANSPLANTATION; MALIGNANT HISTIOCYTOSIS; GENE; IDENTIFICATION; MUTATIONS; REPEAT	Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disorder characterized by the early onset of overwhelming activation of T lymphocytes and macrophages, invariably leading to death, in the absence of allogeneic bone marrow transplantation, Using genomewide genetic Linkage analysis, we analyzed a group of 17 families with FHL and mapped a locus for FHL to the proximal region of the long arm of chromosome 10. Ten families showed no recombination with three tightly linked markers, D10S1650 (LOD score [Z]=6.99), D10S556 (Z=5.40), and D10S206 (Z= 3.24), with a maximum multipoint LOD score of 11.22 at the D10S1650 locus. Haplotype analysis of these 10 families allowed us to establish D10S206 and D10S1665 as the telomeric and the centromeric flanking markers, respectively, Heterogeneity analysis and haplotype inspection of the remaining families confirmed that in seven families FHL was not linked to the 10q21-22 region, thus providing evidence for genetic heterogeneity of this condition.	Hop Necker Enfants Malad, INSERM U429, Unite Rech Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, F-75015 Paris, France; Hop Robert Debre, Unite Hematol Immunol, F-75019 Paris, France; Unite Hematol & Oncol Pediat, St Etienne, France; Hop Debrousse, Lyon, France; Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands; Univ Dusseldorf, Inst Hamostaseol & Transfus Med, D-4000 Dusseldorf, Germany; Childrens Univ Hosp, Dept Hematol & Oncol, Hamburg, Germany	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Wilhelmina Kinderziekenhuis; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Basile, GD (corresponding author), Hop Necker Enfants Malad, INSERM U429, Unite Rech Dev Normal & Pathol Syst Immunitaire, 149 Rue Sevres, F-75015 Paris, France.	sbasile@necker.fr	Jabado, Nada/AAN-4026-2020; de Saint Basile, Genevieve/G-9731-2017	de Saint Basile, Genevieve/0000-0002-1913-5269				Arico M, 1996, LEUKEMIA, V10, P197; Baker KS, 1997, BLOOD, V89, P3857, DOI 10.1182/blood.V89.10.3857.3857_3857_3863; Barbosa MDFS, 1997, HUM MOL GENET, V6, P1091, DOI 10.1093/hmg/6.7.1091; BEJAOUI M, 1989, ARCH FR PEDIATR, V46, P733; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; ESKDALE J, 1995, IMMUNOGENETICS, V42, P444; FARQUHAR JW, 1952, ARCH DIS CHILD, V27, P519, DOI 10.1136/adc.27.136.519; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; Haddad E, 1997, BLOOD, V89, P794, DOI 10.1182/blood.V89.3.794; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P428, DOI 10.1111/j.1651-2227.1991.tb11878.x; HENTER JI, 1991, BLOOD, V78, P2918, DOI 10.1182/blood.V78.11.2918.2918; Henter JI, 1998, HEMATOL ONCOL CLIN N, V12, P417, DOI 10.1016/S0889-8588(05)70520-7; Jabado N, 1997, BLOOD, V90, P4743, DOI 10.1182/blood.V90.12.4743.4743_4743_4748; JAFFE ES, 1983, AM J MED, V75, P741, DOI 10.1016/0002-9343(83)90402-3; Jarman PR, 1997, AM J HUM GENET, V61, P928, DOI 10.1086/514883; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Nagle DL, 1996, NAT GENET, V14, P307, DOI 10.1038/ng1196-307; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4018, DOI 10.1093/nar/19.14.4018-a; PURTILO DT, 1975, LANCET, V1, P936; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RISDALL RJ, 1979, CANCER, V44, P993, DOI 10.1002/1097-0142(197909)44:3<993::AID-CNCR2820440329>3.0.CO;2-5; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SELVAKUMAR A, 1992, IMMUNOGENETICS, V36, P175, DOI 10.1007/BF00661094; STEPHAN JL, 1993, BLOOD, V82, P2319; Weiler T, 1998, AM J HUM GENET, V63, P140, DOI 10.1086/301925; *WRIT GROUP HIST S, 1987, LANCET, V1, P1091	30	105	110	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					172	179		10.1086/302194	http://dx.doi.org/10.1086/302194			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915956	Bronze, Green Published			2022-12-18	WOS:000078477400022
J	Hofstra, RMW; Valdenaire, O; Arch, E; Osinga, J; Kroes, H; Loffler, BM; Hamosh, A; Meijers, C; Buys, CHCM				Hofstra, RMW; Valdenaire, O; Arch, E; Osinga, J; Kroes, H; Loffler, BM; Hamosh, A; Meijers, C; Buys, CHCM			A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SHAH-WAARDENBURG SYNDROME; GERMLINE MUTATIONS; RET PROTOONCOGENE; B RECEPTOR; GENE; GDNF		Univ Groningen, Dept Med Genet, Groningen, Netherlands; Hoffmann La Roche Ltd, Preclin Res, Div Pharma, Basel, Switzerland; Johns Hopkins Med Inst, Ctr Med Genet, Baltimore, MD 21205 USA; Erasmus Univ, Inst Paediat Surg Cell Biol & Genet, Rotterdam, Netherlands	University of Groningen; Roche Holding; Johns Hopkins University; Johns Hopkins Medicine; Erasmus University Rotterdam	Hofstra, RMW (corresponding author), Univ Groningen, Dept Med Genet, Groningen, Netherlands.		, Otto/P-4127-2018	, Otto/0000-0003-2101-4105; Hofstra, Robert/0000-0001-7498-3829				Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bolk S, 1997, AM J HUM GENET, V61, pA41; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Gershon MD, 1997, CURR OPIN NEUROBIOL, V7, P101, DOI 10.1016/S0959-4388(97)80127-4; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; KURIHARA Y, 1995, J CARDIOVASC PHAR S3, V26, pA13; Loeffler B., 1994, ENDOTHELIUM, V1, P273, DOI [10.3109/10623329409100966, DOI 10.3109/10623329409100966]; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; VALDENAIRE O, 1995, J BIOL CHEM, V270, P29794; Yanagisawa H, 1998, DEVELOPMENT, V125, P825	17	105	108	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					304	308		10.1086/302184	http://dx.doi.org/10.1086/302184			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915973	Bronze, Green Published			2022-12-18	WOS:000078477400039
J	Fong, GCY; Shah, PU; Gee, MN; Serratosa, JM; Castroviejo, IP; Khan, S; Ravat, SH; Mani, J; Huang, Y; Zhao, HZ; Medina, MT; Treiman, LJ; Pineda, G; Delgado-Escueta, AV				Fong, GCY; Shah, PU; Gee, MN; Serratosa, JM; Castroviejo, IP; Khan, S; Ravat, SH; Mani, J; Huang, Y; Zhao, HZ; Medina, MT; Treiman, LJ; Pineda, G; Delgado-Escueta, AV			Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4-Hz spike and multispike-slow wave complexes: Linkage to chromosome 8q24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE MYOCLONIC EPILEPSY; IDIOPATHIC GENERALIZED EPILEPSY; HUMAN GENOME; LOCALIZATION; FAMILIES; PEDIGREE; GENES; LOCUS; MAP	Childhood absence epilepsy (CAE), a common form of idiopathic generalized epilepsy, accounts for 5%-15% of childhood epilepsies. To map the chromosomal locus of persisting CAE, we studied the clinical and electroencephalographic traits of 78 members of a five-generation family from Bombay, India. The model-free affected-pedigree member method was used during initial screening with chromosome Gp, 8q, and Ip microsatellites, and only individuals with absence seizures and/or electroencephalogram 3-4-Hz spike- and multi-spike-slow wave complexes were considered to be affected. Significant P values of .00000-.02 for several markers on 8q were obtained. Two-point linkage analysis, assuming autosomal dominant inheritance with 50% penetrance, yielded a maximum LOD score (Z(max)) of 3.6 for D8S502. No other locus in the genome achieved a significant Z(max). For five smaller multiplex families, summed Z(max) was 2.4 for D8S537 and 1.7 for D8S1761. Haplotypes composed of the same 8q24 microsatellites segregated with affected members of the large family from India and with all five smaller families. Recombinations positioned the CAE gene in a 3.2-cM interval.	W Los Angeles Vet Affairs Med Ctr, Serv Neurol, Los Angeles, CA 90073 USA; W Los Angeles Vet Affairs Med Ctr, Res Serv, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Sch Med, Calif Comprehens Epilepsy Program, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Inst Brain Res, Los Angeles, CA USA; King Edward Mem Hosp, Bombay, Maharashtra, India; Seth GS Med Coll, Bombay, Maharashtra, India; Fdn Jimenez Diaz, Serv Neurol, Epilepsy Unit, E-28040 Madrid, Spain; Univ Hosp La Paz, Madrid, Spain; Riyadh Armed Forces Hosp, Dept Neurosci, Riyadh, Saudi Arabia; Natl Univ Honduras, Tegucigalpa, Honduras	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Hospital Universitario La Paz; Prince Sultan Military Medical City; Universidad Nacional Autonoma de Honduras	Delgado-Escueta, AV (corresponding author), W Los Angeles Vet Affairs Med Ctr, Serv Neurol, Room 3405 127B,Bldg 500,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	escueta@ucla.edu		Serratosa, Jose/0000-0003-2239-8948; Medina, Marco Tulio/0000-0003-0469-054X; Delgado-Escueta, Antonio V./0000-0002-1581-6999	NINDS NIH HHS [NS21908] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS021908] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BEYER L, 1966, NERVENARZT, V37, P333; BLUME WT, 1982, ATLAS PEDIAT ELECTRO; CAVAZZUTI GB, 1980, EPILEPSIA, V21, P57, DOI 10.1111/j.1528-1157.1980.tb04044.x; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; CHUMAKOV IM, 1995, NATURE, V377, P175; DALBY MA, 1969, ACTA NEUROL SCAND, VS 45, P6; DELGADOESCUETA AV, 1990, EPILEPSIA, V31, pS19, DOI 10.1111/j.1528-1157.1990.tb05855.x; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; Hauser WA, 1990, EPILEPSY FREQUENCY C, P1; JANZ D, 1969, EPILPESIEN; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LENNOX WG, 1945, JAMA-J AM MED ASSOC, V129, P1069, DOI 10.1001/jama.1945.02860500001001; LENNOX WG, 1960, EPILEPSY RELATED DIS, P66; Lewis TB, 1996, GENOMICS, V32, P131, DOI 10.1006/geno.1996.0088; LIU AW, 1995, AM J HUM GENET, V57, P368; Livingstone S., 1965, JAMA-J AM MED ASSOC, V194, P113, DOI [10.1001/jama.1965.03090160005001, DOI 10.1001/JAMA.1965.03090160005001]; Loiseau Pierre, 1992, P135; METRAKOS K, 1961, NEUROLOGY, V11, P474, DOI 10.1212/WNL.11.6.474; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PEET MJ, 1987, EXCITATORY AMINO ACI, P35; RISCH N, 1991, AM J HUM GENET, V48, P1058; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Serratosa JM, 1996, ANN NEUROL, V39, P187, DOI 10.1002/ana.410390208; TOTH M, 1995, NAT GENET, V11, P71, DOI 10.1038/ng0995-71; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1988, AM J HUM GENET, V42, P315; Weeks DE., 1990, AM J HUM GENET, V47, pA203; Westling B., 1996, American Journal of Human Genetics, V59, pA241; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; Wolf Peter, 1992, P307; ZARA F, 1995, HUM MOL GENET, V4, P1201, DOI 10.1093/hmg/4.7.1201	38	105	122	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1117	1129		10.1086/302066	http://dx.doi.org/10.1086/302066			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758624	Green Published, Bronze			2022-12-18	WOS:000076577800026
J	Jenisch, S; Henseler, T; Nair, RP; Guo, SW; Westphal, E; Stuart, P; Kronke, M; Voorhees, JJ; Christophers, E; Elder, JT				Jenisch, S; Henseler, T; Nair, RP; Guo, SW; Westphal, E; Stuart, P; Kronke, M; Voorhees, JJ; Christophers, E; Elder, JT			Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: Strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXTENDED HAPLOTYPE; ENDOTHELIAL-CELLS; CLASS-I; ASSOCIATION; DISEASE; GENE; SUSCEPTIBILITY; VULGARIS; MHC; SEQUENCE	Although psoriasis is strongly associated with certain human leukocyte antigens (HLAs), evidence for linkage to HLA markers has been limited. The objectives of this study were (1) to provide more definitive evidence for linkage of psoriasis to HLA markers in multiplex families; (2) to compare the major HLA risk alleles in these families with those determined by previous case-control studies; and (3) to localize the gene moro precisely. By applying the transmission/disequilibrium test (TDT) and parametric linkage analysis, we found evidence for linkage of psoriasis to HLA-C, -B, -DR, and -DQ, with HLA-B and -C yielding the most-significant results. Linkage was detectable by parametric methods only when marker-trait disequilibrium was considered. Case-control association tests and the TDT identified alleles belonging to the EH57.1 ancestral haplotype as the major risk alleles in our sample. Among individuals carrying recombinant ancestral haplotypes involving EH57.1, the class I markers were retained selectively among affecteds four times more often than among unaffecteds; among the few affected individuals carrying only the class II alleles from the ancestral haplotype, all but one also carried Cw6. These data show that familial and "sporadic" psoriasis share the same risk alleles. They also illustrate that substantial parametric linkage information can be extracted by accounting for linkage disequilibrium. Finally, they strongly suggest that a major susceptibility gene resides near HLA-C.	Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Radiat Oncol Canc Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Grad Sch, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; Univ Kiel, Dept Immunol, D-2300 Kiel, Germany; Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Kiel; University of Kiel	Elder, JT (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, 3312 Canc Ctr & Geriatr Ctr Bldg,Box 0932, Ann Arbor, MI 48109 USA.	jelder@umich.edu	Voorhees, John/AAM-9966-2020	Voorhees, John/0000-0003-1856-785X	NHGRI NIH HHS [P30 HG00209-03] Funding Source: Medline; NIAMS NIH HHS [R01 AR4274-01] Funding Source: Medline; NIGMS NIH HHS [GM52205] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM052205] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAHINA A, 1991, J INVEST DERMATOL, V97, P254, DOI 10.1111/1523-1747.ep12480361; BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; BODMER JG, 1995, TISSUE ANTIGENS, V46, P1; BUNCE M, 1994, TISSUE ANTIGENS, V44, P200, DOI 10.1111/j.1399-0039.1994.tb02381.x; Bunce M, 1996, TISSUE ANTIGENS, V48, P680, DOI 10.1111/j.1399-0039.1996.tb02692.x; CAMPBELL RD, 1993, IMMUNOL TODAY, V14, P349, DOI 10.1016/0167-5699(93)90234-C; CANNINGS C, 1977, CLIN GENET, V12, P208; CAO K, 1993, CHINESE MED J-PEKING, V106, P132; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P177; Christophers E, 1993, DERMATOLOGY GEN MED, P489; CHRISTOPHERS E, 1990, PSORIASIS, P15; CIVATTE J, 1977, ANN DERMATOL VENER, V104, P525; CLERGETDARPOUX F, 1982, ANN HUM GENET, V46, P363, DOI 10.1111/j.1469-1809.1982.tb01587.x; CURTIS D, 1995, AM J HUM GENET, V56, P811; DEBOER OJ, 1994, ARCH DERMATOL RES, V286, P87, DOI 10.1007/BF00370733; DEGLIESPOSTI MA, 1992, HUM IMMUNOL, V34, P242, DOI 10.1016/0198-8859(92)90023-G; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; FARBER EM, 1974, DERMATOLOGICA, V148, P1, DOI 10.1159/000251595; Foissac A, 1997, TISSUE ANTIGENS, V49, P197, DOI 10.1111/j.1399-0039.1997.tb02740.x; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; JOHNSON MT, 1978, NAT HLTH SURVEY, V212; KARVONEN J, 1976, ANN CLIN RES, V8, P298; Kimura A., 1991, HLA 1991 P 11 INT HI, VVolume 1, P397; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEELAYUWAT C, 1995, J IMMUNOL, V155, P692; LIN JD, 1991, J INVEST DERMATOL, V96, P535; MARSHALL B, 1993, HUM IMMUNOL, V38, P24, DOI 10.1016/0198-8859(93)90516-4; Matthews D, 1996, NAT GENET, V14, P231, DOI 10.1038/ng1096-231; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; MORGANROTH GS, 1991, J INVEST DERMATOL, V96, P333, DOI 10.1111/1523-1747.ep12465237; MUTO M, 1995, TISSUE ANTIGENS, V45, P362, DOI 10.1111/j.1399-0039.1995.tb02468.x; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; NAIR RP, 1995, HUM HERED, V45, P219, DOI 10.1159/000154293; NAKAGAWA H, 1991, ARCH DERMATOL RES, V283, P281, DOI 10.1007/BF00376613; RISCH N, 1989, PROG CLIN BIOL RES, V329, P183; RUSSELL TJ, 1972, NEW ENGL J MED, V287, P738, DOI 10.1056/NEJM197210122871503; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SchmittEgenolf M, 1996, J INVEST DERMATOL, V106, P711, DOI 10.1111/1523-1747.ep12345600; SCHMITTEGENOLF M, 1993, J INVEST DERMATOL, V100, P749, DOI 10.1111/1523-1747.ep12476080; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZALMAZOR ME, 1990, ARCH DERMATOL, V126, P1040, DOI 10.1001/archderm.126.8.1040; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Thompson EA, 1997, AM J HUM GENET, V60, P197; Thomson G, 1977, HLA DISEASE, P84; Tiwari JL, 1985, HLA DISEASE ASS, P32; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; Tsuji K, 1979, Acta Derm Venereol Suppl (Stockh), V87, P107; YOUNG A, 1993, GENETIC ANAL SYSTEM	53	105	105	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					191	199		10.1086/301899	http://dx.doi.org/10.1086/301899			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634500	Bronze, Green Published			2022-12-18	WOS:000074761000027
J	White, WM; Willard, HF; Van Dyke, DL; Wolff, DJ				White, WM; Willard, HF; Van Dyke, DL; Wolff, DJ			The spreading of X inactivation into autosomal material of an X;autosome translocation: Evidence for a difference between autosomal and X-chromosomal DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; STEROID SULFATASE; LATE REPLICATION; HIGH-RESOLUTION; Y-CHROMOSOME; MOUSE; EVOLUTION; IDENTIFICATION; REACTIVATION; METHYLATION	X inactivation involves initiation, propagation, and maintenance of genetic inactivation. Studies of replication timing in X;autosome translocations have suggested that X inactivation may spread into adjacent autosomal DNA. To examine the inactivation of autosomal material at the molecular level, we assessed the transcriptional activity of X-Linked and autosomal loci spanning an inactive translocation in a phenotypically normal female with a karyotype of 46,X,der(X)t(X;4)(q22;q24). Since 4q duplications usually manifest dysmorphic features and severe growth and mental retardation, the normal phenotype of this individual suggested the spreading of X inactivation throughout the autosomal material. Consistent with this model, reverse transcription-PCR analysis of 20 transcribed sequences spanning 4q24-qter revealed that three known genes and 11 expressed sequence tags (ESTs) were not expressed in a somatic-cell hybrid that carries the translocation chromosome. However, three ESTs and three known genes were expressed from the t(X;4) chromosome and thus "escaped" X inactivation. This direct assay of expression demonstrated that the spreading of inactivation from the adjoining X chromosome was incomplete and noncontiguous. These findings are broadly consistent with the existence of genes known to escape inactivation on normal inactive X chromosomes. However, the fact that a high proportion (30%) of tested autosomal genes escaped inactivation may indicate that autosomal material lacks X chromosome-specific features that are associated with the spreading and/or maintenance of inactivation.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Henry Ford Hosp, Dept Med Genet, Detroit, MI 48202 USA	Case Western Reserve University; University Hospitals of Cleveland; Henry Ford Health System; Henry Ford Hospital	Wolff, DJ (corresponding author), Ctr Med Genet, 1901 Res Blvd,Suite 160, Rockville, MD 20850 USA.				NIGMS NIH HHS [GM45441] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], ADV DEV BIO; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; Brown CJ, 1997, AM J HUM GENET, V60, P1333, DOI 10.1086/515488; BROWN CJ, 1994, NATURE, V394, P38; BUZIN CH, 1994, DEVELOPMENT, V120, P3529; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; COUTURIER J, 1979, HUM GENET, V49, P319, DOI 10.1007/BF00569351; DISTECHE CM, 1995, TRENDS GENET, V11, P17, DOI 10.1016/S0168-9525(00)88981-7; Disteche CM, 1997, AM J HUM GENET, V60, P1312, DOI 10.1086/515484; DISTECHE CM, 1984, HUM GENET, V66, P71, DOI 10.1007/BF00275190; DISTECHE CM, 1979, P NATL ACAD SCI USA, V76, P5234, DOI 10.1073/pnas.76.10.5234; DUTRILLAUX B, 1976, CHROMOSOMA, V58, P51, DOI 10.1007/BF00293440; EICHER EM, 1970, ADV GENET, V15, P175, DOI 10.1016/S0065-2660(08)60074-7; ELLIS N, 1990, CELL, V63, P977, DOI 10.1016/0092-8674(90)90501-5; FRASER N, 1987, DEVELOPMENT, V101, P127; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GARTLER SM, 1994, DEV GENET, V15, P504, DOI 10.1002/dvg.1020150609; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GRAVES JAM, 1991, CHROMOSOMA, V101, P63, DOI 10.1007/BF00357055; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KEITGES EA, 1986, HUM GENET, V72, P231, DOI 10.1007/BF00291884; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LINDENBAUM RH, 1991, AM J HUM GENET, V49, P285; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MATTEI MG, 1982, HUM GENET, V61, P295; MATTEI MG, 1981, HUM GENET, V56, P401, DOI 10.1007/BF00274702; MCCARREY JR, 1992, NAT GENET, V2, P200, DOI 10.1038/ng1192-200; MILLER AP, 1995, HUM MOL GENET, V4, P731, DOI 10.1093/hmg/4.4.731; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; MOHANDAS T, 1981, CYTOGENET CELL GENET, V29, P215, DOI 10.1159/000131572; MOHANDAS T, 1982, AM J HUM GENET, V34, P811; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; SCHANZ S, 1989, HUM GENET, V82, P244, DOI 10.1007/BF00291163; Schinzel A, 1984, CATALOGUE UNBALANCED; SCHWEMMLE S, 1989, HUM GENET, V83, P26, DOI 10.1007/BF00274142; THERMAN E, 1983, CYTOGENETICS MAMMALI, P315; TILGHMAN SM, 1995, CHROMATIN STRUCTURE, P201; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; VANDYKE DL, 1987, HUM GENET, V77, P57, DOI 10.1007/BF00284715; WATSON JM, 1990, P NATL ACAD SCI USA, V87, P7125, DOI 10.1073/pnas.87.18.7125; WILLARD HF, 1993, COLD SPRING HARB SYM, V58, P315, DOI 10.1101/SQB.1993.058.01.037; Willard HF, 1996, CELL, V86, P5, DOI 10.1016/S0092-8674(00)80071-9; WILLARD HF, 1983, CYTOGENETICS MAMMA A, P427; YEN PH, 1988, CELL, V55, P1123, DOI 10.1016/0092-8674(88)90257-7; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	54	105	108	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					20	28		10.1086/301922	http://dx.doi.org/10.1086/301922			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634520	Bronze, Green Published			2022-12-18	WOS:000074761000005
J	Hedrick, PW; Black, FL				Hedrick, PW; Black, FL			HLA and mate selection: No evidence in South Amerindians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MATING PREFERENCES; BALANCING SELECTION; MHC GENOTYPE; MICE; POPULATIONS; HUMANS; GENES	There have been reports of nonrandom mating (negative-assortative mating) or preference for individuals of different major histocompatibility complex (MHC) genotypes in both mice and humans. We have examined the association of HLA-A and HLA-B genotypes, both for each locus by itself and for two-locus genotypes, in mates of 194 couples from 11 South Amerindian tribes. The proportion of couples sampled averaged >50% of the total matings with progeny for 10 of the tribes. In nearly all cases, HLA-sharing proportions were very close to those expected from random mating, suggesting strong negative-assortative mating for MHC is not present in these South Amerindians.	YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510	Yale University	Hedrick, PW (corresponding author), ARIZONA STATE UNIV,DEPT BIOL,TEMPE,AZ 85287, USA.							ALBERTS SC, 1993, YEARB PHYS ANTHROPOL, V36, P71; BHATIA KK, 1995, AM J PHYS ANTHROPOL, V97, P291, DOI 10.1002/ajpa.1330970304; BLACK FL, 1981, AM J HUM GENET, V33, P894; BLACK FL, 1980, TISSUE ANTIGENS, V16, P368; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; EGID K, 1989, ANIM BEHAV, V38, P548, DOI 10.1016/S0003-3472(89)80051-X; EKLUND A, 1991, ANIM BEHAV, V42, P693, DOI 10.1016/S0003-3472(05)80254-4; Hedrick P, 1996, TRENDS ECOL EVOL, V11, P24, DOI 10.1016/0169-5347(96)80237-0; Hedrick P, 1997, NATURE, V387, P138, DOI 10.1038/387138a0; HEDRICK PW, 1992, GENETICS, V132, P575; HEDRICK PW, 1983, GENETICS, V104, P449; HEDRICK PW, 1983, AM J HUM GENET, V35, P1055; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; Hedrick PW, 1985, GENETICS POPULATIONS; HEDRICK PW, IN PRESS EVOLUTIONAR; JIN K, 1995, BIOMETRICS, V51, P1064, DOI 10.2307/2533005; MARKOW T, 1993, AM J HUM GENET, V53, P943; MURDOCK GP, 1957, AM ANTHROPOL, V59, P664, DOI 10.1525/aa.1957.59.4.02a00090; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; POLLACK MS, 1982, IMMUNOGENETICS, V15, P579; POTTS WK, 1991, NATURE, V352, P619, DOI 10.1038/352619a0; POTTS WK, 1993, TRENDS GENET, V9, P408, DOI 10.1016/0168-9525(93)90103-O; ROSENBERG LT, 1983, IMMUNOGENETICS, V17, P89, DOI 10.1007/BF00364292; VOLLRATH F, 1995, TRENDS ECOL EVOL, V10, P307, DOI 10.1016/S0169-5347(00)89113-2; vonSchantz T, 1996, P ROY SOC B-BIOL SCI, V263, P265, DOI 10.1098/rspb.1996.0041; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1988, SCIENCE, V240, P1331, DOI 10.1126/science.3375818	28	105	107	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					505	511		10.1086/515519	http://dx.doi.org/10.1086/515519			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326315	Green Published, hybrid			2022-12-18	WOS:A1997XY52300007
J	Inoue, K; Osaka, H; Sugiyama, N; Kawanishi, C; Onishi, H; Nezu, A; Kimura, K; Kimura, S; Yamada, Y; Kosaka, K				Inoue, K; Osaka, H; Sugiyama, N; Kawanishi, C; Onishi, H; Nezu, A; Kimura, K; Kimura, S; Yamada, Y; Kosaka, K			A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEOLIPID PROTEIN GENE; LINKED SPASTIC PARAPLEGIA; POINT MUTATION; TIGHT LINKAGE; X-CHROMOSOME; TYPE-1A; DOSAGE; FAMILY; HYPOMYELINATION; OVEREXPRESSION	Pelizaeus-Merzbacher disease (PMD) is an X-linked dysmyelinating disorder caused by abnormalities in the proteolipid protein (PLP) gene, which is essential for oligodendrocyte differentiation and CNS myelin formation. Although linkage analysis has shown the homogeneity at the PLP locus in patients with PMD, exonic mutations in the PLP gene have been identified in only 10%-25% of all cases, which suggests the presence of other genetic aberrations, including gene duplication. In this study, we examined five families with PMD not carrying exonic mutations in PLP gene, using comparative multiplex PCR (CM-PCR) as a semiquantitative assay of gene dosage. PLP gene duplications were identified in four families by CM-PCR and confirmed in three families by densitometric RFLP analysis. Because a homologous myelin protein gene, PMP22, is duplicated in the majority of patients with Charcot-Marie-Tooth 1A, PLP gene overdosage may be a important genetic abnormality in PMD and affect myelin formation.	YOKOHAMA CITY UNIV,SCH MED,DEPT PEDIAT,KANAZAWA KU,YOKOHAMA,KANAGAWA 236,JAPAN	Yokohama City University	Inoue, K (corresponding author), YOKOHAMA CITY UNIV,SCH MED,DEPT PSYCHIAT,KANAZAWA KU,3-9 FUKUURA,YOKOHAMA,KANAGAWA 236,JAPAN.							BOESPFLUGTANGUY O, 1994, AM J HUM GENET, V55, P461; BOISON D, 1989, EMBO J, V8, P3295, DOI 10.1002/j.1460-2075.1989.tb08490.x; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; CARANGO P, 1995, ANN NEUROL, V38, P610, DOI 10.1002/ana.410380409; CREMERS FPM, 1987, HUM GENET, V77, P23, DOI 10.1007/BF00284707; DINH DP, 1991, P NATL ACAD SCI USA, V88, P7562; DINH DP, 1993, HUM MOL GENET, V2, P465; DOLL R, 1992, AM J HUM GENET, V51, P161; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; GENCIC S, 1990, J NEUROSCI, V10, P117; GENCIC S, 1989, AM J HUM GENET, V45, P435; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; IWAKI A, 1993, HUM MOL GENET, V2, P19, DOI 10.1093/hmg/2.1.19; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; KITAGAWA K, 1993, NEURON, V11, P433, DOI 10.1016/0896-6273(93)90148-K; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; KUROSAWA K, 1993, HUM MOL GENET, V2, P2187, DOI 10.1093/hmg/2.12.2187; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; NADON NL, 1990, DEVELOPMENT, V110, P529; NAVE KA, 1986, P NATL ACAD SCI USA, V83, P9264, DOI 10.1073/pnas.83.23.9264; NEZU A, 1995, BRAIN DEV-JPN, V17, P175, DOI 10.1016/0387-7604(95)00028-A; OSAKA H, 1995, BIOCHEM BIOPH RES CO, V215, P835, DOI 10.1006/bbrc.1995.2539; Pelizaeus F., 1885, ARCH PSYCHIAT NERVEN, V16, P698; PRATT VM, 1993, AM J HUM GENET, V52, P1053; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; Seitelberger F., 1970, HDB CLINICAL NEUROLO, V10, P150; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J	38	105	107	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					32	39						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659540				2022-12-18	WOS:A1996VL45500006
J	Renieri, A; Bruttini, M; Galli, L; Zanelli, P; Neri, T; Rossetti, S; Turco, A; Heiskari, N; Zhou, J; Gusmano, R; Massella, L; Banfi, G; Scolari, F; Sessa, A; Rizzoni, G; Tryggvason, K; Pignatti, PF; Savi, M; Ballabio, A; DeMarchi, M				Renieri, A; Bruttini, M; Galli, L; Zanelli, P; Neri, T; Rossetti, S; Turco, A; Heiskari, N; Zhou, J; Gusmano, R; Massella, L; Banfi, G; Scolari, F; Sessa, A; Rizzoni, G; Tryggvason, K; Pignatti, PF; Savi, M; Ballabio, A; DeMarchi, M			X-linked Alport syndrome: An SSCP-based mutation survey over all 51 exons of the COL4A5 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN GENE; CHAIN; IDENTIFICATION; HETEROGENEITY; DELETIONS; GLYCINE	The COL4A5 gene encodes the alpha 5 (type IV) collagen chain and is defective in X-linked Alport syndrome (AS). Here, we report the first systematic analysis of all 51 exons of COL4A5 gene in a series of 201 Italian AS patients. We have previously reported nine major rearrangements, as well as 18 small mutations identified in the same patient series by SSCP analysis of several exons. After systematic analysis of all 51 exons of COL4A5, we have now identified 30 different mutations: 10 glycine substitutions in the triple helical domain of the protein, 3 frameshift mutations, 4 in-frame deletions, 1 start codon, 1 nonsense, and 5 splice-site mutations. These mutations were either unique or found in two unrelated families, thus excluding the presence of a common mutation in the coding part of the gene. Overall, mutations were detected in only 45% of individuals with a certain or likely diagnosis of X-linked AS. This finding suggests that mutations in noncoding segments of COL4A5 account for a high number of X-linked AS cases. An alternative hypothesis is the presence of locus heterogeneity, even within the X-linked form of the disease. A genotype/phenotype comparison enabled us to better substantiate a significant correlation between the degree of predicted disruption of the alpha 5 chain and the severity of phenotype in affected male individuals. Our study has significant implications in the diagnosis and follow-up of AS patients.	UNIV PARMA,I-43100 PARMA,ITALY; UNIV VERONA,INST BIOL SCI & GENET,I-37100 VERONA,ITALY; DEPT BIOCHEM,OULU,FINLAND; BIOCTR OULU,OULU,FINLAND; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA; IST GIANNINA GASLINI,DEPT PEDIAT NEPHROL,I-16148 GENOA,ITALY; OSPED BAMBINO GESU,DEPT PEDIAT NEPHROL,ROME,ITALY; POLICLIN MAGGIORE,DEPT NEPHROL,MILAN,ITALY; SPEDALI CIVILE,DEPT NEPHROL,BRESCIA,ITALY; OSPED VIMERCATE,DEPT NEPHROL,VIMERCATE,ITALY; UNIV TURIN,DEPT CLIN & BIOL SCI,TURIN,ITALY	University of Parma; University of Verona; Finland National Institute for Health & Welfare; University of Oulu; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Bambino Gesu; Hospital Spedali Civili Brescia; Ospedale di Vimercate; University of Turin	Renieri, A (corresponding author), POLICLIN LE SCOTTE,DEPT BIOL MOLEC,VIALE BRACCI 2,I-53100 SIENA,ITALY.		Renieri, Alessandra/K-5950-2016; De Marchi, Mario E./G-7558-2011; scolari, francesco/AAC-5957-2022; BALLABIO, Andrea/AAL-2672-2020; Massella, Laura/AAA-6165-2020	Renieri, Alessandra/0000-0002-0846-9220; De Marchi, Mario E./0000-0002-6425-3205; BALLABIO, Andrea/0000-0003-1381-4604; Scolari, Francesco/0000-0003-0233-9705	Telethon [E.0134, TGM06S01, TGM94000] Funding Source: Medline	Telethon(Fondazione Telethon)		BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BOYE E, 1995, HUM MUTAT, V5, P197, DOI 10.1002/humu.1380050303; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; DOCKHORNDWORNICZAK B, 1991, NUCLEIC ACIDS RES, V19, P2500, DOI 10.1093/nar/19.9.2500; FEINGOLD J, 1985, KIDNEY INT, V27, P672, DOI 10.1038/ki.1985.63; FLINTER FA, 1988, LANCET, V2, P1005, DOI 10.1016/S0140-6736(88)90753-2; FORREST S, 1995, NAT GENET, V10, P375, DOI 10.1038/ng0895-375; GOVAN JAA, 1983, BRIT J OPHTHALMOL, V67, P493, DOI 10.1136/bjo.67.8.493; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; Gubler M C, 1993, Adv Nephrol Necker Hosp, V22, P15; GUO CY, 1993, KIDNEY INT, V44, P1316, DOI 10.1038/ki.1993.384; HABIB R, 1982, KID INT S, V11, P20; HAMALAINEN ER, IN PRESS HUM MUTAT; HASSTEDT SJ, 1986, AM J HUM GENET, V38, P940; HEIDET L, 1995, HUM MOL GENET, V4, P99, DOI 10.1093/hmg/4.1.99; HEISKARI N, IN PRESS J AM SOC NE; KNEBELMANN B, 1992, AM J HUM GENET, V51, P135; KRAWCZAK M, 1991, HUM GENET, V86, P425; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEMMINK HH, 1993, GENOMICS, V17, P485, DOI 10.1006/geno.1993.1351; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; MASSELLA L, 1994, NEPHROL DIAL TRANSPL, V9, P1408; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PEISSEL B, 1994, HUM MUTAT, V3, P386, DOI 10.1002/humu.1380030410; PEISSEL B, 1995, J CLIN INVEST, V96, P1948, DOI 10.1172/JCI118241; RENIERI A, 1993, HUM GENET, V92, P417, DOI 10.1007/BF01247348; RENIERI A, 1994, NEPHRON, V67, P444, DOI 10.1159/000188020; RENIERI A, 1994, HUM MOL GENET, V3, P201, DOI 10.1093/hmg/3.1.201; RENIERI A, 1995, AM J MED GENET, V59, P380, DOI 10.1002/ajmg.1320590320; RENIERI A, 1994, HUM MUTAT, V4, P195, DOI 10.1002/humu.1380040304; RENIERI A, IN PRESS MOL PATHOLO; Renieri Alessandra, 1992, Human Molecular Genetics, V1, P127, DOI 10.1093/hmg/1.2.127; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; TRYGGVASON K, IN PRESS MOL PATHOLO; Turco AE, 1995, CLIN GENET, V48, P261; WANG Q, 1993, J BIOL CHEM, V268, P25162; YAP EPH, 1992, TRENDS GENET, V8, P49, DOI 10.1016/0168-9525(92)90339-6; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449; ZHOU J, 1994, J BIOL CHEM, V269, P6608; ZHOU J, 1991, GENOMICS, V9, P1, DOI 10.1016/0888-7543(91)90214-Y	44	105	111	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1192	1204						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651296				2022-12-18	WOS:A1996UM27100012
J	Floridia, G; Piantanida, M; Minelli, A; Dellavecchia, C; Bonaglia, C; Rossi, E; Gimelli, G; Croci, G; Franchi, F; Gilgenkrantz, S; Grammatico, P; Dalpra, L; Wood, S; Danesino, C; Zuffardi, O				Floridia, G; Piantanida, M; Minelli, A; Dellavecchia, C; Bonaglia, C; Rossi, E; Gimelli, G; Croci, G; Franchi, F; Gilgenkrantz, S; Grammatico, P; Dalpra, L; Wood, S; Danesino, C; Zuffardi, O			The same molecular mechanism at the maternal meiosis I produces mono- and dicentric 8p duplications	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT ARM; HUMAN GENOME; CHROMOSOME-8; GENE; MAP; SEQUENCE	We studied 16 cases of 8p duplications, with a karyotype 46,XX or XY,dup(8p), associated with mental retardation, facial dysmorphisms, and brain defects. We demonstrate that these 8p rearrangements can be either dicentric (6 cases) with the second centromere at the tip of the short arm or monocentric (10 cases). The distal 8p23 region, from D8S349 to the telomere, including the defensin 1 locus, is deleted in all the cases. The region spanning from D8S252 to D8S265, at the proximal 8p23 region, is present in single copy, and the remaining part of the abnormal 8 short arm is duplicated in the dicentric cases and partially duplicated in the monocentric ones. The distal edge of the duplication always spans up to D8S552 (8p23.1), while its proximal edge includes the centromere in the dicentric cases and varies from case to case in the monocentric ones. The analysis of DNA polymorphisms indicates that the rearrangement is consistently of maternal origin. In the deleted region, only paternal alleles were present in the patient. In the duplicated region, besides one paternal allele, some loci showed two different maternal alleles, while others, which were duplicated by FISH analysis, showed only one maternal allele. We hypothesize that, at maternal meiosis I, there was abnormal pairing of chromosomes 8 followed by anomalous crossover at the regions delimited by D8S552 and D8S35 and by D8S252 and D8S349, which presumably contain inverted repeated sequences. The resulting dicentric chromosome, 8qter-8p23.1(D8S552)::8p23.1-(D8S35)-8qter, due to the presence of two centromeres, breaks at anaphase I, generating an inverted duplicated 8p, dicentric if the breakage occurs at the centromere or monocentric if it occurs between centromeres.	UNIV PAVIA,I-27100 PAVIA,ITALY; IST GIANNINA GASLINI,LAB CITOGENET,I-16148 GENOA,ITALY; AZIENDA OSPED S MARIA NUOVA,GENET LAB,REGGIO EMILIA,ITALY; CHRU,GENET LAB,NANCY,FRANCE; UNIV ROMA LA SAPIENZA,CATTEDRA GENET MED,I-00185 ROME,ITALY; UNIV MILAN,DIPARTIMENTO BIOL & GENET SCI MED,I-20122 MILAN,ITALY; UNIV MILAN,OSPED SAN RAFFAELE,LAB CITOGENET,I-20127 MILAN,ITALY; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC V5Z 1M9,CANADA	University of Pavia; University of Genoa; IRCCS Istituto Giannina Gaslini; CHU de Nancy; Sapienza University Rome; University of Milan; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of British Columbia			FLORIDIA, GIOVANNA/A-6640-2015; Bonaglia, Maria Clara/K-2775-2016; Rossi, Elena/O-1664-2016	FLORIDIA, GIOVANNA/0000-0003-4187-8816; Bonaglia, Maria Clara/0000-0002-7121-7712; Rossi, Elena/0000-0001-9152-435X; zuffardi, orsetta/0000-0002-1466-4559				BARBER JCK, 1994, AM J MED GENET, V50, P296, DOI 10.1002/ajmg.1320500315; BONDESON ML, 1995, HUM MOL GENET, V4, P615, DOI 10.1093/hmg/4.4.615; CHENG SD, 1994, AM J HUM GENET, V55, P753; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DAHER KA, 1988, P NATL ACAD SCI USA, V85, P7327, DOI 10.1073/pnas.85.19.7327; DEGEN SJF, 1985, J BIOL CHEM, V261, P6972; DEMCZUK S, 1995, HUM GENET, V96, P9, DOI 10.1007/BF00214179; DIGILIO MC, 1994, J MED GENET, V31, P238, DOI 10.1136/jmg.31.3.238; DILL FJ, 1987, CLIN GENET, V32, P109; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DONLON TA, 1987, CYTOGENET CELL GENET, V46, P607; DUTRILLAUX B, 1981, HUM GENET, V57, P93; FELDMAN GL, 1993, AM J MED GENET, V47, P482, DOI 10.1002/ajmg.1320470410; FLINT J, 1994, AM J HUM GENET, V55, P505; GEORGE DL, 1976, CYTOGENET CELL GENET, V17, P282, DOI 10.1159/000130723; GUO WJ, 1995, AM J MED GENET, V58, P230, DOI 10.1002/ajmg.1320580307; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HEINZMANN C, 1987, NUCLEIC ACIDS RES, V15, P6763, DOI 10.1093/nar/15.16.6763; HENDERSON KG, 1992, AM J MED GENET, V44, P615, DOI 10.1002/ajmg.1320440517; HUTCHINSON R, 1992, J MED GENET, V29, P407, DOI 10.1136/jmg.29.6.407; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LAMB J, 1993, AM J HUM GENET, V52, P668; MINELLI A, 1993, HUM GENET, V92, P391, DOI 10.1007/BF01247342; MITCHELL JJ, 1994, AM J MED GENET, V4, P384; MYERS MW, 1987, EMBO J, V6, P1617, DOI 10.1002/j.1460-2075.1987.tb02409.x; OSHIMA J, 1994, GENOMICS, V23, P100, DOI 10.1006/geno.1994.1464; RAIMONDI E, 1987, NUCLEIC ACIDS RES, V17, P7653; RAY M, 1980, ANN GENET-PARIS, V23, P100; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; ROSSI E, 1994, GENOMICS, V24, P34, DOI 10.1006/geno.1994.1579; ROSSI E, 1993, J MED GENET, V30, P926, DOI 10.1136/jmg.30.11.926; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; SENGUPTA DN, 1986, BIOCHEM BIOPH RES CO, V136, P341, DOI 10.1016/0006-291X(86)90916-2; Spurr N. K., 1995, Cytogenetics and Cell Genetics, V68, P147, DOI 10.1159/000133908; TUPLER R, 1994, ANN GENET-PARIS, V37, P153; WALLACE BMN, 1985, ANN HUM GENET, V49, P215, DOI 10.1111/j.1469-1809.1985.tb01695.x; WEBB T, 1994, J MED GENET, V31, P585, DOI 10.1136/jmg.31.8.585; WELEBER RG, 1976, ANN GENET-PARIS, V19, P241; WOOD S, 1992, CYTOGENET CELL GENET, V59, P243, DOI 10.1159/000133260; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; [No title captured]	44	105	110	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					785	796						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644743				2022-12-18	WOS:A1996UA38000017
J	NATH, SK; MAJUMDER, PP; NORDLUND, JJ				NATH, SK; MAJUMDER, PP; NORDLUND, JJ			GENETIC EPIDEMIOLOGY OF VITILIGO - MULTILOCUS RECESSIVITY CROSS-VALIDATED	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIGOGENIC TRAITS; LINKAGE ANALYSIS; 2-LOCUS MODELS; DISEASE	Vitiligo is a dermatological disorder characterized by hypopigmentary patches that tend to become progressive over time. There are reports of extensive familial aggregation. A genetic model for this disorder was earlier proposed by us. This model postulates that recessive alleles at multiple unlinked autosomal loci interact epistatically in the pathogenesis of vitiligo. The present family study was primarily undertaken to cross-validate the proposed genetic model. Data on 194 families from the United States were collected. Each family was ascertained through an affected proband. Analyses of these data reveal that similar to 20% of probands have at least one first-degree relative afflicted with vitiligo. All types of first-degree relatives of probands show a significant risk of developing vitiligo. Results of segregation and robustness analyses reveal that the genetic model postulated by us previously is the most parsimonious model for the present family data set.	INDIAN STAT INST,ANTHROPOMETRY & HUMAN GENET UNIT,CALCUTTA 700035,W BENGAL,INDIA; UNIV CINCINNATI,MED CTR,DEPT DERMATOL,CINCINNATI,OH 45267	Indian Statistical Institute; Indian Statistical Institute Kolkata; University of Cincinnati								Breslow N, 1980, STATISTICAL METHODS, V32; CHAKRAVARTI IM, 1967, HDB METHODS APPLIED, V1; DAS SK, 1985, GENET EPIDEMIOL, V2, P71; DIZIER MH, 1993, AM J HUM GENET, V53, P793; El-Mofty A. M., 1968, VITILIGO PSORALENS; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; GOLDIN LR, 1993, AM J HUM GENET, V53, P1006; HAFEZ M, 1983, ACTA DERM-VENEREOL, V63, P249; HARTL DL, 1968, J THEOR BIOL, V20, P129, DOI 10.1016/0022-5193(68)90186-0; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; HEARING VJ, 1993, AM J HUM GENET, V52, P1; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; LERNER AB, 1959, J INVEST DERMATOL, V32, P285, DOI 10.1038/jid.1959.49; LI CC, 1987, AM J HUM GENET, V41, P517; MAJUMDER PP, 1989, AM J HUM GENET, V44, P86; MAJUMDER PP, 1993, ARCH DERMATOL, V129, P994, DOI 10.1001/archderm.129.8.994; MAJUMDER PP, 1988, AM J HUM GENET, V43, P119; MAJUMDER PP, 1992, J GENET, V71, P89, DOI 10.1007/BF02927890; MAJUMDER PP, 1993, HUMAN POPULATION GENETICS, P139; MAJUMDER PP, 1989, AM J HUM GENET, V45, P412; MOSHER DB, 1979, DERMATOLOGY GENERAL, P582; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; NORDLUND JJ, 1987, ARCH DERMATOL, V123, P1005, DOI 10.1001/archderm.123.8.1005; PENROSE L S, 1953, Acta Genet Stat Med, V4, P257; QUEVEDO WC, 1987, DERMATOLOGY GENERAL, P224; RICE JP, 1993, AM J HUM GENET, V53, P66; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X; WICK MM, 1987, DERMATOLOGY GENERAL, P251	32	105	111	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					981	990						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977362				2022-12-18	WOS:A1994QB68200019
J	NOBLE, EP; BERMAN, SM; OZKARAGOZ, TZ; RITCHIE, T				NOBLE, EP; BERMAN, SM; OZKARAGOZ, TZ; RITCHIE, T			PROLONGED P300 LATENCY IN CHILDREN WITH THE D-2 DOPAMINE-RECEPTOR AL ALLELE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EVENT-RELATED POTENTIALS; EVOKED-POTENTIALS; BRAIN POTENTIALS; DEVELOPING ALCOHOLISM; PARKINSONS-DISEASE; AUDITORY-STIMULI; LOW-RISK; GENE; ASSOCIATION; COMPONENT	Previous studies have indicated the presence of a hereditary component in the generation of the P300, or P3, a late positive component of the event-related potential. Moreover, the dopaminergic system has been implicated in the P3. In the present study, 98 healthy Caucasian boys, mean age of 12.5 years and of above-average intelligence, were studied. The sample was composed of 32 sons of active alcoholic (SAA) fathers, 36 sons of recovering alcoholic (SRA) fathers, and 30 sons of social drinker (SSD) fathers, with none of them having yet begun to consume alcohol or other drugs. TaqI A D-2 dopamine receptor alleles (A1 and A2) were determined. A significant difference in the frequency of the A1 allele was found among these three groups of boys, with the SAA group having the highest A1 allele frequency (.313), followed by the SRA (.133) and the SSD (.133) groups. The relationship of the A1 and A2 alleles to P3 amplitude and latency was also determined. The results showed no significant difference in P3 amplitude between boys with the A1 and A2 allele. However, P3 latency was significantly longer in the total sample of boys with the A1 allele compared with those carrying the A2 allele. These findings suggest that polymorphism of the D-2 dopamine receptor gene is an important determinant of P3 latency.	UNIV CALIF LOS ANGELES, INST BRAIN RES, LOS ANGELES, CA USA	University of California System; University of California Los Angeles	NOBLE, EP (corresponding author), UNIV CALIF LOS ANGELES, ALCOHOL RES CTR, INST NEUROPSYCHIAT, 760 WESTWOOD PL, LOS ANGELES, CA 90024 USA.				NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008020] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA-08020] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BEGLEITER H, 1984, SCIENCE, V225, P1493, DOI 10.1126/science.6474187; BERMAN S, IN PRESS AMSAS PRINC; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BLUM K, 1991, ALCOHOL, V8, P409, DOI 10.1016/0741-8329(91)90693-Q; BOLOS AM, 1990, JAMA-J AM MED ASSOC, V264, P3156; BROWN WS, 1983, ELECTROEN CLIN NEURO, V55, P277, DOI 10.1016/0013-4694(83)90205-5; CIESIELSKI KT, 1985, ALCOHOL ALCOHOLISM, V20, P403; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; CORTES R, 1989, BRAIN RES, V483, P30, DOI 10.1016/0006-8993(89)90031-0; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; COURCHESNE E, 1984, TUTORIALS ERP RES EN, P329; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; DONCHIN E, 1984, COGNITIVE PSYCHOPHYS, P107; ELMASIAN R, 1982, P NATL ACAD SCI-BIOL, V79, P7900, DOI 10.1073/pnas.79.24.7900; FRIEDMAN D, 1975, ELECTROEN CLIN NEURO, V38, P255, DOI 10.1016/0013-4694(75)90246-1; GELERNTER J, 1991, JAMA-J AM MED ASSOC, V266, P1801, DOI 10.1001/jama.266.13.1801; GOMER FE, 1976, PHYSIOL PSYCHOL, V4, P61; GOODIN DS, 1978, ELECTROEN CLIN NEURO, V44, P447, DOI 10.1016/0013-4694(78)90029-9; GOODIN DS, 1978, BRAIN, V101, P635, DOI 10.1093/brain/101.4.635; GRANDY DK, 1989, AM J HUM GENET, V45, P778; HANSCH EC, 1982, ANN NEUROL, V11, P599, DOI 10.1002/ana.410110608; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HAUGE XY, 1991, GENOMICS, V10, P527, DOI 10.1016/0888-7543(91)90431-D; HILL SY, 1988, ALCOHOL CLIN EXP RES, V12, P545, DOI 10.1111/j.1530-0277.1988.tb00240.x; HILL SY, 1990, ALCOHOL CLIN EXP RES, V14, P6, DOI 10.1111/j.1530-0277.1990.tb00438.x; HOWARD L, 1985, DEV PSYCHOL, V21, P283, DOI 10.1037/0012-1649.21.2.283; JELLINEK EM, 1960, DISEASE CONCEPT ALCO; JESSOR R, 1977, PROBLEM BEHAVIOR PSY; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; MORROW LA, 1992, ARCH NEUROL-CHICAGO, V49, P315, DOI 10.1001/archneur.1992.00530270135031; NESHIGE R, 1988, J NEUROL NEUROSUR PS, V51, P1120, DOI 10.1136/jnnp.51.9.1120; NEWTON MR, 1989, BRAIN, V112, P1637, DOI 10.1093/brain/112.6.1637; Noble E P, 1993, Drug Alcohol Rev, V12, P283, DOI 10.1080/09595239300185341; NOBLE EP, 1991, JAMA-J AM MED ASSOC, V265, P2667, DOI 10.1001/jama.1991.03460200047016; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; NOBLE EP, IN PRESS ALCOHOL ALC; OCONNOR S, 1986, PROG NEURO-PSYCHOPH, V10, P211, DOI 10.1016/0278-5846(86)90075-8; ODONNELL BF, 1987, BIOL PSYCHOL, V24, P23, DOI 10.1016/0301-0511(87)90097-4; OLDS JM, 1986, HUMAN GENETIC DISEAS, P1; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; PFEFFERBAUM A, 1979, ELECTROEN CLIN NEURO, V47, P637, DOI 10.1016/0013-4694(79)90292-X; PFEFFERBAUM A, 1987, ALCOHOL, V4, P275, DOI 10.1016/0741-8329(87)90023-1; PICTON TW, 1984, PSYCHOPHYSIOLOGY, V21, P312, DOI 10.1111/j.1469-8986.1984.tb02941.x; POLICH J, 1987, ALCOHOL, V4, P301, DOI 10.1016/0741-8329(87)90027-9; POLICH J, 1987, NEUROPSYCHOLOGIA, V25, P299, DOI 10.1016/0028-3932(87)90143-6; POLICH J, 1988, ALCOHOL CLIN EXP RES, V12, P248, DOI 10.1111/j.1530-0277.1988.tb00189.x; POLICH J, 1986, ELECTROEN CLIN NEURO, V65, P236, DOI 10.1016/0168-5597(86)90059-6; POLICH J, 1993, ELECTROEN CLIN NEURO, V86, P408, DOI 10.1016/0013-4694(93)90136-J; POLICH J, 1984, PSYCHOPHYSIOLOGY, V21, P592; POLICH J, 1983, PSYCHOPHYSIOLOGY, V20, P665, DOI 10.1111/j.1469-8986.1983.tb00936.x; POLICH J, 1988, ALCOHOL CLIN EXP RES, V12, P368, DOI 10.1111/j.1530-0277.1988.tb00210.x; POLICH J, IN PRESS PSYCHOL B; PORJESZ B, 1981, ALCOHOL CLIN EXP RES, V5, P304, DOI 10.1111/j.1530-0277.1981.tb04904.x; Porjesz B., 1985, ALCOHOL BRAIN CHRONI, P139; RITTER W, 1969, SCIENCE, V164, P326, DOI 10.1126/science.164.3877.326; ROGERS TD, 1991, ACTA PSYCHIAT SCAND, V83, P412, DOI 10.1111/j.1600-0447.1991.tb05566.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCATTON B, 1982, NEUROLOGY, V32, P1039, DOI 10.1212/WNL.32.9.1039; SCHMIDT AL, 1985, ALCOHOL, V2, P529, DOI 10.1016/0741-8329(85)90129-6; SEEMAN P, 1987, SYNAPSE, V1, P399, DOI 10.1002/syn.890010503; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SEVERSON JA, 1982, J NEUROCHEM, V39, P1623, DOI 10.1111/j.1471-4159.1982.tb07996.x; SKLARE DA, 1984, ELECTROENCEPHALOGR C, V63, P154; SPITZER RL, 1989, INSTRUCTIONAL MANUAL; SQIRES KC, 1977, ELECTROEN CLIN NEURO, V42, P1; SQUIRES NK, 1977, J EXP PSYCHOL HUMAN, V3, P299, DOI 10.1037/0096-1523.3.2.299; STANZIONE P, 1991, ELECTROEN CLIN NEURO, V80, P446, DOI 10.1016/0168-5597(91)90093-D; STANZIONE P, 1990, ELECTROEN CLIN NEURO, P216; STARKSTEIN SE, 1989, J NEUROL NEUROSUR PS, V52, P338, DOI 10.1136/jnnp.52.3.338; STEINHAUER SR, 1987, ALCOHOL, V4, P307, DOI 10.1016/0741-8329(87)90028-0; SURWILLO WW, 1980, BEHAV GENET, V10, P201, DOI 10.1007/BF01066270; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; SYNDULKO K, 1982, CLIN APPLICATIONS EV, P279; UHL G, 1993, TRENDS NEUROSCI, V16, P83, DOI 10.1016/0166-2236(93)90128-9; Wechsler D., 1974, MANUAL WECHSLER INTE; WHIPPLE SC, 1988, J STUD ALCOHOL, V49, P240, DOI 10.15288/jsa.1988.49.240; WHIPPLE SC, 1991, ALCOHOL, V8, P321, DOI 10.1016/0741-8329(91)90497-K; WONG DF, 1984, SCIENCE, V226, P1393, DOI 10.1126/science.6334363; 1992, SAS P229 TECHN REP; 1989, SAS USERS GUIDE VERS	84	105	108	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					658	668						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128963				2022-12-18	WOS:A1994NC83600010
J	OSBORNE, L; KNIGHT, R; SANTIS, G; HODSON, M				OSBORNE, L; KNIGHT, R; SANTIS, G; HODSON, M			A MUTATION IN THE 2ND NUCLEOTIDE BINDING FOLD OF THE CYSTIC-FIBROSIS GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIDRUG RESISTANCE; SEQUENCE; IDENTIFICATION; TRANSPORT; DNA; ESCHERICHIA-COLI-K12; TYPHIMURIUM; COMPONENTS; PROTEIN; CLONING	The discovery last year of the deletion of a phenylalanine residue at amino acid position 508 of the cystic fibrosis (CF) gene has meant that approximately 70% of mutant chromosomes associated with CF can be accounted for. We report the finding of a substitution at nucleotide position 4041 of the CF gene, resulting in a change from asparagine to lysine at amino acid position 1303. We believe that this is a disease-causing mutation, as it involves a nonconservative amino acid change and has only been found on CF chromosomes with a consistent haplotype background. The mutation was detected using direct sequencing of PCR-amplified genomic DNA and was confirmed by dot hybridization to both normal and mutant allele-specific oligonucleotides. The mutation was detected on three chromosomes from four individuals but not on any normal chromosome. Its presence in the heterozygous state is not correlated with the clinical status of the individual patients.			OSBORNE, L (corresponding author), NATL HEART & LUNG INST,DEPT CYST FIBROSIS,EMMANUEL KAYE BLDG,MANRESA RD,LONDON SW3 6LR,ENGLAND.							BELL AW, 1986, J BIOL CHEM, V261, P7652; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1990, NEW ENGL J MED, V323, P1685, DOI 10.1056/NEJM199012133232407; DEAN M, 1990, CELL, V61, P833; ESTIVILL X, 1989, LANCET, V2, P1404; FRIEDRICH MJ, 1986, J BACTERIOL, V167, P928, DOI 10.1128/jb.167.3.928-934.1986; GILSON E, 1982, NUCLEIC ACIDS RES, V10, P7449, DOI 10.1093/nar/10.22.7449; GROS P, 1988, MOL CELL BIOL, V8, P2770, DOI 10.1128/MCB.8.7.2770; HIGGINS CF, 1982, NATURE, V298, P723, DOI 10.1038/298723a0; HILES ID, 1987, J MOL BIOL, V195, P125, DOI 10.1016/0022-2836(87)90332-9; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; OHARE K, 1984, J MOL BIOL, V180, P437, DOI 10.1016/0022-2836(84)90021-4; RIORDAN JR, 1989, SCIENCE, V245, P1066; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SANTIS G, 1990, LANCET, V335, P1426, DOI 10.1016/0140-6736(90)91448-J; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0	19	105	108	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					608	612						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998343				2022-12-18	WOS:A1991FK47000021
J	COHEN, IL; SUDHALTER, V; PFADT, A; JENKINS, EC; BROWN, WT; VIETZE, PM				COHEN, IL; SUDHALTER, V; PFADT, A; JENKINS, EC; BROWN, WT; VIETZE, PM			WHY ARE AUTISM AND THE FRAGILE-X SYNDROME ASSOCIATED - CONCEPTUAL AND METHODOLOGICAL ISSUES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARTIN-BELL SYNDROME; INFANTILE-AUTISM; SWEDISH MULTICENTER; MENTAL-RETARDATION; MALES; DISABILITIES; CHROMOSOME; BEHAVIOR; GAZE	Investigations of the association between autism and the fragile-X syndrome have yielded conflicting results with some studies indicating a strong correlation and others indicating no relation between the disorders. In this paper, we review the relevant research on this controversy and discuss the conceptual and methodological problems involved in such an inquiry. We conclude that autism and fragile X are associated and that this relation will prove fruitful in understanding the role of the X chromosome in a variety of behavior disorders and in unraveling various theoretical accounts on the etiology of autism.	NEW YORK STATE OFF MENTAL RETARDAT & DEV DISABIL, STATEN ISL, NY USA; CORNELL UNIV, MED CTR, NEW YORK HOSP, COLL MED, NEW YORK, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital	COHEN, IL (corresponding author), NEW YORK STATE INST BASIC RES DEV DISABILITIES, DEPT PSYCHOL, 1050 FOREST HILL RD, STATEN ISL, NY 10314 USA.		Brown, William/GXN-2777-2022		NIMH NIH HHS [MH38201] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038201] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BLOMQUIST HK, 1985, CLIN GENET, V27, P113; BREGMAN JD, 1988, J AUTISM DEV DISORD, V18, P343, DOI 10.1007/BF02212191; BROWN WT, 1982, LANCET, V1, P100; BROWN WT, 1986, AM J MED GENET, V23, P341, DOI 10.1002/ajmg.1320230126; BROWN WT, 1982, J AUTISM DEV DISORD, V12, P303, DOI 10.1007/BF01531375; BUCKLE VJ, 1989, CYTOGENET CELL GENET, V51, P972; COHEN IL, 1989, J CHILD PSYCHOL PSYC, V30, P845, DOI 10.1111/j.1469-7610.1989.tb00286.x; COHEN IL, 1988, AM J MENT RETARD, V92, P436; COHEN IL, IN PRESS AM J MED GE; Coleman M., 1976, AUTISTIC SYNDROMES; EINFELD S, 1989, AM J MED GENET, V34, P187, DOI 10.1002/ajmg.1320340211; FISCH GS, 1986, AM J PSYCHIAT, V143, P71; FISCH GS, 1988, AM J MED GENET, V30, P655, DOI 10.1002/ajmg.1320300166; Fonnum F., 1987, PSYCHOPHARMACOLOGY 3, P173; GILLBERG C, 1983, BRIT J PSYCHIAT, V143, P256, DOI 10.1192/bjp.143.3.256; GOLDFINE PE, 1985, AM J PSYCHIAT, V142, P108; Green DM., 1966, SIGNAL DETECTION THE; HAGERMAN R, 1985, AM J DIS CHILD, V139, P674, DOI 10.1001/archpedi.1985.02140090036021; HAGERMAN RJ, 1986, AM J MED GENET, V23, P359, DOI 10.1002/ajmg.1320230128; Hommer DW, 1987, PSYCHOPHARMACOLOGY 3, P977; HUTT C, 1966, BEHAV SCI, V11, P346, DOI 10.1002/bs.3830110504; JENKINS EC, 1988, AM J MED GENET, V30, P429, DOI 10.1002/ajmg.1320300144; KEMPER TL, 1988, DISORDERS DEV NERVOU, P125; LAIRD CD, 1987, GENETICS, V117, P587; LEVITAS A, 1983, FRAGILE X SYNDROME D, P153; LLOYD KG, 1987, PSYCHOPHARMACOLOGY 3, P183; LOVAAS OI, 1987, J CONSULT CLIN PSYCH, V55, P3, DOI 10.1037/0022-006X.55.1.3; MERYASH DL, 1982, J AUTISM DEV DISORD, V12, P295, DOI 10.1007/BF01531374; PARTINGTON MW, 1984, AM J MED GENET, V17, P175, DOI 10.1002/ajmg.1320170111; PAYTON JB, 1986, ANN NEUROL, V20, P417; REISS AL, 1988, NEW ENGL J MED, V319, P1152; REISS AL, IN PRESS J AM ACAD C; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; ROSS S, 1976, 1ST COURSE PROBABILI; SHAH A, 1986, SOCIAL BEHAVIOR AUTI, P153; SUTHERLAND GR, IN PRESS AM J MED GE; UNGERER JA, 1985, CHILDREN EMOTIONAL D, P137; VENTER PA, 1986, AM J MED GENET, V23, P597, DOI 10.1002/ajmg.1320230154; VOELCKEL MA, 1989, HUM GENET, V81, P353, DOI 10.1007/BF00283690; WAHLSTROM J, 1986, AM J MED GENET, V23, P403, DOI 10.1002/ajmg.1320230132; WATSON MS, 1984, NEW ENGL J MED, V310, P1462; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; WISNIEWSKI KE, 1985, ANN NEUROL, V18, P665, DOI 10.1002/ana.410180607; WOLFF PH, 1989, AM J MENT RETARD, V93, P406; ZAHNER GEP, 1987, HDB AUTISM PERVASIVE, P199; [No title captured]; 1980, DIAGNOSTIC STATISTIC; 1987, DIAGNOSTIC STATISTIC; [No title captured]	49	105	106	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					195	202						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990832				2022-12-18	WOS:A1991EV74400003
J	DEBRAEKELEER, M; LAROCHELLE, J				DEBRAEKELEER, M; LAROCHELLE, J			GENETIC EPIDEMIOLOGY OF HEREDITARY TYROSINEMIA IN QUEBEC AND IN SAGUENAY-LAC-ST-JEAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP CHICOUTIMI,CHICOUTIMI,QUEBEC,CANADA		DEBRAEKELEER, M (corresponding author), UNIV QUEBEC,SOREP,555 BLVD UNIV,CHICOUTIMI G7H 2B1,QUEBEC,CANADA.							BERGERON P, 1974, CLIN GENET, V5, P157; BERUBE D, 1989, CYTOGENET CELL GENET, V51, P962; BOUCHARD G, 1985, RECONSTRUCTION AUTOM, V1; DEBRAEKELEER M, 1988, ANN HUM GENET, V52, P63, DOI 10.1111/j.1469-1809.1988.tb01078.x; DEBRAEKELEER M, 1988, MALADIES HEREDITAIRE; GAGNE R, 1982, PRENATAL DIAG, V2, P185, DOI 10.1002/pd.1970020307; GAUVREAU D, 1988, REV HIST AM FR, V42, P167, DOI 10.7202/304677ar; JACQUARD A, 1974, GENETIQUE POPULATION; LABERGE C, 1967, CAN MED ASSOC J, V97, P1099; LABERGE C, 1969, AM J HUM GENET, V21, P36; LAMARRE V, 1988, EVOLUTION FECONDITE; LAROCHELLE J, 1967, CAN MED ASSOC J, V97, P1051; LAROCHELLE J, 1988, POPULATION DYNAMICS, P353; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; PHANEUF D, 1988, GENOME S1, V30, P32; Roy R, 1988, Cah Que Demogr, V17, P113; Rubinstein R. Y., 2017, SIMULATION MONTE CAR, V3rd, DOI 10.1002/9781118631980; SCRIVER CR, 1967, CAN MED ASSOC J, V97, P1047; SCRIVER CR, 1967, AM J DIS CHILD, V113, P41, DOI 10.1001/archpedi.1967.02090160091008	19	105	108	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					302	307						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378355				2022-12-18	WOS:A1990DT87100016
J	YOUSSOUFIAN, H; MCAFEE, M; KWIATKOWSKI, DJ				YOUSSOUFIAN, H; MCAFEE, M; KWIATKOWSKI, DJ			CLONING AND CHROMOSOMAL LOCALIZATION OF THE HUMAN CYTOSKELETAL ALPHA-ACTININ GENE REVEALS LINKAGE TO THE BETA-SPECTRIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,HEMATOL ONCOL UNIT,BOSTON,MA 02114	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL001582, K11HL002277] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02277, HL01582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARIMURA C, 1988, EUR J BIOCHEM, V177, P649, DOI 10.1111/j.1432-1033.1988.tb14419.x; BARON MD, 1987, J BIOL CHEM, V262, P17623; BARON MD, 1987, J BIOL CHEM, V262, P2258; BENNETT JP, 1984, BIOCHEMISTRY-US, V23, P5081, DOI 10.1021/bi00316a039; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; BRUNS GAP, 1979, BIOCHEM GENET, V17, P1031, DOI 10.1007/BF00504344; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; BURN P, 1985, NATURE, V314, P469, DOI 10.1038/314469a0; BURRIDGE K, 1981, NATURE, V294, P565, DOI 10.1038/294565a0; BYERS TJ, 1989, J CELL BIOL, V109, P1633, DOI 10.1083/jcb.109.4.1633; COHEN CM, 1980, CELL, V21, P875, DOI 10.1016/0092-8674(80)90451-1; CONDEELIS J, 1982, J CELL BIOL, V94, P466, DOI 10.1083/jcb.94.2.466; CUTTING GR, 1988, MOL BIOL MED, V5, P173; DAVISON MD, 1988, CELL, V52, P159, DOI 10.1016/0092-8674(88)90503-X; DUBREUIL RR, 1989, J CELL BIOL, V109, P2197, DOI 10.1083/jcb.109.5.2197; DUHAIMAN AS, 1984, BIOCHEMISTRY-US, V23, P1600, DOI 10.1021/bi00303a003; EBASHI S, 1964, NATURE, V203, P645, DOI 10.1038/203645a0; ENDO T, 1982, J BIOCHEM, V92, P1457, DOI 10.1093/oxfordjournals.jbchem.a134070; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; GLENNEY JR, 1982, J BIOL CHEM, V257, P9781; GORLIN J, 1989, Journal of Cell Biology, V109, p272A; HAMMONDS RG, 1987, CELL, V51, P1, DOI 10.1016/0092-8674(87)90002-X; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; IMAMURA M, 1988, J BIOL CHEM, V263, P7800; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P13857; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P5910; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDON F, 1985, EUR J BIOCHEM, V153, P231, DOI 10.1111/j.1432-1033.1985.tb09291.x; MABUCHI I, 1985, J CELL BIOL, V100, P375, DOI 10.1083/jcb.100.2.375; Maniatis T., 1982, MOL CLONING; MIMURA N, 1987, J BIOL CHEM, V262, P4717; MORTON CC, 1984, AM J HUM GENET, V36, P576; NARVANEN O, 1987, FEBS LETT, V224, P156, DOI 10.1016/0014-5793(87)80440-4; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; OTEY C A, 1989, Journal of Cell Biology, V109, p190A; POLLARD TD, 1981, J BIOL CHEM, V256, P7666; PRCHAL JT, 1987, P NATL ACAD SCI USA, V84, P7468, DOI 10.1073/pnas.84.21.7468; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SINGH I, 1977, BIOCHIM BIOPHYS ACTA, V491, P29, DOI 10.1016/0005-2795(77)90038-1; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; SUZUKI A, 1976, J BIOL CHEM, V251, P6860; WACHSSTOCK DH, 1987, BIOCHEM BIOPH RES CO, V146, P554, DOI 10.1016/0006-291X(87)90564-X; WINKELMANN JC, 1988, BLOOD, V72, P328	47	105	108	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					62	72						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349951				2022-12-18	WOS:A1990DK48200009
J	CHEN, TR; MCMORRIS, FA; CREAGAN, R; RICCIUTI, F; TISCHFIELD, J; RUDDLE, F				CHEN, TR; MCMORRIS, FA; CREAGAN, R; RICCIUTI, F; TISCHFIELD, J; RUDDLE, F			ASSIGNMENT OF GENES FOR MALATE OXIDOREDUCTASE DECARBOXYLATING TO CHROMOSOME-6 AND PEPTIDASE-B AND LACTATE DEHYDROGENASE-B TO CHROMOSOME-12 IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, MD ANDERSON HOSP, HOUSTON, TX 77025 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; YALE UNIV, KLINE BIOL TOWER, NEW HAVEN, CT 06520 USA	University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); Yale University				Tischfield, Jay/0000-0003-3217-8287				CASPERSSON T, 1971, HEREDITAS-GENETISK A, V67, P89; CHEN TR, 1971, CHROMOSOMA, V34, P51, DOI 10.1007/BF00285516; COMINGS DE, 1972, NATURE, V238, P455, DOI 10.1038/238455a0; KLEBE R, 1970, THESIS YALE U; KLEBE RJ, 1970, J CELL BIOL, V45, P74, DOI 10.1083/jcb.45.1.74; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; MCMORRIS FA, IN PRESS; PUCK TT, 1971, P NATL ACAD SCI USA, V68, P3102, DOI 10.1073/pnas.68.12.3102; RICCIUTI FC, IN PRESS; Ruddle F. H., 1970, Symposia of the International Society for Cell Biology, V9, P233; RUDDLE FH, 1971, IN VITRO CELL DEV B, V7, P120; RUDDLE FH, 1970, NATURE, V227, P251, DOI 10.1038/227251a0; RUDDLE FH, 1972, ADV HUM GENET, V3, P173; SANTACHI.AS, 1970, NATURE, V227, P248, DOI 10.1038/227248a0; SUMNER AT, 1971, NATURE-NEW BIOL, V232, P31, DOI 10.1038/newbio232031a0; TISCHFIELD J, IN PRESS; VOGT M, 1960, P NATL ACAD SCI USA, V46, P365, DOI 10.1073/pnas.46.3.365; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104	18	105	105	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	2					200	207						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P0622	4689040				2022-12-18	WOS:A1973P062200009
J	KISTENMACHER, ML; PUNNETT, HH				KISTENMACHER, ML; PUNNETT, HH			COMPARATIVE BEHAVIOR OF RING CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLDERDICE PW, 1968, AUTORADIOGRAPHIC IDE, P49; AMERIO JM, 1968, ANN GENET-PARIS, V11, P258; ATKINS L, 1966, ANN HUM GENET, V30, P1, DOI 10.1111/j.1469-1809.1966.tb00001.x; AULA P, 1967, ACTA NEUROL SCAND, VS 43, P51; BAIN AD, 1963, LANCET, V2, P304; BAIN AD, 1965, LANCET, V1, P820; Baue G, 1967, Bull Fed Soc Gynecol Obstet Lang Fr, V19, P343; Bernard R, 1966, Ann Pediatr (Paris), V13, P525; BISHOP AUDREY M., 1966, J MED GENET, V3, P129, DOI 10.1136/jmg.3.2.129; BUTLER L. J., 1967, J MED GENET, V4, P295, DOI 10.1136/jmg.4.4.295; CHALLACOMBE DN, 1969, ARCH DIS CHILD, V44, P113, DOI 10.1136/adc.44.233.113; COHEN MM, 1964, J CELL BIOL, V23, P386, DOI 10.1083/jcb.23.2.386; COMINGS DE, 1968, AM J HUM GENET, V20, P440; CONGER ALAN D., 1965, RADIAT BOT, V5, P81, DOI 10.1016/S0033-7560(65)80027-8; COOKE P, 1965, ANN HUM GENET, V29, P147, DOI 10.1111/j.1469-1809.1965.tb00510.x; DEGROUCHY J, 1964, ANN GENET-PARIS, V7, pG17; DEGROUCHY J, 1968, ANN GENET-PARIS, V11, P33; DEMINATTI M, 1968, ANN GENET-PARIS, V11, P56; FISHER GW, 1965, J MENT DEFIC RES, V9, P39; GENEST P, 1963, LANCET, V1, P1426; GERALD PS, 1967, J PEDIATR-US, V70, P172, DOI 10.1016/S0022-3476(67)80411-6; GILGENKR.S, 1967, CR SOC BIOL, V161, P874; GRIPENBERG U, 1967, CHROMOSOMA, V20, P284, DOI 10.1007/BF00326186; GROPP A, 1964, NATURE, V202, P829, DOI 10.1038/202829a0; HOEFNAGEL D, 1967, HUMANGENETIK, V4, P52, DOI 10.1007/BF00279179; HUSTINX TWJ, 1964, GENETICA, V35, P1, DOI 10.1007/BF01804870; IYER VN, 1963, P NATL ACAD SCI USA, V50, P355, DOI 10.1073/pnas.50.2.355; LEJEUNE J, 1966, ANN GENET-PARIS, V9, pG173; LEJEUNE J, 1968, ANN GENET-PARIS, V11, P79; LINDSTEN J, 1962, LANCET, V1, P593; LUCAS M, 1963, ANN HUM GENET, V27, P189, DOI 10.1111/j.1469-1809.1963.tb00212.x; LUERS T, 1963, LANCET, V2, P887; MACINTYRE MN, 1964, ANAT RECORD, V148, P386; McClintock B, 1938, GENETICS, V23, P315; McClintock B, 1932, P NATL ACAD SCI USA, V18, P677, DOI 10.1073/pnas.18.12.677; Morgan LV, 1933, GENETICS, V18, P0250; MUKERJEE D, 1966, NATURE, V212, P153, DOI 10.1038/212153a0; NEU RL, 1969, J PEDIATR, V74, P794, DOI 10.1016/S0022-3476(69)80146-0; NICHOLS WW, 1967, J CELL BIOL, V35, P257, DOI 10.1083/jcb.35.1.257; NOWELL PC, 1964, EXP CELL RES, V33, P445, DOI 10.1016/0014-4827(64)90008-4; PALMER CATHERINE G., 1967, J MED GENET, V4, P117, DOI 10.1136/jmg.4.2.117; PAOLINI P, 1966, ANN GENET-PARIS, V9, pG79; PETIT P, 1967, ANN GENET-PARIS, V10, P134; PFEIFFER RA, 1964, NATURE, V204, P804, DOI 10.1038/204804b0; PUNNETT HH, 1954, THESIS YALE U; REISMAN LE, 1965, LANCET, V2, P445; ROHDE RA, 1965, LANCET, V2, P1075; ROWLEY J, 1964, P NATL ACAD SCI USA, V51, P779, DOI 10.1073/pnas.51.5.779; SANDLER L, 1965, 18 NAT CANC I MON, P243; SCHWARTZ D, 1953, AM NAT, V87, P19, DOI 10.1086/281752; SCHWARTZ D, 1958, GENETICS, V43, P86; SCHWARTZ D, 1953, GENETICS, V38, P250; SHAW MW, 1965, GENETICS, V51, P181; SINHA AK, 1968, ACTA GENET MED GEMEL, V17, P487, DOI 10.1017/S1120962300012658; SMITHWHITE S, 1963, NATURE, V197, P102, DOI 10.1038/197102b0; SPARKES RS, 1967, AM J HUM GENET, V19, P644; STEELE MW, 1966, CYTOGENETICS, V5, P419, DOI 10.1159/000129917; STOLTZ DB, 1967, CANCER RES, V27, P587; TEPLITZ RL, 1967, J PEDIATR-US, V70, P936, DOI 10.1016/S0022-3476(67)80266-X; TURNER B, 1962, MED J AUSTRALIA, V2, P56, DOI 10.5694/j.1326-5377.1962.tb19973.x; TURNER B, 1963, P AUST ASSOC NEUROL, V1, P41; VARELA M A, 1969, Journal of Medical Genetics, V6, P334, DOI 10.1136/jmg.6.3.334; VIG BK, 1968, MUTAT RES, V5, P279; WANG HC, 1962, NATURE, V195, P733, DOI 10.1038/195733a0; WATSON JD, 1965, MOLECULAR BIOLOGY GE; WELEBER RG, 1968, AM J DIS CHILD, V115, P489, DOI 10.1001/archpedi.1968.02100010491015; WOLF CB, 1967, J PEDIATR-US, V71, P719, DOI 10.1016/S0022-3476(67)80211-7	67	105	106	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1970	22	3					304	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	G6436	5445002				2022-12-18	WOS:A1970G643600006
J	STEINBERG, AG; BECKER, SW; FITZPATRICK, TB; KIERLAND, RR				STEINBERG, AG; BECKER, SW; FITZPATRICK, TB; KIERLAND, RR			A GENETIC AND STATISTICAL STUDY OF PSORIASIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Gahan E, 1943, ARCH DERMATOL SYPH, V48, P305, DOI 10.1001/archderm.1943.01510030058009; HARRIS H, 1950, ANN EUGENIC, V15, P95; HOEDE K, 1931, WURZB ABH MED, V27, P211; LERNER CHARLES, 1940, JOUR INVEST DERMAT, V3, P347; LOBITZ, 1948, DISEASES SKIN, P311; Pincus G, 1933, AM J MED SCI, V186, P1; ROMANUS T, 1945, ACTA DERM-VENEREOL, V26, P1; SMYTH CJ, 1948, J CLIN INVEST, V27, P749, DOI 10.1172/JCI102025; STECHER RM, 1949, ANN INTERN MED, V31, P595, DOI 10.7326/0003-4819-31-4-595; STEINBERG AG, 1950, P STAFF M MAYO CLIN, V25, P625; STEINKE A, 1935, CITED INDIRECTLY; 1948, VITAL STATISTICS U 1	12	105	106	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1951	3	3					267	281						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS394	14902766				2022-12-18	WOS:A1951XS39400003
J	Leslie, EJ; Taub, MA; Liu, H; Steinberg, KM; Koboldt, DC; Zhang, QY; Carlson, JC; Hetmanski, JB; Wang, H; Larson, DE; Fulton, RS; Kousa, YA; Fakhouri, WD; Naji, A; Ruczinski, I; Begum, F; Parker, MM; Busch, T; Standley, J; Rigdon, J; Hecht, JT; Scott, AF; Wehby, GL; Christensen, K; Czeizel, AE; Deleyiannis, FWB; Schutte, BC; Wilson, RK; Cornell, RA; Lidral, AC; Weinstock, GM; Beaty, TH; Marazita, ML; Murray, JC				Leslie, Elizabeth J.; Taub, Margaret A.; Liu, Huan; Steinberg, Karyn Meltz; Koboldt, Daniel C.; Zhang, Qunyuan; Carlson, Jenna C.; Hetmanski, Jacqueline B.; Wang, Hang; Larson, David E.; Fulton, Robert S.; Kousa, Youssef A.; Fakhouri, Walid D.; Naji, Ali; Ruczinski, Ingo; Begum, Ferdouse; Parker, Margaret M.; Busch, Tamara; Standley, Jennifer; Rigdon, Jennifer; Hecht, Jacqueline T.; Scott, Alan F.; Wehby, George L.; Christensen, Kaare; Czeizel, Andrew E.; Deleyiannis, Frederic W. -B.; Schutte, Brian C.; Wilson, Richard K.; Cornell, Robert A.; Lidral, Andrew C.; Weinstock, George M.; Beaty, Terri H.; Marazita, Mary L.; Murray, Jeffrey C.			Identification of Functional Variants for Cleft Lip with or without Cleft Palate in or near PAX7, FGFR2, and NOG by Targeted Sequencing of GWAS Loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE VARIANTS; NEURAL CREST; MUTATIONS; RISK; NETRIN-1; ENHANCERS; FAMILY; IRF6; TOOL	Although genome-wide association studies (GWASs) for nonsyndromic orofacial clefts have identified multiple strongly associated regions, the causal variants are unknown. To address this, we selected 13 regions from GWASs and other studies, performed targeted sequencing in 1,409 Asian and European trios, and carried out a series of statistical and functional analyses. Within a cluster of strongly associated common variants near NOG, we found that one, rs227727, disrupts enhancer activity. We furthermore identified significant clusters of non-coding rare variants near NTN1 and NOG and found several rare coding variants likely to affect protein function, including four nonsense variants in ARHGAP29. We confirmed 48 de novo mutations and, based on best biological evidence available, chose two of these for functional assays. One mutation in PAX7 disrupted the DNA binding of the encoded transcription factor in an in vitro assay. The second, a non-coding mutation, disrupted the activity of a neural crest enhancer downstream of FGFR2 both in vitro and in vivo. This targeted sequencing study provides strong functional evidence implicating several specific variants as primary contributory risk alleles for nonsyndromic clefting in humans.	[Leslie, Elizabeth J.; Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15219 USA; [Taub, Margaret A.; Ruczinski, Ingo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Liu, Huan; Lidral, Andrew C.] Univ Iowa, Dept Orthodont, Coll Dent, Iowa City, IA 52242 USA; [Liu, Huan] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Liu, Huan] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Steinberg, Karyn Meltz; Koboldt, Daniel C.; Larson, David E.; Fulton, Robert S.; Wilson, Richard K.; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Zhang, Qunyuan] Washington Univ, Sch Med, Dept Stat Genet, St Louis, MO 63108 USA; [Carlson, Jenna C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Hetmanski, Jacqueline B.; Wang, Hang; Begum, Ferdouse; Parker, Margaret M.; Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Kousa, Youssef A.] Michigan State Univ, Coll Osteopath Med, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Fakhouri, Walid D.; Naji, Ali] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77030 USA; [Busch, Tamara; Standley, Jennifer; Rigdon, Jennifer; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Hecht, Jacqueline T.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Scott, Alan F.] Johns Hopkins Univ, Inst Med Genet, Sch Med, Baltimore, MD 21205 USA; [Wehby, George L.] Univ Iowa, Coll Publ Hlth, Dept Hlth Management & Policy, Iowa City, IA 52242 USA; [Christensen, Kaare] Univ Southern Denmark, Inst Publ Hlth, Dept Epidemiol, DK-5230 Odense, Denmark; [Czeizel, Andrew E.] Fdn Community Control Hereditary Dis, H-1148 Budapest, Hungary; [Deleyiannis, Frederic W. -B.] Univ Colorado, Sch Med, Dept Surg Plast & Reconstruct Surg, Denver, CO 80045 USA; [Schutte, Brian C.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Cornell, Robert A.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Weinstock, George M.] Jackson Lab Genom Med, Farmington, CT 06117 USA; [Marazita, Mary L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15260 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Iowa; Wuhan University; Wuhan University; Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Michigan State University; Michigan State University College of Osteopathic Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Iowa; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University; University of Iowa; University of Southern Denmark; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Michigan State University; University of Iowa; Jackson Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Leslie, EJ (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15219 USA.	ejl40@pitt.edu; marazita@pitt.edu	Christensen, Kaare/C-2360-2009; Leslie, Elizabeth/AAP-8941-2021; Youssef A Kousa/AAR-3064-2020; Wilson, Richard K./AAF-4139-2019; Liu, Huan/AAJ-1566-2020; Weinstock, George M/C-6314-2013; Fakhouri, Walid/I-5297-2019	Christensen, Kaare/0000-0002-5429-5292; Leslie, Elizabeth/0000-0002-5735-1712; Youssef A Kousa/0000-0001-6049-8144; Wilson, Richard K./0000-0002-1992-1358; Liu, Huan/0000-0002-9947-6687; Weinstock, George M/0000-0002-2997-4592; Fakhouri, Walid/0000-0002-2199-3828; Larson, David/0000-0001-7934-5906; Carlson, Jenna/0000-0001-5483-0833; Cornell, Robert/0000-0003-4207-9100; Meltz Steinberg, Karyn/0000-0002-8676-3337; Parker, PhD, Margaret/0000-0001-6368-5033	NIH [HG005925, DE008559, DE009886, DE016930, DE016148, DE014581, DE018993, HD073107, LM007059, GM008629, DE022696, DE011931]; National Science Foundation [IOS-114722]; Craniofacial Anomalies Research Center, University of Iowa; Department of Orthodontics, College of Dentistry, University of Iowa; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014581, R01DE023575, U01DE020057, R01DE011931, R37DE008559, F31DE022696, R01DE016148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009886, R21DE016930, U01DE018993, R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Craniofacial Anomalies Research Center, University of Iowa; Department of Orthodontics, College of Dentistry, University of Iowa; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We are grateful to the families who participated in this study and to the staff at each recruitment site around the world, without whose efforts this study would not have been possible. We would like to acknowledge the contributions of Adela Mansilla for assistance in study design, Laura Henkle, Chika Richter, and Wendy Carricato for sample management, Nichole Nidey, Rebecca De-Sensi, Margaret Cooper, and Toby McHenry for managing phenotypic data, Bhama Ramkhelawon for sharing reagents, Greg Bonde and Quynh Duong for technical assistance, the Operations Group and the Bioinformatics Group at the Genome Institute, Gabriel Sanderson for analysis pipeline support, and Holger Schwender for assistance in statistical analysis design for rare variants and for genotypic TDT. This work was supported by grants from the NIH (HG005925 [J.C.M., M.L.M.], DE008559 [J.C.M., M.L.M.], DE009886 [M.L.M.], DE016930 [M.L.M.], DE016148 [M.L.M.], DE014581 [T.H.B.], DE018993 [T.H.B.], HD073107 [R.A.C.], LM007059 [E.J.L.], GM008629 [E.J.L.], DE022696 [Y.A.K.], DE011931 [J.T.H.], HD073107 [R.A.C.]), the National Science Foundation (IOS-114722 [R.A.C.]), the Craniofacial Anomalies Research Center and the Department of Orthodontics, College of Dentistry, both at the University of Iowa (A.C.L.).	Al Tassan N, 2012, HUM MUTAT, V33, P351, DOI 10.1002/humu.21650; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Beaty TH, 2013, HUM GENET, V132, P771, DOI 10.1007/s00439-013-1283-6; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Burke TR, 2011, OPHTHALMIC GENET, V32, P165, DOI 10.3109/13816810.2011.565397; Carey Michael F, 2013, Cold Spring Harb Protoc, V2013, P636, DOI 10.1101/pdb.prot075861; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fakhouri WD, 2014, HUM MOL GENET, V23, P2711, DOI 10.1093/hmg/ddt664; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Gilchrist EP, 2000, ORAL SURG ORAL MED O, V90, P340, DOI 10.1067/moe.2000.107360; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Ionita-Laza I, 2013, EUR J HUM GENET, V21, P1158, DOI 10.1038/ejhg.2012.308; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Leoyklang P, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036442; Leslie EJ, 2012, BIRTH DEFECTS RES A, V94, P934, DOI 10.1002/bdra.23076; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Ludwig KU, 2014, J DENT RES, V93, P376, DOI 10.1177/0022034514523987; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Mansilla MA, 2006, CLEFT PALATE-CRAN J, V43, P21, DOI 10.1597/04-169R.1; Mansouri A, 1996, DEVELOPMENT, V122, P831; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; Osoegawa K, 2008, J MED GENET, V45, P81, DOI 10.1136/jmg.2007.052191; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Peng KC, 2010, FISH SHELLFISH IMMUN, V28, P905, DOI 10.1016/j.fsi.2010.02.003; Peyrard-Janvid M, 2014, AM J HUM GENET, V94, P23, DOI 10.1016/j.ajhg.2013.11.009; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Salminen M, 2000, DEVELOPMENT, V127, P13; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Slaney SF, 1996, AM J HUM GENET, V58, P923; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stanier P, 2012, FRONT ORAL BIOL, V16, P71, DOI 10.1159/000337618; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang H, 2013, CLEFT PALATE-CRAN J, V50, P96, DOI 10.1597/11-132; Westerfield M, 1993, ZEBRAFISH BOOK; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	62	104	106	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					397	411		10.1016/j.ajhg.2015.01.004	http://dx.doi.org/10.1016/j.ajhg.2015.01.004			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25704602	Green Published, Bronze			2022-12-18	WOS:000350747800012
J	Aavikko, M; Li, SP; Saarinen, S; Alhopuro, P; Kaasinen, E; Morgunova, E; Li, YL; Vesanen, K; Smith, MJ; Evans, DGR; Poyhonen, M; Kiuru, A; Auvinen, A; Aaltonen, LA; Taipale, J; Vahteristo, P				Aavikko, Mervi; Li, Song-Ping; Saarinen, Silva; Alhopuro, Pia; Kaasinen, Eevi; Morgunova, Ekaterina; Li, Yilong; Vesanen, Kari; Smith, Miriam J.; Evans, D. Gareth R.; Poyhonen, Minna; Kiuru, Anne; Auvinen, Anssi; Aaltonen, Lauri A.; Taipale, Jussi; Vahteristo, Pia			Loss of SUFU Function in Familial Multiple Meningioma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEDGEHOG SIGNALING PATHWAY; GERMLINE MUTATION; SUPPRESSOR; GENE; GLI; DIVERGENCE; MECHANISM; VARIANTS; RISK	Meningiomas are the most common primary tumors of the CNS and account for up to 30% of all CNS tumors. An increased risk of meningiomas has been associated with certain tumor-susceptibility syndromes, especially neurofibromatosis type II, but no gene defects predisposing to isolated familial meningiomas have thus far been identified. Here, we report on a family of five meningioma-affected siblings, four of whom have multiple tumors. No NF2 mutations were identified in the germline or tumors. We combined genome-wide linkage analysis and exome sequencing, and we identified in suppressor of fused homolog (Drosophila), SUFU, a c.367C>T (p.Arg123Cys) mutation segregating with the meningiomas in the family. The variation was not present in healthy controls, and all seven meningiomas analyzed displayed loss of the wild-type allele according to the classic two-hit model for tumor-suppressor genes. In silico modeling predicted the variant to affect the tertiary structure of the protein, and functional analyses showed that the activity of the altered SUFU was significantly reduced and therefore led to dysregulated hedgehog (Hh) signaling. SUFU is a known tumor-suppressor gene previously associated with childhood medulloblastoma predisposition. Our genetic and functional analyses indicate that germline mutations in SUFU also predispose to meningiomas, particularly to multiple meningiomas. It is possible that other genic mutations resulting in aberrant activation of the Hh pathway might underlie meningioma predisposition in families with an unknown etiology.	[Aavikko, Mervi; Li, Song-Ping; Saarinen, Silva; Alhopuro, Pia; Kaasinen, Eevi; Li, Yilong; Vesanen, Kari; Aaltonen, Lauri A.; Taipale, Jussi; Vahteristo, Pia] Univ Helsinki, Genome Scale Biol Res Program, FIN-00014 Helsinki, Finland; [Aavikko, Mervi; Saarinen, Silva; Kaasinen, Eevi; Li, Yilong; Vesanen, Kari; Aaltonen, Lauri A.; Vahteristo, Pia] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Alhopuro, Pia; Poyhonen, Minna] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki 00029, Finland; [Morgunova, Ekaterina; Taipale, Jussi] Karolinska Inst, Dept Biosci & Nutr, Sci Life Ctr, S-14183 Stockholm, Sweden; [Smith, Miriam J.; Evans, D. Gareth R.] Univ Manchester, Dept Med Genet, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Kiuru, Anne] Radiat & Nucl Safety Author, Dept Res & Environm Surveillance, Helsinki 00881, Finland; [Auvinen, Anssi] Univ Tampere, Tampere Sch Publ llealth, Tampere 33014, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; University of Manchester; Radiation & Nuclear Safety Authority (STUK); Tampere University	Vahteristo, P (corresponding author), Univ Helsinki, Genome Scale Biol Res Program, FIN-00014 Helsinki, Finland.	pia.vahteristo@helsinki.fi	Auvinen, Anssi/AAD-9311-2020; Morgunova, Ekaterina/G-2479-2018; Smith, Miriam/J-4001-2015; Poyhonen, Minna/K-4866-2018; Auvinen, Anssi/AAL-2111-2020; Aaltonen, Lauri/A-5375-2010; Evans, D Gareth/AAB-4308-2022	Morgunova, Ekaterina/0000-0002-7754-9021; Smith, Miriam/0000-0002-3184-0817; Poyhonen, Minna/0000-0003-2037-2744; Auvinen, Anssi/0000-0003-1125-4818; Aaltonen, Lauri/0000-0001-6839-4286; Evans, D Gareth/0000-0002-8482-5784; Kaasinen, Eevi/0000-0002-1333-8049	Academy of Finland (Center of Excellence in Cancer Genetics); Academy of Finland [21290]; Cancer Society of Finland; Sigrid Juselius Foundation	Academy of Finland (Center of Excellence in Cancer Genetics); Academy of Finland(Academy of Finland); Cancer Society of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by the Academy of Finland (Center of Excellence in Cancer Genetics and grant 21290), the Cancer Society of Finland, and the Sigrid Juselius Foundation. We would like to thank all the individuals who participated in the study. We thank Riitta Herva and Hannu Tuominen for expertise in pathology and Sini Nieminen, Mairi Kuris, Iina Vuoristo, and Inga-Lill Svedberg for excellent technical assistance. We acknowledge the Finnish Institute for Molecular Medicine Genome and Technology Centre for service, the CSC-IT Center for Science for the allocation of computational resources, and the Nordic Center of Excellence in Disease Genetics for providing the Finnish control SNP data.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bethke L, 2008, J NATL CANCER I, V100, P270, DOI 10.1093/jnci/djn004; Bostrom J, 1998, CANCER RES, V58, P29; *CBTRUS, 2011, CBTRUS STAT REP PRIM; Christiaans I, 2011, J MED GENET, V48, P93, DOI 10.1136/jmg.2010.082420; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hadfield KD, 2010, J MED GENET, V47, P567, DOI 10.1136/jmg.2009.075721; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Krampla W, 2004, CANCER-AM CANCER SOC, V100, P1208, DOI 10.1002/cncr.20088; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laurendeau I, 2010, MOL MED, V16, P262, DOI 10.2119/molmed.2010.00005; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; NAHSER HC, 1981, NEURORADIOLOGY, V21, P259, DOI 10.1007/BF02100156; NCBI, NAT CTR BIOT INF NCB; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; ROBERTS WM, 1989, CANCER RES, V49, P5407; Ruel L, 2009, GENE DEV, V23, P1843, DOI 10.1101/gad.1838109; Stone DM, 1999, J CELL SCI, V112, P4437; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tate G, 2003, JPN J CLIN ONCOL, V33, P47, DOI 10.1093/jjco/hyg005; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3	29	104	107	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					520	526		10.1016/j.ajhg.2012.07.015	http://dx.doi.org/10.1016/j.ajhg.2012.07.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22958902	Green Published, Bronze			2022-12-18	WOS:000308683100012
J	Dowdle, WE; Robinson, JF; Kneist, A; Sirerol-Piquer, MS; Frints, SGM; Corbit, KC; Zaghloul, NA; van Lijnschoten, G; Mulders, L; Verver, DE; Zerres, K; Reed, RR; Attie-Bitach, T; Johnson, CA; Garcia-Verdugo, JM; Katsanis, N; Bergmann, C; Reiter, JE				Dowdle, William E.; Robinson, Jon F.; Kneist, Andreas; Salome Sirerol-Piquer, M.; Frints, Suzanna G. M.; Corbit, Kevin C.; Zaghloul, Norran A.; van Lijnschoten, Gesina; Mulders, Leon; Verver, Dideke E.; Zerres, Klaus; Reed, Randall R.; Attie-Bitach, Tania; Johnson, Colin A.; Manuel Garcia-Verdugo, Jose; Katsanis, Nicholas; Bergmann, Carsten; Reiter, Jeremy E.			Disruption of a Ciliary B9 Protein Complex Causes Meckel Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; INTRAFLAGELLAR TRANSPORT PROTEINS; LEFT-RIGHT ASYMMETRY; SONIC-HEDGEHOG; GRUBER-SYNDROME; PRIMARY CILIUM; REPRESSOR FUNCTIONS; SITUS-INVERSUS; MOUSE EMBRYOS; NODAL CILIA	Nearly every ciliated organism possesses three B9 domain-containing proteins: MKS1, B9D1, and B9D2. Mutations in human MKS1 cause Meckel syndrome (MKS), a severe ciliopathy characterized by occipital encephalocele, liver ductal plate malformations, polydactyly, and kidney cysts. Mouse mutations in either Mks1 or B9d2 compromise ciliogenesis and result in phenotypes similar to those of MKS. Given the importance of these two B9 proteins to ciliogenesis, we examined the role of the third B9 protein, B9d1. Mice lacking B9d1 displayed polydactyly, kidney cysts, ductal plate malformations, and abnormal patterning of the neural tube, concomitant with compromised ciliogenesis, ciliary protein localization, and Hedgehog (Hh) signal transduction. These data prompted us to screen MKS patients for mutations in B9D1 and B9D2. We identified a homozygous c.301A>C (p.Ser101Arg) B9D2 mutation that segregates with MKS, affects an evolutionarily conserved residue, and is absent from controls. Unlike wild-type B9D2 mRNA, the p.Ser101Arg mutation failed to rescue zebrafish phenotypes induced by the suppression of b9d2. With coimmunoprecipitation and mass spectrometric analyses, we found that Mks1, B9d1, and B9d2 interact physically, but that the p.Ser101Arg mutation abrogates the ability of B9d2 to interact with Mks1, further suggesting that the mutation compromises B9d2 function. Our data indicate that B9d1 is required for normal Hh signaling, ciliogenesis, and ciliary protein localization and that B9d1 and B9d2 are essential components of a B9 protein complex, disruption of which causes MKS.	[Robinson, Jon F.; Zaghloul, Norran A.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Robinson, Jon F.; Zaghloul, Norran A.; Katsanis, Nicholas] Duke Univ, Dept Pediat, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Dowdle, William E.; Corbit, Kevin C.; Reiter, Jeremy E.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Dowdle, William E.; Corbit, Kevin C.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kneist, Andreas; Zerres, Klaus; Bergmann, Carsten] Rhein Westfal TH Aachen, Dept Human Genet, D-52056 Aachen, Germany; [Salome Sirerol-Piquer, M.] CIBERNED, Unidad Mixta CIPF UVEG, Dept Cellular Morphol, Valencia 46012, Spain; [Frints, Suzanna G. M.] Maastricht Univ, Med Ctr, Dept Clin Genet Prenatal Diag & Therapy, NL-6200 MD Maastricht, Netherlands; [Frints, Suzanna G. M.; Verver, Dideke E.] Maastricht Univ, GROW, Res Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands; [Zaghloul, Norran A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [van Lijnschoten, Gesina] PAMM, Dept Pathol, NL-5623 EJ Eindhoven, Netherlands; [Mulders, Leon] Maxima Med Ctr, Dept Gynecol, NL-5500 MB Veldhoven, Netherlands; [Verver, Dideke E.; Manuel Garcia-Verdugo, Jose] Univ Paris 06, Dev Biol Lab, CNRS, UMR 7622, F-75005 Paris, France; [Reed, Randall R.] Johns Hopkins Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, F-75006 Paris, France; [Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75006 Paris, France; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Manuel Garcia-Verdugo, Jose] Cavanilles Inst Biodivers & Evolut Biol CIBERNED, Dept Comparat Neurol, Valencia 46980, Spain; [Bergmann, Carsten] Bioscientia, Ctr Human Genet, D-55218 Ingelheim, Germany	Duke University; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; RWTH Aachen University; CIBERNED; Prince Felipe Research Center; Maastricht University; Maastricht University; University System of Maryland; University of Maryland Baltimore; Maxima Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Johns Hopkins University; Johns Hopkins Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint James's University Hospital; University of Leeds; CIBERNED	Katsanis, N (corresponding author), Duke Univ, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA.	katsanis@cellbio.duke.edu; carsten.bergmann@bioscientia.de	García-Verdugo, José Manuel/L-8421-2017; ATTIE-BITACH, Tania/K-1453-2017; Sirerol, Salome/K-6141-2012; Dowdle, William/F-3424-2011; Katsanis, Nicholas/E-1837-2012	García-Verdugo, José Manuel/0000-0001-9872-6499; ATTIE-BITACH, Tania/0000-0002-1155-3626; Sirerol, Salome/0000-0002-9678-4502; Johnson, Colin/0000-0002-2979-8234; Frints, Suzanna G.M./0000-0002-5027-8364; Katsanis, Nicholas/0000-0002-2480-0171	NSF; NIH [R01DK072301, R01DK075972, R01HD04260, R01AR054396]; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; PKD Foundation; Deutsche Nierenstiftung; Deutsche Forschungsgemeinschaft (DFG) [BE 3910/4-1, SFB/TRR57]; MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, K01DK092402, R01DK072301] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; PKD Foundation; Deutsche Nierenstiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Caroline Miller and JoDee Fish at the Gladstone Institute Histology Core, the Berkeley EM lab, Kurt Thorn and the Nikon Imaging Center at UCSF, William Wallantus and the Institute for Regenerative Medicine Imaging Core at UCSF, Chris Adams and the Stanford University Mass Spectrometry Bio-X core, and members of the J.F.R. lab for discussions and critical reading of this manuscript. This work was funded by grants from the NSF to WED., the NIH (R01DK072301, R01DK075972, and R01HD04260 to N.K. and R01AR054396 to J.F.R.), the Burroughs Wellcome Fund, the Packard Foundation, and the Sandler Family Supporting Foundation to J.F.R., the PKD Foundation and the Deutsche Nierenstiftung to C.B., and the Deutsche Forschungsgemeinschaft (DFG BE 3910/4-1 and SFB/TRR57) to K.Z. and C.B. N.K. is a Distinguished Brumley Professor.	Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Chen Chih-Ping, 2007, Taiwan J Obstet Gynecol, V46, P9; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Consugar MB, 2007, HUM GENET, V121, P591, DOI 10.1007/s00439-007-0341-3; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cui C, 2011, DIS MODEL MECH, V4, P43, DOI 10.1242/dmm.006262; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Eggenschwiler JT, 2006, DEV BIOL, V290, P1, DOI 10.1016/j.ydbio.2005.09.022; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Hadjantonakis AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002511; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hopp K, 2011, HUM MOL GENET, V20, P2524, DOI 10.1093/hmg/ddr151; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurd TW, 2011, NEPHRON EXP NEPHROL, V118, pE9, DOI 10.1159/000320888; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Janssen S, 2011, HUM GENET, V129, P79, DOI 10.1007/s00439-010-0902-8; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; LEATHEM A, 1983, J CLIN PATHOL, V36, P747, DOI 10.1136/jcp.36.7.747; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nagy A., 2003, MANIPULATING MOUSE E; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Ponsard C, 2007, FRONT BIOSCI-LANDMRK, V12, P1661; Rana AA, 2004, DEVELOPMENT, V131, P4999, DOI 10.1242/dev.01389; Reiter JF, 2006, GENE DEV, V20, P22, DOI 10.1101/gad.1363606; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shaheen R, 2011, HUM MUTAT, V32, P573, DOI 10.1002/humu.21507; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Tallila J, 2009, HUM MUTAT, V30, pE813, DOI 10.1002/humu.21057; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Town T, 2008, P NATL ACAD SCI USA, V105, P2853, DOI 10.1073/pnas.0712385105; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; van Eyll JM, 2004, J CELL SCI, V117, P2077, DOI 10.1242/jcs.01067; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Warner JP, 1996, J MED GENET, V33, P1022, DOI 10.1136/jmg.33.12.1022; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zhang DP, 2010, GENE, V469, P18, DOI 10.1016/j.gene.2010.08.006; Zhang M, 2004, BIOCHEM BIOPH RES CO, V324, P1413, DOI 10.1016/j.bbrc.2004.09.207	88	104	108	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					94	110		10.1016/j.ajhg.2011.06.003	http://dx.doi.org/10.1016/j.ajhg.2011.06.003			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21763481	Green Published, Bronze			2022-12-18	WOS:000293041700008
J	Carrasquillo, MM; Nicholson, AM; Finch, N; Gibbs, JR; Baker, M; Rutherford, NJ; Hunter, TA; DeJesus-Hernandez, M; Bisceglio, GD; Mackenzie, IR; Singleton, A; Cookson, MR; Crook, JE; Dillman, A; Hernandez, D; Petersen, RC; Graff-Radford, NR; Younkin, SG; Rademakers, R				Carrasquillo, Minerva M.; Nicholson, Alexandra M.; Finch, NiCole; Gibbs, J. Raphael; Baker, Matt; Rutherford, Nicola J.; Hunter, Talisha A.; DeJesus-Hernandez, Mariely; Bisceglio, Gina D.; Mackenzie, Ian R.; Singleton, Andrew; Cookson, Mark R.; Crook, Julia E.; Dillman, Allissa; Hernandez, Dena; Petersen, Ronald C.; Graff-Radford, Neill R.; Younkin, Steven G.; Rademakers, Rosa			Genome-wide Screen Identifies rs646776 near Sortilin as a Regulator of Progranulin Levels in Human Plasma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; GENETIC-VARIABILITY; DEMENTIA; ASSOCIATION; RECEPTOR; CHOLESTEROL; MUTATIONS; PROTEIN; CONTRIBUTES	Recent studies suggest progranulin (GRN) is a neurotrophic factor. Loss-of-function mutations in the progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD), a progressive neurodegenerative disease affecting similar to 10% of early-onset dementia patients. Using an enzyme-linked immunosorbent assay, we previously showed that GRN is detectable in human plasma and can be used to predict URN mutation status. This study also showed a wide range in plasma GRN levels in non-GRN mutation carriers, including controls. We have now performed a genome-wide association study of 313,504 single-nucleotide polymorphisms (SNPs) in 533 control samples and identified on chromosome 1p13.3 two SNPs with genome-wide significant association with plasma GRN levels (top SNP rs646776; p = 1.7 x 10(-30)). The association of rs646776 with plasma GRN levels was replicated in two independent series of 508 controls (p = 1.9 x 10(-19)) and 197 FTLD patients (p = 6.4 x 10(-12)). Overall, each copy of the minor C allele decreased GRN levels by similar to 15%. SNP rs646776 is located near sortilin (SORT1), and the minor C allele of rs646776 was previously associated with increased SORT1 mRNA levels. Supporting these findings, overexpression of SORT1 in cultured HeLa cells dramatically reduced GRN levels in the conditioned media, whereas knockdown of SORT1 increased extracellular GRN levels. In summary, we identified significant association of a locus on chromosome 1p13.3 with plasma GRN levels through an unbiased genome-wide screening approach and implicated SORT1 as an important regulator of GRN levels. This finding opens avenues for future research into GRN biology and the pathophysiology of neurodegenerative diseases.	[Carrasquillo, Minerva M.; Nicholson, Alexandra M.; Finch, NiCole; Baker, Matt; Rutherford, Nicola J.; Hunter, Talisha A.; DeJesus-Hernandez, Mariely; Bisceglio, Gina D.; Crook, Julia E.; Younkin, Steven G.; Rademakers, Rosa] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Gibbs, J. Raphael; Singleton, Andrew; Cookson, Mark R.; Dillman, Allissa; Hernandez, Dena] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Gibbs, J. Raphael; Hernandez, Dena] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Gibbs, J. Raphael; Hernandez, Dena] UCL, Inst Neurol, Reta Lila Weston Labs, London WC1N 3BG, England; [Mackenzie, Ian R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Petersen, Ronald C.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [Graff-Radford, Neill R.] Mayo Clin, Coll Med, Dept Neurol, Jacksonville, FL 32224 USA	Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; University of British Columbia; Mayo Clinic; Mayo Clinic	Rademakers, R (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	rademakers.rosa@mayo.edu	Cookson, Mark/AAW-2516-2021; Singleton, Andrew B/C-3010-2009; Gibbs, J. Raphael/A-3984-2010	Cookson, Mark/0000-0002-1058-3831; Gibbs, J. Raphael/0000-0002-6985-0658	National Institutes of Health, Mayo Alzheimer's Disease Research Center [P50 AG16574]; National Institutes of Health, Mayo Alzheimer's Disease Patient Registry [U01 AG06576]; National Institutes of Health [R01 NS065782, R01 AG18023]; Consortium for Frontotemporal Dementia Research; Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Canadian Institutes of Health Research [74580]; Pacific Alzheimer's Disease Research Foundation; National Institute on Aging, National Institutes of Health, Department of Health and Human Services [ZIA AG000932-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000951, ZIAAG000947, ZIAAG000932, P50AG016574, R01AG018023] Funding Source: NIH RePORTER	National Institutes of Health, Mayo Alzheimer's Disease Research Center; National Institutes of Health, Mayo Alzheimer's Disease Patient Registry; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pacific Alzheimer's Disease Research Foundation; National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors wish to acknowledge and thank the families who contributed samples that were critically important to this study. This work was supported by the National Institutes of Health (grant numbers P50 AG16574 [Mayo Alzheimer's Disease Research Center, R.C.P. as PI; to R.R., N.R.G.-R., and S.G.Y.], U01 AG06576 [Mayo Alzheimer's Disease Patient Registry: R.C.P. as PI], R01 NS065782 [to R.R.], and R01 AG18023 [to N.R.G.-R. and S.G.Y.]). This project was also generously supported by the Consortium for Frontotemporal Dementia Research (to R.R.), the Robert and Clarice Smith Postdoctoral Fellowship (to M.M.C.), the Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (to R.C.P., N.R.G.-R., and S.G.Y.), and the Palumbo Professorship in Alzheimer's Disease Research (to S.G.Y.). I.R.M. was supported by the Canadian Institutes of Health Research Operating (#74580) and the Pacific Alzheimer's Disease Research Foundation. This work was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services; project number ZIA AG000932-03.	*1000 GEN, 1000 GEN PROJ; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; [Anonymous], ONLINE MENDELIAN INH; [Anonymous], PLINK; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kleber ME, 2010, ATHEROSCLEROSIS, V209, P492, DOI 10.1016/j.atherosclerosis.2009.09.068; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lu YC, 2010, ATHEROSCLEROSIS, V213, P200, DOI 10.1016/j.atherosclerosis.2010.08.053; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Mendez Mario F., 2009, V24, P168, DOI 10.1159/000197896; Muendlein A, 2009, ATHEROSCLEROSIS, V206, P494, DOI 10.1016/j.atherosclerosis.2009.02.040; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nuytemans K, 2008, NEUROLOGY, V71, P1147, DOI 10.1212/01.wnl.0000327563.10320.2b; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rademakers R, 2009, TRENDS NEUROSCI, V32, P451, DOI 10.1016/j.tins.2009.05.005; Ronald J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-52; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; SCHOFIELD EC, 2010, J ALZHEIMERS DIS; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Sleegers K, 2010, BIOMARK MED, V4, P37, DOI 10.2217/BMM.09.82; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Viswanathan J, 2009, AM J MED GENET B, V150B, P747, DOI 10.1002/ajmg.b.30889; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; ALZHEIMER DIS FRONTO	48	104	109	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					890	897		10.1016/j.ajhg.2010.11.002	http://dx.doi.org/10.1016/j.ajhg.2010.11.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21087763	Bronze, Green Published			2022-12-18	WOS:000285564600017
J	Malan, V; Rajan, D; Thomas, S; Shaw, AC; Picard, HLD; Layet, V; Till, M; van Haeringen, A; Mortier, G; Nampoothiri, S; Puseljic, S; Legeai-Mallet, L; Carter, NP; Vekemans, M; Munnich, A; Hennekam, RC; Colleaux, L; Cormier-Daire, V				Malan, Valerie; Rajan, Diana; Thomas, Sophie; Shaw, Adam C.; Picard, Helene Louis Dit; Layet, Valerie; Till, Marianne; van Haeringen, Arie; Mortier, Geert; Nampoothiri, Sheela; Puseljic, Silvija; Legeai-Mallet, Laurence; Carter, Nigel P.; Vekemans, Michel; Munnich, Arnold; Hennekam, Raoul C.; Colleaux, Laurence; Cormier-Daire, Valerie			Distinct Effects of Allelic NFIX Mutations on Nonsense-Mediated mRNA Decay Engender Either a Sotos-like or a Marshall-Smith Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; GENE; TRANSCRIPTION; OVERGROWTH; CHICKEN; IDENTIFICATION; PHENOTYPES; FAMILIES; RECEPTOR; ELASTIN	By using a combination of array comparative genomic hybridization and a candidate gene approach, we identified nuclear factor I/X (NFIX) deletions or nonsense mutation in three sporadic cases of a Sotos-like overgrowth syndrome with advanced bone age, macrocephaly, developmental delay, scoliosis, and unusual facies. Unlike the aforementioned human syndrome, Nfix-deficient mice are unable to gain weight and die in the first 3 postnatal weeks, while they also present with a spinal deformation and decreased bone mineralization. These features prompted us to consider NFIX as a candidate gene for Marshall-Smith syndrome (MSS), a severe malformation syndrome characterized by failure to thrive, respiratory insufficiency, accelerated osseous maturation, kyphoscoliosis, osteopenia, and unusual facies. Distinct frameshift and splice NFIX mutations that escaped nonsense-mediated mRNA decay (NMD) were identified in nine MSS subjects. NFIX belongs to the Nuclear factor one (NFI) family of transcription factors, but its specific function is presently unknown. We demonstrate that NFIX is normally expressed prenatally during human brain development and skeletogenesis. These findings demonstrate that allelic NFIX mutations trigger distinct phenotypes, depending specifically on their impact on NMD.	[Malan, Valerie; Thomas, Sophie; Picard, Helene Louis Dit; Legeai-Mallet, Laurence; Vekemans, Michel; Munnich, Arnold; Colleaux, Laurence; Cormier-Daire, Valerie] Univ Paris 05, INSERM, U781, Hop Necker Enfants Malad, F-75015 Paris, France; [Malan, Valerie; Thomas, Sophie; Picard, Helene Louis Dit; Legeai-Mallet, Laurence; Vekemans, Michel; Munnich, Arnold; Colleaux, Laurence; Cormier-Daire, Valerie] Univ Paris 05, Dept Genet, Hop Necker Enfants Malad, F-75015 Paris, France; [Rajan, Diana; Carter, Nigel P.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Shaw, Adam C.] UCL Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; [Layet, Valerie] CH Le Havre, Serv Genet Clin, F-76600 Le Havre, France; [Till, Marianne] Groupement Hosp Est, Hosp Femme Mere Enfant, Serv Genet Clin, F-69677 Bron, France; [van Haeringen, Arie] LUMC, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; [Mortier, Geert] Univ Antwerp Hosp, Ctr Med Genet, B-2650 Edegem, Belgium; [Nampoothiri, Sheela] Amrita Inst Med Sci & Res Ctr, Dept Pediat Genet, Cochin 682041, Kerala, India; [Puseljic, Silvija] Clin Hosp Ctr Osijek KBC, Pediat Clin, Osijek 31000, Croatia; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Wellcome Trust Sanger Institute; University of London; University College London; CHU Lyon; Leiden University; Leiden University Medical Center (LUMC); University of Antwerp; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Colleaux, L (corresponding author), Univ Paris 05, INSERM, U781, Hop Necker Enfants Malad, F-75015 Paris, France.	laurence.colleaux@inserm.fr; valerie.cormier-daire@inserm.fr	Mortier, Geert/D-2542-2012; Malan, Valerie/H-7423-2017; Nampoothiri, Sheela/AAQ-4854-2021; Legeai-Mallet, Laurence/E-6112-2016; COLLEAUX, LAURENCE/AAA-8144-2022; COLLEAUX, Laurence/H-6455-2017; THOMAS, Sophie/F-4492-2017; thomas, sophie/GVS-1279-2022; cormier-daire, valerie/H-6520-2017	Mortier, Geert/0000-0001-9871-4578; Malan, Valerie/0000-0002-3450-4958; Nampoothiri, Sheela/0000-0002-9575-0722; Legeai-Mallet, Laurence/0000-0003-4989-5856; COLLEAUX, LAURENCE/0000-0002-0987-7648; THOMAS, Sophie/0000-0002-8569-3277; cormier-daire, valerie/0000-0002-2839-9856	Centre National de la Recherche Scientifique; GIS-Maladies Rares; Agence de BioMedecine; international Marshall-Smith Support group	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); GIS-Maladies Rares; Agence de BioMedecine; international Marshall-Smith Support group	We are grateful to the patients and their family and to the French association "L'eveil" for their participation in the study. This study was supported by the Centre National de la Recherche Scientifique, the GIS-Maladies Rares, the Agence de BioMedecine, and the international Marshall-Smith Support group. The authors declare no competing financial interests.	Adam MP, 2005, AM J MED GENET A, V137A, P117, DOI 10.1002/ajmg.a.30580; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cossais F, 2010, HUM MOL GENET, V19, P2409, DOI 10.1093/hmg/ddq124; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Faivre L, 2002, EUR J HUM GENET, V10, P699, DOI 10.1038/sj.ejhg.5200879; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; GOUNARI F, 1990, EMBO J, V9, P559, DOI 10.1002/j.1460-2075.1990.tb08143.x; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hopyan S, 2002, NAT GENET, V30, P306, DOI 10.1038/ng844; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; KRUSE U, 1991, NUCLEIC ACIDS RES, V19, P6641, DOI 10.1093/nar/19.23.6641; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Malan V, 2010, EUR J HUM GENET, V18, P227, DOI 10.1038/ejhg.2009.162; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Metcalfe K, 2000, EUR J HUM GENET, V8, P955, DOI 10.1038/sj.ejhg.5200564; Micale L, 2010, EUR J HUM GENET, V18, P317, DOI 10.1038/ejhg.2009.181; Neri G, 1998, AM J MED GENET, V79, P279, DOI 10.1002/(SICI)1096-8628(19981002)79:4<279::AID-AJMG9>3.0.CO;2-H; Partington MW, 1997, J MED GENET, V34, P719, DOI 10.1136/jmg.34.9.719; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; RUPP RAW, 1990, NUCLEIC ACIDS RES, V18, P2607, DOI 10.1093/nar/18.9.2607; Visser R, 2003, CURR OPIN PEDIATR, V15, P598, DOI 10.1097/00008480-200312000-00010; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Weksberg R, 2003, HUM MOL GENET, V12, pR61, DOI 10.1093/hmg/ddg067	29	104	106	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					189	198		10.1016/j.ajhg.2010.07.001	http://dx.doi.org/10.1016/j.ajhg.2010.07.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20673863	Green Published, Bronze			2022-12-18	WOS:000281107000003
J	Merrill, AE; Merriman, B; Farrington-Rock, C; Camacho, N; Sebald, ET; Funari, VA; Schibler, MJ; Firestein, MH; Cohn, ZA; Priore, MA; Thompson, AK; Rimoin, DL; Nelson, SF; Cohn, DH; Krakow, D				Merrill, Amy E.; Merriman, Barry; Farrington-Rock, Claire; Camacho, Natalia; Sebald, Eiman T.; Funari, Vincent A.; Schibler, Matthew J.; Firestein, Marc H.; Cohn, Zachary A.; Priore, Mary Ann; Thompson, Alicia K.; Rimoin, David L.; Nelson, Stanley F.; Cohn, Daniel H.; Krakow, Deborah			Ciliary Abnormalities Due to Defects in the Retrograde Transport Protein DYNC2H1 in Short-Rib Polydactyly Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPHYXIATING THORACIC DYSTROPHY; CHONDROCYTE PRIMARY CILIUM; VAN-CREVELD-SYNDROME; INTRAFLAGELLAR TRANSPORT; CONTINUOUS-SPECTRUM; DYNEIN; MOUSE; MOTOR; LOCALIZATION; DISORDERS	The short-rib polydactyly (SRP) syndromes are a heterogenous group of perinatal lethal skeletal disorders with polydactyly and multisystem organ abnormalities. Homozygosity by descent mapping in a consanguineous SRP family identified a genomic region that contained DYNC2H1, a cytoplasmic dynein involved in retrograde transport in the cilium. Affected individuals in the family were homozygous for an exon 12 missense mutation that predicted the amino acid substitution R587C. Compound heterozygosity for one missense and one null mutation was identified in two additional nonconsanguineous SRP families. Cultured chondrocytes from affected individuals showed morphologically abnormal, shortened cilia. In addition, the chondrocytes showed abnormal cytoskeletal microtubule architecture, implicating an altered microtubule network as part of the disease process. These findings establish SRP as a cilia disorder and demonstrate that DYNC2H1 is essential for skeletogenesis and growth.	[Merrill, Amy E.; Farrington-Rock, Claire; Sebald, Eiman T.; Funari, Vincent A.; Cohn, Zachary A.; Priore, Mary Ann; Rimoin, David L.; Cohn, Daniel H.; Krakow, Deborah] Cedars Sinai Med Ctr, Med Genet Res Inst, Los Angeles, CA 90048 USA; [Merrill, Amy E.; Camacho, Natalia; Firestein, Marc H.; Krakow, Deborah] Univ Calif Los Angeles, Dept Orthoped Surg, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Merriman, Barry; Rimoin, David L.; Nelson, Stanley F.; Cohn, Daniel H.; Krakow, Deborah] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Funari, Vincent A.; Rimoin, David L.; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Pediat, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Rimoin, David L.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Obstet & Gynecol, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Schibler, Matthew J.] Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Schibler, Matthew J.] Univ Calif Los Angeles, Calif NanoSyst Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Thompson, Alicia K.] Univ So Calif, Ctr Electron Microscopy, Los Angeles, CA 90089 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California	Krakow, D (corresponding author), Cedars Sinai Med Ctr, Med Genet Res Inst, Los Angeles, CA 90048 USA.	dkrakow@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009; Krakow, Deborah/B-5778-2009	Nelson, Stanley F/0000-0002-2082-3114; Krakow, Deborah/0000-0001-9906-4968; Merrill-Brugger, Amy/0000-0002-3660-1575	NIH [HD22657]; Joseph Drown Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joseph Drown Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the families for their active and longstanding participation in this project and particularly acknowledge the [srps] family network for their advocacy on behalf of the study. This project was supported in part by a grant from the NIH (HD22657) and the Joseph Drown Foundation. Fluorescence microscopy was performed at the CNSI Advanced Light Microscopy/Spectroscopy Shared Facility at UCLA.	Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; BERNSTEIN R, 1985, J MED GENET, V22, P46, DOI 10.1136/jmg.22.1.46; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Corsi A, 2002, PEDIATR DEVEL PATHOL, V5, P91, DOI 10.1007/s10024-001-0122-2; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elcioglu NH, 2002, AM J MED GENET, V111, P392, DOI 10.1002/ajmg.10562; ERZEN M, 1988, ANN GENET-PARIS, V31, P144; FRANCESCHINI P, 1995, AM J MED GENET, V59, P359, DOI 10.1002/ajmg.1320590316; Galdzicka M, 2002, MOL GENET METAB, V77, P291, DOI 10.1016/S1096-7192(02)00178-6; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Krakow D, 2000, EUR J HUM GENET, V8, P645, DOI 10.1038/sj.ejhg.5200507; Krakow D, 2008, AM J MED GENET A, V146A, P1917, DOI 10.1002/ajmg.a.32269; MARTINEZFRIAS ML, 1993, J MED GENET, V30, P937, DOI 10.1136/jmg.30.11.937; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Ruiz-Perez VL, 2000, NAT GENET, V25, P125; Sakato M, 2004, J STRUCT BIOL, V146, P58, DOI 10.1016/j.jsb.2003.09.026; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Tompson SWJ, 2007, HUM GENET, V120, P663, DOI 10.1007/s00439-006-0237-7; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Vallee RB, 2006, J STRUCT BIOL, V156, P175, DOI 10.1016/j.jsb.2006.02.012; Yang S S, 1987, Am J Med Genet Suppl, V3, P191; Yoon SY, 2008, NEUROSCI LETT, V437, P111, DOI 10.1016/j.neulet.2008.03.083	34	104	110	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					542	549		10.1016/j.ajhg.2009.03.015	http://dx.doi.org/10.1016/j.ajhg.2009.03.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19361615	Green Published, Bronze			2022-12-18	WOS:000265232800015
J	Vink, JM; Smit, AB; de Geus, EJC; Sullivan, P; Willemsen, G; Hottenga, JJ; Smit, JH; Hoogendijk, WJ; Zitman, FG; Peltonen, L; Kaprio, J; Pedersen, NL; Magnusson, PK; Spector, TD; Kyvik, KO; Morleyis, KI; Heath, AC; Martin, NG; Westendorp, RGJ; Slagboom, PE; Tiemeier, H; Hofman, A; Uitterlinden, AG; Aulchenko, YS; Amin, N; van Duijn, C; Penninx, BW; Boomsma, DI				Vink, Jacqueline M.; Smit, August B.; de Geus, Eco J. C.; Sullivan, Patrick; Willemsen, Gonneke; Hottenga, Jouke-Jan; Smit, Johannes H.; Hoogendijk, Witte J.; Zitman, Frans G.; Peltonen, Leena; Kaprio, Jaakko; Pedersen, Nancy L.; Magnusson, Patrik K.; Spector, Tim D.; Kyvik, Kirsten Ohm; Morleyis, Katherine I.; Heath, Andrew C.; Martin, Nicholas G.; Westendorp, Rudi G. J.; Slagboom, P. Eline; Tiemeier, Henning; Hofman, Albert; Uitterlinden, Andre G.; Aulchenko, Yurii S.; Amin, Najaf; van Duijn, Cornelia; Penninx, Brenda W.; Boomsma, Dorret I.			Genome-wide Association Study of Smoking Initiation and Current Smoking	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NICOTINE DEPENDENCE; MOLECULAR-GENETICS; MAJOR DEPRESSION; BEHAVIOR; GENES; RISK; TWIN; VULNERABILITY; HAPLOTYPES; RECEPTORS	For the identification of genes associated with smoking initiation and current smoking, genome-wide association analyses were carried out in 3497 subjects. Significant genes that replicated in three independent samples(n - 405, 5810, and 1648) were visualized into a biologically meaningful network showing cellular location and direct interaction of their proteins. Several interesting groups of proteins stood out, including glutamate receptors (e.g., GRIN2B, GRIN2A, GRIK2, GRM8), proteins involved in tyrosine kinase receptor signaling (e.g., NTRK2, GRB14), transporters (e.g., SLC1A2, SLC9A9) and cell-adhesion molecules (e.g., CDH23). We conclude that a network-based genome-wide association approach can identify genes influencing smoking behavior.	[Vink, Jacqueline M.; de Geus, Eco J. C.; Willemsen, Gonneke; Hottenga, Jouke-Jan; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Smit, August B.] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Sullivan, Patrick] Univ N Carolina, Dept Genet & Psychiat, Chapel Hill, NC USA; [Smit, Johannes H.; Hoogendijk, Witte J.; Penninx, Brenda W.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, EMGO Inst, Dept Psychiat, Amsterdam, Netherlands; [Zitman, Frans G.; Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Fac Med, Helsinki, Finland; [Peltonen, Leena] MIT, Broad Inst, Cambridge, MA 02139 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; [Pedersen, Nancy L.; Magnusson, Patrik K.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Kyvik, Kirsten Ohm] Univ So Denmark, Inst Publ Hlth, Inst Reg Hlth Serv Res & Danish Twin Registry, Odense C, Denmark; [Kyvik, Kirsten Ohm] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Sch Populat Hlth & Orygen Youth Hlth Res Ctr, Dept Psychiat, Melbourne, Vic, Australia; [Heath, Andrew C.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Morleyis, Katherine I.; Martin, Nicholas G.] Queensland Inst Med Res, Genet Epidemiol Lab, Brisbane, Qld 4006, Australia; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Tiemeier, Henning; Hofman, Albert; Uitterlinden, Andre G.; Aulchenko, Yurii S.; Amin, Najaf; van Duijn, Cornelia] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of North Carolina; University of North Carolina Chapel Hill; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Finland National Institute for Health & Welfare; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Karolinska Institutet; University of London; King's College London; University of Southern Denmark; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Washington University (WUSTL); QIMR Berghofer Medical Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Groningen	Vink, JM (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands.	jm.vink@psy.vu.nl	Aulchenko, Yurii/M-8270-2013; Kyvik, Kirsten O/K-5680-2016; Magnusson, Patrik KE/C-4458-2017; Penninx, Brenda WJH/S-7627-2017; Tiemeier, Henning/H-6534-2019; Slagboom, P. Eline/R-4790-2016; Boomsma, Dorret I/AAX-4470-2020; Amin, Najaf N/D-1859-2012; Morley, Katherine I/A-2986-2011; Smit, August B/E-8410-2011; Kaprio, Jaakko/A-1820-2008; Vink, Jacqueline/A-7648-2012; Zitman, Frans G./E-7705-2010; de Geus, Eco J.C./M-9318-2015	Aulchenko, Yurii/0000-0002-7899-1575; Kyvik, Kirsten O/0000-0003-2981-0245; Magnusson, Patrik KE/0000-0002-7315-7899; Penninx, Brenda WJH/0000-0001-7779-9672; Tiemeier, Henning/0000-0002-4395-1397; Slagboom, P. Eline/0000-0002-2875-4723; Morley, Katherine I/0000-0002-2725-5535; Kaprio, Jaakko/0000-0002-3716-2455; de Geus, Eco J.C./0000-0001-6022-2666; Amin, Najaf/0000-0002-8944-1771; Van Duijn, Cornelia/0000-0002-2374-9204; Martin, Nicholas/0000-0003-4069-8020; Willemsen, Gonneke/0000-0003-3755-0236	NIMH NIH HHS [MH081802, R01 MH074027, R01 MH081802, MH074027, R01 MH077139, MH077139] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139, R01MH074027, R01MH081802] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barman SK, 2004, ADDICTION, V99, P1049, DOI 10.1111/j.1360-0443.2004.00789.x; Barnby G, 2005, AM J HUM GENET, V76, P950, DOI 10.1086/430454; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; Beuten J, 2007, BIOL PSYCHIAT, V61, P48, DOI 10.1016/j.biopsych.2006.02.023; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/twin.9.6.849; Broms U, 2006, TWIN RES HUM GENET, V9, P64, DOI 10.1375/twin.9.1.64; Chen ACH, 2009, AM J MED GENET B, V150B, P359, DOI 10.1002/ajmg.b.30818; CONNER AC, 2008, J MED GENET B, V147, P1476; Dorval KM, 2007, GENES BRAIN BEHAV, V6, P444, DOI 10.1111/j.1601-183X.2006.00273.x; Ho MK, 2007, PHARMACOGENOMICS J, V7, P81, DOI 10.1038/sj.tpj.6500436; Lang UE, 2007, PSYCHOPHARMACOLOGY, V190, P433, DOI 10.1007/s00213-006-0647-1; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; LI CY, 2008, NAT GENET IN PRESS; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Liu QR, 2005, P NATL ACAD SCI USA, V102, P11864, DOI 10.1073/pnas.0500329102; Lyons M, 2008, NICOTINE TOB RES, V10, P97, DOI 10.1080/14622200701705332; Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; McGehee DS, 2006, MOL INTERV, V6, P311, DOI 10.1124/mi.6.6.4; Monuteaux MC, 2008, NICOTINE TOB RES, V10, P1549, DOI 10.1080/14622200802326137; Morley KI, 2007, PSYCHOL MED, V37, P1357, DOI 10.1017/S0033291707000748; Munafo MR, 2008, ADDICTION, V103, P893, DOI 10.1111/j.1360-0443.2007.02071.x; Munafo MR, 2004, NICOTINE TOB RES, V6, P583, DOI 10.1080/14622200410001734030; Nielsen DA, 2008, MOL PSYCHIATR, V13, P417, DOI 10.1038/sj.mp.4002147; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; Peltonen L, 2003, TWIN RES, V6, P354, DOI 10.1375/twin.6.5.354; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ray R, 2006, PSYCHOPHARMACOLOGY, V188, P355, DOI 10.1007/s00213-006-0504-2; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sun DX, 2007, NEUROPSYCHOPHARMACOL, V32, P110, DOI 10.1038/sj.npp.1301134; TERRACCIANO A, 2008, MOL PSYCHIATR, DOI DOI 10.1038/MP.2008.113; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tzschentke TM, 2003, MOL PSYCHIATR, V8, P373, DOI 10.1038/sj.mp.4001269; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Vink J, 2005, BEHAV GENET, V35, P397, DOI 10.1007/s10519-004-1327-8; Vink JM, 2005, ADDICT BEHAV, V30, P575, DOI 10.1016/j.addbeh.2004.05.023; Vink JM, 2004, PHARMACOGENOMICS J, V4, P274, DOI 10.1038/sj.tpj.6500255; Walss-Bass C, 2009, AM J MED GENET B, V150B, P219, DOI 10.1002/ajmg.b.30791; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Wiesner A, 2006, CELL MOL LIFE SCI, V63, P2818, DOI 10.1007/s00018-006-6081-z	56	104	106	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					367	379		10.1016/j.ajhg.2009.02.001	http://dx.doi.org/10.1016/j.ajhg.2009.02.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19268276	Green Published, Bronze			2022-12-18	WOS:000264304200007
J	Tallila, J; Jakkula, E; Peltonen, L; Salonen, R; Kestila, M				Tallila, Jonna; Jakkula, Evelfina; Peltonen, Leena; Salonen, Riitta; Kestila, Marjo			Identification of CC2D2A as a Meckel syndrome gene adds an important piece to the ciliopathy puzzle	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BARDET-BIEDL-SYNDROME; BASAL BODY PROTEOME; GRUBER-SYNDROME; JOUBERT-SYNDROME; CILIA; MUTATIONS; DISEASE; MKS3; FLAGELLAR; PROTEINS	Meckel syndrome (MKS) is a lethal malformation disorder characterized classically by encephalocele, polycystic kidneys, and polydactyly. MKS is also one of the major contributors to syndromic neural tube defects (NTDs). Recent findings have shown primary cilia dysfunction in the molecular background of MKS, indicating that cilia are critical for early human development. However, even though four genes behind MKS have been identified to date, they elucidate only a minor proportion of the MKS cases. In this study, instead of traditional linkage analysis, we selected 10 nonrelated affected fetuses and looked for the homozygous regions shared by them. Based on this strategy, we identified the sixth locus and the fifth gene, CC2D2A (MKS6), behind MKS. The biological function of CC2D2A is uncharacterized, but the corresponding polypeptide is predicted to be involved in ciliary functions and it has a calcium binding domain (C2). Immunofluorescence staining of patient's fibroblast cells demonstrates that the cells lack cilia, providing evidence for the critical role of CC2D2A in cilia formation. Our finding is very significant not only to understand the molecular background of MKS, but also to obtain additional information about the function of the cilia, which can help to understand their significance in normal development and also in other ciliopathies, which are an increasing group of disorders with overlapping phenotypes.	[Tallila, Jonna; Jakkula, Evelfina; Peltonen, Leena; Kestila, Marjo] Natl Publ Hlth Inst, Helsinki 00290, Finland; [Tallila, Jonna; Jakkula, Evelfina; Peltonen, Leena; Kestila, Marjo] Inst Mol Med Finland, Helsinki 00290, Finland; [Jakkula, Evelfina] Univ Helsinki, Inst Mol Med Finland, Finnish Genome Ctr, FIN-00014 Helsinki, Finland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Peltonen, Leena] Broad Inst, Cambridge, MA 02142 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Salonen, Riitta] Univ Helsinki, Dept Med Genet, SF-00100 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute; University of Helsinki	Kestila, M (corresponding author), Natl Publ Hlth Inst, Helsinki 00290, Finland.	marjo.kestila@ktl.fi			NIEHS NIH HHS [P01 ES011253, P01 ES11253-03] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Clotman F, 2008, LIVER INT, V28, P377, DOI 10.1111/j.1478-3231.2007.01617.x; Consugar MB, 2007, HUM GENET, V121, P591, DOI 10.1007/s00439-007-0341-3; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Frank V, 2007, HUM MUTAT, V28, P638, DOI 10.1002/humu.9496; Ickowicz V, 2006, ULTRASOUND OBST GYN, V27, P296, DOI 10.1002/uog.2708; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Noor A, 2008, AM J HUM GENET, V82, P1011, DOI 10.1016/j.ajhg.2008.01.021; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; SALONEN R, 1984, AM J MED GENET, V18, P671, DOI 10.1002/ajmg.1320180414; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tamm Sidney, 1994, Trends in Cell Biology, V4, P305, DOI 10.1016/0962-8924(94)90226-7; Tobin JL, 2007, PEDIATR NEPHROL, V22, P926, DOI 10.1007/s00467-007-0435-0; Webb SE, 2006, BBA-MOL CELL RES, V1763, P1192, DOI 10.1016/j.bbamcr.2006.08.004	27	104	109	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1361	1367		10.1016/j.ajhg.2008.05.004	http://dx.doi.org/10.1016/j.ajhg.2008.05.004			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18513680	Green Published, Bronze			2022-12-18	WOS:000256647000014
J	Wagenstaller, J; Spranger, S; Lorenz-Depiereux, B; Kazmierczak, B; Nathrath, M; Wahl, D; Heye, B; Glaser, D; Liebscher, V; Meitinger, T; Strom, TM				Wagenstaller, Janine; Spranger, Stephanie; Lorenz-Depiereux, Bettina; Kazmierczak, Bernd; Nathrath, Michaela; Wahl, Dagmar; Heye, Babett; Glaeser, Dieter; Liebscher, Volkmar; Meitinger, Thomas; Strom, Tim M.			Copy-number variations measured by single-nucleotide polymorphism oligonucleotide Arrays in patients with mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; X-LINKED ICHTHYOSIS; CHROMOSOMAL-ABNORMALITIES; COMMON INVERSION; VCX-A; GENE; MICRODELETION; DELETION; REARRANGEMENTS; ARCHITECTURE	Whole-genome analysis using high-density single-nucleotide-polymorphism oligonucleotide arrays allows identification of microdeletions, microduplications, and uniparental disomies. We studied 67 children with unexplained mental retardation with normal karyotypes, as assessed by G-banded chromosome analyses. Their DNAs were analyzed with Affymetrix 100K arrays. We detected 11 copy-number variations that most likely are causative of mental retardation, because they either arose de novo (9 cases) and/or overlapped with known microdeletions (2 cases). The eight deletions and three duplications varied in size from 200 kb to 7.5 Mb. Of the 11 copy-number variations, 5 were flanked by low-copy repeats. Two of those, on chromosomes 15q25.2 and Xp22.31, have not been described before and have a high probability of being causative of new deletion and duplication syndromes, respectively. In one patient, we found a deletion affecting only a single gene, MBD5, which codes for the methyl-CpG-binding domain protein 5. In addition to the 67 children, we investigated 4 mentally retarded children with apparent balanced translocations and detected four deletions at breakpoint regions ranging in size from 1.1 to 14 Mb.	GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, Munich, Germany; Tech Univ Munich, Inst Human Genet, D-8000 Munich, Germany; Tech Univ Munich, Dept Pediat, D-8000 Munich, Germany; Praxis Humangenet, Bremen, Germany; Praxis Humangenet Beratung, Augsburg, Germany; Zentrum Humangenet, Neu Ulm, Germany; Univ Greifswald, Dept Math & Comp Sci, Greifswald, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Technical University of Munich; Ernst Moritz Arndt Universitat Greifswald	Strom, TM (corresponding author), GSF, Natl Res Ctr, Inst Human Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	TimStrom@gsf.de	Liebscher, Volkmar/R-6865-2019; Liebscher, Volkmar/P-3543-2018; Meitinger, Thomas/O-1318-2015	Liebscher, Volkmar/0000-0003-1446-4423; Liebscher, Volkmar/0000-0003-1446-4423; Meitinger, Thomas/0000-0002-8838-8403				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Devriendt K, 1999, AM J HUM GENET, V64, P1119, DOI 10.1086/302330; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; Faivre L, 1998, PRENATAL DIAG, V18, P1055, DOI 10.1002/(SICI)1097-0223(1998100)18:10<1055::AID-PD405>3.0.CO;2-I; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Fukami M, 2000, AM J HUM GENET, V67, P563, DOI 10.1086/303047; Green EK, 2000, J MED GENET, V37, P581, DOI 10.1136/jmg.37.8.581; Hernandez-Martin A, 1999, BRIT J DERMATOL, V141, P617; Horn D, 2007, MED GENETIK, V19, P62; Koolen DA, 2004, J MED GENET, V41, P892, DOI 10.1136/jmg.2004.023671; Koolen DA, 2004, CLIN GENET, V65, P429, DOI 10.1111/j.0009-9163.2004.00245.x; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; Roloff TC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-1; Schinzel A., 2001, CATALOGUE UNBALANCED; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Slater HR, 2005, AM J HUM GENET, V77, P709, DOI 10.1086/497343; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Van Esch H, 2005, HUM MOL GENET, V14, P1795, DOI 10.1093/hmg/ddi186; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977	36	104	111	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					768	779		10.1086/521274	http://dx.doi.org/10.1086/521274			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847001	Green Published, Bronze			2022-12-18	WOS:000249307600017
J	Dubrova, YE; Grant, G; Chumak, AA; Stezhka, VA; Karakasian, AN				Dubrova, YE; Grant, G; Chumak, AA; Stezhka, VA; Karakasian, AN			Elevated minisatellite mutation rate in the post-Chernobyl families from Ukraine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERMLINE MUTATION; RADIATION INDUCTION; IONIZING-RADIATION; ALLELE DIVERSITY; DOSE-RESPONSE; X-RAYS; DNA; ACCIDENT; EXPOSURE; SPECTRUM	Germline mutation at eight human minisatellite loci has been studied among families from rural areas of the Kiev and Zhitomir regions of Ukraine, which were heavily contaminated by radionuclides after the Chernobyl accident. The control and exposed groups were composed of families containing children conceived before and after the Chernobyl accident, respectively. The groups were matched by ethnicity, maternal age, parental occupation, and smoking habits, and they differed only slightly by paternal age. A statistically significant 1.6-fold increase in mutation rate was found in the germline of exposed fathers, whereas the maternal germline mutation rate in the exposed families was not elevated. These data, together with the results of our previous analysis of the exposed families from Belarus, suggest that the elevated minisatellite mutation rate can be attributed to post-Chernobyl radioactive exposure. The mechanisms of mutation induction at human minisatellite loci are discussed.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Res Ctr Radiat Med, Dept Clin Immunol, Kiev, Ukraine; Inst Occupat Hlth, Dept Med Biol Study, Kiev, Ukraine; Inst Occupat Hlth, Dept Occupat Hyg & Physiol Women & Teenagers, Kiev, Ukraine	University of Leicester; National Academy of Medical Sciences of Ukraine; National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; Kundiiev Institute of Occupational Health of the National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; Kundiiev Institute of Occupational Health of the National Academy of Medical Sciences of Ukraine	Dubrova, YE (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	yed2@le.ac.uk	Dubrova, Yuri/ABA-7148-2020	Dubrova, Yuri/0000-0001-5281-7539; Chumak, Anatolii/0000-0002-2117-6174				Balonov M. 1., 1993, CHERNOBYL PAPERS, P23; Barber R, 2000, MUTAT RES-FUND MOL M, V457, P79, DOI 10.1016/S0027-5107(00)00130-5; Buard J, 2000, GENOMICS, V65, P95, DOI 10.1006/geno.2000.6161; Buard J, 1998, EMBO J, V17, P3495, DOI 10.1093/emboj/17.12.3495; Chakraborty R, 1996, MUTAT RES-FUND MOL M, V354, P41, DOI 10.1016/0027-5107(96)00014-0; Darroudi F., 1996, Radiological Consequences of the Chernobyl Accident. Proceedings of the First International Conference (EUR 16544 EN), P1067; Dubrova YE, 2000, MUTAT RES-FUND MOL M, V453, P17, DOI 10.1016/S0027-5107(00)00068-3; Dubrova YE, 1998, P NATL ACAD SCI USA, V95, P6251, DOI 10.1073/pnas.95.11.6251; Dubrova YE, 1997, MUTAT RES-FUND MOL M, V381, P267; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; Dubrova YE, 2002, SCIENCE, V295, P1037, DOI 10.1126/science.1068102; FAN YJ, 1995, INT J RADIAT BIOL, V68, P177, DOI 10.1080/09553009514551081; GIVER CR, 1995, CARCINOGENESIS, V16, P267, DOI 10.1093/carcin/16.2.267; Golikov VY., 1993, CHERNOBYL PAPERS, V1, P247; *INT ADV COMM, 1991, INT CHERN PROJ ASS R; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jeffreys AJ, 1997, HUM MOL GENET, V6, P129, DOI 10.1093/hmg/6.1.129; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; Kovalchuk O, 2000, NATURE, V407, P583, DOI 10.1038/35036692; Likhtarev IA, 2000, HEALTH PHYS, V79, P341, DOI 10.1097/00004032-200010000-00002; Likhtarev IA, 2002, HEALTH PHYS, V82, P290, DOI 10.1097/00004032-200203000-00002; May CA, 1996, HUM MOL GENET, V5, P1823, DOI 10.1093/hmg/5.11.1823; Maznik NA, 1997, RADIAT PROT DOSIM, V74, P5, DOI 10.1093/oxfordjournals.rpd.a032181; Mikhalevich LS, 2000, RADIAT PROT DOSIM, V87, P109, DOI 10.1093/oxfordjournals.rpd.a032982; Morgan WF, 1996, RADIAT RES, V146, P247, DOI 10.2307/3579454; NELSON SL, 1994, CARCINOGENESIS, V15, P495, DOI 10.1093/carcin/15.3.495; Office of Population Censuses and Surveys, 1980, CLASS OCC COD IND; Prohl G, 2002, HEALTH PHYS, V82, P173, DOI 10.1097/00004032-200202000-00004; SADAMOTO S, 1994, INT J RADIAT BIOL, V65, P549, DOI 10.1080/09553009414550641; Sankaranarayanan K, 2000, MUTAT RES-FUND MOL M, V453, P107, DOI 10.1016/S0027-5107(00)00108-1; SCHIESTL RH, 1994, SCIENCE, V266, P1573, DOI 10.1126/science.7985029; SOUTHERN EM, 1979, ANAL BIOCHEM, V100, P319, DOI 10.1016/0003-2697(79)90235-5; Stead JDH, 2000, HUM MOL GENET, V9, P713, DOI 10.1093/hmg/9.5.713; Tamaki K, 1999, HUM MOL GENET, V8, P879, DOI 10.1093/hmg/8.5.879; United Nations Scientific Committee on the Effect of Atomic Radiation, 1993, SOURC EFF ION RAD; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; VOGEL F, 1975, ADV HUM GENET, V5, P223; Vogel F., 1997, HUMAN GENETICS; Yauk CL, 2002, MUTAT RES-FUND MOL M, V500, P147, DOI 10.1016/S0027-5107(02)00005-2	39	104	114	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					801	809		10.1086/342729	http://dx.doi.org/10.1086/342729			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12226793	Bronze, Green Published			2022-12-18	WOS:000178613800009
J	Kaplan, DE; Gayan, J; Ahn, J; Won, TW; Pauls, D; Olson, RK; DeFries, JC; Wood, F; Pennington, BF; Page, GP; Smith, SD; Gruen, JR				Kaplan, DE; Gayan, J; Ahn, J; Won, TW; Pauls, D; Olson, RK; DeFries, JC; Wood, F; Pennington, BF; Page, GP; Smith, SD; Gruen, JR			Evidence for linkage and association with reading disability, on 6p21.3-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT LOCUS; PHONOLOGICAL CODING DYSLEXIA; MULTIPLE-REGRESSION ANALYSIS; CHROMOSOME 6P INFLUENCES; INSULIN GENE REGION; DEVELOPMENTAL DYSLEXIA; ESSENTIAL-HYPERTENSION; DISEQUILIBRIUM; POLYMORPHISM; CONFIRMATION	Reading disability (RD), or dyslexia, is a common heterogeneous syndrome with a large genetic component. Several studies have consistently found evidence for a quantitative-trait locus (QTL) within the 17 Mb (14.9 cM) that span D6S109 and D6S291 on chromosome 6p21.3-22. To characterize further linkage to the QTL, to define more accurately the location and the effect size, and to identify a peak of association, we performed Haseman-Elston and DeFries-Fulker linkage analyses, as well as transmission/disequilibrium, total-association, and variance-components analyses, on 11 quantitative reading and language phenotypes. One hundred four families with RD were genotyped with a new panel of 29 markers that spans 9 Mb of this region. Linkage results varied widely in degree of statistical significance for the different linkage tests, but multipoint analysis suggested a peak near D6S461. The average 6p QTL heritability for the 11 reading and language phenotypes was 0.27, with a maximum of 0.66 for orthographic choice. Consistent with the region of linkage described by these studies and others, there was a peak of transmission disequilibrium with a QTL centered at JA04 (chi(2) = 9.48 empirical P = .0033; orthographic choice), and there was strong evidence for total association at this same marker (chi(2) = 11.49; P = .0007; orthographic choice). Although the boundaries of the peak could not be precisely defined, the most likely location of the QTL is within a 4-Mb region surrounding JA04.	Yale Univ, Sch Med, Dept Pediat, Yale Child Hlth Res Ctr, New Haven, CT 06520 USA; Univ Oxford, Oxford OX1 2JD, England; Wont Int Patent & Law Firm, Dept Biotechnol, Seoul, South Korea; Harvard Med Sch, Psychiat & Neurodev Genet Unit, Charlestown, MA USA; Univ Colorado, Boulder, CO 80309 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Univ Denver, Denver, CO USA; Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA; Univ Nebraska, Med Ctr, Munroe Meyer Inst, Omaha, NE USA	Yale University; University of Oxford; University of Colorado System; University of Colorado Boulder; Wake Forest University; University of Denver; University of Alabama System; University of Alabama Birmingham; University of Nebraska System; University of Nebraska Medical Center	Gruen, JR (corresponding author), Yale Univ, Sch Med, Dept Pediat, Yale Child Hlth Res Ctr, 464 Congress Ave, New Haven, CT 06520 USA.			Page, Grier/0000-0003-2582-3786	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD021887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038820, R01MH038820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012849, R01DA012690] Funding Source: NIH RePORTER; NICHD NIH HHS [2P01 HD21887-11, P01 HD021887, U01 HD98002, P50 HD027802, P50 HD27802] Funding Source: Medline; NIDA NIH HHS [R01 DA012690, R01 DA012849, R01 DA12690, R01 DA12849] Funding Source: Medline; NIMH NIH HHS [R01 MH038820, R37 MH038820, MH38820] Funding Source: Medline; NINDS NIH HHS [R01 NS043530] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Ahn J, 2001, GENOMICS, V78, P19, DOI 10.1006/geno.2001.6645; Allison DB, 1999, AM J HUM GENET, V64, P1754, DOI 10.1086/302404; Allison DB, 1997, AM J HUM GENET, V60, P676; CAMBIEN F, 1994, CLIN GENET, V46, P94; CARDON LR, 1995, SCIENCE, V268, P1553, DOI 10.1126/science.7777847; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CRITCHLEY M, 1970, DYSLEXIC CHILD; DeFries J. C., 1997, LEARNING DISABILITIE, V8, P7; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; DUNN LM, 1970, PEABODY INDIVIDUAL A; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Fagerheim T, 1999, J MED GENET, V36, P664; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Field LL, 1998, AM J HUM GENET, V63, P1448, DOI 10.1086/302107; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Fisher SE, 2002, NAT GENET, V30, P86, DOI 10.1038/ng792; FULKER DW, 1991, READ WRIT, V3, P299, DOI 10.1007/BF00354964; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Gayan J, 2001, DEV NEUROPSYCHOL, V20, P483, DOI 10.1207/S15326942DN2002_3; Grigorenko EL, 2000, AM J HUM GENET, V66, P715, DOI 10.1086/302755; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HATA A, 1994, J CLIN INVEST, V93, P1285, DOI 10.1172/JCI117083; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; JULIER C, 1994, AM J HUM GENET, V55, P1247; LERNER JW, 1989, J AM ACAD CHILD PSY, V28, P326, DOI 10.1097/00004583-198905000-00004; Lessem JL, 2001, BIOINFORMATICS, V17, P371, DOI 10.1093/bioinformatics/17.4.371; Malfroy L, 1997, GENOMICS, V43, P226, DOI 10.1006/geno.1997.4800; Morris DW, 2000, HUM MOL GENET, V9, P843, DOI 10.1093/hmg/9.5.843; Nothen MM, 1999, EUR CHILD ADOLES PSY, V8, P56; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OLSON R, 1989, J LEARN DISABIL, V22, P339, DOI 10.1177/002221948902200604; OLSON RK, 1994, VARIETIES ORTHOGRAPH, V1, P27; Page GP, 1999, AM J HUM GENET, V64, P1194, DOI 10.1086/302331; Petryshen TL, 2000, AM J HUM GENET, V66, P708, DOI 10.1086/302764; RABIN M, 1993, LANCET, V342, P178, DOI 10.1016/0140-6736(93)91384-X; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schork NJ, 2001, ADV GENET, V42, P191, DOI 10.1016/S0065-2660(01)42023-2; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; SMITH SD, 1991, READ WRIT, V3, P285, DOI 10.1007/BF00354963; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; Sobel E, 1996, AM J HUM GENET, V58, P1323; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; WECHSLER D, 1974, WECHSLERS INTELLIGEN; Yoshida K, 2000, J HUM GENET, V45, P294, DOI 10.1007/s100380070019	54	104	108	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1287	1298		10.1086/340449	http://dx.doi.org/10.1086/340449			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	541XT	11951179	Bronze, Green Published			2022-12-18	WOS:000175012400018
J	Schmidt, S; Barcellos, LF; DeSombre, K; Rimmler, JB; Lincoln, RR; Bucher, P; Saunders, AM; Lai, E; Martin, ER; Vance, JM; Oksenberg, JR; Hauser, SL; Pericak-Vance, MA; Haines, JL				Schmidt, S; Barcellos, LF; DeSombre, K; Rimmler, JB; Lincoln, RR; Bucher, P; Saunders, AM; Lai, E; Martin, ER; Vance, JM; Oksenberg, JR; Hauser, SL; Pericak-Vance, MA; Haines, JL		Multiple Sclerosis Genetics Grp	Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; APOE EPSILON-4 ALLELE; ALZHEIMERS-DISEASE; GENETIC-BASIS; LINKAGE; RISK; GENOTYPE; IMPAIRMENT; DISABILITY; EXPRESSION	Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system, with a complex etiology that includes a strong genetic component. The contribution of the major histocompatibility complex (MHC) has been established in numerous genetic linkage and association studies. In addition to the MHC, the chromosome 19q13 region surrounding the apolipoprotein E (APOE) gene has shown consistent evidence of involvement in MS when family-based analyses were conducted. Furthermore, several clinical reports have suggested that the APOE-4 allele may be associated with more-severe disease and faster progression of disability. To thoroughly examine the role of APOE in MS, we genotyped its functional alleles, as well as seven single-nucleotide polymorphisms (SNPs) located primarily within 13 kb of APOE, in a data set of 398 families. Using family-based association analysis, we found statistically significant evidence that an SNP haplotype near APOE is associated with MS susceptibility (P = .005). An analysis of disease progression in 614 patients with MS from 379 families indicated that APOE- 4 carriers are more likely to be affected with severe disease (P = .03), whereas a higher proportion of APOE- 2 carriers exhibit a mild disease course (P = .02).	Duke Univ, Med Ctr, Dept Med, Ctr Human Genet,Sect Med Genet, Durham, NC 27710 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; GlaxoSmithKline, US Discovery Genet, Res Triangle Pk, NC USA; Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Program Human Genet, Nashville, TN USA	Duke University; University of California System; University of California San Francisco; GlaxoSmithKline; Vanderbilt University	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Dept Med, Ctr Human Genet,Sect Med Genet, Box 3445, Durham, NC 27710 USA.	mpv@chg.mc.duke.edu	Hauser, Stephen L/J-2978-2016; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Vance, Jeffery/0000-0003-3815-8199	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS032830] Funding Source: NIH RePORTER; NINDS NIH HHS [NS32830, NS26799, R01 NS026799, R01 NS032830] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Artiga MJ, 1998, HUM MOL GENET, V7, P1887, DOI 10.1093/hmg/7.12.1887; Ballerini C, 2000, NEUROSCI LETT, V296, P174, DOI 10.1016/S0304-3940(00)01646-3; Barcellos LF, 1997, JAMA-J AM MED ASSOC, V278, P1256, DOI 10.1001/jama.278.15.1256; Barcellos LF, 2002, BRAIN, V125, P150; Carlin C, 2000, J NEUROPATH EXP NEUR, V59, P361, DOI 10.1093/jnen/59.5.361; Chapman J, 2001, NEUROLOGY, V56, P312, DOI 10.1212/WNL.56.3.312; Chataway J, 1998, BRAIN, V121, P1869, DOI 10.1093/brain/121.10.1869; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; D'Alfonso S, 1999, EUR J HUM GENET, V7, P377, DOI 10.1038/sj.ejhg.5200301; D'Alfonso S, 2000, J NEUROVIROL, V6, pS18; DOUSSET V, 1998, MULT SCLER, V4, P357; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; EGGERDING FA, 1995, HUM MUTAT, V5, P153, DOI 10.1002/humu.1380050209; Evangelou N, 1999, J NEUROL NEUROSUR PS, V67, P203, DOI 10.1136/jnnp.67.2.203; Fazekas F, 2000, J NEUROL NEUROSUR PS, V69, P25, DOI 10.1136/jnnp.69.1.25; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Ferri C, 1999, NEUROLOGY, V53, P888, DOI 10.1212/WNL.53.4.888; Gaillard O, 1998, J NEUROL SCI, V158, P180, DOI 10.1016/S0022-510X(98)00118-X; GOODKIN DE, 1991, ARCH NEUROL-CHICAGO, V48, P805, DOI 10.1001/archneur.1991.00530200041016; Haines JL, 2000, AM J HUM GENET, V67, P21; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; HAINES JL, 1993, AM J HUM GENET, V53, P266; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hauser SL, 2001, HARRISONS PRINC INT, V2, P2452; Haynes C., 1995, American Journal of Human Genetics, V57, pA193; Hogh P, 2000, MULT SCLER J, V6, P226, DOI 10.1191/135245800678827851; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lambert JC, 1998, HUM MOL GENET, V7, P533, DOI 10.1093/hmg/7.3.533; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lucotte G, 2000, ALZHEIMERS REP, V3, P151; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Martin ER, 2001, JAMA-J AM MED ASSOC, V286, P2245, DOI 10.1001/jama.286.18.2245; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2001, AM J HUM GENET, V68, P1065, DOI 10.1086/319525; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oliveri RL, 1999, ACTA NEUROL SCAND, V100, P290; Pericak-Vance MA, 2001, NEUROGENETICS, V3, P195; Pirttila T, 2000, ACTA NEUROL SCAND, V102, P94, DOI 10.1034/j.1600-0404.2000.102002094.x; RIFAI N, 1987, CLIN CHEM, V33, P1155; RIMMLER J, 1998, AM J HUM GENET S, V63, pA240; ROSATI G, 1994, ANN NEUROL, V36, pS164, DOI 10.1002/ana.410360803; SADOVNICK AD, 1993, ANN NEUROL, V33, P281, DOI 10.1002/ana.410330309; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Sobel E, 1996, AM J HUM GENET, V58, P1323; Vance Jeffery M., 1998, P201; Weatherby SJM, 2000, MULT SCLER, V6, P32, DOI 10.1191/135245800678827464; Weatherby SJM, 2000, J NEUROL NEUROSUR PS, V68, P532, DOI 10.1136/jnnp.68.4.532; Weinshenker BG, 1997, NEUROLOGY, V49, P378, DOI 10.1212/WNL.49.2.378; Williamson JM, 1999, COMPUT METH PROG BIO, V58, P25, DOI 10.1016/S0169-2607(98)00063-7; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162; Zouali H, 1999, MULT SCLER, V5, P134, DOI 10.1177/135245859900500211	61	104	107	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					708	717		10.1086/339269	http://dx.doi.org/10.1086/339269			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11836653	Green Published, Bronze			2022-12-18	WOS:000173880000013
J	Aouizerat, BE; Allayee, H; Cantor, RM; Davis, RC; Lanning, CD; Wen, PZ; Dallinga-Thie, GM; de Bruin, TWA; Rotter, JI; Lusis, AJ				Aouizerat, BE; Allayee, H; Cantor, RM; Davis, RC; Lanning, CD; Wen, PZ; Dallinga-Thie, GM; de Bruin, TWA; Rotter, JI; Lusis, AJ			A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OXYSTEROL-BINDING-PROTEIN; COMPLEX SEGREGATION ANALYSIS; SERUM TRIGLYCERIDE LEVELS; CORONARY-ARTERY DISEASE; APOLIPOPROTEIN-B LEVELS; AIV GENE-CLUSTER; COMBINED HYPERLIPEMIA; LIPOPROTEIN PHENOTYPE; GOLGI LOCALIZATION; STABLE ISOTOPES	Familial combined hyperlipidemia (FCHL) is a common familial lipid disorder characterized by a variable pattern of elevated levels of plasma cholesterol and/or triglycerides. It is present in 10%-20% of patients with premature coronary heart disease. The genetic etiology of the disease, including the number of genes involved and the magnitude of their effects, is unknown. Using a subset of 35 Dutch families ascertained for FCHL, we screened the genome, with a panel of 393 genetic markers, for chromosomal regions linked to genes contributing to FCHL. The results were analyzed by use of parametric-linkage methods in a two-stage study design. Four loci, on chromosomes 2p, 11p, 16q, and 19q, exhibited suggestive evidence for linkage with FCHL (LOD scores of 1.3-2.6). Markers within each of these regions were then examined in the original sample and in additional Dutch families with FCHL. The locus on chromosome 2 failed to show evidence for linkage, and the loci on chromosome 16q and 19q yielded only equivocal or suggestive evidence for linkage. However, one locus, near marker D11S1324 on the short arm of human chromosome 11, continued to show evidence for linkage with FCHL, in the second stage of this design. This region does not contain any strong candidate genes. These results provide evidence for a candidate chromosomal region for FCHL and support the concept that FCHL is complex and heterogeneous.	Univ Calif Los Angeles, Sch Med, Dept Med, Div Cardiol,Mol Biol Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Pediat & Human Genet, Los Angeles, CA 90095 USA; Steven Spielberg Pediat Res Ctr, Dept Med, Div Med Genet, Los Angeles, CA USA; Steven Spielberg Pediat Res Ctr, Dept Pediat, Los Angeles, CA USA; Univ Utrecht Hosp, Dept Med, Utrecht, Netherlands; Univ Utrecht Hosp, Dept Endocrinol, Utrecht, Netherlands; State Univ Limburg Hosp, Dept Med & Endocrinol, NL-6201 BX Maastricht, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maastricht University	Lusis, AJ (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Cardiol,Mol Biol Inst, 47-123 CHS, Los Angeles, CA 90095 USA.	jlusis@mednet.ucla.edu		dallinga-thie, geesje/0000-0001-5412-5923	NCRR NIH HHS [P41 RR03655] Funding Source: Medline; NHLBI NIH HHS [HL-28481] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AguilarSalinas CA, 1997, ARTERIOSCL THROM VAS, V17, P72, DOI 10.1161/01.ATV.17.1.72; Aitman TJ, 1997, ARTERIOSCL THROM VAS, V17, P748, DOI 10.1161/01.ATV.17.4.748; Allayee H, 1998, AM J HUM GENET, V63, P577, DOI 10.1086/301983; Aouizerat BE, 1999, CURR OPIN LIPIDOL, V10, P113, DOI 10.1097/00041433-199904000-00005; AOUIZERAT BE, IN PRESS ARTERIOSCLE; Bredie SJH, 1996, AM J HUM GENET, V58, P812; Bredie SJH, 1997, ARTERIOSCL THROM VAS, V17, P834, DOI 10.1161/01.ATV.17.5.834; Bredie SJH, 1997, EUR J CLIN INVEST, V27, P802, DOI 10.1046/j.1365-2362.1997.1850734.x; BRUNZELL JD, 1983, J LIPID RES, V24, P147; CABEZAS MC, 1992, NETH J MED, V40, P83; CABEZAS MC, 1993, ARTERIOSCLER THROMB, V13, P804, DOI 10.1161/01.ATV.13.6.804; Castellani LW, 1998, NAT GENET, V18, P374, DOI 10.1038/ng0498-374; CIANFLONE K, 1995, INT J OBESITY, V19, pS34; CORTNER JA, 1991, J INHERIT METAB DIS, V14, P915, DOI 10.1007/BF01800473; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CULLEN P, 1994, ARTERIOSCLER THROMB, V14, P1233, DOI 10.1161/01.ATV.14.8.1233; DallingaThie GM, 1996, J LIPID RES, V37, P136; DallingaThie GM, 1997, J CLIN INVEST, V99, P953, DOI 10.1172/JCI119260; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DEBRUIN TWA, 1991, AM J PHYSIOL, V260, pE492, DOI 10.1152/ajpendo.1991.260.3.E492; ELSTON RC, 1997, STAT ANAL GENETIC EP; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hegele RA, 1998, J HUM GENET, V43, P37, DOI 10.1007/s100380050034; ISELIUS L, 1981, HUM HERED, V31, P222, DOI 10.1159/000153212; JARVIK GP, 1994, ARTERIOSCLER THROMB, V14, P1687, DOI 10.1161/01.ATV.14.11.1687; JARVIK GP, 1993, GENET EPIDEMIOL, V10, P257, DOI 10.1002/gepi.1370100406; Juo SHH, 1998, AM J HUM GENET, V63, P586, DOI 10.1086/301962; KISSEBAH AH, 1981, METABOLISM, V30, P856, DOI 10.1016/0026-0495(81)90064-0; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Lagace TA, 1999, J LIPID RES, V40, P109; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LEVANON D, 1990, GENOMICS, V7, P65, DOI 10.1016/0888-7543(90)90519-Z; NIKKILA EA, 1973, LANCET, V1, P954; OTT J, 1991, ANAL HUMAN GENETIC L, P54; Pajukanta P, 1997, ARTERIOSCL THROM VAS, V17, P841, DOI 10.1161/01.ATV.17.5.841; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; Ridgway ND, 1998, J BIOL CHEM, V273, P31621, DOI 10.1074/jbc.273.47.31621; ROSE HG, 1973, AM J MED, V54, P148, DOI 10.1016/0002-9343(73)90218-0; Rusch TL, 1996, P SOC PHOTO-OPT INS, V2680, P316, DOI 10.1117/12.237620; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; Terwillinger JD, 1994, HDB HUMAN GENETIC LI; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; Vakkilainen J, 1998, EUR J CLIN INVEST, V28, P24; vanBarlingen HHJJ, 1996, ATHEROSCLEROSIS, V121, P75, DOI 10.1016/0021-9150(95)05703-X; VENKATESAN S, 1993, ARTERIOSCLER THROMB, V13, P1110, DOI 10.1161/01.ATV.13.7.1110; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLIAMS WR, 1982, HUM HERED, V32, P24, DOI 10.1159/000153254; WOJCIECHOWSKI AP, 1991, NATURE, V349, P161, DOI 10.1038/349161a0; Yang WS, 1996, J LIPID RES, V37, P2627; Yuan B, 1997, AM J HUM GENET, V60, P459	58	104	107	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					397	412		10.1086/302490	http://dx.doi.org/10.1086/302490			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417282	Green Published, Bronze			2022-12-18	WOS:000081836900015
J	Athanassiadou, A; Voutsinas, G; Psiouri, L; Leroy, E; Polymeropoulos, MH; Ilias, A; Maniatis, GM; Papapetropoulos, T				Athanassiadou, A; Voutsinas, G; Psiouri, L; Leroy, E; Polymeropoulos, MH; Ilias, A; Maniatis, GM; Papapetropoulos, T			Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ALZHEIMER-DISEASE; G209A MUTATION; LEWY BODIES; ASSIGNMENT; COMPONENT; ABSENCE		Univ Patras, Fac Med, Dept Biol, Patras, Greece; Univ Patras, Fac Med, Dept Neurol, Patras, Greece; Natl Human Genome Res Inst, Lab Genet Dis Res, NIH, Bethesda, MD USA; Novartis Pharmaceut Corp, Pharmacogenet, Gaithersburg, MD USA; Univ Athens, Eginit Hosp, Athens, Greece	University of Patras; University of Patras; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Novartis; National & Kapodistrian University of Athens	Athanassiadou, A (corresponding author), Univ Patras, Fac Med, Dept Biol, Patras, Greece.							Baba M, 1998, AM J PATHOL, V152, P879; Bennett P, 1998, NEUROLOGY, V50, P1183, DOI 10.1212/WNL.50.4.1183; CAMPION D, 1995, GENOMICS, V26, P254, DOI 10.1016/0888-7543(95)80208-4; Chan P, 1998, NEUROLOGY, V50, P1136, DOI 10.1212/WNL.50.4.1136; Chan P, 1998, NEUROLOGY, V50, P513, DOI 10.1212/WNL.50.2.513; CHEN XH, 1995, GENOMICS, V26, P425, DOI 10.1016/0888-7543(95)80237-G; Farrer M, 1998, ANN NEUROL, V43, P394, DOI 10.1002/ana.410430320; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; MANGE EJ, 1994, BASIC HUMAN GENETICS; Munoz E, 1997, NEUROSCI LETT, V235, P57, DOI 10.1016/S0304-3940(97)00710-6; Papadimitriou A, 1999, NEUROLOGY, V52, P651, DOI 10.1212/WNL.52.3.651; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; UEDA K, 1994, BIOCHEM BIOPH RES CO, V205, P1366, DOI 10.1006/bbrc.1994.2816; Vaughan JR, 1998, HUM MOL GENET, V7, P751, DOI 10.1093/hmg/7.4.751; Zareparsi S, 1998, LANCET, V351, P37, DOI 10.1016/S0140-6736(05)78089-2	21	104	109	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					555	558		10.1086/302486	http://dx.doi.org/10.1086/302486			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417297	Green Published, Bronze			2022-12-18	WOS:000081836900030
J	Rufenacht, UB; Gouya, L; Schneider-Yin, X; Puy, H; Schafer, BW; Aquaron, R; Nordmann, Y; Minder, EI; Deybach, JC				Rufenacht, UB; Gouya, L; Schneider-Yin, X; Puy, H; Schafer, BW; Aquaron, R; Nordmann, Y; Minder, EI; Deybach, JC			Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIVER-FAILURE; HOUSE MOUSE; MUTATION; RNA; IDENTIFICATION; DEFICIENCY; EXTRACTION; EXPRESSION; DELETION; SITE	Erythropoietic protoporphyria (EPP; MIM 177000) is an inherited disorder caused by partial deficiency of ferrochelatase (FECH), the last enzyme in the heme biosynthetic pathway. In EPP patients, the FECH deficiency causes accumulation of free protoporphyrin in the erythron, associated with a painful skin photosensitivity. In rare cases, the massive accumulation of protoporphyrin in hepatocytes may lead to a rapidly progressive liver failure. The mode of inheritance in EPP is complex and can be either autosomal dominant with low clinical penetrance, as it is in most cases, or autosomal recessive. To acquire an in-depth knowledge of the genetic basis of EPP, we conducted a systematic mutation analysis of the FECH gene, following a procedure that combines the exon-by-exon denaturing-gradient-gel-electrophoresis screening of the FECH genomic DNA and direct sequencing. Twenty different mutations, 15 of which are newly described here, have been characterized in 26 of 29 EPP patients of Swiss and French origin. All the EPP patients, including those with liver complications, were heterozygous for the mutations identified in the FECH gene. The deleterious effect of all missense mutations has been assessed by bacterial expression of the respective FECH cDNAs generated by site-directed mutagenesis. Mutations leading to a null allele were a common feature among three EPP pedigrees with liver complications. Our systematic molecular study has resulted in a significant enlargement of the mutation repertoire in the FECH gene and has shed new light on the hereditary behavior of EPP.	Hop Louis Mourier, Fac Xavier Bichat, INSERM, U409,Ctr Francais Porphyries, F-92701 Colombes, France; Stadtspital Triemli, Zent Lab, Zurich, Switzerland; Univ Zurich, Kinderklin, Abt Klin Chem & Biochem, Zurich, Switzerland; Fac Med Marseille, F-13385 Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Triemli Hospital; University of Zurich; UDICE-French Research Universities; Aix-Marseille Universite	Nordmann, Y (corresponding author), Hop Louis Mourier, Fac Xavier Bichat, INSERM, U409,Ctr Francais Porphyries, F-92701 Colombes, France.	jcdaphlm@msn.com	PUY, HERVE/O-1785-2017	PUY, HERVE/0000-0003-3362-2634; Gouya, Laurent/0000-0002-1326-7025; Schafer, Beat/0000-0001-5988-2915				BONKOWSKY HL, 1975, J CLIN INVEST, V56, P1139, DOI 10.1172/JCI108189; BOULECHFAR S, 1993, GENOMICS, V16, P645, DOI 10.1006/geno.1993.1242; BRENNER DA, 1992, AM J HUM GENET, V50, P1203; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cox TM, 1997, J INHERIT METAB DIS, V20, P258, DOI 10.1023/A:1005317124985; DAILEY HA, 1994, J BIOL CHEM, V269, P390; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DEYBACH JC, 1986, PORPHYRINS PROPHYRIA, P193; Gouya L, 1996, AM J HUM GENET, V58, P292; Henriksson M, 1996, J INVEST DERMATOL, V106, P346, DOI 10.1111/1523-1747.ep12343020; Imoto S, 1996, BRIT J HAEMATOL, V94, P191, DOI 10.1046/j.1365-2141.1996.d01-1771.x; KAPPAS A, 1995, METABOLIC MOL BASIS, P2139; LAMORIL J, 1995, HUM MOL GENET, V4, P275, DOI 10.1093/hmg/4.2.275; LAMORIL J, 1991, BIOCHEM BIOPH RES CO, V181, P594, DOI 10.1016/0006-291X(91)91231-Z; LERMAN L, 1987, METHOD ENZYMOL, V155, P484; Li F M, 1987, Biomed Chromatogr, V2, P164, DOI 10.1002/bmc.1130020408; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; MAGNESS ST, 1994, HUM MOL GENET, V3, P1695, DOI 10.1093/hmg/3.9.1695; MAGNUS IA, 1961, LANCET, V2, P448; NAKAHASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P748, DOI 10.1016/S0006-291X(05)80099-3; NAKAHASHI Y, 1993, HUM MOL GENET, V2, P1069, DOI 10.1093/hmg/2.7.1069; NAKAHASHI Y, 1993, HUM GENET, V91, P303; NORRIS PG, 1990, J INVEST DERMATOL, V95, P260, DOI 10.1111/1523-1747.ep12484876; Puy H, 1997, AM J HUM GENET, V60, P1373, DOI 10.1086/515455; SARKANY RPE, 1994, LANCET, V343, P1394, DOI 10.1016/S0140-6736(94)92525-9; SARKANY RPE, 1994, J INVEST DERMATOL, V102, P481, DOI 10.1111/1523-1747.ep12373073; SCHNEIDERYIN X, 1995, HUM GENET, V95, P391; SCHNEIDERYIN X, 1994, LANCET, P344; SCHNEIDERYIN XY, 1994, HUM GENET, V93, P711; TAKETANI S, 1992, EUR J BIOCHEM, V205, P217, DOI 10.1111/j.1432-1033.1992.tb16771.x; TODD DJ, 1993, HUM MOL GENET, V2, P1495, DOI 10.1093/hmg/2.9.1495; TUTOIS S, 1991, J CLIN INVEST, V88, P1730, DOI 10.1172/JCI115491; Wang XH, 1996, BBA-MOL BASIS DIS, V1316, P149, DOI 10.1016/0925-4439(96)00003-8; WANG XH, 1994, BBA-MOL BASIS DIS, V1227, P25, DOI 10.1016/0925-4439(94)90101-5; WANG XH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P198, DOI 10.1016/0925-4439(93)90112-E; WANG XH, 1995, BBA-MOL BASIS DIS, V1271, P358, DOI 10.1016/0925-4439(95)00059-D; WHITCOMBE DM, 1991, GENOMICS, V11, P1152, DOI 10.1016/0888-7543(91)90044-F	37	104	104	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1998	62	6					1341	1352		10.1086/301870	http://dx.doi.org/10.1086/301870			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZU224	9585598	Green Published, Bronze			2022-12-18	WOS:000074174700010
J	Serova, O; Montagna, M; Torchard, D; Narod, SA; Tonin, P; Sylla, B; Lynch, HT; Feunteun, J; Lenoir, GM				Serova, O; Montagna, M; Torchard, D; Narod, SA; Tonin, P; Sylla, B; Lynch, HT; Feunteun, J; Lenoir, GM			A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RISK FAMILIES; MESSENGER-RNA; CHROMOSOME-17Q21; LINKAGE; GENE	We have analyzed 20 breast-ovarian cancer families, the majority of which show positive evidence of linkage to chromosome 17q12, for germ-line mutations in the BRCA1 gene. BRCA1 mutations cosegregating with breast and ovarian cancer susceptibility were identified in 16 families, including 1 family with a case of male breast cancer. Nine of these mutations have not been reported previously. The majority of mutations were found to generate a premature stop codon leading to the formation of a truncated BRCA1 protein of 2%-88% of the expected normal length. Two mutations altered the RING finger domain. Sequencing of genomic DNA led to the identification of a mutation in the coding region of BRCA1 in 12 families, and cDNA analysis revealed an abnormal or missing BRCA1 transcript in 4 of the 8 remaining families. A total of eight mutations were associated with a reduced quantity of BRCA1 transcript. We were unable to detect BRCA1 mutations in 4 of the 20 families, but only 1 of these was clearly linked to BRCA1. Ir is expected that the majority of clear examples of the breast-ovarian cancer syndrome will be associated with germ-line mutations in the coding region of BRCA1.	INT AGCY RES CANC,F-69372 LYON,FRANCE; INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE; MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; CREIGHTON UNIV,SCH MED,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE	World Health Organization; International Agency for Research on Cancer (IARC); UNICANCER; Gustave Roussy; McGill University; McGill University; Creighton University			montagna, marco/E-2225-2012; Feunteun, Jean/AAZ-1267-2020; Narod, Steven A/AAA-6112-2022	montagna, marco/0000-0002-4929-2150; Feunteun, Jean/0000-0003-1212-9189	NATIONAL CANCER INSTITUTE [R01CA063678] Funding Source: NIH RePORTER; NCI NIH HHS [1RO1 CA 63678-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GO RCP, 1983, J NATL CANCER I, V71, P455; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LYNCH HT, 1993, ARCH INTERN MED, V153, P1979; LYNCH HT, 1981, GENETICS BREAST CANC; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD S, 1995, AM J HUM GENET, V57, P957; NAROD SA, 1995, AM J HUM GENET, V56, P254; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; SCHILDKRAUT JM, 1989, AM J HUM GENET, V45, P521; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STOLZENBERG MC, 1994, ONCOGENE, V9, P2799; STRATTON MR, 1994, NAT GENET, V7, P103, DOI 10.1038/ng0594-103; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; TONIN P, 1995, AM J HUM GENET, V57, P189; TONIN P, 1994, HUM MOL GENET, V3, P1679, DOI 10.1093/hmg/3.9.1679; TORCHARD D, 1994, NAT GENET, V6, P106, DOI 10.1038/ng0194-106	30	104	107	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					42	51						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554067				2022-12-18	WOS:A1996TL69700008
J	CHOU, YHW; POLLAK, MR; BRANDI, ML; TOSS, G; ARNQVIST, H; ATKINSON, AB; PAPAPOULOS, SE; MARX, S; BROWN, EM; SEIDMAN, JG; SEIDMAN, CE				CHOU, YHW; POLLAK, MR; BRANDI, ML; TOSS, G; ARNQVIST, H; ATKINSON, AB; PAPAPOULOS, SE; MARX, S; BROWN, EM; SEIDMAN, JG; SEIDMAN, CE			MUTATIONS IN THE HUMAN CA2+-SENSING-RECEPTOR GENE THAT CAUSE FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE PRIMARY HYPERPARATHYROIDISM; RECEPTOR; KINDREDS	We report five novel mutations in the human Ca2+-sensing-receptor gene that cause familial hypocalciuric hypercalcemia (FHH) or neonatal severe hyperparathyroidism. Each gene defect is a missense mutation ((228)Arg-->Gln, (139)Thr-->Met, (144)Gly-->Glu, (63)Arg-->Met, and (67)Arg-->Cys) that encodes a nonconservative amino acid alteration, These mutations are each predicted to be in the Ca2+-sensing receptor's large extracellular domain. In three families with FHH linked to the Ca2+-sensing-receptor gene on chromosome 3 and in unrelated individuals probands with FHH, mutations were not detected in protein-coding sequences. On the basis of these data and previous analyses, we suggest that there are a wide range of mutations that cause FHH. Mutations that perturb the structure and function of the extracellular or transmembrane domains of the receptor and those that affect noncoding sequences of the Ca2+-sensing-receptor gene can cause FHH.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,HOWARD HUGHES MED INST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DIV RENAL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; CHANG GUNG MEM HOSP,LIVER RES UNIT,TAYUAN,TAIWAN; UNIV FLORENCE,DEPT CLIN PHYSIOPATHOL,FLORENCE,ITALY; LINKOPING UNIV,DEPT INTERNAL MED,LINKOPING,SWEDEN; ROYAL VICTORIA HOSP,SIR GEORGE E CLARK METAB UNIT,BELFAST,ANTRIM,NORTH IRELAND; UNIV LEIDEN HOSP,DEPT ENDOCRINOL & METAB DIS,LEIDEN,NETHERLANDS; NIDDKD,METAB DIS BRANCH,BETHESDA,MD	Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Chang Gung Memorial Hospital; University of Florence; Linkoping University; Leiden University; Leiden University Medical Center (LUMC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K11DK002138, R01DK046422, R01DK044588] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK44588, DK46422, DK02138] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATTIE MF, 1983, J CLIN INVEST, V72, P667, DOI 10.1172/JCI111016; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; CHOU YHW, 1992, NAT GENET, V1, P395; HEATH H, 1993, AM J HUM GENET, V53, P193; HOLCOMBE R F, 1987, Genomics, V1, P287, DOI 10.1016/0888-7543(87)90058-9; JACOBS KA, 1989, CURRENT PROTOCOLS MO; KAUFMAN DL, 1990, GENOMICS, V8, P656, DOI 10.1016/0888-7543(90)90252-P; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; MACRAE CA, 1994, CIRCULATION, V89, P33, DOI 10.1161/01.CIR.89.1.33; MARX SJ, 1982, NEW ENGL J MED, V306, P257, DOI 10.1056/NEJM198202043060502; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; MARX SJ, 1985, AM J MED, V62, P698; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MENKO FH, 1983, Q J MED, V206, P120; NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773; Ott J., 1991, ANAL HUMAN GENETIC L; PEARCE SHS, 1994, J BONE MINER RES  S1, V9, pS145; POLLAK M, 1994, J CLIN INVEST, V93, P1109; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; STEINMANN B, 1984, HELV PAEDIATR ACTA, V39, P171; WATKINS H, 1994, CURRENT PROTOCOLS HU; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	23	104	106	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1075	1079						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726161				2022-12-18	WOS:A1995QU58600008
J	MORRISON, KE; MARIYAMA, M; YANGFENG, TL; REEDERS, ST				MORRISON, KE; MARIYAMA, M; YANGFENG, TL; REEDERS, ST			SEQUENCE AND LOCALIZATION OF A PARTIAL CDNA-ENCODING THE HUMAN ALPHA-3 CHAIN OF TYPE-IV COLLAGEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOMERULAR BASEMENT-MEMBRANE; ALPORT FAMILIAL NEPHRITIS; CARBOXYL-TERMINAL DOMAIN; GOODPASTURE ANTIGEN; X-CHROMOSOME; HEREDITARY NEPHRITIS; GLOBULAR DOMAIN; GENE; IDENTIFICATION; ALPHA-1-CHAIN	A novel type IV collagen, alpha-3(IV), has recently been identified in human and bovine basement membranes. Here we describe the cloning and sequencing of a cDNA encoding 218 residues of the NC1 domain of the human alpha-3(IV) chain. Of interest is the possible role of abnormalities of the alpha-3(IV) chain in Alport syndrome, as suggested by the failure to detect the NC1 domain of alpha-3(IV) in the basement membranes of some Alport syndrome patients. To determine whether the alpha-3(IV) gene (COL4A3) may be mutated in Alport syndrome, we localized it, by somatic cell hybrid analysis and in situ hybridization of metaphase chromosomes, to chromosome 2q35-2q37. Mutations in alpha-3(IV) cannot therefore be responsible for the vast majority of cases of Alport syndrome, which have been shown to be X linked. One explanation for the immunochemical data implicating alpha-3(IV) in Alport syndrome pathogenesis is that mutations of the alpha-5(IV) chain, which has been localized to Xq22 and found to be mutated in at least three kindreds with Alport syndrome, lead to failure to incorporate the alpha-3(IV) chains into the multimeric structure of glomerular basement membrane in a stable fashion.	YALE UNIV, SCH MED,DEPT INTERNAL MED,NEPHROL SECT,2073 LMP, 333 CEDAR ST, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, DEPT HUMAN GENET, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, HOWARD HUGHES MED INST, NEW HAVEN, CT 06510 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University				Morrison, Karen Elaine/0000-0003-0216-5717	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040703] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK40703] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKIN CL, 1988, AM J HUM GENET, V42, P249; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; BRINKER JM, 1985, P NATL ACAD SCI USA, V82, P3649, DOI 10.1073/pnas.82.11.3649; BRUNNER H, 1988, KIDNEY INT, V34, P507, DOI 10.1038/ki.1988.210; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; BUTKOWSKI RJ, 1990, J LAB CLIN MED, V115, P365; BUTKOWSKI RJ, 1985, J BIOL CHEM, V260, P3739; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DION AS, 1987, J MOL BIOL, V193, P127, DOI 10.1016/0022-2836(87)90632-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLINTER FA, 1989, GENOMICS, V4, P335, DOI 10.1016/0888-7543(89)90339-X; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1989, LAB INVEST, V61, P256; JENIS EH, 1981, CLIN NEPHROL, V15, P111; KASHTAN C, 1986, J CLIN INVEST, V78, P1035, DOI 10.1172/JCI112658; KLEPPEL MM, 1987, J CLIN INVEST, V80, P263, DOI 10.1172/JCI113057; KLEPPEL MM, 1989, LAB INVEST, V61, P278; KLEPPEL MM, 1986, J BIOL CHEM, V261, P6547; MARTIN GR, 1988, ADV PROTEIN CHEM, V39, P1; MORRISON KE, 1991, J BIOL CHEM, V266, P34; MUTHUKUMARAN G, 1989, J BIOL CHEM, V264, P6310; MYERS JC, 1990, AM J HUM GENET, V46, P1024; MYERS JC, 1987, J BIOL CHEM, V262, P9231; OLSON DL, 1980, J PEDIATR-US, V96, P697, DOI 10.1016/S0022-3476(80)80746-3; PIHLAJANIEMI T, 1985, J BIOL CHEM, V260, P7681; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P13758; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; SAUS J, 1989, J BIOL CHEM, V264, P6318; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAVAGE COS, 1989, LAB INVEST, V60, P613; SAVAGE COS, 1986, KIDNEY INT, V30, P107, DOI 10.1038/ki.1986.158; SOININEN R, 1987, FEBS LETT, V225, P188; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; YANGFENG TL, 1985, AM J HUM GENET, V37, P1117; ZHOU J, 1991, GENOMICS, V9, P10, DOI 10.1016/0888-7543(91)90215-Z; ZHOU J, 1991, GENOMICS, V9, P1, DOI 10.1016/0888-7543(91)90214-Y	41	104	107	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					545	554						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1882840				2022-12-18	WOS:A1991GE36700007
J	EXCOFFIER, L; LANGANEY, A				EXCOFFIER, L; LANGANEY, A			ORIGIN AND DIFFERENTIATION OF HUMAN MITOCHONDRIAL-DNA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											EXCOFFIER, L (corresponding author), UNIV GENEVA,GENET & BIOMETRIE LAB,12 RUE GUSTAVE REVILLIOD,1227 CAROUGE,CH-1211 GENEVA 4,SWITZERLAND.		Excoffier, Laurent/D-3498-2013	Excoffier, Laurent/0000-0002-7507-6494				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BIRKY CW, 1983, GENETICS, V103, P513; BONNETAMIR B, 1986, AM J HUM GENET, V38, P341; BREGA A, 1986, AM J HUM GENET, V39, P502; BREGA A, 1986, ANN HUM GENET, V50, P327, DOI 10.1111/j.1469-1809.1986.tb01754.x; Brown W.M., 1985, MOL EVOLUTIONARY GEN, P95, DOI DOI 10.1007/978-1-4684-4988-4_2; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANN RL, 1982, THESIS U CALIFORNIA; CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777; DARLU P, 1987, NATURE, V329, P111, DOI 10.1038/329111b0; DARLU P, 1987, RECHERCHE, V18, P979; DARLU P, 1987, HUM EVOL, V2, P407; DELSON E, 1988, NATURE, V332, P206, DOI 10.1038/332206a0; ECKHARDT RB, 1987, NATURE, V326, P749, DOI 10.1038/326749a0; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EWENS WJ, 1983, STATISTICAL ANAL DNA, P45; EXCOFFIER L, 1988, IN PRESS 2EME C DEM; EXCOFFIER L, 1988, YB PHYS ANTHR, V30, P151; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; GRIFFITHS RC, 1979, ADV APPL PROBAB, V11, P326, DOI 10.2307/1426843; HARIHARA S, 1986, JPN J HUM GENET, V31, P73, DOI 10.1007/BF01871401; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; NEI M, 1981, GENETICS, V97, P145; NEI M, 1974, AM J HUM GENET, V26, P421; NEI M, 1983, GENETICS, V105, P207; POULTON J, 1987, NEW SCI, V1640, P51; SAITOU N, 1987, NATURE, V327, P288, DOI 10.1038/327288a0; SANCHEZMAZAS A, 1988, HUM GENET, V78, P161, DOI 10.1007/BF00278189; STRINGER C, 1988, NATURE, V331, P565, DOI 10.1038/331565a0; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; TAKAHATA N, 1985, GENETICS, V110, P325; VALLADAS H, 1988, NATURE, V331, P614, DOI 10.1038/331614a0; WAINSCOAT J, 1987, NATURE, V325, P13, DOI 10.1038/325013a0; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1977, THEOR POPUL BIOL, V11, P141, DOI 10.1016/0040-5809(77)90023-5; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WHITTAM TS, 1986, P NATL ACAD SCI USA, V83, P9611, DOI 10.1073/pnas.83.24.9611	46	104	107	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1989	44	1					73	85						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R5596	2562823				2022-12-18	WOS:A1989R559600014
J	GUALANDRI, V; FRANCESCHINI, G; SIRTORI, CR; GIANFRANCESCHI, G; ORSINI, GB; CERRONE, A; MENOTTI, A				GUALANDRI, V; FRANCESCHINI, G; SIRTORI, CR; GIANFRANCESCHI, G; ORSINI, GB; CERRONE, A; MENOTTI, A			AIMILANO APOPROTEIN IDENTIFICATION OF THE COMPLETE KINDRED AND EVIDENCE OF A DOMINANT GENETIC TRANSMISSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MILAN,CTR E GROSSI PAOLETTI,I-20129 MILAN,ITALY; UNIV MILAN,CHAIR CHEMOTHERAPY,I-20129 MILAN,ITALY; BUR MED OFFICER,LIMONE SUL GARDA,ITALY; IST SUPER SANITA,EPIDEMIOL & BIOSTAT LAB,ROME,ITALY	University of Milan; University of Milan; Istituto Superiore di Sanita (ISS)	GUALANDRI, V (corresponding author), UNIV MILAN,DEPT GENET,CORSO VENEZIA 55,I-20122 MILAN,ITALY.		Sirtori, Cesare/F-4658-2012	FRANCESCHINI, GUIDO/0000-0003-2687-1771	NHLBI NIH HHS [1-R01-HL28961-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028961] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1967, INT CLASSIFICATION D; ASSMANN G, 1977, J CLIN INVEST, V60, P1025, DOI 10.1172/JCI108853; BLACKBURN H, 1969, CIRCULATION, V21, P1160; BUCOLO G, 1973, CLIN CHEM, V19, P476; BURNSTEIN M, 1969, NOUV REV FR HEMATOL, V9, P231; CARLSON LA, 1982, EUR J CLIN INVEST, V12, P41, DOI 10.1111/j.1365-2362.1982.tb00938.x; FRANCESCHINI G, 1980, J CLIN INVEST, V66, P892, DOI 10.1172/JCI109956; FRANCESCHINI G, 1981, METABOLISM, V30, P502, DOI 10.1016/0026-0495(81)90188-8; FRANCESCHINI G, 1982, J BIOL CHEM, V257, P1513; GUALANDRI V, 1985, METABOLISM, V34, P212, DOI 10.1016/0026-0495(85)90003-4; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; ROSCHLAU P, 1974, Z KLIN CHEM KLIN BIO, V12, P403; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; SNEDECOR GW, 1980, STATISTICAL METHODS, P54; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WEISGRABER KH, 1980, J CLIN INVEST, V66, P901, DOI 10.1172/JCI109957; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2508; WITZTUM JL, 1978, DIABETES, V27, P1215, DOI 10.2337/diabetes.27.12.1215; 1981, AM J EPIDEMIOL, V113, P338; 1981, ANNUARIO STATISTICA	20	104	112	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1985	37	6					1083	1097						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AXE36	3936350				2022-12-18	WOS:A1985AXE3600004
J	MORTON, NE				MORTON, NE			FURTHER SCORING TYPES IN SEQUENTIAL LINKAGE TESTS, WITH A CRITICAL REVIEW OF AUTOSOMAL AND PARTIAL SEX LINKAGE IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDRESEN PH, 1951, ACTA HAEMATOL-BASEL, V5, P123, DOI 10.1159/000203817; BELL J, 1948, TREASURY HUMAN INHER, V4; Bernstein F, 1943, J IMMUNOL, V46, P245; BIANCO I, 1954, ANN HUM GENET, V19, P81, DOI 10.1111/j.1469-1809.1954.tb01266.x; Burks BS, 1941, GENETICS, V26, P223; Cockayne EA, 1933, INHERITED ABNORMALIT; Finney DJ, 1940, ANN EUGENIC, V10, P171, DOI 10.1111/j.1469-1809.1940.tb02246.x; Fisher RA, 1936, ANN EUGENIC, V7, P17, DOI 10.1111/j.1469-1809.1936.tb02125.x; Fisher RA, 1936, ANN EUGENIC, V7, P87, DOI 10.1111/j.1469-1809.1936.tb02131.x; Gates Reginald Ruggles, 1946, HUMAN GENETICS; GATES RR, 1954, GENETIC LINKAGE MAN; GRUBB R, 1949, BRIT J EXP PATHOL, V30, P198; Haldane JBS, 1936, ANN EUGENIC, V7, P28, DOI 10.1111/j.1469-1809.1936.tb02127.x; HALDANE JBS, 1946, ANN EUGENIC, V13, P122, DOI 10.1111/j.1469-1809.1946.tb02348.x; Haldane JBS, 1941, J GENET, V41, P141, DOI 10.1007/BF02983017; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; Harris H, 1948, EUGEN REV, V40, P70; Hogben L, 1935, J GENET, V31, P353, DOI 10.1007/BF02982406; HOLT HA, 1952, HEREDITY, V6, P213, DOI 10.1038/hdy.1952.21; JAMESON RJ, 1956, ANN HUM GENET, V20, P348; KALLIS N, 1943, GENETICS, V28, P78; KOLLER PC, 1948, BRIT J CANCER, V2, P149, DOI 10.1038/bjc.1948.22; KOLLER PC, 1937, P ROY SOC EDINB B, V57, P194; MACKLIN MT, 1952, AM J HUM GENET, V4, P356; MATTHEY R, 1951, ADV GENET, V4, P159, DOI 10.1016/S0065-2660(08)60234-5; MOHR J, 1956, Acta Genet Stat Med, V6, P24; Mohr J, 1954, STUDY LINKAGE MAN; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1955, ANN HUM GENET, V20, P116; NEEL JV, 1952, AM J HUM GENET, V4, P204; Neel JV, 1954, HUMAN HEREDITY; NERGER B, 1906, THESIS KIEL; OGUMA KAN, 1930, ARCH BIOL, V40, P205; PIPKIN AC, 1945, J HERED, V36, P313, DOI 10.1093/oxfordjournals.jhered.a105430; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; ROBERTS JAF, 1945, Q J MED, P27; RYWLIN A., 1951, ACTA GENET ET STATIST MED, V2, P85; SACHS L, 1954, ANN EUGENIC, V18, P255; SCHUT JW, 1951, AM J HUM GENET, V3, P93; SMITH CAB, 1954, ANN EUGENIC, V18, P278; Snyder LH, 1943, J HERED, V34, P207, DOI 10.1093/oxfordjournals.jhered.a105287; SNYDER LH, 1949, 8TH P INT C GEN HE S, P446; STEINBERG AG, 1956, AM J HUM GENET, V8, P177; STEPHENS FE, 1951, AM J HUM GENET, V3, P303; STURTZ GS, 1956, NEW ENGL J MED, V254, P1123, DOI 10.1056/NEJM195606142542404; WALLER M, 1952, P SOC EXP BIOL MED, V80, P479; WALTON JN, 1955, ANN HUM GENET, V20, P1, DOI 10.1111/j.1469-1809.1955.tb01274.x; WOOLF B, 1953, J ROY STAT SOC     B, V15, P153; [No title captured]	50	104	104	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1957	9	1					55	75						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA214	13410901				2022-12-18	WOS:A1957WA21400005
J	Li, J; Woods, SL; Healey, S; Beesley, J; Chen, XQ; Lee, JS; Sivakumaran, H; Wayte, N; Nones, K; Waterfall, JJ; Pearson, J; Patch, AM; Senz, J; Ferreira, MA; Kaurah, P; Mackenzie, R; Heravi-Moussavi, A; Hansford, S; Lannagan, TRM; Spurdle, AB; Simpson, PT; da Silva, L; Lakhani, SR; Clouston, AD; Bettington, M; Grimpen, F; Busuttil, RA; Di Costanzo, N; Boussioutas, A; Jeanjean, M; Chong, G; Fabre, A; Olschwang, S; Faulkner, GJ; Bellos, E; Coin, L; Rioux, K; Bathe, OF; Wen, XG; Martin, HC; Neklason, DW; Davis, SR; Walker, RL; Calzone, KA; Avital, I; Heller, T; Koh, C; Pineda, M; Rudloff, U; Quezado, M; Pichurin, PN; Hulick, PJ; Weissman, SM; Newlin, A; Rubinstein, WS; Sampson, JE; Hamman, K; Goldgar, D; Poplawski, N; Phillips, K; Schofield, L; Armstrong, J; Kiraly-Borri, C; Suthers, GK; Huntsman, DG; Foulkes, WD; Carneiro, F; Lindor, NM; Edwards, SL; French, JD; Waddell, N; Meltzer, PS; Worthley, DL; Schrader, KA; Chenevix-Trench, G				Li, Jun; Woods, Susan L.; Healey, Sue; Beesley, Jonathan; Chen, Xiaoqing; Lee, Jason S.; Sivakumaran, Haran; Wayte, Nicci; Nones, Katia; Waterfall, Joshua J.; Pearson, John; Patch, Anne-Marie; Senz, Janine; Ferreira, Manuel A.; Kaurah, Pardeep; Mackenzie, Robertson; Heravi-Moussavi, Alireza; Hansford, Samantha; Lannagan, Tamsin R. M.; Spurdle, Amanda B.; Simpson, Peter T.; da Silva, Leonard; Lakhani, Sunil R.; Clouston, Andrew D.; Bettington, Mark; Grimpen, Florian; Busuttil, Rita A.; Di Costanzo, Natasha; Boussioutas, Alex; Jeanjean, Marie; Chong, George; Fabre, Aurelie; Olschwang, Sylviane; Faulkner, Geoffrey J.; Bellos, Evangelos; Coin, Lachlan; Rioux, Kevin; Bathe, Oliver F.; Wen, Xiaogang; Martin, Hilary C.; Neklason, Deborah W.; Davis, Sean R.; Walker, Robert L.; Calzone, Kathleen A.; Avital, Itzhak; Heller, Theo; Koh, Christopher; Pineda, Marbin; Rudloff, Udo; Quezado, Martha; Pichurin, Pavel N.; Hulick, Peter J.; Weissman, Scott M.; Newlin, Anna; Rubinstein, Wendy S.; Sampson, Jone E.; Hamman, Kelly; Goldgar, David; Poplawski, Nicola; Phillips, Kerry; Schofield, Lyn; Armstrong, Jacqueline; Kiraly-Borri, Cathy; Suthers, Graeme K.; Huntsman, David G.; Foulkes, William D.; Carneiro, Fatima; Lindor, Noralane M.; Edwards, Stacey L.; French, Juliet D.; Waddell, Nicola; Meltzer, Paul S.; Worthley, Daniel L.; Schrader, Kasmintan A.; Chenevix-Trench, Georgia			Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FUNDIC GLAND POLYPS; HIGH-GRADE DYSPLASIA; PROMOTER 1B; SEQUENCING DATA; COLI GENE; CANCER; GENOME; PATIENT; FAP; RETROTRANSPOSITION	Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) is an autosomal-dominant cancer-predisposition syndrome with a significant risk of gastric, but not colorectal, adenocarcinoma. We mapped the gene to 5q22 and found loss of the wild-type allele on 5q in fundic gland polyps from affected individuals. Whole-exome and -genome sequencing failed to find causal mutations but, through Sanger sequencing, we identified point mutations in APC promoter 1B that co-segregated with disease in all six families. The mutations reduced binding of the YY1 transcription factor and impaired activity of the APC promoter 1B in luciferase assays. Analysis of blood and saliva from carriers showed allelic imbalance of APC, suggesting that these mutations lead to decreased allele-specific expression in vivo. Similar mutations in APC promoter 1B occur in rare families with familial adenomatous polyposis (FAP). Promoter 1A is methylated in GAPPS and sporadic FGPs and in normal stomach, which suggests that 1B transcripts are more important than 1A in gastric mucosa. This might explain why all known GAPPS-affected families carry promoter 1B point mutations but only rare FAP-affected families carry similar mutations, the colonic cells usually being protected by the expression of the 1A isoform. Gastric polyposis and cancer have been previously described in some FAP-affected individuals with large deletions around promoter 1B. Our finding that GAPPS is caused by point mutations in the same promoter suggests that families with mutations affecting the promoter 1B are at risk of gastric adenocarcinoma, regardless of whether or not colorectal polyps are present.	[Li, Jun; Healey, Sue; Beesley, Jonathan; Chen, Xiaoqing; Lee, Jason S.; Sivakumaran, Haran; Wayte, Nicci; Nones, Katia; Pearson, John; Patch, Anne-Marie; Ferreira, Manuel A.; Spurdle, Amanda B.; Edwards, Stacey L.; French, Juliet D.; Waddell, Nicola; Chenevix-Trench, Georgia] QIMR Berghofer, Dept Genet & Computat Biol, Herston, Qld 4029, Australia; [Woods, Susan L.; Lannagan, Tamsin R. M.; Worthley, Daniel L.] Univ Adelaide & Canc Theme, Sch Med, SAHMRI, Adelaide, SA 5000, Australia; [Waterfall, Joshua J.; Davis, Sean R.; Walker, Robert L.; Calzone, Kathleen A.; Pineda, Marbin; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Pearson, John; Bellos, Evangelos; Coin, Lachlan; Waddell, Nicola] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Senz, Janine; Hansford, Samantha] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Kaurah, Pardeep; Schrader, Kasmintan A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Mackenzie, Robertson; Huntsman, David G.; Schrader, Kasmintan A.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Heravi-Moussavi, Alireza] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Simpson, Peter T.; da Silva, Leonard; Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld 4029, Australia; [Simpson, Peter T.; da Silva, Leonard; Lakhani, Sunil R.; Bettington, Mark] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Anat Pathol, Pathol Queensland, Brisbane, Qld 4029, Australia; [Clouston, Andrew D.] Univ Queensland, Ctr Liver Dis Res, TRI Bldg, Woolloongabba, Qld 4102, Australia; [Clouston, Andrew D.; Bettington, Mark] Envoi Specialist Pathologists, Bishop St, Kelvin Grove, Qld 4059, Australia; [Bettington, Mark] QIMR Berghofer, Conjoint Gastroenterol Lab, Herston, Qld 4029, Australia; [Grimpen, Florian] Royal Brisbane & Womens Hosp, Dept Gastroenterol, Brisbane, Qld 4006, Australia; [Grimpen, Florian] Royal Brisbane & Womens Hosp, Dept Hepatol, Brisbane, Qld 4006, Australia; [Busuttil, Rita A.; Di Costanzo, Natasha; Boussioutas, Alex] Peter MacCallum Canc Ctr, Canc Genet & Genom Lab, Locked Bag 1, Melbourne, Vic 8006, Australia; [Busuttil, Rita A.; Boussioutas, Alex] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Busuttil, Rita A.; Boussioutas, Alex] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Parkville, Vic 3010, Australia; [Boussioutas, Alex] Royal Melbourne Hosp, Dept Gastroenterol, Parkville, Vic 3010, Australia; [Jeanjean, Marie; Foulkes, William D.] Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Chong, George] McGill Univ, Jewish Gen Hosp, Dept Pathol, Mol Pathol Ctr, Montreal, PQ H3T 1E2, Canada; [Fabre, Aurelie; Olschwang, Sylviane] AP HM Timone, Dept Med Genet, F-13385 Marseille, France; [Fabre, Aurelie; Olschwang, Sylviane] Aix Marseille Univ, INSERM, GMGF UMR S 910, F-13385 Marseille, France; [Fabre, Aurelie; Olschwang, Sylviane] Clairval Hosp, Gen Sante, Oncol Unit, F-13009 Marseille, France; [Faulkner, Geoffrey J.] Univ Queensland, Mater Res Inst, TRI Bldg, Woolloongabba, Qld 4102, Australia; [Bellos, Evangelos] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London W12 0NN, England; [Rioux, Kevin] Univ Calgary, Dept Med, Dept Microbiol & Infect Dis, Div Gastroenterol,Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Surg, Calgary, AB T2N 4N1, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Bathe, Oliver F.] Tom Baker Canc Clin, Div Surg Oncol, 1331 29th St NW, Calgary, AB T2N 4N1, Canada; [Wen, Xiaogang; Carneiro, Fatima] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP Inst Invest & Inovacao Saude, P-4200135 Oporto, Portugal; [Wen, Xiaogang] Ctr Hosp Vila Nova Gaia Espinho, P-4430027 Oporto, Portugal; [Martin, Hilary C.] Ctr Human Genet, Wellcome Trust, Oxford OX3 7BN, England; [Neklason, Deborah W.] Univ Utah, Huntsman Canc Inst, Dept Internal Med, Salt Lake City, UT 84112 USA; [Avital, Itzhak] Rutgers State Univ, St Peters Univ Hosp, Dept Surg, New Brunswick, NJ 08901 USA; [Heller, Theo; Koh, Christopher] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Rudloff, Udo] NCI, Thorac & Gastrointestinal Oncol Branch, CCR, NIH, Bethesda, MD 20892 USA; [Quezado, Martha] NCI, Pathol Lab, CCR, NIH, Bethesda, MD 20892 USA; [Pichurin, Pavel N.] Mayo Clin, Dept Med Genet, Rochester, MN 55905 USA; [Hulick, Peter J.; Newlin, Anna] NorthShore Univ HealthSyst, Ctr Med Genet, Evanston, IL 60201 USA; [Weissman, Scott M.] GeneDx, 207 Perry Pkwy, Gaithersburg, MD 20877 USA; [Rubinstein, Wendy S.] NIH, NCBI, Natl Lib Med, Bethesda, MD 20892 USA; [Sampson, Jone E.; Hamman, Kelly] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Goldgar, David] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT 84112 USA; [Goldgar, David] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Poplawski, Nicola; Phillips, Kerry; Armstrong, Jacqueline] Womens & Childrens Hosp, Adult Genet Unit, SA Pathol, Adelaide, SA 5006, Australia; [Poplawski, Nicola; Phillips, Kerry; Suthers, Graeme K.] Univ Adelaide, Univ Dept Paediat, Adelaide, SA 5005, Australia; [Schofield, Lyn; Kiraly-Borri, Cathy] King Edward Mem Hosp Women, Genet Serv Western Australia, Subiaco, WA 6008, Australia; [Huntsman, David G.] Univ British Columbia, Dept Pathol & Obstet & Gynaecol, Vancouver, BC V6Z 2K5, Canada; [Foulkes, William D.] McGill Univ, Program Canc Genet, Dept Oncol, Montreal, PQ H3A 1B1, Canada; [Foulkes, William D.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Carneiro, Fatima] Univ Porto, Fac Med, Ctr Hosp Sao Joao, P-4200319 Oporto, Portugal; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ 85259 USA	QIMR Berghofer Medical Research Institute; South Australian Health & Medical Research Institute (SAHMRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Queensland; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; Lady Davis Institute; McGill University; McGill University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Mater Research; University of Queensland; Imperial College London; University of Calgary; University of Calgary; University of Calgary; Tom Baker Cancer Clinic; University of Calgary; Universidade do Porto; University of Oxford; Wellcome Centre for Human Genetics; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Rutgers State University New Brunswick; Saint Peter's University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; NorthShore University Health System; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Oregon Health & Science University; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; SA Pathology; University of Adelaide; King Edward Memorial Hospital; University of Western Australia; University of British Columbia; McGill University; McGill University; Sao Joao Hospital; Universidade do Porto; Mayo Clinic; Mayo Clinic Phoenix	Chenevix-Trench, G (corresponding author), QIMR Berghofer, Dept Genet & Computat Biol, Herston, Qld 4029, Australia.	georgia.trench@qimrberghofer.edu.au	Nones, Katia/AAX-6453-2021; Patch, Ann-Marie/C-4201-2018; Carneiro, Fatima/AAV-8677-2021; French, Juliet/AAV-4435-2020; Edwards, Stacey/A-4980-2011; Spurdle, Amanda B/A-4978-2011; Simpson, Peter/F-1225-2010; chen, xia/GXM-5435-2022; Coin, Lachlan JM/A-9001-2014; chen, xia/GYR-3948-2022; Carneiro, Fatima/J-6432-2013; Huntsman, David/ABE-6082-2020; Hulick, Peter J/AAC-9444-2020; Faulkner, Geoffrey J/M-3168-2014; Waddell, Nicola/H-4929-2015; Lee, Jason/M-7522-2016; Lakhani, Sunil R/I-1970-2018; Foulkes, William D./AAR-9586-2021; Coin, Lachlan/O-4976-2019; Pearson, John/AAT-4211-2020; Fabre, Aurelie/M-1660-2016; Chenevix-Trench, Georgia/AAV-2014-2020; chen, xi/GXH-3653-2022; Da Silva, Leonard M/C-4562-2017; Davis, Sean/AAD-1801-2021; Olschwang, Sylviane/G-2716-2013; Clouston, Andrew/E-7199-2011	Nones, Katia/0000-0003-1925-5196; Patch, Ann-Marie/0000-0001-6121-4019; Carneiro, Fatima/0000-0002-1964-1006; French, Juliet/0000-0002-9770-0198; Spurdle, Amanda B/0000-0003-1337-7897; Simpson, Peter/0000-0002-4816-8289; Coin, Lachlan JM/0000-0002-4300-455X; Carneiro, Fatima/0000-0002-1964-1006; Hulick, Peter J/0000-0001-8397-4078; Faulkner, Geoffrey J/0000-0001-5769-4494; Waddell, Nicola/0000-0002-3950-2476; Lee, Jason/0000-0003-0879-934X; Lakhani, Sunil R/0000-0003-4067-2760; Foulkes, William D./0000-0001-7427-4651; Coin, Lachlan/0000-0002-4300-455X; Fabre, Aurelie/0000-0002-6748-0147; Chenevix-Trench, Georgia/0000-0002-1878-2587; Da Silva, Leonard M/0000-0001-6751-6819; Davis, Sean/0000-0002-8991-6458; Olschwang, Sylviane/0000-0001-7078-3029; Beesley, Jonathan/0000-0003-1942-325X; Sivakumaran, Haran/0000-0002-4691-4989; Lannagan, Tamsin/0000-0002-8206-8898; Waterfall, Joshua/0000-0002-3762-5050; Kiraly-Borri, Catherine/0000-0003-1711-8390; Walker, Robert/0000-0001-8235-4686; Heller, Theo/0000-0002-2643-6289; Boussioutas, Alex/0000-0002-8109-6897; Li, Jun/0000-0002-3126-3271; Calzone, Kathleen/0000-0002-2354-6810; Clouston, Andrew/0000-0002-9601-7952; Bettington, Mark/0000-0002-0880-3049; Schrader, Kasmintan/0000-0002-7413-4314; Rudloff, Udo/0000-0003-2137-9040	NHMRC; NIH [PO1-CA073992]; Canadian Institutes of Health Research [MOP-123517]; Ride to Conquer Cancer; NHMRC [GNT1045237]; Cancer Council South Australia; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; BC Cancer Foundation; NIH; Amgen; Sanofi Canada; pathology lab: Perth Pathology; pathology lab: St John of God Pathology; pathology lab: Western Diagnostics; pathology lab: PathWest (Royal Perth Hospital); pathology lab: PathWest (Fremantle Hospital); pathology lab: PathWest (King Edward Memorial Hospital); pathology lab: PathWest (Sir Charles Gairdner Hospital); NATIONAL CANCER INSTITUTE [ZIABC011091, P01CA073992] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ride to Conquer Cancer; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council South Australia(Cancer Council South Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); BC Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen(Amgen); Sanofi Canada(Sanofi-Aventis); pathology lab: Perth Pathology; pathology lab: St John of God Pathology; pathology lab: Western Diagnostics; pathology lab: PathWest (Royal Perth Hospital); pathology lab: PathWest (Fremantle Hospital); pathology lab: PathWest (King Edward Memorial Hospital); pathology lab: PathWest (Sir Charles Gairdner Hospital); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the individuals from the GAPPS-affected families who took part in this study, Andrew Giraud for providing the AGS and MKN74 cell lines, and Vicki Whitehall for HCT116 and RKO. The work was funded by the NHMRC, NIH (PO1-CA073992), and grant MOP-123517 from the Canadian Institutes of Health Research and the Ride to Conquer Cancer. G.J.F. acknowledges the support of an NHMRC Career Development Fellowship (GNT1045237); D.L.W., T.R.M.L., and S.L.W. are funded by Cancer Council South Australia Beat Cancer Project; G.C.-T. and A.B.S. by NHMRC Research Fellowships; and K.A.S. by the Canadian Institutes of Health Research, Michael Smith Foundation for Health Research, and BC Cancer Foundation. W.D.F. thanks Ms. N. Wong for clinical contributions. We acknowledge the support provided by the following pathology labs: Perth Pathology, St John of God Pathology, Western Diagnostics, and PathWest (Royal Perth Hospital, Fremantle Hospital, King Edward Memorial Hospital, and Sir Charles Gairdner Hospital). The authors are very grateful to staff at the Australian Red Cross Blood Services for their assistance with the collection of risk factor information and blood samples of healthy donor control subjects and thank members of the QIMR Molecular Cancer Epidemiology Laboratory for their assistance with recruitment and biospecimen processing. This study was in part (P.S.M., U.R.) supported by the Intramural Research Program of the NIH. O.F.B. has been paid consultancy fees by Amgen and Sanofi Canada.	Abraham SC, 2000, AM J PATHOL, V157, P747, DOI 10.1016/S0002-9440(10)64588-9; Abraham SC, 2002, AM J PATHOL, V161, P1735, DOI 10.1016/S0002-9440(10)64450-1; Abraham SC, 2001, AM J PATHOL, V158, P1005, DOI 10.1016/S0002-9440(10)64047-3; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnason T, 2014, HISTOPATHOLOGY, V65, P353, DOI 10.1111/his.12393; Atchison Michael, 2011, Critical Reviews in Oncogenesis, V16, P143; Attard TM, 2004, AM J GASTROENTEROL, V99, P681, DOI 10.1111/j.1572-0241.2004.04115.x; Bellos E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r120; Burt RW, 2003, GASTROENTEROLOGY, V125, P1462, DOI 10.1016/j.gastro.2003.07.017; Cao X, 2006, AM J GASTROENTEROL, V101, P2810, DOI 10.1111/j.1572-0241.2006.00842.x; Dickey W, 1996, J CLIN GASTROENTEROL, V23, P73, DOI 10.1097/00004836-199607000-00022; Doucet-O'Hare TT, 2015, P NATL ACAD SCI USA, V112, pE4894, DOI 10.1073/pnas.1502474112; Ewing AD, 2015, GENOME RES, V25, P1536, DOI 10.1101/gr.196238.115; Ezzedine S., 2014, JSM GASTROENTEROL HE, V2, P1035; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P1318, DOI 10.3748/wjg.14.1318; Garrean S, 2008, AM SURGEON, V74, P79; Genta RM, 2009, CLIN GASTROENTEROL H, V7, P849, DOI 10.1016/j.cgh.2009.05.015; Gismondi V, 1998, GENE CHROMOSOME CANC, V22, P278, DOI 10.1002/(SICI)1098-2264(199808)22:4<278::AID-GCC3>3.3.CO;2-Q; Groves C, 2002, AM J PATHOL, V160, P2055, DOI 10.1016/S0002-9440(10)61155-8; Hofgartner WT, 1999, AM J GASTROENTEROL, V94, P2275; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hosoya K, 2009, CANCER LETT, V285, P182, DOI 10.1016/j.canlet.2009.05.016; Huang CZ, 2014, EUR J GASTROEN HEPAT, V26, P1217, DOI 10.1097/MEG.0000000000000199; Jalving M, 2003, EUR J GASTROEN HEPAT, V15, P1229, DOI 10.1097/00042737-200311000-00013; Jalving M, 2003, SCAND J GASTROENTERO, V38, P916, DOI 10.1080/00365520310005433; Johnatty SE, 2008, BREAST CANCER RES TR, V109, P91, DOI 10.1007/s10549-007-9627-3; Kadiyska TK, 2014, CLIN GENET, V85, P452, DOI 10.1111/cge.12210; Kanter-Smoler G, 2006, CLIN GASTROENTEROL H, V4, P499, DOI 10.1016/j.cgh.2006.01.005; Kassahn KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074380; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lagarde A, 2010, J MED GENET, V47, P721, DOI 10.1136/jmg.2010.078964; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee C, 2013, BIOTECHNIQUES, V54, P141, DOI 10.2144/000113999; Lee JS, 2010, MOL CELL, V39, P71, DOI 10.1016/j.molcel.2010.06.008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin YI, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0148-0; LYNCH HT, 1995, CANCER, V76, P2427, DOI 10.1002/1097-0142(19951215)76:12<2427::AID-CNCR2820761205>3.0.CO;2-B; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; MIKI Y, 1992, CANCER RES, V52, P643; Ngamruengphong S, 2014, HERED CANCER CLIN PR, V12, DOI 10.1186/1897-4287-12-4; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Ohtaka Masahiko, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P945; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Pavicic W, 2014, GENE CHROMOSOME CANC, V53, P857, DOI 10.1002/gcc.22197; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rohlin A, 2011, ONCOGENE, V30, P4977, DOI 10.1038/onc.2011.201; Sekine S, 2004, MODERN PATHOL, V17, P1421, DOI 10.1038/modpathol.3800178; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; Snow AK, 2015, CLIN GENET, V88, P360, DOI 10.1111/cge.12503; Stolte M, 2003, EUR J GASTROEN HEPAT, V15, P1153, DOI 10.1097/00042737-200311000-00001; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; Thiede C, 2000, BONE MARROW TRANSPL, V25, P575, DOI 10.1038/sj.bmt.1702170; Tominaga O, 1998, DIGEST DIS SCI, V43, P306, DOI 10.1023/A:1018846103834; Torbenson M, 2002, MODERN PATHOL, V15, P718, DOI 10.1097/01.MP.0000018976.15044.9B; Tsuchiya T, 2000, ONCOGENE, V19, P3642, DOI 10.1038/sj.onc.1203704; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wijsman EM, 2006, AM J HUM GENET, V79, P846, DOI 10.1086/508472; Wood LD, 2014, AM J SURG PATHOL, V38, P389, DOI 10.1097/PAS.0000000000000146; Worthley DL, 2012, GUT, V61, P774, DOI 10.1136/gutjnl-2011-300348; Wu TT, 1998, AM J SURG PATHOL, V22, P293, DOI 10.1097/00000478-199803000-00003; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zwick A, 1997, GASTROENTEROLOGY, V113, P659, DOI 10.1053/gast.1997.v113.pm9247488	69	103	106	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 5	2016	98	5					830	842		10.1016/j.ajhg.2016.03.001	http://dx.doi.org/10.1016/j.ajhg.2016.03.001			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DL8DF	27087319	Bronze, Green Published			2022-12-18	WOS:000375869300003
J	Hjeij, R; Onoufriadis, A; Watson, CM; Slagle, CE; Klena, NT; Dougherty, GW; Kurkowiak, M; Loges, NT; Diggle, CP; Morante, NFC; Gabrie, GC; Lemke, KL; Li, Y; Pennekamp, P; Menchen, T; Konert, F; Marthin, JK; Mans, DA; Letteboer, SJF; Werner, C; Burgoyne, T; Westermann, C; Rutman, A; Carr, IM; O'Callaghan, C; Moya, E; Chung, EMK; Sheridan, E; Nielsen, KG; Roepman, R; Bartscherer, K; Burdine, RD; Lo, CW; Omran, H; Mitchison, HM				Hjeij, Rim; Onoufriadis, Alexandros; Watson, Christopher M.; Slagle, Christopher E.; Klena, Nikolai T.; Dougherty, Gerard W.; Kurkowiak, Malgorzata; Loges, Niki T.; Diggle, Christine P.; Morante, Nicholas F. C.; Gabrie, George C.; Lemke, Kristi L.; Li, You; Pennekamp, Petra; Menchen, Tabea; Konert, Franziska; Marthin, June Kehlet; Mans, Dorus A.; Letteboer, Stef J. F.; Werner, Claudius; Burgoyne, Thomas; Westermann, Cordula; Rutman, Andrew; Carr, Ian M.; O'Callaghan, Christopher; Moya, Eduardo; Chung, Eddie M. K.; Sheridan, Eamonn; Nielsen, Kim G.; Roepman, Ronald; Bartscherer, Kerstin; Burdine, Rebecca D.; Lo, Cecilia W.; Omran, Heymut; Mitchison, Hannah M.		UK10K Consortium	CCDC151 Mutations Cause Primary Ciliary Dyskinesia by Disruption of the Outer Dynein Arm Docking Complex Formation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEQUENCING IDENTIFIES MUTATIONS; OF-FUNCTION MUTATIONS; MOTILE CILIA; ELECTRON-MICROSCOPY; REGULATORY COMPLEX; AXONEMAL PROTEIN; HEART-DEFECTS; EXOME; ZEBRAFISH; INNER	A diverse family of cytoskeletal dynein motors powers various cellular transport systems, including axonemal dyneins generating the force for ciliary and flagellar beating essential to movement of extracellular fluids and of cells through fluid. Multisubunit outer dynein arm (ODA) motor complexes, produced and preassembled in the cytosol, are transported to the ciliary or flagellar compartment and anchored into the axonemal microtubular scaffold via the ODA docking complex (ODA-DC) system. In humans, defects in ODA assembly are the major cause of primary ciliary dyskinesia (PCD), an inherited disorder of ciliary and flagellar dysmotility characterized by chronic upper and lower respiratory infections and defects in laterality. Here, by combined high-throughput mapping and sequencing, we identified CCDC151 loss-of-function mutations in five affected individuals from three independent families whose cilia showed a complete loss of ODAs and severely impaired ciliary beating. Consistent with the laterality defects observed in these individuals, we found Ccdc151 expressed in vertebrate left-right organizers. Homozygous zebrafish ccdc151(ts272a) and mouse Ccdc151(snb1) mutants display a spectrum of situs defects associated with complex heart defects. We demonstrate that CCDC151 encodes an axonemal coiled coil protein, mutations in which abolish assembly of CCDC151 into respiratory cilia and cause a failure in axonemal assembly of the ODA component DNAH5 and the ODA-DC-associated components CCDC114 and ARMC4. CCDC151-deficient zebrafish, planaria, and mice also display ciliary dysmotility accompanied by ODA loss. Furthermore, CCDC151 coimmunoprecipitates CCDC114 and thus appears to be a highly evolutionarily conserved ODA-DC-related protein involved in mediating assembly of both ODAs and their axonemal docking machinery onto ciliary microtubules.	[Hjeij, Rim; Dougherty, Gerard W.; Kurkowiak, Malgorzata; Loges, Niki T.; Pennekamp, Petra; Menchen, Tabea; Werner, Claudius; Omran, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Onoufriadis, Alexandros; Mitchison, Hannah M.] UCL, Inst Child Hlth, Genet & Genom Med Programme, London WC1N 1EH, England; [Watson, Christopher M.] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; [Watson, Christopher M.; Diggle, Christine P.; Carr, Ian M.; Sheridan, Eamonn] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Biomed & Clin Sci, Leeds LS9 7TF, W Yorkshire, England; [Slagle, Christopher E.; Morante, Nicholas F. C.; Burdine, Rebecca D.] Princeton Univ, Dept Mol Biol, Washington, NJ 08544 USA; [Klena, Nikolai T.; Gabrie, George C.; Lemke, Kristi L.; Li, You; Lo, Cecilia W.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15201 USA; [Kurkowiak, Malgorzata] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Kurkowiak, Malgorzata] Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland; [Konert, Franziska; Bartscherer, Kerstin] Univ Munster, Max Planck Inst Mol Biomed, Max Planck Res Grp Stem Cells & Regenerat, D-48149 Munster, Germany; [Konert, Franziska; Bartscherer, Kerstin] Univ Munster, Fac Med, D-48149 Munster, Germany; [Marthin, June Kehlet; Nielsen, Kim G.] Rigshosp, Danish PCD Ctr, DK-2100 Copenhagen, Denmark; [Marthin, June Kehlet; Nielsen, Kim G.] Rigshosp, Pediat Pulm Serv, Dept Pediat & Adolescent Med, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Mans, Dorus A.; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Mans, Dorus A.; Letteboer, Stef J. F.; Roepman, Ronald] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Burgoyne, Thomas] UCL Inst Ophthalmol, London EC1V 9EL, England; [Westermann, Cordula] Univ Childrens Hosp Muenster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Rutman, Andrew; O'Callaghan, Christopher] Univ Leicester, Ctr PCD Diag & Res, Dept Infect Immun & Inflammat, RKCSB, Leicester LE2 7LX, Leics, England; [O'Callaghan, Christopher] UCL, Inst Child Hlth, London WC1N 1EH, England; [O'Callaghan, Christopher] Great Ormond St Childrens Hosp, London WC1N 1EH, England; [Moya, Eduardo] Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England; [Chung, Eddie M. K.] UCL, Gen & Adolescent Paediat Sect, Populat Policy & Practice Programme, Inst Child Hlth, London WC1N 1EH, England	University of Munster; University of London; University College London; Saint James's University Hospital; Saint James's University Hospital; University of Leeds; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; Max Planck Society; University of Munster; University of Munster; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Radboud University Nijmegen; Radboud University Nijmegen; University of London; University College London; University of Munster; University of Leicester; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Bradford Royal Infirmary; University of London; University College London	Omran, H (corresponding author), Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany.	heymut.omran@ukmuenster.de	Roepman, Ronald/B-1339-2014; Burgoyne, Thomas/HCI-9054-2022; Noethe-Menchen, Tabea/AAW-1667-2021; Letteboer, Stef JF/P-8272-2015; Nielsen, KG/AAE-6575-2020	Roepman, Ronald/0000-0002-5178-8163; Burgoyne, Thomas/0000-0002-8428-720X; Noethe-Menchen, Tabea/0000-0002-0571-6767; Nielsen, KG/0000-0001-5906-9449; Hjeij, Rim/0000-0003-1464-7289; Mitchison, Hannah/0000-0002-3163-6293; Omran, Heymut/0000-0003-0282-6765; Kurkowiak, Malgorzata/0000-0002-4968-7136; Burdine, Rebecca/0000-0001-6620-5015; Kelly, Kirsten/0000-0003-4234-543X; Watson, Christopher Mark/0000-0003-2371-1844; Klena, Nikolai/0000-0002-2631-2294; Gabriel, George/0000-0003-3250-2518	NICHD [2R01HD048584]; NHLBI [U01-HL098180]; NRW Research School "Cell Dynamics and Disease, CEDAD"; Deutsche Forschungsgemeinschaft [DFG OM 6/4]; IZKF, Muenster [Om2/009/12]; Schroder Stiftung; Kindness for Kids; SYSCILIA (EU) [241955]; NWO [Vici-016.130.664]; BESTCILIA (EU) [305404]; Max Planck Society; DFG [SFB629]; European Union - Regional Development Fund; Wellcome Trust [WT091310]; Great Ormond Street Hospital Children's Charity; Milena Carvajal Pro-Kartagener Foundation, Action Medical Research [GN2101]; Newlife Foundation for Disabled Children UK [10-11/15]; MRC [MR/L01629X/1]; Wellcome Trust; Medical Research Council [MR/L01629X/1] Funding Source: researchfish; Action Medical Research [2101] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1299] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NRW Research School "Cell Dynamics and Disease, CEDAD"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF, Muenster; Schroder Stiftung; Kindness for Kids; SYSCILIA (EU); NWO(Netherlands Organization for Scientific Research (NWO)); BESTCILIA (EU); Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); European Union - Regional Development Fund(European Commission); Wellcome Trust(Wellcome Trust); Great Ormond Street Hospital Children's Charity; Milena Carvajal Pro-Kartagener Foundation, Action Medical Research; Newlife Foundation for Disabled Children UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Action Medical Research; Great Ormond Street Hospital Childrens Charity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the PCD individuals and their families, the German patient support group "Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V.," and the UK PCD Family Support Group. We thank Badie Jacob for clinical diagnostic studies. We thank M. Herting, L. Overkamp, F.J. Seesing, P. Fischer, and M. Patel for technical work, M. Turmaine for TEM, and Maria Philipsen for assistance. We are grateful to the UK10K consortium (investigators listed at http://www.uk10k.org/), in particular the Rare Diseases Group, for making this study possible. This work was supported by NICHD grant 2R01HD048584 to C.E.S. and R.D.B., NHLBI grant U01-HL098180 to C.W.L., NRW Research School "Cell Dynamics and Disease, CEDAD" to R.H. and H.O., "Deutsche Forschungsgemeinschaft" (DFG OM 6/4), the IZKF (Om2/009/12) Muenster, Schroder Stiftung, and Kindness for Kids to H.O., SYSCILIA (EU FP7 GA nr. 241955) to H.O. and R.R., NWO (Vici-016.130.664) to R.R., BESTCILIA (EU FP7 GA nr. 305404) to H.O. and K.G.N., the Max Planck Society and the DFG (SFB629) to K.B., "Studies of nucleic acids and proteins - from basic to applied research" within the International PhD Projects Programme of Foundation for Polish Science, cofinanced by European Union - Regional Development Fund, for M.K., Wellcome Trust award WT091310 to UK10K, Great Ormond Street Hospital Children's Charity to H.M.M., Milena Carvajal Pro-Kartagener Foundation, Action Medical Research (GN2101), and Newlife Foundation for Disabled Children UK (10-11/15) to H.M.M. and E.M.K.C., and MRC grant MR/L01629X/1 to C.M.W., I.M.C., C.P.D., and E.S. Open Access publication charges for this article were funded by the Wellcome Trust.	Alkuraya FS, 2013, HUM GENET, V132, P1197, DOI 10.1007/s00439-013-1344-x; AlSaadi MM, 2012, ANN HUM GENET, V76, P211, DOI 10.1111/j.1469-1809.2012.00704.x; Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; BROKAW CJ, 1994, CELL MOTIL CYTOSKEL, V28, P199, DOI 10.1002/cm.970280303; Bukowy-Bieryllo Z, 2013, PEDIATR PULM, V48, P352, DOI 10.1002/ppul.22632; Carr IM, 2013, HUM MUTAT, V34, P50, DOI 10.1002/humu.22220; Casey DM, 2003, MOL BIOL CELL, V14, P3650, DOI 10.1091/mbc.E03-01-0057; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Dean AB, 2013, MOL BIOL CELL, V24, P3689, DOI 10.1091/mbc.E13-06-0310; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Francis R, 2013, JOVE-J VIS EXP, DOI 10.3791/50343; Haffter P, 1996, DEVELOPMENT, V123, P1; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Jaffe KM, 2010, METHOD CELL BIOL, V97, P415, DOI 10.1016/S0091-679X(10)97022-2; Jerber J, 2014, HUM MOL GENET, V23, P563, DOI 10.1093/hmg/ddt445; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Liu XQ, 2014, CIRC-CARDIOVASC IMAG, V7, P31, DOI 10.1161/CIRCIMAGING.113.000451; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Lucas J.S., 2014, ARCH DIS CHILD; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2014, HUM MOL GENET, V23, P3362, DOI 10.1093/hmg/ddu046; Onoufriadis A, 2014, J MED GENET, V51, P61, DOI 10.1136/jmedgenet-2013-101938; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Pennarun G., 1999, AM J HUM GENET; Rompolas P, 2010, MOL BIOL CELL, V21, P3669, DOI 10.1091/mbc.E10-04-0373; Schottenfeld J, 2007, DEVELOPMENT, V134, P1605, DOI 10.1242/dev.02827; Shapiro A.J., 2014, CHEST, V13, P1704; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Shen Y, 2005, PHYSIOL GENOMICS, V24, P23, DOI 10.1152/physiolgenomics.00129.2005; Shoemark A, 2012, J CLIN PATHOL, V65, P267, DOI 10.1136/jclinpath-2011-200415; Sullivan-Brown J, 2011, NAT PROTOC, V6, P46, DOI 10.1038/nprot.2010.165; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Wallmeier J, 2014, NAT GENET, V46, P646, DOI 10.1038/ng.2961; Watson CM, 2014, HUM MUTAT, V35, P434, DOI 10.1002/humu.22490; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Wu DH, 2013, CLIN GENET, V83, P526, DOI 10.1111/cge.12127; Yoshiba S, 2014, TRENDS GENET, V30, P10, DOI 10.1016/j.tig.2013.09.001; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zariwala Maimoona A, 2011, Proc Am Thorac Soc, V8, P430, DOI 10.1513/pats.201103-023SD	69	103	110	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 4	2014	95	3					257	274		10.1016/j.ajhg.2014.08.005	http://dx.doi.org/10.1016/j.ajhg.2014.08.005			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AO5RX	25192045	Green Published, hybrid			2022-12-18	WOS:000341404100002
J	Urban, Z; Hucthagowder, V; Schurmann, N; Todorovic, V; Zilberberg, L; Choi, J; Sens, C; Brown, CW; Clark, RD; Holland, KE; Marble, M; Sakai, LY; Dabovic, B; Rifkin, DB; Davis, EC				Urban, Zsolt; Hucthagowder, Vishwanathan; Schuermann, Nura; Todorovic, Vesna; Zilberberg, Lior; Choi, Jiwon; Sens, Carla; Brown, Chester W.; Clark, Robin D.; Holland, Kristen E.; Marble, Michael; Sakai, Lynn Y.; Dabovic, Branka; Rifkin, Daniel B.; Davis, Elaine C.			Mutations in LTBP4 Cause a Syndrome of Impaired Pulmonary, Gastrointestinal, Genitourinary, Musculoskeletal, and Dermal Development	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LATENT-TGF-BETA; DOMINANT CUTIS LAXA; ELASTIN GENE; MISSENSE MUTATION; BINDING-PROTEINS; LUNG DEVELOPMENT; MARFAN-SYNDROME; IN-VIVO; FIBULIN-5; ELASTOGENESIS	We report recessive mutations in the gene for the latent transforming growth factor-beta binding protein 4 (LTBP4) in four unrelated patients with a human syndrome disrupting pulmonary, gastrointestinal, urinary, musculoskeletal, craniofacial, and dermal development. All patients had severe respiratory distress, with cystic and atelectatic changes in the lungs complicated by tracheomalacia and diaphragmatic hernia. Three of the four patients died of respiratory failure. Cardiovascular lesions were mild, limited to pulmonary artery stenosis and patent foramen ovale. Gastrointestinal malformations included diverticulosis, enlargement, tortuosity and stenosis at various levels of the intestinal tract. The urinary tract was affected by diverticulosis and hydronephrosis. Joint laxity and low muscle tone contributed to musculoskeletal problems compounded by postnatal growth delay. Craniofacial features included microretrognathia, flat midface, receding forehead, and wide fontanelles. All patients had cutis laxa. Four of the five identified LTBP4 mutations led to premature termination of translation and destabilization of the LTBP4 mRNA. Impaired synthesis and lack of deposition of LTBP4 into the extracellular matrix (ECM) caused increased transforming growth factor-beta (TGF-beta) activity in cultured fibroblasts and defective elastic fiber assembly in all tissues affected by the disease. These molecular defects were associated with blocked alveolarization and airway collapse in the lung. Our results show that coupling of TGF-beta signaling and ECM assembly is essential for proper development and is achieved in multiple human organ systems by multifunctional proteins such as LTBP4.	[Urban, Zsolt; Hucthagowder, Vishwanathan; Schuermann, Nura; Sens, Carla] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Urban, Zsolt] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Urban, Zsolt] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Todorovic, Vesna; Zilberberg, Lior; Dabovic, Branka; Rifkin, Daniel B.] NYU, Langone Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Rifkin, Daniel B.] NYU, Langone Sch Med, Dept Med, New York, NY 10016 USA; [Choi, Jiwon; Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Brown, Chester W.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Brown, Chester W.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Clark, Robin D.] Loma Linda Sch Med, Dept Pediat, Loma Linda, CA 92354 USA; [Holland, Kristen E.] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Marble, Michael] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Marble, Michael] Childrens Hosp, New Orleans, LA 70118 USA; [Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; McGill University; Baylor College of Medicine; Baylor College of Medicine; Loma Linda University; Medical College of Wisconsin; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; Oregon Health & Science University	Urban, Z (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	urban_z@kids.wustl.edu	Davis, Elaine/F-3449-2012; Hucthagowder, Vishwanathan/C-9831-2009; Urban, Zsolt/A-2018-2013	Urban, Zsolt/0000-0003-3890-1843; Todorovic, Vesna/0000-0003-4110-8395	U.S. National Institutes of Health [HL084922, CA034282, AR49698]; March of Dimes [1-FY09-33]; Phillip Morris USA Inc; Canadian Institutes of Health [MOP86713]; NATIONAL CANCER INSTITUTE [R01CA034282] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Phillip Morris USA Inc; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the patients and their family members for participating in the study. We are also grateful to James Southern for providing pathological materials and to Barbara Mordue and Subhadra Ramanathan for clinical information and images. This study was funded in part by U.S. National Institutes of Health grants HL084922 (Z.U.), CA034282 (D.B.R.), and AR49698 (D.B.R.); March of Dimes grant 1-FY09-33 (Z.U.); Phillip Morris USA Inc. (D.B.R.), and Canadian Institutes of Health grant MOP86713 (E.C.D.). F.C.D. is a Canada Research Chair.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Callewaert BL, 2009, HUM MUTAT, V30, P334, DOI 10.1002/humu.20854; Claus S, 2008, J INVEST DERMATOL, V128, P1442, DOI 10.1038/sj.jid.5701211; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Coucke PJ, 2006, NAT GENET, V38, P452, DOI 10.1038/ng1764; Dabovic B, 2009, J CELL PHYSIOL, V219, P14, DOI 10.1002/jcp.21643; Dasouki M, 2007, AM J MED GENET A, V143A, P2635, DOI 10.1002/ajmg.a.31980; DAVIS EC, 1993, LAB INVEST, V68, P89; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Elahi E, 2006, J INVEST DERMATOL, V126, P1506, DOI 10.1038/sj.jid.5700247; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Jensen SA, 2009, STRUCTURE, V17, P759, DOI 10.1016/j.str.2009.03.014; Kantola AK, 2008, EXP CELL RES, V314, P2488, DOI 10.1016/j.yexcr.2008.05.010; Koli K, 2001, J CELL SCI, V114, P2869; Lack J, 2003, J MOL BIOL, V334, P281, DOI 10.1016/j.jmb.2003.09.053; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Noor A, 2009, AM J HUM GENET, V84, P519, DOI 10.1016/j.ajhg.2009.03.007; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rodriguez-Revenga L, 2004, ARCH DERMATOL, V140, P1135, DOI 10.1001/archderm.140.9.1135; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Szabo Z, 2006, J MED GENET, V43, P255, DOI 10.1136/jmg.2005.034157; Tassabehji M, 1998, HUM MOL GENET, V7, P1021, DOI 10.1093/hmg/7.6.1021; Urban Z, 2005, J INVEST DERMATOL, V124, P1193, DOI 10.1111/j.0022-202X.2005.23758.x; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	35	103	107	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					593	605		10.1016/j.ajhg.2009.09.013	http://dx.doi.org/10.1016/j.ajhg.2009.09.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19836010	Bronze, Green Published			2022-12-18	WOS:000271916500007
J	Duan, S; Huang, RS; Zhang, W; Bleibel, WK; Roe, CA; Clark, TA; Chen, TX; Schweitzer, AC; Blume, JE; Cox, NJ; Dolan, ME				Duan, Shiwei; Huang, R. Stephanie; Zhang, Wei; Bleibel, Wasim K.; Roe, Cheryl A.; Clark, Tyson A.; Chen, Tina X.; Schweitzer, Anthony C.; Blume, John E.; Cox, Nancy J.; Dolan, M. Eileen			Genetic architecture of transcript-level variation in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROSOMAL EPOXIDE HYDROLASE; GENOME-WIDE ASSOCIATION; INDUCED CYTOTOXICITY; CHILDHOOD ASTHMA; EXPRESSION; VARIANTS; IDENTIFICATION; POLYMORPHISM; DISEASE; MICROARRAY	We report here the results of testing the pairwise association of 12,747 transcriptional gene-expression values with more than two million single-nucleotide polymorphisms (SNPs) in samples of European (CEPH from Utah; CEU) and African (Yoruba from Ibadan; YRI) ancestry. We found 4,677 and 5,125 significant associations between expression quantitative nucleotides (eQTNs) and transcript clusters in the CEU and the YRI samples, respectively. The physical distance between an eQTN and its associated transcript cluster was referred to as the intrapair distance. An association with 4 Mb or less intrapair distance was defined as local; otherwise, it was defined as distant. The enrichment analysis of functional categories shows that genes harboring the local eQTNs are enriched in the categories related to nucleosome and chromatin assembly; the genes harboring the distant eQTNs are enriched in the categories related to transmembrane signal transduction, suggesting that these biological pathways are likely to play a significant role in regulation of gene expression. We highlight in the EPHX1 gene a deleterious nonsynonymous SNP that is distantly associated with gene expression of ORMDL3, a susceptibility gene for asthma.	[Duan, Shiwei; Huang, R. Stephanie; Zhang, Wei; Bleibel, Wasim K.; Dolan, M. Eileen] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Roe, Cheryl A.; Cox, Nancy J.] Univ Chicago, Med Genet Sect, Dept Med & Human Genet, Chicago, IL 60637 USA; [Clark, Tyson A.; Chen, Tina X.; Schweitzer, Anthony C.; Blume, John E.] Affymetrix Inc, Affymetrix Lab, Express Res, Santa Clara, CA 95051 USA	University of Chicago; University of Chicago; Affymetrix	Dolan, ME (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu	Pillay, Nischalan/F-9536-2012; Duan, Shiwei/AAA-4782-2022; Duan, Shiwei/J-9633-2012	Duan, Shiwei/0000-0001-7682-2877; Clark, Tyson/0000-0002-7779-3227; Blume, John/0000-0003-3026-953X; Huang, R. Stephanie/0000-0002-9862-0368	NIGMS NIH HHS [U01GM61374, U01 GM061393, U01 GM061374, U01GM61393] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; DeCook R, 2006, GENETICS, V172, P1155, DOI 10.1534/genetics.105.042275; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; HASSETT C, 1994, HUM MOL GENET, V3, P421, DOI 10.1093/hmg/3.3.421; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Lawrence R, 2005, GENOME RES, V15, P1503, DOI 10.1101/gr.4217605; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Salam MT, 2007, THORAX, V62, P1050, DOI 10.1136/thx.2007.080127; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Sarmanova J, 2001, HUM MOL GENET, V10, P1265, DOI 10.1093/hmg/10.12.1265; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schleef RR, 2000, J BIOL CHEM, V275, P26385, DOI 10.1074/jbc.C000389200; Shioji G, 2005, J HUM GENET, V50, P507, DOI 10.1007/s10038-005-0285-1; Smith CAD, 1997, LANCET, V350, P630, DOI 10.1016/S0140-6736(96)08061-0; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zusterzeel PLM, 2001, J MED GENET, V38, P234, DOI 10.1136/jmg.38.4.234	43	103	110	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1101	1113		10.1016/j.ajhg.2008.03.006	http://dx.doi.org/10.1016/j.ajhg.2008.03.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18439551	Green Published, Bronze			2022-12-18	WOS:000255923600009
J	Sun, B; Bird, A; Young, SP; Kishnani, PS; Chen, YT; Koeberl, DD				Sun, Baodong; Bird, Andrew; Young, Sarah P.; Kishnani, Priya S.; Chen, Y.-T.; Koeberl, Dwight D.			Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID-ALPHA-GLUCOSIDASE; ADENOASSOCIATED VIRUS VECTORS; MUSCLE-SPECIFIC PROMOTER; DIRECTED GENE-TRANSFER; FACTOR-IX; SUSTAINED EXPRESSION; GALACTOSIDASE-A; AAV VECTOR; FABRY MICE; GLYCOGEN	Pompe disease, which results from mutations in the gene encoding the glycogen-degrading lysosomal enzyme acid alpha-glucosidase (GAA) (also called "acid maltase"), causes death in early childhood related to glycogen accumulation in striated muscle and an accompanying infantile-onset cardiomyopathy. The efficacy of enzyme replacement therapy (ERT) with recombinant human GAA was demonstrated during clinical trials that prolonged subjects' overall survival, prolonged ventilator-free survival, and also improved cardiomyopathy, which led to broad-label approval by the U. S. Food and Drug Administration. Patients who lack any residual GAA expression and are deemed negative for cross-reacting immunologic material (CRIM) have a poor response to ERT. We previously showed that gene therapy with an adenoassociated virus (AAV) vector containing a liver-specific promoter elevated the GAA activity in plasma and prevented anti-GAA antibody formation in immunocompetent GAA-knockout mice for 18 wk, predicting that liver-specific expression of human GAA with the AAV vector would induce immune tolerance and enhance the efficacy of ERT. In this study, a very low number of AAV vector particles was administered before initiation of ERT, to prevent the antibody response in GAA-knockout mice. A robust antibody response was provoked in naive GAA-knockout mice by 6 wk after a challenge with human GAA and Freund's adjuvant; in contrast, administration of the AAV vector before the GAA challenge prevented the antibody response. Most compellingly, the antibody response was prevented by AAV vector administration during the 12 wk of ERT, and the efficacy of ERT was thereby enhanced. Thus, AAV vector-mediated gene therapy induced a tolerance to introduced GAA, and this strategy could enhance the efficacy of ERT in CRIM-negative patients with Pompe disease and in patients with other lysosomal storage diseases.	Duke Univ, Med Ctr, Div Med Genet, Dept Pediat, Durham, NC 27710 USA; Acad Sinica, Taipei 115, Taiwan	Duke University; Academia Sinica - Taiwan	Koeberl, DD (corresponding author), Duke Univ, Med Ctr, Div Med Genet, Dept Pediat, DUMC Box 3528,Bell Bldg, Durham, NC 27710 USA.	dwight.koeberl@duke.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081122] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081122-01A1, R01 HL081122] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amalfitano A, 1999, P NATL ACAD SCI USA, V96, P8861, DOI 10.1073/pnas.96.16.8861; Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; Bijvoet AGA, 1999, HUM MOL GENET, V8, P2145, DOI 10.1093/hmg/8.12.2145; Cresawn KO, 2005, HUM GENE THER, V16, P68, DOI 10.1089/hum.2005.16.68; Ding EY, 2001, HUM GENE THER, V12, P955, DOI 10.1089/104303401750195917; Franco LM, 2005, MOL THER, V12, P876, DOI 10.1016/j.ymthe.2005.04.024; Gao GP, 2006, MOL THER, V13, P77, DOI 10.1016/j.ymthe.2005.08.017; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Halbert CL, 1997, J VIROL, V71, P5932, DOI 10.1128/JVI.71.8.5932-5941.1997; Halbert CL, 1998, J VIROL, V72, P9795, DOI 10.1128/JVI.72.12.9795-9805.1998; HAYASHI Y, 1993, MOL ENDOCRINOL, V7, P1049, DOI 10.1210/me.7.8.1049; Herzog RW, 2001, MOL THER, V4, P192, DOI 10.1006/mthe.2001.0442; High K, 2005, J THROMB HAEMOST, V3, P1682, DOI 10.1111/j.1538-7836.2005.01460.x; Hirschhorn R. a. R. AJJ., 2001, METABOLIC MOL BASES, P3389; Hoffman BE, 2007, HUM GENE THER, V18, P603, DOI 10.1089/hum.2007.042; Ill CR, 1997, BLOOD COAGUL FIBRIN, V8, pS23; Kikuchi T, 1998, J CLIN INVEST, V101, P827, DOI 10.1172/JCI1722; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035; Liu YL, 2004, HUM GENE THER, V15, P783, DOI 10.1089/1043034041648453; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Pauly DF, 2001, HUM GENE THER, V12, P527, DOI 10.1089/104303401300042447; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 2002, MOL THER, V6, P601, DOI 10.1006/mthe.2002.0716; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; ROUET P, 1992, J BIOL CHEM, V267, P20765; Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003; Sun BD, 2006, MOL THER, V14, P822, DOI 10.1016/j.ymthe.2006.08.001; Sun BD, 2005, MOL THER, V11, P889, DOI 10.1016/j.ymthe.2005.01.012; Sun BD, 2005, MOL THER, V11, P57, DOI 10.1016/j.ymthe.2004.10.004; Sun BD, 2003, MOL THER, V7, P467, DOI 10.1016/S1525-0016(03)00022-4; Wang LL, 2000, MOL THER, V1, P154, DOI 10.1006/mthe.2000.0031; Wang LL, 1999, P NATL ACAD SCI USA, V96, P3906, DOI 10.1073/pnas.96.7.3906; Ziegler RJ, 2004, MOL THER, V9, P231, DOI 10.1016/j.ymthe.2003.11.015; Ziegler RJ, 2007, MOL THER, V15, P492, DOI 10.1038/sj.mt.6300066	39	103	108	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1042	1049		10.1086/522236	http://dx.doi.org/10.1086/522236			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924344	Bronze, Green Published			2022-12-18	WOS:000250480900014
J	Visscher, PM; Macgregor, S; Benyamin, B; Zhu, G; Gordon, S; Medland, S; Hill, WG; Hottenga, JJ; Willemsen, G; Boomsma, DI; Liu, YZ; Deng, HW; Montgomery, GW; Martin, NG				Visscher, Peter M.; Macgregor, Stuart; Benyamin, Beben; Zhu, Gu; Gordon, Scott; Medland, Sarah; Hill, William G.; Hottenga, Jouke-Jan; Willemsen, Gonneke; Boomsma, Dorret I.; Liu, Yao-Zhong; Deng, Hong-Wen; Montgomery, Grant W.; Martin, Nicholas G.			Genome partitioning of genetic variation for height from 11,214 sibling pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE-TRAIT-LOCUS; ADULT BODY HEIGHT; WIDE ASSOCIATION; COMPLEX TRAITS; LINKAGE ANALYSIS; MASS INDEX; STATURE; SCAN; CHROMOSOME; HERITABILITY	Height has been used for more than a century as a model by which to understand quantitative genetic variation in humans. We report that the entire genome appears to contribute to its additive genetic variance. We used genotypes and phenotypes of 11,214 sibling pairs from three countries to partition additive genetic variance across the genome. Using genome scans to estimate the proportion of the genomes of each chromosome from siblings that were identical by descent, we estimated the heritability of height contributed by each of the 22 autosomes and the X chromosome. We show that additive genetic variance is spread across multiple chromosomes and that at least six chromosomes (i. e., 3, 4, 8, 15, 17, and 18) are responsible for the observed variation. Indeed, the data are not inconsistent with a uniform spread of trait loci throughout the genome. Our estimate of the variance explained by a chromosome is correlated with the number of times suggestive or significant linkage with height has been reported for that chromosome. Variance due to dominance was not significant but was difficult to assess because of the high sampling correlation between additive and dominance components. Results were consistent with the absence of any large between-chromosome epistatic effects. Notwithstanding the proposed architecture of complex traits that involves widespread gene-gene and gene-environment interactions, our results suggest that variation in height in humans can be explained by many loci distributed over all autosomes, with an additive mode of gene action.	Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; Vrije Univ Amsterdam, Amsterdam, Netherlands; Univ Missouri, Sch Med, Dept Orthoped Surg, Kansas City, MO 64110 USA; Univ Missouri, Sch Med, Dept Bas Med Sci, Kansas City, MO 64110 USA	QIMR Berghofer Medical Research Institute; Virginia Commonwealth University; University of Edinburgh; Vrije Universiteit Amsterdam; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Visscher, PM (corresponding author), Queensland Inst Med Res, 300 Herston Rd, Brisbane, Qld 4029, Australia.	peter.visscher@qimr.edu.au	Benyamin, Beben/D-9195-2012; Montgomery, Grant W/B-7148-2008; Liu, Yaozhong/ABD-5544-2020; Boomsma, Dorret I/AAX-4470-2020; Macgregor, Stuart/C-6442-2009; Medland, Sarah/AAT-7595-2020; Visscher, Peter/ABB-6151-2020; Hill, William/B-3198-2012; Medland, Sarah E/C-7630-2013	Benyamin, Beben/0000-0001-5608-2293; Montgomery, Grant W/0000-0002-4140-8139; Macgregor, Stuart/0000-0001-6731-8142; Medland, Sarah/0000-0003-1382-380X; Visscher, Peter/0000-0002-2143-8760; Medland, Sarah E/0000-0003-1382-380X; Willemsen, Gonneke/0000-0003-3755-0236; Deng, Hong-Wen/0000-0002-0387-8818; Martin, Nicholas/0000-0003-4069-8020	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR002170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, R01AA010249, R01AA014041, R37AA007728, R01AA007535, R01AA007728, P50AA011998, R01AA013326, P60AA011998] Funding Source: NIH RePORTER; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NHLBI NIH HHS [N01HV48141] Funding Source: Medline; NIAAA NIH HHS [P50 AA011998, AA07728, AA014041, R01 AA007535, R37 AA007728, AA013326, AA013320, R01 AA013326, AA11998, R01 AA007728, R01 AA013320, R01 AA014041, R01 AA010249] Funding Source: Medline; NIAMS NIH HHS [K01 AR002170] Funding Source: Medline; NIGMS NIH HHS [R01 GM060402] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; DAVIES RW, 1971, GENETICS, V69, P353; Dempfle A, 2006, HUM MOL GENET, V15, P2772, DOI 10.1093/hmg/ddl218; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Gagnon A, 2005, GENET EPIDEMIOL, V29, P215, DOI 10.1002/gepi.20090; GALTON F, 1886, NATURE, V33, P295; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; HARRISON BJ, 1950, HEREDITY, V4, P295, DOI 10.1038/hdy.1950.23; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Kent JW, 2005, GENET EPIDEMIOL, V29, P377, DOI 10.1002/gepi.20093; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Korstanje R, 2002, NAT GENET, V31, P235, DOI 10.1038/ng0702-235; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Liu YZ, 2006, HUM GENET, V119, P295, DOI 10.1007/s00439-006-0136-y; Mukhopadhyay N, 2003, HUM HERED, V55, P191, DOI 10.1159/000073203; NEALE MC, 2003, MX STAT MODELING; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Sale MM, 2005, ANN HUM GENET, V69, P517, DOI 10.1046/j.1529-8817.2005.00176.x; Sammalisto S, 2005, J MED GENET, V42, P932, DOI 10.1136/jmg.2005.031278; Schork NJ, 2001, ADV GENET, V42, P299, DOI 10.1016/S0065-2660(01)42030-X; Shmulewitz D, 2006, P NATL ACAD SCI USA, V103, P3502, DOI 10.1073/pnas.0510156103; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/136905203770326402; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Visscher PM, 1998, HEREDITY, V81, P317, DOI 10.1046/j.1365-2540.1998.00398.x; Visscher PM, 1996, THEOR APPL GENET, V93, P691, DOI 10.1007/BF00224064; Visscher PM, 2004, BEHAV GENET, V34, P477, DOI 10.1023/B:BEGE.0000023652.93162.e8; Willemsen G, 2004, EUR J HUM GENET, V12, P820, DOI 10.1038/sj.ejhg.5201229; Wiltshire S, 2002, AM J HUM GENET, V70, P543, DOI 10.1086/338760; Xu JF, 2002, AM J HUM GENET, V71, P646, DOI 10.1086/342216; Zhu G, 2004, TWIN RES, V7, P197, DOI 10.1375/136905204323016186	39	103	105	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					1104	1110		10.1086/522934	http://dx.doi.org/10.1086/522934			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924350	Green Published, Bronze			2022-12-18	WOS:000250480900020
J	Risch, NJ; Bressman, SB; Senthil, G; Ozelius, LJ				Risch, Neil J.; Bressman, Susan B.; Senthil, Geetha; Ozelius, Laurie J.			Intragenic cis and trans modification of genetic susceptibility in DYT1 torsion dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASHKENAZI JEWS; PROTEIN TORSINA; ASSOCIATION; HAPLOTYPE; MUTATION; 9Q34	A GAG deletion in the DYT1 gene is a major cause of early-onset dystonia, but clinical disease expression occurs in only 30% of mutation carriers. To gain insight into genetic factors that may influence penetrance, we evaluated three DYT1 single-nucleotide polymorphisms, including D216H, a coding-sequence variation that moderates the effects of the DYT1 GAG deletion in cellular models. We tested DYT1 GAG-deletion carriers with (n = 119) and without (n = 113) clinical signs of dystonia and control individuals (n = 197) and found the frequency of the 216H allele to be increased in GAG-deletion carriers without dystonia and to be decreased in carriers with dystonia, compared with the control individuals. Analysis of haplotypes demonstrated a highly protective effect of the H allele in trans with the GAG deletion; there was also suggestive evidence that the D216 allele in cis is required for the disease to be penetrant. Our findings establish, for the first time, a clinically relevant gene modifier of DYT1.	Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Beth Israel Deaconess Med Ctr, Dept Neurol, New York, NY 10003 USA; Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Risch, NJ (corresponding author), Univ Calif San Francisco, Inst Human Genet, 513 Parnassus Ave,MS 0794,Room 901F HSW, San Francisco, CA 94143 USA.	rischn@humgen.ucsf.edu			NINDS NIH HHS [P01 NS037409, NS38142, NS37409, NS26656, R01 NS026656] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038142, P01NS037409, P50NS037409, R01NS026656] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bressman SB, 2000, NEUROLOGY, V54, P1746, DOI 10.1212/WNL.54.9.1746; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; Clarimon J, 2005, ANN NEUROL, V57, P765, DOI 10.1002/ana.20485; Clarimon J, 2007, MOVEMENT DISORD, V22, P162, DOI 10.1002/mds.21182; Dang MT, 2006, NEUROSCI RES, V56, P470, DOI 10.1016/j.neures.2006.09.005; Gambarin M, 2006, MOVEMENT DISORD, V21, P1782, DOI 10.1002/mds.21056; Geyer HL, 2006, LANCET NEUROL, V5, P780, DOI 10.1016/S1474-4422(06)70547-6; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Hague S, 2006, NEUROLOGY, V66, P951, DOI 10.1212/01.wnl.0000203344.43342.18; Heiman GA, 2004, NEUROLOGY, V63, P631, DOI 10.1212/01.WNL.0000137113.39225.FA; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Kabakci K, 2004, NEUROLOGY, V62, P395, DOI 10.1212/01.WNL.0000113024.84178.F7; Kamm C, 2006, NEUROLOGY, V67, P1857, DOI 10.1212/01.wnl.0000244423.63406.17; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; KRAMER PL, 1994, AM J HUM GENET, V55, P468; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Ozelius LJ, 1997, GENOME RES, V7, P483, DOI 10.1101/gr.7.5.483; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; RISCH NJ, 1990, AM J HUM GENET, V46, P533; Sibbing D, 2003, NEUROLOGY, V61, P1097, DOI 10.1212/01.WNL.0000090560.20641.AB; Svenson IK, 2004, NEUROGENETICS, V5, P157, DOI 10.1007/s10048-004-0186-z	25	103	108	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1188	1193		10.1086/518427	http://dx.doi.org/10.1086/518427			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503336	Green Published, Bronze			2022-12-18	WOS:000246553800017
J	Gao, XC; Gordon, D; Zhang, DP; Browne, R; Helms, C; Gillum, J; Weber, S; Devroy, S; Swaney, S; Dobbs, M; Morcuende, J; Sheffield, V; Lovett, M; Bowcock, A; Herring, J; Wise, C				Gao, Xiaochong; Gordon, Derek; Zhang, Dongping; Browne, Richard; Helms, Cynthia; Gillum, Joseph; Weber, Samuel; Devroy, Shonn; Swaney, Saralove; Dobbs, Matthew; Morcuende, Jose; Sheffield, Val; Lovett, Michael; Bowcock, Anne; Herring, John; Wise, Carol			CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; CHARGE SYNDROME; TRANSMISSION/DISEQUILIBRIUM TEST; PHENOTYPIC SPECTRUM; GENOTYPING ERRORS; LOCUS; MUTATIONS; TRANSMISSION; EXPRESSION; PROBES	Idiopathic scoliosis ( IS) is the most common spinal deformity in children, and its etiology is unknown. To refine the search for genes underlying IS susceptibility, we ascertained a new cohort of 52 families and conducted a follow-up study of genomewide scans that produced evidence of linkage and association with 8q12 loci ( multipoint LOD 2.77; P = .0028). Further fine mapping in the region revealed significant evidence of disease-associated haplotypes (P < 1.0 x 10(-4)) centering over exons 2 - 4 of the CHD7 gene associated with the CHARGE (coloboma of the eye, heart defects, 54 10 atresia of the choanae, retardation of growth and/ or development, genital and/ or urinary abnormalities, and ear abnormalities and deafness) syndrome of multiple developmental anomalies. Resequencing CHD7 exons and conserved intronic sequence blocks excluded coding changes but revealed at least one potentially functional polymorphism that is over-transmitted (P = .005) to affected offspring and predicts disruption of a caudal-type (cdx) transcription-factor binding site. Our results identify the first gene associated with IS susceptibility and suggest etiological overlap between the rare, early-onset CHARGE syndrome and common, later-onset IS.	Univ Texas, SW Med Ctr, Seay Ctr Musculoskeletal Res, Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; Univ Texas, SW Med Ctr, Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; Univ Texas, SW Med Ctr, Dept Orthopaed Surg, Dallas, TX 75219 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75219 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08855 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63130 USA; Univ Iowa, Sch Med, Dept Orthopaed Surg & Rehabil, Iowa City, IA 52242 USA; Univ Iowa, Sch Med, Dept Pediat, Iowa City, IA 52242 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Rutgers State University New Brunswick; Washington University (WUSTL); Washington University (WUSTL); University of Iowa; University of Iowa	Wise, C (corresponding author), Univ Texas, SW Med Ctr, Seay Ctr Musculoskeletal Res, Texas Scottish Rite Hosp Children, 2222 Welborn St, Dallas, TX 75219 USA.	carol.wise@tsrh.org	Gordon, Derek/AAU-2281-2020	Gordon, Derek/0000-0003-2945-1748; Bowcock, Anne/0000-0001-8691-9090; Sheffield, Val/0000-0002-6282-0835; Wise, Carol/0000-0002-6790-2194				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Bashiardes S, 2004, HUM GENET, V115, P81, DOI 10.1007/s00439-004-1121-y; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chan V, 2002, AM J HUM GENET, V71, P401, DOI 10.1086/341607; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; de Kok JB, 2002, HUM MUTAT, V19, P554, DOI 10.1002/humu.10076; Doyle C, 2005, AM J MED GENET A, V133A, P340, DOI 10.1002/ajmg.a.30564; EMERY AH, 1990, PRINCIPLES PRACTICE; Gordon D, 2000, GENOMICS, V66, P87, DOI 10.1006/geno.2000.6190; Gordon D, 2004, EUR J HUM GENET, V12, P752, DOI 10.1038/sj.ejhg.5201219; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HERRING JA, 2002, TACHDJIANS PEDIAT OR, V1; HILL WG, 1994, AM J HUM GENET, V54, P705; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Justice CM, 2003, SPINE, V28, P589, DOI 10.1097/00007632-200303150-00014; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lohnes D, 2003, BIOESSAYS, V25, P971, DOI 10.1002/bies.10340; Miller NH, 2005, SPINE, V30, P1181, DOI 10.1097/01.brs.0000162282.46160.0a; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Salehi LB, 2002, HUM GENET, V111, P401, DOI 10.1007/s00439-002-0785-4; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wise CA, 2000, SPINE, V25, P2372, DOI 10.1097/00007632-200009150-00017	32	103	138	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					957	965		10.1086/513571	http://dx.doi.org/10.1086/513571			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436250	Green Published, Bronze			2022-12-18	WOS:000245973200014
J	Dhami, P; Coffey, AJ; Abbs, S; Vermeesch, JR; Dumanski, JP; Woodward, KJ; Andrews, RM; Langford, C; Vetrie, D				Dhami, P; Coffey, AJ; Abbs, S; Vermeesch, JR; Dumanski, JP; Woodward, KJ; Andrews, RM; Langford, C; Vetrie, D			Exon array CGH: Detection of copy-number changes at the resolution of individual exons in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PELIZAEUS-MERZBACHER-DISEASE; PROTEOLIPID PROTEIN GENE; DEPENDENT PROBE AMPLIFICATION; MICROARRAY ANALYSIS; BINDING-SITES; MAJOR CAUSE; DMD GENE; DNA; HYBRIDIZATION; DELETION	The development of high-throughput screening methods such as array-based comparative genome hybridization (array CGH) allows screening of the human genome for copy-number changes. Current array CGH strategies have limits of resolution that make detection of small (less than a few tens of kilobases) gains or losses of genomic DNA difficult to identify. We report here a significant improvement in the resolution of array CGH, with the development of an array platform that utilizes single-stranded DNA array elements to accurately measure copy-number changes of individual exons in the human genome. Using this technology, we screened 31 patient samples across an array containing a total of 162 exons for five disease genes and detected copy-number changes, ranging from whole-gene deletions and duplications to single-exon deletions and duplications, in 100% of the cases. Our data demonstrate that it is possible to screen the human genome for copy-number changes with array CGH at a resolution that is 2 orders of magnitude higher than that previously reported.	Wellcome Trust Sanger Inst, Microarray Facil, Hinxton CB10 1SA, Cambs, England; Guys & St Thomas Natl Hlth Serv Fdn Trust, DNA Lab, Genet Ctr, London, England; Inst Child Hlth, London, England; Katholieke Univ Leuven, Dept Ophthalmol, Louvain, Belgium; Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden	Wellcome Trust Sanger Institute; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; KU Leuven; Uppsala University	Vetrie, D (corresponding author), Wellcome Trust Sanger Inst, Microarray Facil, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	vt1@sanger.ac.uk		Vetrie, David/0000-0003-2075-4662; Vermeesch, Joris/0000-0002-3071-1191; Dumanski, Jan Piotr/0000-0002-1489-1452				Akrami SM, 2003, J MED GENET, V40; Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Armour JAL, 2002, HUM MUTAT, V20, P325, DOI 10.1002/humu.10133; Armour JAL, 2000, NUCLEIC ACIDS RES, V28, P605, DOI 10.1093/nar/28.2.605; ATKIN CL, 1988, AM J HUM GENET, V42, P249; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Bruder CEG, 2001, HUM MOL GENET, V10, P271, DOI 10.1093/hmg/10.3.271; Buckley PG, 2002, HUM MOL GENET, V11, P3221, DOI 10.1093/hmg/11.25.3221; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; GILLARD EF, 1989, AM J HUM GENET, V45, P507; HARDING B, 1995, NEUROPATH APPL NEURO, V21, P111, DOI 10.1111/j.1365-2990.1995.tb01036.x; Heim P, 1997, AM J MED GENET, V71, P475, DOI 10.1002/(SICI)1096-8628(19970905)71:4<475::AID-AJMG20>3.0.CO;2-C; Heiskanen MA, 2000, CANCER RES, V60, P799; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inazawa J, 2004, CANCER SCI, V95, P559, DOI 10.1111/j.1349-7006.2004.tb02486.x; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Lemmink HH, 1997, HUM MUTAT, V9, P477; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Lucito R, 2000, GENOME RES, V10, P1726, DOI 10.1101/gr.138300; Mantripragada KK, 2004, TRENDS GENET, V20, P87, DOI 10.1016/j.tig.2003.12.008; Mantripragada KK, 2004, INT J MOL MED, V13, P273; Mantripragada KK, 2003, J MOL MED-JMM, V81, P443, DOI 10.1007/s00109-003-0458-3; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Mimault C, 1999, AM J HUM GENET, V65, P360, DOI 10.1086/302483; Nelis E, 1996, EUR J HUM GENET, V4, P25; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Plant KE, 1999, HUM MUTAT, V13, P124, DOI 10.1002/(SICI)1098-1004(1999)13:2<124::AID-HUMU4>3.0.CO;2-Z; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; RAUTENSTRAUSS B, 2000, DRAFT BEST PRACTICE; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rozen S, 2000, Methods Mol Biol, V132, P365; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sellner LN, 2004, HUM MUTAT, V23, P413, DOI 10.1002/humu.20035; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Snijders Antoine M., 2003, Briefings in Functional Genomics & Proteomics, V2, P37, DOI 10.1093/bfgp/2.1.37; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; STRAUTNIEKS S, 1992, AM J HUM GENET, V51, P871; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; White SJ, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.10.e113; Woodward K, 2000, EUR J HUM GENET, V8, P449, DOI 10.1038/sj.ejhg.5200480; Woodward K, 1998, AM J HUM GENET, V63, P207, DOI 10.1086/301933; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125	56	103	126	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2005	76	5					750	762		10.1086/429588	http://dx.doi.org/10.1086/429588			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	914BB	15756638	Green Published, Bronze			2022-12-18	WOS:000228198300003
J	Young, JI; Zoghbi, HY				Young, JI; Zoghbi, HY			X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CPG-BINDING PROTEIN-2; LINKED MENTAL-RETARDATION; MECP2 MUTATIONS; CONTROLLING ELEMENTS; SYNDROME BRAIN; GENE; LOCALIZATION; EXPRESSION; LOCATION; VARIANTS	Rett syndrome (RTT), a neurodevelopmental disorder affecting mostly females, is caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2). Although the majority of girls with classic RTT have a random pattern of X-chromosome inactivation (XCI), nonbalanced patterns have been observed in patients carrying mutant MECP2 and, in some cases, account for variability of phenotypic manifestations. We have generated an RTT mouse model that recapitulates all major aspects of the human disease, but we found that females exhibit a high degree of phenotypic variability beyond what is observed in human patients with similar mutations. To evaluate whether XCI influences the phenotypic outcome of Mecp2 mutation in the mouse, we studied the pattern of XCI at the single-cell level in brains of heterozygous females. We found that XCI patterns were unbalanced, favoring expression of the wild-type allele, in most mutant females. It is notable that none of the animals had nonrandom XCI favoring the mutant allele. To explore why the XCI patterns favored expression of the wild-type allele, we studied primary neuronal cultures from Mecp2-mutant mice and found selective survival of neurons in which the wild-type X chromosome was active. Quantitative analysis indicated that fewer phenotypes are observed when a large percentage of neurons have the mutant X chromosome inactivated. The study of neuronal XCI patterns in a large number of female mice carrying a mutant Mecp2 allele highlights the importance of MeCP2 for neuronal viability. These findings also raise the possibility that there are human females who carry mutant MECP2 alleles but are not recognized because their phenotypes are subdued owing to favorable XCI patterns.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, T807,1 baylor Plaza,Mail Stop 225, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu		Zoghbi, Huda/0000-0002-0700-3349	NICHD NIH HHS [P01 HD040301, P01HD40301] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD040301] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADLER DA, 1995, MAMM GENOME, V6, P491, DOI 10.1007/BF00356163; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; Armstrong DD, 2003, J CHILD NEUROL, V18, P683; Balmer D, 2002, HUM GENET, V110, P545, DOI 10.1007/s00439-002-0724-4; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Carney RM, 2003, PEDIATR NEUROL, V28, P205, DOI 10.1016/S0887-8994(02)00624-0; CATTANACH BM, 1969, GENET RES, V14, P223, DOI 10.1017/S0016672300002068; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1995, NEUROPEDIATRICS, V26, P62, DOI 10.1055/s-2007-979723; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hammer S, 2003, AM J MED GENET A, V122A, P223, DOI 10.1002/ajmg.a.20320; Hammer S, 2002, MENT RETARD DEV D R, V8, P94, DOI 10.1002/mrdd.10023; Hoffbuhr K, 2001, NEUROLOGY, V56, P1486, DOI 10.1212/WNL.56.11.1486; Hoffbuhr KC, 2002, MENT RETARD DEV D R, V8, P99, DOI 10.1002/mrdd.10026; Huppke P, 2002, NEUROPEDIATRICS, V33, P63, DOI 10.1055/s-2002-32365; Ishii T, 2001, BRAIN DEV-JPN, V23, pS161, DOI 10.1016/S0387-7604(01)00344-8; KUNIEDA T, 1992, BIOL REPROD, V46, P692, DOI 10.1095/biolreprod46.4.692; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; Lyon MF, 2002, ACTA PAEDIATR, V91, P107, DOI 10.1080/080352502762458030; MCMAHON A, 1983, GENET RES, V41, P69, DOI 10.1017/S0016672300021078; MONK M, 1992, J INHERIT METAB DIS, V15, P499, DOI 10.1007/BF01799608; Newall AET, 2001, HUM MOL GENET, V10, P581, DOI 10.1093/hmg/10.6.581; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; Renieri A, 2003, J MOL MED, V81, P346, DOI 10.1007/s00109-003-0444-9; Rett A, 1966, Wien Med Wochenschr, V116, P723; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, AM J MED GENET, V111, P164, DOI 10.1002/ajmg.10557; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Sirianni N, 1998, AM J HUM GENET, V63, P1552, DOI 10.1086/302105; Temudo T, 2002, Rev Neurol, V34 Suppl 1, pS54; TREVATHAN E, 1988, ANN NEUROL, V23, P425; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Watson P, 2001, J MED GENET, V38, P224, DOI 10.1136/jmg.38.4.224; Weaving LS, 2003, AM J MED GENET A, V118A, P103, DOI 10.1002/ajmg.a.10053; Yntema HG, 2002, EUR J HUM GENET, V10, P487, DOI 10.1038/sj.ejhg.5200836; Zappella M, 2001, AM J MED GENET, V104, P14, DOI 10.1002/ajmg.10005; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X	44	103	106	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					511	520		10.1086/382228	http://dx.doi.org/10.1086/382228			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14973779	Bronze, Green Published			2022-12-18	WOS:000220118500017
J	Schliekelman, P; Slatkin, M				Schliekelman, P; Slatkin, M			Multiplex relative risk and estimation of the number of loci underlying an inherited disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; ASCERTAINMENT BIAS; LINKAGE STRATEGIES; MULTILOCUS MODELS; CLEFT-PALATE; SUSCEPTIBILITY; SCHIZOPHRENIA; LIMITS; RATIO; PAIRS	Knowledge of the number of causative loci is necessary to estimate the power of mapping studies of complex diseases. In the present article, we reexamine a theory developed by Risch and its implications for estimating the number L of causative loci affecting a complex inherited disease. We first show that methods based on Risch's analysis can produce estimates of L that are inconsistent with the observed population prevalence of the disease. We demonstrate this point by showing that the maximum-likelihood estimate for L produced by the method of Farrall and Holder for cleft lip/cleft palate data is not consistent with the prevalence under the multiplicative model. We show how to incorporate disease prevalence and develop a maximum-likelihood method for estimating L that uses the entire distribution of numbers of affected individuals in families containing an affected individual. This method avoids the potential inconsistencies of the Risch method and has greater precision. We apply our method to data on cleft lip/cleft palate and schizophrenia.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schliekelman, P (corresponding author), Univ Georgia, Dept Stat, 204 Stat Bldg, Athens, GA 30602 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40282, R01 GM040282] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; BEAR JC, 1976, CLIN GENET, V9, P277; CARTER CO, 1982, J MED GENET, V19, P246, DOI 10.1136/jmg.19.4.246; Cordell HJ, 2000, GENET EPIDEMIOL, V18, P307, DOI 10.1002/(SICI)1098-2272(200004)18:4<307::AID-GEPI4>3.0.CO;2-3; CRADDOCK N, 1995, AM J HUM GENET, V57, P690; FARRALL M, 1992, AM J HUM GENET, V50, P270; Guo SW, 2000, AM J EPIDEMIOL, V151, P1121, DOI 10.1093/oxfordjournals.aje.a010156; Guo SW, 2002, AM J HUM GENET, V70, P818, DOI 10.1086/339369; Guo SW, 1998, AM J HUM GENET, V63, P252, DOI 10.1086/301928; Hovatta I, 1997, AM J MED GENET, V74, P353, DOI 10.1002/(SICI)1096-8628(19970725)74:4<353::AID-AJMG3>3.3.CO;2-I; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Olson JM, 2000, GENET EPIDEMIOL, V18, P217, DOI 10.1002/(SICI)1098-2272(200003)18:3<217::AID-GEPI3>3.0.CO;2-8; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; RICE J, 1982, HUM HERED, V32, P202, DOI 10.1159/000153292; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; Rybicki BA, 2000, AM J HUM GENET, V66, P593, DOI 10.1086/302778; SMITH C, 1971, AM J HUM GENET, V23, P578; SUAREZ BK, 1976, ANN HUM GENET, V40, P231, DOI 10.1111/j.1469-1809.1976.tb00186.x	20	103	106	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1369	1385		10.1086/344779	http://dx.doi.org/10.1086/344779			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12454800	Green Published, Bronze			2022-12-18	WOS:000179586800011
J	Leuer, M; Oldenburg, J; Lavergne, JM; Ludwig, M; Fregin, A; Eigel, A; Ljung, R; Goodeve, A; Peake, I; Olek, K				Leuer, M; Oldenburg, J; Lavergne, JM; Ludwig, M; Fregin, A; Eigel, A; Ljung, R; Goodeve, A; Peake, I; Olek, K			Somatic mosaicism in hemophilia A: A fairly common event	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FACTOR-VIII GENE; OSTEOGENESIS IMPERFECTA; GEL-ELECTROPHORESIS; FEMALE CARRIER; GERM-CELLS; MUTATIONS; METHYLATION; INVERSIONS; RECURRENCE; DIAGNOSIS	Mutations in the large gene of clotting factor VIII (FVIII) are the most common events leading to severe human bleeding disorder. The high proportion of de novo mutations observed in this gene raises the possibility that a significant proportion of such mutations does not derive from a single germ cell but instead should be attributed to a germline or somatic mosaic originating from a mutation during early embryogenesis. The present study explores this hypothesis by using allele-specific PCR to analyze 61 families that included members who had sporadic severe hemophilia A and known FVIII gene defects. The presence of somatic mosaicisms of varying degrees (0.2%-25%) could be shown in 8 (13%) of the 61 families and has been confirmed by a mutation-enrichment procedure. All mosaics were found in families with point mutations (8 [25%] of 32 families). In the subgroup of 8 families with CpG transitions, the percentage with mosaicism increased to 50% (4 of 8 families). In contrast, no mosaics were observed in 13 families with small deletions/insertions or in 16 families with intron 22 inversions. Our data suggest that mosaicism may represent a fairly common event in hemophilia A. As a consequence, risk assessment in genetic counseling should include consideration of the possibility of somatic mosaicism in families with apparently de novo mutations, especially families with the subtype of point mutations.	Univ Bonn, Inst Expt Hematol & Transfus Med, D-53105 Bonn, Germany; Univ Bonn, Dept Clin Biochem, D-53105 Bonn, Germany; Inst Mol Biol Diagnost, Rheinbach, Germany; Univ Wurzburg, Biozentrum, Dept Human Genet, Wurzburg, Germany; Hop Bicetre, INSERM, U143, Le Kremlin Bicetre, France; Univ Sheffield, Royal Hallamshire Hosp, Div Genom Med, Sheffield S10 2JF, S Yorkshire, England; Malmo Univ Hosp, Dept Pediat, Malmo, Sweden; Univ Munster, Dept Human Genet, D-4400 Munster, Germany	University of Bonn; University of Bonn; University of Wurzburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Sheffield; Lund University; Skane University Hospital; University of Munster	Oldenburg, J (corresponding author), Univ Bonn, Inst Expt Hematol & Transfus Med, Sigmund Freud Str 25, D-53105 Bonn, Germany.	johannes.oldenburg@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020	Oldenburg, Johannes/0000-0002-1585-4100; Goodeve, Anne/0000-0002-6177-7062				ANTONARAKIS SE, 1995, BLOOD, V86, P2206, DOI 10.1182/blood.V86.6.2206.bloodjournal8662206; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; Becker J, 1996, AM J HUM GENET, V58, P657; BROCKERVRIENDS AHJT, 1990, HUM GENET, V85, P288; Buehr M, 1997, EXP CELL RES, V232, P194, DOI 10.1006/excr.1997.3508; Casey GJ, 1999, BRIT J HAEMATOL, V107, P560, DOI 10.1046/j.1365-2141.1999.01743.x; Chu G, 1996, TRENDS GENET, V12, P187, DOI 10.1016/0168-9525(96)10021-4; CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20; COHN DH, 1990, AM J HUM GENET, V46, P591; Colman SD, 1996, AM J HUM GENET, V58, P484; Drost JB, 1998, GENETICA, V102-3, P421, DOI 10.1023/A:1017002221520; El-Maarri O, 1998, AM J HUM GENET, V63, P1001, DOI 10.1086/302065; Froissart R, 1997, J MED GENET, V34, P137, DOI 10.1136/jmg.34.2.137; Hezard N, 1997, THROMB RES, V88, P59, DOI 10.1016/S0049-3848(97)00191-6; HIGUCHI M, 1988, MOL BIOL MED, V5, P23; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Ketterling RP, 1999, HUM GENET, V105, P629, DOI 10.1007/s004390051155; Knoll A, 1996, HUM GENET, V98, P539, DOI 10.1007/s004390050256; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LAVERGNE JM, 1992, NOUV REV FR HEMATOL, V34, P85; LEVINSON B, 1990, AM J HUM GENET, V46, P53; Liu Q, 1998, BLOOD, V92, P1458, DOI 10.1182/blood.V92.4.1458.splL4_1458_1459; Ljung RCR, 1999, BRIT J HAEMATOL, V106, P870, DOI 10.1046/j.1365-2141.1999.01631.x; Lund AM, 1996, PRENATAL DIAG, V16, P1032, DOI 10.1002/(SICI)1097-0223(199611)16:11<1032::AID-PD984>3.0.CO;2-9; Oldenburg J, 2000, BLOOD, V96, P2905; PASSOSBUENO MR, 1992, AM J HUM GENET, V51, P1150; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; Schmutte C, 1998, BIOL CHEM, V379, P377; Schwaab R, 1997, HUM GENET, V101, P323, DOI 10.1007/s004390050636; SCHWAAB R, 1993, BRIT J HAEMATOL, V83, P450, DOI 10.1111/j.1365-2141.1993.tb04670.x; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; SORIANO P, 1986, CELL, V46, P19, DOI 10.1016/0092-8674(86)90856-1; STRAUSS HS, 1967, PEDIATRICS, V39, P186; Tavassoli K, 1998, HUM MUTAT, V12, P301, DOI 10.1002/(SICI)1098-1004(1998)12:5<301::AID-HUMU2>3.3.CO;2-3; VANESSEN AJ, 1992, HUM GENET, V88, P249, DOI 10.1007/BF00197255; Verhoef S, 1999, AM J HUM GENET, V64, P1632, DOI 10.1086/302412; VOGEL F, 1977, AM J HUM GENET, V29, P312; VOGEL F, 1986, HUM GENET, P301; Williams IJ, 1998, THROMB HAEMOSTASIS, V79, P723, DOI 10.1055/s-0037-1615052; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7	40	103	106	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					75	87		10.1086/321285	http://dx.doi.org/10.1086/321285			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11410838	Bronze, Green Published			2022-12-18	WOS:000170108100008
J	Slager, SL; Schaid, DJ				Slager, SL; Schaid, DJ			Evaluation of candidate genes in case-control studies: A statistical method to account for related subjects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX HUMAN-DISEASES; GENOMIC CONTROL; ASSOCIATION; DESIGNS; POWER; BIAS	Traditional case-control studies provide a powerful and efficient method for evaluation of association between candidate genes and disease. The sampling of cases from multiplex pedigrees, rather than from a catchment area, can increase the likelihood that genetic cases are selected. However, use of all the related cases without accounting for their biological relationship can increase the type I error rate of the statistical test. To overcome this problem, we present an analysis method that is used to compare genotype frequencies between cases and controls, according to a trend in proportions as the dosage of the risk allele increases. This method uses the appropriate variance to account for the correlated family data, thus maintaining the correct type I error rate. The magnitude of the association is estimated by the odds ratio, with the variance of the odds ratio also accounting for the correlated data. Our method makes efficient use of data collected from multiplex families and should prove useful for the analysis of candidate genes among families sampled for linkage studies. An application of our method, to family data from a prostate cancer study, is presented to illustrate the method's utility.	Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic	Slager, SL (corresponding author), Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Harwick 6, Rochester, MN 55905 USA.		Slager, Susan L./B-6756-2009		NIDCR NIH HHS [DE13276] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013276] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Khoury MJ, 1998, EPIDEMIOLOGY, V9, P350, DOI 10.1097/00001648-199805000-00023; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Li CC., 1955, POPULATION GENETICS; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; RAO C.R., 1973, LINEAR STAT INFERENC, V2nd; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Teng J, 1999, GENOME RES, V9, P234; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Witte JS, 1999, AM J EPIDEMIOL, V149, P693	15	103	104	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1457	1462		10.1086/320608	http://dx.doi.org/10.1086/320608			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11353403	Bronze, Green Published			2022-12-18	WOS:000169094600016
J	Markianos, K; Daly, MJ; Kruglyak, L				Markianos, K; Daly, MJ; Kruglyak, L			Efficient multipoint linkage analysis through reduction of inheritance space	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC-ANALYSIS; FASTER; ALGORITHM; MODEL; MAP	Computational constraints currently limit exact multipoint linkage analysis to pedigrees of moderate size. We introduce new algorithms that allow analysis of larger pedigrees by reducing the time and memory requirements of the computation. We use the observed pedigree genotypes to reduce the number of inheritance patterns that need to be considered. The algorithms are implemented in a new version (version 2.1) of the software package GENEHUNTER. Performance gains depend on marker heterozygosity and on the number of pedigree members available for genotyping, but typically are 10-1,000-fold, compared with the performance of the previous release (version 2.0). As a result, families with up to 30 bits of inheritance information have been analyzed, and further increases in family size are feasible. In addition to computation of linkage statistics and haplotype determination, GENEHUNTER can also perform single-locus and multilocus transmission/disequilibrium tests. We describe and implement a set of permutation tests that allow determination of empirical significance levels in the presence of linkage disequilibrium among marker loci.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA USA; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Markianos, K (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1100 Fairview Ave N,D4-100,POB 19024, Seattle, WA 98109 USA.	markiano@fhcrc.org	Daly, Mark J/B-2453-2017; Peng, Bo/A-6920-2009	Daly, Mark J/0000-0002-0949-8752; Peng, Bo/0000-0001-8225-2284; Markianos, Kyriacos/0000-0003-0214-6014	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059520, R37MH059520] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-59520, R01 MH059520, R37 MH059520] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Goldin LR, 1997, GENET EPIDEMIOL, V14, P563; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Idury RM, 1997, HUM HERED, V47, P197, DOI 10.1159/000154413; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Laitinen T, 1997, HUM MOL GENET, V6, P2069, DOI 10.1093/hmg/6.12.2069; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Sobel E, 1993, Stat Methods Med Res, V2, P263, DOI 10.1177/096228029300200305; Sobel E, 1996, AM J HUM GENET, V58, P1323; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202	20	103	113	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					963	977		10.1086/319507	http://dx.doi.org/10.1086/319507			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254453	Green Published, Bronze			2022-12-18	WOS:000167666000018
J	Saleem, RA; Banerjee-Basu, S; Berry, FB; Baxevanis, AD; Walter, MA				Saleem, RA; Banerjee-Basu, S; Berry, FB; Baxevanis, AD; Walter, MA			Analyses of the effects that disease-causing missense mutations have on the structure and function of the winged-helix protein FOXC1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR GENE; POSITIVE CONTROL; DNA-BINDING; CONGENITAL HYDROCEPHALUS; RIEGER-SYNDROME; FORK HEAD; TGF-BETA; MF1; REPRESSOR; ACTIVATION	Five missense mutations of the winged-helix FOXC1 transcription factor, found in patients with Axenfeld-Rieger (AR) malformations, were investigated for their effects on FOXC1 structure and function. Molecular modeling of the FOXC1 forkhead domain predicted that the missense mutations did not alter FOXC1 structure. Biochemical analyses indicated that, whereas all mutant proteins correctly localize to the cell nucleus, the I87M mutation reduced FOXC1- protein levels. DNA-binding experiments revealed that, although the S82T and S131L mutations decreased DNA binding, the F112S and I126M mutations did not. However, the F112S and I126M mutations decrease the transactivation ability of FOXC1. All the FOXC1 mutations had the net effect of reducing FOXC1 transactivation ability. These results indicate that the FOXC1 forkhead domain contains separable DNA-binding and transactivation functions. In addition, these findings demonstrate that reduced stability, DNA binding, or transactivation, all causing a decrease in the ability of FOXC1 to transactivate genes, can underlie AR malformations.	Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2H7, Canada; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	University of Alberta; University of Alberta; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Walter, MA (corresponding author), Univ Alberta, Dept Ophthalmol, Edmonton, AB T6G 2H7, Canada.			Baxevanis, Andy/0000-0002-5370-0014				Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Becker R.A., 1988, NEW S LANGUAGE PROGR; Blixt A, 2000, GENE DEV, V14, P245; BRYANT SH, 1993, PROTEINS, V16, P92, DOI 10.1002/prot.340160110; FETROW JS, 1993, BIO-TECHNOL, V11, P479, DOI 10.1038/nbt0493-479; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P2236, DOI 10.1073/pnas.79.7.2236; HAWLEY DK, 1983, CELL, V32, P327, DOI 10.1016/0092-8674(83)90452-X; Hiemisch H, 1998, MECH DEVELOP, V73, P129, DOI 10.1016/S0925-4773(98)00039-2; HOCHSCHILD A, 1983, CELL, V32, P319, DOI 10.1016/0092-8674(83)90451-8; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Jin CW, 1999, J MOL BIOL, V289, P683, DOI 10.1006/jmbi.1999.2819; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kidson SH, 1999, DEV BIOL, V211, P306, DOI 10.1006/dbio.1999.9314; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Kulak SC, 1998, HUM MOL GENET, V7, P1113, DOI 10.1093/hmg/7.7.1113; Kume T, 2000, DEVELOPMENT, V127, P1387; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LAI JS, 1992, GENE DEV, V6, P2058, DOI 10.1101/gad.6.11.2058; LAI JS, 1992, GENE DEV, V6, P2663; Larsson C, 1995, GENOMICS, V30, P464, DOI 10.1006/geno.1995.1266; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; LI M, 1994, SCIENCE, V263, P75, DOI 10.1126/science.8272867; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Mirzayans F, 2000, EUR J HUM GENET, V8, P71, DOI 10.1038/sj.ejhg.5200354; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Swiderski RE, 1999, DEV DYNAM, V216, P16, DOI 10.1002/(SICI)1097-0177(199909)216:1<16::AID-DVDY4>3.0.CO;2-1; VINCENT S, 1993, NUCLEIC ACIDS RES, V21, P1498, DOI 10.1093/nar/21.6.1498; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Yeo CY, 1999, J BIOL CHEM, V274, P26584, DOI 10.1074/jbc.274.37.26584; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	37	103	105	1	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					627	641		10.1086/318792	http://dx.doi.org/10.1086/318792			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179011	Bronze, Green Published			2022-12-18	WOS:000166994200008
J	Brewer, C; Holloway, S; Zawalnyski, P; Schinzel, A; FitzPatrick, D				Brewer, C; Holloway, S; Zawalnyski, P; Schinzel, A; FitzPatrick, D			A chromosomal duplication map of malformations: Regions of suspected haplo- and triplolethality - and tolerance of segmental aneuploidy - in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; CONGENITAL-MALFORMATIONS; THANATOPHORIC DYSPLASIA; GENETIC INTERACTIONS; MUTATIONS; ABNORMALITIES; GAIN	The distribution of simple autosomal duplications, associated with congenital malformations has been analyzed by means of data contained in the Human Cytogenetics. Database. For each of the 47 malformations, the frequency of duplication of a given chromosome band associated with the malformation was compared with the overall frequency of duplication of that band recorded in the database. In total, there were 143 malformation-associated chromosomal regions (MACR); 21 of these contained at least one band with a highly significant (P < .001) association. The average number of bands per MACR was 3.1, Eight bands, representing 2.1% of haploid autosomal length, were not involved in any duplication, and we suggest that these are potentially triplolethal. This compares with 31 bands, representing 11% of haploid autosomal length, that were identified in the previously reported deletion map and that were not involved in any deletion and are potentially haplolethal. In both cases, approximately half of these bands are pericentromeric. The longest duplication involves 4.3% of haploid autosomal length; and the longest deletion involves 2.7%.	Western Gen Hosp, Mol Med Ctr, Dept Human & Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Zurich, Inst Med Genet, Zurich, Switzerland	University of Edinburgh; University of Zurich	FitzPatrick, D (corresponding author), Western Gen Hosp, Mol Med Ctr, Dept Human Genet, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.		FitzPatrick, David R/B-8311-2008; FitzPatrick, David R/C-7301-2013	FitzPatrick, David R./0000-0003-4861-969X				BECKER KL, 1963, MAYO CLIN PROC, V38, P242; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; CHUNG CS, 1968, AM J HUM GENET, V20, P44; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; GAGNON G, 1961, UNION MED CAN, V90, P1220; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Hecht F, 1987, ANEUPLOIDY A, P9; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; Hogue C J, 1989, MMWR CDC Surveill Summ, V38, P1; HRUBEC Z, 1984, NEW ENGL J MED, V310, P435, DOI 10.1056/NEJM198402163100706; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; Joyce JA, 1997, HUM MOL GENET, V6, P1543, DOI 10.1093/hmg/6.9.1543; KALTER H, 1983, NEW ENGL J MED, V308, P491, DOI 10.1056/NEJM198303033080904; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; Li QY, 1997, NAT GENET, V15, P21; LINDSLEY DL, 1972, GENETICS, V71, P157; LINDSLEY DL, 1968, PUBL CARNEGIE I, V627; LURIE IW, 1993, AM J MED GENET, V47, P410, DOI 10.1002/ajmg.1320470323; MANGE AP, 1973, GENETICS, V73, P73; MITTELMAN F, 1995, ISCN INT SYSTEM HUMA; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; POLLOCK RA, 1995, P NATL ACAD SCI USA, V92, P4492, DOI 10.1073/pnas.92.10.4492; SANDLER L, 1973, AM J HUM GENET, V25, P332; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; SCHINZEL A, 1994, HUMAN CYTOGENETICS D; TAVORMINA PL, 1995, HUM MOL GENET, V4, P2175, DOI 10.1093/hmg/4.11.2175; VASARHELYI K, 1989, ANN HUM GENET, V53, P375, DOI 10.1111/j.1469-1809.1989.tb01805.x; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Zachgo J, 1998, DEV GENET, V23, P86, DOI 10.1002/(SICI)1520-6408(1998)23:1<86::AID-DVG9>3.0.CO;2-2	29	103	109	1	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1702	1708		10.1086/302410	http://dx.doi.org/10.1086/302410			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330358	Green Published, Bronze			2022-12-18	WOS:000080696200023
J	Devriendt, K; Matthijs, G; Van Dael, R; Gewillig, M; Eyskens, B; Hjalgrim, H; Dolmer, B; McGaughran, J; Brondum-Nielsen, K; Marynen, P; Fryns, JP; Vermeesch, JR				Devriendt, K; Matthijs, G; Van Dael, R; Gewillig, M; Eyskens, B; Hjalgrim, H; Dolmer, B; McGaughran, J; Brondum-Nielsen, K; Marynen, P; Fryns, JP; Vermeesch, JR			Delineation of the critical deletion region for congenital heart defects, on chromosome 8p23.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; VENTRAL MORPHOGENESIS; INSITU HYBRIDIZATION; TRANSCRIPTION FACTOR; MENTAL-RETARDATION; TUBE FORMATION; 8P SYNDROME; SHORT ARM; DISEASE; GATA4	Deletions in the distal region of chromosome 8p (del8p) are associated with congenital heart malformations. Other major manifestations include microcephaly, intrauterine growth retardation, mental retardation, and a characteristic hyperactive, impulsive behavior. We studied genotype-phenotype correlations in nine unrelated patients with a de novo del8p, by using the combination of classic cytogenetics, FISH, and the analysis of polymorphic DNA markers. With the exception of one large terminal deletion, all deletions were interstitial. In five patients, a commonly deleted region of similar to 6 Mb was present, with breakpoints clustering in the same regions. One patient without a heart defect or microcephaly but with mild mental retardation and characteristic behavior had a smaller deletion within this commonly deleted region. Two patients without a heart defect had a more proximal interstitial deletion that did not overlap with the commonly deleted region. Taken together, these data allowed us to define the critical deletion regions for the major features of a del8p.	Katholieke Univ Leuven Hosp, Ctr Human Genet, Louvain, Belgium; Katholieke Univ Leuven Hosp, Pediat Cardiol Unit, Louvain, Belgium; Flemish Interuniv Inst Biotechnol, Louvain, Belgium; Cent Hosp Hillerod, John F Kennedy Inst, Glostrup, Denmark; Cent Hosp Hillerod, Dept Pediat, Glostrup, Denmark; St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Manchester	Devriendt, K (corresponding author), Catholic Univ Louvain, Ctr Human Genet, Herestr 49, B-3000 Louvain, Belgium.	Koen.devriendt@med.kuleuven.ac.be	McGaughran, Julie/A-2563-2012	Vermeesch, Joris/0000-0002-3071-1191; Matthijs, Gert/0000-0001-6710-1912; McGaughran, Julie/0000-0002-0926-7858				Baumer A, 1998, HUM MOL GENET, V7, P887, DOI 10.1093/hmg/7.5.887; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; CARMI R, 1992, AM J MED GENET, V43, P569, DOI 10.1002/ajmg.1320430313; Claeys I, 1997, AM J MED GENET, V74, P515, DOI 10.1002/(SICI)1096-8628(19970919)74:5<515::AID-AJMG12>3.0.CO;2-F; Devriendt K, 1995, ANN GENET-PARIS, V38, P228; Devriendt K, 1998, PRENATAL DIAG, V18, P65, DOI 10.1002/(SICI)1097-0223(199801)18:1<65::AID-PD207>3.0.CO;2-4; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Digilio MC, 1998, AM J MED GENET, V75, P534, DOI 10.1002/(SICI)1096-8628(19980217)75:5<534::AID-AJMG15>3.3.CO;2-J; DIGILIO MC, 1993, AM J MED GENET, V47, P437, DOI 10.1002/ajmg.1320470331; DOBYNS WB, 1985, AM J MED GENET, V22, P125, DOI 10.1002/ajmg.1320220114; FRYNS JP, 1989, ANN GENET-PARIS, V32, P171; GELB BD, 1991, AM J MED GENET, V40, P471, DOI 10.1002/ajmg.1320400420; Huang WY, 1996, CYTOGENET CELL GENET, V72, P217, DOI 10.1159/000134194; HUTCHINSON R, 1992, J MED GENET, V29, P407, DOI 10.1136/jmg.29.6.407; KORENBERG JR, 1992, AM J HUM GENET, V50, P294; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; Lopes J, 1997, NAT GENET, V17, P136, DOI 10.1038/ng1097-136; MARINO B, 1992, AM J MED GENET, V42, P424, DOI 10.1002/ajmg.1320420404; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; OSTERGAARD GZ, 1989, ANN GENET-PARIS, V32, P87; PATTERSON DG, 1995, CURR OPIN PSYCHIATR, V8, P57, DOI 10.1097/00001504-199501000-00014; PAYNE RM, 1995, CIRCULATION, V91, P494, DOI 10.1161/01.CIR.91.2.494; Sambrook J, 1989, MOL CLONING LAB MANU; VERMEESCH JR, 1995, GENOMICS, V25, P327, DOI 10.1016/0888-7543(95)80152-C; WIEGANT J, 1992, HUM MOL GENET, V1, P587, DOI 10.1093/hmg/1.8.587; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; Wu BL, 1996, AM J MED GENET, V62, P77, DOI 10.1002/(SICI)1096-8628(19960301)62:1<77::AID-AJMG16>3.0.CO;2-S	29	103	105	1	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1119	1126		10.1086/302330	http://dx.doi.org/10.1086/302330			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090897	Bronze, Green Published			2022-12-18	WOS:000079632900023
J	Crawford, DC; Meadows, KL; Newman, JL; Taft, LF; Pettay, DL; Gold, LB; Hersey, SJ; Hinkle, EF; Stanfield, ML; Holmgreen, P; Yeargin-Allsopp, M; Boyle, C; Sherman, SL				Crawford, DC; Meadows, KL; Newman, JL; Taft, LF; Pettay, DL; Gold, LB; Hersey, SJ; Hinkle, EF; Stanfield, ML; Holmgreen, P; Yeargin-Allsopp, M; Boyle, C; Sherman, SL			Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X-SYNDROME; FMR1 CGG REPEAT; MENTAL-RETARDATION; CARRIER FEMALES; MYOTONIC-DYSTROPHY; 2 FAMILIES; GENE; PREMUTATION; EXPRESSION; MODEL	We conducted a large population-based survey of fragile X (FRAXA) syndrome in ethnically diverse metropolitan Atlanta. The eligible study population consisted of public school children, aged 7-10 years, in special education-needs (SEN) classes. The purpose of the study was to estimate the prevalence among whites and, for the first time, African Americans, among a non-clinically referred population. At present, 5 males with FRAXA syndrome (4 whites and 1 African American), among 1,979 tested males, and no females, among 872 tested females, were identified. All males with FRAXA syndrome were mentally retarded and had been diagnosed previously The prevalence for FRAXA syndrome was estimated to be 1/3,460 (confidence interval [CI] 1/7,143-1/1,742) for the general white male population and 1/4,048 (CI 1/16,260-1/1,244) for the general African American male population. We also compared the frequency of intermediate and premutation FRAXA alleles (41-199 repeats) and fragile XE syndrome alleles (31-199 repeats) in the SEN population with that in a control population, to determine if there was a possible phenotype consequence of such high-repeat alleles, as has been reported previously. No difference was observed between our case and control populations, and no difference was observed between populations when the probands were grouped by a rough estimate of IQ based on class placement. These results suggest that there is no phenotype consequence of larger alleles that would cause carriers to be placed in an SEN class.	Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Div Child Dev Disabil & Hlth, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Sherman, SL (corresponding author), Emory Univ, Sch Med, Dept Genet, 1462 Clifton Rd NE, Atlanta, GA 30322 USA.		Crawford, Dana/O-5578-2019; Crawford, Dana/C-1054-2012	Crawford, Dana/0000-0002-6437-6248; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029909] Funding Source: NIH RePORTER; NICHD NIH HHS [HD29909] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLINGHAMHAWKIN.DJ, IN PRESS AM J MED GE; AllinghamHawkins DJ, 1996, AM J MED GENET, V64, P329, DOI 10.1002/(SICI)1096-8628(19960809)64:2<329::AID-AJMG19>3.0.CO;2-H; ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; ASHLEY AE, 1995, AM J HUM GENET, V57, P1414; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Barnicoat AJ, 1997, J MED GENET, V34, P13, DOI 10.1136/jmg.34.1.13; Biancalana V, 1996, AM J HUM GENET, V59, P847; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; Brown WT, 1996, AM J HUM GENET, V58, P903; Conway GS, 1998, HUM REPROD, V13, P1184, DOI 10.1093/humrep/13.5.1184; CONWAY GS, 1995, LANCET, V346, P309, DOI 10.1016/S0140-6736(95)92194-X; CRONISTER A, 1991, AM J MED GENET, V38, P269, DOI 10.1002/ajmg.1320380221; DAWSON AJ, 1995, BIOCHEM MOL MED, V56, P63, DOI 10.1006/bmme.1995.1057; Deissler H, 1996, J BIOL CHEM, V271, P4327; DENNIS NR, 1992, AM J MED GENET, V43, P232, DOI 10.1002/ajmg.1320430137; deVries BBA, 1997, AM J HUM GENET, V61, P660, DOI 10.1086/515496; Elbaz A, 1998, J INTELL DISABIL RES, V42, P81, DOI 10.1046/j.1365-2788.1998.00064.x; FENG Y, 1995, AM J HUM GENET, V56, P106; Fleiss J. L., 1981, STATISTICAL METHODS, P1; FLYNN GA, 1993, J MED GENET, V30, P97, DOI 10.1136/jmg.30.2.97; Franke P, 1996, AM J MED GENET, V64, P334, DOI 10.1002/(SICI)1096-8628(19960809)64:2<334::AID-AJMG20>3.0.CO;2-F; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Gecz J, 1997, HUM MOL GENET, V6, P435, DOI 10.1093/hmg/6.3.435; GOLDMAN A, 1994, J MED GENET, V31, P37, DOI 10.1136/jmg.31.1.37; Goldman A, 1997, S AFR MED J, V87, P418; HADDAD LA, IN PRESS AM J MED GE; HAGERMAN RJ, 1991, AM J MED GENET, V38, P283, DOI 10.1002/ajmg.1320380223; HAGERMAN RJ, 1992, J CHILD PSYCHOL PSYC, V33, P1127, DOI 10.1111/j.1469-7610.1992.tb00933.x; HAGERMAN RJ, 1996, FRAGILE X SYNDROME D, P3; HAMEL BCJ, 1994, AM J HUM GENET, V55, P923; Hecimovic S, 1997, CLIN GENET, V52, P147; Holden JJA, 1995, DEV BRAIN DYSFUNCT, V8, P405; HOWARDPEEBLES PN, 1980, AM J HUM GENET, V32, P629; HULL C, 1993, AM J DIS CHILD, V147, P1236, DOI 10.1001/archpedi.1993.02160350110017; Knight SJL, 1996, AM J HUM GENET, V58, P906; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOLEHMAINEN K, 1994, AM J MED GENET, V51, P428, DOI 10.1002/ajmg.1320510425; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LOESCH DZ, 1994, AM J MED GENET, V51, P392, DOI 10.1002/ajmg.1320510418; MAZZOCCO MMM, 1993, J DEV BEHAV PEDIATR, V14, P328; Mazzocco MMM, 1997, J DEV BEHAV PEDIATR, V18, P392, DOI 10.1097/00004703-199712000-00004; MCCARTNEY K, 1990, PSYCHOL BULL, V107, P226, DOI 10.1037/0033-2909.107.2.226; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; MEADOWS KL, 1996, AM J MED GENET, V64, P425; Mornet E, 1998, CLIN GENET, V53, P200; MORRIS A, 1995, P NATL ACAD SCI USA, V92, P4833, DOI 10.1073/pnas.92.11.4833; MORRIS A, 1995, ANN HUM GENET, V59, P283, DOI 10.1111/j.1469-1809.1995.tb00748.x; Morton JE, 1997, J MED GENET, V34, P1, DOI 10.1136/jmg.34.1.1; MORTON NE, 1992, P NATL ACAD SCI USA, V89, P4215, DOI 10.1073/pnas.89.9.4215; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P233; MULLEY JC, 1995, J MED GENET, V32, P162, DOI 10.1136/jmg.32.3.162; Murray A, 1998, J MED GENET, V35, P637, DOI 10.1136/jmg.35.8.637; Murray A, 1996, HUM MOL GENET, V5, P727, DOI 10.1093/hmg/5.6.727; Nolin SL, 1996, AM J HUM GENET, V59, P1252; Partington MW, 1996, AM J MED GENET, V64, P370, DOI 10.1002/(SICI)1096-8628(19960809)64:2<370::AID-AJMG27>3.0.CO;2-B; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; PULLIAM LH, 1988, P GREENWOOD GENET CT, V7, P109; REISS AL, 1993, AM J HUM GENET, V52, P884; Riddle JE, 1998, AM J MENT RETARD, V102, P590; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006; SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419; SHERMAN SL, 1995, AM J HUM GENET, V57, P991; SHERMAN SL, 1995, MENT RETARD DEV D R, V1, P263; Spence WC, 1996, AM J MED GENET, V64, P181, DOI 10.1002/(SICI)1096-8628(19960712)64:1<181::AID-AJMG31>3.3.CO;2-Q; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Sutherland Grant R., 1992, Human Molecular Genetics, V1, P111, DOI 10.1093/hmg/1.2.111; SVED JA, 1990, AM J HUM GENET, V46, P443; Syrrou M, 1998, GENET EPIDEMIOL, V15, P103, DOI 10.1002/(SICI)1098-2272(1998)15:1<103::AID-GEPI8>3.3.CO;2-L; Teague JW, 1998, P NATL ACAD SCI USA, V95, P719, DOI 10.1073/pnas.95.2.719; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; VENTER PA, 1982, S AFR MED J, V62, P947; Venter PA, 1981, S AFR MED J, V21, P807; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WATKINS WS, 1995, HUM MOL GENET, V4, P1485, DOI 10.1093/hmg/4.9.1485; WINTER RM, 1987, HUM GENET, V75, P269, DOI 10.1007/BF00281072; WOLFF PH, 1988, AM J MED GENET, V30, P213, DOI 10.1002/ajmg.1320300121; Zhong N, 1996, AM J MED GENET, V64, P415, DOI 10.1002/(SICI)1096-8628(19960809)64:2<415::AID-AJMG36>3.0.CO;2-G	79	103	106	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					495	507		10.1086/302260	http://dx.doi.org/10.1086/302260			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973286	Green Published, Bronze			2022-12-18	WOS:000078740600018
J	ELBAZ, A; VALESANTOS, J; JURKATROTT, K; LAPIE, P; OPHOFF, RA; BADY, B; LINKS, TP; PIUSSAN, C; VILA, A; MONNIER, N; PADBERG, GW; ABE, K; FEINGOLD, N; GUIMARAES, J; WINTZEN, AR; VANDERHOEVEN, JH; SAUDUBRAY, JM; GRUNFELD, JP; LENOIR, G; NIVET, H; ECHENNE, B; FRANTS, RR; FARDEAU, M; LEHMANNHORN, F; FONTAINE, B				ELBAZ, A; VALESANTOS, J; JURKATROTT, K; LAPIE, P; OPHOFF, RA; BADY, B; LINKS, TP; PIUSSAN, C; VILA, A; MONNIER, N; PADBERG, GW; ABE, K; FEINGOLD, N; GUIMARAES, J; WINTZEN, AR; VANDERHOEVEN, JH; SAUDUBRAY, JM; GRUNFELD, JP; LENOIR, G; NIVET, H; ECHENNE, B; FRANTS, RR; FARDEAU, M; LEHMANNHORN, F; FONTAINE, B			HYPOKALEMIC PERIODIC PARALYSIS AND THE DIHYDROPYRIDINE RECEPTOR (CACNLIA3) - GENOTYPE-PHENOTYPE CORRELATIONS FOR 2 PREDOMINANT MUTATIONS AND EVIDENCE FOR THE ABSENCE OF A FOUNDER EFFECT IN 16 CAUCASIAN FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHANNEL ALPHA-SUBUNIT; SKELETAL-MUSCLE; SODIUM-CHANNEL; PARAMYOTONIA-CONGENITA; GENOMIC STRUCTURE; LINKAGE MAP; GENE; MYOTONIA; DOMINANT; DISEASE	Hypokalemic periodic paralysis (hypoPP) is an autosomal dominant disorder belonging to a group of muscle diseases involving the abnormal function of ion channels. This group of muscle diseases also comprises hyperkalemic periodic paralysis and paramyotonia congenita, both sodium-channel diseases, and myotonia congenita, a chloride-channel disorder. HypoPP is characterized by acute attacks of muscle weakness concomitant with a fall in blood potassium levels. We recently localized the hypoPP locus (hypoPP1) to chromosome 1q31-32, in an interval where the alpha 1 subunit of the dihydropyridine receptor calcium channel (CACNL1A3) also maps. Subsequently, deleterious mutations in the voltage-sensor segment S4 were found, establishing the dihydropyridine receptor CACNL1A3 as the causative gene for hypoPP. In this paper, we report the study of 16 hypoPP families of Caucasian origin. found only two mutations-Arg528His and Arg1239His-that cosegregated with hypoPP, each in half of the families. Analysis of the clinical characteristics of both groups of families demonstrated that incomplete penetrance is a distinctive feature of the Arg528His mutation. Using dinucleotide repeats contained within or close to the dihydropyridine receptor gene, in conjunction with evidence of a de novo Arg1239His mutation, we show that a founder effect is unlikely to account for the two predominant mutations.	HOP LA PITIE SALPETRIERE,INSERM,U134,F-75013 PARIS,FRANCE; HOP LA PITIE SALPETRIERE,FEDERAT NEUROL,PARIS,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,U155,PARIS,FRANCE; HOP NECKER ENFANTS MALAD,DEPT PEDIAT,PARIS,FRANCE; HOP NECKER ENFANTS MALAD,DEPT NEPHROL,PARIS,FRANCE; INSERM,U153,PARIS,FRANCE; UNIV ULM,ANGEW PHYSIOL ABT,W-7900 ULM,GERMANY; HOSP EGAZ MINIZ,SERV NEUROL,LISBON,PORTUGAL; LEIDEN UNIV,DEPT NEUROL,LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; HOP LYON,LYON,FRANCE; UNIV GRONINGEN,DEPT INTERNAL MED,GRONINGEN,NETHERLANDS; CHU AMIENS,AMIENS,FRANCE; CHU GRENOBLE,GRENOBLE,FRANCE; CATHOLIC UNIV NIJMEGEN,DEPT NEUROL,NIJMEGEN,NETHERLANDS; TOHOKU UNIV,SCH MED,SENDAI,MIYAGI 980,JAPAN; CHU TOURS,TOURS,FRANCE; CHU MONTPELLIER,MONTPELLIER,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Ulm University; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; CHU Lyon; University of Groningen; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Radboud University Nijmegen; Tohoku University; CHU Tours; Universite de Montpellier; CHU de Montpellier			Elbaz, Alexis/F-8952-2017; Padberg, G.W.A.M./H-8079-2014	Elbaz, Alexis/0000-0001-9724-5490; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F05NS065682] Funding Source: NIH RePORTER; NINDS NIH HHS [F05 NS065682] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; CATTERALL WA, 1993, TRENDS NEUROSCI, V16, P500, DOI 10.1016/0166-2236(93)90193-P; CHAHINE M, 1994, NEURON, V12, P281, DOI 10.1016/0896-6273(94)90271-2; CUMMINS TR, 1993, NEURON, V10, P667, DOI 10.1016/0896-6273(93)90168-Q; FEERO WG, 1993, NEUROLOGY, V43, P668, DOI 10.1212/WNL.43.4.668; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; FONTAINE B, 1994, NAT GENET, V6, P267, DOI 10.1038/ng0394-267; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; GEORGE AL, 1992, ANN NEUROL, V31, P131, DOI 10.1002/ana.410310203; GREGG RG, 1993, GENOMICS, V15, P107, DOI 10.1006/geno.1993.1017; GUSELLA JF, 1986, ANNU REV BIOCHEM, V55, P831, DOI 10.1146/annurev.biochem.55.1.831; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HEINE R, 1993, HUM MOL GENET, V2, P1349, DOI 10.1093/hmg/2.9.1349; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JURKATROTT K, 1994, HUM MOL GENET, V3, P1415, DOI 10.1093/hmg/3.8.1415; KOCH MC, 1993, J MED GENET, V30, P914, DOI 10.1136/jmg.30.11.914; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; LINKS TP, 1994, J NEUROL SCI, V122, P33, DOI 10.1016/0022-510X(94)90049-3; LORY P, 1991, NEWS PHYSIOL SCI, V6, P277; MCCLATCHEY AI, 1992, HUM MOL GENET, V1, P521; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; McKusick VA, 1990, MENDELIAN INHERITANC; MEYERKLEINE C, 1994, HUM GENET, V93, P707; PLASSART E, 1994, HUM GENET, V94, P551; Plassart Emmanuelle, 1994, European Journal of Human Genetics, V2, P110; PTACEK LJ, 1993, ANN NEUROL, V33, P300, DOI 10.1002/ana.410330312; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; PTACEK LJ, 1994, NEUROLOGY, V44, P1500, DOI 10.1212/WNL.44.8.1500; PTACEK LJ, 1994, CELL, V77, P863; QUANE KA, 1994, HUM MOL GENET, V3, P471, DOI 10.1093/hmg/3.3.471; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; TABB JS, 1994, J NEUROSCI, V14, P763; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; WANG J, 1993, AM J HUM GENET, V52, P1074; WANG JZ, 1992, BIOCHEM BIOPH RES CO, V182, P794, DOI 10.1016/0006-291X(92)91802-W; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	40	103	108	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					374	380						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847370				2022-12-18	WOS:A1995QF42300003
J	ALFORD, RL; HAMMOND, HA; COTO, I; CASKEY, CT				ALFORD, RL; HAMMOND, HA; COTO, I; CASKEY, CT			RAPID AND EFFICIENT RESOLUTION OF PARENTAGE BY AMPLIFICATION OF SHORT TANDEM REPEATS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALLELE FREQUENCY-DISTRIBUTION; VARIABLE NUMBER; DNA-SEQUENCES; PATERNITY; LOCI; MARKERS; POLYMORPHISMS; IDENTITY; GENE	Short tandem repeat (STR) loci are highly informative polymorphic loci that are gaining popularity for identity testing. We have conducted parentage testing by using nine STR loci on 50 paternity trios that had been previously tested using VNTR loci. These nine unlinked STR loci are amplified in three multiplex reactions and, when examined for genetic informativeness, provide a combined average power of exclusion of 99.73% (Caucasian data). The informative value of the selected loci is based on extensive STR typing of four racial/ethnic populations. In 37 of the 50 cases, paternity could not be excluded by any of the loci. In the remaining 13 cases, paternity was excluded by at least two of the STR markers. The probability of paternity calculated for the alleged father of each matching trio was >99% in 36 of the 37 inclusion cases. All data agreed with the results reported using VNTR loci and conventional Southern technology. Our studies validate the use of DNA typing with STR loci for parentage testing, thus providing an accurate, highly sensitive, and rapid assay.	BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; UNIV NAPLES FEDERICO II,DIPARTIMENTO BIOCHIM & BIOTECNOL MED,NAPLES,ITALY	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Naples Federico II								BAIRD M, 1986, AM J HUM GENET, V39, P489; BILOFSKY HS, 1988, NUCLEIC ACIDS RES, V16, P1861, DOI 10.1093/nar/16.5.1861; BUDOWLE B, 1990, CLIN BIOCHEM, V23, P287, DOI 10.1016/0009-9120(90)80055-N; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; CHAKRABORTY R, 1981, GENETICS, V98, P461; CHAKRABORTY R, 1976, AM J HUM GENET, V28, P615; CHAKRAVARTI A, 1983, INCLUSION PROBABILIT, P411; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GJERTSON DW, 1988, AM J HUM GENET, V43, P860; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; HAMMOND HA, 1992, 3RD P INT S HUM ID P, P163; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LITT M, 1989, AM J HUM GENET, V44, P397; MORRIS JW, 1989, J FORENSIC SCI, V34, P1311; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; SMOUSE PE, 1986, AM J HUM GENET, V38, P918; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1989, AM J HUM GENET, V44, P388; 1993, EXECUTIVE SUMMARY	22	103	124	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					190	195						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NW461	8023845				2022-12-18	WOS:A1994NW46100025
J	RANUM, LPW; DUVICK, LA; RICH, SS; SCHUT, LJ; LITT, M; ORR, HT				RANUM, LPW; DUVICK, LA; RICH, SS; SCHUT, LJ; LITT, M; ORR, HT			LOCALIZATION OF THE AUTOSOMAL DOMINANT HLA-LINKED SPINOCEREBELLAR ATAXIA (SCAI) LOCUS, IN 2 KINDREDS, WITHIN AN 8-CM SUBREGION OF CHROMOSOME-6P	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; CEREBELLAR-ATAXIA; HEREDITARY ATAXIA; GENETIC-LINKAGE; FACTOR-XIIIA; HETEROGENEITY; MARKERS; POLYMORPHISM; REGION; FAMILY	Two large kindreds with HLA-linked, autosomal dominant spinocerebellar ataxia (SCA1) were examined with markers from chromosome 6p to determine the location of the SCA1 locus. Results of the three-point analysis between the markers HLA-A, SCA1, and F13A overwhelmingly favor the conclusion that SCA1 is located distal of HLA and proximal of F13A. In addition, our data strongly support the conclusion that SCA1 lies centromeric and genetically very close to the highly informative D6S89 marker within the 8-cM chromosomal segment flanked by the D6S88 and D6S89 markers. In the two kindreds, one recombinant was observed between D6S89 and SCA1, resulting in a recombination fraction of .014 between the two loci.	UNIV MINNESOTA,DEPT LAB MED & PATHOL,BOX 206 UMHC,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; VET ADM MED CTR,MINNEAPOLIS,MN 55417; OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MED GENET,PORTLAND,OR 97201	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Oregon Health & Science University; Oregon Health & Science University				Orr, Harry/0000-0001-6118-741X; Rich, Stephen/0000-0003-3872-7793	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R37NS022920] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01632] Funding Source: Medline; NINDS NIH HHS [NS22920] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUBURGER G, 1990, AM J HUM GENET, V46, P1163; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; DUVICK L, 1990, NUCLEIC ACIDS RES, V18, P3105, DOI 10.1093/nar/18.10.3105; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GRAY RC, 1941, MINN MED, V24, P327; GRUNDMANN U, 1986, P NATL ACAD SCI USA, V83, P8024, DOI 10.1073/pnas.83.21.8024; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HAINES JL, 1986, GENET EPIDEMIOL, V3, P399, DOI 10.1002/gepi.1370030604; HANAUER A, 1990, AM J HUM GENET, V46, P133; HOPKINS K, 1981, AACHT LABORATORY MAN; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KUMAR D, 1986, HUM GENET, V72, P327, DOI 10.1007/BF00290959; LANDIS DMD, 1974, ARCH NEUROL-CHICAGO, V31, P295, DOI 10.1001/archneur.1974.00490410043003; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; MARX JL, 1985, SCIENCE, V229, P150, DOI 10.1126/science.2990043; MORTON NE, 1980, AM J MED GENET, V6, P251, DOI 10.1002/ajmg.1320060309; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1974, AM J HUM GENET, V26, P588; PEDERSEN L, 1980, HUM GENET, V54, P371, DOI 10.1007/BF00291585; RICH SS, 1987, AM J HUM GENET, V41, P524; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; WHITTINGTON JE, 1980, CYTOGENET CELL GENET, V28, P145, DOI 10.1159/000131524; WILKIE PJ, IN PRESS HUM GENET; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49	33	103	105	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					31	41						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	1676561				2022-12-18	WOS:A1991FW51100005
J	CORMIER, V; ROTIG, A; TARDIEU, M; COLONNA, M; SAUDUBRAY, JM; MUNNICH, A				CORMIER, V; ROTIG, A; TARDIEU, M; COLONNA, M; SAUDUBRAY, JM; MUNNICH, A			AUTOSOMAL DOMINANT DELETIONS OF THE MITOCHONDRIAL GENOME IN A CASE OF PROGRESSIVE ENCEPHALOMYOPATHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; MYOPATHIES	Multiple deletions of the mitochondrial genome were found in a family in which the proband had ataxia and ketoacidotic comas. A progressive multiorgan involvement appeared in the course of the disease, and histopathological investigation demonstrated mitochondrial myopathy features with ragged red fibers. A defect of oxidative phosphorylation was found in both skeletal muscle and lymphocytes. It is surprising that various mtDNA deletions were detected both in the proband and in his healthy mother and maternal aunt but not in the rest of the maternal progeny. All the deletions were located between Cox II and cytochrome b genes, and short (4-5 bp) repeated sequences were consistently present at the boundaries of the rearrangements in different tissues. Therefore, the deletions appear not to be transmitted per se but to be inherited in a Mendelian manner, being possibly dominant. Both the Mendelian inheritance of the trait and the variety of the deletions in carriers suggest that a nuclearly encoded factor(s) might be involved in the triggering of the deletions. However, the presence of the rearrangements in healthy individuals raises the question of whether mtDNA deletions actually cause the clinical expression of the disease.	HOP NECKER ENFANTS MALAD,INSERM,U12,UNITE RECH HANDICAPS GENET ENFANT,149 RUE SEVRES,F-75743 PARIS 15,FRANCE; DEPT PEDIAT,SERV NEUROL,LE KREMLIN BICETR,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Rötig, Agnès/G-9592-2017; cormier-daire, valerie/H-6520-2017	Rötig, Agnès/0000-0003-0589-0703; cormier-daire, valerie/0000-0002-2839-9856				BOOKELMAN H, 1978, BIOCHEM MEDICA, V19, P336; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465; LUTFALLA G, 1985, SOMAT CELL MOLEC GEN, V11, P223, DOI 10.1007/BF01534679; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V154, P1240, DOI 10.1016/0006-291X(88)90272-0; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; ROTIG A, 1989, LANCET, V1, P902; ROTIG A, 1988, LANCET, V2, P567; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	12	103	104	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1991	48	4					643	648						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK478	2014791				2022-12-18	WOS:A1991FK47800001
J	MCGUFFIN, P; SARGEANT, M; HETTI, G; TIDMARSH, S; WHATLEY, S; MARCHBANKS, RM				MCGUFFIN, P; SARGEANT, M; HETTI, G; TIDMARSH, S; WHATLEY, S; MARCHBANKS, RM			EXCLUSION OF A SCHIZOPHRENIA SUSCEPTIBILITY GENE FROM THE CHROMOSOME-5Q11-Q13 REGION - NEW DATA AND A REANALYSIS OF PREVIOUS REPORTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST PSYCHIAT,DEPT NEUROSCI,LONDON SE5 8AF,ENGLAND	University of London; King's College London	MCGUFFIN, P (corresponding author), UNIV COLL CARDIFF,DEPT PSYCHOL MED,CARDIFF CF4 4XN,S GLAM,WALES.		McGuffin, Peter/A-1565-2012	McGuffin, Peter/0000-0002-9888-2907				ANDREW B, 1987, PSYCHOL MED, V17, P363, DOI 10.1017/S0033291700024910; BASSETT AS, 1988, LANCET, V1, P799; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHADDA R, 1986, BRIT J PSYCHIAT, V149, P612, DOI 10.1192/bjp.149.5.612; DETERAWADLEIGH SD, 1989, NATURE, V340, P391, DOI 10.1038/340391a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FARMER AE, 1987, ARCH GEN PSYCHIAT, V44, P634; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOLDIN LR, 1987, PSYCHIAT RES, V20, P69, DOI 10.1016/0165-1781(87)90124-7; GURLING H, 1990, TRANSMISSION, V9, P15; KENDLER KS, 1981, ARCH GEN PSYCHIAT, V38, P982; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MCGUE M, 1985, Genetic Epidemiology, V2, P99, DOI 10.1002/gepi.1370020110; MCGUFFIN P, 1988, BRIT J PSYCHIAT, V153, P591, DOI 10.1192/bjp.153.5.591; MCGUFFIN P, 1986, PSYCHOL MED, V16, P461, DOI 10.1017/S0033291700009302; MCGUFFIN P, 1984, ARCH GEN PSYCHIAT, V41, P541; MCGUFFIN P, 1986, HUM HERED, V36, P65, DOI 10.1159/000153604; MCGUFFIN P, 1983, PSYCHOL MED, V13, P31, DOI 10.1017/S0033291700050042; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1982, METHODS HAEMATOLOGY, V6; OROURKE DH, 1982, AM J HUM GENET, V34, P630; OTT J, 1985, ANAL HUMAN GENETIC L; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; Shields J, 1982, SCHIZOPHRENIA EPIGEN; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STCLAIR D, 1989, NATURE, V339, P305; STURT E, 1985, PSYCHOL MED, V15, P455, DOI 10.1017/S0033291700031330; SVJEGAARD A, 1975, TRANSPLANT REV, V22, P3; TURNER WJ, 1979, BIOL PSYCHIAT, V14, P177; WEINER AS, 1906, LANCET, V1, P813; Wing J. K. C., 1974, MEASUREMENT CLASSIFI; 1987, DIAGNOSTIC STATISTIC	36	103	103	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					524	535						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DX223	2393025				2022-12-18	WOS:A1990DX22300017
J	KNOWLTON, RG; WEAVER, EJ; STRUYK, AF; KNOBLOCH, WH; KING, RA; NORRIS, K; SHAMBAN, A; UITTO, J; JIMENEZ, SA; PROCKOP, DJ				KNOWLTON, RG; WEAVER, EJ; STRUYK, AF; KNOBLOCH, WH; KING, RA; NORRIS, K; SHAMBAN, A; UITTO, J; JIMENEZ, SA; PROCKOP, DJ			GENETIC-LINKAGE ANALYSIS OF HEREDITARY ARTHRO-OPHTHALMOPATHY (STICKLER SYNDROME) AND THE TYPE-II PROCOLLAGEN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DEPT MED,PHILADELPHIA,PA 19107; UNIV MINNESOTA,SCH MED,DEPT OPHTHALMOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT MED,MINNEAPOLIS,MN 55455; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT MED,TORRANCE,CA 90509	Jefferson University; Jefferson University; Jefferson University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center				Jimenez, Sergio/0000-0001-5213-1203	NIAMS NIH HHS [AR39740, AR38923, AR 39530] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923, R01AR039530, P01AR039740] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BALAZS I, 1984, HUM GENET, V68, P57, DOI 10.1007/BF00293873; Barker D, 1983, Mol Biol Med, V1, P199; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BLAIR NP, 1979, AM J OPHTHALMOL, V82, P876; BUROKER NE, 1986, HUM GENET, V72, P86, DOI 10.1007/BF00278825; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; HERMANN J, 1975, BIRTH DEFECTS, V11, P76; Knobloch W H, 1975, Trans Am Ophthalmol Soc, V73, P417; KNOBLOCH WH, 1972, AM J OPHTHALMOL, V73, P517, DOI 10.1016/0002-9394(72)90003-7; KNOWLTON RG, 1986, BLOOD, V68, P378; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIBERFARB RM, 1981, J PEDIATR-US, V99, P394, DOI 10.1016/S0022-3476(81)80324-1; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P779, DOI 10.1093/nar/16.2.779; NUNEZ AM, 1985, BIOCHEMISTRY-US, V24, P6343, DOI 10.1021/bi00344a004; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; OTT J, 1974, AM J HUM GENET, V26, P588; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; SANGIORGI FO, 1985, NUCLEIC ACIDS RES, V13, P2207, DOI 10.1093/nar/13.7.2207; STICKLER GB, 1967, MAYO CLIN PROC, V42, P495; STICKLER GB, 1965, MAYO CLIN PROC, V40, P433; STOKER NG, 1985, NUCLEIC ACIDS RES, V13, P4613, DOI 10.1093/nar/13.13.4613; TEMPLE IK, 1989, J MED GENET, V26, P119, DOI 10.1136/jmg.26.2.119	27	103	108	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1989	45	5					681	688						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AZ049	2573273				2022-12-18	WOS:A1989AZ04900004
J	EASTON, DF; PONDER, MA; CUMMINGS, T; GAGEL, RF; HANSEN, HH; REICHLIN, S; TASHJIAN, AH; TELENIUSBERG, M; PONDER, BAJ				EASTON, DF; PONDER, MA; CUMMINGS, T; GAGEL, RF; HANSEN, HH; REICHLIN, S; TASHJIAN, AH; TELENIUSBERG, M; PONDER, BAJ			THE CLINICAL AND SCREENING AGE-AT-ONSET DISTRIBUTION FOR THE MEN-2 SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST CANC RES,INST HUMAN CANC GENET,SUTTON SM2 5NG,SURREY,ENGLAND; TUFTS UNIV,NEW ENGLAND MED CTR,DIV ENDOCRINOL,BOSTON,MA 02111; VET ADM MED CTR,DEPT MED & CELL BIOL,HOUSTON,TX 77211; BAYLOR COLL MED,HOUSTON,TX 77030; AARHUS KOMMUNE HOSP,DEPT NUCL MED,DK-8000 AARHUS C,DENMARK; HARVARD UNIV,SCH PUBL HLTH,DEPT TOXICOL,BOSTON,MA 02115; FAC MED SAFAT,DEPT INTERNAL MED,SAFAT,KUWAIT	University of London; Institute of Cancer Research - UK; Tufts Medical Center; Tufts University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; Aarhus University; Harvard University; Harvard T.H. Chan School of Public Health; Kuwait University	EASTON, DF (corresponding author), INST CANC RES,EPIDEMIOL SECT,BLOCK D 15 COTSWOLD RD,SUTTON SM2 5NG,SURREY,ENGLAND.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031307] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR0054-26] Funding Source: Medline; NIA NIH HHS [AG 31307] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLOCK MA, 1980, ARCH SURG-CHICAGO, V115, P142; CHONG GC, 1975, CANCER, V35, P695, DOI 10.1002/1097-0142(197503)35:3<695::AID-CNCR2820350323>3.0.CO;2-W; Cox D.R., 1984, ANAL SURVIVAL DATA; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EMERY AEH, 1976, METHODOLOGY MED GENE; FARNDON JR, 1986, BRIT J SURG, V73, P278, DOI 10.1002/bjs.1800730411; GAGEL RF, 1988, NEW ENGL J MED, V318, P478, DOI 10.1056/NEJM198802253180804; GAGEL RF, 1982, J PEDIATR-US, V101, P941, DOI 10.1016/S0022-3476(82)80014-0; GRAZE K, 1978, NEW ENGL J MED, V299, P980, DOI 10.1056/NEJM197811022991804; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P375, DOI 10.1111/j.1469-1809.1981.tb00351.x; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PONDER BAJ, 1988, LANCET, V1, P397; SCHIMKE RN, 1984, ANNU REV MED, V35, P25, DOI 10.1146/annurev.me.35.020184.000325; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; Telenius-Berg M, 1984, Henry Ford Hosp Med J, V32, P225; TELENIUSBERG M, 1977, EUR J CLIN INVEST, V7, P7, DOI 10.1111/j.1365-2362.1977.tb01563.x; Wahrendorf J, 1986, IARC SCI PUBL, V79; WATERHOUSE S, 1982, IARC SCI PUBL, V42	21	103	105	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					208	215						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2563193				2022-12-18	WOS:A1989R970500005
J	YOUSSOUFIAN, H; ANTONARAKIS, SE; BELL, W; GRIFFIN, AM; KAZAZIAN, HH				YOUSSOUFIAN, H; ANTONARAKIS, SE; BELL, W; GRIFFIN, AM; KAZAZIAN, HH			NONSENSE AND MISSENSE MUTATIONS IN HEMOPHILIA-A - ESTIMATE OF THE RELATIVE MUTATION-RATE AT CG DINUCLEOTIDES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT MED, DIV HEMATOL, BALTIMORE, MD 21205 USA; UNIV N CAROLINA, SCH MED, DEPT MED, DIV HEMATOL, CHAPEL HILL, NC 27514 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, GENET UNIT, BALTIMORE, MD 21205 USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University			Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823				ANTONARAKIS SE, 1987, MOL BIOL MED, V4, P81; ANTONARAKIS SE, 1985, NEW ENGL J MED, V313, P842, DOI 10.1056/NEJM198510033131402; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BENTLEY AK, 1986, CELL, V45, P343, DOI 10.1016/0092-8674(86)90319-3; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; Bunn HF, 1986, HEMOGLOBIN MOL GENET; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DUCHANGE N, 1986, NUCLEIC ACIDS RES, V14, P2408, DOI 10.1093/nar/14.5.2408; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1985, NATURE, V314, P738, DOI 10.1038/314738a0; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GITSCHIER J, 1986, SCIENCE, V232, P1415, DOI 10.1126/science.3012775; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HARPER K, 1984, LANCET, V2, P6; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P869; KAZAZIAN HH, 1987, PROGR MED GENETICS, V7, P43; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; LAZARCHICK J, 1978, J CLIN INVEST, V62, P1048, DOI 10.1172/JCI109209; MANDEL JL, 1979, NUCLEIC ACIDS RES, V7, P2081, DOI 10.1093/nar/7.8.2081; MCKEE PA, 1983, METABOLIC BASIS INHE, P1531; NUSSINOV R, 1981, J MOL BIOL, V149, P125, DOI 10.1016/0022-2836(81)90264-3; OBERLE I, 1985, P NATL ACAD SCI USA, V82, P2824, DOI 10.1073/pnas.82.9.2824; ROMEO G, 1987, P NATL ACAD SCI USA, V84, P2829, DOI 10.1073/pnas.84.9.2829; SALSER W, 1977, COLD SPRING HARB SYM, V42, P985; SHIBASAKI Y, 1985, J CLIN INVEST, V76, P378, DOI 10.1172/JCI111973; TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; WALLACE RB, 1981, NUCLEIC ACIDS RES, V9, P879, DOI 10.1093/nar/9.4.879; WION KL, 1986, NUCLEIC ACIDS RES, V14, P4535, DOI 10.1093/nar/14.11.4535; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; YOUSSOUFIAN H, 1987, P NATL ACAD SCI USA, V84, P3772, DOI 10.1073/pnas.84.11.3772	35	103	105	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					718	725						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	2833855				2022-12-18	WOS:A1988N143800007
J	FRANCKE, U; HARPER, JF; DARRAS, BT; COWAN, JM; MCCABE, ERB; KOHLSCHUTTER, A; SELTZER, WK; SAITO, F; GOTO, J; HARPEY, JP; WISE, JE				FRANCKE, U; HARPER, JF; DARRAS, BT; COWAN, JM; MCCABE, ERB; KOHLSCHUTTER, A; SELTZER, WK; SAITO, F; GOTO, J; HARPEY, JP; WISE, JE			CONGENITAL ADRENAL HYPOPLASIA, MYOPATHY, AND GLYCEROL KINASE-DEFICIENCY - MOLECULAR GENETIC-EVIDENCE FOR DELETIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,SCH MED,DEPT PEDIAT,DENVER,CO 80202; UNIV COLORADO,SCH MED,DEPT BIOCHEM,DENVER,CO 80202; UNIV COLORADO,SCH MED,DEPT BIOPHYS & GENET,DENVER,CO 80202; UNIV HAMBURG,DEPT PEDIAT,D-2000 HAMBURG 13,FED REP GER; TOKYO MED & DENT UNIV,DEPT CYTOGENET,TOKYO 113,JAPAN; UNIV TOKYO,DEPT NEUROL,TOKYO 113,JAPAN; UNIV ILLINOIS,COLL MED,DEPT PEDIAT,PEORIA,IL 61656; GH PITIE SALPETIERE,PEDIAT CLIN,PARIS,FRANCE	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Hamburg; Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Illinois System; University of Illinois Peoria	FRANCKE, U (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510, USA.		Kohlschütter, Alfried/ABH-5710-2020; Kohlschütter, Alfried/ABE-3495-2021	Kohlschütter, Alfried/0000-0002-2700-0401; Darras, Basil/0000-0002-1536-8145	NIADDK NIH HHS [AM26265] Funding Source: Medline; NICHD NIH HHS [HD08315] Funding Source: Medline; NIGMS NIH HHS [GM32156] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM032156] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BARTLEY JA, 1986, J PEDIATR-US, V108, P189, DOI 10.1016/S0022-3476(86)80980-5; BARTLEY JA, 1982, LANCET, V2, P733; BARTLEY JA, 1985, PEDIATR RES, V19, P313, DOI 10.1203/00006450-198503000-00012; BERTELSON CJ, 1986, J MED GENET, V23, P531, DOI 10.1136/jmg.23.6.531; BROWN WRA, 1986, NATURE, V322, P477, DOI 10.1038/322477a0; DEMARTINVILLE B, 1982, AM J HUM GENET, V34, P216; DEMARTINVILLE B, 1985, AM J HUM GENET, V37, P235; DEMARTINVILLE B, 1984, AM J HUM GENET, V36, P1357; DORKINS H, 1985, HUM GENET, V71, P103, DOI 10.1007/BF00283362; DUNGER DB, 1986, LANCET, V1, P585; ERIKSSON A, 1983, CLIN CHEM, V29, P718; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIEK C, 1982, BIOCHIM BIOPHYS ACTA, V688, P429, DOI 10.1016/0005-2736(82)90354-6; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1981, CYTOGENET CELL GENET, V31, P24, DOI 10.1159/000131622; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; FRANCKE U, 1987, IN PRESS HUMAN GENET; GINNS EI, 1984, J PEDIATR-US, V104, P736, DOI 10.1016/S0022-3476(84)80956-7; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; GOUSSAULT Y, 1982, CLIN CHIM ACTA, V123, P269, DOI 10.1016/0009-8981(82)90171-1; GUGGENHEIM MA, 1980, ANN NEUROL, V7, P441, DOI 10.1002/ana.410070509; HAMMOND J, 1985, LANCET, V1, P54; HENSLEIGH PA, 1978, OBSTET GYNECOL, V52, P228; HOFKER MH, 1986, HUM GENET, V74, P275, DOI 10.1007/BF00282548; HOFKER MH, 1985, HUM GENET, V70, P148, DOI 10.1007/BF00273073; KOHLSCHUTTER A, 1987, IN PRESS EUR J PEDIA; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; KUNKEL LM, 1985, GENE, V33, P251, DOI 10.1016/0378-1119(85)90232-X; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001; LINDEN M, 1982, FEBS LETT, V141, P189, DOI 10.1016/0014-5793(82)80044-6; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCABE ERB, 1977, BIOCHEM BIOPH RES CO, V78, P1327, DOI 10.1016/0006-291X(77)91437-1; MCCABE ERB, 1983, BIOCHEM MED METAB B, V30, P215, DOI 10.1016/0006-2944(83)90088-1; MCCABE ERB, 1986, MYOCARDIAL SKELETAL, P481; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; MONACO AP, 1987, IN PRESS HUM GENET; NEWSHOLME EA, 1967, BIOCHIM BIOPHYS ACTA, V132, P338, DOI 10.1016/0005-2744(67)90153-2; OLD JM, 1985, LANCET, V1, P73; OSTLUND AK, 1983, BIOCHEM MED METAB B, V30, P231, DOI 10.1016/0006-2944(83)90089-3; PATIL SR, 1985, CYTOGENET CELL GENET, V40, P720; PETERSEN KE, 1982, ACTA PAEDIATR SCAND, V71, P947, DOI 10.1111/j.1651-2227.1982.tb09554.x; POMETTA D, 1984, EUR J CLIN INVEST, V14, P103, DOI 10.1111/j.1365-2362.1984.tb02096.x; POUSTKA A, 1986, TRENDS GENET, V2, P174, DOI 10.1016/0168-9525(86)90219-2; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; RENIER WO, 1983, CLIN GENET, V24, P243; ROSE CI, 1978, J CLIN INVEST, V61, P163, DOI 10.1172/JCI108914; SAITO F, 1986, CLIN GENET, V29, P92; SELTZER WK, 1984, MOL CELL BIOCHEM, V64, P51, DOI 10.1007/BF00420928; SELTZER WK, 1984, MOL CELL BIOCHEM, V62, P43; SELTZER WK, 1986, LIFE SCI, V39, P1417, DOI 10.1016/0024-3205(86)90545-X; SELTZER WK, 1985, BIOCHEM MED METAB B, V33, P189, DOI 10.1016/0006-2944(85)90027-4; SMITH CL, 1987, IN PRESS METHODS ENZ; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TOYOFUKU T, 1981, BRAIN DEV-JPN, V3, P241; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; VONPETRYKOWSKI W, 1982, HELV PAEDIATR ACTA, V37, P387; WEISS L, 1970, Journal of Medical Genetics, V7, P27, DOI 10.1136/jmg.7.1.27; WIERINGA B, 1985, CLIN GENET, V27, P522; WILLARD HF, 1985, CYTOGENET CELL GENET, V40, P360, DOI 10.1159/000132180; WIRTH A, 1985, DEUT MED WOCHENSCHR, V110, P843, DOI 10.1055/s-2008-1068916; WISE JE, 1987, IN PRESS AM J DIS CH	66	103	104	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1987	40	3					212	227						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H0854	2883886				2022-12-18	WOS:A1987H085400002
J	JACOBS, PA				JACOBS, PA			MUTATION-RATES OF STRUCTURAL CHROMOSOME REARRANGEMENTS IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											JACOBS, PA (corresponding author), UNIV HAWAII,JOHN A BURNS SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822, USA.				NICHD NIH HHS [HD-07879] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BIERMAN JM, 1965, AM J OBSTET GYNECOL, V91, P37, DOI 10.1016/0002-9378(65)90584-3; BOCHKOV NP, 1974, HUMANGENETIK, V22, P139; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; CREASY MR, 1976, HUM GENET, V31, P177, DOI 10.1007/BF00296145; DUTRILLA.B, 1970, ANN GENET-PARIS, V13, P11; Gedeon M., 1977, POPULATION CYTOGENET, P1; HAMERTON JL, 1975, CLIN GENET, V8, P223; HASSOLD TJ, 1978, ANN HUM GENET, V41, P443, DOI 10.1111/j.1469-1809.1978.tb00914.x; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; JACOBS PA, 1972, ANN HUM GENET, V35, P301, DOI 10.1111/j.1469-1809.1957.tb01403.x; KAJII T, 1978, AM J OBSTET GYNECOL, V131, P33, DOI 10.1016/0002-9378(78)90470-2; Lauritsen J G, 1976, Acta Obstet Gynecol Scand Suppl, V52, P1; LUBS HA, 1970, HUMAN POPULATION CYT, P119; NIELSEN J, 1975, HUMANGENETIK, V30, P1, DOI 10.1007/BF00273626; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; TAKAHARA H, 1977, ACTA OBSTET GYNAECOL, V29, P715; Walzer S, 1977, POPULATION CYTOGENET, P45; WARBURTON D, 1964, AM J HUM GENET, V16, P1	18	103	107	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	1					44	54						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA930	7468593				2022-12-18	WOS:A1981LA93000005
J	GO, RCP; ELSTON, RC; KAPLAN, EB				GO, RCP; ELSTON, RC; KAPLAN, EB			EFFICIENCY AND ROBUSTNESS OF PEDIGREE SEGREGATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA, CURRICULUM GENET, CHAPEL HILL, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	GO, RCP (corresponding author), UNIV N CAROLINA, DEPT BIOSTAT, CHAPEL HILL, NC 27514 USA.							BERG K, 1976, CYTOGENET CELL GENET, V16, P266, DOI 10.1159/000130606; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1976, CYTOGENET CELL GENET, V16, P294, DOI 10.1159/000130613; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; ELSTON RC, 1974, AM J HUM GENET, V26, P13; ELSTON RC, 1975, AM J HUM GENET, V27, P31; ELSTON RC, NEUROPSYCHOBIOLOGY; ELSTON RC, IN PRESS; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MORTON NE, 1974, AM J HUM GENET, V26, P489	13	103	103	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1978	30	1					28	37						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL575	623101				2022-12-18	WOS:A1978EL57500004
J	NEEL, JV				NEEL, JV			RARE VARIANTS, PRIVATE POLYMORPHISMS, AND LOCUS HETEROZYGOSITY IN AMERINDIAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											NEEL, JV (corresponding author), UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109, USA.							ARENDS T, 1970, AM J HUM GENET, V22, P526; Arends T, 1971, ONGOING EVOLUTION LA, P509; BERNSTEIN SC, 1973, P NATL ACAD SCI USA, V70, P3928, DOI 10.1073/pnas.70.12.3928; BLAKE NM, 1975, ANN HUM GENET, V38, P251, DOI 10.1111/j.1469-1809.1975.tb00610.x; CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL, pR16; CROW JF, 1972, 6 P BERK S MATH STAT, V5, P1; FERRELL RE, 1977, ANN HUM GENET, V40, P407, DOI 10.1111/j.1469-1809.1977.tb02028.x; Ford E. B., 1940, NEW SYSTEMATICS, P493; FORD EB, 1956, GENETICS MEDICAL STU, P202; FUERST PA, 1977, GENETICS, V86, P455; GAJDUSEK D. C., 1967, J MED GENET, V4, P1, DOI 10.1136/jmg.4.1.1; GEERDINK RA, 1974, AM J HUM GENET, V26, P581; GEERDINK RA, 1974, AM J HUM GENET, V26, P45; GEERDINK RA, 1974, HUM HERED, V24, P40, DOI 10.1159/000152635; GERSHOWITZ H, 1967, AM J HUM GENET, V19, P502; GERSHOWITZ H, 1970, AM J HUM GENET, V22, P515; GERSHOWITZ H, 1972, ANN HUM GENET, V35, P261, DOI 10.1111/j.1469-1809.1957.tb01400.x; GERSHOWITZ H, AM J PHYS ANTHR; GERSHOWITZ H, UNPUBLISHED; HARRIS H, 1974, ANN HUM GENET, V37, P237, DOI 10.1111/j.1469-1809.1974.tb01832.x; HARRIS H, 1975, PRINCIPLES HUMAN BIO, pR14; IUCHI I, 1968, ACTA HAEMATOL JAPON, V31, P218; JENKINS T, 1972, ANN HUM GENET, V35, P379; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KIMURA M, 1975, P NATL ACAD SCI USA, V72, P2761, DOI 10.1073/pnas.72.7.2761; KIRK RL, 1977, AM J PHYS ANTHROPOL, V46, P377, DOI 10.1002/ajpa.1330460302; KIRK RL, 1974, AM J PHYS ANTHROPOL, V41, P301, DOI 10.1002/ajpa.1330410213; KIRK RL, 1975, ISOZYMES, V4, P169; LATTER BDH, 1975, NATURE, V257, P590, DOI 10.1038/257590a0; LAYRISSE M, 1963, HUM BIOL, V35, P140; LEHMANN H, 1975, ABNORMAL HAEMOGLOBIN, P323; LEWIS WHP, 1969, ANN HUM GENET, V33, P93, DOI 10.1111/j.1469-1809.1969.tb01634.x; LI WH, 1977, P NATL ACAD SCI USA, V74, P2509, DOI 10.1073/pnas.74.6.2509; MARKS PA, 1961, NOUV REV FR HEMATOL, V1, P900; MATSON GA, 1968, AM J PHYS ANTHROPOL, V28, P303, DOI 10.1002/ajpa.1330280318; MAURANSENDRAIL A, 1977, J MED GENET, V14, P245, DOI 10.1136/jmg.14.4.245; MOHRENWEISER H, UNPUBLISHED; MOORE MJ, 1971, BIOCHEM GENET, V5, P497, DOI 10.1007/BF00485667; MOURANT AE, 1976, DISTRIBUTION HUMAN B, pR15; NEEL JV, 1976, AM J HUM GENET, V28, P262; NEEL JV, 1978, ANN HUM GENET, V41, P429, DOI 10.1111/j.1469-1809.1978.tb00913.x; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEEL JV, 1977, HUM GENET, V36, P81, DOI 10.1007/BF00390440; NEEL JV, 1973, P NATL ACAD SCI USA, V70, P3311, DOI 10.1073/pnas.70.12.3311; NEEL JV, 1977, HUM GENET, V37, P207, DOI 10.1007/BF00393584; NEEL JV, ANN REV GENET; NEI M, 1976, NATURE, V262, P491, DOI 10.1038/262491a0; NEI M, 1976, P NATL ACAD SCI USA, V73, P4164, DOI 10.1073/pnas.73.11.4164; NURSE GT, 1977, HLTH HUNTER GATHERER, pR9; OHBA Y, 1973, NATURE-NEW BIOL, V243, P205, DOI 10.1038/newbio243205a0; OHBA Y, 1975, ACTA HAEMATOL JAPON, V38, P1; OHBA Y, 1975, ACTA HAEMATOL JAPON, V38, P53; OHTA T, 1975, P NATL ACAD SCI USA, V72, P3194, DOI 10.1073/pnas.72.8.3194; QUILICI JC, 1975, STRUCTURE HEMOTYPOLO, P121; SALZANO FM, 1972, HUM BIOL, V44, P443; SALZANO FM, 1972, AM J PHYS ANTHROPOL, V36, P417, DOI 10.1002/ajpa.1330360313; SALZANO FM, 1977, AM J PHYS ANTHROPOL, V47, P337, DOI 10.1002/ajpa.1330470214; SALZANO FM, 1978, HUM BIOL, V50, P121; SATOH C, ANN HUM GENET; SCHNEIDER RG, 1976, BLOOD, V48, P629; SHREFFLER DC, 1967, AM J HUM GENET, V19, P514; SINGH RS, 1975, GENETICS, V80, P637; SINGH RS, 1976, GENETICS, V84, P609; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x; SPIELMAN RS, 1977, GENETICS, V85, P355; SPIELMAN RS, CURR ANTHR; TANIS R, 1974, ANN HUM GENET, V38, P179, DOI 10.1111/j.1469-1809.1974.tb01949.x; TANIS RJ, 1977, AM J HUM GENET, V29, P419; TANIS RJ, 1973, AM J HUM GENET, V25, P655; TANIS RJ, 1976, HUM GENET, V34, P29; TASHIAN RE, 1967, AM J HUM GENET, V19, P524; THORIG GEW, 1975, BIOCHEM GENET, V13, P721, DOI 10.1007/BF00484929; VERGNES H, 1976, ANN HUM BIOL, V3, P577, DOI 10.1080/03014467600001841; WARD RH, 1975, AM J HUM GENET, V27, P1; WEITKAMP L, 1970, AM J HUM GENET, V22, P533; WEITKAMP LR, 1973, ISRAEL J MED SCI, V9, P1238; WEITKAMP LR, 1973, ANN HUM GENET, V36, P381, DOI 10.1111/j.1469-1809.1973.tb00602.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P433, DOI 10.1111/j.1469-1809.1957.tb01868.x; WEITKAMP LR, 1972, ANN HUM GENET, V35, P271, DOI 10.1111/j.1469-1809.1957.tb01401.x; YAMAZAKI T, 1972, SCIENCE, V178, P56, DOI 10.1126/science.178.4056.56	81	103	103	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	5					465	490						26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GA288	367157				2022-12-18	WOS:A1978GA28800002
J	WILLARD, HF; MELLMAN, IS; ROSENBERG, LE				WILLARD, HF; MELLMAN, IS; ROSENBERG, LE			GENETIC COMPLEMENTATION AMONG INHERITED DEFICIENCIES OF METHYLMALONYL-COA MUTASE ACTIVITY - EVIDENCE FOR A NEW CLASS OF HUMAN COBALAMIN MUTANT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											WILLARD, HF (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510, USA.		Mellman, Ira/ABG-5896-2020					ASTRIN KH, 1976, ARCH BIOCHEM BIOPHYS, V176, P397, DOI 10.1016/0003-9861(76)90182-X; BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2; CHASIN LA, 1976, SOMAT CELL GENET, V2, P453, DOI 10.1007/BF01542725; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P271, DOI 10.1007/BF01538965; DILLON MJ, 1974, CLIN SCI MOL MED, V47, P43, DOI 10.1042/cs0470043; FRANTANTONI JC, 1968, SCIENCE, V162, P570; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; GALJAARD H, 1975, NATURE, V257, P60, DOI 10.1038/257060a0; GALJAARD H, 1974, EXP CELL RES, V87, P444, DOI 10.1016/0014-4827(74)90515-1; GOODMAN SI, 1970, BIOCHEM MED METAB B, V4, P500, DOI 10.1016/0006-2944(70)90080-3; GRAVEL RA, 1977, AM J HUM GENET, V29, P378; GRAVEL RA, 1975, P NATL ACAD SCI USA, V72, P3181, DOI 10.1073/pnas.72.8.3181; HOFFMAN RM, 1976, P NATL ACAD SCI USA, V73, P1523, DOI 10.1073/pnas.73.5.1523; KAO FT, 1969, P NATL ACAD SCI USA, V64, P1284, DOI 10.1073/pnas.64.4.1284; KRAEMER KH, 1975, MUTAT RES, V33, P327, DOI 10.1016/0027-5107(75)90208-0; LINNELL JC, 1976, PEDIATR RES, V10, P179, DOI 10.1203/00006450-197603000-00007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYONS LB, 1973, NATURE, V243, P533, DOI 10.1038/243533a0; MAHONEY MJ, 1975, P NATL ACAD SCI USA, V72, P2799, DOI 10.1073/pnas.72.7.2799; MAHONEY MJ, 1971, J LAB CLIN MED, V78, P302; MAHONEY MJ, 1971, BIOCHEM BIOPH RES CO, V44, P375, DOI 10.1016/0006-291X(71)90610-3; MELLMAN I, 1977, AM J HUM GENET, V29, pA75; MELLMAN IS, 1977, P NATL ACAD SCI USA, V74, P916, DOI 10.1073/pnas.74.3.916; MORROW G, 1969, P NATL ACAD SCI USA, V63, P191, DOI 10.1073/pnas.63.1.191; MUDD SH, 1970, BIOCHEM MED METAB B, V4, P193, DOI 10.1016/0006-2944(70)90049-9; MUDD SH, 1970, BIOCHEM MED METAB B, V4, P215, DOI 10.1016/0006-2944(70)90050-5; NADLER HL, 1970, P NATL ACAD SCI USA, V67, P976, DOI 10.1073/pnas.67.2.976; PATTERSO.D, 1974, P NATL ACAD SCI USA, V71, P2057, DOI 10.1073/pnas.71.5.2057; PONTECORVO G, 1977, NATURE, V265, P257, DOI 10.1038/265257a0; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; ROSENBERG LE, 1975, P NATL ACAD SCI USA, V72, P4617, DOI 10.1073/pnas.72.11.4617; ROSENBERG LE, 1968, SCIENCE, V162, P805, DOI 10.1126/science.162.3855.805; ROSENBERG LE, 1977, METABOLIC BASIS INHE; SIMINOVITCH L, 1976, CELL, V7, P1, DOI 10.1016/0092-8674(76)90249-X; SINGH S, 1977, CLIN GENET, V11, P277; THOMAS GH, 1974, NATURE, V250, P580, DOI 10.1038/250580a0; WILLARD H, 1977, HUM HERED, V27, P221; WILLARD HF, 1976, HUM GENET, V34, P277, DOI 10.1007/BF00295291; WILLARD HF, BIOCHEM BIOPHYS RES	40	103	103	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	1					1	13						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EL575	23678				2022-12-18	WOS:A1978EL57500001
J	FUNDERBURK, SJ; SPENCE, MA; SPARKES, RS				FUNDERBURK, SJ; SPENCE, MA; SPARKES, RS			MENTAL-RETARDATION ASSOCIATED WITH BALANCED CHROMOSOME REARRANGEMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF LOS ANGELES,HLTH SCI CTR,DEPT PSYCHIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,HLTH SCI CTR,DEPT BIOMATH,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,HLTH SCI CTR,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,HLTH SCI CTR,DEPT PEDIAT,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles								ASKROG V, 1970, Nordisk Medicin, V83, P498; BREG WR, 1972, AM J DIS CHILD, V123, P561, DOI 10.1001/archpedi.1972.02110120085007; BROGGER A, 1964, INT COPENHAGEN C SCI, P128; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; CHEN A T L, 1970, Journal of Pediatrics, V76, P393, DOI 10.1016/S0022-3476(70)80478-4; CRANDALL B F, 1970, Journal of Medical Genetics, V7, P413, DOI 10.1136/jmg.7.4.413; CRANDALL BF, 1972, J PEDIATR-US, V80, P62, DOI 10.1016/S0022-3476(72)80454-2; CRANDALL BF, 1970, CYTOGENETICS, V9, P307, DOI 10.1159/000130100; DALY RF, 1970, J PEDIATR-US, V77, P444, DOI 10.1016/S0022-3476(70)80013-0; FRANCKE U, 1972, AM J HUM GENET, V24, P189; FRIEDRICH U, 1973, CLIN GENET, V4, P333; GERALD PS, 1970, HUMAN POPULATION GEN, P144; HAMERTON JL, 1975, CLIN GENET, V8, P223; IIVANAINEN M, 1967, ACTA NEUROL SCAND, VS 43, P53; JACOBS PA, 1974, NATURE, V249, P164, DOI 10.1038/249164a0; JACOBS PA, 1974, J MED GENET, V11, P50, DOI 10.1136/jmg.11.1.50; JACOBS PA, 1974, ANN HUM GENET, V37, P359, DOI 10.1111/j.1469-1809.1974.tb01843.x; Lubs H.A., 1973, NOBEL S, V23, P241; LUBS HA, 1970, HUMAN POPULATION CYT, P120; SEABRIGH.M, 1971, LANCET, V2, P971; SERGOVICH F, 1969, NEW ENGL J MED, V280, P851, DOI 10.1056/NEJM196904172801602; SUMMITT RL, 1969, J PEDIATR-US, V74, P58, DOI 10.1016/S0022-3476(69)80008-9; THORBURN MJ, 1971, J MED GENET, V8, P59, DOI 10.1136/jmg.8.1.59; YANAGISAWA S, 1968, ACTA PAEDIATR JAPON, V10, P30	24	103	103	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	2					136	141						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DB507	848489				2022-12-18	WOS:A1977DB50700002
J	TURNER, BM; TURNER, VS; BERATIS, NG; HIRSCHHORN, K				TURNER, BM; TURNER, VS; BERATIS, NG; HIRSCHHORN, K			POLYMORPHISM OF HUMAN ALPHA-FUCOSIDASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MT SINAI SCH MED,DEPT PEDIAT,DIV MED GENET,5TH AVE & 100TH ST,NEW YORK,NY 10029; CITY UNIV NEW YORK,NEW YORK,NY 10029	Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System								ALHADEFF JA, 1974, CLIN CHIM ACTA, V57, P307, DOI 10.1016/0009-8981(74)90412-4; DURAND P, 1969, J PEDIATR, V75, P665, DOI 10.1016/S0022-3476(69)80464-6; KOUSSEFF BG, IN PRESS; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MERRITT AD, 1973, AM J HUM GENET, V25, P510; NG WG, 1973, PEDIATR RES, V7, P391; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; RUDDLE FH, 1972, ADV HUM GENET, V3, P173; TURNER BM, 1974, CLIN CHIM ACTA, V57, P29, DOI 10.1016/0009-8981(74)90174-0; VANHOOF F, 1968, LANCET, V1, P1198; WOOD S, 1974, AM J HUM GENET, V26, pA94	11	103	103	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					651	661						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AR239	1163537				2022-12-18	WOS:A1975AR23900008
J	WRIGHT, SW; MORTON, NE				WRIGHT, SW; MORTON, NE			GENETIC STUDIES ON CYSTIC FIBROSIS IN HAWAII	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARRAI I, 1965, AM J HUM GENET, V17, P221; BURDETTE WJ, 1962, METHODOLOGY HUMAN ED, P17; CAVALLIS.LL, 1964, COLD SPRING HARB SYM, V29, P9, DOI 10.1101/SQB.1964.029.01.006; DANKS DM, 1965, ANN HUM GENET, V28, P323, DOI 10.1111/j.1469-1809.1965.tb00489.x; DEWEY WJ, 1965, AM J HUM GENET, V17, P237; GOLDSCHMIDT E, 1963, GENETICS MIGRANT  ED, P148; HALLETT WY, 1965, AM REV RESPIR DIS, V92, P714; HAMAMOTO E, 1961, ACTA PAEDIATR JAPON, V65, P502; HARRIS RK, IN PRESS; Ikai K, 1965, Acta Paediatr Jpn, V7, P23; KANDAR HR, 1961, ANTISEPTIC, V58, P863; KNUDSON AG, 1967, AM J HUM GENET, V19, P388; KRAMM ER, 1962, AM J PUBLIC HEALTH N, V52, P2041, DOI 10.2105/AJPH.52.12.2041; KULCZYCKI LL, 1964, CLIN PEDIATR, V3, P692, DOI 10.1177/000992286400301202; LEVIN S, 1963, GENETICS MIGRANT ISO, P148; LOBECK CC, 1966, METABOLIC BASIS INHE, P1301; MERRITT AD, 1962, J LAB CLIN MED, V60, P998; MORTON NE, 1967, GENETICS INTERRACIAL, V3; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; NEEL JV, 1965, GENETICS EPIDEMIO ED, P23; SALEM M, 1962, J MED LIBAN, V15, P61; SCHWACHMAN H, 1965, PEDIATRICS, V36, P689; STANBURY JB, 1966, METABOLIC BASIS I ED, P1301; STEINBERG AG, 1960, AM J HUM GENET, V12, P416; THOMAIDIS TS, 1963, J PEDIATR-US, V63, P444, DOI 10.1016/S0022-3476(63)80434-5; Warwick W J, 1966, JAMA, V198, P177, DOI 10.1001/jama.198.1.177; YAMAMOTO T, 1957, SHONIKA RINSHO, V10, P1003; [No title captured]	28	103	104	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	2					157	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	B2183	5643180				2022-12-18	WOS:A1968B218300008
J	Selzam, S; Ritchie, SJ; Pingault, JB; Reynolds, CA; O'Reilly, PF; Plomin, R				Selzam, Saskia; Ritchie, Stuart J.; Pingault, Jean-Baptiste; Reynolds, Chandra A.; O'Reilly, Paul F.; Plomin, Robert			Comparing Within- and Between-Family Polygenic Score Prediction	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENDELIAN RANDOMIZATION; EDUCATIONAL-ATTAINMENT; ACHIEVEMENT; REGRESSION; TRAITS; PERSONALITY; HERITABILITY; INTELLIGENCE; ARCHITECTURE; ASSOCIATION	Polygenic scores are a popular tool for prediction of complex traits. However, prediction estimates in samples of unrelated participants can include effects of population stratification, assortative mating, and environmentally mediated parental genetic effects, a form of genotype-environment correlation (rGE). Comparing genome-wide polygenic score (GPS) predictions in unrelated individuals with predictions between siblings in a within-family design is a powerful approach to identify these different sources of prediction. Here, we compared within- to between-family GPS predictions of eight outcomes (anthropometric, cognitive, personality, and health) for eight corresponding GPSs. The outcomes were assessed in up to 2,366 dizygotic (DZ) twin pairs from the Twins Early Development Study from age 12 to age 21. To account for family clustering, we used mixed-effects modeling, simultaneously estimating within- and between-family effects for target- and cross-trait GPS prediction of the outcomes. There were three main findings: (1) DZ twin GPS differences predicted DZ differences in height, BMI, intelligence, educational achievement, and ADHD symptoms; (2) target and cross-trait analyses indicated that GPS prediction estimates for cognitive traits (intelligence and educational achievement) were on average 60% greater between families than within families, but this was not the case for non-cognitive traits; and (3) much of this within- and between-family difference for cognitive traits disappeared after controlling for family socio-economic status (SES), suggesting that SES is a major source of between-family prediction through rGE mechanisms. These results provide insights into the patterns by which rGE contributes to GPS prediction, while ruling out confounding due to population stratification and assortative mating.	[Selzam, Saskia; Ritchie, Stuart J.; Pingault, Jean-Baptiste; O'Reilly, Paul F.; Plomin, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Pingault, Jean-Baptiste] UCL, Div Psychol & Language Sci, London WC1H 0AP, England; [Reynolds, Chandra A.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [O'Reilly, Paul F.] Icahn Sch Med, New York, NY 10029 USA	University of London; King's College London; University of London; University College London; University of California System; University of California Riverside; Icahn School of Medicine at Mount Sinai	Selzam, S (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England.	saskia.selzam@kcl.ac.uk	Reynolds, Chandra/AAH-2886-2020	Ritchie, Stuart/0000-0001-8512-7825; Plomin, Robert/0000-0002-0756-3629; Pingault, Jean-Baptiste/0000-0003-2557-4716; O'Reilly, Paul/0000-0001-7515-0845	UK Medical Research Council [MR/N015746/1, MR/M021475/1]; US National Institutes of Health [AG046938]; European Research Council under the European Union [602768, 295366]; Medical Research Council Professorship award [G19/2]; MRC/IoPPN Excellence Award; GSTT Charity [TR130505]; Maudsley Charity [980]; NATIONAL INSTITUTE ON AGING [R01AG046938] Funding Source: NIH RePORTER; MRC [MR/M021475/1, G0901245, MR/N015746/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council under the European Union(European Research Council (ERC)); Medical Research Council Professorship award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/IoPPN Excellence Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GSTT Charity; Maudsley Charity; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge the ongoing contribution of the participants in the Twins Early Development Study (TEDS) and their families. TEDS is supported by a program grant to R.P. from the UK Medical Research Council (MR/M021475/1 and previously G0901245), with additional support from the US National Institutes of Health (AG046938). The research leading to these results has also received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/grant agreement no. 602768 and ERC grant agreement no. 295366. R.P. is supported by a Medical Research Council Professorship award (G19/2). S.S. is supported by the MRC/IoPPN Excellence Award and by the US National Institutes of Health (AG046938). P.F.O. received funding from the UK Medical Research Council (MR/N015746/1). High-performance computing facilities were funded with capital equipment grants from the GSTT Charity (TR130505) and Maudsley Charity (980).	Allegrini AG, 2019, MOL PSYCHIATR, V24, P819, DOI 10.1038/s41380-019-0394-4; ANDREASEN NC, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P49; Bates TC, 2018, TWIN RES HUM GENET, V21, P73, DOI 10.1017/thg.2018.11; Bell V, 2006, SCHIZOPHRENIA BULL, V32, P366, DOI 10.1093/schbul/sbj014; Belsky DW, 2019, CURR DIR PSYCHOL SCI, V28, P82, DOI 10.1177/0963721418807729; Belsky DW, 2018, P NATL ACAD SCI USA, V115, pE7275, DOI 10.1073/pnas.1801238115; Belsky DW, 2016, PSYCHOL SCI, V27, P957, DOI 10.1177/0956797616643070; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benyamin B, 2009, PHARMACOGENOMICS, V10, P181, DOI 10.2217/14622416.10.2.181; Berg JJ, 2019, ELIFE, V8, DOI 10.7554/eLife.39725; Briley DA, 2014, LEARN INDIVID DIFFER, V32, P26, DOI 10.1016/j.lindif.2014.03.010; Brumpton B., 2019, NAT COMMUN, P1; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Choi SW., 2018, BIORXIV, DOI [DOI 10.1257/aer.100.2.234, 10.1101/416545, DOI 10.1101/416545]; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Conners C.K., 2003, CONNERS RATING SCALE; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; De Ridder KAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074954; de Zeeuw EL, 2014, AM J MED GENET B, V165, P510, DOI 10.1002/ajmg.b.32254; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Domingue BW, 2015, AERA OPEN, V1, DOI 10.1177/2332858415599972; Du Rietz E, 2016, J PSYCHIATR RES, V82, P91, DOI 10.1016/j.jpsychires.2016.07.020; FENIGSTEIN A, 1992, J PERS SOC PSYCHOL, V62, P129, DOI 10.1037/0022-3514.62.1.129; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fletcher JM, 2011, HEALTH ECON, V20, P889, DOI 10.1002/hec.1745; Martin AF, 2018, ACTUAL JURID AMBIENT, P6; Genser B, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0047-2; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Hagenaars SP, 2016, MOL PSYCHIATR, V21, P1624, DOI 10.1038/mp.2015.225; Haworth CMA, 2013, TWIN RES HUM GENET, V16, P117, DOI 10.1017/thg.2012.91; Hill WD, 2016, CURR BIOL, V26, P3083, DOI 10.1016/j.cub.2016.09.035; Kaplan E, 1999, WISC III PROCESS INS; Koellinger PD, 2018, SCIENCE, V359, P386, DOI 10.1126/science.aar6429; Kong A, 2018, SCIENCE, V359, P424, DOI 10.1126/science.aan6877; Kovas Y, 2013, PSYCHOL SCI, V24, P2048, DOI 10.1177/0956797613486982; Krapohl E, 2016, MOL PSYCHIATR, V21, P1188, DOI 10.1038/mp.2015.126; Krapohl E, 2016, MOL PSYCHIATR, V21, P437, DOI 10.1038/mp.2015.2; Krapohl E, 2014, P NATL ACAD SCI USA, V111, P15273, DOI 10.1073/pnas.1408777111; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Luciano M, 2018, NAT GENET, V50, P6, DOI 10.1038/s41588-017-0013-8; Marques SC, 2011, J HAPPINESS STUD, V12, P1049, DOI 10.1007/s10902-010-9244-4; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McInnes G, 2018, BIOINFORMATICS, V9, P1612; Mottus R, 2017, PSYCHOL SCI, V28, P1631, DOI 10.1177/0956797617719083; Mullins-Sweatt SN, 2006, ASSESSMENT, V13, P119, DOI 10.1177/1073191106286748; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Pingault JB, 2018, NAT REV GENET, V19, P566, DOI 10.1038/s41576-018-0020-3; Pingault JB, 2011, AM J PSYCHIAT, V168, P1164, DOI 10.1176/appi.ajp.2011.10121732; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Plomin R., 2018, BLUEPRINT; Plomin R., 1994, GENETICS EXPERIENCE; Plomin R, 2018, NAT REV GENET, V19, P148, DOI 10.1038/nrg.2017.104; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Raven JC, 1996, MANUAL RAVENS PROGR; Rietveld CA, 2014, P NATL ACAD SCI USA, V111, P13790, DOI 10.1073/pnas.1404623111; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Selzam S, 2017, MOL PSYCHIATR, V22, P267, DOI 10.1038/mp.2016.107; Selzam S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007757; Shakeshaft NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080341; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Smith GD, 2007, J ROY SOC MED, V100, P432, DOI 10.1258/jrsm.100.9.432; Smith-Woolley E, 2019, J PERS SOC PSYCHOL; Spinath B, 2006, INTELLIGENCE, V34, P363, DOI 10.1016/j.intell.2005.11.004; Trejo S, 2019, BIORXIV, DOI [10.1101/524850, DOI 10.1101/524850]; Trzaskowski M, 2014, INTELLIGENCE, V42, P83, DOI 10.1016/j.intell.2013.11.002; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D., 1992, WECHSLER INTELLIGENC; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2014, J CHILD PSYCHOL PSYC, V55, P1068, DOI 10.1111/jcpp.12295; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Young AI, 2018, NAT GENET, V50, P1304, DOI 10.1038/s41588-018-0178-9; Zuffiano A, 2013, LEARN INDIVID DIFFER, V23, P158, DOI 10.1016/j.lindif.2012.07.010	80	102	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					351	363		10.1016/j.ajhg.2019.06.006	http://dx.doi.org/10.1016/j.ajhg.2019.06.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	IM5GK	31303263	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000478022200009
J	Aschard, H; Vilhjalmsson, BJ; Greliche, N; Morange, PE; Tregouet, DA; Kraft, P				Aschard, Hugues; Vilhjalmsson, Bjarni J.; Greliche, Nicolas; Morange, Pierre-Emmanuel; Tregouet, David-Alexandre; Kraft, Peter			Maximizing the Power of Principal-Component Analysis of Correlated Phenotypes in Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMA-LEVELS; POPULATION; PLEIOTROPY; GENOTYPES; DISEASE; TRAITS; LOCUS	Many human traits are highly correlated. This correlation can be leveraged to improve the power of genetic association tests to identify markers associated with one or more of the traits. Principal component analysis (PCA) is a useful tool that has been widely used for the multivariate analysis of correlated variables. PCA is usually applied as a dimension reduction method: the few top principal components (PCs) explaining most of total trait variance are tested for association with a predictor of interest, and the remaining components are not analyzed. In this study we review the theoretical basis of PCA and describe the behavior of PCA when testing for association between a SNP and correlated traits. We then use simulation to compare the power of various PCA-based strategies when analyzing up to 100 correlated traits. We show that contrary to widespread practice, testing only the top PCs often has low power, whereas combining signal across all PCs can have greater power. This power gain is primarily due to increased power to detect genetic variants with opposite effects on positively correlated traits and variants that are exclusively associated with a single trait. Relative to other methods, the combined-PC approach has close to optimal power in all scenarios considered while offering more flexibility and more robustness to potential confounders. Finally, we apply the proposed PCA strategy to the genome-wide association study of five correlated coagulation traits where we identify two candidate SNPs that were not found by the standard approach.	[Aschard, Hugues; Vilhjalmsson, Bjarni J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Vilhjalmsson, Bjarni J.] Broad Inst, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Greliche, Nicolas; Tregouet, David-Alexandre] UPMC Univ Paris 06, UMR S 1166, Sorbonne Univ, F-75005 Paris, France; [Greliche, Nicolas; Tregouet, David-Alexandre] INSERM, UMR S 1166, Genom & Physiopathol Cardiovasc Dis, F-75013 Paris, France; [Tregouet, David-Alexandre] Inst Cardiometabolism & Nutr ICAN, F-75013 Paris, France; [Morange, Pierre-Emmanuel] Aix Marseille Univ, INSERM, UMR S 1062, F-13385 Marseille, France	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Aschard, H (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, 665 Huntington Ave, Boston, MA 02115 USA.	haschard@hsph.harvard.edu	Greliche, Nicolas/P-4180-2015; Trégouët, David-Alexandre/P-9210-2019; Morange, Pierre/T-9070-2019; Vilhjalmsson, Bjarni/K-3971-2014; Tregouet, David-Alexandre/E-3961-2016; Vilhjálmsson, Bjarni/ABC-1369-2020	Greliche, Nicolas/0000-0003-0683-2257; Trégouët, David-Alexandre/0000-0001-9084-7800; Morange, Pierre/0000-0002-9065-722X; Vilhjalmsson, Bjarni/0000-0003-2277-9249; Vilhjálmsson, Bjarni/0000-0003-2277-9249	Program Hospitalier de la Recherche Clinique; Region Ile de France; Pierre and Marie Curie University; ICAN Institute for Cardiometabolism and Nutrition [ANR-10-IAHU-05];  [R03HG006720];  [R21CA165920]; NATIONAL CANCER INSTITUTE [P01CA134294, R21CA165920] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R03HG006720] Funding Source: NIH RePORTER	Program Hospitalier de la Recherche Clinique; Region Ile de France(Region Ile-de-France); Pierre and Marie Curie University; ICAN Institute for Cardiometabolism and Nutrition; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank Alkes L. Price, Alexander Gusev; Amit Joshi, Po-Ru Loh, Nan Laird, and Matthew Stephens for valuable discussions and helpful comments. H.A. was supported by grant R03HG006720. P.K. and H.A. were supported by grant R21CA165920. The MARTHA project was supported by a grant from the Program Hospitalier de la Recherche Clinique. Statistical analyses of the MARTHA data sets were performed with the C2BIG computing cluster, funded by the Region Ile de France, Pierre and Marie Curie University, and the ICAN Institute for Cardiometabolism and Nutrition (ANR-10-IAHU-05).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antoni G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-102; Aschard H, 2013, GENET EPIDEMIOL, V37, P323, DOI 10.1002/gepi.21716; Avery CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002322; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; GILL JC, 1987, BLOOD, V69, P1691; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; He LN, 2008, ANN HUM GENET, V72, P319, DOI 10.1111/j.1469-1809.2007.00423.x; JOLLIFFE IT, 1982, APPL STAT-J ROY ST C, V31, P300, DOI 10.2307/2348005; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Karasik D, 2004, BONE, V34, P547, DOI 10.1016/j.bone.2003.11.017; Karasik D, 2012, J BONE MINER RES, V27, P319, DOI 10.1002/jbmr.563; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89; Oudot-Mellakh T, 2012, BRIT J HAEMATOL, V157, P230, DOI 10.1111/j.1365-2141.2011.09025.x; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Rainwater DL, 2004, ATHEROSCLEROSIS, V176, P379, DOI 10.1016/j.atherosclerosis.2004.06.004; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Tang WH, 2012, AM J HUM GENET, V91, P152, DOI 10.1016/j.ajhg.2012.05.009; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; Xu S., 2013, PRINCIPLES STAT GENO, P61; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yang Q, 2012, J PROBAB STAT, V2012, P13, DOI DOI 10.1155/2012/652569; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Zhang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053320; Zhou X., 2014, NAT METHODS	35	102	105	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					662	676		10.1016/j.ajhg.2014.03.016	http://dx.doi.org/10.1016/j.ajhg.2014.03.016			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24746957	Bronze, Green Published			2022-12-18	WOS:000335485700002
J	Gupta, VA; Ravenscroft, G; Shaheen, R; Todd, EJ; Swanson, LC; Shiina, M; Ogata, K; Hsu, C; Clarke, NF; Darras, BT; Farrar, MA; Hashem, A; Manton, ND; Muntoni, F; North, KN; Sandaradura, SA; Nishino, I; Hayashi, YK; Sewry, CA; Thompson, EM; Yau, KS; Brownstein, CA; Yu, TW; Allcock, RJN; Davis, MR; Wallgren-Pettersson, C; Matsumoto, N; Alkuraya, FS; Laing, NG; Beggs, AH				Gupta, Vandana A.; Ravenscroft, Gianina; Shaheen, Ranad; Todd, Emily J.; Swanson, Lindsay C.; Shiina, Masaaki; Ogata, Kazuhiro; Hsu, Cynthia; Clarke, Nigel F.; Darras, Basil T.; Farrar, Michelle A.; Hashem, Amal; Manton, Nicholas D.; Muntoni, Francesco; North, Kathryn N.; Sandaradura, Sarah A.; Nishino, Ichizo; Hayashi, Yukiko K.; Sewry, Caroline A.; Thompson, Elizabeth M.; Yau, Kyle S.; Brownstein, Catherine A.; Yu, Timothy W.; Allcock, Richard J. N.; Davis, Mark R.; Wallgren-Pettersson, Carina; Matsumoto, Naomichi; Alkuraya, Fowzan S.; Laing, Nigel G.; Beggs, Alan H.			Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; PROTEIN; KRP1; DIFFERENTIATION; PROLIFERATION; DEFECTS; FAMILY; RODS; CUL3	Nemaline myopathy (NM) is a rare congenital muscle disorder primarily affecting skeletal muscles that results in neonatal death in severe cases as a result of associated respiratory insufficiency. NM is thought to be a disease of sarcomeric thin filaments as six of eight known genes whose mutation can cause NM encode components of that structure, however, recent discoveries of mutations in non-thin filament genes has called this model in question. We performed whole-exome sequencing and have identified recessive small deletions and missense changes in the Kelch-like family member 41 gene (KLHL41) in four individuals from unrelated NM families. Sanger sequencing of 116 unrelated individuals with NM identified compound heterozygous changes in KLHL41 in a fifth family. Mutations in KLHL41 showed a clear phenotype-genotype correlation: Frameshift mutations resulted in severe phenotypes with neonatal death, whereas missense changes resulted in impaired motor function with survival into late childhood and/or early adulthood. Functional studies in zebrafish showed that loss of Klhl41 results in highly diminished motor function and myofibrillar disorganization, with nemaline body formation, the pathological hallmark of NM. These studies expand the genetic heterogeneity of NM and implicate a critical role of BTB-Kelch family members in maintenance of sarcomeric integrity in NM.	[Gupta, Vandana A.; Swanson, Lindsay C.; Hsu, Cynthia; Yu, Timothy W.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Genet & Genom,Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Ravenscroft, Gianina; Todd, Emily J.; Yau, Kyle S.; Laing, Nigel G.] Univ Western Australia, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; [Ravenscroft, Gianina; Todd, Emily J.; Yau, Kyle S.; Laing, Nigel G.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Shaheen, Ranad; Hashem, Amal; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dev Genet Unit, Riyadh 11211, Saudi Arabia; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Clarke, Nigel F.; Sandaradura, Sarah A.] Univ Sydney, Inst Neurosci & Muscle Res, Childrens Hosp Westmead, Sydney, NSW 2145, Australia; [Clarke, Nigel F.; Sandaradura, Sarah A.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2145, Australia; [Darras, Basil T.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Farrar, Michelle A.] Sydney Childrens Hosp, Dept Neurol, Randwick, NSW 2032, Australia; [Manton, Nicholas D.] Womens & Childrens Hosp, SA Pathol, Dept Surg Pathol, Adelaide, SA 5006, Australia; [Muntoni, Francesco; Sewry, Caroline A.] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Muntoni, Francesco; Sewry, Caroline A.] Great Ormond St Hosp Sick Children, London WC1N 1EH, England; [North, Kathryn N.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Nishino, Ichizo; Hayashi, Yukiko K.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan; [Thompson, Elizabeth M.] Univ Adelaide, Dept Paediat, Adelaide, SA 5000, Australia; [Thompson, Elizabeth M.] Womens & Childrens Hosp, SA Pathol, SA Clin Genet Serv, Adelaide, SA 5006, Australia; [Allcock, Richard J. N.] Univ Western Australia, Lotterywest State Biomed Facil Genom, Perth, WA 6000, Australia; [Allcock, Richard J. N.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6000, Australia; [Davis, Mark R.] Royal Perth Hosp, Dept Anat Pathol, Perth, WA 6000, Australia; [Wallgren-Pettersson, Carina] Univ Helsinki, Folkhalsan Inst Genet, Samfundet Folkhalsan, Biomedicum Helsinki, FIN-00014 Helsinki, Finland; [Wallgren-Pettersson, Carina] Univ Helsinki, Dept Med Genet, Haartman Inst, FIN-00014 Helsinki, Finland; [Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Western Australia; University of Western Australia; King Faisal Specialist Hospital & Research Center; Yokohama City University; University of Sydney; University of Sydney; Harvard University; Boston Children's Hospital; Harvard Medical School; SA Pathology; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; National Center for Neurology & Psychiatry - Japan; University of Adelaide; SA Pathology; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Samfundet Folkhalsan; University of Helsinki; University of Helsinki; Yokohama City University	Beggs, AH (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Genet & Genom,Manton Ctr Orphan Dis Res, Boston, MA 02115 USA.	beggs@enders.tch.harvard.edu	Nishino, Ichizo/G-2676-2010; North, Kathryn N/K-6476-2012; Ravenscroft, Gina/H-5695-2014; Yu, Timothy W./AAF-5738-2019	Nishino, Ichizo/0000-0001-9452-112X; North, Kathryn N/0000-0003-0841-8009; Ravenscroft, Gina/0000-0003-3634-211X; Yu, Timothy W./0000-0003-2988-7701; Laing, Nigel/0000-0001-5111-3732; SHAHEEN, RANAD/0000-0002-2590-1759; Gupta, Vandana/0000-0002-4057-8451; Darras, Basil/0000-0002-1536-8145; Brownstein, Catherine/0000-0002-7371-0340; Beggs, Alan/0000-0001-8818-0568; Alhashem, Amal/0000-0002-9668-7809	National Institute of Arthritis and Musculoskeletal and Skin Diseases of National Institute of Health [K01 AR062601]; Muscular Dystrophy Association of USA [MDA201302]; National Institutes of Health grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR044345]; AUism Charitable Foundation; Foundation Building Strength; National Health and Medical Research Council of Australia Early Career Researcher Fellowship [1035955]; Association Francaise contre les Myopathies; Dubai-Harvard Foundation for Medical Research Collaborative Research Grant; UWA Collaborative Research Award; Great Ormond Street Hospital Children's Charity; University of Western Australia Postgraduate Awards; National Institutes of Health [P30 HD18655];  [APP1002147];  [APP1022707]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062601, R01AR044345] Funding Source: NIH RePORTER; Medical Research Council [MR/K000608/1] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	National Institute of Arthritis and Musculoskeletal and Skin Diseases of National Institute of Health; Muscular Dystrophy Association of USA(Muscular Dystrophy Association); National Institutes of Health grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; AUism Charitable Foundation; Foundation Building Strength; National Health and Medical Research Council of Australia Early Career Researcher Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Dubai-Harvard Foundation for Medical Research Collaborative Research Grant; UWA Collaborative Research Award; Great Ormond Street Hospital Children's Charity; University of Western Australia Postgraduate Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the many NM affected individuals and their families, and to their treating physicians, for their participation in this research. Whole-exome sequencing was made possible through the generous support and assistance of David Margulies and the entire staff of The Gene Partnership Project at Boston Children's Hospital. We would like to thank Pankaj Agrawal and Wen-Hann Tan for many helpful discussions during the course of this work. We are thankful to Louise Trakimas of the electron microscope facility at Harvard Medical School for excellent help with zebrafish histology, and the Genotyping and Sequencing Core Facilities at KFSHRC for their technical help. V.A.G. is supported by K01 AR062601 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of National Institute of Health. This work was also supported by the Muscular Dystrophy Association of USA (MDA201302), National Institutes of Health grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 AR044345, the AUism Charitable Foundation, and A Foundation Building Strength (to A.H.B.); National Health and Medical Research Council of Australia Early Career Researcher Fellowship #1035955 (to G.R.); Research Fellowship APP1002147 and Project Grant APP1022707(to N.G.L.); the Association Francaise contre les Myopathies (#15734), Dubai-Harvard Foundation for Medical Research Collaborative Research Grant (to F.S.A.); a UWA Collaborative Research Award (G.R.); and the Great Ormond Street Hospital Children's Charity (to EM.). E.J.T. and K.S.Y. are supported by University of Western Australia Postgraduate Awards. DNA sequencing was performed by the Boston Children's Hospital Genomics Program Molecular Genetics Core, and confocal microscopy was performed at Boston Children's Hospital Intellectual and Developmental Disability Research Center Imaging Core, both supported by National Institutes of Health grant P30 HD18655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Alkuraya FS, 2012, CURR PROTOC HUM GENE, V6, P12, DOI DOI 10.1002/0471142905.HG0612S75; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Du Puy L, 2012, INT J DEV BIOL, V56, P301, DOI 10.1387/ijdb.113327lp; Gray CH, 2009, J BIOL CHEM, V284, P30498, DOI 10.1074/jbc.M109.023259; Greenberg CC, 2008, EXP CELL RES, V314, P1177, DOI 10.1016/j.yexcr.2007.12.009; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gupta V, 2012, FASEB J, V26, P1892, DOI 10.1096/fj.11-194548; Gupta VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043794; Hutchinson DO, 2006, NEUROMUSCULAR DISORD, V16, P113, DOI 10.1016/j.nmd.2005.11.004; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; Kaisto T, 2003, EXP CELL RES, V289, P47, DOI 10.1016/S0014-4827(03)00231-3; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Lawlor MW, 2012, AM J PATHOL, V181, P961, DOI 10.1016/j.ajpath.2012.05.016; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu SJ, 2003, J CELL SCI, V116, P2169, DOI 10.1242/jcs.00425; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Paxton CW, 2011, AM J PHYSIOL-CELL PH, V300, pC1345, DOI 10.1152/ajpcell.00321.2010; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Ryan MM, 2001, ANN NEUROL, V50, P312, DOI 10.1002/ana.1080; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Sewry CA, 2008, J MUSCLE RES CELL M, V29, P231, DOI 10.1007/s10974-008-9155-8; Smith L.S., 2013, JOVE-J VIS EXP, V82; Spence HJ, 2006, MOL CELL BIOL, V26, P1480, DOI 10.1128/MCB.26.4.1480-1495.2006; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Tajsharghi H, 2007, ARCH NEUROL-CHICAGO, V64, P1334, DOI 10.1001/archneur.64.9.1334; Wallgren-Pettersson C, 2011, SEMIN PEDIATR NEUROL, V18, P230, DOI 10.1016/j.spen.2011.10.004; Wallgren-Pettersson Carina, 2002, Semin Pediatr Neurol, V9, P132, DOI 10.1053/spen.2002.33804; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200	34	102	110	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1108	1117		10.1016/j.ajhg.2013.10.020	http://dx.doi.org/10.1016/j.ajhg.2013.10.020			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24268659	Green Published, Bronze			2022-12-18	WOS:000328521300010
J	Rinaldi, C; Grunseich, C; Sevrioukova, IF; Schindler, A; Horkayne-Szakaly, I; Lamperti, C; Landoure, G; Kennerson, ML; Burnett, BG; Bonnemann, C; Biesecker, LG; Ghezzi, D; Zeviani, M; Fischbeck, KH				Rinaldi, Carlo; Grunseich, Christopher; Sevrioukova, Irina F.; Schindler, Alice; Horkayne-Szakaly, Iren; Lamperti, Costanza; Landoure, Guida; Kennerson, Marina L.; Burnett, Barrington G.; Boennemann, Carsten; Biesecker, Leslie G.; Ghezzi, Daniele; Zeviani, Massimo; Fischbeck, Kenneth H.			Cowchock Syndrome Is Associated with a Mutation in Apoptosis-Inducing Factor	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; MOTOR-SENSORY NEUROPATHY; MENTAL-RETARDATION; CELL-DEATH; FACTOR AIF; DEAFNESS	Cowchock syndrome (CMTX4) is a slowly progressive X-linked recessive disorder with axonal neuropathy, deafness, and cognitive impairment. The disease locus was previously mapped to an 11 cM region at chromosome X: q24-q26. Exome sequencing of an affected individual from the originally described family identified a missense change c.1478A>T (p.Glu493Val) in AIFM1, the gene encoding apoptosis-inducing factor (AIF) mitochondrion-associated 1. The change is at a highly conserved residue and cosegregated with the phenotype in the family. AIF is an FAD-dependent NADH oxidase that is imported into mitochondria. With apoptotic insults, a N-terminal transmembrane linker is cleaved off, producing a soluble fragment that is released into the cytosol and then transported into the nucleus, where it triggers caspase-independent apoptosis. Another AIFM1 mutation that predicts p.Arg201del has recently been associated with severe mitochondrial encephalomyopathy in two infants by impairing oxidative phosphorylation. The c.1478A>T (p.Glu493Val) mutation found in the family reported here alters the redox properties of the AIF protein and results in increased cell death via apoptosis, without affecting the activity of the respiratory chain complexes. Our findings expand the spectrum of AIF-related disease and provide insight into the effects of AIFM1 mutations.	[Rinaldi, Carlo; Grunseich, Christopher; Schindler, Alice; Landoure, Guida; Burnett, Barrington G.; Boennemann, Carsten; Fischbeck, Kenneth H.] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Sevrioukova, Irina F.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Horkayne-Szakaly, Iren] Joint Pathol Ctr Neuropathol & Ophthalm Pathol, Silver Spring, MD 20910 USA; [Lamperti, Costanza; Ghezzi, Daniele; Zeviani, Massimo] Ist Ricovero & Cura Carattere Sci, Carlo Resta Neurol Inst Fdn, Div Mol Neurogenet, I-20126 Milan, Italy; [Landoure, Guida] Ctr Hosp Univ Point G, Serv Neurol, Bamako, Mali; [Kennerson, Marina L.] Univ Sydney, ANZAC Res Inst, Northcott Neurosci Lab, Concord, NSW 2139, Australia; [Kennerson, Marina L.] Concord Hosp, Mol Med Lab, Concord, NSW 2139, Australia; [Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Biesecker, Leslie G.] NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of California System; University of California Irvine; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Rinaldi, C (corresponding author), NINDS, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	rinaldic@ninds.nih.gov	Zeviani, Massimo/AAU-2632-2021; lamperti, costanza/J-8801-2016; Research Institute, ANZAC/CAE-9030-2022; Biesecker, Leslie/AAG-2526-2021; Zeviani, Massimo/K-2891-2014; Ghezzi, Daniele/J-7873-2016; Kennerson, Marina L/B-5058-2014	Zeviani, Massimo/0000-0002-9067-5508; lamperti, costanza/0000-0002-2280-2253; Ghezzi, Daniele/0000-0002-6564-3766; Rinaldi, Carlo/0000-0002-8307-6638; Kennerson, Marina/0000-0003-3332-5074	NINDS; NHGRI; National Institutes of Health [GM67637]; Pierfranco and Luisa Mariani Foundation, Italy; Fondazione Telethon [GGP11011, GPP10005]; CARIPLO [2011/0526]; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129, ZIANS002974] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pierfranco and Luisa Mariani Foundation, Italy; Fondazione Telethon(Fondazione TelethonEuropean Commission); CARIPLO(Fondazione Cariplo); Italian Association of Mitochondrial Disease Patients and Families (Mitocon); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the family members for their participation and to Justin Y. Kwan, at NINDS, for performing the muscle biopsy. This work was supported in part by NINDS and NHGRI intramural research funding; National Institutes of Health Grant GM67637; the Pierfranco and Luisa Mariani Foundation, Italy; Fondazione Telethon grants GGP11011 and GPP10005; CARIPLO grant 2011/0526; and the Italian Association of Mitochondrial Disease Patients and Families (Mitocon).	Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Berger I, 2011, MOL GENET METAB, V104, P517, DOI 10.1016/j.ymgme.2011.09.020; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Boerkoel CF, 2002, ANN NEUROL, V51, P190, DOI 10.1002/ana.10089; Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200; COWCHOCK FS, 1985, AM J MED GENET, V20, P307, DOI 10.1002/ajmg.1320200214; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kim HJ, 2007, AM J HUM GENET, V81, P552, DOI 10.1086/519529; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3; PRIEST JM, 1995, GENOMICS, V29, P409, DOI 10.1006/geno.1995.9987; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Sevrioukova IF, 2009, J MOL BIOL, V390, P924, DOI 10.1016/j.jmb.2009.05.013; SKRE H, 1974, CLIN GENET, V6, P98; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461	23	102	109	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1095	1102		10.1016/j.ajhg.2012.10.008	http://dx.doi.org/10.1016/j.ajhg.2012.10.008			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23217327	Bronze, Green Published			2022-12-18	WOS:000312417400013
J	Ostergaard, P; Simpson, MA; Mendola, A; Vasudevan, P; Connell, FC; van Impel, A; Moore, AT; Loeys, BL; Ghalamkarpour, A; Onoufriadis, A; Martinez-Corral, I; Devery, S; Leroy, JG; van Laer, L; Singer, A; Bialer, MG; McEntagart, M; Quarrell, O; Brice, G; Trembath, RC; Schulte-Merker, S; Makinen, T; Vikkula, M; Mortimer, PS; Mansour, S; Jeffery, S				Ostergaard, Pia; Simpson, Michael A.; Mendola, Antonella; Vasudevan, Pradeep; Connell, Fiona C.; van Impel, Andreas; Moore, Anthony T.; Loeys, Bart L.; Ghalamkarpour, Arash; Onoufriadis, Alexandros; Martinez-Corral, Ines; Devery, Sophie; Leroy, Jules G.; van Laer, Lut; Singer, Amihood; Bialer, Martin G.; McEntagart, Meriel; Quarrell, Oliver; Brice, Glen; Trembath, Richard C.; Schulte-Merker, Stefan; Makinen, Taija; Vikkula, Miikka; Mortimer, Peter S.; Mansour, Sahar; Jeffery, Steve			Mutations in KIF11 Cause Autosomal-Dominant Microcephaly Variably Associated with Congenital Lymphedema and Chorioretinopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-THE-LITERATURE; MITOTIC SPINDLE; MOTOR PROTEIN; KINESIN EG5; DYSPLASIA	We have identified KIF11 mutations in individuals with syndromic autosomal-dominant microcephaly associated with lymphedema and/or chorioretinopathy. Initial whole-exome sequencing revealed heterozygous KIF11 mutations in three individuals with a combination of microcephaly and lymphedema from a microcephaly-lymphedema-chorioretinal-dysplasia cohort. Subsequent Sanger sequencing of KIF11 in a further 15 unrelated microcephalic probands with lymphedema and/or chorioretinopathy identified additional heterozygous mutations in 12 of them. KIF11 encodes EGS, a homotetramer kinesin motor. The variety of mutations we have found (two nonsense, two splice site, four missense, and six indels causing frameshifts) are all predicted to have an impact on protein function. EG5 has previously been shown to play a role in spindle assembly and function, and these findings highlight the critical role of proteins necessary for spindle formation in CNS development. Moreover, identification of KIF11 mutations in patients with chorioretinopathy and lymphedema suggests that EGS is involved in the development and maintenance of retinal and lymphatic structures.	[Ostergaard, Pia; Jeffery, Steve] St Georges Univ London, Med Genet Unit, London SW17 0RE, England; [Simpson, Michael A.; Onoufriadis, Alexandros; Trembath, Richard C.] Kings Coll London, Sch Med, Div Genet & Mol Med, Guys Hosp, London SE1 9RT, England; [Mendola, Antonella; Ghalamkarpour, Arash; Vikkula, Miikka] Catholic Univ Louvain, de Duve Inst, Lab Human Mol Genet, B-1200 Brussels, Belgium; [Vasudevan, Pradeep] Univ Hosp Leicester Natl Hlth Serv Trust, Leicester Royal Infirm, Leicester LE1 5WW, Leics, England; [Connell, Fiona C.] Guys & St Thomas Natl Hlth Serv Fdn Trust, Guys Hosp, London SE1 9RT, England; [van Impel, Andreas; Schulte-Merker, Stefan] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Moore, Anthony T.] UCL, Inst Ophthalmol, Moorfields Eye Hosp, London EC1V 2PD, England; [Moore, Anthony T.] Hosp Children, London EC1V 2PD, England; [Loeys, Bart L.; van Laer, Lut] Univ Antwerp Hosp, Ctr Med Genet, B-2650 Antwerp, Belgium; [Loeys, Bart L.; van Laer, Lut] Univ Antwerp, B-2650 Antwerp, Belgium; [Martinez-Corral, Ines] Canc Res UK London Res Inst, Lymphat Dev Lab, London WC2A 3PX, England; [Devery, Sophie] Moorfields Eye Hosp NHS Fdn Trust, London EC1V 2PD, England; [Leroy, Jules G.] Ghent Univ Hosp, C Hooft Childrens Hosp, B-9000 Ghent, Belgium; [Singer, Amihood] Barzilai Govt Hosp, IL-78306 Ashqelon, Israel; [Bialer, Martin G.] N Shore Long Isl Jewish Hlth Syst, Div Med Genet, Manhasset, NY 11030 USA; [McEntagart, Meriel; Brice, Glen; Mansour, Sahar] St Georges Univ London, S W Thames Reg Genet Serv, London SW17 0RE, England; [Quarrell, Oliver] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Vikkula, Miikka] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Mortimer, Peter S.] St Georges Univ London, Dept Cardiac & Vasc Sci, London SW17 0RE, England	St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Universite Catholique Louvain; University Hospitals of Leicester NHS Trust; University of Leicester; Guy's & St Thomas' NHS Foundation Trust; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Antwerp; University of Antwerp; Cancer Research UK; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Ghent University; Ghent University Hospital; Ben Gurion University; Barzilai Medical Center; Northwell Health; St Georges University London; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Universite Catholique Louvain; St Georges University London	Jeffery, S (corresponding author), St Georges Univ London, Med Genet Unit, London SW17 0RE, England.	sggt100@sgul.ac.uk	van Impel, Andreas/G-7284-2014; Martinez-Corral, Ines/F-1799-2016; Loeys, Bart/B-3236-2017; Makinen, Taija/CAI-2233-2022; Vikkula, Miikka/Q-1038-2018; Makinen, Taija/C-5765-2014; Ostergaard, Pia/H-8522-2019; Simpson, Michael/F-4737-2011	Martinez-Corral, Ines/0000-0001-9194-2412; Loeys, Bart/0000-0003-3703-9518; Makinen, Taija/0000-0002-9338-1257; Vikkula, Miikka/0000-0002-6236-338X; Makinen, Taija/0000-0002-9338-1257; Ostergaard, Pia/0000-0002-2190-1356; Simpson, Michael/0000-0002-8539-8753; Trembath, Richard/0000-0003-0550-3400; van Impel, Andreas/0000-0002-4737-3547	British Heart Foundation [RG/08/006/25302, PG/10/58/28477, FS/06/063/21445]; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; Specialist Biomedical Research Centre; University College London Institute of Ophthalmology; Sheffield Childrens' Hospital charity; Cancer Research UK; British Heart Foundation [PG/10/58/28477] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Specialist Biomedical Research Centre; University College London Institute of Ophthalmology; Sheffield Childrens' Hospital charity; Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was possible by the participation of the families concerned, and we are indebted to them. We would like to thank the clinicians involved: Denise Williams (Birmingham Women's National Health Services [NHS] Foundation Trust, Birmingham) and Sixto Garcia Minaur (Hospital Universitario La Paz, Madrid). We thank Carolyn Moores (Crystallography, Birkbeck College, London) for advice on EG5 function and Anukampa Barth (University College, London) for help with documentation and analysis of the in situ hybridizations. This work was supported by British Heart Foundation grants RG/08/006/25302, PG/10/58/28477, and FS/06/063/21445. We also acknowledge support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, the specialist Biomedical Research Centre award for Ophthalmology to Moorfields Eye Hospital and the University College London Institute of Ophthalmology, the Sheffield Childrens' Hospital charity, Marie Curie Fellowship, and Cancer Research UK. These studies were also partially supported by the Interuniversity Attraction Poles initiated by the Belgian Federal Science Policy, network 6/05; Concerted Research Actions Convention No 07/12-005 of the Belgian French Community Ministry; the Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique; and la Communaute Francaise de Wallonie-Bruxelles and la Lotterie Nationale, Belgium. This research utilized the resources of the Biomics Centre, St. George's University of London, and the Advanced Sequencing Facility of the Cancer Research UK London Research Institute. Special thanks go to Nik Matthews.	Castillo A, 2007, BIOCHEM BIOPH RES CO, V357, P694, DOI 10.1016/j.bbrc.2007.04.021; Chauviere M, 2008, BIOCHEM BIOPH RES CO, V372, P513, DOI 10.1016/j.bbrc.2008.04.177; Coffey AJ, 2011, EUR J HUM GENET, V19, P827, DOI 10.1038/ejhg.2011.28; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Eventov-Friedman S, 2009, ACTA PAEDIATR, V98, P758, DOI 10.1111/j.1651-2227.2008.01161.x; Ferhat L, 1998, J NEUROSCI, V18, P7822; FRYNS JP, 1995, CLIN GENET, V48, P131; JARMAS AL, 1981, AM J DIS CHILD, V135, P930, DOI 10.1001/archpedi.1981.02130340036013; LEUNG AKC, 1985, CLIN GENET, V27, P611; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Kelvin, 2010, BMC Res Notes, V3, P191, DOI 10.1186/1756-0500-3-191; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Ostergaard P, 2011, CLIN GENET, V80, P110, DOI 10.1111/j.1399-0004.2011.01706.x; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Ostergaard P, 2011, J MED GENET, V48, P251, DOI 10.1136/jmg.2010.085563; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Vasudevan PC, 2005, CLIN DYSMORPHOL, V14, P109, DOI 10.1097/00019605-200507000-00001; WARBURG M, 1994, AM J MED GENET, V52, P117, DOI 10.1002/ajmg.1320520124; Weinger JS, 2011, CURR BIOL, V21, P154, DOI 10.1016/j.cub.2010.12.038	24	102	103	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					356	362		10.1016/j.ajhg.2011.12.018	http://dx.doi.org/10.1016/j.ajhg.2011.12.018			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22284827	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000300742200018
J	Peachey, NS; Ray, TA; Florijn, R; Rowe, LB; Sjoerdsma, T; Contreras-Alcantara, S; Baba, K; Tosini, G; Pozdeyev, N; Iuvone, PM; Bojang, P; Pearring, JN; Simonsz, HJ; van Genderen, M; Birch, DG; Traboulsi, EI; Dorfman, A; Lopez, I; Ren, HN; Goldberg, AFX; Nishina, PM; Lachapelle, P; McCall, MA; Koenekoop, RK; Bergen, AAB; Kamermans, M; Gregg, RG				Peachey, Neal S.; Ray, Thomas A.; Florijn, Ralph; Rowe, Lucy B.; Sjoerdsma, Trijntje; Contreras-Alcantara, Susana; Baba, Kenkichi; Tosini, Gianluca; Pozdeyev, Nikita; Iuvone, P. Michael; Bojang, Pasano, Jr.; Pearring, Jillian N.; Simonsz, Huibert Jan; van Genderen, Maria; Birch, David G.; Traboulsi, Elias I.; Dorfman, Allison; Lopez, Irma; Ren, Huanan; Goldberg, Andrew F. X.; Nishina, Patsy M.; Lachapelle, Pierre; McCall, Maureen A.; Koenekoop, Robert K.; Bergen, Arthur A. B.; Kamermans, Maarten; Gregg, Ronald G.			GPR179 Is Required for Depolarizing Bipolar Cell Function and Is Mutated in Autosomal-Recessive Complete Congenital Stationary Night Blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RICH REPEAT PROTEIN; CONE ELECTRORETINOGRAM; SYNAPTIC-TRANSMISSION; LIGHT RESPONSE; COMPLETE FORM; MOUSE MODEL; MUTATIONS; NYCTALOPIN; CHANNEL; MGLUR6	Complete congenital stationary night blindness (cCSNB) is a clinically and genetically heterogeneous group of retinal disorders characterized by nonprogressive impairment of night vision, absence of the electroretinogram (ERG) b-wave, and variable degrees of involvement of other visual functions. We report here that mutations in GPR179, encoding an orphan G protein receptor, underlie a form of autosomal-recessive cCSNB. The Gpr179(nob5/nob5) mouse model was initially discovered by the absence of the ERG b-wave, a component that reflects depolarizing bipolar cell (DBC) function. We performed genetic mapping, followed by next-generation sequencing of the critical region and detected a large transposon-like DNA insertion in Gpr179. The involvement of GPR179 in DBC function was confirmed in zebrafish and humans. Functional knockdown of gpr179 in zebrafish led to a marked reduction in the amplitude of the ERG h-wave. Candidate gene analysis of GPR179 in DNA extracted from patients with cCSNB identified GPR179-inactivating mutations in two patients. We developed an antibody against mouse GPR179, which robustly labeled DBC dendritic terminals in wild-type mice. This labeling colocalized with the expression of GRM6 and was absent in Gpr179(nob5/nob5) mutant mice. Our results demonstrate that GPR179 plays a critical role in DBC signal transduction and expands our understanding of the mechanisms that mediate normal rod vision.	[Sjoerdsma, Trijntje; Kamermans, Maarten] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Retinal Signal Proc, NL-1105 BA Amsterdam, Netherlands; [Peachey, Neal S.; Traboulsi, Elias I.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44195 USA; [Peachey, Neal S.] Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Peachey, Neal S.; Traboulsi, Elias I.] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44195 USA; [Ray, Thomas A.; Bojang, Pasano, Jr.; Pearring, Jillian N.; Gregg, Ronald G.] Univ Louisville, Dept Biochem, Louisville, KY 40202 USA; [Florijn, Ralph; Bergen, Arthur A. B.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Clin & Mol Ophthalmogenet, Amsterdam, Netherlands; [Rowe, Lucy B.; Nishina, Patsy M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Contreras-Alcantara, Susana; Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Dept Pharmacol & Toxicol, Inst Neurosci, Atlanta, GA 30310 USA; [Pozdeyev, Nikita; Iuvone, P. Michael] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Simonsz, Huibert Jan] Erasmus Univ, Med Ctr, Dept Ophthalmol, NL-3015 CE Rotterdam, Netherlands; [van Genderen, Maria] Bartimeus Inst Visually Impaired, NL-3702 AD Zeist, Netherlands; [Birch, David G.] Retina Fdn SW, Dallas, TX 75231 USA; [Dorfman, Allison; Lopez, Irma; Ren, Huanan; Lachapelle, Pierre; Koenekoop, Robert K.] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Paediat Ophthalmol Div, Montreal, PQ H3H 1P3, Canada; [Goldberg, Andrew F. X.] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA; [McCall, Maureen A.; Gregg, Ronald G.] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University of Louisville; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Jackson Laboratory; Morehouse School of Medicine; Emory University; Erasmus University Rotterdam; Erasmus MC; Retina Foundation of the Southwest; McGill University; Oakland University; University of Louisville; University of Amsterdam; Academic Medical Center Amsterdam	Kamermans, M (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Retinal Signal Proc, NL-1105 BA Amsterdam, Netherlands.	m.kamermans@nin.knaw.nl; ron.gregg@louisville.edu	Koenekoop, Robert/AAT-6676-2021; Bergen, Arthur/J-3637-2013; Farrington, Ken/V-1531-2019; Grodzicki, Tomasz/K-4451-2012; Traboulsi, Elias/AAY-7443-2020; Covic, Adrian/G-5017-2016; Peachey, Neal/G-5533-2010	Grodzicki, Tomasz/0000-0003-0159-4915; Covic, Adrian/0000-0002-9985-2486; Peachey, Neal/0000-0002-4419-7226; Bergen, Arthur/0000-0002-6333-9576; tosini, gianluca/0000-0003-3645-4533; Birch, David/0000-0002-6594-2897; Gregg, Ronald/0000-0001-5805-224X; Pearring, Jillian/0000-0002-5352-2852; McCall, Maureen/0000-0002-9781-315X; Lachapelle, Pierre/0000-0002-7792-1102	National Institutes of Health [R21EY021852, R01EY12354, R01EY014701, RR017890, R01EY016501, P30CA34196, R01EY004864, P30EY006360, R01NS43459, R01EY020821]; Veterans Administration Medical Research Service; Netherlands Organization for Scientific Research (Zon-MW NWO); ODAS; European Commission [RETICIRC HEALTH-F2-2009-223156]; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Foundation Fighting Blindness Canada; Canadian Institutes for Health Research; Reseau Vision; Fonds de recherche du Quebec-Sante; Foundation Fighting Blindness Center; Research to Prevent Blindness; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017890] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY020821, R21EY021852, R01EY004864, P30EY006360, R01EY016501, R01EY012354, R01EY014701, R01EY009076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Medical Research Service; Netherlands Organization for Scientific Research (Zon-MW NWO); ODAS; European Commission(European CommissionEuropean Commission Joint Research Centre); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Foundation Fighting Blindness Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Reseau Vision; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Foundation Fighting Blindness Center; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Mathieu Gauvin for assistance with data analyses, Wim de Graaff for the morphohno injections in zebrafish larvae, and Takahisa Furakawa for the gift of the GRM6 antibody. We also thank the patients for their participation. This research was supported by grants from the National Institutes of Health (R21EY021852 to N.S.P. and R.G.G.; R01EY12354 to R.G.G.; R01EY014701 to M.A.M.; RR017890 to A.F.X.G.; R01EY016501 and P30CA34196 to P.M.N.; R01EY004864 and P30EY006360 to P.M.I.; and R01NS43459 and R01EY020821 to G.T.); the Veterans Administration Medical Research Service; the Netherlands Organization for Scientific Research (Zon-MW NWO to M.K.); ODAS and European Commission FP7 Grant RETICIRC HEALTH-F2-2009-223156 (to M.K.); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (to A.A.B.B.); the Foundation Fighting Blindness Canada (to R.K.K.); the Canadian Institutes for Health Research (to R.K.K.); Reseau Vision (to R.K.K.); Fonds de recherche du Quebec-Sante (to R.K.K.), a Foundation Fighting Blindness Center Grant to the Cole Eye Institute, Cleveland Clinic; and unrestricted awards from Research to Prevent Blindness to the Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine; to the Department of Ophthalmology, Emory University; and to the Department of Ophthalmology and Visual Sciences, University of Louisville. P.M.I. is a recipient of an RPB Senior Scientific Investigator Award.	ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bahadori R, 2006, EUR J NEUROSCI, V24, P1664, DOI 10.1111/j.1460-9568.2006.05053.x; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Dhingra A, 2008, J COMP NEUROL, V510, P484, DOI 10.1002/cne.21807; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Frishman L., 2011, ADLERS PHYSL EYE, P480; Goldberg AFX, 2007, INVEST OPHTH VIS SCI, V48, P2975, DOI 10.1167/iovs.07-0049; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; LACHAPELLE P, 1983, INVEST OPHTH VIS SCI, V24, P442; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Maddox DM, 2008, J PHYSIOL-LONDON, V586, P4409, DOI 10.1113/jphysiol.2008.157289; Makhankov YV, 2004, J NEUROSCI METH, V135, P205, DOI 10.1016/j.jneumeth.2003.12.015; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; McCall MA, 2008, J PHYSIOL-LONDON, V586, P4385, DOI 10.1113/jphysiol.2008.159327; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nakajima Y, 2009, J BIOCHEM, V145, P811, DOI 10.1093/jb/mvp038; Nakamura M, 2010, MOL VIS, V16, P425; Pardue M. T., 2001, NEW INSIGHTS RETINAL, P319; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Pinto LH, 2007, VISUAL NEUROSCI, V24, P111, DOI 10.1017/S0952523807070149; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Samuels IS, 2010, J NEUROPHYSIOL, V104, P391, DOI 10.1152/jn.00088.2010; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; TAYLOR BA, 1994, GENOMICS, V21, P626, DOI 10.1006/geno.1994.1323; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526	36	102	105	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					331	339		10.1016/j.ajhg.2011.12.006	http://dx.doi.org/10.1016/j.ajhg.2011.12.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22325362	Green Published, Bronze			2022-12-18	WOS:000300742200015
J	Enattah, NS; Trudeau, A; Pimenoff, V; Maiuri, L; Auricchio, S; Greco, L; Rossi, M; Lentze, M; Seo, JK; Rahgozar, S; Khalil, I; Alifrangis, M; Natah, S; Groop, L; Shaat, N; Kozlov, A; Verschubskaya, G; Comas, D; Bulayeva, K; Mehdi, SQ; Terwilliger, JD; Sahi, T; Savilahti, E; Perola, M; Sajantila, A; Jarvela, I; Peltonen, L				Enattah, Nabil Sabri; Trudeau, Aimee; Pimenoff, Ville; Maiuri, Luigi; Auricchio, Salvatore; Greco, Luigi; Rossi, Mauro; Lentze, Michael; Seo, J. K.; Rahgozar, Soheila; Khalil, Insaf; Alifrangis, Michael; Natah, Sirajedin; Groop, Leif; Shaat, Nael; Kozlov, Andrew; Verschubskaya, Galina; Comas, David; Bulayeva, Kazima; Mehdi, S. Qasim; Terwilliger, Joseph D.; Sahi, Timo; Savilahti, Erkki; Perola, Markus; Sajantila, Antti; Jaervelae, Irma; Peltonen, Leena			Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADULT-TYPE HYPOLACTASIA; ACTIVITY IN-VITRO; LINKAGE DISEQUILIBRIUM; LACTOSE-MALABSORPTION; POLYMORPHISM; GENE; POPULATIONS; UPSTREAM; ELEMENT; AFRICA	A single-nucleotide variant, C/T-13910, located 14 kb upstream of the lactase gene (LCT), has been shown to be completely correlated with lactase persistence (LP) in northern Europeans. Here, we analyzed the background of the alleles carrying the critical variant in 1,611 DNA samples from 37 populations. Our data show that the T-13910 variant is found on two different, highly divergent haplotype backgrounds in the global populations. The first is the most common LP haplotype (LP H98) present in all populations analyzed, whereas the others (LP H8-H12), which originate from the same ancestral allelic haplotype, are found in geographically restricted populations living west of the Urals and north of the Caucasus. The global distribution pattern of LP T-13910 H98 supports the Caucasian origin of this allele. Age estimates based on different mathematical models show that the common LP T-13910 H98 allele (similar to 5,000-12,000 years old) is relatively older than the other geographically restricted LP alleles (similar to 1,400-3,000 years old). Our data about global allelic haplotypes of the lactose-tolerance variant imply that the T-13910 allele has been independently introduced more than once and that there is a still-ongoing process of convergent evolution of the LP alleles in humans.	Univ Helsinki, Dept Med Genet & Mol Med, Natl Publ Hlth Inst, FIN-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; Univ Helsinki, Dept Forens Med, SF-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, SF-00300 Helsinki, Finland; Univ Helsinki Hosp, Hosp Children & Adolescents, Finland Dept Pediat, Helsinki, Finland; HUSLAB, Genet Mol Lab, Helsinki, Finland; Univ Naples Federico II, Europen Lab Food Induced Dis, Dept Pediat, Naples, Italy; CNR, Ist Sci Alimentaz, Avellino, Italy; Univ Bonn, Med Ctr, Childrens Hosp, Dept Pediat, D-5300 Bonn, Germany; Seoul Natl Univ, Clin Res Inst, Coll Med, Dept Pediat, Seoul, South Korea; Blood Transfus Ctr, Esfahan, Iran; Panum Inst, Ctr Med Parasitol, Inst Med Microbiol & Immunol, Copenhagen, Denmark; Univ Calgary, Hlth Sci Ctr, Gastrointestinal Res Grp, Dept Physiol Biophys & Med Gastrointestinal Div, Calgary, AB T2N 1N4, Canada; Malmo Univ Hosp, Dept Endocrinol, Malmo, Sweden; Russian Acad Sci, ArcAn C Innovat Lab, Moscow, Russia; Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Moscow, Russia; Univ Pompeu Fabra, Fac Ciencies Salut, Unitat Biol Evoult, Barcelona, Spain; Univ Karachi, Inst Biotechnol & Genet Engn, Karachi, Pakistan; Columbia Univ, Coll Genome Ctr, Dept Psychiat, New York, NY 10027 USA; New York State Psychiat Inst & Hosp, Div Med Genet, New York, NY 10032 USA	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Bonn; Seoul National University (SNU); University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; Lund University; Skane University Hospital; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Pompeu Fabra University; University of Karachi; Columbia University; New York State Psychiatry Institute	Peltonen, L (corresponding author), Univ Helsinki, Dept Med Genet & Mol Med, Natl Publ Hlth Inst, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	leena.peltonen@ktl.fi	Rossi, Mauro/AAC-2968-2021; Mehdi, Syed Qasim/L-2385-2015; Jarvela, Irma E/L-5836-2013; Kozlov, Andrew/Z-2925-2019; Rossi, Mauro/B-5930-2012; Comas, David/D-5382-2014; Rahgozar, Soheila/T-7240-2017; Sajantila, Antti/AAY-9084-2021; Pimenoff, Ville/H-9865-2019; Rossi, Mauro/R-1715-2019; Bulayeva, Kazima/E-7610-2016	Jarvela, Irma E/0000-0002-1770-6187; Rossi, Mauro/0000-0001-8631-1683; Comas, David/0000-0002-5075-0956; Pimenoff, Ville/0000-0002-0813-7031; Rossi, Mauro/0000-0002-0252-4321; Sajantila, Antti/0000-0003-4117-5248; Bulayeva, Kazima/0000-0003-4830-5383; Vershubsky, Galina/0000-0002-9836-1765; Alifrangis, Michael/0000-0002-3835-3333				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Flatz G, 1977, Prog Med Genet, V2, P205; Hartl DL, 1997, PRINCIPLES POPULATIO; Harvey CB, 1998, ANN HUM GENET, V62, P215, DOI 10.1046/j.1469-1809.1998.6230215.x; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; Holden C, 1997, HUM BIOL, V69, P605; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; Labuda M, 1996, AM J HUM GENET, V59, P633; Lewinsky RH, 2005, HUM MOL GENET, V14, P3945, DOI 10.1093/hmg/ddi418; Modiano D, 2001, TISSUE ANTIGENS, V57, P128, DOI 10.1034/j.1399-0039.2001.057002128.x; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; Myles S, 2005, HUM GENET, V117, P34, DOI 10.1007/s00439-005-1266-3; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; Rasinpera H, 2004, GUT, V53, P1571, DOI 10.1136/gut.2004.040048; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Roessli D, 2000, ARLEQUIN VERSION 2 0; SAHI T, 1994, SCAND J GASTROENTERO, V29, P7, DOI 10.3109/00365529409091740; SAHI T, 1973, LANCET, V2, P823; SIMOONS FJ, 1978, AM J DIG DIS, V23, P963, DOI 10.1007/BF01263095; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031	32	102	107	2	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					615	625		10.1086/520705	http://dx.doi.org/10.1086/520705			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701907	Bronze, Green Published			2022-12-18	WOS:000249128200018
J	Stendel, C; Roos, A; Deconinck, T; Pereira, J; Castagner, F; Niemann, A; Kirschner, J; Korinthenberg, R; Ketelsen, UP; Battaloglu, E; Parman, Y; Nicholson, G; Ouvrier, R; Seeger, J; De Jonghe, P; Weis, J; Kruttgen, A; Rudnik-Schoneborn, S; Bergmann, C; Suter, U; Zerres, K; Timmerman, V; Relvas, JB; Senderek, J				Stendel, Claudia; Roos, Andreas; Deconinck, Tine; Pereira, Jorge; Castagner, Francois; Niemann, Axel; Kirschner, Janbernd; Korinthenberg, Rudolf; Ketelsen, Uwe-Peter; Battaloglu, Esra; Parman, Yesim; Nicholson, Garth; Ouvrier, Robert; Seeger, Juergen; De Jonghe, Peter; Weis, Joachim; Kruettgen, Alexander; Rudnik-Schoeneborn, Sabine; Bergmann, Carsten; Suter, Ueli; Zerres, Klaus; Timmerman, Vincent; Relvas, Joao B.; Senderek, Jan			Peripheral nerve demyelination caused by a mutant Rho GTPase guanine nucleotide exchange factor, frabin/FGD4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; MYOTUBULARIN-RELATED PROTEIN-2; PHOSPHATASE-ACTIVITY; MICROSPIKE FORMATION; CELLS; CDC42; ASSOCIATION; ACTIVATION; ACTIN; NEUROPATHIES	GTPases of the Rho subfamily are widely involved in the myelination of the vertebrate nervous system. Rho GTPase activity is temporally and spatially regulated by a set of specific guanine nucleotide exchange factors (GEFs). Here, we report that disruption of frabin/ FGD4, a GEF for the Rho GTPase cell- division cycle 42 (Cdc42), causes peripheral nerve demyelination in patients with autosomal recessive Charcot-Marie-Tooth ( CMT) neuropathy. These data, together with the ability of frabin to induce Cdc42- mediated cell-shape changes in transfected Schwann cells, suggest that Rho GTPase signaling is essential for proper myelination of the peripheral nervous system.	ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; Rhein Westfal TH Aachen, Dept Neuropathol, Aachen, Germany; Univ Antwerp VIB, Neurogenet Grp, B-2610 Antwerp, Belgium; Univ Antwerp VIB, Peripheral Neuropathy Grp, B-2610 Antwerp, Belgium; Univ Antwerp VIB, Mol Genet Dept, Lab Neurogenet, Inst Born Bunge, B-2610 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Div Neuropediat & Muscular Disorders, Freiburg, Germany; Univ Istanbul, Istanbul Fac Med, Dept Neurol, TR-34452 Istanbul, Turkey; Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; Univ Sydney, Australia & New Zealand Army Corps Res Inst, Northcott Neurosci Lab, Sydney, NSW 2006, Australia; Childrens Hosp, Inst Neuromuscular Res, Sydney, NSW, Australia; German Clin Diagnost, Dept Pediat, Wiesbaden, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; RWTH Aachen University; RWTH Aachen University; Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Freiburg; Istanbul University; Bogazici University; University of Sydney; University of Sydney	Stendel, C (corresponding author), ETH, Inst Cell Biol, Schafmatt Str 18, CH-8093 Zurich, Switzerland.	claudia.stendel@cell.biol.ethz.ch	Korinthenberg, Rudolf/A-9796-2009; Timmerman, Vincent/O-7283-2019; Kirschner, Janbernd/H-7418-2016; Senderek, Jan/F-8405-2015; Battaloğlu, Esra/AAF-1559-2020; Relvas, Joao B/A-1142-2008; Niemann, Axel/J-5245-2013; Suter, Ueli/A-1624-2010; Rudnik-Schöneborn, Sabine/F-8473-2015; Niemann, Axel/A-6245-2012; Weis, Joachim/G-1984-2014; Kirschner, Janbernd/Q-1493-2019; Kruttgen, Alexander P/E-9232-2010	Timmerman, Vincent/0000-0002-2162-0933; Kirschner, Janbernd/0000-0003-1618-7386; Senderek, Jan/0000-0002-8263-1783; Relvas, Joao B/0000-0001-7636-0924; Niemann, Axel/0000-0002-2930-0950; Weis, Joachim/0000-0003-3280-6773; Kirschner, Janbernd/0000-0003-1618-7386; Korinthenberg, Rudolf/0000-0002-4638-3460; Nicholson, Garth/0000-0001-9694-066X; Castagner, Francois/0000-0002-9830-0057				Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Berger P, 2002, HUM MOL GENET, V11, P1569, DOI 10.1093/hmg/11.13.1569; Berger P, 2006, GLIA, V54, P243, DOI 10.1002/glia.20386; De Sandre-Giovannoli A, 2005, J MED GENET, V42, P260, DOI 10.1136/jmg.2004.024364; Dubourg O, 2006, NEUROMOL MED, V8, P75, DOI 10.1385/NMM:8:1:75; Dyck P.J, 1993, PNP, P1094; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kim Y, 2002, GENES CELLS, V7, P413, DOI 10.1046/j.1365-2443.2002.00524.x; Lobsiger CS, 2002, BIOL CHEM, V383, P245, DOI 10.1515/BC.2002.026; Nakahara H, 2003, GENES CELLS, V8, P1019, DOI 10.1111/j.1365-2443.2003.00695.x; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Obaishi H, 1998, J BIOL CHEM, V273, P18697, DOI 10.1074/jbc.273.30.18697; PASTERIS NG, 1994, CELL, V79, P669; Pendaries C, 2003, FEBS LETT, V546, P25, DOI 10.1016/S0014-5793(03)00437-X; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; SKRE H, 1974, CLIN GENET, V6, P98; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Umikawa M, 1999, J BIOL CHEM, V274, P25197, DOI 10.1074/jbc.274.36.25197; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Yasuda T, 2000, GENES CELLS, V5, P583, DOI 10.1046/j.1365-2443.2000.00349.x; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	26	102	107	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					158	164		10.1086/518770	http://dx.doi.org/10.1086/518770			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564972	Bronze, Green Published			2022-12-18	WOS:000247039700014
J	Hustad, S; Midttun, O; Schneede, J; Vollset, SE; Grotmol, T; Ueland, PM				Hustad, Steinar; Midttun, Oivind; Schneede, Jorn; Vollset, Stein Emil; Grotmol, Tom; Ueland, Per Magne			The methylenetetrahydrofolate reductase 677C -> T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMA TOTAL HOMOCYSTEINE; CORONARY-HEART-DISEASE; GENETIC RISK-FACTOR; COMMON MUTATION; COLORECTAL-CANCER; CARDIOVASCULAR-DISEASE; C677T POLYMORPHISM; FOLATE STATUS; MICROBIOLOGICAL ASSAY; THERMOLABILE VARIANT	Folates are carriers of one-carbon units and are metabolized by 5,10-methylenetetrahydrofolate reductase ( MTHFR) and other enzymes that use riboflavin, cobalamin, or vitamin B6 as cofactors. These B vitamins are essential for the remethylation and transsulfuration of homocysteine, which is an important intermediate in one-carbon metabolism. We studied the MTHFR 677C -> T polymorphism and B vitamins as modulators of one-carbon metabolism in 10,601 adults from the Norwegian Colorectal Cancer Prevention (NORCCAP) cohort, using plasma total homocysteine (tHcy) as the main outcome measure. Mean concentrations of plasma tHcy were 10.4 mu mol/liter, 10.9 mu mol/liter, and 13.3 mu mol/liter in subjects with the CC ( 51%), CT (41%), and TT (8%) genotypes, respectively. The MTHFR 677C -> T polymorphism, folate, riboflavin, cobalamin, and vitamin B6 were independent predictors of tHcy in multivariate models (P <.001), and genotype effects were strongest when B vitamins were low (P <=.006). Conversely, the MTHFR polymorphism influenced B vitamin effects, which were strongest in the TT group, in which the estimated tHcy difference between subjects with vitamin concentrations in the lowest compared with the highest quartile was 5.4 mu mol/ liter for folate, 4.1 mu mol/ liter for riboflavin, 3.2 mu mol/ liter for cobalamin, and 2.1 mu mol/ liter for vitamin B6. Furthermore, interactions between B vitamins were observed, and B vitamins were more strongly related to plasma tHcy when concentrations of other B vitamins were low. The study provides comprehensive data on the MTHFR - B vitamin network, which has major effects on the transfer of one-carbon units. Individuals with the TT genotype were particularly sensitive to the status of several B vitamins and might be candidates for personalized nutritional recommendations.	Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; Univ Bergen, LOCUS Homocysteine & Related Vitamins, N-5020 Bergen, Norway; Univ Bergen, Inst Med, Pharmacol Sect, N-5020 Bergen, Norway; Bevital AS, Bergen, Norway; Canc Registry Norway, Oslo, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Oslo	Hustad, S (corresponding author), Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway.	steinar.hustad@farm.uib.no	Ueland, Per M/C-7340-2013	Ueland, Per Magne/0000-0002-1903-0571				Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616; Backstrand JR, 2002, NUTR REV, V60, P15, DOI 10.1301/002966402760240390; Bagley PJ, 1998, P NATL ACAD SCI USA, V95, P13217, DOI 10.1073/pnas.95.22.13217; BATHUM L, IN PRESS CLIN CHEM; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brattstrom L, 1996, J NUTR, V126, pS1276, DOI 10.1093/jn/126.suppl_4.1276S; Bretthauer M, 2002, GUT, V50, P604, DOI 10.1136/gut.50.5.604; Carmel R, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P289; D'Angelo A, 2000, THROMB HAEMOSTASIS, V83, P563; Duthie SJ, 2002, AM J CLIN NUTR, V75, P908, DOI 10.1093/ajcn/75.5.908; Finkelstein JD, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P92; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Guttormsen AB, 1996, J CLIN INVEST, V98, P2174, DOI 10.1172/JCI119024; Halsted CH, 2001, AM J CLIN NUTR, V73, P501; Herrmann M, 2005, CLIN CHEM, V51, P2348, DOI 10.1373/clinchem.2005.053363; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Hustad S, 2004, AM J CLIN NUTR, V80, P1050, DOI 10.1093/ajcn/80.4.1050; Hustad S, 2000, CLIN CHEM, V46, P1065; Jacques PF, 2001, AM J CLIN NUTR, V73, P613; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; KANG SS, 1988, AM J HUM GENET, V43, P414; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; Kono S, 2005, CANCER SCI, V96, P535, DOI 10.1111/j.1349-7006.2005.00090.x; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; Leclerc D, 1999, GENE, V240, P75, DOI 10.1016/S0378-1119(99)00431-X; Lichtenstein AH, 2005, JAMA-J AM MED ASSOC, V294, P351, DOI 10.1001/jama.294.3.351; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Ma J, 1997, CANCER RES, V57, P1098; Maohua Le, 2002, Smarandache Notions Journal, V13, P239; MCCORMICK DB, 1989, PHYSIOL REV, V69, P1170, DOI 10.1152/physrev.1989.69.4.1170; McKinley MC, 2001, AM J CLIN NUTR, V73, P759; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; McNulty H, 2006, CIRCULATION, V113, P74, DOI 10.1161/CIRCULATIONAHA.105.580332; Midttun O, 2005, CLIN CHEM, V51, P1206, DOI 10.1373/clinchem.2005.051169; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Molloy AM, 2004, CURR OPIN LIPIDOL, V15, P49, DOI 10.1097/00041433-200402000-00010; Monsen AUB, 2003, CLIN CHEM, V49, P2067, DOI 10.1373/clinchem.2003.019869; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; Rozen R, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P259; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; SELHUB J, 1992, AM J CLIN NUTR, V55, P131, DOI 10.1093/ajcn/55.1.131; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Shelnutt KP, 2004, J NUTR BIOCHEM, V15, P554, DOI 10.1016/j.jnutbio.2004.04.003; Shields DC, 1999, AM J HUM GENET, V64, P1045, DOI 10.1086/302310; Shimakawa T, 1997, ANN EPIDEMIOL, V7, P285, DOI 10.1016/S1047-2797(97)00004-5; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Splaver A, 2004, AM HEART J, V148, P34, DOI 10.1016/j.ahj.2004.02.004; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; Ubbink JB, 1996, J CLIN INVEST, V98, P177, DOI 10.1172/JCI118763; Ueland PM, 2001, TRENDS PHARMACOL SCI, V22, P195, DOI 10.1016/S0165-6147(00)01675-8; Ulrich CM, 1999, CANCER EPIDEM BIOMAR, V8, P659; Ulvik A, 2001, AM J MED GENET, V101, P246, DOI 10.1002/ajmg.1370; Ulvik A, 2004, CANCER EPIDEM BIOMAR, V13, P2175; Ulvik A, 2001, CLIN CHEM, V47, P2050; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Verhoef P, 1998, J AM COLL CARDIOL, V32, P353, DOI 10.1016/S0735-1097(98)00244-7; Vollset SE, 2001, AM J CLIN NUTR, V73, P499; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Windelberg A, 2005, CLIN CHEM, V51, P2103, DOI 10.1373/clinchem.2005.053835; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Zhang H, 2003, PHYSCHEMCOMM, V6, P12, DOI 10.1039/b300284p	67	102	105	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					846	855		10.1086/513520	http://dx.doi.org/10.1086/513520			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436239	Green Published, Bronze			2022-12-18	WOS:000245973200003
J	Weedon, MN; Clark, VJ; Qian, YD; Ben-Shlomo, Y; Timpson, N; Ebrahim, S; Lawlor, DA; Pembrey, ME; Ring, S; Wilkin, TJ; Voss, LD; Jeffery, AN; Metcalf, B; Ferrucci, L; Corsi, AM; Murray, A; Melzer, D; Knight, B; Shields, B; Smith, GD; Hattersley, AT; Di Rienzo, A; Frayling, TM				Weedon, Michael N.; Clark, Vanessa J.; Qian, Yudong; Ben-Shlomo, Yoav; Timpson, Nicholas; Ebrahim, Shah; Lawlor, Debbie A.; Pembrey, Marcus E.; Ring, Susan; Wilkin, Terry J.; Voss, Linda D.; Jeffery, Alison N.; Metcalf, Brad; Ferrucci, Luigi; Corsi, Anna Maria; Murray, Anna; Melzer, David; Knight, Bridget; Shields, Bev; Smith, George Davey; Hattersley, Andrew T.; Di Rienzo, Anna; Frayling, Tim M.			A common haplotype of the glucokinase gene alters fasting glucose and birth weight: Association in six studies and population-genetics analyses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSULIN-RESISTANCE SYNDROME; LINKAGE DISEQUILIBRIUM; STATISTICAL-METHOD; BLOOD-GLUCOSE; FETAL-GROWTH; RISK-FACTORS; POLYMORPHISM; EVOLUTION; PROMOTER; DNA	Fasting glucose is associated with future risk of type 2 diabetes and ischemic heart disease and is tightly regulated despite considerable variation in quantity, type, and timing of food intake. In pregnancy, maternal fasting glucose concentration is an important determinant of offspring birth weight. The key determinant of fasting glucose is the enzyme glucokinase (GCK). Rare mutations of GCK cause fasting hyperglycemia and alter birth weight. The extent to which common variation of GCK explains normal variation of fasting glucose and birth weight is not known. We aimed to comprehensively define the role of variation of GCK in determination of fasting glucose and birth weight, using a tagging SNP (tSNP) approach and studying 19,806 subjects from six population-based studies. Using 22 tSNPs, we showed that the variant rs1799884 is associated with fasting glucose at all ages in the normal population and exceeded genomewide levels of significance (P = 10(-9)). rs3757840 was also highly significantly associated with fasting glucose (P = 8 x 10(-7)), but haplotype analysis revealed that this is explained by linkage disequilibrium (r(2) = 0.2) with rs1799884. A maternal A allele at rs1799884 was associated with a 32-g (95% confidence interval 11-53 g) increase in offspring birth weight (P = .002). Genetic variation influencing birth weight may have conferred a selective advantage in human populations. We performed extensive population-genetics analyses to look for evidence of recent positive natural selection on patterns of GCK variation. However, we found no strong signature of positive selection. In conclusion, a comprehensive analysis of common variation of the glucokinase gene shows that this is the first gene to be reproducibly associated with fasting glucose and fetal growth.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England; Univ Bristol, Avon Longitudinal Study Parents & Children, Bristol BS8 1TH, Avon, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; Peninsula Med Sch, Dept Endocrinol & Metab, Plymouth, Devon, England; NIA, Clin Res Branch, NIH, Baltimore, MD 21224 USA; Natl Inst Res & Care Aging, Dept Geriatr, Lab Clin Epidemiol, Florence, Italy	University of Exeter; University of Chicago; University of Bristol; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of Plymouth; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Frayling, TM (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter EX1 2LU, Devon, England.	Tim.Frayling@pms.ac.uk	Davey Smith, George/A-7407-2013; Attrill, Lauren/V-1688-2018; Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Ben-Shlomo, Yoav/ABD-2004-2021	Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Ben-Shlomo, Yoav/0000-0001-6648-3007; Di Rienzo, Anna/0000-0002-8982-9098; Weedon, Michael/0000-0002-6174-6135; Murray, Anna/0000-0002-2351-2522; Melzer, David/0000-0002-0170-3838; Lawlor, Debbie A/0000-0002-6793-2262; Frayling, Timothy/0000-0001-8362-2603	MRC [G0500070] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056670, F32DK066974] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AG999999] Funding Source: Medline; Medical Research Council [G0500070, G9815508] Funding Source: Medline; NIDDK NIH HHS [F32 DK066974, DK66974, R01 DK056670] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bjornholt JV, 1999, DIABETES CARE, V22, P45, DOI 10.2337/diacare.22.1.45; Bjornholt JV, 2001, DIABETIC MED, V18, P261, DOI 10.1046/j.1464-5491.2001.00488.x; BRESCHI MC, 1993, DIABETOLOGIA, V36, P1315, DOI 10.1007/BF00400812; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CHARLES MA, 1991, DIABETES, V40, P796, DOI 10.2337/diabetes.40.7.796; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; FARMER G, 1988, DIABETOLOGIA, V31, P134, DOI 10.1007/BF00276845; Frayling TM, 2002, DIABETES, V51, P2313, DOI 10.2337/diabetes.51.7.2313; Freeman MS, 2002, DIABETIC MED, V19, P994, DOI 10.1046/j.1464-5491.2002.00843.x; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; HUDSON RR, 1994, GENETICS, V136, P1329; Hudson RR, 2001, GENETICS, V159, P1805; HUDSON RR, 1987, GENETICS, V116, P153; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Knight B, 2005, EARLY HUM DEV, V81, P823, DOI 10.1016/j.earlhumdev.2005.06.003; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Marz W, 2004, CIRCULATION, V109, P2844, DOI 10.1161/01.CIR.0000129306.44085.C4; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Nachman MW, 1998, GENETICS, V150, P1133; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Rose CS, 2005, DIABETES, V54, P3026, DOI 10.2337/diabetes.54.10.3026; Snieder H, 1999, GENET EPIDEMIOL, V16, P426, DOI 10.1002/(SICI)1098-2272(1999)16:4<426::AID-GEPI8>3.3.CO;2-2; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens JC, 2001, SCIENCE, V293, P1048; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stride A, 2002, DIABETOLOGIA, V45, P427, DOI 10.1007/s00125-001-0770-9; TAJIMA F, 1989, GENETICS, V123, P585; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; TRINDER P, 1969, J CLIN PATHOL, V22, P246, DOI 10.1136/jcp.22.2.246-b; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Weedon MN, 2005, DIABETES, V54, P576, DOI 10.2337/diabetes.54.2.576; Wells JCK, 2002, AM J PHYS ANTHROPOL, V119, P276, DOI 10.1002/ajpa.10137; Wilkin TJ, 2004, INT J OBESITY, V28, pS64, DOI 10.1038/sj.ijo.0802807	47	102	104	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					991	1001		10.1086/509517	http://dx.doi.org/10.1086/509517			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186458	Green Published, Bronze			2022-12-18	WOS:000242131600001
J	Stevenson, DA; Zhou, H; Ashrafi, S; Messiaen, LM; Carey, JC; D'Astous, JL; Santora, SD; Viskochil, DH				Stevenson, DA; Zhou, H; Ashrafi, S; Messiaen, LM; Carey, JC; D'Astous, JL; Santora, SD; Viskochil, DH			Double inactivation of NF1 in tibial pseudarthrosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL PSEUDARTHROSIS; NEUROFIBROMATOSIS; GENE; HETEROZYGOSITY; IDENTIFICATION; POLYMORPHISM; MUTATIONS; PATHOLOGY; HISTORY; MOUSE	Osseous abnormalities, including long-bone dysplasia with pseudarthrosis ( PA), are associated with neurofibromatosis type 1 ( NF1). Prospectively acquired tissue from the PA site of two individuals with NF1 was used for immunohistochemical characterization and genotype analysis of the NF1 locus. Typical immunohistochemical features of neurofibroma were not observed. Genotype analysis of PA tissue with use of four genetic markers ( D17S1863, GXALU, IN38, and 3NF1-1) spanning the NF1 locus demonstrated loss of heterozygosity. These results are the first to document double inactivation of NF1 in PA tissue and suggest that the neurofibromin-Ras signal transduction pathway is involved in this bone dysplasia in NF1.	Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Med Genet, Salt Lake City, UT 84132 USA; Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA; Univ Utah, Dept Orthoped, Salt Lake City, UT 84132 USA; Shriners Hosp Children Intermt, Salt Lake City, UT USA; Univ Alabama, Dept Genet, Birmingham, AL USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham	Stevenson, DA (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pediat, Div Med Genet, 2C412 SOM, Salt Lake City, UT 84132 USA.	David.Stevenson@hsc.utah.edu			NCRR NIH HHS [M01 RR000064] Funding Source: Medline; NINDS NIH HHS [K23 NS052500] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLAUTH M, 1984, ARCH ORTHOP TRAUM SU, V103, P269, DOI 10.1007/BF00387333; BOYD HB, 1982, CLIN ORTHOP RELAT R, P5; BRINER J, 1973, ARCH PATHOL, V95, P97; Correa CL, 1999, HUM MUTAT, V14, P387, DOI 10.1002/(SICI)1098-1004(199911)14:5<387::AID-HUMU4>3.0.CO;2-4; Crawford A H, 1999, J Am Acad Orthop Surg, V7, P217; Hefti F, 2000, J PEDIATR ORTHOP B, V9, P11, DOI 10.1097/01202412-200001000-00003; Ippolito E, 2000, J PEDIATR ORTHOP B, V9, P3, DOI 10.1097/01202412-200001000-00002; Kuorilehto T, 2006, J HISTOCHEM CYTOCHEM, V54, P363, DOI 10.1369/jhc.5A6784.2005; Kuorilehto T, 2004, J BONE MINER RES, V19, P983, DOI 10.1359/JBMR.040130; LAZARO C, 1993, HUM GENET, V92, P429, DOI 10.1007/BF01247353; MCELHANNON FM, 1975, SOUTHERN MED J, V68, P824, DOI 10.1097/00007611-197507000-00007; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Paulson TG, 1999, GENOME RES, V9, P482; Rasmussen SA, 2000, GENE CHROMOSOME CANC, V28, P425, DOI 10.1002/1098-2264(200008)28:4<425::AID-GCC8>3.0.CO;2-E; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Sawada S, 1996, NAT GENET, V14, P110, DOI 10.1038/ng0996-110; Stevenson DA, 1999, AM J MED GENET, V84, P413, DOI 10.1002/(SICI)1096-8628(19990611)84:5<413::AID-AJMG5>3.0.CO;2-1; XU GF, 1991, NUCLEIC ACIDS RES, V19, P3764, DOI 10.1093/nar/19.13.3764; Yu X, 2005, BONE, V36, P793, DOI 10.1016/j.bone.2005.01.022	19	102	111	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					143	148		10.1086/504441	http://dx.doi.org/10.1086/504441			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773574	Bronze, Green Published			2022-12-18	WOS:000238341200015
J	Hinrichs, AL; Wang, JC; Bufe, B; Kwon, JM; Budde, J; Allen, R; Bertelsen, S; Evans, W; Dick, D; Rice, J; Foroud, T; Nurnberger, J; Tischfield, JA; Kuperman, S; Crowe, R; Hesselbrock, V; Schuckit, M; Almasy, L; Porjesz, B; Edenberg, HJ; Begleiter, H; Meyerhof, W; Bierut, LJ; Goate, AM				Hinrichs, AL; Wang, JC; Bufe, B; Kwon, JM; Budde, J; Allen, R; Bertelsen, S; Evans, W; Dick, D; Rice, J; Foroud, T; Nurnberger, J; Tischfield, JA; Kuperman, S; Crowe, R; Hesselbrock, V; Schuckit, M; Almasy, L; Porjesz, B; Edenberg, HJ; Begleiter, H; Meyerhof, W; Bierut, LJ; Goate, AM			Functional variant in a bitter-taste receptor (hTAS2R16) influences risk of alcohol dependence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCI; GENETIC-LINKAGE; FAMILY; ALLELE; 6-N-PROPYLTHIOURACIL; IDENTIFICATION; POLYMORPHISMS; SENSITIVITY; DIVERSITY	A coding single-nucleotide polymorphism (cSNP), K172N, in hTAS2R16, a gene encoding a taste receptor for bitter beta-glucopyranosides, shows significant association with alcohol dependence (P = .00018). This gene is located on chromosome 7q in a region reported elsewhere to exhibit linkage with alcohol dependence. The SNP is located in the putative ligand-binding domain and is associated with an increased sensitivity to many bitter beta-glucopyranosides in the presence of the N172 allele. Individuals with the ancestral allele K172 are at increased risk of alcohol dependence, regardless of ethnicity. However, this risk allele is uncommon in European Americans ( minor-allele frequency [MAF] 0.6%), whereas 45% of African Americans carry the allele (MAF 26%), which makes it a much more significant risk factor in the African American population.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; German Inst Human Nutr Potsdam Rehbrucke, Nuthetal, Germany; NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Rutgers State Univ, Piscataway, NJ USA; Univ Iowa, Sch Med, Iowa City, IA 52242 USA; Univ Connecticut, Sch Med, Farmington, CT USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; SW Fdn Biomed Res, San Antonio, TX USA; SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA	Washington University (WUSTL); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Indiana University System; Indiana University-Purdue University Indianapolis; Rutgers State University New Brunswick; University of Iowa; University of Connecticut; University of California System; University of California San Diego; Texas Biomedical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Goate, AM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid Ave, St Louis, MO 63110 USA.	goate@icarus.wustl.edu	Bierut, Laura Jean/W-6806-2019; Almasy, Laura/V-3156-2019	Bierut, Laura Jean/0000-0002-9952-4810; Nurnberger, John/0000-0002-7674-1767; Kuperman, Samuel/0000-0002-5995-1981; Edenberg, Howard/0000-0003-0344-9690; Tischfield, Jay/0000-0003-3217-8287; Goate, Alison/0000-0002-0576-2472; Budde, John/0000-0001-7778-7276	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NIAAA NIH HHS [U10 AA008401, U10AA08401] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; *AM PSYCH ASS, 1987, DIAGN STAT MAN MENT, P166; American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th, P194; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Cann HM, 2002, SCIENCE, V296, P261; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Culverhouse R, 2005, ARCH GEN PSYCHIAT, V62, P753, DOI 10.1001/archpsyc.62.7.753; Duffy VB, 2004, ALCOHOL CLIN EXP RES, V28, P1629, DOI 10.1097/01.ALC.0000145789.55183.D4; Duffy VB, 2004, PHYSIOL BEHAV, V82, P435, DOI 10.1016/j.physbeh.2004.04.060; Ehlers CL, 2004, AM J MED GENET B, V129B, P110, DOI 10.1002/ajmg.b.30057; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Jones KA, 2004, INT J PSYCHOPHYSIOL, V53, P75, DOI 10.1016/j.ijpsycho.2004.02.004; KENDLER KS, 1994, AM J PSYCHIAT, V151, P707; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Ma JZ, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S104; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Nurnberger JI, 2001, AM J PSYCHIAT, V158, P718, DOI 10.1176/appi.ajp.158.5.718; PICKENS RW, 1991, ARCH GEN PSYCHIAT, V48, P19; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Spielman RS, 1996, AM J HUM GENET, V59, P983; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; Ueda T, 2001, BIOCHEM BIOPH RES CO, V285, P147, DOI 10.1006/bbrc.2001.5136; Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194; *WHO, 1993, INT CLASS DIS, P55; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092	37	102	106	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					103	111		10.1086/499253	http://dx.doi.org/10.1086/499253			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385453	Green Published, Bronze			2022-12-18	WOS:000233930400010
J	Posthuma, D; Luciano, M; de Geus, EJC; Wright, MJ; Slagboom, PE; Montgomery, GW; Boomsma, DI; Martin, NG				Posthuma, D; Luciano, M; de Geus, EJC; Wright, MJ; Slagboom, PE; Montgomery, GW; Boomsma, DI; Martin, NG			A genomewide scan for intelligence identifies quantitative trait loci on 2q and 6p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENERAL COGNITIVE-ABILITY; READING-DISABILITY; CHROMOSOME 6P; ASSOCIATION ANALYSIS; GENETIC DISSECTION; DNA MARKERS; WIDE SCAN; LINKAGE; AUTISM; DYSLEXIA	Between 40% and 80% of the variation in human intelligence ( IQ) is attributable to genetic factors. Except for many rare mutations resulting in severe cognitive dysfunction, attempts to identify these factors have not been successful. We report a genomewide linkage scan involving 634 sibling pairs designed to identify chromosomal regions that explain variation in IQ. Model-free multipoint linkage analysis revealed evidence of a significant quantitative-trait locus for performance IQ at 2q24.1-31.1 (LOD score 4.42), which overlaps the 2q21-33 region that has repeatedly shown linkage to autism. A second region revealed suggestive linkage for both full-scale and verbal IQs on 6p25.3-22.3 ( LOD score 3.20 for full-scale IQ and 2.33 for verbal IQ), overlapping marginally with the 6p22.3-21.31 region implicated in reading disability and dyslexia.	Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands	Vrije Universiteit Amsterdam; QIMR Berghofer Medical Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Posthuma, D (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Boechorstr 1, NL-1081 BT Amsterdam, Netherlands.	danielle@psy.vu.nl	Boomsma, Dorret I/AAX-4470-2020; Luciano, Michelle/F-7277-2010; Montgomery, Grant W/B-7148-2008; Wright, Margaret Jane/A-4560-2016; de Geus, Eco J.C./M-9318-2015; Slagboom, P. Eline/R-4790-2016; Wright, Margaret J/H-3308-2014	Luciano, Michelle/0000-0003-0935-7682; Montgomery, Grant W/0000-0002-4140-8139; Wright, Margaret Jane/0000-0001-7133-4970; de Geus, Eco J.C./0000-0001-6022-2666; Slagboom, P. Eline/0000-0002-2875-4723; Martin, Nicholas/0000-0003-4069-8020; Posthuma, Danielle/0000-0001-7582-2365	NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Badcock JC, 2005, J PSYCHIATR RES, V39, P11, DOI 10.1016/j.jpsychires.2004.05.002; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; Butcher LM, 2005, MOL PSYCHIATR, V10, P384, DOI 10.1038/sj.mp.4001589; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; Chorney MJ, 1998, PSYCHOL SCI, V9, P159, DOI 10.1111/1467-9280.00032; CHURCHILL GA, 1994, GENETICS, V138, P963; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; Fisher PJ, 1999, HUM MOL GENET, V8, P915, DOI 10.1093/hmg/8.5.915; Fisher SE, 1999, AM J HUM GENET, V64, P146, DOI 10.1086/302190; Flint J, 1999, BRAIN, V122, P2015, DOI 10.1093/brain/122.11.2015; Gayan J, 1999, AM J HUM GENET, V64, P157, DOI 10.1086/302191; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Grigorenko EL, 2000, AM J HUM GENET, V66, P715, DOI 10.1086/302755; HALLMAYER JF, IN PRESS AM J HUM GE; HEIJMANS BT, IN PRESS EUR J HUM G; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Inlow JK, 2004, GENETICS, V166, P835, DOI 10.1534/genetics.166.2.835; Jackson D. N., 1998, MULTIDIMENSIONAL APT; Kaplan DE, 2002, AM J HUM GENET, V70, P1287, DOI 10.1086/340449; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Luciano M, 2004, TWIN RES, V7, P62, DOI 10.1375/twin.7.1.62; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; NEALE MC, 1997, MIX SOFTWARE STAT MO; Palferman S, 2001, AM J HUM GENET, V69, P570; Petrill SA, 1996, INTELLIGENCE, V23, P191, DOI 10.1016/S0160-2896(96)90003-3; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Plomin R, 2004, MOL PSYCHIATR, V9, P582, DOI 10.1038/sj.mp.4001441; Plomin R, 2001, BEHAV GENET, V31, P497, DOI 10.1023/A:1013385125887; Posthuma D, 2001, BEHAV GENET, V31, P593, DOI 10.1023/A:1013349512683; Rabionet R, 2004, NEUROSCI LETT, V372, P209, DOI 10.1016/j.neulet.2004.09.037; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662; RASKIN WH, 2005, MOL PSYCHIAT; Shao YJ, 2002, AM J HUM GENET, V70, P1058, DOI 10.1086/339765; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; Willcutt EG, 2002, AM J MED GENET, V114, P260, DOI 10.1002/ajmg.10205; Willcutt EG, 2001, J ABNORM PSYCHOL, V110, P157, DOI 10.1037//0021-843X.1001.1.157; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/twin.4.1.48; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Zhu G, 2004, TWIN RES, V7, P197, DOI 10.1375/136905204323016186; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494	50	102	104	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					318	326		10.1086/432647	http://dx.doi.org/10.1086/432647			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	16001363	Green Published, Bronze			2022-12-18	WOS:000230387200013
J	van den Brink, DM; Brites, P; Haasjes, J; Wierzbicki, AS; Mitchell, J; Lambert-Hamill, M; de Belleroche, J; Jansen, GA; Waterham, HR; Wanders, RJA				van den Brink, DM; Brites, P; Haasjes, J; Wierzbicki, AS; Mitchell, J; Lambert-Hamill, M; de Belleroche, J; Jansen, GA; Waterham, HR; Wanders, RJA			Identification of PEX7 as the second gene involved in Refsum disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; PHYTANOYL-COA HYDROXYLASE; HUMAN SKIN FIBROBLASTS; ACID ALPHA-OXIDATION; PEROXISOMAL DISORDERS; PTS2 RECEPTOR; DEFICIENCY; THIOLASE; ACCUMULATION; MUTATIONS	Patients affected with Refsum disease (RD) have elevated levels of phytanic acid due to a deficiency of the peroxisomal enzyme phytanoyl-CoA hydroxylase (PhyH). In most patients with RD, disease-causing mutations in the PHYH gene have been identified, but, in a subset, no mutations could be found, indicating that the condition is genetically heterogeneous. Linkage analysis of a few patients diagnosed with RD, but without mutations in PHYH, suggested a second locus on chromosome 6q22-24. This region includes the PEX7 gene, which codes for the peroxin 7 receptor protein required for peroxisomal import of proteins containing a peroxisomal targeting signal type 2. Mutations in PEX7 normally cause rhizomelic chondrodysplasia punctata type 1, a severe peroxisomal disorder. Biochemical analyses of the patients with RD revealed defects not only in phytanic acid alpha-oxidation but also in plasmalogen synthesis and peroxisomal thiolase. Furthermore, we identified mutations in the PEX7 gene. Our data show that mutations in the PEX7 gene may result in a broad clinical spectrum ranging from severe rhizomelic chondrodysplasia punctata to relatively mild RD and that clinical diagnosis of conditions involving retinitis pigmentosa, ataxia, and polyneuropathy may require a full screen of peroxisomal functions.	Univ Amsterdam, Acad Med Ctr, Dept Pediat, Emma Childrens Hosp,Lab Genet Metab Dis F0224, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ London Kings Coll, Dept Chem Pathol, London WC2R 2LS, England; Chelsea & Westminster Hosp, Refsums Dis Clin, London, England; Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Neuromuscular Dis, London, England	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; Imperial College London; University of London; University College London; Imperial College London	Wanders, RJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pediat, Emma Childrens Hosp,Lab Genet Metab Dis F0224, POB 22700, NL-1100 DE Amsterdam, Netherlands.		Brites, Pedro/K-4231-2013; van den Brink, Daan/S-7529-2017; Wierzbicki, Anthony/AAP-1735-2020	Brites, Pedro/0000-0003-1754-1543; van den Brink, Daan/0000-0002-3048-5382; Wierzbicki, Anthony/0000-0003-2756-372X				Barth PG, 1996, AM J MED GENET, V62, P164, DOI 10.1002/(SICI)1096-8628(19960315)62:2<164::AID-AJMG9>3.0.CO;2-W; Braverman N, 2000, GENOMICS, V63, P181, DOI 10.1006/geno.1999.6080; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Braverman N, 2002, HUM MUTAT, V20, P284, DOI 10.1002/humu.10124; BROWN PJ, 1993, J HUM NUTR DIET, V6, P295, DOI 10.1111/j.1365-277X.1993.tb00375.x; CLARIDGE KG, 1992, EYE, V6, P371, DOI 10.1038/eye.1992.76; DeVet ECJM, 1997, EUR J BIOCHEM, V247, P511; Gould SJ., 2001, METABOLIC MOL BASES, P3181; HEIKOOP JC, 1991, BIOCHIM BIOPHYS ACTA, V1097, P62, DOI 10.1016/0925-4439(91)90025-5; HEIKOOP JC, 1990, J CLIN INVEST, V86, P126, DOI 10.1172/JCI114674; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; Jansen GA, 2000, HUM MOL GENET, V9, P1195, DOI 10.1093/hmg/9.8.1195; Jansen GA, 1997, NAT GENET, V17, P190, DOI 10.1038/ng1097-190; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; MOSER HW, 1991, TECHNIQUES DIAGNOSTI, P193; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Motley AM, 2002, AM J HUM GENET, V70, P612, DOI 10.1086/338998; Mukherji M, 2001, HUM MOL GENET, V10, P1971, DOI 10.1093/hmg/10.18.1971; PLANT GR, 1990, BRIT J RADIOL, V63, P537, DOI 10.1259/0007-1285-63-751-537; POLLTHE BT, 1991, J INHERIT METAB DIS, V14, P361, DOI 10.1007/BF01811703; Purdue PE, 1999, NEUROCHEM RES, V24, P581, DOI 10.1023/A:1023957110171; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; SCHRAKAMP G, 1988, J LIPID RES, V29, P325; SMEITINK JAM, 1992, J INHERIT METAB DIS, V15, P377, DOI 10.1007/BF02435981; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TENBRINK HJ, 1992, J LIPID RES, V33, P1449; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434; Wanders RJA, 2001, J NEUROPATH EXP NEUR, V60, P1021, DOI 10.1093/jnen/60.11.1021; WANDERS RJA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P345, DOI 10.1016/0005-2760(93)90239-6; WANDERS RJA, 2001, METABOLIC MOL BASES, P3303; Wierzbicki AS, 2000, EUR J HUM GENET, V8, P649, DOI 10.1038/sj.ejhg.5200511; Wierzbicki AS, 2002, J NEUROCHEM, V80, P727, DOI 10.1046/j.0022-3042.2002.00766.x	33	102	105	1	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2003	72	2					471	477		10.1086/346093	http://dx.doi.org/10.1086/346093			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	640GK	12522768	Green Published, Bronze			2022-12-18	WOS:000180680000027
J	Chen, Q; Reis, SE; Kammerer, CM; McNamara, DM; Holubkov, R; Sharaf, BL; Sopko, G; Pauly, DF; Merz, CNB; Kamboh, MI				Chen, Q; Reis, SE; Kammerer, CM; McNamara, DM; Holubkov, R; Sharaf, BL; Sopko, G; Pauly, DF; Merz, CNB; Kamboh, MI		WISE Study Grp	Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-DENSITY-LIPOPROTEIN; SERUM PARAOXONASE; OXIDATIVE MODIFICATION; GLN-ARG192 POLYMORPHISM; CARDIOVASCULAR-DISEASE; INCREASED RISK; PON1; ATHEROSCLEROSIS; PROTECTION; ATHEROGENESIS	(PON), a high-density lipoprotein-associated enzyme, is believed to protect against low-density lipoprotein oxidation and thus affects the risk of coronary artery disease (CAD). Three polymorphisms in the PON1 (Leu55Met and Gln192Arg) and PON2 (Ser311Cys) genes have been shown to be associated with the risk of CAD in several European or European-derived populations. In the present study, we examined the associations between these three markers and the severity of CAD as determined by the number of diseased coronary artery vessels in 711 subjects (589 whites and 122 blacks) from the Women's Ischemia Syndrome Evaluation (WISE) study. WISE is a National Heart, Lung, and Blood Institute-sponsored multicenter study designed to address issues related to ischemic-heart-disease recognition and diagnosis in women. Subjects were classified as having normal/minimal CAD (<20% stenosis), mild CAD (20%-49% stenosis), and significant CAD (&GE;50% stenosis). The women who had &GE;50% stenosis were further classified into groups with one-, two-, or three-vessel disease if any of the three coronary arteries had diameter stenosis &GE;50%. No significant association was found between the PON polymorphisms and stenosis severity in either white or black women. However, among white women, when data were stratified by the number of diseased vessels, the frequency of the PON1 codon 192 Arg/Arg genotype was significantly higher in the group with three-vessel disease than in the other groups (those with one- vessel and two- vessel disease) combined (17.02% vs. 4.58%; P = .0066). Similarly, the frequency of the PON2 codon 311 Cys/Cys genotype was significantly higher in the group with three-vessel disease than in the other groups combined (15.22% vs. 4.61%; P = .018). The adjusted odds ratios for the development of three-vessel disease were 2.80 (95% confidence interval 1.06-7.37; P = .038 ) for PON1 codon 192 Arg/Arg and 3.68 (95% confidence interval 1.26-10.68; for PON2 codon 311 Cys/Cys. Our data indicate that the severity of CAD, in terms of the number of diseased vessels, may be affected by common genetic variation in the PON gene cluster, on chromosome 7.	Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Math, Cardiovasc Inst, Pittsburgh, PA 15260 USA; Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT 84112 USA; Rhode Isl Hosp, Div Cardiol, Providence, RI USA; NHLBI, Div Heart & Vasc Dis, Bethesda, MD 20892 USA; Univ Florida, Div Cardiol, Gainesville, FL USA; Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Lifespan Health Rhode Island; Rhode Island Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University System of Florida; University of Florida; Cedars Sinai Medical Center	Kamboh, MI (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, 130 De Soto St, Pittsburgh, PA 15261 USA.		Reis, Steven E/J-3957-2014	Kammerer, Candace M/0000-0002-2841-4761; Kamboh, M. Ilyas/0000-0002-3453-1438; Reis, Steven/0000-0001-8023-0102	DIVISION OF HEART AND VASCULAR DISEASES [N01HV068164, N01HV068162, N01HV068163, N01HV068161] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068162, R01HL054900, U01HL064829, U01HL064924] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL054900, U01 HL064924, N01 HV068164, HL54900, N01-HV68163, N01 HV068161, U01 HL064829, N01HV68162, R01 HL64914-01, R01 HL64829-01, N01-HV68164, R01 HL64924-01, N01HV68163, N01-HV68162] Funding Source: Medline	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al Suwaidi J, 2001, AM J CARDIOL, V88, P1300, DOI 10.1016/S0002-9149(01)02093-8; Aviram M, 2000, CIRCULATION, V101, P2510, DOI 10.1161/01.CIR.101.21.2510; Aviram M, 1998, ARTERIOSCL THROM VAS, V18, P1617, DOI 10.1161/01.ATV.18.10.1617; Aynacioglu AS, 2000, INT J CARDIOL, V74, P33, DOI 10.1016/S0167-5273(00)00242-4; Bittner V, 2000, AM J CARDIOL, V85, P1083, DOI 10.1016/S0002-9149(00)00700-1; BLATTER MC, 1993, EUR J BIOCHEM, V211, P871, DOI 10.1111/j.1432-1033.1993.tb17620.x; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; FRIED LP, 1987, AM J EPIDEMIOL, V125, P844, DOI 10.1093/oxfordjournals.aje.a114600; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gardemann A, 2000, ATHEROSCLEROSIS, V152, P421, DOI 10.1016/S0021-9150(99)00489-X; Garin MCB, 1997, J CLIN INVEST, V99, P62, DOI 10.1172/JCI119134; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Heinecke JW, 1998, AM J HUM GENET, V62, P20, DOI 10.1086/301691; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Imai Y, 2000, ATHEROSCLEROSIS, V149, P435, DOI 10.1016/S0021-9150(99)00340-8; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; KELSO GJ, 1994, BIOCHEMISTRY-US, V33, P832, DOI 10.1021/bi00169a026; Ko YL, 1998, ATHEROSCLEROSIS, V141, P259, DOI 10.1016/S0021-9150(98)00179-8; *LIP RES CLIN PROG, 1974, MAN LAB OP LIP LIP A; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 1998, FEBS LETT, V423, P57, DOI 10.1016/S0014-5793(98)00064-7; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Mackness MI, 1997, FEBS LETT, V416, P377, DOI 10.1016/S0014-5793(97)01243-X; MACKNESS MI, 1995, ATHEROSCLEROSIS, V115, P243, DOI 10.1016/0021-9150(94)05524-M; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453; Navab M, 2000, J LIPID RES, V41, P1495; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Newman SC, 2001, BIOSTATISTICAL METHO; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Odawara M, 1997, J CLIN ENDOCR METAB, V82, P2257, DOI 10.1210/jc.82.7.2257; Ombres D, 1998, ARTERIOSCL THROM VAS, V18, P1611, DOI 10.1161/01.ATV.18.10.1611; Papas A. M., 1996, LIPIDS, V31, P77; PEARSON TA, 1991, AM J EPIDEMIOL, V134, P123, DOI 10.1093/oxfordjournals.aje.a116064; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Reddi AH, 2001, ARTHRITIS RES, V3, P1; REED D, 1991, AM J EPIDEMIOL, V134, P111, DOI 10.1093/oxfordjournals.aje.a116063; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; RUIZ J, 1995, LANCET, V346, P869, DOI 10.1016/S0140-6736(95)92709-3; Sanghera DK, 1997, ARTERIOSCL THROM VAS, V17, P1067, DOI 10.1161/01.ATV.17.6.1067; Sanghera DK, 1998, AM J HUM GENET, V62, P36, DOI 10.1086/301669; Sanghera DK, 1998, ATHEROSCLEROSIS, V136, P217, DOI 10.1016/S0021-9150(97)00206-2; Senti M, 2001, ARTERIOSCL THROM VAS, V21, P415, DOI 10.1161/01.ATV.21.3.415; Sharaf BL, 1997, J AM COLL CARDIOL, V29, P78, DOI 10.1016/S0735-1097(96)00444-5; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shih DM, 1996, J CLIN INVEST, V97, P1630, DOI 10.1172/JCI118589; STEINBERG D, 1989, CIRCULATION, V80, P719, DOI 10.1161/01.CIR.80.3.719; Topic E, 2001, CLIN CHEM LAB MED, V39, P346, DOI 10.1515/CCLM.2001.054; Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; XIE X, 1993, AM J HUM GENET, V53, P1107; Zama T, 1997, ARTERIOSCL THROM VAS, V17, P3565, DOI 10.1161/01.ATV.17.12.3565; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	57	102	110	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					13	22		10.1086/345312	http://dx.doi.org/10.1086/345312			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12454802	Green Published, Bronze			2022-12-18	WOS:000180186800002
J	Crolla, JA; van Heyningen, V				Crolla, JA; van Heyningen, V			Frequent chromosome aberrations revealed by molecular cytogenetic studies in patients with aniridia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IN-SITU HYBRIDIZATION; GERM-LINE MOSAICISM; HUMAN PAX6 GENE; WILMS-TUMOR; SPORADIC ANIRIDIA; INSITU HYBRIDIZATION; SOMATIC MOSAICISM; WAGR REGION; DELETION; MUTATIONS	Seventy-seven patients with aniridia, referred for cytogenetic analysis predominantly to assess Wilms tumor risk, were studied by fluorescence in situ hybridization (FISH), through use of a panel of cosmids encompassing the aniridia-associated PAX6 gene, the Wilms tumor predisposition gene WT1, and flanking markers, in distal chromosome 11p13. Thirty patients were found to be chromosomally abnormal. Cytogenetically visible interstitial deletions involving 11p13 were found in 13 patients, 11 of which included WT1. A further 13 patients had cryptic deletions detectable only by FISH, 3 of which included WT1. Six of these, with deletions <500 kb, share a similar proximal breakpoint within a cosmid containing the last 10 exons of PAX6 and part of the neighboring gene, ELP4. Two of these six patients were mosaic for the deletion. The remaining four had chromosomal rearrangements: an unbalanced translocation, t(11;13), with a deletion including the WAGR (<(W)under bar>ilms' tumor, (a) under bar niridia, (g) under bar enitourinary abnormalities, and mental (R) under bar etardation) region, and three balanced rearrangements with what appear to be position effect breakpoints 3' of PAX6:(a) a t(7;11) with the 11p13 breakpoint 30 kb downstream of PAX6, (b)a dir ins(12;11) with a breakpoint >50 kb from PAX6, and (c) an inv(11)(p13q13) with a breakpoint >75 kb downstream of PAX6. The proportion and spectrum of chromosome anomalies in familial (4/14, or 28.5%) and sporadic (26/63, or 41%) cases are not significantly different. An unexpectedly high frequency of chromosomal rearrangements is associated with both sporadic and familial aniridia in this cohort.	Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Salisbury District Hospital; University of Edinburgh	Crolla, JA (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England.		VAN HEYNINGEN, Veronica/GYE-0531-2022; van Heyningen, Veronica/B-8039-2008	van Heyningen, Veronica/0000-0003-0359-0141	MRC [MC_U127527199] Funding Source: UKRI; Medical Research Council [MC_U127527199] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ainsworth PJ, 1997, HUM MUTAT, V9, P452, DOI 10.1002/(SICI)1098-1004(1997)9:5<452::AID-HUMU12>3.3.CO;2-V; Axton R, 1997, J MED GENET, V34, P279, DOI 10.1136/jmg.34.4.279; BUNYAN DJ, 1995, HUM GENET, V95, P43; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chao LY, 2000, HUM MUTAT, V15, P332, DOI 10.1002/(SICI)1098-1004(200004)15:4<332::AID-HUMU5>3.0.CO;2-1; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Crolla JA, 1997, J MED GENET, V34, P207, DOI 10.1136/jmg.34.3.207; Crolla JA, 1996, J MED GENET, V33, P66, DOI 10.1136/jmg.33.1.66; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; DRESCHLER M, 1994, HUM GENET, V94, P331; Eugster EA, 1997, AM J MED GENET, V70, P409, DOI 10.1002/(SICI)1096-8628(19970627)70:4<409::AID-AJMG14>3.0.CO;2-L; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FANTES JA, 1995, GENOMICS, V25, P447, DOI 10.1016/0888-7543(95)80045-N; FANTES JA, 1992, AM J HUM GENET, V51, P1286; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; FUKUSHIMA Y, 1993, HUM GENET, V91, P205; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; Gronskov K, 2001, HUM GENET, V109, P11, DOI 10.1007/s004390100529; HANSON IM, 1993, HUM MOL GENET, V2, P915; Hatchwell E, 1998, AM J MED GENET, V78, P103, DOI 10.1002/(SICI)1096-8628(19980630)78:2<103::AID-AJMG1>3.0.CO;2-P; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kara-Mostefa A, 1999, AM J HUM GENET, V64, P1475, DOI 10.1086/302362; Kasprzak L, 1998, AM J MED GENET, V75, P288, DOI 10.1002/(SICI)1096-8628(19980123)75:3<288::AID-AJMG12>3.3.CO;2-S; Kent J, 1997, GENOMICS, V42, P260, DOI 10.1006/geno.1997.4706; Kleinjan DA, 2002, MAMM GENOME, V13, P102, DOI 10.1007/s00335-001-3058-y; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; Llerena JC, 2000, GENET MOL BIOL, V23, P535, DOI 10.1590/S1415-47572000000300006; MANNENS M, 1991, GENOMICS, V11, P284, DOI 10.1016/0888-7543(91)90134-Z; Mikelsaar R V, 2001, J Med Genet, V38, pE2, DOI 10.1136/jmg.38.1.e2; MOORE JW, 1986, HUM GENET, V72, P297, DOI 10.1007/BF00290952; Muto R, 2002, AM J MED GENET, V108, P285, DOI 10.1002/ajmg.10094; NELSON LB, 1984, SURV OPHTHALMOL, V28, P621, DOI 10.1016/0039-6257(84)90184-X; Pearson H, 2002, NATURE, V417, P10, DOI 10.1038/417010a; Phelan MC, 2001, PRENATAL DIAG, V21, P1100, DOI 10.1002/pd.195; Prosser J, 1998, HUM MUTAT, V11, P93, DOI 10.1002/(SICI)1098-1004(1998)11:2<93::AID-HUMU1>3.0.CO;2-M; Riegel M, 2000, PRENATAL DIAG, V20, P76, DOI 10.1002/(SICI)1097-0223(200001)20:1<76::AID-PD752>3.0.CO;2-M; SIMOLA KOJ, 1982, HUM GENET, V63, P158; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tekin M, 2000, AM J MED GENET, V95, P145, DOI 10.1002/1096-8628(20001113)95:2<145::AID-AJMG10>3.0.CO;2-R; Tinschert S, 2000, EUR J HUM GENET, V8, P455, DOI 10.1038/sj.ejhg.5200493; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TURLEAU C, 1984, HUM GENET, V67, P455, DOI 10.1007/BF00291410; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592	47	102	106	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1138	1149		10.1086/344396	http://dx.doi.org/10.1086/344396			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12386836	Green Published, Bronze			2022-12-18	WOS:000178884300011
J	Chan, V; Fong, GCY; Luk, KDK; Yip, B; Lee, MK; Wong, MS; Lu, DDS; Chan, TK				Chan, V; Fong, GCY; Luk, KDK; Yip, B; Lee, MK; Wong, MS; Lu, DDS; Chan, TK			A genetic locus for adolescent idiopathic scoliosis linked to chromosome 19p13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; STRATEGIES	Adolescent idiopathic scoliosis (AIS) is one of the most common orthopedic disorders, affecting up to 4% of schoolchildren worldwide. We studied seven unrelated multiplex families of southern Chinese descent with AIS, consisting of 25 affected members. A genomewide scan with >400 fluorescent microsatellite markers was performed. Multipoint linkage analysis by GENEHUNTER revealed significant linkage of the abnormal phenotype to the distal short arm of chromosome 19, with both a maximum multipoint LOD score and a nonparametric LOD score of 4.93. Two-point linkage analysis by MLINK gave a LOD score of 3.63 (recombination fraction theta([m=f]) = 0.00) at D19S216. Further high-density mapping and informative recombinations defined the AIS critical region in the vicinity of D19S216, flanked by D19S894 and D19S1034, spanning 5.2 cM on the sex-averaged genetic map on chromosome 19p13.3.	Univ Hong Kong, Queen Mary Hosp, Univ Dept Med, Div Mol Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Univ Dept Med, Div Neurol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Duchess Kent Childrens Hosp, Dept Orthopaed Surg, Div Spine Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, V (corresponding author), Univ Hong Kong, Queen Mary Hosp, Univ Dept Med, Div Mol Med, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	vanychana@hkucc.hku.hk	Chan, Vivian/C-4217-2009					Adams W., 1865, LECT PATHOLOGY TREAT; BELL M, 1995, AM J MED GENET, V55, P112, DOI 10.1002/ajmg.1320550126; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; FISHER RL, 1967, J BONE JOINT SURG AM, VA 49, P1005; FREIMER NB, 1993, AM J HUM GENET, V52, P1102; Garland HG, 1934, BRIT MED J, V1934, P328, DOI 10.1136/bmj.1.3816.328; HARRINGTON PR, 1977, CLIN ORTHOP RELAT R, P17; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Liu SL, 1996, CLIN ORTHOP RELAT R, P113; Lonstein JE, 1995, MOES TXB SCOLIOSIS O, P219; LUK KDK, 1996, J ORTHOP SURG, V4, P5; Miller NH, 2000, SPINE, V25, P2416; Murray D W, 1996, Eur Spine J, V5, P251, DOI 10.1007/BF00301328; Newton PO, 1997, SPINE, V22, P1398, DOI 10.1097/00007632-199706150-00020; OTT J, 1992, AM J HUM GENET, V51, P283; Ott J, 1999, ANAL HUMAN GENETIC L; Reamy BV, 2001, AM FAM PHYSICIAN, V64, P111; RISEBOROUGH EJ, 1973, J BONE JOINT SURG AM, VA 55, P974, DOI 10.2106/00004623-197355050-00006; TSE LY, 1997, PUBLIC HLTH EPIDEMIO, P9; Wise CA, 2000, SPINE, V25, P2372, DOI 10.1097/00007632-200009150-00017; WYNNE-DAVIES R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P24; [No title captured]	24	102	125	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					401	406		10.1086/341607	http://dx.doi.org/10.1086/341607			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12094330	Bronze, Green Published			2022-12-18	WOS:000176977700018
J	Schrijver, I; Liu, WG; Odom, R; Brenn, T; Oefner, P; Furthmayr, H; Francke, U				Schrijver, I; Liu, WG; Odom, R; Brenn, T; Oefner, P; Furthmayr, H; Francke, U			Premature termination mutations in FBN1: Distinct effects on differential allelic expression and on protein and clinical phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEONATAL MARFAN-SYNDROME; MESSENGER-RNA DECAY; EGF-LIKE DOMAINS; FIBRILLIN GENE; PATHOGENETIC MECHANISMS; GENOMIC ORGANIZATION; ECTOPIA LENTIS; SEQUENCE; GENOTYPE; DISORDERS	Marfan syndrome (MFS) and other type 1 fibrillinopathies result from mutations in the FBN1 gene, which encodes the connective-tissue microfibrillar protein fibrillin 1. Attempts at correlating genotype with phenotype have suggested considerable heterogeneity. To define the subtype of fibrillinopathy caused by premature termination codon (PTC) mutations, we integrate genotype information and mRNA expression levels with clinical and biochemical phenotypes. By screening the entire FBN1 gene for mutations, we identified 34 probands with PTC mutations. With the exception of two recurrent mutations, these nonsense and frameshift mutations are unique and span the entire FBN1 gene, from IVS2 to IVS63. Allele-specific reverse-transcriptase polymerase chain reaction analyses revealed differential allelic expression in all studied samples, with variable reduction of the mutant transcript. Fibrillin protein synthesis and deposition into the extracellular matrix were studied by pulse-chase analysis of cultured fibroblasts. In the majority of PTC samples, synthesis of normal-sized fibrillin protein was 50% of control levels, but matrix deposition was disproportionately decreased. Probands and mutation-positive relatives were clinically evaluated by means of a standardized protocol. Only 71% (22/31) of probands and 58% (14/24) of the mutation-positive family members met current clinical diagnostic criteria for MFS. When compared with our previously reported study group of 44 individuals with FBN1 cysteine substitutions, the PTC group showed statistically significant differences in the frequency of individual signs, especially in the ocular manifestations. Whereas large-joint hypermobility was more common, lens dislocation and retinal detachment were distinctly less common in the PTC group. We conclude that PTC mutations have a major impact on the pathogenesis of type 1 fibrillinopathies and convey a distinct biochemical, clinical, and prognostic profile.	Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Med Ctr,Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University	Francke, U (corresponding author), Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Med Ctr,Howard Hughes Med Inst, 279 Campus Dr, Stanford, CA 94305 USA.	francke@cmgm.stanford.edu	Furthmayr, Heinz -/A-6295-2010		NIGMS NIH HHS [P01 GM028428, R01 GM 28428] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM028428] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOYAMA T, 1995, AM J MED GENET, V58, P169, DOI 10.1002/ajmg.1320580216; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; Beroud C, 2000, HUM MUTAT, V15, P86, DOI 10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4; Biery NJ, 1999, GENOMICS, V56, P70, DOI 10.1006/geno.1998.5697; Booms P, 1999, CLIN GENET, V55, P110, DOI 10.1034/j.1399-0004.1999.550207.x; Brenn T, 1996, LAB INVEST, V75, P389; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; FRANCKE U, 1995, AM J HUM GENET, V56, P1287; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Furthmayr H, 1997, Semin Thorac Cardiovasc Surg, V9, P191; Guo D, 2001, AM J MED GENET, V101, P130, DOI 10.1002/1096-8628(20010615)101:2<130::AID-AJMG1333>3.0.CO;2-V; HALL JR, 1984, ANN THORAC SURG, V37, P500, DOI 10.1016/S0003-4975(10)61142-3; Halliday D, 1999, HUM GENET, V105, P587, DOI 10.1007/s004390051150; Handford PA, 2000, MATRIX BIOL, V19, P457, DOI 10.1016/S0945-053X(00)00100-1; HAYWARD C, 1994, HUM MOL GENET, V3, P373, DOI 10.1093/hmg/3.2.373; HEWETT D, 1994, AM J HUM GENET, V55, P447; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KAINULAINEN K, 1994, NAT GENET, V6, P64, DOI 10.1038/ng0194-64; Karttunen L, 1998, HUM MUTAT, pS34; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Liu W, 2001, BMC Med Genet, V2, P11, DOI 10.1186/1471-2350-2-11; Liu WG, 1996, HUM MOL GENET, V5, P1581, DOI 10.1093/hmg/5.10.1581; Liu WG, 1997, NAT GENET, V16, P328, DOI 10.1038/ng0897-328; Liu WO, 1997, GENET TEST, V1, P237, DOI 10.1089/gte.1997.1.237; Loeys B, 2001, ARCH INTERN MED, V161, P2447, DOI 10.1001/archinte.161.20.2447; LONNQVIST L, 1994, GENOMICS, V19, P573, DOI 10.1006/geno.1994.1110; Lonnqvist L, 1998, HUM MOL GENET, V7, P2039, DOI 10.1093/hmg/7.13.2039; MILEWICZ DM, 1994, AM J HUM GENET, V54, P447; Montgomery RA, 1998, AM J HUM GENET, V63, P1703, DOI 10.1086/302144; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Palz M, 2000, AM J MED GENET, V91, P212, DOI 10.1002/(SICI)1096-8628(20000320)91:3<212::AID-AJMG12>3.0.CO;2-3; Pepe G, 2001, CLIN GENET, V59, P444, DOI 10.1034/j.1399-0004.2001.590610.x; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Richards CS, 1997, AM J HUM GENET, V60, P1085; Robinson PN, 2000, J MED GENET, V37, P9, DOI 10.1136/jmg.37.1.9; Rose PS, 2000, GENET MED, V2, P278, DOI 10.1097/00125817-200009000-00002; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Schrijver I, 1999, AM J HUM GENET, V65, P1007, DOI 10.1086/302582; SCHRIJVER I, 2001, MANAGEMENT GENETIC S, P207; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Tiecke F, 2001, EUR J HUM GENET, V9, P13, DOI 10.1038/sj.ejhg.5200582; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813; Wang M, 1997, HUM MUTAT, V9, P359, DOI 10.1002/(SICI)1098-1004(1997)9:4<359::AID-HUMU10>3.0.CO;2-1	55	102	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					223	237		10.1086/341581	http://dx.doi.org/10.1086/341581			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12068374	Bronze, Green Published			2022-12-18	WOS:000176977700002
J	Aradhya, S; Courtois, G; Rajkovic, A; Lewis, RA; Levy, M; Israel, A; Nelson, DL				Aradhya, S; Courtois, G; Rajkovic, A; Lewis, RA; Levy, M; Israel, A; Nelson, DL			Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NF-KAPPA-B; HYPOHIDROTIC ECTODERMAL DYSPLASIA; BLOCH-SULZBERGER SYNDROME; X-LINKED DISORDER; IMMUNE-DEFICIENCY; KINASE COMPLEX; IKK-GAMMA; MICE; INACTIVATION; NEUTROPHIL	Familial incontinentia pigmenti (IP [MIM 308310]), or Bloch-Sulzberger syndrome, is an X-linked dominant and male-lethal disorder. We recently demonstrated that mutations in NEMO (IKK-gamma), which encodes a critical component of the NF-kappaB signaling pathway, were responsible for IP. Virtually all mutations eliminate the production of NEMO, causing the typical skewing of X inactivation in female individuals and lethality in male individuals, possibly through enhanced sensitivity to apoptosis. Most mutations also give rise to classic signs of IP, but, in this report, we describe two mutations in families with atypical phenotypes. Remarkably, each family included a male individual with unusual signs, including postnatal survival and either immune dysfunction or hematopoietic disturbance. We found two duplication mutations in these families, at a cytosine tract in exon 10 of NEMO, both of which remove the zinc (Zn) finger at the C-terminus of the protein. Two deletion mutations were also identified in the same tract in additional families. However, only the duplication mutations allowed male individuals to survive, and affected female individuals with duplication mutations demonstrated random or slight skewing of X inactivation. Similarly, NF-kappaB activation was diminished in the presence of duplication mutations and was completely absent in cells with deletion mutations. These results strongly indicate that male individuals can also suffer from IP caused by NEMO mutations, and we therefore urge a reevaluation of the diagnostic criteria.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA; Inst Pasteur, Unite Biol Mol Express Genet, CNRS, URA 1773, Paris, France	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nelson, DL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 902F, Houston, TX 77030 USA.	nelson@bcm.tmc.edu		ARADHYA, SWAROOP/0000-0001-6219-2931; COURTOIS, Gilles/0000-0003-3117-9595	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035617] Funding Source: NIH RePORTER; NICHD NIH HHS [5 R01 HD35617, R01 HD035617, P30 HD024064, 2 P30 HD24064] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; DAHL MV, 1975, ARCH DERMATOL, V111, P1603, DOI 10.1001/archderm.111.12.1603; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Francis JS, 1997, SEMIN CUTAN MED SURG, V16, P54, DOI 10.1016/S1085-5629(97)80036-3; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; GOLDBERG MF, 1993, OPHTHALMOLOGY, V100, P1645; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; JESSEN RT, 1978, ARCH DERMATOL, V114, P1182, DOI 10.1001/archderm.114.8.1182; Karkkainen MJ, 2000, NAT GENET, V25, P153, DOI 10.1038/75997; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; KIRCHMAN TTT, 1995, J MED GENET, V32, P887, DOI 10.1136/jmg.32.11.887; KUMAR A, 2000, IN PRESS J BIOL CHEM; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; MENNI S, 1990, PEDIATR DERMATOL, V7, P275, DOI 10.1111/j.1525-1470.1990.tb01024.x; MENT L, 1978, ARCH DERMATOL, V114, P1043, DOI 10.1001/archderm.114.7.1043; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; PERSON JR, 1985, J AM ACAD DERMATOL, V13, P120, DOI 10.1016/S0190-9622(85)80318-2; Roberts JL, 1998, AM J MED GENET, V75, P159, DOI 10.1002/(SICI)1096-8628(19980113)75:2<159::AID-AJMG7>3.0.CO;2-O; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; RuizMaldonado R, 1997, SEMIN CUTAN MED SURG, V16, P36, DOI 10.1016/S1085-5629(97)80034-X; Scheuerle AE, 1998, AM J MED GENET, V77, P201, DOI 10.1002/(SICI)1096-8628(19980518)77:3<201::AID-AJMG5>3.3.CO;2-N; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Smahi A, 2000, NATURE, V405, P466; SPITZ JL, 1996, GENODERMATOSES FULL, P66; Woffendin H, 1999, CLIN GENET, V55, P55, DOI 10.1034/j.1399-0004.1999.550110.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	33	102	108	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					765	771		10.1086/318806	http://dx.doi.org/10.1086/318806			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179023	Green Published, Bronze			2022-12-18	WOS:000166994200020
J	Warren, DS; Morrell, JC; Moser, HW; Valle, D; Gould, SJ				Warren, DS; Morrell, JC; Moser, HW; Valle, D; Gould, SJ			Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; INTEGRAL MEMBRANE-PROTEIN; PTS1 RECEPTOR; TARGETING SIGNAL; ZELLWEGER SYNDROME; IMPORT; ENCODES; MUTATIONS; BINDING; MEMBER	The peroxisome-biogenesis disorders (PBDs) are a group of genetically heterogeneous, lethal diseases that are characterized by neuronal, hepatic, and renal abnormalities; severe mental retardation; and, in their most severe form, death within the 1st year of life. Cells from all PBD patients exhibit decreased import of one or more classes of peroxisome matrix proteins, a phenotype shared by yeast per mutants. We identified the human orthologue of yeast PEX10 and observed that its expression rescues peroxisomal matrix-protein import in PBD patients' fibroblasts from complementation group 7 (CG7). In addition, we detected mutations on both copies of PEX10 in two unrelated CG7 patients. A Zellweger syndrome patient, PBD100, was homozygous for a splice donor-site mutation that results in exon skipping and loss of 407 bp from the PEX10 open reading frame. A more mildly affected neonatal adrenoleukodystrophy patient was a compound heterozygote for a missense mutation in the PEX10 zinc-binding domain, H290Q, and for a nonsense mutation, R125ter. Although all three mutations attenuate PEX10 activity, the two alleles detected in the mildly affected patient, PBD052, encode partially functional PEX10 proteins. PEX10-deficient PBD100 cells contain many peroxisomes and import peroxisomal membrane proteins but do not import peroxisomal matrix proteins, indicating that loss of PEX10 has its most pronounced effect on peroxisomal matrix-protein import.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER; NICHD NIH HHS [HD10891] Funding Source: Medline; NIDDK NIH HHS [DK45787] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Chang CC, 1997, NAT GENET, V15, P385, DOI 10.1038/ng0497-385; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Dyer JM, 1996, J CELL BIOL, V133, P269, DOI 10.1083/jcb.133.2.269; Eitzen GA, 1997, J CELL BIOL, V137, P1265, DOI 10.1083/jcb.137.6.1265; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Erdmann R, 1996, J CELL BIOL, V135, P111, DOI 10.1083/jcb.135.1.111; Fukuda S, 1996, AM J HUM GENET, V59, P1210; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; KALISH JE, 1995, MOL CELL BIOL, V15, P6406; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Lazarow P. B., 1995, METABOLIC MOL BASES, P2287; LAZAROW PB, 1982, ANN NY ACAD SCI, V386, P285, DOI 10.1111/j.1749-6632.1982.tb21423.x; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; MAQUAT LE, 1995, RNA, V1, P453; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; Mihalik SJ, 1997, NAT GENET, V17, P185, DOI 10.1038/ng1097-185; MOSER AB, 1995, J PEDIATR-US, V127, P13, DOI 10.1016/S0022-3476(95)70250-4; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; Okumoto K, 1997, NAT GENET, V17, P265, DOI 10.1038/ng1197-265; Portsteffen H, 1997, NAT GENET, V17, P449, DOI 10.1038/ng1297-449; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Purdue PE, 1996, J CELL BIOL, V134, P849, DOI 10.1083/jcb.134.4.849; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Sambrook J, 1989, MOL CLONING LAB MANU; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SLAWECKI ML, 1995, J CELL SCI, V108, P1817; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; TAN XQ, 1995, J CELL BIOL, V128, P307, DOI 10.1083/jcb.128.3.307; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x	42	102	104	1	6	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					347	359		10.1086/301963	http://dx.doi.org/10.1086/301963			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683594	Green Published, hybrid			2022-12-18	WOS:000075360800010
J	Krynetski, EY; Evans, WE				Krynetski, EY; Evans, WE			Pharmacogenetics of cancer therapy: Getting personal	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THIOPURINE METHYLTRANSFERASE ACTIVITY; DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY; AZATHIOPRINE-INDUCED MYELOSUPPRESSION; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEART-TRANSPLANT RECIPIENT; S-METHYLTRANSFERASE; MERCAPTOPURINE METABOLISM; ERYTHROCYTE CORRELATION; BIOCHEMICAL-PROPERTIES; CLINICAL IMPORTANCE		St Jude Childrens Res Hosp, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Evans, WE (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Evans, William E./C-2069-2012	Evans, William E./0000-0002-9333-5322	NCI NIH HHS [R37 CA36401, CA20180, CA21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, P01CA020180, R37CA036401] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chang TKH, 1997, PHARMACOGENETICS, V7, P211, DOI 10.1097/00008571-199706000-00006; CHOCAIR PR, 1992, TRANSPLANTATION, V53, P1051, DOI 10.1097/00007890-199205000-00016; Czwerwinski M, 1996, DRUG METAB DISPOS, V24, P1015; DIASIO RB, 1988, J CLIN INVEST, V81, P47, DOI 10.1172/JCI113308; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; EVANS WE, 1991, J PEDIATR-US, V119, P985, DOI 10.1016/S0022-3476(05)83063-X; GONZALEZ FJ, 1995, TRENDS PHARMACOL SCI, V16, P325, DOI 10.1016/S0165-6147(00)89065-3; GRANT DM, 1993, PHARMACOGENETICS, V3, P45, DOI 10.1097/00008571-199302000-00005; Hartsough MT, 1998, AM J HUM GENET, V63, P6, DOI 10.1086/301942; HOLLANDER AAMJ, 1995, LANCET, V345, P610, DOI 10.1016/S0140-6736(95)90520-0; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Krynetski EY, 1996, PHARMACOGENETICS, V6, P279, DOI 10.1097/00008571-199608000-00001; KRYNETSKI EY, 1995, P NATL ACAD SCI USA, V92, P949, DOI 10.1073/pnas.92.4.949; LENNARD, 1990, J CLIN ONCOL, V8, P567; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LENNARD L, 1989, J CLIN ONCOL, V7, P1816, DOI 10.1200/JCO.1989.7.12.1816; LENNARD L, 1986, CLIN PHARMACOL THER, V40, P287, DOI 10.1038/clpt.1986.178; MCLEOD HL, 1995, BLOOD, V85, P1897, DOI 10.1182/blood.V85.7.1897.bloodjournal8571897; MCLEOD HL, 1993, LANCET, V341, P1151, DOI 10.1016/0140-6736(93)93168-Z; MCLEOD HL, 1994, CLIN PHARMACOL THER, V55, P15, DOI 10.1038/clpt.1994.4; Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269; Narod SA, 1998, AM J HUM GENET, V63, P1, DOI 10.1086/301939; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; Nebert DW, 1997, AM J HUM GENET, V60, P265; Otterness D, 1997, CLIN PHARMACOL THER, V62, P60, DOI 10.1016/S0009-9236(97)90152-1; RATAIN MJ, 1991, CLIN PHARMACOL THER, V50, P573, DOI 10.1038/clpt.1991.183; SCHUTZ E, 1993, LANCET, V341, P436, DOI 10.1016/0140-6736(93)93028-Y; Szumlanski C, 1996, DNA CELL BIOL, V15, P17, DOI 10.1089/dna.1996.15.17; SZUMLANSKI CL, 1992, PHARMACOGENETICS, V2, P148, DOI 10.1097/00008571-199208000-00002; Tai HL, 1996, AM J HUM GENET, V58, P694; Tai HL, 1997, P NATL ACAD SCI USA, V94, P6444, DOI 10.1073/pnas.94.12.6444; VANLOON JA, 1982, BIOCHEM GENET, V20, P637, DOI 10.1007/BF00483962; VANLOON JA, 1992, BIOCHEM PHARMACOL, V44, P775, DOI 10.1016/0006-2952(92)90416-G; Wei XX, 1996, J CLIN INVEST, V98, P610, DOI 10.1172/JCI118830; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651; WEINSHILBOUM RM, 1978, CLIN CHIM ACTA, V85, P323, DOI 10.1016/0009-8981(78)90311-X; WOODSON LC, 1982, J PHARMACOL EXP THER, V222, P174; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003	38	102	107	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					11	16		10.1086/301941	http://dx.doi.org/10.1086/301941			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634537	Green Published, Bronze			2022-12-18	WOS:000074761000003
J	Fink, JK; Rainier, S; Wilkowski, J; Jones, SM; Kume, A; Hedera, P; Albin, R; Mathay, J; Girbach, L; Varvil, T; Otterud, B; Leppert, M				Fink, JK; Rainier, S; Wilkowski, J; Jones, SM; Kume, A; Hedera, P; Albin, R; Mathay, J; Girbach, L; Varvil, T; Otterud, B; Leppert, M			Paroxysmal dystonic choreoathetosis: Tight linkage to chromosome 2q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; SODIUM-CHANNEL; CEREBELLAR-ATAXIA; GENE; LOCALIZATION; MUTATIONS; MYOKYMIA; MAPS; FAMILIES; REGION	Paroxysmal dystonic choreoathetosis (PDC) is characterized by attacks of involuntary movements that last up to several hours and occur at rest both spontaneously and following caffeine or alcohol consumption. We analyzed a Polish-American kindred with autosomal dominant PDC and identified tight linkage between the disorder and microsatellite markers on chromosome 2q (maximum two-point LOD score 4.77; recombination fraction 0). Our results clearly establish the existence of a locus for autosomal dominant PDC on distal chromosome 2q. The fact that three other paroxysmal neurological disorders (periodic ataxia with myokymia and hypo- and hyperkalemic periodic paralysis) are due to mutation in ion-channel genes raises the possibility that PDC is also due to an ion-channel gene mutation. It is noteworthy that a cluster of sodium-channel genes is located on distal chromosome 2q, near the PDC locus. Identifying the PDC locus on chromosome 2q will facilitate discovery of the PDC gene and enable investigators to determine whether PDC is genetically homogeneous and whether other paroxysmal movement disorders are also genetically linked to the PDC locus.	VET AFFAIRS MED CTR,CTR GERIATR RES EDUC & CLIN,ANN ARBOR,MI; UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV UTAH,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT 84112	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Fink, JK (corresponding author), UNIV MICHIGAN,MED CTR,DEPT NEUROL,MED SCI RES BLDG 3,1150 W MED CTR DR,ROOM 6301,ANN ARBOR,MI 48109, USA.			Hedera, Peter/0000-0003-2699-4085	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033645] Funding Source: NIH RePORTER; NINDS NIH HHS [1R1 NS33645] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auburger G, 1996, GENOMICS, V31, P90, DOI 10.1006/geno.1996.0013; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BYRNE E, 1991, J NEUROL NEUROSUR PS, V54, P1090, DOI 10.1136/jnnp.54.12.1090; DEMIRKIRAN M, 1995, ANN NEUROL, V38, P571, DOI 10.1002/ana.410380405; FAHN S, 1987, J NEUROL NEUROSUR PS, V50, P117, DOI 10.1136/jnnp.50.1.117; FONTAINE B, 1994, NAT GENET, V6, P267, DOI 10.1038/ng0394-267; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JURKATROTT K, 1994, HUM MOL GENET, V3, P1415, DOI 10.1093/hmg/3.8.1415; LANCE JW, 1977, ANN NEUROL, V2, P285, DOI 10.1002/ana.410020405; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1989, GENOMICS, V5, P204, DOI 10.1016/0888-7543(89)90047-5; LITT M, 1994, AM J HUM GENET, V55, P702; MALO MS, 1994, P NATL ACAD SCI USA, V91, P2975, DOI 10.1073/pnas.91.8.2975; MALO MS, 1994, CYTOGENET CELL GENET, V67, P178, DOI 10.1159/000133818; MCCLATCHEY AI, 1992, NAT GENET, V2, P148, DOI 10.1038/ng1092-148; Mount LA, 1940, ARCH NEURO PSYCHIATR, V44, P841, DOI 10.1001/archneurpsyc.1940.02280100143011; NAKANO T, 1982, CLIN NEUROL, V23, P199; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; PTACEK LJ, 1994, NEUROLOGY, V44, P1500, DOI 10.1212/WNL.44.8.1500; PTACEK LJ, 1994, CELL, V77, P836; RICHARDS RN, 1968, NEUROLOGY, V18, P461, DOI 10.1212/WNL.18.5.461; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; SPURR NK, 1994, CYTOGENET CELL GENET, V67, P216, DOI 10.1159/000133857; STOFFEL M, 1994, GENOMICS, V21, P254, DOI 10.1006/geno.1994.1253; TEH BT, 1995, AM J HUM GENET, V56, P1443; VAHEDI K, 1995, ANN NEUROL, V37, P289, DOI 10.1002/ana.410370304; VONBREDERLOW B, 1995, HUM MOL GENET, V4, P279, DOI 10.1093/hmg/4.2.279	28	102	106	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					140	145						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659518				2022-12-18	WOS:A1996VL45500020
J	HOLMANS, P; CLAYTON, D				HOLMANS, P; CLAYTON, D			EFFICIENCY OF TYPING UNAFFECTED RELATIVES IN AN AFFECTED-SIB-PAIR LINKAGE STUDY WITH SINGLE-LOCUS AND MULTIPLE TIGHTLY LINKED MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; STRATEGIES; POWER	In an affected-sib-pair study, the parents are often unavailable for typing, particularly for diseases of late onset. In many cases, however, it is possible to sample unaffected siblings. It is therefore desirable to assess the contribution of such siblings to the power of such a study. The likelihood ratio introduced by Risch and improved by Holmans was extended to incorporate data from unaffected siblings. Tests based on two likelihoods were considered: the full likelihood of the data, based on the identity-by-descent (IBD) sharing states of the entire sibship, and a pseudolikelihood based on the IBD sharing states of the affected pair only, using the unaffected siblings to infer parental genotypes. The latter approach was found to be more powerful, except when penetrance was high. Typing an unaffected sibling, or just one parent, was found to give only a small increase in power except when the PIC of the marker was low. Even then, typing an unaffected relative increased the overall number of individuals that had to be typed to achieve a given power. If there is no highly informative marker locus in the area under study, it may be possible to ''build'' one by combining the alleles from two or more neighboring tightly linked loci into haplotypes. Typing two loci gave a sizeable power increase over a single locus, but typing further loci gave much smaller gains. Building haplotypes will introduce phase uncertainties, with the result that such a system will yield less power than will a single locus with the same number of alleles. This power loss was small, however, and did not affect the conclusions regarding the worth of typing unaffected relatives.	INST PUBL HLTH,MRC,BIOSTAT UNIT,CAMBRIDGE,ENGLAND	MRC Biostatistics Unit; University of Cambridge	HOLMANS, P (corresponding author), UNIV WALES COLL MED,DEPT PSYCHOL MED,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES.		Holmans, Peter/F-4518-2015	Holmans, Peter/0000-0003-0870-9412				BISHOP DT, 1990, AM J HUM GENET, V46, P254; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HOLMANS P, 1994, THESIS CAMBRIDGE U C; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEVINSON DF, 1993, PSYCHIAT GENET, V3, P45; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1992, AM J HUM GENET, V51, P673; SANDKUYL LA, 1989, MULTIPOINT MAPPING L, P117; SRIBNEY WM, 1992, AM J HUM GENET, V51, P773; WARD PJ, 1993, AM J HUM GENET, V52, P1200	14	102	103	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1221	1232						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485174				2022-12-18	WOS:A1995TA44900030
J	JOUTEL, A; DUCROS, A; VAHEDI, K; LABAUGE, P; DELRIEU, O; PINSARD, N; MANCINI, J; PONSOT, G; GOUTTIERE, F; GASTAUT, JL; MAZIACECK, J; WEISSENBACH, J; BOUSSER, MG; TOURNIERLASSERVE, E				JOUTEL, A; DUCROS, A; VAHEDI, K; LABAUGE, P; DELRIEU, O; PINSARD, N; MANCINI, J; PONSOT, G; GOUTTIERE, F; GASTAUT, JL; MAZIACECK, J; WEISSENBACH, J; BOUSSER, MG; TOURNIERLASSERVE, E			GENETIC-HETEROGENEITY OF FAMILIAL HEMIPLEGIC MIGRAINE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISMS	Familial hemiplegic migraine (FHM) is an autosomal dominant variety of migraine with aura. We previously mapped a gene responsible for this disorder to the short arm of chromosome 19, within a 30-cM interval bracketed by D19S216 and D19S215. Linkage analysis conducted on two large pedigrees did not show any evidence of heterogeneity, despite their clinical differences due to the presence, in one family, of cerebellar ataxia and nystagmus. Herein we report linkage data on seven additional FHM families including another one with cerebellar ataxia. Analysis was conducted with a set of seven markers spanning the D19S216-D19S215 interval. Two-point and multipoint lod score analyses as well as HOMOG testing provided strong evidence for genetic heterogeneity. Strong evidence of linkage was obtained in two families and of absence of linkage in four families. The posterior probability of being of the linked type was >.95 in the first two families and <.01 in four other ones. It was not possible to draw any firm conclusion for the last family. Thus, within the nine families so far tested, four were linked, including those with associated cerebellar ataxia. We could not find any clinical difference between the pure FHM families regardless of whether they were linked. In addition to the demonstration of genetic heterogeneity of FHM, this study also allowed us to establish that the most likely location of the gene was within an interval of 12 cM between D19S413 and D19S226.	HOP ST ANTOINE,INSERM,U25,PARIS,FRANCE; HOP ST ANTOINE,SERV NEUROL,PARIS,FRANCE; HOP ST VINCENT DE PAUL,SERV NEUROPEDIAT,PARIS,FRANCE; HOP NECKER ENFANTS MALAD,SERV NEUROPEDIAT,PARIS,FRANCE; CHU MONTPELLIER,NEUROL CLIN,MONTPELLIER,FRANCE; HOP ENFANTS LA TIMONE,SERV NEUROPEDIAT,PARIS,FRANCE; HOP ST MARGUERITE,SERV NEUROL,MARSEILLE,FRANCE; GENETHON,EVRY,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille			DUCROS, Anne/D-1899-2010; Joutel, Anne/K-5601-2017; Tournier-Lasserve, Elisabeth/N-7134-2017	DUCROS, Anne/0000-0001-5560-5013; Joutel, Anne/0000-0003-3963-3860; Tournier-Lasserve, Elisabeth/0000-0002-3039-1677				BLAU JN, 1955, LANCET, V2, P1115; CODINA A, 1970, REV NEUROL PARIS, V124, P526; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; Miller S. A., 1998, NUCLEIC ACIDS RES, V16, P215, DOI DOI 10.1093/NAR/16.3.1215; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OHTA M, 1967, NEUROLOGY, V17, P813, DOI 10.1212/WNL.17.8.813; Ott J., 1991, ANAL HUMAN GENETIC L; PAGES M, 1993, SEM HOP PARIS, V12, P337; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITTY CWM, 1953, J NEUROL NEUROSUR PS, V16, P172, DOI 10.1136/jnnp.16.3.172; YOUNG GF, 1970, ARCH NEUROL-CHICAGO, V23, P201, DOI 10.1001/archneur.1970.00480270011002; ZIFKIN B, 1980, ANN NEUROL, V8, P329, DOI 10.1002/ana.410080319; 1988, CEPHALALGIA S, V8, P19	15	102	107	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1994	55	6					1166	1172						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB684	7977376				2022-12-18	WOS:A1994QB68400013
J	KRAMER, PL; HEIMAN, GA; GASSER, T; OZELIUS, LJ; DELEON, D; BRIN, MF; BURKE, RE; HEWETT, J; HUNT, AL; MOSKOWITZ, C; NYGAARD, TG; WILHELMSEN, KC; FAHN, S; BREAKEFIELD, XO; RISCH, NJ; BRESSMAN, SB				KRAMER, PL; HEIMAN, GA; GASSER, T; OZELIUS, LJ; DELEON, D; BRIN, MF; BURKE, RE; HEWETT, J; HUNT, AL; MOSKOWITZ, C; NYGAARD, TG; WILHELMSEN, KC; FAHN, S; BREAKEFIELD, XO; RISCH, NJ; BRESSMAN, SB			THE DYTI GENE ON 9Q34 IS RESPONSIBLE FAR MOST CASES OF EARLY LIMB-ONSET IDIOPATHIC TORSION DYSTONIA IN NON-JEWS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL DOMINANT INHERITANCE; ASHKENAZI JEWS; SEGREGATION ANALYSIS; LINKAGE ANALYSIS; MAP	Idiopathic torsion dystonia (ITD) is characterized by involuntary twisting movements and postures. A gene for this disorder, DYT1, was mapped to chromosome 3q34 in 12 Ashkenazi Jewish (AJ) families and one large non-Jewish kindred. In the AJ population, strong linkage disequilibrium exists between DYT1 and adjacent markers within a 2-cM region. The associated haplotype occurs in >90% of early limb-onset AJ cases. We examined seven non-Jewish ITD families of northern European and French Canadian descent to determine the extent to which early-onset ITD in non-Jews maps to DYT1. Results are consistent with linkage to the DYT1 region. Affected individuals in these families are clinically similar to the AJ cases; i.e., the site of onset is predominantly in the limbs and at least one individual in each pedigree had onset before age 12 years. None carries the AJ haplotype; therefore, they probably represent different mutations in the DYT1 gene. The two French Canadian families, however, display the same haplotype. Estimates of penetrance in non-Jewish families range from .40 to .75. We identified disease gene carriers and, with adjustments for age at onset, obtained a direct estimate of penetrance of .46. This is consistent with estimates of 30%-40% in the AJ population. Two other non-Jewish families with atypical ITD (later onset and/or cranial or cervical involvement) are not linked to DYT1, which indicates involvement of other genes in dystonia.	COLUMBIA PRESBYTERIAN MED CTR,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA PRESBYTERIAN MED CTR,DYSTORIA CLIN RES CTR,DEPT NEUROL,NEW YORK,NY 10032; UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT NEUROL,MUNICH,GERMANY; MASSACHUSETTS GEN HOSP E,NEUROSCI CTR NEUROL,MOLEC NEUROGENET UNIT,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT GENET,CAMBRIDGE,MA 02138; HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,CAMBRIDGE,MA 02138; TACOMA SPECIALTY CTR,NEUROL SECT,TACOMA,WA; YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; University of Munich; Harvard University; Harvard University; Yale University; Yale University	KRAMER, PL (corresponding author), OREGON HLTH SCI UNIV,DEPT NEUROL,CDW-2,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.		Heiman, Gary A/K-2366-2018; Burke, Robert/B-7226-2011	Heiman, Gary A/0000-0001-5859-0259; Burke, Robert/0000-0002-4760-8553; Gasser, Thomas/0000-0002-1069-1146	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028384, R01NS026656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001139] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC01139] Funding Source: Medline; NINDS NIH HHS [NS28384, NS26656] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BREAKEFIELD XO, 1986, J NEUROGENET, V3, P159, DOI 10.3109/01677068609106846; BRESSMAN SB, 1994, NEUROLOGY, V44, P283, DOI 10.1212/WNL.44.2.283; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; BRESSMAN SB, IN PRESS ANN NEUROL; BRESSMAN SB, IN PRESS MOV DISORD; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; FAHN S, 1984, NEUROL CLIN, V2, P541, DOI 10.1016/S0733-8619(18)31090-9; FLETCHER NA, 1990, BRAIN, V113, P379, DOI 10.1093/brain/113.2.379; HENSKE EP, 1993, GENOMICS, V17, P587, DOI 10.1006/geno.1993.1376; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V49, P366; MARSDEN CD, 1974, BRAIN, V97, P793, DOI 10.1093/brain/97.1.793; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; OZELIUS LJ, 1992, GENOMICS, V14, P715, DOI 10.1016/S0888-7543(05)80173-9; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PAULS DL, 1990, NEUROLOGY, V40, P1107, DOI 10.1212/WNL.40.7.1107; RISCH NJ, 1990, AM J HUM GENET, V46, P533; RISCH NJ, 1991, OCT UK ISR BIN S MOL, pA24; SCHAFFER AA, IN PRESS HUM HERED; WADDY HM, 1991, ANN NEUROL, V29, P320, DOI 10.1002/ana.410290315; WARNER TT, 1993, BRAIN, V116, P739, DOI 10.1093/brain/116.3.739	26	102	106	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1994	55	3					468	475						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PF509	8079990				2022-12-18	WOS:A1994PF50900008
J	JODICE, C; MALASPINA, P; PERSICHETTI, F; NOVELLETTO, A; SPADARO, M; GIUNTI, P; MOROCUTTI, C; TERRENATO, L; HARDING, AE; FRONTALI, M				JODICE, C; MALASPINA, P; PERSICHETTI, F; NOVELLETTO, A; SPADARO, M; GIUNTI, P; MOROCUTTI, C; TERRENATO, L; HARDING, AE; FRONTALI, M			EFFECT OF TRINUCLEOTIDE REPEAT LENGTH AND PARENTAL SEX ON PHENOTYPIC VARIATION IN SPINOCEREBELLAR ATAXIA-I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBELLAR-ATAXIA; LARGE KINDREDS; CAG REPEAT; GENE; LOCUS; MAPS; MECHANISM; TYPE-1; SCA1	Trinucleotide repeat expansion has been found in 64 subjects from 19 families: 57 patients with SCA1 and 7 subjects predicted, by haplotype analysis, to carry the mutation. Comparison with a large set of normal chromosomes shows two distinct distributions, with a much wider variation among expanded chromosomes. The sex of transmitting parent plays a major role in the size distribution of expanded alleles, those with >54 repeats being transmitted by affected fathers exclusively. Our data suggest that alleles with >54 repeats have a reduced chance of survival; these appear to be replaced in each generation by further expansion of alleles in the low- to medium-expanded repeat range, preferentially in male transmissions. Detailed clinical follow-up of a subset of our patients demonstrates significant relationships between increasing repeat number on expanded chromosomes and earlier age at onset, faster progression of the disease, and earlier age at death.	UNIV ROMA LA SAPIENZA,IST CLIN MALATTIE NERVOSE & MENTALI,ROME,ITALY; CNR,IST MED SPERIMENTALE,I-00137 ROME,ITALY; INST NEUROL,LONDON,ENGLAND	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); University of London; University College London	JODICE, C (corresponding author), UNIV ROMA TOR VERGATA,DEPT BIOL,VIA RIC SCI,I-00133 ROME,ITALY.		Giunti, Paola/E-5526-2012; Malaspina, Patrizia/G-7772-2017	Giunti, Paola/0000-0003-3508-4788; iodice, carla/0000-0002-1549-5005; Malaspina, Patrizia/0000-0002-0067-369X; Novelletto, Andrea/0000-0002-1146-7680; Persichetti, Francesca/0000-0002-9804-644X	Telethon [358] Funding Source: Medline	Telethon(Fondazione Telethon)		CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; HARDING AE, 1981, J MED GENET, V18, P436, DOI 10.1136/jmg.18.6.436; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; JODICE C, 1993, HUM MOL GENET, V2, P1383, DOI 10.1093/hmg/2.9.1383; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MORTON NE, 1980, AM J MED GENET, V6, P251, DOI 10.1002/ajmg.1320060309; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RANUM LPW, 1991, AM J HUM GENET, V49, P31; SHRIMPTON AE, 1993, J MED GENET, V30, P616, DOI 10.1136/jmg.30.7.616; SPADARO M, 1992, ACTA NEUROL SCAND, V85, P257; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; 1993, CELL, V72, P971	17	102	102	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1994	54	6					959	965						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NP053	8198139				2022-12-18	WOS:A1994NP05300004
J	SCHELLENBERG, GD; ANDERSON, L; ODAHL, S; WISJMAN, EM; SADOVNICK, AD; BALL, MJ; LARSON, EB; KUKULL, WA; MARTIN, GM; ROSES, AD; BIRD, TD				SCHELLENBERG, GD; ANDERSON, L; ODAHL, S; WISJMAN, EM; SADOVNICK, AD; BALL, MJ; LARSON, EB; KUKULL, WA; MARTIN, GM; ROSES, AD; BIRD, TD			APP717, APP693, AND PRIP GENE-MUTATIONS ARE RARE IN ALZHEIMER-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERSTMANN-STRAUSSLER SYNDROME; HEREDITARY CEREBRAL-HEMORRHAGE; CREUTZFELDT-JAKOB DISEASE; BETA-PROTEIN GENE; FAMILIAL DEMENTIA; DUTCH TYPE; LINKAGE; CHROMOSOME-21; PRECURSOR; DEFECT	The amyloid precursor protein (APP) gene codes for the precursor to the beta-protein found in the amyloid deposits of Alzheimer disease (AD). Recently Goate et al. identified in codon 717 of this gene a missense mutation which segregates with AD in a familial AD (FAD) kindred. The same mutation was also found in affected subjects from a second FAD family but not in other FAD families or in normal controls. The following work was undertaken to determine the frequency of the codon 717 mutation in FAD and nonfamilial AD cases and in normal controls. We tested 76 FAD families, 127 "sporadic" AD subjects, 16 Down syndrome cases, and 256 normal controls for this mutation, and none were positive. We also tested for the APP codon 693 mutation associated with hereditary cerebral hemorrhage with amyloidosis-Dutch type, for PRIP gene missense mutations at codons 102, 117, and 200, and for the PRIP insertion mutations which are associated with Creutzfeld-Jakob disease and Gerstmann-Straussler Scheinker syndrome. No examples of these mutations were found in our population. Thus these APP and PRIP mutations are rare in both FAD and nonfamilial AD.	UNIV WASHINGTON,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; VET ADM MED CTR,DIV NEUROL,SEATTLE,WA 98108; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1W5,BC,CANADA; OREGON HLTH SCI UNIV,DIV NEUROPATHOL,PORTLAND,OR 97201; DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,DURHAM,NC 27710	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of British Columbia; Oregon Health & Science University; Duke University	SCHELLENBERG, GD (corresponding author), UNIV WASHINGTON,DIV NEUROL,RG-27,SEATTLE,WA 98195, USA.			Kukull, Walter/0000-0001-8761-9014	NATIONAL INSTITUTE ON AGING [P50AG005136, R35AG007922] Funding Source: NIH RePORTER; NIA NIH HHS [AG05128, AG05136, AG07922] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; COLLINGE J, 1989, LANCET, V2, P15, DOI 10.1016/S0140-6736(89)90256-0; COLLINGE J, 1990, LANCET, V336, P7, DOI 10.1016/0140-6736(90)91518-F; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; OWEN F, 1989, LANCET, V1, P51; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; PRELLI F, 1988, BIOCHEM BIOPH RES CO, V151, P1150, DOI 10.1016/S0006-291X(88)80486-8; SCHELLENBERG GD, 1987, J NEUROGENET, V4, P97, DOI 10.3109/01677068709102337; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729	28	102	106	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					511	517						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1679288				2022-12-18	WOS:A1991GE36700002
J	MEINER, V; LANDSBERGER, D; BERKMAN, N; RESHEF, A; SEGAL, P; SEFTEL, HC; VANDERWESTHUYZEN, DR; JEENAH, MS; COETZEE, GA; LEITERSDORF, E				MEINER, V; LANDSBERGER, D; BERKMAN, N; RESHEF, A; SEGAL, P; SEFTEL, HC; VANDERWESTHUYZEN, DR; JEENAH, MS; COETZEE, GA; LEITERSDORF, E			A COMMON LITHUANIAN MUTATION CAUSING FAMILIAL HYPERCHOLESTEROLEMIA IN ASHKENAZI JEWS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; GENE; DNA; HETERODUPLEXES; PHENOTYPE; DELETION; DISEASE; LOCUS	Familial hypercholesterolemia (FH) is an autosomal dominant disease caused by mutations in the low-density-lipoprotein (LDL) receptor. Here we characterize an LDL-receptor founder mutation that is associated with a distinct LDL-receptor haplotype and is responsible for FH in 35% of 71 Jewish-Ashkenazi FH families in Israel. Sixty four percent (16/25) of the Ashkenazi patients who carry this mutant allele were of Lithuanian origin. The mutation was not found in 47 non-Ashkenazi FH families. This mutation was prevalent (8/10 FH cases) in the Jewish community in South Africa, which originated mainly from Lithuania. The mutation, a 3-bp in-frame deletion that would result in the elimination of Gly197, has been previously designated FH-Piscataway. PCR amplification of a DNA fragment that includes the mutation in heterozygous individuals results in the formation of a heteroduplex that can be demonstrated by PAGE and used for molecular diagnosis.	HADASSAH UNIV HOSP,DEPT INTERNAL MED B,IL-91120 JERUSALEM,ISRAEL; HADASSAH UNIV HOSP,LIPID RES LAB,IL-91120 JERUSALEM,ISRAEL; CHAIM SHEBA MED CTR,DIABET & LIPID UNIT,IL-52621 TEL HASHOMER,ISRAEL; UNIV WITWATERSRAND,DEPT MED,JOHANNESBURG 2001,SOUTH AFRICA; UNIV CAPE TOWN,SCH MED,DEPT MED BIOCHEM,CELL BIOL ATHEROSCLEROSIS RES UNIT,MRC,CAPE TOWN,SOUTH AFRICA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Chaim Sheba Medical Center; University of Witwatersrand; University of Cape Town			Coetzee, Gerhard/AAG-8439-2019; coetzee, Gerhard/AAT-6203-2020	Coetzee, Gerhard/0000-0001-8820-8364				AALTOSETALA K, 1989, J CLIN INVEST, V84, P499, DOI 10.1172/JCI114192; Ankori Zvi., 1979, GENETIC DIS ASHKENAZ, P19; Bonn?-Tamir Batsheva., 1979, GENETIC DISEASES ASH, P59; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GAR J, 1971, JUDAICA ENCY, P362; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; HOBBS HH, 1986, J BIOL CHEM, V261, P3114; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; HOBBS HH, 1987, NEW ENGL J MED, V317, P734, DOI 10.1056/NEJM198709173171204; KHACHADURIAN AK, 1973, NUTR METAB, V15, P132; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; LEITERSDORF E, 1989, J CLIN INVEST, V84, P954, DOI 10.1172/JCI114258; LEITERSDORF E, 1990, J CLIN INVEST, V85, P1014, DOI 10.1172/JCI114531; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; MOORJANI S, 1989, ARTERIOSCLEROSIS, V9, P212; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NAVON R, 1990, AM J HUM GENET, V46, P817; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEFTEL HC, 1980, BRIT MED J, V281, P633, DOI 10.1136/bmj.281.6241.633; SEFTEL HC, 1989, AM J MED GENET, V34, P545, DOI 10.1002/ajmg.1320340418; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TRIGGSRAINE BL, 1990, AM J HUM GENET, V46, P183	23	102	103	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					443	449						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867200				2022-12-18	WOS:A1991GA86600023
J	CHAKRABORTY, R				CHAKRABORTY, R			MITOCHONDRIAL-DNA POLYMORPHISM REVEALS HIDDEN HETEROGENEITY WITHIN SOME ASIAN POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											CHAKRABORTY, R (corresponding author), UNIV TEXAS, GRAD SCH BIOMED SCI, CTR DEMOG & POPULAT GENET, POB 20334, HOUSTON, TX 77225 USA.				NIGMS NIH HHS [GM 41399] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041399] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLANC H, 1983, AM J HUM GENET, V35, P167; BREGA A, 1986, AM J HUM GENET, V39, P502; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; CANN RL, 1983, GENETICS, V104, P699; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CANN RL, 1982, HUMAN GENETICS A, P157; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; CHAKRABORTY R, 1982, THEOR POPUL BIOL, V21, P205, DOI 10.1016/0040-5809(82)90014-4; CHAKRABORTY R, 1990, AM J HUM BIOL, V2, P1, DOI 10.1002/ajhb.1310020102; CHAKRABORTY R, IN PRESS ANTHR ANZ; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; ELLEPOLA SB, 1986, CEYLON J MED SCI, V29, P1; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FUERST PA, 1977, GENETICS, V86, P455; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1987, HUM GENET, V74, P177; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KIMURA M, 1964, GENETICS, V49, P725; LI WH, 1975, GENET RES, V25, P229, DOI 10.1017/S0016672300015664; MARUYAMA T, 1985, GENETICS, V111, P691; MARUYAMA T, 1984, GENETICS, V108, P745; NEEL JV, 1988, AM J HUM GENET, V43, P870; NEI M, 1974, GENETICS, V76, P379; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1966, HEREDITY, V21, P183, DOI 10.1038/hdy.1966.17; NEI M, 1978, GENETICS, V89, P583; NEI M, 1966, HEREDITY, V21, P9, DOI 10.1038/hdy.1966.2; Nei M., 1987, MOL EVOLUTIONARY GEN; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; OHTA T, 1976, THEOR POPUL BIOL, V10, P254, DOI 10.1016/0040-5809(76)90019-8; OMOTO K, 1978, AM J HUM GENET, V30, P190; OMOTO K, 1972, Human Biology in Oceania, V1, P278; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1984, THEOR POPUL BIOL, V26, P387, DOI 10.1016/0040-5809(84)90042-X; WHITTAM TS, 1986, P NATL ACAD SCI USA, V83, P9611, DOI 10.1073/pnas.83.24.9611; ZOUROS E, 1979, GENETICS, V92, P623	37	102	107	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					87	94						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349953				2022-12-18	WOS:A1990DK48200012
J	KISHI, K; YASUDA, T; IKEHARA, Y; SAWAZAKI, K; SATO, W; LIDA, R				KISHI, K; YASUDA, T; IKEHARA, Y; SAWAZAKI, K; SATO, W; LIDA, R			HUMAN SERUM DEOXYRIBONUCLEASE-I (DNASE-I) POLYMORPHISM - PATTERN SIMILARITIES AMONG ISOZYMES FROM SERUM, URINE, KIDNEY, LIVER, AND PANCREAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											KISHI, K (corresponding author), FUKUI MED SCH,DEPT LEGAL MED,MATSUOKA CHO,FUKUI 91011,JAPAN.							DONAHUE JK, 1958, SURGERY, V44, P1070; GAVASTO F, 1959, CLIN CHIM ACTA, V4, P192; GUPTA S, 1963, ARCH BIOCHEM BIOPHYS, V101, P88, DOI 10.1016/0003-9861(63)90538-1; HERRIOTT RM, 1961, NATURE, V189, P817, DOI 10.1038/189817a0; ITO K, 1984, J BIOCHEM, V95, P1399, DOI 10.1093/oxfordjournals.jbchem.a134747; KIM HS, 1982, ANAL BIOCHEM, V119, P96, DOI 10.1016/0003-2697(82)90671-6; KISHI K, 1987, HUM GENET, V75, P209, DOI 10.1007/BF00281060; KISHI K, 1989, HUM GENET, V81, P295; KISHI K, 1982, P JPN ACAD B-PHYS, V58, P229, DOI 10.2183/pjab.58.229; KISHI K, IN PRESS FORENSIC SC; KOWLESSAR OD, 1956, J CLIN INVEST, V35, P1325, DOI 10.1172/JCI103388; Laskowski M., 1971, HYDROLYSIS, V4, P289; LIAO TH, 1973, J BIOL CHEM, V248, P1489; LOVE JD, 1979, J BIOL CHEM, V254, P2588; MIZUTA K, 1989, BIOCHEM GENET, V27, P731; SALNIKOW J, 1973, J BIOL CHEM, V248, P1480; STRONG JE, 1975, ISOZYMES, V3, P473; SUCK D, 1984, EMBO J, V3, P2423, DOI 10.1002/j.1460-2075.1984.tb02149.x; WROBLEWSKI F, 1950, P SOC EXP BIOL MED, V74, P443; YASUDA T, 1989, HUM GENET, V82, P89, DOI 10.1007/BF00288282; YASUDA T, 1988, BIOCHIM BIOPHYS ACTA, V966, P107, DOI 10.1016/0304-4165(88)90134-1; YASUDA T, 1988, AM J HUM GENET, V42, P608; YASUDA T, 1989, ANAL BIOCHEM, V183, P84, DOI 10.1016/0003-2697(89)90175-9; YASUDA T, IN PRESS ARCH BIOCH; ZOLLNER EJ, 1974, ANAL BIOCHEM, V58, P71, DOI 10.1016/0003-2697(74)90442-4	25	102	108	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					121	126						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349940				2022-12-18	WOS:A1990DK48200017
J	ROULEAU, GA; SEIZINGER, BR; WERTELECKI, W; HAINES, JL; SUPERNEAU, DW; MARTUZA, RL; GUSELLA, JF				ROULEAU, GA; SEIZINGER, BR; WERTELECKI, W; HAINES, JL; SUPERNEAU, DW; MARTUZA, RL; GUSELLA, JF			FLANKING MARKERS BRACKET THE NEUROFIBROMATOSIS TYPE-2 (NF2) GENE ON CHROMOSOME-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MASSACHUSETTS GEN HOSP E,CTR NEUROSCI,149-13TH ST,6TH FLOOR,BOSTON,MA 02129; MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DEPT SURG,NEUROSURG SERV,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNIV SO ALABAMA,DEPT MED GENET,MOBILE,AL 36688	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of South Alabama			Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K07NS000654, R01NS020012, R01NS022224] Funding Source: NIH RePORTER; NINDS NIH HHS [NS00654, NS22224, NS20012] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BOLGER GB, 1985, NEW ENGL J MED, V312, P564, DOI 10.1056/NEJM198502283120907; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; DUMANSKI JP, 1987, P NATL ACAD SCI USA, V84, P9275, DOI 10.1073/pnas.84.24.9275; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HANSEN MF, 1986, TRENDS GENET, V2, P299; Hodge SE, 1979, AM J HUM GENET, V31, P761; HOFKER MH, 1985, NUCLEIC ACIDS RES, V13, P7167, DOI 10.1093/nar/13.19.7167; JULIER C, 1988, AM J HUM GENET, V42, P297; KAPLAN JC, 1987, J MED GENET, V24, P65, DOI 10.1136/jmg.24.2.65; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; OKAZAKI M, 1988, MOL BIOL MED, V5, P15; OTT J, 1976, AM J HUM GENET, V28, P528; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; ROSCHMANN E, 1987, NUCLEIC ACIDS RES, V15, P1883, DOI 10.1093/nar/15.4.1883; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; ROULEAU GA, 1989, GENOMICS, V4, P1, DOI 10.1016/0888-7543(89)90306-6; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; SEIZINGER BR, 1987, SCIENCE, V236, P317, DOI 10.1126/science.3105060; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; WERTELECKI W, 1988, NEW ENGL J MED, V319, P278, DOI 10.1056/NEJM198808043190505	26	102	107	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					323	328						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	2105641				2022-12-18	WOS:A1990CM93800013
J	FORD, JH; SCHULTZ, CJ; CORRELL, AT				FORD, JH; SCHULTZ, CJ; CORRELL, AT			CHROMOSOME ELIMINATION IN MICRONUCLEI - A COMMON CAUSE OF HYPOPLOIDY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											FORD, JH (corresponding author), QUEEN ELIZABETH HOSP,DEPT GENET,WOODVILLE,SA 5011,AUSTRALIA.		Ford, Judith Helen/C-1355-2009; Ford, Judith/AAG-8609-2019	Ford, Judith Helen/0000-0001-8978-1744; 				BROWN T, 1983, MUTAT RES, V122, P403, DOI 10.1016/0165-7992(83)90027-1; CORRELL AT, 1987, MUTAT RES, V190, P137, DOI 10.1016/0165-7992(87)90045-5; FENECH M, 1985, CYTOBIOS, V43, P233; FITZGERALD PH, 1977, HUM GENET, V39, P329, DOI 10.1007/BF00295428; FORD CE, 1981, TRISOMY, V21, P103; FORD JH, 1987, CYTOBIOS, V51, P183; FORD JH, 1982, CYTOGENET CELL GENET, V33, P327, DOI 10.1159/000131779; FORD JH, 1984, CYTOBIOS, V39, P81; FORD JH, 1983, CYTOGENET CELL GENET, V36, P537, DOI 10.1159/000131969; PETERS GB, 1981, CHROMOSOMA, V81, P593, DOI 10.1007/BF00285852; RIDLER MAC, 1968, J CELL SCI, V3, P595; RUDD NL, 1986, 7TH INT C HUM GEN 1, P134; VIAGGI S, 1987, MUTAGENESIS, V2, P367, DOI 10.1093/mutage/2.5.367	13	102	104	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1988	43	5					733	740						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q9336	3189336				2022-12-18	WOS:A1988Q933600020
J	BOEHNKE, M				BOEHNKE, M			ESTIMATING THE POWER OF A PROPOSED LINKAGE STUDY - A PRACTICAL COMPUTER-SIMULATION APPROACH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BOEHNKE, M (corresponding author), UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,ANN ARBOR,MI 48109, USA.				NATIONAL CANCER INSTITUTE [P01CA026803] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024489] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA-26803] Funding Source: Medline; NHLBI NIH HHS [R01-HL-24489] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bishop D.T., 1983, STAT ANAL DNA SEQUEN, P181; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CHOTAI J, 1984, ANN HUM GENET, V48, P359, DOI 10.1111/j.1469-1809.1984.tb00849.x; DAHLQUIST G, 1974, NUMERICAL METHODS, P266; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; ELSTON RC, 1984, GENETIC EPIDEMIOLOGY, P349; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; LANGE K, 1982, AM J HUM GENET, V34, P842; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1976, AM J HUM GENET, V28, P528; OTT J, 1985, ANAL HUMAN GENETIC L, P40; RAO CR, 1973, LINEAR STAT INFERENC, P329; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; SKOLNICK MH, 1984, GENETIC EPIDEMIOLOGY, P271; Thompson E. A., 1978, GENETIC EPIDEMIOLOGY, P247	17	102	103	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1986	39	4					513	527						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	E7063	3464203				2022-12-18	WOS:A1986E706300009
J	HARPER, ME; BARRERASALDANA, HA; SAUNDERS, GF				HARPER, ME; BARRERASALDANA, HA; SAUNDERS, GF			CHROMOSOMAL LOCALIZATION OF THE HUMAN PLACENTAL LACTOGEN-GROWTH HORMONE GENE-CLUSTER TO 17Q22-24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,GRAD SCH BIOMED SCI,HOUSTON,TX 77030	University of Texas System	HARPER, ME (corresponding author), UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOCHEM,HOUSTON,TX 77030, USA.			Barrera Saldana, Hugo A./0000-0003-1587-4571	NATIONAL CANCER INSTITUTE [R01CA020124, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA-20124, CA-16672] Funding Source: Medline; NIGMS NIH HHS [GM-23965] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; CHANDLER ME, 1979, SCIENCE, V205, P908, DOI 10.1126/science.472711; DEISSEROTH A, 1977, CELL, V12, P205, DOI 10.1016/0092-8674(77)90198-2; FIDDES JC, 1979, P NATL ACAD SCI USA, V76, P4294, DOI 10.1073/pnas.76.9.4294; GOODMAN HM, 1980, MOBILIZATION REASSEM, P155; GUSELLA JF, 1980, P NATL ACAD SCI-BIOL, V77, P2829, DOI 10.1073/pnas.77.5.2829; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; JEFFREYS AJ, 1979, NATURE, V281, P606, DOI 10.1038/281606a0; KATZ L, 1973, J BACTERIOL, V114, P577, DOI 10.1128/JB.114.2.577-591.1973; LAI EC, 1979, CELL, V16, P201; LAWN RM, 1978, CELL, V15, P1157, DOI 10.1016/0092-8674(78)90043-0; MCKUSICK VA, 1977, SCIENCE, V196, P390, DOI 10.1126/science.850784; MCWILLIAMS D, 1977, P NATL ACAD SCI USA, V74, P1024, DOI 10.1073/pnas.74.3.1024; NIALL HD, 1971, P NATL ACAD SCI USA, V68, P866, DOI 10.1073/pnas.68.4.866; OHTA T, 1971, NATURE, V233, P118, DOI 10.1038/233118a0; OWERBACH D, 1980, SCIENCE, V209, P289, DOI 10.1126/science.7384802; OWERBACH D, 1981, SCIENCE, V212, P815, DOI 10.1126/science.7221563; SAHASRABUDDHE CG, 1977, NUCLEIC ACIDS RES, V4, P853, DOI 10.1093/nar/4.4.853; SHINE J, 1977, NATURE, V270, P494, DOI 10.1038/270494a0; SHOME B, 1977, J CLIN ENDOCR METAB, V45, P1112, DOI 10.1210/jcem-45-5-1112; Smith H O, 1980, Methods Enzymol, V65, P371; WILHELM X, 1969, EUR J BIOCHEM, V10, P102; Yu L C, 1978, Cold Spring Harb Symp Quant Biol, V42 Pt 2, P1101; YUNIS JJ, 1978, CYTOGENET CELL GENET, V22, P679, DOI 10.1159/000131052; YUNIS JJ, 1977, CHROMOSOMA, V61, P335, DOI 10.1007/BF00288617; YUNIS JJ, 1977, PROGR CLIN PATHOL, V7, P267; 1979, BIRTH DEFECTS OAS, V15, P11	27	102	102	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	2					227	234						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH732	7072716				2022-12-18	WOS:A1982NH73200006
J	GALL, JC; BREWER, GJ; DERN, RJ				GALL, JC; BREWER, GJ; DERN, RJ			STUDIES OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACTIVITY OF INDIVIDUAL ERYTHROCYTES - METHEMOGLOBIN-ELUTION TEST FOR IDENTICATION OF FEMALES HETEROZYGOUS FOR G6PD DEFICIENTY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1964, LANCET, V1, P189; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BEUTLER E, 1963, BLOOD, V22, P323, DOI 10.1182/blood.V22.3.323.323; BREWER G J, 1960, Bull World Health Organ, V22, P633; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; Evelyn KA, 1938, J BIOL CHEM, V126, P655; FRISCHER H, 1964, 10 C INT SOC HEM; FRISCHER H, 1964, CLIN RES, V12, P86; KLEIHAUER E, 1963, NATURE, V199, P1196, DOI 10.1038/1991196b0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; SANSONE G, 1963, Pathologica, V55, P371; TARLOV AR, 1962, ARCH INTERN MED, V109, P209, DOI 10.1001/archinte.1962.03620140081013; TONZ O, 1964, NATURE, V202, P606, DOI 10.1038/202606b0; ZINKHAM WH, 1959, J PEDIATR-US, V55, P319, DOI 10.1016/S0022-3476(59)80228-6	14	102	102	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	4					359	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	66220	17948502				2022-12-18	WOS:A19656622000008
J	MORTON, NE				MORTON, NE			THE MUTATIONAL LOAD DUE TO DETRIMENTAL GENES IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEMISS SM, 1858, T AM MED ASS, V11, P319; BOOK JA, 1957, ANN HUM GENET, V21, P191; CARTER TC, 1957, BRIT J RADIOL, V30, P641, DOI 10.1259/0007-1285-30-360-641; CHU EHY, 1959, AM J HUM GENET, V11, P63; CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; CROW JAMES F., 1958, HUMAN BIOL, V30, P1; DEWEY WJ, 1960, UNPUB; GREENBERG R, GENETICS; KROOTH RS, 1957, AM J HUM GENET, V9, P170; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LERNER IM, 1954, GENETIC HOMCOSTASIS; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1959, AM J HUM GENET, V11, P360; MULLER HJ, 1950, AM J HUM GENET, V2, P111; NEEL J. V., 1953, JAPANESE JOUR GENETICS, V28, P211, DOI 10.1266/jjg.28.211; NEEL JV, 1949, AM J HUM GENET, V1, P156; NEEL JV, 1958, AM J HUM GENET, V10, P398; NEEL JV, 1956, NAT ACAD SC NAT RES, V461; OSTER II, 1959, SCIENCE, V130, P1423; Penrose Lionel, 1949, BIOL MENTAL DEFECT; PENROSE LS, 1959, AM J HUMAN GENET, V11, P81; PENROSE LS, 1938, GREAT BRITAIN MEDICA, V229, P1; RUSSELL WL, 1958, SCIENCE, V128, P1546, DOI 10.1126/science.128.3338.1546; SCHULL WJ, 1958, SCIENCE, V128, P343, DOI 10.1126/science.128.3320.343; SCHULL WJ, 1958, AM J HUM GENET, V10, P294; SLATIS HERMAN M., 1958, ANN HUMAN GENETICS, V22, P153; SLATIS HM, 1958, AM J HUM GENET, V10, P446; SLATIS HM, 1960, GENETICS; STEVENSON AC, 1956, ANN HUM GENET, V20, P177; SUTTER J, 1958, RECHERCHES EFFETS CO; Sutter J, 1951, POPULATION, V6, P59, DOI 10.2307/1523486; Wright S, 1935, J GENET, V30, P243, DOI 10.1007/BF02982239; Wright S., 1949, P365; WRIGHT S, 1950, J CELL COMPAR PHYSL, V35, P187, DOI 10.1002/jcp.1030350414	35	102	102	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	3					348	364						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF079	14424476				2022-12-18	WOS:A1960WF07900007
J	OSBORNE, RH; HOROWITZ, SL; DEGEORGE, FV				OSBORNE, RH; HOROWITZ, SL; DEGEORGE, FV			GENETIC VARIATION IN TOOTH DIMENSIONS - TWIN STUDY OF THE PERMANENT ANTERIOR TEETH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; DAHLBERG AA, 1949, 4TH VIK FUND SUMM SE, P138; FISHER RA, 1954, STATISTICAL METHODS; HOOTON EA, 1947, UP APE; KINGSLEY NW, 1888, TREATISE ORAL DEFORM; KORKHAUS G, 1930, Z ANAT ENTWICKLUNGS, V91, P594; LASKER GW, 1950, COLD SPRING HARB SYM, V15, P191, DOI 10.1101/SQB.1950.015.01.021; Lerner I. M., 1950, POPULATION GENETICS; LUNDSTROM A, 1948, TOOTH SIZE OCCLUSION; Moorrees C.F.A., 1957, ALEUT DENTITION; MOORREES CFA, 1951, J DENT RES, V30, P815, DOI 10.1177/00220345510300061201; MOORREES COENRAAD F. A., 1957, JOUR DENTAL RES, V36, P39, DOI 10.1177/00220345570360011501; OSBORNE RH, 1956, DISS ABSTR; PRICE B, 1950, AM J HUM GENET, V2, P293; Schour I., 1940, J AM DENT ASSOC, V27, P1778; SCHOUR I, 1955, ANALYSIS DEVELOPMENT, P492; SEIPEL CM, 1946, SVENSK TANDL TIDSK S, P39	17	102	103	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1958	10	3					350	356						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA220	13571223				2022-12-18	WOS:A1958WA22000007
J	Oosterhof, N; Chang, IJ; Karimiani, EG; Kuil, LE; Jensen, DM; Daza, R; Young, E; Astle, L; van der Linde, HC; Shivaram, GM; Demmers, J; Latimer, CS; Keene, CD; Loter, E; Maroofian, R; van Ham, TJ; Hevner, RF; Bennett, JT				Oosterhof, Nynke; Chang, Irene J.; Karimiani, Ehsan Ghayoor; Kuil, Laura E.; Jensen, Dana M.; Daza, Ray; Young, Erica; Astle, Lee; van der Linde, Herma C.; Shivaram, Giridhar M.; Demmers, Jeroen; Latimer, Caitlin S.; Keene, C. Dirk; Loter, Emily; Maroofian, Reza; van Ham, Tjakko J.; Hevner, Robert F.; Bennett, James T.			Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY; AXONAL SPHEROIDS; EXPRESSION PATTERNS; EARLY MACROPHAGES; REVEALS; BRAIN; DIFFERENTIATION; PROGENITOR; ZEBRAFISH; DAP12	Microglia are CNS-resident macrophages that scavenge debris and regulate immune responses. Proliferation and development of macrophages, including microglia, requires Colony Stimulating Factor 1 Receptor (CSF1R), a gene previously associated with a dominant adult-onset neurological condition (adult-onset leukoencephalopathy with axonal spheroids and pigmented glia). Here, we report two unrelated individuals with homozygous CSF1R mutations whose presentation was distinct from ALSP. Post-mortem examination of an individual with a homozygous splice mutation (c. 1754 - 1G>C) demonstrated several structural brain anomalies, including agenesis of corpus callosum. Immunostaining demonstrated almost complete absence of microglia within this brain, suggesting that it developed in the absence of microglia. The second individual had a homozygous missense mutation (c. 1929C> A [p. His643Gln]) and presented with developmental delay and epilepsy in childhood. We analyzed a zebrafish model (csf1r(DM)) lacking Csf1r function and found that their brains also lacked microglia and had reduced levels of CUX1, a neuronal transcription factor. CUX1(+) neurons were also reduced in sections of homozygous CSF1R mutant human brain, identifying an evolutionarily conserved role for CSF1R signaling in production or maintenance of CUX1(+) neurons. Since a large fraction of CUX1(+) neurons project callosal axons, we speculate that microglia deficiency may contribute to agenesis of the corpus callosum via reduction in CUX1(+) neurons. Our results suggest that CSF1R is required for human brain development and establish the csf1r DM fish as a model for microgliopathies. In addition, our results exemplify an under-recognized form of phenotypic expansion, in which genes associated with well-recognized, dominant conditions produce different phenotypes when biallelically mutated.	[Oosterhof, Nynke; Kuil, Laura E.; van der Linde, Herma C.; van Ham, Tjakko J.] Univ Med Ctr Rotterdam, Dept Clin Genet, Erasmus MC, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Chang, Irene J.; Bennett, James T.] Univ Washington, Dept Pediat, Div Med Genet, Sch Med, Seattle, WA 98195 USA; [Karimiani, Ehsan Ghayoor] Univ London, Genet Res Ctr, Mol & Clin Sci Inst, Cranmer Terrace, London SW17 0RE, England; [Jensen, Dana M.; Bennett, James T.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Daza, Ray; Young, Erica; Hevner, Robert F.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Astle, Lee] Alaska Native Med Ctr, Dept Lab & Pathol, Anchorage, AK 99508 USA; [Shivaram, Giridhar M.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA 98105 USA; [Demmers, Jeroen] Erasmus Univ, Prote Ctr, Med Ctr, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Latimer, Caitlin S.; Keene, C. Dirk; Hevner, Robert F.] Univ Washington, Dept Pathol, Sch Med, Seattle, WA 98195 USA; [Loter, Emily] Seattle Childrens Hosp, Dept Labs, Seattle, WA 98105 USA; [Maroofian, Reza] UCL Inst Neurol, Dept Neuromuscular Disorders, Queen Sq, London WC1N 3BG, England; [Maroofian, Reza] UCL Inst Neurol, Dept Clin & Expt Epilepsy, Queen Sq, London WC1N 3BG, England; [Oosterhof, Nynke] Univ Med Ctr Groningen, European Res Inst Biol Ageing, Antonius Deusinglaan,1, NL-9713 AV Groningen, Netherlands; [Daza, Ray; Hevner, Robert F.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; St Georges University London; University of London; Seattle Children's Hospital; Seattle Children's Hospital; Alaska Native Medical Center; Seattle Children's Hospital; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of London; University College London; University of London; University College London; University of Groningen; University of California System; University of California San Diego	van Ham, TJ (corresponding author), Univ Med Ctr Rotterdam, Dept Clin Genet, Erasmus MC, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.; Bennett, JT (corresponding author), Univ Washington, Dept Pediat, Div Med Genet, Sch Med, Seattle, WA 98195 USA.; Bennett, JT (corresponding author), Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA.	t.vanham@erasmusmc.nl; jtbenn@uw.edu	Oosterhof, Nynke/AAK-1820-2021; Demmers, Jeroen AA/F-4046-2016; Ghayoor Karimiani, Ehsan/AFS-7844-2022; van Ham, Tjakko/W-8614-2019	Demmers, Jeroen AA/0000-0002-8757-9611; van Ham, Tjakko/0000-0002-2175-8713; Oosterhof, Nynke/0000-0001-7286-0526	NIH [T32GM007454, AG005136]; Nancy and Buster Alvord Endowed Chair for Neuropathology; Burroughs Wellcome Fund Career Award for Medical Scientists; Arnold Lee Smith Endowed Professorship for Research Faculty Development; Erasmus University Rotterdam fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy and Buster Alvord Endowed Chair for Neuropathology; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Arnold Lee Smith Endowed Professorship for Research Faculty Development; Erasmus University Rotterdam fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the families for their consent and participation. I.J.C. is supported by NIH T32GM007454. We also thank M. M. Formosa (University of Malta) for her help with the alizarin red staining. C.D.K. is supported by the Nancy and Buster Alvord Endowed Chair for Neuropathology as well as NIH AG005136. J.T.B. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists and the Arnold Lee Smith Endowed Professorship for Research Faculty Development. T.J.v.H. is supported by an Erasmus University Rotterdam fellowship.	Adams SJ, 2018, J CLIN NEUROSCI, V48, P42, DOI 10.1016/j.jocn.2017.10.060; Baba Y, 2006, ACTA NEUROPATHOL, V111, P300, DOI 10.1007/s00401-006-0046-z; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Bianchin MM, 2010, NAT REV NEUROL, V6, P1, DOI 10.1038/nrneurol.2010.17-c1; Bianchin MM, 2006, NEUROLOGY, V66, P615, DOI 10.1212/01.wnl.0000216105.11788.0f; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chitu V, 2017, CURR TOP DEV BIOL, V123, P229, DOI 10.1016/bs.ctdb.2016.10.004; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; Cipriani S, 2016, CEREB CORTEX, V26, P1255, DOI 10.1093/cercor/bhv079; Codjia P, 2018, AM J NEURORADIOL, V39, P1657, DOI 10.3174/ajnr.A5744; Cuadrado E, 2013, BRAIN, V136, P245, DOI 10.1093/brain/aws321; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Hoffmann S, 2014, BRAIN PATHOL, V24, P452, DOI 10.1111/bpa.12120; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kiialainen A, 2005, NEUROBIOL DIS, V18, P314, DOI 10.1016/j.nbd.2004.09.007; Konno Takuya, 2014, Brain Nerve, V66, P581; Liu Y, 2014, METHODS, V69, P58, DOI 10.1016/j.ymeth.2014.02.011; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Makrythanasis P, 2018, EUR J HUM GENET, V26, P330, DOI 10.1038/s41431-017-0088-9; Meireles AM, 2014, CELL REP, V8, P1659, DOI 10.1016/j.celrep.2014.08.018; Monies D, 2017, GENET MED, V19, P1144, DOI 10.1038/gim.2017.22; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Nicholson AM, 2013, NEUROLOGY, V80, P1033, DOI 10.1212/WNL.0b013e31828726a7; Oosterhof N, 2018, CELL REP, V24, P1203, DOI 10.1016/j.celrep.2018.06.113; Oosterhof N, 2017, METHODS MOL BIOL, V1559, P377, DOI 10.1007/978-1-4939-6786-5_26; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Pridans C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03013; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; REES JH, 1995, J NEUROIMMUNOL, V62, P53, DOI 10.1016/0165-5728(95)00102-8; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Sundal C, 2015, EUR J NEUROL, V22, P328, DOI 10.1111/ene.12572; van der Knaap MS, 2017, ACTA NEUROPATHOL, V134, P351, DOI 10.1007/s00401-017-1739-1; van Ham TJ, 2014, DIS MODEL MECH, V7, P857, DOI 10.1242/dmm.014886; Wider C, 2014, NEUROLOGY, V82, P102, DOI 10.1212/WNL.0000000000000026; Wimmer K, 2014, J MED GENET, V51, P355, DOI 10.1136/jmedgenet-2014-102284; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; 2016, NEURON, V89, P494, DOI DOI 10.1016/J.NEURON.2015.12.020	52	101	103	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2019	104	5					936	947		10.1016/j.ajhg.2019.03.010	http://dx.doi.org/10.1016/j.ajhg.2019.03.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HW3QV	30982608	Green Published, Bronze			2022-12-18	WOS:000466608700012
J	Dumanski, JP; Lambert, JC; Rasi, C; Giedraitis, V; Davies, H; Grenier-Boley, B; Lindgren, CM; Campion, D; Dufouil, C; Pasquier, F; Amouyel, P; Lannfelt, L; Ingelsson, M; Kilander, L; Lind, L; Forsberg, LA				Dumanski, Jan P.; Lambert, Jean-Charles; Rasi, Chiara; Giedraitis, Vilmantas; Davies, Hanna; Grenier-Boley, Benjamin; Lindgren, Cecilia M.; Campion, Dominique; Dufouil, Carole; Pasquier, Florence; Amouyel, Philippe; Lannfelt, Lars; Ingelsson, Martin; Kilander, Lena; Lind, Lars; Forsberg, Lars A.		European Alzheimers Dis Initiative	Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; PERIPHERAL-BLOOD; COPY NUMBER; GENOME-WIDE; AGE; RISK; CANCER; CELLS; VARIANTS; SMOKING	Men have a shorter life expectancy compared with women but the underlying factor(s) are not clear. Late-onset, sporadic Alzheimer disease (AD) is a common and lethal neurodegenerative disorder and many germline inherited variants have been found to influence the risk of developing AD. Our previous results show that a fundamentally different genetic variant, i.e., lifetime-acquired loss of chromosome Y (LOY) in blood cells, is associated with all-cause mortality and an increased risk of non-hematological tumors and that LOY could be induced by tobacco smoking. We tested here a hypothesis that men with LOY are more susceptible to AD and show that LOY is associated with AD in three independent studies of different types. In a case-control study, males with AD diagnosis had higher degree of LOY mosaicism (adjusted odds ratio = 2.80, p = 0.0184, AD events = 606). Furthermore, in two prospective studies, men with LOY at blood sampling had greater risk for incident AD diagnosis during follow-up time (hazard ratio [HR] = 6.80, 95% confidence interval [95% CI] = 2.16-21.43, AD events = 140, p = 0.0011). Thus, LOY in blood is associated with risks of both AD and cancer, suggesting a role of LOY in blood cells on disease processes in other tissues, possibly via defective immunosurveillance. As a male-specific risk factor, LOY might explain why males on average live shorter lives than females.	[Dumanski, Jan P.; Rasi, Chiara; Davies, Hanna; Forsberg, Lars A.] Uppsala Univ, Dept Immunol Genet & Pathol, S-75108 Uppsala, Sweden; [Dumanski, Jan P.; Rasi, Chiara; Davies, Hanna; Forsberg, Lars A.] Uppsala Univ, Sci Life Lab, S-75123 Uppsala, Sweden; [Lambert, Jean-Charles; Grenier-Boley, Benjamin; Amouyel, Philippe] Univ Lille, INSERM, CHU Lille, Pasteur Lille,U1167,RID AGE Risk Factors & Mol De, F-59000 Lille, France; [Giedraitis, Vilmantas; Lannfelt, Lars; Ingelsson, Martin; Kilander, Lena] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75185 Uppsala, Sweden; [Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Lindgren, Cecilia M.] Broad Inst MIT, Cambridge, MA 02142 USA; [Lindgren, Cecilia M.] Harvard Univ, Cambridge, MA 02142 USA; [Campion, Dominique] Rouen Univ Hosp, INSERM, CNR MAJ, U1079, F-76031 Rouen, France; [Dufouil, Carole] Victor Segalen Univ, INSERM, U708, F-33076 Bordeaux, France; [Pasquier, Florence] Univ Lille, CNR MAJ, Inserm 1171, F-59000 Lille, France; [Pasquier, Florence] CHU Lille, F-59000 Lille, France; [Lind, Lars] Uppsala Univ, Dept Med Sci, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Uppsala University; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Uppsala University	Dumanski, JP; Forsberg, LA (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, S-75108 Uppsala, Sweden.; Dumanski, JP; Forsberg, LA (corresponding author), Uppsala Univ, Sci Life Lab, S-75123 Uppsala, Sweden.	jan.dumanski@igp.uu.se; lars.forsberg@igp.uu.se	lambert, jean-charles/F-8787-2013; Dufouil, Carole/F-5751-2014; Lambert, jean-charles/A-9553-2014; Dufouil, Carole/J-4968-2012; Pasquier, Florence/F-1527-2017	lambert, jean-charles/0000-0003-0829-7817; Dufouil, Carole/0000-0003-2442-4476; Lambert, jean-charles/0000-0003-0829-7817; Pasquier, Florence/0000-0001-9880-9788; Forsberg, Lars/0000-0002-1701-755X; Amouyel, Philippe/0000-0001-9088-234X; Davies, Hanna/0000-0002-6289-3815; Dumanski, Jan Piotr/0000-0002-1489-1452; Lindgren, Cecilia/0000-0002-4903-9374	Olle Enqvist Byggmastare Foundation; European Research Council (ERC); Swedish Cancer Society; Swedish Research Council; Swedish Heart-Lung Foundation; Torsten Soderberg Foundation; Sci-Life-Lab-Uppsala; Wellcome Trust [WT098017, WT064890, WT090532]; Uppsala University; Uppsala University Hospital; French National Fondation on Alzheimer's disease and related disorders; Fondation pour la recherche sur le cerveau (FRC); Lille Metropole Communaute urbaine council; LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease)	Olle Enqvist Byggmastare Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Torsten Soderberg Foundation; Sci-Life-Lab-Uppsala; Wellcome Trust(Wellcome TrustEuropean Commission); Uppsala University; Uppsala University Hospital; French National Fondation on Alzheimer's disease and related disorders; Fondation pour la recherche sur le cerveau (FRC); Lille Metropole Communaute urbaine council; LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease)	We thank John Armour, Bradley Hyman, Alfredo Ramirez, and Constanin Polychronachos for critical evaluation of the manuscript. The study was sponsored by funding from the Olle Enqvist Byggmastare Foundation and European Research Council (ERC) Starting Grant to L.A.F. and by the Swedish Cancer Society, the Swedish Research Council, the Swedish Heart-Lung Foundation, the Torsten Soderberg Foundation, and Sci-Life-Lab-Uppsala to J.P.D. Genotyping and next-generation sequencing was performed by the SNP&SEQ Technology Platform in Uppsala, Sweden, and supported by Wellcome Trust Grants WT098017, WT064890, WT090532, Uppsala University, Uppsala University Hospital, the Swedish Research Council, and the Swedish Heart-Lung Foundation. The SNP&SEQ Technology Platform is part of Science for Life Laboratory at Uppsala University and supported as a national infrastructure by the Swedish Research Council. C.M.L. is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z). The work on EADI1 dataset was funded by the French National Fondation on Alzheimer's disease and related disorders, The Fondation pour la recherche sur le cerveau (FRC), the Lille Metropole Communaute urbaine council, and the LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease).	Ahmad AS, 2015, BRIT J CANCER, V112, P943, DOI 10.1038/bjc.2014.606; Alperovitch A, 2003, NEUROEPIDEMIOLOGY, V22, P316, DOI 10.1159/000072920; Arendt T, 2012, MOL NEUROBIOL, V46, P125, DOI 10.1007/s12035-012-8262-0; Benitez BA, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.010; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Bianchi NO, 2009, MUTAT RES-REV MUTAT, V682, P21, DOI 10.1016/j.mrrev.2009.02.001; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Bonnefond A, 2013, NAT GENET, V45, P1040, DOI 10.1038/ng.2700; Case LK, 2013, GENOME RES, V23, P1474, DOI 10.1101/gr.156703.113; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chapman J, 2013, HUM MOL GENET, V22, P816, DOI 10.1093/hmg/dds476; *CTR INT AG, 2013, WORLD FACTB 2013 14; de Carvalho Claudia Marcia Benedetto, 2005, J Mol Genet Med, V1, P63; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Escott-Price V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094661; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Forsberg LA, 2012, AM J HUM GENET, V90, P217, DOI 10.1016/j.ajhg.2011.12.009; Forsberg LA, 2013, J MED GENET, V50, P1, DOI 10.1136/jmedgenet-2012-101322; Ganster C, 2015, GENE CHROMOSOME CANC, V54, P717, DOI 10.1002/gcc.22282; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; GRIFFITHS MJ, 1992, GENE CHROMOSOME CANC, V5, P83; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Hughes JF, 2012, ANNU REV GENOM HUM G, V13, P83, DOI 10.1146/annurev-genom-090711-163855; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jacobs PA, 2013, BRIT J CANCER, V108, P959, DOI 10.1038/bjc.2012.577; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Jones L, 2015, ALZHEIMERS DEMENT, V11, P658, DOI 10.1016/j.jalz.2014.05.1757; Kalben BB, 2000, N AM ACTUAR J, V4, P83; Lambert JC, 2013, MOL PSYCHIATR, V18, P461, DOI 10.1038/mp.2012.14; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Lleo A, 2013, J AUTOIMMUN, V41, P87, DOI 10.1016/j.jaut.2012.12.008; Lovheim H, 2015, ALZHEIMERS DEMENT, V11, P587, DOI 10.1016/j.jalz.2014.07.157; Maheshwari P, 2015, J ALZHEIMERS DIS, V43, P957, DOI 10.3233/JAD-140621; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Noveski P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146264; NOWINSKI GP, 1990, AM J HUM GENET, V46, P1101; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Persani L, 2012, J AUTOIMMUN, V38, pJ193, DOI 10.1016/j.jaut.2011.11.011; PIERRE RV, 1972, CANCER, V30, P889, DOI 10.1002/1097-0142(197210)30:4<889::AID-CNCR2820300405>3.0.CO;2-1; R Development Core Team, 2012, R LANG ENV STAT COMP; Schwartz M, 2010, MOL PSYCHIATR, V15, P342, DOI 10.1038/mp.2010.31; Score J, 2015, LEUKEMIA, V29, P1600, DOI 10.1038/leu.2015.13; Veiga LCS, 2012, BRAZ J MED BIOL RES, V45, P172, DOI 10.1590/S0100-879X2012007500004; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.3.CO;2-9; Wiktor AE, 2011, LEUKEMIA RES, V35, P1297, DOI 10.1016/j.leukres.2011.05.002; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; Zhang LJ, 2007, CHINESE MED J-PEKING, V120, P2002, DOI 10.1097/00029330-200711020-00012	62	101	103	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1208	1219		10.1016/j.ajhg.2016.05.014	http://dx.doi.org/10.1016/j.ajhg.2016.05.014			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27231129	hybrid, Green Published			2022-12-18	WOS:000377286000014
J	Green, RC; Goddard, KAB; Jarvik, GP; Amendola, LM; Appelbaum, PS; Berg, JS; Bernhardt, BA; Biesecker, LG; Biswas, S; Blout, CL; Bowling, KM; Brothers, KB; Burke, W; Caga-anan, CF; Chinnaiyan, AM; Chung, WK; Clayton, EW; Cooper, GM; East, K; Evans, JP; Fullerton, SM; Garraway, LA; Garrett, JR; Gray, SW; Henderson, GE; Hindorff, LA; Holm, IA; Lewis, MH; Hutter, CM; Janne, PA; Joffe, S; Kaufman, D; Knoppers, BM; Koenig, BA; Krantz, ID; Manolio, TA; McCullough, L; McEwen, J; McGuire, A; Muzny, D; Myers, RM; Nickerson, DA; Ou, J; Parsons, DW; Petersen, GM; Plon, SE; Rehm, HL; Roberts, JS; Robinson, D; Salama, JS; Scollon, S; Sharp, RR; Shirts, B; Spinner, NB; Tabor, HK; Tarczy-Hornoch, P; Veenstra, DL; Wagle, N; Weck, K; Wilfond, BS; Wilhelmsen, K; Wolf, SM; Wynn, J; Yu, JH				Green, Robert C.; Goddard, Katrina A. B.; Jarvik, Gail P.; Amendola, Laura M.; Appelbaum, Paul S.; Berg, Jonathan S.; Bernhardt, Barbara A.; Biesecker, Leslie G.; Biswas, Sawona; Blout, Carrie L.; Bowling, Kevin M.; Brothers, Kyle B.; Burke, Wylie; Caga-anan, Charlisse F.; Chinnaiyan, Arul M.; Chung, Wendy K.; Clayton, Ellen W.; Cooper, Gregory M.; East, Kelly; Evans, James P.; Fullerton, Stephanie M.; Garraway, Levi A.; Garrett, Jeremy R.; Gray, Stacy W.; Henderson, Gail E.; Hindorff, Lucia A.; Holm, Ingrid A.; Lewis, Michelle Huckaby; Hutter, Carolyn M.; Janne, Pasi A.; Joffe, Steven; Kaufman, David; Knoppers, Bartha M.; Koenig, Barbara A.; Krantz, Ian D.; Manolio, Teri A.; McCullough, Laurence; McEwen, Jean; McGuire, Amy; Muzny, Donna; Myers, Richard M.; Nickerson, Deborah A.; Ou, Jeffrey; Parsons, Donald W.; Petersen, Gloria M.; Plon, Sharon E.; Rehm, Heidi L.; Roberts, J. Scott; Robinson, Dan; Salama, Joseph S.; Scollon, Sarah; Sharp, Richard R.; Shirts, Brian; Spinner, Nancy B.; Tabor, Holly K.; Tarczy-Hornoch, Peter; Veenstra, David L.; Wagle, Nikhil; Weck, Karen; Wilfond, Benjamin S.; Wilhelmsen, Kirk; Wolf, Susan M.; Wynn, Julia; Yu, Joon-Ho		CSER Consortium	Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBTAINING INFORMED-CONSENT; GENETIC RESEARCH FINDINGS; ELECTRONIC HEALTH RECORD; INCIDENTAL-FINDINGS; WHOLE-EXOME; MEDSEQ PROJECT; RESEARCH PARTICIPANTS; ACMG RECOMMENDATIONS; BEHAVIORAL ECONOMICS; PERCEIVED UTILITY	Despite rapid technical progress and demonstrable effectiveness for some types of diagnosis and therapy, much remains to be learned about clinical genome and exome sequencing (CGES) and its role within the practice of medicine. The Clinical Sequencing Exploratory Research (CSER) consortium includes 18 extramural research projects, one National Human Genome Research Institute (NHGRI) intramural project, and a coordinating center funded by the NHGRI and National Cancer Institute. The consortium is exploring analytic and clinical validity and utility, as well as the ethical, legal, and social implications of sequencing via multidisciplinary approaches; it has thus far recruited 5,577 participants across a spectrum of symptomatic and healthy children and adults by utilizing both germline and cancer sequencing. The CSER consortium is analyzing data and creating publically available procedures and tools related to participant preferences and consent, variant classification, disclosure and management of primary and secondary findings, health outcomes, and integration with electronic health records. Future research directions will refine measures of clinical utility of CGES in both germline and somatic testing, evaluate the use of CGES for screening in healthy individuals, explore the penetrance of pathogenic variants through extensive phenotyping, reduce discordances in public databases of genes and variants, examine social and ethnic disparities in the provision of genomics services, explore regulatory issues, and estimate the value and downstreamcosts of sequencing. The CSER consortium has established a shared community of research sites by using diverse approaches to pursue the evidence-based development of best practices in genomic medicine.	[Green, Robert C.; Blout, Carrie L.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Green, Robert C.; Garraway, Levi A.; Rehm, Heidi L.; Wagle, Nikhil] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Green, Robert C.; Gray, Stacy W.; Holm, Ingrid A.; Janne, Pasi A.; Rehm, Heidi L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Green, Robert C.; Rehm, Heidi L.] Partners Personalized Med, Boston, MA 02139 USA; [Goddard, Katrina A. B.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR 97227 USA; [Jarvik, Gail P.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Jarvik, Gail P.; Amendola, Laura M.; Burke, Wylie; Ou, Jeffrey; Salama, Joseph S.; Tarczy-Hornoch, Peter] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail P.; Amendola, Laura M.; Burke, Wylie; Ou, Jeffrey; Salama, Joseph S.] Univ Washington, Clin Sequencing Exploratory Res Coordinating Ctr, Seattle, WA 98195 USA; [Appelbaum, Paul S.] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Berg, Jonathan S.; Evans, James P.; Weck, Karen; Wilhelmsen, Kirk] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Bernhardt, Barbara A.; Biswas, Sawona; Krantz, Ian D.; Spinner, Nancy B.] Univ Penn, Perelman Sch Med, Dept Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Biesecker, Leslie G.] NHGRI, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA; [Biswas, Sawona; Krantz, Ian D.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Bowling, Kevin M.; Cooper, Gregory M.; East, Kelly; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Brothers, Kyle B.] Univ Louisville, Dept Pediat, Louisville, KY 40202 USA; [Burke, Wylie; Fullerton, Stephanie M.] Univ Washington, Dept Med, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Caga-anan, Charlisse F.] NCI, NIH, Bethesda, MD 20892 USA; [Chinnaiyan, Arul M.; Robinson, Dan] Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chung, Wendy K.; Wynn, Julia] Columbia Univ, Dept Pediat, New York, NY 10029 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Clayton, Ellen W.] Vanderbilt Univ, Ctr Biomed Eth & Soc, Nashville, TN 37203 USA; [Garraway, Levi A.; Wagle, Nikhil] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Garraway, Levi A.; Wagle, Nikhil] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA; [Garraway, Levi A.; Wagle, Nikhil] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Garrett, Jeremy R.] Childrens Mercy Hosp, Childrens Mercy Bioeth Ctr, Kansas City, MO 64108 USA; [Garrett, Jeremy R.] Univ Missouri, Dept Pediat, Kansas City, MO 64110 USA; [Garrett, Jeremy R.] Univ Missouri, Dept Philosophy, Kansas City, MO 64110 USA; [Gray, Stacy W.; Janne, Pasi A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Henderson, Gail E.] Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27599 USA; [Hindorff, Lucia A.; Hutter, Carolyn M.; Manolio, Teri A.] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Holm, Ingrid A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Holm, Ingrid A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Lewis, Michelle Huckaby] Johns Hopkins, Berman Inst Bioeth, Baltimore, MD 21205 USA; [Joffe, Steven; McGuire, Amy] Univ Penn, Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Kaufman, David; McEwen, Jean] NHGRI, Div Genom & Soc, NIH, Bethesda, MD 20892 USA; [Knoppers, Bartha M.] McGill Univ, Dept Human Genet, Fac Med, Ctr Genom & Policy, Montreal, PQ H3A 1B1, Canada; [Koenig, Barbara A.] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA 94118 USA; [McCullough, Laurence; McGuire, Amy] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Muzny, Donna] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Parsons, Donald W.; Plon, Sharon E.] Baylor Coll Med, Houston, TX 77030 USA; [Parsons, Donald W.; Plon, Sharon E.] Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Petersen, Gloria M.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Rehm, Heidi L.] Partners HealthCare, Mol Med Lab, Cambridge, MA 02139 USA; [Roberts, J. Scott] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Scollon, Sarah] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Sharp, Richard R.] Mayo Clin, Coll Med, Biomed Eth Res Program, Rochester, MN 55905 USA; [Shirts, Brian] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Spinner, Nancy B.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Tabor, Holly K.; Wilfond, Benjamin S.; Yu, Joon-Ho] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Tabor, Holly K.; Wilfond, Benjamin S.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Tarczy-Hornoch, Peter] Univ Washington, Seattle, WA 98105 USA; [Veenstra, David L.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Weck, Karen] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Wolf, Susan M.] Univ Minnesota, Sch Med, Sch Law, Minneapolis, MN 55455 USA; [Wolf, Susan M.] Univ Minnesota, Consortium Law & Values Hlth Environm & Life Sci, Minneapolis, MN 55455 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Kaiser Permanente; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; New York State Psychiatry Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; HudsonAlpha Institute for Biotechnology; University of Louisville; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Columbia University; Columbia University; Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Johns Hopkins University; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); McGill University; University of California System; University of California San Francisco; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Mayo Clinic; Partners Healthcare System; University of Michigan System; University of Michigan; Baylor College of Medicine; Mayo Clinic; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Green, RC (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Green, RC (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Green, RC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Green, RC (corresponding author), Partners Personalized Med, Boston, MA 02139 USA.	rcgreen@genetics.med.harvard.edu	Wagle, Nikhil/Q-7428-2019; Fullerton, Stephanie Malia/H-8696-2019; Joffe, Steven/H-3941-2019; Lupo, Philip/R-8314-2019; Seifert, Bryce/R-6071-2019; Taylor, Deanne M/Q-4777-2017; Gray, Stacy/AAJ-2956-2020; Biesecker, Leslie/AAG-2526-2021; Gray, Stacy/GRF-6833-2022; Appelbaum, Paul/AFU-3908-2022; Garrett, Jeremy R/GNH-3985-2022; Cooper, Gregory/D-6914-2011	Fullerton, Stephanie Malia/0000-0002-0938-6048; Joffe, Steven/0000-0002-0667-7384; Lupo, Philip/0000-0003-0978-5863; Seifert, Bryce/0000-0001-7970-3611; Taylor, Deanne M/0000-0002-3302-4610; Gray, Stacy/0000-0001-6948-0143; Appelbaum, Paul/0000-0002-1940-0042; Rivera-Munoz, Edgar/0000-0002-0610-4770; Lebo, Matthew/0000-0002-9733-5207; Arora, Nonie/0000-0001-8399-3818; Gordon, Adam/0000-0002-2058-7289; Zikmund-Fisher, Brian/0000-0002-1637-4176; Christensen, Kurt/0000-0003-4068-776X; Rehm, Heidi L./0000-0002-6025-0015; MOONEY, SEAN D/0000-0003-2654-0833; Shirts, brian/0000-0002-7188-6764; Vats, Pankaj/0000-0001-8441-7732; Cooper, Gregory/0000-0001-5509-9923; Mieczkowski, Piotr/0000-0003-2418-0096; Strande, Natasha/0000-0001-5148-9772; Ou, Jeffrey/0000-0002-7067-0056; Hart, Ragan/0000-0003-3758-8082; Blout Zawatsky, Carrie/0000-0001-6328-0386; Tarczy-Hornoch, Peter/0000-0003-1047-179X; Parsons, Donald/0000-0002-8775-3501; Holm, Ingrid/0000-0003-4712-8821; Robinson, Marguerite/0000-0001-6412-2013; De Vries, Raymond/0000-0003-3087-3040; Vassy, Jason/0000-0001-6113-5564	NHGRI;  [U01HG0006546];  [U01HG006485];  [U01HG006500];  [U01HG006492];  [UM1HG007301];  [UM1HG007292];  [UM1HG006508];  [U01HG006487];  [U01HG006507];  [U01HG007307];  [U01HG006379];  [U41HG006834];  [U54HG003273];  [R21HG006596];  [P20HG007243];  [P50HG007257];  [R01HG006600];  [R01HG004500];  [R01CA154517];  [R01HG006618];  [R21HG006594];  [R01HG006615];  [R21HG006612];  [5R21HG006613];  [R01HG007063];  [HG008685];  [UL1TR000423];  [UA01AG047109];  [K99HG007076]; NATIONAL CANCER INSTITUTE [R01CA154517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423, UL1TR002319] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007307, UM1HG006508, U01HG006507, R01HG006615, R21HG006596, U41HG006834, U01HG006485, R01HG004500, U01HG008685, P20HG007243, U01HG006487, R01HG006618, R01HG006600, U54HG003273, U01HG009599, R21HG006594, P50HG007257, R21HG006612, U24HG007307, U01HG006546, U01HG006500, R01HG007063, U01HG006379, U01HG007292, ZIAHG200387, UM1HG007292, R21HG006613, K99HG007076, UM1HG007301, U01HG006492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG047109] Funding Source: NIH RePORTER; Div Of Information & Intelligent Systems [1413864] Funding Source: National Science Foundation	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors thank Julia Fekecs of the National Human Genome Research Institute (NHGRI) for her technical assistance with Figure 1. The authors would like to thank all of the Clinical Sequencing Exploratory Research (CSER) participants for their involvement in this research. The authors also thank the members of their CSER advisory panel: Katrina Armstrong, MD; Rex L. Chisholm, PhD; Mildred K. Cho, PhD; Chanita H. Halbert, PhD; Elaine Lyon, PhD; Kenneth Offit, MD; Dan Roden, MD; Pamela Sankar, PhD; and Alan Williamson, PhD. The research described in this report was funded by grants U01HG0006546, U01HG006485, U01HG006500, U01HG006492, UM1HG007301, UM1HG007292, UM1HG006508, U01HG006487, U01HG006507, U01HG007307, U01HG006379, U41HG006834, U54HG003273, R21HG006596, P20HG007243, R01HG006600, P50HG007257, R01HG006600, R01HG004500, R01CA154517, R01HG006618, R21HG006594, R01HG006615, R21HG006612, 5R21HG006613, R01HG007063, HG008685, UL1TR000423, UA01AG047109, and K99HG007076. ClinSeq is supported by the NHGRI Intramural Research Program. C.F.C.-A., L.A.H., C.M.H., D.K., T.A.M., and J.M. are members of the NIH CSER staff team, responsible for management of the CSER program.	Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024; Amendola LM, 2015, PERS MED, V12, P283, DOI 10.2217/PME.14.89; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Appelbaum PS, 2014, HASTINGS CENT REP, V44, P22, DOI 10.1002/hast.328; Appelbaum PS, 2014, GENET MED, V16, P367, DOI 10.1038/gim.2013.145; Bennette CS, 2015, GENET MED, V17, P587, DOI 10.1038/gim.2014.156; Bennette CS, 2013, GENET MED, V15, P873, DOI 10.1038/gim.2013.63; Berg JS, 2013, GENET MED, V15, P860, DOI 10.1038/gim.2013.133; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Bernhardt B, 2014, GENOME MED, V6, DOI 10.1186/gm565; Bernhardt BA, 2015, AM J MED GENET A, V167, P2635, DOI 10.1002/ajmg.a.37256; Biesecker BB, 2014, GENET MED, V16, P977, DOI 10.1038/gim.2014.57; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Blumenthal-Barby JS, 2014, ANN INTERN MED, V161, P605, DOI 10.7326/M14-2074; Blumenthal-Barby JS, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0132-8; Branum R, 2015, J LAW MED ETHICS, V43, P576, DOI 10.1111/jlme.12301; Brothers KB, 2014, MAYO CLIN PROC, V89, P1471, DOI 10.1016/j.mayocp.2014.07.006; Burke W., 2011, ACHIEVING JUSTICE GE; Burke W, 2014, AM J MED GENET C, V166, P105, DOI 10.1002/ajmg.c.31393; Burke W, 2013, GENET MED, V15, P854, DOI 10.1038/gim.2013.113; Christensen KD, 2016, CLIN GENET, V89, P228, DOI 10.1111/cge.12626; Christensen KD, 2015, J PERS MED, V5, P470, DOI 10.3390/jpm5040470; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Clayton EW, 2014, AM J BIOETHICS, V14, P3, DOI 10.1080/15265161.2013.879945; Clayton EW, 2013, GENET MED, V15, P624, DOI 10.1038/gim.2013.7; Ng D, 2013, CIRC-CARDIOVASC GENE, V6, P337, DOI 10.1161/CIRCGENETICS.113.000039; Delaney SK, 2016, EXPERT REV MOL DIAGN, V16, P521, DOI 10.1586/14737159.2016.1146593; Eckstein L, 2014, J LAW MED ETHICS, V42, P190, DOI 10.1111/jlme.12135; Evans BJ, 2015, NEW ENGL J MED, V372, P2258, DOI 10.1056/NEJMsr1501194; Evans BJ, 2014, GENET MED, V16, P799, DOI 10.1038/gim.2014.127; Evans BJ, 2014, J LAW MED ETHICS, V42, P51, DOI 10.1111/jlme.12162; Evans BJ, 2013, GENET MED, V15, P915, DOI 10.1038/gim.2013.135; Evans JP, 2015, JAMA-J AM MED ASSOC, V313, P669, DOI 10.1001/jama.2014.18145; Everett JN, 2014, J GENET COUNS, V23, P655, DOI 10.1007/s10897-014-9698-3; Facio FM, 2013, EUR J HUM GENET, V21, P261, DOI 10.1038/ejhg.2012.179; Ferrer RA, 2015, COGNITION EMOTION, V29, P1456, DOI 10.1080/02699931.2014.985188; Goddard KAB, 2013, GENET MED, V15, P721, DOI 10.1038/gim.2013.37; Gonsalves SG, 2013, ANESTHESIOLOGY, V119, P1043, DOI 10.1097/ALN.0b013e3182a8a8e7; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Gray SW, 2014, GENET MED, V16, P727, DOI 10.1038/gim.2014.26; Green RC, 2015, NEW ENGL J MED, V372, P397, DOI 10.1056/NEJMp1404776; Green RC, 2013, JAMA-J AM MED ASSOC, V310, P365, DOI 10.1001/jama.2013.41703; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Green RC, 2012, GENET MED, V14, P405, DOI 10.1038/gim.2012.21; Hazin R, 2013, GENET MED, V15, P810, DOI 10.1038/gim.2013.117; Henderson GE, 2014, J LAW MED ETHICS, V42, P344, DOI 10.1111/jlme.12151; Jarvik GP, 2014, AM J HUM GENET, V94, P818, DOI 10.1016/j.ajhg.2014.04.009; Johnston JJ, 2015, AM J HUM GENET, V96, P913, DOI 10.1016/j.ajhg.2015.04.013; Kaphingst KA, 2012, CLIN GENET, V82, P408, DOI 10.1111/j.1399-0004.2012.01909.x; Khan CM, 2015, J GENET COUNS, V24, P193, DOI 10.1007/s10897-014-9804-6; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Klitzman R, 2014, GENET MED, V16, P311, DOI 10.1038/gim.2013.140; Klitzman R, 2013, GENET MED, V15, P888, DOI 10.1038/gim.2013.87; Klitzman R, 2013, JAMA-J AM MED ASSOC, V310, P369, DOI 10.1001/jama.2013.41709; Koenig BA, 2014, HASTINGS CENT REP, V44, P33, DOI 10.1002/hast.329; Kong SW, 2015, GENET MED, V17, P536, DOI 10.1038/gim.2014.143; Lane WJ, 2016, TRANSFUSION, V56, P743, DOI 10.1111/trf.13416; Lee IH, 2014, HUM MUTAT, V35, P537, DOI 10.1002/humu.22520; Lee K, 2015, AM J OPHTHALMOL, V160, P354, DOI 10.1016/j.ajo.2015.04.026; Levenseller BL, 2014, J GENET COUNS, V23, P552, DOI 10.1007/s10897-013-9626-y; Li MH, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0038-y; Lupo PJ, 2016, PERS MED, V13, P13, DOI 10.2217/pme.15.45; Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McCullough LB, 2016, PEDIATR BLOOD CANCER, V63, P511, DOI 10.1002/pbc.25815; McCullough LB, 2015, PEDIATRICS, V136, pE974, DOI 10.1542/peds.2015-0624; McGuire AL, 2014, GENOME RES, V24, P719, DOI 10.1101/gr.170514.113; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; McLaughlin HM, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0134-1; Mody RJ, 2015, JAMA-J AM MED ASSOC, V314, P913, DOI 10.1001/jama.2015.10080; National Cancer Institute, 2015, PED MATCH; National Institutes of Health, 2011, CLIN SEQ EXPL RES U0; National Institutes of Health, 2011, DEV PREL EV BAS INF; National Institutes of Health, 2012, CLIN SEQ EXPL RES CO; National Institutes of Health, 2012, CLIN SEQ EXPL RES UM; Parens E, 2013, HASTINGS CENT REP, V43, P16, DOI 10.1002/hast.189; Parsons D.W., 2016, JAMA ONCOL; Parsons DW, 2014, J CLIN ONCOL, V32, P2203, DOI 10.1200/JCO.2013.54.8917; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Raymond VM, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv351; Rees MG, 2012, J CLIN INVEST, V122, P205, DOI 10.1172/JCI46425; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JO, 2016, J EMPIR RES HUM RES, V11, P21, DOI 10.1177/1556264615624078; Schneider JL, 2016, J GENET COUNS, V25, P135, DOI 10.1007/s10897-015-9851-7; Scollon S, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0069-3; Shirts BH, 2015, J AM MED INFORM ASSN, V22, P1231, DOI 10.1093/jamia/ocv065; Sloan JL, 2011, NAT GENET, V43, P883, DOI 10.1038/ng.908; Taber JM, 2015, ANN BEHAV MED, V49, P616, DOI 10.1007/s12160-014-9679-7; Tallego CJ, 2014, CONTEMP CLIN TRIALS, V39, P1, DOI 10.1016/j.cct.2014.06.016; Tarczy-Hornoch P, 2013, GENET MED, V15, P824, DOI 10.1038/gim.2013.120; Teer JK, 2012, BIOINFORMATICS, V28, P599, DOI 10.1093/bioinformatics/btr711; Tomlinson AN, 2016, J GENET COUNS, V25, P62, DOI 10.1007/s10897-015-9842-8; Vassy JL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2401; Vassy JL, 2015, PUBLIC HEALTH GENOM, V18, P123, DOI 10.1159/000370102; Vassy JL, 2015, PERS MED, V12, P23, DOI 10.2217/PME.14.68; Vassy JL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-85; Vassy JL, 2013, POSTGRAD MED J, V89, P615, DOI 10.1136/postgradmedj-2013-132093; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Wilfond BS, 2015, J LAW MED ETHICS, V43, P552, DOI 10.1111/jlme.12298; Wolf SM, 2015, J LAW MED ETHICS, V43, P437, DOI 10.1111/jlme.12287; Wolf SM, 2015, J LAW MED ETHICS, V43, P486, DOI 10.1111/jlme.12291; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Wright MF, 2014, GENET MED, V16, P442, DOI 10.1038/gim.2013.170; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yu JH, 2014, AM J HUM GENET, V95, P77, DOI 10.1016/j.ajhg.2014.06.004; Ziniel SI, 2014, PUBLIC HEALTH GENOM, V17, P105, DOI 10.1159/000358539	109	101	101	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1051	1066		10.1016/j.ajhg.2016.04.011	http://dx.doi.org/10.1016/j.ajhg.2016.04.011			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27181682	Green Published, Bronze			2022-12-18	WOS:000377286000001
J	Setta-Kaffetzi, N; Simpson, MA; Navarini, AA; Patel, VM; Lu, HC; Allen, MH; Duckworth, M; Bachelez, H; Burden, AD; Choon, SE; Griffiths, CEM; Kirby, B; Kolios, A; Seyger, MMB; Prins, C; Smahi, A; Trembath, RC; Fratemali, F; Smith, CH; Barker, JN; Capon, F				Setta-Kaffetzi, Niovi; Simpson, Michael A.; Navarini, Alexander A.; Patel, Varsha M.; Lu, Hui-Chun; Allen, Michael H.; Duckworth, Michael; Bachelez, Herve; Burden, A. David; Choon, Siew-Eng; Griffiths, Christopher E. M.; Kirby, Brian; Kolios, Antonios; Seyger, Marieke M. B.; Prins, Christa; Smahi, Asma; Trembath, Richard C.; Fratemali, Franca; Smith, Catherine H.; Barker, Jonathan N.; Capon, Francesca			AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERLEUKIN-36-RECEPTOR ANTAGONIST DEFICIENCY; IL36RN MUTATIONS; VARIANTS; ANAKINRA; COMPLEX; AP-1	Adaptor protein complex 1 (AP-1) is an evolutionary conserved heterotetramer that promotes vesicular trafficking between the trans-Golgi network and the endosomes. The knockout of most murine AP-1 complex subunits is embryonically lethal, so the identification of human disease-associated alleles has the unique potential to deliver insights into gene function. Here, we report two founder mutations (c.11T>G [p.Phe4Cys] and c.97C>T [p.Arg33Trp]) in AP1S3, the gene encoding AP-1 complex subunit sigma 1C, in 15 unrelated individuals with a severe autoinflammatory skin disorder known as pustular psoriasis. Because the variants are predicted to destabilize the 3D structure of the AP-1 complex, we generated AP1S3-knockdown cell lines to investigate the consequences of AP-1 deficiency in skin keratinocytes. We found that AP1S3 silencing disrupted the endosomal translocation of the innate pattern-recognition receptor TLR-3 (Toll-like receptor 3) and resulted in a marked inhibition of downstream signaling. These findings identify pustular psoriasis as an autoinflammatory phenotype caused by defects in vesicular trafficking and demonstrate a requirement of AP-1 for Toll-like receptor homeostasis.	[Setta-Kaffetzi, Niovi; Simpson, Michael A.; Navarini, Alexander A.; Patel, Varsha M.; Allen, Michael H.; Duckworth, Michael; Trembath, Richard C.; Smith, Catherine H.; Barker, Jonathan N.; Capon, Francesca] Kings Coll London, Div Genet & Mol Med, London SE1 9RT, England; [Lu, Hui-Chun] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 9RT, England; [Bachelez, Herve; Smahi, Asma] Hop Necker Enfants Malad, Inst Imagine, Inst Natl Sante & Rech Med Unite 781, F-75015 Paris, France; [Bachelez, Herve] Univ Paris Diderot, Sorbonne Paris Cite, Dept Dermatol, F-75010 Paris, France; [Bachelez, Herve] Hop St Louis, Assistance Publ Hop Paris, F-75010 Paris, France; [Burden, A. David] Univ Glasgow, Dept Dermatol, Glasgow G11 6NT, Lanark, Scotland; [Choon, Siew-Eng] Hosp Sultanah Aminah, Dept Dermatol, Johor Baharu 80100, Malaysia; [Griffiths, Christopher E. M.] Univ Manchester, Dept Dermatol, Salford M6 8HD, Lancs, England; [Kirby, Brian] St Vincents Hosp, Dept Dermatol, Dublin 4, Ireland; [Kolios, Antonios] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Seyger, Marieke M. B.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6500 HB Nijmegen, Netherlands; [Prins, Christa] Univ Hosp Geneva, Dept Dermatol, CH-1211 Geneva 4, Switzerland; [Trembath, Richard C.] Queen Mary Univ London, Barts & London Sch Med & Dent, London EC1M 6QB, England	University of London; King's College London; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; University of Glasgow; University of Manchester; University College Dublin; University of Zurich; University Zurich Hospital; Radboud University Nijmegen; University of Geneva; University of London; Queen Mary University London	Capon, F (corresponding author), Kings Coll London, Div Genet & Mol Med, London SE1 9RT, England.	francesca.capon@kcl.ac.uk	Fraternali, Franca/D-4410-2011; CHOON, SIEW ENG/AAU-8192-2021; Smahi, Asma/J-4184-2017; Griffiths, Christopher E.M./P-5448-2014; Smith, Catherine H./G-5268-2012; Fraternali, Franca/C-8912-2009; Capon, Francesca/F-4763-2011; Seyger, M.M.B./L-4648-2015; Simpson, Michael/F-4737-2011; Navarini, Alexander/C-5504-2014	CHOON, SIEW ENG/0000-0002-7796-5746; Smahi, Asma/0000-0002-6002-0981; Griffiths, Christopher E.M./0000-0001-5371-4427; Smith, Catherine H./0000-0001-9918-1144; Fraternali, Franca/0000-0002-3143-6574; Capon, Francesca/0000-0003-2432-5793; Trembath, Richard/0000-0003-0550-3400; Simpson, Michael/0000-0002-8539-8753; Duckworth, Michael/0000-0003-0295-9621; Barker, Jonathan/0000-0002-9030-183X; bachelez, herve/0000-0003-3567-9095; Navarini, Alexander/0000-0001-7059-632X; Kolios, Antonios/0000-0002-3897-4578	Department of Health via the National Institute for Health Research BioResource Clinical Research Facility and comprehensive Biomedical Research Centre; King's College London; Lung GO Sequencing Project [HL-102923]; Women's Health Initiative Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; National Psoriasis Foundation; Wellcome Trust; European Commission; British Skin Foundation [3007s]; Swiss National Science Foundation [PASMP3_140074/WGS]; King's College Hospital NHS Foundation Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102926, RC2HL102924, RC2HL102923, UC2HL102924, RC2HL103010, RC2HL102925, UC2HL102926, UC2HL102925, UC2HL102923, UC2HL103010] Funding Source: NIH RePORTER; BBSRC [BB/I023291/1] Funding Source: UKRI; MRC [MR/L01257X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I023291/1] Funding Source: researchfish; Medical Research Council [MR/L01257X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	Department of Health via the National Institute for Health Research BioResource Clinical Research Facility and comprehensive Biomedical Research Centre; King's College London; Lung GO Sequencing Project; Women's Health Initiative Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; National Psoriasis Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); British Skin Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); King's College Hospital NHS Foundation Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We acknowledge support from the Department of Health via the National Institute for Health Research BioResource Clinical Research Facility and comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We would like to thank the NHLBI Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, which provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). This work was supported by the National Psoriasis Foundation through a discovery grant to F.C. The exome data for British healthy control individuals were provided by TwinsUK, which is funded by grants from the Wellcome Trust and the European Commission Seventh Framework Programme (FP7/2007-2013). N.S.K.'s PhD studentship is funded by the British Skin Foundation (grant 3007s). A.A.N. is supported by Swiss National Science Foundation grant PASMP3_140074/WGS.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aksentijevich I, 2011, NAT REV RHEUMATOL, V7, P468, DOI 10.1038/nrrheum.2011.94; Capon F, 2013, J INVEST DERMATOL, V133, P2503, DOI 10.1038/jid.2013.361; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Griffiths C.E.M., 2010, ROOKS TXB DERMATOLOG; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hirst J, 2012, CURR BIOL, V22, P1711, DOI 10.1016/j.cub.2012.07.012; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Huffmeier U, 2014, BRIT J DERMATOL, V170, P202, DOI 10.1111/bjd.12548; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lim KH, 2012, BIOINFORMATICS, V28, P1031, DOI 10.1093/bioinformatics/bts074; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rossi-Semerano L, 2013, PEDIATRICS, V132, pE1043, DOI 10.1542/peds.2012-3935; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Setta-Kaffetzi N, 2013, J INVEST DERMATOL, V133, P1366, DOI 10.1038/jid.2012.490; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	30	101	104	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 1	2014	94	5					790	797		10.1016/j.ajhg.2014.04.005	http://dx.doi.org/10.1016/j.ajhg.2014.04.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AG5VB	24791904	Green Published, Bronze			2022-12-18	WOS:000335485700013
J	Lohmueller, KE; Sparso, T; Li, QB; Andersson, E; Korneliussen, T; Albrechtsen, A; Banasik, K; Grarup, N; Hallgrimsdottir, I; Kiil, K; Kilpelainen, TO; Krarup, NT; Pers, TH; Sanchez, G; Hu, YN; DeGiorgio, M; Jorgensen, T; Sandbaek, A; Lauritzen, T; Brunak, S; Kristiansen, K; Li, YR; Hansen, T; Wang, J; Nielsen, R; Pedersen, O				Lohmueller, Kirk E.; Sparso, Thomas; Li, Qibin; Andersson, Ehm; Korneliussen, Thorfinn; Albrechtsen, Anders; Banasik, Karina; Grarup, Niels; Hallgrimsdottir, Ingileif; Kiil, Kristoffer; Kilpelainen, Tuomas O.; Krarup, Nikolaj T.; Pers, Tune H.; Sanchez, Gaston; Hu, Youna; DeGiorgio, Michael; Jorgensen, Torben; Sandbaek, Annelli; Lauritzen, Torsten; Brunak, Soren; Kristiansen, Karsten; Li, Yingrui; Hansen, Torben; Wang, Jun; Nielsen, Rasmus; Pedersen, Oluf			Whole-Exome Sequencing of 2,000 Danish Individuals and the Role of Rare Coding Variants in Type 2 Diabetes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSING HERITABILITY; GENETIC ARCHITECTURE; HIGH-RISK; ASSOCIATION; POPULATION; MELLITUS; DISEASE; MUTATIONS; EVOLUTION; IDENTIFY	It has been hypothesized that, in aggregate, rare variants in coding regions of genes explain a substantial fraction of the heritability of common diseases. We sequenced the exomes of 1,000 Danish cases with common forms of type 2 diabetes (including body mass index > 27.5 kg/m(2) and hypertension) and 1,000 healthy controls to an average depth of 56x. Our simulations suggest that our study had the statistical power to detect at least one causal gene (a gene containing causal mutations) if the heritability of these common diseases was explained by rare variants in the coding regions of a limited number of genes. We applied a series of gene-based tests to detect such susceptibility genes. However, no gene showed a significant association with disease risk after we corrected for the number of genes analyzed. Thus, we could reject a model for the genetic architecture of type 2 diabetes where rare nonsynonymous variants clustered in a modest number of genes (fewer than 20) are responsible for the majority of disease risk.	[Lohmueller, Kirk E.; Hu, Youna; DeGiorgio, Michael; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Sparso, Thomas; Andersson, Ehm; Banasik, Karina; Grarup, Niels; Kiil, Kristoffer; Kilpelainen, Tuomas O.; Krarup, Nikolaj T.; Hansen, Torben; Wang, Jun; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark; [Li, Qibin; Kristiansen, Karsten; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Korneliussen, Thorfinn] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Albrechtsen, Anders; Kristiansen, Karsten; Wang, Jun; Nielsen, Rasmus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Hallgrimsdottir, Ingileif; Sanchez, Gaston] Univ Calif Berkeley, Ctr Theoret Evolutionary Genom, Berkeley, CA 94720 USA; [Pers, Tune H.; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Pers, Tune H.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Pers, Tune H.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Pers, Tune H.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, DK-9220 Aalborg, Denmark; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten] Aarhus Univ, Sect Gen Practice, Dept Publ Hlth, DK-8000 Aarhus, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-5230 Odense M, Denmark; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Inst Biomed Sci, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Aarhus Univ, Fac Hlth Sci, DK-8000 Aarhus, Denmark	University of California System; University of California Berkeley; Novo Nordisk Foundation; University of Copenhagen; Beijing Genomics Institute (BGI); University of Copenhagen; University of Copenhagen; University of California System; University of California Berkeley; Technical University of Denmark; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Copenhagen; Aalborg University; University of Copenhagen; Aarhus University; University of Southern Denmark; University of California System; University of California Berkeley; University of Copenhagen; Aarhus University	Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rasmus_nielsen@berkeley.edu; oluf@sund.ku.dk	Albrechtsen, Anders/K-4281-2013; Kilpeläinen, Tuomas/F-8569-2012; Pedersen, Oluf/AAG-8015-2020; Wang, Jun/A-7261-2013; Banasik, Karina/S-3475-2019; Li, Yingrui/K-1064-2015; Korneliussen, Thorfinn Sand/F-6421-2014; Grarup, Niels/K-2807-2015; Pedersen, Oluf/Z-1731-2019; Korneliussen, Thorfinn Sand/ABB-7656-2021; Kristiansen, Karsten/J-5148-2014; Jørgensen, Torben/Z-1335-2018; Wang, Jun/B-9503-2016; Brunak, Soren/O-6621-2016; Wang, Jun/C-8434-2016	Albrechtsen, Anders/0000-0001-7306-031X; Kilpeläinen, Tuomas/0000-0002-8349-3028; Banasik, Karina/0000-0003-2489-2499; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Grarup, Niels/0000-0001-5526-1070; Pedersen, Oluf/0000-0002-3321-3972; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Kristiansen, Karsten/0000-0002-6024-0917; Pers, Tune/0000-0003-0207-4831; Krarup, Nikolaj Thure/0000-0001-6526-8663; Wang, Jun/0000-0002-2113-5874; Brunak, Soren/0000-0003-0316-5866; Jorgensen, Torben/0000-0001-9453-2830; Hallgrimsdottir, Ingileif/0000-0002-4710-0047; Wang, Jun/0000-0002-8540-8931; Hansen, Torben/0000-0001-8748-3831	Miller Research Institute at the University of California, Berkeley; Danish Council for Independent Research; National Science Foundation [DBI-1103639]; Lundbeck Foundation; Novo Nordisk Foundation; Danish Council for Independent Research Medical Sciences; Danish Research Council; Danish Centre for Health Technology Assessment; Novo Nordisk; Research Foundation of Copenhagen County; Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; Danish Diabetes Association; Villum Fonden [00007171] Funding Source: researchfish	Miller Research Institute at the University of California, Berkeley(University of California System); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); National Science Foundation(National Science Foundation (NSF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Centre for Health Technology Assessment; Novo Nordisk(Novo Nordisk); Research Foundation of Copenhagen County; Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation; Danish Diabetes Association; Villum Fonden(Villum Fonden)	We thank Melissa Wilson Sayres and Vincent Plagnol for helpful discussions and comments on the manuscript. We also thank A. Forman, T. Lorentzen, B. Andreasen, and G.J. Klavsen for technical assistance and A.L. Nielsen, G. Lademann, and M.M.H. Kristensen for management assistance. K.E.L. was supported by a Miller Research Fellowship from the Miller Research Institute at the University of California, Berkeley. T.S. was supported by the Danish Council for Independent Research. T.H.P. was supported by The Danish Council for Independent Research Medical Sciences. M.D. was supported by National Science Foundation grant DBI-1103639. This project was funded by the Lundbeck Foundation and produced by The Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (www.lucamp.org). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen and is partially funded by an unrestricted donation from the Novo Nordisk Foundation (hlip://metabol.ku.dk/). Further funding came from the Danish Council for Independent Research Medical Sciences. The Inter99 was initiated by Torben Jorgensen (principal invesitigator [PI]), Knut Borch-Johnsen (co-PI), Hans Ibsen, and Troels F. Thomsen. The steering committee comprises the former two and Charlotta Pisinger. The study was financially supported by research grants from the Danish Research Council, the Danish Centre for Health Technology Assessment, Novo Nordisk, the Research Foundation of Copenhagen County, the Ministry of Internal Affairs and Health, the Danish Heart Foundation, the Danish Pharmaceutical Association, the Augustinus Foundation, the Ib Henriksen Foundation, the Becket Foundation, and the Danish Diabetes Association.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albrechtsen A, 2013, DIABETOLOGIA, V56, P298, DOI 10.1007/s00125-012-2756-1; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Almgren P, 2011, DIABETOLOGIA, V54, P2811, DOI 10.1007/s00125-011-2267-5; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bamshad MJ, 2012, AM J MED GENET A, V158A, P1523, DOI 10.1002/ajmg.a.35470; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chang D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002600; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ellard S, 2006, HUM MUTAT, V27, P854, DOI 10.1002/humu.20357; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kim SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-231; King R. A., 2002, GENETIC BASIS COMMON, V2; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Long AD, 1999, GENOME RES, V9, P720; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Madsen B.E., 2009, PLOS GENET, V5; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Need AC, 2012, AM J HUM GENET, V91, P303, DOI 10.1016/j.ajhg.2012.06.018; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nielsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037558; Orr HA, 1998, EVOLUTION, V52, P935, DOI 10.1111/j.1558-5646.1998.tb01823.x; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pan W, 2011, HUM HERED, V72, P98, DOI 10.1159/000330632; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Skotte L, 2012, GENET EPIDEMIOL, V36, P430, DOI 10.1002/gepi.21636; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thornton KR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003258; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	83	101	103	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 5	2013	93	6					1072	1086		10.1016/j.ajhg.2013.11.005	http://dx.doi.org/10.1016/j.ajhg.2013.11.005			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	273FS	24290377	Green Published, Bronze			2022-12-18	WOS:000328521300007
J	Fabre, A; Charroux, B; Martinez-Vinson, C; Roquelaure, B; Odul, E; Sayar, E; Smith, H; Colomb, V; Andre, N; Hugot, JP; Goulet, O; Lacoste, C; Sarles, J; Royet, J; Levy, N; Badens, C				Fabre, Alexandre; Charroux, Bernard; Martinez-Vinson, Christine; Roquelaure, Bertrand; Odul, Egritas; Sayar, Ersin; Smith, Hilary; Colomb, Virginie; Andre, Nicolas; Hugot, Jean-Pierre; Goulet, Olivier; Lacoste, Caroline; Sarles, Jacques; Royet, Julien; Levy, Nicolas; Badens, Catherine			SKIV2L Mutations Cause Syndromic Diarrhea, or Trichohepatoenteric Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEPATO-ENTERIC SYNDROME; INTRACTABLE DIARRHEA; RNA; EXOSOME; COMPLEX	Syndromic diarrhea (or trichohepatoenteric syndrome) is a rare congenital bowel disorder characterized by intractable diarrhea and woolly hair, and it has recently been associated with mutations in TTC37. Although databases report TTC37 as being the human ortholog of Ski3p, one of the yeast Ski-complex cofactors, this lead was not investigated in initial studies. The Ski complex is a multiprotein complex required for exosome-mediated RNA surveillance, including the regulation of normal mRNA and the decay of nonfunctional mRNA. Considering the fact that TTC37 is homologous to Ski3p, we explored a gene encoding another Ski-complex cofactor, SKIV2L, in six individuals presenting with typical syndromic diarrhea without variation in TTC37. We identified mutations in all six individuals. Our results show that mutations in genes encoding cofactors of the human Ski complex cause syndromic diarrhea, establishing a link between defects of the human exosome complex and a Mendelian disease.	[Fabre, Alexandre; Levy, Nicolas; Badens, Catherine] Aix Marseille Univ, Fac Med, INSERM, UMR S 910, F-13385 Marseille, France; [Fabre, Alexandre; Roquelaure, Bertrand; Sarles, Jacques] Hop Enfants La Timone, Serv Pediat Multidisciplinaire, AP HM, F-13385 Marseille, France; [Charroux, Bernard; Royet, Julien] Aix Marseille Univ, Inst Biol Dev Marseille Luminy, F-13288 Marseille, France; [Martinez-Vinson, Christine; Hugot, Jean-Pierre] Hop Robert Debre, AP HP, Serv Gastroenterol, F-75019 Paris, France; [Odul, Egritas] Gazi Univ, Sch Med, Dept Pediat Gastroenterol, TR-06500 Ankara, Turkey; [Sayar, Ersin] Akdeniz Univ, Dept Pediat Gastroenterol, TR-07058 Antalya, Turkey; [Smith, Hilary] Childrens Mem Hosp, Dept Pediat, Chicago, IL 60614 USA; [Colomb, Virginie; Goulet, Olivier] Hop Necker Enfants Malad, AP HP, Serv Gastroenterol, F-75004 Paris, France; [Andre, Nicolas] Hop Enfants La Timone, AP HM, Serv Oncol Pediat, F-13385 Marseille, France; [Lacoste, Caroline; Levy, Nicolas; Badens, Catherine] Hop Enfants La Timone, AP HM, Lab Genet Mol, F-13385 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Gazi University; Akdeniz University; Ann & Robert H. Lurie Children's Hospital of Chicago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Badens, C (corresponding author), Aix Marseille Univ, Fac Med, INSERM, UMR S 910, F-13385 Marseille, France.	catherine.badens@ap-hm.fr	Hugot, Jean-Pierre/F-6594-2012; LEVY, Nicolas/J-1632-2014; Badens, Catherine/J-8727-2016; FABRE, Alexandre JM/M-3457-2016; Egritas Gurkan, Odul/O-1363-2016	LEVY, Nicolas/0000-0001-5171-6365; Badens, Catherine/0000-0001-9024-310X; FABRE, Alexandre JM/0000-0001-5155-6437; Egritas Gurkan, Odul/0000-0003-0230-7551; ANDRE, Nicolas/0000-0002-6786-4968; Hugot, Jean-Pierre/0000-0002-8446-6056; Sayar, Ersin/0000-0002-0993-4825	Assistance Publique-Hopitaux de Marseille (AORC); Fondation de l'Universite de la Mediterranee	Assistance Publique-Hopitaux de Marseille (AORC); Fondation de l'Universite de la Mediterranee	We are extremely grateful to the individuals with trichohepatoenteric syndrome and the family members for their participation in the study. We also want to acknowledge Sylvain Baulande and Pascal Soularue (from Partnerchip), who kindly performed bioinformatics analysis after the linkage studies, Julies Salomon, who provided DNA samples, and Laurent Villard for helpful discussion. DNA extraction and storage were performed in the Biobank of the Department of Genetics of La Timone Hospital. This work was financially supported by the Assistance Publique-Hopitaux de Marseille (AORC 2010). A.F. is supported by a scholarship from the Fondation de l'Universite de la Mediterranee.	Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; DANGEL AW, 1995, NUCLEIC ACIDS RES, V23, P2120, DOI 10.1093/nar/23.12.2120; Egritas O, 2009, EUR J PEDIATR, V168, P933, DOI 10.1007/s00431-008-0861-4; Fabre A, 2007, AM J MED GENET A, V143A, P584, DOI 10.1002/ajmg.a.31634; Fabre A, 2011, HUM MUTAT, V32, P277, DOI 10.1002/humu.21420; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GIRAULT D, 1994, J PEDIATR-US, V125, P36, DOI 10.1016/S0022-3476(94)70118-0; Hartley JL, 2010, GASTROENTEROLOGY, V138, P2388, DOI 10.1053/j.gastro.2010.02.010; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; LEE SG, 1995, GENOMICS, V25, P660, DOI 10.1016/0888-7543(95)80008-A; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Schaeffer D, 2010, ADV EXP MED BIOL, V702, P79, DOI 10.1007/978-1-4419-7841-7_7; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Staals RHJ, 2010, ADV EXP MED BIOL, V702, P132, DOI 10.1007/978-1-4419-7841-7_11; TOHE A, 1980, P NATL ACAD SCI-BIOL, V77, P527, DOI 10.1073/pnas.77.1.527; Van Dijk EL, 2007, RNA, V13, P1027, DOI 10.1261/rna.575107; Verloes A, 1997, AM J MED GENET, V68, P391, DOI 10.1002/(SICI)1096-8628(19970211)68:4<391::AID-AJMG3>3.0.CO;2-P; Wang LN, 2005, RNA, V11, P1291, DOI 10.1261/rna.2060405; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	20	101	106	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					689	692		10.1016/j.ajhg.2012.02.009	http://dx.doi.org/10.1016/j.ajhg.2012.02.009			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22444670	Bronze, Green Published			2022-12-18	WOS:000302833400011
J	de Greef, JC; Wang, J; Balog, J; den Dunnen, JT; Frants, RR; Straasheijm, KR; Aytekin, C; van der Burg, M; Duprez, L; Ferster, A; Gennery, AR; Gimelli, G; Reisli, I; Schuetz, C; Schulz, A; Smeets, DFCM; Sznajer, Y; Wijmenga, C; van Eggermond, MC; van Ostaijen-ten Dam, MM; Lankester, AC; van Tol, MJD; van den Elsen, PJ; Weemaes, CM; van der Maarel, SM				de Greef, Jessica C.; Wang, Jun; Balog, Judit; den Dunnen, Johan T.; Frants, Rune R.; Straasheijm, Kirsten R.; Aytekin, Caner; van der Burg, Mirjam; Duprez, Laurence; Ferster, Alina; Gennery, Andrew R.; Gimelli, Giorgio; Reisli, Ismail; Schuetz, Catharina; Schulz, Ansgar; Smeets, Dominique F. C. M.; Sznajer, Yves; Wijmenga, Cisca; van Eggermond, Maria C.; van Ostaijen-ten Dam, Monique M.; Lankester, Arjan C.; van Tol, Maarten J. D.; van den Elsen, Peter J.; Weemaes, Corry M.; van der Maarel, Silvere M.			Mutations in Z8T824 Are Associated with Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome Type 2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ICF SYNDROME; DNA METHYLATION; CHROMOSOME INSTABILITY; MAMMALIAN DEVELOPMENT; DNMT3B MUTATIONS; SATELLITE DNA; POZ DOMAIN; EXPRESSION; DIFFERENTIATION; PROTEINS	Autosomal-recessive immunodeficiency, centromeric instability, and facial anomalies (ICE) syndrome is mainly characterized by recurrent, often fatal, respiratory and gastrointestinal infections. About 50% of patients carry mutations in the DNA methyltransferase 3B gene (DNMT3B) (ICF1). The remaining patients carry unknown genetic defects (1072) but share with ICF1 patients the same immunological and epigenetic features, including hypomethylation of juxtacentromeric repeat sequences. We performed homozygosity mapping in five unrelated ICF2 patients with consanguineous parents and then performed whole-exome sequencing in one of these patients and Sanger sequencing in all to identify mutations in the zinc-finger- and BTB (bric-a-bric, tramtrack, broad complex)-domain-containing 24 (ZBTB24) gene in four consanguineously descended ICF2 patients. Additionally, we found ZBTB24 mutations in an affected sibling pair and in one patient for whom it was not known whether his parents were consanguineous. ZBTB24 belongs to a large family of transcriptional repressors that include members, such as BCL6 and PATZ1, with prominent regulatory roles in hematopoietic development and malignancy. These data thus indicate that ZBTB24 is involved in DNA methylation of juxtacentromeric DNA and in B cell development and/or B and cell interactions. Because ZBTB24 is a putative DNA-binding protein highly expressed in the lymphoid lineage, we predict that by studying the molecular function of ZBTB24, we will improve our understanding of the molecular pathophysiology of ICF syndrome and of lymphocyte biology in general.	[de Greef, Jessica C.; Wang, Jun; Balog, Judit; den Dunnen, Johan T.; Frants, Rune R.; Straasheijm, Kirsten R.; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [Aytekin, Caner] Dr Sami Ulus Childrens Hlth & Dis Training & Res, Dept Pediat Immunol, TR-06080 Ankara, Turkey; [van der Burg, Mirjam] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Immunol, NL-3015 CE Rotterdam, Netherlands; [Duprez, Laurence] Univ Libre Bruxelles, Hop Erasme, Dept Med Genet, B-1070 Brussels, Belgium; [Ferster, Alina] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Dept Paediat, Haematooncol Unit, B-1070 Brussels, Belgium; [Gennery, Andrew R.] NHS Fdn Trust, Newcastle Tyne Hosp, Dept Paediat Immunol, Newcastle Upon Tyne, Tyne & Wear, England; [Gennery, Andrew R.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Gimelli, Giorgio] Inst Giannina Gaslini, Lab Citogenet, I-16148 Genoa, Italy; [Reisli, Ismail] Selcuk Univ, Dept Pediat Immunol & Allergy, TR-42003 Konya, Turkey; [Schuetz, Catharina; Schulz, Ansgar] Univ Hosp Ulm, Dept Pediat & Adolescent Med, D-89075 Ulm, Germany; [Smeets, Dominique F. C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6526 GA Nijmegen, Netherlands; [Sznajer, Yves] Hop Univ Enfants Reine Fabiola HUDERF, Ctr Human Genet, B-1020 Brussels, Belgium; [Wijmenga, Cisca] Univ Med Ctr Groningen, Genet Dept, NL-9713 GZ Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, NL-9713 GZ Groningen, Netherlands; [van Eggermond, Maria C.; van den Elsen, Peter J.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; [van Ostaijen-ten Dam, Monique M.; Lankester, Arjan C.; van Tol, Maarten J. D.] Leiden Univ, Med Ctr, Dept Pediat, NL-2333 ZA Leiden, Netherlands; [van den Elsen, Peter J.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands; [Weemaes, Corry M.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Paediat Infect Dis & Immunol, NL-6526 GA Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Dr. Sami Ulus Education & Research Hospital; Erasmus University Rotterdam; Erasmus MC; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; University of Genoa; IRCCS Istituto Giannina Gaslini; Selcuk University; Ulm University; Radboud University Nijmegen; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Radboud University Nijmegen	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands.	maarel@lumc.nl	Wang, Jun/B-2414-2009; de Greef, Jessica/AAN-2716-2020; Weemaes, C.M.R./L-4747-2015; Wijmenga, Cisca/AAE-7719-2019; Smeets, D.F.C.M./L-4653-2015; dunnen, johan den/ABH-4228-2020; Wang, Jun/AGJ-1311-2022; Wijmenga, Cisca/D-2173-2009; van der Maarel, Silvere/X-3631-2018	Wang, Jun/0000-0002-4458-3741; de Greef, Jessica/0000-0002-2819-6098; Wijmenga, Cisca/0000-0002-5635-1614; dunnen, johan den/0000-0002-6304-1710; Wang, Jun/0000-0002-4458-3741; van der Maarel, Silvere/0000-0001-8103-711X; Van den Elsen, Peter/0000-0002-5196-0082	National Institutes of Health/National Institute of Allergy and Infectious Diseases [R21 AI090135]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090135] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the ICE patients and their families for their participation. We thank J. van Reeuwijk, (Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands) for his help with the homozygosity mapping data analysis, J.J. Houwing-Duistermaat, (Leiden University Medical Center, Leiden, the Netherlands) for statistical advice, and S. Klingeman Plati for technical assistance. This research was supported by funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases R21 AI090135.	BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Bilic I, 2007, IMMUNOL LETT, V108, P1, DOI 10.1016/j.imlet.2006.09.007; Blanco-Betancourt CE, 2004, BLOOD, V103, P2683, DOI 10.1182/blood-2003-08-2632; BROWN DC, 1995, HUM GENET, V96, P411; Colucci M, 2004, J NEUROL SCI, V217, P107, DOI 10.1016/j.jns.2003.08.009; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Ehrlich M, 2001, HUM MOL GENET, V10, P2917, DOI 10.1093/hmg/10.25.2917; Gennery AR, 2007, PEDIATRICS, V120, pE1341, DOI 10.1542/peds.2007-0640; GIMELLI G, 1993, J MED GENET, V30, P429, DOI 10.1136/jmg.30.5.429; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Hagleitner MM, 2008, J MED GENET, V45, P93, DOI 10.1136/jmg.2007.053397; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Jefferson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011364; Jiang YL, 2005, HUM MUTAT, V25, P56, DOI 10.1002/humu.20113; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Kang BY, 2005, MOL CELL BIOL, V25, P554, DOI 10.1128/MCB.25.2.554-562.2005; Kloeckener-Gruissem B, 2005, AM J MED GENET A, V136A, P31, DOI 10.1002/ajmg.a.30767; Kubota T, 2004, AM J MED GENET A, V129A, P290, DOI 10.1002/ajmg.a.30135; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manders PM, 2005, P NATL ACAD SCI USA, V102, P7418, DOI 10.1073/pnas.0501585102; MARASCHIO P, 1988, J MED GENET, V25, P173, DOI 10.1136/jmg.25.3.173; Matarazzo MR, 2007, P NATL ACAD SCI USA, V104, P16546, DOI 10.1073/pnas.0702924104; Miniou P, 1997, HUM GENET, V99, P738, DOI 10.1007/s004390050441; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pezzolo A, 2001, J ALLERGY CLIN IMMUN, V108, P310, DOI 10.1067/mai.2001.116863; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Piazza F, 2004, MOL CELL BIOL, V24, P10456, DOI 10.1128/MCB.24.23.10456-10469.2004; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Schuetz C, 2007, AM J MED GENET A, V143A, P2052, DOI 10.1002/ajmg.a.31885; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Takamori M, 2004, INT IMMUNOL, V16, P1439, DOI 10.1093/intimm/dxh144; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Wijmenga C, 2000, HUM MUTAT, V16, P509, DOI 10.1002/1098-1004(200012)16:6<509::AID-HUMU8>3.3.CO;2-M; Wijmenga C, 1998, AM J HUM GENET, V63, P803, DOI 10.1086/302021; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Ye BH, 1995, EMBO J, V14, P6209, DOI 10.1002/j.1460-2075.1995.tb00311.x	48	101	103	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					796	804		10.1016/j.ajhg.2011.04.018	http://dx.doi.org/10.1016/j.ajhg.2011.04.018			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21596365	Bronze, Green Published			2022-12-18	WOS:000291768500011
J	Soares, P; Rito, T; Trejaut, J; Mormina, M; Hill, C; Tinkler-Hundal, E; Braid, M; Clarke, DJ; Loo, JH; Thomson, N; Denham, T; Donohue, M; Macaulay, V; Lin, M; Oppenheimer, S; Richards, MB				Soares, Pedro; Rito, Teresa; Trejaut, Jean; Mormina, Maru; Hill, Catherine; Tinkler-Hundal, Emma; Braid, Michelle; Clarke, Douglas J.; Loo, Jun-Hun; Thomson, Noel; Denham, Tim; Donohue, Mark; Macaulay, Vincent; Lin, Marie; Oppenheimer, Stephen; Richards, Martin B.			Ancient Voyaging and Polynesian Origins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA VARIATION; ISLAND SOUTHEAST-ASIA; Y-CHROMOSOME; BISMARCK ARCHIPELAGO; MELANESIAN ORIGIN; GENETIC DIVERSITY; HUMAN-POPULATION; MTDNA VARIATION; LAPITA; LINEAGES	The "Polynesian motif" defines a lineage of human mtDNA that is restricted to Austronesian-speaking populations and is almost fixed in Polynesians. It is widely thought to support a rapid dispersal of maternal lineages from Taiwan -4000 years ago (4 ka), but the chronological resolution of existing control-region data is poor, and an East Indonesian origin has also been proposed. By analyzing 157 complete mtDNA genomes, we show that the motif itself most likely originated >6 ka in the vicinity of the Bismarck Archipelago, and its immediate ancestor is >8 ka old and virtually restricted to Near Oceania. This indicates that Polynesian maternal lineages from Island Southeast Asia gained a foothold in Near Oceania much earlier than dispersal from either Taiwan or Indonesia 3-4 ka would predict. However, we find evidence in minor lineages for more recent two-way maternal gene flow between Island Southeast Asia and Near Oceania, likely reflecting movements along a "voyaging corridor" between them, as previously proposed on archaeological grounds. Small-scale mid-Holocene movements from Island Southeast Asia likely transmitted Austronesian languages to the long-established Southeast Asian colonies in the Bismarcks carrying the Polynesian motif, perhaps also providing the impetus for the expansion into Polynesia.	[Soares, Pedro; Rito, Teresa; Mormina, Maru; Hill, Catherine; Tinkler-Hundal, Emma; Braid, Michelle; Richards, Martin B.] Univ Leeds, Inst Integrat & Comparat Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Soares, Pedro] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; [Rito, Teresa; Clarke, Douglas J.] Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Rito, Teresa] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Trejaut, Jean; Loo, Jun-Hun; Lin, Marie] Mackay Mem Hosp, Mol Anthropol & Transfus Med Res Lab, Taipei 10449, Taiwan; [Mormina, Maru] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Thomson, Noel; Macaulay, Vincent] Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland; [Denham, Tim] Monash Univ, Sch Geog & Environm Sci, Clayton, Vic 3800, Australia; [Donohue, Mark] Australian Natl Univ, Dept Linguist, Res Sch Pacific & Asian Studies, Canberra, ACT 0200, Australia; [Lin, Marie] Natl Taiwan Univ, Dept & Grad Inst Forens Med, Coll Med, Taipei 10617, Taiwan; [Oppenheimer, Stephen] Univ Oxford, Sch Anthropol, Oxford OX2 6QS, England	University of Leeds; Universidade do Porto; University of Huddersfield; Liverpool School of Tropical Medicine; University of Liverpool; Mackay Memorial Hospital; University of Cambridge; University of Glasgow; Monash University; Australian National University; National Taiwan University; University of Oxford	Richards, MB (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	m.b.richards@leeds.ac.uk	Soares, Pedro A/G-9422-2011; Mormina, Maru/HGC-2853-2022; Rito, Teresa/AAC-9041-2019; Rito, Teresa/O-7726-2014	Soares, Pedro A/0000-0002-2807-690X; Rito, Teresa/0000-0002-8374-6347; Rito, Teresa/0000-0002-8374-6347	Marie Curie Early Stage Training Grant; Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/64233/2009]; European Union; British Academy; Bradshaw Foundation; de Laszlo Foundation; National Science Council of Taiwan [NSC96-2627-H-195-001]; National Health Research Institute of Taiwan [NHRI-EX94-9218BI]	Marie Curie Early Stage Training Grant(European Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Union(European Commission); British Academy; Bradshaw Foundation; de Laszlo Foundation; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	We thank John Clegg and Salam Sofro for DNA samples, Matthew Spriggs for advice on settlement chronology, Jonathan and Francoise Friedlaender for providing HVS-I data, and Robert Simpson for laboratory assistance. P.S. was supported by a Marie Curie Early Stage Training Grant and by a Portuguese Foundation for Science and Technology (FCT) grant (SFRH/BPD/64233/2009), and we thank the European Union, the British Academy, the Bradshaw Foundation, the de Laszlo Foundation, the National Science Council of Taiwan (grant NSC96-2627-H-195-001), and the National Health Research Institute of Taiwan (grant NHRI-EX94-9218BI) for financial support. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adelaar K. A, 2006, AUSTRONESIAN DIASPOR, P205; BANDELT HJ, 1995, GENETICS, V141, P743; Bedford S, 2006, ANTIQUITY, V80, P812, DOI 10.1017/S0003598X00094448; Bellwood P., 2005, 1 FARMERS ORIGINS AG; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; Blust Robert, 2009, AUSTRONESIAN LANGUAG; Bulbeck D., 2008, AUST ARCHAEOL, V67, P31, DOI DOI 10.1080/03122417.2008.11681877; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Donohue M, 2010, CURR ANTHROPOL, V51, P223, DOI 10.1086/650991; Forster P, 1996, AM J HUM GENET, V59, P935; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Friedlaender JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000248; FRIEDLAENDER JS, 2007, GENES LANGUAGE CULTU, P231; FRIEDLAENDER JS, 2006, PAPUAN PASTS STUDIES, P693; GREEN RC, 2003, PACIFIC ARCHAEOLOGY; Grivet L, 2004, ETHNOBOT RES APPL, V2, P9, DOI DOI 10.17348/era.2.0.9-17; Hage P, 2003, CURR ANTHROPOL, V44, pS121, DOI 10.1086/379272; Hagelberg E, 2000, P ROY SOC B-BIOL SCI, V267, P1595, DOI 10.1098/rspb.2000.1183; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Irwin G., 1992, PREHISTORIC EXPLORAT; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kjaer A, 2004, ANN BOT-LONDON, V94, P109, DOI 10.1093/aob/mch112; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malapa R, 2005, GENET RESOUR CROP EV, V52, P919, DOI 10.1007/s10722-003-6122-5; Meierhofer D, 2005, MITOCHONDRION, V5, P282, DOI 10.1016/j.mito.2005.06.001; Melton T, 1998, AM J HUM GENET, V63, P1807, DOI 10.1086/302131; Ohashi J, 2006, AM J PHYS ANTHROPOL, V130, P551, DOI 10.1002/ajpa.20383; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Pawley A, 2007, TERRA AUSTRALIS, V26, P17; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Ricaut FX, 2008, ANN HUM GENET, V72, P349, DOI 10.1111/j.1469-1809.2008.00430.x; Richards M, 1998, AM J HUM GENET, V63, P1234, DOI 10.1086/302043; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rieth TM, 2008, J ARCHAEOL SCI, V35, P1901, DOI 10.1016/j.jas.2007.12.001; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Solheim W.G., 2006, ARCHAEOLOGY CULTURE; Specht J, 2007, TERRA AUSTRALIS, V26, P51; Spriggs M, 2007, SE ASIA PACIFIC ARCH, P104; SWADLING P, 2005, PAPUAN PASTS CULTURA, P289; SYKES B, 1995, AM J HUM GENET, V57, P1463; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Tajima A, 2004, J HUM GENET, V49, P187, DOI 10.1007/s10038-004-0131-x; Tajima A, 2003, HUM GENET, V113, P24, DOI 10.1007/s00439-003-0945-1; Terrell JE, 1997, ANTIQUITY, V71, P548, DOI 10.1017/S0003598X0008532X; Terrell JE, 2004, WORLD ARCHAEOL, V36, P601, DOI 10.1080/0043824042000303782; Thomason Sarah G., 1988, LANGUAGE CONTACT CRE; Tofanelli S, 2009, MOL BIOL EVOL, V26, P2109, DOI 10.1093/molbev/msp120; Torrence R, 2008, ANTIQUITY, V82, P600, DOI 10.1017/S0003598X00097258; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Vilar MG, 2008, J HUM GENET, V53, P698, DOI 10.1007/s10038-008-0301-3; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040	62	101	102	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					239	247		10.1016/j.ajhg.2011.01.009	http://dx.doi.org/10.1016/j.ajhg.2011.01.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	725YZ		Green Published, Bronze, Green Accepted			2022-12-18	WOS:000287684100013
J	Guelly, C; Zhu, PP; Leonardis, L; Papic, L; Zidar, J; Schabhuttl, M; Strohmaier, H; Weis, J; Strom, TM; Baets, J; Willems, J; De Jonghe, P; Reilly, MM; Frohlich, E; Hatz, M; Trajanoski, S; Pieber, TR; Janecke, AR; Blackstone, C; Auer-Grumbach, M				Guelly, Christian; Zhu, Peng-Peng; Leonardis, Lea; Papic, Lea; Zidar, Janez; Schabhuettl, Maria; Strohmaier, Heimo; Weis, Joachim; Strom, Tim M.; Baets, Jonathan; Willems, Jan; De Jonghe, Peter; Reilly, Mary M.; Froehlich, Eleonore; Hatz, Martina; Trajanoski, Slave; Pieber, Thomas R.; Janecke, Andreas R.; Blackstone, Craig; Auer-Grumbach, Michaela			Targeted High-Throughput Sequencing Identifies Mutations in atlastin-1 as a Cause of Hereditary Sensory Neuropathy Type I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERINE PALMITOYLTRANSFERASE; SPASTIC PARAPLEGIA; GTPASE ATLASTIN; MORPHOGENESIS; GENERATION; FAMILY	Hereditary sensory neuropathy type I (HSN I) is an axonal form of autosomal-dominant hereditary motor and sensory neuropathy distinguished by prominent sensory loss that leads to painless injuries. Unrecognized, these can result in delayed wound healing and osteomyelitis, necessitating distal amputations. To elucidate the genetic basis of an HSN I subtype in a family in which mutations in the few known HSN I genes had been excluded, we employed massive parallel exon sequencing of the 14.3 Mb disease interval on chromosome 14q. We detected a missense mutation (c.1065C>A, p.Asn355Lys) in atlastin-1 (ATL1), a gene that is known to be mutated in early-onset hereditary spastic paraplegia SPG3A and that encodes the large dynamin-related GTPase atlastin-1. The mutant protein exhibited reduced GTPase activity and prominently disrupted ER network morphology when expressed in COS7 cells, strongly supporting pathogenicity. An expanded screen in 115 additional HSN I patients identified two further dominant ATL1 mutations (c.196G>C [p.Glu66Gln] and c.976 delG [p.Val326TrpfsX8]). This study highlights an unexpected major role for atlastin-1 in the function of sensory neurons and identifies HSN I and SPG3A as allelic disorders.	[Papic, Lea; Schabhuettl, Maria; Pieber, Thomas R.; Auer-Grumbach, Michaela] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, A-8036 Graz, Austria; [Guelly, Christian; Strohmaier, Heimo; Froehlich, Eleonore; Hatz, Martina; Trajanoski, Slave] Med Univ Graz, Med Res Ctr, A-8010 Graz, Austria; [Zhu, Peng-Peng; Blackstone, Craig] Natl Inst Neurol Disorders & Stroke, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; [Leonardis, Lea; Zidar, Janez] Univ Clin Ctr, Inst Clin Neurophysiol, Ljubljana 1000, Slovenia; [Weis, Joachim] Univ Aachen, Rhein Westfal TH, Fac Med, Inst Neuropathol, D-52074 Aachen, Germany; [Strom, Tim M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp VIB, Dept Mol Genet, Neurogenet Grp, B-2610 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2610 Antwerp, Belgium; [Baets, Jonathan; De Jonghe, Peter] Univ Antwerp Hosp, Div Neurol, B-2650 Antwerp, Belgium; [Willems, Jan] Hosp Network Antwerp Middelheim, Dept Phys & Rehabil Med, B-2020 Antwerp, Belgium; [Reilly, Mary M.] UCL, Inst Neurol, Med Res Ctr Neuromuscular Dis, London WC1N 3BG, England; [Janecke, Andreas R.] Innsbruck Med Univ, Dept Pediat 2, A-6020 Innsbruck, Austria; [Janecke, Andreas R.] Innsbruck Med Univ, Div Human Genet, A-6020 Innsbruck, Austria	Medical University of Graz; Medical University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); RWTH Aachen University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Antwerp; University of London; University College London; Medical University of Innsbruck; Medical University of Innsbruck	Auer-Grumbach, M (corresponding author), Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, A-8036 Graz, Austria.	michaela.auergrumbach@medunigraz.at	Fröhlich, Eleonore/M-8943-2014; Janecke, Andreas/AAA-5227-2019; Weis, Joachim/G-1984-2014	Fröhlich, Eleonore/0000-0002-6056-6829; Weis, Joachim/0000-0003-3280-6773; Reilly, Mary/0000-0003-0686-905X; Pieber, Thomas/0000-0003-3554-0405; Janecke, Andreas/0000-0001-7155-0315	Austrian Science Fund (FWF) [P19455-B05]; Oesterreichische Nationalbank (ONB) [13010]; National Institute of Neurological Disorders and Stroke, US National Institutes of Health; University of Antwerp; Fund for Scientific Research (FWO-Flanders); Medical Foundation Queen Elisabeth (GSKE); Association Beige contre les Maladies Neuromusculaires (ABMM); Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office (BELSPO) [P6/43]; Deutsche Forschungsgemeinschaft [WE 1406 13/1]; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002992] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Oesterreichische Nationalbank (ONB); National Institute of Neurological Disorders and Stroke, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Antwerp; Fund for Scientific Research (FWO-Flanders)(FWO); Medical Foundation Queen Elisabeth (GSKE); Association Beige contre les Maladies Neuromusculaires (ABMM); Interuniversity Attraction Poles Program of the Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful for the participation of the patients and families, and we thank C. Fischer, H. Knausz, J. Nagle, and T. Deconinck for expert technical assistance. This work was supported by the Austrian Science Fund (FWF, P19455-B05), the Oesterreichische Nationalbank (ONB, project 13010), and the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, US National Institutes of Health. This project was in part funded by a Methusalem grant of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), the Medical Foundation Queen Elisabeth (GSKE), the Association Beige contre les Maladies Neuromusculaires (ABMM), and the Interuniversity Attraction Poles P6/43 Program of the Belgian Federal Science Policy Office (BELSPO). J.B. is supported by a PhD fellowship of the FWO-Flanders, and J.W. is supported by Deutsche Forschungsgemeinschaft grant WE 1406 13/1.	Auer-Grumbach M, 2000, NEUROLOGY, V55, P1552, DOI 10.1212/WNL.55.10.1552; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Fassier C, 2010, NAT NEUROSCI, V13, P1380, DOI 10.1038/nn.2662; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Ivanova N, 2007, ARCH NEUROL-CHICAGO, V64, P706, DOI 10.1001/archneur.64.5.706; MCCORQUODALE DS, 2010, CLIN GENET IN PRESS; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Meijer IA, 2007, ANN NEUROL, V61, P599, DOI 10.1002/ana.21114; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; NICHOLSON GA, 2010, GENEREVIEWS; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054	23	101	103	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					99	105		10.1016/j.ajhg.2010.12.003	http://dx.doi.org/10.1016/j.ajhg.2010.12.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21194679	hybrid, Green Published			2022-12-18	WOS:000286501500010
J	Zaitlen, N; Pasaniuc, B; Gur, T; Ziv, E; Halperin, E				Zaitlen, Noah; Pasaniuc, Bogdan; Gur, Tom; Ziv, Elad; Halperin, Eran			Leveraging Genetic Variability across Populations for the Identification of Causal Variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY; METAANALYSIS; LOCUS	Genome-wide association studies have been performed extensively in the last few years, resulting in many new discoveries of genomic regions that are associated with complex traits. It is often the case that a SNP found to be associated with the condition is not the causal SNP, but a proxy to it as a result of linkage disequilibrium. For the identification of the actual causal SNP, fine-mapping follow-up is performed, either with the use of dense genotyping or by sequencing of the region. In either case, if the causal SNP is in high linkage disequilibrium with other SNPs, the fine-mapping procedure win require a very large sample size for the identification of the causal SNP. Here, we show that by leveraging genetic variability across populations, We Significantly increase the localization success rate (LSR) for a causal SNP in a follow-up study that involves Multiple populations as compared to a study that involves only one population. Thus, the average power for detection of the causal variant win be higher in a joint analysis than than in Studies fine-mapping which only One population is analyzed at a time. Oil the basis of this observation, we developed a framework to efficiently search for a follow-up Study design: Our framework searches for the best combination of populations from a pool Of available populations to maximize the LSR for detection of a causal variant. This framework and its accompanying software can be used to considerably enhance the power of fine-mapping Studies.	[Zaitlen, Noah; Gur, Tom; Halperin, Eran] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Zaitlen, Noah; Halperin, Eran] Tel Aviv Univ, Mol Microbiol & Biotechnol Dept, IL-69978 Tel Aviv, Israel; [Pasaniuc, Bogdan; Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Ziv, Elad] Univ Calif San Francisco, Inst Human Genet, Dept Med, San Francisco, CA 94143 USA; [Ziv, Elad] Univ Calif San Francisco, Inst Human Genet, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Ziv, Elad] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Tel Aviv University; Tel Aviv University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Halperin, E (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	heran@icsi.berkeley.edu	Ziv, Elad/L-5396-2014; Pasaniuc, Bogdan/E-9310-2012	Pasaniuc, Bogdan/0000-0002-0227-2056; Gur, Tom/0000-0001-7864-7013	NCI NIH HHS [R01 CA120120, R01CA120120] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA120120] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Kavvoura FK, 2008, HUM GENET, V123, P1, DOI 10.1007/s00439-007-0445-9; Lawrence R, 2005, GENOME RES, V15, P1503, DOI 10.1101/gr.4217605; Li N, 2003, GENETICS, V165, P2213; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Zaitlen N, 2009, HUM HERED, V68, P73, DOI 10.1159/000212500; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	21	101	101	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					23	33		10.1016/j.ajhg.2009.11.016	http://dx.doi.org/10.1016/j.ajhg.2009.11.016			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20085711	Green Published, Bronze			2022-12-18	WOS:000274471200002
J	Grillet, N; Schwander, M; Hildebrand, MS; Sczaniecka, A; Kolatkar, A; Velasco, J; Webster, JA; Kahrizi, K; Najmabadi, H; Kimberling, WJ; Stephan, D; Bahlo, M; Wiltshire, T; Tarantino, LM; Kuhn, P; Smith, RJH; Muller, U				Grillet, Nicolas; Schwander, Martin; Hildebrand, Michael S.; Sczaniecka, Anna; Kolatkar, Anand; Velasco, Janice; Webster, Jennifer A.; Kahrizi, Kimia; Najmabadi, Hossein; Kimberling, William J.; Stephan, Dietrich; Bahlo, Melanie; Wiltshire, Tim; Tarantino, Lisa M.; Kuhn, Peter; Smith, Richard J. H.; Mueller, Ulrich			Mutations in LOXHD1, an Evolutionarily Conserved Stereociliary Protein, Disrupt Hair Cell Function in Mice and Cause Progressive Hearing Loss in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOUSE MODELS; PLAT DOMAIN; PATTERNS; REVEALS; COMPLEX; BINDING	Hearing loss is the most common form of sensory impairment in humans and is frequently progressive in nature. Here we link a previously uncharacterized gene to hearing impairment in mice and humans. We show that hearing loss in the ethylnitrosourea (ENU)-induced samba mouse line is caused by a mutation in Loxhd1. LOXHD1 consists entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains and is expressed along the membrane of mature hair cell stereocilia. Stereociliary development is unaffected in samba mice, but hair cell function is perturbed and hair cells eventually degenerate. Based on the studies in mice, we screened DNA from human families segregating deafness and identified a mutation in LOXHD1, which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL). LOXHD1, MYO3a, and PJVK are the only human genes to date linked to progressive ARNSHL. These three genes are required for hair cell function, suggesting that age-dependent hair cell failure is a common mechanism for progressive ARNSHL.	[Grillet, Nicolas; Schwander, Martin; Sczaniecka, Anna; Kolatkar, Anand; Kuhn, Peter; Mueller, Ulrich] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Hildebrand, Michael S.; Smith, Richard J. H.] Univ Iowa City, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Velasco, Janice; Stephan, Dietrich] Novartis Res Fdn, Genome Inst, San Diego, CA 92121 USA; [Webster, Jennifer A.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA; [Kahrizi, Kimia; Najmabadi, Hossein] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran, Iran; [Kimberling, William J.] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA; [Stephan, Dietrich] Arizona Alzheimers Consortium, Phoenix, AZ 85004 USA; [Stephan, Dietrich] Banner Alzheimers Inst, Phoenix, AZ 85004 USA; [Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3052, Australia; [Wiltshire, Tim; Tarantino, Lisa M.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27516 USA	Scripps Research Institute; University of Iowa; Novartis; Translational Genomics Research Institute; Boys Town National Research Hospital; Banner Research; Banner Health; Banner Alzheimer's Institute; Walter & Eliza Hall Institute; University of North Carolina; University of North Carolina Chapel Hill	Muller, U (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	umueller@scripps.edu	Kahrizi, Kimia/D-7989-2017; Sczaniecka, Anna/GXZ-6653-2022; Najmabadi, Hossein/P-8182-2017	Grillet, Nicolas/0000-0001-8007-9246; Hildebrand, Michael/0000-0003-2739-0515; Smith, Richard/0000-0003-1201-6731; Najmabadi, Hossein/0000-0002-6084-7778; Bahlo, Melanie/0000-0001-5132-0774	NIDCD [DC007704, DC005965, DC002842]; Skaggs Institute for Chemical Biology; Bruce Ford and Anne Smith Bundy Foundation; Australian National Health and Medical Research Council (NHMRC); NHMRC Overseas Biomedical Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007704, R01DC005965, R01DC002842] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Skaggs Institute for Chemical Biology; Bruce Ford and Anne Smith Bundy Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Overseas Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors sincerely thank the family for their participation in this study. They would also like to thank D. McCarthy for help with data assembly and K. Crozat and D. Logan for sharing expertise in fine mapping and bioinformatics. This research was funded by NIDCD grants DC007704, DC005965 (U.M.), and DC002842 (R.J.H.S.), the Skaggs Institute for Chemical Biology (U.M.), a fellowship from the Bruce Ford and Anne Smith Bundy Foundation (N.G.), an Australian National Health and Medical Research Council (NHMRC) Career Development Award (M.B.), and an NHMRC Overseas Biomedical Fellowship (M.S.H.). R.J.H.S. is the Sterba Hearing Research Professor, University of Iowa College of Medicine.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Bateman A, 1999, CURR BIOL, V9, pR588, DOI 10.1016/S0960-9822(99)80380-7; Delrieu I, 2002, MOL BIOCHEM PARASIT, V121, P11, DOI 10.1016/S0166-6851(02)00016-6; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Eswar N., 2006, CURRENT PROTOCOLS BI, P1; EYKEN V, 2007, AUDIOL NEURO-OTOL, V12, P345; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman LM, 2007, INT J DEV BIOL, V51, P609, DOI 10.1387/ijdb.072365lf; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hegele Robert A., 1992, Human Mutation, V1, P320, DOI 10.1002/humu.1380010410; Hildebrand MS, 2008, MOL THER, V16, P224, DOI 10.1038/sj.mt.6300351; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Hu JH, 2005, MOL BIOL CELL, V16, P458, DOI 10.1091/mbc.E04-09-0851; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Noben-Trauth K, 2009, BRAIN RES, V1277, P42, DOI 10.1016/j.brainres.2009.02.012; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; Vrijens K, 2008, HUM GENET, V124, P325, DOI 10.1007/s00439-008-0556-y; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529	34	101	108	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 11	2009	85	3					328	337		10.1016/j.ajhg.2009.07.017	http://dx.doi.org/10.1016/j.ajhg.2009.07.017			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	497ZN	19732867	Bronze, Green Published			2022-12-18	WOS:000270104500003
J	Reeve, AK; Krishnan, KJ; Elson, JL; Morris, CM; Bender, A; Lightowlers, RN; Turnbull, DM				Reeve, Amy K.; Krishnan, Kim J.; Elson, Joanna L.; Morris, Christopher M.; Bender, Andreas; Lightowlers, Robert N.; Turnbull, Douglass M.			Nature of mitochondrial DNA deletions in substantial nigra neurons	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MTDNA DELETIONS; LAGGING-STRAND; MUSCLE-FIBERS; REPLICATION; MUTATIONS; DEFECTS; REGION	Mitochondrial DNA (mtDNA) deletions have been investigated in a number of neurodegenerative diseases. This study aimed to investigate the characteristics of mtDNA deletions found in single substantia nigra neurons from three patient groups: controls, Parkinson disease patients, and a patient with Parkinsonism due to multiple mtDNA deletions. We have identified 89 deletions from these neurons and examined the breakpoint characteristics of them. There was no difference in the types of mtDNA deletions detected in these neurons. These results suggest that the mechanism leading to the formation of these deletions in these three distinct groups could be the same.	[Reeve, Amy K.; Krishnan, Kim J.; Elson, Joanna L.; Lightowlers, Robert N.; Turnbull, Douglass M.] Univ Newcastle, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Krishnan, Kim J.; Morris, Christopher M.; Turnbull, Douglass M.] Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Bender, Andreas] Univ Munich, Dept Neurol, D-81377 Munich, Germany	Newcastle University - UK; Newcastle University - UK; University of Munich	Turnbull, DM (corresponding author), Univ Newcastle, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	d.m.turnbull@ncl.ac.uk	Bender, Andreas/A-7401-2012	Reeve, Amy/0000-0002-4474-2204; /0000-0002-3551-5624; Bender, Andreas/0000-0002-6328-7104; Morris, Christopher/0000-0002-3749-0993	Medical Research Council [G0700718, G90/63, G0502157, G0400074] Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline; MRC [G0400074, G0700718, G90/63, G0502157] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	14	101	103	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					228	235		10.1016/j.ajhg.2007.09.018	http://dx.doi.org/10.1016/j.ajhg.2007.09.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179904	Bronze, Green Published			2022-12-18	WOS:000253223800026
J	Khajavi, M; Shiga, K; Wiszniewski, W; He, F; Shaw, CA; Yan, J; Wensel, TG; Snipes, GJ; Lupski, JR				Khajavi, Mehrdad; Shiga, Kensuke; Wiszniewski, Wojciech; He, Feng; Shaw, Chad A.; Yan, Jiong; Wensel, Theodore G.; Snipes, G. Jackson; Lupski, James R.			Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: A potential therapy for inherited neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; PERIPHERAL MYELIN PROTEIN-22; INDUCED APOPTOSIS; POINT MUTATIONS; SCHWANN-CELLS; ANIMAL-MODEL; PMP22; GENE; AGGREGATION; MUTANTS	Mutations in myelin genes cause inherited peripheral neuropathies that range in severity from adult-onset Charcot-Marie-Tooth disease type 1 to childhood-onset Dejerine-Sottas neuropathy and congenital hypomyelinating neuropathy. Many myelin gene mutants that cause severe disease, such as those in the myelin protein zero gene (MPZ) and the peripheral myelin protein 22 gene (PMP22), appear to make aberrant proteins that accumulate primarily within the endoplasmic reticulum (ER), resulting in Schwann cell death by apoptosis and, subsequently, peripheral neuropathy. We previously showed that curcumin supplementation could abrogate ER retention and aggregation-induced apoptosis associated with neuropathy-causing MPZ mutants. We now show reduced apoptosis after curcumin treatment of cells in tissue culture that express PMP22 mutants. Furthermore, we demonstrate that oral administration of curcumin partially mitigates the severe neuropathy phenotype of the Trembler-J mouse model in a dose-dependent manner. Administration of curcumin significantly decreases the percentage of apoptotic Schwann cells and results in increased number and size of myelinated axons in sciatic nerves, leading to improved motor performance. Our findings indicate that curcumin treatment is sufficient to relieve the toxic effect of mutant aggregation-induced apoptosis and improves the neuropathologic phenotype in an animal model of human neuropathy, suggesting a potential therapeutic role in selected forms of inherited peripheral neuropathies.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu		Shaw, Chad/0000-0001-7267-5398; Wensel, Theodore/0000-0003-3518-9352; Yan, Jiong/0000-0003-0536-8130	NINDS NIH HHS [R01NS27042, R01 NS027042] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bronstein JM, 2000, CURR OPIN NEUROBIOL, V10, P552, DOI 10.1016/S0959-4388(00)00125-2; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Colby J, 2000, NEUROBIOL DIS, V7, P561, DOI 10.1006/nbdi.2000.0323; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Fortun J, 2006, NEUROBIOL DIS, V22, P153, DOI 10.1016/j.nbd.2005.10.010; Garriga P, 2002, FEBS LETT, V528, P17, DOI 10.1016/S0014-5793(02)03241-6; Gow A, 1998, J CELL BIOL, V140, P925, DOI 10.1083/jcb.140.4.925; Haney C, 1996, J NEUROPATH EXP NEUR, V55, P290, DOI 10.1097/00005072-199603000-00004; Inoue T, 2005, ADV INFORM TECHNOL, V2, P1; Ionasescu VV, 1997, MUSCLE NERVE, V20, P97, DOI 10.1002/(SICI)1097-4598(199701)20:1<97::AID-MUS13>3.0.CO;2-Z; Isaacs AM, 2000, HUM MOL GENET, V9, P1865, DOI 10.1093/hmg/9.12.1865; Kamholz J, 1999, ANN NY ACAD SCI, V883, P91, DOI 10.1111/j.1749-6632.1999.tb08572.x; Khajavi M, 2005, AM J HUM GENET, V77, P841, DOI 10.1086/497541; Kobsar I, 2005, J NEUROSCI RES, V81, P857, DOI 10.1002/jnr.20601; Lester HA, 2000, ANNU REV NEUROSCI, V23, P89, DOI 10.1146/annurev.neuro.23.1.89; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 2001, METABOLIC MOL BASES, P5759; Lupski JR, 2005, PERIPHERAL NEUROPATH, P1659, DOI DOI 10.1016/B978-0-7216-9491-7.50073-9; Martini R, 1997, J ANAT, V191, P321, DOI 10.1046/j.1469-7580.1997.19130321.x; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Naef R, 1999, NEUROBIOL DIS, V6, P1, DOI 10.1006/nbdi.1998.0227; Notterpek L, 1997, J NEUROSCI, V17, P4190; PAREEK S, 1993, J BIOL CHEM, V268, P10372; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; PRICE RL, 1988, J NEUROCYTOL, V17, P55, DOI 10.1007/BF01735377; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Sancho S, 2001, BRAIN, V124, P2177, DOI 10.1093/brain/124.11.2177; Sarkar FH, 2004, MUTAT RES-FUND MOL M, V555, P53, DOI 10.1016/j.mrfmmm.2004.04.015; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; Snipes GJ, 1999, ANN NY ACAD SCI, V883, P143, DOI 10.1111/j.1749-6632.1999.tb08577.x; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; Starr R, 1996, J NEUROSCI RES, V44, P328; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; Teijido O, 2004, HUM MOL GENET, V13, P2581, DOI 10.1093/hmg/ddh291; Thomas PK, 2005, PERIPHERAL NEUROPATH, V2, P1623; TIMMERMAN V, 2006, MOL GENETICS BIOL TH, P1; Tomassini B, 2004, FASEB J, V18, P1553, DOI 10.1096/fj.04-1675fje; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang PW, 1996, BIOCHEM MOL BIOL INT, V38, P393	47	101	110	1	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2007	81	3					438	453		10.1086/519926	http://dx.doi.org/10.1086/519926			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205PX	17701891	Bronze, Green Published			2022-12-18	WOS:000249128200002
J	Mayr, JA; Merkel, O; Kohlwein, SD; Gebhardt, BR; Bohles, H; Fotschl, U; Koch, J; Jaksch, M; Lochmuller, H; Horvath, R; Freisinger, P; Sperl, W				Mayr, Johannes A.; Merkel, Olaf; Kohlwein, Sepp D.; Gebhardt, Boris R.; Boehles, Hansjosef; Foetschl, Ulrike; Koch, Johannes; Jaksch, Michaela; Lochmueller, Hanns; Horvath, Rita; Freisinger, Peter; Sperl, Wolfgang			Mitochondrial phosphate-carrier deficiency: A novel disorder of oxidative phosphorylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; TISSUE DISTRIBUTION; SPECIFICITY; TRANSPORT; FAMILY; MUSCLE; SLC25	The mitochondrial phosphate carrier SLC25A3 transports inorganic phosphate into the mitochondrial matrix, which is essential for the aerobic synthesis of adenosine triphosphate (ATP). We identified a homozygous mutation -c.215G -> A (p.Gly72Glu)-in the alternatively spliced exon 3A of this enzyme in two siblings with lactic acidosis, hypertrophic cardiomyopathy, and muscular hypotonia who died within the 1st year of life. Functional investigation of intact mitochondria showed a deficiency of ATP synthesis in muscle but not in fibroblasts, which correlated with the tissue-specific expression of exon 3A in muscle versus exon 3B in fibroblasts. The enzyme defect was confirmed by complementation analysis in yeast. This is the first report of patients with mitochondrial phosphate-carrier deficiency.	Parcelsus Private Med Univ, Dept Pediat, A-5020 Salzburg, Austria; Graz Univ, Inst Mol Biosci, Graz, Austria; Univ Frankfurt, Dept Gen Pediat, D-6000 Frankfurt, Germany; Tech Univ Munich, Metab Dis Ctr, Klinikum Schwabing, D-8000 Munich, Germany; Tech Univ Munich, Dept Pediat, Klinikum Schwabing, D-8000 Munich, Germany; Univ Munich, Friedrich Baur Inst, Munich, Germany; Univ Munich, Dept Neurol, Munich, Germany	Paracelsus Private Medical University; University of Graz; Goethe University Frankfurt; Munchen Klinik; Technical University of Munich; Munchen Klinik; Technical University of Munich; University of Munich; University of Munich	Mayr, JA (corresponding author), Parcelsus Private Med Univ, Dept Pediat, Mullner Hauptstr 48, A-5020 Salzburg, Austria.	h.mayr@salk.at	Horvath, Rita/AAY-7042-2020	Merkel, Olaf/0000-0001-5089-344X; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Lochmuller, Hanns/0000-0003-2324-8001; Horvath, Rita/0000-0002-9841-170X; Mayr, Johannes/0000-0001-6970-336X				BOOKELMAN H, 1978, BIOCHEM MED METAB B, V20, P395, DOI 10.1016/0006-2944(78)90089-3; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890; Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Reichenbach J, 2006, PEDIATR RES, V60, P321, DOI 10.1203/01.pdr.0000233252.60457.cf; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; SPERL W, 1993, ENZYME PROTEIN, V47, P37, DOI 10.1159/000468654; Wohlrab H, 2005, BBA-BIOENERGETICS, V1709, P157, DOI 10.1016/j.bbabio.2005.07.003; ZARA V, 1992, J BIOL CHEM, V267, P12077	17	101	107	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2007	80	3					478	484		10.1086/511788	http://dx.doi.org/10.1086/511788			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139AB	17273968	Green Published, Bronze			2022-12-18	WOS:000244403300008
J	Zhao, JY; Jin, L; Xiong, MM				Zhao, Jinying; Jin, Li; Xiong, Momiao			Test for interaction between two unlinked loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; GENE-GENE INTERACTIONS; LINKAGE-DISEQUILIBRIUM; BREAST-CANCER; ASSOCIATION; 2-LOCUS; POLYMORPHISMS; STRATEGIES; EPISTASIS	Despite the growing consensus on the importance of testing gene-gene interactions in genetic studies of complex diseases, the effect of gene-gene interactions has often been defined as a deviance from genetic additive effects, which is essentially treated as a residual term in genetic analysis and leads to low power in detecting the presence of interacting effects. To what extent the definition of gene-gene interaction at population level reflects the genes' biochemical or physiological interaction remains a mystery. In this article, we introduce a novel definition and a new measure of gene-gene interaction between two unlinked loci (or genes). We developed a general theory for studying linkage disequilibrium (LD) patterns in disease population under two-locus disease models. The properties of using the LD measure in a disease population as a function of the measure of gene-gene interaction between two unlinked loci were also investigated. We examined how interaction between two loci creates LD in a disease population and showed that the mathematical formulation of the new definition for gene-gene interaction between two loci was similar to that of the LD between two loci. This finding motived us to develop an LD-based statistic to detect gene-gene interaction between two unlinked loci. The null distribution and type I error rates of the LD-based statistic for testing gene-gene interaction were validated using extensive simulation studies. We found that the new test statistic was more powerful than the traditional logistic regression under three two-locus disease models and demonstrated that the power of the test statistic depends on the measure of gene-gene interaction. We also investigated the impact of using tagging SNPs for testing interaction on the power to detect interaction between two unlinked loci. Finally, to evaluate the performance of our new method, we applied the LD-based statistic to two published data sets. Our results showed that the P values of the LD-based statistic were smaller than those obtained by other approaches, including logistic regression models.	Univ Texas, Hlth Sci Ctr, Human Sci Ctr, Houston, TX 77225 USA; Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, German Max Soc Partner Inst Computat Biol, Shanghai, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xiong, MM (corresponding author), Univ Texas, Hlth Sci Ctr, Human Sci Ctr, POB 20334, Houston, TX 77225 USA.	Momiao.Xiong@uth.tmc.edu	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Anthropology, MOE KeyLab Fudan/A-9454-2010	Jin, Li/0000-0002-4546-2415; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054144, P01AR052915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL074735, HL74735] Funding Source: Medline; NIAMS NIH HHS [P01 AR052915-01A1, P01 AR052915, P50 AR054144] Funding Source: Medline; NIEHS NIH HHS [R01 ES009912, ES09912] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bastone L, 2004, HUM HERED, V58, P82, DOI 10.1159/000083029; Byng MC, 2003, ANN HUM GENET, V67, P543, DOI 10.1046/j.1529-8817.2003.00055.x; Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; CHEVERUD JM, 1995, GENETICS, V139, P1455; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; COCKERHAM CC, 1954, GENETICS, V39, P859; Coffey CS, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-49; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Foulkes AS, 2004, J ROY STAT SOC C-APP, V53, P311, DOI 10.1046/j.1467-9876.2003.05094.x; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Hosmer D. W., 2000, APPL LOGISTIC REGRES, V2nd; KEMPTHORNE O, 1954, PROC R SOC SER B-BIO, V143, P103, DOI 10.1098/rspb.1954.0056; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kooperberg C, 2001, GENET EPIDEMIOL, V21, pS626, DOI 10.1002/gepi.2001.21.s1.s626; Lu FM, 2003, CANCER RES, V63, P7056; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mitrunen K, 2003, MUTAT RES-REV MUTAT, V544, P9, DOI 10.1016/S1383-5742(03)00016-4; Moore Jason H, 2002, Pac Symp Biocomput, P53; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; Nielsen DM, 2004, GENETICS, V168, P1029, DOI 10.1534/genetics.103.022335; NOTHNAGEL M, 2002, AM J HUM GENET S, V71; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; Serfling R, 1980, APPROXIMATION THEORE; Soares ML, 2005, HUM MOL GENET, V14, P543, DOI 10.1093/hmg/ddi051; Takahashi N, 2000, ANN HUM GENET, V64, P197, DOI 10.1017/S0003480000008083; Takahashi N, 2000, HEARTWEB, V5, pU1; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Wagner GP, 1998, GENETICA, V102-3, P569, DOI 10.1023/A:1017088321094; Wang XW, 1996, GENE DEV, V10, P1219, DOI 10.1101/gad.10.10.1219; Weir BS, 1990, GENETIC DATA ANAL; Williams SM, 2000, HYPERTENSION, V36, P2, DOI 10.1161/01.HYP.36.1.2; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Willmore J, 2003, T+D-BETTER PERFORM W, V57, P28; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	43	101	104	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					831	845		10.1086/508571	http://dx.doi.org/10.1086/508571			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033960	Green Published, Bronze			2022-12-18	WOS:000241667400005
J	Beysen, D; Raes, J; Leroy, BP; Lucassen, A; Yates, JRW; Clayton-Smith, J; Ilyina, H; Brooks, SS; Christin-Maitre, S; Fellous, M; Fryns, JP; Kim, JR; Lapunzina, P; Lemyre, E; Meire, F; Messiaen, LM; Oley, C; Splitt, M; Thomson, J; Van de Peer, Y; Veitia, RA; De Paepe, A; De Baere, E				Beysen, D; Raes, J; Leroy, BP; Lucassen, A; Yates, JRW; Clayton-Smith, J; Ilyina, H; Brooks, SS; Christin-Maitre, S; Fellous, M; Fryns, JP; Kim, JR; Lapunzina, P; Lemyre, E; Meire, F; Messiaen, LM; Oley, C; Splitt, M; Thomson, J; Van de Peer, Y; Veitia, RA; De Paepe, A; De Baere, E			Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in Blepharophimosis syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPICANTHUS INVERSUS SYNDROME; TRANSCRIPTION FACTOR FOXL2; PREMATURE OVARIAN FAILURE; GENE-EXPRESSION; HUMAN GENOME; BPES; IDENTIFICATION; TRANSLOCATION; MUTATIONS; PTOSIS	The expression of a gene requires not only a normal coding sequence but also intact regulatory regions, which can be located at large distances from the target genes, as demonstrated for an increasing number of developmental genes. In previous mutation studies of the role of FOXL2 in blepharophimosis syndrome (BPES), we identified intragenic mutations in 70% of our patients. Three translocation breakpoints upstream of FOXL2 in patients with BPES suggested a position effect. Here, we identified novel microdeletions outside of FOXL2 in cases of sporadic and familial BPES. Specifically, four rearrangements, with an overlap of 126 kb, are located 230 kb upstream of FOXL2, telomeric to the reported translocation breakpoints. Moreover, the shortest region of deletion overlap (SRO) contains several conserved nongenic sequences (CNGs) harboring putative transcription-factor binding sites and representing potential long-range cis-regulatory elements. Interestingly, the human region orthologous to the 12-kb sequence deleted in the polled intersex syndrome in goat, which is an animal model for BPES, is contained in this SRO, providing evidence of human-goat conservation of FOXL2 expression and of the mutational mechanism. Surprisingly, in a fifth family with BPES, one rearrangement was found downstream of FOXL2. In addition, we report nine novel rearrangements encompassing FOXL2 that range from partial gene deletions to submicroscopic deletions. Overall, genomic rearrangements encompassing or outside of FOXL2 account for 16% of all molecular defects found in our families with BPES. In summary, this is the first report of extragenic deletions in BPES, providing further evidence of potential long-range cis-regulatory elements regulating FOXL2 expression. It contributes to the enlarging group of developmental diseases caused by defective distant regulation of gene expression. Finally, we demonstrate that CNGs are candidate regions for genomic rearrangements in developmental genes.	Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; Ghent Univ Hosp, Dept Ophthalmol, B-9000 Ghent, Belgium; State Univ Ghent VIB, Res Grp Bioinformat & Evolut Genom, Dept Plant Syst Biol, Ghent, Belgium; Univ Southampton, Wessex Clin Genet Serv, Southampton SO9 5NH, Hants, England; Univ Cambridge, Dept Med Genet, Cambridge, England; Addenbrookes Hosp, Dept Med Genet, Cambridge, England; St Marys Hosp, Acad Dept Med Genet, Manchester M13 0JH, Lancs, England; Belorussian Inst Hereditary Disorders, Minsk, BELARUS; New York State Inst Basic Res Dev Disabil, New York, NY USA; Hop St Antoine, Serv Endocrinol, Paris, France; INSERM, Hop Cochin, U361, Paris, France; Ctr Human Genet, B-3000 Louvain, Belgium; Yeungnam Univ, Dept Biochem & Mol Biol, Taegu, South Korea; Hosp Univ La Paz, Serv Genet, Madrid, Spain; Univ Montreal, Dept Pediat, Med Genet Serv, Montreal, PQ H3C 3J7, Canada; Univ Alabama, Tuscaloosa, AL 35487 USA; Birmingham Womens Hosp, Birmingham, W Midlands, England; Guys & St Thomas Hosp Natl Hlth Serv Trust, Dept Clin Genet, London, England; St James Univ Hosp, Leeds, W Yorkshire, England	Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; University of Southampton; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Manchester; Institute for Basic Research in Developmental Disabilities; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Yeungnam University; Hospital Universitario La Paz; Universite de Montreal; University of Alabama System; University of Alabama Tuscaloosa; Birmingham Women's Hospital; Saint James's University Hospital	De Baere, E (corresponding author), Ghent Univ Hosp, Ctr Med Genet, Pintelaan 185, B-9000 Ghent, Belgium.	Elfride.DeBaere@UGent.be	De Baere, Elfride/E-7405-2017; raes, jeroen/D-7835-2018; Van de Peer, Yves/AAE-7666-2019; Van de Peer, Yves/D-4388-2009; Lucassen, Anneke/D-7764-2017; Lapunzina, Pablo/L-7075-2014	De Baere, Elfride/0000-0002-5609-6895; raes, jeroen/0000-0002-1337-041X; Van de Peer, Yves/0000-0003-4327-3730; Van de Peer, Yves/0000-0003-4327-3730; Lucassen, Anneke/0000-0003-3324-4338; Lapunzina, Pablo/0000-0002-6324-4825				Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bodega B, 2004, MOL HUM REPROD, V10, P555, DOI 10.1093/molehr/gah078; Cha SC, 2003, CLIN GENET, V64, P485, DOI 10.1046/j.1399-0004.2003.00162.x; Cocquet J, 2003, CYTOGENET GENOME RES, V101, P206, DOI 10.1159/000074338; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crisponi L, 2004, GENOMICS, V83, P757, DOI 10.1016/j.ygeno.2003.11.010; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Davies AF, 1999, J MED GENET, V36, P708; De Baere E, 2000, GENOMICS, V68, P296, DOI 10.1006/geno.2000.6304; De Baere E, 2003, AM J HUM GENET, V72, P478, DOI 10.1086/346118; De Baere E, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.8.e43; De Baere E, 1999, GENOMICS, V57, P70, DOI 10.1006/geno.1999.5747; De Baere E, 2001, HUM MOL GENET, V10, P1591, DOI 10.1093/hmg/10.15.1591; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Gille JJP, 2003, AM J HUM GENET, V73, P287; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lopes J, 1997, NAT GENET, V17, P136, DOI 10.1038/ng1097-136; Matyas G, 2002, HUM MUTAT, V19, P58, DOI 10.1002/humu.10013; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Messiaen L, 1996, EUR J HUM GENET, V4, P34; Nikic S, 2004, CHROMOSOME RES, V12, P465, DOI 10.1023/B:CHRO.0000034746.46789.e0; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Plessy C, 2005, TRENDS GENET, V21, P207, DOI 10.1016/j.tig.2005.02.006; Praphanphoj V, 2000, GENOMICS, V65, P67, DOI 10.1006/geno.2000.6157; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Udar N, 2003, HUM MUTAT, V22, P222, DOI 10.1002/humu.10251; Velagaleti GVN, 2005, AM J HUM GENET, V76, P652, DOI 10.1086/429252; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	41	101	112	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					205	218		10.1086/432083	http://dx.doi.org/10.1086/432083			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	15962237	Green Published, Bronze			2022-12-18	WOS:000230387200003
J	Bonnevie-Nielsen, V; Field, LL; Lu, S; Zheng, DJ; Li, M; Martensen, PM; Nielsen, TB; Beck-Nielsen, H; Lau, YL; Pociot, F				Bonnevie-Nielsen, V; Field, LL; Lu, S; Zheng, DJ; Li, M; Martensen, PM; Nielsen, TB; Beck-Nielsen, H; Lau, YL; Pociot, F			Variation in antiviral 2 ',5 '-oligoadenylate synthetase (2 ' 5 ' AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							2'-5' OLIGOADENYLATE SYNTHETASE; WEST-NILE-VIRUS; 2'-5'-OLIGOADENYLATE SYNTHETASE; PROSTATE-CANCER; RNASE-L; INFECTION; MUTATIONS; SUSCEPTIBILITY; PROGRESSION; PROTEIN	It is likely that human genetic differences mediate susceptibility to viral infection and virus-triggered disorders. OAS genes encoding the antiviral enzyme 2', 5'-oligoadenylate synthetase (2'5'AS) are critical components of the innate immune response to viruses. This enzyme uses adenosine triphosphate in 2'-specific nucleotidyl transfer reactions to synthesize 2', 5'-oligoadenylates, which activate latent ribonuclease, resulting in degradation of viral RNA and inhibition of virus replication. We showed elsewhere that constitutive (basal) activity of 2'5'AS is correlated with virus-stimulated activity. In the present study, we asked whether constitutive activity is genetically determined and, if so, by which variants. Analysis of 83 families containing two parents and two children demonstrated significant correlations between basal activity in parent-child pairs (P < .0001) and sibling pairs (P = .0044), but not spousal pairs, suggesting strong genetic control of basal activity. We next analyzed association between basal activity and 15 markers across the OAS gene cluster. Significant association was detected at multiple markers, the strongest being at an A/G single-nucleotide polymorphism at the exon 7 splice-acceptor site (AG or AA) of the OAS1 gene. At this unusual polymorphism, allele G had a higher gene frequency in persons with high enzyme activity than in those with low enzyme activity (0.44 vs. 0.20; P = 3 x 10(-11)). Enzyme activity varied in a dose-P dependent manner across the GG, GA, and AA genotypes ( tested by analysis of variance; P = 1 x 10(-14)). Allele G generates the previously described p46 enzyme isoform, whereas allele A ablates the splice site and generates a dual-function antiviral/proapoptotic p48 isoform and a novel p52 isoform. This genetic polymorphism makes OAS1 an excellent candidate for a human gene that influences host susceptibility to viral infection.	Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark; Odense Univ, Dept Endocrinol, Odense, Denmark; Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; Steno Diabet Ctr, DK-2820 Gentofte, Denmark	University of British Columbia; University of British Columbia; Aarhus University; University of Southern Denmark; University of Hong Kong; Steno Diabetes Center	Field, LL (corresponding author), British Columbia Res Inst Childrens & Womens Hlth, 950 W 28 Ave, Vancouver, BC V5Z 4H4, Canada.	llfield@interchange.ubc.ca	Lau, Yu Lung/C-4322-2009; Martensen, Pia/I-3996-2012	Pociot, Flemming/0000-0003-3274-5448; Martensen, Pia Moller/0000-0002-1259-0226				Bonnevie-Nielsen V, 2000, CLIN IMMUNOL, V96, P11, DOI 10.1006/clim.2000.4874; BONNEVIENIELSEN V, 1989, DIABETES, V38, P1636, DOI 10.2337/diabetes.38.12.1636; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Crosdale DJ, 2000, EUR J IMMUNOGENET, V27, P111, DOI 10.1046/j.1365-2370.2000.00211.x; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; FIELD LL, IN PRESS DIABETES; Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Ghosh A, 1997, J BIOL CHEM, V272, P33220, DOI 10.1074/jbc.272.52.33220; Ghosh A, 2001, J BIOL CHEM, V276, P25447, DOI 10.1074/jbc.M100496200; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hiltunen M, 1997, J INFECT DIS, V175, P554, DOI 10.1093/infdis/175.3.554; HYOTY H, 1995, DIABETES, V44, P652, DOI 10.2337/diabetes.44.6.652; Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644; Knapp S, 2003, GENES IMMUN, V4, P411, DOI 10.1038/sj.gene.6363984; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Lonnrot M, 2000, DIABETES, V49, P1314, DOI 10.2337/diabetes.49.8.1314; Lucas M, 2003, IMMUNOL CELL BIOL, V81, P230, DOI 10.1046/j.1440-1711.2003.01166.x; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Minchinton RM, 2002, SCAND J IMMUNOL, V56, P630, DOI 10.1046/j.1365-3083.2002.01167.x; Perelygin AA, 2002, P NATL ACAD SCI USA, V99, P9322, DOI 10.1073/pnas.142287799; Rogozin IB, 2003, J MOL BIOL, V326, P1449, DOI 10.1016/S0022-2836(03)00055-X; Roivainen M, 1998, J MED VIROL, V56, P74, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;74::AID-JMV12&gt;3.0.CO;2-W; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Silverman RH, 2003, BIOCHEMISTRY-US, V42, P1805, DOI 10.1021/bi027147i; Xiang Y, 2003, CANCER RES, V63, P6795; Yuen MF, 1999, HEPATOLOGY, V29, P1248, DOI 10.1002/hep.510290417	26	101	111	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					623	633		10.1086/429391	http://dx.doi.org/10.1086/429391			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15732009	Green Published, Bronze			2022-12-18	WOS:000227516000008
J	Ligon, AH; Moore, SDP; Parisi, MA; Mealiffe, ME; Harris, DJ; Ferguson, HL; Quade, BJ; Morton, CC				Ligon, AH; Moore, SDP; Parisi, MA; Mealiffe, ME; Harris, DJ; Ferguson, HL; Quade, BJ; Morton, CC			Constitutional rearrangement of the architectural factor HMGA2: A novel human phenotype including overgrowth and lipomas	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HORMONE-RELATED PEPTIDE; TRANSLOCATION BREAKPOINTS; UTERINE LEIOMYOMATA; C GENE; EXPRESSION; DISRUPTION; PROTEINS; IDENTIFICATION; TRANSFORMATION; TRANSCRIPTION	Although somatic mutations in a number of genes have been associated with development of human tumors, such as lipomas, relatively few examples exist of germline mutations in these genes. Here we describe an 8-year-old boy who has a de novo pericentric inversion of chromosome 12, with breakpoints at p11.22 and q14.3, and a phenotype including extreme somatic overgrowth, advanced endochondral bone and dental ages, a cerebellar tumor, and multiple lipomas. His chromosomal inversion was found to truncate HMGA2, a gene that encodes an architectural factor involved in the etiology of many benign mesenchymal tumors and that maps to the 12q14.3 breakpoint. Similar truncations of murine Hmga2 in transgenic mice result in somatic overgrowth and, in particular, increased abundance of fat and lipomas, features strikingly similar to those observed in the child. This represents the first report of a constitutional rearrangement affecting HMGA2 and demonstrates the role of this gene in human growth and development. Systematic genetic analysis and clinical studies of this child may offer unique insights into the role of HMGA2 in adipogenesis, osteogenesis, and general growth control.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Childrens Hosp & Reg Med Ctr, Div Genet & Dev Med, Seattle, WA USA; Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Ligon, AH (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	aligon@rics.bwh.harvard.edu		Moore, Steven/0000-0002-3209-6102	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61354, P01 GM061354] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand A, 2000, NAT GENET, V24, P377, DOI 10.1038/74207; Andrieux J, 2004, GENE CHROMOSOME CANC, V39, P82, DOI 10.1002/gcc.10297; Arlotta P, 2000, J BIOL CHEM, V275, P14394, DOI 10.1074/jbc.M000564200; Ashar HR, 2003, CANCER GENET CYTOGEN, V143, P160, DOI 10.1016/S0165-4608(03)00037-2; ASHAR HR, 1995, CELL, V82, P57; Battista S, 1999, CANCER RES, V59, P4793; Broberg K, 2001, MODERN PATHOL, V14, P311, DOI 10.1038/modpathol.3880308; Broberg K, 1999, GENE CHROMOSOME CANC, V24, P278; BULLERDIEK J, 1993, CANCER GENET CYTOGEN, V65, P27, DOI 10.1016/0165-4608(93)90054-P; Dahlen A, 2003, MODERN PATHOL, V16, P1132, DOI 10.1097/01.MP.0000092954.42656.94; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fedele M, 1998, ONCOGENE, V17, P413, DOI 10.1038/sj.onc.1201952; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; FEJZO MS, 1995, GENOMICS, V26, P265, DOI 10.1016/0888-7543(95)80210-D; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; Gattas GJF, 1999, GENE CHROMOSOME CANC, V25, P316, DOI 10.1002/(SICI)1098-2264(199908)25:4<316::AID-GCC2>3.0.CO;2-0; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Kazmierczak B, 1998, CANCER GENET CYTOGEN, V103, P175; Kazmierczak B, 1996, ONCOGENE, V12, P515; Kwok SCM, 2001, DNA CELL BIOL, V20, P349, DOI 10.1089/10445490152122460; NEY PA, 1993, MOL CELL BIOL, V13, P5604, DOI 10.1128/MCB.13.9.5604; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Pierantoni GM, 2003, INT J ONCOL, V23, P363; Quade BJ, 2003, CANCER RES, V63, P1351; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Rommel B, 1997, LEUKEMIA LYMPHOMA, V26, P603, DOI 10.3109/10428199709050896; Sambrook J, 2001, MOL CLONING LAB MANU; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; Santulli B, 2000, CANCER GENET CYTOGEN, V119, P70, DOI 10.1016/S0165-4608(99)00205-8; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; SREEKANTAIAH C, 1991, CANCER RES, V51, P422; Tkachenko A, 1997, CANCER RES, V57, P2276; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	37	101	105	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2005	76	2					340	348		10.1086/427565	http://dx.doi.org/10.1086/427565			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	886GO	15593017	Green Published, Bronze			2022-12-18	WOS:000226215100019
J	Visser, R; Shimokawa, O; Harada, N; Kinoshita, A; Ohta, T; Niikawa, N; Matsumoto, N				Visser, R; Shimokawa, O; Harada, N; Kinoshita, A; Ohta, T; Niikawa, N; Matsumoto, N			Identification of a 3.0-kb major recombination hotspot in patients with Sotos syndrome who carry a common 1.9-mb microdeletion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOW-COPY REPEATS; GENOMIC DISORDERS; SEGMENTAL DUPLICATIONS; MOLECULAR-MECHANISMS; NSD1 MUTATIONS; OVERGROWTH PHENOTYPES; MEIOTIC RECOMBINATION; STRAND EXCHANGE; HNPP DELETION; HOT-SPOTS	Sotos syndrome (SoS) is a congenital dysmorphic disorder characterized by overgrowth in childhood, distinctive craniofacial features, and mental retardation. Haploinsufficiency of the NSD1 gene owing to either intragenic mutations or microdeletions is known to be the major cause of SoS. The common similar to 2.2-Mb microdeletion encompasses the whole NSD1 gene and neighboring genes and is flanked by low-copy repeats (LCRs). Here, we report the identification of a 3.0-kb major recombination hotspot within these LCRs, in which we mapped deletion breakpoints in 78.7% (37/47) of patients with SoS who carry the common microdeletion. The deletion size was subsequently refined to 1.9 Mb. Sequencing of breakpoint fragments from all 37 patients revealed junctions between a segment of the proximal LCR (PLCR-B) and the corresponding region of the distal LCR (DLCR-2B). PLCR-B and DLCR-2B are the only directly oriented regions, whereas the remaining regions of the PLCR and DLCR are in inverted orientation. The PLCR, with a size of 394.0 kb, and the DLCR, with a size of of 429.8 kb, showed high overall homology (similar to 98.5%), with an increased sequence similarity (similar to 99.4%) within the 3.0-kb breakpoint cluster. Several recombination-associated motifs were identified in the hotspot and/or its vicinity. Interestingly, a 10-fold average increase of a translin motif, as compared with the normal distribution within the LCRs, was recognized. Furthermore, a heterozygous inversion of the interval between the LCRs was detected in all fathers of the children carrying a deletion in the paternally derived chromosome. The functional significance of these findings remains to be elucidated. Segmental duplications of the primate genome play a major role in chromosomal evolution. Evolutionary study showed that the duplication of the SoS LCRs occurred 23.3 - 47.6 million years ago, before the divergence of Old World monkeys.	Yokohama City Univ, Dept Human Genet, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Nagasaki Univ, Dept Human Genet, Grad Sch Biomed Sci, Nagasaki 852, Japan; 21st Century Ctr Excellence, Int Consortium Med Care Hibakusha & Radiat Life S, Nagasaki, Japan; Kyushu Med Sci Nagasaki Lab, Nagasaki, Japan; Nagasaki Univ, Ctr Frontier Life Sci, Div Funct Gen, Nagasaki 852, Japan; Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Japan; Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Ishikari, Hokkaido 06102, Japan	Yokohama City University; Nagasaki University; Nagasaki University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Yokohama City University; Japan Science & Technology Agency (JST); Health Sciences University of Hokkaido	Matsumoto, N (corresponding author), Yokohama City Univ, Dept Human Genet, Grad Sch Med, Kanazawa Ku, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp						Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Ayyadevara S, 2000, ANAL BIOCHEM, V284, P11, DOI 10.1006/abio.2000.4635; Badge RM, 2000, HUM MOL GENET, V9, P1239, DOI 10.1093/hmg/9.8.1239; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Boerkoel CF, 1999, ANN NY ACAD SCI, V883, P22, DOI 10.1111/j.1749-6632.1999.tb08563.x; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; COLE TRP, 1994, J MED GENET, V31, P20, DOI 10.1136/jmg.31.1.20; de Boer L, 2004, HORM RES, V62, P197, DOI 10.1159/000081063; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kamimura J, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.11.e126; Kasai M, 1997, J BIOL CHEM, V272, P11402; Kiyosawa H, 1996, HUM MOL GENET, V5, P745, DOI 10.1093/hmg/5.6.745; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kurotaki N, 2003, HUM MUTAT, V22, P378, DOI 10.1002/humu.10270; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lopes J, 1999, HUM MOL GENET, V8, P2285, DOI 10.1093/hmg/8.12.2285; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Miyake N, 2003, AM J HUM GENET, V72, P1331, DOI 10.1086/375166; Nagai T, 2003, J MED GENET, V40, P285, DOI 10.1136/jmg.40.4.285; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Pettersson M, 2003, GENOMICS, V82, P390, DOI 10.1016/S0888-7543(03)00177-0; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Rio M, 2003, J MED GENET, V40, P436, DOI 10.1136/jmg.40.6.436; Rozen S, 2000, Methods Mol Biol, V132, P365; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shimokawa O, 2004, AM J MED GENET A, V128A, P133, DOI 10.1002/ajmg.a.30063; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; TATTONBROWN K, 2004, CLIN GEN SOC SPRING; Turkmen S, 2003, EUR J HUM GENET, V11, P858, DOI 10.1038/sj.ejhg.5201050; Visser R, 2003, CURR OPIN PEDIATR, V15, P598, DOI 10.1097/00008480-200312000-00010	47	101	102	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					52	67		10.1086/426950	http://dx.doi.org/10.1086/426950			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15580547	Bronze, Green Published			2022-12-18	WOS:000225643600005
J	Williams, NM; Norton, N; Williams, H; Ekholm, B; Hamshere, ML; Lindblom, Y; Chowdari, KV; Cardno, AG; Zammit, S; Jones, LA; Murphy, KC; Sanders, RD; McCarthy, G; Gray, MY; Jones, G; Holmans, P; Nimgaonkar, V; Adolfson, R; Osby, U; Terenius, L; Sedvall, G; O'Donovan, MC; Owen, MJ				Williams, NM; Norton, N; Williams, H; Ekholm, B; Hamshere, ML; Lindblom, Y; Chowdari, KV; Cardno, AG; Zammit, S; Jones, LA; Murphy, KC; Sanders, RD; McCarthy, G; Gray, MY; Jones, G; Holmans, P; Nimgaonkar, V; Adolfson, R; Osby, U; Terenius, L; Sedvall, G; O'Donovan, MC; Owen, MJ			A systematic genomewide linkage study in 353 sib pairs with schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; SUSCEPTIBILITY LOCUS; BIPOLAR DISORDER; GENETIC-VARIATION; SCAN METAANALYSIS; PSYCHOTIC ILLNESS; ONSET PSYCHOSIS; COMPLEX TRAITS; 6P22.3 GENE; WIDE SCAN	We undertook a genomewide linkage study in a total of 353 affected sib pairs (ASPs) with schizophrenia. Our sample consisted of 179 ASPs from the United Kingdom, 134 from Sweden, and 40 from the United States. We typed 372 microsatellite markers at similar to10-cM intervals. Our strongest finding was a LOD score of 3.87 on chromosome 10q25.3-q26.3, with positive results being contributed by all three samples and a LOD-1 interval of 15 cM. This finding achieved genomewide significance (P < .05), on the basis of simulation studies. We also found two regions, 17p11.2-q25.1 (maximum LOD score [MLS] = 3.35) and 22q11 (MLS = 2.29), in which the evidence for linkage was highly suggestive. Linkage to all of these regions has been supported by other studies. Moreover, we found strong evidence for linkage (genomewide P < .02) to 17p11.2-q25.1 in a single pedigree with schizophrenia. In our view, the evidence is now sufficiently compelling to undertake detailed mapping studies of these three regions.	Cardiff Univ, Dept Psychol Med, Neuropsychiat Genet Unit, Cardiff CF14 4XN, S Glam, Wales; Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Human Genet, Pittsburgh, PA USA; Univ Pittsburgh, Western Psychiat Inst & Clin, Grad Sch Publ Hlth, Pittsburgh, PA 15213 USA; Umea Univ, Div Psychiat, Dept Clin Sci, Umea, Sweden	Cardiff University; Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Umea University	Owen, MJ (corresponding author), Cardiff Univ, Dept Psychol Med, Neuropsychiat Genet Unit, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	odonovanmc@cardiff.ac.uk; owenmj@cardiff.ac.uk	O'Donovan, Michael C/P-7005-2018; Peng, Bo/A-6920-2009; Williams, Hywel/AAL-2440-2021; Holmans, Peter/F-4518-2015; Murphy, Kieran C/D-3577-2012	O'Donovan, Michael C/0000-0001-7073-2379; Peng, Bo/0000-0001-8225-2284; Williams, Hywel/0000-0001-7758-0312; Holmans, Peter/0000-0003-0870-9412; Jones, Lisa/0000-0002-5122-8334; Murphy, Kieran/0000-0003-2930-4465; McCarthy, Geraldine/0000-0002-1312-0998; Zammit, Stanley/0000-0002-2647-9211	Medical Research Council [G9810900, G9309834] Funding Source: Medline; NIMH NIH HHS [MH66263, R01 MH63480, R01 MH063480, MH56242, R10 MH056242, R01 MH066263, R01 MH056242] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066263, R01MH056242, R10MH056242, R01MH063480] Funding Source: NIH RePORTER; MRC [G9309834, G9810900] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Bray NJ, 2001, TRENDS MOL MED, V7, P169, DOI 10.1016/S1471-4914(01)01950-5; Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; DeLisi LE, 2002, AM J PSYCHIAT, V159, P803, DOI 10.1176/appi.ajp.159.5.803; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Gottesman II, 1991, SCHIZOPHRENIA GENESI; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; Ivanov D, 2003, BRIT J PSYCHIAT, V183, P409, DOI 10.1192/bjp.183.5.409; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Levinson DF, 1996, AM J MED GENET, V67, P580; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Levinson DF, 2003, AM J HUM GENET, V73, P17, DOI 10.1086/376548; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Martinez M, 1999, AM J MED GENET, V88, P337, DOI 10.1002/(SICI)1096-8628(19990820)88:4<337::AID-AJMG9>3.3.CO;2-1; Maziade M, 1997, AM J MED GENET, V74, P666; MCGUE M, 1988, ARCH GEN PSYCHIAT, V45, P641; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Mowry BJ, 2000, AM J MED GENET, V96, P864, DOI 10.1002/1096-8628(20001204)96:6<864::AID-AJMG35>3.3.CO;2-4; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Murray R, 2003, EPIDEMIOLOGY SCHIZOP; MURRAY RM, 1988, BRIT MED J, V296, P63, DOI 10.1136/bmj.296.6614.63; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Donovan MC, 2003, HUM MOL GENET, V12, pR125, DOI 10.1093/hmg/ddg302; Owen M, 2000, MOL PSYCHIATR, V5, P22, DOI 10.1038/sj.mp.4000702; Owen MJ, 2002, PSYCHIAT GENETICS GE, P247; Papolos DF, 1996, AM J PSYCHIAT, V153, P1541; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; RISCH N, 1990, AM J HUM GENET, V46, P229; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams HJ, 2003, MOL PSYCHIATR, V8, P644, DOI 10.1038/sj.mp.4001276; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729; Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348; Wing J. K. C., 1974, MEASUREMENT CLASSIFI; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589	70	101	104	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1355	1367		10.1086/380206	http://dx.doi.org/10.1086/380206			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14628288	Green Published, Bronze			2022-12-18	WOS:000187491100012
J	Cuajungco, MP; Leyne, M; Mull, J; Gill, SP; Lu, WN; Zagzag, D; Axelrod, FB; Maayan, C; Gusella, JF; Slaugenhaupt, SA				Cuajungco, MP; Leyne, M; Mull, J; Gill, SP; Lu, WN; Zagzag, D; Axelrod, FB; Maayan, C; Gusella, JF; Slaugenhaupt, SA			Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE-II HOLOENZYME; REAL-TIME; GENE-EXPRESSION; ELONGATOR; COMPLEX; IKAP; VALIDATION; COMPONENT; PROTEIN; SUBUNIT	We recently identified a mutation in the I-kappaB kinase associated protein (IKBKAP) gene as the major cause of familial dysautonomia (FD), a recessive sensory and autonomic neuropathy. This alteration, located at base pair 6 of the intron 20 donor splice site, is present on >99.5% of FD chromosomes and results in tissue-specific skipping of exon 20. A second FD mutation, a missense change in exon 19 (R696P), was seen in only four patients heterozygous for the major mutation. Here, we have further characterized the consequences of the major mutation by examining the ratio of wild-type to mutant (WT: MU) IKBKAP transcript in EBV-transformed lymphoblast lines, primary fibroblasts, freshly collected blood samples, and postmortem tissues from patients with FD. We consistently found that WT IKBKAP transcripts were present, albeit to varying extents, in all cell lines, blood, and postmortem FD tissues. Further, a corresponding decrease in the level of WT protein is seen in FD cell lines and tissues. The WT: MU ratio in cultured lymphoblasts varied with growth phase but not with serum concentration or inclusion of antibiotics. Using both densitometry and real-time quantitative polymerase chain reaction, we found that relative WT: MU IKBKAP RNA levels were highest in cultured patient lymphoblasts and lowest in postmortem central and peripheral nervous tissues. These observations suggest that the relative inefficiency of WT IKBKAP mRNA production from the mutant alleles in the nervous system underlies the selective degeneration of sensory and autonomic neurons in FD. Therefore, exploration of methods to increase the WT: MU IKBKAP transcript ratio in the nervous system offers a promising approach for developing an effective therapy for patients with FD.	Harvard Univ, Sch Med, Inst Human Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Collis Genome Lab, Boston, MA 02115 USA; NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA; NYU, Med Ctr, Dept Pediat, New York, NY 10016 USA; Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; New York University; New York University; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital	Slaugenhaupt, SA (corresponding author), Harvard Univ, Sch Med, Inst Human Genet, 77 Ave Louis Pasteur,HIM 422, Boston, MA 02115 USA.	susan_slaugenhaupt@hms.harvard.edu	Cuajungco, Math/B-2647-2008	Cuajungco, Math/0000-0003-0749-9564; Lu, Weining/0000-0002-6570-3044	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036326] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-8-3284] Funding Source: Medline; NINDS NIH HHS [R01 NS036326, R01 NS36326] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alonso J, 2001, HUM MUTAT, V17, P412, DOI 10.1002/humu.1117; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Axelrod F B, 1974, Adv Pediatr, V21, P75; Axelrod FB, 1984, CELL MOL BIOL NEURON, P331; Axelrod FP, 1995, DISORDERS AUTONOMIC, P217; Birrell GW, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<75::AID-HUMU16>3.0.CO;2-6; Chang JG, 2001, P NATL ACAD SCI USA, V98, P9808, DOI 10.1073/pnas.171105098; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Cuajungco MP, 2001, DNA CELL BIOL, V20, P579, DOI 10.1089/104454901317094990; Dong JL, 2002, AM J MED GENET, V110, P253, DOI 10.1002/ajmg.10450; Fellows J, 2000, J BIOL CHEM, V275, P12896, DOI 10.1074/jbc.275.17.12896; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Guimaraes CP, 2001, HUM GENET, V109, P616, DOI 10.1007/s00439-001-0632-z; Guo D, 2001, AM J MED GENET, V101, P130, DOI 10.1002/1096-8628(20010615)101:2<130::AID-AJMG1333>3.0.CO;2-V; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hertweck M, 2002, EUR J BIOCHEM, V269, P175, DOI 10.1046/j.0014-2956.2001.02636.x; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Li Y, 2001, J BIOL CHEM, V276, P29628, DOI 10.1074/jbc.C100274200; Mayer K, 2000, BBA-MOL BASIS DIS, V1502, P495, DOI 10.1016/S0925-4439(00)00072-7; Nissim-Rafinia M, 2002, TRENDS GENET, V18, P123, DOI 10.1016/S0168-9525(01)02619-1; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; PEARSON J, 1979, J AUTONOM NERV SYST, V1, P119, DOI 10.1016/0165-1838(79)90010-9; PEARSON J, 1978, J NEUROL SCI, V39, P123, DOI 10.1016/0022-510X(78)90193-4; PEARSON J, 1978, J NEUROL SCI, V39, P47, DOI 10.1016/0022-510X(78)90187-9; PEARSON J, 1978, J NEUROL SCI, V35, P77, DOI 10.1016/0022-510X(78)90103-X; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; RILEY CM, 1949, PEDIATRICS, V3, P468; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X	42	101	103	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					749	758		10.1086/368263	http://dx.doi.org/10.1086/368263			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12577200	Green Published, Bronze			2022-12-18	WOS:000181152600026
J	Crosby, AH; Proukakis, C				Crosby, AH; Proukakis, C			Is the transportation highway the right road for hereditary spastic paraplegia?	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							ENDOSOMAL TRANSPORT; TROYER-SYNDROME; GENE-MUTATIONS; SORTING NEXIN; AAA PROTEIN; ATPASE; IDENTIFICATION; FORM; HYDROCEPHALUS; PARAPARESIS	The term "hereditary spastic paraplegia" (HSP) refers to a genetically and clinically diverse group of disorders whose primary feature is progressive spasticity of the lower extremities. The condition arises because of degeneration of the longest motor and sensory axons on the spinal cord, which appear to be most sensitive to the underlying mutations. The marked genetic heterogeneity in HSP, with 20 loci chromosomally mapped and eight genes now identified, suggests that a number of defective cellular processes may be shown to result in the disease. Although previous studies have suggested a mitochondrial basis for at least one form of the disease, a mechanism common to a number of the other genes mutated in HSP has remained elusive until now. The identification of the most recent genes for the condition suggests that aberrant cellular-trafficking dynamics may be a common process responsible for the specific pattern of neurodegeneration seen in HSP.	Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England; UCL Royal Free & Univ Coll Med Sch, Dept Clin Neurosci, London, England	St Georges University London; University of London; University College London; UCL Medical School	Crosby, AH (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Med Genet, Cranmer Terrace, London SW17 0RE, England.	acrosby@sghms.ac.uk	Proukakis, Christos/G-4548-2013; proukakis, christos/ABE-3447-2020; Crosby, Andrew H/E-2218-2015	proukakis, christos/0000-0001-6423-6539; Crosby, Andrew H/0000-0003-3667-9054				Almenar-Queralt A, 2001, CURR OPIN NEUROBIOL, V11, P550, DOI 10.1016/S0959-4388(00)00248-8; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Barr VA, 2000, TRAFFIC, V1, P904, DOI 10.1034/j.1600-0854.2000.011109.x; BEHAN WMH, 1974, J NEUROL NEUROSUR PS, V37, P8, DOI 10.1136/jnnp.37.1.8; Beyer A, 1997, PROTEIN SCI, V6, P2043; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4; CROSS HE, 1967, ARCH NEUROL-CHICAGO, V16, P473, DOI 10.1001/archneur.1967.00470230025003; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FERREIRINHA F, 2001, MITOCHONDRION, V1, pS21; Fonknechten N, 2000, HUM MOL GENET, V9, P637, DOI 10.1093/hmg/9.4.637; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hayashi S, 2002, J BIOL CHEM, V277, P33319, DOI 10.1074/jbc.M201442200; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; HOYT MA, 1993, GENETICS, V135, P35; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; McDermott CJ, 2000, J NEUROL NEUROSUR PS, V69, P150, DOI 10.1136/jnnp.69.2.150; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Muglia M, 2002, ANN NEUROL, V51, P794, DOI 10.1002/ana.10185; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Phillips SA, 2001, J BIOL CHEM, V276, P5074, DOI 10.1074/jbc.M004671200; Prekeris R, 1999, J NEUROSCI, V19, P10324; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; SCHWARZ GA, 1956, ARCH NEURO PSYCHIATR, V75, P144, DOI 10.1001/archneurpsyc.1956.02330200038005; Seeligmuller A, 1876, DEUT MED WOCHENSCHR, V2, P185; Slavotinek AM, 2001, TRENDS GENET, V17, P528, DOI 10.1016/S0168-9525(01)02413-1; Struampell A., 1880, ARCH PSYCHIAT NERVEN, V10, P676, DOI [10.1007/BF02224539, DOI 10.1007/BF02224539, 10.1007/bf02054821]; Svenson IK, 2001, AM J HUM GENET, V68, P1077, DOI 10.1086/320111; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758	53	101	103	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2002	71	5					1009	1016		10.1086/344206	http://dx.doi.org/10.1086/344206			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	609CD	12355399	Bronze, Green Published			2022-12-18	WOS:000178884300001
J	Thompson, DA; McHenry, CL; Li, Y; Richards, JE; Othman, MI; Schwinger, E; Vollrath, D; Jacobson, SG; Gal, A				Thompson, DA; McHenry, CL; Li, Y; Richards, JE; Othman, MI; Schwinger, E; Vollrath, D; Jacobson, SG; Gal, A			Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with homoallelism for mutations in RPE65 or MERTK, respectively	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATERNAL UNIPARENTAL DISOMY; LEBER CONGENITAL AMAUROSIS; JUNCTIONAL EPIDERMOLYSIS-BULLOSA; CONFINED PLACENTAL MOSAICISM; RECEPTOR TYROSINE KINASE; PIGMENT EPITHELIUM; RETINITIS-PIGMENTOSA; RCS RAT; GENE; GROWTH	Uniparental disomy (UPD) is a rare condition in which a diploid offspring carries a chromosomal pair from a single parent. We now report the first two cases of UPD resulting in retinal degeneration. We identified an apparently homozygous loss-of-function mutation of RPE65 (1p31) in one retinal dystrophy patient and an apparently homozygous loss-of-function mutation of MERTK (2q14.1) in a second retinal dystrophy patient. In both families, the gene defect was present in the patient's heterozygous father but not in the patient's mother. Analysis of haplotypes in each nuclear kindred, by use of DNA polymorphisms distributed along both chromosomal arms, indicated the absence of the maternal allele for all informative markers tested on chromosome 1 in the first patient and on chromosome 2 in the second patient. Our results suggest that retinal degeneration in these individuals is due to apparently complete paternal isodisomy involving reduction to homoallelism for RPE65 or MERTK loss-of-function alleles. Our findings provide evidence for the first time, in the case of chromosome 2, and confirm previous observations, in the case of chromosome 1, that there are no paternally imprinted genes on chromosomes 1 and 2 that have a major effect on phenotype.	Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, D-22529 Hamburg, Germany; Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI USA; Univ Klinikum Lubeck, Inst Human Genet, Lubeck, Germany; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Penn, Sch Med, Dept Ophthalmol, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Hamburg; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Lubeck; Stanford University; University of Pennsylvania	Gal, A (corresponding author), Univ Hamburg, Klinikum Eppendorf, Inst Human Genet, Butenfeld 42, D-22529 Hamburg, Germany.			Thompson, Debra/0000-0003-3485-0794; Jacobson, Samuel/0000-0003-2122-169X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012298, P30EY007003, R01EY005627] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00042, M01 RR000042] Funding Source: Medline; NEI NIH HHS [R01-EY05627, R01 EY012298, P30 EY007003, P30-EY07003, R01-EY12298, R01-EY13365] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albrecht B, 2001, J MED GENET, V38, P214, DOI 10.1136/jmg.38.3.214; Bernasconi F, 1996, AM J HUM GENET, V59, P1114; Chen H, 1999, AM J MED GENET, V82, P215, DOI 10.1002/(SICI)1096-8628(19990129)82:3<215::AID-AJMG4>3.0.CO;2-Z; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dufourcq-Lagelouse R, 1999, EUR J HUM GENET, V7, P633, DOI 10.1038/sj.ejhg.5200355; EDWARDS RB, 1977, SCIENCE, V197, P1001, DOI 10.1126/science.560718; Engel E, 1998, AM J HUM GENET, V63, P962, DOI 10.1086/302074; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Field LL, 1998, AM J HUM GENET, V63, P1216, DOI 10.1086/302050; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gelb BD, 1998, AM J HUM GENET, V62, P848, DOI 10.1086/301795; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Hansen WF, 1997, PRENATAL DIAG, V17, P443, DOI 10.1002/(SICI)1097-0223(199705)17:5<443::AID-PD82>3.0.CO;2-2; HARRISON K, 1995, AM J MED GENET, V58, P147, DOI 10.1002/ajmg.1320580211; Heide E, 2000, AM J MED GENET, V92, P260, DOI 10.1002/(SICI)1096-8628(20000605)92:4<260::AID-AJMG7>3.0.CO;2-#; Kotzot D, 1999, AM J MED GENET, V82, P265, DOI 10.1002/(SICI)1096-8628(19990129)82:3<265::AID-AJMG14>3.3.CO;2-Y; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Miura Y, 2000, HUM GENET, V107, P205, DOI 10.1007/s004390000369; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; NICOLETTI A, 1995, HUM MOL GENET, V4, P641, DOI 10.1093/hmg/4.4.641; Nicoletti A, 1998, INVEST OPHTH VIS SCI, V39, P637; Perrault I, 1999, AM J HUM GENET, V64, P1225, DOI 10.1086/302335; Phelan JK, 2000, MOL VIS, V6, P116; Preece MA, 2000, TRENDS ENDOCRIN MET, V11, P270, DOI 10.1016/S1043-2760(00)00277-0; Pulkkinen L, 1997, AM J HUM GENET, V61, P611, DOI 10.1086/515524; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Robinson WP, 2000, BIOESSAYS, V22, P452; Shaffer LG, 1997, AM J HUM GENET, V61, P461; Takizawa Y, 2000, J INVEST DERMATOL, V115, P307, DOI 10.1046/j.1523-1747.2000.00052.x; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Webb AL, 1996, PRENATAL DIAG, V16, P958, DOI 10.1002/(SICI)1097-0223(199610)16:10<958::AID-PD971>3.0.CO;2-U	36	101	104	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					224	229		10.1086/338455	http://dx.doi.org/10.1086/338455			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11727200	Green Published, Bronze			2022-12-18	WOS:000172571900019
J	Kayser, M; Brauer, S; Weiss, G; Schiefenhovel, W; Underhill, PA; Stoneking, M				Kayser, M; Brauer, S; Weiss, G; Schiefenhovel, W; Underhill, PA; Stoneking, M			Independent histories of human y chromosomes from melanesia and Australia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAPUA-NEW-GUINEA; HUMAN OCCUPATION SITE; MITOCHONDRIAL-DNA; ABORIGINAL AUSTRALIANS; ASIAN POPULATIONS; EVOLUTIONARY HISTORY; DR,DQ HAPLOTYPES; GENETIC-EVIDENCE; PACIFIC ISLAND; NEW-WORLD	To investigate the origins and relationships of Australian and Melanesian populations, 611 males from 18 populations from Australia, Melanesia, and eastern/southeastern Asia were typed for eight single-nucleotide polymorphism (SNP) loci and seven short tandem-repeat loci on the Y chromosome. A unique haplotype, DYS330.1del/RPS4Y711T, was found at a frequency of 53%-69% in Australian populations, whereas the major haplotypes found in Melanesian populations (M4G/M5T/M9G and DYS390.3del/RPS4Y711T) are absent from the Australian populations. The Y-chromosome data thus indicate independent histories for Australians and Melanesians, a finding that is in agreement with evidence from mtDNA but that contradicts some analyses of autosomal loci, which show a close relationship between Australian and Melanesian (specifically, highland Papua New Guinean) populations. Since the Australian and New Guinean landmasses were connected when first colonized by humans greater than or equal to 50,000 years ago but separated some 8,000 years ago, a possible way to reconcile all the genetic data is to infer that the Y-chromosome and mtDNA results reflect the past 8,000 years of independent history for Australia and New Guinea, whereas the autosomal loci reflect the long preceding period of common origin and shared history. Two Y-chromosome haplotypes (M119C/M9G and M122C/M9G) that originated in eastern/southeastern Asia are present in coastal and island Melanesia but are rare or absent in both Australia and highland Papua New Guinea. This distribution, along with demographic analyses indicating that population expansions for both haplotypes began similar to4,000-6,000 years ago, suggests that these haplotypes were brought to Melanesia by the Austronesian expansion. Most of the populations in this study were previously typed for mtDNA SNPs; population differentiation is greater for the Y chromosome than for mtDNA and is significantly correlated with geographic distance, a finding in agreement with results of similar analyses of European populations.	Max Planck Inst Evolut Anthropol, Dept Evolut Genet, D-04103 Leipzig, Germany; Max Planck Inst Behav Physiol, Andechs, Germany; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Max Planck Society; Max Planck Society; Stanford University	Kayser, M (corresponding author), Max Planck Inst Evolut Anthropol, Dept Evolut Genet, Inselstr 22, D-04103 Leipzig, Germany.							ALLEN J, 1989, SEARCH, V20, P149; ALLEN J, 1988, NATURE, V331, P707, DOI 10.1038/331707a0; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; Bellwood P., 1978, MANS CONQUEST PACIFI; Bellwood P, 1987, POLYNESIANS, V2nd; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; Bergen AW, 1999, ANN HUM GENET, V63, P63, DOI 10.1046/j.1469-1809.1999.6310063.x; Blust R., 1984, ASIAN PERSPECT, V26, P45; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; BOWDLER S, 1997, ARCHAEOLOGY LINGUIST, P17; FLINT J, 1989, HUM GENET, V83, P257, DOI 10.1007/BF00285167; Forster P, 1998, MOL BIOL EVOL, V15, P1108, DOI 10.1093/oxfordjournals.molbev.a026018; GAO X, 1991, HUM IMMUNOL, V32, P269, DOI 10.1016/0198-8859(91)90090-V; GAO X, 1992, P 11 INT HIST WORKSH, P229; GAO XJ, 1991, IMMUNOGENETICS, V34, P401, DOI 10.1007/BF01787491; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; Hagelberg E, 1999, PHILOS T R SOC B, V354, P141, DOI 10.1098/rstb.1999.0367; HARPENDING H, 1996, MOL BIOL HUMAN DIVER, P283; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HILL AVS, 1989, COLONIZATION PACIFIC, P246; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; JONES R, 1995, ANNU REV ANTHROPOL, V24, P423; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kayser M, 2000, AM J HUM GENET, V66, P1580, DOI 10.1086/302905; KAYSER M, IN PRESS CURR BIOL; KEATS B, 1977, J HUM EVOL, V6, P319, DOI 10.1016/S0047-2484(77)80002-X; KIRCH PV, 1995, LAPITA PEOPLES; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; LOURANDOS H, 1985, PREHISTORIC HUNTER G, P384; Lourandos H., 1994, AUST ARCHAEOL, V39, P54, DOI [10.1080/03122417.1994.11681528, DOI 10.1080/03122417.1994.11681528]; LUM JK, 1994, HUM BIOL, V66, P567; Lum JK, 1998, AM J HUM GENET, V63, P613, DOI 10.1086/301949; Mack SJ, 2000, TISSUE ANTIGENS, V55, P383, DOI 10.1034/j.1399-0039.2000.550501.x; MELTON T, 1995, AM J HUM GENET, V57, P403; Merriwether DA, 1999, AM J PHYS ANTHROPOL, V110, P243, DOI 10.1002/(SICI)1096-8644(199911)110:3<243::AID-AJPA1>3.0.CO;2-M; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; NEI M, 1993, MOL BIOL EVOL, V10, P927; OSHAUGHNESSY DF, 1990, AM J HUM GENET, V46, P144; PAVLIDES C, 1994, ANTIQUITY, V68, P604, DOI 10.1017/S0003598X00047104; Pellekaan SMV, 1998, AM J HUM GENET, V62, P435, DOI 10.1086/301710; Pellekaan SV, 1997, ELECTROPHORESIS, V18, P1538, DOI 10.1002/elps.1150180909; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Redd AJ, 1999, AM J HUM GENET, V65, P808, DOI 10.1086/302533; Redd AJ, 1997, BIOL CHEM, V378, P923; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; Roessli D, 2000, ARLEQUIN VERSION 2 0; ROYCHOUDHURY AK, 1984, HUM HERED, V34, P314, DOI 10.1159/000153487; Salem AH, 1996, AM J HUM GENET, V59, P741; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; SPRIGGS M, 1985, J PAC HIST, P185; Stoneking M, 1998, NAT GENET, V20, P219, DOI 10.1038/3012; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1989, COLONIZATION PACIFIC, P215; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; SYKES B, 1995, AM J HUM GENET, V57, P1463; Thorne A, 1999, J HUM EVOL, V36, P591, DOI 10.1006/jhev.1999.0305; TSINTSOF AS, 1990, AM J HUM GENET, V46, P138; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Vandenberg N, 1999, HUM BIOL, V71, P915; WHITE JP, 1982, PREHISTORY AUSTR; WICKLER S, 1988, ANTIQUITY, V62, P703, DOI 10.1017/S0003598X00075104; Wilson IJ, 1998, GENETICS, V150, P499; YENCHITSOMANUS PT, 1986, AUST J EXP BIOL MED, V64, P297, DOI 10.1038/icb.1986.31; Zeitoun Elizabeth, 1999, SELECTED PAPERS 8 IN, P31; Zimdahl H, 1999, EUR J IMMUNOGENET, V26, P405, DOI 10.1046/j.1365-2370.1999.00183.x	74	101	102	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					173	190		10.1086/316949	http://dx.doi.org/10.1086/316949			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	392FG	11115381	Green Published, Bronze			2022-12-18	WOS:000166399900016
J	Dudbridge, F; Koeleman, BPC; Todd, JA; Clayton, DG				Dudbridge, F; Koeleman, BPC; Todd, JA; Clayton, DG			Unbiased application of the transmission/disequilibrium test to multilocus haplotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; TRANSMISSION; ASSOCIATION; ALLELES; DISEASE; LOCI; TDT	When the transmission/disequilibrium test (TDT) is applied to multilocus haplotypes, a bias may be introduced in some families for which both parents have the same heterozygous genotype at some locus. The bias occurs because haplotypes can only be deduced from certain offspring, with the result that the transmissions of the two parental haplotypes are not independent. We obtain an unbiased TDT for individual haplotypes by calculating the correct variance for the transmission count within a family, using information from multiple siblings if they are available. An existing correction for dependence between siblings in the presence of linkage is retained. To obtain an unbiased multihaplotype TDT, we must either count transmissions from one randomly chosen parent or count all transmissions and estimate the significance level empirically. Alternatively, we may use missing-data techniques to estimate uncertain haplotypes, but these methods are not robust to population stratification. An illustration using data from the insulin-gene region in type 1 diabetes shows that the validity and power of the TDT may vary by an order of magnitude, depending on the method of analysis.	Univ Cambridge, Wellcome Trust Ctr Mol Mechanisms Dis, Cambridge, England; MRC, Biostat Unit, Cambridge CB2 2BW, England; Leiden Univ, Dept Immunohaematol, NL-2300 RA Leiden, Netherlands; Leiden Univ, Blood Bank, NL-2300 RA Leiden, Netherlands	University of Cambridge; MRC Biostatistics Unit; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Dudbridge, F (corresponding author), Addenbrookes Hosp, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	frank.dudbridge@cimr.cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148				BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cleves MA, 1997, GENET EPIDEMIOL, V14, P337, DOI 10.1002/(SICI)1098-2272(1997)14:4<337::AID-GEPI1>3.3.CO;2-S; CUCCA F, 1996, HLA MHC GENES MOL FU, P383; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Hodge SE, 1999, NAT GENET, V21, P360, DOI 10.1038/7687; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Knapp M, 1999, AM J HUM GENET, V64, P861, DOI 10.1086/302285; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506	17	101	103	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					2009	2012		10.1086/302915	http://dx.doi.org/10.1086/302915			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10775523	Bronze, Green Published			2022-12-18	WOS:000088373800033
J	Nuytinck, L; Freund, M; Lagae, L; Pierard, GE; Hermanns-Le, T; De Paepe, A				Nuytinck, L; Freund, M; Lagae, L; Pierard, GE; Hermanns-Le, T; De Paepe, A			Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							V COLLAGEN; SPONDYLOEPIPHYSEAL DYSPLASIA; SKIN FRAGILITY; GENE; COL5A1; FIBRILLOGENESIS; COL2A1; CHAINS	Classical Ehlers-Danlos syndrome (EDS) is characterized by skin hyperelasticity, joint hypermobility, increased tendency to bruise, and abnormal scarring. Mutations in type V collagen, a regulator of type I collagen fibrillogenesis, have been shown to underlie this type of EDS. However, to date, mutations have been found in only a limited number of patients, which suggests genetic heterogeneity. In this article, we report two unrelated patients with typical features of classical EDS, including excessive skin fragility, in whom we found an identical arginine-->cysteine substitution in type I collagen, localized at position 134 of the alpha 1(I) collagen chain. The arginine residue is highly conserved and localized in the X position of the Gly-X-Y triplet. As a consequence, intermolecular disulfide bridges are formed, resulting in type I collagen aggregates, which are retained in the cells. Whereas substitutions of glycine residues in type I collagen invariably result in osteogenesis imperfecta, substitutions of nonglycine residues in type I collagen have not yet been associated with a human disease. In contrast, arginine-->cysteine substitutions in type II collagen have been identified in a variety of chondrodysplasias. Our findings show that mutations in other fibrillar collagens can be causally involved in classical EDS and point to genetic heterogeneity of this disorder.	Ghent Univ Hosp, Ctr Genet Med, B-9000 Ghent, Belgium; Catholic Univ Louvain, Ctr Genet Humaine, Brussels, Belgium; Katholieke Univ Leuven Hosp, Dept Pediatr Neurol, Louvain, Belgium; Univ Liege, Lab Expt Dermatol & Dermatopathol, Liege, Belgium	Ghent University; Ghent University Hospital; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Liege	De Paepe, A (corresponding author), Ctr Genet Med, 0K5,185 Pintelaan, B-9000 Ghent, Belgium.	Anne.Depaepe@rug.ac.be		Nuytinck, Lieve/0000-0002-5165-6937				ANDRIKOPOULOS K, 1995, NAT GENET, V9, P31, DOI 10.1038/ng0195-31; Ballo R, 1998, AM J MED GENET, V80, P6, DOI 10.1002/(SICI)1096-8628(19981102)80:1<6::AID-AJMG2>3.0.CO;2-0; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BIRK DE, 1990, J CELL SCI, V95, P649; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; Byers PH, 1997, AM J MED GENET, V72, P94, DOI 10.1002/(SICI)1096-8628(19971003)72:1<94::AID-AJMG20>3.0.CO;2-O; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; CHAN D, 1993, J BIOL CHEM, V268, P15238; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; DePaepe A, 1997, AM J HUM GENET, V60, P547; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; Richards AJ, 1998, J MED GENET, V35, P846, DOI 10.1136/jmg.35.10.846; Steinmann Beat, 1993, P351; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WILLIAMS CJ, 1993, HUM GENET, V92, P499, DOI 10.1007/BF00216458	20	101	113	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1398	1402		10.1086/302859	http://dx.doi.org/10.1086/302859			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739762	Green Published, Bronze			2022-12-18	WOS:000088373400020
J	Rizzo, WB; Carney, G; Lin, ZL				Rizzo, WB; Carney, G; Lin, ZL			The molecular basis of Sjogren-Larsson syndrome: Mutation analysis of the fatty aldehyde dehydrogenase gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CULTURED FIBROBLASTS; ETHNIC-ORIGINS; FALDH GENE; EXPRESSION; LINKAGE; OXIDOREDUCTASE; ORGANIZATION; FAMILIES; SPECTRUM; ALCOHOL	Sjogren-Larsson syndrome (SLS) is an autosomal recessive disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH). To define the molecular defects causing SLS, we performed mutation analysis of the FALDH gene in probands from 63 kindreds with SLS. Among these patients, 49 different mutations-including 10 deletions, 2 insertions, 22 amino acid substitutions, 3 nonsense mutations, 9 splice-site defects, and 3 complex mutations-were found. All of the patients with SLS were found to carry mutations. Nineteen of the missense mutations resulted in a severe reduction of FALDH enzyme catalytic activity when expressed in mammalian cells, but one mutation (798G-->C [K266N]) seemed to have a greater effect on mRNA stability. The splice-site mutations led to exon skipping or utilization of cryptic acceptor-splice sites. Thirty-seven mutations were private, and 12 mutations were seen in two or more probands of European or Middle Eastern descent. Four single-nucleotide polymorphisms (SNPs) were found in the FALDH gene. At least four of the common mutations (551C-->T, 682C-->T, 733G-->A, and 798+1delG) were associated with multiple SNP haplotypes, suggesting that these mutations originated independently on more than one occasion or were ancient SLS genes that had undergone intragenic recombination. Our results demonstrate that SLS is caused by a strikingly heterogeneous group of mutations in the FALDH gene and provide a framework for understanding the genetic basis of SLS and the development of DNA-based diagnostic tests.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Pediat, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Human Genet, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Rizzo, WB (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Pediat, POB 980259, Richmond, VA 23298 USA.				NCRR NIH HHS [RR00065, M01 RR000065] Funding Source: Medline; NIAMS NIH HHS [R01 AR044552, AR44552] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044552] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Antonarakis SE, 1998, HUM MUTAT, V11, P1; Chang C, 1997, GENOMICS, V40, P80, DOI 10.1006/geno.1996.4547; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; DeLaurenzi V, 1997, J INVEST DERMATOL, V109, P79, DOI 10.1111/1523-1747.ep12276622; DeLaurenzi V, 1996, NAT GENET, V12, P52; JAGELL S, 1980, ACTA OPHTHALMOL, V58, P321; JAGELL S, 1982, HELV PAEDIATR ACTA, V37, P519; James PF, 1997, J BIOL CHEM, V272, P23532, DOI 10.1074/jbc.272.38.23532; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; Lacour M, 1996, J MED GENET, V33, P258, DOI 10.1136/jmg.33.3.258; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Maquat LE, 1996, AM J HUM GENET, V59, P279; MASAKI R, 1994, J CELL BIOL, V126, P1407, DOI 10.1083/jcb.126.6.1407; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; O'Neil JP, 1998, MUTAT RES-REV MUTAT, V411, P179, DOI 10.1016/S1383-5742(98)00013-1; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; PIGG M, 1994, NAT GENET, V8, P361, DOI 10.1038/ng1294-361; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; RIZZO WB, 1988, J CLIN INVEST, V81, P738, DOI 10.1172/JCI113379; RIZZO WB, 1991, J CLIN INVEST, V88, P1643, DOI 10.1172/JCI115478; Rizzo WB, 1997, BIOCHEM MOL MED, V62, P178, DOI 10.1006/bmme.1997.2640; RIZZO WB, IN PRESS METABOLIC M; ROGERS GR, 1995, AM J HUM GENET, V57, P1123; Rogers GR, 1997, GENOMICS, V39, P127, DOI 10.1006/geno.1996.4501; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Sillen A, 1997, HUM GENET, V100, P201, DOI 10.1007/s004390050490; Sillen A, 1998, HUM MUTAT, V12, P377, DOI 10.1002/(SICI)1098-1004(1998)12:6<377::AID-HUMU3>3.0.CO;2-I; Sjogren T, 1957, ACTA PSYCHIAT NEUROL, V32, P1; Tsukamoto N, 1997, ANN HUM GENET, V61, P235, DOI 10.1017/S0003480097006143; Willemsen MAAP, 1999, J INVEST DERMATOL, V112, P827, DOI 10.1046/j.1523-1747.1999.00574.x	31	101	103	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1547	1560		10.1086/302681	http://dx.doi.org/10.1086/302681			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577908	Green Published, Bronze			2022-12-18	WOS:000084282500009
J	Schaid, DJ				Schaid, DJ			Transmission disequilibrium, family controls, and great expectations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANDIDATE-GENE ASSOCIATION; DIABETES-MELLITUS IDDM; LINKAGE DISEQUILIBRIUM; RELATIVE RISKS; INSULIN GENE; TESTS; DISEASE; SUSCEPTIBILITY; PARENTS; MARKERS		Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, 200 1st St SW,Harwick 7, Rochester, MN 55905 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051256] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51256] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 1997, AM J HUM GENET, V60, P676; Boehnke M, 1997, AM J HUM GENET, V61, pA269; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Bui MM, 1996, J AUTOIMMUN, V9, P97, DOI 10.1006/jaut.1996.0012; Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; Cervino ACL, 1997, INT J LEPROSY, V65, P456; CURTIS D, 1995, AM J HUM GENET, V56, P811; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kaplan NL, 1998, AM J HUM GENET, V62, P703, DOI 10.1086/301760; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; Li T, 1996, PSYCHIAT GENET, V6, P131, DOI 10.1097/00041444-199623000-00005; Maestri NE, 1997, AM J MED GENET, V73, P337, DOI 10.1002/(SICI)1096-8628(19971219)73:3<337::AID-AJMG21>3.0.CO;2-J; Marlow A, 1997, J RHEUMATOL, V24, P208; Marron MP, 1997, HUM MOL GENET, V6, P1275, DOI 10.1093/hmg/6.8.1275; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; Merriman T, 1997, HUM MOL GENET, V6, P1003, DOI 10.1093/hmg/6.7.1003; Morris AP, 1997, ANN HUM GENET, V61, P335, DOI 10.1017/S0003480097006349; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Petronzelli F, 1997, ANN HUM GENET, V61, P307; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Reed P, 1997, HUM MOL GENET, V6, P1011, DOI 10.1093/hmg/6.7.1011; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; Schaid DJ, 1997, GENET EPIDEMIOL, V14, P1113, DOI 10.1002/(SICI)1098-2272(1997)14:6<1113::AID-GEPI92>3.0.CO;2-J; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Schaid DJ, 1995, GENET EPIDEMIOL, V12, P813, DOI 10.1002/gepi.1370120647; SCHAID DJ, 1998, IN PRESS AM J HUM GE, V63; SCHAID DJ, IN PRESS QUANTITATIV; SCHAID DJ, IN PRESS GENET EPIDE; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1994, AM J HUM GENET, V54, P559; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Waldman ID, 1997, GENET EPIDEMIOL, V14, P699, DOI 10.1002/(SICI)1098-2272(1997)14:6<699::AID-GEPI25>3.0.CO;2-K; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Wyszynski DF, 1997, HUM GENET, V99, P22; XIONG M, IN PRESS HUM HERED	44	101	106	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					935	941		10.1086/302077	http://dx.doi.org/10.1086/302077			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758635	Green Published, Bronze			2022-12-18	WOS:000076577800003
J	Mehenni, H; Blouin, JL; Radhakrishna, U; Bhardwaj, SS; Bhardwaj, K; Dixit, VB; Richards, KF; Bermejo-Fenoll, A; Leal, AS; Raval, RC; Antonarakis, SE				Mehenni, H; Blouin, JL; Radhakrishna, U; Bhardwaj, SS; Bhardwaj, K; Dixit, VB; Richards, KF; Bermejo-Fenoll, A; Leal, AS; Raval, RC; Antonarakis, SE			Peutz-Jeghers syndrome: Confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENOMA MALIGNUM; CERVIX; MAP	Peutz-Jeghers syndrome (PJS) is an autosomal dominant disease with variable expression and incomplete penetrance, characterized by mucocutaneous pigmentation and hamartomatous polyposis. Patients with PJS have increased frequency of gastrointestinal and extraintestinal malignancies (ovaries, testes, and breast). In order to map the locus (or loci) associated with PJS, we performed a genomewide linkage analysis, using DNA polymorphisms in six families (two from Spain, two from India, one from the United States, and one from Portugal) comprising a total of 93 individuals, including 39 affected and 48 unaffected individuals and 6 individuals with unknown status. During this study, localization of a PJS gene to 13p13.3 (around marker D19S886) had been reported elsewhere. For our families, marker D19S886 yielded a maximum LOD score of 4.74 at a recombination fraction (theta) of .045; multipoint linkage analysis resulted in a LOD score of 7.51 for the interval between D19S886 and 19pter. However, markers on 19q13.4 also showed significant evidence for linkage. For example, D19S880 resulted in a maximum LOD score of 3.8 at theta = .13. Most of this positive linkage was contributed by a single family, PJS07. These results confirm the mapping of a common PJS locus on 19p13.3 but also suggest the existence, in a minority of families, of a potential second PJS locus, on 19q13.4. Positional cloning and characterization of the PJS mutations will clarify the genetics of the syndrome and the implication of the gene(s) in the predisposition to neoplasias.	Univ Geneva, Sch Med, Dept Genet & Microbiol, Lab Human Mol Genet, CH-1211 Geneva, Switzerland; Cantonal Hosp, Div Med Genet, Geneva, Switzerland; Govt Gen Hosp, Bhiwani, India; Univ Hosp Utah, Med Ctr, Salt Lake City, UT USA; Univ Murcia, Catedrat Med Bucal, Murcia, Spain; Univ Porto, Dept Surg, P-4100 Oporto, Portugal; Civil Hosp & Med Coll, Dept Dermatol, Ahmedabad, Gujarat, India	University of Geneva; University of Geneva; University of Murcia; Universidade do Porto	Antonarakis, SE (corresponding author), Ctr Med Univ Geneva, Div Med Genet, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Stylianos.Antonarakis@medecine.unige.ch	Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823				BLOUIN JL, 1995, AM J HUM GENET, V57, P388; BUCK JL, 1992, RADIOGRAPHICS, V12, P366; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FOLEY TR, 1988, GASTROENTEROLOGY, V95, P1535, DOI 10.1016/S0016-5085(88)80074-X; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; GILKS CB, 1989, AM J SURG PATHOL, V13, P717, DOI 10.1097/00000478-198909000-00001; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hemminki A, 1997, NAT GENET, V15, P87, DOI 10.1038/ng0197-87; JEGHERS H, 1949, NEW ENGL J MED, V241, P992; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHUR PA, 1984, DIGEST DIS SCI, V29, P178, DOI 10.1007/BF01317062; Mohrenweiser Harvey, 1996, Cytogenetics and Cell Genetics, V74, P161, DOI 10.1159/000134408; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PERZIN KH, 1982, CANCER-AM CANCER SOC, V49, P971, DOI 10.1002/1097-0142(19820301)49:5<971::AID-CNCR2820490522>3.0.CO;2-1; YOUNG RH, 1982, CANCER, V50, P1384, DOI 10.1002/1097-0142(19821001)50:7<1384::AID-CNCR2820500726>3.0.CO;2-5; YOUNG S, 1995, AM J SURG PATHOL, V19, P50, DOI 10.1097/00000478-199501000-00007	21	101	108	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1327	1334		10.1086/301644	http://dx.doi.org/10.1086/301644			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399902	Green Published, Bronze			2022-12-18	WOS:000071555900016
J	Urban, Z; Helms, C; Fekete, G; Csiszar, K; Bonnet, D; Munnich, A; DonisKeller, H; Boyd, CD				Urban, Z; Helms, C; Fekete, G; Csiszar, K; Bonnet, D; Munnich, A; DonisKeller, H; Boyd, CD			7q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							ELASTIN GENE; LINKAGE MAP; POLYMORPHISM		UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT SURG,NEW BRUNSWICK,NJ 08903; WASHINGTON UNIV,SCH MED,DEPT SURG,ST LOUIS,MO; SEMMELWEIS UNIV MED,DEPT PEDIAT 2,H-1085 BUDAPEST,HUNGARY; HOP NECKER ENFANTS MALAD,IFREM,INST NECKER,PARIS,FRANCE	Rutgers State University New Brunswick; Rutgers State University Medical Center; Washington University (WUSTL); Semmelweis University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite			Urban, Zsolt/B-1977-2008; Urban, Zsolt/A-2018-2013	Urban, Zsolt/0000-0003-3890-1843	NHGRI NIH HHS [HG00469] Funding Source: Medline; NHLBI NIH HHS [HL37438] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037438] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000469] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BEUREN AJ, 1962, CIRCULATION, V26, P1235, DOI 10.1161/01.CIR.26.6.1235; CHUMAKOV IM, 1995, NATURE, V377, P175; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FOSTER K, 1993, ANN HUM GENET, V57, P87, DOI 10.1111/j.1469-1809.1993.tb00890.x; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HELM ET, 1994, AM POTATO J, V71, P1, DOI 10.1007/BF02848741; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; LOWERY MC, 1995, AM J HUM GENET, V57, P49; Lupski JR, 1996, AM J HUM GENET, V58, P21; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; Peoples R, 1996, AM J HUM GENET, V58, P1370; SUTER U, 1994, HUM MUTAT, V3, P95, DOI 10.1002/humu.1380030203; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P4314, DOI 10.1093/nar/19.15.4314-a; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311	15	101	102	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					958	962						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808614				2022-12-18	WOS:A1996VL28300028
J	SAVUKOSKI, M; KESTILA, M; WILLIAMS, R; JARVELA, I; SHARP, J; HARRIS, K; SANTAVUORI, P; GARDINER, M; PELTONEN, L				SAVUKOSKI, M; KESTILA, M; WILLIAMS, R; JARVELA, I; SHARP, J; HARRIS, K; SANTAVUORI, P; GARDINER, M; PELTONEN, L			DEFINED CHROMOSOMAL ASSIGNMENT OF CLN5 DEMONSTRATES THAT AT LEAST 4 GENETIC-LOCI ARE INVOLVED IN THE PATHOGENESIS OF HUMAN CEROID-LIPOFUSCINOSES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JANSKY-BIELSCHOWSKY DISEASE; LINKAGE DISEQUILIBRIUM; BATTEN DISEASE; INFANTILE FORM; JUVENILE; VARIANT; MAPS	We demonstrate here that at least four genetically separate loci are involved in the pathogenesis of human neuronal ceroid lipofuscinoses (NCLs), fatal brain disorders of children. Earlier the assignments of the infantile and juvenile subtypes of NCL to 1p32 and 16p12 had revealed two loci; and here a variant subtype of the late-infantile form of NCL is mapped to a well-defined region on 13q21.1-q32, whereas the clinically similar, classical form of late-infantile NCL was found to represent the fourth, yet-unidentified NCL locus. The linkage disequilibrium was crucial for locus assignment in our highly limited family material, and the data exemplify the significance of this phenomenon in the random mapping of rare human diseases.	NATL PUBL HLTH INST, DEPT HUMAN MOLEC GENET, SF-00300 HELSINKI, FINLAND; UNIV HELSINKI, DEPT CHILD NEUROL, HELSINKI, FINLAND; UNIV OULU, BIOCTR, OULU, FINLAND; UNIV OULU, DEPT BIOCHEM, OULU, FINLAND; RAYNE INST, DEPT PAEDIAT, LONDON, ENGLAND	Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of London; King's College London			Jarvela, Irma E/L-5836-2013	Jarvela, Irma E/0000-0002-1770-6187				Andermann E, 1988, Am J Med Genet Suppl, V5, P111; BOWCOCK A, 1993, GENOMICS, V15, P376, DOI 10.1006/geno.1993.1071; CARPENTER S, 1977, BRAIN, V100, P137, DOI 10.1093/brain/100.1.137; GARDINER M, 1990, GENOMICS, V8, P387, DOI 10.1016/0888-7543(90)90297-8; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; JARVELA I, 1991, GENOMICS, V9, P170, DOI 10.1016/0888-7543(91)90235-7; JARVELA I, 1991, GENOMICS, V10, P333, DOI 10.1016/0888-7543(91)90316-7; KIMURA S, 1987, BRAIN DEV-JPN, V9, P576, DOI 10.1016/S0387-7604(87)80088-8; LAKE BD, 1978, J NEUROL SCI, V36, P265, DOI 10.1016/0022-510X(78)90087-4; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Luria SE, 1943, GENETICS, V28, P491; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; SANTAVUORI P, 1988, BRAIN DEV-JPN, V10, P80, DOI 10.1016/S0387-7604(88)80075-5; SANTAVUORI P, 1991, NEUROPEDIATRICS, V22, P92, DOI 10.1055/s-2008-1071423; SANTAVUORI P, 1982, NEUROPEDIATRICS, V13, P135, DOI 10.1055/s-2008-1059612; SANTAVUORI P, 1993, J INHERIT METAB DIS, V16, P230, DOI 10.1007/BF00710251; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; TACKMANN W, 1979, EUR NEUROL, V18, P234, DOI 10.1159/000115082; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WILLIAMS R, 1993, AM J HUM GENET, V53, P931	22	101	102	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					695	701						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942847				2022-12-18	WOS:A1994PJ02700012
J	KESTILA, M; MANNIKKO, M; HOLMBERG, C; GYAPAY, G; WEISSENBACH, J; SAVOLAINEN, ER; PELTONEN, L; TRYGGVASON, K				KESTILA, M; MANNIKKO, M; HOLMBERG, C; GYAPAY, G; WEISSENBACH, J; SAVOLAINEN, ER; PELTONEN, L; TRYGGVASON, K			CONGENITAL NEPHROTIC SYNDROME OF THE FINNISH TYPE MAPS TO THE LONG ARM OF CHROMOSOME-19	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRENATAL DIAGNOSIS	Congenital nephrotic syndrome of the Finnish type (CNF) is an autosomal recessive disease that is characterized by massive proteinuria and nephrotic syndrome at birth. CNF represents a unique, apparently specific dysfunction of the renal basement membranes, and the estimated incidence of CNF in the isolated population of Finland is 1 in 8,000 newborns. The basic defect is unknown, and no specific biochemical defect or chromosomal aberrations have been described. Here we report the assignment of the CNF locus to 19q12-q13.1 on the basis of linkage analyses in 17 Finnish families. Multipoint analyses and observed recombination events place the CNF locus between multiallelic markers D19S416 and D19S224, and the significant linkage disequilibrium observed suggests that the CNF gene lies in the immediate vicinity of the markers D19S224 and D19S220.	NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,SF-00300 HELSINKI,FINLAND; UNIV OULU,BIOCTR,OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,OULU,FINLAND; UNIV OULU,DEPT CLIN CHEM,OULU,FINLAND; UNIV HELSINKI,CHILDRENS HOSP,HELSINKI,FINLAND; GENETHON,EVRY,FRANCE	Finland National Institute for Health & Welfare; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Helsinki			Mannikko, Minna/C-5877-2008	Mannikko, Minna/0000-0002-6857-6423				AULA P, 1978, AM J DIS CHILD, V132, P984, DOI 10.1001/archpedi.1978.02120350048008; CAULFIELD JP, 1978, LAB INVEST, V39, P505; DRESSLER GR, 1993, NATURE, V362, P65, DOI 10.1038/362065a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HALLMAN N, 1973, NEPHRON, V11, P101, DOI 10.1159/000180223; HALLMAN NIILO, 1967, ACTA PAEDIAT SCAND SUPPL, V172., P75; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOLMBERG C, 1991, TRANSPLANT P, V23, P1378; HUTTUNEN NP, 1976, ARCH DIS CHILD, V51, P344, DOI 10.1136/adc.51.5.344; KESTILA M, IN PRESS KIDNEY INT; KESTILA M, IN PRESS GENOMICS; KOSKIMIES O, 1990, INHERITANCE KIDNEY U, P131; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Luria SE, 1943, GENETICS, V28, P491; SEPPALA M, 1976, LANCET, V2, P123; TRASK B, 1993, GENOMICS, V15, P133, DOI 10.1006/geno.1993.1021	16	101	108	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					757	764						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178817				2022-12-18	WOS:A1994NH39400004
J	YU, CE; PAYAMI, H; OLSON, JM; BOEHNKE, M; WIJSMAN, EM; ORR, HT; KUKULL, WA; GODDARD, KAB; NEMENS, E; WHITE, JA; ALONSO, ME; TAYLOR, TD; BALL, MJ; KAYE, J; MORRIS, J; CHUI, H; SADOVNICK, AD; MARTIN, GM; LARSON, EB; HESTON, LL; BIRD, TD; SCHELLENBERG, GD				YU, CE; PAYAMI, H; OLSON, JM; BOEHNKE, M; WIJSMAN, EM; ORR, HT; KUKULL, WA; GODDARD, KAB; NEMENS, E; WHITE, JA; ALONSO, ME; TAYLOR, TD; BALL, MJ; KAYE, J; MORRIS, J; CHUI, H; SADOVNICK, AD; MARTIN, GM; LARSON, EB; HESTON, LL; BIRD, TD; SCHELLENBERG, GD			THE APOLIPOPROTEIN E/CI/CII GENE-CLUSTER AND LATE-ONSET ALZHEIMER-DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; LINKAGE ANALYSIS; E POLYMORPHISM; APO-E; PROTEIN; ALLELE; LOCUS; PREVALENCE; CII; CHROMOSOME-14	The chromosome 19 apolipoprotein E/CI/CII gene cluster was examined for evidence of linkage to a familial Alzheimer disease (FAD) locus. The family groups studied were Volga German (VG), early-onset non-VG (ENVG; mean age at onset <60 years), and late-onset families. A genetic association was observed between apolipoprotein E (ApoE) allele epsilon 4 and FAD in late-onset families; the epsilon 4 allele frequency was .51 in affected subjects, .37 in at-risk subjects, .11 in spouses, and .19 in unrelated controls. The differences between the epsilon 4 frequencies in affected subjects versus controls and in at-risk subjects versus controls were highly significant (standard normal deviate [Z(SND)] = 7.37, P < 10(-9); and Z(SND) = 4.07, P <.00005, respectively). No association between the epsilon 4 allele and FAD was observed in the ENVG or VG groups. A statistically significant allelic association between epsilon 4 and AD was also observed in a group of unrelated subjects; the epsilon 4 frequency was .26 in affected subjects, versus .19 in controls (Z(SND) = 2.20, P <.03). Evidence of linkage of ApoE and ApoCII to FAD was examined by maximum-likelihood methods, using three models and assuming autosomal dominant inheritance: (1) age-dependent penetrance, (2) extremely low (1%) penetrance, and (3) age-dependent penetrance corrected for sporadic Alzheimer disease (AD). For ApoCII in late-onset families, results for close linkage were negative, and only small positive led-score-statistic (Z) values were obtained (model 1, maximum Z [Z(max)] = 0.61, recombination fraction [theta] = .30; model 2, Z(max) = 0.47, theta = .20). For ApoE in late-onset kindreds, positive Z values were obtained when either allele frequencies from controls (model 1, Z(max) = 2.02, theta = .15; model 2, Z(max) = 3.42, theta = .05) or allele frequencies from the families (model 1, Z(max) = 1.43, theta = .15; model 2, Z(max) = 1.70, theta = .05) were used. When linkage disequilibrium was incorporated into the analysis, the Z values increased (model 1, Z(max) = 3.17, theta = .23; model 3, Z(max) = 1.85, theta = .20). For the ENVG group, results for ApoE and ApoCII were uniformly negative. Affected-pedigree-member analysis gave significant results for the late-onset kindreds, for ApoE (Z(SND) = 3.003, P = .003) and ApoCII (Z(SND) = 2.319, P = .016), when control allele frequencies were used but not when allele frequencies were derived from the families.	UNIV WASHINGTON,DIV NEUROL RG27,SEATTLE,WA 98195; UNIV WASHINGTON,DIV MED GENET,SEATTLE,WA; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA; UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA; UNIV WASHINGTON,DEPT MED,SEATTLE,WA; VET ADM MED CTR,DEPT PSYCHIAT,WASHINGTON INST MENTAL ILLNESS RES & TRAINING,SEATTLE,WA; VET ADM MED CTR,DIV NEUROL,SEATTLE,WA; OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR; OREGON HLTH SCI UNIV,DIV NEUROPATHOL,PORTLAND,OR; UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN; UNIV MINNESOTA,DEPT PSYCHIAT,MINNEAPOLIS,MN; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN; NATL INST NEUROL & NEUROSURG,DEPT GENET,MEXICO CITY,DF,MEXICO; WASHINGTON UNIV,DEPT NEUROL,ST LOUIS,MO; UNIV SO CALIF,DEPT NEUROL,LOS ANGELES,CA; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC,CANADA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); University of Southern California; University of British Columbia			Taylor, Todd/A-7121-2009	Taylor, Todd/0000-0003-4247-6253; Orr, Harry/0000-0001-6118-741X; Kaye, Jeffrey/0000-0002-9971-3478; Kukull, Walter/0000-0001-8761-9014	NATIONAL INSTITUTE ON AGING [P50AG005136, U01AG006781, U24AG021886, P30AG008017] Funding Source: NIH RePORTER; NIA NIH HHS [NIA AG08017, U24 AG021886, NIA AG05136, NIA AG06781] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BACHMAN DL, 1992, NEUROLOGY, V42, P115, DOI 10.1212/WNL.42.1.115; BERGEM A L M, 1992, Neurobiology of Aging, V13, pS66; BIRD TD, 1989, ANN NEUROL, V25, P12, DOI 10.1002/ana.410250104; BIRD TD, 1988, ANN NEUROL, V23, P25, DOI 10.1002/ana.410230106; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BREITNER J C S, 1992, Neurobiology of Aging, V13, pS66; CAULEY JA, 1993, GENET EPIDEMIOL, V10, P27, DOI 10.1002/gepi.1370100104; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DEKNIJFF P, 1992, ARTERIOSCLER THROMB, V12, P1371, DOI 10.1161/01.ATV.12.12.1371; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; GERSHON ES, 1977, J PSYCHIAT RES, V13, P161, DOI 10.1016/0022-3956(77)90005-X; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOODRUM JF, 1991, J NEUROCHEM, V56, P2082, DOI 10.1111/j.1471-4159.1991.tb03469.x; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; GREENBERG DA, 1989, GENET EPIDEMIOL, V6, P259, DOI 10.1002/gepi.1370060145; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; HIXSON JE, 1990, J LIPID RES, V31, P545; HOULSTON RS, 1989, HUM GENET, V83, P364, DOI 10.1007/BF00291382; KAMINO K, 1992, AM J HUM GENET, V51, P998; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAHLEY RW, 1979, BIOCHIM BIOPHYS ACTA, V575, P81, DOI 10.1016/0005-2760(79)90133-4; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MARGARITTE P, 1992, AM J HUM GENET, V50, P1231; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MORTON NE, 1955, AM J HUM GENET, V7, P277; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NECHIPORUK A, 1993, AM J MED GENET, V48, P63, DOI 10.1002/ajmg.1320480113; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; OLSON JM, IN PRESS BIOMETRICS; OTT J, 1992, AM J HUM GENET, V51, P283; Ott J., 1991, ANAL HUMAN GENETIC L; PAYAMI H, UNPUB SEX DIFFERENCE; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; POPKO B, 1993, J NEUROCHEM, V60, P1155, DOI 10.1111/j.1471-4159.1993.tb03268.x; ROCCA WA, 1991, ANN NEUROL, V30, P381, DOI 10.1002/ana.410300310; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1987, J NEUROGENET, V4, P97, DOI 10.3109/01677068709102337; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1991, AM J HUM GENET, V49, P511; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SCHELLENBERG GD, 1992, ANN NEUROL, V31, P223, DOI 10.1002/ana.410310214; SNOW AD, 1987, LAB INVEST, V56, P120; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TANZI RE, 1992, AM J HUM GENET, V51, P273; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VANDUIJN CM, 1991, INT J EPIDEMIOL, V20, pS13, DOI 10.1093/ije/20.Supplement_2.S13; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WIJSMAN EM, 1993, GENET EPIDEMIOL, V10, P349, DOI 10.1002/gepi.1370100604; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C	58	101	102	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1994	54	4					631	642						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NC836	8128960				2022-12-18	WOS:A1994NC83600007
J	STEFANINI, M; VERMEULEN, W; WEEDA, G; GILIANI, S; NARDO, T; MEZZINA, M; SARASIN, A; HARPER, JI; ARLETT, CF; HOEIJMAKERS, JHJ; LEHMANN, AR				STEFANINI, M; VERMEULEN, W; WEEDA, G; GILIANI, S; NARDO, T; MEZZINA, M; SARASIN, A; HARPER, JI; ARLETT, CF; HOEIJMAKERS, JHJ; LEHMANN, AR			A NEW NUCLEOTIDE-EXCISION-REPAIR GENE ASSOCIATED WITH THE DISORDER TRICHOTHIODYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENTATION GROUP-D; XERODERMA-PIGMENTOSUM; DNA-REPAIR; COCKAYNES-SYNDROME; HOMOLOG; MUTATION; ENCODES; CLONING; ERCC-3	The sun-sensitive, cancer-prone genetic disorder xeroderma pigmentosum (XP) is associated in most cases with a defect in the ability to carry out excision repair of UV damage. Seven genetically distinct complementation groups (i.e., A-G) have been identified. A large proportion of patients with the unrelated disorder trichothiodystrophy (TTD), which is characterized by hair-shaft abnormalities, as well as by physical and mental retardation, are also deficient in excision repair of UV damage. In most of these cases the repair deficiency is in the same complementation group as is XP group D. We report here on cells from a patient, TTD1BR, in which the repair defect complements all known XP groups (including XP-D). Furthermore, microinjection of various cloned human repair genes fails to correct the repair defect in this cell strain. The defect in TTD1BR cells is therefore in a new gene involved in excision repair in human cells. The finding of a second DNA repair gene that is associated with the clinical features of TTD argues strongly for an involvement of repair proteins in hair-shaft development.	UNIV SUSSEX,MRC,CELL MUTAT UNIT,BRIGHTON BN1 9RR,ENGLAND; CNR,INST GENET BIOCHIM EVOLUZ,PAVIA,ITALY; ERASMUS UNIV ROTTERDAM,CTR MED GENET,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS; INST RECH SCI CANC,F-94802 VILLEJUIF,FRANCE; HOSP SICK CHILDREN,DEPT PEDIAT DERMATOL,LONDON WC1N 3JH,ENGLAND	University of Sussex; Consiglio Nazionale delle Ricerche (CNR); Erasmus University Rotterdam; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust			Vermeulen, Wim/W-8708-2019; Giliani, Silvia/AAX-8843-2020; Hoeijmakers, Jan/AAX-6972-2021	Vermeulen, Wim/0000-0003-3616-734X; Giliani, Silvia/0000-0001-8137-4642; 				BROUGHTON BC, 1990, MUTAT RES, V235, P33, DOI 10.1016/0921-8777(90)90020-6; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; HOEIJMAKERS JHJ, 1990, CANCER CELL-MON REV, V2, P311; JORIZZO JL, 1982, BRIT J DERMATOL, V106, P705, DOI 10.1111/j.1365-2133.1982.tb11687.x; KOKEN MHM, 1992, NUCLEIC ACIDS RES, V20, P5541, DOI 10.1093/nar/20.21.5541; LEHMANN AR, 1988, CANCER RES, V48, P6090; LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6; MOUNKES LC, 1992, CELL, V71, P925, DOI 10.1016/0092-8674(92)90389-T; NORRIS PG, 1990, J INVEST DERMATOL, V94, P94, DOI 10.1111/1523-1747.ep12873952; RIBONI R, 1992, CANCER RES, V52, P6690; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; STEFANINI M, 1986, HUM GENET, V74, P107, DOI 10.1007/BF00282072; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; TROELSTRA C, 1992, CELL, V71, P1; VANDUIN M, 1989, MUTAT RES, V217, P83, DOI 10.1016/0921-8777(89)90059-1; VERMEULEN W, 1991, MUTAT RES, V255, P201, DOI 10.1016/0921-8777(91)90054-S; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U	20	101	101	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					817	821						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213812				2022-12-18	WOS:A1993LY62700004
J	SHIMOZAWA, N; SUZUKI, Y; ORII, T; MOSER, A; MOSER, HW; WANDERS, RJA				SHIMOZAWA, N; SUZUKI, Y; ORII, T; MOSER, A; MOSER, HW; WANDERS, RJA			STANDARDIZATION OF COMPLEMENTATION GROUPING OF PEROXISOME-DEFICIENT DISORDERS AND THE 2ND ZELLWEGER PATIENT WITH PEROXISOMAL ASSEMBLY FACTOR-I (PAF-I) DEFECT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							HETEROGENEITY		JOHNS HOPKINS UNIV,KENNEDY KRIEGER INST,BALTIMORE,MD 21218; UNIV AMSTERDAM HOSP,DEPT PEDIAT,AMSTERDAM,NETHERLANDS	Johns Hopkins University; Kennedy Krieger Institute; University of Amsterdam; Academic Medical Center Amsterdam	SHIMOZAWA, N (corresponding author), GIFU UNIV,SCH MED,DEPT PEDIAT,GIFU 500,JAPAN.							BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; ROSCHER AA, 1989, PEDIATR RES, V26, P67, DOI 10.1203/00006450-198907000-00019; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; YAJIMA S, 1992, HUM GENET, V88, P491, DOI 10.1007/BF00219334	4	101	101	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					843	844						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	7681622				2022-12-18	WOS:A1993KY05900027
J	GOLTSOV, AA; EISENSMITH, RC; KONECKI, DS; LICHTERKONECKI, U; WOO, SLC				GOLTSOV, AA; EISENSMITH, RC; KONECKI, DS; LICHTERKONECKI, U; WOO, SLC			ASSOCIATIONS BETWEEN MUTATIONS AND A VNTR IN THE HUMAN PHENYLALANINE-HYDROXYLASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHIC DNA HAPLOTYPES; MOLECULAR CHARACTERIZATION; HYPERVARIABLE REGION; RECURRENT MUTATION; PRENATAL-DIAGNOSIS; MISSENSE MUTATIONS; PHENYLKETONURIA; LOCUS; SEQUENCE; POPULATION	The HindIII RFLP in the human phenylalanine hydroxylase (PAH) gene is caused by the presence of an AT-rich (70%) minisatellite region. This region contains various multiples of 30-bp tandem repeats and is located 3 kb downstream of the final exon of the gene. PCR-mediated amplification of th's region from haplotyped PAH chromosomes indicates that the previously reported 4.0-kb HindIII allele contains three of these repeats, while the 4.4-kb HindIII allele contains 12 of these repeats. The 4.2-kb HindIII fragment can contain six, seven, eight, or nine copies of this repeat. These variations permit more detailed analysis of mutant haplotypes 1, 5, 6, and, possibly, others. Kindred analysis in phenylketonuria families demonstrates Mendelian segregation of these VNTR alleles, as well as associations between these alleles and certain PAH mutations. The R261Q mutation, associated with haplotype 1, is associated almost exclusively with an allele containing eight repeats; the R408W mutation, when occurring on a haplotype 1 background, may also be associated with the eight-repeat VNTR allele. Other PAH mutations associated with haplotype 1, R252W and P281L, do not appear to segregate with specific VNTR alleles. The IVS-10 mutation, when associated with haplotype 6, is associated exclusively with an allele containing seven repeats. The combined use of this VNTR system and the existing RFLP haplotype system will increase the performance of prenatal diagnostic tests based on haplotype analysis. In addition, this VNTR may prove useful in studies concerning the origins and distributions of PAH mutations in different human populations.	BAYLOR COLL MED,DEPT CELL BIOL,HOWARD HUGHES MED INST,HOUSTON,TX 77030; UNIV HEIDELBERG,KINDERKLIN,W-6900 HEIDELBERG,GERMANY	Baylor College of Medicine; Howard Hughes Medical Institute; Ruprecht Karls University Heidelberg					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD017711, R01HD017711] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17711] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; Aoki K, 1988, Acta Paediatr Jpn, V30, P429; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BICKEL H, 1981, EUR J PEDIATR, V137, P133; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CHAKRABORTY R, 1987, HUM GENET, V76, P40; DAIGER SP, 1989, AM J HUM GENET, V45, P310; DASOVICH M, 1991, SOMAT CELL MOLEC GEN, V17, P303, DOI 10.1007/BF01232824; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; DWORNICZAK B, 1991, GENOMICS, V9, P193, DOI 10.1016/0888-7543(91)90238-A; HUANG LS, 1987, J BIOL CHEM, V262, P8952; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JOHN SWM, 1990, AM J HUM GENET, V46, P970; KALAYDJIEVA L, 1991, LANCET, V337, P865, DOI 10.1016/0140-6736(91)92584-O; KALAYDJIEVA L, 1991, AM J HUM GENET S, V49, pA1027; KONECKI DS, 1991, HUM GENET, V87, P377; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LICHTERKONECKI U, 1989, HUM GENET, V81, P373, DOI 10.1007/BF00283695; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LUDWIG EH, 1989, AM J HUM GENET, V45, P458; OKANO Y, 1991, GENOMICS, V9, P96, DOI 10.1016/0888-7543(91)90225-4; OKANO Y, 1990, AM J HUM GENET, V46, P919; OKANO Y, 1990, AM J HUM GENET, V46, P18; OZALP I, 1986, J INHERIT METAB DIS, V9, P237, DOI 10.1007/BF01799716; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; REICHARDT JKV, 1991, P NATL ACAD SCI USA, V88, P2633, DOI 10.1073/pnas.88.7.2633; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SVENSSON E, 1990, HUM GENET, V85, P300; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7; WOO SLC, 1983, NATURE, V306, P151, DOI 10.1038/306151a0	32	101	107	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					627	636						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1353941				2022-12-18	WOS:A1992JJ82800019
J	PURVISSMITH, SG; SAVILLE, T; MANASS, S; YIP, MY; LAMPOTANG, PRL; DUFFY, B; JOHNSTON, H; LEIGH, D; MCDONALD, B				PURVISSMITH, SG; SAVILLE, T; MANASS, S; YIP, MY; LAMPOTANG, PRL; DUFFY, B; JOHNSTON, H; LEIGH, D; MCDONALD, B			UNIPARENTAL DISOMY 15 RESULTING FROM CORRECTION OF AN INITIAL TRISOMY-15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									PRINCE WALES HOSP,CHILDRENS HOSP,RANDWICK,NSW 2031,AUSTRALIA; PRINCE WALES HOSP,MOLEC GENET UNIT,RANDWICK,NSW 2031,AUSTRALIA		PURVISSMITH, SG (corresponding author), PRINCE WALES HOSP,CYTOGENET UNIT,RANDWICK,NSW 2031,AUSTRALIA.							ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; KALOUSEK DK, 1989, AM J HUM GENET, V44, P338; KALOUSEK DK, 1991, PRENATAL DIAG, V11, P743, DOI 10.1002/pd.1970111002; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; SPENCE JE, 1988, AM J HUM GENET, V42, P217; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z	8	101	101	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1348	1349						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1598916				2022-12-18	WOS:A1992HY65400030
J	BOTTEMA, CDK; KETTERLING, RP; II, S; YOON, HS; PHILLIPS, JA; SOMMER, SS				BOTTEMA, CDK; KETTERLING, RP; II, S; YOON, HS; PHILLIPS, JA; SOMMER, SS			MISSENSE MUTATIONS AND EVOLUTIONARY CONSERVATION OF AMINO-ACIDS - EVIDENCE THAT MANY OF THE AMINO-ACIDS IN FACTOR-IX FUNCTION AS SPACER ELEMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COAGULATION FACTOR-IX; HEMOPHILIA-B; BLOOD-COAGULATION; BETA-LACTAMASE; MESSENGER-RNA; HAEMOPHILIA-B; FACTOR-VII; PROTEIN-C; FACTOR-X; SEQUENCE	We report 31 point mutations in the factor IX gene and explore the relationship between the level of evolutionary conservation of an amino acid and the probability of a mutation causing hemophilia B. From our total sample of 125 hemophiliacs and from those reported by others, we identify 95 independent missense mutations, 94 of which occur at amino acids that are evolutionarily conserved in the available mammalian factor IX sequences. The likelihood of a missense mutation causing hemophilia B depends on whether the residue is also conserved in the factor IX-related proteases: factor VII, factor X, and protein C. Most of the possible missense mutations in generically conserved residues (i.e., those conserved in factor IX and in all the related proteases) should cause disease. In contrast, missense mutations in factor IX-specific residues (i.e., those conserved in human, cow, dog, and mouse factor IX but not in the related proteases) are sixfold less likely to cause disease. Missense mutations at nonconserved residues are 33-fold less likely to cause disease. At least three models are compatible with these observations. A comparison of sequence alignments from four and nine species of factor IX and an examination of the missense mutations occurring at CpG residues suggest a model in which most residues fall on opposite ends of a spectrum. In about 40% of residues, virtually any missense mutation in a minority of the residues will cause disease, while virtually no missense mutations will cause disease in most of the remaining residues. Thus, many of the residues in factor IX are spacers; that is, the main chains are presumably necessary to keep other amino acid interactions in register, but the nature of the side chain is unimportant.	MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905; VANDERBILT UNIV,MED CTR,SCH MED,DEPT PEDIAT,DIV GENET,NASHVILLE,TN 37232	Mayo Clinic; Vanderbilt University				Ketterling, Rhett/0000-0001-6479-7897; Bottema, Cynthia/0000-0001-6245-0099	NHLBI NIH HHS [HL39762] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039762] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKMANN RJ, 1985, NUCLEIC ACIDS RES, V13, P5233, DOI 10.1093/nar/13.14.5233; BOTTEMA CDK, 1989, LANCET, V2, P526; BOTTEMA CDK, 1990, BRIT J HAEMATOL, V75, P212, DOI 10.1111/j.1365-2141.1990.tb02651.x; BOTTEMA CDK, 1990, AM J HUM GENET, V47, P835; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P839; CAMERINO G, 1984, P NATL ACAD SCI-BIOL, V81, P498, DOI 10.1073/pnas.81.2.498; DOOLITTLE RF, 1987, COLD SPRING HARB SYM, V52, P869, DOI 10.1101/SQB.1987.052.01.095; DOOLITTLE RF, 1964, NATURE, V202, P147, DOI 10.1038/202147a0; DUBE DK, 1989, BIOCHEMISTRY-US, V28, P5703, DOI 10.1021/bi00440a001; EVANS JP, 1989, BLOOD, V74, P207; EYSTER ME, 1980, AM J HEMATOL, V9, P277, DOI 10.1002/ajh.2830090306; FUNG MR, 1984, NUCLEIC ACIDS RES, V12, P4481, DOI 10.1093/nar/12.11.4481; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GIANNELLI F, 1990, NUCLEIC ACIDS RES, V18, P4053, DOI 10.1093/nar/18.14.4053; GREEN PM, 1990, NUCLEIC ACIDS RES, V18, P3227, DOI 10.1093/nar/18.11.3227; GUSTAFSON S, 1987, ANAL BIOCHEM, V165, P294, DOI 10.1016/0003-2697(87)90272-7; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; KATAYAMA K, 1979, P NATL ACAD SCI USA, V76, P4990, DOI 10.1073/pnas.76.10.4990; KETTERLING RP, 1991, GENOMICS, V10, P1093, DOI 10.1016/0888-7543(91)90207-U; KETTERLING RP, IN PRESS HUM GENET; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; LENINGER AL, 1989, BIOCH MOL BASIS CELL, V339, P31; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; LONG GL, 1984, P NATL ACAD SCI-BIOL, V81, P5653, DOI 10.1073/pnas.81.18.5653; MONTANDON AJ, 1990, HUM GENET, V85, P200; PANG CP, 1990, NUCLEIC ACIDS RES, V18, P6731, DOI 10.1093/nar/18.22.6731; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; REIDHAAROLSON JF, 1988, SCIENCE, V241, P53, DOI 10.1126/science.3388019; SARKAR G, 1990, GENOMICS, V6, P133, DOI 10.1016/0888-7543(90)90458-7; SCHULTZ SC, 1986, P NATL ACAD SCI USA, V83, P1588, DOI 10.1073/pnas.83.6.1588; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SOMMER SS, 1990, PCR PROTOCOLS GUIDE, P197; STOFLET ES, 1988, SCIENCE, V239, P414; TAKEYA H, 1988, J BIOL CHEM, V263, P14868; THOMPSON AR, 1990, LANCET, V335, P418, DOI 10.1016/0140-6736(90)90259-8; VOGEL F, 1986, HUM GENET, P368; WINSHIP PR, 1984, NUCLEIC ACIDS RES, V12, P8861, DOI 10.1093/nar/12.23.8861; WINSHIP PR, 1989, LANCET, V1, P631; WU SM, 1990, GENE, V86, P275, DOI 10.1016/0378-1119(90)90290-8; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	42	101	108	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1991	49	4					820	838						19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG665	1680287				2022-12-18	WOS:A1991GG66500014
J	ARINAMI, T; ISHIKAWA, M; INOUE, A; YANAGISAWA, M; MASAKI, T; YOSHIDA, MC; HAMAGUCHI, H				ARINAMI, T; ISHIKAWA, M; INOUE, A; YANAGISAWA, M; MASAKI, T; YOSHIDA, MC; HAMAGUCHI, H			CHROMOSOMAL ASSIGNMENTS OF THE HUMAN ENDOTHELIN FAMILY GENES - THE ENDOTHELIN-I GENE (EDNI) TO 6P23-P24, THE ENDOTHELIN-2 GENE (EDN2) TO IP34, AND THE ENDOTHELIN-3 GENE (EDN3) TO 20Q13.2-Q13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VASOCONSTRICTOR PEPTIDE; CLONING; HYBRIDIZATION	Chromosomal assignments of the genes for the human endothelin family, the endothelin-1 gene (EDN1), the endothelin-2 gene (EDN2), and the endothelin-3 gene (EDN3), were accomplished by in situ hybridization to human metaphase chromosomes using a H-3-labeled human preproendothelin cDNA probe for each endothelin. The chromosomal assignment of the EDN2 was also performed by Southern blot analysis of somatic cell hybrid DNAs. EDN1, EDN2, and EDN3 were mapped to 6p23-p24, 1p34, and 20q13.2-q13.3, respectively	HOKKAIDO UNIV,CHROMOSOME RES UNIT,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN	Hokkaido University	ARINAMI, T (corresponding author), UNIV TSUKUBA,INST BASIC MED SCI,SAKURA,IBARAKI 305,JAPAN.							BLOCH KD, 1989, J BIOL CHEM, V264, P10851; BLOCH KD, 1989, J BIOL CHEM, V264, P18156; DAVIDSON RL, 1976, SOMAT CELL GENET, V2, P165, DOI 10.1007/BF01542629; DUTRILLAUX B, 1981, HUM GENET, V57, P93; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; ITOH Y, 1988, FEBS LETT, V231, P440, DOI 10.1016/0014-5793(88)80867-6; KLOOG Y, 1988, SCIENCE, V242, P268, DOI 10.1126/science.2845579; MASUDA Y, 1989, FEBS LETT, V257, P208, DOI 10.1016/0014-5793(89)81535-2; SAIDA K, 1989, J BIOL CHEM, V264, P14613; TAKASAKI C, 1988, NATURE, V335, P303, DOI 10.1038/335303b0; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOSHIDA MC, 1975, P JPN ACAD, V51, P184, DOI 10.2183/pjab1945.51.184; YOSHIZAWA T, 1990, SCIENCE, V247, P462, DOI 10.1126/science.2405487	14	101	105	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					990	996						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	2018043				2022-12-18	WOS:A1991FK89700019
J	PHANEUF, D; LABELLE, Y; BERUBE, D; ARDEN, K; CAVENEE, W; GAGNE, R; TANGUAY, RM				PHANEUF, D; LABELLE, Y; BERUBE, D; ARDEN, K; CAVENEE, W; GAGNE, R; TANGUAY, RM			CLONING AND EXPRESSION OF THE CDNA-ENCODING HUMAN FUMARYLACETOACETATE HYDROLASE, THE ENZYME DEFICIENT IN HEREDITARY TYROSINEMIA - ASSIGNMENT OF THE GENE TO CHROMOSOME-15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LIVER-TRANSPLANTATION; PRENATAL-DIAGNOSIS; INSITU HYBRIDIZATION; NUCLEOTIDE-SEQUENCE; LOCALIZATION; TRANSLATION; SPECIFICITY; PROTEINS; TISSUES; CELLS	Type 1 hereditary tyrosinemia (HT) is an autosomal recessive disease characterized by a deficiency of the enzyme fumarylacetoacetate hydrolase (FAH;E.C.3.7.1.2). We have isolated human FAH cDNA clones by screening a liver cDNA expression library using specific antibodies and plaque hybridization with a rat FAH cDNA probe. A 1,477-bp cDNA was sequenced and shown to code for FAH by an in vitro transcription-translation assay and sequence homology with tryptic fragments of purified FAH. Transient expression of this FAH cDNA in transfected CV-1 mammalian cells resulted in the synthesis of an immunoreactive protein comigrating with purified human liver FAH on SDS-PAGE and having enzymatic activity as shown by the hydrolysis of the natural substrate fumarylacetoacetate. This indicates that the single polypeptide chain encoded by the FAH gene contains all the genetic information required for functional activity, suggesting that the dimer found in vivo is a homodimer. The human FAH cDNA was used as a probe to determine the gene's chromosomal localization using somatic cell hybrids and in situ hybridization. The human FAH gene maps to the long arm of chromosome 15 in the region q23-q25.	CHU LAVAL,CTR RECH,2705 BLVD LAURIER,QUEBEC CITY G1V 4G2,QUEBEC,CANADA; LUDWIG INST CANC RES,MONTREAL,QUEBEC,CANADA	Laval University; Ludwig Institute for Cancer Research								AGSTERIBBE E, 1990, NUCLEIC ACIDS RES, V18, P1887, DOI 10.1093/nar/18.7.1887; Ausubel F., 1992, MOL REPROD DEV, DOI DOI 10.1002/MRD.1080010210; BERGELEFRANC JL, 1985, HUM GENET, V69, P28, DOI 10.1007/BF00295525; BERGER R, 1987, PEDIATR RES, V22, P394, DOI 10.1203/00006450-198710000-00005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DEBRAEKELEER M, 1990, AM J HUM GENET, V47, P302; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLATMARK A, 1986, TRANSPLANT P, V18, P67; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; GOLDSMITH LA, 1989, METABOLIC BASIS INHE, P547; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRIFFIN CA, 1987, P NATL ACAD SCI USA, V84, P512, DOI 10.1073/pnas.84.2.512; HOLME E, 1985, LANCET, V1, P527; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KELLEY PM, 1982, MOL CELL BIOL, V2, P267, DOI 10.1128/MCB.2.3.267; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KVITTINGEN EA, 1986, EUR J PEDIATR, V144, P597, DOI 10.1007/BF00496047; KVITTINGEN EA, 1986, SCAND J CLIN LAB INV, V46, P27; KVITTINGEN EA, 1986, J INHERIT METAB DIS, V9, P216, DOI 10.1007/BF01799465; KVITTINGEN EA, 1985, PEDIATR RES, V19, P334, DOI 10.1203/00006450-198519040-00002; KVITTINGEN EA, 1983, PEDIATR RES, V14, P541; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; MAHURAN DJ, 1977, CAN J BIOCHEM CELL B, V55, P1; Mason PJ, 1985, NUCLEIC ACID HYBRIDI, P113; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MITCHELL G, 1990, NEW ENGL J MED, V322, P432, DOI 10.1056/NEJM199002153220704; NICOLE LM, 1986, BIOCHEM CELL BIOL, V64, P489, DOI 10.1139/o86-068; NICOLE LM, 1987, BIOSCIENCE REP, V7, P239, DOI 10.1007/BF01124795; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; PHANEUF D, 1989, MAY COLD SPRING HARB; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STARZL TE, 1985, J PEDIATR-US, V106, P604, DOI 10.1016/S0022-3476(85)80081-0; TANGUAY RM, 1990, AM J HUM GENET, V47, P308; TANGUAY RM, 1984, ADV GENE TECHNOLOGY, P256; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUCHMAN M, 1987, J PEDIATR-US, V110, P399, DOI 10.1016/S0022-3476(87)80501-2	38	101	102	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1991	48	3					525	535						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK470	1998338				2022-12-18	WOS:A1991FK47000013
J	MERRITT, AD; RIVAS, ML; BIXLER, D; NEWELL, R				MERRITT, AD; RIVAS, ML; BIXLER, D; NEWELL, R			SALIVARY AND PANCREATIC AMYLASE - ELECTROPHORETIC CHARACTERIZATIONS AND GENETIC STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INDIANA UNIV,MED CTR,DEPT MED GENET,INDIANAPOLIS,IN 46202; RUTGERS STATE UNIV,DOUGLASS COLL,DEPT BIOL SCI,NEW BRUNSWICK,NJ 08903	Indiana University System; Indiana University-Purdue University Indianapolis; Rutgers State University New Brunswick								BOETTCHER B, 1971, ENZYMOLOGIA, V40, P234; BOETTCHER B, 1969, AUST J EXP BIOL MED, V47, P97, DOI 10.1038/icb.1969.9; DEJONG G, 1972, NATURE, V238, P453, DOI 10.1038/238453a0; DELALANDE FA, 1969, ENZYMOLOGIA, V37, P335; KAMARYT J, 1971, HUMANGENETIK, V11, P213, DOI 10.1007/BF00274740; KAMARYT J, 1965, HUMANGENETIK, V1, P579; KAMARYT J, 1966, HUMANGENETIK, V3, P41, DOI 10.1007/BF00273017; LAXOVA R, 1970, FEBS S, V18, P335; MALACINSKI GM, 1969, BIOCHEMISTRY-US, V8, P4382, DOI 10.1021/bi00839a024; MERRITT AD, 1972, NATURE-NEW BIOL, V239, P243, DOI 10.1038/newbio239243a0; MERRITT AD, 1971, EXCERPTA MEDICA  233, P120; REED TE, 1969, SCIENCE, V165, P762, DOI 10.1126/science.165.3895.762; SANDERS TG, 1972, BIOCHEMISTRY-US, V11, P130, DOI 10.1021/bi00751a022; WARD JC, 1971, AM J HUM GENET, V23, P403	14	101	101	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	5					510	522						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q7858	4741846				2022-12-18	WOS:A1973Q785800004
J	REED, TE; NEEL, JV				REED, TE; NEEL, JV			HUNTINGTON CHOREA IN MICHIGAN .2. SELECTION AND MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Bell, 1934, TREASURY HUMAN INH 1, VIV; Brothers CRD, 1949, P ROY AUST COLL PHYC, V4, P48; Cochran W.G., 1953, SAMPLING TECHNIQUES, Vsecond; Crowe FW, 1956, CLIN PATHOLOGICAL GE; Entres JL, 1921, Z GESAMTE NEUROL PSY, V73, P541, DOI 10.1007/BF02895313; KISHIMOTO K, 1957, 1ST P INT C NEUR SC; KROOTH RS, 1955, AM J HUM GENET, V7, P325; PALM JD, 1953, THESIS U MINNESOTA; REED SC, 1951, SCIENCE, V113, P294, DOI 10.1126/science.113.2933.294; REED TE, 1955, AM J HUM GENET, V7, P236; REED TE, 1958, AM J HUM GENET, V10, P201; REED TE, 1959, AM J HUM GENET, V11, P137; REED TE, 1957, JAPAN J HUMAN GENE S, V2, P48; VOGEL F, 1957, Z MENSCH VERERB KONS, V34, P205; WHELPTON PK, 1954, COHORT FERTILITY; WITKOP C J, 1957, Acta Genet Stat Med, V7, P236; [No title captured]	17	101	102	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1959	11	2					107	136						30	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF073	13661148				2022-12-18	WOS:A1959WF07300001
J	ULLRICH, O				ULLRICH, O			TURNERS SYNDROME AND STATUS BONNEVIE-ULLRICH - A SYNTHESIS OF ANIMAL PHENOGENETICS AND CLINICAL OBSERVATIONS ON A TYPICAL COMPLEX OF DEVELOPMENTAL ANOMALIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review																		ABERLEHORSTENEG.W, 1937, Z ORTHOP, V67, P21; ALESSANDRI H, 1945, REV MED CHILE, V73, P630; ATRIA RA, 1946, REV MED CHILE, V74, P491; Bagg HJ, 1924, AM J ANAT, V33, P119, DOI 10.1002/aja.1000330107; BAUMANN T, 1945, ANN PAEDIAT, V165, P160; BETTMAN AG, 1946, PLAST RECONSTR SURG, V1, P205, DOI 10.1097/00006534-194609000-00010; Bizarro AH, 1938, LANCET, V2, P828; BLECHSCHMIDT E, 1947, ABH AKAD WISS GOTTIN, V3; Blechschmidt E., 1948, MECHANISCHE GENWIRKU; Bonnevie K, 1934, J EXP ZOOL, V67, P443, DOI 10.1002/jez.1400670304; BONNEVIE K, 1932, ARCH ENTWICKLUNGSMEC, V126, P348; BONNEVIE K, 1936, ERBARZT, V2, P145; BONNEVIE K, 1940, HDB ERBBIOLOGIE MENS, V1; BRAKHAGE S, 1941, Z KINDERHEILKD, V62, P686; BREMER FRIEDRICH WILHELM, 1927, DEUTSCHE ZEITSCHR NERVENHEILK, V99, P104, DOI 10.1007/BF01669012; BREMER FW, 1926, DEUTSCH ZTSCHR NERVE, V95, P1; Bussiere JA., 1902, ANN HYG MED COLON, V5, P686; CAPURRO AM, 1941, DIA MED B AIR, V13, P124; Carpenter G, 1909, Proc R Soc Med, V2, P45; Chandler FA, 1937, AM J DIS CHILD, V53, P798; CLAUSEN F, 1939, Z INDUKT ABSTAMM, V76, P14; COTTERMAN CW, 1948, GENETICS, V33, P607; De Bruin M, 1928, AM J DIS CHILD, V36, P333; DORFF G B, 1948, Arch Pediatr, V65, P555; DRACHTER R, 1923, KLIN WOCHENSCHR, V2, P664; DREYFUS JR, 1936, Z KINDERHEILKD, V58, P165; Dunn LC, 1934, P NATL ACAD SCI USA, V20, P230, DOI 10.1073/pnas.20.4.230; Ebstein E, 1918, DERMATOL WOCHENSCHR, V67, P607; Engel D, 1940, AM J DIS CHILD, V60, P562; ESSENMOLLER, 1928, Z MENSCHL VERERB, V14, P52; FANCONI G, 1934, KLIN FORENSISCHE BED, P681; Flavell G, 1943, BRIT J SURG, V31, P150, DOI 10.1002/bjs.18003112208; FOUCAR HO, 1948, CAN MED ASSOC J, V59, P251; Frawley JM, 1925, AM J DIS CHILD, V29, P799; Freeman E A, 1938, Arch Dis Child, V13, P277; Freeman E A, 1938, Proc R Soc Med, V31, P1116; Funke, 1902, DTSCH Z F R CHIRURG, V63, P162; GAUTHERET R, 1948, CR HEBD ACAD SCI, V226, P270; Gilmour JR, 1941, J PATHOL BACTERIOL, V53, P117, DOI 10.1002/path.1700530112; GLANZMANN E, 1946, EINFUHRUNG KINDERHEI, V2, P172; GREBE H, 1944, Z MENSCHL VERERB KON, V28, P209; GREENBLATT RB, 1948, J CLIN ENDOCRINOL, V8, P993, DOI 10.1210/jcem-8-11-993; GROSS M, 1939, MSCHR KINDERH, V78, P187; Gruber GB, 1934, BEITR PATHOL ANAT AL, V93, P459; GRUNEBERG H, 1947, ANIMAL GENETICS MED, P296; GRUNEBERG H, 1943, GENETICS MOUSE, P412; GUINAND-DONIOL J, 1947, Ann Paediatr, V169, P317; GUTERMANN F, 1902, DEUT Z NERVENHEILKD, V57, P203; HAASE L, 1942, VEROFF KONST WEHRPAT, V51; HACKENBROCH M, 1924, Z ORTHOP, V43, P508; HAMNE B, 1948, NORD MED, V38, P1135; HEIJBROEK NI, 1941, MSCHR KINDERGENEESK, V10, P267; HEUBNER O, 1900, CHARITE ANN, V25; HOFFMANN H, 1937, ARCH KINDERHEILKD, V110, P1; HOFMANN A, 1925, ARCH KINDERHEILKD, V76, P285; HUSLER J, 1942, HDB KINDERHK; JACCOTTET M, 1945, ANN PAEDIATR, V165, P160; KALDEBO J, 1933, ZBL CHIR, V60, P2601; KAVEN A, 1943, ERBARZT, V11, P49; KIESER W, 1939, Z MENSCHL VERERB KON, V23, P594; Kobylinski O., 1883, ARCH ANTHR, V14, P343; KOPITS E, 1937, ARCHIV ORTHOPAEDISCH, V37, P539; KRUCKE W, 1949, DTSCH Z NERVENHEILK, V160, P196; LEOPOLD JS, 1934, ARCH PEDIATR, V51, P34; LIEBENAM L, 1938, Z MENSCHL VERERB KON, V22, P373; Little CC, 1932, GENETICS, V17, P0674; MacCollum DW, 1938, NEW ENGL J MED, V219, P251, DOI 10.1056/NEJM193808252190801; MARQUARDT W, 1938, Z ORTHOP, V67, P379; Martin Charles A., 1947, LAVAL MED, V12, P461; MASLOWSKI H, 1928, MONATSSCHR KINDERH, V40, P436; MATOLCSY T, 1936, ARCH KLIN CHIR, V185, P675; MENZEL W, 1939, Z KLIN MED, V135, P423; MEYER F, 1943, ARCH KINDERHEILKD, V129, P35; MORANDO G C, 1948, Pediatria (Rio), V56, P746; MOSEBACH H, 1936, Z ORTHOP, V65, P134; MOSS J M, 1949, Va Med Mon (1918), V76, P186; Nachtsheim H., 1943, Jenaische Zeitschrift fuer Medicin und Naturwissenschaft, V76, P81; NAGEOTTEWILBOUC.M, 1934, B SOC PEDIAT PARIS, V32, P683; NIEMEYER ML, 1946, THESIS GOTTINGEN; NIEUWENHUIJSE AC, 1942, GENETICA, V23, P289; OSTERTAG M, 1936, DTSCH Z NERVENH, V141, P1; PALOS LA, 1948, SCHWEIZ MED WSCHR, V78, P1130; PASSOW A, 1933, ARCH AUGENHEILKD, V107, P1; PERITZ R, 1912, NERVENKRANKHEITEN KI; PETERSEN GA, 1939, Z KINDERHEILKD, V61, P130; PFAUNDLER M, 1939, Z KINDERHEILKD, V60, P467; Plagens GM, 1933, J MORPHOL, V55, P151, DOI 10.1002/jmor.1050550110; RANTASALO V, 1936, ACTA PEDIAT, V18, P368; RASPI M, 1927, RIV CLIN PEDIATR, V25, P648; Rinvik Roald, 1944, ACTA PAEDIATRICA [UPPSALA], V31, P417, DOI 10.1111/j.1651-2227.1944.tb16233.x; ROSSI E, 1947, Helv Paediatr Acta, V2, P98; ROSSI E, 1945, HELV PAEDIATR ACTA, V1, P134; Ruh HO, 1927, AM J DIS CHILD, V33, P249, DOI 10.1001/archpedi.1927.04130140069009; SCHADE H, 1937, Z MORPHOL ANTHROPOL, V36, P375; SCHMIDT A, 1897, Z NERVENH, V10, P400; SCHNEIDER RW, 1943, CLEV CLIN Q, V10, P112; SCHUSSLER E, 1944, Z MENSCHL VERERB, V27, P745; SCHWARTZER K, 1938, MONATSSCHR KINDERH, V76, P193; SEHESTEDT H, 1938, KINDERARZTL PRAX, V9, P56; Sharpey-Schafer EP, 1941, LANCET, V2, P559; SHERESHEVSKI NA, 1925, VEST ENDOKR; SHERESHEVSKI NA, 1926, REV FR ENDOCR; SHERESHEVSKI NA, 1944, AM REV SOV MED, V1, P337; SIEGMUND H, 1938, ZBL ALLG PATH, V70, P243; SLONIMSKI, 1928, T CLIN NEUROLOGIQUE, V1, P173; SPATZ H, 1931, Z KINDERHEILKD, V51, P579; STECHE O, 1905, DTSCH Z NERVENHEILK, V28, P217; Sturkie PD, 1941, J MORPHOL, V69, P517, DOI 10.1002/jmor.1050690307; SYLVEST O, 1940, UGESKRIFT LAEGER, V102, P1270; TEVELI L, 1930, ORVOSI HETILAP, V1, P92; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566; ULLRICH O, 1938, KLIN WOCHENSCHR, V17, P185; ULLRICH O, 1943, Z MENSCHL VERERB, V27, P651; ULLRICH O, 1936, HDB NEUROLOGIE, V16, P139; ULLRICH O, 1943, ERG INN MED KINDERHK, V63, P929; ULLRICH O, 1944, ANTRITTSVORLES RHEIN, V26, P1; ULLRICH O, 1949, IN PRESS ERG INN MED; Ullrich O, 1930, Z KINDERHEILKD, V49, P271, DOI DOI 10.1007/BF02248090; VOLZ H, 1938, Z GEBURTSH GYNAKOL, V117, P131; VONVERSCHUER OF, 1940, MENSCHLICHE ERBLEHRE, V1; WAARDENBURG PJ, 1934, KLIN MBL AUGENHEILK, V92, P29; WEISSENBERG S., 1928, ANTHROP ANZEIGER, V5, P141; WERNHER O, 1843, ANGEBORENEN ZYSTENHY; WIETSCHKE L, 1932, WIEN KLIN WSCHR, P1014; WITH TK, 1935, HOSPITALSTIDENDE, V78, P556	125	101	102	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1949	1	2					179	202						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU076	17948393				2022-12-18	WOS:A1949XU07600005
J	Ceyhan-Birsoy, O; Murry, JB; Machini, K; Lebo, MS; Yu, TW; Fayer, S; Genetti, CA; Schwartz, TS; Agrawal, PB; Parad, RB; Holm, IA; McGuire, AL; Green, RC; Rehm, HL; Beggs, AH; Betting, WN; Christensen, KD; Dukhovny, D; Frankel, LA; Graham, C; Guiterrez, AM; Harden, M; Krier, JB; Levy, HL; Lu, XQ; Naik, M; Nguyen, TT; Peoples, HA; Pereira, S; Petersen, D; Ramamurthy, U; Ramanathan, V; Roberts, A; Robinson, JO; Roumiantsev, S; Truong, TK; Vannoy, GE; Waisbren, SE				Ceyhan-Birsoy, Ozge; Murry, Jaclyn B.; Machini, Kalotina; Lebo, Matthew S.; Yu, Timothy W.; Fayer, Shawn; Genetti, Casie A.; Schwartz, Talia S.; Agrawal, Pankaj B.; Parad, Richard B.; Holm, Ingrid A.; McGuire, Amy L.; Green, Robert C.; Rehm, Heidi L.; Beggs, Alan H.; Betting, Wendi N.; Christensen, Kurt D.; Dukhovny, Dmitry; Frankel, Leslie A.; Graham, Chet; Guiterrez, Amanda M.; Harden, Maegan; Krier, Joel B.; Levy, Harvey L.; Lu, Xingquan; Naik, Medha; Nguyen, Tiffany T.; Peoples, Hayley A.; Pereira, Stacey; Petersen, Devan; Ramamurthy, Uma; Ramanathan, Vivek; Roberts, Amy; Robinson, Jill O.; Roumiantsev, Serguei; Truong, Tina K.; Vannoy, Grace E.; Waisbren, Susan E.		BabySeq Project Team	Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION TASK-FORCE; CONGENITAL ADRENAL-HYPERPLASIA; 2011 ACCF/AHA GUIDELINE; HEART-DISEASE; HYPERTROPHIC CARDIOMYOPATHY; INCIDENTAL FINDINGS; FUNCTIONAL-ANALYSIS; SYSTEMATIC-APPROACH; MOLECULAR FINDINGS; SECONDARY FINDINGS	Genomic sequencing provides many opportunities in newborn clinical care, but the challenges of interpreting and reporting newborn genomic sequencing (nGS) results need to be addressed for its broader and effective application. The BabySeq Project is a pilot randomized clinical trial that explores the medical, behavioral, and economic impacts of nGS in well newborns and those admitted to a neonatal intensive care unit (NICU). Here we present childhood-onset and actionable adult-onset disease risk, carrier status, and pharmacogenomics findings from nGS of 159 newborns in the BabySeq Project. nGS revealed a risk of childhood-onset disease in 15/159 (9.4%) newborns; none of the disease risks were anticipated based on the infants' known clinical or family histories. nGS also revealed actionable adult-onset disease risk in 3/85 (3.5%) newborns whose parents consented to receive this information. Carrier status for recessive diseases and pharmacogenomics variants were reported in 88% and 5% of newborns, respectively. Additional indication-based analyses were performed in 29/32 (91%) NICU newborns and 6/127 (5%) healthy newborns who later had presentations that prompted a diagnostic analysis. No variants that sufficiently explained the reason for the indications were identified; however, suspicious but uncertain results were reported in five newborns. Testing parental samples contributed to the interpretation and reporting of results in 13/159 (8%) newborns. Our results suggest that nGS can effectively detect risk and carrier status for a wide range of disorders that are not detectable by current newborn screening assays or predicted based on the infant's known clinical or family history, and the interpretation of results can substantially benefit from parental testing.	[Ceyhan-Birsoy, Ozge] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Ceyhan-Birsoy, Ozge; Murry, Jaclyn B.; Machini, Kalotina; Lebo, Matthew S.; Rehm, Heidi L.] Partners HealthCare Personalized Med, Lab Mol Med, Cambridge, MA 02139 USA; [Lebo, Matthew S.; Rehm, Heidi L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Murry, Jaclyn B.; Machini, Kalotina; Lebo, Matthew S.; Yu, Timothy W.; Agrawal, Pankaj B.; Parad, Richard B.; Holm, Ingrid A.; Green, Robert C.; Rehm, Heidi L.; Beggs, Alan H.] Harvard Med Sch, Boston, MA 02115 USA; [Yu, Timothy W.; Genetti, Casie A.; Schwartz, Talia S.; Agrawal, Pankaj B.; Holm, Ingrid A.; Beggs, Alan H.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA; [Yu, Timothy W.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Fayer, Shawn; Green, Robert C.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Agrawal, Pankaj B.] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Parad, Richard B.] Brigham & Womens Hosp, Dept Pediat Newborn Med, 75 Francis St, Boston, MA 02115 USA; [McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Lebo, Matthew S.; Green, Robert C.; Rehm, Heidi L.] Brd Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rehm, Heidi L.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA	Memorial Sloan Kettering Cancer Center; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Baylor College of Medicine; Harvard University; Massachusetts General Hospital	Beggs, AH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Beggs, AH (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA.	beggs@enders.tch.harvard.edu	Agrawal, Pankaj/ABG-8957-2021; Nguyen, Tiffany/HGD-2431-2022; Parad, Richard B/AGX-7702-2022; Naik, Medha/GZH-1122-2022; Yu, Timothy W./AAF-5738-2019; Pereira, Stacey/ABB-8280-2021; Roumiantsev, Sergey/L-1428-2018	Parad, Richard B/0000-0002-4326-0609; Yu, Timothy W./0000-0003-2988-7701; Pereira, Stacey/0000-0001-6541-3904; Lebo, Matthew/0000-0002-9733-5207; Roumiantsev, Sergey/0000-0002-7418-0222	National Institutes of Health [U19HD077671, R01HD075802, U41HG006834]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077671, R01HD075802] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors would like to thank the families for their participation in the BabySeq Project. Research reported in this publication was supported by the National Institutes of Health under award numbers U19HD077671, R01HD075802, and U41HG006834. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akinrinade O, 2016, CLIN GENET, V90, P49, DOI 10.1111/cge.12741; Akinrinade O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145284; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Bailey DB, 2015, JAMA-J AM MED ASSOC, V313, P1511, DOI 10.1001/jama.2014.17488; Balsamo A, 2000, CLIN ENDOCRINOL, V53, P117, DOI 10.1046/j.1365-2265.2000.01048.x; Barbaro M, 2004, J CLIN ENDOCR METAB, V89, P2402, DOI 10.1210/jc.2003-031630; Berg JS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2252; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; Botkin JR, 2015, AM J HUM GENET, V97, P6, DOI 10.1016/j.ajhg.2015.05.022; Bottillo Irene, 2013, BMC Res Notes, V6, P376, DOI 10.1186/1756-0500-6-376; Brouillard P, 2013, MOL SYNDROMOL, V4, P157, DOI 10.1159/000348675; Burkett EL, 2005, J AM COLL CARDIOL, V45, P969, DOI 10.1016/j.jacc.2004.11.066; Ceyhan-Birsoy O, 2017, GENET MED, V19, P809, DOI 10.1038/gim.2016.193; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Chu CS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002224; De Marco G, 2011, J CLIN ENDOCR METAB, V96, pE1335, DOI 10.1210/jc.2010-2467; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Fahed AC, 2013, CIRC RES, V112, P707, DOI 10.1161/CIRCRESAHA.112.300853; Feldkamp ML, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2249; Fernandez CS, 2015, ENDOCRINE, V50, P72, DOI 10.1007/s12020-015-0680-0; Finkielstain GP, 2011, J CLIN ENDOCR METAB, V96, pE161, DOI 10.1210/jc.2010-0319; Franaszczyk M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169007; Gambin T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0171-1; Gelb BD, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013953; Genetti CA, 2018, GENET MED; Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230; Gersh BJ, 2011, J THORAC CARDIOV SUR, V142, pE153, DOI 10.1016/j.jtcvs.2011.10.020; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Goldstein B, 2017, UROL NURS, V37, P102; Goldstein Boss, 2017, Urol Nurs, V37, P81; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Holm IA, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1200-1; Hymes J, 2001, HUM MUTAT, V18, P375, DOI 10.1002/humu.1208; Johnston J, 2018, HASTINGS CENT REP, V48, DOI 10.1002/hast.874; Kavanagh D, 2006, BRIT MED BULL, V77-78, P5, DOI 10.1093/bmb/ldl004; Kingsmore SF, 2016, GENET MED, V18, P214, DOI 10.1038/gim.2015.172; Konkle B. A., 1993, GENEREVIEWS; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; Livadas S, 2015, CLIN ENDOCRINOL, V82, P543, DOI 10.1111/cen.12543; Low K, 2016, AM J MED GENET A, V170, P2835, DOI 10.1002/ajmg.a.37842; Lubbe SJ, 2009, J CLIN ONCOL, V27, P3975, DOI 10.1200/JCO.2008.21.6853; Maugeri A, 2002, EUR J HUM GENET, V10, P197, DOI 10.1038/sj.ejhg.5200784; McLaughlin HM, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0134-1; Meng LY, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3438; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Murry JB, 2018, CSH MOL CASE STUD, V4, DOI 10.1101/mcs.a002873; Naito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063231; New MI, 2006, J CLIN ENDOCR METAB, V91, P4205, DOI 10.1210/jc.2006-1645; Norrgard K J, 1998, Hum Mutat, V11, P410, DOI 10.1002/(SICI)1098-1004(1998)11:5<410::AID-HUMU10>3.3.CO;2-#; Pagon R. A., 1993, GENEREVIEWS; Petrikin JE, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0045-8; Petrucelli N., 1993, GENEREVIEWS; Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Reclos GJ, 2000, J MED SCREEN, V7, P46, DOI 10.1136/jms.7.1.46; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Ross LF, 2013, GENET MED, V15, P321, DOI [10.1038/gim.2012.176, 10.1038/gim.2013.39]; Sirmaci A, 2011, AM J HUM GENET, V89, P289, DOI 10.1016/j.ajhg.2011.06.007; Skordis N, 2011, HORM RES PAEDIAT, V75, P180, DOI 10.1159/000320040; Tabish Ali M, 2017, Biophys Rev, V9, P207, DOI 10.1007/s12551-017-0265-7; Treem WR, 2012, J PEDIATR GASTR NUTR, V55, pS7, DOI 10.1097/01.mpg.0000421401.57633.90; Vetter VL, 2008, CIRCULATION, V117, P2407, DOI 10.1161/CIRCULATIONAHA.107.189473; Votava F, 2005, EUR J ENDOCRINOL, V152, P869, DOI 10.1530/eje.1.01929; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Wilfond BS, 2015, J LAW MED ETHICS, V43, P552, DOI 10.1111/jlme.12298; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	69	100	107	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 3	2019	104	1					76	93		10.1016/j.ajhg.2018.11.016	http://dx.doi.org/10.1016/j.ajhg.2018.11.016			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HG2EH	30609409	Bronze, Green Published			2022-12-18	WOS:000454775500010
J	Zech, M; Boesch, S; Maier, EM; Borggraefe, I; Vill, K; Laccone, F; Pilshofer, V; Ceballos-Baumann, A; Alhaddad, B; Berutti, R; Poewe, W; Haack, TB; Haslinger, B; Strom, TM; Winkelmann, J				Zech, Michael; Boesch, Sylvia; Maier, Esther M.; Borggraefe, Ingo; Vill, Katharina; Laccone, Franco; Pilshofer, Veronika; Ceballos-Baumann, Andres; Alhaddad, Bader; Berutti, Riccardo; Poewe, Werner; Haack, Tobias B.; Haslinger, Bernhard; Strom, Tim M.; Winkelmann, Juliane			Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; INTELLECTUAL DISABILITY; MICRODELETION SYNDROME; MEMORY FORMATION; CRITICAL REGION; STEM-CELLS; SCHIZOPHRENIA; DISEASE; GENE; MLL2	Early-onset generalized dystonia represents the severest form of dystonia, a hyperkinetic movement disorder defined by involuntary twisting postures. Although frequently transmitted as a single-gene trait, the molecular basis of dystonia remains largely obscure. By whole-exome sequencing a parent-offspring trio in an Austrian kindred affected by non-familial early-onset generalized dystonia, we identified a dominant de novo frameshift mutation, c.6406delC (p.Leu2136Serfs*17), in KMT2B, encoding a lysine-specific methyltransferase involved in transcriptional regulation via post-translational modification of histones. Whole-exome-sequencing-based exploration of a further 30 German-Austrian individuals with early-onset generalized dystonia uncovered another three deleterious mutations in KMT2B-one de novo nonsense mutation (c.1633C>T [p.Arg545*]), one de novo essential splice-site mutation (c.7050-2A>G [p.Phe2321Serfs*93]), and one inherited nonsense mutation (c.2428C>T [p.Gln810*]) co-segregating with dystonia in a three-generation kindred. Each of the four mutations was predicted to mediate a loss-of-function effect by introducing a premature termination codon. Suggestive of haploinsufficiency, we found significantly decreased total mRNA levels of KMT2B in mutant fibroblasts. The phenotype of individuals with KMT2B loss-of-function mutations was dominated by childhood lower-limb-onset generalized dystonia, and the family harboring c.2428C>T (p.Gln810*) showed variable expressivity. In most cases, dystonic symptoms were accompanied by heterogeneous non-motor features. Independent support for pathogenicity of the mutations comes from the observation of high rates of dystonic presentations in KMT2B-involving microdeletion syndromes. Our findings thus establish generalized dystonia as the human phenotype associated with haploinsufficiency of KMT2B. Moreover, we provide evidence for a causative role of disordered histone modification, chromatin states, and transcriptional deregulation in dystonia pathogenesis.	[Zech, Michael; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Neurogenom, D-85764 Munich, Germany; [Zech, Michael; Ceballos-Baumann, Andres; Haslinger, Bernhard; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Neurol, D-81675 Munich, Germany; [Boesch, Sylvia; Poewe, Werner] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Maier, Esther M.; Borggraefe, Ingo; Vill, Katharina] Ludwig Maximilians Univ Munchen, Dr von Haunersches Kinderspital, D-80337 Munich, Germany; [Laccone, Franco] Med Sch Vienna, Inst Med Genet, A-1090 Vienna, Austria; [Pilshofer, Veronika] Krankenhaus Barmherzigen Schwestern Linz, A-4020 Linz, Austria; [Ceballos-Baumann, Andres] Schon Klin Munchen Schwabing, D-80804 Munich, Germany; [Alhaddad, Bader; Haack, Tobias B.; Strom, Tim M.; Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany; [Berutti, Riccardo; Haack, Tobias B.; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Munich, Germany; [Haack, Tobias B.] Univ Klinikum Tubingen, Devis Mol Genet, D-72076 Tubingen, Germany; [Winkelmann, Juliane] SyNergy, Munich Cluster Syst Neurol, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Medical University of Innsbruck; University of Munich; Konventhospital Der Barmherzigen Bruder; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Winkelmann, J (corresponding author), Helmholtz Zentrum Munchen, Inst Neurogenom, D-85764 Munich, Germany.; Winkelmann, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Neurol, D-81675 Munich, Germany.; Winkelmann, J (corresponding author), Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany.; Winkelmann, J (corresponding author), SyNergy, Munich Cluster Syst Neurol, D-81377 Munich, Germany.	winkelmann@lrz.tu-muenchen.de	Alhaddad, Bader/AAJ-5504-2021; Vill, Katharina/GRJ-4074-2022; Borggraefe, Ingo/AAC-4966-2020; Laccone, Franco A/B-3655-2018	Alhaddad, Bader/0000-0003-4542-5267; Vill, Katharina/0000-0003-1925-7538; Boesch, Sylvia/0000-0003-1657-7368	Else Kroner-Fresenius-Stiftung [2015_A151]; Technische Universitat Munchen (Munich); Helmholtz Zentrum Munchen (Munich); Medizinische Universitat Innsbruck (Austria); Langmatz-Stiftung; German Federal Ministry of Education and Research (BMBF) [FKZ 01ZX1405C]	Else Kroner-Fresenius-Stiftung; Technische Universitat Munchen (Munich); Helmholtz Zentrum Munchen (Munich); Medizinische Universitat Innsbruck (Austria); Langmatz-Stiftung; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank all individuals with dystonia and their family members who participated in this study. This study was funded by a research grant from the Else Kroner-Fresenius-Stiftung (2015_A151) as well as in part by in-house institutional funding from Technische Universitat Munchen (Munich), Helmholtz Zentrum Munchen (Munich), and Medizinische Universitat Innsbruck (Austria). M.Z. receives intramural funding from the Langmatz-Stiftung. T.B.H. was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (grant FKZ 01ZX1405C).	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Bai G, 2015, HUM MOL GENET, V24, P1441, DOI 10.1093/hmg/ddu561; Balint B, 2014, CURR OPIN NEUROL, V27, P468, DOI 10.1097/WCO.0000000000000114; Berdasco M, 2013, HUM GENET, V132, P359, DOI 10.1007/s00439-013-1271-x; Bjornsson HT, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009278; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Dale RC, 2012, DEV MED CHILD NEUROL, V54, P618, DOI 10.1111/j.1469-8749.2012.04287.x; Domingo A, 2016, MOVEMENT DISORD, V31, P471, DOI 10.1002/mds.26600; Forzano F, 2012, EUR J MED GENET, V55, P429, DOI 10.1016/j.ejmg.2012.03.002; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gana S, 2012, EUR J HUM GENET, V20, P852, DOI 10.1038/ejhg.2012.19; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Gupta S, 2010, J NEUROSCI, V30, P3589, DOI 10.1523/JNEUROSCI.3732-09.2010; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008; Kerimoglu C, 2013, J NEUROSCI, V33, P3452, DOI 10.1523/JNEUROSCI.3356-12.2013; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kleefstra T, 2012, AM J HUM GENET, V91, P73, DOI 10.1016/j.ajhg.2012.05.003; Klein Christine, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS137, DOI 10.1016/S1353-8020(13)70033-6; Kulharya AS, 1998, AM J MED GENET, V77, P391, DOI 10.1002/(SICI)1096-8628(19980605)77:5<391::AID-AJMG7>3.3.CO;2-V; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Malan V, 2009, J MED GENET, V46, P635, DOI 10.1136/jmg.2008.062034; Melo JB, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0123-x; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schuurs-Hoeijmakers JHM, 2009, J MED GENET, V46, P421, DOI 10.1136/jmg.2009.066910; Shen E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0514; Takata A, 2014, NEURON, V82, P773, DOI 10.1016/j.neuron.2014.04.043; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vallianatos CN, 2015, EPIGENOMICS-UK, V7, P503, DOI 10.2217/epi.15.1; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Zech M., 2016, MOV DISORD	43	100	104	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1377	1387		10.1016/j.ajhg.2016.10.010	http://dx.doi.org/10.1016/j.ajhg.2016.10.010			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27839873	Bronze, Green Published			2022-12-18	WOS:000389148600013
J	Royer-Bertrand, B; Torsello, M; Rimoldi, D; El Zaoui, I; Cisarova, K; Pescini-Gobert, R; Raynaud, F; Zografos, L; Schalenbourg, A; Speiser, D; Nicolas, M; Vallat, L; Klein, R; Leyvraz, S; Ciriello, G; Riggi, N; Moulin, AP; Rivolta, C				Royer-Bertrand, Beryl; Torsello, Matteo; Rimoldi, Donata; El Zaoui, Ikram; Cisarova, Katarina; Pescini-Gobert, Rosanna; Raynaud, Franck; Zografos, Leonidas; Schalenbourg, Ann; Speiser, Daniel; Nicolas, Michael; Vallat, Laureen; Klein, Robert; Leyvraz, Serge; Ciriello, Giovanni; Riggi, Nicolo; Moulin, Alexandre P.; Rivolta, Carlo			Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLORECTAL-CANCER; SOMATIC MUTATIONS; OCULAR MELANOMA; PROTEINS DLK1; RISK; EXPRESSION; METASTASES; RADIATION; CELLS; SF3B1	Uveal melanoma (UM) is a rare intraocular tumor that, similar to cutaneous melanoma, originates from melanocytes. To gain insights into its genetics, we performed whole-genome sequencing at very deep coverage of tumor-control pairs in 33 samples (24 primary and 9 metastases). Genome-wide, the number of coding mutations was rather low (only 17 variants per tumor on average; range 7-28), thus radically different from cutaneous melanoma, where hundreds of exonic DNA insults are usually detected. Furthermore, no UV light-induced mutational signature was identified. Recurrent coding mutations were found in the known UM drivers GNAQ GNA11, BAP1, EIF1AX, and SF3B1. Other genes, i.e., TP53BP1, CSMD1, TTC28, DLK2, and KTN1, were also found to harbor somatic mutations in more than one individual, possibly indicating a previously undescribed association with UM pathogenesis. De novo assembly of unmatched reads from non-coding DNA revealed peculiar copy-number variations defining specific UM subtypes, which in turn could be associated with metastatic transformation. Mutational-driven comparison with other tumor types showed that UM is very similar to pediatric tumors, characterized by very few somatic insults and, possibly, important epigenetic changes. Through the analysis of whole-genome sequencing data, our findings shed new light on the molecular genetics of uveal melanoma, delineating it as an atypical tumor of the adult for which somatic events other than mutations in exonic DNA shape its genetic landscape and define its metastatic potential.	[Royer-Bertrand, Beryl; El Zaoui, Ikram; Cisarova, Katarina; Pescini-Gobert, Rosanna; Rivolta, Carlo] Univ Lausanne, Unit Med Genet, Dept Computat Biol, CH-1011 Lausanne, Switzerland; [Royer-Bertrand, Beryl] Univ Lausanne Hosp, Ctr Mol Dis, CH-1011 Lausanne, Switzerland; [Torsello, Matteo; Riggi, Nicolo] Univ Lausanne Hosp, Inst Pathol, Expt Pathol, CH-1011 Lausanne, Switzerland; [Rimoldi, Donata; Speiser, Daniel] Univ Lausanne Hosp, Inst Pathol, Expt Pathol, CH-1011 Lausanne, Switzerland; [Raynaud, Franck; Ciriello, Giovanni] Univ Lausanne, Dept Computat Biol, Computat Syst Oncol, CH-1011 Lausanne, Switzerland; [Raynaud, Franck; Ciriello, Giovanni] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Zografos, Leonidas; Schalenbourg, Ann; Nicolas, Michael; Vallat, Laureen; Moulin, Alexandre P.] Univ Lausanne, Jules Gonin Eye Hosp, Dept Ophthalmol, Fdn Asile Aveugles, CH-1004 Lausanne, Switzerland; [Klein, Robert] Formerly Complete Genom, Mountain View, CA 94043 USA; [Leyvraz, Serge] Univ Lausanne Hosp, Dept Oncol, CH-1011 Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Rivolta, C (corresponding author), Univ Lausanne, Unit Med Genet, Dept Computat Biol, CH-1011 Lausanne, Switzerland.	carlo.rivolta@unil.ch	Speiser, Daniel E./F-2173-2013; Klein, Robert/ABI-7857-2020	Klein, Robert/0000-0003-3539-5391; Rivolta, Carlo/0000-0002-0733-9950; Cisarova, Katarina/0000-0003-2711-0480; Ciriello, Giovanni/0000-0003-2021-8683; raynaud, franck/0000-0001-6667-7370; Pescini Gobert, Rosanna/0000-0002-2434-7530	"Fond'action contre le cancer" foundation, Switzerland; Swiss National Science Foundation (Div III grant) [156260]; Swiss National Science Foundation (SNF Professorship grant) [PP00P3-157468/1]; MEDIC Foundation	"Fond'action contre le cancer" foundation, Switzerland; Swiss National Science Foundation (Div III grant); Swiss National Science Foundation (SNF Professorship grant); MEDIC Foundation	This work was supported by the "Fond'action contre le cancer" foundation, Switzerland, the Swiss National Science Foundation (Div III grant# 156260 to C.R. and SNF Professorship grant# PP00P3-157468/1 to N.R.), and the MEDIC Foundation. We wish to thank Complete Genomics (Mountain View, CA) for providing the whole-genome sequencing and Patricia Martin for her invaluable help. We thank as well the Lausanne Institutional Biobank and Danielle Minaidis for help in collecting biological material from affected individuals.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Bergman L, 2002, INVEST OPHTH VIS SCI, V43, P2579; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bi JP, 2015, INT J CLIN EXP PATHO, V8, P6070; Breyer JP, 2014, AM J HUM GENET, V94, P395, DOI 10.1016/j.ajhg.2014.01.019; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Cassoux N, 2014, BRIT J OPHTHALMOL, V98, P769, DOI 10.1136/bjophthalmol-2013-303867; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cimino PJ, 2016, EXP MOL PATHOL, V100, P476, DOI 10.1016/j.yexmp.2016.05.002; Cruz F, 2003, CANCER RES, V63, P5761; Damato B, 2010, CLIN CANCER RES, V16, P6083, DOI 10.1158/1078-0432.CCR-10-2076; Decatur CL, 2016, JAMA OPHTHALMOL, V134, P728, DOI 10.1001/jamaophthalmol.2016.0903; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Ehlers JP, 2008, CLIN CANCER RES, V14, P115, DOI 10.1158/1078-0432.CCR-07-1825; Foster WJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P1311, DOI 10.1001/archopht.121.9.1311; Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330; FUTTERER A, 1995, MOL BIOL CELL, V6, P161; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hayashi H, 2015, ONCOGENE, V34, P199, DOI 10.1038/onc.2013.547; Holly EA, 1996, EPIDEMIOLOGY, V7, P55, DOI 10.1097/00001648-199601000-00010; Hu DN, 2005, AM J OPHTHALMOL, V140, P612, DOI 10.1016/j.ajo.2005.05.034; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; Izumiyama T, 2012, GENE, V511, P202, DOI 10.1016/j.gene.2012.09.061; Johansson P, 2016, ONCOTARGET, V7, P4624, DOI 10.18632/oncotarget.6614; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Luke JJ, 2015, PIGM CELL MELANOMA R, V28, P135, DOI 10.1111/pcmr.12304; Luscan A, 2015, BRIT J OPHTHALMOL, V99, P437, DOI 10.1136/bjophthalmol-2014-305371; Ma CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/cbt.8.10.8132; Machleidt T, 1998, FEBS LETT, V436, P51, DOI 10.1016/S0014-5793(98)01095-3; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; Moore AR, 2016, NAT GENET, V48, P675, DOI 10.1038/ng.3549; Nueda ML, 2014, BBA-MOL CELL RES, V1843, P2674, DOI 10.1016/j.bbamcr.2014.07.015; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Park SJ, 2015, INVEST OPHTH VIS SCI, V56, P4719, DOI 10.1167/iovs.15-16532; Pitkanen E, 2014, ONCOTARGET, V5, P853, DOI 10.18632/oncotarget.1781; Prescher G, 1996, LANCET, V347, P1222; Rivolta C, 2016, J HUM GENET, V61, P361, DOI 10.1038/jhg.2015.152; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; Schmidt-Pokrzywniak A, 2009, OPHTHALMOLOGY, V116, P340, DOI 10.1016/j.ophtha.2008.09.040; SEDDON JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P1274, DOI 10.1001/archopht.1990.01070110090031; Shields JA, 2015, OPHTHALMOLOGY, V122, P414, DOI 10.1016/j.ophtha.2014.08.046; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Sisley K, 1997, GENE CHROMOSOME CANC, V19, P22, DOI 10.1002/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Tang MR, 2012, APOPTOSIS, V17, P927, DOI 10.1007/s10495-012-0727-0; Trolet J, 2009, INVEST OPHTH VIS SCI, V50, P2572, DOI 10.1167/iovs.08-2296; Vajdic CM, 2002, INT J CANCER, V101, P175, DOI 10.1002/ijc.10579; van Essen TH, 2014, BRIT J OPHTHALMOL, V98, P1738, DOI 10.1136/bjophthalmol-2014-305047; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Woodman SE, 2012, CANCER J, V18, P148, DOI 10.1097/PPO.0b013e31824bd256; Yavuzyigitoglu S, 2016, OPHTHALMOLOGY, V123, P1118, DOI 10.1016/j.ophtha.2016.01.023; Yin D, 2006, ONCOGENE, V25, P1852, DOI 10.1038/sj.onc.1209219	62	100	100	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 3	2016	99	5					1190	1198		10.1016/j.ajhg.2016.09.008	http://dx.doi.org/10.1016/j.ajhg.2016.09.008			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB6XT	27745836	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000387529600016
J	Pagani, L; Schiffels, S; Gurdasani, D; Danecek, P; Scally, A; Chen, Y; Xue, YL; Haber, M; Ekong, R; Oljira, T; Mekonnen, E; Luiselli, D; Bradman, N; Bekele, E; Zalloua, P; Durbin, R; Kivisild, T; Tyler-Smith, C				Pagani, Luca; Schiffels, Stephan; Gurdasani, Deepti; Danecek, Petr; Scally, Aylwyn; Chen, Yuan; Xue, Yali; Haber, Marc; Ekong, Rosemary; Oljira, Tamiru; Mekonnen, Ephrem; Luiselli, Donata; Bradman, Neil; Bekele, Endashaw; Zalloua, Pierre; Durbin, Richard; Kivisild, Toomas; Tyler-Smith, Chris			Tracing the Route of Modern Humans out of Africa by Using 225 Human Genome Sequences from Ethiopians and Egyptians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC DIVERSITY; HUMAN-POPULATIONS; EASTERN AFRICA; HOMO-SAPIENS; ANCESTRY; HISTORY; STRATIFICATION; INDIVIDUALS; ASSOCIATION; EVOLUTION	The predominantly African origin of all modern human populations is well established, but the route taken out of Africa is still unclear. Two alternative routes, via Egypt and Sinai or across the Bab el Mandeb strait into Arabia, have traditionally been proposed as feasible gateways in light of geographic, paleoclimatic, archaeological, and genetic evidence. Distinguishing among these alternatives has been difficult. We generated 225 whole-genome sequences (225 at 8x depth, of which 8 were increased to 30x; Illumina HiSeq 2000) from six modern Northeast African populations (100 Egyptians and five Ethiopian populations each represented by 25 individuals). West Eurasian components were masked out, and the remaining African haplotypes were compared with a panel of sub-Saharan African and non-African genomes. We showed that masked Northeast African haplotypes overall were more similar to non-African haplotypes and more frequently present outside Africa than were any sets of haplotypes derived from a West African population. Furthermore, the masked Egyptian haplotypes showed these properties more markedly than the masked Ethiopian haplotypes, pointing to Egypt as the more likely gateway in the exodus to the rest of the world. Using five Ethiopian and three Egyptian high-coverage masked genomes and the multiple sequentially Markovian coalescent (MSMC) approach, we estimated the genetic split times of Egyptians and Ethiopians from non-African populations at 55,000 and 65,000 years ago, respectively, whereas that of West Africans was estimated to be 75,000 years ago. Both the haplotype and MSMC analyses thus suggest a predominant northern route out of Africa via Egypt.	[Pagani, Luca; Schiffels, Stephan; Gurdasani, Deepti; Danecek, Petr; Chen, Yuan; Xue, Yali; Haber, Marc; Durbin, Richard; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Pagani, Luca; Kivisild, Toomas] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge CB2 1QH, England; [Pagani, Luca; Luiselli, Donata] Univ Bologna, Dept Biol Geol & Environm Sci, I-40126 Bologna, Italy; [Scally, Aylwyn] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Haber, Marc; Zalloua, Pierre] Lebanese Amer Univ, Beirut 11022801, Lebanon; [Ekong, Rosemary] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Oljira, Tamiru; Mekonnen, Ephrem; Bekele, Endashaw] Univ Addis Ababa, Addis Ababa, Ethiopia; [Bradman, Neil] Henry Stewart Grp, London WC1A 2HN, England; [Zalloua, Pierre] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; University of Cambridge; University of Bologna; University of Cambridge; Lebanese American University; University of London; University College London; Addis Ababa University; Harvard University; Harvard T.H. Chan School of Public Health	Pagani, L (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	lp.lucapagani@gmail.com	Durbin, Richard/AAE-7178-2019; Kivisild, Toomas/P-5889-2017; Schiffels, Stephan/D-5675-2018; Pagani, Luca/G-8511-2017; Haber, Marc/Y-5090-2019	Durbin, Richard/0000-0002-9130-1006; Kivisild, Toomas/0000-0002-6297-7808; Schiffels, Stephan/0000-0002-1017-9150; Pagani, Luca/0000-0002-6639-524X; Haber, Marc/0000-0003-1000-1448; Ekong, Rosemary/0000-0002-5984-7893; Gurdasani, Deepti/0000-0001-9996-6929; Mekonnen, Ephrem/0000-0003-0416-649X	Wellcome Trust [098051]; European Research Council (ERC) [FP7-261213]; ERC [FP7-295733]; Melford Charitable Trust; Cordell Homes	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); Melford Charitable Trust; Cordell Homes	The authors would like to acknowledge all the donors who kindly contributed samples to this study. L.P., S.S., D.G., P.D., Y.C., Y.X., M.H., R.D., and C.T.-S. were funded by Wellcome Trust grant 098051. T.K. was funded by European Research Council (ERC) Starting Grant FP7-261213, and D.L. was funded by ERC Advanced Grant FP7-295733. R.D. is a founder and non-executive director of Congenica. N.B. is the senior trustee, settlor, and principal donor of Melford Charitable Trust and the director and beneficial owner of the entire share capital of Cordell Homes, a company that provided the financial support for the collection of the Ethiopian samples analyzed in this paper.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Brisbin A, 2012, HUM BIOL, V84, P343, DOI 10.3378/027.084.0401; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Haber M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003316; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hershkovitz I, 2015, NATURE, V520, P216, DOI 10.1038/nature14134; Hodgson JA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004393; Jobling M, 2014, HUMAN EVOLUTIONARY GENETICS, SECOND EDITION, P1; Kitchen A, 2009, P ROY SOC B-BIOL SCI, V276, P2703, DOI 10.1098/rspb.2009.0408; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Petraglia MD, 2010, ANN HUM BIOL, V37, P288, DOI 10.3109/03014461003639249; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Serjeant GR, 1997, LANCET, V350, P725, DOI 10.1016/S0140-6736(97)07330-3; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Wright S, 1931, GENETICS, V16, P0097	32	100	101	0	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 4	2015	96	6					986	991		10.1016/j.ajhg.2015.04.019	http://dx.doi.org/10.1016/j.ajhg.2015.04.019			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	CK0YH	26027499	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000355931200013
J	Newman, S; Hermetz, KE; Weckselblatt, B; Rudd, MK				Newman, Scott; Hermetz, Karen E.; Weckselblatt, Brooke; Rudd, M. Katharine			Next-Generation Sequencing of Duplication CNVs Reveals that Most Are Tandem and Some Create Fusion Genes at Breakpoints	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; CONGENITAL HEART-DISEASE; HUMAN GENOME; DE-NOVO; MUTATIONAL MECHANISMS; STRUCTURAL VARIATION; DEVELOPMENTAL DELAY; DELETION SYNDROME; REARRANGEMENTS; TRIPLICATION	Interpreting the genomic and phenotypic consequences of copy-number variation (CNV) is essential to understanding the etiology of genetic disorders. Whereas deletion CNVs lead obviously to haploinsufficiency, duplications might cause disease through triplosensitivity, gene disruption, or gene fusion at breakpoints. The mutational spectrum of duplications has been studied at certain loci, and in some cases these copy-number gains are complex chromosome rearrangements involving triplications and/or inversions. However, the organization of clinically relevant duplications throughout the genome has yet to be investigated on a large scale. Here we fine-mapped 184 germline duplications (14.7 kb-25.3 Mb; median 532 kb) ascertained from individuals referred for diagnostic cytogenetics testing. We performed next-generation sequencing (NGS) and whole-genome sequencing (WGS) to sequence 130 breakpoints from 112 subjects with 119 CNVs and found that most (83%) were tandem duplications in direct orientation. The remainder were triplications embedded within duplications (8.4%), adjacent duplications (4.2%), insertional translocations (2.5%), or other complex rearrangements (1.7%). Moreover, we predicted six in-frame fusion genes at sequenced duplication breakpoints; four gene fusions were formed by tandem duplications, one by two interconnected duplications, and one by duplication inserted at another locus. These unique fusion genes could be related to clinical phenotypes and warrant further study. Although most duplications are positioned head-to-tail adjacent to the original locus, those that are inverted, triplicated, or inserted can disrupt or fuse genes in a manner that might not be predicted by conventional copy-number assays. Therefore, interpreting the genetic consequences of duplication CNVs requires breakpoint-level analysis.	[Newman, Scott; Hermetz, Karen E.; Weckselblatt, Brooke; Rudd, M. Katharine] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Rudd, MK (corresponding author), Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA.	katie.rudd@emory.edu			NIH [MH092902]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092902] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Madhuri Hegde and Arun Ankala for scientific discussions on duplication formation. Kelly Shaw, Michael Christopher, and Alev Cagla Ozdemir performed breakpoint junction experiments. We thank Cheryl Strauss for editorial assistance. This study was supported by a grant from the NIH (MH092902 to M.K.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Arndt AK, 2013, AM J HUM GENET, V93, P67, DOI 10.1016/j.ajhg.2013.05.015; Baldwin EL, 2008, GENET MED, V10, P415, DOI 10.1097/GIM.0b013e318177015c; Boone PM, 2014, AM J HUM GENET, V95, P143, DOI 10.1016/j.ajhg.2014.06.014; Bose P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101607; Brand H, 2014, AM J HUM GENET, V95, P454, DOI 10.1016/j.ajhg.2014.09.005; Carvalho CMB, 2013, NAT GENET, V45, P1319, DOI 10.1038/ng.2768; Carvalho CMB, 2011, NAT GENET, V43, P1074, DOI 10.1038/ng.944; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cottrell CE, 2011, AUTISM RES, V4, P189, DOI 10.1002/aur.184; Deak KL, 2011, CLIN LAB MED, V31, P543, DOI 10.1016/j.cll.2011.08.008; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; Fujita A, 2013, AM J MED GENET A, V161, P1904, DOI 10.1002/ajmg.a.36026; Giorda R, 2011, AM J MED GENET A, V155A, P2681, DOI 10.1002/ajmg.a.34248; Giorda R, 2009, AM J HUM GENET, V85, P394, DOI 10.1016/j.ajhg.2009.08.001; Giorgio E, 2013, HUM MUTAT, V34, P1160, DOI 10.1002/humu.22348; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hellsten U, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1461; Hermetz KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004139; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kang SHL, 2010, AM J MED GENET A, V152A, P1111, DOI 10.1002/ajmg.a.33278; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu PF, 2012, CURR OPIN GENET DEV, V22, P211, DOI 10.1016/j.gde.2012.02.012; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Luo Y, 2011, HUM MOL GENET, V20, P3769, DOI 10.1093/hmg/ddr293; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Medves S, 2012, J CELL MOL MED, V16, P237, DOI 10.1111/j.1582-4934.2011.01415.x; Michaelson JJ, 2012, NAT METHODS, V9, P819, DOI [10.1038/NMETH.2085, 10.1038/nmeth.2085]; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Neill NJ, 2011, GENOME RES, V21, P535, DOI 10.1101/gr.114579.110; Neill NJ, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-11; Ng CKY, 2012, J PATHOL, V226, P703, DOI 10.1002/path.3980; Nowakowska BA, 2012, EUR J HUM GENET, V20, P166, DOI 10.1038/ejhg.2011.157; Poultney CS, 2013, AM J HUM GENET, V93, P607, DOI 10.1016/j.ajhg.2013.09.001; Purcell S. M., 2014, CURR PROTOC HUM GENE, V81, P21, DOI [10.1002/0471142905.hg0723-81, DOI 10.1002/0471142905.HG0723-81]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Rosenfeld JA, 2013, GENET MED, V15, P478, DOI 10.1038/gim.2012.164; Rudd MK, 2009, HUM MOL GENET, V18, P2957, DOI 10.1093/hmg/ddp233; Rudd MK, 2011, GENOMIC STRUCTURAL V; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shimojima K, 2012, EUR J MED GENET, V55, P400, DOI 10.1016/j.ejmg.2012.02.013; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Soler-Alfonso C, 2014, EUR J HUM GENET, V22, P1071, DOI 10.1038/ejhg.2013.302; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Thienpont B, 2010, J MED GENET, V47, P155, DOI 10.1136/jmg.2009.070573; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Warburton D, 2014, HUM GENET, V133, P11, DOI 10.1007/s00439-013-1353-9; Watson CT, 2014, ANNU REV GENOM HUM G, V15, P215, DOI 10.1146/annurev-genom-091212-153408; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108; Zenker M, 2007, J MED GENET, V44, P651, DOI 10.1136/jmg.2007.051276	69	100	105	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 5	2015	96	2					208	220		10.1016/j.ajhg.2014.12.017	http://dx.doi.org/10.1016/j.ajhg.2014.12.017			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CA9WY	25640679	Green Published, Bronze			2022-12-18	WOS:000349276700003
J	Hjeij, R; Lindstrand, A; Francis, R; Zariwala, MA; Liu, XQ; Li, Y; Damerla, R; Dougherty, GW; Abouhamed, M; Olbrich, H; Loges, NT; Pennekamp, P; Davis, EE; Carvalho, CMB; Pehlivan, D; Werner, C; Raidt, J; Kohler, G; Haffner, K; Reyes-Mugica, M; Lupski, JR; Leigh, MW; Rosenfeld, M; Morgan, LC; Knowles, MR; Lo, CW; Katsanis, N; Omranl, H				Hjeij, Rim; Lindstrand, Anna; Francis, Richard; Zariwala, Maimoona A.; Liu, Xiaoqin; Li, You; Damerla, Rama; Dougherty, Gerard W.; Abouhamed, Marouan; Olbrich, Heike; Loges, Niki T.; Pennekamp, Petra; Davis, Erica E.; Carvalho, Claudia M. B.; Pehlivan, Davut; Werner, Claudius; Raidt, Johanna; Koehler, Gabriele; Haeffner, Karsten; Reyes-Mugica, Miguel; Lupski, James R.; Leigh, Margaret W.; Rosenfeld, Margaret; Morgan, Lucy C.; Knowles, Michael R.; Lo, Cecilia W.; Katsanis, Nicholas; Omranl, Heymut			ARMC4 Mutations Cause Primary Ciliary Dyskinesia with Randomization of Left/Right Body Asymmetry	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; OUTER DYNEIN ARM; PROTEOMIC ANALYSIS; DEFECTS; IDENTIFICATION; DYSFUNCTION; EXPRESSION; CCDC114; GENES; DNAH5	The motive forces for ciliary movement are generated by large multiprotein complexes referred to as outer dynein arms (ODAs), which are preassembled in the cytoplasm prior to transport to the ciliary axonemal compartment. In humans, defects in structural components, docking complexes, or cytoplasmic assembly factors can cause primary ciliary dyskinesia (PCD), a disorder characterized by chronic airway disease and defects in laterality. By using combined high resolution copy-number variant and mutation analysis, we identified ARMC4 mutations in twelve PCD individuals whose cells showed reduced numbers of ODAs and severely impaired ciliary beating. Transient suppression in zebrafish and analysis of an ENU mouse mutant confirmed in both model organisms that ARMC4 is critical for left-right patterning. We demonstrate that ARMC4 is an axonemal protein that is necessary for proper targeting and anchoring of ODAs.	[Hjeij, Rim; Dougherty, Gerard W.; Abouhamed, Marouan; Olbrich, Heike; Loges, Niki T.; Pennekamp, Petra; Werner, Claudius; Raidt, Johanna; Koehler, Gabriele; Omranl, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Lindstrand, Anna; Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Francis, Richard; Liu, Xiaoqin; Li, You; Damerla, Rama; Lo, Cecilia W.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15201 USA; [Zariwala, Maimoona A.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Carvalho, Claudia M. B.; Pehlivan, Davut; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Haeffner, Karsten] Univ Hosp Freiburg, D-79106 Freiburg, Germany; [Reyes-Mugica, Miguel] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15232 USA; [Leigh, Margaret W.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Rosenfeld, Margaret] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Rosenfeld, Margaret] Univ Washington, Sch Med, Seattle, WA 98105 USA; [Morgan, Lucy C.] Concord Hosp, Dept Resp Med, Concord 2139, Australia; [Knowles, Michael R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of Munster; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Baylor College of Medicine; University of Freiburg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Concord Repatriation General Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Omranl, H (corresponding author), Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany.	heymut.omran@ukmuenster.de	Pehlivan, Davut/I-3235-2019; Lindstrand, Anna M/J-3566-2012; Francis, Richard/P-2524-2015; Reyes-Mugica, Miguel/C-2483-2008; Lindstrand, Anna/AAT-9969-2021	Lindstrand, Anna M/0000-0003-0806-5602; Francis, Richard/0000-0002-4401-1946; Reyes-Mugica, Miguel/0000-0001-5698-3702; Lindstrand, Anna/0000-0003-0806-5602; Damerla, Rama Rao/0000-0001-6815-0097; Omran, Heymut/0000-0003-0282-6765; Rosenfeld, Margaret/0000-0002-8105-614X; Katsanis, Nicholas/0000-0002-2480-0171; Raidt, Johanna/0000-0002-1571-2647; Morgan, Lucy/0000-0001-6389-1953; Hjeij, Rim/0000-0003-1464-7289; Davis, Erica/0000-0002-2412-8397; Pehlivan, Davut/0000-0001-5788-0270	NRW Research School "Cell Dynamics and Disease, CEDAD"; "Deutsche Forschungsgemeinschaft" [DFG OM 6/4, OM 6/5]; IZKF Muenster [Om2/009/12]; EU [241955, 305404]; US National Institute of Health (NIH) [U01-HL098180, 5U54HG006542, 5R0/NS058529, DK072301]; NIH/ORDR [U54 HL096458-10, RO1 HL071798]; PCD Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019480] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL096458, R01HL071798, U01HL098180] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	NRW Research School "Cell Dynamics and Disease, CEDAD"; "Deutsche Forschungsgemeinschaft"(German Research Foundation (DFG)); IZKF Muenster; EU(European Commission); US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/ORDR; PCD Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the PCD-affected individuals and their families for their participation and acknowledge the German patient support group "Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V." We are grateful to investigators and the coordinators of the "Genetic Disorders of Mucociliary Clearance Consortium" that is part of the Rare Disease Clinical Research Network; its members are listed in the Supplemental Data file. We thank D. Nergenau, M. Herting, S. Weiser, F.J. Seesing, P. Fischer, W. Wolf, K. Burns, and R. Pace for excellent technical work and E. Godwin for administrative support. We would like to acknowledge Robbert de Iongh from University of Melbourne, Australia for providing DNA from PCD families, K. Landwehr from Evangelical Hospital Bielefeld, L. Greiner from Helius Klinikum Wuppertal, and H. Mitchison and A. Shoemark for providing samples of individuals with CCDC114 mutations. This work was supported by a fellowship of the NRW Research School "Cell Dynamics and Disease, CEDAD" to R.H., by the "Deutsche Forschungsgemeinschaft" (DFG OM 6/4, OM 6/5) and the IZKF (Om2/009/12) Muenster to H.O., as well as funding from EU 7th under GA nr. 241955, project SYSCILIA to H.O. and N.K., and under GA nr. 305404, project BESTCILIA to H.O.; the US National Institute of Health (NIH) grants U01-HL098180 (Bench to Bassinet Program) to C.W.L., 5U54HG006542 and 5R0/NS058529 to J.R.L., and DK072301 to N.K. M.R.K., M.W.L., M.R., and M.A.Z. are supported by NIH/ORDR U54 HL096458-10 and RO1 HL071798 research grants and PCD Foundation.	Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Lonergan KM, 2006, AM J RESP CELL MOL, V35, P651, DOI 10.1165/rcmb.2006-0056OC; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Tan SY, 2007, J CLIN INVEST, V117, P3742, DOI 10.1172/JCI33284; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Yu Q, 2008, ULTRASOUND MED BIOL, V34, P741, DOI 10.1016/j.ultrasmedbio.2007.11.001	28	100	104	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					357	367		10.1016/j.ajhg.2013.06.009	http://dx.doi.org/10.1016/j.ajhg.2013.06.009			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23849778	Green Published, Bronze			2022-12-18	WOS:000323186200016
J	Kosova, G; Scott, NM; Niederberger, C; Prins, GS; Ober, C				Kosova, Gueluem; Scott, Nicole M.; Niederberger, Craig; Prins, Gail S.; Ober, Carole			Genome-wide Association Study Identifies Candidate Genes for Male Fertility Traits in Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LATENT TGF-BETA; LITTER SIZE; OVULATION RATE; SPERM QUALITY; EXPRESSION; CELLS; HERITABILITY; COMPLEX; LOCI; MICE	Despite the fact that hundreds of genes are known to affect fertility in animal models, relatively little is known about genes that influence natural fertility in humans. To broadly survey genes contributing to variation in male fertility, we conducted a genome-wide association study (GWAS) of two fertility traits (family size and birth rate) in 269 married men who are members of a founder population of European descent that proscribes contraception and has large family sizes. Associations between similar to 250,000 autosomal SNPs and the fertility traits were examined. A total of 41 SNPs with p <= 1 x 10(-4) for either trait were taken forward to a validation study of 123 ethnically diverse men from Chicago who had previously undergone semen analyses. Nine (22%) of the SNPs associated with reduced fertility in the GWAS were also associated with one or more of the ten measures of reduced sperm quantity and/or function, yielding 27 associations with p values < 0.05 and seven with p values < 0.01 in the validation study. On the basis of 5,000 permutations of our data, the probabilities of observing this many or more small p values were 0.0014 and 5.6 x 10(-4), respectively. Among the nine associated loci, outstanding candidates for male fertility genes include USP8, an essential deubiquitinating enzyme that has a role in acrosome assembly; UBD and EPSTI1, which have potential roles in innate immunity; and LRRC32, which encodes a latent transforming growth factor beta (TGF-beta) receptor on regulatory T cells. We suggest that mutations in these genes that are more severe may account for some of the unexplained infertility (or subfertility) in the general population.	[Kosova, Gueluem; Scott, Nicole M.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Niederberger, Craig; Prins, Gail S.] Univ Illinois, Dept Urol, Chicago, IL 60612 USA; [Ober, Carole] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu	Badita, Liliana-Laura L/E-8791-2017	Badita, Liliana-Laura L/0000-0001-9528-5149; Ober, Carole/0000-0003-4626-9809	National Institutes of Health (NIH) [HD21244, HL085197]; National Heart, Lung, and Blood Institute (NHLBI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank Mark Abney, Donald F. Conrad, Dan Nicolae, and Molly Przeworski for statistical consultation and helpful comments on this manuscript; Lawrence Urricchio, Gaixin Du, and Ying Sun for computational assistance; Raul Torres and Kevin Ross for genotyping the Chicago cohort; Mathis Morrison and William Birch for technical assistance with semen analysis; Mary Coppolillo for subject coordination at the UIC andrology clinic; and the Hutterites and subjects in Chicago for their participation in our studies. This work is supported by National Institutes of Health (NIH) grants HD21244 and HL085197; exome-sequencing studies were performed by the National Heart, Lung, and Blood Institute (NHLBI)-funded Exome Sequencing Service at the Broad Institute.	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Aitken RJ, 2006, INT J ANDROL, V29, P69, DOI 10.1111/j.1365-2605.2005.00630.x; Allan MF, 2009, J ANIM SCI, V87, P46, DOI 10.2527/jas.2008-0959; Austerlitz F, 1998, P NATL ACAD SCI USA, V95, P15140, DOI 10.1073/pnas.95.25.15140; Berruti G, 2010, BIOL REPROD, V82, P930, DOI 10.1095/biolreprod.109.081679; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Bourgain C, 2004, GENETICS, V168, P2349, DOI 10.1534/genetics.104.031617; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Castellanos-Rubio A, 2010, HUM IMMUNOL, V71, P96, DOI 10.1016/j.humimm.2009.09.359; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; De Bellabarba GA, 2000, ARCH ANDROLOGY, V45, P131; Dejucq N, 1998, J REPROD IMMUNOL, V41, P291, DOI 10.1016/S0165-0378(98)00065-5; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Diemer T, 2003, ANDROLOGIA, V35, P283, DOI 10.1046/j.1439-0272.2003.00556.x; Diemer T, 2003, ANDROLOGIA, V35, P55, DOI 10.1046/j.1439-0272.2003.00537.x; Distl O, 2007, REPROD DOMEST ANIM, V42, P10, DOI 10.1111/j.1439-0531.2007.00887.x; Ferlin A, 2004, FERTIL STERIL, V81, P1013, DOI 10.1016/j.fertnstert.2003.08.053; Golas A, 2008, INT J DEV BIOL, V52, P287, DOI 10.1387/ijdb.072333ag; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; Hackstein JHP, 2000, TRENDS GENET, V16, P565, DOI 10.1016/S0168-9525(00)02140-5; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P364, DOI 10.1002/jemt.20785; HILL JA, 1987, FERTIL STERIL, V47, P460; Hostetler J, 1974, HUTTERITE SOC; Hughes KA, 2006, EVOLUTION, V60, P1427, DOI 10.1111/j.0014-3820.2006.tb01221.x; Hwang Kathleen, 2010, Ann N Y Acad Sci, V1214, pE1, DOI 10.1111/j.1749-6632.2010.05917.x; IMAIZUMI Y, 1970, ANN HUM GENET, V33, P251, DOI 10.1111/j.1469-1809.1970.tb01650.x; Ishii T, 2005, DNA RES, V12, P429, DOI 10.1093/dnares/dsi020; Keel B.A., 1990, HDB LAB DIAGNOSIS TR, P27; Kim HH, 2010, PRINCIPLES OF GENDER-SPECIFIC MEDICINE, 2ND EDITION, P366, DOI 10.1016/B978-0-12-374271-1.00034-4; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Kosova G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000974; Kosova G, 2010, P NATL ACAD SCI USA, V107, P1772, DOI 10.1073/pnas.0906196106; Laissue P, 2009, INT J DEV BIOL, V53, P623, DOI 10.1387/ijdb.082613pl; Layman LC, 2002, J MED GENET, V39, P153, DOI 10.1136/jmg.39.3.153; Liljander M, 2009, GENET RES, V91, P259, DOI 10.1017/S0016672309000214; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Madrigal L, 2003, AM J HUM BIOL, V15, P16, DOI 10.1002/ajhb.10109; MANGE AP, 1964, HUM BIOL, V36, P104; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Mortimer D., 1990, HDB LAB DIAGNOSIS TR, P97; Mullenbach E, 2006, GENE, V372, P53, DOI 10.1016/j.gene.2005.12.004; NEEL JV, 1970, SCIENCE, V170, P815, DOI 10.1126/science.170.3960.815; Nielsen HL, 2002, GENOMICS, V79, P703, DOI 10.1006/geno.2002.6755; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ober C, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.1.33; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; OBER C, 1992, AM J HUM GENET, V50, P6; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Ober C, 2009, J LIPID RES, V50, P798, DOI 10.1194/jlr.M800515-JLR200; ORAVA M, 1985, BIOCHEM BIOPH RES CO, V127, P809, DOI 10.1016/S0006-291X(85)80015-2; PEARSON K, 1899, PHILOS T R SOC A, V192, P282; Pentikainen V, 2001, J CLIN ENDOCR METAB, V86, P4480, DOI 10.1210/jc.86.9.4480; Peripato AC, 2004, J EVOLUTION BIOL, V17, P593, DOI 10.1111/j.1420-9101.2004.00702.x; Peterlin B, 2006, MOL HUM REPROD, V12, P777, DOI 10.1093/molehr/gal088; R Development Core Team, 2011, R LANG ENV STAT COMP; Rocha JL, 2004, MAMM GENOME, V15, P878, DOI 10.1007/s00335-004-2364-6; Schuppe HC, 2005, CHEM IMMUNOL ALLERGY, V88, P1, DOI 10.1159/000087816; Seshadri S, 2009, AM J REPROD IMMUNOL, V62, P275, DOI 10.1111/j.1600-0897.2009.00736.x; SHEPS MC, 1965, POP STUD-J DEMOG, V19, P65, DOI 10.2307/2173165; Simpson JL, 2002, BEST PRACT RES CL OB, V16, P685, DOI 10.1053/beog.2002.0317; STEINBERG ARTHUR G., 1967, P267; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Truong BN, 2003, ASIAN J ANDROL, V5, P137; Urbanek M, 1999, P NATL ACAD SCI USA, V96, P8573, DOI 10.1073/pnas.96.15.8573; Uricchio LH, 2012, GENET EPIDEMIOL, V36, P312, DOI 10.1002/gepi.21623; World Health Organization, 1987, INT J ANDROL, V7, P1; Xing YY, 2009, ANIM REPROD SCI, V114, P210, DOI 10.1016/j.anireprosci.2008.08.008	75	100	106	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					950	961		10.1016/j.ajhg.2012.04.016	http://dx.doi.org/10.1016/j.ajhg.2012.04.016			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22633400	Bronze, Green Published			2022-12-18	WOS:000305262600002
J	Tetreault, M; Choquet, K; Orcesi, S; Tonduti, D; Balottin, U; Teichmann, M; Fribourg, S; Schiffmann, R; Brais, B; Vanderver, A; Bernard, G				Tetreault, Martine; Choquet, Karine; Orcesi, Simona; Tonduti, Davide; Balottin, Umberto; Teichmann, Martin; Fribourg, Sebastien; Schiffmann, Raphael; Brais, Bernard; Vanderver, Adeline; Bernard, Genevieve			Recessive Mutations in POLR3B, Encoding the Second Largest Subunit of Pol III, Cause a Rare Hypomyelinating Leukodystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA-POLYMERASE-III; HYPOGONADOTROPIC HYPOGONADISM; LEUKOENCEPHALOPATHY; HYPODONTIA; SUBCOMPLEX; ATAXIA	Mutations in POLR3A encoding the largest subunit of RNA polymerase Ill (Pol III) were found to be responsible for the majority of cases presenting with three clinically overlapping hypomyelinating leukodystrophy phenotypes. We uncovered in three cases without POLR3A mutation recessive mutations in POLR3B, which codes for the second largest subunit of Pol III. Mutations in genes coding for Pol III subunits are a major cause of childhood-onset hypomyelinating leukodystrophies with prominent cerebellar dysfunction, oligodontia, and hypogonadotropic hypogonadism.	[Bernard, Genevieve] McGill Univ Heath Ctr, Div Pediat Neurol, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada; [Bernard, Genevieve] McGill Univ Heath Ctr, Div Pediat Neurol, Montreal Childrens Hosp, Dept Neurol, Montreal, PQ H3H 1P3, Canada; [Bernard, Genevieve] McGill Univ Heath Ctr, Div Pediat Neurol, Montreal Childrens Hosp, Dept Neurosurg, Montreal, PQ H3H 1P3, Canada; [Tetreault, Martine; Choquet, Karine; Brais, Bernard] McGill Univ, Montreal Neurol Inst, Neurogenet Mot Lab, Montreal, PQ H3A 2B4, Canada; [Tetreault, Martine] Univ Montreal, Fac Med, Dept Mol Biol, Montreal, PQ H3T 1J4, Canada; [Choquet, Karine] Univ Montreal, Arts & Sci Fac, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Orcesi, Simona; Tonduti, Davide; Balottin, Umberto] Univ Pavia, IRCCS C Mondino Natl Inst Neurol Fdn, Child Neurol & Psychiat Unit, I-27100 Pavia, Italy; [Teichmann, Martin; Fribourg, Sebastien] Univ Bordeaux, INSERM, Inst Europeen Chim & Biol, F-33607 Pessac, France; [Schiffmann, Raphael] Baylor Res Inst, Inst Metab Dis, Dallas, TX 75226 USA; [Vanderver, Adeline] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA	McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal; IRCCS Fondazione Casimiro Mondino; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Baylor Scott & White Health; Baylor University Medical Center; Children's National Health System	Bernard, G (corresponding author), McGill Univ Heath Ctr, Div Pediat Neurol, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada.	genevieve.bernard@muhc.mcgill.ca	tonduti, davide/K-1673-2016; Fribourg, Sebastien/M-7418-2014; Brais, Bernard/Y-3910-2019; Bernard, Geneviève/AAU-7569-2020; orcesi, simona/J-6030-2016; Vanderver, Adeline/CAG-5072-2022; Teichmann, Martin/M-7407-2014	tonduti, davide/0000-0001-9371-7454; Fribourg, Sebastien/0000-0003-4112-7510; Bernard, Geneviève/0000-0002-9634-2966; orcesi, simona/0000-0001-8947-9342; Teichmann, Martin/0000-0002-5257-0510; Balottin, Umberto/0000-0001-6317-7784; Vanderver, Adeline/0000-0002-6290-6751	Fondation sur les Leucodystrophies; European Leukodystrophy Association; Reseau de Medecine Genetique Appliquee; Fonds de Recherche en Sante du Quebec; Canadian Institute of Health Research; National Human Genome Research Institute; Myelin Disorders Bioregistry Project; Agence Nationale de Recherche; National Cancer Institute; regional government of Aquitaine; Ligue Contre le Cancer (equipe labellisee); La Ligue Contre le Cancer (Comite Dordogne); Inserm; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060695] Funding Source: NIH RePORTER	Fondation sur les Leucodystrophies; European Leukodystrophy Association; Reseau de Medecine Genetique Appliquee; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Myelin Disorders Bioregistry Project; Agence Nationale de Recherche(French National Research Agency (ANR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); regional government of Aquitaine; Ligue Contre le Cancer (equipe labellisee); La Ligue Contre le Cancer (Comite Dordogne); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank all participants and the clinicians who referred patients to us. We would like to thank the "Fondation sur les Leucodystrophies" and the European Leukodystrophy Association for financing this research project. G.B. received fellowship scholarships from the Reseau de Medecine Genetique Appliquee and Fonds de Recherche en Sante du Quebec. M. Tetreault received the Frederick Banting and Charles Best Doctoral scholarship from the Canadian Institute of Health Research. A.V.'s contribution is supported in part by the Intramural Research Program of the National Human Genome Research Institute and by the Myelin Disorders Bioregistry Project. M. Teichmann has received grants from the Agence Nationale de Recherche, the National Cancer Institute, the regional government of Aquitaine, and the Ligue Contre le Cancer (equipe labellisee). S.F. has received grants from La Ligue Contre le Cancer (Comite Dordogne), the regional government of Aquitaine, and the Inserm. The authors wish to thank all collaborators (including William McClintock) and patients participating in the Myelin Bioregistry Project.	[Anonymous], PHD SNP; [Anonymous], SIFT; [Anonymous], ALIGNGVGD; [Anonymous], POLYPHEN; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Atrouni S, 2003, AM J MED GENET A, V118A, P76, DOI 10.1002/ajmg.a.10019; Bekiesinska-Figatowska M, 2010, BRAIN DEV-JPN, V32, P574, DOI 10.1016/j.braindev.2009.07.008; Bernard G, 2011, AM J HUM GENET, V89, P415, DOI 10.1016/j.ajhg.2011.07.014; Bernard G, 2010, NEUROGENETICS, V11, P457, DOI 10.1007/s10048-010-0251-8; Boespflug-Tanguy O, 2011, AM J HUM GENET, V88, P392, DOI 10.1016/j.ajhg.2010.12.015; Chouery E, 2011, NEUROGENETICS, V12, P73, DOI 10.1007/s10048-010-0256-3; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dumay-Odelot H, 2010, CELL CYCLE, V9, P3687, DOI 10.4161/cc.9.18.13203; Feinstein M, 2010, AM J HUM GENET, V87, P820, DOI 10.1016/j.ajhg.2010.10.016; Fernandez-Tornero C, 2010, EMBO J, V29, P3762, DOI 10.1038/emboj.2010.266; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Orcesi S, 2010, PEDIATR NEUROL, V42, P359, DOI 10.1016/j.pediatrneurol.2010.01.015; Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schiffmann R, 2009, NEUROLOGY, V72, P750, DOI 10.1212/01.wnl.0000343049.00540.c8; Steenweg ME, 2010, BRAIN, V133, P2971, DOI 10.1093/brain/awq257; Tetreault M., CAN J NEURO IN PRESS; Timmons M, 2006, NEUROLOGY, V67, P2066, DOI 10.1212/01.wnl.0000247666.28904.35; Vazquez-Lopez M, 2008, REV NEUROLOGIA, V47, P204, DOI 10.33588/rn.4704.2008163; Wolf NI, 2007, NEUROPEDIATRICS, V38, P64, DOI 10.1055/s-2007-985137; Wolf NI, 2005, NEUROLOGY, V64, P1461, DOI 10.1212/01.WNL.0000158615.56071.E3; Wolff A, 2010, PEDIATR DENT, V32, P386; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11	28	100	102	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 11	2011	89	5					652	655		10.1016/j.ajhg.2011.10.006	http://dx.doi.org/10.1016/j.ajhg.2011.10.006			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	848YD	22036172	Green Published, Bronze			2022-12-18	WOS:000297090100007
J	Agamy, O; Ben Zeev, B; Lev, D; Marcus, B; Fine, D; Su, D; Narkis, G; Ofir, R; Hoffmann, C; Leshinsky-Silver, E; Flusser, H; Sivan, S; Soll, D; Lerman-Sagie, T; Birk, OS				Agamy, Orly; Ben Zeev, Bruria; Lev, Dorit; Marcus, Barak; Fine, Dina; Su, Dan; Narkis, Ginat; Ofir, Rivka; Hoffmann, Chen; Leshinsky-Silver, Esther; Flusser, Hagit; Sivan, Sara; Soll, Dieter; Lerman-Sagie, Tally; Birk, Ohad S.			Mutations Disrupting Selenocysteine Formation Cause Progressive Cerebello-Cerebral Atrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							APOLIPOPROTEIN-E RECEPTOR-2; SELENOPROTEIN-P; NEUROLOGICAL DYSFUNCTION; MOUSE-BRAIN; SELENIUM; DELETION; GENE; MICE; NEURODEGENERATION; EXPRESSION	The essential micronutrient selenium is found in proteins as selenocysteine (Sec), the only genetically encoded amino acid whose biosynthesis occurs on its cognate tRNA in humans. In the final step of selenocysteine formation, the essential enzyme SepSecS catalyzes the conversion of Sep-tRNA to Sec-tRNA We demonstrate that SepSecS mutations cause autosomal-recessive progressive cerebellocerebral atrophy (PCCA) in Jews of Iraqi and Moroccan ancestry Both founder mutations, common in these two populations, disrupt the sole route to the biosynthesis of the 21st amino acid, Sec, and thus to the generation of selenoproteins in humans	[Agamy, Orly; Marcus, Barak; Fine, Dina; Narkis, Ginat; Ofir, Rivka; Flusser, Hagit; Sivan, Sara; Birk, Ohad S.] Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Ben Zeev, Bruria; Hoffmann, Chen] Chaim Sheba Med Ctr, Pediat Neurol Unit, Ramat Gan, Israel; [Ben Zeev, Bruria; Hoffmann, Chen] Chaim Sheba Med Ctr, Dept Diagnost Imaging, Ramat Gan, Israel; [Lev, Dorit; Leshinsky-Silver, Esther; Lerman-Sagie, Tally] Wolfson Med Ctr, Inst Med Genet, Holon, Israel; [Lev, Dorit; Leshinsky-Silver, Esther; Lerman-Sagie, Tally] Wolfson Med Ctr, Pediat Neurol Unit, Holon, Israel; [Su, Dan; Soll, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Su, Dan; Soll, Dieter] Yale Univ, Dept Chem, New Haven, CT USA; [Narkis, Ginat; Birk, Ohad S.] Soroka Univ, Med Ctr, Genet Inst, Beer Sheva, Israel	Ben Gurion University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Yale University; Yale University; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Ben Gurion Univ Negev, Morris Kahn Lab Human Genet, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.		Su, Dan/B-1972-2010; Lerman-Sagie, Tally/AAY-7598-2021	Lerman-Sagie, Tally/0000-0001-6641-6875; Birk, Ohad/0000-0003-1430-1296	Morris Kahn Foundation; ISF-Morasha Legacy Heritage Fund; National Institute of General Medical Sciences; Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022854] Funding Source: NIH RePORTER	Morris Kahn Foundation; ISF-Morasha Legacy Heritage Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We deeply thank the Morris Kahn Foundation and the ISF-Morasha Legacy Heritage Fund for making these studies possible. We thank Sotiria Palioura and Miljan Simonovic for inspired discussions This work was supported in part by grants from the National Institute of General Medical Sciences (D S) and the Department of Energy (D S.).	Aeby E, 2009, P NATL ACAD SCI USA, V106, P5088, DOI 10.1073/pnas.0901575106; Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Ben-Zeev B, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e96; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Ganichkin OM, 2008, J BIOL CHEM, V283, P5849, DOI 10.1074/jbc.M709342200; Gefen A, 2010, HUM MUTAT, V31, P229, DOI 10.1002/humu.21171; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Kuiper GGJM, 2003, ENDOCRINOLOGY, V144, P2505, DOI 10.1210/en.2003-0084; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Nakayama A, 2007, J NUTR, V137, P690, DOI 10.1093/jn/137.3.690; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Valentine WM, 2008, J NEUROPATH EXP NEUR, V67, P68, DOI 10.1097/NEN.0b013e318160f347; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Zachara BA, 2001, ARCH ENVIRON HEALTH, V56, P461, DOI 10.1080/00039890109604483; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200	23	100	102	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 8	2010	87	4					538	544		10.1016/j.ajhg.2010.09.007	http://dx.doi.org/10.1016/j.ajhg.2010.09.007			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	665LU	20920667	Green Published, Bronze			2022-12-18	WOS:000283037600010
J	Volpi, L; Roversi, G; Colombo, EA; Leijsten, N; Concolino, D; Calabria, A; Mencarelli, MA; Fimiani, M; Macciardi, F; Pfundt, R; Schoenmakers, EFPM; Larizza, L				Volpi, Ludovica; Roversi, Gaia; Colombo, Elisa Adele; Leijsten, Nico; Concolino, Daniela; Calabria, Andrea; Mencarelli, Maria Antonietta; Fimiani, Michele; Macciardi, Fabio; Pfundt, Rolph; Schoenmakers, Eric F. P. M.; Larizza, Lidia			Targeted Next-Generation Sequencing Appoints C16orf57 as Clericuzio-Type Poikiloderma with Neutropenia Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ROTHMUND-THOMSON-SYNDROME		[Roversi, Gaia; Colombo, Elisa Adele; Larizza, Lidia] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20142 Milan, Italy; [Volpi, Ludovica] Univ Milan, Dipartimento Biol & Genet Sci Med, I-20133 Milan, Italy; [Roversi, Gaia] Ist Nazl Tumori, Fdn IRCCS, Unit Med Genet, I-20133 Milan, Italy; [Leijsten, Nico; Pfundt, Rolph; Schoenmakers, Eric F. P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Leijsten, Nico; Pfundt, Rolph; Schoenmakers, Eric F. P. M.] Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Concolino, Daniela] Univ Catanzaro, Dipartimento Pediat, I-88100 Catanzaro, Italy; [Calabria, Andrea] CNR, Inst Biomed Technol, I-20138 Milan, Italy; [Mencarelli, Maria Antonietta] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Fimiani, Michele] Univ Siena, Dermatol Clin, I-53100 Siena, Italy; [Macciardi, Fabio] Univ Milan, Dipartimento Sci & Tecnol Biomed, I-20138 Milan, Italy	University of Milan; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Radboud University Nijmegen; Radboud University Nijmegen; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Siena; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan	Larizza, L (corresponding author), Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20142 Milan, Italy.	lidia.larizza@unimi.it	Mencarelli, Maria Antonietta/AAC-5615-2022; Calabria, Andrea/AAA-3349-2019; Macciardi, Fabio/N-3768-2014; Pfundt, Rolph/L-4576-2015; Colombo, Elisa/H-7091-2015	Mencarelli, Maria Antonietta/0000-0001-5131-3718; Calabria, Andrea/0000-0003-3515-3384; Macciardi, Fabio/0000-0003-0537-4266; Colombo, Elisa/0000-0001-9062-3188	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Brkanac Z, 2009, AM J HUM GENET, V84, P692, DOI 10.1016/j.ajhg.2009.04.008; Clericuzio C., 1991, AM J HUM GENET, V49, pA661; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Genin E, 1998, ANN HUM GENET, V62, P419, DOI 10.1046/j.1469-1809.1998.6250419.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mostefai R, 2008, AM J MED GENET A, V146A, P2762, DOI 10.1002/ajmg.a.32524; Pianigiani E, 2001, PEDIATR DERMATOL, V18, P422, DOI 10.1046/j.1525-1470.2001.01971.x; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Van Hove JLK, 2005, AM J MED GENET A, V132A, P152, DOI 10.1002/ajmg.a.30430; Wang LL, 2003, AM J MED GENET A, V118A, P299, DOI 10.1002/ajmg.a.10057	12	100	104	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2010	86	1					72	76		10.1016/j.ajhg.2009.11.014	http://dx.doi.org/10.1016/j.ajhg.2009.11.014			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	554XZ	20004881	Green Published, Bronze			2022-12-18	WOS:000274471200007
J	Young, JM; Endicott, RM; Parghi, SS; Walker, M; Kidd, JM; Trask, BJ				Young, Janet M.; Endicott, RaeLynn M.; Parghi, Sean S.; Walker, Megan; Kidd, Jeffrey M.; Trask, Barbara J.			Extensive copy-number variation of the human olfactory receptor gene family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN-GENOME; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; FINE-SCALE; EVOLUTION; SEQUENCE; INSIGHTS; MOUSE; POLYMORPHISM; REPERTOIRES	As much as a quarter of the human genome has been reported to vary in copy number between individuals, including regions containing about half of the members of the olfactory receptor (OR) gene family. We have undertaken a detailed study of copy-number variation of ORs to elucidate the selective and mechanistic forces acting on this gene family and the true impact of copy-number variation on human OR repertoires. We argue that the properties of copy-number variants (CNVs) and other sets of large genomic regions violate the assumptions of statistical methods that are commonly used in the assessment of gene enrichment. Using more appropriate methods, we provide evidence that OR enrichment in CNVs is not due to positive selection but is because of OR preponderance in segmentally duplicated regions, which are known to be frequently copy-number variable, and because purifying selection against CNVs is lower in OR-containing regions than in regions containing essential genes. We also combine multiplex ligation-dependent probe amplification (MLPA) and PCR to assay the copy numbers of 37 candidate CNV ORs in a panel of similar to 50 human individuals. We confirm copy-number variation of 18 ORs but find no variation in this human-diversity panel for 16 other ORs, highlighting the caveat that reported intervals often overrepresent true CNVs. The copy-number variation we describe is likely to underpin significant variation in olfactory abilities among human individuals. Finally, we show that both homology-based and homology-independent processes have played a recent role in remodeling the OR family.	[Young, Janet M.; Endicott, RaeLynn M.; Parghi, Sean S.; Walker, Megan; Kidd, Jeffrey M.; Trask, Barbara J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Trask, BJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	btrask@fhcrc.org		Kidd, Jeffrey/0000-0002-9631-1465	NIDCD NIH HHS [R01 DC004209, R01 DC004209-10, DC0042090] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; GRIFF IC, 1995, CELL, V83, P407, DOI 10.1016/0092-8674(95)90118-3; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Holcomb IN, 2008, CANCER RES, V68, P5599, DOI 10.1158/0008-5472.CAN-08-0812; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li W.H., 1997, MOL EVOLUTION; Liman ER, 2006, PFLUG ARCH EUR J PHY, V453, P125, DOI 10.1007/s00424-006-0120-3; Linardopoulou E, 2001, HUM MOL GENET, V10, P2373, DOI 10.1093/hmg/10.21.2373; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; LISON M, 1980, BRIT MED J, V281, P1676, DOI 10.1136/bmj.281.6256.1676; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Neuhaus EM, 2006, CHEM SENSES, V31, P445, DOI 10.1093/chemse/bjj049; Newman T, 2003, GENOME RES, V13, P781, DOI 10.1101/gr.769003; NGAI J, 1993, CELL, V72, P667, DOI 10.1016/0092-8674(93)90396-8; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Quignon P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r83; Quignon P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r80; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Tsai PS, 2006, NAT CLIN PRACT ENDOC, V2, P160, DOI 10.1038/ncpendmet0119; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Walsh S, 1998, METHOD BIOCHEM ANAL, V39, P299; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; WHISSELLBUECHY D, 1973, NATURE, V242, P271, DOI 10.1038/242271a0; Young JM, 2005, GENOME RES, V15, P231, DOI 10.1101/gr.3339905; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang J, 2007, P NATL ACAD SCI USA, V104, P20147, DOI 10.1073/pnas.0710524104; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	73	100	105	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					228	242		10.1016/j.ajhg.2008.07.005	http://dx.doi.org/10.1016/j.ajhg.2008.07.005			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18674749	Bronze, Green Published, Green Accepted			2022-12-18	WOS:000258418200008
J	Gayden, T; Cadenas, AM; Regueiro, M; Singh, NB; Zhivotovsky, LA; Underhill, PA; Cavalli-Sforza, LL; Herrera, RJ				Gayden, Tenzin; Cadenas, Alicia M.; Regueiro, Maria; Singh, Nanda B.; Zhivotovsky, Lev A.; Underhill, Peter A.; Cavalli-Sforza, Luigi L.; Herrera, Rene J.			The Himalayas as a directional barrier to gene flow	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME EVIDENCE; HIGH-RESOLUTION ANALYSIS; HUMAN-POPULATIONS; MICROSATELLITE HAPLOTYPES; HUMAN MIGRATIONS; ANDAMAN ISLANDERS; PATERNAL LINEAGES; DIVERGENCE TIME; SOUTHEAST-ASIA; MODERN HUMANS	High-resolution Y-chromosome haplogroup analyses coupled with Y - short tandem repeat (STR) haplotypes were used to ( 1) investigate the genetic affinities of three populations from Nepal - including Newar, Tamang, and people from cosmopolitan Kathmandu ( referred to as "Kathmandu" subsequently) - as well as a collection from Tibet and ( 2) evaluate whether the Himalayan mountain range represents a geographic barrier for gene flow between the Tibetan plateau and the South Asian subcontinent. The results suggest that the Tibetans and Nepalese are in part descendants of Tibeto-Burman - speaking groups originating from Northeast Asia. All four populations are represented predominantly by haplogroup O3a5-M134-derived chromosomes, whose Y-STR-based age ( +/- SE) was estimated at thousand years ago 8.1 +/- 2.9 (KYA), more recent than its Southeast Asian counterpart. The most pronounced difference between the two regions is reflected in the opposing high-frequency distributions of haplogroups D in Tibet and R in Nepal. With the exception of Tamang, both Newar and Kathmandu exhibit considerable similarities to the Indian Y-haplogroup distribution, particularly in their haplogroup R and H composition. These results indicate gene flow from the Indian subcontinent and, in the case of haplogroup R, from Eurasia as well, a conclusion that is also supported by the admixture analysis. In contrast, whereas haplogroup D is completely absent in Nepal, it accounts for 50.6% of the Tibetan Y- chromosome gene pool. Coalescent analyses suggest that the expansion of haplogroup D derivatives - namely, D1-M15 and D3-P47 in Tibet involved two different demographic events ( and KYA, respectively) that are more recent than those 5.1 +/- 1.8 11.3 +/- 3.7 of D2-M55 representatives common in Japan. Low frequencies, relative to Nepal, of haplogroup J and R lineages in Tibet are also consistent with restricted gene flow from the subcontinent. Yet the presence of haplogroup O3a5-M134 representatives in Nepal indicates that the Himalayas have been permeable to dispersals from the east. These genetic patterns suggest that this cordillera has been a biased bidirectional barrier.	Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; Tribhuvan Univ, Cent Dept Zool, Kathmandu, Nepal; Henan Univ, Coll Med, Kiafeng, Peoples R China; Russian Acad Sci, NI Vavilov Gen Genet Res Inst, Moscow 117901, Russia; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	State University System of Florida; Florida International University; Tribhuvan University; Henan University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Stanford University	Herrera, RJ (corresponding author), Florida Int Univ, Dept Biol Sci, Univ Pk,OE 304, Miami, FL 33199 USA.	herrerar@fiu.edu	Zhivotovsky, Lev A/A-1351-2012					Al-Zahery N, 2003, MOL PHYLOGENET EVOL, V28, P458, DOI 10.1016/S1055-7903(03)00039-3; Aldenderfer M, 2004, J WORLD PREHIST, V18, P1, DOI 10.1023/B:JOWO.0000038657.79035.9e; Antunez de Mayolo G, 2002, ELECTROPHORESIS, V23, P3346, DOI 10.1002/1522-2683(200210)23:19<3346::AID-ELPS3346>3.0.CO;2-J; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Cadenas AM, 2007, FORENSIC SCI INT, V166, P155, DOI 10.1016/j.forsciint.2006.05.002; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HIST; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; Cordaux R, 2004, MOL BIOL EVOL, V21, P1525, DOI 10.1093/molbev/msh151; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Ellis N, 2002, GENOME RES, V12, P339; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1997, GENETICS, V145, P787; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafev TM, 2005, HUM BIOL, V77, P93, DOI 10.1353/hub.2005.0030; Katoh T, 2005, GENE, V346, P63, DOI 10.1016/j.gene.2004.10.023; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; KRAAIJENBRINK T, 2006, FORENSIC SCI INT; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; LONG JC, 1991, AM J PHYS ANTHROPOL, V84, P141, DOI 10.1002/ajpa.1330840204; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Martinez L, 2005, HUM HERED, V59, P109, DOI 10.1159/000085225; MATISOFF JA, 1991, ANNU REV ANTHROPOL, V20, P469, DOI 10.1146/annurev.an.20.100191.002345; Mukherjee N, 2001, J GENET, V80, P125, DOI 10.1007/BF02717908; NIE M, 1993, MOL BIOL EVOL, V10, P927; PANDYA A, 1998, IND J HUM GENET, V4, P52; Parkin EJ, 2007, FORENSIC SCI INT, V166, P176, DOI 10.1016/j.forsciint.2006.05.007; Perez-Miranda AM, 2006, HUM HERED, V61, P67, DOI 10.1159/000092648; Qian YP, 2000, HUM GENET, V106, P453, DOI 10.1007/s004390000259; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Ramana GV, 2001, EUR J HUM GENET, V9, P695, DOI 10.1038/sj.ejhg.5200708; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; ROHLF F, 2002, NTSYSPC; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Tajima A, 2004, J HUM GENET, V49, P187, DOI 10.1007/s10038-004-0131-x; Tajima A, 2002, HUM GENET, V110, P80, DOI 10.1007/s00439-001-0651-9; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Van Driem George, 2005, PEOPLING E ASIA PUTT, P81, DOI DOI 10.4324/9780203343685_CHAPTER_6; VANDRIEM G, 2002, EXAMINING FARMING LA, P233; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wilson IJ, 1998, GENETICS, V150, P499; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	69	100	104	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					884	894		10.1086/516757	http://dx.doi.org/10.1086/516757			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436243	Bronze, Green Published			2022-12-18	WOS:000245973200007
J	Hoffmann, K; Muller, JS; Stricker, S; Megarbane, A; Rajab, A; Lindner, TH; Cohen, M; Chouery, E; Adaimy, L; Ghanem, I; Delague, V; Boltshauser, E; Talim, B; Horvath, R; Robinson, PN; Lochmuller, H; Hubner, C; Mundlos, S				Hoffmann, Katrin; Mueller, Juliane S.; Stricker, Sigmar; Megarbane, Andre; Rajab, Anna; Lindner, Tom H.; Cohen, Monika; Chouery, Eliane; Adaimy, Lynn; Ghanem, Ismat; Delague, Valerie; Boltshauser, Eugen; Talim, Beril; Horvath, Rita; Robinson, Peter N.; Lochmueller, Hanns; Huebner, Christoph; Mundlos, Stefan			Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARTHROGRYPOSIS MULTIPLEX CONGENITA; MULTIPOINT LINKAGE ANALYSIS; TO-EPSILON-SWITCH; SKELETAL-MUSCLE; MATERNAL MYASTHENIA; NEONATAL MYASTHENIA; ADULT; GRAVIS; INNERVATION; MAINTENANCE	Escobar syndrome is a form of arthrogryposis multiplex congenita and features joint contractures, pterygia, and respiratory distress. Similar findings occur in newborns exposed to nicotinergic acetylcholine receptor (AChR) antibodies from myasthenic mothers. We performed linkage studies in families with Escobar syndrome and identified eight mutations within the gamma-subunit gene (CHRNG) of the AChR. Our functional studies show that g-subunit mutations prevent the correct localization of the fetal AChR in human embryonic kidney-cell membranes and that the expression pattern in prenatal mice corresponds to the human clinical phenotype. AChRs have five subunits. Two alpha, one beta, and one delta subunit are always present. By switching gamma to epsilon subunits in late fetal development, fetal AChRs are gradually replaced by adult AChRs. Fetal and adult AChRs are essential for neuromuscular signal transduction. In addition, the fetal AChRs seem to be the guide for the primary encounter of axon and muscle. Because of this important function in organogenesis, human mutations in the g subunit were thought to be lethal, as they are in gamma-knockout mice. In contrast, many mutations in other subunits have been found to be viable but cause postnatally persisting or beginning myasthenic syndromes. We conclude that Escobar syndrome is an inherited fetal myasthenic disease that also affects neuromuscular organogenesis. Because g expression is restricted to early development, patients have no myasthenic symptoms later in life. This is the major difference from mutations in the other AChR subunits and the striking parallel to the symptoms found in neonates with arthrogryposis when maternal AChR auto-antibodies crossed the placenta and caused the transient inactivation of the AChR pathway.	Humboldt Univ, Charite Univ Med Sch, Inst Med Genet, D-13353 Berlin, Germany; Humboldt Univ, Charite Univ Med Sch, Dept Neuropediat, D-13353 Berlin, Germany; Max Planck Inst Mol Genet, Dept Dev & Dis, Berlin, Germany; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; Kinderzentrum Munchen, Munich, Germany; Hosp Munich Schwabing, Munich, Germany; St Josephs Univ, Fac Med, Gen Med Serv, Beirut, Lebanon; Minist Hlth, Directorate Gen Hlth Serv, Genet Unit, Muscat, Oman; Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Med Clin 4, Nurnberg, Germany; Hacettepe Univ, Dept Pediat Pathol, Ankara, Turkey; Univ Childrens Hosp, Dept Neurol, Zurich, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Munich; Saint Joseph University Beirut; University of Erlangen Nuremberg; Hacettepe University; University Children's Hospital Zurich	Hoffmann, K (corresponding author), Humboldt Univ, Charite Univ Med Sch, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	katrin.hoffmann.genetik@charite.de	Megarbane, Andre/ABD-5574-2021; Horvath, Rita/AAY-7042-2020; Stricker, Sigmar/B-9169-2009; Chouery, Eliane/AAC-5957-2021; Mundlos, Stefan/ABH-9585-2020; delague, valerie/K-5837-2013	Stricker, Sigmar/0000-0002-7174-5363; Mundlos, Stefan/0000-0002-9788-3166; delague, valerie/0000-0003-2652-362X; Robinson, Peter/0000-0002-0736-9199; Lochmuller, Hanns/0000-0003-2324-8001; Horvath, Rita/0000-0002-9841-170X				BARNES PRJ, 1995, NEUROMUSCULAR DISORD, V5, P59, DOI 10.1016/0960-8966(94)E0029-8; Beeson D, 2003, ANN NY ACAD SCI, V998, P114, DOI 10.1196/annals.1254.013; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brueton LA, 2000, AM J MED GENET, V92, P1, DOI 10.1002/(SICI)1096-8628(20000501)92:1<1::AID-AJMG1>3.0.CO;2-H; Cantagrel S, 2002, AM J PERINAT, V19, P297, DOI 10.1055/s-2002-34468; DRACHMAN DB, 1962, LANCET, V2, P523; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; ESCOBAR V, 1978, AM J DIS CHILD, V132, P609, DOI 10.1001/archpedi.1978.02120310073016; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002; Hammond E, 1995, Obstet Gynecol Surv, V50, P240, DOI 10.1097/00006254-199503000-00028; HESSELMANS LFGM, 1993, ANAT REC, V236, P553, DOI 10.1002/ar.1092360315; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; JAGO RH, 1970, ARCH DIS CHILD, V45, P277, DOI 10.1136/adc.45.240.277; Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429; KOPTA C, 1994, J NEUROSCI, V14, P3922; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; Missias AC, 1997, DEVELOPMENT, V124, P5075; MOESSINGER AC, 1983, PEDIATRICS, V72, P857; MURRAY PDF, 1969, J EMBRYOL EXP MORPH, V22, P349; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; Polizzi A, 2000, TERATOLOGY, V62, P332, DOI 10.1002/1096-9926(200011)62:5<332::AID-TERA7>3.3.CO;2-5; Rajab A, 2005, AM J MED GENET A, V134A, P151, DOI 10.1002/ajmg.a.30583; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Shen XM, 2005, BRAIN, V128, P345, DOI 10.1093/brain/awh364; Takahashi M, 2002, EMBO REP, V3, P674, DOI 10.1093/embo-reports/kvf128; VERNETDERGARABEDIAN B, 1994, J CLIN INVEST, V94, P555, DOI 10.1172/JCI117369; VINCENT A, 1995, LANCET, V346, P24, DOI 10.1016/S0140-6736(95)92652-6; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wanamaker CP, 2003, ANN NY ACAD SCI, V998, P66, DOI 10.1196/annals.1254.009; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Yumoto N, 2005, BIOCHEM BIOPH RES CO, V331, P1522, DOI 10.1016/j.bbrc.2005.04.081	35	100	106	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					303	312		10.1086/506257	http://dx.doi.org/10.1086/506257			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826520	Green Published, Bronze			2022-12-18	WOS:000239040400011
J	Browning, SR				Browning, Sharon R.			Multilocus association mapping using variable-length Markov chains	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; HAPLOTYPE RECONSTRUCTION; CLADISTIC-ANALYSIS; TESTS; GENE; IDENTIFICATION; MODEL	I propose a new method for association-based gene mapping that makes powerful use of multilocus data, is computationally efficient, and is straightforward to apply over large genomic regions. The approach is based on the fitting of variable-length Markov chain models, which automatically adapt to the degree of linkage disequilibrium (LD) between markers to create a parsimonious model for the LD structure. Edges of the fitted graph are tested for association with trait status. This approach can be thought of as haplotype testing with sophisticated windowing that accounts for extent of LD to reduce degrees of freedom and number of tests while maximizing information. I present analyses of two published data sets that show that this approach can have better power than singlemarker tests or sliding-window haplotypic tests.	Univ Auckland, Dept Stat, Auckland 1, New Zealand; GlaxoSmithKline, Genet Res, Res Triangle Pk, NC USA	University of Auckland; GlaxoSmithKline	Browning, SR (corresponding author), Univ Auckland, Dept Stat, Private Bag 92019, Auckland 1, New Zealand.	browning@stat.auckland.ac.nz	Browning, Sharon/B-1530-2008	Browning, Sharon/0000-0001-7251-9715				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x; Buhlmann P, 1999, ANN STAT, V27, P480; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; ERONEN L, 2004, PAC S BIOC KAM HI JA; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier Laurent, 2003, Human Genomics, V1, P7; Greenspan G, 2004, BIOINFORMATICS, V20, P137, DOI 10.1093/bioinformatics/bth907; Hurley JD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh187; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Mathew CG, 2004, HUM MOL GENET, V13, pR161, DOI 10.1093/hmg/ddh079; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Morris AP, 2000, AM J HUM GENET, V67, P155, DOI 10.1086/302956; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ron D, 1996, MACH LEARN, V25, P117, DOI 10.1007/BF00114008; Ron D, 1998, J COMPUT SYST SCI, V56, P133, DOI 10.1006/jcss.1997.1555; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TEMPLETON AR, 1987, GENETICS, V117, P343; Thomas A, 2005, GENET EPIDEMIOL, V29, P23, DOI 10.1002/gepi.20076; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Verzilli C, 2005, ANN HUM GENET, V69, P774; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799	34	100	112	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					903	913		10.1086/503876	http://dx.doi.org/10.1086/503876			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685642	Green Published, Bronze			2022-12-18	WOS:000237553800001
J	Thiel, CT; Horn, D; Zabel, B; Ekici, AB; Salinas, K; Gebhart, E; Ruschendorf, F; Sticht, H; Spranger, J; Muller, D; Zweier, C; Schmitt, ME; Reis, A; Rauch, A				Thiel, CT; Horn, D; Zabel, B; Ekici, AB; Salinas, K; Gebhart, E; Ruschendorf, F; Sticht, H; Spranger, J; Muller, D; Zweier, C; Schmitt, ME; Reis, A; Rauch, A			Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARTILAGE-HAIR HYPOPLASIA; MRP RIBONUCLEOPROTEIN COMPLEX; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; SECONDARY STRUCTURE; GENETIC-DISORDERS; CYCLE PROGRESSION; LOD SCORES; COMPONENT; REVEALS	The growth of an individual is deeply influenced by the regulation of cell growth and division, both of which also contribute to a wide variety of pathological conditions, including cancer, diabetes, and inflammation. To identify a major regulator of human growth, we performed positional cloning in an autosomal recessive type of profound short stature, anauxetic dysplasia. Homozygosity mapping led to the identification of novel mutations in the RMRP gene, which was previously known to cause two milder types of short stature with susceptibility to cancer, cartilage hair hypoplasia, and metaphyseal dysplasia without hypotrichosis. We show that different RMRP gene mutations lead to decreased cell growth by impairing ribosomal assembly and by altering cyclin-dependent cell cycle regulation. Clinical heterogeneity is explained by a correlation between the level and type of functional impairment in vitro and the severity of short stature or predisposition to cancer. Whereas the cartilage hair hypoplasia founder mutation affects both pathways intermediately, anauxetic dysplasia mutations do not affect B-cyclin messenger RNA (mRNA) levels but do severely incapacitate ribosomal assembly via defective endonucleolytic cleavage. Anauxetic dysplasia mutations thus lead to poor processing of ribosomal RNA while allowing normal mRNA processing and, therefore, genetically separate the different functions of RNase MRP.	Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; Humboldt Univ, Inst Med Genet, Klinikum Rudolf Virchow, Berlin, Germany; Max Delbruck Ctr, Gene Mapping Ctr, Berlin, Germany; Univ Mainz, Childrens Hosp, D-6500 Mainz, Germany; Klinkum Chemnitz, Inst Med Genet, Chemnitz, Germany; Greenwood Genet Ctr, Greenwood, SC 29646 USA; SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY USA	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Johannes Gutenberg University of Mainz; Chemnitz Clinic; Greenwood Genetic Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Rauch, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Schwabachanlage 10, D-91054 Erlangen, Germany.	Anita.Rauch@humgenet.uni-erlangen.de	Rauch, Anita/C-5568-2014; Zweier, Christiane/F-2202-2015; Thiel, Christian T/H-8964-2012; Ekici, Arif B/C-3971-2013; Reis, André/D-2309-2009	Rauch, Anita/0000-0003-2930-3163; Zweier, Christiane/0000-0001-8002-2020; Thiel, Christian T/0000-0003-3817-7277; Ekici, Arif B/0000-0001-6099-7066; Reis, André/0000-0002-6301-6363; Sticht, Heinrich/0000-0001-5644-045X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063798] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM063798, R01 GM063798] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonafe L, 2002, CLIN GENET, V61, P146, DOI 10.1034/j.1399-0004.2002.610210.x; Cai T, 1999, MOL CELL BIOL, V19, P7857; Cai T, 2002, GENETICS, V161, P1029; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Hall MN, 2004, CELL GROWTH CONTROL; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; Horn D, 2000, AM J MED GENET, V92, P285, DOI 10.1002/(SICI)1096-8628(20000605)92:4<285::AID-AJMG13>3.3.CO;2-4; Horn D, 2001, J MED GENET, V38, P262, DOI 10.1136/jmg.38.4.262; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LINDAHL L, 1992, NUCLEIC ACIDS RES, V20, P295, DOI 10.1093/nar/20.2.295; Liu JH, 1999, ONCOGENE, V18, P269, DOI 10.1038/sj.onc.1202263; MAKITIE O, 1995, J MED GENET, V32, P39, DOI 10.1136/jmg.32.1.39; Menger H, 1996, AM J MED GENET, V63, P80, DOI 10.1002/(SICI)1096-8628(19960503)63:1<80::AID-AJMG16>3.0.CO;2-Q; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pluk H, 1999, RNA, V5, P512, DOI 10.1017/S1355838299982079; Ridanpaa M, 2003, J MED GENET, V40, P741, DOI 10.1136/jmg.40.10.741; Ridanpaa M, 2003, AM J MED GENET C, V121C, P81, DOI 10.1002/ajmg.c.20006; Ridanpaa M, 2002, EUR J HUM GENET, V10, P439, DOI 10.1038/sj.ejhg.5200824; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Rosenfeld RG, 2004, J CLIN ENDOCR METAB, V89, P1066, DOI 10.1210/jc.2004-0092; Sarafan-Vasseur N, 2002, ONCOGENE, V21, P2051, DOI 10.1038/sj.onc.1205257; Scharpf M, 2000, EUR J BIOCHEM, V267, P2397, DOI 10.1046/j.1432-1327.2000.01251.x; Schmitt ME, 1999, J MOL BIOL, V292, P827, DOI 10.1006/jmbi.1999.3116; SCHMITT ME, 1993, FASEB J, V7, P208, DOI 10.1096/fasebj.7.1.7678563; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Shadel GS, 2000, GENE, V245, P175, DOI 10.1016/S0378-1119(00)00013-5; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; Thiel CT, 2003, EUR J HUM GENET, V11, P170, DOI 10.1038/sj.ejhg.5200920; TOPPER JN, 1990, J BIOL CHEM, V265, P13254; van Driel MA, 2003, EUR J HUM GENET, V11, P57, DOI 10.1038/sj.ejhg.5200918; Welting TJM, 2004, NUCLEIC ACIDS RES, V32, P2138, DOI 10.1093/nar/gkh539; Zhao Y, 2003, MOL CELL BIOL, V23, P699, DOI 10.1128/MCB.23.2.699-707.2003	36	100	100	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					795	806		10.1086/497708	http://dx.doi.org/10.1086/497708			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252239	Green Published, Bronze			2022-12-18	WOS:000232569600009
J	Nakajima, T; Wooding, S; Sakagami, T; Emi, M; Tokunaga, K; Tamiya, G; Ishigami, T; Umemura, S; Munkhbat, B; Jin, F; Guan-jun, J; Hayasaka, I; Ishida, T; Saitou, N; Pavelka, K; Lalouel, JM; Jorde, LB; Inoue, I				Nakajima, T; Wooding, S; Sakagami, T; Emi, M; Tokunaga, K; Tamiya, G; Ishigami, T; Umemura, S; Munkhbat, B; Jin, F; Guan-jun, J; Hayasaka, I; Ishida, T; Saitou, N; Pavelka, K; Lalouel, JM; Jorde, LB; Inoue, I			Natural selection and population history in the human angiotensinogen gene (AGT): 736 complete AGT sequences in chromosomes from around the world	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOLECULAR-GENETICS; HAPLOTYPE STRUCTURE; HUMAN HYPERTENSION; HUMAN GENOME; DIVERSITY; PATTERNS; MUTATION; LINKAGE	Several lines of evidence suggest that patterns of genetic variability in the human angiotensinogen gene (AGT) contribute to phenotypic variability in human hypertension. The A(-6) promoter variant of AGT is associated with higher plasma angiotensinogen levels and increased risk of essential hypertension. The geographic distribution of the A(-6) variant leads to the intriguing hypothesis that the G(-6) promoter variant has been selectively advantageous outside Africa. To test these hypotheses, we investigated the roles of population history and natural selection in shaping patterns of genetic diversity in AGT, by sequencing the entire AGT gene (14,400 bp) in 736 chromosomes from Africa, Asia, and Europe. We found that the A(-6) variant is present at higher frequency in African populations than in non-African populations. Neutrality tests found no evidence of a departure from selective neutrality, when whole AGT sequences were compared. However, tests restricted to sites in the vicinity of the A(-6)G polymorphism found evidence of a selective sweep. Sliding-window analyses showed that evidence of the sweep is restricted to sites in tight linkage disequilibrium (LD) with the A(-6)G polymorphism. Further, haplotypes carrying the G(-6) variant showed elevated levels of LD, suggesting that they have risen recently to high frequency. Departures from neutral expectation in some but not all regions of AGT indicate that patterns of diversity in the gene cannot be accounted for solely by population history, which would affect all regions equally. Taken together, patterns of genetic diversity in AGT suggest that natural selection has generally favored the G(-6) variant over the A(-6) variant in non-African populations. However, important localized effects may also be present.	Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; Univ Tokyo, Sch Sci, Unit Human Biol & Genet, Tokyo, Japan; Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84132 USA; Nippon Med Coll, Inst Gerontol, Dept Mol Biol, Kawasaki, Kanagawa, Japan; Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Natl Inst Med, Cent Sci Res Lab, Ulaanbaatar, Mongolia; Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; Red Cross Blood Ctr Harbin, Harbin, Peoples R China; Sanwa Kagaku Kenkyusho Co Ltd, Kumamoto, Japan; Natl Inst Genet, Div Populat Genet, Mishima, Shizuoka 411, Japan; Inst Rheumatol, Prague, Czech Republic	University of Tokyo; University of Tokyo; University of Tokyo; Utah System of Higher Education; University of Utah; Nippon Medical School; Tokai University; Yokohama City University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Sanwa Kagaku Kenkyusho Co., Ltd.; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Institute of Rheumatology	Nakajima, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Genet Diag, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tnakajim@ims.u-tokyo.ac.jp	Pavelka, Karel/E-6578-2017	Pavelka, Karel/0000-0003-1952-8422; MUNKHBAT, Batmunkh/0000-0002-8664-7483; Tamiya, Gen/0000-0002-0597-415X	NHLBI NIH HHS [HL070048, R01 HL070048] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070048] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Corvol P, 1997, ENDOCR REV, V18, P662, DOI 10.1210/er.18.5.662; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; GLEIBERMANN L., 1973, Ecology of Food and Nutrition, V2, P143, DOI 10.1080/03670244.1973.9990329; Goudet J., 2001, CLADISTICS; Harpending H, 2000, ANNU REV GENOM HUM G, V1, P361, DOI 10.1146/annurev.genom.1.1.361; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KAPLAN NL, 1994, NAT GENET, V8, P216, DOI 10.1038/ng1194-216a; KIMURA M, 1973, GENETICS, V75, P199; LEWONTIN RC, 1964, GENETICS, V49, P49; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Luft FC, 2001, DRUG METAB DISPOS, V29, P500; MENARD J, 1991, HYPERTENSION, V18, P705, DOI 10.1161/01.HYP.18.5.705; Nakajima T, 2002, AM J HUM GENET, V70, P108, DOI 10.1086/338454; Nei M., 1987, MOL EVOLUTIONARY GEN; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Rogers A. R., 1997, PROGR POPULATION GEN, P55; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Sealey JE, 1990, HYPERTENSION PATHOPH, P1287; SMITHIES O, 1994, P NATL ACAD SCI USA, V91, P3612, DOI 10.1073/pnas.91.9.3612; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi N, 1999, J AM SOC NEPHROL, V10, P1598; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Toomajian C, 2002, GENETICS, V161, P1609; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wooding S, 2002, GENETICS, V161, P1641; Wooding SP, 2002, AM J HUM GENET, V71, P528, DOI 10.1086/342260	36	100	107	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2004	74	5					898	916		10.1086/420793	http://dx.doi.org/10.1086/420793			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	813SF	15077204	Bronze, Green Published			2022-12-18	WOS:000220926100011
J	Morris, AP; Whittaker, JC; Balding, DJ				Morris, AP; Whittaker, JC; Balding, DJ			Fine-scale mapping of disease loci via shattered coalescent modeling of genealogies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME SEQUENCE; LINKAGE-DISEQUILIBRIUM; POPULATIONS; RECOMBINATION; ALLELE; MUTANT; GENE; AGE; MAP	We present a Bayesian, Markov-chain Monte Carlo method for fine-scale linkage-disequilibrium gene mapping using high-density marker maps. The method explicitly models the genealogy underlying a sample of case chromosomes in the vicinity of a putative disease locus, in contrast with the assumption of a star-shaped tree made by many existing multipoint methods. Within this modeling framework, we can allow for missing marker information and for uncertainty about the true underlying genealogy and the makeup of ancestral marker haplotypes. A crucial advantage of our method is the incorporation of the shattered coalescent model for genealogies, allowing for multiple founding mutations at the disease locus and for sporadic cases of disease. Output from the method includes approximate posterior distributions of the location of the disease locus and population-marker haplotype proportions. In addition, output from the algorithm is used to construct a cladogram to represent genetic heterogeneity at the disease locus, highlighting clusters of case chromosomes sharing the same mutation. We present detailed simulations to provide evidence of improvements over existing methodology. Furthermore, inferences about the location of the disease locus are shown to remain robust to modeling assumptions.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Reading, Dept Appl Stat, Reading RG6 2AH, Berks, England; Imperial Coll Fac Med, Dept Epidemiol & Publ Hlth, London, England	University of Oxford; Wellcome Centre for Human Genetics; University of Reading; Imperial College London	Morris, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	amorris@well.ox.ac.uk	Balding, David/G-9898-2011; Whittaker, John C/B-8609-2012	Balding, David/0000-0002-1480-6115; Whittaker, John C/0000-0002-3529-2379				Bertranpetit J, 1996, CIBA F SYMP, V197, P97; Clayton D, 2000, INT STAT REV, V68, P23, DOI 10.2307/1403555; Collins A, 1998, P NATL ACAD SCI USA, V95, P1741, DOI 10.1073/pnas.95.4.1741; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Graham J, 1998, AM J HUM GENET, V63, P1517, DOI 10.1086/302102; Griffiths R., 1997, PROGR POPULATION GEN, P257; Griffiths RC, 1996, J COMPUT BIOL, V3, P479, DOI 10.1089/cmb.1996.3.479; Hudson R, 1991, OXFORD SURVEYS EVOLU, V7, P1; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Lam JC, 2000, AM J HUM GENET, V66, P659, DOI 10.1086/302756; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; McCullagh P, 1989, GEN LINEAR MODELS, V2nd; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moran P., 1962, STAT PROCESSES EVOLU; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; Morris AP, 2000, AM J HUM GENET, V67, P155, DOI 10.1086/302956; Nordborg M., 2001, HDB STAT GENETICS, P179; Pennisi E, 1998, SCIENCE, V281, P1787, DOI 10.1126/science.281.5384.1787; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; Rannala B, 2000, GENET EPIDEMIOL, V19, pS71, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI11>3.0.CO;2-D; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SERRE JL, 1990, HUM GENET, V84, P449; Slatkin M, 1997, AM J HUM GENET, V60, P447; Slatkin M, 1996, GENETICS, V143, P579; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; Wiuf C, 1999, THEOR POPUL BIOL, V56, P183, DOI 10.1006/tpbi.1998.1411; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475	33	100	101	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					686	707		10.1086/339271	http://dx.doi.org/10.1086/339271			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11836651	Green Published, Bronze			2022-12-18	WOS:000173880000012
J	Lee, YA; Ruschendorf, F; Windemuth, C; Schmitt-Egenolf, M; Stadelmann, A; Nurnberg, G; Stander, M; Wienker, TF; Reis, A; Traupe, H				Lee, YA; Ruschendorf, F; Windemuth, C; Schmitt-Egenolf, M; Stadelmann, A; Nurnberg, G; Stander, M; Wienker, TF; Reis, A; Traupe, H			Genomewide scan in German families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; GENETIC DISSECTION; COMPLEX TRAITS; DISEASE; IDENTIFICATION; SIMULATION; ACTIVATION; MODELS; MAP; HLA	Psoriasis is a common chronic inflammatory: skin disease with a strong genetic component. Few psoriasis-susceptibility loci have been reported, and only two have been confirmed in independent data sets. This article reports results of a genomewide scan that was performed, using 370 microsatellite markers, for psoriasis-susceptibility loci in 32 German extended families, comprising 162 affected and 195 unaffected individuals. Nonparametric linkage analysis of all families provided strong evidence for a novel psoriasis-susceptibility locus on chromosome 19p (Z(lr) = 3.50; P = .0002). Parametric analysis revealed a heterogeneity LOD score of 4.06, corresponding to a genomewide significance level of .037, under the assumption of a recessive model with high disease-allele frequency and 66% as the proportion of linked families. This study confirms linkage of psoriasis to the HLA region on chromosome 6p and suggests additional regions on chromosomes 8q and 21q for further investigations.	Univ Munster, Dept Dermatol, D-48149 Munster, Germany; Humboldt Univ, Max Delbruck Ctr Mol Med, Berlin, Germany; Humboldt Univ, Dept Pediat Pneumol & Immunol, Berlin, Germany; Humboldt Univ, Inst Human Genet, Charite, Berlin, Germany; Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; Norwegian Univ Sci & Technol, Dept Dermatol, N-7034 Trondheim, Norway; Fachklin, Dept Dermatol, Bad Bentheim, Germany	University of Munster; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; Norwegian University of Science & Technology (NTNU)	Traupe, H (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-48149 Munster, Germany.		Schmitt-Egenolf, Marcus/H-7310-2014; Reis, André/D-2309-2009	Schmitt-Egenolf, Marcus/0000-0002-3858-8474; Reis, André/0000-0002-6301-6363				ABELE DC, 1963, ARCH DERMATOL, V88, P38, DOI 10.1001/archderm.1963.01590190044005; Boehncke WH, 1997, J CUTAN PATHOL, V24, P1, DOI 10.1111/j.1600-0560.1997.tb00778.x; BRANDRUP F, 1978, ARCH DERMATOL, V114, P874, DOI 10.1001/archderm.114.6.874; Capon F, 1999, J INVEST DERMATOL, V112, P32, DOI 10.1046/j.1523-1747.1999.00471.x; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Enlund F, 1999, EUR J HUM GENET, V7, P783, DOI 10.1038/sj.ejhg.5200365; FARBER EM, 1974, ARCH DERMATOL, V109, P207, DOI 10.1001/archderm.109.2.207; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Leder RO, 1998, HUM HERED, V48, P198, DOI 10.1159/000022802; Lomholt G, 1963, PSORIASIS PREVALENCE; Matthews D, 1996, NAT GENET, V14, P231, DOI 10.1038/ng1096-231; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; Nevitt GJ, 1996, BRIT J DERMATOL, V135, P533, DOI 10.1046/j.1365-2133.1996.d01-1035.x; NICKOLOFF BJ, 1993, J IMMUNOL, V150, P2148; NICKOLOFF BJ, 1995, J INVEST DERMATOL S, V105, P25; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; SIU G, 1989, J IMMUNOL, V143, P3813; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; SWANBECK G, 1994, BRIT J DERMATOL, V131, P32, DOI 10.1111/j.1365-2133.1994.tb08454.x; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; YBARRONDO B, 1994, J EXP MED, V179, P359, DOI 10.1084/jem.179.1.359	32	100	106	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					1020	1024		10.1086/303075	http://dx.doi.org/10.1086/303075			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10986047	Green Published, Bronze			2022-12-18	WOS:000089651100028
J	Freeman, SB; Yang, QH; Allran, K; Taft, LF; Sherman, SL				Freeman, SB; Yang, QH; Allran, K; Taft, LF; Sherman, SL			Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FOLLICLE-STIMULATING-HORMONE; INVITRO FERTILIZATION; OVULATION INDUCTION; 2 OVARIES; PROGRAM; POPULATION; ESTRADIOL; AGE	Advanced maternal age is the only well-established risk factor for trisomy 21 Down syndrome (DS), but the basis of the maternal-age effect is not known. In a population-based, case-control study of DS, women who reported surgical removal of all or part of an ovary or congenital absence of one ovary were significantly more likely to have delivered a child with DS than were women who did not report a reduced ovarian complement (odds ratio 9.61; 35% confidence interval 1.18-446.3). Because others have observed that women who have had an ovary removed exhibit elevated levels of FSH and similar hallmarks of advanced maternal age, our finding suggests that the physiological status of the ovary is key to the maternal-age effect. In addition, it suggests that women With a reduced ovarian complement should be offered prenatal diagnosis.	Emory Univ, Sch Med, Dept Genet, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Birth Defects & Pediat Genet Branch, Atlanta, GA 30341 USA	Emory University; Centers for Disease Control & Prevention - USA	Freeman, SB (corresponding author), Emory Univ, Sch Med, Dept Genet, 1462 Clifton Rd, Atlanta, GA 30322 USA.				NCRR NIH HHS [MO1RR00039] Funding Source: Medline; NICHD NIH HHS [N01HD92907, P01HD32111] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111, N01HD092907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALPER MM, 1985, FERTIL STERIL, V44, P652; Backer LC, 1999, MENOPAUSE, V6, P29; BOUTTEVILLE C, 1987, FERTIL STERIL, V47, P821; BROOK JD, 1984, HUM GENET, V66, P41, DOI 10.1007/BF00275184; CRAMER DW, 1995, AM J OBSTET GYNECOL, V172, P568, DOI 10.1016/0002-9378(95)90574-X; *CYTEL, 1996, LOGX WIND US MAN; DIAMOND MP, 1984, FERTIL STERIL, V41, P524; EDMONDS LD, 1981, INT J EPIDEMIOL, V10, P247, DOI 10.1093/ije/10.3.247; Hardy R, 1999, AM J EPIDEMIOL, V149, P612; HORNSTEIN MD, 1989, J REPROD MED, V34, P277; KHALIFA E, 1992, FERTIL STERIL, V57, P835; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lass A, 1997, HUM REPROD, V12, P298, DOI 10.1093/humrep/12.2.298; Nasseri A, 1999, FERTIL STERIL, V71, P715, DOI 10.1016/S0015-0282(98)00525-1; van Montfrans JM, 1999, LANCET, V353, P1853, DOI 10.1016/S0140-6736(99)00936-8; Yang QH, 1999, GENET MED, V1, P80; [No title captured]	17	100	108	1	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1680	1683		10.1086/302907	http://dx.doi.org/10.1086/302907			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10733467	Green Published, Bronze			2022-12-18	WOS:000088373700021
J	Hinek, A; Smith, AC; Cutiongco, EM; Callahan, JW; Gripp, KW; Weksberg, R				Hinek, A; Smith, AC; Cutiongco, EM; Callahan, JW; Gripp, KW; Weksberg, R			Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMOOTH-MUSCLE CELLS; CHONDROITIN SULFATE; NATURAL-HISTORY; CUTIS LAXA; DIFFERENTIAL-DIAGNOSIS; CD44; MUCOPOLYSACCHARIDOSES; TROPOELASTIN; RECEPTOR; EXPRESSION	Costello syndrome is characterized by mental retardation, loose skin, coarse face, skeletal deformations, cardiomyopathy, and predisposition to numerous malignancies. The genetic origin of Costello syndrome has not yet been defined. Using immunohistochemistry and metabolic labeling with [H-3]-valine, we have established that cultured skin fibroblasts obtained from patients with Costello syndrome did not assemble elastic fibers, despite an adequate synthesis of tropoelastin and normal deposition of the microfibrillar scaffold. We found that impaired production of elastic fibers by these fibroblasts is associated with a functional deficiency of the 67-kD elastin-binding protein (EBP), which is normally required to chaperone tropoelastin through the secretory pathways and to its extracellular assembly. Metabolic pulse labeling of the 67-kD EBP with radioactive serine and further chase of this tracer indicated that both normal fibroblasts and fibroblasts from patients with Costello syndrome initially synthesized comparable amounts of this protein; however, the fibroblasts from Costello syndrome patients quickly lost it into the conditioned media. Because the normal association between EBP and tropoelastin can be disrupted on contact with galactosugarbearing moieties, and the fibroblasts from patients with Costello syndrome revealed an unusual accumulation of chondroitin sulfate-bearing proteoglycans (CD44 and biglycan), we postulate that a chondroitin sulfate may be responsible for shedding EBP from Costello cells and in turn for their impaired elastogenesis. This was further supported by the fact that exposure to chondroitinase ABC, an enzyme capable of chondroitin sulfate degradation, restored normal production of elastic fibers by fibroblasts from patients with Costello syndrome. We also present evidence that loss of EBP from fibroblasts of Costello syndrome patients is associated with an unusually high rate of cellular proliferation.	Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Hinek, A (corresponding author), Hosp Sick Children, Div Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Hinek, Aleksander/V-8790-2019; Smith, Adam/GPS-8322-2022; Smith, Adam/N-1935-2017	Smith, Adam/0000-0001-9927-4914				BELCHER RW, 1972, ARCH PATHOL, V94, P511; Borland G, 1998, IMMUNOLOGY, V93, P139; BOROCHOWITZ Z, 1992, AM J MED GENET, V43, P678, DOI 10.1002/ajmg.1320430405; Chiu RK, 1999, EXP CELL RES, V248, P314, DOI 10.1006/excr.1999.4391; CHRISTIANO AM, 1994, J INVEST DERMATOL, V103, pS53, DOI 10.1111/1523-1747.ep12399044; CLEARY EG, 1967, J CELL BIOL, V33, P469, DOI 10.1083/jcb.33.3.469; COSTELLO JM, 1977, AUST PAEDIATR J, V13, P114; Costello JM, 1996, AM J MED GENET, V62, P199, DOI 10.1002/ajmg.1320620203; CZEIZEL AE, 1995, AM J MED GENET, V57, P501, DOI 10.1002/ajmg.1320570331; DAVIES SJ, 1994, J MED GENET, V31, P486, DOI 10.1136/jmg.31.6.486; DAVIES SJ, 1994, J MED GENET, V31, P85, DOI 10.1136/jmg.31.1.85; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Feingold M, 1999, J MED GENET, V36, P582; Franceschini P, 1999, AM J MED GENET, V86, P174, DOI 10.1002/(SICI)1096-8628(19990910)86:2<174::AID-AJMG17>3.3.CO;2-P; Fukao T, 1996, CLIN GENET, V50, P244; Haust M D, 1987, Am J Cardiovasc Pathol, V1, P231; Herrlich P, 1998, CELL ADHES COMMUN, V6, P141, DOI 10.3109/15419069809004470; Hinek A, 1999, ACTA NEUROPATHOL, V97, P399, DOI 10.1007/s004010051004; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; HINEK A, 1992, EXP CELL RES, V203, P344, DOI 10.1016/0014-4827(92)90008-V; HINEK A, 1991, J CLIN INVEST, V88, P2083, DOI 10.1172/JCI115538; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Hinek A, 1996, BIOL CHEM, V377, P471; Hinek A, 1996, EXP CELL RES, V225, P122, DOI 10.1006/excr.1996.0163; HINEK A, 2000, IN PRESS AM J PATHOL; HOLZENBERGER M, 1993, ANAT EMBRYOL, V188, P481; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; Humphrey G, 1999, BRIT J CANCER, V80, P918, DOI 10.1038/sj.bjc.6690442; HURLE JM, 1994, J CELL SCI, V107, P2623; JOHNSON GL, 1981, PEDIATRICS, V67, P401; Johnson JP, 1998, J PEDIATR-US, V133, P441, DOI 10.1016/S0022-3476(98)70284-7; Jung S, 1998, J NEUROPATH EXP NEUR, V57, P439, DOI 10.1097/00005072-199805000-00007; Kerr B, 1998, J MED GENET, V35, P1036, DOI 10.1136/jmg.35.12.1036; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; LURIE IW, 1994, AM J MED GENET, V52, P358, DOI 10.1002/ajmg.1320520321; MCGOWAN SE, 1993, ARCH BIOCHEM BIOPHYS, V302, P322, DOI 10.1006/abbi.1993.1218; Mecham R.P., 1991, CELL BIOL EXTRACELLU, V2nd, P79; MECHAM RP, 1988, BIOCHEM BIOPH RES CO, V151, P822, DOI 10.1016/S0006-291X(88)80355-3; MECHAM RP, 1991, J CELL BIOL, V113, P187, DOI 10.1083/jcb.113.1.187; Mori M, 1996, AM J MED GENET, V61, P304, DOI 10.1002/(SICI)1096-8628(19960202)61:4<304::AID-AJMG2>3.0.CO;2-U; NELSON J, 1990, J MED GENET, V27, P94, DOI 10.1136/jmg.27.2.94; Neufeld EF, 1997, METABOLIC BASIS INHE, P2465; PasqualiRonchetti I, 1997, MICROSC RES TECHNIQ, V38, P428, DOI 10.1002/(SICI)1097-0029(19970815)38:4<428::AID-JEMT10>3.0.CO;2-L; PATTON MA, 1993, J MED GENET, V30, P622, DOI 10.1136/jmg.30.7.622; Philip N, 1998, J MED GENET, V35, P238, DOI 10.1136/jmg.35.3.238; Ponta H, 1998, INT J BIOCHEM CELL B, V30, P299, DOI 10.1016/S1357-2725(97)00152-0; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; PROSSER J, 1991, CONNECT TISSUE RES, V265, P265; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; SAY B, 1993, AM J MED GENET, V47, P163, DOI 10.1002/ajmg.1320470203; SCHIEKEN RM, 1975, CIRCULATION, V52, P700, DOI 10.1161/01.CIR.52.4.700; SELMIN O, 1991, MATRIX, V11, P347, DOI 10.1016/S0934-8832(11)80206-4; Siwik ES, 1998, PEDIATRICS, V101, P706, DOI 10.1542/peds.101.4.706; Sneath RJS, 1998, J CLIN PATHOL-MOL PA, V51, P191, DOI 10.1136/mp.51.4.191; Suri M, 1998, CLIN DYSMORPHOL, V7, P149, DOI 10.1097/00019605-199804000-00014; TEEBI AS, 1993, AM J MED GENET, V47, P166, DOI 10.1002/ajmg.1320470204; Tomita H, 1998, ACTA PAEDIATR JAPON, V40, P608; TORRES JV, 1994, ANAL QUANT CYTOL, V16, P421; van Eeghen AM, 1999, AM J MED GENET, V82, P187, DOI 10.1002/(SICI)1096-8628(19990115)82:2<187::AID-AJMG17>3.0.CO;2-2; VARTIO T, 1987, J CELL SCI, V88, P419; VINALLONGA X, 1992, PEDIATR CARDIOL, V13, P107, DOI 10.1007/BF00798216; Volpi N, 1997, CHEM-BIOL INTERACT, V105, P157, DOI 10.1016/S0009-2797(97)00045-8; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wieczorek D, 1997, CLIN GENET, V52, P37; YING QL, 1997, AM J PHYSIOL, V272, P533; ZAMPINO G, 1993, AM J MED GENET, V47, P176, DOI 10.1002/ajmg.1320470210; Zhou CJ, 1999, ARCH HISTOL CYTOL, V62, P261, DOI 10.1679/aohc.62.261	69	100	111	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					859	872		10.1086/302829	http://dx.doi.org/10.1086/302829			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712202	Bronze, Green Published			2022-12-18	WOS:000088373200010
J	Boon, LM; Brouillard, P; Irrthum, A; Karttunen, L; Warman, ML; Rudolph, R; Mulliken, JB; Olsen, BR; Vikkula, M				Boon, LM; Brouillard, P; Irrthum, A; Karttunen, L; Warman, ML; Rudolph, R; Mulliken, JB; Olsen, BR; Vikkula, M			A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECEPTOR TYROSINE KINASE; MULTIPLE GLOMANGIOMAS; BINDING-PROTEIN; TIE2 RECEPTOR; TISSUE FACTOR; ANGIOPOIETIN-1; ANGIOGENESIS; MALFORMATIONS; EXPRESSION; MUTATION	Venous malformations (VMs) are localized defects of vascular morphogenesis. They can occur in every organ system, most commonly in skin and muscle. They can cause pain and bleeding, and in some critical locations they can be life threatening. Usually venous anomalies occur sporadically, but families with dominant inheritance have been identified. Using linkage analysis, we have established in earlier reports that some families with inherited VMs show linkage to chromosome 9p21; the mutation causes ligand-independent activation of an endothelial cell-specific receptor tyrosine kinase, TIE-2. Here we show that VMs with glomus cells (known as "glomangiomas"), inherited as an autosomal dominant trait in five families, are not linked to 9p21 but, instead, link to a new locus, on 1p21-p22, called "VMGLOM" (LOD score 12.70 at recombination fraction .00). We exclude three known positional candidate genes, DR1 (depressor of transcription 1), TGFBR3 (transforming growth factor-beta receptor, type 3), and TFA (tissue factor). We hypothesize that cutaneous venous anomalies (i.e., glomangiomas) are caused by mutations in a novel gene that may act to regulate angiogenesis, in concert with the TIE-2 signaling pathway.	Catholic Univ Louvain, B-3000 Louvain, Belgium; Catholic Univ Louvain, Clin Univ St Luc, Div Plast Surg, Ctr Vasc Anomalies, B-1348 Louvain, Belgium; Harvard Univ, Sch Med, Dept Cell Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Dent Med, Forsyth Dept Oral Biol, Cambridge, MA 02138 USA; Childrens Hosp, Div Plast Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Scripps Res Inst, Div Plast & Reconstruct Surg, La Jolla, CA 92037 USA; Univ California, La Jolla, CA USA	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Harvard University; Harvard University; Forsyth Institute; Harvard School of Dental Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University; Scripps Research Institute; University of California System; University of California San Diego		vikkula@bchm.ucl.ac.be	BROUILLARD, Pascal/AER-9771-2022; Boon, Laurence/HCI-3629-2022; Vikkula, Miikka/Q-1038-2018	BROUILLARD, Pascal/0000-0001-9548-8229; Vikkula, Miikka/0000-0002-6236-338X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR036820, R01AR036820] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL33014] Funding Source: Medline; NIAMS NIH HHS [AR36820] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; BOON LM, 1994, HUM MOL GENET, V3, P1583, DOI 10.1093/hmg/3.9.1583; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Cheung AH, 1998, GENOMICS, V48, P389, DOI 10.1006/geno.1997.5207; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Enjolras O, 1996, PEDIATR SURG INT, V11, P290, DOI 10.1007/BF00497795; GOODMAN TF, 1971, ARCH DERMATOL, V103, P11, DOI 10.1001/archderm.103.1.11; GORLIN RJ, 1960, ARCH DERMATOL, V82, P776, DOI 10.1001/archderm.1960.01580050118018; HUANG LW, 1995, ONCOGENE, V11, P2097; Iqbal A, 1998, BRIT J PLAST SURG, V51, P32, DOI 10.1016/S0007-1226(97)90116-8; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Jones N, 1998, ONCOGENE, V17, P1097, DOI 10.1038/sj.onc.1202115; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; Korpelainen EI, 1999, ONCOGENE, V18, P1, DOI 10.1038/sj.onc.1202288; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MEISTER A, 1974, ANN INTERN MED, V81, P247, DOI 10.7326/0003-4819-81-2-247; MULLIKEN JB, 1997, GRABB SMITHS PLASTIC, P191; Rozet JM, 1996, GENOMICS, V36, P554, DOI 10.1006/geno.1996.0508; RUDOLPH R, 1993, ANN PLAS SURG, V30, P183, DOI 10.1097/00000637-199302000-00017; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Toomey JR, 1996, BLOOD, V88, P1583; TOURAINE A, 1936, B SOC FRANC DERM SYP, V43, P736; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904; Vikkula M, 1998, TRENDS CARDIOVAS MED, V8, P281, DOI 10.1016/S1050-1738(98)00024-3; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Young AE, 1988, VASCULAR BIRTHMARKS, P24	32	100	104	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					125	133		10.1086/302450	http://dx.doi.org/10.1086/302450			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364524	Bronze, Green Published			2022-12-18	WOS:000081224300016
J	Chapman, K; Mustafa, Z; Irven, C; Carr, AJ; Clipsham, K; Smith, A; Chitnavis, J; Sinsheimer, JS; Bloomfield, VA; McCartney, M; Cox, O; Cardon, LR; Sykes, B; Loughlin, J				Chapman, K; Mustafa, Z; Irven, C; Carr, AJ; Clipsham, K; Smith, A; Chitnavis, J; Sinsheimer, JS; Bloomfield, VA; McCartney, M; Cox, O; Cardon, LR; Sykes, B; Loughlin, J			Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAIR ANALYSIS; RADIOGRAPHIC OSTEOARTHRITIS; GENERALIZED OSTEOARTHRITIS; BONE MASS; GENE; WOMEN; ASSOCIATION; STRATEGIES; 11Q12-13; COLLAGEN	We present a two-stage genomewide scan for osteoarthritis-susceptibility loci, using 481 families that each contain at least one affected sibling pair. The first stage, with 272 microsatellite markers and 297 families, involved a sparse map covering 23 chromosomes at intervals of similar to 15 cM. Sixteen markers that showed evidence of linkage at nominal P less than or equal to .05 were then taken through to the second stage, with an additional 184 families. This second stage confirmed evidence of linkage for markers on chromosome 11q. Additional markers from this region were then typed to create a denser map. We obtained a maximum single-point LOD score, at D11S901, of 2.40 (P = .0004) and a maximum multipoint-LOD score of 3.15, between markers D11S1358 and D11S35. A subset of 196 of the 481 families, comprising affected female sibling pairs, generated a corrected LOD score of 2.54 (P = .0003) for marker D11S901, with evidence for linkage extending 12 cM proximal to this marker. When we stratified for affected male sibling pairs there was no evidence of linkage to chromosome 11. Our data suggest that a female-specific susceptibility gene for idiopathic osteoarthritis is located on chromosome 11q.	Univ Oxford, Inst Mol Med, Cellular Genet Grp, Oxford OX3 9DS, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 9DS, England; Nuffield Orthopaed Ctr, Oxford OX3 7LD, England; Musgrave Pk Hosp, Belfast, Antrim, North Ireland; Univ Calif Los Angeles, Dept Biostat & Biomath, Los Angeles, CA USA	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Nuffield Orthopaedic Centre; University of California System; University of California Los Angeles	Loughlin, J (corresponding author), Univ Oxford, Inst Mol Med, Cellular Genet Grp, Oxford OX3 9DS, England.			Loughlin, John/0000-0003-2018-3361	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aerssens J, 1998, ARTHRITIS RHEUM, V41, P1946, DOI 10.1002/1529-0131(199811)41:11<1946::AID-ART8>3.3.CO;2-Q; Chitnavis J, 1997, J BONE JOINT SURG BR, V79B, P660, DOI 10.1302/0301-620X.79B4.7437; COOPER C, 1994, J RHEUMATOL, V21, P307; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dequeker J, 1997, MICROSC RES TECHNIQ, V37, P358, DOI 10.1002/(SICI)1097-0029(19970515)37:4<358::AID-JEMT10>3.0.CO;2-L; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Gong YQ, 1996, AM J HUM GENET, V59, P146; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Heaney C, 1998, HUM MOL GENET, V7, P1407, DOI 10.1093/hmg/7.9.1407; Hirsch R, 1998, ARTHRITIS RHEUM, V41, P1227, DOI 10.1002/1529-0131(199807)41:7<1227::AID-ART13>3.0.CO;2-N; Holmans P, 1997, AM J HUM GENET, V60, P657; Horton WA, 1996, AM J MED GENET, V63, P4; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kaprio J, 1996, BRIT MED J, V313, P232, DOI 10.1136/bmj.313.7051.232; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; Koller DL, 1998, J BONE MINER RES, V13, P1903, DOI 10.1359/jbmr.1998.13.12.1903; LANE NE, 1994, J RHEUMATOL, V21, P1393; LINDBERG H, 1986, CLIN ORTHOP RELAT R, P273; LOUGHLIN J, 1994, BRIT J RHEUMATOL, V33, P1103; Mansell JP, 1998, J CLIN INVEST, V101, P1596, DOI 10.1172/JCI867; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; PENDAS AM, 1996, GENOMICS, V37, P264; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RISCH N, 1990, AM J HUM GENET, V46, P222; Spector TD, 1996, BRIT MED J, V312, P940; Uitterlinden AG, 1997, J CLIN INVEST, V100, P259, DOI 10.1172/JCI119530; VIKKULA M, 1993, ARTHRITIS RHEUM, V36, P401, DOI 10.1002/art.1780360317; Wright GD, 1996, ANN RHEUM DIS, V55, P317, DOI 10.1136/ard.55.5.317	31	100	109	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					167	174		10.1086/302465	http://dx.doi.org/10.1086/302465			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364529	Green Published, Bronze			2022-12-18	WOS:000081224300021
J	Allison, DB; Heo, M; Kaplan, N; Martin, ER				Allison, DB; Heo, M; Kaplan, N; Martin, ER			Sibling-based tests of linkage and association for quantitative traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; DISCORDANT SIB PAIRS; TRANSMISSION/DISEQUILIBRIUM TEST; LOCI; SELECTION; POWER; EFFICIENCY; PEDIGREES; DISEASES; OBESITY	The transmission/disequilibrium test (TDT) developed by Spielman et al. can be a powerful family-based test of linkage and, in some cases, a test of association as well as linkage. It has recently been extended in several ways; these include allowance for implementation with quantitative traits, allowance for multiple alleles, and, in the case of dichotomous traits, allowance for testing in the absence of parental data. In this article, these three extensions are combined, and two procedures are developed that offer valid joint tests of linkage and (in the case of certain sibling configurations) association with quantitative traits, with use of data from siblings only, and that can accommodate biallelic or multiallelic loci. The first procedure uses a mixed-effects (i.e., random and fixed effects) analysis of variance in which sibship is. the random factor, marker genotype is the red factor, and the continuous phenotype is the dependent variable. Covariates can easily be accommodated, and the procedure can be implemented in commonly available statistical software. The second procedure is a permutation-based procedure. Selected power studies are conducted to illustrate the relative power of each test under a variety of circumstances.	Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Obes Res Ctr, New York, NY 10025 USA; NIEHS, Biostat Branch, Dept Hlth & Human Resources, NIH, Bethesda, MD USA; Duke Univ, Med Ctr, Dept Med, Med Genet Sect, Durham, NC 27710 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Allison, DB (corresponding author), Columbia Univ, Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Obes Res Ctr, 1090 Amsterdam Ave,14th Floor, New York, NY 10025 USA.			Heo, Moonseong/0000-0001-7711-1209; Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051716, R29DK047256, P30DK026687] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30DK26687, R29DK47256, R01DK51716] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison DB, 1998, HUM HERED, V48, P97, DOI 10.1159/000022788; Allison DB, 1997, BEHAV GENET, V27, P401, DOI 10.1023/A:1025696232582; Allison DB, 1997, AM J HUM GENET, V60, P676; Allison DB, 1998, GENET EPIDEMIOL, V15, P87, DOI 10.1002/(SICI)1098-2272(1998)15:1<87::AID-GEPI7>3.0.CO;2-1; Becker R.A., 1988, NEW S LANGUAGE PROGR; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Burdick R. K., 1992, CONFIDENCE INTERVALS; CHUNG WK, IN PRESS DIABETES; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; EAVES L, 1994, BEHAV GENET, V24, P443, DOI 10.1007/BF01076180; EGGEBEEN DJ, 1992, SOC BIOL, V39, P27; Elston RC, 1998, GENET EPIDEMIOL, V15, P565, DOI 10.1002/(SICI)1098-2272(1998)15:6<565::AID-GEPI2>3.0.CO;2-J; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Frankel WN, 1996, NAT GENET, V14, P371, DOI 10.1038/ng1296-371; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; Georges M, 1996, REPROD NUTR DEV, V36, P651; Good P, 1995, PERMUTATION TESTS PR; Goring HHH, 1997, EUR J HUM GENET, V5, P69, DOI 10.1159/000484736; HUME D, 1988, ENQUIRY HUMAN UNDERA; JAMIESON A, 1994, ANIM GENET, V25, P37, DOI 10.1111/j.1365-2052.1994.tb00401.x; Kaplan NL, 1998, AM J HUM GENET, V62, P703, DOI 10.1086/301760; KEPPEL G, 1982, DESIGN ANAL; Krzanowski W.J., 1988, PRINCIPLES MULTIVARI; Markel P. D., 1994, Psychiatric Genetics, V4, P205, DOI 10.1097/00041444-199400440-00003; Mitchell BD, 1998, J CLIN INVEST, V101, P584, DOI 10.1172/JCI512; Morris AP, 1997, ANN HUM GENET, V61, P335, DOI 10.1017/S0003480097006349; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; Neter J., 1990, APPL LINEAR STAT MOD; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 1996, AM J HUM GENET, V58, P836; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Sage MR, 1997, INT J NEURORADIOL, V3, P1; SCHORK NJ, 1993, AM J HUM GENET, V53, P1306; Searle S.R., 1987, LINEAR MODELS UNBALA; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; *SPSS INC, 1997, SPSS ADV STAT VERS 7; Todorov AA, 1997, HUM HERED, V47, P1, DOI 10.1159/000154381; Tregouet DA, 1997, AM J HUM GENET, V61, P189, DOI 10.1086/513895; Wilcox RR, 2022, INTRO ROBUST ESTIMAT	47	100	101	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1754	1764		10.1086/302404	http://dx.doi.org/10.1086/302404			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330363	Green Published, Bronze			2022-12-18	WOS:000080696200028
J	Edwards, SJ; Gladwin, AJ; Dixon, MJ				Edwards, SJ; Gladwin, AJ; Dixon, MJ			The mutational spectrum in Treacher Collins syndrome reveals a predominance of mutations that create a premature-termination codon	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE BASE SUBSTITUTIONS; POLYMERASE CHAIN-REACTION; MANDIBULOFACIAL DYSOSTOSIS; SYNDROME LOCUS; HEMIFACIAL MICROSOMIA; GEL-ELECTROPHORESIS; NONSENSE MUTATIONS; GENETIC-LINKAGE; DNA; POLYMORPHISMS	Treacher Collins syndrome (TCS) is an autosomal dominant disorder of craniofacial development, the features of which include conductive hearing loss and cleft palate. The TCS locus has been mapped to human chromosome 5q31.3-32 and the mutated gene identified. In the current investigation, 25 previously undescribed mutations, which are spread throughout the gene, are presented. This brings the total reported to date to 35, which represents a detection rate of 60%. Of the mutations that have been reported to date, all but one result in the introduction of a premature-termination codon into the predicted protein, treacle. Moreover, the mutations are largely family specific, although a common 5-bp deletion in exon 24 (seven different families) and a recurrent splicing mutation in intron 3 (two different families) have been identified. This mutational spectrum supports the hypothesis that TCS results from haploin-sufficiency.	UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND; UNIV MANCHESTER,DEPT DENT MED,MANCHESTER M13 9PT,LANCS,ENGLAND; UNIV MANCHESTER,DEPT SURG,MANCHESTER M13 9PT,LANCS,ENGLAND	University of Manchester; University of Manchester; University of Manchester				Edwards, Sara/0000-0002-3468-1217	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; COHEN J, 1995, AM J PERINAT, V12, P416, DOI 10.1055/s-2007-994511; CONNOR JM, 1988, ESSENTIAL MED GENETI; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIXON J, 1995, GENOMICS, V26, P239, DOI 10.1016/0888-7543(95)80206-2; DIXON J, 1994, AM J HUM GENET, V55, P372; Dixon M J, 1994, Clin Dysmorphol, V3, P96; Dixon Michael J., 1992, Human Molecular Genetics, V1, P249, DOI 10.1093/hmg/1.4.249; Dixon MJ, 1996, HUM MOL GENET, V5, P1391, DOI 10.1093/hmg/5.Supplement_1.1391; DIXON MJ, 1991, AM J HUM GENET, V49, P17; DIXON MJ, 1991, AM J HUM GENET, V48, P274; DIXON MJ, 1993, AM J HUM GENET, V52, P907; Edwards SJ, 1996, J MED GENET, V33, P603, DOI 10.1136/jmg.33.7.603; FAZEN LE, 1967, AM J DIS CHILD, V113, P406; Gladwin AJ, 1996, HUM MOL GENET, V5, P1533, DOI 10.1093/hmg/5.10.1533; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Gorlin RJ, 1990, PLAST RECONSTR SURG; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; JABS EW, 1991, GENOMICS, V11, P193; JABS EW, 1993, GENOMICS, V18, P7, DOI 10.1006/geno.1993.1420; JONES KL, 1975, J PEDIATR-US, V86, P84, DOI 10.1016/S0022-3476(75)80709-8; JURILOFF DM, 1987, J CRAN GENET DEV BIO, V7, P27; KAY ED, 1989, AM J MED GENET, V32, P27, DOI 10.1002/ajmg.1320320107; KEEN J, 1991, TRENDS GENET, V7, P5; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; LOFTUS SK, 1993, HUM MOL GENET, V2, P1785, DOI 10.1093/hmg/2.11.1785; Loftus SK, 1996, GENOME RES, V6, P26, DOI 10.1101/gr.6.1.26; MARRES HAM, 1995, ARCH OTOLARYNGOL, V121, P509; MEIZNER I, 1991, J CLIN ULTRASOUND, V19, P124, DOI 10.1002/jcu.1870190213; MILLIGAN DA, 1994, MIL MED, V159, P250, DOI 10.1093/milmed/159.3.250; MULVIHILL JT, 1995, NAT GENET, V9, P101, DOI 10.1038/ng0295-101; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NICOLAIDES KH, 1984, PRENATAL DIAG, V4, P201, DOI 10.1002/pd.1970040307; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PHELPS PD, 1981, CLIN OTOLARYNGOL, V6, P15, DOI 10.1111/j.1365-2273.1981.tb01782.x; PINSKY L, 1979, PENETRANCE VARIABILI, P207; ROVIN S, 1964, J PEDIATR-US, V65, P215, DOI 10.1016/S0022-3476(64)80522-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; SULIK KK, 1987, AM J MED GENET, V27, P359, DOI 10.1002/ajmg.1320270214; SULIK KK, 1988, TERATOLOGY, V37, P527, DOI 10.1002/tera.1420370602; SULIK KK, 1989, CLEFT PALATE J, V26, P209; *TREACH COLL SYNDR, 1996, NAT GENET, V12, P130; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5	49	100	103	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					515	524						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042910				2022-12-18	WOS:A1997WK40300007
J	Slatkin, M; Rannala, B				Slatkin, M; Rannala, B			Estimating the age of alleles by use of intraallelic variability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS MUTATION; GENETIC-ANALYSIS; DELTA-F508; POPULATIONS; DESCENT	A method is presented for estimating the age of an allele by use of its frequency and the extent of variation among different copies. The method uses the joint distribution of the number of copies in a population sample and the coalescence times of the intraallelic gene genealogy conditioned on the number of copies. The linear birth-death process is used to approximate the dynamics of a rare allele in a finite population. A maximum-likelihood estimate of the age of the allele is obtained by Monte Carlo integration over the coalescence times. The method is applied to two alleles at the cystic fibrosis (CFTR) locus, Delta F508 and G542X, for which intraallelic variability at three intronic microsatellite loci has been examined. Our results indicate that G542X is somewhat older than Delta F508. Although absolute estimates depend on the mutation rates at the microsatellite loci, our results support the hypothesis that Delta F508 arose <500 generations (approximate to 10,000 years) ago.			Slatkin, M (corresponding author), UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720, USA.		Rannala, Bruce/M-3188-2014	Rannala, Bruce/0000-0002-8355-9955	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40282] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CASALS T, 1993, HUM GENET, V91, P66; Cox DR, 1974, THEORETICAL STATISTI; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DONNELLY P, 1986, ADV APPL PROBAB, V18, P1, DOI 10.2307/1427237; Edwards A.W.F, 1972, LIKELIHOOD; Ewens W.J., 1979, MATH POPULATION GENE; Fishman G. S., 1996, MONTE CARLO CONCEPTS; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; KAPLAN NL, 1994, NAT GENET, V8, P216, DOI 10.1038/ng1194-216a; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; RANNALA B, IN PRESS HEREDITY; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROMERO G, 1979, HUM GENET, V14, P439; SAWYER S, 1979, J APPL PROBAB, V14, P439; SCHROEDER SA, 1995, NAT MED, V1, P703, DOI 10.1038/nm0795-703; SERRE JL, 1990, HUM GENET, V84, P449; Slatkin M, 1996, GENETICS, V143, P579; SLATKIN M, 1991, GENETICS, V129, P355; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; Thompson E.A., 1975, HUMAN EVOLUTIONARY T; THOMPSON EA, 1976, AM J HUM GENET, V28, P442; WATTERSON GA, 1976, THEOR POPUL BIOL, V10, P239, DOI 10.1016/0040-5809(76)90018-6; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; *WOLFR RES, 1992, MATH VERS 2 2; YANG Z, IN PRESS GENETICS	32	100	101	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					447	458						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012419				2022-12-18	WOS:A1997WE93100025
J	Albarosa, R; Colombo, BM; Roz, L; Magnani, I; Pollo, B; Cirenei, N; Giani, C; Conti, AMF; DiDonato, S; Finocchiaro, G				Albarosa, R; Colombo, BM; Roz, L; Magnani, I; Pollo, B; Cirenei, N; Giani, C; Conti, AMF; DiDonato, S; Finocchiaro, G			Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; HETEROZYGOSITY; LOCI	The loss of genetic material on chromosome 10q is frequent in different tumors and particularly in malignant gliomas. We analyzed 90 of these tumors and found loss of heterozygosity (LOH) in >90% of the informative loci in glioblastoma multiforme (GBM). Initial studies restricted the common LOH region to 10q24-qter. Subsequently, the study of a pediatric GBM suggested D10S221 and D10S209, respectively, as centromeric and telomeric markers of a 4-cM LOH region. It is interesting to note that, in one subset of cells from this tumor, locus D10S209 seems involved in the allelic imbalance of a larger region, with D10S214 as telomeric marker. This 17-cM region contains the D10S587-D10S216 interval of common deletion recently defined on another set of gliomas.	IST NAZL NEUROL C BESTA,DEPT BIOCHEM & GENET,LAB MOL NEUROONCOL & GENE TRANSFER,I-20133 MILAN,ITALY; IST NAZL NEUROL C BESTA,DEPT NEUROPATHOL,I-20133 MILAN,ITALY; UNIV MILAN,DEPT BIOL & GENET MED SCI,MILAN,ITALY	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; University of Milan			Roz, Luca/AAB-3889-2019; Finocchiaro, Gaetano/AAG-6791-2020; Pollo, Bianca/K-5347-2018; Di Donato, Stefano/B-9717-2012	Roz, Luca/0000-0001-5817-7149; Pollo, Bianca/0000-0002-5523-4256; Finocchiaro, Gaetano/0000-0003-3583-4040				ALBAROSA R, 1995, HUM GENET, V95, P709; CHUMAKOV IM, 1995, NATURE, V377, P175; Colombo B. M., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P512; COSTELLO JF, 1994, MOL CELL BIOL, V14, P6515, DOI 10.1128/MCB.14.10.6515; DECKER RA, 1992, GENOMICS, V12, P604, DOI 10.1016/0888-7543(92)90455-2; EAGLE LR, 1995, NAT GENET, V9, P249, DOI 10.1038/ng0395-249; EDELHOFF S, 1994, ONCOGENE, V9, P665; FULTS D, 1993, GENE CHROMOSOME CANC, V7, P173, DOI 10.1002/gcc.2870070311; GARDNER E, 1991, GENOMICS, V11, P475, DOI 10.1016/0888-7543(91)90162-8; GRAY IC, 1995, CANCER RES, V55, P4800; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HERBST RA, 1994, CANCER RES, V54, P3111; KARLBOM AE, 1993, HUM GENET, V92, P169; Kleihues P, 1993, HISTOLOGICAL TYPING; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; MAGNANI I, 1994, CANCER GENET CYTOGEN, V75, P77, DOI 10.1016/0165-4608(94)90157-0; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MINEURA K, 1994, ACTA ONCOL, V33, P29, DOI 10.3109/02841869409098371; MORITA R, 1991, CANCER RES, V51, P5817; PEGG AE, 1990, CANCER RES, V50, P6119; PEIFFER SL, 1995, CANCER RES, V55, P1922; PERSHOUSE MA, 1993, CANCER RES, V53, P5043; RASHEED BKA, 1992, GENE CHROMOSOME CANC, V5, P75, DOI 10.1002/gcc.2870050111; RASHEED BKA, 1995, ONCOGENE, V10, P2243; REMPEL SA, 1993, CANCER RES, V53, P2386; SHINDO H, 1993, ACTA NEUROPATHOL, V86, P345, DOI 10.1007/BF00369446; SPEAKS SL, 1992, GENE CHROMOSOME CANC, V5, P239, DOI 10.1002/gcc.2870050311; TENAN M, 1994, CANCER GENET CYTOGEN, V74, P139, DOI 10.1016/0165-4608(94)90012-4; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	31	100	106	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1996	58	6					1260	1267						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UM271	8651304				2022-12-18	WOS:A1996UM27100020
J	PUIG, S; RUIZ, A; LAZARO, C; CASTEL, T; LYNCH, M; PALOU, J; VILALTA, A; WEISSENBACH, J; MASCARO, JM; ESTIVILL, X				PUIG, S; RUIZ, A; LAZARO, C; CASTEL, T; LYNCH, M; PALOU, J; VILALTA, A; WEISSENBACH, J; MASCARO, JM; ESTIVILL, X			CHROMOSOME 9P DELETIONS IN CUTANEOUS MALIGNANT-MELANOMA TUMORS - THE MINIMAL DELETED REGION INVOLVES MARKERS OUTSIDE THE P16 (CDKN2) GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMOZYGOUS DELETIONS; FAMILIAL MELANOMA; SHORT ARM	We have analyzed 12 microsatellite markers on chromosome 9p in 54 paired cutaneous malignant melanoma (CMM) tumors and normal tissues. Forty-six percent of the tumors, including two in situ CMMs, showed loss of heterozygosity (LOH) at 9p. Only one tumor was homozygously deleted for 9p markers. The smallest deleted region was defined by five tumors and included markers D9S126 to D9S253. Loss of eight or more markers correlated significantly with worse prognosis (P < .002). Among the primary tumors, 87.5% of those with large deletions have a high risk of metastasis, as compared with only 18% of those without deletions or with loss of fewer than 8 markers (P < .001). It was not possible to demonstrate homozygous deletions of p16 in any of the CMM tumors. In four tumors, the LOH for 9p markers did not involve p16. The reported data suggest the existence of several tumor suppressor genes at 9p that are involved in the predisposition to and/or progression of CMM and exclude p16 from involvement in the early development of some melanoma tumors.	HOSP DURAN & REYNALS,CANC RES INST,DEPT MOLEC GENET,E-08907 BARCELONA,SPAIN; HOSP CLIN BARCELONA,DEPT DERMATOL,BARCELONA,SPAIN; HOSP CLIN BARCELONA,GENET SERV,BARCELONA,SPAIN; INST PASTEUR,MOLEC GENET UNIT,PARIS,FRANCE	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			GARCIA, CONXI LAZARO/Q-2410-2016; Estivill, Xavier/A-3125-2013	GARCIA, CONXI LAZARO/0000-0002-7198-5906; Estivill, Xavier/0000-0002-0723-2256; Puig, Susana/0000-0003-1337-9745				BAGLEY FH, 1981, CANCER-AM CANCER SOC, V47, P2126, DOI 10.1002/1097-0142(19810501)47:9<2126::AID-CNCR2820470904>3.0.CO;2-C; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; CAIRNS P, 1994, SCIENCE, V265, P415, DOI 10.1126/science.8023167; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CHENG JQ, 1993, CANCER RES, V53, P4761; CHILCOTE RR, 1985, NEW ENGL J MED, V313, P286, DOI 10.1056/NEJM198508013130503; CLARK WH, 1969, CANCER RES, V29, P705; Fleiss JL, 1981, STAT METHODS RATES P; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; Gruis N. A., 1994, American Journal of Human Genetics, V55, pA58; GUERRY D, 1993, J INVEST DERMATOL, V100, pS342, DOI 10.1111/1523-1747.ep12470248; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hayward N. K., 1994, American Journal of Human Genetics, V55, pA59; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; ISSHIKI K, 1994, ONCOGENE, V9, P1649; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KOH HK, 1991, NEW ENGL J MED, V325, P171, DOI 10.1056/NEJM199107183250306; MACGEOCH C, 1994, HUM MOL GENET, V3, P2195, DOI 10.1093/hmg/3.12.2195; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; NANCARROW DJ, 1993, AM J HUM GENET, V53, P936; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; OHTA M, 1994, CANCER RES, V54, P5269; OLOPADE OI, 1992, GENOMICS, V14, P437, DOI 10.1016/S0888-7543(05)80238-1; PARMITER AH, 1993, J INVEST DERMATOL, V100, pS254, DOI 10.1038/jid.1993.46; PETTY EM, 1993, AM J HUM GENET, V53, P96; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SPRUCK CH, 1994, NATURE, V370, P183, DOI 10.1038/370183a0; UEKI K, 1994, HUM MOL GENET, V3, P1841, DOI 10.1093/hmg/3.10.1841; Walker G. J., 1994, American Journal of Human Genetics, V55, pA73; WALKER GJ, 1994, ONCOGENE, V9, P819; WEAVERFELDHAUS J, 1994, P NATL ACAD SCI USA, V91, P7563, DOI 10.1073/pnas.91.16.7563	36	100	101	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					395	402						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668266				2022-12-18	WOS:A1995RL77100023
J	HAO, HL; BONILLA, E; MANFREDI, G; DIMAURO, S; MORAES, CT				HAO, HL; BONILLA, E; MANFREDI, G; DIMAURO, S; MORAES, CT			SEGREGATION PATTERNS OF A NOVEL MUTATION IN THE MITOCHONDRIAL TRANSFER-RNA GLUTAMIC-ACID GENE ASSOCIATED WITH MYOPATHY AND DIABETES-MELLITUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER RNA(LEU(UUR)) GENE; STROKE-LIKE EPISODES; PROTEIN-SYNTHESIS; LACTIC-ACIDOSIS; MELAS MUTATION; DNA; DELETIONS; DEAFNESS; DEFECTS; DISEASE	We have identified a novel mtDNA mutation in a 29-year-old man with myopathy and diabetes mellitus. This T-->C transition at mtDNA position 14709 alters an evolutionarily conserved nucleotide in the region specifying for the anticodon loop of the mitochondrial tRNA(Glu). The nt-14709 mutation was heteroplasmic but present at very high levels in the patient's muscle, white blood cells (WBCs), and hair follicles; lower proportions of mutated mtDNA were observed in WBCs and hair follicles of all examined maternal relatives. In the patient's muscle, abnormal fibers showed mitochondrial proliferation, severe focal defects in cytochrome c oxidase activity, and absence of cross-reacting material for mitochondrially synthesized polypeptides. These fibers had higher levels of mutated mtDNA than did surrounding ''normal'' fibers. Although the percentage of mutated mtDNA in WBCs from family members were distributed around the percentage observed in the mothers, the pattern was different in hair follicles, where the mutated population tended to increase in subsequent generations. PCR/RFLP analysis of single hairs showed that the intercellular variations in the percentage of mutated mtDNA differed among family members, with younger generations having a more homogeneous distribution of mutated mtDNA in different hair follicles. These results suggest that the intercellular distribution of the mutated and wild-type mtDNA populations may drift toward homogeneity in subsequent generations.	UNIV MIAMI,SCH MED,DEPT NEUROL,MIAMI,FL 33136; UNIV MIAMI,DEPT CELL BIOL & ANAT,MIAMI,FL 33136; COLUMBIA UNIV,DEPT NEUROL,NEW YORK,NY	University of Miami; University of Miami; Columbia University			Moraes, Carlos/AAT-3818-2021					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAGERVALL TG, 1990, BIOCHIM BIOPHYS ACTA, V1050, P263, DOI 10.1016/0167-4781(90)90178-5; HANNA MG, 1994, AM J HUM GENET S, V55, P1298; HOLT IJ, 1990, AM J HUM GENET, V46, P428; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284; MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913; MORAES CT, 1992, AM J HUM GENET, V50, P934; MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q; PENA SDJ, 1994, P NATL ACAD SCI USA, V91, P1946, DOI 10.1073/pnas.91.5.1946; PETRUZZELLA V, 1994, HUM MOL GENET, V3, P449, DOI 10.1093/hmg/3.3.449; POULTON J, 1993, HUM MOL GENET, V2, P23, DOI 10.1093/hmg/2.1.23; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SERVIDEI S, 1994, NEUROMUSCULAR DISORD, V4, P285; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; WALLACE DC, 1990, CYTOGENET CELL GENET, V55, P395, DOI 10.1159/000133024; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324	27	100	103	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1017	1025						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726154				2022-12-18	WOS:A1995QU58600001
J	BROUGHTON, BC; THOMPSON, AF; HARCOURT, SA; VERMEULEN, W; HOEIJMAKERS, JHJ; BOTTA, E; STEFANINI, M; KING, MD; WEBER, CA; COLE, J; ARLETT, CF; LEHMANN, AR				BROUGHTON, BC; THOMPSON, AF; HARCOURT, SA; VERMEULEN, W; HOEIJMAKERS, JHJ; BOTTA, E; STEFANINI, M; KING, MD; WEBER, CA; COLE, J; ARLETT, CF; LEHMANN, AR			MOLECULAR AND CELLULAR ANALYSIS OF THE DNA-REPAIR DEFECT IN A PATIENT IN XERODERMA-PIGMENTOSUM COMPLEMENTATION GROUP-D WHO HAS THE CLINICAL-FEATURES OF XERODERMA-PIGMENTOSUM AND COCKAYNE-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; RAD3 PROTEIN; YEAST RAD3; HUMAN-FIBROBLASTS; UV-SENSITIVITY; GROUP-H; HELICASE; GENE; TRICHOTHIODYSTROPHY	Xeroderma pigmentosum (XP) and Cockayne syndrome (CS) are quite distinct genetic disorders that are associated with defects in excision repair of UV-induced DNA damage. A few patients have been described previously with the clinical features of both disorders. In this paper we describe an individual in this category who has unusual cellular responses to UV light. We show that his cultured fibroblasts and lymphocytes are extremely sensitive to irradiation with UV-C, despite a level of nucleotide excision repair that is 30%-40% that of normal cells. The deficiency is assigned to the XP-D complementation group, and we have identified two causative mutations in the XPD gene: a gly-->arg change at amino acid 675 in the allele inherited from the patient's mother and a -1 frameshift at amino acid 669 in the allele inherited from his father. These mutations are in the C-terminal 20% of the 760-amino-acid XPD protein, in a region where we have recently identified several mutations in patients with trichothiodystrophy.	UNIV SUSSEX,MRC,CELL MUTAT UNIT,BRIGHTON BN1 9RR,E SUSSEX,ENGLAND; ERASMUS UNIV ROTTERDAM,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS; IST GENET BIOCHIM EVOLUZ,PAVIA,ITALY; OUR LADYS HOSP SICK CHILDREN,DUBLIN,IRELAND; LAWRENCE LIVERMORE NATL LAB,BIOL & BIOTECHNOL RES PROGRAM,LIVERMORE,CA	University of Sussex; Erasmus University Rotterdam; Our Ladys Children Hospital Crumlin; United States Department of Energy (DOE); Lawrence Livermore National Laboratory			Botta, Elena/B-9065-2015; Hoeijmakers, Jan/AAX-6972-2021; Vermeulen, Wim/W-8708-2019	Vermeulen, Wim/0000-0003-3616-734X; BOTTA, ELENA/0000-0003-2060-0110				ARLETT CF, 1993, CANCER RES, V53, P609; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; BROUGHTON BC, 1994, NAT GENET, V7, P189, DOI 10.1038/ng0694-189; Cleaver JE, 1989, METABOLIC BASIS INHE, V6th, P2949; Cole J, 1984, MUTAGENICITY TESTING, P233; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; GALLOWAY AM, 1994, J BIOL CHEM, V269, P974; ITIN PH, 1990, J AM ACAD DERMATOL, V20, P705; JOHNSON RT, 1989, HUM GENET, V81, P203; JOHNSON RT, 1992, MUTAT RES, V273, P97, DOI 10.1016/0921-8777(92)90072-B; KOVALIC D, 1991, NUCLEIC ACIDS RES, V19, P4560, DOI 10.1093/nar/19.16.4560; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; LAFFORET D, 1978, ARCH FR PEDIATR, V35, P65; LEHMANN A R, 1987, Cancer Reviews, V7, P82; LEHMANN AR, 1980, MUTAT RES, V69, P177, DOI 10.1016/0027-5107(80)90187-6; LEHMANN AR, 1993, J MED GENET, V30, P679, DOI 10.1136/jmg.30.8.679; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; LEHMANN AR, 1985, LANCET, V1, P486; LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6; MAYNE LV, 1982, MUTAT RES, V106, P179, DOI 10.1016/0027-5107(82)90200-7; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; MOSHELL AM, 1986, CELLULAR RESPONSES D, P209; MURRAY JM, 1992, NUCLEIC ACIDS RES, V20, P2673, DOI 10.1093/nar/20.11.2673; NAEGELI H, 1992, J BIOL CHEM, V267, P7839; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; ROBBINS JH, 1974, ANN INTERN MED, V80, P221, DOI 10.7326/0003-4819-80-2-221; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SCOTT RJ, 1993, J AM ACAD DERMATOL, V29, P883, DOI 10.1016/0190-9622(93)70263-S; SMITH CA, 1976, BIOCHIM BIOPHYS ACTA, V447, P121, DOI 10.1016/0005-2787(76)90335-X; SONG JM, 1990, J BACTERIOL, V172, P6620, DOI 10.1128/jb.172.12.6620-6630.1990; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; STEFANINI M, 1993, AM J HUM GENET, V53, P817; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERMEULEN W, 1993, AM J HUM GENET, V53, P185; VERMEULEN W, 1991, MUTAT RES, V255, P201, DOI 10.1016/0921-8777(91)90054-S; VERMEULEN W, IN PRESS COLD SPRING; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x	44	100	104	1	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					167	174						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825573				2022-12-18	WOS:A1995QC10100021
J	SAVELYEVA, L; CORVI, R; SCHWAB, M				SAVELYEVA, L; CORVI, R; SCHWAB, M			TRANSLOCATION INVOLVING 1P AND 17Q IS A RECURRENT GENETIC ALTERATION OF HUMAN NEUROBLASTOMA-CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN NEURO-BLASTOMA; SINGLE HUMAN-CHROMOSOMES; SHORT ARM; HETEROZYGOSITY; ABNORMALITIES; AMPLIFICATION; DEFINITION; MUTATIONS; LINES	Human neuroblastoma cells often are monosomic for the distal portion of Ip (1p36). We report that the deleted 1p material in cells of neuroblastoma lines is preferentially replaced by material from chromosome 17, resulting from an unbalanced 1;17 translocation. Chromosome 17 often acquires instability, followed by the integration of fragments into various marker chromosomes. As a consequence, 17q material can increase over 17p material. The nonrandom frequency of 1;17 translocations appears to indicate an as-yet-undefined contribution to neuroblastoma development.	DEUTSCH KREBSFORSCHUNGSZENTRUM,ZYTOGENET ABT 0130,D-69120 HEIDELBERG,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ)								AMLER LC, 1989, MOL CELL BIOL, V9, P4906; BADER SA, 1991, CELL GROWTH DIFFER, V2, P245; BARKER PE, 1993, ONCOGENE, V8, P3353; BARKER PE, 1993, METHODS MOL GENETICS, V2, P129; BRODEUR GM, 1981, CANCER RES, V41, P4678; BRODEUR GM, 1989, CANCER GENET CYTOGEN, V41, P153, DOI 10.1016/0165-4608(89)90243-4; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; BUROKER N, 1987, HUM GENET, V77, P175, DOI 10.1007/BF00272388; CARON H, 1994, AM J HUM GENET, V55, P341; CHRISTIANSEN H, 1988, BRIT J CANCER, V57, P121, DOI 10.1038/bjc.1988.24; COLLINS C, 1991, GENOMICS, V11, P997, DOI 10.1016/0888-7543(91)90025-A; CROPP CS, 1990, P NATL ACAD SCI USA, V87, P7737, DOI 10.1073/pnas.87.19.7737; DONTI E, 1988, CANCER GENET CYTOGEN, V60, P225; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FONG CT, 1992, CANCER RES, V52, P1780; GILBERT F, 1984, CANCER RES, V44, P5444; HAYASHI Y, 1989, CANCER, V63, P126, DOI 10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z; HUNT JD, 1990, GENE CHROMOSOME CANC, V2, P137, DOI 10.1002/gcc.2870020210; LAUREYS G, 1990, GENE CHROMOSOME CANC, V2, P252, DOI 10.1002/gcc.2870020315; MARTINSSON T, 1989, GENE CHROMOSOME CANC, V1, P67, DOI 10.1002/gcc.2870010111; Mitelman F., 1991, ISCN GUIDELINES CANC; OHGAKI H, 1993, MOL CARCINOGEN, V8, P74, DOI 10.1002/mc.2940080203; PIETSCH T, 1988, ANTICANCER RES, V8, P1329; RITKE MK, 1989, CYTOGENET CELL GENET, V50, P84, DOI 10.1159/000132729; ROSS RA, 1983, J NATL CANCER I, V71, P741; SCHWAB M, 1991, ADV NEUROBLASTOMA RE, V3, P1; SEEGER RC, 1982, J IMMUNOL, V128, P983; SEEGER RC, 1977, CANCER RES, V37, P1364; SHAPIRO DN, 1993, AM J PATHOL, V142, P1339; TAKAYAMA H, 1992, ONCOGENE, V7, P1185; TAKEDA O, 1994, GENE CHROMOSOME CANC, V10, P30, DOI 10.1002/gcc.2870100106; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; VOGAN K, 1993, CANCER RES, V53, P5269; WADA RK, 1988, ADV NEUROBLASTOMA RE, V2, P57; WEITH A, 1989, GENE CHROMOSOME CANC, V1, P159, DOI 10.1002/gcc.2870010209	35	100	101	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					334	340						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037210				2022-12-18	WOS:A1994NZ33600015
J	RICHARDS, JE; LICHTER, PR; BOEHNKE, M; URO, JLA; TORREZ, D; WONG, D; JOHNSON, AT				RICHARDS, JE; LICHTER, PR; BOEHNKE, M; URO, JLA; TORREZ, D; WONG, D; JOHNSON, AT			MAPPING OF A GENE FOR AUTOSOMAL-DOMINANT JUVENILE-ONSET OPEN-ANGLE GLAUCOMA TO CHROMOSOME-IQ	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; ATRIAL-NATRIURETIC-FACTOR; AQUEOUS-HUMOR DYNAMICS; EPSTEIN-BARR VIRUS; INTRAOCULAR-PRESSURE; TRABECULAR-MESHWORK; CILIARY EPITHELIUM; CHAIN-REACTION; 2 GENES; LOCALIZATION	A large Caucasian family is presented, in which a juvenile-onset form of open-angle glaucoma is transmitted in an autosomal dominant fashion. Sixteen affected family members were identified from 31 at-risk individuals descended from the affected founder. Affected patients developed high intraocular pressures (sometimes >40 mm Hg) within the first 2 decades of life. Linkage analysis between the disease phenotype and 12 microsatellite repeat markers located on chromosome 1q gave a maximum lod score of 8.38 at a recombination fraction of zero for marker D1S210. Analysis of recombinant haplotypes suggests a total inclusion region of about 14 cM between markers D1S194 and D1S218 at 1q21-q31. This represents the second juvenile-glaucoma family, in which the disease has been mapped to the long arm of chromosome 1.	UNIV MICHIGAN,DEPT EPIDEMIOL,ANN ARBOR,MI 48105; UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI 48105	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	RICHARDS, JE (corresponding author), UNIV MICHIGAN,W K KELLOGG EYE CTR,DEPT OPHTHALMOL,1000 WALL ST,ANN ARBOR,MI 48105, USA.			Lichter, Paul/0000-0001-8394-4813; Johnson, Arlan/0000-0002-9519-2943	NEI NIH HHS [EY09580, EY07003] Funding Source: Medline; NHGRI NIH HHS [P30 HG00209] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009580] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000209] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BECKER B, 1980, INVEST OPHTH VIS SCI, V19, P1156; BEIGUELMAN B, 1963, J GENET HUM, V12, P53; BELL J, 1932, SOME HEREDITARY STRU, V2; Berg F., 1932, ACTA OPHTHALMOL, V10, P568, DOI [10.1111/j.1755-3768.1932.tb07210.x, DOI 10.1111/J.1755-3768.1932.TB07210.X]; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; Courtney RH, 1931, J AMER MED ASSOC, V97, P1602; CROMBIE A L, 1964, Br J Ophthalmol, V48, P143, DOI 10.1136/bjo.48.3.143; DAVID R, 1980, BRIT J OPHTHALMOL, V64, P227, DOI 10.1136/bjo.64.4.227; DIESTELHORST M, 1989, INT OPHTHALMOL, V13, P99, DOI 10.1007/BF02028647; ELLIS OH, 1948, AM J OPHTHALMOL, V31, P1589, DOI 10.1016/S0002-9394(48)91298-7; ENGELSTEIN M, 1993, GENOMICS, V15, P251, DOI 10.1006/geno.1993.1054; FERNANDEZDURANGO R, 1990, VISION RES, V30, P1305, DOI 10.1016/0042-6989(90)90004-5; FRANCOIS J, 1980, J FR OPHTALMOL, V3, P429; FUKUSHIMA Y, 1988, CYTOGENET CELL GENET, V48, P137, DOI 10.1159/000132610; GHOSH S, 1991, J CELL PHYSIOL, V149, P184, DOI 10.1002/jcp.1041490203; JOHNSON AT, 1993, OPHTHALMOLOGY, V100, P524; KOBAYASHI T, 1989, Nippon Ganka Gakkai Zasshi, V93, P396; KRUPIN T, 1986, T OPHTHAL SOC UK, V105, P156; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; KUROSAWA A, 1987, EXP EYE RES, V45, P239, DOI 10.1016/S0014-4835(87)80147-1; LANE LK, 1989, GENOMICS, V5, P445, DOI 10.1016/0888-7543(89)90008-6; LANGE K, 1988, GENET EPIDEMIOL, V5, P461; LITT M, 1989, AM J HUM GENET, V44, P397; LOTUFO D, 1989, JAMA-J AM MED ASSOC, V261, P429; LOWE DG, 1990, GENOMICS, V8, P304, DOI 10.1016/0888-7543(90)90286-4; MARTIN JP, 1974, BR J OPTHALMOL, V58, P236; McKusick V.A., 1992, MENDELIAN INHERITANC; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; MORTON NE, 1955, AM J HUM GENET, V7, P277; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MURPHY CG, 1987, AM J OPHTHALMOL, V104, P33, DOI 10.1016/0002-9394(87)90290-X; OLSON JM, 1990, AM J HUM GENET, V47, P470; OLSON S, 1991, GENOMICS, V9, P629, DOI 10.1016/0888-7543(91)90356-J; PODOS SM, 1984, INVEST OPHTH VIS SCI, V25, P359; RAEYMAEKERS P, 1989, HUM GENET, V81, P231, DOI 10.1007/BF00278994; Richardson C.C., 1981, ENZYMES A, V14, P299, DOI DOI 10.1016/S1874-6047(08)60342-X; RILEY MV, 1986, EXP EYE RES, V42, P559, DOI 10.1016/0014-4835(86)90046-1; ROGNE S, 1989, GENOMICS, V4, P169, DOI 10.1016/0888-7543(89)90296-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELDIN MF, 1989, CYTOGENET CELL GENET, V51, P1077; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SOMMER A, 1991, NEW ENGL J MED, V325, P1412, DOI 10.1056/NEJM199111143252004; Stokes WH, 1940, ARCH OPHTHALMOL-CHIC, V24, P885, DOI 10.1001/archopht.1940.00870050035002; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; TINNING S, 1975, HUM HERED, V25, P453, DOI 10.1159/000152760; UUSITALO RJ, 1985, ACTA OPHTHALMOL, V63, P401; VALTOT F, 1991, OPHTALMOLOGIE, V5, P461; WEATHERI.JR, 1969, BRIT J OPHTHALMOL, V53, P433, DOI 10.1136/bjo.53.7.433; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2835; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2199; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILSON MR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1066; YANG-FENG T L, 1988, Genomics, V2, P128, DOI 10.1016/0888-7543(88)90094-8	57	100	117	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1994	54	1					62	70						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ700	8279471				2022-12-18	WOS:A1994MQ70000009
J	KOCKUM, I; WASSMUTH, R; HOLMBERG, E; MICHELSEN, B; LERNMARK, A				KOCKUM, I; WASSMUTH, R; HOLMBERG, E; MICHELSEN, B; LERNMARK, A			HLA-DQ PRIMARILY CONFERS PROTECTION AND HLA-DR SUSCEPTIBILITY IN TYPE-I (INSULIN-DEPENDENT) DIABETES STUDIED IN POPULATION-BASED AFFECTED FAMILIES AND CONTROLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; BETA-CHAIN; GENETIC SUSCEPTIBILITY; ASPARTIC-ACID; RESTRICTION FRAGMENTS; IDDM PATIENTS; A ANTIGENS; MELLITUS; HAPLOTYPES; JAPANESE	The association between HLA-DR and -DQ and insulin-dependent diabetes mellitus (IDDM) in a defined high-incidence area was analyzed in a total of 58 population-based patients, representing 77% of IDDM patients with age at onset below 16 years, and in 92 unrelated parents in control families without IDDM. HLA haplotypes were confirmed by analyzing first-degree relatives in both groups. Seven different methods were used to analyze risk: (1) odds ratio, (2) absolute risk, (3) haplotype relative risk, (4) transcomplementation relative risk, (5) relative predisposing effects, (6) stratification analysis, and (7) test of predisposing allele on haplotype. DQB1*0302 indicated somewhat higher risk than did DR4, while DR3 had a higher risk than DQB1*0201; however, the 95% confidence intervals of the risk estimates overlapped. The positive association between IDDM and the DQB1*0201-DQA1*0501-DR3 haplotype seems to be due to DR3 or to an unknown linked gene. More important, DQA1*0301 was present among 93% of the patients, and this allele in various transcomplementation combinations with DQB1 alleles showed closer association to IDDM than did any other alleles. The strong negative association of the DQB1*0602 allele also in the presence of either DR4 or DQB1*0302 or both suggests that, in a high-risk population for IDDM, HLA-DQ primarily confers protection, perhaps by induction of tolerance. Consistent with known functions, HLA-DR may primarily confer susceptibility, perhaps by induction of autoreactive T lymphocytes.	KAROLINSKA INST,KAROLINSKA HOSP,DEPT ENDOCRINOL,S-10401 STOCKHOLM 60,SWEDEN; UNIV WASHINGTON,DEPT MED,RH WILLIAMS LAB,SEATTLE,WA 98195; LUND UNIV,WALLENBERG LAB,S-22101 LUND,SWEDEN; UNIV ERLANGEN NURNBERG,MED KLIN 3,W-8520 ERLANGEN,GERMANY; UMEA UNIV,DEPT PEDIAT,S-90187 UMEA,SWEDEN; HAGEDORN RES LAB,GENTOFTE,DENMARK	Karolinska Institutet; Karolinska University Hospital; University of Washington; University of Washington Seattle; Lund University; University of Erlangen Nuremberg; Umea University; Novo Nordisk; Hagedorn Research Institute			Lernmark, Åke/F-8140-2015; Kockum, Ingrid/O-8781-2018	Lernmark, Åke/0000-0003-1735-0499; Kockum, Ingrid/0000-0002-0867-4726	NIDDK NIH HHS [DK 47426] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTMANN DM, 1991, IMMUNOL TODAY, V12, P267, DOI 10.1016/0167-5699(91)90124-C; APARICIO JMR, 1988, IMMUNOGENETICS, V28, P240, DOI 10.1007/BF00345500; AWATA T, 1990, DIABETES, V39, P266, DOI 10.2337/diabetes.39.2.266; BADENHOOP K, 1990, TISSUE ANTIGENS, V35, P32, DOI 10.1111/j.1399-0039.1990.tb01752.x; BAISCH JM, 1990, NEW ENGL J MED, V322, P1836, DOI 10.1056/NEJM199006283222602; BARBOSA J, 1980, J CLIN INVEST, V65, P592, DOI 10.1172/JCI109704; BHATIA E, 1986, HORM METAB RES, V18, P331, DOI 10.1055/s-2007-1012308; BLOOM BR, 1992, IMMUNOL TODAY, V13, P131, DOI 10.1016/0167-5699(92)90110-S; BODMER JG, 1990, HUM IMMUNOL, V28, P326, DOI 10.1016/0198-8859(90)90060-3; BOHME J, 1986, J IMMUNOL, V137, P941; BRUSERUD O, 1987, SCAND J IMMUNOL, V25, P235, DOI 10.1111/j.1365-3083.1987.tb01069.x; CHANG HC, 1983, NATURE, V305, P813, DOI 10.1038/305813a0; COHENHAGUENAUER O, 1985, P NATL ACAD SCI USA, V82, P3335, DOI 10.1073/pnas.82.10.3335; CUDWORTH AG, 1975, DIABETES, V24, P345, DOI 10.2337/diabetes.24.4.345; DUNSTON GM, 1989, TRANSPLANT P, V21, P653; EASTEAL S, 1990, TISSUE ANTIGENS, V35, P71, DOI 10.1111/j.1399-0039.1990.tb01759.x; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FLETCHER J, 1988, DIABETOLOGIA, V31, P343, DOI 10.1007/BF02341501; FLETCHER J, 1988, DIABETOLOGIA, V31, P864; HAGGLOF B, 1986, HUM HERED, V36, P201, DOI 10.1159/000153627; HAGGLOF B, 1982, HUM HERED, V32, P408, DOI 10.1159/000153330; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HAWKINS BR, 1987, DIABETES, V36, P1297, DOI 10.2337/diabetes.36.11.1297; HENSON V, 1987, IMMUNOGENETICS, V25, P152, DOI 10.1007/BF00344028; HIRAYAMA K, 1987, NATURE, V327, P426, DOI 10.1038/327426a0; HITMAN GA, 1988, BIOMED BIOCHIM ACTA, V47, P329; HURLEY CK, 1989, HUM IMMUNOL, V25, P37, DOI 10.1016/0198-8859(89)90068-2; JENKINS D, 1991, DIABETOLOGIA, V34, P109, DOI 10.1007/BF00500381; JENKINS D, 1990, DIABETOLOGIA, V33, P387, DOI 10.1007/BF00404086; JU LY, 1991, TISSUE ANTIGENS, V37, P218, DOI 10.1111/j.1399-0039.1991.tb01875.x; KHALIL I, 1990, J CLIN INVEST, V85, P1315, DOI 10.1172/JCI114569; LONG EO, 1983, EMBO J, V2, P389, DOI 10.1002/j.1460-2075.1983.tb01435.x; MAEDA H, 1980, TISSUE ANTIGENS, V15, P173; MICHELSEN B, 1987, J CLIN INVEST, V79, P1144, DOI 10.1172/JCI112931; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; MIJOVIC CH, 1991, DIABETES, V40, P748, DOI 10.2337/diabetes.40.6.748; MONOS DS, 1987, IMMUNOGENETICS, V26, P299, DOI 10.1007/BF00346526; MOREL PA, 1988, P NATL ACAD SCI USA, V85, P8111, DOI 10.1073/pnas.85.21.8111; NEPOM BS, 1986, J EXP MED, V164, P345, DOI 10.1084/jem.164.1.345; NEPOM GT, 1990, DIABETES, V39, P1153, DOI 10.2337/diabetes.39.10.1153; NERUP J, 1974, LANCET, V2, P864; OLERUP O, 1992, P NATL ACAD SCI USA, V89, P10653, DOI 10.1073/pnas.89.22.10653; OWERBACH D, 1989, DIABETES, V38, P942, DOI 10.2337/diabetes.38.7.942; PAYAMI H, 1989, AM J HUM GENET, V45, P541; PLATZ P, 1981, DIABETOLOGIA, V21, P108; REIJONEN H, 1990, DIABETOLOGIA, V33, P357, DOI 10.1007/BF00404640; RONNINGEN KS, 1991, DIABETES, V40, P759, DOI 10.2337/diabetes.40.6.759; RUBINSTEIN P, 1990, DIABETES, V39, P1138, DOI 10.2337/diabetes.39.9.1138; SCHLESSEMAN JJ, 1982, CASE CONTROL STUDIES; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SINGAL DP, 1973, DIABETES, V22, P429, DOI 10.2337/diab.22.6.429; SOLOW H, 1979, DIABETES, V28, P1, DOI 10.2337/diabetes.28.1.1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STERKERS G, 1988, P NATL ACAD SCI USA, V85, P6473, DOI 10.1073/pnas.85.17.6473; SVEJGAARD A, 1989, GENET EPIDEMIOL, V6, P1, DOI 10.1002/gepi.1370060104; THOMSON G, 1988, AM J HUM GENET, V43, P799; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, 1984, AM J HUM GENET, V36, P1309; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; TODD JA, 1990, P NATL ACAD SCI USA, V87, P1094, DOI 10.1073/pnas.87.3.1094; VADHEIM CM, 1989, DIABETES CARE, V12, P497, DOI 10.2337/diacare.12.7.497; VALLETCOLOM I, 1990, DIABETOLOGIA, V33, P174, DOI 10.1007/BF00404046; WASSMUTH R, UNPUB HLA DR DQ GENO; WASSMUTH R, 1990, CLIN IMMUNOL IMMUNOP, V53, P358; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; YAMAGATA K, 1991, DIABETOLOGIA, V34, P133, DOI 10.1007/BF00500386	67	100	100	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					150	167						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317480				2022-12-18	WOS:A1993LJ38500019
J	DACOUVOUTETAKIS, C; FELTQUATE, DM; DRAKOPOULOU, M; KOURIDES, IA; DRACOPOLI, NC				DACOUVOUTETAKIS, C; FELTQUATE, DM; DRAKOPOULOU, M; KOURIDES, IA; DRACOPOLI, NC			FAMILIAL HYPOTHYROIDISM CAUSED BY A NONSENSE MUTATION IN THE THYROID-STIMULATING HORMONE BETA-SUBUNIT GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MIT,CTR CANC RES,E17-536,77 MASSACHUSETTS AVE,CAMBRIDGE,MA 02139; MEM SLOAN KETTERING CANC CTR,MOLEC ENDOCRINOL LAB,NEW YORK,NY 10021; UNIV ATHENS,AGHIA SOPHIA CHILDRENS HOSP,DEPT PEDIAT 1,ATHENS,GREECE; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Massachusetts Institute of Technology (MIT)				Dracopoli, Nicholas/0000-0003-3962-4059	NCI NIH HHS [CA-44176, CA-23185] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R23CA044176, R29CA044176, R01CA023185] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTONARAKIS SE, 1985, NEW ENGL J MED, V313, P842, DOI 10.1056/NEJM198510033131402; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BENTLEY AK, 1986, CELL, V45, P343, DOI 10.1016/0092-8674(86)90319-3; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; BREAKEFIELD XO, 1984, P NATL ACAD SCI-BIOL, V81, P4213, DOI 10.1073/pnas.81.13.4213; DRACOPOLI N C, 1988, Genomics, V3, P161, DOI 10.1016/0888-7543(88)90148-6; DRACOPOLI NC, 1987, CANCER RES, V47, P3995; DRACOPOLI NC, 1986, P NATL ACAD SCI USA, V83, P1822, DOI 10.1073/pnas.83.6.1822; DRACOPOLI NC, 1988, AM J HUM GENET, V43, P462; DUCHANGE N, 1986, NUCLEIC ACIDS RES, V14, P2408, DOI 10.1093/nar/14.5.2408; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GITSCHIER J, 1985, NATURE, V315, P427, DOI 10.1038/315427a0; GITSCHIER J, 1986, SCIENCE, V232, P1415, DOI 10.1126/science.3012775; GUIDON PT, 1988, DNA-J MOLEC CELL BIO, V7, P691, DOI 10.1089/dna.1988.7.691; GUSELLA JF, 1984, IN VITRO, V20, P856; HATA A, 1989, AM J HUM GENET, V45, P123; HAYASHIZAKI Y, 1985, FEBS LETT, V188, P394, DOI 10.1016/0014-5793(85)80409-9; HAYASHIZAKI Y, 1989, EMBO J, V8, P2291, DOI 10.1002/j.1460-2075.1989.tb08355.x; KIDD VJ, 1983, NATURE, V304, P230, DOI 10.1038/304230a0; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; LABBE A, 1984, CLIN PEDIATR, V23, P675, DOI 10.1177/000992288402301202; LUDWIG M, 1989, AM J HUM GENET, V45, P115; MAEDA S, 1986, MOL BIOL MED, V3, P329; MIYAI K, 1971, NEW ENGL J MED, V285, P1043, DOI 10.1056/NEJM197111042851902; OCONNELL P, 1989, GENOMICS, V4, P12, DOI 10.1016/0888-7543(89)90308-X; ROMEO G, 1987, P NATL ACAD SCI USA, V84, P2829, DOI 10.1073/pnas.84.9.2829; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHIBASAKI Y, 1985, J CLIN INVEST, V76, P378, DOI 10.1172/JCI111973; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; WONDISFORD FE, 1988, J BIOL CHEM, V263, P12538; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	34	100	103	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					988	993						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	1971148				2022-12-18	WOS:A1990DD89600019
J	RICCARDI, VM; LEWIS, RA				RICCARDI, VM; LEWIS, RA			PENETRANCE OF VONRECKLINGHAUSEN NEUROFIBROMATOSIS - A DISTINCTION BETWEEN PREDECESSORS AND DESCENDANTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED, CULLEN EYE INST, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT OPHTHALMOL, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	RICCARDI, VM (corresponding author), BAYLOR COLL MED, DEPT MED, NEUROFIBROMATOSIS PROGRAM, HOUSTON, TX 77030 USA.							BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BERRY S A, 1984, American Journal of Human Genetics, V36, p44S; Carey J C, 1979, Birth Defects Orig Artic Ser, V15, P271; CROWE FW, 1956, CLIN PATHOLOGICAL GE, P1; MARTUZA RL, IN PRESS N ENGL J ME; RICCARDI V M, 1982, Current Problems in Cancer, V7, P1, DOI 10.1016/S0147-0272(82)80016-0; RICCARDI VM, 1984, AM J MED GENET, V18, P169, DOI 10.1002/ajmg.1320180121; RICCARDI VM, 1987, J MED GENET, V24, P521, DOI 10.1136/jmg.24.9.521; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; Rubenstein AE, 1983, NEUROLOGY S2, V33, P76; SCHMALE MC, 1986, ANN NY ACAD SCI, V486, P386, DOI 10.1111/j.1749-6632.1986.tb48092.x; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SERGEYEV AS, 1975, HUMANGENETIK, V28, P129, DOI 10.1007/BF00735745; SPENCE MA, 1983, J MED GENET, V20, P334, DOI 10.1136/jmg.20.5.334	16	100	105	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					284	289						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	3124613				2022-12-18	WOS:A1988M313300010
J	SMITH, B; SKARECKY, D; BENGTSSON, U; MAGENIS, RE; CARPENTER, N; WASMUTH, JJ				SMITH, B; SKARECKY, D; BENGTSSON, U; MAGENIS, RE; CARPENTER, N; WASMUTH, JJ			ISOLATION OF DNA MARKERS IN THE DIRECTION OF THE HUNTINGTON DISEASE GENE FROM THE G8 LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF IRVINE,CALIF COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; OREGON HLTH SCI UNIV,DIV CRIPPLED CHILDRENS,DEPT MED GENET,PORTLAND,OR 97201; CHILDRENS MED CTR,H ALLEN CHAPMAN RES INST MED GENET,TULSA,OK	University of California System; University of California Irvine; Oregon Health & Science University				Skarecky, Douglas/0000-0002-9234-6716	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025339] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25339] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARLOCK L, 1986, SOMAT CELL MOLEC GEN, V11, P163; CARPENTER NJ, IN PRESS J MED GENET; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; DANA S, 1982, MOL CELL BIOL, V2, P1220, DOI 10.1128/MCB.2.10.1220; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GILLIAM TC, 1987, CELL, V50, P565, DOI 10.1016/0092-8674(87)90029-8; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; LANDEGENT JE, 1986, HUM GENET, V73, P354, DOI 10.1007/BF00279100; MAGENIS RE, 1986, AM J HUM GENET, V39, P383; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; OVERHAUSER J, 1986, AM J HUM GENET, V39, P562; OVERHAUSER J, 1986, AM J HUM GENET, V39, P1; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; STANLEY W, 1978, CYTOGENET CELL GENET, V22, P228, DOI 10.1159/000130943; WANG HS, 1986, AM J HUM GENET, V39, P392; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	22	100	101	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1988	42	2					335	344						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M3133	2963539				2022-12-18	WOS:A1988M313300016
J	THOMSON, G				THOMSON, G			HLA DR ANTIGENS AND SUSCEPTIBILITY TO INSULIN-DEPENDENT DIABETES-MELLITUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											THOMSON, G (corresponding author), UNIV CALIF BERKELEY,DEPT GENET,MULFORD HALL,BERKELEY,CA 94720, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-12731] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARBOSA J, 1979, TISSUE ANTIGENS, V14, P426; BAUR MP, 1980, HISTOCOMPATIBILITY T, P994; CAMBONDEMOUZON A, 1982, TISSUE ANTIGENS, V19, P366; CONTU L, 1982, TISSUE ANTIGENS, V20, P123; DAUSSET J, 1978, TISSUE ANTIGENS, V12, P297, DOI 10.1111/j.1399-0039.1978.tb01337.x; DECASTRO JAL, 1982, P NATL ACAD SCI-BIOL, V79, P3813; DESCHAMPS I, 1980, DIABETOLOGIA, V19, P189, DOI 10.1007/BF00275267; FARID NR, 1979, DIABETES, V28, P552, DOI 10.2337/diabetes.28.6.552; GAROVOY MR, 1978, TRANSPLANT P, V10, P967; LUDWIG H, 1979, METABOLISM, V28, P797, DOI 10.1016/0026-0495(79)90204-X; MURPHY CC, 1983, CLIN GENET, V23, P405; NERUP J, 1982, GENETICS DIABETES ME, P35; OWERBACH D, 1983, NATURE, V303, P815, DOI 10.1038/303815a0; PLATZ P, 1981, DIABETOLOGIA, V21, P108; REITNAUER PJ, 1981, TISSUE ANTIGENS, V17, P286; RODEY GE, 1979, NEW ENGL J MED, V301, P810, DOI 10.1056/NEJM197910113011503; ROTTER JI, 1983, DIABETES, V32, P169, DOI 10.2337/diabetes.32.2.169; SAKURAMI T, 1982, DIABETES, V31, P105, DOI 10.2337/diabetes.31.2.105; SOLOW H, 1979, DIABETES, V28, P1, DOI 10.2337/diabetes.28.1.1; SUCIUFOCA N, 1979, TRANSPLANT P, V11, P1309; SVEJGAARD A, 1981, ANN HUM GENET, V45, P293, DOI 10.1111/j.1469-1809.1981.tb00340.x; SVEJGAARD A, 1975, TRANSPLANT REV, V22, P3; SVEJGAARD A, 1980, HISTOCOMPATIBILITY T, P638; THOMSON G, 1983, TISSUE ANTIGENS, V21, P81; THOMSON G, UNPUB ANAL NEGATIVE; WINNEARLS B, UNPUB FAMILY STUDY A; WOLF E, 1983, DIABETOLOGIA, V24, P224; ZEIDLER A, 1980, DIABETES, V29, P247, DOI 10.2337/diabetes.29.4.247	28	100	102	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	6					1309	1317						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TZ590	6334991				2022-12-18	WOS:A1984TZ59000012
J	ELSTON, RC; YELVERTON, KC				ELSTON, RC; YELVERTON, KC			GENERAL MODELS FOR SEGREGATION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV N CAROLINA,BIOL SCI RES CTR,CHAPEL HILL,NC 27514; UNIV N CAROLINA,DEPT BIOSTATISTICS,CHAPEL HILL,NC 27514; UNIV N CAROLINA,GENET CURRICULUM,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill								ELANDTJOHNSON RC, 1970, AM J HUM GENET, V22, P129; ELANDTJOHNSON RC, 1971, AM J HUM GENET, V23, P17; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; ELSTON RC, 1974, AM J HUM GENET, V26, P13; ELSTON RC, 1969, COMPUTER APPLICATION, P30; KAPLAN EB, 1972, 823 U N CAR I STAT M; LANGE K, IN PRESS; MACLEAN CJ, IN PRESS; MORTON NE, 1958, SCIENCE, V127, P79, DOI 10.1126/science.127.3289.79; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1962, METHODOLOGY HUMAN GE, P17; MURPHY EA, 1967, AM J HUM GENET, V19, P322; PERITZ E, 1966, ANN HUM GENET, V30, P183, DOI 10.1111/j.1469-1809.1966.tb00017.x	15	100	100	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	1					31	45						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V5202	1171617				2022-12-18	WOS:A1975V520200002
J	SCHULL, WJ; NEEL, JV				SCHULL, WJ; NEEL, JV			EFFECTS OF PARENTAL CONSANGUINITY AND INBREEDING IN HIRADO, JAPAN. .5. SUMMARY AND INTERPRETATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BODMER WF, 1967, GENETICS, V57, P237; BRESLER JB, 1970, SOC BIOL, V17, P17, DOI 10.1080/19485565.1970.9987838; CARTER C. O., 1965, PROGR MED GENET, V4, P59; CHUNG C S, 1970, American Journal of Human Genetics, V22, P630; CHUNG CS, 1969, HUM HERED, V19, P321, DOI 10.1159/000152236; CHUNG CS, 1959, AM J HU GEN, V23, P557; CONTERIO F, 1966, ATTI ASSOC GENET IT, V11, P378; COOK ROBERT, 1966, J TROP PEDIAT AFR CHILD HEALTH, V11, P95; CROW JF, 1963, AM J HUM GENET, V15, P310; DOBZHANSKY T, 1951, GENETICS ORGIN SPECI; EDWARDS AWF, 1963, 2 P INT C HUM GEN RO, P222; ERHARDT CL, 1963, AM J PUBLIC HEALTH N, V53, P1337, DOI 10.2105/AJPH.53.9.1337; Falconer D.S., 1960, INTRO QUANTITATIVE G; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FELDMAN MW, 1969, AM J HUM GENET, V21, P171; FRANKLIN I, 1970, GENETICS, V65, P707; FREIREMAIA N, 1963, ANN HUM GENET, V27, P31, DOI 10.1111/j.1469-1809.1963.tb00778.x; FREIREMAIA N, 1963, ACTA GENET STAT MED, V13, P199; FREIREMAIA N, 1971, AM J HUM GENET, V23, P1; FREIREMAIA N, 1963, ACTA GENET STAT MED, V13, P185; FREIREMAIA N, 1964, ANN HUM GENET, V27, P329; FRENCH FE, 1962, PUBLIC HEALTH REP, V77, P835, DOI 10.2307/4591645; FUJIKI N, 1968, Japanese Journal of Human Genetics, V12, P205; GEORGES A, 1968, POPULATION, V23, P1055, DOI 10.2307/1528644; GRUNEBERG H, 1952, J GENET, V51, P95, DOI 10.1007/BF02986708; HALDANE JBS, 1965, J GENET, V59, P171; HAMILTON HB, 1961, J CLIN INVEST, V40, P2199, DOI 10.1172/JCI104446; HARRIS RL, 1968, PEDIATRICS, V41, P733; HERTIG AT, 1956, AM J ANAT, V98, P435, DOI 10.1002/aja.1000980306; HERTIG AT, 1959, PEDIATRICS, V23, P202; HIATT HOWARD H., 1966, P109; KALMUS H, 1969, ANN HUM GENET, V32, P311, DOI 10.1111/j.1469-1809.1969.tb00079.x; KIKZYCKI LL, 1964, CLIN PEDIATR, V3, P692; KIMURA M, 1969, P NATL ACAD SCI USA, V63, P1181, DOI 10.1073/pnas.63.4.1181; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KING JL, 1967, GENETICS, V55, P483; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; KISHIMOTO K, 1962, EUGEN QUART, V9, P5, DOI 10.1080/19485565.1962.9987495; KRIEGER H, 1969, AM J HUM GENET, V21, P537; KRIEGER H, 1971, AM J HUM GENET, V23, P8; KRIEGER H, 1966, THESIS U HAWAII; KUMAR S, 1967, ANN HUM GENET, V31, P141, DOI 10.1111/j.1469-1809.1967.tb00545.x; LASKER MARGARET, 1941, HUMAN BIOL, V13, P51; Lerner I.M., 1954, GENETIC HOMEOSTASIS, P134; LEWONTIN RC, 1964, GENETICS, V50, P757; LEWONTIN RC, 1964, GENETICS, V49, P49; LI CC, 1963, AM J HUM GENET, V15, P316; LINDENOV H, 1945, OPERA DOMO BIOL HERE, V8, P268; LIVINGSTON FRANK B., 1967; LIVINGSTONE FB, 1967, ABNORMAL HEMOGLOBINS, P470; LOBECK LL, 1966, METABOLIC BASIS INHE, P1300; MARCALLO FA, 1964, ANN HUM GENET, V27, P203, DOI 10.1111/j.1469-1809.1963.tb00787.x; MI MP, 1965, ACTA GENET STAT MED, V15, P177; MILKMAN RD, 1967, GENETICS, V55, P493; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NE, 1959, AM J HUM GENET, V11, P360; MORTON NE, 1966, EUGEN QUART, V13, P276; MORTON NE, 1967, GENETICS INTERRACIAL, P158; MORTON NE, 1967, GENETICS INTERRACIAL, pR8; Motulsky A G, 1971, Birth Defects Orig Artic Ser, V7, P22; MOTULSKY AG, 1960, NUM BIOL, V32, P28; MULLER HJ, 1950, AM J HUM GENET, V2, P111; MULLER HJ, 1948, B NEW YORK ACAD MED, V24, P447; NAGANO H, 1969, FUKUOKA ACTA MED, V60, P725; NEEL JV, 1951, SCIENCE, V114, P419, DOI 10.1126/science.114.2964.419; NEEL JV, 1949, AM J HUM GENET, V1, P156; NEEL JV, 1970, AM J HUM GENET, V22, P263; NEEL JV, 1968, P NATL ACAD SCI USA, V59, P680, DOI 10.1073/pnas.59.3.680; NEEL JV, 1970, HUM HERED, V20, P129, DOI 10.1159/000152303; NEEL JV, 1958, AM J HUM GENET, V10, P398; NEEL JV, 1968, PERSPECT BIOL MED, V11, P565; NEEL JV, 1965, GENETICS TODAY, V3, P495; NEEL JV, 1968, 8 P C ANTHR ETHN SCI, V1, P356; Newcombe H B, 1965, Eugen Rev, V57, P109; PENROSE LS, 1957, ANN HUM GENET, V21, P222, DOI 10.1111/j.1469-1809.1972.tb00283.x; PERRIN EB, 1964, BIOMETRICS, V20, P28, DOI 10.2307/2527616; POTTER RG, 1964, POP STUD-J DEMOG, V18, P99, DOI 10.2307/2172634; RACE RR, 1944, BRIT MED B, V2, P165; REED SC, 1954, J HERED, V45, P17, DOI 10.1093/oxfordjournals.jhered.a106423; REED TE, 1971, AM J HUM GENET, V23, P215; REID RM, 1971, THESIS U ILLINOIS; ROBERTSON A, 1949, GENETICS, V34, P395; RUSSELL WL, 1952, S RADIOBIOLOGY, P427; SALDANHA PH, 1962, ACTA GENET MED GEMEL, V11, P158, DOI 10.1017/S1120962300020321; SALDANHA PH, 1964, 2 P INT C CONG MALF, P323; SANGHVI LD, 1963, AM J HUM GENET, V15, P298; SCHULL WJ, 1966, AM J HUM GENET, V18, P144; SCHULL WJ, 1970, AM J HUM GENET, V22, P239; SCHULL WJ, 1970, HUMANGENETIK, V9, P294, DOI 10.1007/BF00286995; SCHULL WJ, 1962, HUM BIOL, V34, P271; SCHULL WJ, 1958, AM J HUM GENET, V10, P294; Schull WJ, 1965, EFFECTS INBREEDING J; SLATIS HM, 1954, AM J HUM GENET, V6, P412; SOHAR E, 1961, ARCH INTERN MED, V107, P529, DOI 10.1001/archinte.1961.03620040055006; STERN C, 1945, SCIENCE, V101, P305, DOI 10.1126/science.101.2621.305; STEVENSON AC, 1956, ANN HUM GENET, V20, P177; SVED JA, 1967, GENETICS, V55, P469; Takahara S., 1968, HERED DISORD, V1, P21; TANAKA K, 1967, P JPN ACAD, V43, P801, DOI 10.2183/pjab1945.43.801; TANAKA K, 1964, P JPN ACAD, V40, P852, DOI 10.2183/pjab1945.40.852; TANAKA K, 1962, GENETICS MIGRANT ISO, P169; WALLACE B, 1968, POPICS POPULATION GE; WILLS C, 1970, GENETICS, V64, P107; WOOLF CM, 1971, J MED GENET, V8, P65, DOI 10.1136/jmg.8.1.65; Wright S W, 1968, Hawaii Med J, V27, P229; YAMAGUCHI M, 1970, AM J HUM GENET, V22, P145; YANASE TOSHIYUKI, 1966, JAP J HUM GENET, V11, P125; [No title captured]	110	100	101	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1972	24	4					425	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M8063	5031982				2022-12-18	WOS:A1972M806300006
J	LI, CC; MANTEL, N				LI, CC; MANTEL, N			A SIMPLE METHOD OF ESTIMATING SEGREGATION RATIO UNDER COMPLETE ASCERTAINMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Haldane JBS, 1932, J GENET, V25, P251, DOI 10.1007/BF02983257; Haldane JBS, 1938, ANN EUGENIC, V8, P255, DOI 10.1111/j.1469-1809.1938.tb02179.x; LI CC, 1965, AM J HUM GENET, V17, P343; LI CC, 1964, ANN HUM GENET, V28, P177, DOI 10.1111/j.1469-1809.1964.tb00473.x; LI CC, 1961, HUMAN GENETICS PRINC, pCH5; LI CC, 1966, P S MUTATION POPULAT, P155; MANTEL N, 1951, BIOMETRICS, V7, P240, DOI 10.2307/3001808; MCKUSICK VA, 1964, B JOHNS HOPKINS HOSP, V115, P306; Weinberg W., 1912, Archiv Rassenbiol Leipzig, V9	9	100	101	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1968	20	1					61	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5889	5635671				2022-12-18	WOS:A1968A588900004
J	ANDERSON, DE; TAYLOR, WB; FALLS, HF; DAVIDSON, RT				ANDERSON, DE; TAYLOR, WB; FALLS, HF; DAVIDSON, RT			NEVOID BASAL CELL CARCINOMA SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDERSON DE, 1966, J ORAL SURG, V24, P15; ANDERSON DE, 1964, TUMORS SKIN, P91; CLENDENNING WE, 1964, ARCH DERMATOL, V90, P38, DOI 10.1001/archderm.1964.01600010044011; CLENDENNING WE, 1966, ANN INTERN MED, V64, P405; GERBER NJ, 1965, HUMANGENETIK, V1, P354, DOI 10.1007/BF00273977; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1965, CANCER-AM CANCER SOC, V18, P89, DOI 10.1002/1097-0142(196501)18:1<89::AID-CNCR2820180114>3.0.CO;2-9; GORLIN RJ, 1964, SYNDROMES HEAD NECK, P544; GRAHAM JH, 1965, J INVEST DERMATOL, V44, P197, DOI 10.1038/jid.1965.34; HOWELL JB, 1959, ARCH DERMATOL, V79, P67, DOI 10.1001/archderm.1959.01560130069008; HOWELL JB, 1964, JAMA-J AM MED ASSOC, V190, P274; HUEBLEIN GW, 1946, AMER J ROENTGENOL, V56, P299; MADDOX WD, 1964, JAMA-J AM MED ASSOC, V188, P106; MASON JK, 1965, ARCH PATHOL, V79, P401; MEERKOTTER V A, 1964, Oral Surg Oral Med Oral Pathol, V18, P498, DOI 10.1016/0030-4220(64)90399-8; NICHOLS L, 1965, ARCH DERMATOL, V91, P188; POLLARD JJ, 1964, RADIOLOGY, V82, P840, DOI 10.1148/82.5.840; RASMUSSEN PE, 1963, NORDISK MED, V23, P606; SCHONNING L, 1964, ACTA DERM-VENEREOL, V44, P437; WARD W H, 1960, Aust J Dermatol, V5, P204, DOI 10.1111/j.1440-0960.1960.tb01595.x; YUNIS JJ, 1963, CHROMOSOMA, V14, P146, DOI 10.1007/BF00336756	21	100	101	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1967	19	1					12	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	88552	4960000				2022-12-18	WOS:A19678855200002
J	CERVENKA, J; GORLIN, RJ; ANDERSON, VE				CERVENKA, J; GORLIN, RJ; ANDERSON, VE			SYNDROME OF PITS OF LOWER LIP AND CLEFT LIP AN/OR PALATE . GENETIC CONSIDERATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAKER BR, 1966, ORAL SURG ORAL MED O, V21, P56, DOI 10.1016/0030-4220(66)90014-4; BAKER BR, 1965, ORAL SURG ORAL MED O, V19, P494, DOI 10.1016/0030-4220(65)90012-5; BAXTER H, 1939, AM J ORTHODONTICS, V25, P1002; BERAUDS, 1962, B SOC CHIR GAZ HOP, P174; CARTER WJ, 1952, J AM DENT ASSOC, V45, P39; Cervenka J, 1966, Cesk Pediatr, V21, P109; CURTIS E, 1957, CAN DENT ASSOC J, V23, P576; Davis WB, 1935, SURG GYNECOL OBSTET, V61, P201; DERMARQUAY JN, 1945, GAZ MED PARIS, V13, P52; Everett FG, 1961, ORAL SURG ORAL MED O, V14, P202; Fogh-Anderson P., 1961, CONGENIT ANOM, P123; FOGHANDERSEN P, 1943, TANDLAEGEBLADET, V47, P411; Fuhs H, 1937, ARCH DERMATOL SYPH-G, V177, P131; GORLIN RJ, 1962, J PEDIATR-US, V61, P520, DOI 10.1016/S0022-3476(62)80143-7; GORLIN RJ, 1964, SYNDROMES HEAD NECK, P117; GRUNBERG S, 1936, THESIS MUNSTER; GURNEY CE, 1940, W J SURG, V48, P753; LANNELONGUE, 1879, B MEM SOC CHIR PARIS, V5, P642; LEMKE G, 1959, Dermatol Wochenschr, V140, P1085; LEVY J, 1962, ACTA GENET STAT MED, V12, P33; LUDY JB, 1938, N INT CLIN, V3, P75; MADELUNG, 1888, ARCH KLIN CHIR, V37, P271; MASON ML, 1940, SURG GYNECOL OBSTET, V70, P12; MULLER D., 1949, DEUTSCH E ZAHNARZTL ZEITSCHR, V4, P299; NEUMAN Z, 1961, Oral Surg Oral Med Oral Pathol, V14, P1415, DOI 10.1016/0030-4220(61)90243-2; OBERST, 1910, BEITR KLIN CHIR, V68, P795; OIDTMANN J, 1942, TIJDSCHR TANDHEELK, V49, P405; PENKAVA J, 1964, CESKOSL STOMAT, V64, P285; PRUZANSKY S, 1961, CONGENITAL ANOMAL ED, P123; Radcliffe W, 1940, BRIT J SURG, V28, P329, DOI 10.1002/bjs.18002811016; REIGNER, 1913, FISTULES CONGENITALE, P1059; RUBALTELLI E, 1930, ARCH ITAL OTOL RINOL, V41, P141; SCHUERMANN H, 1966, KRANKHEITEN MUNDSCHL, P23; SICHER H, 1934, Z STOMATOL, V32, P552; SORRICELLI DA, 1966, ORAL SURG, V21, P511; STIEDA A, 1906, ARCH KLIN CHIR, V79, P293; TARSITANI D, 1963, ACTA GENET MED GEMEL, V12, P166, DOI 10.1017/S1120962300016450; TEST A. R., 1947, JOUR ORAL SURG, V5, P292; VANDERWOUDE A, 1954, AM J HUM GENET, V6, P244; WANG MKH, 1956, PLAST RECONSTR SURG, V18, P319; WARBRICK JG, 1952, BRIT J PLAST SURG, V4, P254; WATANABE Y, 1951, ORAL SURG ORAL MED O, V4, P709, DOI 10.1016/0030-4220(51)90420-3; WITKOP CJ, 1963, AM J PHYS ANTHROPOL, V21, P15, DOI 10.1002/ajpa.1330210103; WITKOP CJ, 1961, GENETICS DENTAL HEAL, P44; Woollcombe WL, 1905, LANCET, V1, P357	45	100	102	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	3P2					416	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	96074	6026934				2022-12-18	WOS:A19679607400006
J	Feng, YCA; Howrigan, DP; Abbott, LE; Tashman, K; Cerrato, F; Singh, T; Heyne, H; Byrnes, A; Churchhouse, C; Watts, N; Solomonson, M; Lal, D; Heinzen, EL; Dhindsa, RS; Stanley, KE; Cavalleri, GL; Hakonarson, H; Helbig, I; Krause, R; May, P; Weckhuysen, S; Petrovski, S; Kamalakaran, S; Sisodiya, SM; Cossette, P; Cotsapas, C; De Jonghe, P; Dixon-Salazar, T; Guerrini, R; Kwan, P; Marson, AG; Stewart, R; Depondt, C; Dlugos, DJ; Scheffer, IE; Striano, P; Freyer, C; McKenna, K; Regan, BM; Bellows, ST; Leu, C; Bennett, CA; Johns, EMC; Macdonald, A; Shilling, H; Burgess, R; Weckhuysen, D; Bahlo, M; O'Brien, TJ; Todaro, M; Stamberger, H; Andrade, DM; Sadoway, TR; Mo, K; Krestel, H; Gallati, S; Papacostas, SS; Kousiappa, I; Tanteles, GA; Sterbova, K; Vlckova, M; Sedlackova, L; Lassuthova, P; Klein, KM; Rosenow, F; Reif, PS; Knake, S; Kunz, WS; Zsurka, G; Elger, CE; Bauer, J; Rademacher, M; Pendziwiat, M; Muhle, H; Rademacher, A; van Baalen, A; von Spiczak, S; Stephani, U; Afawi, Z; Korczyn, AD; Kanaan, M; Canavati, C; Kurlemann, G; Muller-Schluter, K; Kluger, G; Hausler, M; Blatt, I; Lemke, JR; Krey, I; Weber, YG; Wolking, S; Becker, F; Hengsbach, C; Rau, S; Maisch, AF; Steinhoff, BJ; Schulze-Bonhage, A; Schubert-Bast, S; Schreiber, H; Borggrafe, I; Schankin, CJ; Mayer, T; Korinthenberg, R; Brockmann, K; Dennig, D; Madeleyn, R; Kalviainen, R; Auvinen, P; Saarela, A; Linnankivi, T; Lehesjoki, AE; Rees, MI; Chung, SK; Pickrell, WO; Powell, R; Schneider, N; Balestrini, S; Zagaglia, S; Braatz, V; Johnson, MR; Auce, P; Sills, GJ; Baum, LW; Sham, PC; Cherny, SS; Lui, CHT; Barisic, N; Delanty, N; Doherty, CP; Shukralla, A; McCormack, M; El-Naggar, H; Canafoglia, L; Franceschetti, S; Castellotti, B; Granata, T; Zara, F; Iacomino, M; Madia, F; Vari, MS; Mancardi, MM; Salpietro, V; Bisulli, F; Tinuper, P; Licchetta, L; Pippucci, T; Stipa, C; Minardi, R; Gambardella, A; Labate, A; Annesi, G; Manna, L; Gagliardi, M; Parrini, E; Mei, D; Vetro, A; Bianchini, C; Montomoli, M; Doccini, V; Marini, C; Suzuki, T; Inoue, Y; Yamakawa, K; Tumiene, B; Sadleir, LG; King, C; Mountier, E; Caglayan, SH; Arslan, M; Yapici, Z; Yis, U; Topaloglu, P; Kara, B; Turkdogan, D; Gundogdu-Eken, A; Bebek, N; Ugur-Iseri, S; Baykan, B; Salman, B; Haryanyan, G; Yucesan, E; Kesim, Y; Ozkara, C; Poduri, A; Shiedley, BR; Shain, C; Buono, RJ; Ferraro, TN; Sperling, MR; Lo, W; Privitera, M; French, JA; Schachter, S; Kuzniecky, RI; Devinsky, O; Hegde, M; Khankhanian, P; Helbig, KL; Ellis, CA; Spalletta, G; Piras, F; Piras, F; Gili, T; Ciullo, V; Reif, A; McQuillin, A; Bass, N; McIntosh, A; Blackwood, D; Johnstone, M; Palotie, A; Pato, MT; Pato, CN; Bromet, EJ; Carvalho, CB; Achtyes, ED; Azevedo, MH; Kotov, R; Lehrer, DS; Malaspina, D; Marder, SR; Medeiros, H; Morley, CP; Perkins, DO; Sobell, JL; Buckley, PF; Macciardi, F; Rapaport, MH; Knowles, JA; Fanous, AH; McCarroll, SA; Gupta, N; Gabriel, SB; Daly, MJ; Lander, ES; Lowenstein, DH; Goldstein, DB; Lerche, H; Berkovic, SF; Neale, BM				Feng, Yen-Chen Anne; Howrigan, Daniel P.; Abbott, Liam E.; Tashman, Katherine; Cerrato, Felecia; Singh, Tarjinder; Heyne, Henrike; Byrnes, Andrea; Churchhouse, Claire; Watts, Nick; Solomonson, Matthew; Lal, Dennis; Heinzen, Erin L.; Dhindsa, Ryan S.; Stanley, Kate E.; Cavalleri, Gianpiero L.; Hakonarson, Hakon; Helbig, Ingo; Krause, Roland; May, Patrick; Weckhuysen, Sarah; Petrovski, Slave; Kamalakaran, Sitharthan; Sisodiya, Sanjay M.; Cossette, Patrick; Cotsapas, Chris; De Jonghe, Peter; Dixon-Salazar, Tracy; Guerrini, Renzo; Kwan, Patrick; Marson, Anthony G.; Stewart, Randy; Depondt, Chantal; Dlugos, Dennis J.; Scheffer, Ingrid E.; Striano, Pasquale; Freyer, Catharine; McKenna, Kevin; Regan, Brigid M.; Bellows, Susannah T.; Leu, Costin; Bennett, Caitlin A.; Johns, Esther M. C.; Macdonald, Alexandra; Shilling, Hannah; Burgess, Rosemary; Weckhuysen, Dorien; Bahlo, Melanie; O'Brien, Terence J.; Todaro, Marian; Stamberger, Hannah; Andrade, Danielle M.; Sadoway, Tara R.; Mo, Kelly; Krestel, Heinz; Gallati, Sabina; Papacostas, Savvas S.; Kousiappa, Ioanna; Tanteles, George A.; Sterbova, Katalin; Vlckova, Marketa; Sedlackova, Lucie; Lassuthova, Petra; Klein, Karl Martin; Rosenow, Felix; Reif, Philipp S.; Knake, Susanne; Kunz, Wolfram S.; Zsurka, Gabor; Elger, Christian E.; Bauer, Jurgen; Rademacher, Michael; Pendziwiat, Manuela; Muhle, Hiltrud; Rademacher, Annika; van Baalen, Andreas; von Spiczak, Sarah; Stephani, Ulrich; Afawi, Zaid; Korczyn, Amos D.; Kanaan, Moien; Canavati, Christina; Kurlemann, Gerhard; Mueller-Schlueter, Karen; Kluger, Gerhard; Hausler, Martin; Blatt, Ilan; Lemke, Johannes R.; Krey, Ilona; Weber, Yvonne G.; Wolking, Stefan; Becker, Felicitas; Hengsbach, Christian; Rau, Sarah; Maisch, Ana F.; Steinhoff, Bernhard J.; Schulze-Bonhage, Andreas; Schubert-Bast, Susanne; Schreiber, Herbert; Borggrafe, Ingo; Schankin, Christoph J.; Mayer, Thomas; Korinthenberg, Rudolf; Brockmann, Knut; Dennig, Dieter; Madeleyn, Rene; Kalviainen, Reetta; Auvinen, Pia; Saarela, Anni; Linnankivi, Tarja; Lehesjoki, Anna-Elina; Rees, Mark, I; Chung, Seo-Kyung; Pickrell, William O.; Powell, Robert; Schneider, Natascha; Balestrini, Simona; Zagaglia, Sara; Braatz, Vera; Johnson, Michael R.; Auce, Pauls; Sills, Graeme J.; Baum, Larry W.; Sham, Pak C.; Cherny, Stacey S.; Lui, Colin H. T.; Barisic, Nina; Delanty, Norman; Doherty, Colin P.; Shukralla, Arif; McCormack, Mark; El-Naggar, Hany; Canafoglia, Laura; Franceschetti, Silvana; Castellotti, Barbara; Granata, Tiziana; Zara, Federico; Iacomino, Michele; Madia, Francesca; Vari, Maria Stella; Mancardi, Maria Margherita; Salpietro, Vincenzo; Bisulli, Francesca; Tinuper, Paolo; Licchetta, Laura; Pippucci, Tommaso; Stipa, Carlotta; Minardi, Raffaella; Gambardella, Antonio; Labate, Angelo; Annesi, Grazia; Manna, Lorella; Gagliardi, Monica; Parrini, Elena; Mei, Davide; Vetro, Annalisa; Bianchini, Claudia; Montomoli, Martino; Doccini, Viola; Marini, Carla; Suzuki, Toshimitsu; Inoue, Yushi; Yamakawa, Kazuhiro; Tumiene, Birute; Sadleir, Lynette G.; King, Chontelle; Mountier, Emily; Caglayan, S. Hande; Arslan, Mutluay; Yapici, Zuhal; Yis, Uluc; Topaloglu, Pinar; Kara, Bulent; Turkdogan, Dilsad; Gundogdu-Eken, Asli; Bebek, Nerses; Ugur-Iseri, Sibel; Baykan, Betul; Salman, Baris; Haryanyan, Garen; Yucesan, Emrah; Kesim, Yesim; Ozkara, Cigdem; Poduri, Annapurna; Shiedley, Beth R.; Shain, Catherine; Buono, Russell J.; Ferraro, Thomas N.; Sperling, Michael R.; Lo, Warren; Privitera, Michael; French, Jacqueline A.; Schachter, Steven; Kuzniecky, Ruben, I; Devinsky, Orrin; Hegde, Manu; Khankhanian, Pouya; Helbig, Katherine L.; Ellis, Colin A.; Spalletta, Gianfranco; Piras, Fabrizio; Piras, Federica; Gili, Tommaso; Ciullo, Valentina; Reif, Andreas; McQuillin, Andrew; Bass, Nick; McIntosh, Andrew; Blackwood, Douglas; Johnstone, Mandy; Palotie, Aarno; Pato, Michele T.; Pato, Carlos N.; Bromet, Evelyn J.; Carvalho, Celia Barreto; Achtyes, Eric D.; Azevedo, Maria Helena; Kotov, Roman; Lehrer, Douglas S.; Malaspina, Dolores; Marder, Stephen R.; Medeiros, Helena; Morley, Christopher P.; Perkins, Diana O.; Sobell, Janet L.; Buckley, Peter F.; Macciardi, Fabio; Rapaport, Mark H.; Knowles, James A.; Fanous, Ayman H.; McCarroll, Steven A.; Gupta, Namrata; Gabriel, Stacey B.; Daly, Mark J.; Lander, Eric S.; Lowenstein, Daniel H.; Goldstein, David B.; Lerche, Holger; Berkovic, Samuel F.; Neale, Benjamin M.		Epi25 Collaborative; Genomic Psychiat Cohort GPC Consor	Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; EPILEPTIC SEIZURES; COMMON EPILEPSIES; VARIANTS; PROTEIN; METAANALYSIS; GENOME; GAMMA-2-SUBUNIT; SUSCEPTIBILITY; EPIDEMIOLOGY	Sequencing-based studies have identified novel risk genes associated with severe epilepsies and revealed an excess of rare deleterious variation in less-severe forms of epilepsy. To identify the shared and distinct ultra-rare genetic risk factors for different types of epilepsies, we performed a whole-exome sequencing (WES) analysis of 9,170 epilepsy-affected individuals and 8,436 controls of European ancestry. We focused on three phenotypic groups: severe developmental and epileptic encephalopathies (DEEs), genetic generalized epilepsy (GGE), and non-acquired focal epilepsy (NAFE). We observed that compared to controls, individuals with any type of epilepsy carried an excess of ultra-rare, deleterious variants in constrained genes and in genes previously associated with epilepsy; we saw the strongest enrichment in individuals with DEEs and the least strong in individuals with NAFE. Moreover, we found that inhibitory GABA(A) receptor genes were enriched for missense variants across all three classes of epilepsy, whereas no enrichment was seen in excitatory receptor genes. The larger gene groups for the GABAergic pathway or cation channels also showed a significant mutational burden in DEEs and GGE. Although no single gene surpassed exome-wide significance among individuals with GGE or NAFE, highly constrained genes and genes encoding ion channels were among the lead associations; such genes included CACNAIG, EEF1A2, and GABRG2 for GGE and LGI1, TRIM3, and GABRG2 for NAFE. Our study, the largest epilepsy WES study to date, confirms a convergence in the genetics of severe and less-severe epilepsies associated with ultra-rare coding variation, and it highlights a ubiquitous role for GABAergic inhibition in epilepsy etiology.				s.berkovic@unimelb.edu.au; bneale@broadinstitute.org	Schulze-Bonhage, Andreas/AAJ-3107-2020; Tumiene, Birute/ABD-4907-2020; Vari, Maria Stella/AAJ-9154-2020; Korinthenberg, Rudolf/A-9796-2009; Lassuthova, Petra/AAA-4246-2021; Franceschetti, Silvana/K-3438-2016; Scheffer, Ingrid E/G-1668-2013; Afawi, Zaid/AAE-7848-2022; Striano, Pasquale/F-9117-2014; Iacomino, Michele/AAB-2366-2019; Bisulli, Francesca/AAB-3307-2019; Borggraefe, Ingo/AAC-4966-2020; Doccini, Viola/AAB-9970-2019; Zara, Federico/U-3477-2017; Marson, Anthony/AAW-9776-2020; Johnstone, Mandy/AAI-1952-2019; Chung, Seo-Kyung/AAT-4693-2021; Minardi, Raffaella/AAB-8290-2020; Pickrell, William Owen/F-7110-2014; Helbig, Ingo/G-8467-2018; Marini, Carla/AAC-2413-2022; Baum, Lawrence/B-1005-2013; Lassuthova, Petra/ABB-8186-2021; Granata, Tiziana/J-9012-2016; Bisulli, Francesca/AAJ-4811-2020; Özkara, Çiğdem/AAA-2562-2020; Yucesan, Emrah/AAQ-7002-2020; Baykan, Betul/J-5307-2014; jiang, yu/HGU-0029-2022; Weckhuysen, Sarah/HGB-9957-2022; O'Brien, Terence/L-8102-2013; Annesi, Grazia/AAX-5732-2020; May, Patrick/N-1019-2019; Muhle, Hiltrud/F-5715-2010; Stamberger, Hannah/ABD-1814-2020; McQuillin, Andrew/C-1623-2008; Licchetta, Laura/ACB-8249-2022; Tinuper, Paolo/AAB-7760-2020; Tumiene, Birute/AFS-6356-2022; Perkins, Diana O/F-5213-2013; O'Brien, Terence/AAU-5525-2021; Kunz, Wolfram/K-1232-2019; Achtyes, Eric/AAA-6372-2020; ARSLAN, MUTLUAY/AAH-7715-2019; Ciullo, Valentina/AAC-5246-2022; Rees, Mark I/J-3129-2012; Balestrini, Simona/AAC-6319-2022; Sedlackova, Lucie/HGD-4007-2022; Goldstein, David/AAY-8125-2020; Dhindsa, Ryan/W-9678-2019; Cherny, Stacey S/B-3315-2008; Knake, Susanne/AAJ-4487-2021; Gambardella, Antonio/F-5295-2012; Madia, Francesca/AAA-7356-2020; French, Jacqueline A/G-6795-2013; Daly, Mark J/B-2453-2017; May, Patrick/B-1238-2010; Mei, Davide/K-4461-2016; Salpietro, Vincenzo/AAA-8706-2020; Chung, Seo-Kyung/I-3329-2017; Piras, Federica/AAC-4768-2022; Helbig, Katherine/B-7454-2012; CASTELLOTTI, BARBARA/J-4939-2016; piras, fabrizio/M-7902-2016; Canafoglia, Laura/K-4787-2016; Morley, Christopher P/K-1907-2014; Achtyes, Eric/M-6024-2016; Yamakawa, Kazuhiro/N-5050-2015	Tumiene, Birute/0000-0001-6010-2584; Franceschetti, Silvana/0000-0002-1921-6755; Scheffer, Ingrid E/0000-0002-2311-2174; Striano, Pasquale/0000-0002-6065-1476; Iacomino, Michele/0000-0003-4788-9719; Bisulli, Francesca/0000-0002-1109-7296; Doccini, Viola/0000-0002-5166-8401; Zara, Federico/0000-0001-9744-5222; Marson, Anthony/0000-0002-6861-8806; Johnstone, Mandy/0000-0002-8398-0862; Chung, Seo-Kyung/0000-0002-5008-8384; Minardi, Raffaella/0000-0002-8190-8517; Pickrell, William Owen/0000-0003-4396-5657; Helbig, Ingo/0000-0001-8486-0558; Marini, Carla/0000-0002-9212-2691; Baum, Lawrence/0000-0002-5345-9355; Granata, Tiziana/0000-0002-0170-6836; Özkara, Çiğdem/0000-0003-0548-1838; Yucesan, Emrah/0000-0003-4512-8764; Weckhuysen, Sarah/0000-0003-2878-1147; O'Brien, Terence/0000-0002-7198-8621; May, Patrick/0000-0001-8698-3770; McQuillin, Andrew/0000-0003-1567-2240; Kunz, Wolfram/0000-0003-1113-3493; Ciullo, Valentina/0000-0002-6870-6259; Rees, Mark I/0000-0003-3570-5986; Balestrini, Simona/0000-0001-5639-1969; Sedlackova, Lucie/0000-0003-2551-4764; Dhindsa, Ryan/0000-0002-8965-0813; Cherny, Stacey S/0000-0002-0269-3352; Gambardella, Antonio/0000-0001-7384-3074; Madia, Francesca/0000-0002-7807-1322; French, Jacqueline A/0000-0003-2242-8027; Daly, Mark J/0000-0002-0949-8752; May, Patrick/0000-0001-8698-3770; Mei, Davide/0000-0001-6790-6251; Chung, Seo-Kyung/0000-0002-5008-8384; Piras, Federica/0000-0002-9546-7038; Klein, Karl Martin/0000-0002-6654-1665; tinuper, paolo/0000-0002-0588-3063; King, Chontelle/0000-0001-6338-0459; Helbig, Katherine/0000-0001-8249-0549; Sadoway, Tara/0000-0001-6000-0596; Guerrini, Renzo/0000-0002-7272-7079; Kousiappa, Ioanna/0000-0002-7491-5946; Berkovic, Samuel/0000-0003-4580-841X; Bellows, Susannah/0000-0003-1949-8489; Lassuthova, Petra/0000-0003-1726-5868; Doherty, Colin/0000-0002-8869-8567; Bass, Nicholas James/0000-0002-4481-778X; Montomoli, Martino/0000-0003-4046-3133; Bahlo, Melanie/0000-0001-5132-0774; Labate, Angelo/0000-0002-8827-7324; Powell, Rob/0000-0002-9768-1142; Sadleir, Lynette/0000-0002-5355-7115; Solomonson, Matthew/0000-0002-5344-9026; Linnankivi, Tarja/0000-0001-9190-2218; Stamberger, Hannah/0000-0001-8308-9511; CASTELLOTTI, BARBARA/0000-0002-9098-3041; Bennett, Caitlin/0000-0002-9109-1483; Knake, Susanne/0000-0002-6298-0513; Ferraro, Thomas/0000-0003-2250-8772; Zsurka, Gabor/0000-0002-6379-849X; Andrade, Danielle/0000-0003-0953-2698; STIPA, CARLOTTA/0000-0001-7628-3711; Perkins, Diana/0000-0001-9396-2206; Cavalleri, Gianpiero/0000-0002-9802-0506; Shukralla, Arif/0000-0002-2808-0386; piras, fabrizio/0000-0003-3566-5494; Canafoglia, Laura/0000-0002-5385-761X; Sozuer, Dilsad/0000-0002-6607-5860; Morley, Christopher P/0000-0003-0185-7148; Suzuki, Toshimitsu/0000-0003-0585-5692; El-Naggar, Hany/0000-0001-6500-5273; Sills, Graeme/0000-0002-3389-8713; Achtyes, Eric/0000-0001-8939-1535; Wolking, Stefan/0000-0002-1460-6623; Yamakawa, Kazuhiro/0000-0002-1478-4390	National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute (NHLBI); NHGRI [5U01HG009088-02, UM1 HG008895]; National Institutes of Health [1R03NS108145-01]; Geisinger Health System and Regeneron; MRC [G0800637] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG009495] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geisinger Health System and Regeneron(Regeneron); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We gratefully thank the Epi25 principal investigators, local staff from individual cohorts, and all of the individuals with epilepsy who participated in the study for making possible this global collaboration and resource to advance epilepsy genetics research. This work is part of the Centers for Common Disease Genomics (CCDG) program, funded by the National Human Genome Research Institute (NHGRI) and the National Heart, Lung, and Blood Institute (NHLBI). CCDG research activities at the Broad Institute were supported by NHGRI grant UM1 HG008895. The Genome Sequencing Program efforts were also supported by NHGRI grant 5U01HG009088-02. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. A supplemental grant for Epi25 phenotyping was supported by "Epi25 Clinical Phenotyping R03," National Institutes of Health (1R03NS108145-01), with D.H.L. and S.F.B. as the principal investigators. Additional funding sources and acknowledgment of individual case and control cohorts were listed in the Supplemental Data. We thank the Stanley Center for Psychiatric Research at the Broad Institute for supporting sequencing effort and control sample aggregation. The authors would like to thank the DiscovEHR collaboration of Geisinger Health System and Regeneron for providing exome variant data for comparison. We also thank Sali Farhan, Kyle Satterstrom, and Chai-Yen Chen for helpful discussions, Nick Watts and Matthew Solomonson for browser development, and the Hail team for analysis support.	Abou-Khalil B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07524-z; Allen AS, 2017, LANCET NEUROL, V16, P135, DOI 10.1016/S1474-4422(16)30359-3; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; ANNEGERS JF, 1982, NEUROLOGY, V32, P174, DOI 10.1212/WNL.32.2.174; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Berkovic S, 2012, EPILEPSIA, V53, P1457, DOI 10.1111/j.1528-1167.2012.03511.x; Berkovic SF, 1998, ANN NEUROL, V43, P435, DOI 10.1002/ana.410430405; Calhoun JD, 2016, EPILEPSIA, V57, pE103, DOI 10.1111/epi.13390; Camfield P, 2015, EPILEPTIC DISORD, V17, P117, DOI 10.1684/epd.2015.0736; Cavalleri GL, 2005, BRAIN, V128, P1832, DOI 10.1093/brain/awh524; Cheung CC, 2010, P NATL ACAD SCI USA, V107, P11883, DOI 10.1073/pnas.1006529107; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Fiest KM, 2017, NEUROLOGY, V88, P296, DOI 10.1212/WNL.0000000000003509; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Ganna A, 2016, NAT NEUROSCI, V19, P1563, DOI 10.1038/nn.4404; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Heyne HO, 2018, NAT GENET, V50, P1048, DOI 10.1038/s41588-018-0143-7; Hildebrand MS, 2013, J MED GENET, V50, P271, DOI 10.1136/jmedgenet-2012-101448; Howell KB, 2018, EPILEPSIA, V59, P1177, DOI 10.1111/epi.14087; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Jallon P, 2001, EPILEPSIA, V42, P464, DOI 10.1046/j.1528-1157.2001.31400.x; Karn CF, 2013, CLIN TRIALS, V10, P568, DOI 10.1177/1740774513484392; Kjeldsen MJ, 2003, EPILEPSY RES, V55, P137, DOI 10.1016/S0920-1211(03)00117-7; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kosmicki JA, 2017, NAT GENET, V49, P504, DOI 10.1038/ng.3789; Lal D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005226; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leu C, 2012, EPILEPSIA, V53, P308, DOI 10.1111/j.1528-1167.2011.03379.x; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Maljevic S, 2019, CURR OPIN NEUROL, V32, P183, DOI 10.1097/WCO.0000000000000657; Marini C, 2004, EPILEPSIA, V45, P467, DOI 10.1111/j.0013-9580.2004.46803.x; May P, 2018, LANCET NEUROL, V17, P699, DOI 10.1016/S1474-4422(18)30215-1; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Myers CT, 2016, AM J HUM GENET, V99, P287, DOI 10.1016/j.ajhg.2016.06.003; Myers CT, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0214-7; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Oyrer J, 2018, PHARMACOL REV, V70, P142, DOI 10.1124/pr.117.014456; Peljto AL, 2014, BRAIN, V137, P795, DOI 10.1093/brain/awt368; Reinthaler EM, 2015, ANN NEUROL, V77, P972, DOI 10.1002/ana.24395; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Samocha KE., 2017, BIORXIV; Satterstrom F. K, BIORXIV; Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709; Shamseldin HE, 2016, AM J HUM GENET, V98, P210, DOI 10.1016/j.ajhg.2015.11.013; Shen DD, 2017, BRAIN, V140, P49, DOI 10.1093/brain/aww272; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tan NCK, 2010, EPILEPSIA, V51, P686, DOI 10.1111/j.1528-1167.2009.02423.x; Tankard RM, 2018, AM J HUM GENET, V103, P858, DOI 10.1016/j.ajhg.2018.10.015; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/88259; Wang J, 2017, SEIZURE-EUR J EPILEP, V44, P11, DOI 10.1016/j.seizure.2016.11.030; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	61	99	101	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					267	282		10.1016/j.ajhg.2019.05.020	http://dx.doi.org/10.1016/j.ajhg.2019.05.020			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5GK	31327507	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-18	WOS:000478022200004
J	Richard, MA; Huan, TX; Ligthart, S; Gondalia, R; Jhun, MA; Brody, JA; Irvin, MR; Marioni, R; Shen, JC; Tsai, PC; Montasser, ME; Jia, YC; Syme, C; Salfati, EL; Boerwinkle, E; Guan, WH; Mosley, TH; Bressler, J; Morrison, AC; Liu, CY; Mendelson, MM; Uitterlinden, AG; van Meurs, JB; Franco, OH; Zhang, GS; Li, Y; Stewart, JD; Bis, JC; Psaty, BM; Chen, YDI; Kardia, SLR; Zhao, W; Turner, ST; Absher, D; Aslibekyan, S; Starr, JM; Mcrae, AF; Hou, LF; Just, AC; Schwartz, JD; Vokonas, PS; Menni, C; Spector, TD; Shuldiner, A; Damcott, CM; Rotter, JI; Palmas, W; Liu, YM; Paus, T; Horvath, S; O'Connell, JR; Guo, XQ; Pausova, Z; Assimes, TL; Sotoodehnia, N; Smith, JA; Arnett, DK; Deary, IJ; Baccarelli, AA; Bell, JT; Whitsel, E; Dehghan, A; Levy, D; Fornage, M				Richard, Melissa A.; Huan, Tianxiao; Ligthart, Symen; Gondalia, Rahul; Jhun, Min A.; Brody, Jennifer A.; Irvin, Marguerite R.; Marioni, Riccardo; Shen, Jincheng; Tsai, Pei-Chien; Montasser, May E.; Jia, Yucheng; Syme, Catriona; Salfati, Elias L.; Boerwinkle, Eric; Guan, Weihua; Mosley, Thomas H., Jr.; Bressler, Jan; Morrison, Alanna C.; Liu, Chunyu; Mendelson, Michael M.; Uitterlinden, Andre G.; van Meurs, Joyce B.; Franco, Oscar H.; Zhang, Guosheng; Li, Yun; Stewart, James D.; Bis, Joshua C.; Psaty, Bruce M.; Chen, Yii-Der Ida; Kardia, Sharon L. R.; Zhao, Wei; Turner, Stephen T.; Absher, Devin; Aslibekyan, Stella; Starr, John M.; Mcrae, Allan F.; Hou, Lifang; Just, Allan C.; Schwartz, Joel D.; Vokonas, Pantel S.; Menni, Cristina; Spector, Tim D.; Shuldiner, Alan; Damcott, Coleen M.; Rotter, Jerome I.; Palmas, Walter; Liu, Yongmei; Paus, Tomas; Horvath, Steve; O'Connell, Jeffrey R.; Guo, Xiuqing; Pausova, Zdenka; Assimes, Themistocles L.; Sotoodehnia, Nona; Smith, Jennifer A.; Arnett, Donna K.; Deary, Ian J.; Baccarelli, Andrea A.; Bell, Jordana T.; Whitsel, Eric; Dehghan, Abbas; Levy, Daniel; Fornage, Myriam		BIOS Consortium	DNA Methylation Analysis Identifies Loci for Blood Pressure Regulation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; METAANALYSIS; COMMON; HEART; HYPERTENSION; EXPRESSION; VARIANTS; RISK; INDIVIDUALS; POPULATIONS	Genome-wide association studies have identified hundreds of genetic variants associated with blood pressure (BP), but sequence variation accounts for a small fraction of the phenotypic variance. Epigenetic changes may alter the expression of genes involved in BP regulation and explain part of the missing heritability. We therefore conducted a two-stage meta-analysis of the cross-sectional associations of systolic and diastolic BP with blood-derived genome-wide DNA methylation measured on the Infinium HumanMethylation450 BeadChip in 17,010 individuals of European, African American, and Hispanic ancestry. Of 31 discovery-stage cytosine-phosphate-guanine (CpG) dinucleotides, 13 replicated after Bonferroni correction (discovery: N = 9,828, p < 1.0 x 10(-7); replication: N = 7,182, p < 1.6 x 10(-3)). The replicated methylation sites are heritable (h(2) > 30%) and independent of known BP genetic variants, explaining an additional 1.4% and 2.0% of the interindividual variation in systolic and diastolic BP, respectively. Bidirectional Mendelian randomization among up to 4,513 individuals of European ancestry from 4 cohorts suggested that methylation at cg08035323 (TAF1B-YWHAQ) influences BP, while BP influences methylation at cg00533891 (ZMIZ1), cg00574958 (CPT1A), and cg02711608 (SLC1A5). Gene expression analyses further identified six genes (TSPAN2, SLC7A11, UNC93B1, CPT1A, PTMS, and LPCAT3) with evidence of triangular associations between methylation, gene expression, and BP. Additional integrative Mendelian randomization analyses of gene expression and DNA methylation suggested that the expression of TSPAN2 is a putative mediator of association between DNA methylation at cg23999170 and BP. These findings suggest that heritable DNA methylation plays a role in regulating BP independently of previously known genetic variants.	[Richard, Melissa A.; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Huan, Tianxiao; Liu, Chunyu; Mendelson, Michael M.; Levy, Daniel] NIH, Natl Heart Lung & Blood Inst, Populat Sci Branch, Bldg 10, Bethesda, MD 20892 USA; [Huan, Tianxiao; Liu, Chunyu; Mendelson, Michael M.; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Ligthart, Symen; Franco, Oscar H.; Dehghan, Abbas] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 Rotterdam, Netherlands; [Huan, Tianxiao; Ligthart, Symen; Gondalia, Rahul; Stewart, James D.; Whitsel, Eric] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Jhun, Min A.; Kardia, Sharon L. R.; Zhao, Wei; Smith, Jennifer A.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48108 USA; [Brody, Jennifer A.; Bis, Joshua C.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Irvin, Marguerite R.; Aslibekyan, Stella] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [Marioni, Riccardo; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Marioni, Riccardo] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Marioni, Riccardo; Mcrae, Allan F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Shen, Jincheng] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT 84108 USA; [Tsai, Pei-Chien; Menni, Cristina; Spector, Tim D.; Bell, Jordana T.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Montasser, May E.; Shuldiner, Alan; Damcott, Coleen M.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Program Personalized & Genom Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Jia, Yucheng; Chen, Yii-Der Ida; Rotter, Jerome I.; Guo, Xiuqing] UCLA, Med Ctr, Inst Translat Genom & Populat Sci, Dept Pediat, Torrance, CA 90502 USA; [Jia, Yucheng; Chen, Yii-Der Ida; Rotter, Jerome I.; Guo, Xiuqing] Univ Calif Los Angeles, Med Ctr, Los Angeles BioMed Res Inst Harbor, Dept Med, Torrance, CA 90502 USA; [Syme, Catriona; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 0A4, Canada; [Salfati, Elias L.; Assimes, Themistocles L.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Boerwinkle, Eric; Bressler, Jan; Morrison, Alanna C.; Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Guan, Weihua] Univ Minnesota, Dept Biostat, Minneapolis, MN 55454 USA; [Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Liu, Chunyu] Boston Univ, Dept Biostat, Boston, MA 02118 USA; [Mendelson, Michael M.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Uitterlinden, Andre G.; van Meurs, Joyce B.] Erasmus Univ, Med Ctr, Dept Internal Med, NL-3000 Rotterdam, Netherlands; [Zhang, Guosheng; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Zhang, Guosheng] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27514 USA; [Zhang, Guosheng] Univ N Carolina, Dept Stat, Chapel Hill, NC 27514 USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Stewart, James D.] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27514 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol & Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Unit, Seattle, WA 98101 USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Absher, Devin] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; [Mcrae, Allan F.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hou, Lifang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Just, Allan C.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Schwartz, Joel D.; Baccarelli, Andrea A.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Vokonas, Pantel S.] Boston Univ, Sch Med, Dept Med, Vet Affairs Normat Aging Study Vet Affairs Boston, Boston, MA 02118 USA; [Shuldiner, Alan] Regeneron Pharmaceut, Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [Palmas, Walter] Columbia Univ, Dept Med, New York, NY 10032 USA; [Liu, Yongmei] Wake Forest Sch Med, Winston Salem, NC 27157 USA; [Paus, Tomas] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Paus, Tomas] Univ Toronto, Dept Psychiat, Toronto, ON M5S 3G3, Canada; [Paus, Tomas] Baycrest, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Paus, Tomas] Child Mind Inst, New York, NY 10022 USA; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Gonda Res Ctr, Dept Human Genet, Los Angeles, CA 90095 USA; [Pausova, Zdenka] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Pausova, Zdenka] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 1A8, Canada; [Sotoodehnia, Nona] Univ Washington, Div Cardiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Arnett, Donna K.] Univ Kentucky, Coll Publ Hlth, Lexington, KY 40563 USA; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH9 8JZ, Midlothian, Scotland; [Whitsel, Eric] Univ N Carolina, Dept Med, Chapel Hill, NC 27514 USA; [Dehghan, Abbas] Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Biostat & Epidemiol, London W2 1PG, England	University of Texas System; University of Texas Health Science Center Houston; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; Erasmus University Rotterdam; Erasmus MC; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; University of Edinburgh; University of Edinburgh; University of Queensland; Utah System of Higher Education; University of Utah; University of London; King's College London; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stanford University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center; Boston University; Harvard University; Boston Children's Hospital; Erasmus University Rotterdam; Erasmus MC; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; Mayo Clinic; HudsonAlpha Institute for Biotechnology; University of Edinburgh; University of Queensland; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Regeneron; Columbia University; Wake Forest University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University of Toronto; University of Washington; University of Washington Seattle; University of Kentucky; University of Edinburgh; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London	Richard, MA; Fornage, M (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA.; Fornage, M (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Houston, TX 77030 USA.	melissa.a.lee@uth.tmc.edu; myriam.fornage@uth.tmc.edu	Levy, Daniel/ABB-2752-2021; Mendelson, Michael/I-2874-2014; Bell, Jordana/AAH-7312-2019; Huan, Tianxiao/AAF-3577-2021; Kiełbasa, Szymon/G-1636-2018; Zhernakova, Alexandra/ABA-9372-2020; Franco, Óscar H/ABE-2305-2020; Pool, René/AFO-8147-2022; Levy, Daniel/ABF-6873-2021; Rotter, Jerome/AAY-6598-2021; Dehghan, Abbas/ABE-7377-2020; Assimes, Themistocles Leonard/D-9696-2015; Turner, Stephen/GXM-4654-2022; Ligthart, Symen/AAF-7185-2020; Deary, Ian J/C-6297-2009; McRae, Allan/J-2644-2014; Suchiman, H. Eka D./F-5024-2017	Mendelson, Michael/0000-0001-7590-3958; Kiełbasa, Szymon/0000-0003-2805-6535; Franco, Óscar H/0000-0002-4606-4929; Pool, René/0000-0001-5579-0933; Levy, Daniel/0000-0003-1843-8724; Assimes, Themistocles Leonard/0000-0003-2349-0009; Deary, Ian J/0000-0002-1733-263X; Smith, Jennifer Ann/0000-0002-3575-5468; Gondalia, Rahul/0000-0001-5976-4863; Marioni, Riccardo/0000-0003-4430-4260; Huan, Tianxiao/0000-0001-5840-9413; TSAI, PEI-CHIEN/0000-0003-1575-9020; van Meurs, Joyce/0000-0001-6245-2123; Bonder, Marc Jan/0000-0002-8431-3180; van der Kallen, Carla/0000-0003-1468-8793; Just, Allan/0000-0003-4312-5957; Bell, Jordana/0000-0002-3858-5986; McRae, Allan/0000-0001-5286-5485; Suchiman, H. Eka D./0000-0002-7168-5516; Schalkwijk, Casper G/0000-0003-0190-2690; Jansen, Rick/0000-0002-3333-6737; van Dongen, Jenny/0000-0003-2063-8741; Stehouwer, Coen/0000-0001-8752-3223; van Greevenbroek, Marleen/0000-0002-2989-1631; Van Duijn, Cornelia/0000-0002-2374-9204; Morrison, Alanna/0000-0001-6381-4296	Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: Medline; Medical Research Council [MR/K026992/1, MR/L01341X/1] Funding Source: Medline; NCATS NIH HHS [UL1 TR001881] Funding Source: Medline; NHLBI NIH HHS [R01 HL133221, K99 HL136875, U01 HL120393, U01 HL130114, T32 HL098049, R01 HL105756] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491, P30 DK079626] Funding Source: Medline; NIEHS NIH HHS [R00 ES023450] Funding Source: Medline; NINDS NIH HHS [R01 NS087541] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, U01HL130114, R01HL133221, K99HL136875, T32HL098049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES023450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087541] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/N000404/1] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; ESRC [ES/N000404/1] Funding Source: UKRI; MRC [MR/L01341X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Breeze CE, 2016, CELL REP, V17, P2137, DOI 10.1016/j.celrep.2016.10.059; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell NR, 2016, J CLIN HYPERTENS, V18, P714, DOI 10.1111/jch.12840; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cowley AW, 2012, HYPERTENSION, V59, P899, DOI 10.1161/HYPERTENSIONAHA.111.190116; de Monasterio-Schrader P, 2013, GLIA, V61, P1832, DOI 10.1002/glia.22561; Dekkers KF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1000-6; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Esserlind AL, 2013, EUR J NEUROL, V20, P765, DOI 10.1111/ene.12055; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Gaunt TR, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0926-z; Guo YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031489; Huan TX, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145399; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Lau JMC, 2007, MOL CELL BIOL, V27, P1455, DOI 10.1128/MCB.01369-06; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; Liu H, 2014, PLACENTA, V35, P981, DOI 10.1016/j.placenta.2014.09.016; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Niiranen TJ, 2016, J CLIN HYPERTENS, V18, P181, DOI 10.1111/jch.12702; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011; Rosand J, 2016, LANCET NEUROL, V15, P174, DOI 10.1016/S1474-4422(15)00338-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zhao JJ, 2017, FASEB J, V31, P2576, DOI 10.1096/fj.201601021R	43	99	100	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2017	101	6					888	902		10.1016/j.ajhg.2017.09.028	http://dx.doi.org/10.1016/j.ajhg.2017.09.028			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP5FD	29198723	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000417644500002
J	Ramoni, RB; Mulvihill, JJ; Adams, DR; Allard, P; Ashley, EA; Bernstein, JA; Gahl, WA; Hamid, R; Loscalzo, J; McCray, AT; Shashi, V; Tifft, CJ; Wise, AL				Ramoni, Rachel B.; Mulvihill, John J.; Adams, David R.; Allard, Patrick; Ashley, Euan A.; Bernstein, Jonathan A.; Gahl, William A.; Hamid, Rizwan; Loscalzo, Joseph; McCray, Alexa T.; Shashi, Vandana; Tifft, Cynthia J.; Wise, Anastasia L.		Undiag Dis Network	The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSTITUTES-OF-HEALTH; RARE DISEASES; GLYCOSYLATION; MUTATIONS; PROGRAM; CARE	Diagnosis at the edges of our knowledge calls upon clinicians to be data driven, cross-disciplinary, and collaborative in unprecedented ways. Exact disease recognition, an element of the concept of precision in medicine, requires new infrastructure that spans geography, institutional boundaries, and the divide between clinical care and research. The National Institutes of Health (NIH) Common Fund supports the Undiagnosed Diseases Network (UDN) as an exemplar of this model of precise diagnosis. Its goals are to forge a strategy to accelerate the diagnosis of rare or previously unrecognized diseases, to improve recommendations for clinical management, and to advance research, especially into disease mechanisms. The network will achieve these objectives by evaluating patients with undiagnosed diseases, fostering a breadth of expert collaborations, determining best practices for translating the strategy into medical centers nationwide, and sharing findings, data, specimens, and approaches with the scientific and medical communities. Building the UDN has already brought insights to human and medical geneticists. The initial focus has been on data sharing, establishing common protocols for institutional review boards and data sharing, creating protocols for referring and evaluating patients, and providing DNA sequencing, metabolomic analysis, and functional studies in model organisms. By extending this precision diagnostic model nationally, we strive to meld clinical and research objectives, improve patient outcomes, and contribute to medical science.	[Ramoni, Rachel B.; McCray, Alexa T.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Ramoni, Rachel B.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, New York, NY 10010 USA; [Mulvihill, John J.; Adams, David R.; Gahl, William A.; Tifft, Cynthia J.; Wise, Anastasia L.] NIH, Natl Human Genome Res Inst, Bldg 10, Bethesda, MD 20892 USA; [Allard, Patrick] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90095 USA; [Allard, Patrick] Univ Calif Los Angeles, Dept Environm Hlth Sci, Fielding Sch Publ Hlth, Los Angeles, CA 90095 USA; [Ashley, Euan A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Ashley, Euan A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Bernstein, Jonathan A.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Hamid, Rizwan] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Loscalzo, Joseph] Harvard Med Sch, Boston, MA 02115 USA; [Shashi, Vandana] Duke Univ, Sch Med, Dept Pediat, Durham, NC 27707 USA	Harvard University; Harvard Medical School; New York University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University; Stanford University; Stanford University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Duke University	Ramoni, RB (corresponding author), Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA.	rachelramoni@nyu.edu	Loscalzo, Joseph/ABD-8980-2021; Yamamoto, Shinya/ABB-2837-2021; Nelson, Stanley F/D-4771-2009	Yamamoto, Shinya/0000-0003-2172-8036; Nelson, Stanley F/0000-0002-2082-3114; Brown, Donna/0000-0002-8805-7225; Holm, Ingrid/0000-0003-4712-8821; Allard, Patrick/0000-0001-7765-1547; Hackbarth, Mary/0000-0003-1325-3165; Haendel, Melissa/0000-0001-9114-8737; Sweetser, David/0000-0002-1621-3284	Intramural Research Program of the National Human Genome Research Institute; NIH Common Fund through the Office of Strategic Coordination and Office of the NIH Director; NIH [U01HG007530, U01HG007674, U01HG007703, U01HG007672, U01HG007708, U01HG007709, U01HG007690, U01HG007942, U01HG007943, U54N5093793, U01TR001395]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U01TR001395] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007530, ZIDHG200352, ZIAHG000215, U01HG007690, U01HG007672, U01HG007703, U01HG007708, U01HG007942, U01HG007943, U01HG007674, U01HG007709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS093793] Funding Source: NIH RePORTER	Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Common Fund through the Office of Strategic Coordination and Office of the NIH Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Rachel Eastwood of the Undiagnosed Diseases Network Coordinating Center prepared Figure 1. We are grateful for the participation of patients and family members and their referring clinicians. This work was supported in part by the Intramural Research Program of the National Human Genome Research Institute and the NIH Common Fund through the Office of Strategic Coordination and Office of the NIH Director. Research reported in this manuscript was supported by the NIH Common Fund through the Office of Strategic Coordination and Office of the NIH Director under award numbers U01HG007530, U01HG007674, U01HG007703, U01HG007672, U01HG007708, U01HG007709, U01HG007690, U01HG007942, U01HG007943, U54N5093793, and U01TR001395. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adams DR, 2014, MOL GENET METAB, V113, P161, DOI 10.1016/j.ymgme.2014.04.001; [Anonymous], 2015, IMPR DIAGN HLTH CAR; Bearn A.G., 1993, ARCHIBALD GARROD IND; Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003; Brownstein CA, 2015, HUM MUTAT, V36, P985, DOI 10.1002/humu.22840; Buske OJ, 2015, HUM MUTAT, V36, P931, DOI 10.1002/humu.22851; Childs B., 1999, GENETIC MED LOGIC DI; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Gahl WA, 2015, JAMA-J AM MED ASSOC, V314, P1797, DOI 10.1001/jama.2015.12249; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Holden J. P, 2013, MEMORANDUM HEADS EXE; Institute of Medicine of the National Academies, 2015, SHAR CLIN TRIAL DAT; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Might M, 2014, GENET MED, V16, P736, DOI 10.1038/gim.2014.23; Miller F. G., 2006, APA NEWSLETTERS NEWS, V5, P10; Miller R W, 1987, Princess Takamatsu Symp, V18, P3; MULVIHILL JJ, 1976, J NATL CANCER I, V57, P3, DOI 10.1093/jnci/57.1.3; National Institutes of Health, 2015, NAT I HLTH PLAN INCR; National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory, 2011, PREC MED BUILD KNOWL, V8; National Technical Information Services, 1989, REP NAT COMM ORPH DI, P17; Ng BG, 2015, HUM MOL GENET, V24, P3050, DOI 10.1093/hmg/ddv057; Ohno-Machado L., 2015, BIOCADDIE WHITE PAPE; Petrovski S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010272; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Robinson PN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004268; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; Singh H, 2015, NEW ENGL J MED, V373, P2493, DOI 10.1056/NEJMp1512241; Taruscio D, 2015, MOL GENET METAB, V116, P223, DOI 10.1016/j.ymgme.2015.11.003; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010	37	99	101	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					185	192		10.1016/j.ajhg.2017.01.006	http://dx.doi.org/10.1016/j.ajhg.2017.01.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28157539	Green Published, Bronze			2022-12-18	WOS:000393352000001
J	Swanger, SA; Chen, WJ; Wells, G; Burger, PB; Tankovic, A; Bhattacharya, S; Strong, KL; Hu, C; Kusumoto, H; Zhang, J; Adams, DR; Millichap, JJ; Petrovski, S; Traynelis, SF; Yuan, H				Swanger, Sharon A.; Chen, Wenjuan; Wells, Gordon; Burger, Pieter B.; Tankovic, Anel; Bhattacharya, Subhrajit; Strong, Katie L.; Hu, Chun; Kusumoto, Hirofumi; Zhang, Jing; Adams, David R.; Millichap, John J.; Petrovski, Slave; Traynelis, Stephen F.; Yuan, Hongjie			Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D-ASPARTATE RECEPTOR; SUBUNIT MESSENGER-RNAS; DE-NOVO MUTATIONS; LIGAND-BINDING; GLUTAMATE BINDING; ENDOPLASMIC-RETICULUM; MOLECULAR-DYNAMICS; PREGNENOLONE SULFATE; GENETIC-VARIATION; GRIN2A MUTATIONS	Epilepsy and intellectual disability are associated with rare variants in the GluN2A and GluN2B (encoded by GRIN2A and GRIN2B) subunits of the N-methyl-D-aspartate receptor (NMDAR), a ligand-gated ion channel with essential roles in brain development and function. By assessing genetic variation across GluN2 domains, we determined that the agonist binding domain, transmembrane domain, and the linker regions between these domains were particularly intolerant to functional variation. Notably, the agonist binding domain of GluN2B exhibited significantly more variation intolerance than that of GluN2A. To understand the ramifications of missense variation in the agonist binding domain, we investigated the mechanisms by which 25 rare variants in the GluN2A and GluN2B agonist binding domains dysregulated NMDAR activity. When introduced into recombinant human NMDARs, these rare variants identified in individuals with neurologic disease had complex, and sometimes opposing, consequences on agonist binding, channel gating, receptor biogenesis, and forward trafficking. Our approach combined quantitative assessments of these effects to estimate the overall impact on synaptic and non-synaptic NMDAR function. Interestingly, similar neurologic diseases were associated with both gain-and loss-of-function variants in the same gene. Most rare variants in GluN2A were associated with epilepsy, whereas GluN2B variants were associated with intellectual disability with or without seizures. Finally, discerning the mechanisms underlying NMDAR dysregulation by these rare variants allowed investigations of pharmacologic strategies to correct NMDAR function.	[Swanger, Sharon A.; Chen, Wenjuan; Tankovic, Anel; Bhattacharya, Subhrajit; Strong, Katie L.; Hu, Chun; Kusumoto, Hirofumi; Zhang, Jing; Traynelis, Stephen F.; Yuan, Hongjie] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Wells, Gordon; Burger, Pieter B.; Strong, Katie L.] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA; [Adams, David R.] NHGRI, Undiagnosed Dis Network, NIH, Bethesda, MD 20892 USA; [Millichap, John J.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Millichap, John J.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Millichap, John J.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Petrovski, Slave] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic 3050, Australia; [Petrovski, Slave] Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; [Traynelis, Stephen F.; Yuan, Hongjie] Emory Univ, Sch Med, CFERV, Atlanta, GA 30322 USA; [Chen, Wenjuan] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410013, Hunan, Peoples R China; [Wells, Gordon] Univ Stellenbosch, Dept Biochem, ZA-7602 Stellenbosch, South Africa	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Emory University; Central South University; Stellenbosch University	Traynelis, SF; Yuan, H (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA.; Traynelis, SF; Yuan, H (corresponding author), Emory Univ, Sch Med, CFERV, Atlanta, GA 30322 USA.	strayne@emory.edu; hyuan@emory.edu	JJ, Millichap/D-5008-2009; Swanger, Sharon A/ABA-4018-2021; Hu, Chun/AAZ-7920-2021	JJ, Millichap/0000-0002-0798-0131; Hu, Chun/0000-0002-0949-9878; Swanger, Sharon/0000-0003-0615-6244; Yuan, Hongjie/0000-0002-8127-7145	Eunice Kennedy Shriver National Institute of Child Health & Human Development [R01HD082373]; National Center for Advancing Translational Sciences of the NIH [UL1TR000454]; National Institute of Neurological Disorders and Stroke [F32NS086361, NS036654]; Xiangya-Emory Medical Schools Visiting Student Program; Janssen; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD082373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036654, R37NS036654] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Xiangya-Emory Medical Schools Visiting Student Program; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at the ExAC website. The authors also thank Dr. Dennis Liotta for generous support of this study. Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (R01HD082373 to H.Y.), the National Center for Advancing Translational Sciences of the NIH (UL1TR000454 to H.Y.), the National Institute of Neurological Disorders and Stroke (F32NS086361 to S.A.S. and NS036654 to S.F.T.), and the Xiangya-Emory Medical Schools Visiting Student Program (to W.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. S.F.T. is co-founder of NeurOp Inc., a consultant of Janssen Pharmaceuticals, Pfizer, and NeurOp Inc., and a PI on a research grant from Janssen to Emory University. S.P. serves on the advisory board of Pairnomix.	Adams DR, 2014, MOL GENET METAB, V113, P161, DOI 10.1016/j.ymgme.2014.04.001; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Bosch DGM, 2016, EUR J HUM GENET, V24, P660, DOI 10.1038/ejhg.2015.186; Burger PB, 2012, MOL PHARMACOL, V82, P344, DOI 10.1124/mol.112.078568; Burnashev N, 2015, CURR OPIN PHARMACOL, V20, P73, DOI 10.1016/j.coph.2014.11.008; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Ceccon M, 2001, NEUROPHARMACOLOGY, V40, P491, DOI 10.1016/S0028-3908(00)00197-0; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Convertino M, 2016, ACS CHEM BIOL, V11, P1471, DOI 10.1021/acschembio.6b00195; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; DeVries SP, 2013, PEDIATR NEUROL, V49, P482, DOI 10.1016/j.pediatrneurol.2013.08.023; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Erreger K, 2005, J NEUROSCI, V25, P7858, DOI 10.1523/JNEUROSCI.1613-05.2005; Ewald RC, 2009, FRONT NEUROSCI, P1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fedder KN, 2015, BIOMOLECULES, V5, P3448, DOI 10.3390/biom5043448; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Freunscht I, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-20; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Gussow AB, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0869-4; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hanrahan JW, 2013, TRENDS PHARMACOL SCI, V34, P119, DOI 10.1016/j.tips.2012.11.006; Hansen KB, 2014, NEURON, V81, P1084, DOI 10.1016/j.neuron.2014.01.035; Hansen KB, 2005, MOL PHARMACOL, V68, P1510, DOI 10.1124/mol.105.014795; Hedegaard M, 2012, NEUROCHEM INT, V61, P601, DOI 10.1016/j.neuint.2011.11.016; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Horak M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00394; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jantzie LL, 2015, CEREB CORTEX, V25, P482, DOI 10.1093/cercor/bht246; Jespersen A, 2014, NEURON, V81, P366, DOI 10.1016/j.neuron.2013.11.033; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kaye SL, 2006, J BIOL CHEM, V281, P12736, DOI 10.1074/jbc.M512728200; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lam VM, 2013, TRAFFIC, V14, P778, DOI 10.1111/tra.12073; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Maier W, 2007, J BIOL CHEM, V282, P1863, DOI 10.1074/jbc.M608156200; Martin GM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00386; McRae J. F., 2016, PREVALENCE PHENOTYPE; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Perszyk R. E., 2016, MOL PHARM, V9, P9; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierson TM, 2014, ANN CLIN TRANSL NEUR, V1, P190, DOI 10.1002/acn3.39; Povysheva NV, 2016, NEUROBIOL DIS, V96, P75, DOI 10.1016/j.nbd.2016.08.006; Serraz B, 2016, NEUROPHARMACOLOGY, V109, P196, DOI 10.1016/j.neuropharm.2016.06.008; She K, 2012, J BIOL CHEM, V287, P27432, DOI 10.1074/jbc.M112.345108; Soto David, 2014, Commun Integr Biol, V7, pe27887, DOI 10.4161/cib.27887; Swanger SA, 2013, J NEUROSCI, V33, P8898, DOI 10.1523/JNEUROSCI.0289-13.2013; Tarabeux J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.52; Thomas CG, 2011, J NEUROSCI, V31, P4743, DOI 10.1523/JNEUROSCI.5953-10.2011; Tovar KR, 1999, J NEUROSCI, V19, P4180; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vance KM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1295; von Engelhardt J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00095; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wang P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00188; WATANABE M, 1993, ANN NY ACAD SCI, V707, P463, DOI 10.1111/j.1749-6632.1993.tb38099.x; WILLIAMS K, 1994, MOL PHARMACOL, V46, P161; WU FS, 1991, MOL PHARMACOL, V40, P333; Wyllie DJA, 2013, NEUROPHARMACOLOGY, V74, P4, DOI 10.1016/j.neuropharm.2013.01.016; Xi D, 2009, J NEUROSCI METH, V176, P172, DOI 10.1016/j.jneumeth.2008.09.013; Yavarna T, 2015, HUM GENET, V134, P967, DOI 10.1007/s00439-015-1575-0; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Yuan HJ, 2015, MOL PHARMACOL, V88, P203, DOI 10.1124/mol.115.097998; Yuan HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4251; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133870; Zhang ZW, 2013, P NATL ACAD SCI USA, V110, P1095, DOI 10.1073/pnas.1212971110; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	101	99	103	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 1	2016	99	6					1261	1280		10.1016/j.ajhg.2016.10.002	http://dx.doi.org/10.1016/j.ajhg.2016.10.002			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ED8VI	27839871	Bronze, Green Published			2022-12-18	WOS:000389148600003
J	Harel, T; Yoon, WH; Garone, C; Gu, S; Coban-Akdemir, Z; Eldomery, MK; Posey, JE; Jhangiani, SN; Rosenfeld, JA; Cho, MT; Fox, S; Withers, M; Brooks, SM; Chiang, T; Duraine, L; Erdin, S; Yuan, B; Shao, YR; Moussallem, E; Lamperti, C; Donati, MA; Smith, JD; McLaughlin, HM; Eng, CM; Walkiewicz, M; Xia, F; Pippucci, T; Magini, P; Seri, M; Zeviani, M; Hirano, M; Hunter, JV; Srour, M; Zanigni, S; Lewis, RA; Muzny, DM; Lotze, TE; Boerwinkle, E; Gibbs, RA; Hickey, SE; Graham, BH; Yang, YP; Buhas, D; Martin, DM; Potocki, L; Graziano, C; Bellen, HJ; Lupski, JR				Harel, Tamar; Yoon, Wan Hee; Garone, Caterina; Gu, Shen; Coban-Akdemir, Zeynep; Eldomery, Mohammad K.; Posey, Jennifer E.; Jhangiani, Shalini N.; Rosenfeld, Jill A.; Cho, Megan T.; Fox, Stephanie; Withers, Marjorie; Brooks, Stephanie M.; Chiang, Theodore; Duraine, Lita; Erdin, Serkan; Yuan, Bo; Shao, Yunru; Moussallem, Elie; Lamperti, Costanza; Donati, Maria A.; Smith, Joshua D.; McLaughlin, Heather M.; Eng, Christine M.; Walkiewicz, Magdalena; Xia, Fan; Pippucci, Tommaso; Magini, Pamela; Seri, Marco; Zeviani, Massimo; Hirano, Michio; Hunter, Jill V.; Srour, Myriam; Zanigni, Stefano; Lewis, Richard Alan; Muzny, Donna M.; Lotze, Timothy E.; Boerwinkle, Eric; Gibbs, Richard A.; Hickey, Scott E.; Graham, Brett H.; Yang, Yaping; Buhas, Daniela; Martin, Donna M.; Potocki, Lorraine; Graziano, Claudio; Bellen, Hugo J.; Lupski, James R.		Univ Washington Ctr Mendelian	Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; DOMAIN-CONTAINING 3A; LOSS-OF-FUNCTION; DEVELOPMENTAL DELAY; OPTIC ATROPHY; DROSOPHILA-MELANOGASTER; TRANSMISSION GENETICS; MOLECULAR FINDINGS; GENOMIC DISORDERS; CPG DINUCLEOTIDES	ATPase family AAA-domain containing protein 3A (ATAD3A) is a nuclear-encoded mitochondrial membrane protein implicated in mitochondrial dynamics, nucleoid organization, protein translation, cell growth, and cholesterol metabolism. We identified a recurrent de novo ATAD3A c.1582C>T (p.Arg528Trp) variant by whole-exome sequencing (WES) in five unrelated individuals with a core phenotype of global developmental delay, hypotonia, optic atrophy, axonal neuropathy, and hypertrophic cardiomyopathy. We also describe two families with biallelic variants in ATAD3A, including a homozygous variant in two siblings, and biallelic ATAD3A deletions mediated by nonallelic homologous recombination (NAHR) between ATAD3A and gene family members ATAD3B and ATAD3C. Tissue-specific over expression of bor(R534W), the Drosophila mutation homologous to the human c.1582C>T (p.Arg528Trp) variant, resulted in a dramatic decrease in mitochondrial content, aberrant mitochondrial morphology, and increased autophagy. Homozygous null bor larvae showed a significant decrease of mitochondria, while overexpression of bor(WT) resulted in larger, elongated mitochondria. Finally, fibroblasts of an affected individual exhibited increased mitophagy. We conclude that the p.Arg528Trp variant functions through a dominant-negative mechanism that results in small mitochondria that trigger mitophagy, resulting in a reduction in mitochondrial content. ATAD3A variation represents an additional link between mitochondrial dynamics and recognizable neurological syndromes, as seen with MFN2, OPA1, DNM1L, and STAT2 mutations.	[Harel, Tamar; Gu, Shen; Coban-Akdemir, Zeynep; Eldomery, Mohammad K.; Posey, Jennifer E.; Jhangiani, Shalini N.; Rosenfeld, Jill A.; Withers, Marjorie; Yuan, Bo; Shao, Yunru; Moussallem, Elie; Eng, Christine M.; Walkiewicz, Magdalena; Xia, Fan; Lewis, Richard Alan; Gibbs, Richard A.; Graham, Brett H.; Yang, Yaping; Potocki, Lorraine; Bellen, Hugo J.; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Yoon, Wan Hee; Duraine, Lita; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Yoon, Wan Hee; Duraine, Lita; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Garone, Caterina] MRC Mitochondrial Biol Unit, Cambridge CB2 OXY, England; [Jhangiani, Shalini N.; Chiang, Theodore; Muzny, Donna M.; Boerwinkle, Eric; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Rosenfeld, Jill A.; Yuan, Bo; Eng, Christine M.; Walkiewicz, Magdalena; Xia, Fan; Yang, Yaping] Baylor Coll Med, Baylor Genet, Houston, TX 77030 USA; [Cho, Megan T.; McLaughlin, Heather M.] GeneDx, Gaithersburg, MD 20877 USA; [Fox, Stephanie; Buhas, Daniela] Montreal Childrens Hosp, Med Genet Dept, Montreal, PQ H4A 3J1, Canada; [Brooks, Stephanie M.; Hickey, Scott E.] Ohio State Univ, Dept Pediat, Coll Med, Div Mol & Human Genet,Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Erdin, Serkan] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Erdin, Serkan] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lamperti, Costanza; Zeviani, Massimo] Fdn Carlo Besta Inst Neurol IRCCS, Unit Mol Neurogenet, I-20126 Milan, Italy; [Donati, Maria A.] Univ Florence, Meyer Childrens Hosp, Metab & Muscular Unit, I-50132 Florence, Italy; [Smith, Joshua D.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Pippucci, Tommaso; Seri, Marco; Graziano, Claudio] Univ Bologna, Med Genet Unit, Policlin St Orsola Malpighi, I-40138 Bologna, Italy; [Magini, Pamela; Seri, Marco] Univ Bologna, Dept Med & Surg Sci, Med Genet Unit, I-40138 Bologna, Italy; [Hirano, Michio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Srour, Myriam] McGill Univ, Dept Pediat Neurol & Neurosurg, Montreal, PQ H4A 3J1, Canada; [Zanigni, Stefano] St Orsola Marcello Malpighi Hosp, Funct MR Unit, I-40138 Bologna, Italy; [Zanigni, Stefano] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, I-40123 Bologna, Italy; [Lewis, Richard Alan; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lewis, Richard Alan; Lotze, Timothy E.; Potocki, Lorraine; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lotze, Timothy E.] Texas Childrens Hosp, Dept Pediat Neurol, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Buhas, Daniela] McGill Univ, Human Genet Dept, Montreal, PQ H3A 0G4, Canada; [Martin, Donna M.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Martin, Donna M.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Div Neurosci, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; McGill University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; IRCCS Istituto Neurologico Besta; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Washington; University of Washington Seattle; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; Columbia University; Baylor College of Medicine; McGill University; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; McGill University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine	Harel, T; Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	harel.tamar@gmail.com; jlupski@bcm.edu	Erdin, Serkan/AAE-4288-2019; Erdin, Serkan/B-4988-2008; Posey, Jennifer E./J-3048-2019; Garone, Caterina/AAB-8659-2019; Pippucci, Tommaso/M-8124-2019; Zeviani, Massimo/AAU-2632-2021; Moussallem, Elie/HGU-6087-2022; Gu, Shen/AAE-2641-2020; Graham, Brett/R-8685-2018; Magini, Pamela/K-4508-2016; lamperti, costanza/J-8801-2016	Erdin, Serkan/0000-0001-6587-2625; Posey, Jennifer E./0000-0003-4814-6765; Garone, Caterina/0000-0003-4928-1037; Zeviani, Massimo/0000-0002-9067-5508; Gu, Shen/0000-0003-3107-1218; Graham, Brett/0000-0001-8451-8154; Magini, Pamela/0000-0002-1752-9977; lamperti, costanza/0000-0002-2280-2253; Bellen, Hugo/0000-0001-5992-5989; Blue, Elizabeth/0000-0002-0633-0305; Graziano, Claudio/0000-0003-3875-6869; Yoon, Wan Hee/0000-0002-9459-3139; MARIA ALICE, DONATI/0000-0003-4769-5025	US National Human Genome Research Institute/National Heart Lung and Blood Institute Baylor Hopkins Center for Mendelian Genomics (NHGRI/NHLBI) [U54HG006542]; Intellectual Developmental Disabilities Research Center, IDDRC (Clinical Translational Core) [NICHD HD083092]; NHGRI/NHLBI University of Washington Center for Mendelian Genomics [2UM1HG006493]; National Institute of Neurological Disease and Stroke (NINDS) [RO1NS058529]; NIH/NIGMS Medical Genetics Research Fellowship Program [T32 GM07526]; European Commission [705560]; Undiagnosed Diseases Network (UDN) [1U54NS093793-01]; Genetic Resource Association of Texas (GReAT), Houston, Texas; NIH [R01 DC009410]; Dointa B. Sullivan, MD Research Professorship; MRC [MC_UP_1002/1] Funding Source: UKRI; Medical Research Council [MC_UP_1002/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, UM1HG006493, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, R35NS105078, U54NS093793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009410] Funding Source: NIH RePORTER	US National Human Genome Research Institute/National Heart Lung and Blood Institute Baylor Hopkins Center for Mendelian Genomics (NHGRI/NHLBI); Intellectual Developmental Disabilities Research Center, IDDRC (Clinical Translational Core); NHGRI/NHLBI University of Washington Center for Mendelian Genomics; National Institute of Neurological Disease and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIGMS Medical Genetics Research Fellowship Program; European Commission(European CommissionEuropean Commission Joint Research Centre); Undiagnosed Diseases Network (UDN); Genetic Resource Association of Texas (GReAT), Houston, Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dointa B. Sullivan, MD Research Professorship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the families for their collaboration and participation in this study. This work was supported in part by the US National Human Genome Research Institute/National Heart Lung and Blood Institute Baylor Hopkins Center for Mendelian Genomics (NHGRI/NHLBI, U54HG006542), the Intellectual Developmental Disabilities Research Center, IDDRC (NICHD HD083092, Clinical Translational Core), and the NHGRI/NHLBI University of Washington Center for Mendelian Genomics (2UM1HG006493). This work was also supported in part by the National Institute of Neurological Disease and Stroke (NINDS, RO1NS058529) to J.R.L. T.H. and J.E.P. are supported by the NIH/NIGMS T32 GM07526 Medical Genetics Research Fellowship Program. C. Garone is supported by European Commission Project 705560, Marie Curie Individual Fellowship. H.J.B. is supported by the Undiagnosed Diseases Network (UDN, 1U54NS093793-01). R.A.L. is supported in part by the Genetic Resource Association of Texas (GReAT), Houston, Texas. D.M. Martin is supported by the NIH (R01 DC009410) and the Dointa B. Sullivan, MD Research Professorship.	Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BELLEN H., 2000, NEUROMUSCULAR JUNCTI; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Buzin CH, 2005, HUM MUTAT, V25, P177, DOI 10.1002/humu.20132; Campbell IM, 2015, TRENDS GENET, V31, P382, DOI 10.1016/j.tig.2015.03.013; Campbell IM, 2014, AM J HUM GENET, V95, P345, DOI 10.1016/j.ajhg.2014.08.010; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chao YH, 2016, HUM MOL GENET, V25, P1846, DOI 10.1093/hmg/ddw059; Chong JX, 2015, AM J HUM GENET, V96, P462, DOI 10.1016/j.ajhg.2015.01.003; Cooper David N, 2010, Hum Genomics, V4, P406; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Dittwald P, 2013, GENOME RES, V23, P1395, DOI 10.1101/gr.152454.112; Fang HY, 2010, J CELL SCI, V123, P1171, DOI 10.1242/jcs.062034; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Goller T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054799; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Harel T, 2016, AM J HUM GENET, V98, P562, DOI 10.1016/j.ajhg.2016.01.011; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Hoffmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007644; Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503; Kaukonen JA, 1996, AM J HUM GENET, V58, P763; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li S., 2014, MOL CELL BIOL; Li SJ, 2014, GENE, V535, P60, DOI 10.1016/j.gene.2013.10.062; Merle N, 2012, MITOCHONDRION, V12, P441, DOI 10.1016/j.mito.2012.05.005; Mishra P, 2014, NAT REV MOL CELL BIO, V15, P634, DOI 10.1038/nrm3877; Muona M, 2015, NAT GENET, V47, P39, DOI 10.1038/ng.3144; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Niemann A, 2009, NEUROBIOL DIS, V36, P509, DOI 10.1016/j.nbd.2009.09.011; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142; Rainger J, 2014, AM J HUM GENET, V94, P915, DOI 10.1016/j.ajhg.2014.05.005; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Rouzier C, 2012, BRAIN, V135, P23, DOI 10.1093/brain/awr323; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1122, DOI 10.1016/j.ajhg.2012.10.013; Shahni R, 2015, BRAIN, V138, P2834, DOI 10.1093/brain/awv182; Simons C, 2015, AM J HUM GENET, V96, P675, DOI 10.1016/j.ajhg.2015.02.012; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361; Teng Y, 2016, ONCOGENE, V35, P333, DOI 10.1038/onc.2015.86; Uddin M, 2015, GENET MED, V17, P747, DOI 10.1038/gim.2014.178; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; You WC, 2013, NEURO-ONCOLOGY, V15, P1342, DOI 10.1093/neuonc/not077; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797	65	99	103	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 6	2016	99	4					831	845		10.1016/j.ajhg.2016.08.007	http://dx.doi.org/10.1016/j.ajhg.2016.08.007			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DY7UB	27640307	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000385333700004
J	Ko, AMS; Chen, CY; Fu, QM; Delfin, F; Li, MK; Chiu, HL; Stoneking, M; Ko, YC				Ko, Albert Min-Shan; Chen, Chung-Yu; Fu, Qiaomei; Delfin, Frederick; Li, Mingkun; Chiu, Hung-Lin; Stoneking, Mark; Ko, Ying-Chin			Early Austronesians: Into and Out Of Taiwan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; HUMAN DISPERSALS; GENOME SEQUENCE; SOUTHEAST-ASIA; MTDNA GENOMES; EAST-ASIA; EXPANSION; ANCIENT; HISTORY; COLONIZATION	A Taiwan origin for the expansion of the Austronesian languages and their speakers is well supported by linguistic and archaeological evidence. However, human genetic evidence is more controversial. Until now, there had been no ancient skeletal evidence of a potential Austronesian-speaking ancestor prior to the Taiwan Neolithic similar to 6,000 years ago, and genetic studies have largely ignored the role of genetic diversity within Taiwan as well as the origins of Formosans. We address these issues via analysis of a complete mitochondrial DNA genome sequence of an similar to 8,000-year-old skeleton from Liang Island (located between China and Taiwan) and 550 mtDNA genome sequences from 8 aboriginal (highland) Formosan and 4 other Taiwanese groups. We show that the Liangdao Man mtDNA sequence is closest to Formosans, provides a link to southern China, and has the most ancestral haplogroup E sequence found among extant Austronesian speakers. Bayesian phylogenetic analysis allows us to reconstruct a history of early Austronesians arriving in Taiwan in the north similar to 6,000 years ago, spreading rapidly to the south, and leaving Taiwan similar to 4,000 years ago to spread throughout Island Southeast Asia, Madagascar, and Oceania.	[Ko, Albert Min-Shan; Fu, Qiaomei; Delfin, Frederick; Li, Mingkun; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Chen, Chung-Yu] Acad Sinica, Inst Hist & Philol, Taipei 11529, Taiwan; [Delfin, Frederick] Univ Philippines, Nat Sci Res Inst, DNA Anal Lab, Quezon City 1101, Philippines; [Chiu, Hung-Lin] Natl Tsinghua Univ, Inst Anthropol, Hsinchu City 30013, Taiwan; [Ko, Ying-Chin] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan	Max Planck Society; Academia Sinica - Taiwan; University of the Philippines System; University of the Philippines Diliman; National Tsing Hua University; China Medical University Taiwan	Stoneking, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	stoneking@eva.mpg.de; ycko0406@gmail.com		Delfin, Frederick/0000-0002-8201-0661; Ko, Albert Min-Shan/0000-0002-2096-1330	Lienchiang County; Hsu Yu-Ziang Science and Technology Memorial Foundation; Max Planck Society	Lienchiang County; Hsu Yu-Ziang Science and Technology Memorial Foundation; Max Planck Society(Max Planck Society)	We thank all those who donated samples and gratefully acknowledge Yang Shui Sheng (Magistrate of Lienchiang County), Tsang Cheng-Hwa, Matsu Liangdao Archeological Team, Svante Paabo, Matthias Meyer, and Ayinuer Aximu-Petri for lab assistance. This research was supported by the Lienchiang County, by the Hsu Yu-Ziang Science and Technology Memorial Foundation, and by the Max Planck Society.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2010, BMC GENET, DOI [10.1186/1471-2156-11-94, DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-11]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 2002, GENETICS, V162, P2025; Bellwood P., 1978, MANS CONQUEST PACIFI; Bellwood P., 1997, PREHISTORY INDO MALA, VRevised ed.; Bellwood P, 2011, RICE, V4, P93, DOI 10.1007/s12284-011-9068-9; Bellwood P, 2011, INVESTIGATING ARCHAEOLOGICAL CULTURES: MATERIAL CULTURE, VARIABILITY, AND TRANSMISSION, P321, DOI 10.1007/978-1-4419-6970-5_16; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delfin F, 2014, EUR J HUM GENET, V22, P228, DOI 10.1038/ejhg.2013.122; Delfin F, 2012, MOL BIOL EVOL, V29, P545, DOI 10.1093/molbev/msr186; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Friedlaender JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000248; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Gunnarsdottir ED, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1235; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Jinam TA, 2012, MOL BIOL EVOL, V29, P3513, DOI 10.1093/molbev/mss169; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Li PJK, 2008, ROUTLEDGE STUD EARLY, V5, P211; Lin CF, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-271; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Mirabal S, 2013, AM J PHYS ANTHROPOL, V150, P551, DOI 10.1002/ajpa.22226; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Neuenschwander S, 2008, MOL ECOL, V17, P757, DOI 10.1111/j.1365-294X.2007.03621.x; Peng MS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-2; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Qi XB, 2013, MOL BIOL EVOL, V30, P1761, DOI 10.1093/molbev/mst093; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Ricaut FX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-605; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Rolett BV, 2011, QUATERNARY SCI REV, V30, P788, DOI 10.1016/j.quascirev.2011.01.015; Ross Malcolm., 2009, AUSTRONESIAN HIST LI, P295; Sagart L, 2008, ROUTLEDGE STUD EARLY, V5, P133; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Tsang C.H., 2005, PEOPLING E ASIA, P63; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vilar MG, 2013, AM J HUM BIOL, V25, P116, DOI 10.1002/ajhb.22349; Wang J.Y, 1967, ACAD SINICA MONOGRAP, P36; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Zeitoun Elizabeth, 1999, SELECTED PAPERS 8 IN, P31	62	99	103	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 6	2014	94	3					426	436		10.1016/j.ajhg.2014.02.003	http://dx.doi.org/10.1016/j.ajhg.2014.02.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AC6DK	24607387	Green Published, Bronze			2022-12-18	WOS:000332611400016
J	Zhou, J; Tawk, M; Tiziano, FD; Veillet, J; Bayes, M; Nolent, F; Garcia, V; Servidei, S; Bertini, E; Castro-Giner, F; Renda, Y; Carpentier, S; Andrieu-Abadie, N; Gut, I; Levade, T; Topaloglu, H; Melki, J				Zhou, Jie; Tawk, Marcel; Tiziano, Francesco Danilo; Veillet, Julien; Bayes, Monica; Nolent, Flora; Garcia, Virginie; Servidei, Serenella; Bertini, Enrico; Castro-Giner, Francesc; Renda, Yavuz; Carpentier, Stephane; Andrieu-Abadie, Nathalie; Gut, Ivo; Levade, Thierry; Topaloglu, Haluk; Melki, Judith			Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy Is Caused by Mutations in ASAH1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FARBER-DISEASE; ZEBRAFISH; GENE; CERAMIDES; CELLS	Spinal muscular atrophy (SMA) is a clinically and genetically heterogeneous disease characterized by the degeneration of lower motor neurons. The most frequent form is linked to mutations in SMN1. Childhood SMA associated with progressive myoclonic epilepsy (SMA-PME) has been reported as a rare autosomal-recessive condition unlinked to mutations in SMN1. Through linkage analysis, homozygosity mapping, and exome sequencing in three unrelated SMA-PME-affected families, we identified a homozygous missense mutation (c.125C>T [p.Thr42Met]) in exon 2 of ASAH1 in the affected children of two families and the same mutation associated with a deletion of the whole gene in the third family. Expression studies of the c.125C>T mutant cDNA in Farber fibroblasts showed that acid-ceramidase activity was only 32% of that generated by normal cDNA. This reduced activity was able to normalize the ceramide level in Farber cells, raising the question of the pathogenic mechanism underlying the CNS involvement in deficient cells. Morpholino knockdown of the ASAH1 ortholog in zebrafish led to a marked loss of motor-neuron axonal branching, a loss that is associated with increased apoptosis in the spinal cord. Our results reveal a wide phenotypic spectrum associated with ASAH1 mutations. An acid-ceramidase activity below 10% results in Farber disease, an early-onset disease starting with subcutaneous lipogranulomata, joint pain, and hoarseness of the voice, whereas a higher residual activity might be responsible for SMA-PME, a later-onset phenotype restricted to the CNS and starting with lower-motor-neuron disease.	[Zhou, Jie; Tawk, Marcel; Veillet, Julien; Nolent, Flora; Melki, Judith] Univ Paris 11, INSERM, UMR 788, Biomed Inst Bicetre, F-94276 Le Kremlin Bicetre, France; [Tiziano, Francesco Danilo] Univ Cattolica Sacro Cuore, Ist Genet Med, I-00168 Rome, Italy; [Bayes, Monica; Castro-Giner, Francesc; Gut, Ivo] Univ Barcelona, Ctr Nacl Anal Genom, Barcelona 080028, Spain; [Garcia, Virginie; Carpentier, Stephane; Andrieu-Abadie, Nathalie; Levade, Thierry] Univ Toulouse 3, Ctr Rech Canc Toulouse, INSERM, UMR 1037, F-31432 Toulouse, France; [Servidei, Serenella] Univ Cattolica Sacro Cuore, Ist Neurol, I-00168 Rome, Italy; [Bertini, Enrico] Osped Bambino Gesu Res Inst, Dept Neurosci, Mol Med Unit, I-00165 Rome, Italy; [Renda, Yavuz; Topaloglu, Haluk] Hacettepe Univ, Dept Pediat, Child Neurol Unit, TR-06100 Ankara, Turkey; [Levade, Thierry] Ctr Hosp Univ Toulouse, Hop Purpan, Inst Federatif Biol, Lab Biochim Metab, F-31432 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Bambino Gesu; Hacettepe University; CHU de Toulouse	Melki, J (corresponding author), Univ Paris 11, INSERM, UMR 788, Biomed Inst Bicetre, F-94276 Le Kremlin Bicetre, France.	judith.melki@inserm.fr	Servidei, Serenella/ABC-4262-2021; Bertini, Enrico/ABG-1278-2020; TOPALOGLU, HALUK AYDIN/I-9318-2013; Tawk, Marcel/M-2913-2018; Andrieu-Abadie, Nathalie/N-6793-2013; Bertini, Enrico/A-2284-2014; Tiziano, Francesco Danilo/A-7260-2010; GARCIA, Virginie/W-8313-2019; Castro-Giner, Francesc/D-7992-2014; Levade, Thierry/O-8948-2014; Gut, Ivo/ABF-3188-2020	Tawk, Marcel/0000-0003-4267-4743; Andrieu-Abadie, Nathalie/0000-0003-2698-1970; Bertini, Enrico/0000-0001-9276-4590; Tiziano, Francesco Danilo/0000-0002-5545-6158; GARCIA, Virginie/0000-0002-9761-7036; Castro-Giner, Francesc/0000-0001-6111-0754; Gut, Ivo/0000-0001-7219-632X; Nolent, Flora/0000-0002-3623-690X; SERVIDEI, Serenella/0000-0001-8478-2799	Association Francaise contre les Myopathies [14383, 13860]; Institut National de la Sante et de la Recherche Medicale; Vaincre les Maladies Lysosomales	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Vaincre les Maladies Lysosomales	This work was supported by the Association Francaise contre les Myopathies (to J.M.; ref. 14383 and 13860), the Institut National de la Sante et de la Recherche Medicale (to J.M.), and Vaincre les Maladies Lysosomales (to T.L.). The authors would like to thank the Biomedical Institute of Bicetre for providing us with Sanger-sequencing facilities, K. Sandhoff and H. Schulze (Bonn, Germany) for providing the rabbit anti-ceramidase antibody, and the National Heart, Lung, and Blood Institute Grand Opportunity (GO) Exome Sequencing Project and its ongoing studies, the Lung GO Sequencing Project (HL-102923), the Women's Health Initiative Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010), which all produced and provided exome variant calls for comparison. The authors wish to dedicate this work to the memory of C. Brahe, who recently passed.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bedia C, 2011, J BIOL CHEM, V286, P28200, DOI 10.1074/jbc.M110.216382; Bedia C, 2010, J LIPID RES, V51, P3542, DOI 10.1194/jlr.D010033; Bielawska A, 2001, ANAL BIOCHEM, V298, P141, DOI 10.1006/abio.2001.5342; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chatelut M, 1998, FEBS LETT, V426, P102, DOI 10.1016/S0014-5793(98)00325-1; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Haliloglu G, 2002, NEUROPEDIATRICS, V33, P314, DOI 10.1055/s-2002-37087; JANKOVIC J, 1979, ANN NEUROL, V6, P227, DOI 10.1002/ana.410060309; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEVADE T, 2009, SCRIVERS OMMBID ONLI; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Medin JA, 1999, HUM GENE THER, V10, P1321, DOI 10.1089/10430349950018003; Melancon E, 1997, J NEUROSCI, V17, P7796; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sabourdy F, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-84; SAMUELSS.K, 1971, SCAND J CLIN LAB INV, V27, P393, DOI 10.3109/00365517109080235; Walia JS, 2011, HUM GENE THER, V22, P679, DOI 10.1089/hum.2010.195; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Yeager AM, 2000, BONE MARROW TRANSPL, V26, P357, DOI 10.1038/sj.bmt.1702489	24	99	107	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2012	91	1					5	14		10.1016/j.ajhg.2012.05.001	http://dx.doi.org/10.1016/j.ajhg.2012.05.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974OE	22703880	Bronze, Green Published			2022-12-18	WOS:000306445000001
J	van Bon, BWM; Gilissen, C; Grange, DK; Hennekam, RCM; Kayserili, H; Engels, H; Reutter, H; Ostergaard, JR; Morava, E; Tsiakas, K; Isidor, B; Le Merrer, M; Eser, M; Wieskamp, N; de Vries, P; Steehouwer, M; Veltman, JA; Robertson, SP; Brunner, HG; de Vries, BBA; Hoischen, A				van Bon, Bregje W. M.; Gilissen, Christian; Grange, Dorothy K.; Hennekam, Raoul C. M.; Kayserili, Hulya; Engels, Hartmut; Reutter, Heiko; Ostergaard, John R.; Morava, Eva; Tsiakas, Konstantinos; Isidor, Bertrand; Le Merrer, Martine; Eser, Metin; Wieskamp, Nienke; de Vries, Petra; Steehouwer, Marloes; Veltman, Joris A.; Robertson, Stephen P.; Brunner, Han G.; de Vries, Bert B. A.; Hoischen, Alexander			Cantu Syndrome Is Caused by Mutations in ABCC9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT INHERITANCE; K-ATP CHANNELS; CONGENITAL HYPERTRICHOSIS; DILATED CARDIOMYOPATHY; ACTIVATING MUTATIONS; MINOXIDIL SULFATE; HEART-FAILURE; SMOOTH-MUSCLE; OSTEOCHONDRODYSPLASIA; TRANSPORTERS	Cantu syndrome is a rare disorder characterized by congenital hypertrichosis, neonatal macrosomia, a distinct osteochondrodysplasia, and cardiomegaly. Using an exome-sequencing approach applied to one proband-parent trio and three unrelated single cases, we identified heterozygous mutations in ABCC9 in all probands. With the inclusion of the remaining cohort of ten individuals with Cantu syndrome, a total of eleven mutations in ABCC9 were found. The de novo occurrence in all six simplex cases in our cohort substantiates the presence of a dominant disease mechanism. All mutations were missense, and several mutations affect Arg1154. This mutation hot spot lies within the second type 1 transmembrane region of this ATP-binding cassette transporter protein, which may suggest an activating mutation. ABCC9 encodes the sulfonylurea receptor (SUR) that forms ATP-sensitive potassium channels (K-ATP channels) originally shown in cardiac, skeletal, and smooth muscle. Previously, loss-of-function mutations in this gene have been associated with idiopathic dilated cardiomyopathy type 10 (CMD10). These findings identify the genetic basis of Cantu syndrome and suggest that this is a new member of the potassium channelopathies.	[van Bon, Bregje W. M.; Gilissen, Christian; Wieskamp, Nienke; de Vries, Petra; Steehouwer, Marloes; Veltman, Joris A.; Brunner, Han G.; de Vries, Bert B. A.; Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [van Bon, Bregje W. M.; Gilissen, Christian; Wieskamp, Nienke; de Vries, Petra; Steehouwer, Marloes; Veltman, Joris A.; Brunner, Han G.; de Vries, Bert B. A.; Hoischen, Alexander] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Disorders, NL-6500 HB Nijmegen, Netherlands; [Grange, Dorothy K.] Washington Univ, Sch Med, Div Genet & Genom Med, Dept Pediat, St Louis, MO 63110 USA; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Paediat & Translat Genet, NL-1105 AZ Amsterdam, Netherlands; [Kayserili, Hulya; Eser, Metin] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Istanbul, Turkey; [Engels, Hartmut; Reutter, Heiko] Univ Bonn, Inst Human Genet, D-53127 Bonn, Germany; [Reutter, Heiko] Univ Bonn, Childrens Hosp, Dept Neonatol, D-53127 Bonn, Germany; [Ostergaard, John R.] Aarhus Univ Hosp Skejby, Dept Pediat, Ctr Rare Dis, DK-8200 Aarhus N, Denmark; [Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Tsiakas, Konstantinos] Univ Med Ctr Eppendorf, Dept Pediat, D-20246 Hamburg, Germany; [Isidor, Bertrand] Univ Hosp Nantes, Clin Genet Unit, F-44093 Nantes, France; [Le Merrer, Martine] Univ Paris 05, Dept Genet, Hop Necker Enfants Malad, F-75015 Paris, France; [Robertson, Stephen P.] Univ Otago, Dept Pediat & Child Hlth, Dunedin Sch Med, Dunedin 9054, New Zealand; [Hoischen, Alexander] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway	Radboud University Nijmegen; Radboud University Nijmegen; Washington University (WUSTL); University of Amsterdam; Academic Medical Center Amsterdam; Istanbul University; University of Bonn; University of Bonn; Aarhus University; Radboud University Nijmegen; Radboud University Nijmegen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Otago; University of Bergen; Haukeland University Hospital	de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	b.devries@gen.umcn.nl	Morava, E./L-4529-2015; van Bon, Bregje/D-3720-2013; Brunner, Han/C-9928-2013; van Bon, Bregje/Q-2445-2015; Hoischen, Alexander/AGF-7293-2022; Hoischen, Alexander/D-1282-2013; Veltman, Joris A/F-5128-2010; Kayserili, Hülya/AAA-5593-2021; Isidor, Bertrand/AAJ-3456-2021; Gilissen, Christian/E-5246-2012; Isidor, Bertrand/L-2435-2015	van Bon, Bregje/0000-0003-2234-0105; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Veltman, Joris A/0000-0002-3218-8250; Kayserili, Hülya/0000-0003-0376-499X; Isidor, Bertrand/0000-0001-6480-126X; Gilissen, Christian/0000-0003-1693-9699; Isidor, Bertrand/0000-0001-6480-126X; Robertson, Stephen/0000-0002-5181-7809	Netherlands Organization for Health Research and Development (ZonMW) [917-66-36, 911-08-025, 917-86-319, 916-12-95]; European Union [Health-F5-2009-223143]; AnEUploidy project [LSHG-CT-2006-37627]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); European Union(European Commission); AnEUploidy project	We thank the patients and their parents for their participation and personnel from the Sequencing Facility Nijmegen for technical assistance. This study was financially supported by (1) the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-36 and 911-08-025 to J.A.V., 917-86-319 to B.B.A.d.V., and 916-12-95 to A.H.); (2) the European Union-funded TECHGENE project (Health-F5-2009-223143 to J.A.V.); and (3) the AnEUploidy project (LSHG-CT-2006-37627 to A.H., B.W.M.v.B., H.G.B., B.B.A.d.V., and J.A.V.).	Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; CANTU JM, 1982, HUM GENET, V60, P36, DOI 10.1007/BF00281261; Cartwright EJ, 2011, BIOFACTORS, V37, P175, DOI 10.1002/biof.149; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chien KR, 2003, NAT MED, V9, P508, DOI 10.1038/nm0503-508; de Wet H, 2007, P NATL ACAD SCI USA, V104, P18988, DOI 10.1073/pnas.0707428104; de Wet H, 2010, FEBS J, V277, P2654, DOI [10.1111/j.1742-4658.2010.07675.x, 10.1111/j.1742-464X.2010.07675.x]; Edghill EL, 2010, REV ENDOCR METAB DIS, V11, P193, DOI 10.1007/s11154-010-9149-x; Engels H, 2002, AM J MED GENET, V111, P205, DOI 10.1002/ajmg.10560; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Garcia-Cruz D, 2011, CLIN DYSMORPHOL, V20, P32, DOI 10.1097/MCD.0b013e32833d015c; GarciaCruz D, 1997, AM J MED GENET, V69, P138, DOI 10.1002/(SICI)1096-8628(19970317)69:2<138::AID-AJMG5>3.0.CO;2-L; Grange DK, 2006, AM J MED GENET A, V140A, P1673, DOI 10.1002/ajmg.a.31348; HAYASHI A, 1994, ARCH BIOCHEM BIOPHYS, V315, P137, DOI 10.1006/abbi.1994.1482; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Kurban M, 2011, DERMATOLOGY, V223, P316, DOI 10.1159/000333800; Lazalde B, 2000, AM J MED GENET, V94, P421, DOI 10.1002/1096-8628(20001023)94:5<421::AID-AJMG15>3.0.CO;2-9; MEISHERI KD, 1988, J PHARMACOL EXP THER, V245, P751; Messenger AG, 2004, BRIT J DERMATOL, V150, P186, DOI 10.1111/j.1365-2133.2004.05785.x; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; O'brien JJ, 2008, PEDIATR ANESTH, V18, P1255, DOI 10.1111/j.1460-9592.2008.02760.x; Robertson SP, 1999, AM J MED GENET, V85, P395, DOI 10.1002/(SICI)1096-8628(19990806)85:4<395::AID-AJMG17>3.3.CO;2-9; Rosser EM, 1998, CLIN DYSMORPHOL, V7, P79, DOI 10.1097/00019605-199804000-00001; Russ U, 2003, BRIT J PHARMACOL, V139, P368, DOI 10.1038/sj.bjp.0705238; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Scurr I, 2011, AM J MED GENET A, V155A, P508, DOI 10.1002/ajmg.a.33885; Tan TY, 2005, AM J MED GENET A, V139A, P216, DOI 10.1002/ajmg.a.31013; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; WINQUIST RJ, 1989, J PHARMACOL EXP THER, V248, P149	33	99	100	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 8	2012	90	6					1094	1101		10.1016/j.ajhg.2012.04.014	http://dx.doi.org/10.1016/j.ajhg.2012.04.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	958TC	22608503	Bronze, Green Published			2022-12-18	WOS:000305262600014
J	Sergouniotis, PI; Davidson, AE; Mackay, DS; Li, Z; Yang, X; Plagnol, V; Moore, AT; Webster, AR				Sergouniotis, Panagiotis I.; Davidson, Alice E.; Mackay, Donna S.; Li, Zheng; Yang, Xu; Plagnol, Vincent; Moore, Anthony T.; Webster, Andrew R.			Recessive Mutations in KCNJ13, Encoding an Inwardly Rectifying Potassium Channel Subunit, Cause Leber Congenital Amaurosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SNOWFLAKE VITREORETINAL DEGENERATION; RECTIFIER K+ CHANNEL; KIR7.1; FAMILY	Inherited retinal degenerations, including retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA), comprise a group of disorders showing high genetic and allelic heterogeneity. The determination of a full catalog of genes that can, when mutated, cause human retinal disease is a powerful means to understand the molecular physiology and pathology of the human retina. As more genes are found, remaining ones are likely to be rarer and/or unexpected candidates. Here, we identify a family in which all known RP/LCA-related genes are unlikely to be associated with their disorder. A combination of homozygosity mapping and exome sequencing identifies a homozygous nonsense mutation, c.496C>T (p.Arg166X), in a gene, KCNJ13, encoding a potassium channel subunit Kir7.1. A screen of a further 333 unrelated individuals with recessive retinal degeneration identified an additional proband, homozygous for a missense mutation, c.722T>C (p.Leu241Pro), in the same gene. The three affected members of the two families have been diagnosed with LCA. All have a distinct and unusual retinal appearance and a similar early onset of visual loss, suggesting both impaired retinal development and progressive retinal degeneration, involving both rod and cone pathways. Examination of heterozygotes revealed no ocular disease. This finding implicates Kir7.1 as having an important role in human retinal development and maintenance. This disorder adds to a small diverse group of diseases consequent upon loss or reduced function of inwardly rectifying potassium channels affecting various organs. The distinct retinal phenotype that results from biallelic mutations in KCNJ13 should facilitate the molecular diagnosis in further families.	[Sergouniotis, Panagiotis I.; Davidson, Alice E.; Mackay, Donna S.; Li, Zheng; Moore, Anthony T.; Webster, Andrew R.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Sergouniotis, Panagiotis I.; Moore, Anthony T.; Webster, Andrew R.] Moorfields Eye Hosp, London EC1V 2PD, England; [Yang, Xu] Beijing Genom Inst Shenzhen, Shenzhen 518083, Peoples R China; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Beijing Genomics Institute (BGI); University of London; University College London	Webster, AR (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	andrew.webster@ucl.ac.uk	Plagnol, Vincent/A-5667-2011	Plagnol, Vincent/0000-0002-5597-9215; Mackay, Donna/0000-0002-2499-1203; Sergouniotis, Panos/0000-0003-0986-4123; Li, Zheng/0000-0002-7060-2213	British Retinitis Pigmentosa Society; Fight for Sight; Moorfields Eye Hospital Special Trustees; National Institute for Health Research UK (Moorfields Eye Hospital and Institute of Ophthalmology, London, UK); Foundation Fighting Blindness (USA)	British Retinitis Pigmentosa Society; Fight for Sight; Moorfields Eye Hospital Special Trustees; National Institute for Health Research UK (Moorfields Eye Hospital and Institute of Ophthalmology, London, UK)(National Institute for Health Research (NIHR)); Foundation Fighting Blindness (USA)	We acknowledge the cooperation and help provided by the family members in this study. We thank Thomas Daskalakis for his key contribution in developing the python program, Geoffrey Maher and Eva Lenassi for their help with homology modeling and patient phenotyping, respectively, and Jill Urqhart and Sarah Daly at NIHR Manchester BRC for their technical assistance with Affymetrix array genotyping. We are grateful to colleagues who referred patients to us at MEH and those who contributed to the assembly of large panels of probands, particularly Louise Ocaka, Naushin Waseem, Bev Scott, Genevieve Wright, Sophie Devery, Michel Michaelides, Cathy Egan, Alan Bird, Graham Holder, Tony Robson, and Shomi Bhattacharya. We acknowledge the following sources of funding: British Retinitis Pigmentosa Society, Fight for Sight, Moorfields Eye Hospital Special Trustees, National Institute for Health Research UK (Moorfields Eye Hospital and Institute of Ophthalmology, London, UK), and the Foundation Fighting Blindness (USA). None of the authors declare a conflict of interest.	[Anonymous], ANNOVAR; [Anonymous], DBSNP; [Anonymous], BLOSSUM62; [Anonymous], CLUSTLW2; [Anonymous], POLYMORPHISM PHENOTY; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CHEN CJ, 1986, SOUTHERN MED J, V79, P1216, DOI 10.1097/00007611-198610000-00006; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Doring F, 1998, J NEUROSCI, V18, P8625; Edwards AO, 2008, EYE, V22, P1233, DOI 10.1038/eye.2008.38; GHEILER M, 1982, BIRTH DEFECTS-ORIG, V18, P577; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HIROSE T, 1974, AM J OPHTHALMOL, V77, P143, DOI 10.1016/0002-9394(74)90665-5; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Kusaka S, 2001, J PHYSIOL-LONDON, V531, P27, DOI 10.1111/j.1469-7793.2001.0027j.x; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LANG GE, 1991, KLIN MONATSBL AUGENH, V198, P207, DOI 10.1055/s-2008-1045954; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; Nakamura N, 1999, BIOCHEM J, V342, P329, DOI 10.1042/0264-6021:3420329; Partiseti M, 1998, FEBS LETT, V434, P171, DOI 10.1016/S0014-5793(98)00972-7; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; POLLACK A, 1983, ARCH OPHTHALMOL-CHIC, V101, P1536, DOI 10.1001/archopht.1983.01040020538005; ROBERTSON DM, 1982, OPHTHALMOLOGY, V89, P1513; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tateno T, 2006, CELL BIOL INT, V30, P270, DOI 10.1016/j.cellbi.2005.11.007; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717	33	99	100	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 15	2011	89	1					183	190		10.1016/j.ajhg.2011.06.002	http://dx.doi.org/10.1016/j.ajhg.2011.06.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	796HF	21763485	Green Published, Bronze			2022-12-18	WOS:000293041700018
J	Balanovsky, O; Rootsi, S; Pshenichnov, A; Kivisild, T; Churnosov, M; Evseeva, I; Pocheshkhova, E; Boldyreva, M; Yankovsky, N; Balanovska, E; Villems, R				Balanovsky, Oleg; Rootsi, Siiri; Pshenichnov, Andrey; Kivisild, Toornas; Churnosov, Michail; Evseeva, Irina; Pocheshkhova, Elvira; Boldyreva, Margarita; Yankovsky, Nikolay; Balanovska, Elena; Villems, Richard			Two sources of the Russian patrilineal heritage in their Eurasian context	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOMAL DIVERSITY; MTDNA HAPLOGROUP-H; MITOCHONDRIAL-DNA; GENETIC-EVIDENCE; POPULATION; DIFFERENTIATION; EASTERN; ORIGINS; EUROPE; POOL	Progress in the mapping of population genetic substructure provides a core source of data for the reconstruction of the demographic history of our species and for the discovery of common signals relevant to disease research: These two aspects of enquiry overlap in their empirical data content and are especially informative at continental and subcontinental levels. In the present study of the variation of the Y chromosome pool of ethnic Russians, we show that the patrilineages within the pre-Ivan the Terrible historic borders of Russia have two main distinct sources. One of these antedates the linguistic split between West and East Slavonic-speaking people and is common for the two groups; the other is genetically highlighted by the pre-eminence of haplogroup (hg) N3 and is most parsimoniously explained by extensive assimilation of (or language change in) northeastern indigenous Finno-Ugric tribes. Although hg N3 is common for both East European and Siberian Y chromosomes, other typically Siberian or Mongolian hgs (Q and C) have negligible influence within the studied Russian Y chromosome pool. The distribution of all frequent Y chromosome haplogroups (which account for 95% of the Y chromosomal spectrum in Russians) follows a similar north-south clinal pattern among autosomal markers, apparent from synthetic maps. Multidimensional scaling (MDS) plots comparing intra ethnic and interethnic variation of Y chromosome in Europe show that although well detectable, intraethnic variation signals do not cross interethnic borders, except between Poles, Ukrainians, and central-southern Russians, thereby revealing their overwhelmingly shared patrilineal ancestry.	[Balanovsky, Oleg; Pshenichnov, Andrey; Evseeva, Irina; Balanovska, Elena] Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; [Balanovsky, Oleg; Rootsi, Siiri; Kivisild, Toornas; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Balanovsky, Oleg; Rootsi, Siiri; Kivisild, Toornas; Villems, Richard] Estonian Bioctr, EE-51010 Tartu, Estonia; [Kivisild, Toornas] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Churnosov, Michail] Belgorod State Univ, Belgorod 308015, Russia; [Evseeva, Irina] No State Med Univ, Arkhangel 163001, Russia; [Pocheshkhova, Elvira] Kuban Med Acad, Krasnodar 350063, Russia; [Boldyreva, Margarita] FMBA Russia, Inst Immunol, Moscow 115478, Russia; [Yankovsky, Nikolay] Vavilov Inst Gen Genet, Moscow 119991, Russia	Research Centre for Medical Genetics; Russian Academy of Medical Sciences; University of Tartu; Estonian Biocentre; University of Cambridge; Belgorod State University; Northern State Medical University; Kuban State Medical University; NRC Institute of Immunology FMBA of Russia; Russian Academy of Sciences; Vavilov Institute of General Genetics	Balanovsky, O (corresponding author), Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia.	balanovsky@inbox.ru	Kivisild, Toomas/P-5889-2017; Churnosov, Mikhail/W-1313-2017; Balanovsky, Oleg/G-1549-2014; Yankovsky, Nick/AAU-9657-2021; Pocheshkhova, Elvira/P-2207-2017	Kivisild, Toomas/0000-0002-6297-7808; Churnosov, Mikhail/0000-0003-1254-6134; Pocheshkhova, Elvira/0000-0002-8991-7194; Yankovsky, Nikolay/0000-0002-2467-2683				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Akey JM, 2001, BIOTECHNIQUES, V30, P358, DOI 10.2144/01302tt05; Anikovich MV, 2007, SCIENCE, V315, P223, DOI 10.1126/science.1133376; BALANOVSKA E, THESIS RES CTR MED G; Balanovskaya E. V., 2001, Genetika, V37, P1125; BALANOVSKAYA EV, 1994, GENETIKA+, V30, P951; Balanovskii O. P., 2001, Genetika, V37, P974; Barac L, 2003, EUR J HUM GENET, V11, P535, DOI 10.1038/sj.ejhg.5200992; Behar DM, 2003, AM J HUM GENET, V73, P768, DOI 10.1086/378506; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Brion M, 2005, FORENSIC SCI INT, V153, P103, DOI 10.1016/j.forsciint.2005.06.002; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Dolukhanov P. M., 2000, ROOTS PEOPLES LANGUA, P71; Ginter EK, 1997, MED GENETICS ADYGEYA, P225; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; Kasperaviciute D, 2004, ANN HUM GENET, V68, P438, DOI 10.1046/j.1529-8817.2003.00119.x; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; KHARKOV VN, THESIS RES I MED GEN; Laitinen V, 2002, HUM HERED, V53, P68, DOI 10.1159/000057985; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Luca F, 2007, AM J PHYS ANTHROPOL, V132, P132, DOI 10.1002/ajpa.20500; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Marjanovic D, 2005, ANN HUM GENET, V69, P757, DOI 10.1111/j.1529-8817.2005.00190.x; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Nasidze I, 2006, CURR BIOL, V16, P668, DOI 10.1016/j.cub.2006.02.021; Nasidze I, 2005, AM J PHYS ANTHROPOL, V128, P846, DOI 10.1002/ajpa.20159; Nasidze I, 2004, ANN HUM GENET, V68, P588, DOI 10.1046/j.1529-8817.2004.00131.x; Nasidze I, 2004, ANN HUM GENET, V68, P205, DOI 10.1046/j.1529-8817.2004.00092.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nurbaev S D, 1998, Genetika, V34, P825; Passarino G, 2002, EUR J HUM GENET, V10, P521, DOI 10.1038/sj.ejhg.5200834; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; RACE E, 2005, AM J HUM GENET, V77, P519; Raitio M, 2001, GENOME RES, V11, P471, DOI 10.1101/gr.156301; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; REVAZOV AA, 1979, GENETIKA+, V15, P917; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; ROSENBERG MS, 2001, PATTERN ANAL SPATIAL; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; RYCHKOV YG, 1992, GENETIKA+, V28, P52; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sokal RR, 1999, HUM BIOL, V71, P1; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; UNDERHILL PA, 2008, RETHINKING HUMAN REV; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; WIIK K, 2002, EUROOPALAISTEN JUURE; *Y CHROM CONS, 1934, GENOME RES, V12, P339; Ye J, 2002, J FORENSIC SCI, V47, P593; Zerjal T, 1997, AM J HUM GENET, V60, P1174	69	99	121	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					236	250		10.1016/j.ajhg.2007.09.019	http://dx.doi.org/10.1016/j.ajhg.2007.09.019			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179905	Bronze, Green Published			2022-12-18	WOS:000253223800027
J	Duan, QL; Nikpoor, B; Dube, MP; Molinaro, G; Meijer, IA; Dion, P; Rochefort, D; Saint-Onge, J; Flury, L; Brown, NJ; Gainer, JV; Rouleau, JL; Agostoni, A; Cugno, M; Simon, P; Clavel, P; Potier, J; Wehbe, B; Benarbia, S; Marc-Aurele, J; Chanard, J; Foroud, T; Adam, A; Rouleau, GA				Duan, QL; Nikpoor, B; Dube, MP; Molinaro, G; Meijer, IA; Dion, P; Rochefort, D; Saint-Onge, J; Flury, L; Brown, NJ; Gainer, JV; Rouleau, JL; Agostoni, A; Cugno, M; Simon, P; Clavel, P; Potier, J; Wehbe, B; Benarbia, S; Marc-Aurele, J; Chanard, J; Foroud, T; Adam, A; Rouleau, GA			A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINOPEPTIDASE-P; LINKAGE ANALYSIS; BRADYKININ; ACE; DES-ARG(9)-BRADYKININ; DEGRADATION; METABOLISM; PREVENTION; THERAPY; CLONING	Angiotensin I-converting enzyme inhibitors (ACEi), which are used to treat common cardiovascular diseases, are associated with a potentially life-threatening adverse reaction known as angioedema (AE-ACEi). We have previously documented a significant association between AE-ACEi and low plasma aminopeptidase P (APP) activity. With eight large pedigrees, we hereby demonstrate that this quantitative trait is partially regulated by genetic factors. We tested APP activity using a variance-component QTL analysis of a 10-cM genomewide microsatellite scan enriched with seven markers over two candidate regions. We found significant linkage (LOD = 3.75) to a locus that includes the YPNPEP2 candidate gene encoding membrane-bound APP. Mutation screening of this QTL identified a large coding deletion segregating in one pedigree and an upstream single-nucleotide polymorphism (C2399A SNP), which segregates in the remaining seven pedigrees. Measured genotype analysis strongly suggests that the linkage signal for APP activity at this locus is accounted for predominantly by the SNP association. In a separate case-control study (20 cases and 60 controls), we found significant association of this SNP to ACEi-induced AE (P =.0364). In conclusion, our findings provide supporting evidence that the C-2399A variant in YPNPEP2 is associated with reduced APP activity and a higher incidence of AE-ACEi.	CHUM, Hop Notre Dame, Ctr Rech, Lab Etude Maladies Cereau, Montreal, PQ H2L 4M1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; Montreal Heart Inst, Dept Med, Montreal, PQ H1T 1C8, Canada; Univ Montreal, Fac Pharm, Montreal, PQ, Canada; Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; Univ Milan, Dept Internal Med, Milan, Italy; CH Beauchee, Serv Nephrol, St Brieuc, France; Univ Reims, Serv Nephrol, Reims, France; Univ Reims, Serv Nephrol Hemodialyse, ARPDD, Reims, France; CH Louis Pasteur, Serv Hematol, Cherbourg, France; Hop Hotel Dieu, St Jerome, PQ, Canada; CH Laennec, Serv Nephrol Hemodialyse, Quimper, France	Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; University of Milan; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rouleau, GA (corresponding author), CHUM, Hop Notre Dame, Ctr Rech, Lab Etude Maladies Cereau, Pavillon deSeve,Local Y-3633,1560,Rue Sherbrooke, Montreal, PQ H2L 4M1, Canada.	guy.rouleau@umontreal.ca	Meijer, Inge/AAL-5157-2020; Dubé, Marie-Pierre/B-9364-2008; Cugno, Massimo/K-8106-2016	Dubé, Marie-Pierre/0000-0001-8442-4393; Cugno, Massimo/0000-0002-9918-0763	NHLBI NIH HHS [R01 HL079184, 1-R01-HL079184] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079184] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adam A, 2002, LANCET, V359, P2088, DOI 10.1016/S0140-6736(02)08914-6; Agostoni A, 1999, IMMUNOPHARMACOLOGY, V44, P21, DOI 10.1016/S0162-3109(99)00107-1; Agostoni A, 2001, DRUG SAFETY, V24, P599, DOI 10.2165/00002018-200124080-00004; Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Almasy L, 2004, BEHAV GENET, V34, P173, DOI 10.1023/B:BEGE.0000013731.03827.69; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Blais C, 1999, IMMUNOPHARMACOLOGY, V43, P293, DOI 10.1016/S0162-3109(99)00133-2; Blais C, 2000, PEPTIDES, V21, P1903, DOI 10.1016/S0196-9781(00)00348-X; Blais C, 1997, ARTHRITIS RHEUM, V40, P1327, DOI 10.1002/1529-0131(199707)40:7<1327::AID-ART18>3.0.CO;2-B; Blais C, 1999, PEPTIDES, V20, P421, DOI 10.1016/S0196-9781(99)00020-0; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bright RA, 1999, NEPHROL DIAL TRANSPL, V14, P799, DOI 10.1093/ndt/14.3.799; Brown NJ, 1996, CLIN PHARMACOL THER, V60, P8, DOI 10.1016/S0009-9236(96)90161-7; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; Coats AJS, 2002, INT J CARDIOL, V86, P1, DOI 10.1016/S0167-5273(02)00389-3; Cugno M, 2003, INT IMMUNOPHARMACOL, V3, P311, DOI 10.1016/S1567-5769(02)00162-5; Cyr M, 2001, AM J PHYSIOL-HEART C, V281, pH275, DOI 10.1152/ajpheart.2001.281.1.H275; Discenza MT, 2004, PHYSIOL GENOMICS, V16, P287, DOI 10.1152/physiolgenomics.00164.2003; Ferreira PK, 2000, REGUL PEPTIDES, V89, P29, DOI 10.1016/S0167-0115(00)00094-X; Gallagher PE, 1999, HYPERTENSION, V33, P323, DOI 10.1161/01.HYP.33.1.323; Germer S, 1999, GENOME RES, V9, P72; HOOPER NM, 1992, HYPERTENSION, V19, P281, DOI 10.1161/01.HYP.19.3.281; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; Kim KS, 2000, J PHARMACOL EXP THER, V292, P295; Kostis OB, 2004, AM J HYPERTENS, V17, P103, DOI 10.1016/j.amjhyper.2003.09.014; Lefebvre J, 2002, HYPERTENSION, V39, P460, DOI 10.1161/hy0202.103054; Molinaro G, 2004, PROTEAS BIOL DIS, P251; Molinaro G, 2002, J PHARMACOL EXP THER, V303, P232, DOI 10.1124/jpet.102.038067; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Soria JM, 2000, BLOOD, V95, P2780, DOI 10.1182/blood.V95.9.2780.009k36_2780_2785; Sprinkle TJ, 2000, ARCH BIOCHEM BIOPHYS, V378, P51, DOI 10.1006/abbi.2000.1792; Sprinkle TJ, 1998, GENOMICS, V50, P114, DOI 10.1006/geno.1998.5302; UNGER T, 1994, CARDIOVASC RES, V28, P146, DOI 10.1093/cvr/28.2.146; Veneman RC, 1997, BBA-GENE STRUCT EXPR, V1354, P45, DOI 10.1016/S0167-4781(97)00126-7; Vleeming W, 1998, DRUG SAFETY, V18, P171, DOI 10.2165/00002018-199818030-00003; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	38	99	102	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					617	626		10.1086/496899	http://dx.doi.org/10.1086/496899			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175507	Bronze, Green Published			2022-12-18	WOS:000232106900009
J	Burwinkel, B; Scott, JW; Buhrer, C; van Landeghem, FKH; Cox, GF; Wilson, CJ; Hardie, DG; Kilimann, MW				Burwinkel, B; Scott, JW; Buhrer, C; van Landeghem, FKH; Cox, GF; Wilson, CJ; Hardie, DG; Kilimann, MW			Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PARKINSON-WHITE-SYNDROME; INFANTILE HYPERTROPHIC CARDIOMYOPATHY; CONDUCTION SYSTEM DISEASE; GAMMA-SUBUNIT ISOFORMS; SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; STORAGE-DISEASE; B KINASE; VENTRICULAR PREEXCITATION; LIVER GLYCOGENOSIS	Fatal congenital nonlysosomal cardiac glycogenosis has been attributed to a subtype of phosphorylase kinase deficiency, but the underlying genes and mutations have not been identified. Analyzing four sporadic, unrelated patients, we found no mutations either in the eight genes encoding phosphorylase kinase subunits or in the two genes encoding the muscle and brain isoforms of glycogen phosphorylase. However, in three of five patients, we identified identical heterozygous R531Q missense mutations of the PRKAG2 gene, which encodes the gamma 2-subunit of AMP-activated protein kinase, a key regulator of energy balance. Biochemical characterization of the recombinant R531Q mutant protein showed > 100-fold reduction of binding affinities for the regulatory nucleotides AMP and ATP but an enhanced basal activity and increased phosphorylation of the alpha-subunit. Other PRKAG2 missense mutations were previously identified in patients with autosomal dominant hypertrophic cardiomyopathy withWolffParkinson- White syndrome, characterized by juvenile-to-adult clinical onset, moderate cardiac glycogenosis, disturbed excitation conduction, risk of sudden cardiac death in midlife, and molecular perturbations that are similar to-but less severe than-those observed for the R531Q mutation. Thus, recurrent heterozygous R531Q missense mutations in PRKAG2 give rise to a massive nonlysosomal cardiac glycogenosis of fetal symptomatic onset and rapidly fatal course, constituting a genotypically and clinically distinct variant of hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome. R531Q and other PRKAG2 mutations enhance the basal activity and alpha-subunit phosphorylation of AMP-activated protein kinase, explaining the dominant nature of PRKAG2 disease mutations. Since not all cases displayed PRKAG2 mutations, fatal congenital nonlysosomal cardiac glycogenosis seems to be genetically heterogeneous. However, the existence of a heart-specific primary phosphorylase kinase deficiency is questionable, because no phosphorylase kinase mutations were found.	Ruhr Univ Bochum, Fak Med, Inst Physiol Chem, D-4630 Bochum, Germany; Univ Dundee, Wellcome Trust Bioctr, Fac Life Sci, Div Mol Physiol, Dundee, Scotland; Charite Virchow Med Ctr, Dept Neonatol, Berlin, Germany; Charite Virchow Med Ctr, Dept Neuropathol, Berlin, Germany; Childrens Hosp, Clin Genet Program, Boston, MA 02115 USA; UCL, Sch Med, Great Ormond St Hosp Children, London W1N 8AA, England	Ruhr University Bochum; University of Dundee; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Boston Children's Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Medical School	Kilimann, MW (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.	Manfred.kilimann@icm.uu.se	Scott, John W/AAA-2676-2021; Scott, John W/P-1170-2018; Hardie, David/Z-1979-2019	Scott, John W/0000-0002-1896-9798; Scott, John W/0000-0002-1896-9798; van Landeghem, Frank/0000-0002-9404-7031; Hardie, Grahame/0000-0002-8373-7379	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD083284] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-8-3284] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANRONARAKIS SE, 2001, METABOLIC MOL BASES, P343; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Arad M, 2003, CIRCULATION, V107, P2850, DOI 10.1161/01.CIR.0000075270.13497.2B; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI14571; Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Barnes K, 2002, J CELL SCI, V115, P2433; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Buhrer C, 2003, ACTA PAEDIATR, V92, P1352, DOI 10.1080/08035250310006458; Burwinkel B, 1998, HUM MOL GENET, V7, P149, DOI 10.1093/hmg/7.1.149; Burwinkel B, 2003, EUR J HUM GENET, V11, P516, DOI 10.1038/sj.ejhg.5200996; Burwinkel B, 1996, HUM MOL GENET, V5, P653, DOI 10.1093/hmg/5.5.653; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P82; CHANG RSM, 1954, P SOC EXP BIOL MED, V87, P440; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; EISHI Y, 1985, HUM PATHOL, V16, P193, DOI 10.1016/S0046-8177(85)80071-X; ELLEDER M, 1993, VIRCHOWS ARCH A, V423, P303, DOI 10.1007/BF01606895; Ewert R, 1999, Z KARDIOL, V88, P850, DOI 10.1007/s003920050361; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; Fryer LGD, 2002, BIOCHEM J, V363, P167, DOI 10.1042/0264-6021:3630167; Gollob MH, 2002, CURR OPIN CARDIOL, V17, P229, DOI 10.1097/00001573-200205000-00004; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; HANSEN L, 1995, HUM MOL GENET, V4, P1313, DOI 10.1093/hmg/4.8.1313; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 2000, METH MOL B, V99, P63; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hirschhorn R. a. R. AJJ., 2001, METABOLIC MOL BASES, P3389; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; KILIMANN MW, 1997, PROTEIN DYSFUNCTION, P57; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lee PJ, 1997, AM J CARDIOL, V79, P834, DOI 10.1016/S0002-9149(96)00885-5; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; MIZUTA K, 1984, BIOCHEM BIOPH RES CO, V119, P582, DOI 10.1016/S0006-291X(84)80288-0; Murphy RT, 2005, J AM COLL CARDIOL, V45, P922, DOI 10.1016/j.jacc.2004.11.053; Oliveira SMJ, 2003, J MOL CELL CARDIOL, V35, P1251, DOI 10.1016/S0022-2828(03)00237-2; Regalado JJ, 1999, PEDIATR CARDIOL, V20, P304, DOI 10.1007/s002469900471; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Scriver C.R., 2001, METABOLIC MOL BASIS, VEighth; SERVIDEI S, 1988, J PEDIATR-US, V113, P82, DOI 10.1016/S0022-3476(88)80535-3; SERVIDEI S, 1987, J PEDIATR-US, V111, P51, DOI 10.1016/S0022-3476(87)80341-4; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Strauss A, 2003, NEW ENGL J MED, V348, P1703, DOI 10.1056/NEJMe030027; Sugie K, 2002, NEUROLOGY, V58, P1773, DOI 10.1212/WNL.58.12.1773; Westphal V, 2002, HUM MOL GENET, V11, P599, DOI 10.1093/hmg/11.5.599; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yamamoto A, 2001, NEUROLOGY, V57, P903, DOI 10.1212/WNL.57.5.903; Ziemssen F, 2000, ANN NEUROL, V47, P536, DOI 10.1002/1531-8249(200004)47:4<536::AID-ANA22>3.3.CO;2-B	58	99	107	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					1034	1049		10.1086/430840	http://dx.doi.org/10.1086/430840			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15877279	Green Published, Bronze			2022-12-18	WOS:000229047900009
J	Niemitz, EL; DeBaun, MR; Fallon, J; Murakami, K; Kugoh, H; Oshimura, M; Feinberg, AP				Niemitz, EL; DeBaun, MR; Fallon, J; Murakami, K; Kugoh, H; Oshimura, M; Feinberg, AP			Microdeletion of LIT1 in familial Beckwith-Wiedemann syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							P57(KIP2); DISRUPTION; TRANSCRIPT; KVDMR1	Beckwith-Wiedemann syndrome (BWS), which causes prenatal overgrowth, midline abdominal wall defects, macroglossia, and embryonal tumors, is a model for understanding the relationship between genomic imprinting, human development, and cancer. The causes are heterogeneous, involving multiple genes on 11p15 and including infrequent mutation of p57(KIP2) or loss of imprinting of either of two imprinted gene domains on 11p15: LIT1, which is near p57(KIP2), or H19/IGF2. Unlike Prader-Willi and Angelman syndromes, no chromosomal deletions have yet been identified. Here we report a microdeletion including the entire LIT1 gene, providing genetic confirmation of the importance of this gene region in BWS. When inherited maternally, the deletion causes BWS with silencing of p57(KIP2), indicating deletion of an element important for the regulation of p57(KIP2) expression. When inherited paternally, there is no phenotype, suggesting that the LIT1 RNA itself is not necessary for normal development in humans.	Johns Hopkins Univ, Sch Med, Predoctoral Program Human Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Med Mol Biol & Genet, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA; Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA; Tottori Univ, Grad Sch Med Sci, Dept Biomed Sci, Tottori, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Washington University (WUSTL); Tottori University	Feinberg, AP (corresponding author), 720 Rutland Ave, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991; Murakami, Kazuhiro/0000-0003-1759-9542	NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA054358, R01 CA054358, CA54358, R37 CA054358-14] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Lee MP, 1997, AM J HUM GENET, V61, P304, DOI 10.1086/514858; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; OKeefe D, 1997, AM J HUM GENET, V61, P295, DOI 10.1086/514854; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Wilke K, 2000, HUM MUTAT, V16, P431, DOI 10.1002/1098-1004(200011)16:5<431::AID-HUMU8>3.0.CO;2-Z	14	99	104	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					844	849		10.1086/425343	http://dx.doi.org/10.1086/425343			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15372379	Green Published, Bronze			2022-12-18	WOS:000224303500009
J	Migeon, BR; Lee, CH; Chowdhury, AK; Carpenter, H				Migeon, BR; Lee, CH; Chowdhury, AK; Carpenter, H			Species differences in TSIX/Tsix reveal the roles of these genes in X-chromosome inactivation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOSAGE COMPENSATION; STEM-CELLS; XIST GENE; TSIX; MOUSE; RNA; ANTISENSE; MICE; DIFFERENTIATION; TRANSCRIPTION	Transcriptional silencing of the human inactive X chromosome is induced by the XIST gene within the human X-inactivation center. The XIST allele must be turned off on one X chromosome to maintain its activity in cells of both sexes. In the mouse placenta, where X inactivation is imprinted (the paternal X chromosome is always inactive), the maternal Xist allele is repressed by a cis-acting antisense transcript, encoded by the Tsix gene. However, it remains to be seen whether this antisense transcript protects the future active X chromosome during random inactivation in the embryo proper. We recently identified the human TSIX gene and showed that it lacks key regulatory elements needed for the imprinting function of murine Tsix. Now, using RNA FISH for cellular localization of transcripts in human fetal cells, we show that human TSIX antisense transcripts are unable to repress XIST. In fact, TSIX is transcribed only from the inactive X chromosome and is coexpressed with XIST. Also, TSIX is not maternally imprinted in placental tissues, and its transcription persists in placental and fetal tissues, throughout embryogenesis. Therefore, the repression of Xist by mouse Tsix has no counterpart in humans, and TSIX is not the gene that protects the active X chromosome from random inactivation. Because human TSIX cannot imprint X inactivation in the placenta, it serves as a mutant for mouse Tsix, providing insights into features responsible for antisense activity in imprinted X inactivation.	Johns Hopkins Univ, Sch Med, Mckusick Nathans Inst Genet Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Migeon, BR (corresponding author), Johns Hopkins Univ Hosp, CMSC 10-04,600 N Wolf St, Baltimore, MD 21287 USA.				NICHD NIH HHS [HD 05465] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beletskii A, 2001, P NATL ACAD SCI USA, V98, P9215, DOI 10.1073/pnas.161173098; Boumil RM, 2001, HUM MOL GENET, V10, P2225; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; CLEMSON CM, 1996, J CELL BIOL, V132, P1; Debrand E, 1999, MOL CELL BIOL, V19, P8513; JACOBS PA, 1979, AM J HUM GENET, V31, P446; JACOBS PA, 1980, NATURE, V286, P714, DOI 10.1038/286714a0; JACOBS PA, 1989, CYTOGENET CELL GENET, V50, P75, DOI 10.1159/000132727; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; LYON MF, 1962, AM J HUM GENET, V14, P135; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; MARTIN GR, 1978, NATURE, V271, P329, DOI 10.1038/271329a0; MIGEON BR, 1979, CELL, V18, P637, DOI 10.1016/0092-8674(79)90118-1; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; Migeon BR, 1999, GENOMICS, V59, P113, DOI 10.1006/geno.1999.5861; Migeon BR, 2001, AM J HUM GENET, V69, P951, DOI 10.1086/324022; MIGEON BR, 1979, AM J HUM GENET, V31, P581; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Onyango P, 2000, GENOME RES, V10, P1697, DOI 10.1101/gr.161800; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Sado T, 2001, DEVELOPMENT, V128, P1275; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1990, DEVELOPMENT, V109, P189; WEAVER DD, 1975, HUMANGENETIK, V28, P39, DOI 10.1007/BF00272480; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	35	99	102	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					286	293		10.1086/341605	http://dx.doi.org/10.1086/341605			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12023758	Bronze, Green Published			2022-12-18	WOS:000176977700007
J	Pras, E; Levy-Nissenbaum, E; Bakhan, T; Lahat, H; Assia, E; Geffen-Carmi, N; Frydman, M; Goldman, B; Pras, E				Pras, E; Levy-Nissenbaum, E; Bakhan, T; Lahat, H; Assia, E; Geffen-Carmi, N; Frydman, M; Goldman, B; Pras, E			A missense mutation in the LIM2 gene is associated with autosomal recessive presenile cataract in an inbred Iraqi Jewish family	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEMBRANE-PROTEINS; LENS; MP20	In an inbred Iraqi Jewish family, we have studied three siblings with presenile cataract first noticed between the ages of 20 and 51 years and segregating in an autosomal recessive mode. Using microsatellite repeat markers in close proximity to 25 genes and loci previously associated with congenital cataracts in humans and mice, we identified five markers on chromosome 19q that cosegregated with the disease. Sequencing of LIM2, one of two candidate genes in this region, revealed a homozygous T G change resulting in a phenylalanine-to-valine substitution at position 105 of the protein. To our knowledge, this constitutes the first report, in humans, of cataract formation associated with a mutation in LIM2. Studies of late-onset single-gene cataracts may provide insight into the pathogenesis of the more common age-related cataracts.	Chaim Sheba Med Ctr, Inst Human Genet, IL-52621 Tel Hashomer, Israel; Sapir Med Ctr, Dept Ophthalmol, Kefar Sava, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Pras, E (corresponding author), Chaim Sheba Med Ctr, Inst Human Genet, IL-52621 Tel Hashomer, Israel.	epras@post.tau.ac.il						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arneson ML, 1998, EXP EYE RES, V66, P495, DOI 10.1006/exer.1998.0477; Foster A, 1999, EYE, V13, P449, DOI 10.1038/eye.1999.120; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; HEIBA IM, 1993, AM J MED GENET, V47, P1208, DOI 10.1002/ajmg.1320470816; Heon E, 2001, AM J HUM GENET, V68, P772, DOI 10.1086/318798; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; JARVIS LJ, 1995, CURR EYE RES, V14, P799, DOI 10.3109/02713689508995802; Lambert SR, 1996, SURV OPHTHALMOL, V40, P427, DOI 10.1016/S0039-6257(96)82011-X; McCarty CA, 2001, INVEST OPHTH VIS SCI, V42, P1677; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Pras E, 2001, ISR MED ASSOC J, V3, P559; Steele E C Jr, 1997, Mol Vis, V3, P5; Steele EC, 2000, MOL VIS, V6, P85; TAYLOR V, 1995, J BIOL CHEM, V270, P28824, DOI 10.1074/jbc.270.48.28824; TENBROEK E, 1992, J CELL SCI, V103, P245; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Zhou L, 2001, MOL VIS, V7, P79	19	99	106	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1363	1367		10.1086/340318	http://dx.doi.org/10.1086/340318			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11917274	Green Published, Bronze			2022-12-18	WOS:000175012400027
J	Abney, M; Ober, C; McPeek, MS				Abney, M; Ober, C; McPeek, MS			Quantitative-trait homozygosity and association mapping and empirical genomewide significance in large, complex pedigrees: Fasting serum-insulin level in the hutterites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; GENETIC DISSECTION; VARIANCE-COMPONENTS; DISEQUILIBRIUM; SCREEN; TESTS	We present methods for linkage and association mapping of quantitative traits for a founder population with a large, known genealogy. We detect linkage to quantitative-trait loci (QTLs) through a multipoint homozygosity-mapping method. We propose two association methods, one of which is single point and uses a general two-allele model and the other of which is multipoint and uses homozygosity by descent for a particular allele. In all three methods, we make extensive use of the pedigree and genotype information, while keeping the computations simple and efficient. To assess significance, we have developed a permutation-based test that takes into account the covariance structure due to relatedness of individuals and can be used to determine empirical genomewide and locus-specific P values. In the case of multivariate-normally distributed trait data, the permutation-based test is asymptotically exact. The test is broadly applicable to a variety of mapping methods that fall within the class of linear statistical models (e. g., variance-component methods), under the assumption of random ascertainment with respect to the phenotype. For obtaining genomewide P values, our proposed method is appropriate when positions of markers are independent of the observed linkage signal, under the null hypothesis. We apply our methods to a genome screen for fasting insulin level in the Hutterites. We detect significant genomewide linkage on chromosome 19 and suggestive evidence of QTLs on chromosomes 1 and 16.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Abney, M (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	abney@genetics.uchicago.edu			NHGRI NIH HHS [R01 HG001645, HG 01645, R29 HG001645] Funding Source: Medline; NHLBI NIH HHS [U01 HL049596, P50 HL056399, HL 49596, HL 56399] Funding Source: Medline; NIDDK NIH HHS [DK55889, R01 DK055889] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056399, U01HL049596] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG001645, R01HG001645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Baum LE, 1972, INEQUALITIES, V3, P1; Bleibtreu H., 1964, THESIS HARVARD U CAM; Boehnke M, 2000, NAT GENET, V25, P246, DOI 10.1038/76980; CHURCHILL GA, 1994, GENETICS, V138, P963; Cox DR., 1974, THEORETICAL STAT; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; Dyer TD, 2001, GENET EPIDEMIOL, V21, pS236, DOI 10.1002/gepi.2001.21.s1.s236; Eaves IA, 2000, NAT GENET, V25, P320; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Ginns EI, 1998, P NATL ACAD SCI USA, V95, P15531, DOI 10.1073/pnas.95.26.15531; Good P., 2000, PERMUTATION TESTS; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Horikawa Y, 2000, NAT GENET, V26, P502; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hostetler J, 1974, HUTTERITE SOC; Hsueh WC, 2001, J CLIN ENDOCR METAB, V86, P1199, DOI 10.1210/jc.86.3.1199; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Iturria SJ, 1999, GENET EPIDEMIOL, V17, pS169; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1978, J MATH BIOL, V6, P59, DOI 10.1007/BF02478517; Lehmann E.L., 1994, TESTING STAT HYPOTHE; Lin S, 2001, AM J HUM GENET, V68, P1219, DOI 10.1086/320116; MANGE AP, 1964, HUM BIOL, V36, P104; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; MARTIN AO, 1970, AM J PHYS ANTHROPOL, V32, P351, DOI 10.1002/ajpa.1330320305; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Newman DL, 2001, AM J HUM GENET, V69, P1146, DOI 10.1086/323659; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 1998, CLIN EXP ALLERGY, V28, P101; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Province MA, 2000, GENET EPIDEMIOL, V19, P301, DOI 10.1002/1098-2272(200012)19:4<301::AID-GEPI3>3.0.CO;2-G; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; THOMPSON EA, 1999, LECT NOTES MONOGRAPH, V33; THOMSON PD, 1994, TRANSPLANT P, V26, P15; Tu IP, 1999, AM J HUM GENET, V64, P641, DOI 10.1086/302253; Wan Y, 1997, ANN HUM GENET, V61, P79; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	49	99	101	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					920	934		10.1086/339705	http://dx.doi.org/10.1086/339705			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11880950	Green Published, Bronze			2022-12-18	WOS:000174252100009
J	Kenwrick, S; Woffendin, H; Jakins, T; Shuttleworth, SG; Mayer, E; Greenhalgh, L; Whittaker, J; Rugolotto, S; Bardaro, T; Esposito, T; D'Urso, M; Soli, F; Turco, A; Smahi, A; Hamel-Teillac, D; Lyonnet, S; Bonnefont, JP; Munnich, A; Aradhya, S; Kashork, CD; Shaffer, LG; Nelson, DL; Levy, M; Lewis, RA				Kenwrick, S; Woffendin, H; Jakins, T; Shuttleworth, SG; Mayer, E; Greenhalgh, L; Whittaker, J; Rugolotto, S; Bardaro, T; Esposito, T; D'Urso, M; Soli, F; Turco, A; Smahi, A; Hamel-Teillac, D; Lyonnet, S; Bonnefont, JP; Munnich, A; Aradhya, S; Kashork, CD; Shaffer, LG; Nelson, DL; Levy, M; Lewis, RA		Int IP Consortium	Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; KAPPA-B ACTIVATION; IKK-GAMMA; GONADAL MOSAICISM; BLOCH-SULZBERGER; HAPPLE-SYNDROME; KINASE COMPLEX; MALE INFANT; NEMO; DISORDER	Incontinentia pigmenti (IP), or "Bloch-Sulzberger syndrome," is an X-linked dominant disorder characterized by abnormalities of skin, teeth, hair, and eyes; skewed X-inactivation; and recurrent miscarriages of male fetuses. IP results from mutations in the gene for NF-kappaB essential modulator (NEMO), with deletion of exons 4-10 of NEMO accounting for >80% of new mutations. Male fetuses inheriting this mutation and other "null" mutations of NEMO usually die in utero. Less deleterious mutations can result in survival of males subjects, but with ectodermal dysplasia and immunodeficiency. Male patients with skin, dental, and ocular abnormalities typical of those seen in female patients with IP (without immunodeficiency) are rare. We investigated four male patients with clinical hallmarks of IP. All four were found to carry the deletion normally associated with male lethality in utero. Survival in one patient is explained by a 47, XXY karyotype and skewed X inactivation. Three other patients possess a normal 46, XY karyotype. We demonstrate that these patients have both wild-type and deleted copies of the NEMO gene and are therefore mosaic for the common mutation. Therefore, the repeat-mediated rearrangement leading to the common deletion does not require meiotic division. Hypomorphic alleles, a 47, XXY karyotype, and somatic mosaicism therefore represent three mechanisms for survival of males carrying a NEMO mutation.	Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2XY, England; Cambridge Inst Med Res, Cambridge, England; Bristol Eye Hosp, Bristol BS1 2LX, Avon, England; St Michaels Hosp, Bristol, Avon, England; Univ Cambridge, Addenbrookes Hosp, Dept Mol Genet, Cambridge CB2 2XY, England; Univ Verona, Mother & Child Dept, Sect Biol & Genet, I-37100 Verona, Italy; Univ Verona, Mother & Child Dept, Sect Pediat, I-37100 Verona, Italy; CNR, Int Inst Genet & Biophys, I-80125 Naples, Italy; Hop Necker Enfants, INSERM, U393, Dept Genet,Unite Rech handicaps Genet Enfant, Paris, France; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA; Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Bristol Eye Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Verona; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kenwrick, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, CIMR Box 139, Cambridge CB2 2XY, England.	SJK12@mole.bio.cam.ac.uk	Esposito, Teresa/AAA-5488-2019; Smahi, Asma/J-4184-2017; Lyonnet, Stanislas/H-5483-2017	Esposito, Teresa/0000-0002-7879-8441; Smahi, Asma/0000-0002-6002-0981; Lyonnet, Stanislas/0000-0001-5426-9417; ARADHYA, SWAROOP/0000-0001-6219-2931; BONNEFONT, Jean-Paul/0000-0002-4235-1197	NICHD NIH HHS [5 R01 HD35617-04, R01 HD035617, 5 P30 HD24064, P30 HD024064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035617] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aradhya S, 2001, AM J HUM GENET, V68, P765, DOI 10.1086/318806; CARNEY RG, 1976, ARCH DERMATOL, V112, P535, DOI 10.1001/archderm.112.4.535; Clayton-Smith J, 2000, LANCET, V356, P830, DOI 10.1016/S0140-6736(00)02661-1; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; FOWELL SM, 1992, J PEDIATR OPHTHALMOL, V29, P180; GARCIADORADO J, 1990, CLIN GENET, V38, P128; Has C, 2000, HUM MOL GENET, V9, P1951, DOI 10.1093/hmg/9.13.1951; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; KIRCHMAN TTT, 1995, J MED GENET, V32, P887, DOI 10.1136/jmg.32.11.887; KUNZE J, 1977, HUM GENET, V35, P237, DOI 10.1007/BF00393976; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; LENZ W, 1975, AM J HUM GENET, V27, P690; Mansour S, 2001, AM J MED GENET, V99, P172, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1155>3.0.CO;2-Y; Oldenburg J, 2000, BLOOD, V96, P2905; ORMEROD AD, 1987, J MED GENET, V24, P439, DOI 10.1136/jmg.24.7.439; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; PRENDIVILLE JS, 1989, J AM ACAD DERMATOL, V20, P937, DOI 10.1016/S0190-9622(89)70114-6; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Scheuerle AE, 1998, AM J MED GENET, V77, P201, DOI 10.1002/(SICI)1096-8628(19980518)77:3<201::AID-AJMG5>3.3.CO;2-N; Smahi A, 2000, NATURE, V405, P466; TRAUPE H, 1992, HUM GENET, V89, P659, DOI 10.1007/BF00221958; VAN AD, 1996, SCIENCE, V274, P787; Woffendin H, 1999, CLIN GENET, V55, P55, DOI 10.1034/j.1399-0004.1999.550110.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	26	99	105	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1210	1217						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11673821				2022-12-18	WOS:000172086900005
J	Migeon, BR; Chowdhury, AK; Dunston, JA; McIntosh, I				Migeon, BR; Chowdhury, AK; Dunston, JA; McIntosh, I			Identification of TSIX, encoding an RNA antisense to human XIST, reveals differences from its murine counterpart: Implications for X inactivation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN CHORIONIC VILLI; CHROMOSOME INACTIVATION; GENE STRUCTURE; REPLICATION; PREDICTION; EXPRESSION; SEQUENCE; NUCLEUS; REPEATS; CELLS	X inactivation is the mammalian method for X-chromosome dosage compensation, but some features of this developmental process vary among mammals. Such species variations provide insights into the essential components of the pathway. Tsix encodes a transcript antisense to the murine Xist transcript and is expressed in the mouse embryo only during the initial stages of X inactivation; it has been shown to play a role in imprinted X inactivation in the mouse placenta. We have identified its counterpart within the human X inactivation center (XIC). Human TSIX produces a >30-kb transcript that is expressed only in cells of fetal origin; it is expressed from human XIC transgenes in mouse embryonic stem cells and from human embryoid-body-derived cells, but not from human adult somatic cells. Differences in the structure of human and murine genes indicate that human TSIX was truncated during evolution. These differences could explain the fact that X inactivation is not imprinted in human placenta, and they raise questions about the role of TSIX in random X inactivation.	Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Ins Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Migeon, BR (corresponding author), Johns Hopkins Univ Hosp, CMSC 10 04, 600 N Wolfe St, Baltimore, MD 21287 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044702, AR44702] Funding Source: Medline; NICHD NIH HHS [HD05465] Funding Source: Medline; NIGMS NIH HHS [T32 GM007814, GM07814] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chow JC, 2000, AM J HUM GENET, V67, P44; CLEMSON CM, 1996, J CELL BIOL, V132, P1; Heard E, 1999, MOL CELL BIOL, V19, P3156; HEARD E, 1997, ANNU REV GENET, V31, P572; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; JACOBS PA, 1979, AM J HUM GENET, V31, P446; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lyon MF, 1996, NATURE, V379, P116, DOI 10.1038/379116a0; LYON MF, 1962, AM J HUM GENET, V14, P135; MIGEON BR, 1990, GENET RES, V56, P91, DOI 10.1017/S0016672300035151; MIGEON BR, 1979, CELL, V18, P637, DOI 10.1016/0092-8674(79)90118-1; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; Migeon BR, 1999, GENOMICS, V59, P113, DOI 10.1006/geno.1999.5861; MIGEON BR, 1986, P NATL ACAD SCI USA, V83, P2182, DOI 10.1073/pnas.83.7.2182; Migeon BR, 2001, GENOMICS, V71, P156, DOI 10.1006/geno.2000.6421; MIGEON BR, 1979, AM J HUM GENET, V31, P581; MIGEON BR, 1978, GENETIC MOSAICS CHIM, P379; Milanesi L, 1999, BIOINFORMATICS, V15, P612, DOI 10.1093/bioinformatics/15.7.612; MOHANDAS TK, 1989, SOMAT CELL MOLEC GEN, V15, P131, DOI 10.1007/BF01535073; Morey C, 2001, HUM MOL GENET, V10, P1403, DOI 10.1093/hmg/10.13.1403; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Prissette M, 2001, HUM MOL GENET, V10, P31, DOI 10.1093/hmg/10.1.31; Ray PF, 1997, HUM MOL GENET, V6, P1323, DOI 10.1093/hmg/6.8.1323; Rogozin IB, 1996, COMPUT APPL BIOSCI, V12, P161; Sado T, 2001, DEVELOPMENT, V128, P1275; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SIMMLER MC, 1993, MAMM GENOME, V4, P523, DOI 10.1007/BF00364788; Simmler MC, 1996, HUM MOL GENET, V5, P1713, DOI 10.1093/hmg/5.11.1713; vandenHurk JAJM, 1997, HUM MOL GENET, V6, P851, DOI 10.1093/hmg/6.6.851; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	38	99	101	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					951	960		10.1086/324022	http://dx.doi.org/10.1086/324022			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11555794	Green Published, Bronze			2022-12-18	WOS:000171413400003
J	Schonberger, J; Seidman, CE				Schonberger, J; Seidman, CE			Many roads lead to a broken heart: The genetics of dilated cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							RIGHT-VENTRICULAR CARDIOMYOPATHY; RYANODINE RECEPTOR GENE; ENCODING LAMIN A/C; X-LINKED GENE; MUSCULAR-DYSTROPHY; WOOLLY HAIR; PALMOPLANTAR KERATODERMA; MISSENSE MUTATIONS; BARTH SYNDROME; SPLICE-SITE		Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Schonberger, J (corresponding author), Univ Hosp Wurzburg, Dept Med, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	j.schoenberger@medizin.uni-wuerzburg.de						Ahmad F, 1998, CIRCULATION, V98, P2791, DOI 10.1161/01.CIR.98.25.2791; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Arbustini E, 2000, J AM COLL CARDIOL, V35, P1760, DOI 10.1016/S0735-1097(00)00650-1; Badorff C, 2000, CIRCULATION, V102, P2276; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; BRACKETT JC, 1995, J CLIN INVEST, V95, P2076, DOI 10.1172/JCI117894; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Cohn RD, 2001, J CLIN INVEST, V107, pR1, DOI 10.1172/JCI11642; Coonar AS, 1998, CIRCULATION, V97, P2049, DOI 10.1161/01.CIR.97.20.2049; DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; Emanueli C, 1999, CIRCULATION, V100, P2359, DOI 10.1161/01.CIR.100.23.2359; EVANS W, 1948, BRIT HEART J, V26, P68; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; GROGAN M, 1995, J AM COLL CARDIOL, V26, P80, DOI 10.1016/0735-1097(95)00148-S; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Jung M, 1999, AM J HUM GENET, V65, P1068, DOI 10.1086/302580; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; KAPLAN JC, 2001, NEUROMUSCULAR DISORD, V11, P104; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; KEELING PJ, 1995, BRIT HEART J, V73, P417; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li DX, 2000, AM J HUM GENET, V66, P148, DOI 10.1086/302713; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122; Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; MICHELS VV, 1993, J MED GENET, V30, P955, DOI 10.1136/jmg.30.11.955; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Milasin J, 1996, HUM MOL GENET, V5, P73, DOI 10.1093/hmg/5.1.73; Milewicz DM, 2000, CIRCULATION, V102, P103; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muntoni F, 1997, HEART, V78, P608, DOI 10.1136/hrt.78.6.608; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Neuwald AF, 1997, CURR BIOL, V7, pR465; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Priori SG, 2001, CIRCULATION, V103, P196; RAMPAZZO A, 1995, HUM MOL GENET, V4, P2151, DOI 10.1093/hmg/4.11.2151; Rampazzo A, 1997, GENOMICS, V45, P259, DOI 10.1006/geno.1997.4927; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; ROE CR, 2001, METABOLIC MOL BASIS, V2, P2297; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Ruppert V, 2000, HERZ, V25, P161, DOI 10.1007/s000590050002; Schonberger J, 2000, CIRCULATION, V101, P1812, DOI 10.1161/01.CIR.101.15.1812; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Severini GM, 1996, GENOMICS, V31, P193, DOI 10.1006/geno.1996.0031; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; Speckman RA, 2000, AM J HUM GENET, V66, P1192, DOI 10.1086/302836; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sylvius N, 2001, AM J HUM GENET, V68, P241, DOI 10.1086/316929; Tesson F, 2000, EUR HEART J, V21, P1872, DOI 10.1053/euhj.2000.2245; Thiene G, 2000, HERZ, V25, P210, DOI 10.1007/s000590050008; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; Wang X, 1999, CLIN HEMORHEOL MICRO, V21, P137; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6	74	99	104	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					249	260		10.1086/321978	http://dx.doi.org/10.1086/321978			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443548	Bronze, Green Published			2022-12-18	WOS:000170108200001
J	Nestadt, G; Lan, T; Samuels, J; Riddle, M; Bienvenu, OJ; Liang, KY; Hoehn-Saric, R; Cullen, B; Grados, M; Beaty, TH; Shugart, YY				Nestadt, G; Lan, T; Samuels, J; Riddle, M; Bienvenu, OJ; Liang, KY; Hoehn-Saric, R; Cullen, B; Grados, M; Beaty, TH; Shugart, YY			Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SCHIZOPHRENIA; SCHEDULE; DISEASE	Evidence from twin and family studies supports a genetic etiology for obsessive-compulsive disorder (OCD). The purpose of this study was to test whether a major gene is implicated in a proportion of families with OCD. Complex segregation analyses of 153 families (80 case and 73 control), ascertained in the Johns Hopkins OCD Family Study, provided strong evidence for a major gene. A Mendelian-dominant model, with significant sex effects and with residual familial effects, best explained the observed data. Stratification of the sample by the sex of probands provided further evidence of heterogeneity with respect to familial aggregation. Segregation analyses of 86 families with a female proband and of the 67 families with a male proband suggested that a Mendelian-dominant model with familial residual effects was the most parsimonious model explaining the inheritance of OCD in both subgroups.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD 21205 USA; Yu Li Vet Hosp, Dept Psychiat, Taipei, Taiwan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Nestadt, G (corresponding author), Meyer 4-181,600 N Wolfe St, Baltimore, MD 21287 USA.		Liang, Kung-Yee/F-8299-2011	Samuels, Jack/0000-0002-6715-7905; Grados, Marco/0000-0002-6189-6264; Bienvenu, Joe/0000-0002-8466-102X; Lan, Tsuo-Hung/0000-0002-2796-1026	NCRR NIH HHS [OPD-GCRC RR00052, M01 RR000052] Funding Source: Medline; NIMH NIH HHS [R01 MH050214, R01 MH50214] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050214] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alsobrook JP, 1999, AM J MED GENET, V88, P669, DOI 10.1002/(SICI)1096-8628(19991215)88:6<669::AID-AJMG17>3.0.CO;2-N; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Bienvenu OJ, 2000, BIOL PSYCHIAT, V48, P287, DOI 10.1016/S0006-3223(00)00831-3; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; CANNINGS C, 1977, CLIN GENET, V12, P208; Carey G, 1981, ANXIETY NEW RES CHAN, P117; Cavallini MC, 2000, AM J MED GENET, V96, P384, DOI 10.1002/1096-8628(20000612)96:3<384::AID-AJMG28>3.0.CO;2-P; Cavallini MC, 1999, AM J MED GENET, V88, P38, DOI 10.1002/(SICI)1096-8628(19990205)88:1<38::AID-AJMG7>3.0.CO;2-#; GO RCP, 1978, AM J HUM GENET, V30, P28; INOUYE E, 1965, AM J PSYCHIAT, V121, P1171, DOI 10.1176/ajp.121.12.1171; Karno M, 1991, PSYCHIAT DISORDERS A, P204; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KHOURY MJ, 1993, AM J EPIDEMIOL, V137, P1241, DOI 10.1093/oxfordjournals.aje.a116626; Lensi P, 1996, BRIT J PSYCHIAT, V169, P101, DOI 10.1192/bjp.169.1.101; MANNUZZA S, 1986, J PSYCHIAT RES, V20, P317, DOI 10.1016/0022-3956(86)90034-8; NESTADT G, 1991, PSYCHOL MED, V21, P461, DOI 10.1017/S0033291700020572; Nestadt G, 1998, J NERV MENT DIS, V186, P401, DOI 10.1097/00005053-199807000-00003; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; NESTADT G, IN PRESS PSYCHOL MED; NICOLINI H, 1991, URSUS MED, V1, P25; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; *SAGE, 1997, SAGE VERS 3 1 COMP P; Samuels J, 2000, BRIT J PSYCHIAT, V177, P457, DOI 10.1192/bjp.177.5.457; Samuels J, 1997, INT REV PSYCHIATR, V9, P61; WILLIAMS W R, 1984, Genetic Epidemiology, V1, P7, DOI 10.1002/gepi.1370010104	27	99	103	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1611	1616		10.1086/316898	http://dx.doi.org/10.1086/316898			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	378WE	11058433	Green Published, Bronze			2022-12-18	WOS:000165607600029
J	Tishkoff, SA; Pakstis, AJ; Ruano, G; Kidd, KK				Tishkoff, SA; Pakstis, AJ; Ruano, G; Kidd, KK			The accuracy of statistical methods for estimation of haplotype frequencies: An example from the CD4 locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; MYOTONIC-DYSTROPHY; MODERN HUMANS; POPULATIONS; POLYMORPHISMS; ALLELE; ORIGIN; GENE; DRD2	Haplotype analysis has become increasingly important for the study of human disease as well as for reconstruction of human population histories. Computer programs have been developed to estimate haplotype frequencies statistically from marker phenotypes in unrelated individuals. However, there currently are few empirical reports on the accuracy of statistical estimates that must infer linkage phase. We have analyzed haplotypes at the CD4 locus on chromosome 12 that consist of a short tandem-repeat polymorphism and an Alu insertion/deletion polymorphism located 9.8 kb apart, in 398 individuals from 10 geographically diverse sub-Saharan African populations. Haplotype frequency estimates obtained using gene counting based on molecularly haplotyped (phase-known) data were compared with haplotype frequency estimates obtained using the expectation-maximization algorithm. We show that the estimated frequencies of common haplotypes do not differ significantly with the use of phase-known versus phase-unknown data. However, rare haplotypes are occasionally miscalled when their presence/absence must be inferred. Thus, for those research questions for which the common haplotypes are most important, frequency estimates based on the phase-unknown marker-typing results from unrelated individuals will be sufficient. However, in cases where knowledge of rare haplotypes is critical, molecular haplotyping will be necessary to determine linkage phase unambiguously.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Genaissance Pharmaceut, New Haven, CT USA	Yale University	Kidd, KK (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.				NIAAA NIH HHS [R01 AA009379] Funding Source: Medline; NIGMS NIH HHS [P01 GM057672, GM57672] Funding Source: Medline; NIMH NIH HHS [MH30929, MH39239] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039239, P50MH030929, R37MH039239, P30MH030929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		EDWARDS MC, 1991, NUCLEIC ACIDS RES, V19, P4791, DOI 10.1093/nar/19.17.4791-a; EDWARDS MC, 1992, GENOMICS, V14, P590, DOI 10.1016/S0888-7543(05)80156-9; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Goldman A, 1996, AM J HUM GENET, V59, P445; Harding RM, 1997, AM J HUM GENET, V60, P772; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; HOGLUND P, 1995, AM J HUM GENET, V57, P95; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; LONG JC, 1995, AM J HUM GENET, V56, P799; Lu RB, 1996, BIOL PSYCHIAT, V39, P419, DOI 10.1016/0006-3223(95)00182-4; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; WORKMAN PZ, 1970, AM J HUM GENET, V1, P24	20	99	105	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					518	522		10.1086/303000	http://dx.doi.org/10.1086/303000			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10859209	Green Published, Bronze			2022-12-18	WOS:000089357800029
J	Tully, LA; Parsons, TJ; Steighner, RJ; Holland, MM; Marino, MA; Prenger, VL				Tully, LA; Parsons, TJ; Steighner, RJ; Holland, MM; Marino, MA; Prenger, VL			A sensitive denaturing gradient-gel electrophoresis assay reveals a high frequency of heteroplasmy in hypervariable region 1 of the human mtDNA control region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; SINGLE-BASE CHANGES; SUBSTITUTION RATE VARIATION; POINT MUTATIONS; GC-CLAMP; HUMAN-EVOLUTION; D-LOOP; SEQUENCE; POLYMORPHISM; REPLICATION	A population study of heteroplasmy in the hypervariable region 1 (HV1) portion of the human mtDNA control region was performed. Blood samples from 253 randomly chosen individuals were examined using a sensitive denaturing gradient-gel electrophoresis (DGGE) system, This method is capable of detecting heteroplasmic proportions as low as 1% and virtually all heteroplasmy where the minor component is greater than or equal to 5%. Heteroplasmy was observed in 35 individuals (13.8%; 95% confidence interval [CI] 9.6-18.0). Of these individuals, 33 were heteroplasmic at one nucleotide position, whereas 2 were heteroplasmic at two different positions (a condition known as "triplasmy"), Although heteroplasmy occurred at a total of 16 different positions throughout HV1, it was most frequently observed at positions 16093 (n = 13) and 16129 (n = 6), In addition, the majority of heteroplasmic variants occurred at low proportions and could not be detected by direct sequencing of PCR products. This study indicates that low-level heteroplasmy in HV1 is relatively common and that it occurs at a broad spectrum of sites. Our results corroborate those of other recent reports indicating that heteroplasmy in the control region is more common than was previously believed-a finding that is of potential importance to evolutionary studies and forensic applications that are based on mtDNA variation.	Univ Maryland, Sch Med, Div Human Genet, Baltimore, MD 21201 USA; Armed Forces Inst Pathol, Ctr Med & Mol Genet, Rockville, MD USA; Armed Forces Inst Pathol, Armed Forces DNA Identificat Lab, Rockville, MD USA	University System of Maryland; University of Maryland Baltimore; United States Department of Defense; United States Department of Defense	Tully, LA (corresponding author), Natl Inst Stand & Technol, Div Biotechnol, 100 Bur Dr,MS 8311, Gaithersburg, MD 20899 USA.							ABRAMS ES, 1990, GENOMICS, V7, P463, DOI 10.1016/0888-7543(90)90188-Z; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BENDALL KE, 1995, AM J HUM GENET, V57, P248; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; BODENTEICH A, 1991, GENE, V108, P305, DOI 10.1016/0378-1119(91)90451-G; Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; COLTON T, 1974, STAT MED, P151; COMAS D, 1995, GENOME RES, V5, P89, DOI 10.1101/gr.5.1.89; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; GILL P, 1994, NAT GENET, V6, P130, DOI 10.1038/ng0294-130; Gocke CD, 1998, HUM GENET, V102, P182, DOI 10.1007/s004390050674; GREENBERG BD, 1983, GENE, V21, P33, DOI 10.1016/0378-1119(83)90145-2; Grzybowski T, 2000, ELECTROPHORESIS, V21, P548, DOI 10.1002/(SICI)1522-2683(20000201)21:3<548::AID-ELPS548>3.0.CO;2-U; Handt O, 1998, NUCLEIC ACIDS RES, V26, P126, DOI 10.1093/nar/26.1.126; Hanekamp JS, 1996, HUM GENET, V98, P243, DOI 10.1007/s004390050201; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Holland M M, 1999, Forensic Sci Rev, V11, P21; HOLLAND MM, 1993, J FORENSIC SCI, V38, P542; HORAI S, 1990, AM J HUM GENET, V46, P828; Howell N, 2000, AM J HUM GENET, V66, P1589, DOI 10.1086/302910; Howell N, 1996, AM J HUM GENET, V59, P501; HOWELL N, 1992, HUM GENET, V90, P117; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KOEHLER CM, 1991, GENETICS, V129, P247; KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965; LAUBSCHER KH, 1994, HUM MUTAT, V3, P411, DOI 10.1002/humu.1380030418; LEVINB C, 1996, 7 INT S HUM ID SCOTT; LOMBES A, 1992, NEUROMUSCULAR DISORD, V2, P323, DOI 10.1016/S0960-8966(06)80003-9; Marchington DR, 1997, AM J HUM GENET, V60, P408; Meyer S, 1999, GENETICS, V152, P1103; Michikawa Y, 1997, NUCLEIC ACIDS RES, V25, P2455, DOI 10.1093/nar/25.12.2455; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; MONNAT RJ, 1986, GENE, V43, P205, DOI 10.1016/0378-1119(86)90208-8; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; PARKER LT, 1995, BIOTECHNIQUES, V19, P116; Parker LT, 1996, BIOTECHNIQUES, V21, P694; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Parsons TJ, 1998, NAT GENET, V18, P110; Poulton J, 1996, PRENATAL DIAG, V16, P1247, DOI 10.1002/(SICI)1097-0223(199612)16:13<1247::AID-PD99>3.0.CO;2-P; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Richards M, 1996, AM J HUM GENET, V59, P185; SEKIGUCHI K, 1999, 10 INT S HUM ID ORL; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Stein LD, 1999, COMPUT SCI ENG, V1, P44, DOI 10.1109/5992.764215; STONEKING M, 1994, J BIOENERG BIOMEMBR, V26, P251, DOI 10.1007/BF00763097; Stoneking M, 1996, BIOL CHEM, V377, P603; SULLIVAN KM, 1996, 7 INT S HUM ID SCOTT; Thomas R, 1996, HUM BIOL, V68, P847; TRAYSTMAN MD, 1990, GENOMICS, V6, P293, DOI 10.1016/0888-7543(90)90569-G; TULLY LA, 1998, THESIS U MARYLAND BA; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WAKELEY J, 1993, J MOL EVOL, V37, P613; WALLACE DC, 1995, AM J HUM GENET, V57, P201; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wilson MR, 1997, HUM GENET, V100, P167, DOI 10.1007/s004390050485; YOON KL, 1991, ANAL BIOCHEM, V196, P427, DOI 10.1016/0003-2697(91)90489-G; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	68	99	106	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					432	443		10.1086/302996	http://dx.doi.org/10.1086/302996			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10873789	Green Published, Bronze			2022-12-18	WOS:000089357800018
J	Tyler-Smith, C; Gimelli, G; Giglio, S; Floridia, C; Pandya, A; Terzoli, G; Warburton, PE; Earnshaw, WC; Zuffardi, O				Tyler-Smith, C; Gimelli, G; Giglio, S; Floridia, C; Pandya, A; Terzoli, G; Warburton, PE; Earnshaw, WC; Zuffardi, O			Transmission of a fully functional human neocentromere through three generations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INNER KINETOCHORE PLATE; ALPHA-SATELLITE DNA; HUMAN CENTROMERE; Y-CHROMOSOME; CENP-A; EVOLUTION; COMPONENT	An unusual Y chromosome with a primary constriction inside the long-arm heterochromatin was found in the amniocytes of a 38-year-old woman. The same Y chromosome was found in her husband and brother-in-law, thus proving that it was already present in the father. FISH with alphoid DNA showed hybridization signals at the usual position of the Y centromere but not at the primary constriction. Centromere proteins (CENP)-A, CENP-C, and CENP-E could not be detected at the site of the canonic centromere but were present at the new constriction, whereas CENP-B was not detected on this Y chromosome. Experiments with 82 Y-specific loci distributed throughout the chromosome confirmed that no gross deletion or rearrangement had taken place, and that the Y chromosome belonged to a haplogroup whose members have a mean alphoid array of 770 kb (range 430-1,600 kb), whereas that of this case was similar to 250 kb. Thus, this Y chromosome appeared to be deleted for part of the alphoid DNA. It seems likely that this deletion was responsible for the silencing of the normal centromere and that the activation of the neocentromere prevented the loss of this chromosome. Alternatively, neocentromere activation could have occurred first and stimulated inactivation of the normal centromere by partial deletion. Whatever the mechanism, the presence of this chromosome in three generations demonstrates that it functions sufficiently well in mitosis for male sex determination and fertility and that neocentromeres can be transmitted normally at meiosis.	Univ Pavia, I-27100 Pavia, Italy; Univ Oxford, Dept Biochem, CRC, Chromosome Mol Biol Grp, Oxford OX1 3QU, England; Ist Giannina Gaslini, I-16148 Genoa, Italy; Univ Milan, Osped San Raffaele, Lab Citogenet, I-20127 Milan, Italy; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh, Midlothian, Scotland; Osped Regina Elena, Milan, Italy	University of Pavia; University of Oxford; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Edinburgh	Zuffardi, O (corresponding author), Univ Pavia, Via Forlanini 14, I-27100 Pavia, Italy.		Earnshaw, William/AAY-7438-2020; FLORIDIA, GIOVANNA/A-6640-2015; Giglio, Sabrina Rita/ABB-1093-2020; Giglio, Sabrina SG/K-9109-2016	FLORIDIA, GIOVANNA/0000-0003-4187-8816; Giglio, Sabrina Rita/0000-0002-3954-326X; Giglio, Sabrina SG/0000-0002-3954-326X; zuffardi, orsetta/0000-0002-1466-4559; Earnshaw, William/0000-0002-7191-0621	Wellcome Trust [073915] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bukvic N, 1996, HUM GENET, V97, P453; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; Csink AK, 1998, TRENDS GENET, V14, P200, DOI 10.1016/S0168-9525(98)01444-9; duSart D, 1997, NAT GENET, V16, P144; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; FISHER AM, 1997, CHROMOSOMA, V106, P188; HAAF T, 1989, HUM GENET, V81, P137, DOI 10.1007/BF00293889; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kwok C, 1996, J MED GENET, V33, P465, DOI 10.1136/jmg.33.6.465; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; PALMER DK, 1990, CHROMOSOMA, V100, P32, DOI 10.1007/BF00337600; ROSSI E, 1994, GENOMICS, V24, P34, DOI 10.1006/geno.1994.1579; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Tyler-Smith C, 1998, CHROMOSOME RES, V6, P65; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0	21	99	102	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1440	1444		10.1086/302380	http://dx.doi.org/10.1086/302380			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205277	Green Published, Bronze			2022-12-18	WOS:000080093000024
J	McIndoe, RA; Stanford, JL; Gibbs, M; Jarvik, GP; Brandzel, S; Neal, CL; Li, S; Gammack, JT; Gay, AA; Goode, EL; Hood, L; Ostrander, EA				McIndoe, RA; Stanford, JL; Gibbs, M; Jarvik, GP; Brandzel, S; Neal, CL; Li, S; Gammack, JT; Gay, AA; Goode, EL; Hood, L; Ostrander, EA			Linkage analysis of 49 high-risk families does not support a common familial prostate cancer susceptibility gene at 1q24-25	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; ALLELIC LOSS; HOMOZYGOUS DELETION; ALZHEIMERS-DISEASE; E-CADHERIN; P53; HETEROZYGOSITY; MUTATION; MARKERS; LOCI	Linkage of a putative prostate cancer-susceptibility locus (HPC1) to chromosome 1q24-25 has recently been reported. Confirmation of this linkage in independent data sets is essential because of the complex nature of this disease. Here we report the results of a linkage analysis using 10 polymorphic markers spanning similar to 37 cM in the region of the putative HPC1 locus in 49 high-risk prostate cancer families. Data were analyzed by use of two parametric models and a nonparametric method. For the parametric LOD-score method, the first model was identical to the original report by Smith and coworkers (''Hopkins''), and the second was based on a segregation analysis previously reported by Carter and coworkers (''Seattle''). In both cases, our results do not confirm the linkage reported for this region. Calculated LOD scores from the two-point analysis for each marker were highly negative at small recombination fractions. Multipoint LOD scores for this linkage group were also highly negative. Additionally, we were unable to demonstrate heterogeneity within the data set, using HOMOG. Although these data do not formally exclude linkage of a prostate cancer-susceptibility locus at HPC1, it is likely that other prostate cancer-susceptibility loci play a more critical role in the families that we studied.	FRED HUTCHINSON CANC RES CTR,DIV CLIN RES M 318,SEATTLE,WA 98104; FRED HUTCHINSON CANC RES CTR,DIV PUBL HLTH,SEATTLE,WA 98104; UNIV WASHINGTON,DEPT MOL BIOTECHNOL,SEATTLE,WA 98195; UNIV WASHINGTON,MED CTR,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT EPIDEMIOL,SEATTLE,WA 98195	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle			Jarvik, Gail P/N-6476-2014	Jarvik, Gail P/0000-0002-6710-8708; McIndoe, Richard/0000-0002-3040-3631; Ostrander, Elaine/0000-0001-6075-9738				BOOKSTEIN R, 1993, CANCER RES, V53, P3369; BOOKSTEIN R, 1994, J CELL BIOCH S, V19, P217; Bova GS, 1996, GENOMICS, V35, P46, DOI 10.1006/geno.1996.0321; BOVA GS, 1993, CANCER RES, V53, P3869; Brooks JD, 1996, CANCER RES, V56, P3814; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; CAVALLISFORZA LL, 1986, AM J HUM GENET, V38, P599; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dong JT, 1996, CANCER RES, V56, P4387; EAGLE LR, 1995, NAT GENET, V9, P249, DOI 10.1038/ng0395-249; HYSLOP PHS, 1987, SCIENCE, V235, P885; ICHIKAWA T, 1996, PROSTATE S, V6, P31; IRVINE RA, 1995, CANCER RES, V55, P1937; KAGAN J, 1995, ONCOGENE, V11, P2121; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACOSKA JA, 1995, CANCER RES, V55, P5390; MASSENKEIL G, 1994, ANTICANCER RES, V14, P2785; MORTON RA, 1993, CANCER RES, V53, P3585; Ott J., 1991, ANAL HUMAN GENETIC L; PARKER SL, 1997, CA CANC J CLIN, V46, P5; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SMITH JR, 1996, SCIENCE, V274, P1374; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; UMBAS R, 1992, CANCER RES, V52, P5104; Walker B, 1995, ENVIRON HEALTH PERSP, V103, P275, DOI 10.1289/ehp.95103s8275; Williams BJ, 1996, J UROLOGY, V155, P720, DOI 10.1016/S0022-5347(01)66509-1; ZENKLUSEN JC, 1994, CANCER RES, V54, P6370	31	99	99	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					347	353		10.1086/514853	http://dx.doi.org/10.1086/514853			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311739	Green Published, Bronze			2022-12-18	WOS:A1997XX70100012
J	Gayther, SA; Harrington, P; Russell, P; Kharkevich, G; Garkavtseva, RF; Ponder, BAJ				Gayther, SA; Harrington, P; Russell, P; Kharkevich, G; Garkavtseva, RF; Ponder, BAJ			Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							BREAST; SEQUENCE		RUSSIAN ACAD MED SCI,CANC RES CTR,MOSCOW,RUSSIA	Russian Academy of Medical Sciences	Gayther, SA (corresponding author), ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,BOX 238,HILLS RD,CAMBRIDGE CB2 2QQ,ENGLAND.							ABEL KJ, 1995, HUM MOL GENET, V4, P2265, DOI 10.1093/hmg/4.12.2265; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Couch FJ, 1996, HUM MUTAT, V8, P8, DOI 10.1002/humu.1380080102; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; Friedman LS, 1997, AM J HUM GENET, V60, P313; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; Gayther SA, 1996, AM J HUM GENET, V58, P451; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Phelan CM, 1996, NAT GENET, V12, P309, DOI 10.1038/ng0396-309; Ramus SJ, 1997, AM J HUM GENET, V60, P1242; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; SHARAN SK, 1995, HUM MOL GENET, V4, P2275, DOI 10.1093/hmg/4.12.2275; STEICHENGERSDORF E, 1994, AM J HUM GENET, V55, P870; STREUWING JP, 1995, NAT GENET, V11, P198	18	99	113	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1239	1242						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150173				2022-12-18	WOS:A1997WX76000026
J	Merriwether, DA; Hall, WW; Vahlne, A; Ferrell, RE				Merriwether, DA; Hall, WW; Vahlne, A; Ferrell, RE			mtDNA variation indicates Mongolia may have been the source for the founding population for the New World	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA POLYMORPHISM; BASE PAIR RECOGNITION; NATIVE-AMERICANS; RESTRICTION ENZYMES; ASIAN POPULATIONS; GENETIC-VARIATION; 9-BP DELETION; REGION; JAPANESE; HAPLOTYPES	mtDNA RFLP variation was analyzed in 12 Mongolians from Ulan Bator. All four founding lineage types (A [4.76%], B [2.38%], C [11.9%], and D [19.04%]) identified by Torroni and colleagues were detected. Seven of the nine founding lineage types proposed by Bailliet and colleagues and Merriwether and Ferrell were detected (A2 [4.76%], B [2.38%], C1 [11.9%], D1 [7.14%], D2 [11.9%], X6 [16.7%], and X7 [9.5%]). Sixty-four percent of these 42 individuals had ''Amerindian founding lineage'' haplotypes. A survey of 24 restriction sites yielded 16 polymorphic sites and 21 different haplotypes. The presence of all four of the founding lineages identified by the Torroni group (and seven of Merriwether and Ferrell's nine founding lineages), combined with Mongolia's location with respect to the Bering Strait. indicates that Mongolia is a potential location for the origin of the founders of the New World. Since lineage B, which is widely distributed in the New World, is absent in Siberia. we conclude that Mongolia or a geographic location common to both contemporary Mongolians and American aboriginals is the more likely origin of the founders of the New World.	ROCKEFELLER UNIV, DEPT VIROL, NEW YORK, NY 10021 USA; KAROLINSKA INST, DEPT CLIN VIROL, STOCKHOLM, SWEDEN	Rockefeller University; Karolinska Institutet	Merriwether, DA (corresponding author), UNIV PITTSBURGH, GRAD SCH PUBL HLTH, DEPT HUMAN GENET, 130 DESOTO ST, PITTSBURGH, PA 15261 USA.							BAILLIET G, 1994, AM J HUM GENET, V55, P27; BALLINGER SW, 1992, GENETICS, V130, P139; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; Easton RD, 1996, AM J HUM GENET, V59, P213; GINTHER C, 1993, EXS, V67, P211; HARIHARA S, 1992, HUM BIOL, V64, P161; HARIHARA S, 1988, AM J HUM GENET, V43, P134; HARIHARA S, 1986, JPN J HUM GENET, V31, P73, DOI 10.1007/BF01871401; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1990, AM J HUM GENET, V46, P828; HORAI S, 1984, HUM GENET, V68, P324, DOI 10.1007/BF00292594; HORAI S, 1986, HUM GENET, V72, P105; HORAI S, 1991, NEW ERA BIOENERGETIC, P273; HORAI S, 1991, NEW ASPECTS GENETICS, P135; HORAI S, 1987, HUM GENET, P177; LORENZ JG, 1994, HUM BIOL, V66, P777; Merriwether D. A., 1992, American Journal of Human Genetics, V51, pA13; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; MERRIWETHER DA, 1994, EXPERIENTIA, V50, P592, DOI 10.1007/BF01921730; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; MERRIWETHER DA, 1995, AM J HUM GENET, V56, P812; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; MERRIWETHER DA, 1993, AM J HUM GENET, V53, P833; Merriwether DA, 1993, THESIS U PITTSBURGH; NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; SHIELDS GF, 1992, AM J HUM GENET, V50, P758; STONEKING M, 1990, GENETICS, V124, P717; SUKERNIK RI, 1995, GENETIKA, V174, P575; Swofford D.L., 1989, PAUP PHYLOGENETIC AN; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; TORRONI A, 1995, AM J HUM GENET, V56, P1234; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720	45	99	103	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					204	212						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659526				2022-12-18	WOS:A1996VL45500027
J	Christiano, AM; McGrath, JA; Tan, KC; Uitto, J				Christiano, AM; McGrath, JA; Tan, KC; Uitto, J			Glycine substitutions in the triple-helical region of type VII collagen result in a spectrum of dystrophic epidermolysis bullosa phenotypes and patterns of inheritance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOOTH DISEASE TYPE-1A; MUTATION	The dystrophic forms of epidermolysis bullosa (DEB) are characterized by fragility of the skin and mucous membranes. DEB can be inherited in either an autosomal dominant or autosomal recessive pattern, and the spectrum of clinical severity is highly variable. The unifying diagnostic hallmark of DEB is abnormalities in the anchoring fibrils, which consist of type VII collagen, and, recently, mutations in the corresponding gene, COL7A1, have been disclosed in a number of families. In this study, we report six families with glycine substitution mutations in the triple-helical region of type VII collagen. Among the six families, two demonstrated a mild phenotype, and the inheritance of the mutation was consistent with the dominantly inherited form of DEB. In the four other families, the mutation was silent in the heterozygous state but, when present in the homozygous state, or combined with a second mutation, resulted in a recessively inherited DEB phenotype. Type VII collagen is, therefore, unique among the collagen genes, in that different glycine substitutions can be either silent in heterozygous individuals or result in a dominantly inherited DEB. Inspection of the locations of the glycine substitutions along the COL7A1 polypeptide suggests that the consequences of these mutations, in terms of phenotype and pattern of inheritance, are position independent.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL & CUTANEOUS BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON INST MOLEC MED,MOLEC DERMATOL SECT,PHILADELPHIA,PA 19107; NATL SKIN CTR,SINGAPORE 1130,SINGAPORE	Jefferson University; Jefferson University; Jefferson University; National Skin Centre			McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964	NIAMS NIH HHS [P01-AR38923] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; Christiano A M, 1996, Adv Dermatol, V11, P199; CHRISTIANO AM, 1994, J BIOL CHEM, V269, P20256; CHRISTIANO AM, 1995, HUM MOL GENET, V4, P1579; CHRISTIANO AM, 1994, P NATL ACAD SCI USA, V91, P3549, DOI 10.1073/pnas.91.9.3549; CHRISTIANO AM, 1995, J INVEST DERMATOL, V104, P438, DOI 10.1111/1523-1747.ep12666033; CHRISTIANO AM, 1994, GENOMICS, V21, P169, DOI 10.1006/geno.1994.1239; Christiano AM, 1996, AM J HUM GENET, V58, P682; DUNNILL MGS, 1994, HUM MOL GENET, V3, P1693, DOI 10.1093/hmg/3.9.1693; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; HILAL L, 1993, NAT GENET, V5, P287, DOI 10.1038/ng1193-287; HOVNANIAN A, 1994, AM J HUM GENET, V55, P289; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; KIVIRIKKO KI, 1993, ANN MED, V25, P113, DOI 10.3109/07853899309164153; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; ROYCE PM, 1992, CONNECTIVE TISSUE IT; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shimizu H, 1996, J INVEST DERMATOL, V106, P119, DOI 10.1111/1523-1747.ep12329600; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; UITTO J, 1994, ARCH DERMATOL RES, V287, P16, DOI 10.1007/BF00370713; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VIKKULA M, 1994, ANN MED, V26, P107; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; ZELICKSON B, 1995, ARCH DERMATOL, V131, P663, DOI 10.1001/archderm.131.6.663	29	99	104	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					671	681						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644729				2022-12-18	WOS:A1996UA38000003
J	MACKE, JP; DAVENPORT, CM; JACOBSON, SG; HENNESSEY, JC; GONZALEZFERNANDEZ, F; CONWAY, BP; HECKENLIVELY, J; PALMER, R; MAUMENEE, IH; SIEVING, P; GOURAS, P; GOOD, W; NATHANS, J				MACKE, JP; DAVENPORT, CM; JACOBSON, SG; HENNESSEY, JC; GONZALEZFERNANDEZ, F; CONWAY, BP; HECKENLIVELY, J; PALMER, R; MAUMENEE, IH; SIEVING, P; GOURAS, P; GOOD, W; NATHANS, J			IDENTIFICATION OF NOVEL RHODOPSIN MUTATIONS RESPONSIBLE FOR RETINITIS-PIGMENTOSA - IMPLICATIONS FOR THE STRUCTURE AND FUNCTION OF RHODOPSIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SINGLE-BASE CHANGES; CYSTEINE RESIDUE-110; BOVINE RHODOPSIN; OCULAR FINDINGS; 2 FAMILIES; CODON 23; GENE; SEQUENCE; ATTACHMENT	Ten rhodopsin mutations have been found in a screen of 282 subjects with retinitis pigmentosa (RP), 76 subjects with Leber congenital amaurosis, and 3 subjects with congenital stationary night blindness. Eight of these mutations (gly51-to-ala, val104-to-ile, gly106-to-arg, arg135-to-gly, cys140-to-ser, gly188-to-glu, val209-to-met, and his211-to-arg) produce amino acid substitutions, one (gln64-to-ter) introduces a stop codon, and one changes a guanosine in the intron 4 consensus splice donor sequence to thymidine. Cosegregation of RP with gln64-to-ter, gly106-to-arg, arg135-to-gly, cys140-to-ser, gly188-to-glu, his211-to-arg, and the splice site guanosine-to-thymidine indicates that these mutations are likely to cause retinal disease. Val104-to-ile does not cosegregate and is therefore unlikely to be related to retinal disease. The relevance of gly51-to-ala and val209-to-met remains to be determined. The finding of gln64-to-ter in a family with autosomal dominant RP is in contrast to a recent report of a recessive disease phenotype associated with the rhodopsin mutation glu249-to-ter. In the present screen, all of the mutations that cosegregate with retinal disease were found among patients with RP. The mutations described here bring to 35 the total number of amino acid substitutions identified thus far in rhodopsin that are associated with RP. The distribution of the substitutions along the polypeptide chain is significantly nonrandom: 63% of the substitutions involve those 19% of amino acids that are identical among vertebrate visual pigments sequenced to date.	JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,805 PCTB,725 N WOLFE ST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,WILMER EYE INST,BALTIMORE,MD 21205; NATL RETINITIS PIGMENTOSA FDN,BALTIMORE,MD; UNIV MIAMI,SCH MED,BASCOM PALMER EYE INST,MIAMI,FL 33152; UNIV VIRGINIA,DEPT OPHTHALMOL,CHARLOTTESVILLE,VA 22903; UNIV CALIF LOS ANGELES,JULES STEIN EYE INST,LOS ANGELES,CA 90024; UNIV MICHIGAN,KELLOGG EYE CTR,ANN ARBOR,MI 48109; COLUMBIA UNIV,DEPT OPHTHALMOL,NEW YORK,NY 10027; UNIV CALIF SAN FRANCISCO,DEPT OPHTHALMOL,SAN FRANCISCO,CA 94143	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Bascom Palmer Eye Institute; University of Miami; University of Virginia; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; Columbia University; University of California System; University of California San Francisco				Jacobson, Samuel/0000-0003-2122-169X; Nathans, Jeremy/0000-0001-8106-5460				ARTLICH A, 1992, AM J HUM GENET, V50, P876; BELL C, 1992, J MED GENET, V29, P667, DOI 10.1136/jmg.29.9.667; BERSON EL, 1991, AM J OPHTHALMOL, V111, P614, DOI 10.1016/S0002-9394(14)73708-0; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; FARRAR GJ, 1990, AM J HUM GENET, V47, P941; FARRAR GJ, 1991, GENOMICS, V11, P1170; FISHMAN GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P646, DOI 10.1001/archopht.1992.01080170068026; FISHMAN GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1582, DOI 10.1001/archopht.1992.01080230082026; FUJIKI K, 1992, JPN J HUM GENET, V37, P125, DOI 10.1007/BF01899733; GAL A, 1991, GENOMICS, V11, P468, DOI 10.1016/0888-7543(91)90159-C; Heckenlively J. R., 1988, RETINITIS PIGMENTOSA; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; HISATOMI O, 1991, BIOCHEM BIOPH RES CO, V174, P1125, DOI 10.1016/0006-291X(91)91537-M; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; KEMP CM, 1992, AM J OPHTHALMOL, V113, P165, DOI 10.1016/S0002-9394(14)71529-6; Knowles A., 1977, PHOTOBIOLOGY VISION; KUWATA O, 1990, FEBS LETT, V272, P128, DOI 10.1016/0014-5793(90)80465-U; MOORE AT, 1992, BRIT J OPHTHALMOL, V76, P465, DOI 10.1136/bjo.76.8.465; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; ORKIN SH, 1984, ANNU REV GENET, V18, P131; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; TAKAO M, 1988, VISION RES, V28, P471, DOI 10.1016/0042-6989(88)90169-1; TOKUNAGA F, 1990, BIOCHEM BIOPH RES CO, V173, P1212, DOI 10.1016/S0006-291X(05)80915-5; VANDENOUWELAND AMW, 1992, NAT GENET, V2, P99, DOI 10.1038/ng1092-99; WANG SZ, 1992, BIOCHEMISTRY-US, V31, P3309, DOI 10.1021/bi00128a002; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315	46	99	102	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					80	89						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317502				2022-12-18	WOS:A1993LJ38500011
J	HOLME, E; LARSSON, NG; OLDFORS, A; TULINIUS, M; SAHLIN, P; STENMAN, G				HOLME, E; LARSSON, NG; OLDFORS, A; TULINIUS, M; SAHLIN, P; STENMAN, G			MULTIPLE SYMMETRICAL LIPOMAS WITH HIGH-LEVELS OF MTDNA WITH THE TRNALYSA-]G(8344) MUTATION AS THE ONLY MANIFESTATION OF DISEASE IN A CARRIER OF MYOCLONUS EPILEPSY AND RAGGED-RED FIBERS (MERRF) SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA MUTATION; TRANSFER RNALYS; PATIENT; TUMORS; ABNORMALITIES; CHROMOSOME; SUBGROUPS; MYOPATHY; GENOMES	We have investigated the morphology, cytogenetics, and the fraction of mtDNA with the tRNA(Lys) A --> G(8344) mutation in three lipomas in a carrier of this mutation. The son of the patient had myoclonus epilepsy and ragged-red fibers syndrome. The fraction of mtDNA with the tRNA(Lys) mutation varied between 62% and 80% in cultured skin fibroblasts, lymphocytes, normal adipose tissue, and muscle. In the three lipomas the mean fraction of mutated mtDNA was 90%, 94%, and 94%. Ultrastructural examination of the lipomas revealed numerous mitochondria with changes such as electron-dense inclusions in some adipocytes. When considered cytogenetically, the lipomas were characterized by a mixture of karyotypically abnormal and normal cells. An identical del(6)(q24) was found in two tumors. The fraction of mutated mtDNA in cultured lipoma cells was the same as in the lipoma in situ, indicating that the cultured cells were representative of the primary tumor. These findings indicate that the lipomas have originated with a grossly normal stem line and subsequently have developed the 6q deletion. We conclude that the lipomas represent clonal growth of adipocytes with a high content of mtDNA with the tRNA(Lys) mutation. The tRNA(Lys) mutation may be either the direct or the indirect cause of pertubation of the maturation process of the adipocytes, leading to an increased risk of lipoma formation.	GOTHENBURG UNIV,DEPT CLIN CHEM,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT PATHOL,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT PEDIAT,S-41124 GOTHENBURG,SWEDEN; GOTHENBURG UNIV,DEPT ORAL PATHOL,S-41124 GOTHENBURG,SWEDEN	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg			Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X; Oldfors, Anders/0000-0002-5758-7397				BERKOVIC SF, 1991, LANCET, V338, P457, DOI 10.1016/0140-6736(91)91090-H; BERKOVIC SF, 1989, BRAIN, V112, P1231, DOI 10.1093/brain/112.5.1231; BERKOVIC SF, 1991, ANN NEUROL, V29, P566, DOI 10.1002/ana.410290519; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; DALCIN P, 1988, CANCER GENET CYTOGEN, V31, P237, DOI 10.1016/0165-4608(88)90222-1; EKBOM K, 1975, ACTA NEUROL SCAND, V51, P393; Fu Y S, 1980, Pathol Annu, V15, P67; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; HAMMANS SR, 1992, BRAIN, V115, P343, DOI 10.1093/brain/115.2.343; HARNDEN DB, 1985, BIRTH DEFECTS, V21; HEIM S, 1988, INT J CANCER, V42, P863, DOI 10.1002/ijc.2910420612; KIM YH, 1982, CANCER, V50, P102, DOI 10.1002/1097-0142(19820701)50:1<102::AID-CNCR2820500119>3.0.CO;2-7; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; MANDAHL N, 1988, HUM GENET, V79, P203, DOI 10.1007/BF00366238; MARK J, 1990, CANCER GENET CYTOGEN, V44, P1, DOI 10.1016/0165-4608(90)90192-D; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; OLDFORS A, 1992, J NEUROL SCI, V110, P169, DOI 10.1016/0022-510X(92)90025-G; OLDFORS A, 1991, MOLECULAR BASIS OF NEUROLOGICAL DISORDERS AND THEIR TREATMENT, P243; ROSING HS, 1985, ANN NEUROL, V17, P228, DOI 10.1002/ana.410170303; SANDBERG AA, 1986, CANCER GENET CYTOGEN, V22, P55, DOI 10.1016/0165-4608(86)90137-8; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SREEKANTAIAH C, 1991, CANCER RES, V51, P422; STENMAN G, 1983, J ORAL PATHOL MED, V12, P458, DOI 10.1111/j.1600-0714.1983.tb00357.x; STENMAN G, 1991, CANCER GENET CYTOGEN, V57, P121, DOI 10.1016/0165-4608(91)90197-3; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; YONEDA M, 1990, BIOCHEM INT, V21, P789; ZANCANARO C, 1990, LAB INVEST, V63, P253; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	31	99	100	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					551	556						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	8447321				2022-12-18	WOS:A1993KR72000012
J	AUSTIN, MA; SANDHOLZER, C; SELBY, JV; NEWMAN, B; KRAUSS, RM; UTERMANN, G				AUSTIN, MA; SANDHOLZER, C; SELBY, JV; NEWMAN, B; KRAUSS, RM; UTERMANN, G			LIPOPROTEIN(A) IN WOMEN TWINS - HERITABILITY AND RELATIONSHIP TO APOLIPOPROTEIN(A) PHENOTYPES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CORONARY HEART-DISEASE; LP(A) GLYCOPROTEIN PHENOTYPES; PLASMA LP(A); RISK-FACTORS; CEREBROVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PLASMINOGEN-ACTIVATOR; GENETIC HERITABILITY; A-I; TRAIT	Lp(a) is a unique lipoprotein consisting of an LDL-like particle and a characteristic protein, apo(a). Increased levels of Lp(a) constitute a risk factor for coronary heart disease. Variation in the size of the apo(a) protein is a phenotype controlled by the apo(a) gene on chromosome 6 and is related to Lp(a) plasma levels. Based on 169 MZ and 125 DZ adult female twin pairs, this study's purpose was to estimate the proportion of the variation in Lp(a) levels that is due to genetic influences and to determine the extent to which the apo(a) locus explains this heritability. Lp(a) levels were significantly more similar in MZ twins than in DZ twins: mean co-twin differences were 3.9 +/- 5.7 mg/dl and 16.0 +/- 19.9 mg/dl (P < .001), respectively. Intraclass correlations were .94 in MZ twins and .32 in DZ twins, resulting in a heritability estimate of .94 (P < .001). Heritability was then calculated using only co-twins with the same apo(a) phenotype: the heritability estimate decreased to .45 but was still highly significant (P < .001). Therefore, on the basis of heritability analysis of women twins, Lp(a) levels are almost entirely genetically controlled. Variation at the apo(a) locus contributes to this heritability, although other genetic factors could be involved.	UNIV INNSBRUCK,INST MED BIOL & HUMAN GENET,A-6020 INNSBRUCK,AUSTRIA; KAISER PERMANENTE MED CARE PROGRAM,DIV RES,OAKLAND,CA; UNIV N CAROLINA,SCH PUBL HLTH,DEPT EPIDEMIOL,CHAPEL HILL,NC 27514; LAWRENCE BERKELEY LAB,DONNER LAB,BERKELEY,CA 94720	University of Innsbruck; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	AUSTIN, MA (corresponding author), UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT EPIDEMIOL,SC-36,SEATTLE,WA 98195, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041830] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-41830, HL-387B0] Funding Source: Medline; PHS HHS [R-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBERS JJ, 1977, J LIPID RES, V18, P331; ALBERS JJ, 1974, BIOCHEM GENET, V11, P475, DOI 10.1007/BF00486079; AUSTIN MA, 1987, AM J EPIDEMIOL, V125, P308, DOI 10.1093/oxfordjournals.aje.a114531; AZROLAN N, 1991, J BIOL CHEM, V266, P13866; BERENSON ML, 1983, INTERMEDIATE STATIST; BERG K, 1979, CLIN GENET, V16, P347; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; BERG K, 1984, ACTA GENET MED GEMEL, V33, P349, DOI 10.1017/S0001566000005808; BERG K, 1990, LIPOPROTEIN A, P13; BOERWINKLE E, 1986, AM J HUM GENET, V39, P137; BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; CARLSON LA, 1989, J INTERN MED, V226, P271, DOI 10.1111/j.1365-2796.1989.tb01393.x; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHRISTIAN JC, 1974, AM J HUM GENET, V26, P154; CHRISTIAN JC, 1987, GENET EPIDEMIOL, V4, P443; CORSETTI JP, 1991, CLIN CHEM, V37, P1191; DRAYNA DT, 1988, GENOMICS, V3, P230, DOI 10.1016/0888-7543(88)90084-5; DURRINGTON PN, 1988, LANCET, V1, P1070; FEINLEIB M, 1977, AM J EPIDEMIOL, V106, P234; FRANK SL, 1988, HUM GENET, V79, P352; GAUBATZ JW, 1990, J LIPID RES, V31, P603; GURAKAR A, 1985, ATHEROSCLEROSIS, V57, P293, DOI 10.1016/0021-9150(85)90041-3; HASSTEDT SJ, 1983, AM J MED GENET, V16, P179, DOI 10.1002/ajmg.1320160208; HEATH AC, 1989, BEHAV GENET, V19, P9, DOI 10.1007/BF01065881; HEWITT D, 1982, CLIN GENET, V21, P301; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; ISELIUS L, 1981, CLIN GENET, V20, P147; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; JAUHIAINEN M, 1991, BIOCHEM J, V274, P491, DOI 10.1042/bj2740491; JORESKOG KG, 1986, LISREL 6; JURGENS G, 1987, NEUROLOGY, V37, P513, DOI 10.1212/WNL.37.3.513; KAMBOH MI, 1991, AM J HUM GENET, V49, P1063; KOSTNER GM, 1981, ATHEROSCLEROSIS, V38, P50; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; LAMONFAVA S, 1991, ATHEROSCLEROSIS, V91, P97, DOI 10.1016/0021-9150(91)90191-5; LINDAHL G, 1989, HUM GENET, V81, P149, DOI 10.1007/BF00293891; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MENZEL HJ, 1990, J BIOL CHEM, V265, P981; MILES LA, 1989, NATURE, V339, P301, DOI 10.1038/339301a0; MORTON N E, 1985, Genetic Epidemiology, V2, P113, DOI 10.1002/gepi.1370020202; MURAI A, 1986, ATHEROSCLEROSIS, V59, P199, DOI 10.1016/0021-9150(86)90048-1; PEPIN JM, 1991, J LIPID RES, V32, P317; RATH M, 1989, ARTERIOSCLEROSIS, V9, P579, DOI 10.1161/01.ATV.9.5.579; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; ROUY D, 1991, ARTERIOSCLER THROMB, V11, P629, DOI 10.1161/01.ATV.11.3.629; SALONEN EM, 1989, EMBO J, V8, P4035, DOI 10.1002/j.1460-2075.1989.tb08586.x; SANDHOLZER C, 1991, HUM GENET, V86, P607; SANDHOLZER C, IN PRESS J CLIN INVE; SANDKAMP M, 1990, CLIN CHEM, V36, P20; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; SELBY JV, 1992, CIRCULATION, V85, P8; SING CF, 1974, ANN HUM GENET, V38, P47, DOI 10.1111/j.1469-1809.1974.tb01992.x; Snedecor G.W., 1980, STAT METHODS, V7; SUNDELL IB, 1989, ATHEROSCLEROSIS, V80, P9; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; UTERMANN G, 1988, HUM GENET, V78, P47, DOI 10.1007/BF00291233; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; UTERMANN G, 1988, HUM GENET, V78, P41, DOI 10.1007/BF00291232; WALTON KW, 1974, ATHEROSCLEROSIS, V20, P323, DOI 10.1016/0021-9150(74)90016-1; WEITKAMP LR, 1988, HUM GENET, V79, P80, DOI 10.1007/BF00291716; WILLIAMS CJ, IN PRESS COMPUT METH; Winer BJ., 1971, STAT PRINCIPLES EXPT, V2nd ed; WOO J, 1990, STROKE, V21, P1407, DOI 10.1161/01.STR.21.10.1407; ZENKER G, 1986, STROKE, V17, P942, DOI 10.1161/01.STR.17.5.942; 1985, SAS USERS GUIDE STAT	66	99	99	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					829	840						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415225				2022-12-18	WOS:A1992JQ66700017
J	WEEKS, DE; LANGE, K				WEEKS, DE; LANGE, K			A MULTILOCUS EXTENSION OF THE AFFECTED-PEDIGREE-MEMBER METHOD OF LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ALZHEIMERS-DISEASE; SIB-PAIR METHOD; BREAST-CANCER; IDENTITY; GENES	The affected-pedigree-member (APM) method of linkage analysis is designed to detect departures from independent segregation of disease and marker phenotypes. The underlying statistic of the APM method operates on the identity-by-state relations implied by the marker phenotypes of the affecteds within a pedigree. Here we generalize the APM statistic to multiple linked markers. This generalization relies on recursive computation of two-locus kinship coefficients by an algorithm of Thompson. The distributional properties of the extended APM statistic are investigated theoretically and by simulation in the context of one real and one artificial data set. In both examples, the multilocus statistic tends to reject, more strongly than the single-locus statistics do, the null hypothesis of independent segregation between the disease locus and the marker loci.	UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOMATH,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	WEEKS, DE (corresponding author), UNIV PITTSBURGH,DEPT HUMAN GENET,A310 CRABTREE HALL,130 DESOTO ST,PITTSBURGH,PA 15261, USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NCI NIH HHS [CA 16042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DAY NE, 1976, TISSUE ANTIGENS, V8, P109; DEVRIES RRP, 1976, LANCET, V2, P1328; FIMMERS R, 1989, MULTIPOINT MAPPING L, V6, P123; FISHMAN PM, 1978, AM J HUM GENET, V30, P308; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDSTEIN AM, 1989, MULTIPOINT MAPPING L, V6, P135; GREEN JR, 1977, TISSUE ANTIGENS, V9, P31; HAILE RW, 1990, GENET EPIDEMIOL, V7, P47, DOI 10.1002/gepi.1370070112; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KARIGL G, 1981, ANN HUM GENET, V5, P299; LABUDA M, 1990, AM J HUM GENET, V47, P28; LANGE K, 1986, AM J HUM GENET, V39, P148; LANGE K, 1990, WORLD REV NUTR DIET, V63, P236; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; LARIGL G, 1982, THEOR POPUL BIOL, V21, P379; MAESTRI NE, 1989, MULTIPOINT MAPPING L, V6, P147; NEWMAN B, 1989, MULTIPOINT MAPPING L, V6, P171; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PENROSE LS, 1935, ANN EUGEN, V6, P133; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1989, CYTOGENET CELL GENET, V51, P1058; PERICAKVANCE MA, 1990, P INT S DEMENTIA MOL, P215; RICE J, 1989, MULTIPOINT MAPPING L, V6, P165; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; SUAREZ BK, 1979, CLIN GENET, V15, P126; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; SUAREZ BK, 1982, TISSUE ANTIGENS, V20, P193; THOMPSON EA, 1988, IMA J MATH APPL MED, V5, P261; THOMSON G, 1986, AM J HUM GENET, V39, P207; Thomson G, 1977, HLA DISEASE, P84; VANEERDEWEGH P, 1989, MULTIPOINT MAPPING L, V6, P153; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEEKS DE, 1988, THESIS U CALIFORNIA; YOUNGMAN S, 1986, HUM GENET, V73, P333, DOI 10.1007/BF00279096	37	99	103	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					859	868						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550129				2022-12-18	WOS:A1992HL84800023
J	FARRALL, M; HOLDER, S				FARRALL, M; HOLDER, S			FAMILIAL RECURRENCE-PATTERN ANALYSIS OF CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETICALLY COMPLEX TRAITS; SEGREGATION ANALYSIS; LINKAGE STRATEGIES; DANISH; FREQUENCY; RELATIVES; ENGLAND	Cleft lip with or without cleft palate (CL/P) is a common congenital malformation with an incidence in European white populations of about 1/1,000. The familial clustering of CL/P has been extensively characterized, and epidemiological studies have proposed monogenic models (with reduced penetrance), multifactorial/threshold models, and mixed major-gene/multifactorial models to explain its inheritance. The recognition of an association between two RFLPs at the transforming growth factor alpha (TGFA) locus and CL/P supports a major-gene component to the etiology of CL/P. Risch has shown that the recurrence risk ratio lambda(R) (risk to relatives, vs. population prevalence) is a useful pointer to the mode of inheritance. Here we further develop the use of lambda(R) to analyze recurrence-risk data for CL/P. Recurrence risks for first-, second-, and third-degree relatives equate well with oligogenic models with as few as four loci. A monogenic/additive model is strongly rejected. The limited available twin data are also consistent with this model. A "major gene" interacting epistatically with an oligogenic background is shown to be a plausible alternative. Power calculations for a linkage study to map the CL/P major-risk locus suggest that a sample of 50 affected sib pairs will be adequate, but linkage to minor-risk loci will require very much larger samples.			FARRALL, M (corresponding author), NORTHWICK PK HOSP & CLIN RES CTR,MRC,CLIN RES CTR,DIV MOLEC MED,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND.							ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BEAR JC, 1976, CLIN GENET, V9, P277; BIXLER D, 1971, Clinical Genetics, V2, P155; BONAITI C, 1982, J MED GENET, V19, P8, DOI 10.1136/jmg.19.1.8; CARTER CO, 1969, BRIT MED BULL, V25, P52, DOI 10.1093/oxfordjournals.bmb.a070671; CARTER CO, 1982, J MED GENET, V9, P246; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHENEVIXTRENCH G, 1991, AM J HUM GENET, V48, P1012; CHUNG CS, 1989, GENET EPIDEMIOL, V6, P625, DOI 10.1002/gepi.1370060507; CHUNG CS, 1974, AM J HUM GENET, V26, P177; CHUNG CS, 1986, AM J HUM GENET, V39, P603; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; Fogh-Andersen, 1942, INHERITANCE HARELIP; HECHT JT, 1991, AM J HUM GENET, V49, P674; HOLDER SE, IN PRESS CYTOGENET C; JAMES JW, 1971, ANN HUM GENET, V35, P47, DOI 10.1111/j.1469-1809.1956.tb01377.x; KURNIT DM, 1987, AM J HUM GENET, V41, P979; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MARAZITA ML, 1986, GENET EPIDEMIOL, V3, P335, DOI 10.1002/gepi.1370030506; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; Melnick M, 1977, Birth Defects Orig Artic Ser, V13, P93; MENDELL NR, 1980, MULTIFACTORIAL THRES, P387; Pearson K., 1990, PHIL  R SOC, V195, P79; PENROSE L S, 1953, Acta Genet Stat Med, V4, P257; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; SHIELDS ED, 1979, CLEFT PALATE J, V16, P1; WOOLF CM, 1971, J MED GENET, V8, P65, DOI 10.1136/jmg.8.1.65	29	99	101	0	17	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					270	277						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1346481				2022-12-18	WOS:A1992HD00100003
J	KOBAYASHI, Y; MOMOI, MY; TOMINAGA, K; SHIMOIZUMI, H; NIHEI, K; YANAGISAWA, M; KAGAWA, Y; OHTA, S				KOBAYASHI, Y; MOMOI, MY; TOMINAGA, K; SHIMOIZUMI, H; NIHEI, K; YANAGISAWA, M; KAGAWA, Y; OHTA, S			RESPIRATION-DEFICIENT CELLS ARE CAUSED BY A SINGLE POINT MUTATION IN THE MITOCHONDRIAL TRANSFER RNA-LEU (UUR) GENE IN MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC-ACIDOSIS, AND STROKE-LIKE EPISODES (MELAS)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYTOCHROME-C OXIDASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; POLYMERASE CHAIN-REACTION; KEARNS-SAYRE SYNDROME; RAGGED-RED FIBERS; DNA; DELETIONS; FEATURES; SEQUENCE; EPILEPSY	MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes) is a major subgroup of heterogeneous mitochondrial diseases. For identifying a mutation in the mitochondrial gene, we isolated, from the same muscle tissue from a patient with MELAS, cell lines with distinctly different phenotypes: one was respiration-deficient, and the other was apparently normal. Compared with the normal cells only one A-to-G nucleotide transition at nucleotide 3243 in the tRNA-Leu (UUR) gene was found in whole mtDNA of the respiration-deficient cells. This mutation was also found in eight patients, from unrelated families, who had MELAS in a heteroplasmic manner but was not found in control individuals. Therefore, the single point mutation causes the functional abnormality in the respiratory chain of mitochondria.	JICHI MED SCH,DEPT BIOCHEM,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; NATL CHILDRENS HOSP,DEPT NEUROL,TOKYO 154,JAPAN	Jichi Medical University; National Center for Child Health & Development - Japan								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BERENBERG RA, 1977, ANN NEUROL, V1, P37, DOI 10.1002/ana.410010104; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; CANN RL, 1984, GENETICS, V106, P479; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; DAVIS LG, 1986, BASIC METHODS MOL BI, P44; DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602; DUBOWITZ V, 1985, MUSCLE BIOPSY PRACTI, P3; ENGEL WK, 1963, NEUROLOGY, V13, P919, DOI 10.1212/WNL.13.11.919; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; GAINES G, 1987, J BIOL CHEM, V262, P1907; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HORAI S, 1986, HUM GENET, V72, P105; JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9; KAGAWA Y, 1990, MEMBRANE TRANSPORT I, P91; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KLUG A, 1974, P NATL ACAD SCI USA, V71, P3711, DOI 10.1073/pnas.71.9.3711; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; MONTAGNA P, 1988, NEUROLOGY, V38, P751, DOI 10.1212/WNL.38.5.751; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; NAKAMIGAWA T, 1988, J NEUROL SCI, V83, P305, DOI 10.1016/0022-510X(88)90077-9; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; PETTY RKH, 1986, BRAIN, V109, P915, DOI 10.1093/brain/109.5.915; Saiki R.K., 1989, PCR TECHNOLOGY, P7; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SERVIDEI S, 1987, NEUROLOGY, V37, P58, DOI 10.1212/WNL.37.1.58; SHIMOIZUMI H, 1989, ANN NEUROL, V25, P615, DOI 10.1002/ana.410250614; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; YONEDA M, 1990, BIOCHEM INT, V21, P789; YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4	39	99	99	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1991	49	3					590	599						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GE367	1715668				2022-12-18	WOS:A1991GE36700012
J	ZUPPAN, P; HALL, JM; LEE, MK; PONGLIKITMONGKOL, M; KING, MC				ZUPPAN, P; HALL, JM; LEE, MK; PONGLIKITMONGKOL, M; KING, MC			POSSIBLE LINKAGE OF THE ESTROGEN-RECEPTOR GENE TO BREAST-CANCER IN A FAMILY WITH LATE-ONSET DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCUS; CDNA	The estrogen-receptor locus is a candidate gene for inherited susceptibility to human breast cancer, particularly among families with later onset, primarily estrogen-receptor-positive tumors. For one extended family with eight patients with late-onset disease, one estrogen-receptor haplotype was consistently coinherited with breast cancer, yielding a +1.85 lod score for linkage at zero recombination. Simulation of this pedigree assuming independent inheritance of breast cancer and estrogen-receptor genotypes led to a lod score greater-than-or-equal-to 1.85 only once in 2,000 replicates. We suggest testing linkage of this gene to breast cancer in other families with late-onset	UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720; FAC MED STRASBOURG,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,STRASBOURG,FRANCE	University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg				King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [CA 27632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HALL JM, 1989, AM J HUM GENET, V44, P577; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEHRER S, 1990, LANCET, V335, P622, DOI 10.1016/0140-6736(90)90410-7; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; Maniatis T., 1982, MOL CLONING; MCARTY KS, 1983, ANN SURG, V197, P2; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; OTT J, 1985, ANAL HUMAN GENETIC L; PONGLIKITMONGKOL M, 1988, EMBO J, V7, P3385, DOI 10.1002/j.1460-2075.1988.tb03211.x; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; ZUPPAN PJ, 1989, CYTOGENET CELL GENET, V51, P1116	15	99	100	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1065	1068						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035527				2022-12-18	WOS:A1991FP09200006
J	MYERS, JC; JONES, TA; POHJOLAINEN, ER; KADRI, AS; GODDARD, AD; SHEER, D; SOLOMON, E; PIHLAJANIEMI, T				MYERS, JC; JONES, TA; POHJOLAINEN, ER; KADRI, AS; GODDARD, AD; SHEER, D; SOLOMON, E; PIHLAJANIEMI, T			MOLECULAR-CLONING OF ALPHA-5(IV) COLLAGEN AND ASSIGNMENT OF THE GENE TO THE REGION OF THE X-CHROMOSOME CONTAINING THE ALPORT SYNDROME LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; UNIV OULU,BIOCTR,COLLAGEN RES UNIT,SF-90100 OULU 10,FINLAND; UNIV OULU,DEPT MED BIOCHEM,SF-90100 OULU 10,FINLAND	Cancer Research UK; University of Oulu; University of Oulu	MYERS, JC (corresponding author), UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104, USA.		Sheer, Denise/C-6705-2011; Corbett-Jones, Tania A/E-4891-2013; Jones, Tania/C-8912-2011	Sheer, Denise/0000-0001-9067-1796; Corbett-Jones, Tania A/0000-0002-0067-3382; Jones, Tania/0000-0002-0067-3382; Pihlajaniemi, Taina/0000-0002-1664-9045	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P01AM020553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041882] Funding Source: NIH RePORTER; Cancer Research UK [A3585] Funding Source: Medline; NHLBI NIH HHS [HL41882] Funding Source: Medline; NIADDK NIH HHS [AM20553] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cancer Research UK(Cancer Research UK); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALPORT AC, 1927, BRIT MED J, V1, P504; ATKIN CL, 1988, AM J HUM GENET, V42, P249; BOYD CD, 1988, AM J HUM GENET, V42, P309; BRINKER JM, 1985, P NATL ACAD SCI USA, V82, P3649, DOI 10.1073/pnas.82.11.3649; BRUNNER H, 1988, KIDNEY INT, V34, P507, DOI 10.1038/ki.1988.210; BURGESON RE, 1988, ANNU REV CELL BIOL, V4, P551, DOI 10.1146/annurev.cb.04.110188.003003; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; EDWARDS YH, 1985, ANN HUM GENET, V49, P101, DOI 10.1111/j.1469-1809.1985.tb01681.x; EMANUEL BS, 1986, AM J HUM GENET, V38, P38; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1983, ANAL BIOCHEM, V137, P117; FEINGOLD J, 1985, KIDNEY INT, V27, P672, DOI 10.1038/ki.1985.63; FLINTER FA, 1989, GENOMICS, V4, P335, DOI 10.1016/0888-7543(89)90339-X; GRIFFIN CA, 1987, P NATL ACAD SCI USA, V84, P512, DOI 10.1073/pnas.84.2.512; HANSON IM, 1989, GENOMICS, V5, P925, DOI 10.1016/0888-7543(89)90135-3; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HASSTEDT SJ, 1986, AM J HUM GENET, V38, P940; HENRY I, 1988, GENOMICS, V3, P81; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HUDSON BG, 1989, LAB INVEST, V61, P256; JONES EA, 1976, SOMAT CELL GENET, V2, P483, DOI 10.1007/BF01542686; KASHTAN CE, 1989, SEMIN NEPHROL, V9, P135; KIELTY CM, 1982, ANN HUM GENET, V46, P307, DOI 10.1111/j.1469-1809.1982.tb01582.x; KILLEN PD, 1987, HUM GENET, V77, P318, DOI 10.1007/BF00291418; KIMURA T, 1989, EUR J BIOCHEM, V179, P71, DOI 10.1111/j.1432-1033.1989.tb14522.x; KIMURA T, 1989, J BIOL CHEM, V264, P13910; KLEPPEL MM, 1987, J CLIN INVEST, V80, P263, DOI 10.1172/JCI113057; KLEPPEL MM, 1989, LAB INVEST, V61, P278; MARTINEZHERNANDEZ A, 1983, LAB INVEST, V48, P656; MILLER EJ, 1987, METHOD ENZYMOL, V144, P3; MYERS JC, 1987, COLLAGEN REL RES, V7, P149; MYERS JC, 1987, J BIOL CHEM, V262, P9231; PAJUNEN L, 1989, CYTOGENET CELL GENET, V52, P190, DOI 10.1159/000132875; PHILLIPS IR, 1985, ANN HUM GENET, V49, P267, DOI 10.1111/j.1469-1809.1985.tb01702.x; PIHLAJANIEMI T, 1985, J BIOL CHEM, V260, P7681; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; POVEY S, 1980, ANN HUM GENET, V43, P241, DOI 10.1111/j.1469-1809.1980.tb01557.x; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RUMPELT HJ, 1980, CLIN NEPHROL, V13, P203; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAVAGE COS, 1989, LAB INVEST, V60, P613; SHOWS TB, 1989, GENOMICS, V5, P128, DOI 10.1016/0888-7543(89)90096-7; SOININEN R, 1988, J BIOL CHEM, V263, P17217; SOLOMON E, 1985, P NATL ACAD SCI USA, V82, P3330, DOI 10.1073/pnas.82.10.3330; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TSIPOURAS P, 1988, GENOMICS, V3, P275; VANHEYNINGEN V, 1975, ANN HUM GENET, V38, P295; WATT JL, 1986, HUMAN CYTOGENETICS P, P39; WEIL D, 1988, AM J HUM GENET, V42, P435; WOLFF S, 1974, CHROMOSOMA, V48, P341, DOI 10.1007/BF00290991; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; YOSHIKAWA N, 1981, J PATHOL, V135, P199, DOI 10.1002/path.1711350305; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	54	99	106	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1024	1033						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339699				2022-12-18	WOS:A1990DF20200003
J	YOSHIMOTO, Y; NEEL, JV; SCHULL, WJ; KATO, H; SODA, M; ETO, R; MABUCHI, K				YOSHIMOTO, Y; NEEL, JV; SCHULL, WJ; KATO, H; SODA, M; ETO, R; MABUCHI, K			MALIGNANT-TUMORS DURING THE 1ST 2 DECADES OF LIFE IN THE OFFSPRING OF ATOMIC-BOMB SURVIVORS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,M4708 MED SCI 2,ANN ARBOR,MI 48109; RADIAT EFFECTS RES FDN,HIROSHIMA 730,JAPAN; UNIV TEXAS,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77025	University of Michigan System; University of Michigan; Radiation Effects Research Foundation - Japan; University of Texas System								BATRA BK, 1964, ACTA UNION INT CONTR, V20, P1181; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; BUNDEY S, 1982, J MED GENET, V19, P16, DOI 10.1136/jmg.19.1.16; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; DAO DD, 1987, AM J HUM GENET, V41, P202; DRAPER GJ, 1977, J MED GENET, V14, P81, DOI 10.1136/jmg.14.2.81; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; GUNZ FW, 1978, J NATL CANCER I, V60, P1243, DOI 10.1093/jnci/60.6.1243; HARTLEY AL, 1986, BRIT J CANCER, V54, P819, DOI 10.1038/bjc.1986.245; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; IKEDA T, 1986, GANN MONOGR CANCER R, V32, P41; ISHIMARU T, 1981, 1181 RAD EFF RES F T; JABLON S, 1971, 2371 AT BOMB CAS COM; KANEKO M, 1988, GANN MONOGR CANCER R, V35, P63; KATO H, 1966, AM J HUM GENET, V18, P339; KITCHIN FD, 1974, J MED GENET, V11, P244, DOI 10.1136/jmg.11.3.244; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KNUDSON AG, 1978, CELL DIFFER, P83; KOHN HI, 1965, RADIAT RES, V25, P423, DOI 10.2307/3571983; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; LECK I, 1977, J MED GENET, V14, P321, DOI 10.1136/jmg.14.5.321; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LI EP, 1987, JAMA-J AM MED ASSOC, V257, P216; LI FP, 1988, CANCER RES, V48, P5358; MACMAHON B, 1964, NEW ENGL J MED, V270, P1082, DOI 10.1056/NEJM196405212702102; MATSUNAGA E, 1981, HUM GENET, V57, P231; MATSUNAGA E, 1988, GANN MONOGR CANCER R, V35, P127; MILLER RW, 1971, J NATL CANCER I, V46, P203; MILTON RC, 1968, 168 AT BOMB CAS COMM; MONZEN T, 1986, GANN MONOGRAPH CANCE, V32, P29; MULVIHILL JJ, 1985, CLINICS ONCOL, V4, P333; MULVIHILL JJ, 1987, LANCET, V2, P813; NEEL JV, 1974, GENETICS, V76, P311; NOMURA T, 1982, NATURE, V296, P575, DOI 10.1038/296575a0; NOMURA T, 1983, MUTAT RES, V121, P59, DOI 10.1016/0165-7992(83)90087-8; Normura T, 1986, Prog Clin Biol Res, V209B, P13; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; ROESCH WE, 1987, US JAPAN REASSESSMEN, V1; SCHIMKE RN, 1985, GENETICS CLIN ONCOLO, P103; SCHULL WJ, 1982, ENV MUTAGENS CARCINO, P687; SHIONOPH, 1980, J NATL CANCER I, V65, P861; STEINBERG AG, 1960, CANCER, V13, P985, DOI 10.1002/1097-0142(196009/10)13:5<985::AID-CNCR2820130520>3.0.CO;2-J; VIDEBAEK A, 1947, OPERA EX DOMO BIOL H, V13; VOGEL F, 1979, HUM GENET, V52, P1; YOSHIMOTO Y, 490 RAD EFF RES F TE; ZUELZER WW, 1969, SEMIN HEMATOL, V6, P228; 1987, CYTOGENET CELL GENET, V46, P1; 1989, JAPAN CHILDRENS CANC, V3	54	99	101	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1041	1052						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2160192				2022-12-18	WOS:A1990DF20200005
J	SEBASTIO, G; VILLA, M; SARTORIO, R; GUZZETTA, V; POGGI, V; AURICCHIO, S; BOLL, W; MANTEI, N; SEMENZA, G				SEBASTIO, G; VILLA, M; SARTORIO, R; GUZZETTA, V; POGGI, V; AURICCHIO, S; BOLL, W; MANTEI, N; SEMENZA, G			CONTROL OF LACTASE IN HUMAN ADULT-TYPE HYPOLACTASIA AND IN WEANING RABBITS AND RATS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									SWISS FED INST TECHNOL,DEPT BIOCHEM,UNIV 16,CH-8092 ZURICH,SWITZERLAND; NAPLES UNIV,CATTEDRA PEDIAT,DEPARTIMENTO PEDIAT,I-80131 NAPLES,ITALY	ETH Zurich; University of Naples Federico II								ASP NG, 1971, SCAND J GASTROENTERO, V6, P755, DOI 10.3109/00365527109179949; ASP NG, 1972, ANAL BIOCHEM, V47, P527, DOI 10.1016/0003-2697(72)90147-9; AURICCHIO S, 1963, ENZYMOL BIOL CLIN, V3, P193, DOI 10.1159/000458059; AURICCHIO S, 1963, LANCET, V2, P324; AURICCHIO S, IN PRESS TXB GASTROE; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BUTS JP, 1981, BIOL NEONATE, V40, P62, DOI 10.1159/000241473; BUTS JP, 1984, PEDIATR RES, V18, P145, DOI 10.1203/00006450-198402000-00006; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CICCIMARRA F, 1968, B SOC ITAL BIOL SPER, V45, P336; DAHLQVIST A, 1963, GASTROENTEROLOGY, V45, P488, DOI 10.1016/S0016-5085(19)34844-9; DANIELSEN EM, 1984, BIOCHEM BIOPH RES CO, V122, P82; DOELL RG, 1962, BIOCHIM BIOPHYS ACTA, V62, P353, DOI 10.1016/0006-3002(62)90097-5; FLATZ G, 1984, AM J HUM GENET, V36, P306; FLATZ G, IN PRESS METABOLIC B; FREUND JN, 1989, FEBS LETT, V248, P39, DOI 10.1016/0014-5793(89)80427-2; HAEMMERLI UP, 1965, AM J MED, V38, P7, DOI 10.1016/0002-9343(65)90156-7; HENNING SJ, 1985, ANNU REV PHYSIOL, V47, P231; HO MW, 1982, AM J HUM GENET, V34, P650; JONAS MM, 1985, PEDIATR RES, V19, P956, DOI 10.1203/00006450-198509000-00018; KEDINGER M, 1986, MOL CELLULAR BASIS D, P315; KLEIN RM, 1983, J PEDIATR GASTR NUTR, V2, P204, DOI 10.1097/00005176-198305000-00002; KOLDOVSKY O, 1981, CARBOHYD METABOL, V3, P418; KOLDOVSKY O, 1981, TXB GASTROENTEROLOGY, P77; KRETCHMER N, 1971, GASTROENTEROLOGY, V61, P805; LEBENTHAL E, 1983, PEDIATR RES, V17, P19, DOI 10.1203/00006450-198301000-00004; LORENZMEYER H, 1972, EUR J CLIN INVEST, V2, P326, DOI 10.1111/j.1365-2362.1972.tb00658.x; Maniatis T., 1982, MOL CLONING; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; MOOG F, 1981, TXB GASTROENTEROLOGY, P139; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NSIEMVO E, 1987, CELL MOL BIOL, V33, P335; POTTER J, 1985, BIOCHEM GENET, V23, P423, DOI 10.1007/BF00499084; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; RINALDI E, 1984, LANCET, V1, P357; RUBINO A, 1964, BIOCHIM BIOPHYS ACTA, V92, P305, DOI 10.1016/0926-6569(64)90187-7; SAHI T, 1973, LANCET, V2, P823; SEBASTIO G, 1987, BIOCHEM BIOPH RES CO, V149, P830, DOI 10.1016/0006-291X(87)90442-6; SEBASTIO G, 1986, FEBS LETT, V208, P460, DOI 10.1016/0014-5793(86)81069-9; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SEMENZA G, 1987, MAMMALIAN ECTOENZYME, P265; SEMENZA G, IN PRESS METABOLIC B; SKOVBJERG H, 1980, GUT, V21, P360, DOI 10.1136/gut.21.5.360; SKOVBJERG H, 1984, BIOCHIM BIOPHYS ACTA, V798, P247, DOI 10.1016/0304-4165(84)90312-X; SKOVBJERG H, 1982, BIOCHIM BIOPHYS ACTA, V707, P89, DOI 10.1016/0167-4838(82)90400-9; SMITH MW, 1987, BIOCHIM BIOPHYS ACTA, V905, P503, DOI 10.1016/0005-2736(87)90481-0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TSUBOI KK, 1985, BIOCHIM BIOPHYS ACTA, V840, P69, DOI 10.1016/0304-4165(85)90163-1; TSUBOI KK, 1981, BIOCHEM BIOPH RES CO, V101, P645, DOI 10.1016/0006-291X(81)91307-3; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175	51	99	99	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1989	45	4					489	497						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AW395	2485006				2022-12-18	WOS:A1989AW39500002
J	DAO, DD; SCHROEDER, WT; CHAO, LY; KIKUCHI, H; STRONG, LC; RICCARDI, VM; PATHAK, S; NICHOLS, WW; LEWIS, WH; SAUNDERS, GF				DAO, DD; SCHROEDER, WT; CHAO, LY; KIKUCHI, H; STRONG, LC; RICCARDI, VM; PATHAK, S; NICHOLS, WW; LEWIS, WH; SAUNDERS, GF			GENETIC MECHANISMS OF TUMOR-SPECIFIC LOSS OF 11P-DNA SEQUENCES IN WILMS-TUMOR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOCHEM & MOLEC BIOL,6723 BERTNER AVE,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT PEDIAT,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT GENET,HOUSTON,TX 77030; BAYLOR COLL MED,RES CYTOGENET LAB,HOUSTON,TX 77030; MERCK SHARP & DOHME RES LABS,DEPT SAFETY ASSESSMENT,W POINT,PA 19486; UNIV TORONTO,DEPT SURG,TORONTO M5S 1A1,ONTARIO,CANADA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Merck & Company; University of Toronto					NCI NIH HHS [CA 33624, CA 34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936, P01CA033624] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BRESLOW NE, 1982, JNCI-J NATL CANCER I, V68, P429; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; GONZALEZCRUSSI F, 1981, AM J SURG PATHOL, V5, P525, DOI 10.1097/00000478-198109000-00001; GOODE ME, 1986, AM J HUM GENET, V38, P437; GRAY KM, 1985, NUCLEIC ACIDS RES, V13, P521, DOI 10.1093/nar/13.2.521; GREENBERG F, 1986, AM J MED GENET, V24, P101, DOI 10.1002/ajmg.1320240112; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HENDY GN, 1981, P NATL ACAD SCI-BIOL, V78, P7365, DOI 10.1073/pnas.78.12.7365; KESSLING AM, 1985, CLIN GENET, V28, P296; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; KORNELUK RG, 1984, J BIOL CHEM, V259, P3819; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KUDO J, 1985, NUCLEIC ACIDS RES, V13, P8827, DOI 10.1093/nar/13.24.8827; LAI EC, 1979, CELL, V16, P201; MATSUNAGA E, 1981, HUM GENET, V57, P231; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NAKAGOME Y, 1984, HUM GENET, V67, P245, DOI 10.1007/BF00291349; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PALMER NF, 1983, MED PEDIATR ONCOL, V11, P242, DOI 10.1002/mpo.2950110407; PATHAK S, 1976, J REPROD MED, V17, P25; QUAN F, 1985, NUCLEIC ACIDS RES, V13, P8288, DOI 10.1093/nar/13.22.8288; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; RICCARDI VM, 1978, PEDIATRICS, V61, P604; RICCARDI VM, 1986, CANCER GENET CYTOGEN, V23, P199, DOI 10.1016/0165-4608(86)90179-2; SCHROEDER WT, 1987, AM J HUM GENET, V41, P413; SCHROEDER WT, IN PRESS CYTOGENET C; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SLATER RM, 1986, CANCER GENET CYTOGEN, V19, P37, DOI 10.1016/0165-4608(86)90369-9; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRONG LC, 1981, SCIENCE, V219, P971; TAGGART RT, 1985, P NATL ACAD SCI USA, V82, P6240, DOI 10.1073/pnas.82.18.6240; TURLEAU C, 1984, CLIN GENET, V26, P356; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592; VOGEL AM, 1984, LAB INVEST, V50, P232; WIGGER HJ, 1976, HUM PATHOL, V7, P613; 1985, CYTOGENET CELL GENET, V40, P187	42	99	99	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					202	217						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	3039839				2022-12-18	WOS:A1987J757500011
J	SU, TS; NUSSBAUM, RL; AIRHART, S; LEDBETTER, DH; MOHANDAS, T; OBRIEN, WE; BEAUDET, AL				SU, TS; NUSSBAUM, RL; AIRHART, S; LEDBETTER, DH; MOHANDAS, T; OBRIEN, WE; BEAUDET, AL			HUMAN CHROMOSOMAL ASSIGNMENTS FOR 14 ARGININOSUCCINATE SYNTHETASE PSEUDOGENES - CLONED DNAS AS REAGENTS FOR CYTOGENETIC ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT INTERNAL MED,HOUSTON,TX 77030; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DIV MED GENET,TORRANCE,CA 90509	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center					NIGMS NIH HHS [GM27593, GM08199] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027593] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; BEAUDET AL, 1982, CELL, V30, P287, DOI 10.1016/0092-8674(82)90034-4; BOCK HGO, 1983, NUCLEIC ACIDS RES, V11, P6505, DOI 10.1093/nar/11.18.6505; CARRITT B, 1979, CYTOGENET CELL GENET, V23, P171, DOI 10.1159/000131323; DAIGER S P, 1983, Genetics, V104, pS20; DAIGER SP, 1984, AM J HUM GENET, V36, P736; DAIGER SP, 1982, NATURE, V298, P682, DOI 10.1038/298682a0; FREYTAG SO, 1984, J BIOL CHEM, V259, P3160; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; MOHANDAS T, 1979, AM J HUM GENET, V31, P586; NUSSBAUM RL, 1983, P NATL ACAD SCI-BIOL, V80, P4035, DOI 10.1073/pnas.80.13.4035; SEABRIGH.M, 1971, LANCET, V2, P971; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SU TS, 1981, J BIOL CHEM, V256, P1826; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; 1982, NIH822011 PUBL	16	99	99	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					954	964						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TS302	6093508				2022-12-18	WOS:A1984TS30200003
J	HARPER, ME; DUGAICZYK, A				HARPER, ME; DUGAICZYK, A			LINKAGE OF THE EVOLUTIONARILY-RELATED SERUM-ALBUMIN AND ALPHA-FETOPROTEIN GENES WITHIN Q11-22 OF HUMAN CHROMOSOME-4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR CANC, DEPT BIOCHEM, HOUSTON, TX 77030 USA; BAYLOR COLL MED, TEXAS MED CTR, DEPT CELL BIOL, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	HARPER, ME (corresponding author), AGOURON INST, 505 COAST BLVD S, LA JOLLA, CA 92037 USA.				NCI NIH HHS [CA-20124, CA-16672] Funding Source: Medline; NIGMS NIH HHS [GM-29797] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA020124, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABELEV GI, 1974, TRANSPLANT REV-DENMA, V20, P3; BEATTIE WG, 1982, GENE, V20, P415, DOI 10.1016/0378-1119(82)90210-4; BELANGER L, 1973, PATHOL BIOL, V21, P449; BELANGER L, 1973, PATHOL BIOL, V21, P457; BOOTSMA D, 1979, CYTOGENET CELL GENET, V25, P21, DOI 10.1159/000131396; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROWN JR, 1976, FED PROC, V35, P2124; CHANDLER ME, 1978, CYTOGENET CELL GENET, V22, P352, DOI 10.1159/000130970; DEUSTACHIO P, 1981, SOMAT CELL GENET, V7, P289, DOI 10.1007/BF01538854; DUGAICZYK A, 1982, P NATL ACAD SCI-BIOL, V79, P71, DOI 10.1073/pnas.79.1.71; DUGAICZYK A, 1982, P NATL ACAD SCI USA, V79, P2124; FRIEDBERG EC, 1979, ADV RADIAT BIOL, V8, P85; GITLIN D, 1975, ANN NY ACAD SCI, V259, P7, DOI 10.1111/j.1749-6632.1975.tb25397.x; GITLIN D, 1970, NATURE, V228, P995, DOI 10.1038/228995a0; GITLIN D, 1975, PLASMA PROTEINS, V2, P321; GORIN MB, 1981, J BIOL CHEM, V256, P1954; HARPER ME, 1982, AM J HUM GENET, V34, P227; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HAWKINS JW, 1982, GENE, V19, P55, DOI 10.1016/0378-1119(82)90188-3; INGRAM RS, 1981, P NATL ACAD SCI-BIOL, V78, P4694, DOI 10.1073/pnas.78.8.4694; JAGODZINSKI LL, 1981, P NATL ACAD SCI-BIOL, V78, P3521, DOI 10.1073/pnas.78.6.3521; LADU BN, 1978, METABOLIC BASIS INHE, P256; LAI EC, 1979, CELL, V16, P201; LAW SW, 1981, NATURE, V291, P201, DOI 10.1038/291201a0; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MCINTIRE KR, 1975, CANCER RES, V35, P991; MIKKELSEN M, 1977, HUM HERED, V27, P105, DOI 10.1159/000152857; RUOSLAHTI E, 1974, TRANSPLANT REV-DENMA, V20, P38; RUOSLAHTI E, 1976, NATURE, V260, P804, DOI 10.1038/260804a0; SARGENT TD, 1981, P NATL ACAD SCI-BIOL, V78, P243, DOI 10.1073/pnas.78.1.243; SELL S, 1976, CANCER RES, V36, P4239; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WALDMANN TA, 1972, LANCET, V2, P1112; WEITKAMP LR, 1970, HUM HERED, V20, P1, DOI 10.1159/000152287; WETMUR JG, 1975, BIOPOLYMERS, V14, P2517, DOI 10.1002/bip.1975.360141208; YUNIS JJ, 1978, CYTOGENET CELL GENET, V22, P679, DOI 10.1159/000131052; YUNIS JJ, 1979, CLIN DIAGNOSIS MANAG, P801	39	99	101	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1983	35	4					565	572						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG731	6192711				2022-12-18	WOS:A1983RG73100002
J	KARLIN, S; KENETT, R; BONNETAMIR, B				KARLIN, S; KENETT, R; BONNETAMIR, B			ANALYSIS OF BIOCHEMICAL GENETIC DATA ON JEWISH POPULATIONS .2. RESULTS AND INTERPRETATIONS OF HETEROGENEITY INDEXES AND DISTANCE MEASURES WITH RESPECT TO STANDARDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,RAMAT AVIV,ISRAEL; WEIZMANN INST SCI,DEPT MATH,REHOVOT 76100,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	KARLIN, S (corresponding author), STANFORD UNIV HOSP,DEPT MATH,STANFORD,CA 94305, USA.		Kenett, Ron/I-7246-2019	Kenett, Ron/0000-0003-2315-0477				ADAM A, 1973, ISRAEL J MED SCI, V9, P1383; Baron Salo, 1964, RUSSIAN JEW TSARS SO; BARON SW, 1960, SOCIAL RELIGIOUS HIS; BENJACOB A, 1965, JEWS MESOPOTAMIA 193; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P235, DOI 10.1111/j.1399-0039.1978.tb01255.x; BONNETAMIR B, AM J HUM GENET, V31, P324; BRUNT PW, 1970, MEDICINE, V49, P343, DOI 10.1097/00005792-197009000-00001; CARMELLI D, HUM BIOL; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CAVALLISFORZA LL, 1979, GENETIC DISEASES ASH; CHOURAQUI AN, 1973, HISTORY N AFRICAN JE; COHEN HJ, 1972, JEWS MIDDLE EASTERN; DUBNOV S, 1948, DIVREY YEMEY AM OLAM, V7; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; FRAIKOR AL, 1977, SOC BIOL, V24, P117, DOI 10.1080/19485565.1977.9988272; GERMAN JL, 1979, GENETIC DISEASES ASH; Goitein, 1973, LETT MEDIEVAL JEWISH; GOODMAN MM, 1972, SYST ZOOL, V21, P174, DOI 10.2307/2412287; HIRSCHBERG HZ, 1973, HISTORY JEWS N AFRIC; JACOBS L, 1968, JEWISH LAW; KARLIN S, 1972, THEOR POPUL BIOL, V3, P186, DOI 10.1016/0040-5809(72)90026-3; LANDAU A, 1971, JEWS 19TH CENTURY EG; LOEB L, 1978, JEWISH LIFE IRAN; MARCUS JR, 1965, JEW MEDIEVAL WORLD; MCKUSICK VA, 1967, J CHRON DIS, V20, P115, DOI 10.1016/0021-9681(67)90045-8; MOTULSKY AG, 1979, POPULATION STUDIES I; Patai Raphael., 1975, MYTH JEWISH RACE; ROTH C, 1941, SASSOON DYNASTY; ROYALTEY HH, 1975, GEOGR ANAL, V7, P369; SASSOON DS, 1949, HISTORY JEWS BAGHDAD; SHEBA C, 1962, AM J PUBLIC HEALTH N, V52, P1101, DOI 10.2105/AJPH.52.7.1101; SMOUSE PE, 1977, GENETICS, V85, P733; SMOUSE PE, UNPUBLISHED; SPIELMAN RS, 1976, AM J HUM GENET, V28, P317; Weinryb Bernard, 1972, JEWS POLAND; 1973, JEWISH COMMUNITIES A, V3	36	99	99	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	3					341	365						25	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	HE538	380330				2022-12-18	WOS:A1979HE53800009
J	IKONNE, JU; RATTAZZI, MC; DESNICK, RJ				IKONNE, JU; RATTAZZI, MC; DESNICK, RJ			CHARACTERIZATION OF HEX-S, MAJOR RESIDUAL BETA-HEXOSAMINIDASE ACTIVITY IN TYPE-O GM2 GANGLIOSIDOSIS (SANDHOFF-JATZKEWITZ DISEASE)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MINNESOTA, DEPT PEDIAT, MINNEAPOLIS, MN 55455 USA; SUNY, CHILDRENS HOSP BUFFALO, DEPT PEDIAT, DIV HUMAN GENET, BUFFALO, NY 14222 USA; UNIV MINNESOTA, DIGHT INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT LAB MED, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, DEPT PATHOL, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; SUNY Maritime College; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities								ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; BARTHOLOMEW WR, 1974, INT ARCH ALLER A IMM, V46, P512, DOI 10.1159/000231154; BEUTLER E, 1974, INT RES COMMUN SYST, V2, P1090; BRAIDMAN I, 1974, BIOCHEM J, V143, P295, DOI 10.1042/bj1430295; BRAIDMAN I, 1974, FEBS LETT, V41, P181, DOI 10.1016/0014-5793(74)81206-8; CARMODY PJ, 1974, BIOCHIM BIOPHYS ACTA, V371, P117, DOI 10.1016/0005-2795(74)90160-3; CARROLL M, 1974, BIOCHEM J, V137, P217, DOI 10.1042/bj1370217; CARROLL M, 1972, BIOCHEM J, V126, pP17; CARROLL M, 1973, BIOCHEM J, V131, P91, DOI 10.1042/bj1310091; DESNICK RJ, IN PRESS; DESNICK RJ, 1972, SPHINGOLIPIDS SPHING, P351; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; HOOGHWIN.GJ, 1972, H-S Z PHYSIOL CHEM, V353, P839; IKONNE JU, 1973, BIOCHEM J, V135, P457, DOI 10.1042/bj1350457; IKONNE JU, 1974, AM J HUM GENET, V26, pA43; IKONNE JU, 1973, THESIS U LONDON; KOLODNY EH, 1972, SPHINGOLIPIDS SPHING, P321; KRIVIT W, 1972, AM J MED, V52, P763, DOI 10.1016/0002-9343(72)90082-4; LEABACK DH, 1961, BIOCHEM J, V78, P151, DOI 10.1042/bj0780151; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; POENARU L, 1973, CLIN CHIM ACTA, V43, P439; POENARU L, 1973, BIOMED EXPRESS, V19, P538; PRICE RG, 1972, BIOCHIM BIOPHYS ACTA, V271, P145, DOI 10.1016/0005-2795(72)90142-0; RATTAZZI MC, 1968, BIOCHEM BIOPH RES CO, V31, P16, DOI 10.1016/0006-291X(68)90024-7; RATTAZZI MC, 1975, ISOZYMES PHYSIOLOGIC; RATTAZZI MC, IN PRESS; RATTAZZI MC, 1972, ANTENATAL DIAGNOSIS, P207; ROBINSON D, 1968, BIOCHEM J, V107, P321, DOI 10.1042/bj1070321; ROPERS HH, 1973, HUMANGENETIK, V20, P167, DOI 10.1007/BF00284854; SANDHOFF K, 1971, J NEUROCHEM, V18, P2469, DOI 10.1111/j.1471-4159.1971.tb00204.x; SANDHOFF K, 1968, H-S Z PHYSIOL CHEM, V349, P1095, DOI 10.1515/bchm2.1968.349.2.1095; SANDHOFF K, 1968, LIFE SCI, V7, P278; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2043; SRIVASTA.SK, 1974, J BIOL CHEM, V249, P2054; STIRLING JL, 1972, BIOCHIM BIOPHYS ACTA, V271, P154, DOI 10.1016/0005-2795(72)90143-2; TALLMAN JF, 1974, J BIOL CHEM, V249, P3489	36	99	99	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					639	650						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AR239	240271				2022-12-18	WOS:A1975AR23900007
J	BEUTLER, E; KUHL, W; TRINIDAD, F; TEPLITZ, R; NADLER, H				BEUTLER, E; KUHL, W; TRINIDAD, F; TEPLITZ, R; NADLER, H			BETA-GLUCOSIDASE ACTIVITY IN FIBROBLASTS FROM HOMOZYGOTES AND HETEROZYGOTES FOR GAUCHERS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BEUTLER E, 1970, LANCET, V2, P369; BEUTLER E, 1970, LANCET, V1, P612; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; NADLER HL, 1970, NEW ENGL J MED, V282, P596, DOI 10.1056/NEJM197003122821105; OCKERMAN PA, 1968, SCAND J CLIN LAB INV, V22, P62, DOI 10.3109/00365516809160739; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; TEPLITZ RL, 1968, EXP CELL RES, V52, P379, DOI 10.1016/0014-4827(68)90479-5	7	99	99	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	1					62	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	I6190	5581982				2022-12-18	WOS:A1971I619000007
J	GIBLETT, ER				GIBLETT, ER			THE INHERITANCE OF SERUM HAPTOGLOBIN TYPES IN AMERICAN NEGROES - EVIDENCE FOR A 3RD ALLELE HP2M	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1958, NATURE, V181, P824, DOI 10.1038/181824a0; CONNELL GE, 1959, BIOCHEM J, V72, P115, DOI 10.1042/bj0720115; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P248; GALATIUSJENSEN F, 1958, ACTA GENET, V8, P232; GIBLETT ER, 1959, NATURE, V183, P192, DOI 10.1038/183192a0; GIBLETT ER, UNPUB; HARRIS H, 1958, NATURE, V182, P1324, DOI 10.1038/1821324b0; HARRIS H, 1959, IN PRESS; NOSSLIN BF, 1958, LANCET, V1, P1000; NYMAN M, 1958, ACTA CLIN CHIM, V3, P111; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; Robbins RB, 1918, GENETICS, V3, P375; SMITHIES O, 1956, NATURE, V178, P694, DOI 10.1038/178694a0; SMITHIES O, 1955, BIOCHEM J, V61, P629, DOI 10.1042/bj0610629	14	99	99	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1960	12	2					160	169						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF078	13827945				2022-12-18	WOS:A1960WF07800003
J	TORGERSEN, J				TORGERSEN, J			SITUS INVERSUS, ASYMMETRY, AND TWINNING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		COCKAYNE E. A., 1939, BIOMETRIKA, V31, P287; Cockayne EA, 1938, Q J MED, V7, P479; DAHLBERG G, 1926, TWIN BIRTHS TWINS HE, P296; DOOLITTLE WF, 1907, CITED INDIRECTLY; DUBREUILCHAMBAR.L, 1927, CITED INDIRECTLY; FROLICH T, 1920, NORSK MAG LAEGEVIDEN, V81, P119; GANSSLEN M, 1940, HDB ERBBIOLOGIE MENS, V4, P198; GUTZEIT K, 1940, HDB ERBBIOLOGIE MENS, V4, P581; HELWEGLARSEN HF, 1947, ANN EUGENIC, V14, P1; Kean BH, 1942, J HERED, V33, P217, DOI 10.1093/oxfordjournals.jhered.a105172; KOMAI T, 1938, MEM COLLEGE SC KYO B, V14; LANDAUER W, 1948, GENETICS, V33, P133; MATTISSON KARL, 1933, ZEITSCHR GES ANAT ABT II ZEITSCHR KONSTITUTIONSL, V17, P325; NATVIG H, 1939, NORD MED, V1, P681; Newman H. H., 1937, TWINS STUDY HEREDITY, P369; PERNKOPF E., 1937, ZEITSCHR MENSCHL VERERBUNGS U KONSTITUTIONSL, V20, P606; REINHARDT C, 1912, CITED INDIRECTLY; Rife DC, 1940, GENETICS, V25, P0178; SCHILLER M, 1937, Z MENSCHL VERERB KON, V20, P284; Siemens HW, 1924, VIRCHOWS ARCH A, V252, P1, DOI 10.1007/BF01960717; SPEMANN H, 1922, ARCH ENTWMECH, V52, P97; TORGERSEN J, 1949, ARCH PATHOL, V47, P566; TORGERSEN J, 1947, ACTA RADIOL, V28, P17, DOI 10.3109/00016924709135208; TORGERSEN J, 1946, ACTA MED SCAND, V126, P319; TORGERSEN J, 1950, ACTA RADIOL, V33, P131, DOI 10.3109/00016925009133882; TORGERSEN J, 1948, J HERED, V39, P293, DOI 10.1093/oxfordjournals.jhered.a105772; TORGERSEN J, 1948, ACTA RADIOL, V29, P311, DOI 10.3109/00016924809132444; VONVERSCHUER O, 1933, ZWILLINGSTUBERKULOSE	28	99	100	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1950	2	4					361	370						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS391	14837905				2022-12-18	WOS:A1950XS39100003
J	Coban-Akdemir, Z; White, JJ; Song, XF; Jhangiani, SN; Fatih, JM; Gambin, T; Bayram, Y; Chinn, IK; Karaca, E; Punetha, J; Poli, C; Boerwinkle, E; Shaw, CA; Orange, JS; Gibbs, RA; Lappalainen, T; Lupski, JR; Carvalho, CMB				Coban-Akdemir, Zeynep; White, Janson J.; Song, Xiaofei; Jhangiani, Shalini N.; Fatih, Jawid M.; Gambin, Tomasz; Bayram, Yavuz; Chinn, Ivan K.; Karaca, Ender; Punetha, Jaya; Poli, Cecilia; Boerwinkle, Eric; Shaw, Chad A.; Orange, Jordan S.; Gibbs, Richard A.; Lappalainen, Tuuli; Lupski, James R.; Carvalho, Claudia M. B.		Baylor-Hopkins Ctr Mendelian Genom	Identifying Genes Whose Mutant Transcripts Cause Dominant Disease Traits by Potential Gain-of-Function Alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; EXON JUNCTION COMPLEX; PROTEIN SIGNALING 3; WEB-BASED TOOL; DE-NOVO; TRUNCATING MUTATIONS; FRAMESHIFT MUTATIONS; MAMMALIAN-CELLS; VARIANTS	Premature termination codon (PTC)-bearing transcripts are often degraded by nonsense-mediated decay (NMD) resulting in loss-of-function (LoF) alleles. However, not all PTCs result in LoF mutations, i.e., some such transcripts escape NMD and are translated to truncated peptide products that result in disease due to gain-of-function (GoF) effects. Since the location of the PTC is a major factor determining transcript fate, we hypothesized that depletion of protein-truncating variants (PTVs) within the gene region predicted to escape NMD in control databases could provide a rank for genic susceptibility for disease through GoF versus LoF. We developed an NMD escape intolerance score to rank genes based on the depletion of PTVs that would render them able to escape NMD using the Atherosclerosis Risk in Communities Study (ARIC) and the Exome Aggregation Consortium (ExAC) control databases, which was further used to screen the Baylor-Center for Mendelian Genomics disease database. This analysis revealed 1,996 genes significantly depleted for PTVs that are predicted to escape from NMD, i.e., PTVesc; further studies provided evidence that revealed a subset as candidate genes underlying Mendelian phenotypes. Importantly, these genes have characteristically low pLI scores, which can cause them to be overlooked as candidates for dominant diseases. Collectively, we demonstrate that this NMD escape intolerance score is an effective and efficient tool for gene discovery in Mendelian diseases due to production of truncated or altered proteins. More importantly, we provide a complementary analytical tool to aid identification of genes associated with dominant traits through a mechanism distinct from LoF.	[Coban-Akdemir, Zeynep; White, Janson J.; Song, Xiaofei; Fatih, Jawid M.; Bayram, Yavuz; Karaca, Ender; Punetha, Jaya; Shaw, Chad A.; Gibbs, Richard A.; Lupski, James R.; Carvalho, Claudia M. B.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jhangiani, Shalini N.; Boerwinkle, Eric; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gambin, Tomasz] Warsaw Univ Technol, Inst Comp Sci, PL-00665 Warsaw, Poland; [Bayram, Yavuz] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chinn, Ivan K.; Poli, Cecilia; Orange, Jordan S.; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chinn, Ivan K.; Poli, Cecilia] Texas Childrens Hosp, Div Pediat Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Poli, Cecilia] Univ Desarrollo, Inst Ciencias Innovac Med, Clin Alemana Santiago, RM7590943, Santiago, Chile; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Shaw, Chad A.] Baylor Genet, Houston, TX 77021 USA; [Lappalainen, Tuuli] New York Genome Ctr, New York, NY 10013 USA; [Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Warsaw University of Technology; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; Baylor College of Medicine; Clinica Alemana; Universidad del Desarrollo; University of Texas System; University of Texas Health Science Center Houston; Columbia University; Baylor College of Medicine	Lupski, JR; Carvalho, CMB (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Lupski, JR (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	jlupski@bcm.edu; cfonseca@bcm.edu	Gambin, Tomasz/HDN-5840-2022	Gambin, Tomasz/0000-0002-0941-4571; Punetha, Jaya/0000-0002-6774-4464; Lappalainen, Tuuli/0000-0002-7746-8109; orange, jordan/0000-0001-7117-7725; Poli, Maria Cecilia/0000-0001-6817-0573; Chinn, Ivan/0000-0001-5684-5457; Fatih, Jawid/0000-0002-3927-2711	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) [UM1HG006542]; National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS058529, R35 NS105078]; National Human Genome Research Institute [U54 HG003273]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, R35NS105078] Funding Source: NIH RePORTER	US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all individuals and their families and the referring physicians who submitted samples for testing. No additional compensation was received for these contributions. This work was funded in part by the US National Human Genome Research Institute (NHGRI)/National Heart Lung and Blood Institute (NHLBI) grant number UM1HG006542 to the Baylor-Hopkins Center for Mendelian Genomics (BHCMG), the National Institute of Neurological Disorders and Stroke (NINDS) R01 NS058529 and R35 NS105078 (J.R.L.), and the National Human Genome Research Institute U54 HG003273 (R.A.G.).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Bartha I, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004647; Bayram Y, 2017, AM J HUM GENET, V101, P149, DOI 10.1016/j.ajhg.2017.06.006; Ben-Shachar S, 2009, CLIN GENET, V75, P394, DOI 10.1111/j.1399-0004.2008.01114.x; Branham-O'Connor M, 2014, J BIOL CHEM, V289, P10738, DOI 10.1074/jbc.M113.515031; Cava C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020274; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Fisher RA, 1925, STAT METHODS RES WOR; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gambin T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0171-1; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007; Harel T, 2016, AM J HUM GENET, V98, P562, DOI 10.1016/j.ajhg.2016.01.011; Hu ZY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15943; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Inoue K, 2007, HUM MOL GENET, V16, P3037, DOI 10.1093/hmg/ddm262; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Jansen S, 2017, AM J HUM GENET, V100, P650, DOI 10.1016/j.ajhg.2017.02.005; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kim SY, 2015, STEM CELLS DEV, V24, P686, DOI 10.1089/scd.2014.0434; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kosmicki JA, 2017, NAT GENET, V49, P504, DOI 10.1038/ng.3789; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lindeboom RGH, 2016, NAT GENET, V48, P1112, DOI 10.1038/ng.3664; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Meehan TF, 2017, NAT GENET, V49, P1231, DOI 10.1038/ng.3901; Mort M, 2008, HUM MUTAT, V29, P1037, DOI 10.1002/humu.20763; MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Poli MC, 2018, AM J HUM GENET, V102, P1126, DOI 10.1016/j.ajhg.2018.04.010; Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767; Redler S, 2017, EUR J HUM GENET, V25, P889, DOI 10.1038/ejhg.2017.52; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; ROTH JR, 1974, ANNU REV GENET, V8, P319, DOI 10.1146/annurev.ge.08.120174.001535; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sauliere J, 2012, NAT STRUCT MOL BIOL, V19, P1124, DOI 10.1038/nsmb.2420; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Sobreira N, 2015, HUM MUTAT, V36, P425, DOI 10.1002/humu.22769; Twigg SRF, 2015, AM J HUM GENET, V97, P378, DOI 10.1016/j.ajhg.2015.07.007; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; White J, 2015, AM J HUM GENET, V96, P612, DOI 10.1016/j.ajhg.2015.02.015; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	58	98	98	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 2	2018	103	2					171	187		10.1016/j.ajhg.2018.06.009	http://dx.doi.org/10.1016/j.ajhg.2018.06.009			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GP1GR	30032986	Bronze, Green Published			2022-12-18	WOS:000440563700001
J	Norman, PJ; Hollenbach, JA; Nemat-Gorgani, N; Marin, WM; Norberg, SJ; Ashouri, E; Jayaraman, J; Wroblewski, EE; Trowsdale, J; Rajalingam, R; Oksenberg, JR; Chiaroni, J; Guethlein, LA; Traherne, JA; Ronaghi, M; Parham, P				Norman, Paul J.; Hollenbach, Jill A.; Nemat-Gorgani, Neda; Marin, Wesley M.; Norberg, Steven J.; Ashouri, Elham; Jayaraman, Jyothi; Wroblewski, Emily E.; Trowsdale, John; Rajalingam, Raja; Oksenberg, Jorge R.; Chiaroni, Jacques; Guethlein, Lisbeth A.; Traherne, James A.; Ronaghi, Mostafa; Parham, Peter			Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; COPY-NUMBER VARIATION; NATURAL-KILLER-CELLS; ALLELIC POLYMORPHISM; MULTIPLE-SCLEROSIS; AFRICAN-AMERICANS; READ ALIGNMENT; GENE CONTENT; DIVERSITY	The physiological functions of natural killer (NK) cells in human immunity and reproduction depend upon diverse interactions between killer cell immunoglobulin-like receptors (KIRs) and their HLA class I ligands: HLA-A, HLA-B, and HLA-C. The genomic regions containing the KIR and HLA class I genes are unlinked, structurally complex, and highly polymorphic. They are also strongly associated with a wide spectrumof diseases, including infections, autoimmune disorders, cancers, and pregnancy disorders, as well as the efficacy of transplantation and other immunotherapies. To facilitate study of these extraordinary genes, we developed a method that captures, sequences, and analyzes the 13 KIR genes and HLA-A, HLA-B, and HLA-C from genomic DNA. We also devised a bioinformatics pipeline that attributes sequencing reads to specific KIR genes, determines copy number by read depth, and calls high-resolution genotypes for each KIR gene. We validated this method by using DNA from well-characterized cell lines, comparing it to established methods of HLA and KIR genotyping, and determining KIR genotypes from 1000 Genomes sequence data. This identified 116 previously uncharacterized KIR alleles, which were all demonstrated to be authentic by sequencing from source DNA via standard methods. Analysis of just two KIR genes showed that 22% of the 1000 Genomes individuals have a previously uncharacterized allele or a structural variant. The method we describe is suited to the large-scale analyses that are needed for characterizing human populations and defining the precise HLA and KIR factors associated with disease. The methods are applicable to other highly polymorphic genes.	[Norman, Paul J.; Nemat-Gorgani, Neda; Ashouri, Elham; Wroblewski, Emily E.; Guethlein, Lisbeth A.; Parham, Peter] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Norman, Paul J.; Nemat-Gorgani, Neda; Ashouri, Elham; Wroblewski, Emily E.; Guethlein, Lisbeth A.; Parham, Peter] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Hollenbach, Jill A.; Marin, Wesley M.; Oksenberg, Jorge R.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94158 USA; [Norberg, Steven J.; Ronaghi, Mostafa] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA; [Jayaraman, Jyothi; Trowsdale, John; Traherne, James A.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; [Jayaraman, Jyothi; Trowsdale, John; Traherne, James A.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1QP, England; [Rajalingam, Raja] Univ Calif San Francisco, Immunogenet & Transplantat Lab, San Francisco, CA 94143 USA; [Chiaroni, Jacques] Aix Marseille Univ, Etab Francais Sang, CNRS, ADES,UMR 7268, F-13344 Marseille, France	Stanford University; Stanford University; University of California System; University of California San Francisco; Illumina; University of Cambridge; University of Cambridge; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite	Norman, PJ (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.; Norman, PJ (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	paul.norman@stanford.edu	Ashouri, Elham/K-1637-2013; Chiaroni, Jacques/ABA-2944-2021	Ashouri, Elham/0000-0002-7310-2847; Chiaroni, Jacques/0000-0002-3133-8990; Norman, Paul/0000-0001-8370-7703	US NIH [U01 AI090905, R01 GM109030, R01 AI17892, U19 AI119350]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI090905, R01AI024258, R01AI017892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U19NS095774] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by US NIH grants U01 AI090905, R01 GM109030, R01 AI17892, and U19 AI119350.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Abi-Rached L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001192; Ahn RS, 2016, BRIT J DERMATOL, V174, P449, DOI 10.1111/bjd.14081; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ba A, 2015, TRANSFUSION, V55, P1423, DOI 10.1111/trf.13109; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Bonfield JK, 2010, BIOINFORMATICS, V26, P1699, DOI 10.1093/bioinformatics/btq268; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Campbell KS, 2011, IMMUNOLOGY, V132, P315, DOI 10.1111/j.1365-2567.2010.03398.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Church DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0587-3; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Cook MA, 2003, HUM IMMUNOL, V64, P567, DOI 10.1016/S0198-8859(03)00042-9; Das J, 2015, IMMUNOL REV, V267, P214, DOI 10.1111/imr.12315; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; DeGiorgio M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004561; Dilthey A, 2015, NAT GENET, V47, P682, DOI 10.1038/ng.3257; Dorak MT, 2006, GENES IMMUN, V7, P450, DOI 10.1038/sj.gene.6364315; Garcia C.A., 2006, IMMUNOBIOLOGY HUMAN, P1203; Gargis AS, 2015, NAT BIOTECHNOL, V33, P689, DOI 10.1038/nbt.3237; Gendzekhadze K, 2009, P NATL ACAD SCI USA, V106, P18692, DOI 10.1073/pnas.0906051106; Gomez-Lozano N, 2002, TISSUE ANTIGENS, V59, P184, DOI 10.1034/j.1399-0039.2002.590302.x; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115; Hollenbach JA, 2016, GENES IMMUN, V17, P199, DOI 10.1038/gene.2016.5; Hollenbach JA, 2012, IMMUNOGENETICS, V64, P719, DOI 10.1007/s00251-012-0629-x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hou LH, 2011, IMMUNOGENETICS, V63, P549, DOI 10.1007/s00251-011-0536-6; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Isobe N, 2016, JAMA NEUROL, V73, P795, DOI 10.1001/jamaneurol.2016.0980; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; Kidd JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-262; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mack SJ, 2013, TISSUE ANTIGENS, V81, P194, DOI 10.1111/tan.12093; Mancusi A, 2015, BLOOD, V125, P3173, DOI 10.1182/blood-2014-09-599993; Marsh S.G.E., 1996, GENETIC DIVERSITY HL, P26; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; McLaren PJ, 2015, NAT IMMUNOL, V16, P577, DOI 10.1038/ni.3147; Mickelson E, 2006, IMM HUM MHC P 13 INT, P523; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Milius RP, 2013, TISSUE ANTIGENS, V82, P106, DOI 10.1111/tan.12150; Nemat-Gorgani N, 2014, IMMUNOGENETICS, V66, P597, DOI 10.1007/s00251-014-0794-1; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Norman PJ, 2015, IMMUNOGENETICS, V67, P479, DOI 10.1007/s00251-015-0857-y; Norman PJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003938; Norman PJ, 2009, GENOME RES, V19, P757, DOI 10.1101/gr.085738.108; PARHAM P, 1988, P NATL ACAD SCI USA, V85, P4005, DOI 10.1073/pnas.85.11.4005; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pelak K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001208; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; R Development Core Team, 2008, LANG ENV STAT COMP; Rajalingam R, 2004, J IMMUNOL, V172, P356, DOI 10.4049/jimmunol.172.1.356; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; Sambrook JG, 2005, GENOME RES, V15, P25, DOI 10.1101/gr.2381205; Shilling HG, 2002, J IMMUNOL, V168, P2307, DOI 10.4049/jimmunol.168.5.2307; Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Vierra-Green C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047491; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Vukcevic D, 2015, AM J HUM GENET, V97, P593, DOI 10.1016/j.ajhg.2015.09.005; WAGTMANN N, 1995, IMMUNITY, V2, P439, DOI 10.1016/1074-7613(95)90025-X; Watanabe Y, 1997, IMMUNOGENETICS, V46, P135, DOI 10.1007/s002510050252; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; YANG SY, 1987, IMMUNOBIOLOGY HLA, V1, P11; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	78	98	98	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 4	2016	99	2					375	391		10.1016/j.ajhg.2016.06.023	http://dx.doi.org/10.1016/j.ajhg.2016.06.023			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TO	27486779	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000381617200009
J	Kichaev, G; Pasaniuc, B				Kichaev, Gleb; Pasaniuc, Bogdan			Leveraging Functional-Annotation Data in Trans-ethnic Fine-Mapping Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSAL VARIANTS; GENETIC-VARIATION; CHROMATIN MARKS; COMMON; METAANALYSIS; LOCI; ARCHITECTURE; ASSOCIATION; IMPUTATION; SIGNALS	Localization of causal variants underlying known risk loci is one of the main research challenges following genome-wide association studies. Risk loci are typically dissected through fine-mapping experiments in trans-ethnic cohorts for leveraging the variability in the local genetic structure across populations. More recent works have shown that genomic functional annotations (i.e., localization of tissue-specific regulatory marks) can be integrated for increasing fine-mapping performance within single-population studies. Here, we introduce methods that integrate the strength of association between genotype and phenotype, the variability in the genetic backgrounds across populations, and the genomic map of tissue-specific functional elements to increase trans-ethnic fine-mapping accuracy. Through extensive simulations and empirical data, we have demonstrated that our approach increases fine-mapping resolution over existing methods. We analyzed empirical data from a large-scale trans-ethnic rheumatoid arthritis (RA) study and showed that the functional genetic architecture of RA is consistent across European and Asian ancestries. In these data, we used our proposed methods to reduce the average size of the 90% credible set from 29 variants per locus for standard non-integrative approaches to 22 variants.	[Kichaev, Gleb; Pasaniuc, Bogdan] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pasaniuc, B (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90095 USA.	pasaniuc@ucla.edu		Pasaniuc, Bogdan/0000-0002-0227-2056	NIH [R01-HG006399, R01-GM53275, R21-CA182821]; NATIONAL CANCER INSTITUTE [R21CA182821] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Alkes Price, Hillary Finucane, Robert Brown, Huwenbo Shi, and Nicholas Mancuso for helpful discussion and feedback on this work. This research was supported by NIH grants R01-HG006399, R01-GM53275, and R21-CA182821.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Chen W., 2015, GENETICS; Chung D., 2014, ARXIV14014764; Coram MA, 2013, AM J HUM GENET, V92, P904, DOI 10.1016/j.ajhg.2013.04.025; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2015, NAT BIOTECHNOL, V33, P364, DOI 10.1038/nbt.3157; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Franceschini N, 2012, AM J HUM GENET, V91, P744, DOI 10.1016/j.ajhg.2012.08.021; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Karczewski KJ, 2013, P NATL ACAD SCI USA, V110, P9607, DOI 10.1073/pnas.1219099110; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Liu CT, 2014, HUM MOL GENET, V23, P4738, DOI 10.1093/hmg/ddu183; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Marigorta UM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003566; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Ong RTH, 2012, EUR J HUM GENET, V20, P1300, DOI 10.1038/ejhg.2012.88; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Teo YY, 2010, GENET EPIDEMIOL, V34, P653, DOI 10.1002/gepi.20522; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tikhonov A. N, 1977, SOLUTIONS ILL POSED; Trynka G, 2013, CURR OPIN GENET DEV, V23, P635, DOI 10.1016/j.gde.2013.10.009; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Udler MS, 2009, HUM MOL GENET, V18, P1692, DOI 10.1093/hmg/ddp078; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang X, 2013, HUM MOL GENET, V22, P2303, DOI 10.1093/hmg/ddt064; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Zaitlen N, 2010, AM J HUM GENET, V86, P23, DOI 10.1016/j.ajhg.2009.11.016	54	98	98	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					260	271		10.1016/j.ajhg.2015.06.007	http://dx.doi.org/10.1016/j.ajhg.2015.06.007			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26189819	Green Published, Bronze			2022-12-18	WOS:000359328800006
J	Bonnen, PE; Yarham, JW; Besse, A; Wu, P; Faqeih, EA; Al-Asmari, AM; Saleh, MAM; Eyaid, W; Hadee, A; He, LP; Smith, F; Yau, S; Simcox, EM; Miwa, S; Donti, T; Abu-Amero, KK; Wong, LJ; Craigen, WJ; Graham, BH; Scott, KL; McFarland, R; Taylor, RW				Bonnen, Penelope E.; Yarham, John W.; Besse, Arnaud; Wu, Ping; Faqeih, Eissa A.; Al-Asmari, Ali Mohammad; Saleh, Mohammad A. M.; Eyaid, Wafaa; Hadee, Alrukban; He, Langping; Smith, Frances; Yau, Shu; Simcox, Eve M.; Miwa, Satomi; Donti, Taraka; Abu-Amero, Khaled K.; Wong, Lee-Jun; Craigen, William J.; Graham, Brett H.; Scott, Kenneth L.; McFarland, Robert; Taylor, Robert W.			Mutations in FBXL4 Cause Mitochondrial Encephalopathy and a Disorder of Mitochondrial DNA Maintenance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTEIN; FRAMEWORK; DEPLETION; DISEASE; FAMILY	Nuclear genetic disorders causing mitochondrial DNA (mtDNA) depletion are clinically and genetically heterogeneous, and the molecular etiology remains undiagnosed in the majority of cases. Through whole-exome sequencing, we identified recessive nonsense and splicing mutations in FBXL4 segregating in three unrelated consanguineous kindreds in which affected children present with a fatal encephalopathy, lactic acidosis, and severe mtDNA depletion in muscle. We show that FBXL4 is an F-box protein that colocalizes with mitochondria and that loss-of-function and splice mutations in this protein result in a severe respiratory chain deficiency, loss of mitochondrial membrane potential, and a disturbance of the dynamic mitochondrial network and nucleoid distribution in fibroblasts from affected individuals. Expression of the wild-type FBXL4 transcript in cell lines from two subjects fully rescued the levels of mtDNA copy number, leading to a correction of the mitochondrial biochemical deficit. Together our data demonstrate that mutations in FBXL4 are disease causing and establish FBXL4 as a mitochondrial protein with a possible role in maintaining mtDNA integrity and stability.	[Bonnen, Penelope E.; Besse, Arnaud; Wu, Ping; Donti, Taraka; Wong, Lee-Jun; Craigen, William J.; Graham, Brett H.; Scott, Kenneth L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bonnen, Penelope E.; Besse, Arnaud] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Yarham, John W.; He, Langping; Simcox, Eve M.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Faqeih, Eissa A.; Al-Asmari, Ali Mohammad; Saleh, Mohammad A. M.] King Fahad Med City, Childrens Hosp, Sect Med Genet, Riyadh 11525, Saudi Arabia; [Eyaid, Wafaa; Hadee, Alrukban] King Saud Bin Abdulaziz Univ Hlth & Sci, King Abdulaziz Med City, Dept Pediat, Riyadh 11426, Saudi Arabia; [Smith, Frances; Yau, Shu] Guys Hosp, Guys & St Thomas Serco Pathol, DNA Lab, London SE1 9RT, England; [Miwa, Satomi] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Abu-Amero, Khaled K.] King Saud Univ, Coll Med, Dept Ophthalmol, Ophthalm Genet Lab, Riyadh 11411, Saudi Arabia	Baylor College of Medicine; Baylor College of Medicine; Newcastle University - UK; King Fahad Medical City; King Saud Bin Abdulaziz University for Health Sciences; Guy's & St Thomas' NHS Foundation Trust; Newcastle University - UK; King Saud University	Bonnen, PE (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	pbonnen@bcm.edu; robert.taylor@ncl.ac.uk	Graham, Brett/R-8685-2018; Donti, Taraka/K-5648-2013	Graham, Brett/0000-0001-8451-8154; Donti, Taraka/0000-0002-3830-155X; Miwa, Satomi/0000-0002-1239-1198; McFarland, Robert/0000-0002-8833-2688	Texas Norman Hackerman Advanced Research Program [[THECB] 02006]; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health [AI036211, CA125123, RR024574]; NHARP [0049-0041-2009]; Medical Research Council (UK) Centenary Early Career Award; HEFCE/DoH Clinical Senior Lecturer Award; Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Specialist Commissioners; MRC [MR/K000608/1, G0800674, G0601943] Funding Source: UKRI; Medical Research Council [G0601943, MR/K000608/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098387] Funding Source: NIH RePORTER	Texas Norman Hackerman Advanced Research Program; Cytometry and Cell Sorting Core at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHARP; Medical Research Council (UK) Centenary Early Career Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HEFCE/DoH Clinical Senior Lecturer Award; Wellcome Trust Strategic Award(Wellcome Trust); MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lily Foundation; UK NHS Specialist Commissioners; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Texas Norman Hackerman Advanced Research Program under Grant No. [THECB] 02006, the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the National Institutes of Health (AI036211, CA125123, and RR024574), NHARP proposal number 0049-0041-2009 (P.E.B.), a Medical Research Council (UK) Centenary Early Career Award (J.W.Y.), an HEFCE/DoH Clinical Senior Lecturer Award (R.M.), a Wellcome Trust Strategic Award (096919/Z/11/Z) (R.W.T.), the MRC Centre for Neuromuscular Diseases (G0601943) (R.M. and R.W.T.), the Lily Foundation (R.M. and R.W.T.), and the UK NHS Specialist Commissioners that funds the "Rare Mitochondrial Disorders of Adults and Children" Diagnostic Service in Newcastle upon Tyne. We thank the families for participating in this study and Gavin Falkous and Joel Sederstrom for excellent technical support.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; BENNETT RL, 1995, AM J HUM GENET, V56, P745, DOI 10.1007/BF01408073; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296; Blakely E, 2008, NEUROMUSCULAR DISORD, V18, P557, DOI 10.1016/j.nmd.2008.04.014; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wong LJC, 2003, J MED GENET, V40	37	98	101	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					471	481		10.1016/j.ajhg.2013.07.017	http://dx.doi.org/10.1016/j.ajhg.2013.07.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23993193	Green Published, hybrid			2022-12-18	WOS:000330268900006
J	Shaheen, R; Faqeih, E; Sunker, A; Morsy, H; Al-Sheddi, T; Shamseldin, HE; Adly, N; Hashem, M; Alkuraya, FS				Shaheen, Ranad; Faqeih, Eissa; Sunker, Asma; Morsy, Heba; Al-Sheddi, Tarfa; Shamseldin, Hanan E.; Adly, Nouran; Hashem, Mais; Alkuraya, Fowzan S.			Recessive Mutations in DOCK6, Encoding the Guanidine Nucleotide Exchange Factor DOCK6, Lead to Abnormal Actin Cytoskeleton Organization and Adams-Oliver Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHO-GTPASES; GROWTH-FACTOR; RAC; CDC42; PROTEIN; ACTIVATION; OUTGROWTH; COMPLEX; APLASIA; BIOLOGY	Adams-Oliver syndrome (AOS) is defined by the combination of aplasia cutis congenita (ACC) and terminal transverse limb defects (TTLD). It is usually inherited as an autosomal-dominant trait, but autosomal-recessive inheritance has also been documented. In an individual with autosomal-recessive AOS, we combined autozygome analysis with exome sequencing to identify a homozygous truncating mutation in dedicator of cytokinesis 6 gene (DOCK6) which encodes an atypical guanidine exchange factor (GEF) known to activate two members of the Rho GTPase family: Cdc42 and Rac1. Another homozygous truncating mutation was identified upon targeted sequencing of DOCK6 in an unrelated individual with AOS. Consistent with the established role of Cdc42 and Rac1 in the organization of the actin cytoskeleton, we demonstrate a cellular phenotype typical of a defective actin cytoskeleton in patient cells. These findings, combined with a Dock6 expression profile that is consistent with an AOS phenotype as well as the very recent demonstration of dominant mutations of ARHGAP31 in AOS, establish Cdc42 and Rac1 as key molecules in the pathogenesis of AOS and suggest that other regulators of these Rho GTPase proteins might be good candidates in the quest to define the genetic spectrum of this genetically heterogeneous condition.	[Shaheen, Ranad; Sunker, Asma; Al-Sheddi, Tarfa; Shamseldin, Hanan E.; Adly, Nouran; Hashem, Mais; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Faqeih, Eissa] King Fahad Med City, Dept Pediat, Riyadh 11525, Saudi Arabia; [Morsy, Heba] Univ Alexandria, Med Res Inst, Dept Human Genet, Alexandria 21526, Egypt; [Alkuraya, Fowzan S.] King Saud Univ, Dept Pediat, King Khalid Univ Hosp, Riyadh 11411, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11411, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Fahad Medical City; Egyptian Knowledge Bank (EKB); Alexandria University; King Saud University; King Khalid University Hospital; King Saud University; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, POB 3354, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Alkuraya, Fowzan S./A-1542-2009	Alkuraya, Fowzan S./0000-0003-4158-341X; SHAHEEN, RANAD/0000-0002-2590-1759; Morsy, Heba/0000-0002-9047-0959	King Abdulaziz City for Science and Technology [09-MED941-20]; Dubai Harvard Foundation for Medical Research	King Abdulaziz City for Science and Technology; Dubai Harvard Foundation for Medical Research	We would like to express our deep appreciation to the family members for their enthusiastic and generous participation. We thank our Sequencing and Genomic Core Facilities at the King Faisal Specialist Hospital and Research Center. This study was supported in part by King Abdulaziz City for Science and Technology grant 09-MED941-20 (F.S.A.) as well as a Collaborative Research Grant from Dubai Harvard Foundation for Medical Research (F.S.A.).	Adams Forrest H., 1945, JOUR HEREDITY, V36, P3; Alkuraya FS, 2010, GENET MED, V12, P765, DOI 10.1097/GIM.0b013e3181fbfcc4; Blasius AL, 2009, P NATL ACAD SCI USA, V106, P2706, DOI 10.1073/pnas.0813208106; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hopyan S, 2011, DEV DYNAM, V240, P1054, DOI 10.1002/dvdy.22601; Ilkovski B, 2001, AM J HUM GENET, V68, P1333, DOI 10.1086/320605; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kolluri R, 1996, P NATL ACAD SCI USA, V93, P5615, DOI 10.1073/pnas.93.11.5615; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Papadopoulou E, 2008, AM J MED GENET A, V146A, P2545, DOI 10.1002/ajmg.a.32410; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Shaheen R, 2011, HUM MUTAT, V32, P573, DOI 10.1002/humu.21507; Snape KMG, 2009, AM J MED GENET A, V149A, P1860, DOI 10.1002/ajmg.a.32708; Southgate L, 2011, AM J HUM GENET, V88, P574, DOI 10.1016/j.ajhg.2011.04.013; Suchy SF, 2002, AM J HUM GENET, V71, P1420, DOI 10.1086/344517; Suzuki D, 2009, DEV BIOL, V335, P396, DOI 10.1016/j.ydbio.2009.09.014; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Tcherkezian J, 2006, BIOL CELL, V98, P445, DOI 10.1042/BC20050101; Temtamy SA, 2007, CLIN DYSMORPHOL, V16, P141, DOI 10.1097/MCD.0b013e3280f9df22; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.E05-10-0955; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; WHITLEY CB, 1991, AM J MED GENET, V40, P319, DOI 10.1002/ajmg.1320400315; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zehnaly Armen, 2007, J Calif Dent Assoc, V35, P865; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	37	98	107	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					328	333		10.1016/j.ajhg.2011.07.009	http://dx.doi.org/10.1016/j.ajhg.2011.07.009			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21820096	Bronze, Green Published			2022-12-18	WOS:000294148800014
J	Sirmaci, A; Walsh, T; Akay, H; Spiliopoulos, M; Sakalar, YB; Hasanefendioglu-Bayrak, A; Duman, D; Farooq, A; King, MC; Tekin, M				Sirmaci, Asli; Walsh, Tom; Akay, Hatice; Spiliopoulos, Michail; Sakalar, Yildirim Bayezit; Hasanefendioglu-Bayrak, Aylin; Duman, Duygu; Farooq, Amjad; King, Mary-Claire; Tekin, Mustafa			MASP1 Mutations in Patients with Facial, Umbilical, Coccygeal, and Auditory Findings of Carnevale, Malpuech, OSA, and Michels Syndromes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEARING-LOSS; SUBSTRATE SPECIFICITIES; CLEFTING SYNDROME; ANTERIOR-CHAMBER; SERINE-PROTEASE; LID ANOMALIES; 3MC SYNDROME; 2 SIBS; BINDING; GROWTH	Distinctive facial features consisting of hypertelorism, telecanthus, blepharophimosis blepharoptosis, epicanthus inversus, periumbil seal defects, and skeletal anomalies are seen in autosomal recessive Carnevale, Malpuech, Michels, and oculo skeletal abdominal (OSA) syndromes The gene or genes responsible for these syndromes were heretofore unknown We report on three individuals from two consanguineous Turkish families with findings characteristic of these syndromes including facial dysmorphism periumbilical depression mixed hearing loss, radioulnar synostosis and coccygeal appendage Homozygosity mapping yielded an autozygous region on chromosome 3q27 in both families In one family, whole exome sequencing revealed a missense mutation, MASP1 c 2059G>A (p G687R) that cosegregated with the phenotype In the second family, Sanger sequencing of MASP1 revealed a nonsense mutation, MASP1 c 870G>A (p W290X) that also cosegregated with the phenotype Neither mutation was found in 192 Turkish controls or 1200 controls of various other ancestries MASP1 encodes mannan binding lectin senne protease 1 The two mutations occur in a MASP1 isoform that has been reported to process IGFBP 5 thereby playing a critical role in insulin growth factor availability during craniofacial and muscle development These results implicate mutations of MASP1 as the cause of a human malformation syndrome and demonstrate the involvement of MASP1 in facial, umbilical, and ear development during the embryonic period	[Sirmaci, Asli; Spiliopoulos, Michail; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Sirmaci, Asli; Spiliopoulos, Michail; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Walsh, Tom; King, Mary-Claire] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Walsh, Tom; King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Akay, Hatice] Veni Vidi Hosp, Radiodiagnost Unit, TR-21100 Diyarbakir, Turkey; [Sakalar, Yildirim Bayezit] Dicle Univ, Sch Med, Dept Ophthalmol, TR-21280 Diyarbakir, Turkey; [Hasanefendioglu-Bayrak, Aylin] Dicle Univ, Sch Med, Dept Radiol, TR-21280 Diyarbakir, Turkey; [Duman, Duygu] Ankara Univ, Div Pediat Genet, Sch Med, TR-06100 Ankara, Turkey; [Farooq, Amjad] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Veni Vidi Hospital; Dicle University; Dicle University; Ankara University; University of Miami	Tekin, M (corresponding author), Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA.		Akay, Hatice/AAD-8547-2021; Tekin, Mustafa/ABG-7627-2020; duman, duygu/AAF-8093-2020; Duman, Duygu/AAG-7765-2019; Farooq, Amjad/B-5084-2012; Spiliopoulos, Michail/AAK-7087-2020	Akay, Hatice/0000-0002-0854-0904; duman, duygu/0000-0001-7583-0349; Spiliopoulos, Michail/0000-0003-1277-7477; King, Mary-Claire/0000-0001-9426-1743; Walsh, Tom/0000-0002-8875-0310; Tekin, Mustafa/0000-0002-3525-7960	National Institutes of Health [R01DC009645, R01DC005641, R01GM083897]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009645, R01DC005641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors are grateful to Fatos Yalcinkaya and Suat Fitoz at Ankara University School of Medicine for clinical and radiological evaluation and to Ming K L e and Anne M Thornton at the University of Washington for advice and assistance This work was supported in part by National Institutes of Health grants R01DC009645, R01DC005641, and R01GM083897, with a supplement from the American Recovery and Reinvestment Act	Al Kaissi A, 2007, AM J MED GENET A, V143A, P349, DOI 10.1002/ajmg.a.31610; ALMEIDA MLG, 1995, AM J MED GENET, V57, P377; ALMEIDA MLG, 1995, AM J MED GENET, V58, P13; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Bobola N, 2008, GENESIS, V46, P52, DOI 10.1002/dvg.20360; CARNEVALE F, 1989, AM J MED GENET, V33, P186, DOI 10.1002/ajmg.1320330210; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chinen Y, 1995, JPN J HUM GENET, V40, P335, DOI 10.1007/BF01900601; Cortesio CL, 2006, ARCH BIOCHEM BIOPHYS, V449, P164, DOI 10.1016/j.abb.2006.02.006; Crisponi G, 1999, AM J MED GENET, V86, P294, DOI 10.1002/(SICI)1096-8628(19990917)86:3<294::AID-AJMG20>3.0.CO;2-2; CUNNIFF C, 1990, AM J MED GENET, V37, P28, DOI 10.1002/ajmg.1320370108; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; DELAPAZ MA, 1991, AM J OPHTHALMOL, V112, P572, DOI 10.1016/S0002-9394(14)76861-8; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; HALL JG, 2007, HDB PHYS MEASUREMENT, P127; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460; Leal GF, 2008, AM J MED GENET A, V146A, P1059, DOI 10.1002/ajmg.a.32252; Leal GF, 2007, AM J MED GENET A, V143A, P2747, DOI 10.1002/ajmg.a.32029; MALPUECH G, 1983, AM J MED GENET, V16, P475, DOI 10.1002/ajmg.1320160405; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; MICHELS VV, 1978, J PEDIATR-US, V93, P444, DOI 10.1016/S0022-3476(78)81154-8; Mingarelli R, 1996, J MED GENET, V33, P884, DOI 10.1136/jmg.33.10.884; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; Priolo M, 2007, EUR J MED GENET, V50, P139, DOI 10.1016/j.ejmg.2006.10.004; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Salih DAM, 2004, P NATL ACAD SCI USA, V101, P4314, DOI 10.1073/pnas.0400230101; Sirmaci A, 2010, AM J HUM GENET, V86, P797, DOI 10.1016/j.ajhg.2010.04.004; Titomanlio L, 2005, AM J MED GENET A, V137A, P332, DOI 10.1002/ajmg.a.30878; TREDERIKSE WSK, 2005, AM J MED GENET, V134, P450; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010	33	98	104	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					679	686		10.1016/j.ajhg.2010.09.018	http://dx.doi.org/10.1016/j.ajhg.2010.09.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21035106	Green Published, Bronze			2022-12-18	WOS:000284668400014
J	Antonicka, H; Ostergaard, E; Sasarman, F; Weraarpachai, W; Wibrand, F; Pedersen, AMB; Rodenburg, RJ; van der Knaap, MS; Smeitink, JAM; Chrzanowska-Lightowlers, ZM; Shoubridge, EA				Antonicka, Hana; Ostergaard, Elsebet; Sasarman, Florin; Weraarpachai, Woranontee; Wibrand, Flemming; Pedersen, Anne Marie B.; Rodenburg, Richard J.; van der Knaap, Marjo S.; Smeitink, Jan A. M.; Chrzanowska-Lightowlers, Zofia M.; Shoubridge, Eric A.			Mutations in C12orf65 in Patients with Encephalomyopathy and a Mitochondrial Translation Defect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER-RNA HYDROLASE; BLUE-NATIVE-ELECTROPHORESIS; RIBOSOME RECYCLING FACTOR; TERMINATION CODONS UAA; CYTOCHROME-C-OXIDASE; PROTEIN-BIOSYNTHESIS; LEIGH-SYNDROME; I-TASSER; COMPLEXES; IDENTIFICATION	We investigated the genetic basis for a global and uniform decrease in mitochondrial translation in fibroblasts from patients in two unrelated pedigrees who developed Leigh syndrome, optic atrophy, and ophthalmoplegia. Analysis of the assembly of the oxidative phosphorylation complexes showed severe decreases of complexes I, IV, and V and a smaller decrease in complex III. The steady-state levels of mitochondrial mRNAs, tRNAs, and rRNAs were not reduced, nor were those of the mitochondrial translation elongation factors or the protein components of the mitochondrial ribosome. Using homozygosity mapping, we identified a 1 bp deletion in C12orf65 in one patient, and DNA sequence analysis showed a different 1 bp deletion in the second patient. Both mutations predict the same premature stop codon. C12orf65 belongs to a family of four mitochondrial class I peptide release factors, which also includes mtRF1a, mtRF1, and Ict1, all characterized by the presence of a GGQ motif at the active site. However, C12orf65 does not exhibit peptidyl-tRNA hydrolase activity in an in vitro assay with bacterial ribosomes. We suggest that it might play a role in recycling abortive peptidyl-tRNA species, released from the ribosome during the elongation phase of translation.	[Antonicka, Hana; Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Ostergaard, Elsebet; Wibrand, Flemming] Rigshosp, Natl Univ Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Pedersen, Anne Marie B.] Glostrup Cty Hosp, Dept Pediat, DK-2600 Glostrup, Denmark; [Rodenburg, Richard J.; Smeitink, Jan A. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [van der Knaap, Marjo S.] Vrije Univ Amsterdam Med Ctr, Dept Pediat, NL-1081 HV Amsterdam, Netherlands; [Chrzanowska-Lightowlers, Zofia M.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	McGill University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Newcastle University - UK	Shoubridge, EA (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	eric@ericpc.mni.mcgill.ca	Rodenburg, Richard/N-3579-2014; Smeitink, Jan A.M./D-6064-2011; Smeitink, Jan/C-1351-2013	Rodenburg, Richard/0000-0001-5227-3527; Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152; Antonicka, Hana/0000-0002-2525-2867	Canadian Institutes of Health Research; Danish Council for Independent Research Medical Sciences; Biotechnology and Biological Sciences Research Council [BB/F011520/1]; Medical Research Council [G0700718B] Funding Source: researchfish; BBSRC [BB/F011520/1] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the families for their participation. We thank Timothy Johns for help with cell culture and immunocytochemistry. This work was supported by grants from the Canadian Institutes of Health Research to E.A.S. and the Danish Council for Independent Research Medical Sciences to E.O. Z.M.C.L. would like to thank the Biotechnology and Biological Sciences Research Council (BB/F011520/1) for continuing support. E.A.S. is an International Scholar of the Howard Hughes Medical Institute.	Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jiang LH, 2009, J MOL BIOL, V386, P1357, DOI 10.1016/j.jmb.2008.10.079; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Nozaki Y, 2008, GENES CELLS, V13, P429, DOI 10.1111/j.1365-2443.2008.01181.x; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Petry S, 2008, CURR OPIN STRUC BIOL, V18, P70, DOI 10.1016/j.sbi.2007.11.005; Richter R, 2010, EMBO J, V29, P1116, DOI 10.1038/emboj.2010.14; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576; Rosas-Sandoval G, 2002, P NATL ACAD SCI USA, V99, P16707, DOI 10.1073/pnas.222659199; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031; Spremulli LL, 2004, PROG NUCLEIC ACID RE, V77, P211, DOI 10.1016/S0079-6603(04)77006-3; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang YL, 1998, BBA-GENE STRUCT EXPR, V1443, P245, DOI 10.1016/S0167-4781(98)00223-1; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	29	98	103	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					115	122		10.1016/j.ajhg.2010.06.004	http://dx.doi.org/10.1016/j.ajhg.2010.06.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598281	Green Published, Bronze			2022-12-18	WOS:000280029200012
J	Zhang, F; Seeman, P; Liu, PF; Weterman, MAJ; Gonzaga-Jauregui, C; Towne, CF; Batish, SD; De Vriendt, E; De Jonghe, P; Rautenstrauss, B; Krause, KH; Khajavi, M; Posadka, J; Vandenberghe, A; Palau, F; Van Maldergem, L; Baas, F; Timmerman, V; Lupski, JR				Zhang, Feng; Seeman, Pavel; Liu, Pengfei; Weterman, Marian A. J.; Gonzaga-Jauregui, Claudia; Towne, Charles F.; Batish, Sat Dev; De Vriendt, Els; De Jonghe, Peter; Rautenstrauss, Bernd; Krause, Klaus-Henning; Khajavi, Mehrdad; Posadka, Jan; Vandenberghe, Antoon; Palau, Francesc; Van Maldergem, Lionel; Baas, Frank; Timmerman, Vincent; Lupski, James R.			Mechanisms for Nonrecurrent Genomic Rearrangements Associated with CMT1A or HNPP: Rare CNVs as a Cause for Missing Heritability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TOOTH DISEASE TYPE-1A; SEGMENTAL DUPLICATIONS; COMPLEX REARRANGEMENTS; HEREDITARY NEUROPATHY; DNA; GENE; RECOMBINATION; ARCHITECTURE; EXPRESSION; DISORDERS	Genomic rearrangements involving the peripheral myelin protein gene (PMP22) in human chromosome 17p12 are associated with neuropathy: duplications cause Charcot-Marie-Tooth disease type IA (CMT1A), whereas deletions lead to hereditary neuropathy with liability to pressure palsies (HNPP). Our previous studies showed that >99% of these rearrangements are recurrent and mediated by nonallelic homologous recombination (NAHR). Rare copy number variations (CNVs) generated by nonrecurrent rearrangements also exist in 17p12, but their underlying mechanisms are not well understood. We investigated 21 subjects with rare CNVs associated with CMT1A or HNPP by oligonucleotide-based comparative genomic hybridization microarrays and breakpoint sequence analyses, and we identified 17 unique CNVs, including two genomic deletions, ten genomic duplications, two complex rearrangements, and three small exonic deletions. Each of these CNVs includes either the entire PMP22 gene, or exon(s) only, or ultraconserved potential regulatory sequences upstream of PMP22, further supporting the contention that PMP22 is the critical gene mediating the neuropathy phenotypes associated with 17p12 rearrangements. Breakpoint sequence analysis reveals that, different from the predominant NAHR mechanism in recurrent rearrangement, various molecular mechanisms, including nonhomologous end joining, Alu-Alu-mediated recombination, and replication-based mechanisms (e.g., FoSTeS and/or MMBIR), can generate nonrecurrent 17p12 rearrangements associated with neuropathy. We document a multitude of ways in which gene function can be altered by CNVs. Given the characteristics, including small size, structural complexity, and location outside of coding regions, of selected rare CNVs, their identification remains a challenge for genome analysis. Rare CNVs may potentially represent an important portion of "missing heritability" for human diseases.	[Zhang, Feng; Liu, Pengfei; Gonzaga-Jauregui, Claudia; Khajavi, Mehrdad; Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zhang, Feng] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Feng] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Zhang, Feng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Seeman, Pavel; Posadka, Jan] Charles Univ Prague, Dept Child Neurol, DNA Lab, Sch Med 2, Prague 15006 5, Czech Republic; [Seeman, Pavel; Posadka, Jan] Univ Hosp Motol, Prague 15006 5, Czech Republic; [Weterman, Marian A. J.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Neurogenet Lab, NL-1105 AZ Amsterdam, Netherlands; [Towne, Charles F.; Batish, Sat Dev] Athena Diagnosit Inc, Worcester, MA 01605 USA; [De Vriendt, Els; De Jonghe, Peter; Timmerman, Vincent] Univ Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; [De Vriendt, Els; De Jonghe, Peter; Timmerman, Vincent] Univ Antwerp, B-2610 Antwerp, Belgium; [Rautenstrauss, Bernd] Ctr Med Genet, D-80335 Munich, Germany; [Rautenstrauss, Bernd; Krause, Klaus-Henning] Univ Munich, Friedrich Baur Inst, D-80336 Munich, Germany; [Vandenberghe, Antoon] Biomnis Inc, F-69357 Lyon, France; [Palau, Francesc] CSIC, Inst Biomed, Valencia 46010, Spain; [Palau, Francesc] CIBERER, Valencia 46010, Spain; [Van Maldergem, Lionel] Univ Liege, Ctr Genet Humaine, B-4000 Liege, Belgium; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Fudan University; Fudan University; Fudan University; Charles University Prague; Motol University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Liege; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Palau, Francesc/A-9391-2014; Gonzaga-Jauregui, Claudia/H-4752-2019; Baas, Frank/F-9574-2010; Zhang, Feng/C-7735-2009; Sander-Effron, Samuel/AAX-2231-2020; Timmerman, Vincent/O-7283-2019; Van Maldergem, Lionel/O-3242-2019; Resource Center, NINDS Human Genetics/AGF-2474-2022; Van Maldergem, Lionel/G-9849-2017	Palau, Francesc/0000-0002-8635-5421; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Baas, Frank/0000-0003-3912-5428; Zhang, Feng/0000-0003-4556-8276; Timmerman, Vincent/0000-0002-2162-0933; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Rautenstrauss, Bernd/0000-0001-5099-7476	National Institute of Neurological Disorders and Stroke (NINDS, NIH) [R01NS058529]; Texas Children's Hospital General Clinical Research Center (GCRC) [M01RR00188]; Intellectual and Developmental Disabilities Research Centers (IDDRC) [P30HD024064]; Shanghai Pujiang Program; Ministry of Education of China [NCET-09-0322]; Ministry of Health of Czech Republic [IGA NS 10554-3]; University of Antwerp; FWO-Flanders; Belgian Federal Science Policy Office (BEL-SPO) [P6/43]; BMBF [01ES0815]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010554, R01NS058529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS, NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Texas Children's Hospital General Clinical Research Center (GCRC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Intellectual and Developmental Disabilities Research Centers (IDDRC); Shanghai Pujiang Program(Shanghai Pujiang Program); Ministry of Education of China(Ministry of Education, China); Ministry of Health of Czech Republic(Ministry of Health, Czech Republic); University of Antwerp; FWO-Flanders(FWO); Belgian Federal Science Policy Office (BEL-SPO)(Belgian Federal Science Policy Office); BMBF(Federal Ministry of Education & Research (BMBF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all participating subjects and families for their kind cooperation in the study. We also thank Drs. E. Ehler, V. Farhanova, R. Mazanec, and J. Zvolska for sending patients to the CMT1A DNA diagnostics. This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS, NIH) grant R01NS058529 to J.R.L.; Texas Children's Hospital General Clinical Research Center (GCRC) grant M01RR00188; and Intellectual and Developmental Disabilities Research Centers (IDDRC) grant P30HD024064. F.Z. is supported by Shanghai Pujiang Program and the Ministry of Education of China grant NCET-09-0322. P.S. is supported by Ministry of Health of Czech Republic grant IGA NS 10554-3. P.D.J. and V.T. are supported by a Methusalem grant of the University of Antwerp, the Fund for Scientific Research (FWO-Flanders), and the Interuniversity Attraction Poles program (P6/43) of the Belgian Federal Science Policy Office (BEL-SPO). B.R. is supported by the BMBF grant 01ES0815. J.R.L. is a consultant for Athena Diagnostics, 23andMe, and Ion Torrent Systems Inc., and holds multiple US and European patents for DNA diagnostics. Furthermore, the Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular diagnostic testing (Medical Genetics Laboratories).	Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Chen JM, 2005, HUM MUTAT, V26, P125, DOI 10.1002/humu.20202; Chen JM, 2005, HUM MUTAT, V25, P207, DOI 10.1002/humu.20133; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Gajecka M, 2008, GENOME RES, V18, P1733, DOI 10.1101/gr.077453.108; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; Kang SHL, 2010, AM J MED GENET A, V152A, P1111, DOI 10.1002/ajmg.a.33278; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lupski JR, 2009, GENOME MED, V1, DOI 10.1186/gm42; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lupski JR, 2005, PERIPHERAL NEUROPATH, P1659, DOI DOI 10.1016/B978-0-7216-9491-7.50073-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Roy A, 2004, MOL REPROD DEV, V67, P295, DOI 10.1002/mrd.20025; Seeman P, 2000, INT J MOL MED, V6, P421; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2010, AM J MED GENET A, V152A, P1089, DOI 10.1002/ajmg.a.33216; Timmerman V, 1997, J MED GENET, V34, P43, DOI 10.1136/jmg.34.1.43; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; Vissers LELM, 2009, HUM MOL GENET, V18, P3579, DOI 10.1093/hmg/ddp306; Voineagu I, 2008, P NATL ACAD SCI USA, V105, P9936, DOI 10.1073/pnas.0804510105; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Weterman MAJ, 2010, EUR J HUM GENET, V18, P421, DOI 10.1038/ejhg.2009.186; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	54	98	102	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 11	2010	86	6					892	903		10.1016/j.ajhg.2010.05.001	http://dx.doi.org/10.1016/j.ajhg.2010.05.001			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	613AT	20493460	Green Published, Bronze			2022-12-18	WOS:000278948900007
J	Klopocki, E; Hennig, BP; Dathe, K; Koll, R; de Ravel, T; Baten, E; Blom, E; Gillerot, Y; Weigel, JFW; Kruger, G; Hiort, O; Seemann, P; Mundlos, S				Klopocki, Eva; Hennig, Bianca P.; Dathe, Katarina; Koll, Randi; de Ravel, Thomy; Baten, Emiel; Blom, Eveline; Gillerot, Yves; Weigel, Johannes F. W.; Krueger, Gabriele; Hiort, Olaf; Seemann, Petra; Mundlos, Stefan			Deletion and Point Mutations of PTHLH Cause Brachydactyly Type E	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HORMONE-RELATED PEPTIDE; ENDOCHONDRAL BONE-FORMATION; MESSENGER-RNA SURVEILLANCE; PARATHYROID-HORMONE; INDIAN HEDGEHOG; HEREDITARY OSTEODYSTROPHY; PTH/PTHRP RECEPTOR; GROWTH-PLATE; PROTEIN; DIFFERENTIATION	Autosomal-dominant brachydactyly type E (BDE) is a congenital limb malformation characterized by small hands and feet predominantly as a result of shortened metacarpals and metatarsals. In a large pedigree with BIDE, short stature, and learning disabilities, we detected a microdeletion of similar to 900 kb encompassing PTHLH, the gene coding for parathyroid hormone related protein (PTHRP). PTHRP is known to regulate the balance between chondrocyte proliferation and the onset of hypertrophic differentiation during endochondral bone development. Inactivation of Pthrp in mice results in short-limbed dwarfism because of premature differentiation of chondrocyte. On the basis of our initial finding, we tested further individuals with BDE and short stature for mutations in PTHLH. We identified two missense (L44P and L60P), a nonstop (X178WextX*54), and a nonsense (K120X) mutation. The missense mutation L60P was tested in chicken micromass culture with the replication-competent avian sarcoma leukosis virus retroviral expression system and was shown to result in a loss of function. Thus, loss-of-function mutations in PTHLH cause BDE with short stature.	[Klopocki, Eva; Hennig, Bianca P.; Dathe, Katarina; Koll, Randi; Mundlos, Stefan] Charite, Inst Med Genet, D-13353 Berlin, Germany; [de Ravel, Thomy] Katholieke Univ Leuven Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; [Baten, Emiel] AZ St Lucas, B-8310 Brugge, Belgium; [Blom, Eveline] Maastricht Univ Ctr, Dept Clin Genet, NL-6200 Maastricht, Netherlands; [Gillerot, Yves] Clin Univ St Luc, Ctr Genet Humaine, B-1200 Brussels, Belgium; [Weigel, Johannes F. W.] Univ Childrens Hosp, D-04103 Leipzig, Germany; [Krueger, Gabriele] Univ Klinikum Rostock, Abt Med Genet, D-18057 Rostock, Germany; [Hiort, Olaf] Med Univ Lubeck, Dept Pediat, D-23538 Lubeck, Germany; [Seemann, Petra; Mundlos, Stefan] Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Klopocki, Eva; Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Maastricht University; Maastricht University Medical Centre (MUMC); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Rostock; University of Lubeck; Max Planck Society	Mundlos, S (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	stefan.mundlos@charite.de	Seemann, Petra/G-3606-2011; Klopocki, Eva/B-6823-2017; Mundlos, Stefan/ABH-9585-2020	Seemann, Petra/0000-0002-6056-6669; Klopocki, Eva/0000-0003-1438-2081; Dathe, Katarina/0000-0002-8674-5817; Mundlos, Stefan/0000-0002-9788-3166; Hennig, Bianca/0000-0002-7733-8160; de Ravel, Thomy/0000-0002-3361-3781	Deutsche Forschungsgemeinschaft [2158/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	we thank the graduate students Nicola Diny and Yu Qian who assisted us in this project during their human genetics module and Mareen Schmidt-von Kegler for technical assistance in micromass experiments. We are grateful to the patients and their families for participating in this study. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; KL 2158/2-1) to E.K., K.D., and S.M. The authors declare no conflict of interest.	Ahrens W, 2001, J CLIN ENDOCR METAB, V86, P4630, DOI 10.1210/jc.86.10.4630; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Bahring S, 2008, HYPERTENSION, V51, P426, DOI 10.1161/HYPERTENSIONAHA.107.101774; Bahring S, 1997, AM J HUM GENET, V60, P732; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Chatr-aryamontri A, 2004, HUM MUTAT, V24, P526, DOI 10.1002/humu.20117; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Guo J, 2006, DEV BIOL, V292, P116, DOI 10.1016/j.ydbio.2005.12.044; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Johnson D, 2003, AM J HUM GENET, V72, P984, DOI 10.1086/374721; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Klopocki E, 2008, J MED GENET, V45, P370, DOI 10.1136/jmg.2007.055699; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lo Muzio L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-32; Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Mundlos S, 2009, CLIN GENET, V76, P123, DOI 10.1111/j.1399-0004.2009.01238.x; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Philbrick WM, 1998, P NATL ACAD SCI USA, V95, P11846, DOI 10.1073/pnas.95.20.11846; Schuster H, 1996, NAT GENET, V13, P98, DOI 10.1038/ng0596-98; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wagner E, 2002, J CELL SCI, V115, P3033; Weir EC, 1996, P NATL ACAD SCI USA, V93, P10240, DOI 10.1073/pnas.93.19.10240; WILSON LC, 1995, AM J HUM GENET, V56, P400	34	98	103	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					434	439		10.1016/j.ajhg.2010.01.023	http://dx.doi.org/10.1016/j.ajhg.2010.01.023			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20170896	Green Published, Bronze			2022-12-18	WOS:000275678800014
J	Dundar, M; Muller, T; Zhang, Q; Pan, J; Steinmann, B; Vodopiutz, J; Gruber, R; Sonoda, T; Krabichler, B; Utermann, G; Baenziger, JU; Zhang, LJ; Janecke, AR				Duendar, Munis; Mueller, Thomas; Zhang, Qi; Pan, Jing; Steinmann, Beat; Vodopiutz, Julia; Gruber, Robert; Sonoda, Tohru; Krabichler, Birgit; Utermann, Gerd; Baenziger, Jacques U.; Zhang, Lijuan; Janecke, Andreas R.			Loss of Dermatan-4-Sulfotransferase 1 Function Results in Adducted Thumb-Clubfoot Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; DERMATAN SULFATE; TENASCIN-X; CHONDROITIN/DERMATAN SULFATE; TARGETED DISRUPTION; MOLECULAR-CLONING; FINE-STRUCTURE; HYBRID CHAINS; FOOT SYNDROME; GLYCOSAMINOGLYCAN	Adducted thumb-clubfoot syndrome is an autosomal-recessive disorder characterized by typical facial appearance, wasted build, thin and translucent skin, congenital contractures of thumbs and feet, joint instability, facial clefting, and coagulopathy, as well as heart, kidney, or intestinal defects. We elucidated the molecular basis of the disease by using a SNP array-based genome-wide linkage approach that identified distinct homozygous nonsense and missense mutations in CHST14 in each of four consanguineous families with this disease. The CHST14 gene encodes N-acetylgalactosamine 4-O-sulfotransferase 1 (D4ST1), which catalyzes 4-O sulfation of N-acetylgalactosamine in the repeating iduronic acid-alpha 1,3-N-acetylgalactosamine disaccharide sequence to form dermatan sulfate. Mass spectrometry of glycosaminoglycans from a patient's fibroblasts revealed absence of dermatan sulfate and excess of chondroitin sulfate, showing that 4-O sulfation by CHST14 is essential for dermatan sulfate formation in vivo. Our results indicate that adducted thumb-clubfoot syndrome is a disorder resulting from a defect specific to dermatan sulfate biosynthesis and emphasize roles for dermatan sulfate in human development and extracellular-matrix maintenance.	[Mueller, Thomas; Janecke, Andreas R.] Innsbruck Med Univ, Dept Pediat 2, A-6020 Innsbruck, Austria; [Duendar, Munis] Erciyes Univ, Dept Med Genet, TR-38039 Kayseri, Turkey; [Zhang, Qi; Pan, Jing; Baenziger, Jacques U.; Zhang, Lijuan] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Steinmann, Beat] Univ Childrens Hosp Zurich, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland; [Vodopiutz, Julia] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria; [Gruber, Robert] Innsbruck Med Univ, Dept Dermatol, A-6020 Innsbruck, Austria; [Sonoda, Tohru] Kyushu Univ Hlth & Welf, Dept Occupat Therapy, Miyazaki 8828508, Japan; [Krabichler, Birgit; Utermann, Gerd; Janecke, Andreas R.] Innsbruck Med Univ, Div Clin Genet, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Erciyes University; Washington University (WUSTL); University Children's Hospital Zurich; Medical University of Vienna; Medical University of Innsbruck; Medical University of Innsbruck	Janecke, AR (corresponding author), Innsbruck Med Univ, Dept Pediat 2, A-6020 Innsbruck, Austria.	andreas.janecke@i-med.ac.at	Vodopiutz, Julia/AAR-4425-2020; Janecke, Andreas/AAA-5227-2019; Dundar, Munis/B-3150-2011; Baenziger, Jacques U/E-9430-2012	Dundar, Munis/0000-0003-0969-4611; Vodopiutz, Julia/0000-0002-8087-7026; Janecke, Andreas/0000-0001-7155-0315	Dr.-Legerlotz-Stiftung and the Jubilaumsfonds der Osterreichischen Nationalbank [12255]; National Institutes of Health [R01GM069968, R01DK41738]; Swiss National Science Foundation [3200B0109370/1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069968] Funding Source: NIH RePORTER	Dr.-Legerlotz-Stiftung and the Jubilaumsfonds der Osterreichischen Nationalbank; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The technical support of Gabriele Rammesmayer is greatly acknowledged. This work was supported by grants from the Dr.-Legerlotz-Stiftung and the Jubilaumsfonds der Osterreichischen Nationalbank (grant no. 12255 to ARJ), the National Institutes of Health Grants R01GM069968 (to L.Z.) and R01DK41738 (to J.U.B.), and the Swiss National Science Foundation 3200B0109370/1 (to B.S.).	Akama TO, 2000, NAT GENET, V26, P237, DOI 10.1038/79987; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Castanon MM, 2007, THROMB RES, V120, P745, DOI 10.1016/j.thromres.2006.12.014; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dundar M, 2001, CLIN DYSMORPHOL, V10, P291, DOI 10.1097/00019605-200110000-00012; Dundar M, 1997, CLIN GENET, V51, P61; Elefteriou F, 2001, FEBS LETT, V495, P44, DOI 10.1016/S0014-5793(01)02361-4; Evers MR, 2001, J BIOL CHEM, V276, P36344, DOI 10.1074/jbc.M105848200; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; GREEN ED, 1985, P NATL ACAD SCI USA, V82, P7850, DOI 10.1073/pnas.82.23.7850; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hou S, 2007, DEV CELL, V13, P226, DOI 10.1016/j.devcel.2007.07.001; Janecke AR, 2001, J MED GENET, V38, P265, DOI 10.1136/jmg.38.4.265; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lethias C, 2006, FEBS LETT, V580, P6281, DOI 10.1016/j.febslet.2006.10.037; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Morava E, 2005, EUR J HUM GENET, V13, P414, DOI 10.1038/sj.ejhg.5201361; Pacheco B, 2009, J BIOL CHEM, V284, P9788, DOI 10.1074/jbc.M809339200; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; ROSENBERG LC, 1985, J BIOL CHEM, V260, P6304; Sonoda T, 2000, AM J MED GENET, V91, P280, DOI 10.1002/(SICI)1096-8628(20000410)91:4<280::AID-AJMG8>3.0.CO;2-B; Studelska DR, 2009, J BIOL CHEM, V284, P2354, DOI 10.1074/jbc.M806458200; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tiedemann K, 2005, GLYCOBIOLOGY, V15, P1277, DOI 10.1093/glycob/cwj027; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Vicente CP, 2004, BLOOD, V104, P3965, DOI 10.1182/blood-2004-02-0598; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746	46	98	101	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					873	882		10.1016/j.ajhg.2009.11.010	http://dx.doi.org/10.1016/j.ajhg.2009.11.010			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004762	Bronze, Green Published			2022-12-18	WOS:000272797100010
J	El-Sayed, W; Parry, DA; Shore, RC; Ahmed, M; Jafri, H; Rashid, Y; Al-Bahlani, S; Al Harasi, S; Kirkham, J; Inglehearn, CF; Mighell, AJ				El-Sayed, Walid; Parry, David A.; Shore, Roger C.; Ahmed, Mushtaq; Jafri, Hussain; Rashid, Yasmin; Al-Bahlani, Suhaila; Al Harasi, Sharifa; Kirkham, Jennifer; Inglehearn, Chris F.; Mighell, Alan J.			Mutations in the Beta Propeller WDR72 Cause Autosomal-Recessive Hypomaturation Amelogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MATURATION STAGE AMELOBLASTS; GDP/GTP EXCHANGE PROTEIN; INHERITED ANOMALIES; ENAMEL MATURATION; FAM83H MUTATIONS; TURKISH FAMILIES; CANDIDATE GENES; MOUSE ENAMEL; CLASSIFICATION; MMP20	Healthy dental enamel is the hardest and most highly mineralized human tissue. Though acellular, nonvital, and without capacity for turnover or repair, it can nevertheless last a lifetime. Amelogenesis imperfecta (AI) is a collective term for failure of normal enamel development, covering diverse clinical phenotypes that typically show Mendelian inheritance patterns. One subset, known as hypomaturation AI, is characterised by near-normal volumes of organic enamel matrix but with weak, creamy-brown opaque enamel that fails prematurely after tooth eruption. Mutations in genes critical to enamel matrix formation have been documented, but current understanding of other key events in enamel biomineralization is limited. We investigated autosomal-recessive hypomaturation AI in a consanguineous Pakistani family. A whole-genome SNP autozygosity screen identified a locus on chromosome 15q21.3. Sequencing candidate genes revealed a point mutation in the poorly characterized WDR72 gene. Screening of WDR72 in a panel of nine additional hypomaturation AI families revealed the same mutation in a second, apparently unrelated, Pakistani family and two further nonsense mutations in Omani families. Immunohistochemistry confirmed intracellular localization in maturation-stage ameloblasts. WDR72 function is unknown, but as a putative 0 propeller is expected to be a scaffold for protein-protein interactions. The nearest homolog, WDR7, is involved in vesicle mobilization and Ca2+-dependent exocytosis at synapses. Vesicle trafficking is important in maturation-stage ameloblasts with respect to secretion into immature enamel and removal of cleaved enamel matrix proteins via endocytosis. This raises the intriguing possibility that WDR72 is critical to ameloblast vesicle turnover during enamel maturation.	[El-Sayed, Walid; Parry, David A.; Inglehearn, Chris F.; Mighell, Alan J.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [El-Sayed, Walid; Shore, Roger C.; Kirkham, Jennifer; Mighell, Alan J.] Univ Leeds, Leeds Dent Inst, Leeds LS2 9LU, W Yorkshire, England; [Ahmed, Mushtaq] Leeds Teaching Hosp NHS Trust, Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Jafri, Hussain] Gene Tech Lab, Lahore 54000, Pakistan; [Rashid, Yasmin] King Edward Med Univ, Lahore 54000, Pakistan; [Al-Bahlani, Suhaila] Al Nahda Hosp, Muscat 111, Oman; [Al Harasi, Sharifa] Mil Dent Ctr, Seeb 111, Oman	Saint James's University Hospital; University of Leeds; University of Leeds; Chapel Allerton Hospital; University of Leeds	Mighell, AJ (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	a.j.mighell@leeds.ac.uk	Inglehearn, Chris/GYD-9783-2022; Ahmed, Mushtaq/GSN-9818-2022	Al Harrasi, Sharifa/0000-0002-3010-4367; El-Sayed, walid/0000-0002-6647-516X; Parry, David/0000-0003-0376-7736	Wellcome Trust [082448, 075945] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aldred MJ, 2003, ORAL DIS, V9, P19, DOI 10.1034/j.1601-0825.2003.00843.x; [Anonymous], EUR J ORAL SCI S1; Asaka T, 2009, AM J PATHOL, V174, P91, DOI 10.2353/ajpath.2009.080573; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Bailleul-Forestier I, 2008, EUR J MED GENET, V51, P383, DOI 10.1016/j.ejmg.2008.05.003; Bailleul-Forestier I, 2008, EUR J MED GENET, V51, P273, DOI 10.1016/j.ejmg.2008.02.009; Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; Becerik S, 2009, AM J MED GENET A, V149A, P1392, DOI 10.1002/ajmg.a.32885; Bei M, 2009, J EXP ZOOL PART B, V312B, P437, DOI 10.1002/jez.b.21261; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Coleman WL, 2009, MOL CELL NEUROSCI, V41, P286, DOI 10.1016/j.mcn.2009.03.008; CUISINIER FJG, 1992, CALCIFIED TISSUE INT, V51, P259, DOI 10.1007/BF00334485; ELSAYED W, 2009, CELLS TISSU IN PRESS; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; Hart PS, 2009, CLIN GENET, V75, P401, DOI 10.1111/j.1399-0004.2008.01112.x; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Hobson GM, 2009, AM J MED GENET A, V149A, P1698, DOI 10.1002/ajmg.a.32968; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Gutierrez SJ, 2007, ARCH ORAL BIOL, V52, P503, DOI 10.1016/j.archoralbio.2006.09.014; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Kang HY, 2009, J DENT RES, V88, P266, DOI 10.1177/0022034509333180; Kawabe H, 2003, GENES CELLS, V8, P537, DOI 10.1046/j.1365-2443.2003.00655.x; Kim JW, 2006, EUR J ORAL SCI, V114, P3, DOI 10.1111/j.1600-0722.2006.00278.x; Kim JW, 2008, AM J HUM GENET, V82, P489, DOI 10.1016/j.ajhg.2007.09.020; Kim JW, 2005, J MED GENET, V42, P271, DOI 10.1136/jmg.2004.024505; Kim JW, 2005, J DENT RES, V84, P278, DOI 10.1177/154405910508400314; Kim JW, 2006, EUR J ORAL SCI, V114, P379; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Lee MJ, 2009, ARCH ORAL BIOL, V54, P846, DOI 10.1016/j.archoralbio.2009.05.009; Lee Sook-Kyung, 2008, Hum Mutat, V29, pE95, DOI 10.1002/humu.20789; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; Moffatt P, 2006, BIOCHEM J, V399, P37, DOI 10.1042/BJ20060662; Nagano F, 2002, J BIOL CHEM, V277, P9629, DOI 10.1074/jbc.C100730200; NANCI A, 1992, MINERALIZATION BIOL, P313; Nusier M, 2004, ORAL SURG ORAL MED O, V97, P220, DOI 10.1016/j.tripleo.2003.08.007; Ozdemir D, 2005, J DENT RES, V84, P1031, DOI 10.1177/154405910508401112; Papagerakis P, 2008, J DENT RES, V87, P56, DOI 10.1177/154405910808700109; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Porto IM, 2009, ARCH ORAL BIOL, V54, P313, DOI 10.1016/j.archoralbio.2009.01.007; Ravassipour DB, 2005, ARCH ORAL BIOL, V50, P611, DOI 10.1016/j.archoralbio.2004.12.003; Sakisaka T, 2005, METHOD ENZYMOL, V403, P401, DOI 10.1016/S0076-6879(05)03035-1; Sanders S, 2000, CYTOGENET CELL GENET, V88, P324, DOI 10.1159/000015520; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SMITH CE, 1995, CALCIFIED TISSUE INT, V57, P133, DOI 10.1007/BF00298434; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Stephanopoulos G, 2005, J DENT RES, V84, P1117, DOI 10.1177/154405910508401206; Sui W, 2003, J DENT RES, V82, P388, DOI 10.1177/154405910308200512; SUNDELL S, 1986, COMMUNITY DENT ORAL, V14, P211, DOI 10.1111/j.1600-0528.1986.tb01537.x; Tanimoto K, 2008, J DENT RES, V87, P451, DOI 10.1177/154405910808700516; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tompkins K, 2006, CONNECT TISSUE RES, V47, P111, DOI 10.1080/03008200600727756; Tsuchiya M, 2009, EUR J ORAL SCI, V117, P105, DOI 10.1111/j.1600-0722.2009.00612.x; Valeyev NV, 2008, EVOL BIOINFORM, V4, P203; WARSHAWSKY H, 1974, ANAT RECORD, V179, P423, DOI 10.1002/ar.1091790403; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; WITKOP CJ, 1988, J ORAL PATHOL MED, V17, P547, DOI 10.1111/j.1600-0714.1988.tb01332.x; Wright JT, 2008, AM J MED GENET A, V146A, P343, DOI 10.1002/ajmg.a.32132; Wright JT, 2009, CELLS TISSUES ORGANS, V189, P224, DOI 10.1159/000151378; Zou Y, 2007, BIOCHEM J, V408, P347, DOI 10.1042/BJ20070881	62	98	101	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 13	2009	85	5					699	705		10.1016/j.ajhg.2009.09.014	http://dx.doi.org/10.1016/j.ajhg.2009.09.014			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	521JH	19853237	Green Published, hybrid			2022-12-18	WOS:000271916500016
J	Arnaud-Lopez, L; Usala, G; Ceresini, G; Mitchell, BD; Pilia, MG; Piras, MG; Sestu, N; Maschio, A; Busonero, F; Albai, G; Dei, M; Lai, S; Mulas, A; Crisponi, L; Tanaka, T; Bandinelli, S; Guralnik, JM; Loi, A; Balaci, L; Sole, G; Prinzis, A; Mariotti, S; Shuldiner, AR; Cao, A; Schlessinger, D; Uda, M; Abecasis, GR; Nagaraja, R; Sanna, S; Naitza, S				Arnaud-Lopez, Lisette; Usala, Gianluca; Ceresini, Graziano; Mitchell, Braxton D.; Pilia, Maria Grazia; Piras, Maria Grazia; Sestu, Natascia; Maschio, Andrea; Busonero, Fabio; Albai, Giuseppe; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Crisponi, Laura; Tanaka, Toshiko; Bandinelli, Stefania; Guralnik, Jack M.; Loi, Angela; Balaci, Lenuta; Sole, Gabriella; Prinzis, Alessia; Mariotti, Stefano; Shuldiner, Alan R.; Cao, Antonio; Schlessinger, David; Uda, Manuela; Abecasis, Goncalo R.; Nagaraja, Ramaiah; Sanna, Serena; Naitza, Silvia			Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLD ORDER AMISH; CAMP-SPECIFIC PHOSPHODIESTERASE; GENOME-WIDE ASSOCIATION; THYROTROPIN RECEPTOR; FEEDBACK-REGULATION; HORMONE; LINKAGE; MUTATIONS; PITUITARY; DISEASE	Thyroid-stimulating hormone (TSH) controls thyroid growth and hormone secretion through binding to its G protein-coupled receptor (TSHR) and production of cyclic AMP (cAMP). Serum TSH is a sensitive indicator of thyroid function, and overt abnormalities in thyroid function lead to common endocrine disorders affecting similar to 10% of individuals over a life span. By genotyping 362,129 SNPs in 4,300 Sardinians, we identified a strong association (p = 1.3 x 10(-11)) between alleles of rs4704397 and circulating TSH levels; each additional copy of the minor A allele was associated with an increase of 0.13 mu IU/ml in TSH. The single-nucleotide polymorphism (SNP) is located in intron 1 of PDE8B, encoding a high-affinity cAMP-specific phosphodiesterase. The association was replicated in 4,158 individuals, including additional Sardinians and two genetically distant cohorts from Tuscany and the Old Order Amish (overall p value = 1.9 x 10(-20)). In addition to association of TSH levels with SNPs in PDE8B, our genome scan provided evidence for association with PDE10A and several biologically interesting candidates in a focused analysis of 24 genes. In particular, we found evidence for association of TSH levels with SNPs in the THRB (rs1505287, p = 7.3 x 10(-5)), GNAQ (rs10512065, p = 2.0 x 10(-4)), TG (rs2252696, p = 2.2 x 10(-3)), POU1F1 (rs1976324, p = 3.9 x 10(-3)), PDE4D (rs27178, p = 8.3 x 10(-3)), and TSHR (rs4903957, p = 8.6 x 10(-3)) loci. Overall, the results suggest a primary effect of PDE8B variants on cAMP levels in the thyroid. This would affect production of T4 and T3 and feedback to alter TSH release by the pituitary. PDE8B may thus provide a candidate target for the treatment of thyroid dysfunction.	[Usala, Gianluca; Pilia, Maria Grazia; Piras, Maria Grazia; Sestu, Natascia; Maschio, Andrea; Busonero, Fabio; Albai, Giuseppe; Dei, Mariano; Lai, Sandra; Mulas, Antonella; Crisponi, Laura; Loi, Angela; Balaci, Lenuta; Sole, Gabriella; Cao, Antonio; Uda, Manuela; Sanna, Serena; Naitza, Silvia] CNR, Ist Neurogenet & Neurofarmacol, I-09042 Cagliari, Italy; [Ceresini, Graziano] Univ Parma, Dept Internal Med, Sect Geriatr, I-43100 Parma, Italy; [Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Tanaka, Toshiko] NIA, Clin Res Branch, Baltimore, MD 21225 USA; [Bandinelli, Stefania] ASF, Geriatr Rehabil Unit, I-50125 Florence, Italy; [Guralnik, Jack M.] NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Prinzis, Alessia; Mariotti, Stefano] Univ Cagliari, Dept Med Sci M Aresu, I-09042 Cagliari, Italy; [Shuldiner, Alan R.] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD 21201 USA; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Arnaud-Lopez, Lisette; Schlessinger, David; Nagaraja, Ramaiah] NIA, Genet Lab, Baltimore, MD 21224 USA	Consiglio Nazionale delle Ricerche (CNR); University of Parma; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Cagliari; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Naitza, S (corresponding author), CNR, Ist Neurogenet & Neurofarmacol, I-09042 Cagliari, Italy.	silvia.naitza@inn.cnr.it	Mulas, Antonella/B-4231-2015; Piras, Maria Grazia/P-2061-2018; Uda, Manuela/AAC-2645-2019; Abecasis, Goncalo R/B-7840-2010; Mariotti, Stefano/AAN-1948-2020; Sole, Gabriella/I-4820-2013; Maschio, Andrea/AAX-8185-2020; NAITZA, SILVIA/AAB-8775-2022; Crisponi, Laura/AAC-2642-2019; Dei, Mariano/AAY-3870-2020; sanna, serena/H-3009-2019; Lai, Sandra/AAY-4176-2020; bandinelli, stefania/AAL-4570-2020; Mitchell, Braxton/CAF-0876-2022; Naitza, Silvia/D-5620-2017	Piras, Maria Grazia/0000-0001-9004-0900; Uda, Manuela/0000-0002-4890-6456; Sole, Gabriella/0000-0001-5292-5038; NAITZA, SILVIA/0000-0002-0108-757X; Crisponi, Laura/0000-0001-9128-8537; sanna, serena/0000-0002-3768-1749; maschio, andrea/0000-0002-4238-9144; LAI, SANDRA/0000-0003-4198-9989; Dei, Mariano/0000-0002-7404-508X; Abecasis, Goncalo/0000-0003-1509-1825; Mulas, Antonella/0000-0002-6856-1483; Mitchell, Braxton/0000-0003-4920-4744; Shuldiner, Alan/0000-0001-9921-4305	Intramural NIH HHS Funding Source: Medline; NCRR NIH HHS [M01 RR016500, M01 RR 000052, M01 RR000052] Funding Source: Medline; NHGRI NIH HHS [R01 HG002651, HG002651] Funding Source: Medline; NHLBI NIH HHS [U01 HL72515, U01 HL084729, U01 HL072515, HL084729] Funding Source: Medline; NIA NIH HHS [N01-AG-916413, N01-AG-821336, R01 AG18728, N01-AG-1-2109, R01 AG018728] Funding Source: Medline; NIMHD NIH HHS [263 MD 821336, R01 MD009164, 263 MD 916413] Funding Source: Medline; PHS HHS [263-MA-410953] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084729, U01HL072515] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG001050, R01AG018728, ZIAAG000675] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Allen EM, 2003, J CLIN ENDOCR METAB, V88, P1292, DOI 10.1210/jc.2002-020634; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Barnett P, 2003, ENDOCRINE, V20, P255, DOI 10.1385/ENDO:20:3:255; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; DAHL GE, 1994, ENDOCRINOLOGY, V135, P2392, DOI 10.1210/en.135.6.2392; Damcott CM, 2005, DIABETES, V54, P2245, DOI 10.2337/diabetes.54.7.2245; Dastidar SG, 2007, CURR OPIN INVEST DR, V8, P364; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; Dov A, 2008, ENDOCRINOLOGY, V149, P741, DOI 10.1210/en.2007-0968; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Hayashi M, 2002, BIOCHEM BIOPH RES CO, V297, P1253, DOI 10.1016/S0006-291X(02)02371-9; Hayashi M, 1998, BIOCHEM BIOPH RES CO, V250, P751, DOI 10.1006/bbrc.1998.9379; Hetman JM, 2000, P NATL ACAD SCI USA, V97, P472, DOI 10.1073/pnas.97.1.472; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Jacobson EM, 2007, THYROID, V17, P949, DOI 10.1089/thy.2007.0153; Kero J, 2007, J CLIN INVEST, V117, P2399, DOI 10.1172/JCI30380; KOPP P, 2005, FUNDAMENTAL CLIN TEX, P52; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LARSEN PR, 1982, NEW ENGL J MED, V306, P23; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Mitchell BD, 2008, AM HEART J, V155, P823, DOI 10.1016/j.ahj.2008.01.019; Oki N, 2000, J BIOL CHEM, V275, P10831, DOI 10.1074/jbc.275.15.10831; Perez-Torres S, 2003, EXP NEUROL, V182, P322, DOI 10.1016/S0014-4886(03)00042-6; Persani L, 2001, J CLIN ENDOCR METAB, V86, P3795, DOI 10.1210/jc.86.8.3795; Persani L, 2000, J CLIN ENDOCR METAB, V85, P2872, DOI 10.1210/jc.85.8.2872; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shumway-Cook A, 2007, J AM GERIATR SOC, V55, P58, DOI 10.1111/j.1532-5415.2006.00962.x; Sorkin J, 2005, MECH AGEING DEV, V126, P347, DOI 10.1016/j.mad.2004.08.027; Tonacchera M, 2004, J CLIN ENDOCR METAB, V89, P5787, DOI 10.1210/jc.2004-1243; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	47	98	100	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1270	1280		10.1016/j.ajhg.2008.04.019	http://dx.doi.org/10.1016/j.ajhg.2008.04.019			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18514160	Bronze, Green Published			2022-12-18	WOS:000256647000005
J	Benito-Sanz, S; Thomas, NS; Huber, C; del Blanco, DG; Aza-Carmona, M; Crolla, JA; Maloney, V; Argente, J; Campos-Barros, A; Cormier-Daire, V; Heath, KE				Benito-Sanz, S; Thomas, NS; Huber, C; del Blanco, DG; Aza-Carmona, M; Crolla, JA; Maloney, V; Argente, J; Campos-Barros, A; Cormier-Daire, V; Heath, KE			A novel class of pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SHORT STATURE HOMEOBOX; GENE SHOX; TURNER-SYNDROME; GROWTH FAILURE; DNA; IDENTIFICATION; RECOMBINATION; HETEROGENEITY; MUTATIONS	Leri-Weill dyschondrosteosis (LWD) is a pseudoautosomal dominant disorder characterized by disproportionate short stature and a characteristic curving of the radius, known as the "Madelung deformity." SHOX mutations resulting in SHOX haploinsufficiency have been found in LWD and in a variable proportion of patients with idiopathic short stature (ISS), whereas homozygous loss of SHOX results in the more severe Langer mesomelic dysplasia (LMD). Defects in SHOX have been identified in similar to 60% of LWD cases, whereas, in the remaining similar to 40%, the molecular basis is unknown. This suggests either genetic heterogeneity or the presence of mutations in unanalyzed regions of SHOX, such as the upstream, intragenic, or downstream regulatory sequences. Therefore, the pseudoautosomal region 1 (PAR1) of 80 patients with LWD, in whom SHOX deletions and mutations had been excluded, was screened for deletions by use of a new panel of microsatellite markers. We identified 12 patients with LWD who presented with a novel class of PAR1 deletions that did not include SHOX. The deletions were of variable size and mapped at least similar to 30-530 kb downstream of SHOX. In our cohort, this type of deletion accounted for 15% of cases. In all cases, the deletions cosegregated with the phenotype. No apparent phenotypic differences were observed between patients with SHOX deletions and those with this new class of PAR1 deletions. Thus, we present here the identification of a second PAR1 region implicated in the etiopathogenesis of MD. Our findings suggest the presence of distal regulatory elements of SHOX transcription in PAR1 or, alternatively, the existence of an additional locus apparently involved in the control of skeletal development. Deletion analysis of this newly identified region should be included in the mutation screening of patients with LWD, LMD, and ISS.	Univ Autonoma Madrid, Dept Endocrinol, Hosp Infantil Univ Nino Jesus, Madrid, Spain; Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury, Wilts, England; Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England; Hop Necker Enfants Malad, Dept Genet, Paris, France; Hop Necker Enfants Malad, INSERM, UMR393, Paris, France	Autonomous University of Madrid; Salisbury District Hospital; Salisbury District Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benito-Sanz, S (corresponding author), Hosp Infantil Univ Nino Jesus, Serv Endocrinol, Avenida Menendez Pelayo 65, Madrid 28009, Spain.	karen.heath@uam.es	Heath, K. E./ABG-4658-2020; Argente, Jesús/M-5226-2019; Argente, Jesús/K-1167-2014; Heath, Karen Elise/K-7760-2014; Barros, Angel Campos/E-6427-2018; del Blanco, Darya Gorbenko/N-6069-2018; cormier-daire, valerie/H-6520-2017	Heath, K. E./0000-0002-5816-7044; Argente, Jesús/0000-0001-5826-0276; Argente, Jesús/0000-0001-5826-0276; Heath, Karen Elise/0000-0002-5816-7044; Barros, Angel Campos/0000-0003-4649-2971; del Blanco, Darya Gorbenko/0000-0002-9674-2388; BENITO-SANZ, SARA/0000-0002-6101-9413; Aza-Carmona, Miriam/0000-0003-4448-9541; cormier-daire, valerie/0000-0002-2839-9856; huber, celine/0000-0002-8601-9655				Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Binder G, 2000, J CLIN ENDOCR METAB, V85, P245, DOI 10.1210/jc.85.1.245; Blaschke RJ, 2003, J BIOL CHEM, V278, P47820, DOI 10.1074/jbc.M306685200; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Falcinelli C, 2002, J Med Genet, V39, pE33, DOI 10.1136/jmg.39.6.e33; Flanagan SF, 2002, J MED GENET, V39, P758, DOI 10.1136/jmg.39.10.758; Grigelioniene G, 2001, HUM GENET, V109, P551, DOI 10.1007/s00439-001-0609-y; HUBER C, 2004, 54 ANN M AM SOC HUM; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; Marchini A, 2004, J BIOL CHEM, V279, P37103, DOI 10.1074/jbc.M307006200; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; NICOLAIDES NC, 1990, BIOTECHNIQUES, V8, P154; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Rappold GA, 2002, J CLIN ENDOCR METAB, V87, P1402, DOI 10.1210/jc.87.3.1402; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Schiller S, 2000, EUR J HUM GENET, V8, P54, DOI 10.1038/sj.ejhg.5200402; Schneider KU, 2005, AM J HUM GENET, V77, P89, DOI 10.1086/431655; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stuppia L, 2003, J Med Genet, V40, pE11, DOI 10.1136/jmg.40.2.e11	26	98	101	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					533	544		10.1086/449313	http://dx.doi.org/10.1086/449313			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175500	Green Published, Bronze			2022-12-18	WOS:000232106900002
J	Dong, CH; Li, WD; Geller, F; Lei, L; Li, D; Gorlova, OY; Hebebrand, J; Amos, CI; Nicholls, RD; Price, RA				Dong, CH; Li, WD; Geller, F; Lei, L; Li, D; Gorlova, OY; Hebebrand, J; Amos, CI; Nicholls, RD; Price, RA			Possible genomic imprinting of three human obesity-related genetic loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VARIANCE-COMPONENTS APPROACH; BODY-MASS INDEX; LINKAGE ANALYSIS; WIDE SCAN; INHERITANCE; FAMILIES; REVEALS; WEIGHT; TWINS; MAPS	To detect potentially imprinted, obesity-related genetic loci, we performed genomewide parent-of-origin linkage analyses under an allele-sharing model for discrete traits and under a family regression model for obesity-related quantitative traits, using a European American sample of 1,297 individuals from 260 families, with 391 microsatellite markers. We also used two smaller, independent samples for replication ( a sample of 370 German individuals from 89 families and a sample of 277 African American individuals from 52 families). For discrete-trait analysis, we found evidence for a maternal effect in chromosome region 10p12 across the three samples, with LOD scores of 5.69 (single-point) and 4.52 (multipoint) for the pooled sample. For quantitative-trait analysis, we found the strongest evidence for a maternal effect (single-point LOD of 2.85; multipoint LOD of 4.01 for body mass index [BMI] and 3.69 for waist circumference) in region 12q24 and for a paternal effect (single-point LOD of 4.79; multipoint LOD of 3.72 for BMI) in region 13q32, in the European American sample. The results suggest that parent-of-origin effects, perhaps including genomic imprinting, may play a role in human obesity.	Univ Penn, Ctr Neurobiol & Behav, Dept Psychiat, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Marburg, Dept Child & Adolescent Psychiat, Clin Res Grp, Marburg, Germany; Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Texas System; UTMD Anderson Cancer Center; Philipps University Marburg; Philipps University Marburg	Price, RA (corresponding author), Univ Penn, Ctr Neurobiol & Behav, Dept Psychiat, 415 Curie Blvd,CRB-105, Philadelphia, PA 19104 USA.	arlen@bgl.psycha.upenn.edu		Geller, Frank/0000-0002-9238-3269; Li, Wei-Dong/0000-0003-0521-7412; Li, Ding/0000-0003-1064-1656	NHGRI NIH HHS [HG02275, R01 HG002275] Funding Source: Medline; NIDDK NIH HHS [R01 DK044073, R01DK56210, R01 DK056210, R01DK44073, R01DK48095] Funding Source: Medline; NIEHS NIH HHS [ES09912, R01 ES009912] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048095, R01DK044073, R01DK056210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009912] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMOS CI, 1994, AM J HUM GENET, V54, P535; Boutin P, 2003, PLOS BIOL, V1, P361, DOI 10.1371/journal.pbio.0000068; Carroll KK, 1998, LIPIDS, V33, P1055, DOI 10.1007/s11745-998-0305-8; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Gorlova OY, 2003, EUR J HUM GENET, V11, P425, DOI 10.1038/sj.ejhg.5200979; Greally JM, 2002, P NATL ACAD SCI USA, V99, P327, DOI 10.1073/pnas.012539199; GRILO CM, 1991, PSYCHOL BULL, V110, P520; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hinney A, 2000, J CLIN ENDOCR METAB, V85, P2962, DOI 10.1210/jc.85.8.2962; Hsueh WC, 2001, J CLIN ENDOCR METAB, V86, P1199, DOI 10.1210/jc.86.3.1199; Itier JM, 1998, NATURE, V393, P125, DOI 10.1038/30120; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Kato MV, 1998, GENOMICS, V47, P146, DOI 10.1006/geno.1997.5089; Keverne EB, 2001, HORM BEHAV, V40, P146, DOI 10.1006/hbeh.2001.1685; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lalande M, 2001, J CLIN INVEST, V107, P793, DOI 10.1172/JCI12645; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Li WD, 2004, DIABETES, V53, P812, DOI 10.2337/diabetes.53.3.812; Li WD, 2003, DIABETES, V52, P1557, DOI 10.2337/diabetes.52.6.1557; Lindsay RS, 2002, HUM GENET, V110, P503, DOI 10.1007/s00439-002-0718-2; Lindsay RS, 2001, DIABETES, V50, P2850, DOI 10.2337/diabetes.50.12.2850; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nicholls RD, 2000, J CLIN INVEST, V105, P413, DOI 10.1172/JCI9460; Okita C, 2003, GENOMICS, V81, P556, DOI 10.1016/S0888-7543(03)00052-1; PRICE RA, 1991, BEHAV GENET, V21, P1, DOI 10.1007/BF01067662; Price RA, 1998, INT J OBESITY, V22, P406, DOI 10.1038/sj.ijo.0800601; PRICE RA, 2001, OBESITY THEORY THERA; Prichard BNC, 2001, BLOOD PRESSURE, V10, P366, DOI 10.1080/080370501753400665; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Shete S, 2002, AM J HUM GENET, V70, P751, DOI 10.1086/338931; Shmulewitz D, 2000, HUM HERED, V51, P8; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262; Snyder EE, 2004, OBES RES, V12, P369, DOI 10.1038/oby.2004.47; SORENSEN TIA, 1989, BRIT MED J, V298, P87, DOI 10.1136/bmj.298.6666.87; Struycken PM, 1997, CLIN OTOLARYNGOL, V22, P71, DOI 10.1046/j.1365-2273.1997.00884.x; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664	45	98	99	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					427	437		10.1086/428438	http://dx.doi.org/10.1086/428438			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15647995	Bronze, Green Published			2022-12-18	WOS:000226851900006
J	Holmans, P; Zubenko, GS; Crowe, RR; DePaulo, JR; Scheftner, WA; Weissman, MM; Zubenko, WN; Boutelle, S; Murphy-Eberenz, K; MacKinnon, D; McInnis, MG; Marta, DH; Adams, P; Knowles, JA; Gladis, M; Thomas, J; Chellis, J; Miller, E; Levinson, DF				Holmans, P; Zubenko, GS; Crowe, RR; DePaulo, JR; Scheftner, WA; Weissman, MM; Zubenko, WN; Boutelle, S; Murphy-Eberenz, K; MacKinnon, D; McInnis, MG; Marta, DH; Adams, P; Knowles, JA; Gladis, M; Thomas, J; Chellis, J; Miller, E; Levinson, DF			Genomewide significant linkage to recurrent, early-onset major depressive disorder on chromosome 15q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC SEGREGATION ANALYSIS; BIPOLAR-II; CLINICAL CHARACTERISTICS; PSYCHIATRIC-DISORDERS; COMPLEX TRAITS; DIAGNOSTIC INTERVIEW; FAMILY HISTORY; PANIC DISORDER; PERSONALITY; UNIPOLAR	A genome scan was performed on the first phase sample of the Genetics of Recurrent Early-Onset Depression (GenRED) project. The sample consisted of 297 informative families containing 415 independent affected sibling pairs (ASPs), or, counting all possible pairs, 685 informative affected relative pairs ( 555 ASPs and 130 other pair types). Affected cases had recurrent major depressive disorder (MDD) with onset before age 31 years for probands or age 41 years for other affected relatives; the mean age at onset was 18.5 years, and the mean number of depressive episodes was 7.3. The Center for Inherited Disease Research genotyped 389 microsatellite markers ( mean spacing of 9.3 cM). The primary linkage analysis considered allele sharing in all possible affected relative pairs with the use of the Z(lr) statistic computed by the ALLEGRO program. A secondary logistic regression analysis considered the effect of the sex of the pair as a covariate. Genomewide significant linkage was observed on chromosome 15q25.3-26.2 (Z(lr)=4.14, equivalent LOD=3.73, empirical genomewide P=.023). The linkage was not sex specific. No other suggestive or significant results were observed in the primary analysis. The secondary analysis produced three regions of suggestive linkage, but these results should be interpreted cautiously because they depended primarily on the small subsample of 42 male-male pairs. Chromosome 15q25.3-26.2 deserves further study as a candidate region for susceptibility to MDD.	Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; Cardiff Univ, Biostat & Bioinformat Unit, Cardiff CF4 4XN, S Glam, Wales; MRC, Biostat Unit, Cambridge CB2 2BW, England; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Mental Hlth CRC, Iowa City, IA USA; Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA; Rush Univ, Med Ctr, Dept Psychiat, Chicago, IL 60612 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Univ Penn, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	University of Pennsylvania; Cardiff University; MRC Biostatistics Unit; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; Johns Hopkins University; Rush University; Columbia University; New York State Psychiatry Institute; University of Pennsylvania; Pennsylvania Medicine	Levinson, DF (corresponding author), Univ Penn, Sch Med, Dept Psychiat, 3535 Market St,Room 4006, Philadelphia, PA 19104 USA.	DFL@mail.med.upenn.edu	Holmans, Peter/F-4518-2015; McInnis, Melvin G/F-6963-2012; MacKinnon, Dean/AAG-6232-2020	Holmans, Peter/0000-0003-0870-9412; McInnis, Melvin G/0000-0002-0375-6247; Weissman, Myrna/0000-0003-3490-3075; DePaulo, J Raymond/0000-0001-9221-9226	Medical Research Council [G9810900, G9309834] Funding Source: Medline; NIMH NIH HHS [5R01MH060866, R01 MH059541, 5R01MH059542, R01 MH061686, 5R01MH060912, 5R01MH061686, 5R01MH059552-04, R01 MH060912, R01 MH059552, R01 MH059542, 5R01MH059541] Funding Source: Medline; MRC [G9810900, G9309834] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060912, R01MH059541, R01MH061686, R01MH060866, R01MH059542, R01MH059552] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abkevich V, 2003, AM J HUM GENET, V73, P1271, DOI 10.1086/379978; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Bierut LJ, 1999, ARCH GEN PSYCHIAT, V56, P557, DOI 10.1001/archpsyc.56.6.557; BLAND RC, 1986, ARCH GEN PSYCHIAT, V43, P1085; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; CADORET RJ, 1978, AM J PSYCHIAT, V135, P463; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103; CORYELL W, 1985, AM J PSYCHIAT, V142, P817; CORYELL W, 1985, J AFFECT DISORDERS, V9, P13, DOI 10.1016/0165-0327(85)90004-7; Costa P T Jr, 1986, Psychol Aging, V1, P144, DOI 10.1037/0882-7974.1.2.144; COSTA PT, 1988, J PERS SOC PSYCHOL, V54, P853, DOI 10.1037/0022-3514.54.5.853; COX N, 1989, J PSYCHIAT RES, V23, P109, DOI 10.1016/0022-3956(89)90002-2; CRADDOCK N, 1994, BRIT J PSYCHIAT, V165, P272, DOI 10.1192/bjp.165.2.272a; DAWSON E, 1995, AM J MED GENET, V60, P94, DOI 10.1002/ajmg.1320600203; Douglas JA, 2000, AM J HUM GENET, V66, P1287, DOI 10.1086/302861; Duggan C, 1995, J AFFECT DISORDERS, V35, P139, DOI 10.1016/0165-0327(95)00062-3; ENDICOTT J, 1985, J AFFECT DISORDERS, V8, P17, DOI 10.1016/0165-0327(85)90068-0; Enns MW, 1997, CAN J PSYCHIAT, V42, P274, DOI 10.1177/070674379704200305; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Fava M, 1996, AM J PSYCHIAT, V153, P1308; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; GERSHON ES, 1986, J AFFECT DISORDERS, V11, P125, DOI 10.1016/0165-0327(86)90018-2; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; GUDBJARTSSON DF, 2000, FAST MULTIPOINT LINK; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HEUN R, 1993, ACTA PSYCHIAT SCAND, V87, P279, DOI 10.1111/j.1600-0447.1993.tb03372.x; Holmans P, 2002, HUM HERED, V53, P92, DOI 10.1159/000057987; Jones I, 2002, MOL PSYCHIATR, V7, P424, DOI 10.1038/sj.mp.4000989; Kendler KS, 1999, ARCH GEN PSYCHIAT, V56, P39, DOI 10.1001/archpsyc.56.1.39; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; KENDLER KS, 1994, BRIT J PSYCHIAT, V165, P66, DOI 10.1192/bjp.165.1.66; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P863; Kendler KS, 1999, ARCH GEN PSYCHIAT, V56, P322, DOI 10.1001/archpsyc.56.4.322; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Kessler R C, 1998, Depress Anxiety, V7, P3, DOI 10.1002/(SICI)1520-6394(1998)7:1<3::AID-DA2>3.0.CO;2-F; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KLEIN DN, 1994, AM J PSYCHIAT, V151, P1043; KLERMAN GL, 1989, JAMA-J AM MED ASSOC, V261, P2229, DOI 10.1001/jama.261.15.2229; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KUPFER DJ, 1989, J AFFECT DISORDERS, V17, P113, DOI 10.1016/0165-0327(89)90033-5; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEBOYER M, 1991, EUR ARCH PSY CLIN N, V241, P165, DOI 10.1007/BF02219716; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Levinson DF, 2003, AM J MED GENET B, V119B, P118, DOI 10.1002/ajmg.b.20009; LEWINSOHN PM, 1993, J ABNORM PSYCHOL, V102, P110, DOI 10.1037/0021-843X.102.1.110; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Lyons MJ, 1998, ARCH GEN PSYCHIAT, V55, P468, DOI 10.1001/archpsyc.55.5.468; Maher BS, 2002, AM J MED GENET, V114, P214, DOI 10.1002/ajmg.10158; MAIER W, 1992, AM J PSYCHIAT, V149, P1666; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; Marazita ML, 1997, AM J HUM GENET, V61, P1370, DOI 10.1086/301627; McCrae, 1992, REVISED NEO PERSONAL; McGuffin P, 1996, ARCH GEN PSYCHIAT, V53, P129; MCGUFFIN P, 1987, J PSYCHIAT RES, V21, P365, DOI 10.1016/0022-3956(87)90083-5; MENDLEWICZ J, 1977, NATURE, V268, P327, DOI 10.1038/268327a0; MENDLEWICZ J, 1981, BRIT J PSYCHIAT, V139, P463, DOI 10.1192/bjp.139.5.463; Merikangas KR, 2002, BIOL PSYCHIAT, V52, P457, DOI 10.1016/S0006-3223(02)01471-3; MOLDIN SO, 1991, BEHAV GENET, V21, P211, DOI 10.1007/BF01065817; Morissette J, 1999, AM J MED GENET, V88, P567, DOI 10.1002/(SICI)1096-8628(19991015)88:5<567::AID-AJMG24>3.0.CO;2-8; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Olson JM, 1999, AM J HUM GENET, V65, P1760, DOI 10.1086/302662; PRICE RA, 1987, ARCH GEN PSYCHIAT, V44, P434; RICE JP, 1986, PSYCHIAT RES, V19, P285, DOI 10.1016/0165-1781(86)90121-6; Rice JP, 1997, AM J MED GENET, V74, P112, DOI 10.1002/(SICI)1096-8628(19970221)74:1<112::AID-AJMG22>3.0.CO;2-T; RISCH N, 1990, AM J HUM GENET, V46, P222; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Schneider B, 2001, J AFFECT DISORDERS, V65, P263, DOI 10.1016/S0165-0327(00)00290-1; SIMON GE, 1993, J PSYCHIAT RES, V27, P247, DOI 10.1016/0022-3956(93)90035-Z; SIMPSON SG, 1993, AM J PSYCHIAT, V150, P901; Simpson SG, 2002, ARCH GEN PSYCHIAT, V59, P736, DOI 10.1001/archpsyc.59.8.736; SOBIN C, 1993, PSYCHIATR GENET, V3, P227, DOI 10.1097/00041444-199324000-00005; Spitzer R.L., 1975, SCHEDULE AFFECTIVE D; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STANCER HC, 1987, J PSYCHIAT RES, V21, P37, DOI 10.1016/0022-3956(87)90007-0; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; THAPAR A, 1994, BRIT J PSYCHIAT, V165, P259, DOI 10.1192/bjp.165.2.259; TSUANG MT, 1994, GENETIC STUDIES AFFE; WEISSMAN MM, 1993, ARCH GEN PSYCHIAT, V50, P767; WEISSMAN MM, 1986, ARCH GEN PSYCHIAT, V43, P430; WEISSMAN MM, 1987, ARCH GEN PSYCHIAT, V44, P847; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; WEISSMAN MM, 1984, ARCH GEN PSYCHIAT, V41, P13; WEISSMAN MM, 1982, ARCH GEN PSYCHIAT, V39, P1397; WENDER PH, 1986, ARCH GEN PSYCHIAT, V43, P923; *WHO, 1996, GLOB BURD DIS; Wickramaratne PJ, 1998, J AM ACAD CHILD PSY, V37, P933, DOI 10.1097/00004583-199809000-00013; Zubenko GS, 2002, AM J MED GENET, V114, P980, DOI 10.1002/ajmg.b.10933; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	96	98	102	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1154	1167		10.1086/421333	http://dx.doi.org/10.1086/421333			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	823ZB	15108123	Green Published, Bronze			2022-12-18	WOS:000221651900008
